PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lines, J; Kleinschmidt, I				Lines, Jo; Kleinschmidt, Immo			Is malaria control better with both treated nets and spraying?	LANCET			English	Editorial Material							VECTOR CONTROL INTERVENTIONS; BED NETS; COMBINATION; RESISTANCE		[Lines, Jo; Kleinschmidt, Immo] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Lines, J (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	jo.lines@lshtm.ac.uk		Lines, Jo/0000-0001-5380-4916	Medical Research Council [MR/K012126/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		[Anonymous], 2014, WHO GUID COUNTR COMB; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Hamel MJ, 2011, AM J TROP MED HYG, V85, P1080, DOI 10.4269/ajtmh.2011.10-0684; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Knox TB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-76; Lines J, 2013, PATHOG GLOB HEALTH, V107, P1, DOI 10.1179/2047772413Z.000000000104; Pinder M, 2014, LANCET; Protopopoff N, 2008, AM J TROP MED HYG, V79, P12, DOI 10.4269/ajtmh.2008.79.12; Quinones ML, 1998, T ROY SOC TROP MED H, V92, P373, DOI 10.1016/S0035-9203(98)91053-7; West PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001630; WHO, 2013, WORLD MALARIA REPORT 2013, P1	13	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1375	1377		10.1016/S0140-6736(14)61306-4	http://dx.doi.org/10.1016/S0140-6736(14)61306-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF7EU	25498846				2022-12-28	WOS:000352719800009
J	Garcia, V; Gray, S; Allison, RM; Cooper, TJ; Neale, MJ				Garcia, Valerie; Gray, Stephen; Allison, Rachal M.; Cooper, Tim J.; Neale, Matthew J.			Tel1(ATM)-mediated interference suppresses clustered meiotic double-strand-break formation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; RECOMBINATION; REPAIR; YEAST; RESPONSES; MUTANTS; HOMOLOG; ATM	Meiotic recombination is a critical step in gametogenesis for many organisms, enabling the creation of genetically diverse haploid gametes. In each meiotic cell, recombination is initiated by numerous DNA double-strand breaks (DSBs) created by Spo11, the evolutionarily conserved topoisomerase-like protein(1), but how these DSBs are distributed relatively uniformly across the four chromatids that make up each chromosome pair is poorly understood. Here we employ Saccharomyces cerevisiae to demonstrate distance-dependent DSB interference in cis (in which the occurrence of a DSB suppresses adjacent DSB formation)-a process that is mediated by the conserved DNA damage response kinase, Tel1(ATM). The inhibitory function of Tel1 acts on a relatively local scale, while over large distances DSBs have a tendency to form independently of one another even in the presence of Tel1. Notably, over very short distances, loss of Tel1 activity causes DSBs to cluster within discrete zones of concerted DSB activity. Our observations support a hierarchical view of recombination initiation where Tel1(ATM) prevents clusters of DSBs, and further suppresses DSBs within the surrounding chromosomal region. Such collective negative regulation will help to ensure that recombination events are dispersed evenly and arranged optimally for genetic exchange and efficient chromosome segregation.	[Garcia, Valerie; Gray, Stephen; Allison, Rachal M.; Cooper, Tim J.; Neale, Matthew J.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Garcia, V (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	v.garcia@sussex.ac.uk; m.neale@sussex.ac.uk	Garcia, Valerie/R-4543-2016	Garcia, Valerie/0000-0002-4941-0989; Gray, Stephen/0000-0003-1483-560X; Neale, Matthew/0000-0002-6453-1877	MRC New Investigator Grant; University Research Fellowship from the Royal Society; Career Development Award from the Human Frontiers Science Program Organisation; Consolidator Grant from the European Research Council; Biotechnology and Biological Sciences Research Council [BB/M010279/1] Funding Source: researchfish; Medical Research Council [G0800005] Funding Source: researchfish; BBSRC [BB/M010279/1] Funding Source: UKRI; MRC [G0800005] Funding Source: UKRI	MRC New Investigator Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University Research Fellowship from the Royal Society(Royal Society of London); Career Development Award from the Human Frontiers Science Program Organisation; Consolidator Grant from the European Research Council; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	V.G. was supported by an MRC New Investigator Grant to M.J.N. M.J.N. is supported by a University Research Fellowship from the Royal Society, a Career Development Award from the Human Frontiers Science Program Organisation, and a Consolidator Grant from the European Research Council. We thank S. Keeney and N. Mohibullah for sharing unpublished observations.	Argunhan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065875; Barchi M, 2005, MOL CELL BIOL, V25, P7203, DOI 10.1128/MCB.25.16.7203-7215.2005; Barchi M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000076; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Blitzblau HG, 2013, ELIFE, V2, DOI 10.7554/eLife.00844; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Carballo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003545; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Gray S, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130019; Joyce EF, 2011, J CELL BIOL, V195, P359, DOI 10.1083/jcb.201104121; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; Kumar R, 2010, GENE DEV, V24, P1266, DOI 10.1101/gad.571710; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; McKee AHZ, 1997, GENETICS, V146, P797; Murakami H, 2009, METHODS MOL BIOL, V557, P117, DOI 10.1007/978-1-59745-527-5_9; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Prinz S, 1997, GENETICS, V146, P781; Steinel NC, 2013, J EXP MED, V210, P233, DOI 10.1084/jem.20121605; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Thacker D, 2014, NATURE, V510, P241, DOI 10.1038/nature13120; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Westmoreland J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000656; Zhang LR, 2011, P NATL ACAD SCI USA, V108, P20036, DOI 10.1073/pnas.1117937108	28	75	75	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					114	U277		10.1038/nature13993	http://dx.doi.org/10.1038/nature13993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25539084	Green Accepted			2022-12-28	WOS:000352027700048
J	Sharfstein, J				Sharfstein, Joshua			FDA Regulation of Laboratory-Developed Diagnostic Tests Protect the Public, Advance the Science	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Dept Hlth & Mental Hyg, Baltimore, MD 21201 USA	Maryland Department of Health & Mental Hygiene	Sharfstein, J (corresponding author), Dept Hlth & Mental Hyg, 201 W Preston St, Baltimore, MD 21201 USA.	joshua.sharfstein@maryland.gov						Carpenter D, 2010, PRINC STUD AM POLIT, P1; Nelson C, 2014, MMWR-MORBID MORTAL W, V63, P333; Topol EJ, 2010, J AM COLL CARDIOL, V56, P1564, DOI 10.1016/j.jacc.2010.06.023; US Food and Drug Administration(FDA), LABORATORY DEVELOPED; US Food and Drug Administration (FDA), 2014, DRAFT GUIDANCE FOR I	5	28	30	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2015	313	7					667	668		10.1001/jama.2014.18135	http://dx.doi.org/10.1001/jama.2014.18135			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB2RQ	25560381				2022-12-28	WOS:000349476100008
J	Boj, SF; Hwang, CI; Baker, LA; Chio, IIC; Engle, DD; Corbo, V; Jager, M; Ponz-Sarvise, M; Tiriac, H; Spector, MS; Gracanin, A; Oni, T; Yu, KH; van Boxtel, R; Huch, M; Rivera, KD; Wilson, JP; Feigin, ME; Ohlund, D; Handly-Santana, A; Ardito-Abraham, CM; Ludwig, M; Elyada, E; Alagesan, B; Biffi, G; Yordanov, GN; Delcuze, B; Creighton, B; Wright, K; Park, Y; Morsink, FHM; Molenaar, IQ; Rinkes, IHB; Cuppen, E; Hao, Y; Jin, Y; Nijman, IJ; Iacobuzio-Donahue, C; Leach, SD; Pappin, DJ; Hammell, M; Klimstra, DS; Basturk, O; Hruban, RH; Offerhaus, GJ; Vries, RGJ; Clevers, H; Tuveson, DA				Boj, Sylvia F.; Hwang, Chang-Il; Baker, Lindsey A.; Chio, Iok In Christine; Engle, Dannielle D.; Corbo, Vincenzo; Jager, Myrthe; Ponz-Sarvise, Mariano; Tiriac, Herve; Spector, Mona S.; Gracanin, Ana; Oni, Tobiloba; Yu, Kenneth H.; van Boxtel, Ruben; Huch, Meritxell; Rivera, Keith D.; Wilson, John P.; Feigin, Michael E.; Oehlund, Daniel; Handly-Santana, Abram; Ardito-Abraham, Christine M.; Ludwig, Michael; Elyada, Ela; Alagesan, Brinda; Biffi, Giulia; Yordanov, Georgi N.; Delcuze, Bethany; Creighton, Brianna; Wright, Kevin; Park, Youngkyu; Morsink, Folkert H. M.; Molenaar, I. Quintus; Rinkes, Inne H. Borel; Cuppen, Edwin; Hao, Yuan; Jin, Ying; Nijman, Isaac J.; Iacobuzio-Donahue, Christine; Leach, Steven D.; Pappin, Darryl J.; Hammell, Molly; Klimstra, David S.; Basturk, Olca; Hruban, Ralph H.; Offerhaus, George Johan; Vries, Robert G. J.; Clevers, Hans; Tuveson, David A.			Organoid Models of Human and Mouse Ductal Pancreatic Cancer	CELL			English	Article							ACINAR-CELL TRANSDIFFERENTIATION; IN-VITRO EXPANSION; ONCOGENIC KRAS; EXPRESSION PROFILES; PROGENITOR CELLS; ADENOCARCINOMA; MICE; NEOPLASIA; PROMOTES; IDENTIFICATION	Pancreatic cancer is one of the most lethal malignancies due to its late diagnosis and limited response to treatment. Tractable methods to identify and interrogate pathways involved in pancreatic tumorigenesis are urgently needed. We established organoid models from normal and neoplastic murine and human pancreas tissues. Pancreatic organoids can be rapidly generated from resected tumors and biopsies, survive cryopreservation, and exhibit ductal-and disease-stage-specific characteristics. Orthotopically transplanted neoplastic organoids recapitulate the full spectrum of tumor development by forming early-grade neoplasms that progress to locally invasive and metastatic carcinomas. Due to their ability to be genetically manipulated, organoids are a platform to probe genetic cooperation. Comprehensive transcriptional and proteomic analyses of murine pancreatic organoids revealed genes and pathways altered during disease progression. The confirmation of many of these protein changes in human tissues demonstrates that organoids are a facile model system to discover characteristics of this deadly malignancy.	[Boj, Sylvia F.; Jager, Myrthe; Gracanin, Ana; van Boxtel, Ruben; Huch, Meritxell; Cuppen, Edwin; Nijman, Isaac J.; Vries, Robert G. J.; Clevers, Hans] Univ Med Ctr Utrecht, Hubrecht Inst, Royal Netherlands Acad Arts & Sci KNAW, NL-3584 CT Utrecht, Netherlands; [Boj, Sylvia F.; Jager, Myrthe; Gracanin, Ana; van Boxtel, Ruben; Huch, Meritxell; Cuppen, Edwin; Nijman, Isaac J.; Vries, Robert G. J.; Clevers, Hans] CancerGenom Nl, NL-3584 CT Utrecht, Netherlands; [Boj, Sylvia F.; Gracanin, Ana; Vries, Robert G. J.] Fdn Hubrecht Organoid Technol HUB, NL-3584 CT Utrecht, Netherlands; [Hwang, Chang-Il; Baker, Lindsey A.; Chio, Iok In Christine; Engle, Dannielle D.; Corbo, Vincenzo; Ponz-Sarvise, Mariano; Tiriac, Herve; Spector, Mona S.; Oni, Tobiloba; Yu, Kenneth H.; Rivera, Keith D.; Wilson, John P.; Feigin, Michael E.; Oehlund, Daniel; Ardito-Abraham, Christine M.; Ludwig, Michael; Elyada, Ela; Alagesan, Brinda; Biffi, Giulia; Delcuze, Bethany; Creighton, Brianna; Wright, Kevin; Park, Youngkyu; Hao, Yuan; Jin, Ying; Pappin, Darryl J.; Hammell, Molly; Tuveson, David A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hwang, Chang-Il; Baker, Lindsey A.; Chio, Iok In Christine; Engle, Dannielle D.; Corbo, Vincenzo; Ponz-Sarvise, Mariano; Tiriac, Herve; Spector, Mona S.; Oni, Tobiloba; Yu, Kenneth H.; Feigin, Michael E.; Oehlund, Daniel; Handly-Santana, Abram; Ardito-Abraham, Christine M.; Ludwig, Michael; Elyada, Ela; Alagesan, Brinda; Biffi, Giulia; Yordanov, Georgi N.; Delcuze, Bethany; Creighton, Brianna; Wright, Kevin; Park, Youngkyu; Tuveson, David A.] Lustgarten Fdn Pancreat Canc Res Lab, Cold Spring Harbor, NY 11724 USA; [Oni, Tobiloba] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA; [Yu, Kenneth H.; Iacobuzio-Donahue, Christine; Leach, Steven D.; Tuveson, David A.] Mem Sloan Kettering Canc Ctr, Rubenstein Ctr Pancreat Canc Res, New York, NY 10065 USA; [Yu, Kenneth H.] Cornell Univ, Weill Med Coll, New York, NY 10065 USA; [Handly-Santana, Abram; Yordanov, Georgi N.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Alagesan, Brinda] SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; [Morsink, Folkert H. M.; Offerhaus, George Johan] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; [Molenaar, I. Quintus; Rinkes, Inne H. Borel] Univ Med Ctr Utrecht, Dept Surg, NL-3584 CX Utrecht, Netherlands; [Klimstra, David S.; Basturk, Olca] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Hruban, Ralph H.] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21231 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Memorial Sloan Kettering Cancer Center; Cornell University; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Memorial Sloan Kettering Cancer Center; Johns Hopkins University	Clevers, H (corresponding author), Univ Med Ctr Utrecht, Hubrecht Inst, Royal Netherlands Acad Arts & Sci KNAW, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu; dtuveson@cshl.edu	Cuppen, Edwin/F-5696-2011; Basturk, Olca/N-7214-2017; Cuppen, Edwin/H-2389-2016; Ponz-Sarvise, Mariano/H-4104-2017; Iacobuzio-Donahue, Christine/ABF-1295-2020; Oni, Tobiloba Emmanuel/X-9513-2019; Ohlund, Daniel/AFR-9335-2022; Corbo, Vincenzo/J-7754-2016; Ardito-Abraham, Christine/F-8823-2014	Cuppen, Edwin/0000-0002-0400-9542; Basturk, Olca/0000-0003-2747-1366; Cuppen, Edwin/0000-0002-0400-9542; Ponz-Sarvise, Mariano/0000-0002-3240-729X; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Oni, Tobiloba Emmanuel/0000-0002-6916-3380; Ohlund, Daniel/0000-0002-5847-2778; Corbo, Vincenzo/0000-0002-6340-8009; Hammell, Molly/0000-0003-0405-8392; Ardito-Abraham, Christine/0000-0002-2824-7019; Rivera, Keith/0000-0003-2979-9576; Hwang, Chang-il/0000-0002-5710-7672; van Boxtel, Ruben/0000-0003-1285-2836; Biffi, Giulia/0000-0003-4592-0970; Feigin, Michael/0000-0002-8189-5568; Jager, Myrthe/0000-0002-1406-1715; Tiriac, Herve/0000-0001-5039-6750; Baker, Lindsey/0000-0002-3098-2231; Hao, Yuan/0000-0002-1588-0587; Engle, Dannielle/0000-0003-1876-7675	Cancer Center Support Grant [5P30CA045508]; Cold SpringHarbor Laboratory Association; Carcinoid Foundation; PCUK; David Rubinstein Center for Pancreatic Cancer Research at MSKCC; Stand Up to Cancer/KWF; STARR foundation [I7-A718]; DOD [W81XWH-13-PRCRP-IA]; Sol Goldman Pancreatic Cancer Research Center; Italian Ministry of Health [FIRB-RBAP10AHJ]; Sociedad Espanola de Oncologia Medica (SEOM); Louis Morin Charitable Trust; Swedish Research Council [537-2013-7277]; Kempe Foundations [JCK-1301]; Swedish Society of Medicine [S-326921, SLS-250831]; Damon Runyon Cancer Research Foundation [DRG-2165-13]; Human Frontiers Science Program [LT000403/2014]; Weizmann Institute of Science Women in Science Award; American Cancer Society [PF-13-317-01-CSM]; Hearst Foundation; NIH [5P30CA45508-26, 5P50CA101955-07, 1U10CA18094401, 5U01CA168409-3, 1R01CA190092-01, CA62924, CA134292, 5T32CA148056, CA101955 UAB/UMN SPORE]; KWF/PF-HUBR [2007-3956]; GenomiCs.nl; CancerGenomics.nl (NWO Gravitation) program;  [EU/232814StemCellMark]; Pancreatic Cancer UK [2010 Grant - Tuveson, PCUK-2011 Grant - Tuveson] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA134292, P30CA008748, P50CA062924, U10CA180944, F32CA180717, T32CA148056, P50CA101955, P30CA045508, R01CA190092, U01CA168409, P20CA101955] Funding Source: NIH RePORTER	Cancer Center Support Grant; Cold SpringHarbor Laboratory Association; Carcinoid Foundation; PCUK; David Rubinstein Center for Pancreatic Cancer Research at MSKCC; Stand Up to Cancer/KWF; STARR foundation; DOD(United States Department of Defense); Sol Goldman Pancreatic Cancer Research Center; Italian Ministry of Health(Ministry of Health, Italy); Sociedad Espanola de Oncologia Medica (SEOM); Louis Morin Charitable Trust; Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundations; Swedish Society of Medicine; Damon Runyon Cancer Research Foundation; Human Frontiers Science Program(Human Frontier Science Program); Weizmann Institute of Science Women in Science Award; American Cancer Society(American Cancer Society); Hearst Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KWF/PF-HUBR; GenomiCs.nl; CancerGenomics.nl (NWO Gravitation) program; ; Pancreatic Cancer UK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Peter Kapitein and Jan Schuurman from Inspire 2 Live for helping to establish the collaboration between D.A.T. and H.C. We also thank H. Begthel and J.Korving for technical assistance. This work was performed with assistance from the CSHL Proteomic, Histology, DNA Sequencing, Antibody, and Bioinformatics Shared Resources, which are supported by the Cancer Center Support Grant 5P30CA045508. D.A.T. is a distinguished scholar of the Lustgarten Foundation and Director of the Lustgarten Foundation-designated Laboratory of Pancreatic Cancer Research. D.A.T. is also supported by the Cold SpringHarbor Laboratory Association, the Carcinoid Foundation, PCUK, and the David Rubinstein Center for Pancreatic Cancer Research at MSKCC. In addition, we are grateful for support from the following: Stand Up to Cancer/KWF (H.C.), the STARR foundation (I7-A718 for D.A.T.), DOD (W81XWH-13-PRCRP-IA for D.A.T.), the Sol Goldman Pancreatic Cancer Research Center (R.H.H.), the Italian Ministry of Health (FIRB-RBAP10AHJ for V.C.), Sociedad Espanola de Oncologia Medica (SEOM for M.P.S.), Louis Morin Charitable Trust (M.E.F.), the Swedish Research Council (537-2013-7277 for D.O.), The Kempe Foundations (JCK-1301 for D.O) and the Swedish Society of Medicine (SLS-326921, SLS-250831 for D.O), the Damon Runyon Cancer Research Foundation (DRG-2165-13 for I.I.C.C.), the Human Frontiers Science Program (LT000403/2014 for E.E.), the Weizmann Institute of Science Women in Science Award (E.E.), the American Cancer Society (PF-13-317-01-CSM for C.M.A.A.), the Hearst Foundation (A.H.S.), and the NIH (5P30CA45508-26, 5P50CA101955-07, 1U10CA18094401, 5U01CA168409-3, and 1R01CA190092-01 for D.A.T.; CA62924 for R.H.H.; CA134292 for S.D.L.; 5T32CA148056 for L.A.B. and D.D.E.; and CA101955 UAB/UMN SPORE for L.A.B.). In addition, S.F.B. and M.H. are supported by KWF/PF-HUBR 2007-3956, A.G is supported by EU/232814StemCellMark, and R.G.J.V. is supported by GenomiCs.nl (CGC). M.J., R.B., and E.C. are supported by the CancerGenomics.nl (NWO Gravitation) program. Ralph Hruban receives royalty payments from Myriad Genetics for the PalB2 inventions. Hans Clevers and Meritxell Huch have patents pending and granted on the organoid technology.	Abbruzzese JL, 2014, J CLIN ONCOL, V32, P2405, DOI 10.1200/JCO.2013.54.4155; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Cleveland MH, 2012, SEMIN CELL DEV BIOL, V23, P711, DOI 10.1016/j.semcdb.2012.06.008; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Dumartin L, 2011, CANCER RES, V71, P7091, DOI 10.1158/0008-5472.CAN-11-1367; Erkan MM, 2009, NEOPLASIA, V11, P497, DOI 10.1593/neo.81618; Frese KK, 2012, CANCER DISCOV, V2, P260, DOI 10.1158/2159-8290.CD-11-0242; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Gould VE, 2000, AM J PATHOL, V157, P1605, DOI 10.1016/S0002-9440(10)64798-0; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Kim J, 2013, CELL REP, V3, P2088, DOI 10.1016/j.celrep.2013.05.036; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Kohler A, 2010, MOL CELL, V38, P6, DOI 10.1016/j.molcel.2010.01.040; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Lee J, 2013, ELIFE, V2, DOI 10.7554/eLife.00940; Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585; MAKOVITZKY J, 1986, VIRCHOWS ARCH B, V51, P535, DOI 10.1007/BF02899058; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Neesse A, 2014, GUT, V63, P974, DOI 10.1136/gutjnl-2013-305559; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Perez-Mancera PA, 2012, GASTROENTEROLOGY, V142, P1079, DOI 10.1053/j.gastro.2012.03.002; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Ray KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016786; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Shain AH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-624; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Villarroel MC, 2011, MOL CANCER THER, V10, P3, DOI 10.1158/1535-7163.MCT-10-0893; von Figura G, 2014, NAT CELL BIOL, V16, P255, DOI 10.1038/ncb2916; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhao LL, 2014, MOL BIOL REP, V41, P2875, DOI 10.1007/s11033-014-3143-4	56	1110	1156	32	291	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					324	338		10.1016/j.cell.2014.12.021	http://dx.doi.org/10.1016/j.cell.2014.12.021			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25557080	Green Accepted, Bronze			2022-12-28	WOS:000347923200028
J	Alcorn, JF; Kolls, JK				Alcorn, John F.; Kolls, Jay K.			Killer fat	SCIENCE			English	Editorial Material							ADIPOCYTES; STIMULATION; METABOLISM; EXPRESSION; IMMUNITY; RECEPTOR		[Alcorn, John F.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA; [Kolls, Jay K.] Univ Pittsburgh, Richard King Mellon Fdn, Pediat Res Inst, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Alcorn, JF (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA.	jay.kolls@chp.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304	NHLBI NIH HHS [R37HL079142, R01HL107380] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107380, R37HL079142] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ajuwon KM, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-8; Aujla SJ, 2011, BBA-GEN SUBJECTS, V1810, P1066, DOI 10.1016/j.bbagen.2011.02.002; Banke E, 2014, METABOLISM, V63, P831, DOI 10.1016/j.metabol.2014.03.004; Braff MH, 2005, INFECT IMMUN, V73, P6771, DOI 10.1128/IAI.73.10.6771-6781.2005; Coimbra S, 2013, OBES REV, V14, P771, DOI 10.1111/obr.12057; Marodi L, 2012, J ALLERGY CLIN IMMUN, V130, P1019, DOI 10.1016/j.jaci.2012.09.011; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Park S, 2009, INFECT IMMUN, V77, P1008, DOI 10.1128/IAI.00976-08; Pietsch J, 2006, ANN NY ACAD SCI, V1072, P407, DOI 10.1196/annals.1326.021; Robinson KM, 2014, J INFECT DIS, V209, P865, DOI 10.1093/infdis/jit527; Sreeramoju P, 2011, AM J SURG, V201, P216, DOI 10.1016/j.amjsurg.2009.12.024; Zhang LJ, 2015, SCIENCE, V347, P67, DOI 10.1126/science.1260972	12	10	10	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					26	27		10.1126/science.aaa4567	http://dx.doi.org/10.1126/science.aaa4567			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554774				2022-12-28	WOS:000347102300033
J	Holden, DW				Holden, David W.			Persisters unmasked	SCIENCE			English	Editorial Material							BACTERIAL PERSISTENCE; SALMONELLA; MECHANISMS; PENICILLIN		Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England	Imperial College London	Holden, DW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Microbiol Sect, MRC Ctr Mol Bacteriol & Infect, Armstrong Rd, London SW7 2AZ, England.	d.holden@imperial.ac.uk		Holden, David/0000-0002-8369-5105	Medical Research Council [MR/J006874/1] Funding Source: Medline; MRC [MR/J006874/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; Casadesus J, 2013, J BIOL CHEM, V288, P13929, DOI 10.1074/jbc.R113.472274; Claudi B, 2014, CELL, V158, P722, DOI 10.1016/j.cell.2014.06.045; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Hobby GL, 1942, P SOC EXP BIOL MED, V50, P281, DOI 10.3181/00379727-50-13773; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Okoro CK, 2012, CLIN INFECT DIS, V54, P955, DOI 10.1093/cid/cir1032; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0	14	23	25	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					30	32		10.1126/science.1262033	http://dx.doi.org/10.1126/science.1262033			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554777				2022-12-28	WOS:000347102300036
J	Tomasetti, C; Vogelstein, B				Tomasetti, Cristian; Vogelstein, Bert			Variation in cancer risk among tissues can be explained by the number of stem cell divisions	SCIENCE			English	Article							CARCINOGENESIS; GENOME; PROLIFERATION; HOMEOSTASIS; MUTATION; ORIGIN	Some tissue types give rise to human cancers millions of times more often than other tissue types. Although this has been recognized for more than a century, it has never been explained. Here, we show that the lifetime risk of cancers of many different types is strongly correlated (0.81) with the total number of divisions of the normal self-renewing cells maintaining that tissue's homeostasis. These results suggest that only a third of the variation in cancer risk among tissues is attributable to environmental factors or inherited predispositions. The majority is due to "bad luck," that is, random mutations arising during DNA replication in normal, noncancerous stem cells. This is important not only for understanding the disease but also for designing strategies to limit the mortality it causes.	[Tomasetti, Cristian] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Canc Ctr,Div Biostat & Bioinformat, Baltimore, MD 21205 USA; [Tomasetti, Cristian] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21205 USA; [Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine	Tomasetti, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Canc Ctr,Div Biostat & Bioinformat, 550 North Broadway, Baltimore, MD 21205 USA.	ctomasetti@jhu.edu; vogelbe@jhmi.edu		Tomasetti, Cristian/0000-0003-3277-4804	Virginia and D. K. Ludwig Fund for Cancer Research; Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Center for Pancreatic Cancer Research; NIH [P30-CA006973, R37-CA43460, RO1-CA57345, P50-CA62924]; NATIONAL CANCER INSTITUTE [P50CA062924, R01CA057345, P30CA006973, R37CA043460] Funding Source: NIH RePORTER	Virginia and D. K. Ludwig Fund for Cancer Research; Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Center for Pancreatic Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank E. Cook for artwork. This work was supported by the The Virginia and D. K. Ludwig Fund for Cancer Research, The Lustgarten Foundation for Pancreatic Cancer Research, The Sol Goldman Center for Pancreatic Cancer Research, and NIH grants P30-CA006973, R37-CA43460, RO1-CA57345, and P50-CA62924.	ALBANES D, 1988, JNCI-J NATL CANCER I, V80, P772, DOI 10.1093/jnci/80.10.772; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; ARMITAGE P, 1957, BRIT J CANCER, V11, P161, DOI 10.1038/bjc.1957.22; Baker SG, 2010, J CLIN ONCOL, V28, P3215, DOI 10.1200/JCO.2010.28.5460; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Boveri T., 1914, FRAGE ENTSTEHUNG MAL; Colditz GA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003218; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Dubal PM, 2014, LARYNGOSCOPE, V124, P1877, DOI 10.1002/lary.24618; Fearon ER, 1997, SCIENCE, V278, P1043, DOI 10.1126/science.278.5340.1043; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Frank S. A., 2007, DYNAMICS CANC INCIDE; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Jaffe N., 2009, PEDIATR ADOLESCENT O; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; SELL S, 1993, ENVIRON HEALTH PERSP, V101, P15, DOI 10.2307/3431838; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; Tomatis L., 1993, ENVIRON HEALTH PER S, V101, P149; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; WARD JM, 1993, ENVIRON HEALTH PERSP, V101, P125, DOI 10.2307/3431855	28	1117	1152	13	434	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					78	81		10.1126/science.1260825	http://dx.doi.org/10.1126/science.1260825			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554788	Green Accepted			2022-12-28	WOS:000347102300052
J	Anell, A				Anell, Anders			INTERNATIONAL HEALTH CARE SYSTEMS The Public-Private Pendulum - Patient Choice and Equity in Sweden	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Lund Univ, Sch Econ & Management, Lund, Sweden	Lund University	Anell, A (corresponding author), Lund Univ, Sch Econ & Management, Lund, Sweden.							Anell Anders, 2012, Health Syst Transit, V14, P1; [Anonymous], 2010, HLTH CARE SYSTEMS EF; SHENKIN BN, 1973, NEW ENGL J MED, V288, P555, DOI 10.1056/NEJM197303152881105; Vardanalys, 2014, LET RIGHT ON WHAT IM	4	73	73	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2015	372	1					1	4		10.1056/NEJMp1411430	http://dx.doi.org/10.1056/NEJMp1411430			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX7MU	25551523				2022-12-28	WOS:000347100800002
J	Bohm, E; Lippold, J; Gutjahr, M; Frank, M; Blaser, P; Antz, B; Fohlmeister, J; Frank, N; Andersen, MB; Deininger, M				Boehm, E.; Lippold, J.; Gutjahr, M.; Frank, M.; Blaser, P.; Antz, B.; Fohlmeister, J.; Frank, N.; Andersen, M. B.; Deininger, M.			Strong and deep Atlantic meridional overturning circulation during the last glacial cycle	NATURE			English	Article							NEODYMIUM ISOTOPIC COMPOSITION; WESTERN NORTH-ATLANTIC; OCEAN CIRCULATION; THERMOHALINE CIRCULATION; WATER CIRCULATION; SEA SEDIMENTS; CLIMATE; VARIABILITY; EXTRACTION; SIGNATURE	Extreme, abrupt Northern Hemisphere climate oscillations during the last glacial cycle (140,000 years ago to present) were modulated by changes in ocean circulation and atmospheric forcing(1). However, the variability of the Atlantic meridional overturning circulation (AMOC), which has a role in controlling heat transport from low to high latitudes and in ocean CO2 storage, is still poorly constrained beyond the Last Glacial Maximum(2-4). Here we show that a deep and vigorous overturning circulation mode has persisted for most of the last glacial cycle, dominating ocean circulation in the Atlantic, whereas a shallower glacial mode with southern-sourced waters filling the deep western North Atlantic prevailed during glacial maxima(3,5). Our results are based on a reconstruction of both the strength and the direction of the AMOC during the last glacial cycle from a highly resolved marine sedimentary record in the deep western North Atlantic. Parallel measurements of two independent chemical water tracers (the isotope ratios of Pa-231/Th-230 and Nd-143/Nd-144)(6-8), which are not directly affected by changes in the global cycle, reveal consistent responses of the AMOC during the last two glacial terminations. Any significant deviations from this configuration, resulting in slowdowns of the AMOC, were restricted to centennial-scale excursions during catastrophic iceberg discharges of the Heinrich stadials. Severe and multicentennial weakening of North Atlantic Deep Water formation occurred only during Heinrich stadials close to glacial maxima with increased ice coverage, probably as a result of increased freshwater input. In contrast, the AMOC was relatively insensitive to sub-millennial meltwater pulses during warmer climate states, and an active AMOC prevailed during Dansgaard-Oeschger interstadials (Greenland warm periods).	[Boehm, E.; Blaser, P.; Antz, B.; Fohlmeister, J.; Frank, N.; Deininger, M.] Heidelberg Univ, Inst Environm Phys, D-69120 Heidelberg, Germany; [Lippold, J.] Univ Bern, Inst Geol Sci, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Gutjahr, M.; Frank, M.] GEOMAR Helmholtz Ctr Ocean Res Kiel, D-24148 Kiel, Germany; [Gutjahr, M.] Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England; [Andersen, M. B.] ETH, Inst Geochem & Petrol, CH-8092 Zurich, Switzerland	Ruprecht Karls University Heidelberg; University of Bern; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; NERC National Oceanography Centre; University of Southampton; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lippold, J (corresponding author), Univ Bern, Inst Geol Sci, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland.	joerg.lippold@geo.unibe.ch	Gutjahr, Marcus/ABC-2674-2020; Blaser, Patrick/ABA-3175-2021; Gutjahr, Marcus/L-9158-2013; Frank, Norbert/D-6486-2016	Gutjahr, Marcus/0000-0003-2556-2619; Gutjahr, Marcus/0000-0003-2556-2619; Frank, Norbert/0000-0002-0416-9546; Frank, Martin/0000-0002-8606-4421; Blaser, Patrick/0000-0001-8102-9777	Deutsche Forschungsgemeinschaft [Ma821/41]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Sediment material for this study was provided by the ODP/IODP core repository Bremen. The manuscript benefited from input by S. Jaccard and A. Mangini. We thank J. Grutzner, H. Dicht, J. Link and S. Rheinberger for advice and analytical assistance. Financial support for this research was provided by the Deutsche Forschungsgemeinschaft through grant Ma821/41 to E.B. J.L. was supported by the FP7-PEOPLE-2013-IEF, Marie Curie proposal 622483.	Adkins JF, 2013, PALEOCEANOGRAPHY, V28, P539, DOI 10.1002/palo.20046; Adkins JF, 1997, NATURE, V390, P154, DOI 10.1038/36540; Andersen KK, 2006, QUATERNARY SCI REV, V25, P3246, DOI 10.1016/j.quascirev.2006.08.002; ANDERSON RF, 1983, EARTH PLANET SC LETT, V66, P73, DOI 10.1016/0012-821X(83)90127-9; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; BOYLE EA, 1987, NATURE, V330, P35, DOI 10.1038/330035a0; Carlson AE, 2008, QUATERNARY SCI REV, V27, P882, DOI 10.1016/j.quascirev.2008.02.004; Carlson AE, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000371; Channell JET, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003897; Christl M, 2010, QUATERNARY SCI REV, V29, P2663, DOI 10.1016/j.quascirev.2010.06.017; COHEN AS, 1988, CONTRIB MINERAL PETR, V98, P303, DOI 10.1007/BF00375181; Elmore AC, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003741; Fietzke J, 1999, NUCL INSTRUM METH B, V149, P353, DOI 10.1016/S0168-583X(98)00912-4; Foster GL, 2007, GEOLOGY, V35, P37, DOI 10.1130/G23204A.1; Frank M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000094; Geibert W, 2008, MAR CHEM, V109, P238, DOI 10.1016/j.marchem.2007.07.012; Gil IM, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001729; Guihou A, 2011, QUATERNARY SCI REV, V30, P1576, DOI 10.1016/j.quascirev.2011.03.017; Gutjahr M, 2008, EARTH PLANET SC LETT, V266, P61, DOI 10.1016/j.epsl.2007.10.037; Gutjahr M, 2007, CHEM GEOL, V242, P351, DOI 10.1016/j.chemgeo.2007.03.021; Gutjahr M, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002114; Hansen R., 1983, PREPARATION CERTIFIC, VM84; Henderson GM, 2003, REV MINERAL GEOCHEM, V52, P493, DOI 10.2113/0520493; Hillaire-Marcel C, 2001, NATURE, V410, P1073, DOI 10.1038/35074059; Jaccard SL, 2013, SCIENCE, V339, P1419, DOI 10.1126/science.1227545; Jaeschke A, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001391; KEIGWIN LD, 1994, J GEOPHYS RES-OCEANS, V99, P12397, DOI 10.1029/94JC00525; Keigwin LD, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001500; Lacan F, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000956; Lacan F, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000742; Lacan F, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019747; Lippold J, 2012, NAT GEOSCI, V5, P813, DOI [10.1038/NGEO1608, 10.1038/ngeo1608]; Lippold J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038068; Lynch-Stieglitz J, 2007, SCIENCE, V316, P66, DOI 10.1126/science.1137127; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; MULLER PJ, 1993, DEEP-SEA RES PT I, V40, P425, DOI 10.1016/0967-0637(93)90140-X; Pahnke K, 2008, NAT GEOSCI, V1, P870, DOI 10.1038/ngeo360; Pichat S, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000994; PIEPGRAS DJ, 1987, GEOCHIM COSMOCHIM AC, V51, P1257, DOI 10.1016/0016-7037(87)90217-1; PIEPGRAS DJ, 1980, EARTH PLANET SC LETT, V50, P128, DOI 10.1016/0012-821X(80)90124-7; PIN C, 1994, ANAL CHIM ACTA, V298, P209, DOI 10.1016/0003-2670(94)00274-6; Piotrowski AM, 2012, EARTH PLANET SC LETT, V357, P289, DOI 10.1016/j.epsl.2012.09.036; Piotrowski AM, 2005, SCIENCE, V307, P1933, DOI 10.1126/science.1104883; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Rasmussen TL, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000736; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Roberts NL, 2012, GEOCHIM COSMOCHIM AC, V94, P57, DOI 10.1016/j.gca.2012.07.009; Roberts NL, 2010, SCIENCE, V327, P75, DOI 10.1126/science.1178068; Sachs JP, 1999, SCIENCE, V286, P756, DOI 10.1126/science.286.5440.756; SARNTHEIN M, 1994, PALEOCEANOGRAPHY, V9, P209, DOI 10.1029/93PA03301; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Stichel T, 2012, EARTH PLANET SC LETT, V317, P282, DOI 10.1016/j.epsl.2011.11.025; STORDAL MC, 1986, EARTH PLANET SC LETT, V77, P259, DOI 10.1016/0012-821X(86)90138-X; Svensson A, 2006, QUATERNARY SCI REV, V25, P3258, DOI 10.1016/j.quascirev.2006.08.003; SWIFT JH, 1984, DEEP-SEA RES, V31, P1339, DOI 10.1016/0198-0149(84)90005-0; Tanaka T, 2000, CHEM GEOL, V168, P279, DOI 10.1016/S0009-2541(00)00198-4; Thornalley DJR, 2013, PALEOCEANOGRAPHY, V28, P253, DOI 10.1002/palo.20025; Tzedakis PC, 2012, CLIM PAST, V8, P1473, DOI 10.5194/cp-8-1473-2012; van de Flierdt T, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001294; Vance D, 2002, CHEM GEOL, V185, P227, DOI 10.1016/S0009-2541(01)00402-8; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wilson DJ, 2013, GEOCHIM COSMOCHIM AC, V109, P197, DOI 10.1016/j.gca.2013.01.042; Wolff EW, 2010, QUATERNARY SCI REV, V29, P2828, DOI 10.1016/j.quascirev.2009.10.013; Yu EF, 1996, NATURE, V379, P689, DOI 10.1038/379689a0	66	296	300	17	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					73	U170		10.1038/nature14059	http://dx.doi.org/10.1038/nature14059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25517093				2022-12-28	WOS:000347178400037
J	Anastasiadou, E; Slack, FJ				Anastasiadou, Eleni; Slack, Frank J.			Malicious exosomes	SCIENCE			English	Editorial Material							MICRORNAS; VESICLES		[Anastasiadou, Eleni; Slack, Frank J.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Anastasiadou, E (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	fslack@bidmc.harvard.edu	ANASTASIADOU, ELENI/AAU-6080-2021; Anastasiadou, Eleni/AAI-1845-2020	ANASTASIADOU, ELENI/0000-0003-0212-6734; Slack, Frank/0000-0001-8263-0409	NCI NIH HHS [R01 CA157749] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA157749] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Federici C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088193; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Le MTN, 2014, J CLIN INVEST, V124, P5109, DOI 10.1172/JCI75695; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Meckes DG, 2013, P NATL ACAD SCI USA, V110, pE2925, DOI 10.1073/pnas.1303906110; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Roma-Rodrigues C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/179486; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610	15	46	48	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1459	1460		10.1126/science.aaa4024	http://dx.doi.org/10.1126/science.aaa4024			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525233				2022-12-28	WOS:000346536500039
J	Lupas, AN				Lupas, Andrei N.			What I cannot create, I do not understand	SCIENCE			English	Editorial Material							COILED-COIL; COMPUTATIONAL DESIGN; CHANNEL		Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	Max Planck Society	Lupas, AN (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany.	andrei.lupas@tuebingen.mpg.de						Burton AJ, 2013, J AM CHEM SOC, V135, P12524, DOI 10.1021/ja4053027; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P685, DOI 10.1107/S0365110X53001952; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Huang PS, 2014, SCIENCE, V346, P481, DOI 10.1126/science.1257481; Joh NH, 2014, SCIENCE, V346, P1520, DOI 10.1126/science.1261172; Kiss G, 2013, ANGEW CHEM INT EDIT, V52, P5700, DOI 10.1002/anie.201204077; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; Perez-Aguilar JM, 2012, STRUCTURE, V20, P5, DOI 10.1016/j.str.2011.12.003; Thomson AR, 2014, SCIENCE, V346, P485, DOI 10.1126/science.1257452; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2	13	6	6	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1455	1456		10.1126/science.aaa2721	http://dx.doi.org/10.1126/science.aaa2721			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525230				2022-12-28	WOS:000346536500036
J	Silber, JH; Rosenbaum, PR; Ross, RN; Niknam, BA; Ludwig, JM; Wang, W; Clark, AS; Fox, KR; Wang, M; Even-Shoshan, O; Giantonio, BJ				Silber, Jeffrey H.; Rosenbaum, Paul R.; Ross, Richard N.; Niknam, Bijan A.; Ludwig, Justin M.; Wang, Wei; Clark, Amy S.; Fox, Kevin R.; Wang, Min; Even-Shoshan, Orit; Giantonio, Bruce J.			Racial Disparities in Colon Cancer Survival A Matched Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							DUTY HOUR REFORM; COLORECTAL-CANCER; PROPENSITY SCORE; MEDICARE BENEFICIARIES; SURGICAL OUTCOMES; CAUSAL INFERENCE; FINE BALANCE; STAGE; MORTALITY; BIAS	Background: Differences in colon cancer survival by race are a recognized problem among Medicare beneficiaries. Objective: To determine to what extent the racial disparity in survival is due to disparity in presentation characteristics at diagnosis or disparity in subsequent treatment. Design: Black patients with colon cancer were matched with 3 groups of white patients: a "demographic characteristics" match controlling for age, sex, diagnosis year, and Survey, Epidemiology, and End Results (SEER) site; a "presentation" match controlling for demographic characteristics plus comorbid conditions and tumor characteristics, including stage and grade; and a "treatment" match, including presentation variables plus details of surgery, radiation, and chemotherapy. Setting: 16 U.S. SEER sites. Patients: 7677 black patients aged 65 years or older diagnosed between 1991 and 2005 in the SEER-Medicare database and 3 sets of 7677 matched white patients, followed until 31 December 2009. Measurements: 5-year survival. Results: The absolute difference in 5-year survival between black and white patients was 9.9% (95% CI, 8.3% to 11.4%; P < 0.001) in the demographic characteristics match. This disparity remained unchanged between 1991 and 2005. After matching for presentation characteristics, the difference decreased to 4.9% (CI, 3.6% to 6.1%; P < 0.001). After additional matching for treatment, this difference decreased to 4.3% (CI, 2.9% to 5.5%; P < 0.001). The disparity in survival attributed to treatment differences made up only an absolute 0.6% of the overall 9.9% survival disparity. Limitation: An observational study limited to elderly Medicare fee-for-service beneficiaries living in selected geographic areas. Conclusion: Racial disparities in colon cancer survival did not decrease among patients diagnosed between 1991 and 2005. This persistent disparity seemed to be more related to presentation characteristics at diagnosis than to subsequent treatment differences.	[Silber, Jeffrey H.] Childrens Hosp Philadelphia, Ctr Outcomes Res, Philadelphia, PA 19104 USA; Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Hosp Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Silber, JH (corresponding author), Childrens Hosp Philadelphia, Ctr Outcomes Res, 3535 Market St,Suite 1029, Philadelphia, PA 19104 USA.	silber@email.chop.edu	Rosenbaum, Paul R/H-8687-2012		Agency for Healthcare Research and Quality [R01 HS 018355]; National Science Foundation [NSF SBS 1260782]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018355] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Science Foundation(National Science Foundation (NSF)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality (grant R01 HS 018355) and the National Science Foundation (grant NSF SBS 1260782).	Agency Healthcare Research and Quality, 2011, 2011 NAT HEALTHC QUA, V2011; Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; [Anonymous], SEER CANC STAT REV C; Arias Elizabeth, 2012, Natl Vital Stat Rep, V61, P1; Bach PB, 2002, MED CARE S, V40; Baldwin LM, 2005, J NATL CANCER I, V97, P1211, DOI 10.1093/jnci/dji241; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Bishop YMM, 1975, DISCRETE MULTIVARIAT, P281; Breslin TM, 2009, J CLIN ONCOL, V27, P3945, DOI 10.1200/JCO.2008.20.8546; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chien C, 2005, CANCER, V104, P629, DOI 10.1002/cncr.21204; Clegg LX, 2002, ARCH INTERN MED, V162, P1985, DOI 10.1001/archinte.162.17.1985; COCHRAN WG, 1973, SANKHYA SER A, V35, P417; Cooper GS, 2004, CANCER-AM CANCER SOC, V100, P418, DOI 10.1002/cncr.20014; Daniel SR, 2008, J COMPUT GRAPH STAT, V17, P914, DOI 10.1198/106186008X385806; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Doubeni CA, 2007, CANCER-AM CANCER SOC, V109, P612, DOI 10.1002/cncr.22437; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; Govindarajan R, 2003, CANCER, V97, P493, DOI 10.1002/cncr.11067; Gross GR, 2008, CANCER-AM CANCER SOC, V112, P900, DOI 10.1002/cncr.23228; Haas JS, 2008, J GEN INTERN MED, V23, P699, DOI 10.1007/s11606-008-0545-9; Hansen BB, 2004, J AM STAT ASSOC, V99, P609, DOI 10.1198/016214504000000647; Hansen BB, 2008, BIOMETRIKA, V95, P481, DOI 10.1093/biomet/asn004; Hashiguchi Y, 2012, ANN SURG ONCOL, V19, P1517, DOI 10.1245/s10434-011-2113-5; Heller R, 2012, CROSS MATCH TEST R P; Heller R, 2010, AM STAT, V64, P299, DOI 10.1198/tast.2010.09210; Hollander M, 1999, NONPARAMETRIC STAT M, p[72, 190, 51, 36]; HOLT JD, 1974, BIOMETRIKA, V61, P17, DOI 10.1093/biomet/61.1.17; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Lu B, 2011, AM STAT, V65, P21, DOI 10.1198/tast.2011.08294; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; National Cancer Institute, SEER MED LINK DAT; National Comprehensive Cancer Network, 2014, CLIN PRACR GUID ONC; OBRIEN PC, 1987, BIOMETRICS, V43, P169, DOI 10.2307/2531957; Quah HM, 2008, DIS COLON RECTUM, V51, P503, DOI 10.1007/s10350-008-9246-z; R Development Core Team, 2013, R PROJ STAT COMP; Robbins AS, 2012, J CLIN ONCOL, V30, P401, DOI 10.1200/JCO.2011.37.5527; Rosenbaum PR, 2007, J AM STAT ASSOC, V102, P75, DOI 10.1198/016214506000001059; Rosenbaum PR, 2013, AM STAT, V67, P67, DOI 10.1080/00031305.2013.769914; Rosenbaum PR, 2005, J ROY STAT SOC B, V67, P515, DOI 10.1111/j.1467-9868.2005.00513.x; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; RUBIN DB, 1979, J AM STAT ASSOC, V74, P318, DOI 10.2307/2286330; Rubin DB, 2008, ANN APPL STAT, V2, P808, DOI 10.1214/08-AOAS187; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; SAS Institute Inc, 1999, SAS OR US GUID MATH, P39; Schenck AP, 2006, AM J PREV MED, V30, P320, DOI 10.1016/j.amepre.2005.11.005; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Silber JH, 2013, JAMA-J AM MED ASSOC, V310, P389, DOI 10.1001/jama.2013.8272; Silber JH, 2012, ANN SURG, V256, P79, DOI 10.1097/SLA.0b013e31825375ef; Silber JH, 2001, MED CARE, V39, P1048, DOI 10.1097/00005650-200110000-00003; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Warren JL, 2002, MED CARE, V40, P3; White A, 2010, CANCER-AM CANCER SOC, V116, P4622, DOI 10.1002/cncr.25395; Wu XC, 2001, CANCER-AM CANCER SOC, V92, P2547, DOI 10.1002/1097-0142(20011115)92:10&lt;2547::AID-CNCR1606&gt;3.0.CO;2-K; Yang D, 2012, BIOMETRICS, V68, P628, DOI 10.1111/j.1541-0420.2011.01691.x	62	60	60	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12					845	U27		10.7326/M14-0900	http://dx.doi.org/10.7326/M14-0900			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UW	25506853				2022-12-28	WOS:000347248400026
J	Armitage, AE; Drakesmith, H				Armitage, Andrew E.; Drakesmith, Hal			The battle for iron	SCIENCE			English	Editorial Material									[Armitage, Andrew E.; Drakesmith, Hal] Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England	University of Oxford	Armitage, AE (corresponding author), Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England.	alexander.drakesmith@ndm.ox.ac.uk		Armitage, Andrew/0000-0001-5977-6602; Drakesmith, Alexander/0000-0002-8503-6103	MRC [MC_UU_12010/10] Funding Source: UKRI; Medical Research Council [MC_UU_12010/10] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barber MF, 2014, SCIENCE, V346, P1362, DOI 10.1126/science.1259329; Carniel E, 1999, Int Microbiol, V2, P161; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Holmes EC, 2004, PLOS BIOL, V2, P1267, DOI 10.1371/journal.pbio.0020307; Noinaj N, 2012, NATURE, V483, P53, DOI 10.1038/nature10823; SCHADE AL, 1946, SCIENCE, V104, P340, DOI 10.1126/science.104.2702.340	7	14	14	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1299	1300		10.1126/science.aaa2468	http://dx.doi.org/10.1126/science.aaa2468			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW3MA	25504706				2022-12-28	WOS:000346189600027
J	Taylor, R				Taylor, Richard			HYDROLOGY When wells run dry	NATURE			English	Editorial Material							WATER		UCL, Dept Geog, London WC1E 6BT, England	University of London; University College London	Taylor, R (corresponding author), UCL, Dept Geog, Mortimer St, London WC1E 6BT, England.	richard.taylor@ucl.ac.uk	Taylor, Richard/AAA-8512-2021	Taylor, Richard/0000-0002-9867-8033	NERC [NE/L002043/1, NE/L001926/1] Funding Source: UKRI; Natural Environment Research Council [NE/L001926/1, NE/L002043/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Allan JA, 1998, GROUND WATER, V36, P545, DOI 10.1111/j.1745-6584.1998.tb02825.x; Allan RP, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/025205; Famiglietti JS, 2014, NAT CLIM CHANGE, V4, P945, DOI 10.1038/nclimate2425; Gleeson T, 2012, NATURE, V488, P197, DOI 10.1038/nature11295; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; Pala C, 2011, SCIENCE, V334, P303, DOI 10.1126/science.334.6054.303; Shiklomanov I.A., 2004, WORLD WATER RESOURCE, P417; Wada Y, 2014, EARTH SYST DYNAM, V5, P15, DOI 10.5194/esd-5-15-2014; Wada Y, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104003; [No title captured]	10	20	21	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					179	180		10.1038/516179a	http://dx.doi.org/10.1038/516179a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6ML	25503230				2022-12-28	WOS:000346383500032
J	Sumner, P; Vivian-Griffiths, S; Boivin, J; Williams, A; Venetis, CA; Davies, A; Ogden, J; Whelan, L; Hughes, B; Dalton, B; Boy, F; Chambers, CD				Sumner, Petroc; Vivian-Griffiths, Solveiga; Boivin, Jacky; Williams, Andy; Venetis, Christos A.; Davies, Aimee; Ogden, Jack; Whelan, Leanne; Hughes, Bethan; Dalton, Bethan; Boy, Fred; Chambers, Christopher D.			The association between exaggeration in health related science news and academic press releases: retrospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COVERAGE; QUALITY	Objective To identify the source (press releases or news) of distortions, exaggerations, or changes to the main conclusions drawn from research that could potentially influence a reader's health related behaviour. Design Retrospective quantitative content analysis. Setting Journal articles, press releases, and related news, with accompanying simulations. Sample Press releases (n=462) on biomedical and health related science issued by 20 leading UK universities in 2011, alongside their associated peer reviewed research papers and news stories (n=668). Main outcome measures Advice to readers to change behaviour, causal statements drawn from correlational research, and inference to humans from animal research that went beyond those in the associated peer reviewed papers. Results 40% (95% confidence interval 33% to 46%) of the press releases contained exaggerated advice, 33% (26% to 40%) contained exaggerated causal claims, and 36% (28% to 46%) contained exaggerated inference to humans from animal research. When press releases contained such exaggeration, 58% (95% confidence interval 48% to 68%), 81% (70% to 93%), and 86% (77% to 95%) of news stories, respectively, contained similar exaggeration, compared with exaggeration rates of 17% (10% to 24%), 18% (9% to 27%), and 10% (0% to 19%) in news when the press releases were not exaggerated. Odds ratios for each category of analysis were 6.5 (95% confidence interval 3.5 to 12), 20 (7.6 to 51), and 56 (15 to 211). At the same time, there was little evidence that exaggeration in press releases increased the uptake of news. Conclusions Exaggeration in news is strongly associated with exaggeration in press releases. Improving the accuracy of academic press releases could represent a key opportunity for reducing misleading health related news.	[Sumner, Petroc; Vivian-Griffiths, Solveiga; Chambers, Christopher D.] Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr, Cardiff CF10 3AT, S Glam, Wales; [Sumner, Petroc; Vivian-Griffiths, Solveiga; Boivin, Jacky; Davies, Aimee; Ogden, Jack; Whelan, Leanne; Hughes, Bethan; Dalton, Bethan; Chambers, Christopher D.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales; [Williams, Andy] Cardiff Univ, Sch Journalism Media & Cultural Studies, Cardiff CF10 3AT, S Glam, Wales; [Venetis, Christos A.] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW 2052, Australia; [Venetis, Christos A.] Univ Wollongong, Fac Sci Med & Hlth, Grad Sch Med, Wollongong, NSW 2522, Australia; [Boy, Fred] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales	Cardiff University; Cardiff University; Cardiff University; University of New South Wales Sydney; University of Wollongong; Swansea University	Sumner, P (corresponding author), Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr, Cardiff CF10 3AT, S Glam, Wales.	sumnerp@cardiff.ac.uk; chambersc1@cardiff.ac.uk	Dalton, Bethan/AAQ-6779-2020; Boivin, Jacky/A-1666-2010; Venetis, Christos/G-3719-2013	Boivin, Jacky/0000-0001-9498-1708; Venetis, Christos/0000-0001-9591-7222; Chambers, Chris/0000-0001-6058-4114; Dalton, Bethan/0000-0003-0898-1926	British Psychological Society; Experimental Psychology Society; Wales Institute of Cognitive Neuroscience; Wellcome Trust; Economic and Social Research Council; Biotechnology and Biological Sciences Research Council; Cardiff University; Economic and Social Research Council [ES/M000664/1] Funding Source: researchfish; ESRC [ES/M000664/1] Funding Source: UKRI	British Psychological Society; Experimental Psychology Society; Wales Institute of Cognitive Neuroscience; Wellcome Trust(Wellcome TrustEuropean Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cardiff University; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was supported by grants from the British Psychological Society, Experimental Psychology Society, Wales Institute of Cognitive Neuroscience, the Wellcome Trust, the Economic and Social Research Council, the Biotechnology and Biological Sciences Research Council, and Cardiff University.	Bartlett C, 2002, BRIT MED J, V325, P81, DOI 10.1136/bmj.325.7355.81; Bauer MW, 2008, JOURNALISM SCI SOC; Boyce Tammy, 2007, HLTH RISK NEWS MMR V; Brechman J, 2009, SCI COMMUN, V30, P453, DOI 10.1177/1075547009332649; Cooper BEJ, 2012, PUBLIC UNDERST SCI, V21, P664, DOI 10.1177/0963662511401782; de Semir V, 1998, JAMA-J AM MED ASSOC, V280, P294, DOI 10.1001/jama.280.3.294; Deer Brian, 2011, BMJ, V342, pc5347, DOI 10.1136/bmj.c5347; Gandy OH, 1982, AGENDA SETTING; Grilli R., 2002, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD000389; Kiernan V., 2006, EMBARGOED SCI; Kitzinger J, 2004, FRAMING ABUSE; Leveson B., 2012, INQUIRY CULTURE PRAC, p[22, 80, 690, 1803]; Lewis J, 2001, PUBLIC OPINION; Lewis J, 2008, JOURNALISM STUD, V9, P1, DOI 10.1080/14616700701767974; Nelkin D., 1995, SELLING SCI; PHILLIPS DP, 1991, NEW ENGL J MED, V325, P1180, DOI 10.1056/NEJM199110173251620; Ramsay ME, 2013, ARCH DIS CHILD, V98, P752, DOI 10.1136/archdischild-2013-304292; Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164; Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095; Science Media Centre, 2012, 10 BEST PRACT GUID F; Sharma V, 2003, ARCH PEDIAT ADOL MED, V157, P257, DOI 10.1001/archpedi.157.3.257; Sturgis P, 2004, PUBLIC UNDERST SCI, V13, P55, DOI 10.1177/0963662504042690; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Williams A., 2009, MAPPING FIELD SPECIA; Woloshin S, 2009, ANN INTERN MED, V150, P613, DOI 10.7326/0003-4819-150-9-200905050-00007; Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308	27	193	194	2	41	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2014	349								g7015	10.1136/bmj.g7015	http://dx.doi.org/10.1136/bmj.g7015			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3DF	25498121	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000346165000001
J	Kibuuka, H; Berkowitz, NM; Millard, M; Enama, ME; Tindikahwa, A; Sekiziyivu, AB; Costner, P; Sitar, S; Glover, D; Hu, ZH; Joshi, G; Stanley, D; Kunchai, M; Eller, LA; Bailer, RT; Koup, RA; Nabel, GJ; Mascola, JR; Sullivan, NJ; Graham, BS; Roederer, M; Michael, NL; Robb, ML; Ledgerwood, JE				Kibuuka, Hannah; Berkowitz, Nina M.; Millard, Monica; Enama, Mary E.; Tindikahwa, Allan; Sekiziyivu, Arthur B.; Costner, Pamela; Sitar, Sandra; Glover, Deline; Hu, Zonghui; Joshi, Gyan; Stanley, Daphne; Kunchai, Meghan; Eller, Leigh Anne; Bailer, Robert T.; Koup, Richard A.; Nabel, Gary J.; Mascola, John R.; Sullivan, Nancy J.; Graham, Barney S.; Roederer, Mario; Michael, Nelson L.; Robb, Merlin L.; Ledgerwood, Julie E.		RV 247 Study Team	Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial	LANCET			English	Article							NONHUMAN-PRIMATES; NEUTROPENIA; VACCINATION; INFECTION; FEVER	Background Ebola virus and Marburg virus cause serious disease outbreaks with high case fatality rates. We aimed to assess the safety and immunogenicity of two investigational DNA vaccines, one (EBO vaccine) encoding Ebola virus Zaire and Sudan glycoproteins and one (MAR) encoding Marburg virus glycoprotein. Methods RV 247 was a phase 1b, double-blinded, randomised, placebo-controlled clinical trial in Kampala, Uganda to examine the safety and immunogenicity of the EBO and MAR vaccines given individually and concomitantly. Healthy adult volunteers aged 18-50 years were randomly assigned (5: 1) to receive three injections of vaccine or placebo at weeks 0, 4, and 8, with vaccine allocations divided equally between three active vaccine groups: EBO vaccine only, MAR vaccine only, and both vaccines. The primary study objective was to investigate the safety and tolerability of the vaccines, as assessed by local and systemic reactogenicity and adverse events. We also assessed immunogenicity on the basis of antibody responses (ELISA) and T-cell responses (ELISpot and intracellular cytokine staining assays) 4 weeks after the third injection. Participants and investigators were masked to group assignment. Analysis was based on the intention-to-treat principle. This trial is registered at ClinicalTrials.gov, number NCT00997607. Findings 108 participants were enrolled into the study between Nov 2, 2009, and April 15, 2010. All 108 participants received at least one study injection (including 100 who completed the injection schedule) and were included in safety and tolerability analyses; 107 for whom data were available were included in the immunogenicity analyses. Study injections were well tolerated, with no significant differences in local or systemic reactions between groups. The vaccines elicited antibody and T-cell responses specific to the glycoproteins received and we detected no differences between the separate and concomitant use of the two vaccines. 17 of 30 (57%, 95% CI 37-75) participants in the EBO vaccine group had an antibody response to the Ebola Zaire glycoprotein, as did 14 of 30 (47%, 28-66) in the group that received both vaccines. 15 of 30 (50%, 31-69) participants in the EBO vaccine group had an antibody response to the Ebola Sudan glycoprotein, as did 15 of 30 (50%, 31-69) in the group that received both vaccines. Nine of 29 (31%, 15-51) participants in the MAR vaccine groups had an antibody response to the Marburg glycoprotein, as did seven of 30 (23%, 10-42) in the group that received both vaccines. 19 of 30 (63%, 44-80) participants in the EBO vaccine group had a T-cell response to the Ebola Zaire glycoprotein, as did 10 of 30 (33%, 17-53) in the group that received both vaccines. 13 of 30 (43%, 25-63) participants in the EBO vaccine group had a T-cell response to the Ebola Sudan glycoprotein, as did 10 of 30 (33%, 17-53) in the group that received both vaccines. 15 of 29 (52%, 33-71) participants in the MAR vaccine group had a T-cell response to the Marburg glycoprotein, as did 13 of 30 (43%, 25-63) in the group that received both vaccines. Interpretation This study is the first Ebola or Marburg vaccine trial done in Africa, and the results show that, given separately or together, both vaccines were well tolerated and elicited antigen-specific humoral and cellular immune responses. These findings have contributed to the accelerated development of more potent Ebola virus vaccines that encode the same wild-type glycoprotein antigens as the EBO vaccine, which are being assessed during the 2014 Ebola virus disease outbreak in west Africa.	[Kibuuka, Hannah; Millard, Monica; Tindikahwa, Allan; Sekiziyivu, Arthur B.] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Berkowitz, Nina M.; Enama, Mary E.; Costner, Pamela; Sitar, Sandra; Stanley, Daphne; Bailer, Robert T.; Koup, Richard A.; Nabel, Gary J.; Mascola, John R.; Sullivan, Nancy J.; Graham, Barney S.; Roederer, Mario; Ledgerwood, Julie E.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Hu, Zonghui] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA; [Glover, Deline; Eller, Leigh Anne; Michael, Nelson L.; Robb, Merlin L.] US Mil HIV Res Program, Bethesda, MD USA; [Joshi, Gyan] Frederick Natl Lab Canc Res, Clin Monitoring Res Program, Leidos Biomed Res, Frederick, MD USA; [Kunchai, Meghan] EMMES Corp, Rockville, MD USA; [Nabel, Gary J.] Sanofi, Cambridge, MA USA; [Michael, Nelson L.] Walter Reed Army Inst Res, Silver Spring, MD USA	Makerere University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emmes Corporation; Sanofi-Aventis; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Ledgerwood, JE (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	Ledgerwood@mail.nih.gov	Mascola, John/AAI-7193-2021; Graham, Barney S./AAC-5898-2019; Roederer, Mario/G-1887-2011	Graham, Barney S./0000-0001-8112-0853; 	US Department of Defense Infectious Disease Clinical Research Program; US National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005072, ZICAI005123, ZICAI005124, ZIAAI005047, ZIAAI005020, ZIAAI005073, ZIAAI005021] Funding Source: NIH RePORTER	US Department of Defense Infectious Disease Clinical Research Program; US National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	US Department of Defense Infectious Disease Clinical Research Program and US National Institutes of Health Intramural Research Program.	Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858; ClinicalTrials.gov, 2014, SAF TOL IMM EB CHIMP; Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Graham BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059340; Haddy TB, 1999, J LAB CLIN MED, V133, P15, DOI 10.1053/lc.1999.v133.a94931; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Hsieh MM, 2007, ANN INTERN MED, V146, P486, DOI 10.7326/0003-4819-146-7-200704030-00004; Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299; Kuhn JH, 2014, ARCH VIROL, V159, P1229, DOI 10.1007/s00705-013-1877-2; Lamontagne F, 2014, NEW ENGL J MED, V371, P1565, DOI 10.1056/NEJMp1411310; Ledgerwood JE, 2010, VACCINE, V29, P304, DOI 10.1016/j.vaccine.2010.10.037; Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; MacNeil A, 2010, EMERG INFECT DIS, V16, P1969, DOI 10.3201/eid1612.100627; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Mbonye A, 2012, AFR HEALTH SCI, V12, P579, DOI 10.4314/ahs.v12i4.31; Meslin FX, 1997, EMERG INFECT DIS, V3, P223, DOI 10.3201/eid0302.970220; Muyanja E, 2014, J CLIN INVEST, V124, P3147, DOI 10.1172/JCI75429; Sarwar UN, 2014, J INFECT DIS; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Wittmann TJ, 2007, P NATL ACAD SCI USA, V104, P17123, DOI 10.1073/pnas.0704076104; World Health Organization, 2014, EB RESP ROADM SIT RE; World Health Organization (WHO), EB VIR DIS FACT SHEE	33	78	87	0	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1545	1554		10.1016/S0140-6736(14)62385-0	http://dx.doi.org/10.1016/S0140-6736(14)62385-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3ZT	25540891	Bronze			2022-12-28	WOS:000353220000036
J	Behringer, K; Goergen, H; Hitz, F; Zijlstra, JM; Greil, R; Markova, J; Sasse, S; Fuchs, M; Topp, MS; Soekler, M; Mathas, S; Meissner, J; Wilhelm, M; Koch, P; Lindemann, HW; Schalk, E; Semrau, R; Kriz, J; Vieler, T; Bentz, M; Lange, E; Mahlberg, R; Hassler, A; Vogelhuber, M; Hahn, D; Mezger, J; Krause, SW; Skoetz, N; Boll, B; von Tresckow, B; Diehl, V; Hallek, M; Borchmann, P; Stein, H; Eich, H; Engert, A				Behringer, Karolin; Goergen, Helen; Hitz, Felicitas; Zijlstra, Josee M.; Greil, Richard; Markova, Jana; Sasse, Stephanie; Fuchs, Michael; Topp, Max S.; Soekler, Martin; Mathas, Stephan; Meissner, Julia; Wilhelm, Martin; Koch, Peter; Lindemann, Hans-Walter; Schalk, Enrico; Semrau, Robert; Kriz, Jan; Vieler, Tom; Bentz, Martin; Lange, Elisabeth; Mahlberg, Rolf; Hassler, Andre; Vogelhuber, Martin; Hahn, Dennis; Mezger, Joerg; Krause, Stefan W.; Skoetz, Nicole; Boell, Boris; von Tresckow, Bastian; Diehl, Volker; Hallek, Michael; Borchmann, Peter; Stein, Harald; Eich, Hans; Engert, Andreas		German Hodgkin Study Grp; Swiss Grp Clinical Canc Res; Arbeitsgemeinschaft Medikamentose	Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial	LANCET			English	Article							2ND MALIGNANCY RISK; RADIATION-THERAPY; COMBINED-MODALITY; FIELD RADIOTHERAPY; CLINICAL-TRIALS; 2 CYCLES; DISEASE; CHEMOTHERAPY; VINBLASTINE; METAANALYSIS	Background The role of bleomycin and dacarbazine in the ABVD regimen (ie, doxorubicin, bleomycin, vinblastine, and dacarbazine) has been questioned, especially for treatment of early-stage favourable Hodgkin's lymphoma, because of the drugs' toxicity. We aimed to investigate whether omission of either bleomycin or dacarbazine, or both, from ABVD reduced the efficacy of this regimen in treatment of Hodgkin's lymphoma. Methods In this open-label, randomised, multicentre trial (HD13) we compared two cycles of ABVD with two cycles of the reduced-intensity regimen variants ABV (doxorubicin, bleomycin, and vinblastine), AVD (doxorubicin, vinblastine, and dacarbazine), and AV (doxorubicin and vinblastine), in patients with newly diagnosed, histologically proven, classic or nodular, lymphocyte predominant Hodgkin's lymphoma. In each treatment group, 30 Gy involved-field radiotherapy (IFRT) was given after both cycles of chemotherapy were completed. From Jan 28, 2003, patients were centrally randomly assigned (1:1:1:1) with a minimisation method to the four groups. Because of high event rates, assignment to the AV and ABV groups stopped early, on Sept 30, 2005, and Feb 10, 2006; assignment to ABVD and AVD continued (1:1) until Sept 30, 2009. Our primary objective was to show non-inferiority of the experimental variants compared with ABVD in terms of freedom from treatment failure (FFTF), by excluding a difference of 6% after 5 years corresponding to a hazard ratio (HR) of 1.72, via a 95% CI. Analyses reported here include qualified patients only, and between-group comparisons include only patients recruited during the same period. The trial was registered, number ISRCTN63474366. Findings Of 1502 qualified patients, 566, 198, 571, and 167 were randomly assigned to receive ABVD, ABV, AVD, or AV, respectively. 5 year FFTF was 93.1%, 81.4%, 89.2%, and 77.1% with ABVD, ABV, AVD, and AV, respectively. Compared with ABVD, inferiority of the dacarbazine-deleted variants was detected with 5 year differences of -11.5% (95% CI -18.3 to -4.7; HR 2.06 [1.21 to 3.52]) for ABV and -15.2% (-23.0 to -7.4; HR 2.57 [1.51 to 4.40]) for AV. Non-inferiority of AVD compared with ABVD could also not be detected (5 year difference -3.9%, -7.7 to -0.1; HR 1.50, 1.00 to 2.26). 178 (33%) of 544 patients given ABVD had WHO grade III or IV toxicity, compared with 53 (28%) of 187 given ABV, 142 (26%) of 539 given AVD, and 40 (26%) of 151 given AV. Leucopenia was the most common event, and highest in the groups given bleomycin. Interpretation Dacarbazine cannot be omitted from ABVD without a substantial loss of efficacy. With respect to our predefined non-inferiority margin, bleomycin cannot be safely omitted either, and the standard of care for patients with early-stage favourable Hodgkin's lymphoma should remain ABVD followed by IFRT.	[Behringer, Karolin; Goergen, Helen; Sasse, Stephanie; Boell, Boris; von Tresckow, Bastian; Diehl, Volker; Borchmann, Peter; Engert, Andreas] Univ Hosp Cologne, Dept Internal Med 1, German Hodgkin Study Grp, D-50924 Cologne, Germany; [Hitz, Felicitas] Cantonal Hosp St Gallen, St Gallen, Switzerland; [Hitz, Felicitas] SAKK Swiss Grp Clin Canc Res, Bern, Switzerland; [Zijlstra, Josee M.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Greil, Richard] Paracelcus Med Univ, Dept Med 3, Salzburg, Austria; [Markova, Jana] Charles Univ Prague, Univ Hosp Kralovske Vinohrady, Fac Med 3, Prague, Czech Republic; [Topp, Max S.] Univ Hosp Wurzburg, Wurzburg, Germany; [Soekler, Martin] Univ Tubingen, Tubingen, Germany; [Mathas, Stephan] Charite, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Meissner, Julia] Heidelberg Univ, Heidelberg, Germany; [Wilhelm, Martin] Klinikum Nurnberg, Nurnberg, Germany; [Koch, Peter; Kriz, Jan; Eich, Hans] Univ Hosp Munster, Munster, Germany; [Lindemann, Hans-Walter] Kathol Krankenhaus, Hagen, Germany; [Schalk, Enrico] Otto Von Guericke Univ, Dept Haematol & Oncol, Med Ctr, Magdeburg, Germany; [Semrau, Robert] Univ Hosp Cologne, Dept Radiat Oncol, Cologne, Germany; [Vieler, Tom] Univ Klin Schleswig Holstein, Med Klin, Kiel, Germany; [Bentz, Martin] Stadt Klinikum Karlsruhe, Med Klin, Karlsruhe, Germany; [Lange, Elisabeth] Evangel Krankenhaus, Med Klin, Hematol Onkol, Hamm, Germany; [Mahlberg, Rolf] Krankenanstalt Mutterhaus Borromaerinnen, Med Klin, Trier, Germany; [Hassler, Andre] Charite Campus Mitte, Zentrum Innere Med, Hamatol Onkol, Berlin, Germany; [Vogelhuber, Martin] Univ Klin Regensburg, Med Klin, Regensburg, Germany; [Hahn, Dennis] Katharinen Hosp, Klin Onkol, D-70174 Stuttgart, Germany; [Mezger, Joerg] St Vincentius Kliniken GAG, Palliat Med, Med Klin Hamatol, Onkol,Immunol, Karlsruhe, Germany; [Krause, Stefan W.] Univ Erlangen Nurnberg, Dept Internal Med 5, Haematol Oncol, Erlangen, Germany; [Skoetz, Nicole] Univ Hosp Cologne, Cochrane Haematol Malignancies Grp, Dept Internal Med 1, Cologne, Germany; [Hallek, Michael] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Stein, Harald] Berlin Reference Ctr Lymphoma & Haematopathol, Berlin, Germany	University of Cologne; Kantonsspital St. Gallen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Paracelsus Private Medical University; Charles University Prague; University Hospital Vinohrady; University of Wurzburg; Eberhard Karls University of Tubingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Klinikum Nurnberg Nord; University of Munster; Otto von Guericke University; University of Cologne; University of Kiel; Schleswig Holstein University Hospital; Municipal Hospital Karlsruhe; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Regensburg; Klinikum Stuttgart; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg; University of Cologne; University of Cologne	Engert, A (corresponding author), Univ Hosp Cologne, Dept Internal Med 1, D-50924 Cologne, Germany.	a.engert@uni-koeln.de	Mathas, Stephan/I-5589-2015; Schalk, Enrico/X-9283-2019; sasse, stephanie/AAV-3317-2020; Hallek, Michael/Y-3191-2019; Greil, Richard F/C-7673-2017; Semrau, Robert/S-2505-2017	Schalk, Enrico/0000-0003-1892-5098; sasse, stephanie/0000-0002-1080-4606; Hallek, Michael/0000-0002-7425-4455; Greil, Richard F/0000-0002-4462-3694; Krause, Stefan/0000-0002-5259-4651	Deutsche Krebshilfe; Swiss State Secretariat for Education and Research	Deutsche Krebshilfe(Deutsche Krebshilfe); Swiss State Secretariat for Education and Research	Deutsche Krebshilfe and Swiss State Secretariat for Education and Research.	AVILES A, 1995, MED PEDIATR ONCOL, V24, P171, DOI 10.1002/mpo.2950240306; Buchler T, 2007, HAEMATOLOGICA, V92, pE120, DOI 10.3324/haematol.11856; Canellos GP, 2004, J CLIN ONCOL, V22, P1532, DOI 10.1200/JCO.2004.99.010; CARDE P, 1993, J CLIN ONCOL, V11, P2258, DOI 10.1200/JCO.1993.11.11.2258; Carde PP, 2012, J CLIN ONCOL, V30; Eghbali H, 2005, BLOOD, V106, p240A; Engert A, 2007, J CLIN ONCOL, V25, P3495, DOI 10.1200/JCO.2006.07.0482; Engert A, 2010, NEW ENGL J MED, V363, P640, DOI 10.1056/NEJMoa1000067; Ferme C, 2007, NEW ENGL J MED, V357, P1916, DOI 10.1056/NEJMoa064601; Franklin J, 2006, ANN ONCOL, V17, P1749, DOI 10.1093/annonc/mdl302; Hamed R H, 2012, Hematol Oncol Stem Cell Ther, V5, P36, DOI 10.5144/1658-3876.2012.36; Herbst C, 2011, COCHRANE DB SYST REV, V2; Hodgson DC, 2011, HEMATOL MALIG, P305, DOI 10.1007/978-3-642-12780-9_22; Horning SJ, 2002, J CLIN ONCOL, V20, P630, DOI 10.1200/JCO.20.3.630; le Maignan C, 2004, BLOOD, V103, P58, DOI 10.1182/blood-2003-05-1611; Loeffler M, 1998, J CLIN ONCOL, V16, P818, DOI 10.1200/JCO.1998.16.3.818; Martin WG, 2005, J CLIN ONCOL, V23, P7614, DOI 10.1200/JCO.2005.02.7243; Meyer RM, 2012, NEW ENGL J MED, V366, P399, DOI 10.1056/NEJMoa1111961; Meyer RM, 2005, J CLIN ONCOL, V23, P4634, DOI 10.1200/JCO.2005.09.085; Nachman JB, 2002, J CLIN ONCOL, V20, P3765, DOI 10.1200/JCO.2002.12.007; Ng AK, 2002, J CLIN ONCOL, V20, P2101, DOI 10.1200/JCO.2002.08.021; Noordijk EM, 2005, J CLIN ONCOL, V23, p561S, DOI 10.1200/jco.2005.23.16_suppl.6505; Press OW, 2001, J CLIN ONCOL, V19, P4238, DOI 10.1200/JCO.2001.19.22.4238; Sharma A, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.8533; Sieniawski M, 2007, J CLIN ONCOL, V25, P2000, DOI 10.1200/JCO.2006.10.1386; Specht L, 1998, J CLIN ONCOL, V16, P830, DOI 10.1200/JCO.1998.16.3.830; Specht L, 2003, BLOOD, V102, p637A; Straus DJ, 2004, BLOOD, V104, P3483, DOI 10.1182/blood-2004-04-1311; TUBIANA M, 1989, BLOOD, V73, P47; van Leeuwen FE, 2000, J CLIN ONCOL, V18, P487, DOI 10.1200/JCO.2000.18.3.487; von Tresckow B, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.637.637	31	112	112	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1418	1427		10.1016/S0140-6736(14)61469-0	http://dx.doi.org/10.1016/S0140-6736(14)61469-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF7EU	25539730				2022-12-28	WOS:000352719800030
J	Rebsamen, M; Pochini, L; Stasyk, T; de Araujo, MEG; Galluccio, M; Kandasamy, RK; Snijder, B; Fauster, A; Rudashevskaya, EL; Bruckner, M; Scorzoni, S; Filipek, PA; Huber, KVM; Bigenzahn, JW; Heinz, LX; Kraft, C; Bennett, KL; Indiveri, C; Huber, LA; Superti-Furga, G				Rebsamen, Manuele; Pochini, Lorena; Stasyk, Taras; de Araujo, Mariana E. G.; Galluccio, Michele; Kandasamy, Richard K.; Snijder, Berend; Fauster, Astrid; Rudashevskaya, Elena L.; Bruckner, Manuela; Scorzoni, Stefania; Filipek, Przemyslaw A.; Huber, Kilian V. M.; Bigenzahn, Johannes W.; Heinz, Leonhard X.; Kraft, Claudine; Bennett, Keiryn L.; Indiveri, Cesare; Huber, Lukas A.; Superti-Furga, Giulio			SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1	NATURE			English	Article							MASS-SPECTROMETRY DATA; RAG GTPASES; MEMBRANE TRANSPORTERS; PROTEOMIC ANALYSIS; TUMOR-SUPPRESSOR; PROTEIN-COMPLEX; MECHANISM; IDENTIFICATION; STRATEGIES; RAGULATOR	Cell growth and proliferation are tightly linked to nutrient availability. The mechanistic target of rapamycin complex 1 (mTORC1) integrates the presence of growth factors, energy levels, glucose and amino acids to modulate metabolic status and cellular responses(1-3). mTORC1 is activated at the surface of lysosomes by the RAG GTPases and the Ragulator complex through a not fully understood mechanism monitoring amino acid availability in the lysosomal lumen and involving the vacuolar H1-ATPase(4-8). Here we describe the uncharacterized human member 9 of the solute carrier family 38 (SLC38A9) as a lysosomal membrane-resident protein competent in amino acid transport. Extensive functional proteomic analysis established SLC38A9 as an integral part of the Ragulator-RAG GTPases machinery. Gain of SLC38A9 function rendered cells resistant to amino acid withdrawal, whereas loss of SLC38A9 expression impaired amino-acid-induced mTORC1 activation. Thus SLC38A9 is a physical and functional component of the amino acid sensing machinery that controls the activation of mTOR.	[Rebsamen, Manuele; Kandasamy, Richard K.; Snijder, Berend; Fauster, Astrid; Rudashevskaya, Elena L.; Bruckner, Manuela; Scorzoni, Stefania; Huber, Kilian V. M.; Bigenzahn, Johannes W.; Heinz, Leonhard X.; Bennett, Keiryn L.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Pochini, Lorena; Galluccio, Michele; Indiveri, Cesare] Univ Calabria, Dept DiBEST Biol Ecol & Earth Sci, I-87036 Arcavacata Di Rende, Italy; [Stasyk, Taras; de Araujo, Mariana E. G.; Filipek, Przemyslaw A.; Huber, Lukas A.] Med Univ Innsbruck, Div Cell Biol, Bioctr, A-6020 Innsbruck, Austria; [Kraft, Claudine] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; University of Calabria; Medical University of Innsbruck; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Superti-Furga, G (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria.	gsuperti@cemm.oeaw.ac.at	Superti-Furga, Giulio/AAE-5681-2019; Snijder, Berend/M-2998-2017; Galluccio, Michele/AAE-1478-2021; Pochini, Lorena/AAD-3337-2019; Huber, Kilian V. M./L-6921-2015; Snijder, Berend/O-9206-2019; Galluccio, Michele/AAA-3972-2020; Huber, Lukas Alfons/AAM-3499-2021; Superti-Furga, Giulio/F-4755-2015; Rebsamen, Manuele/A-7980-2011; Kandasamy, Richard Kumaran/C-8981-2009	Snijder, Berend/0000-0003-3386-6583; Huber, Kilian V. M./0000-0002-1103-5300; Galluccio, Michele/0000-0001-6268-9489; Superti-Furga, Giulio/0000-0002-0570-1768; Rebsamen, Manuele/0000-0001-6172-4211; Kandasamy, Richard Kumaran/0000-0002-0894-1222; Fauster, Astrid/0000-0003-4608-5604; Bigenzahn, Johannes/0000-0002-5214-4570; Bennett, Keiryn L./0000-0001-9356-7708; Heinz, Leonhard/0000-0002-6921-1493; Eca Guimaraes de Araujo, Mariana/0000-0003-0576-2680; Stasyk, Taras/0000-0003-0568-6841; Scorzoni, Stefania/0000-0002-2049-3688; Huber, Lukas Alfons/0000-0003-1116-2120	Austrian Academy of Sciences; ERC [i-FIVE 250179]; EMBO [ALTF 1346-2011, IEF 301663, ALTF 314-2012]; Swiss NSF [P300P3_147897]; Vienna Science and Technology Fund [WWTF VRG10-001]; Austrian Science Fund [FWF P 25522-B20, MCBO/SFB021]; Italian Ministry of Instruction University and Research, PON-ricerca e competitivita [PON01_00937]; Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF) [P 25522] Funding Source: researchfish	Austrian Academy of Sciences; ERC(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Swiss NSF(Swiss National Science Foundation (SNSF)); Vienna Science and Technology Fund; Austrian Science Fund(Austrian Science Fund (FWF)); Italian Ministry of Instruction University and Research, PON-ricerca e competitivita; Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank D. M. Sabatini, S. Wang and Z. Tsun for discussing results before publication and generously providing Flag-SLC38A9 and Flag-METAP2 stably expressing cells, all members of the Superti-Furga laboratory for discussions, the Bennett laboratory for the proteomic analyses, F. Pauler and the Barlow laboratory for the RNA-seq analysis and M. Gstaiger for providing expression vectors. This work was supported by the Austrian Academy of Sciences, ERC grant to G.S.-F. (i-FIVE 250179), EMBO long-term and Marie Curie fellowships to M.R. (ALTF 1346-2011, IEF 301663), EMBO long-term fellowship to R.K.K. (ALTF 314-2012), Swiss NSF fellowship (P300P3_147897) to B.S., Vienna Science and Technology Fund (WWTF VRG10-001) and the Austrian Science Fund (FWF P 25522-B20) to C.K., the Italian Ministry of Instruction University and Research, PON-ricerca e competitivita 2007-2013 (no. PON01_00937) to C.I., the Austrian Federal Ministry for Science and Research (GenAu projects, APP-III and BIN-III) to L.A.H., K.L.B. and G.S.-F., the Austrian Science Fund MCBO/SFB021 to L.A.H.	Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Colinge J, 2003, PROTEOMICS, V3, P1454, DOI 10.1002/pmic.200300485; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Galluccio M, 2009, PROTEIN EXPRES PURIF, V68, P215, DOI 10.1016/j.pep.2009.06.015; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Giambruno R, 2013, J PROTEOME RES, V12, P4018, DOI 10.1021/pr4003323; Goberdhan DCI, 2005, DEVELOPMENT, V132, P2365, DOI 10.1242/dev.01821; Hagglund MGA, 2011, J BIOL CHEM, V286, P20500, DOI 10.1074/jbc.M110.162404; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Ogmundsdottir MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036616; Oppedisano F, 2011, BBA-BIOMEMBRANES, V1808, P2551, DOI 10.1016/j.bbamem.2011.05.011; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; Pochini L, 2011, BIOCHEM J, V439, P227, DOI 10.1042/BJ20110544; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schioth HB, 2013, MOL ASPECTS MED, V34, P571, DOI 10.1016/j.mam.2012.07.012; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Taylor PM, 2009, BIOCHEM SOC T, V37, P237, DOI 10.1042/BST0370237; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Varjosalo M, 2013, NAT METHODS, V10, P307, DOI [10.1038/NMETH.2400, 10.1038/nmeth.2400]; Wu BQ, 2006, J CELL BIOL, V173, P327, DOI 10.1083/jcb.200602089; Zhang Z, 2008, J BIOL CHEM, V283, P12284, DOI 10.1074/jbc.M706774200; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	40	427	455	6	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					477	+		10.1038/nature14107	http://dx.doi.org/10.1038/nature14107			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25561175	Green Accepted			2022-12-28	WOS:000351602800057
J	Naghavi, M; Wang, HD; Lozano, R; Davis, A; Liang, XF; Zhou, MG; Vollset, SE; Ozgoren, AA; Abdalla, S; Abd-Allah, F; Aziz, MIA; Abera, SF; Aboyans, V; Abraham, B; Abraham, JP; Abuabara, KE; Abubakar, I; Abu-Raddad, LJ; Abu-Rmeileh, NME; Achoki, T; Adelekan, A; Ademi, ZN; Adofo, K; Adou, AK; Adsuar, JC; Arnlov, J; Agardh, EE; Akena, D; Al Khabouri, MJ; Alasfoor, D; Albittar, M; Alegretti, MA; Aleman, AV; Alemu, ZA; Alfonso-Cristancho, R; Alhabib, S; Ali, MK; Ali, R; Alla, F; Al Lami, F; Allebeck, P; AlMazroa, MA; Salman, RAS; Alsharif, U; Alvarez, E; Alviz-Guzman, N; Amankwaa, AA; Amare, AT; Ameli, O; Amini, H; Ammar, W; Anderson, HR; Anderson, BO; Antonio, CAT; Anwari, P; Apfel, H; Cunningham, SA; Arsenijevic, VSA; Al Artaman; Asad, MM; Asghar, RJ; Assadi, R; Atkins, LS; Atkinson, C; Badawi, A; Bahit, MC; Bakfalouni, T; Balakrishnan, K; Balalla, S; Banerjee, A; Barber, RM; Barker-Collo, SL; Barquera, S; Barregard, L; Barrero, LH; Barrientos-Gutierrez, T; Basu, A; Basu, S; Basulaiman, MO; Beardsley, J; Bedi, N; Beghi, E; Bekele, T; Bell, ML; Benjet, C; Bennett, DA; Bensenor, IM; Benzian, H; Bertozzi-Villa, A; Beyene, TJ; Bhala, N; Bhalla, A; Bhutta, ZA; Bikbov, B; Bin Abdulhak, A; Biryukov, S; Blore, JD; Blyth, FM; Bohensky, MA; Borges, G; Bose, D; Boufous, S; Bourne, RR; Boyers, LN; Brainin, M; Brauer, M; Brayne, CEG; Brazinova, A; Breitborde, N; Brenner, H; Briggs, ADM; Brown, JC; Brugha, TS; Buckle, GC; Bui, LN; Bukhman, G; Burch, M; Nonato, IRC; Carabin, H; Cardenas, R; Carapetis, J; Carpenter, DO; Caso, V; Castaneda-Orjuela, CA; Castro, RE; Catala-Lopez, F; Cavalleri, F; Chang, JC; Charlson, FC; Che, X; Chen, HL; Chen, YY; Chen, JS; Chen, ZM; Chiang, PPC; Chimed-Ochir, O; Chowdhury, R; Christensen, H; Christophi, CA; Chuang, TW; Chugh, SS; Cirillo, M; Coates, MM; Coffeng, LE; Coggeshall, MS; Cohen, A; Colistro, V; Colquhoun, SM; Colomar, M; Cooper, LT; Cooper, C; Coppola, LM; Cortinovis, M; Courville, K; Cowie, BC; Criqui, MH; Crump, JA; Cuevas-Nasu, L; Leite, IDC; Dabhadkar, KC; Dandona, L; Dandona, R; Dansereau, E; Dargan, PI; Dayama, A; De la Cruz-Gongora, V; de la Vega, SF; De Leo, D; Degenhardt, L; del Pozo-Cruz, B; Dellavalle, RP; Deribe, K; Jarlais, DCD; Dessalegn, M; deVeber, GA; Dharmaratne, SD; Dherani, M; Diaz-Ortega, JL; Diaz-Torne, C; Dicker, D; Ding, EL; Dokova, K; Dorsey, ER; Driscoll, TR; Duan, LL; Duber, HC; Durrani, AM; Ebel, BE; Edmond, KM; Ellenbogen, RG; Elshrek, Y; Ermakov, SP; Erskine, HE; Eshrati, B; Esteghamati, A; Estep, K; Furst, T; Fahimi, S; Fahrion, AS; Faraon, EJA; Farzadfar, F; Fay, DFJ; Feigl, AB; Feigin, VL; Felicio, MM; Fereshtehnejad, SM; Fernandes, JG; Ferrari, AJ; Fleming, TD; Foigt, N; Foreman, K; Forouzanfar, MH; Fowkes, FGR; Paleo, UF; Franklin, RC; Futran, ND; Gaffikin, L; Gambashidze, K; Gankpe, FG; Garcia-Guerra, FA; Garcia, AC; Geleijnse, JM; Gessner, BD; Gibney, KB; Gillum, RF; Gilmour, S; Abdelmageem, I; Ginawi, M; Giroud, M; Glaser, EL; Goenka, S; Dantes, HG; Gona, P; Gonzalez-Medina, D; Guinovart, C; Gupta, R; Gupta, R; Gosselin, RA; Gotay, CC; Goto, A; Gowda, HN; Graetz, N; Greenwell, KF; Gugnani, HC; Gunnell, D; Gutierrez, RA; Haagsma, J; Hafezi-Nejad, N; Hagan, H; Hagstromer, M; Halasa, YA; Hamadeh, RR; Hamavid, H; Hammami, M; Hancock, J; Hankey, GJ; Hansen, GM; Harb, HL; Harewood, H; Haro, JM; Havmoeller, R; Hay, RJ; Hay, SI; Hedayati, MT; Pi, IBH; Heuton, KR; Heydarpour, P; Higashi, H; Hijar, M; Hoek, HW; Hoffman, HJ; Hornberger, JC; Hosgood, HD; Hossain, M; Hotez, PJ; Hoy, DG; Hsairi, M; Hu, GQ; Huang, JJ; Huffman, MD; Hughes, AJ; Husseini, A; Huynh, C; Iannarone, M; Iburg, KM; Idrisov, BT; Ikeda, N; Innos, K; Inoue, M; Islami, F; Ismayilova, S; Jacobsen, KH; Jassal, S; Jayaraman, SP; Jensen, PN; Jha, V; Jiang, GH; Jiang, Y; Jonas, JB; Joseph, J; Juel, K; Kabagambe, EK; Kan, HD; Karch, A; Karimkhani, C; Karthikeyan, G; Kassebaum, N; Kaul, A; Kawakami, N; Kazanjan, K; Kazi, DS; Kemp, AH; Kengne, AP; Keren, A; Kereselidze, M; Khader, YS; Khalifa, SEAH; Khan, EA; Khan, G; Khang, YH; Kieling, C; Kinfu, Y; Kinge, JM; Kim, D; Kim, S; Kivipelto, M; Knibbs, L; Knudsen, AK; Kokubo, Y; Kosen, S; Kotagal, M; Kravchenko, MA; Krishnaswami, S; Krueger, H; Defo, BK; Kuipers, EJ; Bicer, BK; Kulkarni, C; Kulkarni, VS; Kumar, K; Kumar, RB; Kwan, GF; Kyu, H; Lai, T; Balaji, AL; Lalloo, R; Lallukka, T; Lam, H; Lan, Q; Lansingh, VC; Larson, HJ; Larsson, A; Lavados, PM; Lawrynowicz, AEB; Leasher, JL; Lee, JT; Leigh, J; Leinsalu, M; Leung, R; Levitz, C; Li, B; Li, YC; Li, YM; Liddell, C; Lim, SS; de Lima, GMF; Lind, ML; Lipshultz, SE; Liu, SW; Liu, Y; Lloyd, BK; Lofgren, KT; Logroscino, G; London, SJ; Lortet-Tieulent, J; Lotufo, PA; Lucas, RM; Lunevicius, R; Lyons, RA; Ma, S; Machado, VMP; MacIntyre, MF; Mackay, MT; MacLachlan, JH; Magis-Rodriguez, C; Mahdi, AA; Majdan, M; Malekzadeh, R; Mangalam, S; Mapoma, CC; Marape, M; Marcenes, W; Margono, C; Marks, GB; Marzan, MB; Masci, JR; Mashal, MTQ; Masiye, F; Mason-Jones, AJ; Matzopolous, R; Mayosi, BM; Mazorodze, TT; McGrath, JJ; Mckay, AC; Mckee, M; McLain, A; Meaney, PA; Mehndiratta, MM; Mejia-Rodriguez, F; Melaku, YA; Meltzer, M; Memish, ZA; Mendoza, W; Mensah, GA; Meretoja, A; Mhimbira, FA; Miller, TR; Mills, EJ; Misganaw, A; Mishra, SK; Mock, CN; Moffitt, TE; Ibrahim, NM; Mohammad, KA; Mokdad, AH; Mola, GL; Monasta, L; Monis, JD; Hernandez, JCM; Montico, M; Montine, TJ; Mooney, MD; Moore, AR; Moradi-Lakeh, M; Moran, AE; Mori, R; Moschandreas, J; Moturi, WN; Moyer, ML; Mozaffarian, D; Mueller, UO; Mukaigawara, M; Mullany, EC; Murray, J; Mustapha, A; Naghavi, P; Naheed, A; Naidoo, KS; Naldi, L; Nand, D; Nangia, V; Narayan, KMV; Nash, D; Nasher, J; Nejjari, C; Nelson, RG; Neuhouser, M; Neupane, SP; Newcomb, PA; Newman, L; Newton, CR; Ng, M; Ngalesoni, FN; Nguyen, G; Nguyen, NTT; Nisar, MI; Nolte, S; Norheim, OF; Norman, RE; Norrving, B; Nyakarahuka, L; Odell, S; O'Donnell, M; Ohkubo, T; Ohno, SL; Olusanya, BO; Omer, SB; Opio, JN; Orisakwe, OE; Ortblad, KF; Ortiz, A; Otayza, MLK; Pain, AW; Pandian, JD; Panelo, CI; Panniyammakal, J; Papachristou, C; Caicedo, AJP; Patten, SB; Patton, GC; Paul, VK; Pavlin, B; Pearce, N; Pellegrini, CA; Pereira, DM; Peresson, SC; Perez-Padilla, R; Perez-Ruiz, FP; Perico, N; Pervaiz, A; Pesudovs, K; Peterson, CB; Petzold, M; Phillips, BK; Phillips, DE; Phillips, MR; Plass, D; Piel, FB; Poenaru, D; Polinder, S; Popova, S; Poulton, RG; Pourmalek, F; Prabhakaran, D; Qato, D; Quezada, AD; Quistberg, DA; Rabito, F; Rafay, A; Rahimi, K; Rahimi-Movaghar, V; Rahman, SUR; Raju, M; Rakovac, I; Rana, SM; Refaat, A; Remuzzi, G; Ribeiro, AL; Ricci, S; Riccio, PM; Richardson, L; Richardus, JH; Roberts, B; Roberts, DA; Robinson, M; Roca, A; Rodriguez, A; Rojas-Rueda, D; Ronfani, L; Room, R; Roth, GA; Rothenbacher, D; Rothstein, DH; Rowley, JT; Roy, N; Ruhago, GM; Rushton, L; Sambandam, S; Soreide, K; Saeedi, MY; Saha, S; Sahathevan, R; Sahraian, MA; Sahle, BW; Salomon, JA; Salvo, D; Samonte, GMJ; Sampson, U; Sanabria, JR; Sandar, L; Santos, IS; Satpathy, M; Sawhney, M; Saylan, M; Scarborough, P; Schottker, B; Schmidt, JC; Schneider, IJC; Schumacher, AE; Schwebel, DC; Scott, JG; Sepanlou, SG; Servan-Mori, EE; Shackelford, K; Shaheen, A; Shahraz, S; Shakh-Nazarova, M; Shangguan, S; She, J; Sheikhbahaei, S; Shepard, DS; Shibuya, K; Shinohara, Y; Shishani, K; Shiue, I; Shivakoti, R; Shrime, MG; Sigfusdottir, ID; Silberberg, DH; Silva, AP; Simard, EP; Sindi, S; Singh, JA; Singh, L; Sioson, E; Skirbekk, V; Sliwa, K; So, S; Soljak, M; Soneji, S; Soshnikov, SS; Sposato, LA; Sreeramareddy, CT; Stanaway, JRD; Stathopoulou, VK; Steenland, K; Stein, C; Steiner, C; Stevens, A; Stoeckl, H; Straif, K; Stroumpoulis, K; Sturua, L; Sunguya, BF; Swaminathan, S; Swaroop, M; Sykes, BL; Tabb, KM; Takahashi, K; Talongwa, RT; Tan, F; Tanne, D; Tanner, M; Tavakkoli, M; Ao, BT; Teixeira, CM; Templin, T; Tenkorang, EY; Terkawi, AS; Thomas, BA; Thorne-Lyman, AL; Thrift, AG; Thurston, GD; Tillmann, T; Tirschwell, DL; Tleyjeh, IM; Tonelli, M; Topouzis, F; Towbin, JA; Toyoshima, H; Traebert, J; Tran, BX; Truelsen, T; Trujillo, U; Trillini, M; Dimbuene, ZT; Tsilimbaris, M; Tuzcu, EM; Ubeda, C; Uchendu, US; Ukwaja, KN; Undurraga, EA; Vallely, AJ; van de Vijver, S; van Gool, CH; Varakin, YY; Vasankari, TJ; Vasconcelos, AMN; Vavilala, MS; Venketasubramanian, N; Vijayakumar, L; Villalpando, S; Violante, FS; Vlassov, VV; Wagner, GR; Waller, SG; Wang, JL; Wang, L; Wang, XR; Wang, YP; Warouw, TS; Weichenthal, S; Weiderpass, E; Weintraub, RG; Wenzhi, W; Werdecker, A; Wessells, KRR; Westerman, R; Whiteford, HA; Wilkinson, JD; Williams, TN; Woldeyohannes, SM; Wolfe, CDA; Wolock, TM; Woolf, AD; Wong, JQ; Wright, JL; Wulf, S; Wurtz, B; Xu, GL; Yang, YC; Yano, Y; Yatsuya, H; Yip, P; Yonemoto, N; Yoon, SJ; Younis, M; Yu, CH; Jin, KY; Zaki, MES; Zamakhshary, MF; Zeeb, H; Zhang, Y; Zhao, Y; Zheng, YF; Zhu, J; Zhu, S; Zonies, D; Zou, XN; Zunt, JR; Vos, T; Lopez, AD; Murray, CJL				Naghavi, Mohsen; Wang, Haidong; Lozano, Rafael; Davis, Adrian; Liang, Xiaofeng; Zhou, Maigeng; Vollset, Stein Emil; Ozgoren, Ayse Abbasoglu; Abdalla, Safa; Abd-Allah, Foad; Aziz, Muna I. Abdel; Abera, Semaw Ferede; Aboyans, Victor; Abraham, Biju; Abraham, Jerry P.; Abuabara, Katrina E.; Abubakar, Ibrahim; Abu-Raddad, Laith J.; Abu-Rmeileh, Niveen M. E.; Achoki, Tom; Adelekan, Ademola; Ademi, Zanfi Na; Adofo, Koranteng; Adou, Arsene Kouablan; Adsuar, Jose C.; Arnlov, Johan; Agardh, Emilie Elisabet; Akena, Dickens; Al Khabouri, Mazin J.; Alasfoor, Deena; Albittar, Mohammed; Alegretti, Miguel Angel; Aleman, Alicia V.; Alemu, Zewdie Aderaw; Alfonso-Cristancho, Rafael; Alhabib, Samia; Ali, Mohammed K.; Ali, Raghib; Alla, Francois; Al Lami, Faris; Allebeck, Peter; AlMazroa, Mohammad A.; Salman, Rustam Al-Shahi; Alsharif, Ubai; Alvarez, Elena; Alviz-Guzman, Nelson; Amankwaa, Adansi A.; Amare, Azmeraw T.; Ameli, Omid; Amini, Hassan; Ammar, Walid; Anderson, H. Ross; Anderson, Benjamin O.; Antonio, Carl Abelardo T.; Anwari, Palwasha; Apfel, Henry; Cunningham, Solveig Argeseanu; Arsenijevic, Valentina S. Arsic; Al Artaman; Asad, Majed Masoud; Asghar, Rana J.; Assadi, Reza; Atkins, Lydia S.; Atkinson, Charles; Badawi, Alaa; Bahit, Maria C.; Bakfalouni, Talal; Balakrishnan, Kalpana; Balalla, Shivanthi; Banerjee, Amitava; Barber, Ryan M.; Barker-Collo, Suzanne L.; Barquera, Simon; Barregard, Lars; Barrero, Lope H.; Barrientos-Gutierrez, Tonatiuh; Basu, Arindam; Basu, Sanjay; Basulaiman, Mohammed Omar; Beardsley, Justin; Bedi, Neeraj; Beghi, Ettore; Bekele, Tolesa; Bell, Michelle L.; Benjet, Corina; Bennett, Derrick A.; Bensenor, Isabela M.; Benzian, Habib; Bertozzi-Villa, Amelia; Beyene, Tariku Jibat; Bhala, Neeraj; Bhalla, Ashish; Bhutta, Zulfiqar A.; Bikbov, Boris; Bin Abdulhak, Aref; Biryukov, Stan; Blore, Jed D.; Blyth, Fiona M.; Bohensky, Megan A.; Borges, Guilherme; Bose, Dipan; Boufous, Soufiane; Bourne, Rupert R.; Boyers, Lindsay N.; Brainin, Michael; Brauer, Michael; Brayne, Carol E. G.; Brazinova, Alexandra; Breitborde, Nicholas; Brenner, Hermann; Briggs, Adam D. M.; Brown, Jonathan C.; Brugha, Traolach S.; Buckle, Geoffrey C.; Bui, Linh Ngoc; Bukhman, Gene; Burch, Michael; Nonato, Ismael Ricardo Campos; Carabin, Helesne; Cardenas, Rosario; Carapetis, Jonathan; Carpenter, David O.; Caso, Valeria; Castaneda-Orjuela, Carlos A.; Castro, Ruben Estanislao; Catala-Lopez, Ferrn; Cavalleri, Fiorella; Chang, Jung-Chen; Charlson, Fiona C.; Che, Xuan; Chen, Honglei; Chen, Yingyao; Chen, Jian Sheng; Chen, Zhengming; Chiang, Peggy Pei-Chia; Chimed-Ochir, Odgerel; Chowdhury, Rajiv; Christensen, Hanne; Christophi, Costas A.; Chuang, Ting-Wu; Chugh, Sumeet S.; Cirillo, Massimo; Coates, Matthew M.; Coffeng, Luc Edgar; Coggeshall, Megan S.; Cohen, Aaron; Colistro, Valentina; Colquhoun, Samantha M.; Colomar, Mercedes; Cooper, Leslie Trumbull; Cooper, Cyrus; Coppola, Luis M.; Cortinovis, Monica; Courville, Karen; Cowie, Benjamin C.; Criqui, Michael H.; Crump, John A.; Cuevas-Nasu, Lucia; Leite, Iuri da Costa; Dabhadkar, Kaustubh C.; Dandona, Lalit; Dandona, Rakhi; Dansereau, Emily; Dargan, Paul I.; Dayama, Anand; De la Cruz-Gongora, Vanessa; de la Vega, Shelley F.; De Leo, Diego; Degenhardt, Louisa; del Pozo-Cruz, Borja; Dellavalle, Robert P.; Deribe, Kebede; Jarlais, Don C. Des; Dessalegn, Muluken; deVeber, Gabrielle A.; Dharmaratne, Samath D.; Dherani, Mukesh; Diaz-Ortega, Jose-Luis; Diaz-Torne, Cesar; Dicker, Daniel; Ding, Eric L.; Dokova, Klara; Dorsey, E. Ray; Driscoll, Tim R.; Duan, Leilei; Duber, Herbert C.; Durrani, Adnan M.; Ebel, Beth E.; Edmond, Karen M.; Ellenbogen, Richard G.; Elshrek, Yousef; Ermakov, Sergey Petrovich; Erskine, Holly E.; Eshrati, Babak; Esteghamati, Alireza; Estep, Kara; Fuerst, Thomas; Fahimi, Saman; Fahrion, Anna S.; Faraon, Emerito Jose A.; Farzadfar, Farshad; Fay, Derek F. J.; Feigl, Andrea B.; Feigin, Valery L.; Felicio, Manuela Mendonca; Fereshtehnejad, Seyed-Mohammad; Fernandes, Jefferson G.; Ferrari, Alize J.; Fleming, Thomas D.; Foigt, Nataliya; Foreman, Kyle; Forouzanfar, Mohammad H.; Fowkes, F. Gerry R.; Fra Paleo, Urbano; Franklin, Richard C.; Futran, Neal D.; Gaffikin, Lynne; Gambashidze, Ketevan; Gankpe, Fortune Gbetoho; Garcia-Guerra, Francisco Armando; Garcia, Ana Cristina; Geleijnse, Johanna M.; Gessner, Bradford D.; Gibney, Katherine B.; Gillum, Richard F.; Gilmour, Stuart; Abdelmageem, Ibrahim; Ginawi, Mohamed; Giroud, Maurice; Glaser, Elizabeth L.; Goenka, Shifalika; Dantes, Hector Gomez; Gona, Philimon; Gonzalez-Medina, Diego; Guinovart, Caterina; Gupta, Rahul; Gupta, Rajeev; Gosselin, Richard A.; Gotay, Carolyn C.; Goto, Atsushi; Gowda, Hube N.; Graetz, Nicholas; Greenwell, K. Fern; Gugnani, Harish Chander; Gunnell, David; Gutierrez, Reyna A.; Haagsma, Juanita; Hafezi-Nejad, Nima; Hagan, Holly; Hagstromer, Maria; Halasa, Yara A.; Hamadeh, Randah Ribhi; Hamavid, Hannah; Hammami, Mouhanad; Hancock, Jamie; Hankey, Graeme J.; Hansen, Gillian M.; Harb, Hilda L.; Harewood, Heather; Haro, Josep Maria; Havmoeller, Rasmus; Hay, Roderick J.; Hay, Simon I.; Hedayati, Mohammad T.; Pi, Ileana B. Heredia; Heuton, Kyle R.; Heydarpour, Pouria; Higashi, Hideki; Hijar, Martha; Hoek, Hans W.; Hoffman, Howard J.; Hornberger, John C.; Hosgood, H. Dean; Hossain, Mazeda; Hotez, Peter J.; Hoy, Damian G.; Hsairi, Mohamed; Hu, Guoqing; Huang, John J.; Huffman, Mark D.; Hughes, Andrew J.; Husseini, Abdullatif; Huynh, Chantal; Iannarone, Marissa; Iburg, Kim M.; Idrisov, Bulat T.; Ikeda, Nayu; Innos, Kaire; Inoue, Manami; Islami, Farhad; Ismayilova, Samaya; Jacobsen, Kathryn H.; Jassal, Simerjot; Jayaraman, Sudha P.; Jensen, Paul N.; Jha, Vivekanand; Jiang, Guohong; Jiang, Ying; Jonas, Jost B.; Joseph, Jonathan; Juel, Knud; Kabagambe, Edmond Kato; Kan, Haidong; Karch, Andre; Karimkhani, Chante; Karthikeyan, Ganesan; Kassebaum, Nicholas; Kaul, Anil; Kawakami, Norito; Kazanjan, Konstantin; Kazi, Dhruv S.; Kemp, Andrew H.; Kengne, Andre Pascal; Keren, Andre; Kereselidze, Maia; Khader, Yousef Saleh; Khalifa, Shams Eldin Ali Hassan; Khan, Ejaz Ahmed; Khan, Gulfaraz; Khang, Young-Ho; Kieling, Christian; Kinfu, Yohannes; Kinge, Jonas M.; Kim, Daniel; Kim, Sungroul; Kivipelto, Miia; Knibbs, Luke; Knudsen, Ann Kristin; Kokubo, Yoshihiro; Kosen, Sowarta; Kotagal, Meera; Kravchenko, Michael A.; Krishnaswami, Sanjay; Krueger, Hans; Defo, Barthelemy Kuate; Kuipers, Ernst J.; Bicer, Burcu Kucuk; Kulkarni, Chanda; Kulkarni, Veena S.; Kumar, Kaushalendra; Kumar, Ravi B.; Kwan, Gene F.; Kyu, Hmwe; Lai, Taavi; Balaji, Arjun Lakshmana; Lalloo, Ratilal; Lallukka, Tea; Lam, Hilton; Lan, Qing; Lansingh, Van C.; Larson, Heidi J.; Larsson, Anders; Lavados, Pablo M.; Lawrynowicz, Alicia E. B.; Leasher, Janet L.; Lee, Jong-Tae; Leigh, James; Leinsalu, Mall; Leung, Ricky; Levitz, Carly; Li, Bin; Li, Yichong; Li, Yongmei; Liddell, Chelsea; Lim, Stephen S.; de Lima, Graca Maria Ferreira; Lind, Maggie L.; Lipshultz, Steven E.; Liu, Shiwei; Liu, Yang; Lloyd, Belinda K.; Lofgren, Katherine T.; Logroscino, Giancarlo; London, Stephanie J.; Lortet-Tieulent, Joannie; Lotufo, Paulo A.; Lucas, Robyn M.; Lunevicius, Raimundas; Lyons, Ronan Anthony; Ma, Stefan; Machado, Vasco Manuel Pedro; MacIntyre, Michael F.; Mackay, Mark T.; MacLachlan, Jennifer H.; Magis-Rodriguez, Carlos; Mahdi, Abbas A.; Majdan, Marek; Malekzadeh, Reza; Mangalam, Srikanth; Mapoma, Christopher Chabila; Marape, Marape; Marcenes, Wagner; Margono, Christopher; Marks, Guy B.; Marzan, Melvin Barrientos; Masci, Joseph R.; Mashal, Mohammad Taufi Q.; Masiye, Felix; Mason-Jones, Amanda J.; Matzopolous, Richard; Mayosi, Bongani M.; Mazorodze, Tasara T.; McGrath, John J.; Mckay, Abigail C.; Mckee, Martin; McLain, Abigail; Meaney, Peter A.; Mehndiratta, Man Mohan; Mejia-Rodriguez, Fabiola; Melaku, Yohannes Adama; Meltzer, Michele; Memish, Ziad A.; Mendoza, Walter; Mensah, George A.; Meretoja, Atte; Mhimbira, Francis A.; Miller, Ted R.; Mills, Edward J.; Misganaw, Awoke; Mishra, Santosh K.; Mock, Charles N.; Moffitt, Terrie E.; Ibrahim, Norlinah Mohamed; Mohammad, Karzan Abdulmuhsin; Mokdad, Ali H.; Mola, Glen Liddell; Monasta, Lorenzo; Monis, Jonathan de la Cruz; Hernandez, Julio C. Montaez; Montico, Marcella; Montine, Thomas J.; Mooney, Meghan D.; Moore, Ami R.; Moradi-Lakeh, Maziar; Moran, Andrew E.; Mori, Rintaro; Moschandreas, Joanna; Moturi, Wilkister Nyaora; Moyer, Madeline L.; Mozaffarian, Dariush; Mueller, Ulrich O.; Mukaigawara, Mitsuru; Mullany, Erin C.; Murray, Joseph; Mustapha, Adetoun; Naghavi, Paria; Naheed, Aliya; Naidoo, Kovin S.; Naldi, Luigi; Nand, Devina; Nangia, Vinay; Narayan, K. M. Venkat; Nash, Denis; Nasher, Jamal; Nejjari, Chakib; Nelson, Robert G.; Neuhouser, Marian; Neupane, Sudan Prasad; Newcomb, Polly A.; Newman, Lori; Newton, Charles R.; Ng, Marie; Ngalesoni, Frida Namnyak; Nguyen, Grant; Nhung Thi Trang Nguyen; Nisar, Muhammad Imran; Nolte, Sandra; Norheim, Ole F.; Norman, Rosana E.; Norrving, Bo; Nyakarahuka, Luke; Odell, Shaun; O'Donnell, Martin; Ohkubo, Takayoshi; Ohno, Summer Lockett; Olusanya, Bolajoko O.; Omer, Saad B.; Opio, John Nelson; Orisakwe, Orish Ebere; Ortblad, Katrina F.; Ortiz, Alberto; Otayza, Maria Lourdes K.; Pain, Amanda W.; Pandian, Jeyaraj D.; Panelo, Carlo Irwin; Panniyammakal, Jeemon; Papachristou, Christina; Paternina Caicedo, Angel J.; Patten, Scott B.; Patton, George C.; Paul, Vinod K.; Pavlin, Boris; Pearce, Neil; Pellegrini, Carlos A.; Pereira, David M.; Peresson, Sophie C.; Perez-Padilla, Rogelio; Perez-Ruiz, Fernando P.; Perico, Norberto; Pervaiz, Aslam; Pesudovs, Konrad; Peterson, Carrie B.; Petzold, Max; Phillips, Bryan K.; Phillips, David E.; Phillips, Michael R.; Plass, Dietrich; Piel, Frederic Bernard; Poenaru, Dan; Polinder, Suzanne; Popova, Svetlana; Poulton, Richie G.; Pourmalek, Farshad; Prabhakaran, Dorairaj; Qato, Dima; Quezada, Amado D.; Quistberg, D. Alex; Rabito, Felicia; Rafay, Anwar; Rahimi, Kazem; Rahimi-Movaghar, Vafa; Rahman, Sajjad U. R.; Raju, Murugesan; Rakovac, Ivo; Rana, Saleem M.; Refaat, Amany; Remuzzi, Giuseppe; Ribeiro, Antonio L.; Ricci, Stefano; Riccio, Patricia M.; Richardson, Lee; Richardus, Jan Hendrik; Roberts, Bayard; Roberts, D. Allen; Robinson, Margaret; Roca, Anna; Rodriguez, Alina; Rojas-Rueda, David; Ronfani, Luca; Room, Robin; Roth, Gregory A.; Rothenbacher, Dietrich; Rothstein, David H.; Rowley, Jane Tf; Roy, Nobhojit; Ruhago, George M.; Rushton, Lesley; Sambandam, Sankar; Soreide, Kjetil; Saeedi, Mohammad Yahya; Saha, Sukanta; Sahathevan, Ramesh; Sahraian, Mohammad Ali; Sahle, Berhe Weldearegawi; Salomon, Joshua A.; Salvo, Deborah; Samonte, Genesis May J.; Sampson, Uchechukwu; Sanabria, Juan Ramon; Sandar, Logan; Santos, Itamar S.; Satpathy, Maheswar; Sawhney, Monika; Saylan, Mete; Scarborough, Peter; Schoettker, Ben; Schmidt, Juergen C.; Schneider, Ione J. C.; Schumacher, Austin E.; Schwebel, David C.; Scott, James G.; Sepanlou, Sadaf G.; Servan-Mori, Edson E.; Shackelford, Katya; Shaheen, Amira; Shahraz, Saeid; Shakh-Nazarova, Marina; Shangguan, Siyi; She, Jun; Sheikhbahaei, Sara; Shepard, Donald S.; Shibuya, Kenji; Shinohara, Yukito; Shishani, Kawkab; Shiue, Ivy; Shivakoti, Rupak; Shrime, Mark G.; Sigfusdottir, Inga Dora; Silberberg, Donald H.; Silva, Andrea P.; Simard, Edgar P.; Sindi, Shireen; Singh, Jasvinder A.; Singh, Lavanya; Sioson, Edgar; Skirbekk, Vegard; Sliwa, Karen; So, Samuel; Soljak, Michael; Soneji, Samir; Soshnikov, Sergey S.; Sposato, Luciano A.; Sreeramareddy, Chandrashekhar T.; Stanaway, Jeff Rey D.; Stathopoulou, Vasiliki Kalliopi; Steenland, Kyle; Stein, Claudia; Steiner, Caitlyn; Stevens, Antony; Stoeckl, Heidi; Straif, Kurt; Stroumpoulis, Konstantinos; Sturua, Lela; Sunguya, Bruno F.; Swaminathan, Soumya; Swaroop, Mamta; Sykes, Bryan L.; Tabb, Karen M.; Takahashi, Ken; Talongwa, Roberto Tchio; Tan, Feng; Tanne, David; Tanner, Marcel; Tavakkoli, Mohammad; Ao, Braden Te; Teixeira, Carolina Maria; Templin, Tara; Tenkorang, Eric Yeboah; Terkawi, Abdullah Sulieman; Thomas, Bernadette A.; Thorne-Lyman, Andrew L.; Thrift, Amanda G.; Thurston, George D.; Tillmann, Taavi; Tirschwell, David L.; Tleyjeh, Imad M.; Tonelli, Marcello; Topouzis, Fotis; Towbin, Jeffrey A.; Toyoshima, Hideaki; Traebert, Jefferson; Tran, Bach X.; Truelsen, Thomas; Trujillo, Ulises; Trillini, Matias; Dimbuene, Zacharie Tsala; Tsilimbaris, Miltiadis; Tuzcu, E. Murat; Ubeda, Clotilde; Uchendu, Uche S.; Ukwaja, Kingsley N.; Undurraga, Eduardo A.; Vallely, Andrew J.; van de Vijver, Steven; van Gool, Coen H.; Varakin, Yuri Y.; Vasankari, Tommi J.; Vasconcelos, Ana Maria Nogales; Vavilala, Monica S.; Venketasubramanian, N.; Vijayakumar, Lakshmi; Villalpando, Salvador; Violante, Francesco S.; Vlassov, Vasiliy Victorovich; Wagner, Gregory R.; Waller, Stephen G.; Wang, JianLi; Wang, Linhong; Wang, XiaoRong; Wang, Yanping; Warouw, Tati Suryati; Weichenthal, Scott; Weiderpass, Elisabete; Weintraub, Robert G.; Wenzhi, Wang; Werdecker, Andrea; Wessells, K. Ryan R.; Westerman, Ronny; Whiteford, Harvey A.; Wilkinson, James D.; Williams, Thomas Neil; Woldeyohannes, Solomon Meseret; Wolfe, Charles D. A.; Wolock, Timothy M.; Woolf, Anthony D.; Wong, John Q.; Wright, Jonathan L.; Wulf, Sarah; Wurtz, Brittany; Xu, Gelin; Yang, Yang C.; Yano, Yuichiro; Yatsuya, Hiroshi; Yip, Paul; Yonemoto, Naohiro; Yoon, Seok-Jun; Younis, Mustafa; Yu, Chuanhua; Jin, Kim Yun; Zaki, Maysaa El Sayed; Zamakhshary, Mohammed Fouad; Zeeb, Hajo; Zhang, Yong; Zhao, Yong; Zheng, Yingfeng; Zhu, Jun; Zhu, Shankuan; Zonies, David; Zou, Xiao Nong; Zunt, Joseph R.; Vos, Theo; Lopez, Alan D.; Murray, Christopher J. L.		GBD Mortal 2013 Causes Death Colla	Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013	LANCET			English	Article							INFLUENZAE TYPE-B; PNEUMOCOCCAL CONJUGATE VACCINE; 187 COUNTRIES; ENTERIC MULTICENTER; CHILDREN YOUNGER; RISK-FACTORS; CHILDHOOD PNEUMONIA; INTEGRATED APPROACH; POPULATION HEALTH; DOUBLE-BLIND	Background Up-to-date evidence on levels and trends for age-sex-specifi c all-cause and cause-specifi c mortality is essential for the formation of global, regional, and national health policies. In the Global Burden of Disease Study 2013 (GBD 2013) we estimated yearly deaths for 188 countries between 1990, and 2013. We used the results to assess whether there is epidemiological convergence across countries. Methods We estimated age-sex-specifi c all-cause mortality using the GBD 2010 methods with some refinements to improve accuracy applied to an updated database of vital registration, survey, and census data. We generally estimated cause of death as in the GBD 2010. Key improvements included the addition of more recent vital registration data for 72 countries, an updated verbal autopsy literature review, two new and detailed data systems for China, and more detail for Mexico, UK, Turkey, and Russia. We improved statistical models for garbage code redistribution. We used six different modelling strategies across the 240 causes; cause of death ensemble modelling (CODEm) was the dominant strategy for causes with sufficient information. Trends for Alzheimer's disease and other dementias were informed by meta-regression of prevalence studies. For pathogen-specifi c causes of diarrhoea and lower respiratory infections we used a counterfactual approach. We computed two measures of convergence (inequality) across countries: the average relative difference across all pairs of countries (Gini coefficient) and the average absolute difference across countries. To summarise broad findings, we used multiple decrement life-tables to decompose probabilities of death from birth to exact age 15 years, from exact age 15 years to exact age 50 years, and from exact age 50 years to exact age 75 years, and life expectancy at birth into major causes. For all quantities reported, we computed 95% uncertainty intervals (UIs). We constrained cause-specific fractions within each age-sex-country-year group to sum to all-cause mortality based on draws from the uncertainty distributions. Findings Global life expectancy for both sexes increased from 65.3 years (UI 65.0-65.6) in 1990, to 71.5 years (UI 71.0-71.9) in 2013, while the number of deaths increased from 47.5 million (UI 46.8-48.2) to 54.9 million (UI 53.6-56.3) over the same interval. Global progress masked variation by age and sex: for children, average absolute diff erences between countries decreased but relative diff erences increased. For women aged 25-39 years and older than 75 years and for men aged 20-49 years and 65 years and older, both absolute and relative diff erences increased. Decomposition of global and regional life expectancy showed the prominent role of reductions in age-standardised death rates for cardiovascular diseases and cancers in high-income regions, and reductions in child deaths from diarrhoea, lower respiratory infections, and neonatal causes in low-income regions. HIV/AIDS reduced life expectancy in southern sub-Saharan Africa. For most communicable causes of death both numbers of deaths and age-standardised death rates fell whereas for most non-communicable causes, demographic shifts have increased numbers of deaths but decreased age-standardised death rates. Global deaths from injury increased by 10.7%, from 4.3 million deaths in 1990 to 4.8 million in 2013; but age-standardised rates declined over the same period by 21%. For some causes of more than 100 000 deaths per year in 2013, age-standardised death rates increased between 1990 and 2013, including HIV/AIDS, pancreatic cancer, atrial fibrillation and flutter, drug use disorders, diabetes, chronic kidney disease, and sickle-cell anaemias. Diarrhoeal diseases, lower respiratory infections, neonatal causes, and malaria are still in the top five causes of death in children younger than 5 years. The most important pathogens are rotavirus for diarrhoea and pneumococcus for lower respiratory infections. Country-specific probabilities of death over three phases of life were substantially varied between and within regions. Interpretation For most countries, the general pattern of reductions in age-sex specifi c mortality has been associated with a progressive shift towards a larger share of the remaining deaths caused by non-communicable disease and injuries. Assessing epidemiological convergence across countries depends on whether an absolute or relative measure of inequality is used. Nevertheless, age-standardised death rates for seven substantial causes are increasing, suggesting the potential for reversals in some countries. Important gaps exist in the empirical data for cause of death estimates for some countries; for example, no national data for India are available for the past decade.	[Naghavi, Mohsen; Wang, Haidong; Lozano, Rafael; Vollset, Stein Emil; Achoki, Tom; Apfel, Henry; Atkinson, Charles; Barber, Ryan M.; Bertozzi-Villa, Amelia; Biryukov, Stan; Brown, Jonathan C.; Catala-Lopez, Ferrn; Coates, Matthew M.; Coffeng, Luc Edgar; Coggeshall, Megan S.; Dandona, Lalit; Dansereau, Emily; Dicker, Daniel; Duber, Herbert C.; Estep, Kara; Fleming, Thomas D.; Forouzanfar, Mohammad H.; Gonzalez-Medina, Diego; Graetz, Nicholas; Haagsma, Juanita; Hamavid, Hannah; Hancock, Jamie; Hansen, Gillian M.; Heuton, Kyle R.; Higashi, Hideki; Huynh, Chantal; Iannarone, Marissa; Joseph, Jonathan; Kassebaum, Nicholas; Kyu, Hmwe; Levitz, Carly; Liddell, Chelsea; Lind, Maggie L.; Lofgren, Katherine T.; MacIntyre, Michael F.; Margono, Christopher; McLain, Abigail; Mokdad, Ali H.; Mooney, Meghan D.; Moradi-Lakeh, Maziar; Moyer, Madeline L.; Mullany, Erin C.; Naghavi, Paria; Ng, Marie; Nguyen, Grant; Odell, Shaun; Ohno, Summer Lockett; Ortblad, Katrina F.; Pain, Amanda W.; Phillips, Bryan K.; Phillips, David E.; Richardson, Lee; Roberts, D. Allen; Robinson, Margaret; Roth, Gregory A.; Sandar, Logan; Schumacher, Austin E.; Shackelford, Katya; Singh, Lavanya; Sioson, Edgar; Stanaway, Jeff Rey D.; Steiner, Caitlyn; Stevens, Antony; Templin, Tara; Thomas, Bernadette A.; Wolock, Timothy M.; Wulf, Sarah; Wurtz, Brittany; Vos, Theo; Murray, Christopher J. L.] Inst Hlth Metr & Evaluat, Seattle, WA USA; [Ellenbogen, Richard G.; Wright, Jonathan L.] Univ Washington, Sch Med, Seattle, WA USA; [Kassebaum, Nicholas] Childrens Hosp, Seattle, WA USA; [Tirschwell, David L.] Dept Neurol, Seattle, WA USA; [Ebel, Beth E.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Alfonso-Cristancho, Rafael; Anderson, Benjamin O.; Futran, Neal D.; Jensen, Paul N.; Kotagal, Meera; Mock, Charles N.; Montine, Thomas J.; Pellegrini, Carlos A.; Quistberg, D. Alex; Vavilala, Monica S.; Zunt, Joseph R.] Univ Washington, Seattle, WA 98195 USA; [Lozano, Rafael; Barquera, Simon; Barrientos-Gutierrez, Tonatiuh; Nonato, Ismael Ricardo Campos; Cuevas-Nasu, Lucia; De la Cruz-Gongora, Vanessa; Diaz-Ortega, Jose-Luis; Garcia-Guerra, Francisco Armando; Dantes, Hector Gomez; Pi, Ileana B. Heredia; Mejia-Rodriguez, Fabiola; Hernandez, Julio C. Montaez; Perez-Padilla, Rogelio; Quezada, Amado D.; Salvo, Deborah; Servan-Mori, Edson E.; Villalpando, Salvador] Natl Inst Publ Hlth Mexico, Mexico City, DF, Mexico; [Davis, Adrian; Fay, Derek F. J.; Schmidt, Juergen C.] Publ Hlth England, London, England; [Zhou, Maigeng; Duan, Leilei; Li, Yichong; Liu, Shiwei; Wang, Linhong] Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Tan, Feng] Natl Inst Occupat Hlth & Control, Beijing, Peoples R China; [Liang, Xiaofeng] China Ctr Dis Control Prevent, Beijing, Peoples R China; [Vollset, Stein Emil; Kinge, Jonas M.; Knudsen, Ann Kristin; Skirbekk, Vegard] Norwegian Inst Publ Hlth, Oslo, Norway; [Vollset, Stein Emil; Norheim, Ole F.] Univ Bergen, Bergen, Norway; [Ozgoren, Ayse Abbasoglu; Bicer, Burcu Kucuk] Hacettepe Univ, Inst Populat Studies, Ankara, Turkey; [Abdalla, Safa] Sudanese Publ Hlth Consultancy Grp, Solihull, W Midlands, England; [Abd-Allah, Foad] Cairo Univ, Fac Med, Cairo, Egypt; [Aziz, Muna I. Abdel] Inst Publ Hlth, Khartoum, Sudan; [Abera, Semaw Ferede] Coll Hlth Sci, Sch Publ Hlth, Mekelle, Tigray, Ethiopia; [Melaku, Yohannes Adama; Sahle, Berhe Weldearegawi] Mekelle Univ, Mekelle, Tigray, Ethiopia; [Aboyans, Victor] Dupuytren Univ Hosp, Limoges, France; [Abraham, Biju] Oslo & Akershus Univ, Coll Appl Sci HiOA, Oslo, Norway; [Abraham, Jerry P.] Univ Texas San Antonio, Sch Med, San Antonio, TX USA; [Abuabara, Katrina E.; Silberberg, Donald H.] Univ Penn, Philadelphia, PA 19104 USA; [Benzian, Habib] Dept Epidemiol & Publ Hlth, London, England; [Benzian, Habib] UCL, London, England; [Abu-Raddad, Laith J.] Weill Cornell Med Coll Qatar, Doha, Qatar; [Abu-Rmeileh, Niveen M. E.] Birzeit Univ, Inst Community & Publ Hlth, Ramallah, W Bank, Israel; [Adelekan, Ademola] Publ Hlth Promot Alliance, Osogbp, Nigeria; [Chiang, Peggy Pei-Chia] Beneral Practice & Primary Hlth Care Acad Ctr, Melbourne, Vic, Australia; [Colquhoun, Samantha M.] Ctr Int Child Hlth, Melbourne, Vic, Australia; [Ademi, Zanfi Na; Blore, Jed D.; Bohensky, Megan A.; Catala-Lopez, Ferrn; Balaji, Arjun Lakshmana; Patton, George C.; Weintraub, Robert G.] Univ Melbourne, Melbourne, Vic, Australia; [Adofo, Koranteng] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ashanti, Ghana; [Adou, Arsene Kouablan] Assoc Ivoirienne Bien Etre Familial, Abidjan, Cote Ivoire; [Adsuar, Jose C.; Fra Paleo, Urbano] Univ Extremadura, Caceres, Spain; [Arnlov, Johan; Larsson, Anders] Uppsala Univ, Uppsala, Sweden; [Agardh, Emilie Elisabet] Inst Publ Hlth Sci, Stockholm, Sweden; [Akena, Dickens; Nyakarahuka, Luke] Makerere Univ, Kampala, Uganda; [Al Khabouri, Mazin J.; Alasfoor, Deena] Minist Hlth, Muscat, Oman; [Al Lami, Faris] Baghdad Coll Med, Baghdad, Iraq; [Albittar, Mohammed] Independent, Damascus, Syria; Grp Invest Ciencias Salud & Neurociencias CISNEUR, Cartagena De Indias, Bolivar, Colombia; [Alegretti, Miguel Angel; Aleman, Alicia V.; Cavalleri, Fiorella; Colistro, Valentina] Univ Republica, Fac Med, Dept Prevent & Social Med, Montevideo, Uruguay; [Alemu, Zewdie Aderaw] Debre Markos Univ, Debre Markos, Amhara, Ethiopia; [Alhabib, Samia] Natl Guard Hlth Affairs, Riyadh, Saudi Arabia; [Simard, Edgar P.; Steenland, Kyle] Rollins Sch Publ Hlth, Atlanta, GA USA; [Ali, Mohammed K.; Cunningham, Solveig Argeseanu; Dabhadkar, Kaustubh C.; Liu, Yang; Narayan, K. M. Venkat; Omer, Saad B.; Phillips, Michael R.] Emory Univ, Atlanta, GA 30322 USA; [Ali, Raghib; Bennett, Derrick A.; Briggs, Adam D. M.; Chen, Zhengming; Hay, Simon I.; Piel, Frederic Bernard; Rahimi, Kazem; Scarborough, Peter] Univ Oxford, Oxford, England; [Alla, Francois] Univ Lorraine, Sch Publ Hlth, Nancy, France; [Allebeck, Peter] Dept Publ Hlth Sci, Stockholm, Sweden; [Fereshtehnejad, Seyed-Mohammad] Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden; [Kivipelto, Miia] Aging Res Ctr, Stockholm, Sweden; [Weiderpass, Elisabete] Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hagstromer, Maria; Havmoeller, Rasmus; Sindi, Shireen] Karolinska Inst, Stockholm, Sweden; [AlMazroa, Mohammad A.; Basulaiman, Mohammed Omar; Memish, Ziad A.; Saeedi, Mohammad Yahya] Saudi Minist Hlth, Riyadh, Saudi Arabia; [Salman, Rustam Al-Shahi; Fowkes, F. Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Alsharif, Ubai; Nolte, Sandra; Papachristou, Christina] Charite, D-13353 Berlin, Germany; [Alvarez, Elena] Government, Madrid, Spain; [Alviz-Guzman, Nelson; Paternina Caicedo, Angel J.] Univ Cartagena, Cartagena De Indias, Colombia; [Amankwaa, Adansi A.] Albany State Univ, Albany, GA 31705 USA; [Amare, Azmeraw T.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Amare, Azmeraw T.] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Ameli, Omid] Boston Univ, Boston, MA 02215 USA; [Amini, Hassan] Kurdistan Univ Med Sci, Kurdistan Environm Hlth Res Ctr, Sanandaj, Kurdistan, Iran; [Amini, Hassan] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Tanner, Marcel] Univ Basel, Basel, Switzerland; [Ammar, Walid] Minist Publ Hlth, Beirut, Lebanon; [Anderson, H. Ross] St Georges Univ London, London, England; [Antonio, Carl Abelardo T.; Faraon, Emerito Jose A.; Panelo, Carlo Irwin] Univ Philippines Manila, Coll Publ Hlth, Manila, Philippines; [Anwari, Palwasha] UNFPA, Kabul, Afghanistan; [Arsenijevic, Valentina S. Arsic] Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Belgrade, Serbia; [Al Artaman] Evidera Inc, Lexington, MA USA; [Asad, Majed Masoud] Minist Hlth, Amman, Jordan; [Asghar, Rana J.] South Asian Publ Hlth Forum, Islamabad, Pakistan; [Assadi, Reza] Mashhad Univ Med Sci, Mashhad, Khorasan Razavi, Iran; [Atkins, Lydia S.] Minist Hlth Wellness Human Serv & Gender Relat, Castries, St Lucia; [Badawi, Alaa] Publ Hlth Agcy Canada, Toronto, ON, Canada; [Bahit, Maria C.] INECO Neurociencias, Santa Fe, NM USA; [Bakfalouni, Talal] Minist Hlth, Damascus, Syria; [Balakrishnan, Kalpana] Sri Ramachandra Univ, Madras, Tamil Nadu, India; [Balalla, Shivanthi; Feigin, Valery L.] Natl Inst Stroke & Appl Neurosciences, Auckland, New Zealand; [Barker-Collo, Suzanne L.] Sch Psychol, Auckland, New Zealand; [del Pozo-Cruz, Borja] Univ Auckland, Auckland 1, New Zealand; [Banerjee, Amitava] Univ Birmingham, Birmingham, W Midlands, England; [Barregard, Lars] Univ Gothenburg, Dept Environm & Occupat Hlth, Gothenburg, Sweden; [Barrero, Lope H.] Pontificia Univ Javeriana, Dept Ind Engn, Bogota, Colombia; [Basu, Arindam] Univ Canterbury, Sch Hlth Sci, Canterbury, New Zealand; [So, Samuel] Asian Liver Ctr, Palo Alto, CA USA; [Gaffikin, Lynne] Stanford Univ, Med Ctr, Sch Med, Stanford, CA 94305 USA; [Basu, Sanjay] Stanford Univ, Stanford, CA 94305 USA; [Beardsley, Justin] Univ Oxford, Ho Hi Minh City, Vietnam; [Bedi, Neeraj] Coll Publ Hlth & Trop Med, Jazan, Saudi Arabia; [Beghi, Ettore; Cortinovis, Monica; Perico, Norberto; Remuzzi, Giuseppe; Trillini, Matias] IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy; [Bekele, Tolesa] Madawalabu Univ, Bale Goba, Oromia, Ethiopia; [Bell, Michelle L.; Huang, John J.] Yale Univ, New Haven, CT USA; [Benjet, Corina; Gutierrez, Reyna A.] Natl Inst Psychiat Ramon de la Fuente, Mexico City, DF, Mexico; [Bensenor, Isabela M.; Kemp, Andrew H.] Univ Hosp, Sao Paulo, Brazil; [Lotufo, Paulo A.; Santos, Itamar S.] Univ Sao Paulo, Sao Paulo, Brazil; [Beyene, Tariku Jibat; Deribe, Kebede] Univ Addis Ababa, Debre Zeit, Ethiopia; [Bhala, Neeraj] Wellington Hosp, Wellington, New Zealand; [Bhalla, Ashish] Postgrad Inst Med Educ & Res, Chandigarh 160012, UT, India; [Bhutta, Zulfiqar A.] Med Ctr, Karachi, Pakistan; [Nisar, Muhammad Imran] Aga Khan Univ, Karachi, Pakistan; [Bikbov, Boris] I Evdokimov Moscow State Univ Med & Dent, Moscow, Russia; [Bin Abdulhak, Aref] Univ Missouri, Kansas City, MO 64110 USA; [Marks, Guy B.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Driscoll, Tim R.] Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Blyth, Fiona M.; Leigh, James] Univ Sydney, Sydney, NSW 2006, Australia; [Borges, Guilherme] Inst Nacl Psiquiatria, Mexico City, DF, Mexico; [Bose, Dipan] World Bank, Washington, DC 20433 USA; [Boufous, Soufiane] Transport & Rd Safety TARS Res, Sydney, NSW, Australia; [Vallely, Andrew J.] Kirby Inst, Sydney, NSW, Australia; [Degenhardt, Louisa; Satpathy, Maheswar] Univ New S Wales, Sydney, NSW, Australia; [Bourne, Rupert R.] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Boyers, Lindsay N.] Georgetown Univ, Sch Med, Washington, DC USA; [Brainin, Michael] Danube Univ Krems, Krems, Austria; [Krueger, Hans] Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Brauer, Michael; Gotay, Carolyn C.; Pourmalek, Farshad] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Brayne, Carol E. G.] Cambridge Inst Publ Hlth, Cambridge, England; [Brazinova, Alexandra; Majdan, Marek] Trnava Univ, Fac Hlth Sci & Social Work, Trnava, Slovakia; [Breitborde, Nicholas] Univ Arizona, Tucson, AZ USA; [Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany; [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England; [Buckle, Geoffrey C.; Gona, Philimon] Univ Massachusetts, Sch Med, Worcester, MA USA; [Bui, Linh Ngoc; Nhung Thi Trang Nguyen] Hanoi Sch Publ Hlth, Hanoi, Vietnam; [Bukhman, Gene] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Ding, Eric L.; Fahimi, Saman; Shangguan, Siyi] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; [Feigl, Andrea B.; Salomon, Joshua A.; Shrime, Mark G.] Harvard Univ, Cambridge, MA 02138 USA; [Burch, Michael] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Cardenas, Rosario] Univ Autonoma Metropolitana, Mexico City, DF, Mexico; [Carabin, Helesne] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA; [Carapetis, Jonathan] Telethon Inst Child Hlth Res, Subiaco, WA, Australia; [Carpenter, David O.] Univ Albany, Rensselaer, NY USA; [Caso, Valeria] Univ Perugia, Stroke Unit, I-06100 Perugia, Italy; [Castaneda-Orjuela, Carlos A.] Colombian Natl Hlth Observ, Inst Nacl Salud, Bogota, Colombia; [Castro, Ruben Estanislao] Univ Diego Portales, Santiago, Chile; [Catala-Lopez, Ferrn] Minist Hlth, Spanish Med & Healthcare Prod Agcy AEMPS, Div Pharmacoepidemiol & Pharmacovigilance, Madrid, Spain; [Chang, Jung-Chen] Natl Taiwan Univ, Taipei 10764, Taiwan; [Hoy, Damian G.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Scott, James G.] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia; [Charlson, Fiona C.; Erskine, Holly E.; Ferrari, Alize J.; Knibbs, Luke; McGrath, John J.; Norman, Rosana E.; Whiteford, Harvey A.] Univ Queensland, Brisbane, Qld, Australia; [Che, Xuan] NIH, Bethesda, MD 20892 USA; [She, Jun] Zhongshan Hosp, Shanghai, Peoples R China; [Chen, Yingyao; Kan, Haidong] Fudan Univ, Shanghai 200433, Peoples R China; [Chen, Zhengming] CTSU, Nuffield Dept Populat Hlth, Oxford, England; [Chen, Honglei; London, Stephanie J.] NIEHS, Div Intramural Res, NIH, Dept Hlth & Human Serv,RTP,NC USA, Res Triangle Pk, NC 27709 USA; [Chen, Jian Sheng] Inst Bone & Joint Res, St Laonards, NSW, Australia; [Chimed-Ochir, Odgerel] Univ Occupat & Environm Hlth, Dept Environm Epidemiol, Kitakyushu, Fukuoka 807, Japan; [Chowdhury, Rajiv; Murray, Christopher J. L.] Univ Cambridge, Cambridge, England; [Christensen, Hanne] Bispebjerg Hosp, Copenhagen, Denmark; [Christophi, Costas A.] Cyprus Univ Technol, Limassol, Cyprus; [Chang, Jung-Chen] Taipei Med Univ, Sch Med, Dept Mol Parasitol & Trop Dis, Taipei, Taiwan; [Chuang, Ting-Wu] Taipei Med Univ, Ctr Int Trop Med, Coll Med, Taipei, Taiwan; [Chugh, Sumeet S.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Cirillo, Massimo] Univ Salerno, I-84081 Baronissi, SA, Italy; [Cohen, Aaron] Hlth Effects Inst, Boston, MA USA; [Colomar, Mercedes] UNICEM, Montevideo, Uruguay; [Cooper, Cyrus] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Cooper, Cyrus; Tleyjeh, Imad M.] Mayo Clin, Rochester, MN USA; [Coppola, Luis M.] Hosp Municipal Ramon Santamarina, Buenos Aires, DF, Argentina; [Cowie, Benjamin C.; MacLachlan, Jennifer H.] Victorian Infect Dis Reference Lab, North Melbourne, Vic, Australia; [Criqui, Michael H.; Jassal, Simerjot] Univ Calif San Diego, La Jolla, CA 92093 USA; [Crump, John A.] Dunedin Sch Med, Ctr Int Hlth, Dunedin, Otago, New Zealand; [Poulton, Richie G.] Univ Otago, Dunedin, Otago, New Zealand; [Leite, Iuri da Costa] Natl Sch Publ Hlth ENSP Fiocruz, Rio De Janeiro, Brazil; [Dandona, Lalit; Dandona, Rakhi; Goenka, Shifalika] Publ Hlth Fdn India, New Delhi, India; [Dandona, Rakhi; Goenka, Shifalika] Indian Inst Publ Hlth, New Delhi, India; [Kumar, Ravi B.] No Organization, Gurgaon, Haryana, India; [Dargan, Paul I.] Guys & St Thomas NHS Fdn Trust, London, England; [Dayama, Anand] Jacobi Med Ctr, Dept Surg, Atlanta, GA USA; [de la Vega, Shelley F.] Univ Philippines, Inst Aging, Manila, Philippines; [Lam, Hilton] Univ Philippines, Natl Inst Hlth, Inst Hlth Policy & Dev Studies, Manila, Philippines; [De Leo, Diego] Griffith Univ, Brisbane, Qld 4111, Australia; [Uchendu, Uche S.] US Dept Vet Affairs, Washington, DC USA; [Dellavalle, Robert P.] Eastern Colorado Healthcare Syst, Denver, CO USA; [Jarlais, Don C. Des] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Dessalegn, Muluken] Africa Med & Res Fdn Ethiopia, Addis Ababa, Ethiopia; [deVeber, Gabrielle A.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka; [Dherani, Mukesh] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Diaz-Torne, Cesar] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Dokova, Klara] Med Univ Varna, Fac Publ Hlth, Dept Social Med, Varna, Bulgaria; [Dorsey, E. Ray] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Durrani, Adnan M.] NIH, Montgomery, MD USA; [Hankey, Graeme J.] Sch Med & Pharmacol, Perth, WA, Australia; [Kabagambe, Edmond Kato] Univ Western Australia, Perth, WA 6009, Australia; [Elshrek, Yousef] Univ Tripoli, Fac Agr, Dept Food Sci, Tripoli, Libya; [Ermakov, Sergey Petrovich] Russian Acad Sci, Inst Social & Econ Studies Populat, Moscow, Russia; [Eshrati, Babak] Arak Univ Med Sci & Hlth Affairs, Arak, Markazi, Iran; [Esteghamati, Alireza; Hafezi-Nejad, Nima; Sheikhbahaei, Sara] Endocrinol & Metab Res Ctr, Tehran, Iran; [Farzadfar, Farshad] Noncommunicable Dis Reesearch Ctr, Tehran, Iran; [Malekzadeh, Reza; Sepanlou, Sadaf G.] Digest Dis Res Ctr, Tehran, Iran; [Rahimi-Movaghar, Vafa] Sina Trauma & Surg Res Ctr, Tehran, Iran; [Sahraian, Mohammad Ali] Res Ctr, Tehran, Iran; [Moradi-Lakeh, Maziar] Dept Community Med, Tehran, Iran; [Heydarpour, Pouria] Univ Tehran Med Sci, Tehran, Iran; [Fuerst, Thomas] Ctr Hlth Policy, London, England; [Fuerst, Thomas] Dept Infect Dis Epidemiol, London, England; [Mustapha, Adetoun] MRC PHE Ctr Hlth & Environm, London, England; [Foreman, Kyle; Rodriguez, Alina; Rushton, Lesley; Soljak, Michael; Williams, Thomas Neil] Univ London Imperial Coll Sci Technol & Med, London, England; [Vollset, Stein Emil] Div Informat Evidence Res & Innovat, Copenhagen, Denmark; [Fahrion, Anna S.; Rakovac, Ivo] WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark; [Newman, Lori] WHO, CH-1211 Geneva, Switzerland; [Teixeira, Carolina Maria] ARS Norte, Oporto, Portugal; [Felicio, Manuela Mendonca; de Lima, Graca Maria Ferreira; Machado, Vasco Manuel Pedro] IP Dept Saude Publ, Oporto, Portugal; [Fernandes, Jefferson G.] German Hosp Oswaldo Cruz, Inst Educ & Sci, Sao Paulo, Brazil; [Foigt, Nataliya] Ukraine Acad Med Sci, Inst Gerontol, UA-252655 Kiev, Ukraine; [Franklin, Richard C.] James Cook Univ, Townsville, Qld 4811, Australia; [Gambashidze, Ketevan; Kazanjan, Konstantin; Kereselidze, Maia; Shakh-Nazarova, Marina; Sturua, Lela] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Gankpe, Fortune Gbetoho] Clin Cooperat Parakou, Parakou, Borgou, Benin; [Garcia, Ana Cristina] Publ Hlth Unit Primary Hlth Care Grp Almada Seixa, Almada, Setubal, Portugal; [Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Gessner, Bradford D.] Agence Med Prevent, Paris, France; [Lloyd, Belinda K.] Eastern Hlth Clin Sch, Melbourne, Vic, Australia; [Gibney, Katherine B.; Thrift, Amanda G.] Monash Univ, Melbourne, Vic 3004, Australia; [Gillum, Richard F.] Howard Univ, Washington, DC 20059 USA; [Inoue, Manami] Grad Sch Med, Tokyo, Japan; [Kawakami, Norito] Sch Publ Hlth, Tokyo, Japan; [Gilmour, Stuart; Shibuya, Kenji] Univ Tokyo, Tokyo, Japan; [Ginawi, Mohamed] Univ Hail, Coll Med, Hail, Saudi Arabia; [Giroud, Maurice] Univ Hosp Dijon, Dijon France, Region Of Burgo, France; [Glaser, Elizabeth L.; Halasa, Yara A.; Idrisov, Bulat T.; Shahraz, Saeid; Shepard, Donald S.; Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA; [Gosselin, Richard A.; Kazi, Dhruv S.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Goto, Atsushi] Natl Ctr Global Hlth & Med, Dept Diabet Res, Tokyo, Japan; [Gugnani, Harish Chander] St James Sch Med, Kralendijk, Bonaire, Netherlands; [Guinovart, Caterina] PATH, Seattle, WA USA; [Gunnell, David] Univ Bristol, Bristol, Avon, England; [Gupta, Rahul] Fortis Escorts Hosp, Jaipur, Rajasthan, India; [Gupta, Rajeev] Kanawha Charleston Hlth Dept, Charleston, WV USA; [Thurston, George D.] NYU, Nelson Inst Environm Med, Tuxedo Pk, NY USA; [Hagan, Holly] NYU, New York, NY USA; [Hamadeh, Randah Ribhi] Arabian Gulf Univ, Manama, Bahrain; [Hammami, Mouhanad] Wayne Cty Dept Hlth & Human Serv, Detroit, MI USA; [Harewood, Heather] Eunice Gibson Polyclin, Bridgetown, St Michael, Barbados; [Haro, Josep Maria] Univ Barcelona, CIBERSAM, Barcelona, Spain; [Hay, Roderick J.] Int Fdn Dermatol, London, England; [Hedayati, Mohammad T.] Mazandaran Univ Med Sci, Sari, Mazandaran, Iran; [Hijar, Martha] Fdn Entornos AC, Cuernavaca, Morelos, Mexico; [Hoek, Hans W.] Parnassia Psychiat Inst, The Hague, Netherlands; [Hoffman, Howard J.] Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD USA; [Hornberger, John C.] Cedar Associates, Menlo Pk, CA USA; [Hosgood, H. Dean] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Hossain, Mazeda; Larson, Heidi J.; Mckee, Martin; Pearce, Neil; Roberts, Bayard; Stoeckl, Heidi; Tillmann, Taavi] London Sch Hyg & Trop Med, London WC1, England; [Hotez, Peter J.] Baylor Coll Med, Houston, TX 77030 USA; [Hoy, Damian G.] Secretariat Pacific Commun, Publ Hlth Div, Herston, Qld, Australia; [Hsairi, Mohamed] Natl Inst Publ Hlth MOH, Tunis, Tunisia; [Hu, Guoqing] Univ Toronto, Toronto, ON, Canada; [Hu, Guoqing] Cent South Univ, Changsha, Hunan, Peoples R China; [Huffman, Mark D.] Feinberg Sch Med, Chicago, IL USA; [Swaroop, Mamta] Northwestern Univ, Chicago, IL 60611 USA; [Husseini, Abdullatif] Qatar Univ, Publ Hlth Program, Doha, Qatar; [Iburg, Kim M.] Aarhus Univ, Aarhus, Denmark; [Ikeda, Nayu] Natl Inst Hlth & Nutr, Bunkyo Ku, Tokyo 162, Japan; [Innos, Kaire; Leinsalu, Mall] Natl Inst Hlth Dev, Tallinn, Estonia; [Islami, Farhad] Amer Canc Soc, New York, NY USA; [Lortet-Tieulent, Joannie] No Organization, Atlanta, GA USA; [Ismayilova, Samaya] Self Employed, Baku, Azerbaijan; [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA; [Jassal, Simerjot] VA San Diego, San Diego, CA USA; [Jayaraman, Sudha P.] Virginia Commonwealth Univ, Richmond, VA USA; [Jha, Vivekanand] Postgrad Inst Med Educ & Res, Chandigarh 160012, India; [Jiang, Guohong] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Jiang, Ying] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Hlth Dev, Dept Environm Epidemiol, Kitakyushu, Fukuoka 807, Japan; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Juel, Knud] Natl Inst Publ Hlth, Copenhagen, Denmark; [Kabagambe, Edmond Kato; Sampson, Uchechukwu] Vanderbilt Univ, Nashville, TN 37235 USA; Univ Balamand, Beirut, Lebanon; [Karch, Andre] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Karch, Andre] German Ctr Infect Res DZIF, Braunschweig, Germany; [Karimkhani, Chante] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Moran, Andrew E.] Columbia Univ, New York, NY USA; [Karthikeyan, Ganesan; Paul, Vinod K.] All India Inst Med Sci, New Delhi, India; [Kaul, Anil] Oklahoma State Univ, Tulsa, OK USA; [Kengne, Andre Pascal; Matzopolous, Richard] South African Med Res Council, Cape Town, Western Cape, South Africa; [Keren, Andre] Hadassah Kerem Univ Hosp, Jerusalem, Israel; [Khader, Yousef Saleh] Jordan Univ Sci & Technol, Irbid, Jordan; [Khalifa, Shams Eldin Ali Hassan] Supreme Council Hlth, Doha, Qatar; [Khan, Ejaz Ahmed] Hlth Serv Acad, Islamabad, Punjab, Pakistan; [Khan, Gulfaraz] UAE Univ, Abu Dhabi, U Arab Emirates; [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Inst Hlth Policy & Management, Seoul, South Korea; [Kieling, Christian] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Kim, Daniel] Northeastern Univ, Boston, MA 02115 USA; [Kim, Sungroul] Soonchunhyang Univ, Asan, South Korea; [Kinfu, Yohannes] Univ Canberra, Canberra, ACT 2601, Australia; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan; [Kosen, Sowarta] Ctr Community Empowerment Hlth Policy & Humanitie, Jakarta, Indonesia; [Warouw, Tati Suryati] NIHRD, Jakarta, Special Provinc, Indonesia; [Kravchenko, Michael A.; Varakin, Yuri Y.] Res Ctr Neurol, Moscow, Russia; [Krishnaswami, Sanjay] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Krishnaswami, Sanjay] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Defo, Barthelemy Kuate] Univ Montreal, Montreal, PQ, Canada; [Polinder, Suzanne] Dept Publ Hlth, Rotterdam, Netherlands; [Kuipers, Ernst J.; Richardus, Jan Hendrik] Erasmus MC Univ Med Ctr, Rotterdam, Netherlands; [Kulkarni, Chanda] Rajrajeshwari Med Coll & Hosp, Bangalore, Karnataka, India; [Kulkarni, Veena S.] Arkansas State Univ, State Univ, AR 72467 USA; [Kumar, Kaushalendra] Int Inst Populat Sci, Bombay, Maharashtra, India; [Kwan, Gene F.] Boston Med Ctr, Boston, MA USA; [Lai, Taavi] Fourth View Consulting, Tallinn, Estonia; [Lalloo, Ratilal] Australian Res Ctr Populat Oral Hlth, Gold Coast, Qld, Australia; [Lalloo, Ratilal] Univ Adelaide, Sch Dent, Gold Coast, Qld, Australia; [Lallukka, Tea] Finnish Inst Occupat Hlth, Helsinki, Finland; [Lallukka, Tea] Univ Helsinki, Fac Med, Hjelt Inst, FIN-00014 Helsinki, Finland; [Lan, Qing] NCI, Rockville, MD USA; [Lansingh, Van C.] IAPB & Vis 2020 LA, Weston, FL USA; [Lavados, Pablo M.] Univ Desarrollo, Serv Neurol Clin Alemana, Santiago, RM, Chile; [Lawrynowicz, Alicia E. B.; Silva, Andrea P.; Ubeda, Clotilde] Inst Nacl Epidemiol Dr Juan H Jara, Buenos Aires, DF, Argentina; [Leasher, Janet L.] Nova SE Univ, Ft Lauderdale, FL 33314 USA; [Lee, Jong-Tae; Yoon, Seok-Jun] Korea Univ, Seoul, South Korea; [Leung, Ricky] SUNY Albany, Rensselaer, NY USA; [Zhang, Yong] Jinan Cent Hosp, Dept Gerontol, Jinan, Shandong, Peoples R China; [Li, Bin] Jinan Cent Hosp, Jinan, Shandong, Peoples R China; [Li, Yichong] Genentech Inc, San Francisco, CA USA; [Lipshultz, Steven E.] Wayne State Univ, Miami, FL USA; [Lloyd, Belinda K.; Room, Robin] Eastern Hlth, Turning Point Alcohol & Drug Ctr, Fitzroy, Vic, Australia; [Logroscino, Giancarlo] Univ Bari, Bari, Italy; Australian Natl Univ, Canberra, ACT, Australia; [Lunevicius, Raimundas] Aintree Univ Hosp NHS Fdn Trust, NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England; [Lyons, Ronan Anthony] Swansea Univ, swauni, Swansea, W Glam, Wales; [Ma, Stefan] Minist Hlth Singapore, Singapore, Singapore; [Mackay, Mark T.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Magis-Rodriguez, Carlos] Ctr Prevenc & Control VIH SIDA, Mexico City, DF, Mexico; [Mahdi, Abbas A.] King Georges Med Univ, Lucknow, Uttar Pradesh, India; [Mangalam, Srikanth] Tech Stand & Safety Author, Toronto, ON, Canada; [Mapoma, Christopher Chabila; Masiye, Felix] Univ Zambia, Lusaka, Zambia; [Marape, Marape] Botswana Baylor Childrens Clin Ctr Excellence, Gaborone, Botswana; [Marcenes, Wagner] Univ London, London, England; [Marzan, Melvin Barrientos] Univ East Ramon Magsaysay, Med Ctr, Quezon City, Metro Manila, Philippines; [Masci, Joseph R.] Elmhurst Hosp Ctr, Mt Sinai Serv, Elmhurst, NY USA; [Mashal, Mohammad Taufi Q.] Minist Publ Hlth, Kabul, Afghanistan; [Mason-Jones, Amanda J.] Univ York, York YO10 5DD, N Yorkshire, England; [Sliwa, Karen] Hatter Inst Cardiovasc Res Africa, Fac Hlth Sci, Cape Town, Western Cape, South Africa; [Mayosi, Bongani M.] Univ Cape Town, Cape Town, Western Cape, South Africa; [Mazorodze, Tasara T.] AIDC EC, Port Elizabeth, Eastern Cape, South Africa; [Mckay, Abigail C.] EmergentCorp, Belize City, Belize District, Belize; [Mehndiratta, Man Mohan] Janakpuri Superspecialty Hosp, Delhi, India; [Meltzer, Michele] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Mendoza, Walter] UNFPA, Lima, Peru; [Mensah, George A.] NHLBI, Ctr Translat Res & Implementat Sci, NIH, Bethesda, MD 20892 USA; [Mhimbira, Francis A.] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Miller, Ted R.] Curtin Univ, Ctr Populat Hlth Res, Perth, WA 6845, Australia; [Mills, Edward J.] Univ Ottawa, Ottawa, ON, Canada; [Mishra, Santosh K.] SNDT Womens Univ, Populat Educ Resource Ctr, Dept Continuing & Adult Educ & Extens, Bombay, Maharashtra, India; [Moffitt, Terrie E.] Duke Univ, Durham, NC USA; [Ibrahim, Norlinah Mohamed] Univ Kebangsaan Malaysia, Med Ctr, Dept Med, Kuala Lumpur, Malaysia; [Mohammad, Karzan Abdulmuhsin] Univ Salahaddin, Erbil, Iraq; [Mola, Glen Liddell] Univ Papua New Guinea, Port Moresby, NCD, Papua N Guinea; [Monasta, Lorenzo; Montico, Marcella; Ronfani, Luca] Inst Maternal & Child Health IRCCS Burlo Garofolo, Trieste, Italy; [Monis, Jonathan de la Cruz] Bur Int Hlth Cooperat, Manila, Philippines; [Moore, Ami R.] Univ N Texas, Denton, TX 76203 USA; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Tsilimbaris, Miltiadis] Dept Med, Iraklion, Greece; [Moschandreas, Joanna] Univ Crete, Iraklion, NE, Greece; [Moturi, Wilkister Nyaora] Egerton Univ, Egerton, Rift Valley, Kenya; [Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Mueller, Ulrich O.] Univ Marburg, Marburg, Germany; [Mukaigawara, Mitsuru] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo, Japan; [Naheed, Aliya] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Naidoo, Kovin S.] Univ KwaZulu Natal, Durban, KwaZulu Natal, South Africa; [Naldi, Luigi] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy; [Nand, Devina] Minist Hlth Fiji, Suva, Fiji; [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India; [Nash, Denis] CUNY, Sch Publ Hlth, New York, NY 10021 USA; [Nasher, Jamal] Minist Publ Hlth & Populat, Sanaa, Yemen; [Nejjari, Chakib] Fac Med, Fes, Morocco; [Nelson, Robert G.] Natl Inst Diabet & Digest & Kidney Dis, Phoenix, AZ USA; [Neuhouser, Marian; Newcomb, Polly A.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Neupane, Sudan Prasad] Univ Oslo, Norwegian Ctr Addict Res SERAF, N-0316 Oslo, Norway; [Ngalesoni, Frida Namnyak] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania; [Norrving, Bo] Lund Univ, Fac Med, Dept Clin Sci, Lund, Sweden; [O'Donnell, Martin] Natl Univ Ireland Galway, Galway, Ireland; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Tokyo 173, Japan; [Olusanya, Bolajoko O.] Ctr Hlth Start Initiat, Lagos, Nigeria; [Opio, John Nelson] Lira Municipal Council, Lira Dist Local Govt, Northern Uganda, Uganda; [Orisakwe, Orish Ebere] Univ Port Harcourt, Fac Pharm, Toxicol Unit, Port Harcourt, Rivers State, Nigeria; [Ortiz, Alberto] IIS Fdn Jimenez Diaz, Madrid, Spain; [Otayza, Maria Lourdes K.] Mariano Marcos Mem Hosp, City Of Batac, Ilocos Norte, Philippines; [Otayza, Maria Lourdes K.] Med Ctr, City Of Batac, Ilocos Norte, Philippines; [Pandian, Jeyaraj D.] Christian Med Coll Ludhiana, Ludhiana, Punjab, India; [Panniyammakal, Jeemon] Ctr Chron Dis Control, Delhi, India; [Patten, Scott B.; Wang, JianLi] Univ Calgary, Calgary, AB, Canada; [Pavlin, Boris] Independent Researcher, Waigani, NCD, Papua N Guinea; [Pereira, David M.] Univ Porto, REQUIMTE, Fac Farm, Dept Quim,Lab Farmacognosia, P-4100 Oporto, Portugal; [Peresson, Sophie C.] Int Diabet Federat, Brussels, Belgium; [Perez-Ruiz, Fernando P.] Hosp Univ Cruces, Baracaldo, Spain; [Pervaiz, Aslam] Postgrad Med Inst, Lahore, Punjab, Pakistan; [Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Peterson, Carrie B.] Aalborg Univ, Aalborg, Denmark; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat, Gothenburg, Sweden; [Phillips, Michael R.] Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China; [Plass, Dietrich] Fed Environm Agcy, Exposure Assessment & Environm Hlth Indicators, Bielefeld, North Rhine Wes, Germany; [Poenaru, Dan] McMaster Univ, Hamilton, ON, Canada; [Popova, Svetlana] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, Delhi, India; [Qato, Dima] Univ Illinois, Coll Pharm, Chicago, IL USA; [Tabb, Karen M.] Univ Illinois, Chicago, IL USA; [Rabito, Felicia] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Rafay, Anwar] Contech Intl, Lahore, Punjab, Pakistan; [Rahman, Sajjad U. R.] Hamad Med Corp, Doha, Qatar; [Raju, Murugesan] Univ Missouri, Columbia, MS USA; [Rana, Saleem M.] Univ Punjab, Dept Publ Hlth, Lahore, Punjab, Pakistan; [Refaat, Amany] Walden Univ, Minneapolis, MN USA; [Ribeiro, Antonio L.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil; [Ricci, Stefano] UO Neurol USL Umbria 1, Perugia, Italy; [Riccio, Patricia M.] Univ Western Ontario, Dept Clin Neurol Sci, London Hlth Sci Ctr, London, ON, Canada; [Roca, Anna] MRC Unit, Fajara, Gambia; [Rojas-Rueda, David] Ctr Res Environm Epidemiol CREAL, Barcelona, Catalonia, Spain; [Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Rothstein, David H.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA; [Roy, Nobhojit] BARC Hosp, Bombay, Maharashtra, India; [Ruhago, George M.; Sunguya, Bruno F.] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; Rwanda Biomed Ctr, Kigali, Rwanda; [Soreide, Kjetil] Stavanger Univ Hosp, Stavanger, Norway; [Saha, Sukanta] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Sahathevan, Ramesh] UKM Med Ctr, Kuala Lumpur, Malaysia; [Samonte, Genesis May J.] Natl Epidemiol Ctr, HIV AIDS & STI Surveillance & Strateg Informat Un, Dept Hlth, Manila, National Capita, Philippines; [Sanabria, Juan Ramon] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Sawhney, Monika] Marshall Univ, Huntington, WV USA; [Saylan, Mete] Novartis, Istanbul, Turkey; [Schoettker, Ben] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Baden Wurttembe, Switzerland; [Schneider, Ione J. C.] Univ Fed Santa Catarina, Florianopolis, SC, Brazil; [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA; [Shaheen, Amira] An Najah Univ, Nablus, Palestine, Israel; [Shinohara, Yukito] Tachikawa Hosp, Tokyo, Japan; [Shishani, Kawkab] Washington State Univ, Spokane, WA USA; [Shiue, Ivy] Heriot Watt Univ, Edinburgh, Midlothian, Scotland; [Shivakoti, Rupak] Ctr Clin Global Hlth Educ, Baltimore, MD USA; [Tran, Bach X.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Sigfusdottir, Inga Dora] Reykjavik Univ, Reykjavik, Iceland; [Soneji, Samir] Dartmouth Coll, Lebanon, NH 03756 USA; [Soshnikov, Sergey S.] Minist Hlth Russian Federat, Fed Res Inst Hlth Org & Informat, Moscow, Russia; [Sposato, Luciano A.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; [Sreeramareddy, Chandrashekhar T.] Univ Tunku Abdul Rahman, Fac Med & Hlth Sci, Kajang, Selangor, Malaysia; [Stathopoulou, Vasiliki Kalliopi] Ctr Hosp Nord Deux Sevres, Bressuire, France; [Straif, Kurt] IARC WHO, Lyon, France; [Stroumpoulis, Konstantinos] Alexandra Gen Hosp Athens, KEELPNO, Ctr Dis Control, Athens, Greece; [Swaminathan, Soumya] Natl Inst Res TB, Madras, Tamil Nadu, India; [Sykes, Bryan L.] Univ Calif Irvine, Dept Criminol Law & Soc & Sociol, Irvine, CA USA; [Takahashi, Ken] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Environm Epidemiol, Kitakyushu, Fukuoka 807, Japan; [Talongwa, Roberto Tchio] Minist Hlth MINSANTE, Yaounde, Cameroon; [Tanne, David] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Tanne, David] Tel Aviv Univ, Tel Hashomer, Israel; [Tavakkoli, Mohammad] Westchester Med Ctr, Valhalla, NY USA; [Ao, Braden Te] Auckland Univ Technol, Auckland, New Zealand; Jhpiego, Addis Ababa, Ethiopia; [Tenkorang, Eric Yeboah] Mem Univ Newfoundland, St John, NF, Canada; [Terkawi, Abdullah Sulieman] Univ Virginia, Dept Anesthesiol, Charlottesville, VA USA; [Terkawi, Abdullah Sulieman; Tleyjeh, Imad M.] King Fahad Med City, Dept Anesthesiol, Riyadh, Saudi Arabia; [Thorne-Lyman, Andrew L.] WorldFish, New York, NY USA; [Tleyjeh, Imad M.] Alfasial Univ, Coll Med, Riyadh, Saudi Arabia; [Tonelli, Marcello] Univ Alberta, Edmonton, AB, Canada; [Topouzis, Fotis] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece; [Towbin, Jeffrey A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Toyoshima, Hideaki] Hlth Care Ctr Anjo Kosei Hosp, Anjo, Aichi, Japan; [Traebert, Jefferson] Univ Southern Santa Catarina, Palhoca, SC, Brazil; [Truelsen, Thomas] Univ Copenhagen, Herlev Hosp, Dept Neurol, Copenhagen, Denmark; [Trujillo, Ulises] Serv Canario Salud, Tenerife, Spain; [Dimbuene, Zacharie Tsala] Univ Kinshasa, Fac Econ & Management, Dept Populat Sci & Dev, Kinshasa, DEM REP CONGO; [Ukwaja, Kingsley N.] Fed Teaching Hosp Abakaliki, Dept Internal Med, Abakailiki, Ebonyi State, Nigeria; [van de Vijver, Steven] African Populat & Hlth Res Ctr, Nairobi, Kenya; [van Gool, Coen H.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Vasankari, Tommi J.] UKK Inst Hlth Promot Res, Tampere, Finland; [Vasconcelos, Ana Maria Nogales] Univ Brasilia, Brasilia, DF, Brazil; [Venketasubramanian, N.] Raffles Hosp, Ctr Neurosci, Singapore, Singapore; [Vijayakumar, Lakshmi] Voluntary Hlth Serv, Madras, Tamil Nadu, India; [Violante, Francesco S.] Univ Bologna, Bologna, Italy; [Vlassov, Vasiliy Victorovich] Higher Sch Econ, Moscow, Russia; [Wagner, Gregory R.] Natl Inst Occupat Safety & Hlth, Washington, DC USA; [Waller, Stephen G.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Wang, Yanping; Zhu, Jun] Natl Off Maternal & Childs Hlth Surveillance, Chengdu, Peoples R China; [Weichenthal, Scott] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Weintraub, Robert G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Wenzhi, Wang] Beijing Neurosurg Inst, Beijing, Peoples R China; [Werdecker, Andrea] Inst Med Sociol & Social Med, Marburg, Hessen, Germany; [Westerman, Ronny] No Organization, Marburg, Hessen, Germany; [Wessells, K. Ryan R.] Univ Calif Davis, Davis, CA 95616 USA; [Wilkinson, James D.] Univ Miami, Miami, FL USA; [Woldeyohannes, Solomon Meseret] Univ Gondar, Inst Publ Hlth, Gondar, Amhara, Ethiopia; [Wong, John Q.] Ateneo Sch Med & Publ Hlth, Pasig, Metro Manila, Philippines; [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, Cornwall, England; [Xu, Gelin] Nanjing Univ, Sch Med, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Yang, Yang C.] Univ N Carolina, Chapel Hill, NC USA; [Yano, Yuichiro] Jichi Med Univ, Sch Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Yatsuya, Hiroshi] Fujita Hlth Univ, Toyoake, Aichi, Japan; [Yip, Paul] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Younis, Mustafa] Jackson State Univ, Jackson, MS USA; [Yu, Chuanhua] Wuhan Univ, Sch Publ Hlth, Global Hlth Inst, Dept Epidemiol & Biostat, Wuhan 430072, Hubei, Peoples R China; [Jin, Kim Yun] TCM Med TK SDN BHD, Nusajaya, Johor Bahru, Malaysia; [Zaki, Maysaa El Sayed] Mansoura Fac Med, Mansoura, Egypt; [Zamakhshary, Mohammed Fouad] Minist Planning & Training, Riyadh, Saudi Arabia; [Zeeb, Hajo] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Zhao, Yong] Chongqing Med Univ, Chongqing, Peoples R China; [Zheng, Yingfeng] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Shankuan] Zhejiang Univ, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Zonies, David] Landstuhl Reg Med Ctr, Landstuhl, NY USA; [Zou, Xiao Nong] Chinese Acad Med Sci, Canc Inst Hosp, Beijing 100730, Peoples R China	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Instituto Nacional de Salud Publica; Public Health England; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute of Occupational Health & Poison Control, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Norwegian Institute of Public Health (NIPH); University of Bergen; Hacettepe University; Egyptian Knowledge Bank (EKB); Cairo University; Mekelle University; CHU Limoges; Oslo Metropolitan University (OsloMet); University of Texas System; University of Texas at San Antonio (UTSA); University of Pennsylvania; University of London; University College London; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Birzeit University; University of Melbourne; Kwame Nkrumah University Science & Technology; Universidad de Extremadura; Uppsala University; Makerere University; Universidad de la Republica, Uruguay; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Ministry of National Guard - Health Affairs; National Guard Health Affairs - Saudi Arabia; Emory University; Rollins School Public Health; Emory University; University of Oxford; Universite de Lorraine; Karolinska Institutet; University of Edinburgh; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universidad de Cartagena; University System of Georgia; Albany State University; University of Groningen; Bahir Dar University; Boston University; Kurdistan University of Medical Sciences; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; St Georges University London; University of the Philippines System; University of the Philippines Manila; University of Belgrade; Evidera; Mashhad University Medical Science; Public Health Agency of Canada; Sri Ramachandra Institute of Higher Education & Research; University of Auckland; University of Birmingham; University of Gothenburg; Pontificia Universidad Javeriana; University of Canterbury; Stanford University; Stanford University; University of Oxford; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Yale University; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Universidade de Sao Paulo; Universidade de Sao Paulo; Addis Ababa University; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Aga Khan University; Moscow State University of Medicine & Dentistry; University of Missouri System; University of Missouri Kansas City; University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of Sydney; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; The World Bank; University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; Anglia Ruskin University; Georgetown University; Danube University Krems; University of British Columbia; University of Cambridge; University of Trnava; University of Arizona; Helmholtz Association; German Cancer Research Center (DKFZ); University of Leicester; University of Massachusetts System; University of Massachusetts Worcester; Hanoi University of Public Health; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Universidad Autonoma Metropolitana - Mexico; University of Oklahoma System; University of Oklahoma Health Sciences Center; Telethon Kids Institute; University of Western Australia; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Perugia; Instituto Nacional de Salud (Colombia); University Diego Portales; National Taiwan University; University of Queensland; University of Queensland; University of Queensland; National Institutes of Health (NIH) - USA; Fudan University; Fudan University; University of Oxford; GlaxoSmithKline; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Occupational & Environmental Health - Japan; University of Cambridge; University of Copenhagen; Bispebjerg Hospital; Cyprus University of Technology; Taipei Medical University; Taipei Medical University; Cedars Sinai Medical Center; University of Salerno; Health Effects Institute (HEI); University of Southampton; Mayo Clinic; Victorian Infectious Diseases Reference Laboratory; University of California System; University of California San Diego; University of Otago; University of Otago; Fundacao Oswaldo Cruz; Public Health Foundation of India; Guy's & St Thomas' NHS Foundation Trust; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; Griffith University; US Department of Veterans Affairs; Harvard University; Beth Israel Deaconess Medical Center; African Medical & Research Foundation (AMREF); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Peradeniya; University of Liverpool; Hospital of Santa Creu i Sant Pau; Medical University Varna; University of Rochester; National Institutes of Health (NIH) - USA; University of Western Australia; Russian Academy of Sciences; Federal Center of Theoretical & Applied Sociology - FCTAS; Institute of Social & Economic Studies of Population; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Imperial College London; World Health Organization; World Health Organization; National Academy of Medical Sciences of Ukraine; D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine; James Cook University; National Center for Disease Control & Public Health - Georgia; Wageningen University & Research; Agence de Medecine Preventive; Monash University; Howard University; University of Tokyo; University Ha'il; CHU Dijon Bourgogne; Brandeis University; University of California System; University of California San Francisco; National Center for Global Health & Medicine - Japan; University of Bristol; Fortis Escorts Hospital; New York University; New York University; Arabian Gulf University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Mazandaran University Medical Sciences; Parnassia Psychiatric Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Yeshiva University; Albert Einstein College of Medicine; University of London; London School of Hygiene & Tropical Medicine; Baylor College of Medicine; University of Toronto; Central South University; Northwestern University; Feinberg School of Medicine; Northwestern University; Qatar University; Aarhus University; National Institute of Health & Nutrition - Japan; National Institute for Health Development - Estonia; American Cancer Society; George Mason University; Virginia Commonwealth University; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Tianjin Center for Disease Control & Prevention; University of Occupational & Environmental Health - Japan; Ruprecht Karls University Heidelberg; Vanderbilt University; University Balamand; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research; Columbia University; Columbia University; All India Institute of Medical Sciences (AIIMS) New Delhi; South African Medical Research Council; Jordan University of Science & Technology; Health Services Academy; United Arab Emirates University; Seoul National University (SNU); Universidade Federal do Rio Grande do Sul; Northeastern University; Soonchunhyang University; University of Canberra; National Cerebral & Cardiovascular Center - Japan; National Institute of Health Research & Development (NIHRD); Research Center of Neurology; Oregon Health & Science University; Oregon Health & Science University; Universite de Montreal; Erasmus University Rotterdam; Erasmus MC; Arkansas State University; International Institute for Population Sciences; Boston Medical Center; University of Adelaide; Finnish Institute of Occupational Health; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidad del Desarrollo; Nova Southeastern University; Korea University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Roche Holding; Genentech; Turning Point Alcohol & Drug Centre - Australia; Universita degli Studi di Bari Aldo Moro; Australian National University; Aintree University Hospitals NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; Swansea University; Ministry of Health-Singapore; Royal Children's Hospital Melbourne; King George's Medical University; University of Zambia; Baylor College of Medicine; University of London; UERM Memorial Medical Center; Icahn School of Medicine at Mount Sinai; University of York - UK; University of Cape Town; Jefferson University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Ifakara Health Institute; Pacific Institute for Research & Evaluation (PIRE); Curtin University; University of Ottawa; Duke University; Universiti Kebangsaan Malaysia; Salahaddin University; University of Papua New Guinea; IRCCS Burlo Garofolo; University of North Texas System; University of North Texas Denton; National Center for Child Health & Development - Japan; University of Crete; Egerton University; Tufts University; Philipps University Marburg; Tokyo Medical & Dental University (TMDU); International Centre for Diarrhoeal Disease Research (ICDDR); University of Kwazulu Natal; ASST Papa Giovanni XXIII; Suraj Eye Institute; City University of New York (CUNY) System; Mohammed First University of Oujda; Sidi Mohamed Ben Abdellah University of Fez; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Fred Hutchinson Cancer Center; University of Oslo; Lund University; Ollscoil na Gaillimhe-University of Galway; Teikyo University; University of Port Harcourt; Fundacion Jimenez Diaz; University of Calgary; Universidade do Porto; Hospital Universitario Cruces; Flinders University South Australia; Aalborg University; University of Gothenburg; Shanghai Jiao Tong University; McMaster University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tulane University; Hamad Medical Corporation; University of Missouri System; University of Missouri Columbia; University of Punjab; Walden University; Universidade Federal de Minas Gerais; London Health Sciences Centre; Western University (University of Western Ontario); University of London; London School of Hygiene & Tropical Medicine; Pompeu Fabra University; Ulm University; Ann & Robert H. Lurie Children's Hospital of Chicago; Bhabha Atomic Research Center (BARC); Muhimbili University of Health & Allied Sciences; Rwanda Biomedical Center; Stavanger University Hospital; Queensland Centre for Mental Health Research; Universiti Kebangsaan Malaysia; Philippine Department Health; Case Western Reserve University; Marshall University; Novartis; Novartis Turkey; Universidade Federal de Santa Catarina (UFSC); University of Alabama System; University of Alabama Birmingham; An Najah National University; Tachikawa Hospital; Washington State University; Heriot Watt University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Reykjavik University; Dartmouth College; Ministry of Health of the Russian Federation; Western University (University of Western Ontario); Universiti Tunku Abdul Rahman (UTAR); World Health Organization; International Agency for Research on Cancer (IARC); Alexandra Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); University of California System; University of California Irvine; University of Occupational & Environmental Health - Japan; Chaim Sheba Medical Center; Tel Aviv University; Westchester Medical Center; Auckland University of Technology; Jhpiego; Memorial University Newfoundland; University of Virginia; King Fahad Medical City; CGIAR; Worldfish; University of Alberta; Aristotle University of Thessaloniki; Cincinnati Children's Hospital Medical Center; Universidade do Sul de Santa Catarina; University of Copenhagen; Herlev & Gentofte Hospital; Universite de Kinshasa; African Population & Health Research Centre; Netherlands National Institute for Public Health & the Environment; UKK Institute; Universidade de Brasilia; Raffles Hospital; University of Bologna; HSE University (National Research University Higher School of Economics); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Uniformed Services University of the Health Sciences - USA; Health Canada; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Beijing Neurosurgical Institute; University of California System; University of California Davis; University of Miami; University of Gondar; Royal Cornwall Hospital; Nanjing University; University of North Carolina; University of North Carolina Chapel Hill; Jichi Medical University; Fujita Health University; University of Hong Kong; National Center for Neurology & Psychiatry - Japan; Jackson State University; Wuhan University; Egyptian Knowledge Bank (EKB); Mansoura University; Leibniz Institute for Prevention Research & Epidemiology (BIPS); Chongqing Medical University; Sun Yat Sen University; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Murray, CJL (corresponding author), 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@uw.edu	CT, Sreeramareddy/I-1203-2019; Davis, Adrian C/E-6022-2015; Vasconcelos, Ana Maria Nogales/E-1935-2019; Yatsuya, Hiroshi/L-4213-2016; alla, francois/D-2295-2014; Deribe, Kebede/I-5422-2019; Cunningham, Solveig A/K-6760-2012; Hankey, Graeme J/H-4968-2014; Kieling, Christian/U-3905-2019; Pesudovs, Konrad/T-9403-2019; Patton, George C/B-5246-2013; Deribe, Kebede/K-7055-2019; Scarborough, Peter/ABD-6111-2021; Narayan, K.M. Venkat/J-9819-2012; Terkawi, Abdullah Suleiman/AAC-1113-2019; Tanne, David/F-2560-2010; Amare, Azmeraw T./B-9487-2018; Heredia-Pi, Ileana Beatriz/L-4247-2019; Mason-Jones, Amanda/ABF-1565-2020; Ginawi, Ibrahim Abdelmageed Mohamed/H-3260-2012; Guinovart, Caterina/ABH-2981-2020; Tonelli, Marcello/B-3028-2009; de la cruz, vanessa/AAH-5999-2020; , Bennett/O-7998-2019; Kengne, Andre Pascal/ABB-3696-2020; Whiteford, Harvey A/A-4840-2009; Liu, Yang/AAA-7224-2019; Zheng, Yingfeng/AAE-2983-2022; Li, Yichong/A-3559-2019; ABBASOGLU OZGOREN, AYSE/I-8707-2013; LOGROSCINO, GIANCARLO/K-5148-2016; Nash, Denis/AFI-7485-2022; Lortet-Tieulent, Joannie/AAE-9099-2019; Majdan, Marek/K-5017-2012; Asghar, Rana Jawad/AAF-7634-2021; Kuipers, Ernst J/H-3293-2019; Hossain, Mazeda/AAL-3202-2020; Bin Abdulhak, Aref/AAM-9492-2020; Malekzadeh, Reza/U-1382-2017; Paternina-Caicedo, Angel/N-4496-2015; Brenner, Hermann/B-4627-2017; Crump, John A./AAZ-6289-2020; Bin Abdulhak, Aref/AAK-4348-2020; Ermakov, Sergey/G-1709-2016; Moffitt, Terrie E/D-5295-2011; Santos, Itamar/M-2208-2019; Alsharif, Ubai/AAK-2088-2021; Charlson, Fiona J/F-5290-2011; Moradi-Lakeh, Maziar/ABC-9793-2021; Higashi, Hideki/D-3797-2011; Jayaraman, Sudha/AAH-3059-2019; Brayne, Carol/AAA-4285-2020; Gunnell, David/ABE-6653-2020; Naohiro, Yonemoto/Y-3761-2019; Chowdhury, Rajiv/AHB-1253-2022; Singh, Jasvinder/R-6172-2019; Foigt, Nataliya/AAU-5229-2020; Brenner, Hermann/ABE-6383-2020; Kravchenko, Michael A/B-2596-2012; Vasconcelos, Ana Maria Nogales/AAL-9776-2020; Kan, Haidong/AGU-0328-2022; Khan, Prof Dr Ejaz/GNP-1245-2022; Takahashi, Ken/AAX-7705-2020; Ali, Mohammed K/N-9833-2013; GANKPE, GBETOHO FORTUNE/GLT-4476-2022; Ding, Eric L./K-1118-2019; Sahathevan, Ramesh/S-9302-2019; Marzan, Melvin/AAP-8443-2020; Zunt, Joseph/ABD-2886-2021; Vasconcelos, Ana/AAK-4526-2020; Salomon, Joshua A/D-3898-2009; Saylan, Mete/AAP-1195-2020; Bell, Michelle/Y-4608-2018; Varakin, Yuriy Ya/C-8634-2012; Perico, Norberto/ABH-3222-2020; Papachristou, Christina/AAR-2187-2021; Ribeiro, Antonio L/C-2707-2009; Monasta, Lorenzo/B-1388-2012; ORISAKWE, ORISH EBERE/X-5852-2019; Hamadeh, Randah R./AAE-9720-2020; Catalá-López, Ferrán/N-6018-2018; Salomon, Joshua/S-1929-2019; Carabin, Helene/B-7600-2016; McGrath, John Joseph/G-5493-2010; A, Naheed/AHB-2940-2022; Bikbov, Boris/I-4594-2013; Franklin, Richard Charles/H-1731-2012; Sposato, Luciano A/D-7782-2012; Waller, Stephen/AAI-1787-2020; Karch, André/D-6973-2017; Karthikeyan, Ganesan/D-5767-2012; Rodriguez, Alina/B-3541-2015; Newton, Charles/V-7872-2019; Rana, Saleem M/Y-9791-2018; Antonio, Carl Abelardo/AAP-4280-2020; Heydarpour, Pouria/J-7330-2019; Schneider, Ione J.C./J-8762-2013; Thurston, George/ABB-1359-2021; Beyene, Tariku Jibat/A-6875-2017; Marks, Guy B./F-5058-2013; Defo, Barthelemy Kuate/I-4818-2017; Mozaffarian, Dariush/ABC-2822-2020; Dokova, Klara/N-2448-2016; Khan, Gulfaraz/AAC-2859-2022; Newton, Charles RJC/B-7578-2014; RUIZ, FERNANDO PEREZ/X-1980-2019; Benzian, Habib/AAN-5866-2020; Søreide, Kjetil/A-9797-2010; Nyakarahuka, Luke/W-8164-2019; Mckee, Martin/E-6673-2018; Pereira, David/M-9286-2013; Jacobsen, Kathryn H./B-5857-2008; Bennett, Derrick/AAH-1220-2022; Room, Robin/ABH-8505-2020; Truelsen, Thomas/AAY-1549-2020; Hedayati, Mohammad T./E-2304-2017; assadi, reza/AAT-6629-2020; Courville, Karen/AAW-1462-2021; Amini, Heresh/B-3076-2010; Rakovac, Ivo/A-7678-2013; Satpathy, Maheswar/J-3135-2017; Bennett, Derrick/AFL-9254-2022; Brugha, Traolach/T-9326-2019; Mapoma, Christopher Chabila/AAX-3368-2020; Refaat, Amany/AAA-8470-2021; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020; wang, xiao/HGB-7081-2022; Brauer, Michael/Y-2810-2019; Kivipelto, Miia/AAS-3557-2021; Knibbs, Luke/C-7865-2012; Villalpando, Salvador/AAS-3874-2021; Prabhakaran, Dorairaj/B-4147-2011; Knudsen, Ann Kristin/AAB-2465-2019; Ribeiro, Ana Cristina/HHN-7466-2022; Memish, Ziad Ahmed/AEJ-9424-2022; Castro, Ruben E/J-1948-2015; Geleijnse, Johanna Marianna M/B-5749-2012; Naidoo, Kovin Shunmugam/AAF-5914-2020; Sepanlou, Sadaf G/H-9343-2016; Soshnikov, Sergey/AAG-9739-2020; Degenhardt, Louisa J/D-4515-2012; Abu-Raddad, Laith J/AAY-1441-2020; Hornberger, John/M-4932-2019; Ronfani, Luca/B-6668-2013; A, Naheed/AHB-2941-2022; Zeeb, Hajo/I-2701-2019; Hay, Simon Iain/F-8967-2015; Ameli, Omid/G-1583-2013; Zheng, Yingfeng/CAE-9225-2022; Scott, James G/D-5900-2012; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Ukwaja, Kingsley N./A-7794-2013; Adsuar, Jose C/C-6558-2008; Naldi, Luigi/AFM-8982-2022; Weiderpass, Elisabete/AAP-2747-2021; assadi, reza/AAI-1124-2021; PACELLA, ROSANA E./F-2774-2010; Phillips, Michael Robert/AAE-7585-2021; Leung, Ricky/P-3702-2015; Violante, Francesco S/A-6934-2009; Undurraga, Eduardo/I-3739-2014; PEREZ-RUIZ, FERNANDO/E-4844-2012; Bensenor, Isabela Judith Martins/L-3306-2017; Ortblad, Katrina/ABF-9070-2020; Olusanya, Bolajoko O./F-4504-2012; Haro, Josep Maria/D-1423-2011; Bedi, Neeraj/H-2838-2019; Zaki, Maysaa El Sayed/H-3049-2019; Bedi, Neeraj/AGR-0606-2022; Wagner, Gregory R/B-1014-2009; Nyakarahuka, Luke/AGH-2432-2022; Badawi, Alaa/ABC-1300-2021; Cowie, Benjamin/HFZ-9941-2022; Carapetis, Jonathan R/H-8933-2014; Richardus, Jan Hendrik/AAE-1278-2021; O'Donnell, Martin/ABE-7459-2020; Zhou, Maigeng/HCH-7703-2022; Montico, Marcella/B-5290-2013; Ameli, Omid/AAA-1209-2020; Díaz-Torné, César/AAG-2419-2020; Zhao, Yong/Z-3231-2019; Crump, John A./AAZ-6412-2020; Poenaru, Dan/S-2562-2017; Naldi, Luigi/K-6343-2016; Khader, Yousef/AAE-9620-2019; Lopez, Alan D/F-1487-2010; Rojas-Rueda, David/AAK-2184-2020; Lozano, Rafael/T-5352-2018; saylan, Mete/B-5648-2008; Pourmalek, Farshad/A-8188-2010; Mokdad, Ali H./AAD-1232-2022; Schöttker, Ben/F-8183-2014; Balakrishnan, Kalpana/B-6653-2015; Lotufo, Paulo/A-9843-2008; Pandian, Jeyaraj Durai/AAV-5591-2020; Lee, Jong-Tae/AAF-5746-2020; McKee, Marc D/E-2187-2011; Alsharif, Ubai/C-6527-2017; Choobkar, Saeed/AAA-3212-2020; Idrisov, Bulat/A-8271-2018; Feigin, Valery/AAF-2313-2019; Nolte, Sandra/B-7498-2008; Patten, Scott/B-4434-2011; Lopez, Alan/AAA-2734-2022; Gona, Philimon/K-1477-2019; CASO, VALERIA/AAC-5156-2022; Woldeyohannes, Solomon Meseret/E-5783-2012; London, Stephanie/C-3734-2019; Trillini, Matias/ABA-7075-2020; Zonies, David/B-6497-2011; Coffeng, Luc/AAL-6631-2021; Mukaigawara, Mitsuru/L-2144-2016; Santos, Itamar S/K-7055-2012; Bose, Dipan/GRS-0467-2022; Tillmann, Taavi/R-6026-2016; Lunevicius, Raimundas/B-2528-2018; Fra.Paleo, Urbano/B-8088-2016; Soshnikov, Sergey/R-7352-2016; Neupane, Sudan Prasad/C-8056-2011; Kemp, Andrew Haddon/C-7984-2012; Ärnlöv, Johan/AAF-2746-2019; Rahimi-Movaghar, Vafa/L-6339-2019; Meretoja, Atte/H-6531-2019; Castañeda-Orjuela, Carlos/N-2601-2017; Ferrari, Alize J/G-1746-2011; Husseini, Abdullatif/E-8377-2015; Charlson, Fiona/R-8963-2019; Norheim, Ole Frithjof/AAC-8771-2020; Zaki, Maysaa El Sayed/C-1522-2013; Quistberg, D Alex/P-3538-2019; Rahimi, Kazem/Q-1279-2015; Weiderpass, Elisabete/M-4029-2016; Ikeda, Nayu/J-9890-2019; Leinsalu, Mall/I-3768-2018; Schwebel, David/GXH-9944-2022; Bicer, Burcu Kucuk/G-4922-2017; Mahdi, Abbas Ali/AAB-2293-2021; Banerjee, Amitava/D-4381-2014; Lavados, Pablo M/E-9918-2016; Kinfu, Yohannes/AAC-8054-2020; Thrift, Amanda/I-6251-2012; Aboyans, Victor/AAN-8308-2020; Melaku, Yohannes Adama/S-2451-2019; Alvarez, Elena/S-1068-2019; wang, YA XING/K-9671-2016; Rahimi, Kazem/AAA-4250-2022; ortiz, alberto/Y-7582-2018; Cunningham, Solveig/W-2672-2019; Soshnikov, Sergey/AAV-8566-2020; Room, Robin/ABF-7460-2021; Dimbuene, Zacharie Tsala/H-3029-2019; Brazinova, Alexandra/C-4265-2016; Venketasubramanian, Narayanaswamy/GPP-5948-2022; ABRAHAM, BIJU/AAK-2461-2020; Khan, Ejaz A/B-9340-2016; Lalloo, Ratilal/O-5624-2014; Murray, Joseph/Z-6274-2019; Beghi, Ettore/AAA-7426-2020; Towbin, Jeffrey A./J-5595-2019; Juel, Knud/C-8916-2013; Kaul, Anil/B-2075-2016; S, Sankar/AAM-1740-2021; Larson, Heidi J./N-1018-2017; Cirillo, Massimo/G-5480-2018; Lansingh, Van/C-8672-2018; Refaat, Amany/K-5419-2016; Vlassov, Vasiliy/B-4036-2014; Leasher, Janet/B-8889-2016; Shivakoti, Rupak/HIU-0448-2022; Remuzzi, Giuseppe/V-9766-2017; Basu, Arindam/C-1224-2009; Erskine, Holly/K-5244-2012	CT, Sreeramareddy/0000-0002-5693-7631; Davis, Adrian C/0000-0001-7134-7528; Yatsuya, Hiroshi/0000-0002-6220-9251; Deribe, Kebede/0000-0002-8526-6996; Cunningham, Solveig A/0000-0002-2354-1526; Hankey, Graeme J/0000-0002-6044-7328; Kieling, Christian/0000-0001-7691-4149; Pesudovs, Konrad/0000-0002-6322-9369; Patton, George C/0000-0001-5039-8326; Scarborough, Peter/0000-0002-2378-2944; Narayan, K.M. Venkat/0000-0001-8621-5405; Terkawi, Abdullah Suleiman/0000-0001-8734-2748; Tanne, David/0000-0002-6699-2220; Amare, Azmeraw T./0000-0002-7940-0335; Heredia-Pi, Ileana Beatriz/0000-0002-9998-9239; Mason-Jones, Amanda/0000-0002-4292-3183; Ginawi, Ibrahim Abdelmageed Mohamed/0000-0001-8628-1840; Tonelli, Marcello/0000-0002-0846-3187; Whiteford, Harvey A/0000-0003-4667-6623; Liu, Yang/0000-0001-5477-2186; Li, Yichong/0000-0003-3842-475X; ABBASOGLU OZGOREN, AYSE/0000-0002-6106-4839; LOGROSCINO, GIANCARLO/0000-0003-0423-3242; Lortet-Tieulent, Joannie/0000-0002-8816-7475; Majdan, Marek/0000-0001-8037-742X; Kuipers, Ernst J/0000-0002-0633-3098; Hossain, Mazeda/0000-0002-1878-8145; Bin Abdulhak, Aref/0000-0001-9988-8609; Malekzadeh, Reza/0000-0002-9820-6335; Paternina-Caicedo, Angel/0000-0002-6332-5174; Brenner, Hermann/0000-0002-6129-1572; Crump, John A./0000-0002-4529-102X; Ermakov, Sergey/0000-0003-1072-1162; Moffitt, Terrie E/0000-0002-8589-6760; Santos, Itamar/0000-0003-3212-8466; Alsharif, Ubai/0000-0002-4024-3950; Charlson, Fiona J/0000-0003-2876-5040; Moradi-Lakeh, Maziar/0000-0001-7381-5305; Higashi, Hideki/0000-0002-5534-0905; Jayaraman, Sudha/0000-0003-1094-5836; Brayne, Carol/0000-0001-5307-663X; Gunnell, David/0000-0002-0829-6470; Singh, Jasvinder/0000-0003-3485-0006; Foigt, Nataliya/0000-0002-3613-5965; Brenner, Hermann/0000-0002-6129-1572; Kravchenko, Michael A/0000-0001-5187-5518; Vasconcelos, Ana Maria Nogales/0000-0001-7589-107X; Khan, Prof Dr Ejaz/0000-0002-7072-8035; Takahashi, Ken/0000-0002-7310-2257; GANKPE, GBETOHO FORTUNE/0000-0002-1242-9686; Ding, Eric L./0000-0002-5881-8097; Sahathevan, Ramesh/0000-0001-7643-0961; Marzan, Melvin/0000-0003-2696-7335; Salomon, Joshua A/0000-0003-3929-5515; Bell, Michelle/0000-0002-3965-1359; Perico, Norberto/0000-0002-3147-4327; Ribeiro, Antonio L/0000-0002-2740-0042; Monasta, Lorenzo/0000-0001-7774-548X; ORISAKWE, ORISH EBERE/0000-0002-5806-9858; Hamadeh, Randah R./0000-0002-4205-1354; Catalá-López, Ferrán/0000-0002-3833-9312; Salomon, Joshua/0000-0003-3929-5515; McGrath, John Joseph/0000-0002-4792-6068; A, Naheed/0000-0002-6016-5603; Bikbov, Boris/0000-0002-1925-7506; Franklin, Richard Charles/0000-0003-1864-4552; Sposato, Luciano A/0000-0001-6425-9343; Karch, André/0000-0003-3014-8543; Karthikeyan, Ganesan/0000-0002-2073-2917; Rodriguez, Alina/0000-0003-1209-8802; Newton, Charles/0000-0002-6999-5507; Rana, Saleem M/0000-0001-6479-9235; Antonio, Carl Abelardo/0000-0001-7476-0553; Heydarpour, Pouria/0000-0001-5644-7555; Schneider, Ione J.C./0000-0001-6339-7832; Beyene, Tariku Jibat/0000-0002-7474-1966; Marks, Guy B./0000-0002-8976-8053; Defo, Barthelemy Kuate/0000-0002-6589-0564; Khan, Gulfaraz/0000-0001-6836-1783; Newton, Charles RJC/0000-0002-6999-5507; RUIZ, FERNANDO PEREZ/0000-0002-5268-1894; Benzian, Habib/0000-0003-3692-4849; Søreide, Kjetil/0000-0001-7594-4354; Nyakarahuka, Luke/0000-0002-2944-9157; Mckee, Martin/0000-0002-0121-9683; Pereira, David/0000-0003-0384-7592; Jacobsen, Kathryn H./0000-0002-4198-6246; Bennett, Derrick/0000-0002-9170-8447; Hedayati, Mohammad T./0000-0001-6415-4648; Courville, Karen/0000-0002-4182-6736; Amini, Heresh/0000-0002-4825-1322; Rakovac, Ivo/0000-0003-3462-2636; Satpathy, Maheswar/0000-0003-3521-4781; Bennett, Derrick/0000-0002-9170-8447; Brugha, Traolach/0000-0002-9786-9591; Mapoma, Christopher Chabila/0000-0001-9233-5462; Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; wang, xiao/0000-0002-4088-3341; Brauer, Michael/0000-0002-9103-9343; Villalpando, Salvador/0000-0001-6429-3816; Prabhakaran, Dorairaj/0000-0002-3172-834X; Ribeiro, Ana Cristina/0000-0002-0493-8376; Memish, Ziad Ahmed/0000-0002-5099-0714; Castro, Ruben E/0000-0002-7289-9081; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Sepanlou, Sadaf G/0000-0002-3669-5129; Soshnikov, Sergey/0000-0002-6983-7066; Degenhardt, Louisa J/0000-0002-8513-2218; Abu-Raddad, Laith J/0000-0003-0790-0506; Ronfani, Luca/0000-0001-5710-3914; A, Naheed/0000-0002-6016-5603; Zeeb, Hajo/0000-0001-7509-242X; Hay, Simon Iain/0000-0002-0611-7272; Ameli, Omid/0000-0001-7878-0551; Zheng, Yingfeng/0000-0002-0914-7864; Scott, James G/0000-0002-0744-0688; Ukwaja, Kingsley N./0000-0002-1974-8735; Adsuar, Jose C/0000-0001-7203-3168; Naldi, Luigi/0000-0002-3160-2835; Weiderpass, Elisabete/0000-0003-2237-0128; PACELLA, ROSANA E./0000-0002-9742-1957; Phillips, Michael Robert/0000-0002-5973-2439; Leung, Ricky/0000-0002-2852-6771; Violante, Francesco S/0000-0003-4084-2782; Undurraga, Eduardo/0000-0002-4425-1253; Ortblad, Katrina/0000-0002-5675-8836; Olusanya, Bolajoko O./0000-0002-3826-0583; Haro, Josep Maria/0000-0002-3984-277X; Bedi, Neeraj/0000-0003-4709-8423; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Bedi, Neeraj/0000-0003-4709-8423; Nyakarahuka, Luke/0000-0002-2944-9157; Cowie, Benjamin/0000-0002-7087-5895; Carapetis, Jonathan R/0000-0002-1182-9792; Richardus, Jan Hendrik/0000-0003-0564-6313; O'Donnell, Martin/0000-0002-7347-7761; Montico, Marcella/0000-0003-0377-8232; Ameli, Omid/0000-0001-7878-0551; Díaz-Torné, César/0000-0001-6275-7699; Zhao, Yong/0000-0001-9290-109X; Crump, John A./0000-0002-4529-102X; Poenaru, Dan/0000-0002-6267-6140; Naldi, Luigi/0000-0002-3160-2835; Khader, Yousef/0000-0002-7830-6857; Lopez, Alan D/0000-0001-5818-6512; Rojas-Rueda, David/0000-0001-5854-2484; Lozano, Rafael/0000-0002-7356-8823; saylan, Mete/0000-0002-8917-1775; Pourmalek, Farshad/0000-0002-2134-0771; Mokdad, Ali H./0000-0002-4994-3339; Schöttker, Ben/0000-0002-1217-4521; Balakrishnan, Kalpana/0000-0002-5905-1801; Lotufo, Paulo/0000-0002-4856-8450; Lee, Jong-Tae/0000-0002-8510-3054; McKee, Marc D/0000-0001-8349-965X; Alsharif, Ubai/0000-0002-4024-3950; Nolte, Sandra/0000-0001-6185-9423; Patten, Scott/0000-0001-9871-4041; CASO, VALERIA/0000-0002-2020-8891; London, Stephanie/0000-0003-4911-5290; Trillini, Matias/0000-0003-1859-1729; Coffeng, Luc/0000-0002-4425-2264; Mukaigawara, Mitsuru/0000-0001-6530-2083; Santos, Itamar S/0000-0003-3212-8466; Tillmann, Taavi/0000-0002-8428-3719; Lunevicius, Raimundas/0000-0003-3295-0142; Fra.Paleo, Urbano/0000-0001-6192-7684; Soshnikov, Sergey/0000-0002-6983-7066; Kemp, Andrew Haddon/0000-0003-1146-3791; Ärnlöv, Johan/0000-0002-6933-4637; Meretoja, Atte/0000-0001-6433-1931; Castañeda-Orjuela, Carlos/0000-0002-8735-6223; Ferrari, Alize J/0000-0002-7863-9117; Husseini, Abdullatif/0000-0001-8767-5956; Charlson, Fiona/0000-0003-2876-5040; Norheim, Ole Frithjof/0000-0002-5748-5956; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Quistberg, D Alex/0000-0001-9730-2686; Rahimi, Kazem/0000-0002-4807-4610; Weiderpass, Elisabete/0000-0003-2237-0128; Ikeda, Nayu/0000-0002-3424-1991; Leinsalu, Mall/0000-0003-4453-4760; Bicer, Burcu Kucuk/0000-0002-5615-264X; Banerjee, Amitava/0000-0001-8741-3411; Lavados, Pablo M/0000-0002-9118-9093; Kinfu, Yohannes/0000-0001-9607-6891; Thrift, Amanda/0000-0001-8533-4170; Melaku, Yohannes Adama/0000-0002-3051-7313; Alvarez, Elena/0000-0002-9679-2721; wang, YA XING/0000-0003-2749-7793; ortiz, alberto/0000-0002-9805-9523; Room, Robin/0000-0002-5618-385X; Dimbuene, Zacharie Tsala/0000-0002-7977-1689; Brazinova, Alexandra/0000-0003-0625-256X; Khan, Ejaz A/0000-0002-7072-8035; Lalloo, Ratilal/0000-0001-5822-1269; Murray, Joseph/0000-0002-5511-3454; Beghi, Ettore/0000-0003-2542-0469; Towbin, Jeffrey A./0000-0002-6585-714X; S, Sankar/0000-0002-6424-1140; van Gool, Coen H/0000-0001-7170-0563; Huffman, Mark/0000-0001-7412-2519; Larson, Heidi J./0000-0002-8477-7583; Mhimbira, Francis/0000-0001-8989-6832; Innos, Kaire/0000-0003-0120-2213; Pearce, Neil/0000-0002-9938-7852; Bohensky, Megan/0000-0001-8370-1408; Mahdi, Abbas Ali/0000-0002-8580-9911; Dokova, Klara/0000-0002-0164-4903; Briggs, Adam/0000-0002-2314-1039; Tenkorang, Eric/0000-0001-6127-3799; Islami, Farhad/0000-0002-7357-5994; Gouda, Hebe/0000-0002-5709-4509; Gibney, Katherine/0000-0001-5851-5339; Riccio, Patricia/0000-0002-5561-5278; Cooper, Cyrus/0000-0003-3510-0709; Stanaway, Jeffrey/0000-0003-2209-8478; Kwan, Gene/0000-0002-0929-6800; Tabb Dina, Karen/0000-0002-4722-9502; Tirschwell, David/0000-0002-8059-2901; Sahle, Berhe W/0000-0003-3243-9176; Farzadfar, Farshad/0000-0001-8288-4046; Borges, Guilherme/0000-0002-3269-0507; del Pozo Cruz, Borja/0000-0002-9728-1317; CHANG, JUNG-CHEN/0000-0001-8651-2602; Sindi, Shireen/0000-0002-3786-0552; Bhala, Neeraj/0000-0003-2502-1177; Aboyans, Victor/0000-0002-0322-9818; Ademi, Zanfina/0000-0002-0625-3522; Pandian, Jeyaraj/0000-0003-0028-1968; Achoki, Tom/0000-0001-6309-8904; Goenka, Shifalika/0000-0001-6993-2883; Yoon, Seok-Jun/0000-0003-3297-0071; Abuabara, Katrina/0000-0002-7736-6946; Cirillo, Massimo/0000-0002-6409-3504; Soljak, Michael/0000-0002-0303-1617; Glaser, Elizabeth/0000-0002-1918-057X; Juel, Knud/0000-0002-4134-1173; Woldeyohannes, Solomon/0000-0003-2431-2730; Roy, Nobhojit/0000-0003-2022-7416; Dargan, Paul/0000-0002-3433-9622; Woolf, Anthony/0000-0001-8482-8056; Lansingh, Van/0000-0002-0090-4195; Che, Xuan/0000-0001-7981-6456; Salvo, Deborah/0000-0002-9726-0882; Tleyjeh, Imad/0000-0002-5551-0353; Abd-Allah, Foad/0000-0001-8308-5756; Khang, Young-Ho/0000-0002-9585-8266; Stroumpoulis, Konstantinos/0000-0003-3234-3772; Barrientos-Gutierrez, Tonatiuh/0000-0002-0826-9106; Kim, Daniel/0000-0001-8907-6420; Dandona, Rakhi/0000-0003-0926-788X; Knibbs, Luke/0000-0002-0399-2370; Hu, Howard/0000-0002-3676-2707; Quezada-Sanchez, Amado D./0000-0003-3258-8198; Ruhago, George Mugambage/0000-0001-7469-7822; Rothenbacher, Dietrich/0000-0002-3563-2791; Chen, Honglei/0000-0003-3446-7779; Jeemon, Panniyammakal/0000-0003-4172-4307; Sunguya, Bruno/0000-0003-3625-0725; Vallely, Andrew/0000-0003-1558-4822; Balalla, Shivanthi/0000-0001-5320-753X; Kumar, Kaushalendra/0000-0001-5913-0297; Duber, Herbert/0000-0002-5077-3170; Knudsen, Ann Kristin/0000-0002-1218-798X; Meaney, Peter/0000-0001-9898-6928; Nash, Denis/0000-0002-3280-5386; Refaat, Amany/0000-0002-0501-6146; Nisar, Muhammad Imran/0000-0002-2378-4720; Vlassov, Vasiliy/0000-0001-5203-549X; Coates, Matthew/0000-0002-8474-4992; Te Ao, Braden/0000-0002-1050-200X; Wessells, K. Ryan/0000-0002-5485-7144; Buckle, Geoffrey/0000-0001-7721-0397; Boufous, Soufiane/0000-0002-5686-1729; Christensen, Hanne/0000-0002-7472-3194; Leasher, Janet/0000-0002-8779-5162; Ali, Mohammed/0000-0001-7266-2503; Hotez, Peter/0000-0001-8770-1042; Benjet, Corina/0000-0002-4569-6094; Shivakoti, Rupak/0000-0002-2773-9310; ABRAHAM, BIJU/0000-0002-3586-2589; Remuzzi, Giuseppe/0000-0002-6194-3446; Mori, Rintaro/0000-0001-7656-6156; MacLachlan, Jennifer/0000-0002-7654-4536; Feigin, Valery L./0000-0002-6372-1740; Esteghamati, Alireza/0000-0001-5114-3982; Miller, Ted/0000-0002-0958-2639; Zamakhshary, Mohammed/0000-0001-8870-8684; Hu, Guoqing/0000-0002-5002-8015; Basu, Arindam/0000-0003-2326-2292; Barrero, Lope/0000-0003-1503-0264; Lucas, Robyn/0000-0003-2736-3541; Liu, Zhi-Hong/0000-0001-6093-0726; FARAON, EMERITO JOSE A./0000-0001-6157-5930; Assadi, Reza/0000-0002-5016-2994; alla, francois/0000-0002-5793-7190; Magis-Rodriguez, Carlos/0000-0001-5481-1253; Al Asfoor, Deena/0000-0002-7973-1935; Ohkubo, Takayoshi/0000-0002-3283-8196; Abubakar, Ibrahim/0000-0002-0370-1430; Blyth, Fiona/0000-0003-1128-6756; , Borja/0000-0003-3944-2212; Colquhoun, Samantha/0000-0002-6750-1147; /0000-0002-9584-0576; Hagstromer, Maria/0000-0002-4607-8677; Tsilimbaris, Miltiadis/0000-0002-0130-1150; Lind, Margaret/0000-0002-1572-4074; Naghavi, Paria/0000-0002-8908-7952; Topouzis, Fotis/0000-0002-8966-537X; Idrisov, Bulat/0000-0002-1971-2572; Piel, Frederic B./0000-0001-8131-7728; Lallukka, Tea/0000-0003-3841-3129; Rakovac, Ivo/0000-0002-6815-5274; Kengne, Andre Pascal/0000-0002-5183-131X; Qato, Dima/0000-0001-5411-6998; Sahraian, Mohammad Ali/0000-0002-3224-8807; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Lyons, Ronan/0000-0001-5225-000X; Servan-Mori, Edson/0000-0001-9820-8325; De la Cruz-Gongora, Vanessa/0000-0002-0408-6580; Neupane, Sudan Prasad/0000-0002-7389-4178; Mustapha, Adetoun/0000-0002-6035-1086; Xu, Gelin/0000-0002-6194-0341; Goto, Atsushi/0000-0003-0669-654X; Erskine, Holly/0000-0003-3119-9211; Jha, Vivekanand/0000-0002-8015-9470; Roberts, Allen/0000-0003-3660-6330; WILKINSON, JAMES/0000-0003-1945-5622; Shibuya, Kenji/0000-0003-2528-7530; Hoek, Hans/0000-0001-6353-5465; Levitz, Carly/0000-0003-3094-411X; Mayosi, Bongani/0000-0001-6641-8950; Moturi, Wilkister Nyaora/0000-0001-6620-4856; Stockl, Heidi/0000-0002-0907-8483; Cooper, Leslie/0000-0003-1002-3313; Shiue, Ivy/0000-0003-1788-3009; O'donnell, Colm/0000-0002-8004-450X; Colistro, Valentina/0000-0002-5727-4980	British Heart Foundation [RG/08/014/24067] Funding Source: Medline; Medical Research Council [MC_U147585819, MC_U147585827, MR/K006525/1, G0400491, MC_U137686851, MC_U147585824, MC_UU_12011/1, G9806489, MR/L003120/1, MC_UP_A620_1014] Funding Source: Medline; NCATS NIH HHS [KL2 TR001088] Funding Source: Medline; NIA NIH HHS [P30 AG017253] Funding Source: Medline; NIEHS NIH HHS [P30 ES000260] Funding Source: Medline; Wellcome Trust [089963, 089276, 099876] Funding Source: Medline; Department of Health [CDF-2013-06-012, RP-PG-0407-10184] Funding Source: Medline; MRC [G9806489, G0400491, MR/L003120/1, MR/K006525/1, MC_U147585819, MC_U137686851, MC_U147585827] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG017253] Funding Source: NIH RePORTER; Medical Research Council [G1002605, U1475000001] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10060, ACF-2011-13-012, RP-PG-0407-10184, CDF-2013-06-012, NF-SI-0512-10165, ACF-2013-17-013, NF-SI-0508-10082, NF-SI-0611-10084, NF-SI-0513-10085] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wellcome Trust(Wellcome Trust); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Ahern RM, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-8; Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; AIWH, 2004, FIELD B RHEUM HEART; [Anonymous], 2013, GLOB BURD DIS GEN EV; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Baqui AH, 2007, PEDIATR INFECT DIS J, V26, P565, DOI 10.1097/INF.0b013e31806166a0; Beltran-Sanchez H, 2008, DEMOGR RES, V19, P1323, DOI 10.4054/DemRes.2008.19.35; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; Blackwelder WC, 2012, CLIN INFECT DIS, V55, pS246, DOI 10.1093/cid/cis788; Bloom DE, 2007, P NATL ACAD SCI USA, V104, P16044, DOI 10.1073/pnas.0702012104; Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236; Bustreo F, 2013, LANCET GLOB HEALTH, V1, pE176, DOI 10.1016/S2214-109X(13)70059-7; Centre for Research on the Epidemiology of Disasters (CRED), EM DAT OFDA CRED INT; Clark R, 2011, SOC SCI MED, V72, P617, DOI 10.1016/j.socscimed.2010.12.008; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Das S, 2007, J Commun Dis, V39, P37; Department for International Development. UKAID, 2011, ZER INF UKS POS PAP; Dhama Kuldeep, 2012, Pak J Biol Sci, V15, P1001, DOI 10.3923/pjbs.2012.1001.1009; Feikin DR, 2014, LANCET, V383, P1762, DOI 10.1016/S0140-6736(13)61682-7; Flaxman A, 2014, INTEGRATED METAREGRE; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Forouzanfar MH, 2014, ARCH IRAN MED, V17, P304, DOI 0141705/AIM.004; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gessner BD, 2005, LANCET, V365, P43, DOI 10.1016/S0140-6736(04)17664-2; Gessner BD, 2008, VACCINE, V26, pB3, DOI 10.1016/j.vaccine.2008.04.013; Gini C., 1912, J R STAT SOC, V76, P326; Gompertz B., 1825, PHILOS T R SOC LOND, V115, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; Hill K, 2013, ADOLESCENT MORTALITY; Institute for Health Metrics and Evaluation, 2013, GBD 2013 PROT GLOB B; International Agency for Research on Cancer, GLOBOCAN 2012 EST CA; James SL, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-12; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Kalantri SP, 2006, NATL MED J INDIA, V19, P315; Kannisto Vaino., 1994, DEV OLDEST OLD MORTA; Ki-Moon Ban, 2011, SECRETARY GEN MESSAG; Klugman KP, 2011, PHILOS T R SOC B, V366, P2790, DOI 10.1098/rstb.2011.0032; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kotila SM, 2011, CLIN MICROBIOL INFEC, V17, P888, DOI 10.1111/j.1469-0691.2010.03384.x; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Laishram S, 2012, INDIAN J GASTROENTER, V31, P3, DOI 10.1007/s12664-012-0161-9; Leon DA, 2010, INT J EPIDEMIOL, V39, P1279, DOI 10.1093/ije/dyq102; Levine MM, 2012, CLIN INFECT DIS, V55, pS215, DOI 10.1093/cid/cis761; Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052; Levine OS, 1999, PEDIATR INFECT DIS J, V18, P1060, DOI 10.1097/00006454-199912000-00006; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2013, SALUD PUBLICA MEXICO, V55, P580; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lucero MG, 2009, PEDIATR INFECT DIS J, V28, P455, DOI 10.1097/INF.0b013e31819637af; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Moser K, 2005, B WORLD HEALTH ORGAN, V83, P202; Mueller Yolanda, 2011, Confl Health, V5, P3, DOI 10.1186/1752-1505-5-3; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Murray CJL, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-5; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262; Murray CJL, 2006, CIRCULATION, V113, P2071, DOI 10.1161/CIRCULATIONAHA.105.595777; Musher DM, 2004, NEW ENGL J MED, V351, P2417, DOI 10.1056/NEJMra041837; Naghavi M, 2014, ARCH IRAN MED, V17, P321, DOI 0141705/AIM.005; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; NASH TE, 1987, J INFECT DIS, V156, P974, DOI 10.1093/infdis/156.6.974; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; North AB, 2003, CANC INCIDENCE 5 CON, VX; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Preston S, 2000, DEMOGRAPHY MEASURING; Quah DT, 1996, ECON J, V106, P1045, DOI 10.2307/2235377; Raheel U, 2011, J INFECT DEV COUNTR, V5, P239, DOI 10.3855/jidc.1017; Ravallion M, 2012, AM ECON REV, V102, P504, DOI 10.1257/aer.102.1.504; RENDTORFF ROBERT C., 1954, AMER JOUR HYG, V59, P209; Roulson J, 2005, HISTOPATHOLOGY, V47, P551, DOI 10.1111/j.1365-2559.2005.02243.x; Sahloul Z, 2014, LANCET, V383, P407, DOI 10.1016/S0140-6736(13)62558-1; Sala-I-Martin X, 2006, Q J ECON, V121, P351, DOI 10.1162/qjec.2006.121.2.351; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Shahraz S, 2014, ARCH IRAN MED, V17, P336, DOI 0141705/AIM.006; Sigauque B, 2013, J PEDIATR-US, V163, pS19, DOI 10.1016/j.jpeds.2013.03.026; Simonsen L, 2011, BIRKHAUSER ADV INFEC, P27, DOI 10.1007/978-3-0346-0279-2_2; Sonderegger-Iseli K, 2000, LANCET, V355, P2027, DOI 10.1016/S0140-6736(00)02349-7; South Africa Info Reporter, 2012, S AFR HIV AIDS BATTL; Stop TB Partnership, 2012, NO MOR CRYING NO MOR; The International Institute For Strategic Studies, ARM CONFL DAT; The world we want, 2013, HLTH POST 2015 AG RE; Treatment Action Group (TAG), 2012, THE ZERO DECLARATION; UNAIDS, 2013, METH UND HIV EST; UNAIDS, 2010, 2011 2015 STRAT GETT; UNICEF, 2015, COMMITTING CHILD SUR; United Nations, WORLD POP AG 2013; United Nations' Department of Economic and Social Affairs, WORLD POP PROSP 2012; United States Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. National Mortality Followback Survey, 1993, NAT MORT FOLL SURV 1; USAID, 2012, CHILD SURV CALL ACT; USAID, 2013, GLOB HLTH PROGR PROG; Vallin Jacques, 2004, SPECIAL COLLECTION, V2, P11, DOI [10.4054/DemRes.2004.S2.2, DOI 10.4054/DEMRES.2004.S2.2]; Vangen S, 2014, TIDSSKR NOR LAEGEFOR, V134, P836; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; Wheldon MC, 2013, J AM STAT ASSOC, V108, P96, DOI 10.1080/01621459.2012.737729; WHO, 2013, 2 M GEN SWITZ; WHO, 2012, POS HLTH POST 2015 W; Wilson C, 2001, POPUL DEV REV, V27, P155, DOI 10.1111/j.1728-4457.2001.00155.x; World Health Organization, INT STAT CLASS DIS R, V10th; World Health Organization (WHO), 2013, ROADM CHILDH TUB; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yoder J, 2010, GIARDIASIS SURVEILLA; ZELLNER A, 1962, J AM STAT ASSOC, V57, P348, DOI 10.2307/2281644	122	4657	4900	102	2717	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2015	385	9963					117	171		10.1016/S0140-6736(14)61682-2	http://dx.doi.org/10.1016/S0140-6736(14)61682-2			55	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY7BI	25530442	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000347715900024
J	Mosquera, RA; Avritscher, EBC; Samuels, CL; Harris, TS; Pedroza, C; Evans, P; Navarro, F; Wootton, SH; Pacheco, S; Clifton, G; Moody, S; Franzini, L; Zupancic, J; Tyson, JE				Mosquera, Ricardo A.; Avritscher, Elenir B. C.; Samuels, Cheryl L.; Harris, Tomika S.; Pedroza, Claudia; Evans, Patricia; Navarro, Fernando; Wootton, Susan H.; Pacheco, Susan; Clifton, Guy; Moody, Shade; Franzini, Luisa; Zupancic, John; Tyson, Jon E.			Effect of an Enhanced Medical Home on Serious Illness and Cost of Care Among High-Risk Children With Chronic Illness A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE; NEEDS; YOUTH; PEDIATRICIANS; ASSOCIATION; QUALITY	IMPORTANCE Patient-centered medical homes have not been shown to reduce adverse outcomes or costs in adults or children with chronic illness. OBJECTIVE To assess whether an enhanced medical home providing comprehensive care prevents serious illness (death, intensive care unit [ICU] admission, or hospital stay >7 days) and/or reduces costs among children with chronic illness. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial of high-risk children with chronic illness (>= 3 emergency department visits, >= 2 hospitalizations, or >= 1 pediatric ICU admissions during previous year, and >50% estimated risk for hospitalization) treated at a high-risk clinic at the University of Texas, Houston, and randomized to comprehensive care (n = 105) or usual care (n = 96). Enrollment was between March 2011 and February 2013 (when predefined stopping rules for benefit were met) and outcome evaluations continued through August 31, 2013. INTERVENTIONS Comprehensive care included treatment from primary care clinicians and specialists in the same clinic with multiple features to promote prompt effective care. Usual care was provided locally in private offices or faculty-supervised clinics without modification. MAIN OUTCOMES AND MEASURES Primary outcome: children with a serious illness (death, ICU admission, or hospital stay >7 days), costs (health system perspective). Secondary outcomes: individual serious illnesses, medical services, Medicaid payments, and medical school revenues and costs. RESULTS In an intent-to-treat analysis, comprehensive care decreased both the rate of children with a serious illness (10 per 100 child-years vs 22 for usual care; rate ratio [RR], 0.45 [95% CI, 0.28-0.73]), and total hospital and clinic costs ($16 523 vs $26 781 per child-year, respectively; cost ratio, 0.58 [95% CI, 0.38-0.88]). In analyses of net monetary benefit, the probability that comprehensive care was cost neutral or cost saving was 97%. Comprehensive care reduced (per 100 child-years) serious illnesses (16 vs 44 for usual care; RR, 0.33 [95% CI, 0.17-0.66]), emergency department visits (90 vs 190; RR, 0.48 [95% CI, 0.34-0.67]), hospitalizations (69 vs 131; RR, 0.51 [95% CI, 0.33-0.77]), pediatric ICU admissions (9 vs 26; RR, 0.35 [95% CI, 0.18-0.70]), and number of days in a hospital (276 vs 635; RR, 0.36 [95% CI, 0.19-0.67]). Medicaid payments were reduced by $6243 (95% CI, $1302-$11 678) per child-year. Medical school losses (costs minus revenues) increased by $6018 (95% CI, $5506-$6629) per child-year. CONCLUSIONS AND RELEVANCE Among high-risk children with chronic illness, an enhanced medical home that provided comprehensive care to promote prompt effective care vs usual care reduced serious illnesses and costs. These findings from a single site of selected patients with a limited number of clinicians require study in larger, broader populations before conclusions about generalizability to other settings can be reached.	[Mosquera, Ricardo A.; Avritscher, Elenir B. C.; Samuels, Cheryl L.; Harris, Tomika S.; Pedroza, Claudia; Navarro, Fernando; Wootton, Susan H.; Pacheco, Susan; Moody, Shade; Tyson, Jon E.] Univ Texas Houston, Sch Med, Dept Pediat, Houston, TX 77030 USA; [Evans, Patricia] Pediatrix Med Grp, Dallas, TX USA; [Clifton, Guy] Univ Texas Houston, Sch Med, Dept Neurosurg, Houston, TX 77030 USA; [Clifton, Guy] Clifton Hlth Ctr, Houston, TX USA; [Franzini, Luisa] Univ Texas Houston, Div Management Policy & Community Hlth, Sch Publ Hlth, Houston, TX 77030 USA; [Zupancic, John] Harvard Univ, Sch Med, Div Newborn Med, Boston, MA USA; [Zupancic, John] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Mosquera, RA (corresponding author), Univ Texas Houston, Sch Med, 6410 Fannin St, Houston, TX 77030 USA.	ricardo.amosquera@uth.tmc.edu	Zupancic, John/G-2009-2018	Zupancic, John/0000-0003-1734-7193; Pedroza, Claudia/0000-0003-4235-1282	University of Texas Health Science Center at Houston; Health Care Innovation Award from Centers for Medicare & Medicaid Services (CMS) [1C1MS331044-01-00]; Texas Health and Human Services; National Center for Advancing Translational Sciences [5 UL1TR00371]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	University of Texas Health Science Center at Houston; Health Care Innovation Award from Centers for Medicare & Medicaid Services (CMS); Texas Health and Human Services; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was supported from the outset by the University of Texas Health Science Center at Houston and subsequently funded in part by Health Care Innovation Award 1C1MS331044-01-00 from the Centers for Medicare & Medicaid Services (CMS); grants and funding from Texas Health and Human Services; and grant 5 UL1TR00371 from the National Center for Advancing Translational Sciences. The Texas Health and Human Services provided Medicaid claims and payment data. The CMS provided written comments considered by the authors in preparing the final manuscript.	Agrawal R, 2012, CLIN PEDIATR, V51, P39, DOI 10.1177/0009922811417288; Andreae MC, 2014, PEDIATRICS, V133, P1158, DOI 10.1542/peds.2014-0866; Berman S, 2002, PEDIATRICS, V110, P239, DOI 10.1542/peds.110.2.239; Bitsko Rebecca H, 2009, Pediatrics, V124 Suppl 4, pS343, DOI 10.1542/peds.2009-1255D; Broyles RS, 2000, JAMA-J AM MED ASSOC, V284, P2070, DOI 10.1001/jama.284.16.2070; Burke R, 2011, PEDIATRICS, V128, pE1645, DOI 10.1542/peds.2011-2219; Carle AC, 2012, MED CARE, V50, pS37, DOI 10.1097/MLR.0b013e3182665189; Carnevale FA, 2006, PEDIATRICS, V117, pE48, DOI 10.1542/peds.2005-0789; Cohen E, 2011, ARCH PEDIAT ADOL MED, V165, P554, DOI 10.1001/archpediatrics.2011.74; Faden RR, 2014, NEW ENGL J MED, V370, P766, DOI 10.1056/NEJMhle1313674; Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Gallagher P, 2009, PEDIATRICS, V124, P1348, DOI 10.1542/peds.2009-0495; Gold MR, 1996, COST EFFECTIVENESS H; Greenberg JO, 2014, JAMA INTERN MED, V174, P454, DOI 10.1001/jamainternmed.2013.14093; Hesselink G, 2012, ANN INTERN MED, V157, P417, DOI 10.7326/0003-4819-157-6-201209180-00006; Hoffman A, 2013, JAMA-J AM MED ASSOC, V309, P661, DOI 10.1001/jama.2012.214571; Homer CJ, 2008, PEDIATRICS, V122, pE922, DOI 10.1542/peds.2007-3762; Jackson GL, 2013, ANN INTERN MED, V158, P169, DOI 10.7326/0003-4819-158-3-201302050-00579; Jaen Carlos Roberto, 2010, Ann Fam Med, V8 Suppl 1, pS57, DOI 10.1370/afm.1121; Kass NE, 2013, HASTINGS CENT REP, V43, pS4, DOI 10.1002/hast.133; Katerndabl DA, 2010, ANN FAM MED, V8, P341, DOI [10.1370/afm.1108, 10.1370/afm.1157]; Kuo DZ, 2011, ARCH PEDIAT ADOL MED, V165, P1020, DOI 10.1001/archpediatrics.2011.172; Liptak GS, 2011, PEDIATRICS, V128, pE1321, DOI 10.1542/peds.2011-1468; Mokkink LB, 2008, EUR J PEDIATR, V167, P1441, DOI 10.1007/s00431-008-0697-y; National Committee on Quality Assurance (NCQA), PAT CTR MED HOM REC; Paustian ML, 2014, HEALTH SERV RES, V49, P52, DOI 10.1111/1475-6773.12085; Rosenthal MB, 2013, JAMA INTERN MED, V173, P1907, DOI 10.1001/jamainternmed.2013.10063; Schwenk TL, 2014, JAMA-J AM MED ASSOC, V311, P802, DOI 10.1001/jama.2014.352; Sia CJ, 2002, PEDIATRICS, V110, P184; Simon TD, 2010, PEDIATRICS, V126, P647, DOI 10.1542/peds.2009-3266; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; Tom JO, 2012, PEDIATRICS, V130, pE183, DOI 10.1542/peds.2011-1786; US Department of Health and Human Services; Agency for Healthcare Research and Quality, CAHPS DAT; US Department of Health and Human Services; Agency for Healthcare Research and Quality, CAPHS SURV TOOLS ADV; US Department of Labor; Bureau of Labor Statistics, CONS PRIC IND; Werner RM, 2013, MED CARE, V51, P487, DOI 10.1097/MLR.0b013e31828d4d29; Zickafoose JS, 2013, PEDIATRICS, V131, P473, DOI 10.1542/peds.2012-2029; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	39	158	159	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2014	312	24					2640	2648		10.1001/jama.2014.16419	http://dx.doi.org/10.1001/jama.2014.16419			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX5KW	25536255	Bronze			2022-12-28	WOS:000346966100016
J	Arie, S				Arie, Sophie			THE BMJ CHRISTMAS APPEAL 2014 MSF: how a humanitarian charity found itself leading the world's response to Ebola	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com							0	4	4	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2014	349								g7737	10.1136/bmj.g7737	http://dx.doi.org/10.1136/bmj.g7737			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY2UJ	25536960	Green Published, Bronze			2022-12-28	WOS:000347444200002
J	Jones, DL; Brewster, RC; Phillips, R				Jones, Daniel L.; Brewster, Robert C.; Phillips, Rob			Promoter architecture dictates cell-to-cell variability in gene expression	SCIENCE			English	Article							ESCHERICHIA-COLI; FLUCTUATING ENVIRONMENTS; TRANSCRIPTIONAL CONTROL; NOISE	Variability in gene expression among genetically identical cells has emerged as a central preoccupation in the study of gene regulation; however, a divide exists between the predictions of molecular models of prokaryotic transcriptional regulation and genome-wide experimental studies suggesting that this variability is indifferent to the underlying regulatory architecture. We constructed a set of promoters in Escherichia coli in which promoter strength, transcription factor binding strength, and transcription factor copy numbers are systematically varied, and used messenger RNA (mRNA) fluorescence in situ hybridization to observe how these changes affected variability in gene expression. Our parameter-free models predicted the observed variability; hence, the molecular details of transcription dictate variability in mRNA expression, and transcriptional noise is specifically tunable and thus represents an evolutionarily accessible phenotypic parameter.	[Jones, Daniel L.; Brewster, Robert C.; Phillips, Rob] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Brewster, Robert C.; Phillips, Rob] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Phillips, R (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu		Jones, Daniel/0000-0002-7902-996X; Brewster, Robert/0000-0002-7656-4086	NIH [DP1 OD000217, R01 GM085286, 1 U54 CA143869]; Fondation Pierre Gilles de Gennes; Donna and Benjamin M. Rosen Center for Bioengineering at Caltech; NATIONAL CANCER INSTITUTE [U54CA143869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085286] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Pierre Gilles de Gennes; Donna and Benjamin M. Rosen Center for Bioengineering at Caltech; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. J. Lee, C. Wiggins, Y. Lin, X. Zhu, F. Weinert, M. Rydenfelt, R. Milo, H. Garcia, N. Belliveau, and J. Sheung for useful discussions. Supported by NIH grants DP1 OD000217 (Directors Pioneer Award), R01 GM085286, and 1 U54 CA143869 (Northwestern PSOC Center); La Fondation Pierre Gilles de Gennes (R.P.); and the Donna and Benjamin M. Rosen Center for Bioengineering at Caltech (D.L.J.). Raw microscopy image data are archived in the Phillips laboratory at Caltech and are available upon request.	Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Brewster RC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002811; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Mitarai N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000109; Paulsson J, 2000, PHYS REV LETT, V84, P5447, DOI 10.1103/PhysRevLett.84.5447; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Salman H, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238105; Sanchez A, 2008, P NATL ACAD SCI USA, V105, P5081, DOI 10.1073/pnas.0707904105; Sanchez A, 2013, ANNU REV BIOPHYS, V42, P469, DOI 10.1146/annurev-biophys-083012-130401; Sanchez A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001100; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Vilar JMG, 2003, J MOL BIOL, V331, P981, DOI 10.1016/S0022-2836(03)00764-2	22	133	134	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1533	1536		10.1126/science.1255301	http://dx.doi.org/10.1126/science.1255301			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525251	Green Accepted			2022-12-28	WOS:000346536500069
J	Sedgwick, P				Sedgwick, Philip			Bias in observational study designs: prospective cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Luo JH, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1016; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6726; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5584	3	22	23	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 19	2014	349								g7731	10.1136/bmj.g7731	http://dx.doi.org/10.1136/bmj.g7731			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX3EN	25527114				2022-12-28	WOS:000346823300004
J	Calegari, F				Calegari, Federico			Tossed out to save the masses	SCIENCE			English	Editorial Material							NEOCORTEX		Tech Univ Dresden, DFG Res Ctr & Cluster Excellence Regenerat Therap, D-01307 Dresden, Germany	Technische Universitat Dresden	Calegari, F (corresponding author), Tech Univ Dresden, DFG Res Ctr & Cluster Excellence Regenerat Therap, D-01307 Dresden, Germany.	federico.calegari@crt-dresden.de	Calegari, Federico/A-2422-2009; Calegari, Federico/N-7827-2019	calegari, federico/0000-0002-3703-2802				Ephesus J., MUSEI VATICANI FRAGM; Gorfinkiel N, 2011, CURR OPIN CELL BIOL, V23, P531, DOI 10.1016/j.ceb.2011.06.002; Gu YP, 2012, CURR OPIN CELL BIOL, V24, P865, DOI 10.1016/j.ceb.2012.09.003; Herrgen L., 2014, DEV CELL, DOI 10.1016/j.devcel.2014.10.012; Lee HO, 2013, TRENDS CELL BIOL, V23, P141, DOI 10.1016/j.tcb.2012.11.001; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Owens DF, 1998, J NEUROSCI, V18, P5374, DOI 10.1523/JNEUROSCI.18-14-05374.1998; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SMART IHM, 1973, J ANAT, V116, P67; Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801; Thomaidou D, 1997, J NEUROSCI, V17, P1075, DOI 10.1523/jneurosci.17-03-01075.1997	11	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1298	1299		10.1126/science.aaa3261	http://dx.doi.org/10.1126/science.aaa3261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504705				2022-12-28	WOS:000346189600026
J	Qian, XF; Liu, JW; Fu, L; Li, J				Qian, Xiaofeng; Liu, Junwei; Fu, Liang; Li, Ju			Quantum spin Hall effect in two-dimensional transition metal dichalcogenides	SCIENCE			English	Article							TOPOLOGICAL INSULATORS; PHASE-TRANSITION; POLARIZATION; GRAPHENE	Quantum spin Hall (QSH) effect materials feature edge states that are topologically protected from backscattering. However, the small band gap in materials that have been identified as QSH insulators limits applications. We use first-principles calculations to predict a class of large-gap QSH insulators in two-dimensional transition metal dichalcogenides with 1T' structure, namely, 1T'-MX2 with M = (tungsten or molybdenum) and X = (tellurium, selenium, or sulfur). A structural distortion causes an intrinsic band inversion between chalcogenide-p and metal-d bands. Additionally, spin-orbit coupling opens a gap that is tunable by vertical electric field and strain. We propose a topological field effect transistor made of van der Waals heterostructures of 1T'-MX2 and two-dimensional dielectric layers that can be rapidly switched off by electric field through a topological phase transition instead of carrier depletion.	[Qian, Xiaofeng; Li, Ju] MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA; [Qian, Xiaofeng; Li, Ju] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Liu, Junwei; Fu, Liang] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Fu, L (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	liangfu@mit.edu; liju@mit.edu	Qian, Xiaofeng/P-4715-2016; Qian, Xiaofeng/AAE-9530-2019; Li, Ju/A-2993-2008; Qian, Xiaofeng/E-7727-2012; LIU, Junwei/B-1468-2010	Qian, Xiaofeng/0000-0003-1627-288X; Qian, Xiaofeng/0000-0003-1627-288X; Li, Ju/0000-0002-7841-8058; Qian, Xiaofeng/0000-0003-1627-288X; LIU, Junwei/0000-0001-8051-7349	NSF [DMR-1120901]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0010526]; Science and Technology Center on Integrated Quantum Materials, NSF [DMR-1231319]; Extreme Science and Engineering Discovery Environment (XSEDE) [TG-DMR130038, TG-DMR140003]	NSF(National Science Foundation (NSF)); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); Science and Technology Center on Integrated Quantum Materials, NSF; Extreme Science and Engineering Discovery Environment (XSEDE)	We acknowledge support from NSF under award DMR-1120901 (X.Q. and J.L.), U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under award DE-SC0010526 (L.F.), and the Science and Technology Center on Integrated Quantum Materials, NSF grant no. DMR-1231319 (J.W.L). Computational time on the Extreme Science and Engineering Discovery Environment (XSEDE) under grant nos. TG-DMR130038 and TG-DMR140003 is gratefully acknowledged. X.Q. and J.W.L. contributed equally to this work. MIT has applied for a provisional patent based on the content of this paper. Both atomic and electronic structures of 1T'-MX<INF>2</INF> can be found in the supplementary materials.	Alicea J, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/7/076501; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Bernevig BA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106802; Brune C, 2012, NAT PHYS, V8, P485, DOI [10.1038/nphys2322, 10.1038/NPHYS2322]; Calandra M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.245428; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Cazalilla MA, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.077201; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Eda G, 2012, ACS NANO, V6, P7311, DOI 10.1021/nn302422x; Feng J, 2012, NAT PHOTONICS, V6, P865, DOI [10.1038/NPHOTON.2012.285, 10.1038/nphoton.2012.285]; Fu L, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045302; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Fu L, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.161408; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Heising J, 1999, J AM CHEM SOC, V121, P11720, DOI 10.1021/ja991644d; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Kong DS, 2011, NAT CHEM, V3, P845, DOI [10.1038/nchem.1171, 10.1038/NCHEM.1171]; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Li CH, 2014, NAT NANOTECHNOL, V9, P218, DOI [10.1038/NNANO.2014.16, 10.1038/nnano.2014.16]; Liu CX, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.236601; Liu CC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.076802; Liu JW, 2014, NAT MATER, V13, P178, DOI [10.1038/nmat3828, 10.1038/NMAT3828]; Mahfouzi F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.166602; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Mellnik AR, 2014, NATURE, V511, P449, DOI 10.1038/nature13534; Mi S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.241405; Michetti P, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4792275; Murakami S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/9/356; Murakami S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.236805; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pesin D, 2012, NAT MATER, V11, P409, DOI [10.1038/nmat3305, 10.1038/NMAT3305]; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Vayrynen JI, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.216402; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Weng HM, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011002; WILSON JA, 1969, ADV PHYS, V18, P193, DOI 10.1080/00018736900101307; Wunderlich J, 2010, SCIENCE, V330, P1801, DOI 10.1126/science.1195816; Xiao D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1602; Xu Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.136804; Yang KS, 2012, NAT MATER, V11, P614, DOI [10.1038/nmat3332, 10.1038/NMAT3332]	45	1267	1280	43	1117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1344	1347		10.1126/science.1256815	http://dx.doi.org/10.1126/science.1256815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504715	Green Submitted			2022-12-28	WOS:000346189600045
J	Donoff, B; McDonough, JE; Riedy, CA				Donoff, Bruce; McDonough, John E.; Riedy, Christine A.			Integrating Oral and General Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Donoff, Bruce] Harvard Univ, Sch Dent Med, Off Dean, Boston, MA 02115 USA; [Donoff, Bruce] Harvard Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Boston, MA 02115 USA; [Riedy, Christine A.] Harvard Univ, Sch Dent Med, Dept Oral Hlth Policy & Epidemiol, Boston, MA 02115 USA; [McDonough, John E.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Donoff, B (corresponding author), Harvard Univ, Sch Dent Med, Off Dean, 188 Longwood Ave, Boston, MA 02115 USA.							Institute of Medicine and National Research Council, 2011, IMPR ACC OR HLTH CAR; Jeffcoat MK, 2014, AM J PREV MED, V47, P166, DOI 10.1016/j.amepre.2014.04.001; Lee HH, 2012, AM J PUBLIC HEALTH, V102, pe77, DOI DOI 10.2105/AJPH.2012; US Department of Health and Human Services, 2000, OR HLTH AM REP SURG	4	40	41	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					2247	2249		10.1056/NEJMp1410824	http://dx.doi.org/10.1056/NEJMp1410824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW1KQ	25494266				2022-12-28	WOS:000346048800003
J	Carson, JL; Sieber, F; Cook, DR; Hoover, DR; Noveck, H; Chaitman, BR; Fleisher, L; Beaupre, L; Macaulay, W; Rhoads, GG; Paris, B; Zagorin, A; Sanders, DW; Zakriya, KJ; Magaziner, J				Carson, Jeffrey L.; Sieber, Frederick; Cook, Donald Richard; Hoover, Donald R.; Noveck, Helaine; Chaitman, Bernard R.; Fleisher, Lee; Beaupre, Lauren; Macaulay, William; Rhoads, George G.; Paris, Barbara; Zagorin, Aleksandra; Sanders, David W.; Zakriya, Khwaja J.; Magaziner, Jay			Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial	LANCET			English	Article							LONG-TERM SURVIVAL; CELL TRANSFUSIONS; CARDIAC-SURGERY; OUTCOMES; IMPACT; IMMUNOMODULATION; MORTALITY; RISK	Background Blood transfusion might affect long-term mortality by changing immune function and thus potentially increasing the risk of subsequent infections and cancer recurrence. Compared with a restrictive transfusion strategy, a more liberal strategy could reduce cardiac complications by lowering myocardial damage, thereby reducing future deaths from cardiovascular disease. We aimed to establish the effect of a liberal transfusion strategy on long-term survival compared with a restrictive transfusion strategy. Methods In the randomised controlled FOCUS trial, adult patients aged 50 years and older, with a history of or risk factors for cardiovascular disease, and with postoperative haemoglobin concentrations lower than 100 g/L within 3 days of surgery to repair a hip fracture, were eligible for enrolment. Patients were recruited from 47 participating hospitals in the USA and Canada, and eligible participants were randomly allocated in a 1:1 ratio by a central telephone system to either liberal transfusion in which they received blood transfusion to maintain haemoglobin level at 100 g/L or higher, or restrictive transfusion in which they received blood transfusion when haemoglobin level was lower than 80 g/L or if they had symptoms of anaemia. In this study, we analysed the long-term mortality of patients assigned to the two transfusion strategies, which was a secondary outcome of the FOCUS trial. Long-term mortality was established by linking the study participants to national death registries in the USA and Canada. Treatment assignment was not masked, but investigators who ascertained mortality and cause of death were masked to group assignment. Analyses were by intention to treat. The FOCUS trial is registered with ClinicalTrials.gov,number NCT00071032. Findings Between July 19, 2004, and Feb 28, 2009, 2016 patients were enrolled and randomly assigned to the two treatment groups: 1007 to the liberal transfusion strategy and 1009 to the restrictive transfusion strategy. The median duration of follow-up was 3.1 years (IQR 2.4-4.1 years), during which 841 (42%) patients died. Long-term mortality did not differ significantly between the liberal transfusion strategy (432 deaths) and the restrictive transfusion strategy (409 deaths) (hazard ratio 1.09 [95% CI 0.95-1.25]; p=0.21). Interpretation Liberal blood transfusion did not affect mortality compared with a restrictive transfusion strategy in a high-risk group of elderly patients with underlying cardiovascular disease or risk factors. The underlying causes of death did not differ between the trial groups. These findings do not support hypotheses that blood transfusion leads to long-term immunosuppression that is severe enough to affect long-term mortality rate by more than 20-25% or cause of death.	[Carson, Jeffrey L.; Noveck, Helaine] Rutgers Robert Wood Johnson Med Sch, Div Gen Internal Med, Dept Med, New Brunswick, NJ 08901 USA; [Sieber, Frederick] Johns Hopkins Bayview Med Ctr, Dept Anesthesiol & Crit Care, Baltimore, MD USA; [Cook, Donald Richard] Univ Calgary, Div Gen Internal Med, Calgary, AB, Canada; [Hoover, Donald R.] Rutgers State Univ, Dept Stat, New Brunswick, NJ 08903 USA; [Chaitman, Bernard R.] St Louis Univ, Dept Med, St Louis, MO 63103 USA; [Fleisher, Lee] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Beaupre, Lauren] Univ Alberta, Dept Phys Therapy, Div Orthopaed Surg, Edmonton, AB, Canada; [Beaupre, Lauren] Univ Alberta, Dept Surg, Div Orthopaed Surg, Edmonton, AB, Canada; [Macaulay, William] Columbia Univ, Dept Orthoped Surg, New York Presbyterian Hosp, New York, NY USA; [Rhoads, George G.] Rutgers Sch Publ Hlth, Piscataway, NJ USA; [Paris, Barbara; Zagorin, Aleksandra] Maimonides Hosp, Div Geriatr, Brooklyn, NY 11219 USA; [Sanders, David W.] Univ Western Ontario, Dept Orthopaed Surg, London, ON, Canada; [Zakriya, Khwaja J.] Surg Surg Ctr, Dept Anesthesia, Cumberland, MD USA; [Magaziner, Jay] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Johns Hopkins University; Johns Hopkins Medicine; University of Calgary; Rutgers State University New Brunswick; Saint Louis University; University of Pennsylvania; University of Alberta; University of Alberta; Columbia University; NewYork-Presbyterian Hospital; Maimonides Medical Center; Western University (University of Western Ontario); University System of Maryland; University of Maryland Baltimore	Carson, JL (corresponding author), Rutgers Robert Wood Johnson Med Sch, Div Gen Internal Med, Dept Med, 125 Paterson St, New Brunswick, NJ 08901 USA.	jeffrey.carson@rutgers.edu	Lee A, Fleisher/Q-9894-2019	Macaulay, William/0000-0003-2684-0676	National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL074815, U01HL073958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028747] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Heart, Lung, and Blood Institute.	Acheson AG, 2012, ANN SURG, V256, P235, DOI 10.1097/SLA.0b013e31825b35d5; Bhaskar B, 2012, ANN THORAC SURG, V94, P460, DOI 10.1016/j.athoracsur.2012.04.005; BUSCH ORC, 1993, NEW ENGL J MED, V328, P1372, DOI 10.1056/NEJM199305133281902; Carson JL, 2006, TRANSFUSION, V46, P2192, DOI 10.1111/j.1537-2995.2006.01056.x; Carson JL, 2013, AM HEART J, V165, P964, DOI 10.1016/j.ahj.2013.03.001; Carson JL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub3; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Cata JP, 2013, BRIT J ANAESTH, V110, P690, DOI 10.1093/bja/aet068; Centers for Disease Control and Prevention, 2014, NAT DEATH IND; Chalfin HJ, 2014, TRANSFUSION, V54, P2168, DOI 10.1111/trf.12611; Clark DA, 2008, TRANSFUSION, V48, P814, DOI 10.1111/j.1537-2995.2008.01654.x; Cooper HA, 2011, AM J CARDIOL, V108, P1108, DOI 10.1016/j.amjcard.2011.06.014; Engoren Milo, 2012, J Intensive Care Med, V27, P112, DOI 10.1177/0885066610394326; HEISS MM, 1993, LANCET, V342, P1328, DOI 10.1016/0140-6736(93)92247-Q; Hod EA, 2012, TRANSFUS CLIN BIOL, V19, P84, DOI 10.1016/j.tracli.2012.04.001; Refaai MA, 2013, EXPERT REV HEMATOL, V6, P653, DOI 10.1586/17474086.2013.850026; Rohde JM, 2014, JAMA-J AM MED ASSOC, V311, P1317, DOI 10.1001/jama.2014.2726; Shaw RE, 2014, TRANSFUSION, V54, P1106, DOI 10.1111/trf.12364; Shishehbor MH, 2009, JACC-CARDIOVASC INTE, V2, P46, DOI 10.1016/j.jcin.2008.09.011; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; *STAT CAN, 2013, VIT STAT DEATH DAT; van Straten AHM, 2010, INTERACT CARDIOV TH, V10, P37, DOI 10.1510/icvts.2009.214551; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; WHO (World Health Organization), 1977, MAN INT STAT CLASS D; Yeoh TY, 2014, TRANSFUSION, V54, P2175, DOI 10.1111/trf.12595	25	127	131	1	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1183	1189		10.1016/S0140-6736(14)62286-8	http://dx.doi.org/10.1016/S0140-6736(14)62286-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE3GQ	25499165	Green Accepted			2022-12-28	WOS:000351715100031
J	Ewald, CY; Landis, JN; Abate, JP; Murphy, CT; Blackwell, TK				Ewald, Collin Y.; Landis, Jess N.; Abate, Jess Porter; Murphy, Coleen T.; Blackwell, T. Keith			Dauer-independent insulin/IGF-1-signalling implicates collagen remodelling in longevity	NATURE			English	Article							LIFE-SPAN EXTENSION; CAENORHABDITIS-ELEGANS; C-ELEGANS; GENE-EXPRESSION; PROLINE CATABOLISM; STRESS-RESPONSE; DAF-2; SKN-1; COMPLEX; MUTATIONS	Interventions that delay ageing mobilize mechanisms that protect and repair cellular components(1-3), but it is unknown how these interventions might slow the functional decline of extracellular matrices(4,5), which are also damaged during ageing(6,7). Reduced insulin/I GF-1 signalling (HIS) extends lifespan across the evolutionary spectrum, and in juvenile Caenorhabditis elegans also allows the transcription factor DAF-16/FOX0 to induce development into dauer, a diapause that withstands harsh conditions(1,2). It has been suggested that rIIS delays C. elegans ageing through activation of dauer-related processes during adulthood(2,8,9), but some HIS conditions confer robust lifespan extension unaccompanied by any dauer-like traits(1,10,11). Here we show that HIS can promote C. elegans longevity through a program that is genetically distinct from the dauer pathway, and requires the Nrf (NF-E2-related factor) orthologue SKN-1 acting in parallel to DAF-16. SKN-1 is inhibited by IIS and has been broadly implicated in longevity(12-14), but is rendered dispensable for HIS lifespan extension by even mild activity of dauer-related processes. When IIS is decreased under conditions that do not induce dauer traits, SKN-1 most prominently increases expression of collagens and other extracellular matrix genes. Diverse genetic, nutritional, and pharmacological pro-longevity interventions delay an age-related decline in collagen expression. These collagens mediate adulthood extracellular matrix remodelling, and are needed for ageing to be delayed by interventions that do not involve dauer traits. By genetically delineating a dauer-independent HIS ageing pathway, our results show that IIS controls a broad set of protective mechanisms during C. elegans adulthood, and may facilitate elucidation of processes of general importance for longevity. The importance of collagen production in diverse anti-ageing interventions implies that extracellular matrix remodelling is a generally essential signature of longevity assurance, and that agents promoting extracellular matrix youthfulness may have systemic benefit.	[Ewald, Collin Y.; Abate, Jess Porter; Blackwell, T. Keith] Joslin Diabet Ctr, Boston, MA 02215 USA; [Ewald, Collin Y.; Abate, Jess Porter; Blackwell, T. Keith] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ewald, Collin Y.; Abate, Jess Porter; Blackwell, T. Keith] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Landis, Jess N.; Murphy, Coleen T.] Princeton Univ, Dept Mol Biol, Lewis Sigler Inst Integrat Genom, Carl Icahn Lab 148, Princeton, NJ 08544 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard University; Harvard Medical School; Princeton University	Blackwell, TK (corresponding author), Joslin Diabet Ctr, One Joslin Pl, Boston, MA 02215 USA.	ctmurphy@princeton.edu; keith.blackwell@joslin.harvard.edu	Ewald, Collin/K-6303-2015	Ewald, Collin/0000-0003-1166-4171; Murphy, Coleen/0000-0002-8257-984X	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; National Institutes of Health [GM062891, 5T32DK007260]; Diabetes Research Center award [P30DK036836]; National Science Foundation; Swiss National Science Foundation [PBSKP3_140135]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, T32DK007260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062891] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research Center award; National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Kenyon,S. Mitani, and J. Shim for strains, P. Sengupta fordauer pheromone, C. Obieglo, L. Moronetti, M. Bland,and K. Patel for assistance,and J. Apfeld, E. Greer, C. Kenyon, W. Mair, and Blackwell laboratory members for discussions or comments on the manuscript. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440). The work was supported by funding from the National Institutes of Health to T.K.B. (GM062891), C.T.M. (New Innovator), and J.P.A. (5T32DK007260), a Diabetes Research Center award to the Joslin Diabetes Center (P30DK036836), and fellowships from the National Science Foundation to J.N.L., and the Swiss National Science Foundation (PBSKP3_140135) to C.Y.E.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Arantes-Oliveira N, 2003, SCIENCE, V302, P611, DOI 10.1126/science.1089169; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Argmann C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000752; Baumann L, 2007, J PATHOL, V211, P241, DOI 10.1002/path.2098; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; BLACKWELL TK, 1994, SCIENCE, V266, P621, DOI 10.1126/science.7939715; BRENNER S, 1974, GENETICS, V77, P71; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen D, 2013, CELL REP, V5, P1600, DOI 10.1016/j.celrep.2013.11.018; Chen S, 2009, P NATL ACAD SCI USA, V106, P1496, DOI 10.1073/pnas.0802674106; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Fu HL, 2013, J BIOL CHEM, V288, P7430, DOI 10.1074/jbc.R112.444158; Gems D, 1998, GENETICS, V150, P129; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Gusarov I, 2013, CELL, V152, P818, DOI 10.1016/j.cell.2012.12.043; Halaschek-Wiener J, 2005, GENOME RES, V15, P603, DOI 10.1101/gr.3274805; Hao LM, 2006, DEV DYNAM, V235, P1469, DOI 10.1002/dvdy.20721; HEDGECOCK EM, 1995, GENETICS, V141, P989; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hillier LW, 2005, GENOME RES, V15, P1651, DOI 10.1101/gr.3729105; Hong L, 2001, J CELL BIOL, V154, P403, DOI 10.1083/jcb.200007075; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iser WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017369; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Jones SJM, 2001, GENOME RES, V11, P1346, DOI 10.1101/gr.184401; Kage-Nakadai E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008857; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim TH, 2011, FEBS LETT, V585, P121, DOI 10.1016/j.febslet.2010.11.020; Kim TH, 2010, MOL CELLS, V29, P413, DOI 10.1007/s10059-010-0049-4; Kwon ES, 2010, NATURE, V466, P498, DOI 10.1038/nature09184; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Link CD, 2002, METHOD ENZYMOL, V353, P497; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Menzel Ralph, 2012, Frontiers in Genetics, V3, P50, DOI 10.3389/fgene.2012.00050; Munger JS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005017; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Narasimhan SD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001377; Neal SJ, 2013, METHODS MOL BIOL, V1068, P273, DOI 10.1007/978-1-62703-619-1_20; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Pang SS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6048; PARTRIDGE L, 1993, NATURE, V366, P404, DOI 10.1038/366404a0; Patel DS, 2008, GENETICS, V178, P931, DOI 10.1534/genetics.107.070813; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Pietsch Kerstin, 2012, Frontiers in Genetics, V3, P48, DOI 10.3389/fgene.2012.00048; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmeisser S, 2013, MOL METAB, V2, P92, DOI 10.1016/j.molmet.2013.02.002; Schultz RD, 2012, JOVE-J VIS EXP, DOI 10.3791/3362; Seeger-Nukpezah T, 2012, CURR OPIN CELL BIOL, V24, P652, DOI 10.1016/j.ceb.2012.06.002; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Shore DE, 2013, TRENDS CELL BIOL, V23, P409, DOI 10.1016/j.tcb.2013.04.007; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Staab TA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003354; Suzuki Y, 2002, GENETICS, V162, P1631; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Thein MC, 2003, DEV DYNAM, V226, P523, DOI 10.1002/dvdy.10259; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Timmons L, 2003, MOL BIOL CELL, V14, P2972, DOI 10.1091/mbc.E03-01-0858; Toyama BH, 2013, NAT REV MOL CELL BIO, V14, P55, DOI 10.1038/nrm3496; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010	93	153	161	1	91	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					97	U212		10.1038/nature14021	http://dx.doi.org/10.1038/nature14021			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25517099	Green Accepted, Green Submitted			2022-12-28	WOS:000350304000043
J	Taylor-Teeples, M; Lin, L; de Lucas, M; Turco, G; Toal, TW; Gaudinier, A; Young, NF; Trabucco, GM; Veling, MT; Lamothe, R; Handakumbura, PP; Xiong, G; Wang, C; Corwin, J; Tsoukalas, A; Zhang, L; Ware, D; Pauly, M; Kliebenstein, DJ; Dehesh, K; Tagkopoulos, I; Breton, G; Pruneda-Paz, JL; Ahnert, SE; Kay, SA; Hazen, SP; Brady, SM				Taylor-Teeples, M.; Lin, L.; de Lucas, M.; Turco, G.; Toal, T. W.; Gaudinier, A.; Young, N. F.; Trabucco, G. M.; Veling, M. T.; Lamothe, R.; Handakumbura, P. P.; Xiong, G.; Wang, C.; Corwin, J.; Tsoukalas, A.; Zhang, L.; Ware, D.; Pauly, M.; Kliebenstein, D. J.; Dehesh, K.; Tagkopoulos, I.; Breton, G.; Pruneda-Paz, J. L.; Ahnert, S. E.; Kay, S. A.; Hazen, S. P.; Brady, S. M.			An Arabidopsis gene regulatory network for secondary cell wall synthesis	NATURE			English	Article							VASCULAR-RELATED NAC-DOMAIN6; TRANSCRIPTION FACTORS; FUNCTIONAL GENOMICS; EXPRESSION; IDENTIFICATION; PATHWAY; MYB46; CELLULOSE; DIVISION; FAMILY	The plant cell wall is an important factor for determining cell shape, function and response to the environment. Secondary cell walls, such as those found in xylem, are composed of cellulose, hemicelluloses and lignin and account for the bulk of plant biomass. The coordination between transcriptional regulation of synthesis for each polymer is complex and vital to cell function. A regulatory hierarchy of developmental switches has been proposed, although the full complement of regulators remains unknown. Here we present a protein-DNA network between Arabidopsis thaliana transcription factors and secondary cell wall metabolic genes with gene expression regulated by a series of feed-forward loops. This model allowed us to develop and validate new hypotheses about secondary wall gene regulation under abiotic stress. Distinct stresses are able to perturb targeted genes to potentially promote functional adaptation. These interactions will serve as a foundation for understanding the regulation of a complex, integral plant component.	[Taylor-Teeples, M.; de Lucas, M.; Turco, G.; Toal, T. W.; Gaudinier, A.; Wang, C.; Dehesh, K.; Brady, S. M.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Taylor-Teeples, M.; de Lucas, M.; Turco, G.; Toal, T. W.; Gaudinier, A.; Tsoukalas, A.; Tagkopoulos, I.; Brady, S. M.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Lin, L.; Young, N. F.; Trabucco, G. M.; Veling, M. T.; Lamothe, R.; Handakumbura, P. P.; Hazen, S. P.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Xiong, G.; Pauly, M.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Corwin, J.; Kliebenstein, D. J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Tsoukalas, A.; Tagkopoulos, I.] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Zhang, L.; Ware, D.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Ware, D.] ARS, USDA, Ithaca, NY 14853 USA; [Breton, G.; Pruneda-Paz, J. L.; Kay, S. A.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Ahnert, S. E.] Univ Cambridge, Cavendish Lab, Theory Condensed Matter Grp, Cambridge CB3 0HE, England	University of California System; University of California Davis; University of California System; University of California Davis; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Davis; Cold Spring Harbor Laboratory; United States Department of Agriculture (USDA); University of California System; University of California San Diego; University of Cambridge	Brady, SM (corresponding author), Univ Calif Davis, Dept Plant Biol, One Shields Ave, Davis, CA 95616 USA.	hazen@bio.umass.edu; sbrady@ucdavis.edu	Brady, Siobhan/AAY-1729-2021; Kay, Steve A/F-6025-2011; Breton, Ghislain/F-7266-2016; Pauly, Markus/B-5895-2008; Toal, Ted W/D-1482-2015	Kay, Steve A/0000-0002-0402-2878; Breton, Ghislain/0000-0001-6400-3858; Pauly, Markus/0000-0002-3116-2198; Corwin, Jason/0000-0001-6455-8474; Wang, Chang-Quan/0000-0003-2668-6541; Hazen, Samuel/0000-0001-9131-8994; Brady, Siobhan/0000-0001-9424-8055	Office of Science (BER) Department of Energy [DE-FG02-08ER64700DE]; National Institute of General Medical Sciences of the National Institutes of Health [RO1GM056006, RC2GM092412]; National Institute of Health [RO1GM107311]; National Science Foundation [IOS-1036491, IOS-1352478]; USDA CRIS [1907-21000-030]; Royal Society UK Fellowship; UC Davis Startup Funds; Hellman Fellowship; Division Of Integrative Organismal Systems [1127112] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092412, R01GM107311, R25GM056765, R01GM056006] Funding Source: NIH RePORTER	Office of Science (BER) Department of Energy(United States Department of Energy (DOE)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); USDA CRIS(United States Department of Agriculture (USDA)); Royal Society UK Fellowship; UC Davis Startup Funds; Hellman Fellowship; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Tierney (University of Vermont) for 35S::GFP seeds, T. Demura for VND7 resources, M.K. Barton for REV:GR seeds, E.P. Spalding for advice on manuscript revision, and C. Gutierrez for E2Fc RNAi and E2Fc N-terminal deletion overexpressor seeds and useful discussion. This research was supported by the Office of Science (BER) Department of Energy Grant DE-FG02-08ER64700DE (to S.P.H. and S.A.K.), National Institute of General Medical Sciences of the National Institutes of Health under award numbers RO1GM056006 and RC2GM092412 (to S.A.K.), National Institute of Health (RO1GM107311) and National Science Foundation (IOS-1036491 and IOS-1352478) to K.D., USDA CRIS 1907-21000-030 to D.W. and L.F., a Royal Society UK Fellowship (to SEA.), and UC Davis Startup Funds and a Hellman Fellowship (to S.M.B).	Ahnert SE, 2013, MOL BIOSYST, V9, P2681, DOI 10.1039/c3mb70236g; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Brady SM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.114; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; de Jager SM, 2009, PLANT MOL BIOL, V71, P345, DOI 10.1007/s11103-009-9527-5; de Jager SM, 2001, PLANT MOL BIOL, V47, P555, DOI 10.1023/A:1011848528377; del Pozo JC, 2002, PLANT CELL, V14, P3057, DOI 10.1105/tpc.006791; del Pozo JC, 2006, PLANT CELL, V18, P2224, DOI 10.1105/tpc.105.039651; del Pozo JC, 2007, PLANT SIGNAL BEHAV, V2, P273, DOI 10.4161/psb.2.4.3897; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Gaudinier A, 2011, NAT METHODS, V8, P1053, DOI [10.1038/NMETH.1750, 10.1038/nmeth.1750]; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Gong W, 2004, PLANT PHYSIOL, V135, P773, DOI 10.1104/pp.104.042176; Greenfield A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013397; Haury AC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-145; Hawker NP, 2004, PLANT PHYSIOL, V135, P2261, DOI 10.1104/pp.104.040196; Heckmann S, 2011, PLANT J, V68, P646, DOI 10.1111/j.1365-313X.2011.04715.x; Hussey SG, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00325; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Iyer-Pascuzzi AS, 2011, DEV CELL, V21, P770, DOI 10.1016/j.devcel.2011.09.009; Kim WC, 2014, PLANT MOL BIOL, V85, P589, DOI 10.1007/s11103-014-0205-x; Kim WC, 2013, PLANT J, V73, P26, DOI 10.1111/j.1365-313x.2012.05124.x; Kim WC, 2012, PLANT MOL BIOL, V78, P489, DOI 10.1007/s11103-012-9880-7; Kosugi S, 2002, PLANT PHYSIOL, V128, P833, DOI 10.1104/pp.010642; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Kuffner R, 2012, BIOINFORMATICS, V28, P1376, DOI 10.1093/bioinformatics/bts143; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/NMETH.2016, 10.1038/nmeth.2016]; Mariconti L, 2002, J BIOL CHEM, V277, P9911, DOI 10.1074/jbc.M110616200; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Mordelet F, 2008, BIOINFORMATICS, V24, pI76, DOI 10.1093/bioinformatics/btn273; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036; Paz-Ares J, 2002, COMP FUNCT GENOM, V3, P102, DOI 10.1002/cfg.146; Pearson RD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-211; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Pyo HJ, 2007, PLANT J, V51, P955, DOI 10.1111/j.1365-313X.2007.03180.x; SCOTT TA, 1953, ANAL CHEM, V25, P1656, DOI 10.1021/ac60083a023; Underwood BA, 2006, PLANT BIOTECHNOL J, V4, P317, DOI 10.1111/j.1467-7652.2006.00183.x; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walhout AJM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-109; Walley JW, 2007, PLOS GENET, V3, P1800, DOI 10.1371/journal.pgen.0030172; Wenkel S, 2007, PLANT CELL, V19, P3379, DOI 10.1105/tpc.107.055772; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yamaguchi M, 2011, PLANT J, V66, P579, DOI [10.1111/j.1365-313X.2011.04514.x, 10.1111/j.1365-313x.2011.04514.x]; Yamaguchi M, 2010, PLANT PHYSIOL, V153, P906, DOI 10.1104/pp.110.154013; Yamaguchi M, 2010, PLANT CELL, V22, P1249, DOI 10.1105/tpc.108.064048; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	53	404	421	33	487	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					571	U307		10.1038/nature14099	http://dx.doi.org/10.1038/nature14099			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25533953	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000348775000034
J	Renard, HF; Simunovic, M; Lemiere, J; Boucrot, E; Garcia-Castillo, MD; Arumugam, S; Chambon, V; Lamaze, C; Wunder, C; Kenworthy, AK; Schmidt, AA; McMahon, HT; Sykes, C; Bassereau, P; Johannes, L				Renard, Henri-Francois; Simunovic, Mijo; Lemiere, Joel; Boucrot, Emmanuel; Garcia-Castillo, Maria Daniela; Arumugam, Senthil; Chambon, Valerie; Lamaze, Christophe; Wunder, Christian; Kenworthy, Anne K.; Schmidt, Anne A.; McMahon, Harvey T.; Sykes, Cecile; Bassereau, Patricia; Johannes, Ludger			Endophilin-A2 functions in membrane scission in clathrin-independent endocytosis	NATURE			English	Article							DOMAIN-CONTAINING PROTEINS; RETROGRADE TRANSPORT; DYNAMIN; BAR; FISSION; TOXIN; RECRUITMENT; INHIBITION; CURVATURE; RETRIEVAL	During endocytosis, energy is invested to narrow the necks of cargo-containing plasma membrane invaginations to radii at which the opposing segments spontaneously coalesce, thereby leading to the detachment by scission of endocytic uptake carriers'. In the clathrin pathway, dynamin uses mechanical energy from GTP hydrolysis to this effect(2-4), assisted by the BIN/amphiphysin/Rvs (BAR) domain-containing protein endophilin(5,6). Clathrin-independent endocytic events are often less reliant on dynamin(7), and whether in these cases BAR domain proteins such as endophilin contribute to scission has remained unexplored. Here we show, in human and other mammalian cell lines, that endophilin-A2 (endoA2) specifically and functionally associates with very early uptake structures that are induced by the bacterial Shiga and cholera toxins, which are both clathrin-independent endocytic cargoes'. In controlled in vitro systems, endoA2 reshapes membranes before scission. Furthermore, we demonstrate that endoA2, dynamin and actin contribute in parallel to the scission of Shiga-toxin-induced tubules. Our results establish a novel function of endoA2 in clathrin-independent endocytosis. They document that distinct scission factors operate in an additive manner, and predict that specificity within a given uptake process arises from defined combinations of universal modules. Our findings highlight a previously unnoticed link between membrane scaffolding by endoA2 and pulling-force-driven dynamic scission.	[Renard, Henri-Francois; Garcia-Castillo, Maria Daniela; Arumugam, Senthil; Chambon, Valerie; Wunder, Christian; Johannes, Ludger] Inst Curie, Ctr Rech, Endocyt Trafficking & Therapeut Delivery Grp, F-75248 Paris 05, France; [Renard, Henri-Francois; Garcia-Castillo, Maria Daniela; Arumugam, Senthil; Chambon, Valerie; Lamaze, Christophe; Wunder, Christian; Johannes, Ludger] CNRS, UMR3666, F-75005 Paris, France; [Renard, Henri-Francois; Garcia-Castillo, Maria Daniela; Arumugam, Senthil; Chambon, Valerie; Lamaze, Christophe; Wunder, Christian; Johannes, Ludger] INSERM, U1143, F-75005 Paris, France; [Simunovic, Mijo; Bassereau, Patricia] Univ Paris 06, CNRS UMR 168, Inst Curie, Ctr Rech,Membrane & Cell Funct Grp, F-75248 Paris 05, France; [Simunovic, Mijo] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Lemiere, Joel; Sykes, Cecile] Univ Paris 06, CNRS UMR 168, Inst Curie, Ctr Rech,Biomimetism Cell Movement Grp, F-75248 Paris 05, France; [Lemiere, Joel] Univ Paris Diderot, Sorbonne Paris Cite, F-75205 Paris, France; [Boucrot, Emmanuel] UCL, Inst Struct & Mol Biol, London WC1E 6BT, England; [Boucrot, Emmanuel] Birkbeck Coll, London WC1E 6BT, England; [Lamaze, Christophe] Inst Curie, Ctr Rech, Membrane Dynam & Mech Intracellular Signaling Grp, F-75248 Paris 05, France; [Kenworthy, Anne K.] Vanderbilt Univ Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Schmidt, Anne A.] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, UMR7592,Inst Jacques Monod, F-75205 Paris 13, France; [McMahon, Harvey T.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of Chicago; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; University of London; Birkbeck University London; University College London; University of London; Birkbeck University London; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Vanderbilt University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; MRC Laboratory Molecular Biology	Johannes, L (corresponding author), Inst Curie, Ctr Rech, Endocyt Trafficking & Therapeut Delivery Grp, 26 Rue Ulm, F-75248 Paris 05, France.	ludger.johannes@curie.fr	Wunder, Christian/K-8542-2017; Johannes, Ludger/M-9778-2017; Lamaze, Christophe/M-4912-2017; Renard, Henri-François/AAL-4905-2020; Johannes, Ludger/W-8593-2019; Sykes, Cécile/B-1271-2016; Bassereau, Patricia/P-8657-2018	Wunder, Christian/0000-0001-9091-0080; Johannes, Ludger/0000-0002-2168-0004; Renard, Henri-François/0000-0002-2406-2519; Johannes, Ludger/0000-0002-2168-0004; Sykes, Cécile/0000-0003-3057-2600; LEMIERE, Joel/0000-0002-9017-1959; Bassereau, Patricia/0000-0002-8544-6778; Boucrot, Emmanuel/0000-0001-7312-6462; Simunovic, Mijo/0000-0001-9394-1552; Kenworthy, Anne/0000-0001-6567-9059; LAMAZE, Christophe/0000-0001-5430-2707	Agence Nationale pour la Recherche [ANR-09-BLAN-283, ANR-10-LBX-0038, ANR-11BSV201403, ANR-12-BSV5-0014]; Indo-French Centre for the Promotion of Advanced Science [3803]; Marie Curie Actions - Networks for Initial Training [FP7-PEOPLE-2010-ITN]; European Research Council [340485]; Marie Curie International Reintegration Grant [FP7-RG-277078]; Royal Society [RG120481]; Fondation ARC pour la Recherche sur le Cancer [DEQ20120323737]; National Institutes of Health [R01 GM106720]; La Ligue contre le Cancer, Comite de Paris [RS08/75-89]; Fondation ARC pour la Recherche sur le Cancer; AXA Research Funds; Biological Sciences Research Council; Chateaubriand fellowship; France and Chicago Collaborating in the Sciences grant; BBSRC [BB/I018921/1] Funding Source: UKRI; MRC [MC_U105178795] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I018921/1] Funding Source: researchfish; Medical Research Council [MC_U105178795] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106720] Funding Source: NIH RePORTER	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Indo-French Centre for the Promotion of Advanced Science(French National Research Agency (ANR)); Marie Curie Actions - Networks for Initial Training; European Research Council(European Research Council (ERC)European Commission); Marie Curie International Reintegration Grant(European Commission); Royal Society(Royal Society of London); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); La Ligue contre le Cancer, Comite de Paris; Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); AXA Research Funds(AXA Research Fund); Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Chateaubriand fellowship; France and Chicago Collaborating in the Sciences grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to acknowledge the following people for help in experiments and providing materials or expertise: A. Berthier, L. Cabanie, K. Carvalho, P. de Camilli, C. Day, D. Drubin, A. El Marjou, V. Fraisier, A. Gautreau, T. Kirchhausen, L. Leconte, C. Merrifield, G. Montagnac, P. Paul-Gilloteaux, M. S. Robinson, L. Sengmanivong and E. Smythe. The facilities as well as scientific and technical assistance from staff in the PICT-IBiSA/Nikon Imaging Centre at Institut Curie-CNRS and the France-Biolmaging infrastructure (ANR-10-INSB-04) are acknowledged. This work was supported by grants from the Agence Nationale pour la Recherche (ANR-09-BLAN-283 to L.J. and C.S.,ANR-10-LBX-0038 to C.L.,ANR-11BSV201403 to L.J. and P.B.,ANR-12-BSV5-0014 to CS.), the Indo-French Centre for the Promotion of Advanced Science (project no. 3803, L.J.), Marie Curie Actions - Networks for Initial Training (FP7-PEOPLE-2010-ITN, L.J.), European Research Council advanced grant (project 340485, L.J.), Marie Curie International Reintegration Grant (FP7-RG-277078, C.W.), the Royal Society (RG120481, E.B.), Fondation ARC pour la Recherche sur le Cancer (DEQ20120323737, CS.), National Institutes of Health (R01 GM106720, A.K.K.), La Ligue contre le Cancer, Comite de Paris (RS08/75-89, A.A.S.), and by fellowships from Fondation ARC pour la Recherche sur le Cancer (H.-F.R., J.L. and M.-D.G.-C.), AXA Research Funds (J.L. and M.-D.G.-C.), the Biological Sciences Research Council (David Phillips Research Fellowship to E.B.), Chateaubriand fellowship and the France and Chicago Collaborating in the Sciences grant (M.S.). The Johannes, Lamaze, Sykes and Bassereau teams are members of Labex CelTisPhyBio (11-LBX-0038) and of Idex Paris Sciences et Lettres (ANR-10-IDEX-0001-02 PSL). P.B.'s group belongs to the French research consortium CellTiss.	Amessou M, 2006, CURR PROTOC CELL BIO, P15, DOI [10.1002/0471143030.cb1510s32, DOI 10.1002/0471143030.CB1510S32]; Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boncompain G., 2012, CURR PROTOC CELL BIO; Campelo F, 2012, ANNU REV BIOCHEM, V81, P407, DOI 10.1146/annurev-biochem-051710-094912; Campillo C, 2013, BIOPHYS J, V104, P1248, DOI 10.1016/j.bpj.2013.01.051; Cuvelier D, 2005, BIOPHYS J, V88, P2714, DOI 10.1529/biophysj.104.056473; DRAPER RK, 1990, SCIENCE, V248, P1539, DOI 10.1126/science.2163108; EVANS E, 1994, CHEM PHYS LIPIDS, V73, P39, DOI 10.1016/0009-3084(94)90173-2; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Gortat A, 2012, J BIOL CHEM, V287, P4232, DOI 10.1074/jbc.M111.325837; Hehnly H, 2006, MOL BIOL CELL, V17, P4379, DOI 10.1091/mbc.E06-04-0310; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kononenko NL, 2014, NEURON, V82, P981, DOI 10.1016/j.neuron.2014.05.007; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Llobet A, 2011, J NEUROSCI, V31, P8512, DOI 10.1523/JNEUROSCI.6223-09.2011; Mallard Frederic, 2003, Methods Mol Med, V73, P209; Meinecke M, 2013, J BIOL CHEM, V288, P6651, DOI 10.1074/jbc.M112.444869; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Mim C, 2012, TRENDS BIOCHEM SCI, V37, P526, DOI 10.1016/j.tibs.2012.09.001; Montagnac G, 2011, CURR BIOL, V21, P574, DOI 10.1016/j.cub.2011.02.034; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Neumann S, 2013, J BIOL CHEM, V288, P25119, DOI 10.1074/jbc.M113.490474; Pautot S, 2003, P NATL ACAD SCI USA, V100, P10718, DOI 10.1073/pnas.1931005100; Pontani LL, 2009, BIOPHYS J, V96, P192, DOI 10.1016/j.bpj.2008.09.029; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Robinson M. S., 2013, CURR PROTOC CELL BIO, V61, P15201; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Sorre B, 2012, P NATL ACAD SCI USA, V109, P173, DOI 10.1073/pnas.1103594108; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; Sundborger A, 2011, J CELL SCI, V124, P133, DOI 10.1242/jcs.072686; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Wolf AA, 1998, J CELL BIOL, V141, P917, DOI 10.1083/jcb.141.4.917; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39	44	205	207	2	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					493	+		10.1038/nature14064	http://dx.doi.org/10.1038/nature14064			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25517096	Green Accepted			2022-12-28	WOS:000348196500036
J	Lee, MW; Odegaard, JI; Mukundan, L; Qiu, YF; Molofsky, AB; Nussbaum, JC; Yun, KR; Locksley, RM; Chawla, A				Lee, Min-Woo; Odegaard, Justin I.; Mukundan, Lata; Qiu, Yifu; Molofsky, Ari B.; Nussbaum, Jesse C.; Yun, Karen; Locksley, Richard M.; Chawla, Ajay			Activated Type 2 Innate Lymphoid Cells Regulate Beige Fat Biogenesis	CELL			English	Article							ADIPOSE-TISSUE DEVELOPMENT; LINEAGE IN-VIVO; NONSHIVERING THERMOGENESIS; ADAPTIVE THERMOGENESIS; GLUCOSE-HOMEOSTASIS; IMMUNITY; BROWN; MACROPHAGES; EOSINOPHILS; ADIPOCYTES	Type 2 innate lymphoid cells (ILC2s), an innate source of the type 2 cytokines interleukin (IL)-5 and -13, participate in the maintenance of tissue homeostasis. Although type 2 immunity is critically important for mediating metabolic adaptations to environmental cold, the functions of ILC2s in beige or brown fat development are poorly defined. We report here that activation of ILC2s by IL-33 is sufficient to promote the growth of functional beige fat in thermoneutral mice. Mechanistically, ILC2 activation results in the proliferation of bipotential adipocyte precursors (APs) and their subsequent commitment to the beige fat lineage. Loss-and gain-of-function studies reveal that ILC2- and eosinophil-derived type 2 cytokines stimulate signaling via the IL-4R alpha in PDGFR alpha(+) APs to promote beige fat biogenesis. Together, our results highlight a critical role for ILC2s and type 2 cytokines in the regulation of adipocyte precursor numbers and fate, and as a consequence, adipose tissue homeostasis.	[Lee, Min-Woo; Odegaard, Justin I.; Mukundan, Lata; Qiu, Yifu; Yun, Karen; Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Molofsky, Ari B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Nussbaum, Jesse C.; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chawla, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	ajay.chawla@ucsf.edu		Molofsky, Ari/0000-0003-0764-3175; Qiu, Yifu/0000-0001-5645-3189	NIH [HL076746, DK094641, R37AI026918, AI119944, K08 DK101604, K08 AI113143]; American Heart Association Innovative Science Award [12PILT11840038, 14ISA20850001]; NIH Director's Pioneer Award [DP1AR064158]; HHMI; Hillblom Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746, P01HL107202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI113143, T32AI007334, R37AI026918, R01AI030663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK094641, P30DK063720, K08DK101604] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Innovative Science Award; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Hillblom Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Chawla laboratory and A. Loh for comments on the manuscript. The authors' work was supported by grants from NIH (HL076746, DK094641), American Heart Association Innovative Science Award (12PILT11840038 and 14ISA20850001), an NIH Director's Pioneer Award (DP1AR064158) to A.C. and NIH (R37AI026918, AI119944) and HHMI to R.M.L. M-W.L. was supported by a Postdoctoral Fellowship from the Hillblom Foundation, A.B.M. by NIH K08 DK101604, and J.C.N. by NIH K08 AI113143.	Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Golozoubova V, 2006, AM J PHYSIOL-ENDOC M, V291, pE350, DOI 10.1152/ajpendo.00387.2005; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hudak CS, 2014, CELL REP, V8, P678, DOI 10.1016/j.celrep.2014.06.060; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Koyasu S, 2013, ANN NY ACAD SCI, V1283, P43, DOI 10.1111/nyas.12106; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; PROFET M, 1991, Q REV BIOL, V66, P23, DOI 10.1086/417049; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; TALAN MI, 1985, J GERONTOL, V40, P8, DOI 10.1093/geronj/40.1.8; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang WS, 2014, P NATL ACAD SCI USA, V111, P14466, DOI 10.1073/pnas.1412685111; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zeve D, 2009, CELL STEM CELL, V5, P472, DOI 10.1016/j.stem.2009.10.014	43	467	486	1	87	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					74	87		10.1016/j.cell.2014.12.011	http://dx.doi.org/10.1016/j.cell.2014.12.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25543153	Green Accepted, Bronze			2022-12-28	WOS:000347923200010
J	Han, S; Brunet, A				Han, Shuo; Brunet, Anne			Lysosomal lipid lengthens life span	SCIENCE			English	Editorial Material							NUCLEAR RECEPTORS; C. ELEGANS; METABOLISM		[Han, Shuo; Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94035 USA	Stanford University	Han, S (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94035 USA.	abrunet1@stanford.edu		han, shuo/0000-0003-1181-351X				Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Dillin A, 2014, CURR OPIN CELL BIOL, V26, P107, DOI 10.1016/j.ceb.2013.12.003; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Folick A, 2015, SCIENCE, V347, P83, DOI 10.1126/science.1258857; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042; Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961; Reiner Z, 2014, ATHEROSCLEROSIS, V235, P21, DOI 10.1016/j.atherosclerosis.2014.04.003; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Settembre C, 2014, TRENDS CELL BIOL, V24, P743, DOI 10.1016/j.tcb.2014.06.006; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011	15	6	6	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					32	33		10.1126/science.aaa4565	http://dx.doi.org/10.1126/science.aaa4565			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554778				2022-12-28	WOS:000347102300037
J	Liu, Y; Sheng, J; Fokine, A; Meng, G; Shin, WH; Long, F; Kuhn, RJ; Kihara, D; Rossmann, MG				Liu, Yue; Sheng, Ju; Fokine, Andrei; Meng, Geng; Shin, Woong-Hee; Long, Feng; Kuhn, Richard J.; Kihara, Daisuke; Rossmann, Michael G.			Structure and inhibition of EV-D68, a virus that causes respiratory illness in children	SCIENCE			English	Article							HUMAN RHINOVIRUS-14; ENTEROVIRUS 71; PICORNAVIRUS; PLECONARIL; POLIOVIRUS; RESOLUTION; SUSCEPTIBILITY; ATTACHMENT; SEROTYPES; FEATURES	Enterovirus D68 (EV-D68) is a member of Picornaviridae and is a causative agent of recent outbreaks of respiratory illness in children in the United States. We report here the crystal structures of EV-D68 and its complex with pleconaril, a capsid-binding compound that had been developed as an anti-rhinovirus drug. The hydrophobic drug-binding pocket in viral protein 1 contained density that is consistent with a fatty acid of about 10 carbon atoms. This density could be displaced by pleconaril. We also showed that pleconaril inhibits EV-D68 at a half-maximal effective concentration of 430 nanomolar and might, therefore, be a possible drug candidate to alleviate EV-D68 outbreaks.	[Liu, Yue; Sheng, Ju; Fokine, Andrei; Meng, Geng; Shin, Woong-Hee; Long, Feng; Kuhn, Richard J.; Kihara, Daisuke; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Kihara, Daisuke] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, Hockmeyer Hall Struct Biol, W Lafayette, IN 47907 USA.	mr@purdue.edu	Meng, Geng/ACY-1510-2022; Kuhn, Richard/AAR-2722-2021; Fokine, Andrei/A-1330-2013	Kuhn, Richard/0000-0003-4148-1026; Liu, Yue/0000-0002-8759-5478; Shin, Woong-Hee/0000-0003-3462-0243	National Institutes of Health, National Center for Research Resources (NIH/NCRR) [RR007707]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-006CH11357]; NIH [AI11219]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI011219, R01AI011219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM111072] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources (NIH/NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Steven Oberste of the Centers for Disease Control and Prevention for supplying us with the prototype strain of EV-D68; M. A. McKinlay of the Task Force for Global Health for helpful discussion and suggestions; S. Kelly for help with the manuscript preparation; and V. Srajer, R. Henning, and the other staff of the Advanced Photon Source BioCARS beamline 14 for help with x-ray diffraction data collection. Use of BioCARS sector 14 was supported by the National Institutes of Health, National Center for Research Resources (NIH/NCRR) grant RR007707. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-006CH11357. This study was supported by NIH grant award AI11219 to M.G.R. Coordinates for native EV-D68 and EV-D68-pleconaril structures were deposited with the Protein Data Bank with accession numbers 4WM8 and 4WM7, respectively.	Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5; Barnard DL, 2004, ANTIMICROB AGENTS CH, V48, P1766, DOI 10.1128/AAC.48.5.1766-1772.2004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FILMAN DJ, 1989, EMBO J, V8, P1567, DOI 10.1002/j.1460-2075.1989.tb03541.x; Hayden FG, 2003, CLIN INFECT DIS, V36, P1523, DOI 10.1086/375069; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Lentz KN, 1997, STRUCTURE, V5, P961, DOI 10.1016/S0969-2126(97)00249-9; MUCKELBAUER JK, 1995, STRUCTURE, V3, P653, DOI 10.1016/S0969-2126(01)00201-5; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; OLIVEIRA MA, 1993, STRUCTURE, V1, P51, DOI 10.1016/0969-2126(93)90008-5; OLSON NH, 1993, P NATL ACAD SCI USA, V90, P507, DOI 10.1073/pnas.90.2.507; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pevear DC, 2005, ANTIMICROB AGENTS CH, V49, P4492, DOI 10.1128/AAC.49.11.4492-4499.2005; Plevka P, 2012, SCIENCE, V336, P1274, DOI 10.1126/science.1218713; Rogers JM, 1999, ADV EXP MED BIOL, V458, P69; ROSSMANN MG, 1994, PROTEIN SCI, V3, P1712, DOI 10.1002/pro.5560031010; ROSSMANN MG, 1989, J BIOL CHEM, V264, P14587; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Rossmann MG, 2002, TRENDS MICROBIOL, V10, P324, DOI 10.1016/S0966-842X(02)02383-1; SHERRY B, 1986, J VIROL, V57, P246, DOI 10.1128/JVI.57.1.246-257.1986; SMITH TJ, 1986, SCIENCE, V233, P1286, DOI 10.1126/science.3018924; Smyth M, 2003, ARCH VIROL, V148, P1225, DOI 10.1007/s00705-002-0974-4; Tijsma A, 2014, ANTIMICROB AGENTS CH, V58, P6990, DOI 10.1128/AAC.03328-14; Tokarz R, 2012, J GEN VIROL, V93, P1952, DOI 10.1099/vir.0.043935-0; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; Verdaguer N, 2000, J MOL BIOL, V300, P1179, DOI 10.1006/jmbi.2000.3943; Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255; Zhao R, 1996, STRUCTURE, V4, P1205, DOI 10.1016/S0969-2126(96)00128-1	33	109	121	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					71	74		10.1126/science.1261962	http://dx.doi.org/10.1126/science.1261962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554786	Green Accepted, Green Submitted			2022-12-28	WOS:000347102300050
J	Poffenroth, M				Poffenroth, Mary			My liberation through science	SCIENCE			English	Editorial Material									San Jose State Univ Calif, San Jose, CA 95192 USA	California State University System; San Jose State University	Poffenroth, M (corresponding author), San Jose State Univ Calif, San Jose, CA 95192 USA.			Poffenroth, Mary/0000-0002-2979-9069					0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					98	98		10.1126/science.347.6217.98	http://dx.doi.org/10.1126/science.347.6217.98			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7NK	25554790	Green Published			2022-12-28	WOS:000347102300055
J	Ellis, G; Silk, J				Ellis, George; Silk, Joe			Defend the integrity of physics	NATURE			English	Editorial Material							MULTIVERSE		[Ellis, George] Univ Cape Town, ZA-7700 Rondebosch, South Africa; [Silk, Joe] Paris Inst Astrophys, Paris, France; [Silk, Joe] Johns Hopkins Univ, Baltimore, MD USA	University of Cape Town; UDICE-French Research Universities; Sorbonne Universite; Johns Hopkins University	Ellis, G (corresponding author), Univ Cape Town, ZA-7700 Rondebosch, South Africa.	george.ellis@uct.ac.za; silk@iap.fr						Baggott J., 2013, FAREWELL REALITY; Dawid R, 2006, PHILOS SCI, V73, P298, DOI 10.1086/515415; Ellis GFR, 2014, GEN RELAT GRAVIT, V46, DOI 10.1007/s10714-013-1619-5; Ellis GFR, 2011, SCI AM, V305, P38, DOI 10.1038/scientificamerican0811-38; Smolin L., 2006, TROUBLE PHYS; Steinhardt P, 2014, NATURE, V510, P9, DOI 10.1038/510009a; Woit P., 2006, NOT EVEN WRONG	7	103	103	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					321	323		10.1038/516321a	http://dx.doi.org/10.1038/516321a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW8BE	25519115	Bronze			2022-12-28	WOS:000346484800021
J	Pasque, V; Tchieu, J; Karnik, R; Uyeda, M; Dimashkie, AS; Case, D; Papp, B; Bonora, G; Patel, S; Ho, R; Schmidt, R; McKee, R; Sado, T; Tada, T; Meissner, A; Plath, K				Pasque, Vincent; Tchieu, Jason; Karnik, Rahul; Uyeda, Molly; Dimashkie, Anupama Sadhu; Case, Dana; Papp, Bernadett; Bonora, Giancarlo; Patel, Sanjeet; Ho, Ritchie; Schmidt, Ryan; McKee, Robin; Sado, Takashi; Tada, Takashi; Meissner, Alexander; Plath, Kathrin			X Chromosome Reactivation Dynamics Reveal Stages of Reprogramming to Pluripotency	CELL			English	Article							DNA METHYLATION; SOMATIC-CELLS; STEM-CELLS; IPS CELLS; XIST RNA; INACTIVATION; MOUSE; NANOG; TRANSITION; MECHANISMS	Reprogramming to iPSCs resets the epigenome of somatic cells, including the reversal of X chromosome inactivation. We sought to gain insight into the steps underlying the reprogramming process by examining the means by which reprogramming leads to X chromosome reactivation (XCR). Analyzing single cells in situ, we found that hallmarks of the inactive X (Xi) change sequentially, providing a direct readout of reprogramming progression. Several epigenetic changes on the Xi occur in the inverse order of developmental X inactivation, whereas others are uncoupled from this sequence. Among the latter, DNA methylation has an extraordinary long persistence on the Xi during reprogramming, and, like Xist expression, is erased only after pluripotency genes are activated. Mechanistically, XCR requires both DNA demethylation and Xist silencing, ensuring that only cells undergoing faithful reprogramming initiate XCR. Our study defines the epigenetic state of multiple sequential reprogramming intermediates and establishes a paradigm for studying cell fate transitions during reprogramming.	[Pasque, Vincent; Uyeda, Molly; Dimashkie, Anupama Sadhu; Case, Dana; Papp, Bernadett; Bonora, Giancarlo; Patel, Sanjeet; Ho, Ritchie; Schmidt, Ryan; McKee, Robin; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Jonsson Comprehens Canc Ctr,Dept Biol Chem, Los Angeles, CA 90095 USA; [Tchieu, Jason] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Karnik, Rahul; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Broad Inst MIT & Harvard, Cambridge, MA 02138 USA; [Tada, Takashi] Kinki Univ, Grad Sch Agr, Dept Adv Biosci, Nara 6318505, Japan; [Tada, Takashi] Kyoto Univ, Dept Stem Cell Engn, Stem Cell Res Ctr, Inst Frontier Med Sci,Sakyo Ku, Kyoto 6068507, Japan	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Kindai University (Kinki University); Kyoto University	Plath, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Jonsson Comprehens Canc Ctr,Dept Biol Chem, Los Angeles, CA 90095 USA.	kplath@mednet.ucla.edu	Tchieu, Jason/AAG-1551-2020; Sado, Takashi/AAI-1689-2019; Pasque, Vincent/M-8231-2017; Pasque, Vincent/X-6720-2019	Tchieu, Jason/0000-0002-9793-9836; Pasque, Vincent/0000-0002-5129-0146; Pasque, Vincent/0000-0002-5129-0146; Sado, Takashi/0000-0002-1232-0250; Karnik, Rahul/0000-0002-0400-635X; Ho, Ritchie/0000-0003-1496-4436; Plath, Kathrin/0000-0001-7796-3372	CIRM Training Grants [TG2-01169, TB1-01183]; UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; NIH [P01 GM099134]; CIRM [RN1-00564]; NIH Ruth L Kirschstein National Research Service Award [GM007185]; Whitcome Pre-doctoral Training Program; UCLA Dissertation Year Fellowship; NIH Training Grant [5T32AI060567-07]; UCLA Graduate Division Dissertation Year Fellowship;  [P01GM099117];  [R25GM055052]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621, R25GM055052, P01GM099117, P01GM099134, T32GM007185] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001686] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26116515] Funding Source: KAKEN	CIRM Training Grants; UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NIH Ruth L Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome Pre-doctoral Training Program; UCLA Dissertation Year Fellowship; NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Graduate Division Dissertation Year Fellowship; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to Drs. Nakamura, Xu, Eng, Berk, Silva, Pei, and Besser for providing reagents; Dr. Chronis for help with bioinformatics; Dr. Ch'ng and A. Sahakyan for help with microscopy and western blot analysis; F. Codrea and J. Scholes at the Broad Stem Cell Center FACS Core for help; and Dr. Lowry and members of the Plath lab for advice and critical reading of the manuscript. V.P., S.P., and A.S.D. are supported by CIRM Training Grants TG2-01169 and TB1-01183; J.T. is supported by a fellowship of the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; A.M. is a NYSCF Robertson Investigator and is supported by P01GM099117; K.P. is supported by the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and NIH P01 GM099134 and CIRM (RN1-00564); D.C. is supported by the NIH Ruth L Kirschstein National Research Service Award (GM007185); G.B. is supported by the Whitcome Pre-doctoral Training Program and a UCLA Dissertation Year Fellowship; M.U. is supported by R25GM055052; R.H. is supported by an NIH Training Grant (5T32AI060567-07) and the UCLA Graduate Division Dissertation Year Fellowship; and R.S. is supported by the UCLA Graduate Division Dissertation Year Fellowship.	Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carter AC, 2014, STEM CELL REP, V2, P119, DOI 10.1016/j.stemcr.2013.12.010; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chen Q, 2014, STEM CELLS, V32, P2642, DOI 10.1002/stem.1775; Chow J, 2009, CURR OPIN CELL BIOL, V21, P359, DOI 10.1016/j.ceb.2009.04.012; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Gendrel AV, 2012, DEV CELL, V23, P265, DOI 10.1016/j.devcel.2012.06.011; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Hu X, 2014, CELL STEM CELL, V14, P512, DOI 10.1016/j.stem.2014.01.001; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; O'Malley J, 2013, NATURE, V499, P88, DOI 10.1038/nature12243; Parchem RJ, 2014, CELL STEM CELL, V14, P617, DOI 10.1016/j.stem.2014.01.021; Pasque V, 2012, J CELL SCI, V125, P6094, DOI 10.1242/jcs.113019; Payer B, 2013, MOL CELL, V52, P805, DOI 10.1016/j.molcel.2013.10.023; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schwarz BA, 2014, CURR BIOL, V24, P347, DOI 10.1016/j.cub.2013.12.050; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Williams LH, 2011, DEVELOPMENT, V138, P2049, DOI 10.1242/dev.061176; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	35	68	70	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1681	1697		10.1016/j.cell.2014.11.040	http://dx.doi.org/10.1016/j.cell.2014.11.040			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525883	Bronze, Green Accepted			2022-12-28	WOS:000347922500020
J	Ofek, G; Diskin, R				Ofek, Gilad; Diskin, Ron			Expanding the breadth of an HIV-1 vaccine	SCIENCE			English	Editorial Material							B-CELL RECEPTORS; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; ENVELOPE TRIMER; BINDING; THERAPY; DESIGN; POTENT		[Ofek, Gilad] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Diskin, Ron] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Ofek, G (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA.	ron.diskin@weizmann.ac.il						Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; McCoy LE, 2013, J EXP MED, V210, P209, DOI 10.1084/jem.20121827; McGuire AT, 2014, SCIENCE, V346, P1380, DOI 10.1126/science.1259206; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; West AL, 2012, P NATL ACAD SCI USA, V109, P5633, DOI 10.1073/pnas.1120283109; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	15	0	0	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1290	1291		10.1126/science.aaa2315	http://dx.doi.org/10.1126/science.aaa2315			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW3MA	25504701				2022-12-28	WOS:000346189600021
J	Rajaram, R; Chung, JW; Jones, AT; Cohen, ME; Dahlke, AR; Ko, CY; Tarpley, JL; Lewis, FR; Hoyt, DB; Bilimoria, KY				Rajaram, Ravi; Chung, Jeanette W.; Jones, Andrew T.; Cohen, Mark E.; Dahlke, Allison R.; Ko, Clifford Y.; Tarpley, John L.; Lewis, Frank R.; Hoyt, David B.; Bilimoria, Karl Y.			Association of the 2011 ACGME Resident Duty Hour Reform With General Surgery Patient Outcomes and With Resident Examination Performance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURGICAL QUALITY; WORK HOURS; RESTRICTIONS; MORTALITY; EDUCATION; INTERNS; CARE; REGULATIONS; MEDICINE; FAILURES	IMPORTANCE In 2011, the Accreditation Council for Graduate Medical Education (ACGME) restricted resident duty hour requirements beyond those established in 2003, leading to concerns about the effects on patient care and resident training. OBJECTIVE To determine if the 2011 ACGME duty hour reform was associated with a change in general surgery patient outcomes or in resident examination performance. DESIGN, SETTING, AND PARTICIPANTS Quasi-experimental study of general surgery patient outcomes 2 years before (academic years 2009-2010) and after (academic years 2012-2013) the 2011 duty hour reform. Teaching and nonteaching hospitals were compared using a difference-in-differences approach adjusted for procedural mix, patient comorbidities, and time trends. Teaching hospitals were defined based on the proportion of cases at which residents were present intraoperatively. Patients were those undergoing surgery at hospitals participating in the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP). General surgery resident performance on the annual in-training, written board, and oral board examinations was assessed for this same period. EXPOSURES National implementation of revised resident duty hour requirements on July 1, 2011, in all ACGME accredited residency programs. MAIN OUTCOMES AND MEASURES Primary outcome was a composite of death or serious morbidity; secondary outcomes were other postoperative complications and resident examination performance. RESULTS In the main analysis, 204 641 patients were identified from 23 teaching (n = 102 525) and 31 nonteaching (n = 102 116) hospitals. The unadjusted rate of death or serious morbidity improved during the study period in both teaching (11.6%[95% CI, 11.3%-12.0%] to 9.4%[95% CI, 9.1%-9.8%], P < .001) and nonteaching hospitals (8.7%[95% CI, 8.3%-9.0%] to 7.1% [95% CI, 6.8%-7.5%], P < .001). In adjusted analyses, the 2011 ACGME duty hour reform was not associated with a significant change in death or serious morbidity in either postreform year 1 (OR, 1.12; 95% CI, 0.98-1.28) or postreform year 2 (OR, 1.00; 95% CI, 0.86-1.17) or when both postreform years were combined (OR, 1.06; 95% CI, 0.93-1.20). There was no association between duty hour reform and any other postoperative adverse outcome. Mean (SD) in-training examination scores did not significantly change from 2010 to 2013 for first-year residents (499.7 [85.2] to 500.5 [84.2], P = .99), for residents from other postgraduate years, or for first-time examinees taking the written or oral board examinations during this period. CONCLUSIONS AND RELEVANCE Implementation of the 2011 ACGME duty hour reform was not associated with a change in general surgery patient outcomes or differences in resident examination performance. The implications of these findings should be considered when evaluating the merit of the 2011 ACGME duty hour reform and revising related policies in the future. Copyright 2014 American Medical Association. All rights reserved.	[Rajaram, Ravi; Cohen, Mark E.; Ko, Clifford Y.; Hoyt, David B.; Bilimoria, Karl Y.] Amer Coll Surg, Div Res & Optimal Patient Care, Chicago, IL USA; [Rajaram, Ravi; Chung, Jeanette W.; Dahlke, Allison R.; Bilimoria, Karl Y.] Northwestern Univ, Dept Surg, SOQIC, Chicago, IL 60611 USA; [Rajaram, Ravi; Chung, Jeanette W.; Dahlke, Allison R.; Bilimoria, Karl Y.] Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth & Med, Ctr Healthcare Studies, Chicago, IL 60611 USA; [Jones, Andrew T.; Lewis, Frank R.] Amer Board Surg, Philadelphia, PA USA; [Ko, Clifford Y.] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA; [Ko, Clifford Y.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Tarpley, John L.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN USA	American College of Surgeons; Northwestern University; Northwestern University; Feinberg School of Medicine; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Vanderbilt University	Bilimoria, KY (corresponding author), Northwestern Univ, Dept Surg, SOQIC, 633 N St Clair St,20th Floor, Chicago, IL 60611 USA.	k-bilimoria@northwestern.edu		Jones, Andrew/0000-0001-7369-4937	Agency for Healthcare Research and Quality [T32HS000078]; American College of Surgeons Clinical Scholars in Residence Program; Merck; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000078] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); American College of Surgeons Clinical Scholars in Residence Program; Merck(Merck & Company); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr Rajaramis supported by grant T32HS000078 from the Agency for Healthcare Research and Quality, the American College of Surgeons Clinical Scholars in Residence Program, and an unrestricted educational grant from Merck.	Ahmed N, 2014, ANN SURG, V259, P1041, DOI 10.1097/SLA.0000000000000595; American College of Surgeons National Surgical Quality Improvement Program, 2014, ACS NSQIP SEM REP; American Hospital Association, FAST FACTS US HOSP; Angrist J., 1999, HDB LABOR EC, V3A; [Anonymous], FLEX DUT HOUR REQ SU; [Anonymous], ACS NSQIP VAR DEF; [Anonymous], MEAS PERF; Antiel RM, 2013, JAMA SURG, V148, P448, DOI 10.1001/jamasurg.2013.1368; Antiel RM, 2011, MAYO CLIN PROC, V86, P185, DOI 10.4065/mcp.2010.0635; BELL BM, 1988, NEW YORK STATE J MED, V88, P617; Cohen ME, 2013, J AM COLL SURGEONS, V217, P336, DOI 10.1016/j.jamcollsurg.2013.02.027; Coleman JJ, 2013, J AM COLL SURGEONS, V216, P764, DOI 10.1016/j.jamcollsurg.2012.12.045; de Virgilio Christian, 2006, Curr Surg, V63, P435, DOI 10.1016/j.cursur.2006.03.006; Desai SV, 2013, JAMA INTERN MED, V173, P649, DOI 10.1001/jamainternmed.2013.2973; Durkin ET, 2008, J SURG EDUC, V65, P54, DOI 10.1016/j.jsurg.2007.08.008; Fischer JE, 2009, AM J SURG, V197, P135, DOI 10.1016/j.amjsurg.2009.01.001; Fletcher KE, 2011, J GEN INTERN MED, V26, P907, DOI 10.1007/s11606-011-1657-1; Ingraham Angela M, 2010, Adv Surg, V44, P251; Institute of Medicine, 2008, RESIDENT DUTY HOURS; Jamal MH, 2012, BRIT J SURG, V99, P336, DOI 10.1002/bjs.8657; Khuri SF, 2008, ANN SURG, V248, P329, DOI 10.1097/SLA.0b013e3181823485; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lawson EH, 2012, ANN SURG, V256, P973, DOI 10.1097/SLA.0b013e31826b4c4f; Lewis FR, 2012, ANN SURG, V256, P553, DOI 10.1097/SLA.0b013e31826bf98c; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Medicare. gov, HOSP COMP; Moffatt-Bruce SD, 2014, J THORAC CARDIOV SUR, V147, P1464, DOI 10.1016/j.jtcvs.2014.01.003; Philibert I, 2013, ANNU REV MED, V64, P467, DOI 10.1146/annurev-med-120711-135717; RITTERBAND AB, 1990, NEW YORK STATE J MED, V90, P565; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Shiloach M, 2010, J AM COLL SURGEONS, V210, P6, DOI 10.1016/j.jamcollsurg.2009.09.031; SILBER JH, 1992, MED CARE, V30, P615, DOI 10.1097/00005650-199207000-00004; The American Board of Surgery, GEN SURG EX; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Volpp KG, 2009, J GEN INTERN MED, V24, P1149, DOI 10.1007/s11606-009-1011-z; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Woolridge J. M., 2006, INTRO ECONOMETRICS M	38	84	84	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2374	2384		10.1001/jama.2014.15277	http://dx.doi.org/10.1001/jama.2014.15277			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YB	25490328				2022-12-28	WOS:000346345700012
J	Wright, CF; Fitzgerald, TW; Jones, WD; Clayton, S; Mcrae, JF; van Kogelenberg, M; King, DA; Ambridge, K; Barrett, DM; Bayzetinova, T; Bevan, AP; Bragin, E; Chatzimichali, EA; Gribble, S; Jones, P; Krishnappa, N; Mason, LE; Miller, R; Morley, KI; Parthiban, V; Prigmore, E; Rajan, D; Sifrim, A; Swaminathan, GJ; Tivey, AR; Middleton, A; Parker, M; Carter, NP; Barrett, JC; Hurles, ME; FitzPatrick, DR; Firth, HV				Wright, Caroline F.; Fitzgerald, Tomas W.; Jones, Wendy D.; Clayton, Stephen; McRae, Jeremy F.; van Kogelenberg, Margriet; King, Daniel A.; Ambridge, Kirsty; Barrett, Daniel M.; Bayzetinova, Tanya; Bevan, A. Paul; Bragin, Eugene; Chatzimichali, Eleni A.; Gribble, Susan; Jones, Philip; Krishnappa, Netravathi; Mason, Laura E.; Miller, Ray; Morley, Katherine I.; Parthiban, Vijaya; Prigmore, Elena; Rajan, Diana; Sifrim, Alejandro; Swaminathan, G. Jawahar; Tivey, Adrian R.; Middleton, Anna; Parker, Michael; Carter, Nigel P.; Barrett, Jeffrey C.; Hurles, Matthew E.; FitzPatrick, David R.; Firth, Helen V.		DDD Study	Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data	LANCET			English	Article							INCIDENTAL FINDINGS; INTELLECTUAL DISABILITY; UNIPARENTAL DISOMY; EXOME; VARIANTS; SEQUENCE; MUTATIONS	Background Human genome sequencing has transformed our understanding of genomic variation and its relevance to health and disease, and is now starting to enter clinical practice for the diagnosis of rare diseases. The question of whether and how some categories of genomic findings should be shared with individual research participants is currently a topic of international debate, and development of robust analytical workflows to identify and communicate clinically relevant variants is paramount. Methods The Deciphering Developmental Disorders (DDD) study has developed a UK-wide patient recruitment network involving over 180 clinicians across all 24 regional genetics services, and has performed genome-wide microarray and whole exome sequencing on children with undiagnosed developmental disorders and their parents. After data analysis, pertinent genomic variants were returned to individual research participants via their local clinical genetics team. Findings Around 80 000 genomic variants were identified from exome sequencing and microarray analysis in each individual, of which on average 400 were rare and predicted to be protein altering. By focusing only on de novo and segregating variants in known developmental disorder genes, we achieved a diagnostic yield of 27% among 1133 previously investigated yet undiagnosed children with developmental disorders, whilst minimising incidental findings. In families with developmentally normal parents, whole exome sequencing of the child and both parents resulted in a 10-fold reduction in the number of potential causal variants that needed clinical evaluation compared to sequencing only the child. Most diagnostic variants identified in known genes were novel and not present in current databases of known disease variation. Interpretation Implementation of a robust translational genomics workflow is achievable within a large-scale rare disease research study to allow feedback of potentially diagnostic findings to clinicians and research participants. Systematic recording of relevant clinical data, curation of a gene-phenotype knowledge base, and development of clinical decision support software are needed in addition to automated exclusion of almost all variants, which is crucial for scalable prioritisation and review of possible diagnostic variants. However, the resource requirements of development and maintenance of a clinical reporting system within a research setting are substantial. Copyright (C) Wright et al. Open Access article distributed under the terms of CC BY.	[Wright, Caroline F.; Fitzgerald, Tomas W.; Jones, Wendy D.; Clayton, Stephen; McRae, Jeremy F.; van Kogelenberg, Margriet; King, Daniel A.; Ambridge, Kirsty; Barrett, Daniel M.; Bayzetinova, Tanya; Bevan, A. Paul; Bragin, Eugene; Chatzimichali, Eleni A.; Gribble, Susan; Jones, Philip; Krishnappa, Netravathi; Mason, Laura E.; Miller, Ray; Morley, Katherine I.; Parthiban, Vijaya; Prigmore, Elena; Rajan, Diana; Sifrim, Alejandro; Swaminathan, G. Jawahar; Tivey, Adrian R.; Middleton, Anna; Carter, Nigel P.; Barrett, Jeffrey C.; Hurles, Matthew E.; Firth, Helen V.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Morley, Katherine I.] Kings Coll London, Inst Psychiat, London, England; [Morley, Katherine I.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Parker, Michael] Univ Oxford, Nuffield Dept Populat Hlth, Ethox Ctr, Oxford, England; [FitzPatrick, David R.] Univ Edinburgh, MRC, Human Genet Unit, MRC IGMM,WGH, Edinburgh, Midlothian, Scotland; [Firth, Helen V.] Cambridge Univ Hosp Fdn Trust, Addenbrookes Hosp, Cambridge, England	Wellcome Trust Sanger Institute; University of London; King's College London; University of Melbourne; University of Oxford; University of Edinburgh; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Wright, CF (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	caroline.wright@sanger.ac.uk	Crow, Yanick J/N-6120-2014; Wright, Caroline/N-5355-2015; Patel, Chirag/AAF-4953-2019; Balasubramanian, Meena/AGB-4083-2022; Dominiczak, Anna F/P-9390-2017; King, Daniel/AAM-8024-2021; Sifrim, Alejandro/AAY-2019-2021; KRISHNAPPA, NETRAVATHI/AAD-9576-2021; Morley, Katherine I/A-2986-2011; LACHLAN, KATHERINE/ABH-6991-2020	Crow, Yanick J/0000-0001-7211-7564; Patel, Chirag/0000-0002-6374-5224; Balasubramanian, Meena/0000-0003-1488-3695; Dominiczak, Anna F/0000-0003-4913-3608; King, Daniel/0000-0001-6451-712X; Sifrim, Alejandro/0000-0001-8247-4020; Morley, Katherine I/0000-0002-2725-5535; FitzPatrick, David R./0000-0003-4861-969X; Middleton, Anna/0000-0003-3103-8098; Burn, John/0000-0002-9823-2322; Bevan, Paul/0000-0002-0656-9164; Barrett, Jeffrey/0000-0002-1152-370X; Wright, Caroline/0000-0003-2958-5076; Fitzgerald, Tomas/0000-0002-2370-8496; LACHLAN, KATHERINE/0000-0002-3816-7346; Swaminathan, Jawahar/0000-0002-0215-4084; Edkins, Sarah/0000-0003-0717-1972; Yang, Fengtang/0000-0002-3573-2354	Health Innovation Challenge Fund; Wellcome Trust; UK Department of Health; MRC [MC_PC_U127561093] Funding Source: UKRI; Cancer Research UK [15934] Funding Source: researchfish; Medical Research Council [MC_PC_U127561093] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10282] Funding Source: researchfish	Health Innovation Challenge Fund; Wellcome Trust(Wellcome TrustEuropean Commission); UK Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Health Innovation Challenge Fund, a parallel funding partnership between the Wellcome Trust and the UK Department of Health.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Bragin E, 2014, NUCLEIC ACIDS RES, V42, pD993, DOI 10.1093/nar/gkt937; DDD Study, NATURE IN PRESS; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Firth HV, 2011, DEV MED CHILD NEUROL, V53, P702, DOI 10.1111/j.1469-8749.2011.04032.x; Gliwa C, 2013, AM J BIOETHICS, V13, P32, DOI 10.1080/15265161.2012.754062; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; King DA, 2014, GENOME RES, V24, P673, DOI 10.1101/gr.160465.113; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Koboldt DC, 2014, AM J HUM GENET, V94, P373, DOI 10.1016/j.ajhg.2014.01.016; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Middleton A, 2014, LANCET; Middleton A, 2013, AM J MED GENET A, V161, P2099, DOI 10.1002/ajmg.a.36067; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pichon Riviere A, 2013, 320 I CLIN EFF HLTH; Piton A, 2013, AM J HUM GENET, V93, P368, DOI 10.1016/j.ajhg.2013.06.013; Ramu A, 2013, NAT METHODS, V10, P985, DOI 10.1038/nmeth.2611; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Robinson PN, 2010, CLIN GENET, V77, P525, DOI 10.1111/j.1399-0004.2010.01436.x; Robinson WP, 2000, BIOESSAYS, V22, P452; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Topper S, 2011, CLIN GENET, V80, P117, DOI 10.1111/j.1399-0004.2011.01720.x; van Karnebeek CDM, 2012, MOL GENET METAB, V105, P368, DOI 10.1016/j.ymgme.2011.11.191; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wolf SM, 2012, GENET MED, V14, P361, DOI 10.1038/gim.2012.23; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Wright CF, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6845; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	39	438	451	3	74	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1305	1314		10.1016/S0140-6736(14)61705-0	http://dx.doi.org/10.1016/S0140-6736(14)61705-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25529582	Green Published, hybrid			2022-12-28	WOS:000352272400036
J	Head, JJ; Polly, PD				Head, Jason J.; Polly, P. David			Evolution of the snake body form reveals homoplasy in amniote Hox gene function	NATURE			English	Article							LATERAL SOMITIC FRONTIER; VERTEBRAL NUMBERS; PLAN; MESODERM; SKELETON; EMBRYOS; DOMAINS; CODE	Hox genes regulate regionalization of the axial skeleton invertebrates(1-7), and changes in their expression have been proposed to be a fundamental mechanism driving the evolution of new body forms(8-14). The origin of the snake-like body form, with its deregionalized pre-cloacal axial skeleton, has been explained as either homogenization of Hox gene expression domains(9), or retention of standard vertebrate Hox domains with alteration of downstream expression that suppresses development of distinct regions(10-13). Both models assume a highly regionalized ancestor, but the extent of deregionalization of the primaxial domain (vertebrae, dorsal ribs) of the skeleton in snake-like body forms has never been analysed. Here we combine geometric morphometrics and maximum-likelihood analysis to show that the pre-cloacal primaxial domain of elongate, limb-reduced lizards and snakes is not deregionalized compared with limbed taxa, and that the phylogenetic structure of primaxial morphology in reptiles does not support a loss of regionalization in the evolution of snakes. We demonstrate that morphometric regional boundaries correspond to mapped gene expression domains in snakes, suggesting that their primaxial domain is patterned by a normally functional Hox code. Comparison of primaxial osteology in fossil and modern amniotes with Hox gene distributions within Amniota indicates that a functional, sequentially expressed Hox code patterned a subtle morphological gradient along the anterior-posterior axis in stem members of amniote clades and extant lizards, including snakes. The highly regionalized skeletons of extant archosaurs and mammals result from independent evolution in the Hox code and do not represent ancestral conditions for clades with snake-like body forms. The developmental origin of snakes is best explained by decoupling of the primaxial and abaxial domains and by increases in somite number(15), not by changes in the function of primaxial Hox genes(9,10).	[Head, Jason J.] Univ Nebraska, Dept Earth & Atmospher Sci, Lincoln, NE 68588 USA; [Head, Jason J.] Univ Nebraska, Nebraska State Museum Nat Hist, Lincoln, NE 68588 USA; [Polly, P. David] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Polly, P. David] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Polly, P. David] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Head, JJ (corresponding author), Univ Nebraska, Dept Earth & Atmospher Sci, Lincoln, NE 68588 USA.	jhead2@unl.edu; pdpolly@indiana.edu	Polly, P. David/ABC-6597-2020	Polly, P. David/0000-0001-7338-8526; Head, Jason/0000-0002-2237-6901	US National Science Foundation Postdoctoral Fellowship in Biological Informatics [DBI-0204082]; Natural Sciences and Engineering Research Council of Canada; US National Science Foundation Grant [EAR-0843935]	US National Science Foundation Postdoctoral Fellowship in Biological Informatics; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); US National Science Foundation Grant(National Science Foundation (NSF))	We thank K. DeQueiroz, G. Zug, R. McDiarmid, K. Seymour, D. Gower, C. McCarthy, C. Bell, H. Voris, C. J. Cole, P. Holroyd and T. Labedz for specimen access, A. K. Behrensmeyer for access to microscopy facilities, and A. Goswami, K. Johnson, P. Mitteroecker, R. Raff, R. Reisz and M. Rowe for useful comments and discussion. This work was supported in part by a US National Science Foundation Postdoctoral Fellowship in Biological Informatics (DBI-0204082) to J. J. H., a Natural Sciences and Engineering Research Council of Canada Discovery Grant to J. J. H., and a US National Science Foundation Grant (EAR-0843935) to P.D.P.	[Anonymous], 2008, MODEL SELECTION MODE; Buchholtz EA, 2009, EVOL DEV, V11, P69, DOI 10.1111/j.1525-142X.2008.00303.x; Burke AC, 2003, DEV CELL, V4, P159, DOI 10.1016/S1534-5807(03)00033-9; BURKE AC, 1995, DEVELOPMENT, V121, P333; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Di-Poi N, 2010, NATURE, V464, P99, DOI 10.1038/nature08789; Favier B, 1997, MOL HUM REPROD, V3, P115, DOI 10.1093/molehr/3.2.115; FEDER PI, 1975, ANN STAT, V3, P84, DOI 10.1214/aos/1176343000; GAUNT SJ, 1994, INT J DEV BIOL, V38, P549; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Guerreiro I, 2013, P NATL ACAD SCI USA, V110, P10682, DOI 10.1073/pnas.1300592110; Hoffstetter R., 1969, P201; HUDSON DJ, 1966, J AM STAT ASSOC, V61, P1097, DOI 10.2307/2283203; Lerman PM., 1980, APPL STATIST, V29, P77, DOI [DOI 10.2307/2346413, 10.2307/2346413]; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Mansfield JH, 2010, J EXP ZOOL PART B, V314B, P629, DOI 10.1002/jez.b.21364; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; Muller J, 2010, P NATL ACAD SCI USA, V107, P2118, DOI 10.1073/pnas.0912622107; Nowicki JL, 2003, MECH DEVELOP, V120, P227, DOI 10.1016/S0925-4773(02)00415-X; Polly PD, 2004, MORPHOMETRICS: APPLICATIONS IN BIOLOGY AND PALEONTOLOGY, P197; Prince VE, 1998, DEVELOPMENT, V125, P407; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Shearman RM, 2009, J EXP ZOOL PART B, V312B, P603, DOI 10.1002/jez.b.21246; Shine R, 2000, J EVOLUTION BIOL, V13, P455; Vinagre T, 2010, DEV CELL, V18, P655, DOI 10.1016/j.devcel.2010.02.011; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Woltering JM, 2012, CURR GENOMICS, V13, P289, DOI 10.2174/138920212800793302; Woltering JM, 2009, DEV BIOL, V332, P82, DOI 10.1016/j.ydbio.2009.04.031	30	86	87	2	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					86	U190		10.1038/nature14042	http://dx.doi.org/10.1038/nature14042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25539083				2022-12-28	WOS:000352027700042
J	Ramdya, P; Lichocki, P; Cruchet, S; Frisch, L; Tse, W; Floreano, D; Benton, R				Ramdya, Pavan; Lichocki, Pawel; Cruchet, Steeve; Frisch, Lukas; Tse, Winnie; Floreano, Dario; Benton, Richard			Mechanosensory interactions drive collective behaviour in Drosophila	NATURE			English	Article							STIMULATION; NEURONS; TASTE	Collective behaviour enhances environmental sensing and decision-making in groups of animals(1,2). Experimental and theoretical investigations of schooling fish, flocking birds and human crowds have demonstrated that simple interactions between individuals can explain emergent group dynamics(3,4). These findings indicate the existence of neural circuits that support distributed behaviours, but the molecular and cellular identities of relevant sensory pathways are unknown. Here we show that Drosophila melanogaster exhibits collective responses to an aversive odour: individual flies weakly avoid the stimulus, but groups show enhanced escape reactions. Using high-resolution behavioural tracking, computational simulations, genetic perturbations, neural silencing and optogenetic activation we demonstrate that this collective odour avoidance arises from cascades of appendage touch interactions between pairs of flies. Interfly touch sensing and collective behaviour require the activity of distal leg mechanosensory sensilla neurons and the mechanosensory channel NOMPC5,6. Remarkably, through these inter-fly encounters, wild-type flies can elicit avoidance behaviour in mutant animals that cannot sense the odour-a basic form of communication. Our data highlight the unexpected importance of social context in the sensory responses of a solitary species and open the door to a neural-circuit-level understanding of collective behaviour in animal groups.	[Ramdya, Pavan; Cruchet, Steeve; Benton, Richard] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Ramdya, Pavan; Lichocki, Pawel; Floreano, Dario] Ecole Polytech Fed Lausanne, Lab Intelligent Syst, CH-1015 Lausanne, Switzerland; [Lichocki, Pawel] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Frisch, Lukas; Tse, Winnie] Ecole Polytech Fed Lausanne, Masters Program Microengn, Inst Microengn, CH-1015 Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Benton, R (corresponding author), Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	ramdya@gmail.com; Richard.Benton@unil.ch			Human Frontier Science Program Long-term Fellowship; Swiss National Science Foundation [200021_127143, CR32I3_141063/1]; FP7-FET European Project INSIGHT [308943]; European Research Council [205202, 615094]	Human Frontier Science Program Long-term Fellowship(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); FP7-FET European Project INSIGHT; European Research Council(European Research Council (ERC)European Commission)	We thank L. Sprecher, J. Weber, A. Gaille, A. Canapini and I. Barbier for help in aggregation density measurements, A. Silbering for generating anosmic Drosophila lines, F. Schutz for advice on statistics, J. Yi for image analysis software, J. Levine, A. Patapoutian, M. Landgraf, M. Gopfert and the Bloomington Drosophila Stock Center for Drosophila strains, T. Oertner for plasmids, and the Developmental Studies Hybridoma Bank for antibodies. We thank D. Cullen, L. Keller, J. Levine, M. Louis, S. Manley, S. Martin, J. Schneider and members of the Benton and Floreano laboratories for discussions. P.R. was supported by a Human Frontier Science Program Long-term Fellowship. P.L. was supported by the Swiss National Science Foundation (200021_127143). D.F. acknowledges support from the Swiss National Science Foundation (CR32I3_141063/1) and the FP7-FET European Project INSIGHT (308943). R.B. acknowledges support from European Research Council Starting Independent Researcher and Consolidator Grants (205202 and 615094).	Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Berdahl A, 2013, SCIENCE, V339, P574, DOI 10.1126/science.1225883; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Billeter JC, 2013, CURR OPIN NEUROBIOL, V23, P17, DOI 10.1016/j.conb.2012.08.009; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Gullan P. J., 2010, THE INSECTS; Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108; HIRSCH J, 1961, SCIENCE, V134, P835, DOI 10.1126/science.134.3482.835; Holtje M, 2003, J EXP BIOL, V206, P2715, DOI 10.1242/jeb.00492; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kamikouchi A, 2010, NAT PROTOC, V5, P1229, DOI 10.1038/nprot.2010.85; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; Ling F, 2014, J NEUROSCI, V34, P7148, DOI 10.1523/JNEUROSCI.0649-14.2014; Luke S., 2010, ECJ OWNERS MANUAL SA; Manoli DS, 2013, CURR OPIN NEUROBIOL, V23, P330, DOI 10.1016/j.conb.2013.04.005; Ramdya P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048381; SCHAEFER PL, 1994, J EXP BIOL, V190, P287; Schneider J, 2012, P NATL ACAD SCI USA, V109, P17174, DOI 10.1073/pnas.1121252109; Schneider J, 2012, ADV GENET, V77, P59, DOI 10.1016/B978-0-12-387687-4.00003-9; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Stocker RF, 2004, CURR BIOL, V14, pR560, DOI 10.1016/j.cub.2004.07.011; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Sumpter D, 2008, THEOR BIOSCI, V127, P177, DOI 10.1007/s12064-008-0040-1; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685	33	112	112	2	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					233	+		10.1038/nature14024	http://dx.doi.org/10.1038/nature14024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25533959	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000350770500039
J	Rudan, I; Chan, KY				Rudan, Igor; Chan, Kit Yee			Global health metrics needs collaboration and competition	LANCET			English	Editorial Material									[Rudan, Igor] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; Univ Edinburgh, Sch Med, Global Hlth Acad, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Rudan, I (corresponding author), Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland.	igor.rudan@ed.ac.uk	Rudan, Igor/I-1467-2012	Rudan, Igor/0000-0001-6993-6884; Chan, Kit Yee/0000-0002-3465-8383				Cohen J, 2012, SCIENCE, V338, P1414, DOI 10.1126/science.338.6113.1414; Gunnison Ballen K, 2012, DECODING OUR DNA CRA; Horton R., 2012, LANCET, V381, P612; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Levine R, 2006, BRIT MED J, V333, P1015, DOI 10.1136/bmj.39020.383102.68; Liu L, 2014, LANCET; Norheim OF, 2014, LANCET; Rudan I, 2012, J GLOB HEALTH, V2; The Lancet, 2014, LANCET; Thomson Reuters, 2014, WORLDS MOST INFL SCI; Victoria CG, 2014, LANCET; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029	12	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 10	2015	385	9963					92	94		10.1016/S0140-6736(14)62006-7	http://dx.doi.org/10.1016/S0140-6736(14)62006-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY7BI	25530441				2022-12-28	WOS:000347715900005
J	Ford, S				Ford, Steven			I would scrap the internal market	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mail@stevenford.co.uk							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2015	350								g7762	10.1136/bmj.g7762	http://dx.doi.org/10.1136/bmj.g7762			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY4JT	25555825				2022-12-28	WOS:000347544900002
J	Ubel, PA				Ubel, Peter A.			Transplantation Traffic - Geography as Destiny for Transplant Candidates	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ubel, Peter A.] Duke Univ, Fuqua Sch Business, Sanford Sch Publ Policy, Durham, NC 27706 USA; [Ubel, Peter A.] Duke Univ, Sch Med, Durham, NC 27706 USA	Duke University; Duke University	Ubel, PA (corresponding author), Duke Univ, Fuqua Sch Business, Sanford Sch Publ Policy, Durham, NC 27706 USA.							Merion RM, 2004, AM J TRANSPLANT, V4, P94, DOI 10.1046/j.1600-6135.2003.00282.x; Neergaard L, 2013, MAPPING BETTER ORGAN; Ubel PA, 1999, NEW ENGL J MED, V340, P964	3	6	6	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2450	2452		10.1056/NEJMp1407639	http://dx.doi.org/10.1056/NEJMp1407639			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX4RZ	25539104				2022-12-28	WOS:000346920300003
J	Epstein, JM; Sauer, LM				Epstein, Joshua M.; Sauer, Lauren M.			Mobilizing Ebola survivors to curb the epidemic	NATURE			English	Editorial Material									[Epstein, Joshua M.] Johns Hopkins Univ, Ctr Adv Modeling, Baltimore, MD 21218 USA; [Sauer, Lauren M.] Johns Hopkins Sch Med, Dept Emergency Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Epstein, JM (corresponding author), Johns Hopkins Univ, Ctr Adv Modeling, Baltimore, MD 21218 USA.	jepste15@jhmi.edu	Hatna, Erez/D-9665-2015	Rothman, Richard/0000-0002-1017-9505				Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bellan SE, 2014, LANCET, V384, P1499, DOI 10.1016/S0140-6736(14)61839-0; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; USAID, 2011, COMM HLTH WORK ASS I; World Health Organization, 2014, EB RESP ROADM SIT RE	6	9	10	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					323	325		10.1038/516323a	http://dx.doi.org/10.1038/516323a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW8BE	25519116	Bronze			2022-12-28	WOS:000346484800022
J	Howard, LM; Megnin-Viggars, O; Symington, I; Pilling, S				Howard, Louise M.; Megnin-Viggars, Odette; Symington, Iona; Pilling, Stephen		Guideline Dev Grp	GUIDELINES Antenatal and postnatal mental health: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISORDERS; DEPRESSION; PERIOD; WOMEN		[Howard, Louise M.] Kings Coll London, Hlth Serv & Populat Res Dept, Sect Womens Mental Hlth, London WC2R 2LS, England; [Megnin-Viggars, Odette] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London SW1X 8PG, England; [Symington, Iona; Pilling, Stephen] UCL, Ctr Outcomes Res & Effectiveness, London, England; [Symington, Iona; Pilling, Stephen] UCL, Natl Collaborating Ctr Mental Hlth, London, England	University of London; King's College London; University of London; University College London; University of London; University College London; University of London; University College London	Pilling, S (corresponding author), UCL, Ctr Outcomes Res & Effectiveness, London, England.	s.pilling@ucl.ac.uk	Howard, Louise/E-3495-2010	Howard, Louise/0000-0001-9942-744X; O'Mahen, Heather/0000-0003-3458-430X; Megnin-Viggars, Odette/0000-0002-2152-0721	Medical Research Council [MR/L010305/1] Funding Source: Medline; Department of Health [NIHR-RP-R3-12-011] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dolman C, 2013, ARCH WOMEN MENT HLTH, V16, P173, DOI 10.1007/s00737-013-0336-0; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9; Jones I, 2014, LANCET, V384, P1789, DOI 10.1016/S0140-6736(14)61278-2; Jones SC, 2014, ROYAL COLL PSYCH INT; National Institute for Health and Care Excellence, 2011, COMM MENT HLTH DIS I; National Institute for Health and Care Excellence, 2007, DRUG MIS OP DET; National Institute for Health and Care Excellence, 2007, ANT POSTN MENT HLTH; National Institute for Health and Care Excellence, 2011, ALC US DIS DIAGN ASS; National Institute for Health Care Management (NICE), 2015, ANT POSTN MENT HLTH; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Vesga-Lopez O, 2008, ARCH GEN PSYCHIAT, V65, P805, DOI 10.1001/archpsyc.65.7.805	16	54	54	1	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2014	349								g7394	10.1136/bmj.g7394	http://dx.doi.org/10.1136/bmj.g7394			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX3EE	25523903				2022-12-28	WOS:000346822400004
J	Razavi, A; Farboud, A; Skinner, R; Saw, K				Razavi, A.; Farboud, A.; Skinner, R.; Saw, K.			PRACTICE POINTER Acute nasal injury	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FRACTURE MANAGEMENT; EPIDEMIOLOGY; SECONDARY		[Razavi, A.; Farboud, A.; Saw, K.] Singleton Hosp, Swansea SA2 8QA, W Glam, Wales; [Skinner, R.] Bryntir Surg, Bargoed, Wales	Singleton Hospital	Razavi, A (corresponding author), Singleton Hosp, Swansea SA2 8QA, W Glam, Wales.	ahmedrazavi786@hotmail.co.uk						Agrawal N, 2007, J EVAL CLIN PRACT, V13, P295, DOI 10.1111/j.1365-2753.2006.00700.x; Bernal-Sprekelsen M, 2000, AM J RHINOL, V14, P257, DOI 10.2500/105065800779954473; Dingman RO, 1969, NOSE SURG FACIAL FRA; Foden N, 2013, INT J SURG, V11, P640; Fry H, 1967, Br J Plast Surg, V20, P146, DOI 10.1016/S0007-1226(67)80031-6; Jaber S, 2011, IRISH J MED SCI, V180, pS91; Joshi H, 2013, INT J SURG, V11, P633; Kelley BP., 2010, SEMIN PLAST SURG, V24, P339, DOI [10.1055/s-0030-1269763, DOI 10.1055/S-0030-1269763]; LOGAN M, 1994, CLIN RADIOL, V49, P192, DOI 10.1016/S0009-9260(05)81775-1; Miyajima Y, 2003, PRACTICA OTO RHINO L, V96, P955; MURRAY J A M, 1989, Facial Plastic Surgery, V6, P88, DOI 10.1055/s-2008-1064714; National Institute for Health and Care Excellence, 2014, HEAD INJ TRIAG ASS I; RENNER GJ, 1991, OTOLARYNG CLIN N AM, V24, P195; Rohrich RJ, 2000, PLAST RECONSTR SURG, V106, P266, DOI 10.1097/00006534-200008000-00003; Sharma S, 2012, CLIN OT C 14 BRIT AC, V37, P197; Trinidade A, 2013, J LARYNGOL OTOL, V127, P1084, DOI 10.1017/S0022215113002260; van Loosen J, 1988, Rhinology, V26, P161; Walker TWM, 2007, CLIN OTOLARYNGOL, V32, P361, DOI 10.1111/j.1749-4486.2007.01530.x	18	4	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2014	349								g6537	10.1136/bmj.g6537	http://dx.doi.org/10.1136/bmj.g6537			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX3EE	25523758				2022-12-28	WOS:000346822400001
J	[Anonymous]				[Anonymous]			Is Aspirin a Dangerous Drug? (Reprinted from vol 124, pg 777, 1944)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							HYPOPROTHROMBINEMIA											[Anonymous], 1940, J A M A, V115, P1199; Honigsberger M., 1943, BRIT MED J, V2, P57; Huebner CF, 1941, J BIOL CHEM, V138, P529; Link KP, 1943, J BIOL CHEM, V147, P463; Meyer OO, 1943, P SOC EXP BIOL MED, V53, P234, DOI 10.3181/00379727-53-14263; Shapiro S, 1943, P SOC EXP BIOL MED, V53, P251, DOI 10.3181/00379727-53-14270; 1944, JAMA, V124, P777	7	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2577	2577		10.1001/jama.2013.279902	http://dx.doi.org/10.1001/jama.2013.279902			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25514315				2022-12-28	WOS:000346346900028
J	Schattner, A				Schattner, Ami			Review: bDMARDs plus conventional synthetic DMARDs have greater efficacy than either alone in RA Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Hebrew Univ & Hadassah, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Schattner, A (corresponding author), Hebrew Univ & Hadassah, Jerusalem, Israel.		Schattner, Ami/ABI-1894-2020	Schattner, Ami/0000-0002-1413-8858				Aletaha D, 2008, ARTHRITIS RHEUM-US, V58, P2622, DOI 10.1002/art.23733; Engvall IL, 2013, RHEUMATOLOGY, V52, P733, DOI 10.1093/rheumatology/kes369; van Vollenhoven RF, 2012, LANCET, V379, P1712, DOI 10.1016/S0140-6736(12)60027-0; Wolfe F, 2007, ARTHRITIS RHEUM-US, V56, P2135, DOI 10.1002/art.22719	4	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12							JC8	10.7326/0003-4819-161-12-201412160-02008	http://dx.doi.org/10.7326/0003-4819-161-12-201412160-02008			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UW	25506880				2022-12-28	WOS:000347248400016
J	Hayes, J; Jackson, JL; McNutt, GM; Hertz, BJ; Ryan, JJ; Pawlikowski, SA				Hayes, John; Jackson, Jeffrey L.; McNutt, Gail M.; Hertz, Brian J.; Ryan, Jeffrey J.; Pawlikowski, Scott A.			Association Between Physician Time-Unlimited vs Time-Limited Internal Medicine Board Certification and Ambulatory Patient Care Quality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; OF-CARE; HEALTH-CARE; PREVENTION; METAANALYSIS; MAINTENANCE; OUTCOMES; DISEASE; SCORES	IMPORTANCE American Board of Internal Medicine (ABIM) initiatives encourage internists with time-unlimited certificates to recertify. However, there are limited data evaluating differences in performance between internists with time-limited or time-unlimited board certification. OBJECTIVE To determine whether there are differences in primary care quality between physicians holding time-limited or time-unlimited certification. DESIGN, SETTING, AND PARTICIPANTS Retrospective analysis of performance data from 1 year (2012-2013) at 4 Veterans Affairs (VA) medical centers. Participants were internists with time-limited (n = 71) or time-unlimited (n = 34) ABIM certification providing primary care to 68 213 patients. Median physician panel size was 610 patients (range, 19-1316), with no differences between groups (P = .90). MAIN OUTCOMES AND MEASURES Ten primary care performance measures: colorectal screening rates; diabetes with glycated hemoglobin (HbA(1c) level) less than 9.0%; diabetes with blood pressure less than 140/90 mmHg; diabetes with low-density lipoprotein cholesterol (LDL-C) level less than 100 mg/dL; hypertension with blood pressure less than 140/90 mmHg; thiazide diuretics used in multidrug hypertensive regimen; atherosclerotic coronary artery disease and LDL-C level less than 100 mg/dL; post-myocardial infarction use of aspirin; post-myocardial infarction use of beta-blockers; congestive heart failure (CHF) with use of angiotensin-converting enzyme (ACE) inhibitor. RESULTS After adjustment for practice site, panel size, years since certification, and clustering by physician, there were no differences in outcomes for patients cared for by internists with time-limited or time-unlimited certification for any performance measure: colorectal screening (odds ratio [OR], 0.95 [95% CI, 0.89-1.01]); diabetes with HbA1c level less than 9.0% (OR, 0.96 [95% CI, 0.74-1.2]); blood pressure control (OR, 0.99 [95% CI, 0.69-1.4]); LDL-C level less than 100 mg/dL (OR, 1.1 [95% CI, 0.79-1.5]); hypertension with blood pressure less than 140/90 mmHg (OR, 1.0 [95% CI, 0.92-1.2]); thiazide use (OR, 1.0 [95% CI, 0.8-1.3]); atherosclerotic coronary artery disease with LDL-C level less than 100 mg/dL (OR, 1.1 [95% CI, 0.75-1.7]); post-myocardial infarction use of aspirin (OR, 0.98 [95% CI, 0.58-1.68]) or beta-blockers (OR, 1.0 [95% CI, 0.57-1.9]); CHF with use of ACE inhibitor (OR, 0.98 [95% CI, 0.61-1.6]). CONCLUSIONS AND RELEVANCE Among internists providing primary care at 4 VA medical centers, there were no significant differences between those with time-limited ABIM certification and those with time-unlimited ABIM certification on 10 primary care performance measures. Additional research to examine the difference in patient outcomes among holders of time-limited and time-unlimited certificates in non-VA and nonacademic settings and the association with other ABIM goals may help clarify the potential benefit of Maintenance of Certification participation. Copyright 2014 American Medical Association. All rights reserved.	[Hayes, John] Clement J Zablocki VA Med Ctr, Milwaukee, WI 53295 USA; [Jackson, Jeffrey L.] Clement J Zablocki VA Med Ctr, GIM Sect, Milwaukee, WI 53295 USA; [McNutt, Gail M.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Hertz, Brian J.; Pawlikowski, Scott A.] Hines VA Med Ctr, Chicago, IL USA; [Ryan, Jeffrey J.] Jesse Brown VA Med Ctr, Chicago, IL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Hayes, J (corresponding author), Clement J Zablocki VA Med Ctr, 5000 W Natl Ave, Milwaukee, WI 53295 USA.	john.hayes3@va.gov	Jackson, Jeffrey/AAA-3519-2019	Jackson, Jeffrey/0000-0002-9820-5834				Abdulla J, 2006, EUR J HEART FAIL, V8, P90, DOI 10.1016/j.ejheart.2005.03.006; Abdulla J, 2006, EUR J HEART FAIL, V8, P522, DOI 10.1016/j.ejheart.2005.10.012; American Board of Internal Medicine (ABIM), FAQ 2014 PROGR CHANG; American Board of Internal Medicine (ABIM), 2014, RES PROGR PASS RAT 2; American Board of Internal Medicine (ABIM), MAINT CERT GUID; American Board of Medical Specialties (ABMS), 2014, THE VAL OF ABMS MOC; BERNER ES, 1993, ACAD MED, V68, P753, DOI 10.1097/00001888-199310000-00005; Buscemi D, 2013, J COMMUNITY HOSP INT, V2, DOI 10.3402/jchimp.v2i4.19753; Centor RM, 2014, ANN INTERN MED, V161, P226, DOI 10.7326/M14-1014; Chen J, 2006, J GEN INTERN MED, V21, P238, DOI 10.1111/j.1525-1497.2006.00326.x; Choo EH, 2014, HEART, V100, P492, DOI 10.1136/heartjnl-2013-305137; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Hennekens CH, 2002, AM J MANAG CARE, V8, pS691; Hess BJ, 2012, ACAD MED, V87, P157, DOI 10.1097/ACM.0b013e31823f3a57; Holmboe ES, 2008, ARCH INTERN MED, V168, P1396, DOI 10.1001/archinte.168.13.1396; Iglehart JK, 2012, NEW ENGL J MED, V367, P2543, DOI 10.1056/NEJMhpr1211043; Johnson DH, 2012, J ONCOL PRACT, V8, P203, DOI 10.1200/JOP.2011.000479; Lipner RS, 2006, ANN INTERN MED, V144, P29, DOI 10.7326/0003-4819-144-1-200601030-00007; National Committee for Quality Assurance (NCQA), HEDIS MEAS; Norcini JJ, 2000, ACAD MED, V75, P1193, DOI 10.1097/00001888-200012000-00016; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; Reid RO, 2010, ARCH INTERN MED, V170, P1442, DOI 10.1001/archinternmed.2010.307; Sharp LK, 2002, ACAD MED, V77, P534, DOI 10.1097/00001888-200206000-00011; Turchin A, 2008, CIRCULATION, V117, P623, DOI 10.1161/CIRCULATIONAHA.107.733949; Vrecer M, 2003, INT J CLIN PHARM TH, V41, P567; Wenghofer E, 2009, MED EDUC, V43, P1166, DOI 10.1111/j.1365-2923.2009.03534.x; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	28	32	32	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2358	2363		10.1001/jama.2014.13992	http://dx.doi.org/10.1001/jama.2014.13992			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YB	25490326				2022-12-28	WOS:000346345700010
J	Coombes, R				Coombes, Rebecca			New year brings new transparency for drug company payments to doctors in UK	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmj.com						Dyer C., 2014, BMJ-BRIT MED J, V349, pg4601; Dyer C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6197; Powrie-Smith A., ABPI SETS OUT DISCLO	3	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2015	350								g7748	10.1136/bmj.g7748	http://dx.doi.org/10.1136/bmj.g7748			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2ZG	25555824				2022-12-28	WOS:000365564700003
J	Ekstrom, MP; Abernethy, AP; Currow, DC				Ekstrom, Magnus P.; Abernethy, Amy P.; Currow, David C.			The management of chronic breathlessness in patients with advanced and terminal illness	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHRONIC HEART-FAILURE; CHRONIC DYSPNEA; DOUBLE-BLIND; OPIOIDS; PREVALENCE; INTENSITY; MORPHINE; RELIEF; OXYGEN; LIFE		[Ekstrom, Magnus P.] Lund Univ, Div Resp Med & Allergol, Dept Clin Sci, Lund, Sweden; [Ekstrom, Magnus P.; Currow, David C.] Flinders Univ S Australia, Discipline Palliat & Support Serv, Adelaide, SA 5001, Australia; [Abernethy, Amy P.] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27710 USA	Lund University; Flinders University South Australia; Duke University	Ekstrom, MP (corresponding author), Blekinge Hosp, Dept Med, Resp Unit, Karlskrona, Sweden.	pmekstrom@gmail.com		Currow, David/0000-0003-1988-1250	Mundipharma; National Institute of Nursing Research; National Cancer Institute; Agency for Healthcare Research and Quality; DARA; Glaxo Smith Kline; Celgene; Helsinn; Dendreon; Pfizer; Genentech; Bristol Myers Squibb; Insys; Kanglaite; American Academy of Hospice & Palliative Medicine	Mundipharma; National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); DARA; Glaxo Smith Kline(GlaxoSmithKline); Celgene(Bristol-Myers SquibbCelgene Corporation); Helsinn; Dendreon; Pfizer(Pfizer); Genentech(Roche HoldingGenentech); Bristol Myers Squibb(Bristol-Myers Squibb); Insys; Kanglaite; American Academy of Hospice & Palliative Medicine	We have read and understood the BMJ policy on declaration of interests and declare the following interests: DCC is on the clinical trials advisory board for Helsinn Pharmaceuticals, is a clinical trials consultant for MaynePharma, and has received research funding from Mundipharma. APA is on the scientific advisory boards for Bristol-Myers Squibb, is a consultant for Bristol-Myers Squibb, Novartis, and Pfizer, has received research funding from National Institute of Nursing Research, National Cancer Institute, Agency for Healthcare Research and Quality, DARA, Glaxo Smith Kline, Celgene, Helsinn, Dendreon, and Pfizer and is due to receive research funding from Genentech, Bristol Myers Squibb, Insys, and Kanglaite. APA has a paid leadership role with American Academy of Hospice & Palliative Medicine (president) and corporate leadership responsibility in Athena Health (health IT company), Advoset (an education company that has a contract with Novartis), and Orange Leaf Associates LLC (an IT development company).	Abernethy AP, 2010, LANCET, V376, P784, DOI 10.1016/S0140-6736(10)61115-4; Abernethy AP, 2003, BRIT MED J, V327, P523, DOI 10.1136/bmj.327.7414.523; Bausewein Claudia, 2010, BMC Palliat Care, V9, P22, DOI 10.1186/1472-684X-9-22; Bolton CE, 2013, THORAX, V68, pii1, DOI 10.1136/thoraxjnl-2013-203808; Campbell ML, 2013, J PAIN SYMPTOM MANAG, V45, P517, DOI 10.1016/j.jpainsymman.2012.02.012; Campbell ML, 2010, J PALLIAT MED, V13, P285, DOI 10.1089/jpm.2009.0229; Carone M, 2007, RESP MED, V101, P2447, DOI 10.1016/j.rmed.2007.07.016; Currow DC, 2011, J PAIN SYMPTOM MANAG, V42, P388, DOI 10.1016/j.jpainsymman.2010.11.021; Currow DC, 2010, J PAIN SYMPTOM MANAG, V39, P680, DOI 10.1016/j.jpainsymman.2009.09.017; Currow DC, 2009, J PAIN SYMPTOM MANAG, V38, P533, DOI 10.1016/j.jpainsymman.2009.01.006; Ekstrom MP, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g445; Higginson IJ, 2014, LANCET RESP MED; Jennings AL, 2002, THORAX, V57, P939, DOI 10.1136/thorax.57.11.939; Johnson MJ, 2013, J PAIN SYMPTOM MANAG, V46, P957, DOI 10.1016/j.jpainsymman.2013.01.011; Johnson MJ, 2013, EUR RESPIR J, V42, P758, DOI 10.1183/09031936.00139812; Johnson MJ, 2002, EUR J HEART FAIL, V4, P753, DOI 10.1016/S1388-9842(02)00158-7; Lecasse Y, 2006, COCHRANE DB SYST REV; Mahler DA, 2013, CHEST, V143, P1378, DOI 10.1378/chest.12-1541; Moens K, 2014, J PAIN SYMPTOM MANAG, V48, P660, DOI 10.1016/j.jpainsymman.2013.11.009; Nava S, 2013, LANCET ONCOL, V14, P219, DOI 10.1016/S1470-2045(13)70009-3; Nishimura K, 2002, CHEST, V121, P1434, DOI 10.1378/chest.121.5.1434; Oxberry SG, 2011, EUR J HEART FAIL, V13, P1006, DOI 10.1093/eurjhf/hfr068; Pedersen F, 2007, INT J CLIN PRACT, V61, P1481, DOI 10.1111/j.1742-1241.2007.01428.x; Pratter MR, 2011, RESP MED, V105, P1014, DOI 10.1016/j.rmed.2010.12.009; PRATTER MR, 1989, ARCH INTERN MED, V149, P2277, DOI 10.1001/archinte.149.10.2277; Schwartzstein RM, 2010, MURRAY NADELS TXB RE; Simon ST, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007354.pub2; Struik FM, 2013, COCHRANE DB SYST REV, V6; Uronis H, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006429.pub2	29	53	53	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2015	349								g7617	10.1136/bmj.g7617	http://dx.doi.org/10.1136/bmj.g7617			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2ZF	25556037	Green Published			2022-12-28	WOS:000365564600002
J	Tippmann, S				Tippmann, Sylvia			PROGRAMMING TOOLS: ADVENTURES WITH R	NATURE			English	Editorial Material																			0	128	131	3	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					109	110		10.1038/517109a	http://dx.doi.org/10.1038/517109a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25557714	Bronze			2022-12-28	WOS:000347178400045
J	Wiegersma, M; Panman, CMCR; Kollen, BJ; Berger, MY; Lisman-Van Leeuwen, Y; Dekker, JH				Wiegersma, Marian; Panman, Chantal M. C. R.; Kollen, Boudewijn J.; Berger, Marjolein Y.; Lisman-Van Leeuwen, Yvonne; Dekker, Janny H.			Effect of pelvic floor muscle training compared with watchful waiting in older women with symptomatic mild pelvic organ prolapse: randomised controlled trial in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SHORT-FORM; BASE-LINE; TERMINOLOGY; DISORDERS; STANDARDIZATION; PREVALENCE; MANAGEMENT; PFDI-20	Objective To compare the effects of pelvic floor muscle training and watchful waiting on pelvic floor symptoms in a primary care population of women aged 55 years and over with symptomatic mild pelvic organ prolapse. Design Randomised controlled trial. Setting Dutch primary care. Participants Women aged 55 years or over with symptomatic mild prolapse (leading edge above the hymen) were identified by screening. Exclusion criteria were current prolapse treatment or treatment in the previous year, malignancy of pelvic organs, current treatment for another gynaecological disorder, severe/terminal illness, impaired mobility, cognitive impairment, and insufficient command of the Dutch language. Interventions Pelvic floor muscle training versus watchful waiting. Main outcome measures The primary outcome was change in bladder, bowel, and pelvic floor symptoms measured with the Pelvic Floor Distress Inventory-20 (PFDI-20), three months after the start of treatment. Secondary outcomes were changes in condition specific and general quality of life, sexual function, degree of prolapse, pelvic floor muscle function, and patients' perceived change in symptoms. Results Of the 287 women who were randomised to pelvic floor muscle training (n= 145) or watchful waiting (n= 142), 250 (87%) completed follow-up. Participants in the intervention group improved by (on average) 9.1 (95% confidence interval 2.8 to 15.4) points more on the PFDI-20 than did participants in the watchful waiting group (P= 0.005). Of women in the pelvic floor muscle training group, 57% (82/145) reported an improvement in overall symptoms from the start of the study compared with 1(% (18/142) in the watchful waiting group (P< 0.001). Other secondary outcomes showed no significant difference between the groups. Conclusions Although pelvic floor muscle training led to a significantly greater improvement in PFDI-20 score, the difference between the groups was below the presumed level of clinical relevance (15 points). Nevertheless, 57% of the participants in the intervention group reported an improvement of overall symptoms. More studies are needed to identify factors related to success of pelvic floor muscle training and to investigate long term effects.	[Wiegersma, Marian; Panman, Chantal M. C. R.; Kollen, Boudewijn J.; Berger, Marjolein Y.; Lisman-Van Leeuwen, Yvonne; Dekker, Janny H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, NL-9700 AD Groningen, Netherlands	University of Groningen	Dekker, JH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, FA21,POB 196, NL-9700 AD Groningen, Netherlands.	j.h.dekker@umcg.nl		Lisman-van Leeuwen, Yvonne/0000-0003-4126-526X; Dekker, Janny/0000-0001-5005-9324	Netherlands Organization for Health Research and Development (ZonMw) [4201.1001]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This trial is funded by the Netherlands Organization for Health Research and Development (ZonMw), project number 4201.1001. The funder played no role in the study design; in the collection, analysis, and interpretation of data; or in the writing of the report and the decision to submit the article for publication. All researchers were independent from funders.	Barber MD, 2005, AM J OBSTET GYNECOL, V193, P103, DOI 10.1016/j.ajog.2004.12.025; Bo K, 2006, ACTA OBSTET GYN SCAN, V85, P263, DOI 10.1080/00016340500486800; Braekken IH, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.037; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Burrows LJ, 2004, OBSTET GYNECOL, V104, P982, DOI 10.1097/01.AOG.0000142708.61298.be; Culligan PJ, 2010, INT UROGYNECOL J, V21, P401, DOI 10.1007/s00192-009-1046-z; de Boer TA, 2010, NEUROUROL URODYNAM, V29, P30, DOI 10.1002/nau.20858; Gelhorn HL, 2012, FEMALE PELVIC MED RE, V18, P221, DOI 10.1097/SPV.0b013e31825e6707; Ghroubi S., 2008, Annales de Readaptation et de Medecine Physique, V51, P96, DOI 10.1016/j.annrmp.2007.11.002; Gutman RE, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.028; Hagen S, 2010, NEUROUROL URODYNAM, V29, P1055; Hagen S, 2014, LANCET, V383, P796, DOI 10.1016/S0140-6736(13)61977-7; Hagen S, 2009, INT UROGYNECOL J, V20, P45, DOI 10.1007/s00192-008-0726-4; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; Kashyap R, 2013, INT J GYNECOL OBSTET, V121, P69, DOI 10.1016/j.ijgo.2012.11.012; Messelink B, 2005, NEUROUROL URODYNAM, V24, P374, DOI 10.1002/nau.20144; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Piya-Anant Manee, 2003, Journal of the Medical Association of Thailand, V86, P509; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Rogers RG, 2003, INT UROGYNECOL J PEL, V14, P164, DOI 10.1007/s00192-003-1063-2; Romanzi LJ, 1999, J UROLOGY, V161, P581, DOI 10.1016/S0022-5347(01)61957-8; Slieker-ten Hove MCP, 2009, INT UROGYNECOL J, V20, P1037, DOI 10.1007/s00192-009-0902-1; Smith Phillip P, 2005, Curr Urol Rep, V6, P340, DOI 10.1007/s11934-005-0050-1; Stupp L, 2011, INT UROGYNECOL J, V22, P1233, DOI 10.1007/s00192-011-1428-x; Swift S, 2005, AM J OBSTET GYNECOL, V192, P795, DOI 10.1016/j.ajog.2004.10.602; Thakar R, 2002, BRIT MED J, V324, P1258, DOI 10.1136/bmj.324.7348.1258; Utomo E, 2014, INT UROGYNECOL J, V25, P531, DOI 10.1007/s00192-013-2263-z; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Ware J. E. J., 2002, SCORE VERSION 2 SF 1; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wiegersma M, 2014, MATURITAS, V77, P168, DOI 10.1016/j.maturitas.2013.10.014; Wu JM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.046	32	48	50	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2014	349								g7378	10.1136/bmj.g7378	http://dx.doi.org/10.1136/bmj.g7378			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY2UG	25533442	Green Published, hybrid			2022-12-28	WOS:000347443900001
J	Fletcher, R				Fletcher, Robert			Invitation for flexible sigmoidoscopy screening reduced colorectal cancer and colorectal cancer mortality Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02138 USA	Harvard University; Harvard Medical School	Fletcher, R (corresponding author), Harvard Univ, Sch Med, Boston, MA 02138 USA.							Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Klabunde CN, 2013, MMWR-MORBID MORTAL W, V62, P881; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284	4	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12							JC2	10.7326/0003-4819-161-12-201412160-02002	http://dx.doi.org/10.7326/0003-4819-161-12-201412160-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UW	25506874				2022-12-28	WOS:000347248400004
J	Oelsner, EC; Hoffman, EA; Folsom, AR; Carr, JJ; Enright, PL; Kawut, SM; Kronmal, R; Lederer, D; Lima, JAC; Lovasi, GS; Shea, S; Barr, RG				Oelsner, Elizabeth C.; Hoffman, Eric A.; Folsom, Aaron R.; Carr, J. Jeffrey; Enright, Paul L.; Kawut, Steven M.; Kronmal, Richard; Lederer, David; Lima, Joao A. C.; Lovasi, Gina S.; Shea, Steven; Barr, R. Graham			Association Between Emphysema-like Lung on Cardiac Computed Tomography and Mortality in Persons Without Airflow Obstruction A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ATHEROSCLEROSIS MESA; CIGARETTE-SMOKING; PULMONARY-DISEASE; REFERENCE VALUES; NATIONAL-HEALTH; CT; QUANTIFICATION; POPULATION; CALCIUM; DENSITY	Background: Low lung function is known to predict mortality in the general population, but the prognostic significance of emphysema on computed tomography (CT) in persons without chronic obstructive pulmonary disease (COPD) is uncertain. Objective: To determine whether greater emphysema-like lung on CT is associated with all-cause mortality among persons in the general population without airflow obstruction or COPD. Design: Prospective cohort study. Setting: Population-based, multiethnic sample from 6 U.S. communities. Participants: 2965 participants aged 45 to 84 years without airflow obstruction on spirometry. Measurements: Emphysema-like lung was defined as the number of lung voxels with attenuation less than -950 Hounsfield units on cardiac CT and was adjusted for the number of total imaged lung voxels. Results: Among 2965 participants, 50.9% of whom had never smoked, there were 186 deaths over a median of 6.2 years. Greater emphysema-like lung was independently associated with increased mortality (adjusted hazard ratio per one-half interquartile range, 1.14 [95% CI, 1.04 to 1.24]; P = 0.004) after adjustment for potential confounders, including cardiovascular risk factors and FEV1. Generalized additive models supported a linear association between emphysema-like lung and mortality without evidence for a threshold. The association was of greatest magnitude among smokers, although multiplicative interaction terms did not support effect modification by smoking status. Limitations: Cardiac CT scans did not include lung apices. The number of deaths was limited among subgroup analyses. Conclusion: Emphysema-like lung on CT was associated with all-cause mortality among persons without airflow obstruction or COPD in a general population sample, particularly among smokers. Recognition of the independent prognostic significance of emphysema on CT among patients without COPD on spirometry is warranted.	Columbia Univ, New York, NY 10032 USA; Univ Iowa, Iowa City, IA USA; Univ Minnesota, Minneapolis, MN USA; Wake Forest Univ, Winston Salem, NC 27109 USA; Univ Arizona, Tucson, AZ USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Washington, Seattle, WA 98195 USA; Johns Hopkins Univ, Baltimore, MD USA	Columbia University; University of Iowa; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; University of Arizona; University of Pennsylvania; University of Washington; University of Washington Seattle; Johns Hopkins University	Oelsner, EC (corresponding author), Columbia Univ, Med Ctr, 630 West 168th St,PH 9 East Room 105, New York, NY 10032 USA.	eco7@cumc.columbia.edu	Carr, John Jeffrey/A-1938-2012; Lovasi, Gina/C-2781-2009; Carr, John/AAN-7531-2021; Lederer, David/W-7957-2018	Carr, John Jeffrey/0000-0002-4398-8237; Lovasi, Gina/0000-0003-2613-9599; Carr, John/0000-0002-4398-8237; Lederer, David/0000-0001-5258-0228; Hoffman, Eric/0000-0001-8456-9437	NHLBI; NHLBI [R01-HL077612, RC1-100543, R01-93081];  [N01-HC-95159];  [N01-HC-95169];  [UL1-RR-024156];  [UL1-RR-025005]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095166, N01HC095165, N01HC095164, N01HC095163, N01HC095162, N01HC095167, N01HC095169, N01HC095159, N01HC095161, N01HC095168, N01HC095160] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156, UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL103844, R01HL103676, R01HL093081, RC1HL100543, R44HL095169, R43HL095169, R01HL077612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	MESA is supported by the NHLBI and was designed and conducted by the MESA investigators in collaboration with NHLBI staff. Support for MESA is provided by contracts N01-HC-95159 through N01-HC-95169, UL1-RR-024156, and UL1-RR-025005. The MESA Lung Study is funded by R01-HL077612, RC1-100543, and R01-93081 from the NHLBI.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; ANDERSON AE, 1964, SCIENCE, V144, P1025, DOI 10.1126/science.144.3621.1025; Ashraf H, 2011, THORAX, V66, P55, DOI 10.1136/thx.2009.132688; AUERBACH O, 1972, NEW ENGL J MED, V286, P853, DOI 10.1056/NEJM197204202861601; Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Bates J., 2005, PHYSL BASIS RESP DIS, P623; Beasley V, 2012, INT J CHRONIC OBSTR, V7, P555, DOI 10.2147/COPD.S28286; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Burt JR, 2008, ARCH INTERN MED, V168, P756, DOI 10.1001/archinte.168.7.756; Camp PG, 2009, CHEST, V136, P1480, DOI 10.1378/chest.09-0676; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Castaldi PJ, 2013, AM J RESP CRIT CARE, V188, P1083, DOI 10.1164/rccm.201305-0873OC; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chong J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009157.pub2; Copley SJ, 2002, RADIOLOGY, V223, P812, DOI 10.1148/radiol.2233010760; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; D'Anna SE, 2012, RESPIRATION, V83, P383, DOI 10.1159/000329871; Dawkins PA, 2003, THORAX, V58, P1020, DOI 10.1136/thorax.58.12.1020; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; deGoma EM, 2012, ATHEROSCLEROSIS, V224, P274, DOI 10.1016/j.atherosclerosis.2012.07.017; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Dirksen A, 2013, AM J RESP CRIT CARE, V188, P1045, DOI 10.1164/rccm.201309-1649ED; Dransfield MT, 2007, CHEST, V132, P464, DOI 10.1378/chest.07-0863; Estepar RSJ, 2013, AM J RESP CRIT CARE, V188, P231, DOI 10.1164/rccm.201301-0162OC; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Guo J, 2002, 2002 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING, PROCEEDINGS, P871, DOI 10.1109/ISBI.2002.1029398; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Hoffman EA, 2003, ACAD RADIOL, V10, P1104, DOI 10.1016/S1076-6332(03)00330-1; Hoffman EA, 2009, ACAD RADIOL, V16, P689, DOI 10.1016/j.acra.2008.12.024; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Johannessen A, 2013, AM J RESP CRIT CARE, V187, P602, DOI 10.1164/rccm.201209-1722OC; Karner C, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009285.pub2, 10.1002/14651858.CD009285.pub3]; Karner C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008989.pub2; Lederer DJ, 2009, AM J RESP CRIT CARE, V180, P407, DOI 10.1164/rccm.200812-1966OC; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manichaikul A, 2014, AM J RESP CRIT CARE, V189, P408, DOI 10.1164/rccm.201306-1061OC; Mannino DM, 2012, CHEST, V141, P73, DOI 10.1378/chest.11-0797; Mannino DM, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-136; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; Marsh SE, 2008, THORAX, V63, P761, DOI 10.1136/thx.2007.089193; Martin C, 2013, INT J CHRONIC OBSTR, V8, P7, DOI 10.2147/COPD.S28290; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; Mascalchi M, 2012, ACTA RADIOL, V53, P53, DOI 10.1258/ar.2011.110419; McAllister DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093221; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Minino Arialdi M, 2011, Natl Vital Stat Rep, V59, P1; Newell JD, 2013, J THORAC IMAG, V28, P266, DOI 10.1097/RTI.0b013e31829f6796; Powell R, 2013, THORAX, V68, P634, DOI 10.1136/thoraxjnl-2012-202116; R Core Team, 2012, R LANG ENV STAT COMP; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; SAETTA M, 1994, EUR RESPIR J, V7, P1505, DOI 10.1183/09031936.94.07081505; Smith BM, 2014, AM J MED, V127, DOI 10.1016/j.amjmed.2013.09.020; Smith NL, 1999, J CLIN EPIDEMIOL, V52, P143, DOI 10.1016/S0895-4356(98)00141-3; Sverzellati N, 2012, RADIOLOGY, V262, P460, DOI 10.1148/radiol.11110364; Tilert T, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-103; Tsushima K, 2010, COPD, V7, P117, DOI 10.3109/15412551003631717; US Preventive Serv Task Force, 2008, ANN INTERN MED, V148, P529, DOI 10.7326/0003-4819-148-7-200804010-00212; Yang IA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002991.pub3; Yokohori N, 2004, CHEST, V125, P626, DOI 10.1378/chest.125.2.626; Zulueta JJ, 2012, CHEST, V141, P1216, DOI 10.1378/chest.11-0101	64	62	62	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12					863	U54		10.7326/M13-2570	http://dx.doi.org/10.7326/M13-2570			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UW	25506855	Green Accepted			2022-12-28	WOS:000347248400028
J	Pottegard, A; Haastrup, MB; Stage, TB; Hansen, MR; Larsen, KS; Meegaard, PM; Meegaard, LHV; Horneberg, H; Gils, C; Dideriksen, D; Aagaard, LS; Almarsdottir, AB; Hallas, J; Damkier, P				Pottegard, Anton; Haastrup, Maija Bruun; Stage, Tore Bjerregaard; Hansen, Morten Rix; Larsen, Kasper Soltoft; Meegaard, Peter Martin; Meegaard, Line Haugaard Vrdlovec; Horneberg, Henrik; Gils, Charlotte; Dideriksen, Dorthe; Aagaard, Li Se; Almarsdottir, Anna Birna; Hallas, Jesper; Damkier, Per			CHRISTMAS 2014: FOUND IN TRANSLATION SearCh for humourIstic and Extravagant acroNyms and Thoroughly Inappropriate names For Important Clinical trials (SCIENTIFIC): qualitative and quantitative systematic study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICINE; IMPACT	Objectives To describe the development of acronym use across five major medical specialties and to evaluate the technical and aesthetic quality of the acronyms. Design Acronyms obtained through a literature search of Pubmed.gov followed by a standardised assessment of acronym quality (BEAUTY and CHEATING criteria). Participants Randomised controlled trials within psychiatry, rheumatology, pulmonary medicine, endocrinology, and cardiology published between 2000 and 2012. Main outcome measures Prevalence proportion of acronyms and composite quality score for acronyms over time. Results 14 965 publications were identified, of which 18.3% (n=2737) contained an acronym in the title. Acronym use was more common among cardiological studies than among the other four medical specialties (40% v 8-15% in 2012, P<0.001). Except for within cardiology, the prevalence of acronyms increased over time, with the average prevalence proportion among the remaining four specialties increasing from 4.0% to 12.4% from 2000 to 2012 (P<0.001). The median combined acronym quality score decreased significantly over the study period (P<0.001), from a median 9.25 in 2000 to 5.50 in 2012. Conclusion From 2000 to 2012 the prevalence of acronyms in trial reports increased, coinciding with a substantial decrease in the technical and aesthetic quality of the acronyms. Strict enforcement of current guidelines on acronym construction by journal editors is necessary to ensure the proper use of acronyms in the future.	[Pottegard, Anton; Stage, Tore Bjerregaard; Hansen, Morten Rix; Larsen, Kasper Soltoft; Horneberg, Henrik; Aagaard, Li Se; Almarsdottir, Anna Birna; Hallas, Jesper; Damkier, Per] Univ Southern Denmark, Inst Publ Hlth, DK-5000 Odense C, Denmark; [Haastrup, Maija Bruun; Gils, Charlotte; Dideriksen, Dorthe; Almarsdottir, Anna Birna; Hallas, Jesper; Damkier, Per] Odense Univ Hosp, Dept Clin Chem & Pharmacol, DK-5000 Odense C, Denmark; [Meegaard, Peter Martin] Rigshosp, Clin Pharmaceut Serv, DK-2100 Copenhagen, Denmark; [Meegaard, Line Haugaard Vrdlovec] Nordsjaellands Hosp, Clin Pharmaceut Serv, Hillerod, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen	Pottegard, A (corresponding author), Univ Southern Denmark, Inst Publ Hlth, DK-5000 Odense C, Denmark.	apottegaard@health.sdu.dk	Aagaard, Lise/AAV-3273-2021; hansen, morten rix/P-8961-2019; Damkier, Per/P-8217-2019; Almarsdottir, Anna Birna/R-5299-2017	hansen, morten rix/0000-0002-1582-7866; Damkier, Per/0000-0003-0591-7187; Almarsdottir, Anna Birna/0000-0002-5354-2976; Soltoft, Kasper/0000-0002-1111-8050; Pottegard, Anton/0000-0001-9314-5679; Haastrup, Maija Bruun/0000-0002-1776-4846; Stage, Tore Bjerregaard/0000-0002-4698-4389; Gils, Charlotte/0000-0002-7378-3718				Berkwits M, 2000, ANN INTERN MED, V133, P755, DOI 10.7326/0003-4819-133-9-200011070-00039; Berlin L, 2013, RADIOLOGY, V266, P383, DOI 10.1148/radiol.12121776; Bhattacharjee Y, 2011, SCIENCE, V334, P1344, DOI 10.1126/science.334.6061.1344; CHENG TO, 1994, BRIT MED J, V309, P683, DOI 10.1136/bmj.309.6956.683; CHENG TO, 1994, EUR HEART J, V15, P720, DOI 10.1093/oxfordjournals.eurheartj.a060578; Cheng TO, 1997, AM J HYPERTENS, V10, P141; Cheng TO, 2000, CATHETER CARDIO INTE, V49, P478, DOI 10.1002/(SICI)1522-726X(200004)49:4<478::AID-CCD29>3.3.CO;2-G; Cheng TO, 2010, INT J CARDIOL, V144, P291, DOI 10.1016/j.ijcard.2009.02.014; Cheng TO, 2009, INT J CARDIOL, V137, P289, DOI 10.1016/j.ijcard.2008.05.056; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Falagas ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049476; Fred HL, 2003, TEX HEART I J, V30, P255; Isles AF, 2014, J PAEDIAT CHILD HLTH; Laszlo S, 2007, PSYCHON B REV, V14, P1158, DOI 10.3758/BF03193106; Macchia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032894; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; Murphy EJ, 2011, LIPIDS, V46, P307, DOI 10.1007/s11745-011-3543-3; Nishijima DK, 2014, ACAD MED, V89, P176, DOI 10.1097/ACM.0000000000000073; Oransky I, 2006, HALT HELP ACRONYMS L; Orlowski JP, 2002, CHEST, V121, P2023, DOI 10.1378/chest.121.6.2023; Playfoot D, 2013, Q J EXP PSYCHOL, V66, P1131, DOI 10.1080/17470218.2012.731073; Stanbrook MB, 2006, NEW ENGL J MED, V355, P101, DOI 10.1056/NEJMc053420; Svider PF, 2013, LARYNGOSCOPE, V123, P118, DOI 10.1002/lary.23659; Thomson_Reuters, 2014, WEB KNOWL REAL FACTS; Uebersax J., 2014, INTRACLASS CORRELATI; Yue WP, 2007, J MED LIBR ASSOC, V95, P70	26	9	9	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2014	349								g7092	10.1136/bmj.g7092	http://dx.doi.org/10.1136/bmj.g7092			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HK	25516539	Green Published, hybrid			2022-12-28	WOS:000346763900001
J	Wilson, N; Clement, C; Summers, JA; Bannister, J; Harper, G				Wilson, Nick; Clement, Christine; Summers, Jennifer A.; Bannister, John; Harper, Glyn			CHRISTMAS 2014: IN LOVE AND WAR Mortality of first world war military personnel: comparison of two military cohorts	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFLUENZA	Objective To identify the impact of the first world war on the lifespan of participating military personnel (including in veterans who survived the war). Design Comparison of two cohorts of military personnel, followed to death. Setting Military personnel leaving New Zealand to participate in the first world war. Participants From a dataset of the New Zealand Expeditionary Forces, we randomly selected participants who embarked on troopships in 1914 and a comparison non-combat cohort who departed on troopships in late 1918 (350 in each group). Main outcome measures Lifespan based on dates of birth and death from a range of sources (such as individual military files and an official database of birth and death records). Results A quarter of the 1914 cohort died during the war, with deaths from injury predominating (94%) over deaths from disease (6%). This cohort had a significantly shorter lifespan than the late 1918 "non-combat" cohort, with median ages of death being 65.9 versus 74.2, respectively (a difference of 8.3 years shown also in Kaplan-Meier survival curves, log rank P<0.001). The difference for the lifespan of veterans in the postwar period was more modest, with median ages of death being 72.6 versus 74.3, respectively (a difference of 1.7 years, log rank P=0.043). There was no evidence for differences between the cohorts in terms of occupational class, based on occupation at enlistment. Conclusions Military personnel going to the first world war in 1914 from New Zealand lost around eight years of life (relative to a comparable military cohort). In the postwar period they continued to have an increased risk of premature death.	[Wilson, Nick] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Summers, Jennifer A.] Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England; [Bannister, John] Queen St Med Practice, Wairoa, New Zealand; [Harper, Glyn] Massey Univ, Palmerston North, New Zealand	University of Otago; University of London; King's College London; Massey University	Wilson, N (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, New Zealand.	nick.wilson@otago.ac.nz		Summers, Jennifer/0000-0002-3156-0479	University of Otago; Massey University; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London	University of Otago; Massey University; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London	This study received partial funding from the University of Otago and Massey University for purchase of death certificate data. JS was supported by the NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London.	[Anonymous], 1920, NZ MED J, V19, P245; Baker P., 1988, KING COUNTRY NZ CONS, P110; Births Deaths and Marriages New Zealand, 2012, BIRTHS DEATHS MARR H; Byerly CR, 2010, PUBLIC HEALTH REP, V125, P82; Carbery ARD, 1924, NZ MED SERVICE GREAT; Chisholm P., 1920, NZ MED J, V19, P222; Crawford J., 2007, NZ GREAT WAR NZ ALLI; Fenton Damien, 2013, NZ 1 WORLD WAR 1914; Harper G., 2007, DARK JOURNEY; Harper GJ, 2011, COMMUNICATION; Kinloch T., 2007, DEVILS HORSES; McLaughlin R, 2008, ANN EPIDEMIOL, V18, P928, DOI 10.1016/j.annepidem.2008.09.002; Ministry for Culture and Heritage, NZ 1 WORLD WAR; Olssen Erik, 2005, CLASS OCCUPATION NZ; Powles C. Guy, 1922, NZ SINAI PALESTINE; Shanks GD, 2009, MED J AUSTRALIA, V191, P654, DOI 10.5694/j.1326-5377.2009.tb03367.x; Statistics New Zealand, 2006, HIST SURV NZ COHORT; Stewart H., 1921, NZ DIVISION 1916 19; Waite Fred, 1921, NZ GALLIPOLI; Weaver JC, 2014, MCGILL QUEENS ASSOC, V40, P1; Wilson J, 2009, AM J EPIDEMIOL, V169, P1362, DOI 10.1093/aje/kwp044; Wilson N, 2013, NZ MED J, V126, P1; Wilson N, 2013, NEW ZEAL MED J, V126, P13; Wilson N, 2012, EMERG INFECT DIS, V18, P71, DOI 10.3201/eid1801.110035	24	9	9	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2014	349								g7168	10.1136/bmj.g7168	http://dx.doi.org/10.1136/bmj.g7168			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HK	25516379	Green Published, hybrid			2022-12-28	WOS:000346763900002
J	St John, PD; Montgomery, PR				St John, Philip D.; Montgomery, Patrick R.			CHRISTMAS 2014: ON THE WARDS, IN THE SURGERY Utility of Hippocrates' prognostic aphorism to predict death in the modern era: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INSTITUTIONALIZATION; MORTALITY; DEMENTIA; HEALTH	Objective To determine if one of Hippocrates' aphorisms, identifying good cognition and good appetite as two prognostic factors, predicts death in community living older adults in the modern era. Design Secondary analysis of an existing population based cohort study. Setting Manitoba Study of Health and Aging. Participants 1751 community living adults aged more than 65 enrolled in the Manitoba Study of Health and Aging in 1991 and followed over five years. Main outcome measure Time to death. Methods We recreated the hippocratic prognosticator using an item that measures appetite drawn from the Center for Epidemiologic Studies-depression subscale, and the mini-mental state examination, with a score of > 25 being considered as normal. People with normal cognition and appetite were compared with those with either poor cognition or poor appetite. We constructed Cox regression models, adjusted for age, sex, education, and functional status. Results The prognostic aphorism predicted death, with an unadjusted hazard ratio of 2.37 (95% confidence interval 1.93 to 2.88) and a hazard ratio of 1.71 (1.37 to 2.12) adjusted for age, sex, and education. Both poor appetite and poor cognition predicted death. The sensitivity and specificity were not, however, sufficient for the measure to be used alone. Conclusion An aphorism devised by Hippocrates millennia ago can predict death in the modern era.	[St John, Philip D.] Univ Manitoba, GE Hlth Sci Ctr 547, Sect Geriatr Med, Dept Med, Winnipeg, MB R3A 1R9, Canada; [St John, Philip D.] Univ Manitoba, GE Hlth Sci Ctr 547, Ctr Aging, Winnipeg, MB R3A 1R9, Canada; [Montgomery, Patrick R.] Vancouver Isl Hlth Author Geriatr Serv Mem Pavil, Victoria, BC, Canada	University of Manitoba; University of Manitoba; Vancouver Island Health Authority	St John, PD (corresponding author), Univ Manitoba, GE Hlth Sci Ctr 547, Sect Geriatr Med, Dept Med, 820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada.	pstjohn@hsc.mb.ca			Manitoba Health; National Health Research and Development Program of Health Canada	Manitoba Health; National Health Research and Development Program of Health Canada	The Manitoba Study of Health and Aging was funded primarily by Manitoba Health, with additional funding provided through the Canadian Study of Health and Aging by the seniors' independence research program of the National Health Research and Development Program of Health Canada. No endorsement from these agencies is implied. The sponsors had no role in the design, methods, subject recruitment, data collection, analysis, or preparation of the paper.	[Anonymous], 1994, CAN MED ASS J, V150, P899; Arnold J, 1962, LANCET, V280, P551; Brock A. J., 1929, GREEK MED; CHANDLER ET, 1987, SOUTHERN MED J, V80, P84, DOI 10.1097/00007611-198701000-00019; DACHEZ Roger, 2004, HIST MED ANTIQUITE 2; Donini LM, 2003, INT PSYCHOGERIATR, V15, P73, DOI 10.1017/S1041610203008779; Dubois MF, 2001, INT PSYCHOGERIATR, V13, P91, DOI 10.1017/S1041610202008025; Fillenbaum GG, 1988, MULTIDIMENSIONAL FUN; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Marketos SG, 1999, SPINE, V24, P1159, DOI 10.1097/00007632-199906010-00019; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; Porter R., 1997, GREATEST BENEFIT MAN; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Scholtz M, 1940, Cal West Med, V53, P35; St John PD, 2002, AGE AGEING, V31, P373, DOI 10.1093/ageing/31.5.373; Teng EL, 1987, PSYCHIATRY, V48, P314, DOI DOI 10.1093/GERONA/GLT064; Todd S, 2013, INT J GERIATR PSYCH, V28, P1109, DOI 10.1002/gps.3946; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013	18	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2014	349								g7390	10.1136/bmj.g7390	http://dx.doi.org/10.1136/bmj.g7390			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX2HD	25512328	Green Published, hybrid			2022-12-28	WOS:000346763200002
J	Verberne, BA; Plumper, O; de Winter, DAM; Spiers, CJ				Verberne, Berend A.; Plumper, Oliver; de Winter, D. A. Matthijs; Spiers, Christopher J.			Superplastic nanofibrous slip zones control seismogenic fault friction	SCIENCE			English	Article							ORIENTED ATTACHMENT; CALCITE; EARTHQUAKES; DIFFUSION; RECRYSTALLIZATION; SURFACES	Understanding the internal mechanisms controlling fault friction is crucial for understanding seismogenic slip on active faults. Displacement in such fault zones is frequently localized on highly reflective (mirrorlike) slip surfaces, coated with thin films of nanogranular fault rock. We show that mirror-slip surfaces developed in experimentally simulated calcite faults consist of aligned nanogranular chains or fibers that are ductile at room conditions. These microstructures and associated frictional data suggest a fault-slip mechanism resembling classical Ashby-Verrall superplasticity, capable of producing unstable fault slip. Diffusive mass transfer in nanocrystalline calcite gouge is shown to be fast enough for this mechanism to control seismogenesis in limestone terrains. With nanogranular fault surfaces becoming increasingly recognized in crustal faults, the proposed mechanism may be generally relevant to crustal seismogenesis.	[Verberne, Berend A.; Plumper, Oliver; Spiers, Christopher J.] Univ Utrecht, Dept Earth Sci, NL-3584 CD Utrecht, Netherlands; [de Winter, D. A. Matthijs] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University	Verberne, BA (corresponding author), Univ Utrecht, Dept Earth Sci, Budapestlaan 4, NL-3584 CD Utrecht, Netherlands.	b.a.verberne@uu.nl	de Winter, Matthijs/B-7858-2012; Verberne, Berend Antonie/L-9478-2018	Verberne, Berend Antonie/0000-0002-1208-6193; Plumper, Oliver/0000-0001-9726-0885; Spiers, Christopher/0000-0002-3436-8941; de Winter, Matthijs/0000-0002-6289-4359	Netherlands Research Centre for Integrated Solid Earth Sciences [2011-75]; Netherlands Organisation for Scientific Research (NWO) [863.13.006]; ISES [2011-74]	Netherlands Research Centre for Integrated Solid Earth Sciences; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ISES	We thank A. Niemeijer, J. Chen, V. Toy, and H. de Bresser. H. King is thanked for the AFM measurements and P. van Krieken for the thermogravimetric analysis. B.A.V. was supported by grant 2011-75, awarded by the Netherlands Research Centre for Integrated Solid Earth Sciences; O.P. by Veni grant 863.13.006, awarded by the Netherlands Organisation for Scientific Research (NWO); and D.A.M.D.W. by ISES grant 2011-74. NWO funded the FIB-SEM. All data are available in the supplementary materials.	ASHBY MF, 1973, ACTA METALL MATER, V21, P149, DOI 10.1016/0001-6160(73)90057-6; Chen XF, 2013, GEOLOGY, V41, P739, DOI 10.1130/G34169.1; Chester JS, 2005, NATURE, V437, P133, DOI 10.1038/nature03942; deLeeuw NH, 1997, J CHEM SOC FARADAY T, V93, P467, DOI 10.1039/a606573b; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; Evans JP, 2014, GEOLOGY, V42, P623, DOI 10.1130/G35617.1; Farver JR, 1996, CONTRIB MINERAL PETR, V123, P77, DOI 10.1007/s004100050144; Fondriest M, 2013, GEOLOGY, V41, P1175, DOI 10.1130/G34641.1; Gehrke N, 2005, CRYST GROWTH DES, V5, P1317, DOI 10.1021/cg050051d; Gratier JP, 2013, ADV GEOPHYS, V54, P47, DOI 10.1016/B978-0-12-380940-7.00002-0; Han R, 2011, GEOLOGY, V39, P599, DOI 10.1130/G31842.1; Kennedy LA, 2001, GEOLOGY, V29, P1027, DOI 10.1130/0091-7613(2001)029<1027:LTRICM>2.0.CO;2; Kirkpatrick JD, 2013, GEOLOGY, V41, P1015, DOI 10.1130/G34483.1; Ma KF, 2006, NATURE, V444, P473, DOI 10.1038/nature05253; Niemeijer AR, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB005008; Oohashi K, 2014, GEOLOGY, V42, P787, DOI 10.1130/G35703.1; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; Siman-Tov S, 2013, GEOLOGY, V41, P703, DOI 10.1130/G34087.1; Smith SAF, 2013, GEOLOGY, V41, P63, DOI 10.1130/G33588.1; Spiers C.J., 2004, PHYSICOCHEMISTRY WAT, P129; Tao NR, 2002, ACTA MATER, V50, P4603, DOI 10.1016/S1359-6454(02)00310-5; Tjong SC, 2004, MAT SCI ENG R, V45, P1, DOI 10.1016/j.mser.2004.07.001; Verberne BA, 2014, PURE APPL GEOPHYS, V171, P2617, DOI 10.1007/s00024-013-0760-0; Verberne BA, 2013, GEOLOGY, V41, P863, DOI 10.1130/G34279.1; Verberne BA, 2010, B SEISMOL SOC AM, V100, P2767, DOI 10.1785/0120090287; Wurschum R, 2003, ADV ENG MATER, V5, P365, DOI 10.1002/adem.200310079; Zhang HZ, 2014, CRYSTENGCOMM, V16, P1568, DOI 10.1039/c3ce41929k; Zhang XM, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB005853	29	90	94	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1342	1344		10.1126/science.1259003	http://dx.doi.org/10.1126/science.1259003			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504714				2022-12-28	WOS:000346189600044
J	Lucey, CR; Golub, RM				Lucey, Catherine R.; Golub, Robert M.			Value, Social Contracts, and Medical Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Lucey, Catherine R.] UCSF Sch Med, San Francisco, CA USA	University of California System; University of California San Francisco	Golub, RM (corresponding author), 330 N Wabash Ave, Chicago, IL 60611 USA.	robert.golub@jamanetwork.org						[Anonymous], CLER PATHWAYS TO EXC; Arrighi JA, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.15580, DOI 10.1001/JAMA]; Asch DA, 2009, JAMA-J AM MED ASSOC, V302, P1277, DOI 10.1001/jama.2009.1356; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Chen C, 2014, JAMA-J AM MED ASSOC, V312, P2385, DOI 10.1001/jama.2014.15973; Cohen JJ, 2006, JAMA-J AM MED ASSOC, V296, P1135, DOI 10.1001/jama.296.9.1135; Diamond L, 2014, JAMA-J AM MED ASSOC, V312, P2405, DOI 10.1001/jama.2014.15444; Fenn J, 2008, MASTERING THE HYPE C; Fletcher KE, 2011, J GEN INTERN MED, V26, P907, DOI 10.1007/s11606-011-1657-1; Gray BM, 2014, JAMA-J AM MED ASSOC, V312, P2348, DOI 10.1001/jama.2014.12716; Hayes J, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.13992, DOI 10.1001/JAMA.2014]; Institute of Medicine, 2014, GRADUATE MEDICAL EDU; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lee TH, 2014, JAMA-J AM MED ASSOC, V312, P2340, DOI 10.1001/jama.2014.13566; Patel MS, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.15273, DOI 10.1001/JAMA.2014]; Pitts SR, 2014, JAMA-J AM MED ASSOC, V312, P2394, DOI 10.1001/jama.2014.16172; Rajaram R, 2014, JAMA-J AM MED ASSOC, V312, P2374, DOI 10.1001/jama.2014.15277; Sirovich BE, 2014, JAMA INTERN MED, V174, P1640, DOI 10.1001/jamainternmed.2014.3337; Smith S, 2014, JAMA-J AM MED ASSOC, V312, P2407, DOI 10.1001/jama.2014.16066	19	1	1	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2345	2347		10.1001/jama.2014.15626	http://dx.doi.org/10.1001/jama.2014.15626			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YB	25490324				2022-12-28	WOS:000346345700008
J	Zabidi, MA; Arnold, CD; Schernhuber, K; Pagani, M; Rath, M; Frank, O; Stark, A				Zabidi, Muhammad A.; Arnold, Cosmas D.; Schernhuber, Katharina; Pagani, Michaela; Rath, Martina; Frank, Olga; Stark, Alexander			Enhancer-core-promoter specificity separates developmental and housekeeping gene regulation	NATURE			English	Article							DROSOPHILA EMBRYO; TRANSCRIPTION; ELEMENTS; EXPRESSION; MACHINERY; MOTIFS; TRF2; DPE	Gene transcription in animals involves the assembly of RNA polymerase II at core promoters and its cell-type-specific activation by enhancers that can be located more distally(1). However, how ubiquitom expression of housekeeping genes is achieved has been less dear. In particular, it is unknown whether ubiquitously active enhancers exist and how developmental and housekeeping gene regulation is separated. An attractive hypothesis is that different core promoters might exhibit an intrinsic specificity to certain enhancers'. This is conceivable, as various core promoter sequence elements are differentially distributed between genes of different functions', including elements that are predominantly found at either developmentally regulated or at housekeeping genes(2-6). Here we show that thousands of enhancers in Drosophila melanogaster S2 and ovarian somatic cells (OSCs) exhibit a marked specificity to one of two core promoters one derived from a ubiquitously expressed ribosomal protein gene and another from a developmentally regulated transcription factor and confirm the existence of these two classes for five additional core promoters from genes with diverse functions. Housekeeping enhancers are active across the two cell types, while developmental enhancers exhibit strong cell-type specificity. Both enhancer classes differ in their genomic distribution, the functions of neighbouring genes, and the core promoter elements of these neighbouring genes. In addition, we identify two transcription factots Dref and Tr that bind and activate housekeeping versus developmental enhancers, respectively. Our results provide evidence for a sequence-encoded enhancer-core-promoter specificity that separates developmental and housekeeping gene regulatory programs for thousands of enhancers and their target genes across the entire genome.	[Zabidi, Muhammad A.; Arnold, Cosmas D.; Schernhuber, Katharina; Pagani, Michaela; Rath, Martina; Frank, Olga; Stark, Alexander] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Stark, A (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	stark@starklab.org	Stark, Alexander/D-1473-2012	Stark, Alexander/0000-0003-2611-0841	Austrian Science Fund (FWF) [F4303-B09]; European Research Council [242922]; Boehringer Ingelheim GmbH	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); Boehringer Ingelheim GmbH(Boehringer Ingelheim)	We thank L. Cochella and O. Bell for comments on the manuscript. Deep sequencing was performed at the CSF Next-Generation Sequencing Unit (http://csf.ac.at). M.A.Z. was supported by the Austrian Science Fund (FWF, F4303-B09) and C.D.A., K.S., M.R. and O.F. by a European Research Council Starting Grant (no. 242922) awarded to A.S. Basic research at the Research Institute of Molecular Pathology is supported by Boehringer Ingelheim GmbH.	Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; FitzGerald PC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r53; Gurudatta BV, 2013, CELL CYCLE, V12, P1605, DOI 10.4161/cc.24742; Hochheimer A, 2002, NATURE, V420, P439, DOI 10.1038/nature01167; Isogai Y, 2007, GENE DEV, V21, P2936, DOI 10.1101/gad.1608807; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; LI XL, 1994, EMBO J, V13, P400, DOI 10.1002/j.1460-2075.1994.tb06274.x; Merli C, 1996, GENE DEV, V10, P1260, DOI 10.1101/gad.10.10.1260; modENCODE Consortium, 2010, SCIENCE, V330, P1787; Ohler U., 2002, GENOME BIOL, V3; Ohler U, 2010, DEVELOPMENT, V137, P15, DOI 10.1242/dev.035493; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; Parry TJ, 2010, GENE DEV, V24, P2013, DOI 10.1101/gad.1951110; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Sharpe J, 1998, EMBO J, V17, P1788, DOI 10.1093/emboj/17.6.1788; Shlyueva D, 2014, MOL CELL, V54, P180, DOI 10.1016/j.molcel.2014.02.026; SMITH D, 1993, GENETICS, V135, P1063; van Arensbergen J., 2014, TRENDS CELL BIOL; Wang YL, 2014, GENE DEV, V28, P1550, DOI 10.1101/gad.245662.114; Yanez-Cuna JO, 2014, GENOME RES, V24, P1147, DOI 10.1101/gr.169243.113; Yanez-Cuna JO, 2012, GENOME RES, V22, P2018, DOI 10.1101/gr.132811.111	30	242	244	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					556	559		10.1038/nature13994	http://dx.doi.org/10.1038/nature13994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25517091	Green Accepted			2022-12-28	WOS:000350097300051
J	Halpern, SD; Emanuel, EJ				Halpern, Scott D.; Emanuel, Ezekiel J.			Ethical Guidance on the Use of Life-Sustaining Therapies for Patients With Ebola in Developed Countries	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Penn, Leonard Davis Inst Hlth Econ, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Halpern, SD (corresponding author), Univ Penn, 719 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	shalpern@exchange.upenn.edu						EMANUEL EJ, 1988, NEW ENGL J MED, V318, P1686, DOI 10.1056/NEJM198806233182511; Fowler RA, 2014, AM J RESP CRIT CARE, V190, P733, DOI 10.1164/rccm.201408-1514CP; Halpern SD, 2007, NEW ENGL J MED, V357, P1340, DOI 10.1056/NEJMsb071595; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Young MJ, 2012, CRIT CARE MED, V40, P261, DOI 10.1097/CCM.0b013e31822d750d	5	7	7	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4					304	305		10.7326/M14-2611	http://dx.doi.org/10.7326/M14-2611			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25545099				2022-12-28	WOS:000350232500021
J	Tachibana-Konwalski, K				Tachibana-Konwalski, Kikue			Hold on and let go	NATURE			English	Editorial Material							MEIOSIS-I; CENTROMERIC COHESION; SEGREGATION; MONOPOLIN		Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Tachibana-Konwalski, K (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.	kikue.tachibana@imba.oeaw.ac.at						Katis VL, 2010, DEV CELL, V18, P397, DOI 10.1016/j.devcel.2010.01.014; Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020; Kim J, 2015, NATURE, V517, P466, DOI 10.1038/nature14097; Lee BH, 2004, CURR BIOL, V14, P2168, DOI 10.1016/j.cub.2004.12.033; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Murdoch B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003241; Tachibana-Konwalski K, 2013, CURR BIOL, V23, P2534, DOI 10.1016/j.cub.2013.10.052; Tanaka K, 2009, DEV CELL, V17, P334, DOI 10.1016/j.devcel.2009.08.004; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	11	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					441	442		10.1038/nature14087	http://dx.doi.org/10.1038/nature14087			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25533954				2022-12-28	WOS:000348196500022
J	Karp, EA; Kuo, AA				Karp, Elizabeth A.; Kuo, Alice A.			Maternal Mental Health After a Child's Diagnosis of Autism Spectrum Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASD	IMPORTANCE The prevalence of psychological distress among mothers of children with autism spectrum disorder (ASD) suggests a need for interventions that address parental mental health during the critical period after the child's autism diagnosis when parents are learning to navigate the complex system of autism services. OBJECTIVE To investigate whether a brief cognitive behavioral intervention, problem-solving education (PSE), decreases parenting stress and maternal depressive symptoms during the period immediately following a child's diagnosis of ASD. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial compared 6 sessions of PSE with usual care. Settings included an autism clinic and 6 community-based early intervention programs that primarily serve low-income families. Participants were mothers of 122 young children (mean age, 34 months) who recently received a diagnosis of ASD. Among mothers assessed for eligibility, 17.0% declined participation. We report outcomes after 3 months of follow-up (immediate postdiagnosis period). INTERVENTIONS Problem-solving education is a brief, cognitive intervention delivered in six 30-minute individualized sessions by existing staff (early intervention programs) or research staff without formal mental health training (autism clinic). MAIN OUTCOMES AND MEASURES Primary outcomes were parental stress and maternal depressive symptoms. RESULTS Fifty-nine mothers were randomized to receive PSE and 63 to receive usual care. The follow-up rate was 91.0%. Most intervention mothers (78.0%) received the full PSE course. At the 3-month follow-up assessment, PSE mothers were significantly less likely than those serving as controls to have clinically significant parental stress (3.8% vs 29.3%; adjusted relative risk [aRR], 0.17; 95% CI, 0.04 to 0.65). For depressive symptoms, the risk reduction in clinically significant symptoms did not reach statistical significance (5.7% vs 22.4%; aRR, 0.33; 95% CI, 0.10 to 1.08); however, the reduction in mean depressive symptoms was statistically significant (Quick Inventory of Depressive Symptomatology score, 4.6 with PSE vs 6.9 with usual care; adjusted mean difference, -1.67; 95% CI, -3.17 to -0.18). CONCLUSIONS AND RELEVANCE The positive effects of PSE in reducing parenting stress and depressive symptoms during the critical postdiagnosis period, when parents are asked to navigate a complex service delivery system, suggest that it may have a place in clinical practice. Further work will monitor these families for a total of 9 months to determine the trajectory of outcomes.	[Karp, Elizabeth A.] Univ Washington, Dept Psychol, POB 351525, Seattle, WA 98195 USA; [Kuo, Alice A.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Kuo, Alice A.] Univ Calif Los Angeles, Dept Internal Med, Los Angeles, CA USA	University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Karp, EA (corresponding author), Univ Washington, Dept Psychol, POB 351525, Seattle, WA 98195 USA.	ekarp@uw.edu						Bauminger N, 2010, AUTISM RES, V3, P101, DOI 10.1002/aur.131; Feinberg E, 2014, JAMA PEDIATR, V168, P40, DOI 10.1001/jamapediatrics.2013.3445; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Hayes SA, 2013, J AUTISM DEV DISORD, V43, P629, DOI 10.1007/s10803-012-1604-y; Ingersoll BR, 2013, AUTISM, V17, P434, DOI 10.1177/1362361311427155; Kasari C, 2010, J AUTISM DEV DISORD, V40, P1045, DOI 10.1007/s10803-010-0955-5; Lee LC, 2008, J AUTISM DEV DISORD, V38, P1147, DOI 10.1007/s10803-007-0491-0	7	5	5	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					81	+		10.1001/jama.2014.11187	http://dx.doi.org/10.1001/jama.2014.11187			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25562269	Green Published			2022-12-28	WOS:000347478000018
J	Wagner, DP				Wagner, Dianne P.			Trust Worthy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Michigan State Univ, Coll Human Med, Dept Internal Med, E Lansing, MI 48824 USA	Michigan State University; Michigan State University College of Human Medicine	Wagner, DP (corresponding author), Michigan State Univ, Coll Human Med, Dept Internal Med, E Lansing, MI 48824 USA.	wagnerd@msu.edu							0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2014	312	24					2621	2622		10.1001/jama.2014.10438	http://dx.doi.org/10.1001/jama.2014.10438			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX5KW	25536250				2022-12-28	WOS:000346966100011
J	O'Dowd, A				O'Dowd, Adrian			NHS regulator delays inspections as it struggles to fill posts in tougher regime	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kmietowicz Z, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7564	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 19	2014	349								g7733	10.1136/bmj.g7733	http://dx.doi.org/10.1136/bmj.g7733			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX3EN	25527713				2022-12-28	WOS:000346823300005
J	Perica, T; Kondo, Y; Tiwari, SP; McLaughlin, SH; Kemplen, KR; Zhang, XW; Steward, A; Reuter, N; Clarke, J; Teichmann, SA				Perica, Tina; Kondo, Yasushi; Tiwari, Sandhya P.; McLaughlin, Stephen H.; Kemplen, Katherine R.; Zhang, Xiuwei; Steward, Annette; Reuter, Nathalie; Clarke, Jane; Teichmann, Sarah A.			Evolution of oligomeric state through allosteric pathways that mimic ligand binding	SCIENCE			English	Article							BACILLUS-SUBTILIS PYRR; ATTENUATION PROTEIN; MOLECULAR-DYNAMICS; MESSENGER-RNA; CALDOLYTICUS; ADAPTATION; PYRIMIDINE; ALIGNMENT; ENZYMES	INTRODUCTION: Evolution and design of protein complexes are frequently viewed through the lens of amino acid mutations at protein interfaces, but we showed previously that residues distant from interfaces are also commonly involved in the evolution of alternative quaternary structures. We hypothesized that in these protein families, the difference in oligomeric state is due to a change in intersubunit geometry. The indirect mutations would act by changing protein conformation and dynamics, similar to the way in which allosteric small molecules introduce functional conformational change. We refer to these substitutions as "allosteric mutations." RATIONALE: In this work, we investigate the mechanism of action of allosteric mutations on oligomeric state in the PyrR family of pyrimidine operon attenuators. In this family, an entirely sequence-conserved helix that forms a tetrameric interface in the thermophilic ortholog (BcPyrR) switches to being solvent-exposed in the mesophilic ortholog (BsPyrR). This results in a homodimeric structure in which the two subunits are clearly rotated relative to their orientation in the tetramer. What is the origin of this rotation and the change in quaternary structure? To dissect the role of the 49 substitutions between BsPyrR and BcPyrR, we used ancestral sequence reconstruction in combination with structural and biophysical methods to identify a set of allosteric mutations that are responsible for this shift in conformation. We compared the conformational changes introduced by the mutations to the protein motion during allosteric regulation by guanosine monophosphate (GMP). RESULTS: We identified 11 key mutations controlling oligomeric state, all distant from the interfaces and outside ligand-binding pockets. We confirmed the role of these allosteric mutations by engineering a shift in oligomeric state in an inferred ancestral PyrR protein (intermediate in sequence between the extant orthologs). We further used the inferred ancestral states and their mutants to show that the allosteric mutations are part of a downhill adaptation of the PyrR proteins to lower temperatures. We compared the x-ray crystal structures of ancestral and engineered PyrR proteins to the free and GMP-bound structure of the mesophilic BsPyrR, which shifts its equilibrium from dimer to tetramer upon ligand binding. Binding of the allosteric molecule introduces a change in intersubunit geometry that is equivalent to the evolutionary difference in intersubunit geometry between the dimeric and tetrameric homologs. We further find that the difference in oligomeric state is coupled to the difference in intrinsic dynamics of the dimers. Finally, we used the residue-residue contact network approach to show that the residues corresponding to the allosteric mutations undergo large contact rewiring when the intersubunit geometry and, in turn, oligomeric state change, either by GMP binding or by the introduction of allosteric mutations. CONCLUSION: We show that evolution employs the intrinsic dynamics of this protein to toggle a conformational switch in a manner similar to that of small molecules. Shifting the relative populations of different states by subtle modifications is a process central to protein function and, as shown here, also to protein evolution. This suggests that we can learn from evolution and design proteins with multiple conformational states.	[Perica, Tina; Zhang, Xiuwei; Teichmann, Sarah A.] Eur Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England; [Perica, Tina; Kondo, Yasushi; McLaughlin, Stephen H.] Med Res Council MRC, Lab Mol Biol, Cambridge CB2 0QH, England; [Tiwari, Sandhya P.; Reuter, Nathalie] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Tiwari, Sandhya P.; Reuter, Nathalie] Univ Bergen, Dept Informat, Comput Biol Unit, N-5020 Bergen, Norway; [Kemplen, Katherine R.; Steward, Annette; Clarke, Jane] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Wellcome Trust Sanger Institute; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Bergen; University of Bergen; University of Cambridge	Teichmann, SA (corresponding author), Eur Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	saraht@ebi.ac.uk	Tiwari, Sandhya/AAY-4580-2020; Reuter, Nathalie/G-2037-2012; Kondo, Yasushi/AAU-1409-2020	Tiwari, Sandhya/0000-0002-0747-3826; Reuter, Nathalie/0000-0002-3649-7675; Kondo, Yasushi/0000-0003-2131-575X; McLaughlin, Stephen/0000-0001-9135-6253; Teichmann, Sarah/0000-0002-6294-6366; Perica, Tina/0000-0003-3152-8425	Nakajima Foundation; Swiss National Science Foundation [PBELP2_143538]; Senior Wellcome Trust Research Fellow [095195]; Bergen Forskningsstiftelse; MRC; Lister Research Prize; Henry Wellcome Postdoctoral Fellowship; MRC [MC_U105161047] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1127551] Funding Source: researchfish; Medical Research Council [MC_U105161047] Funding Source: researchfish	Nakajima Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Senior Wellcome Trust Research Fellow; Bergen Forskningsstiftelse; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Research Prize; Henry Wellcome Postdoctoral Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. L. Switzer (University of Illinois) for the cDNA of B. subtilis and B. caldolyticus PyrR; E. Natan and D. Gruszka for practical help; C. Vogel, E. Fuglebakk, and N. Tokuriki for helpful discussions and insights; K. Nagai for generous access to his laboratory; and E. Levy, J. Marsh, R. Laskowski, M. Wouters, and B. Lenhard for feedback on the manuscript. Y.K. was supported by the Nakajima Foundation. X.Z. is supported by an Early Postdoc Mobility Fellowship from the Swiss National Science Foundation (grant number PBELP2_143538). J.C. is a Senior Wellcome Trust Research Fellow (grant number 095195). S.P.T. and N.R. are supported by the Bergen Forskningsstiftelse. This work was supported by the MRC, the Lister Research Prize to S.A.T., and a Henry Wellcome Postdoctoral Fellowship to T.P. Coordinates and structural factors have been deposited with the Protein Data Bank (PDB) (accession codes 4P80, 4P81, 4P82, 4P83, 4P84, 4P86, and 4P3K)	Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Bonner ER, 2001, NUCLEIC ACIDS RES, V29, P4851, DOI 10.1093/nar/29.23.4851; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Chander P, 2005, J BACTERIOL, V187, P1773, DOI 10.1128/JB.187.5.1773-1782.2005; Dellus-Gur E, 2013, J MOL BIOL, V425, P2609, DOI 10.1016/j.jmb.2013.03.033; Echave J, 2008, CHEM PHYS LETT, V457, P413, DOI 10.1016/j.cplett.2008.04.042; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fugebakk E, 2013, J CHEM THEORY COMPUT, V9, P5618, DOI 10.1021/ct400399x; Fuglebakk E, 2012, BIOINFORMATICS, V28, P2431, DOI 10.1093/bioinformatics/bts445; Fukuchi S, 2001, J MOL BIOL, V309, P835, DOI 10.1006/jmbi.2001.4718; GERSTEIN M, 1991, J MOL BIOL, V220, P133, DOI 10.1016/0022-2836(91)90387-L; Gong LI, 2013, ELIFE, V2, DOI 10.7554/eLife.00631; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; HEINEN UJ, 1972, ARCH MIKROBIOL, V82, P1, DOI 10.1007/BF00424925; Hinsen K, 2000, CHEM PHYS, V261, P25, DOI 10.1016/S0301-0104(00)00222-6; Hobbs JK, 2012, MOL BIOL EVOL, V29, P825, DOI 10.1093/molbev/msr253; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Jorgensen CM, 2008, FEBS J, V275, P655, DOI 10.1111/j.1742-4658.2007.06227.x; Juritz E, 2013, MOL BIOL EVOL, V30, P79, DOI 10.1093/molbev/mss080; Kaltenbach M, 2014, J EXP ZOOL PART B, V322, P468, DOI 10.1002/jez.b.22562; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Leo-Macias A, 2005, BIOPHYS J, V88, P1291, DOI 10.1529/biophysj.104.052449; Maass S, 2011, ANAL CHEM, V83, P2677, DOI 10.1021/ac1031836; Maguid S, 2006, J MOL EVOL, V63, P448, DOI 10.1007/s00239-005-0209-x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Perica T, 2012, P NATL ACAD SCI USA, V109, P8127, DOI 10.1073/pnas.1120028109; Raimondi F, 2010, STRUCTURE, V18, P402, DOI 10.1016/j.str.2009.12.015; Reuter N, 2003, BIOPHYS J, V85, P2186, DOI 10.1016/S0006-3495(03)74644-X; Robinson-Rechavi M, 2006, J MOL BIOL, V356, P547, DOI 10.1016/j.jmb.2005.11.065; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Savacool HK, 2002, J BACTERIOL, V184, P2521, DOI 10.1128/JB.184.9.2521-2528.2002; Soundararajan V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009391; Stock D, 2005, PROG BIOPHYS MOL BIO, V88, P311, DOI 10.1016/j.pbiomolbio.2004.07.009; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Taverna DM, 2002, PROTEINS, V46, P105, DOI 10.1002/prot.10016; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tomchick DR, 1998, STRUCTURE, V6, P337, DOI 10.1016/S0969-2126(98)00036-7; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406; Zhang XW, 2013, CURR OPIN STRUC BIOL, V23, P954, DOI 10.1016/j.sbi.2013.07.004; ZIMM BH, 1948, J CHEM PHYS, V16, P1093, DOI 10.1063/1.1746738	51	49	50	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216							1254346	10.1126/science.1254346	http://dx.doi.org/10.1126/science.1254346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525255	Green Accepted			2022-12-28	WOS:000346536500055
J	Brooks, TM				Brooks, Thomas M.			CONSERVATION Mind the gaps	NATURE			English	Editorial Material							TARGETS; COSTS; NEEDS		Int Union Conservat Nat, CH-1196 Gland, Switzerland		Brooks, TM (corresponding author), Int Union Conservat Nat, CH-1196 Gland, Switzerland.	thomas.brooks@iucn.org		Brooks, Thomas/0000-0001-8159-3116				Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Borrini-Feyerabend G., 2014, GOVERNANCE PROTECTED; Butchart SHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032529; Juffe-Bignoli D., 2014, 2014 UNEP WCMC; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Pouzols FM, 2014, NATURE, V516, P383, DOI 10.1038/nature14032; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sachs J. D., 2014, INDICATORS MONITORIN; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947	10	12	12	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					336	337		10.1038/516336a	http://dx.doi.org/10.1038/516336a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW8BE	25519127				2022-12-28	WOS:000346484800033
J	Dorr, K; Herklotz, A				Doerr, Kathrin; Herklotz, Andreas			MATERIALS SCIENCE Two steps for a magnetoelectric switch	NATURE			English	Editorial Material							NOBEL LECTURE		[Doerr, Kathrin] Univ Halle Wittenberg, Inst Phys, D-06099 Halle, Germany; [Herklotz, Andreas] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA	Martin Luther University Halle Wittenberg; United States Department of Energy (DOE); Oak Ridge National Laboratory	Dorr, K (corresponding author), Univ Halle Wittenberg, Inst Phys, D-06099 Halle, Germany.	kathrin.doerr@physik.uni-halle.de		Herklotz, Andreas/0000-0002-1545-131X				Boyn S, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4864100; Ederer C, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.060401; Fert A, 2008, REV MOD PHYS, V80, P1517, DOI 10.1103/RevModPhys.80.1517; Grunberg PA, 2008, REV MOD PHYS, V80, P1531, DOI 10.1103/RevModPhys.80.1531; Heron JT, 2014, NATURE, V516, P370, DOI 10.1038/nature14004; Heron JT, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.217202; Spaldin NA, 2005, SCIENCE, V309, P391, DOI 10.1126/science.1113357; Trassin M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.134426	8	13	13	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					337	338		10.1038/516337a	http://dx.doi.org/10.1038/516337a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25519128				2022-12-28	WOS:000346484800034
J	Grande, D; Mitra, N; Shah, A; Wan, F; Asch, DA				Grande, David; Mitra, Nandita; Shah, Anand; Wan, Fei; Asch, David A.			The Importance of Purpose: Moving Beyond Consent in the Societal Use of Personal Health Information	ANNALS OF INTERNAL MEDICINE			English	Article							AFRICAN-AMERICANS; MEDICAL-RESEARCH; SELECTION BIAS; ATTITUDES; PRIVACY; REGISTRY; ACCESS; TRUST	Background: Adoption of electronic health record systems has increased the availability of patient-level electronic health information. Objective: To examine public support for secondary uses of electronic health information under different consent arrangements. Design: National experimental survey to examine perceptions of uses of electronic health information according to patient consent (obtained vs. not obtained), use (research vs. marketing), and framing of the findings (abstract description without results vs. specific results). Setting: Nationally representative survey. Participants: 3064 African American, Hispanic, and non-Hispanic white persons (response rate, 65%). Measurements: Appropriateness of health information use described in vignettes on a scale of 1 (not at all appropriate) to 10 (very appropriate). Results: Mean ratings ranged from a low of 3.81 for a marketing use when consent was not obtained and specific results were presented to a high of 7.06 for a research use when consent was obtained and specific results were presented. Participants rated scenarios in which consent was obtained as more appropriate than when consent was not obtained (difference, 1.01 [95% CI, 0.69 to 1.34]; P < 0.001). Participants rated scenarios in which the use was marketing as less appropriate than when the use was research (difference, -2.03 [CI, -2.27 to -1.78]; P < 0.001). Unconsented research uses were rated as more appropriate than consented marketing uses (5.65 vs. 4.52; difference, 1.13 [CI, 0.87 to 1.39]). Limitations: Participants rated hypothetical scenarios. Results could be vulnerable to nonresponse bias despite the high response rate. Conclusion: Although approaches to health information sharing emphasize consent, public opinion also emphasizes purpose, which suggests a need to focus more attention on the social value of information use.	Univ Penn, Philadelphia, PA 19104 USA; Parkland Hlth & Hosp Syst, Dallas, TX USA	University of Pennsylvania	Grande, D (corresponding author), 3641 Locust Walk,Colonial Penn Ctr 407, Philadelphia, PA 19014 USA.	dgrande@wharton.upenn.edu	Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735; Asch, David/0000-0002-7970-286X	National Human Genome Research Institute [5R21HG006047-02]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006047] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	By the National Human Genome Research Institute (grant 5R21HG006047-02; Dr. Grande).	[Anonymous], 2009, HIPAA PRIVACY RULE E; Berry JG, 2013, CLIN TRIALS, V10, P483, DOI 10.1177/1740774513480568; Bloomrosen M, 2008, J AM MED INFORM ASSN, V15, P715, DOI 10.1197/jamia.M2905; Buckley B, 2007, HEART, V93, P1116, DOI 10.1136/hrt.2006.111591; Centers for Disease Control and Prevention, NAT HLTH INT SURV QU; Centers for Disease Control and Prevention, 2010, 2010 BEH RISK FACT S; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; Corbie-Smith G, 2002, ARCH INTERN MED, V162, P2458, DOI 10.1001/archinte.162.21.2458; Damschroder LJ, 2007, SOC SCI MED, V64, P223, DOI 10.1016/j.socscimed.2006.08.045; Emanuel EJ, 2011, NEW ENGL J MED, V365, P1145, DOI 10.1056/NEJMsb1106942; *FORR RES, 2005, NAT CONS HLTH PRIV S; Freimuth VS, 2001, SOC SCI MED, V52, P797, DOI 10.1016/S0277-9536(00)00178-7; GfK Knowledge Networks, 2012, KNOWL PAN DEM PROF; Gostin LO, 2009, JAMA-J AM MED ASSOC, V301, P1373, DOI 10.1001/jama.2009.424; Grande D, 2013, JAMA INTERN MED, V173, P1798, DOI 10.1001/jamainternmed.2013.9166; Grande D, 2009, NEW ENGL J MED, V360, P747, DOI 10.1056/NEJMp0810410; Hall MA, 2001, MILBANK Q, V79, P613, DOI 10.1111/1468-0009.00223; Hall MA, 2009, JAMA-J AM MED ASSOC, V301, P1282, DOI 10.1001/jama.2009.389; Ingelfinger JR, 2004, NEW ENGL J MED, V350, P1452, DOI 10.1056/NEJMe048027; Institute of Medicine Roundtable on Value and Science-Driven Health Care, 2013, DIG DAT IMPR PRIOR C; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Markle Foundation, 2006, SURV FINDS AM WANT E; Nair Kalpana, 2004, J Health Serv Res Policy, V9, P22, DOI 10.1258/135581904322716076; Rhodes R, 2011, AM J BIOETHICS, V11, P1, DOI 10.1080/15265161.2011.615588; Robling MR, 2004, J MED ETHICS, V30, P104, DOI 10.1136/jme.2003.005157; Schaefer GO, 2009, JAMA-J AM MED ASSOC, V302, P67, DOI 10.1001/jama.2009.931; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; Whiddett R, 2006, INT J MED INFORM, V75, P530, DOI 10.1016/j.ijmedinf.2005.08.009; Willison DJ, 2007, J AM MED INFORM ASSN, V14, P706, DOI 10.1197/jamia.M2457; Woolf SH, 2000, ARCH FAM MED, V9, P1111, DOI 10.1001/archfami.9.10.1111; Yeager DS, 2011, PUBLIC OPIN QUART, V75, P709, DOI 10.1093/poq/nfr020	31	21	21	1	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12					855	U37		10.7326/M14-1118	http://dx.doi.org/10.7326/M14-1118			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX9UW	25506854	Green Accepted			2022-12-28	WOS:000347248400027
J	Meerman, R; Brown, AJ				Meerman, Ruben; Brown, Andrew J.			CHRISTMAS 2014: GASTROENTEROLOGICAL TRACTS When somebody loses weight, where does the fat go?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADIPOSE-TISSUE	Ruben Meerman and Andrew Brown explain why the answer might not be what you expect Considering the soaring overweight and obesity rates and strong interest in this topic, there is surprising ignorance and confusion about the metabolic process of weight loss among the general public and health professionals alike. We encountered widespread misconceptions about how humans lose weight among general practitioners, dietitians, and personal trainers (fig 1.). Most people believed that fat is converted to energy or heat, which violates the law of conservation of mass. We suspect this misconception is caused by the "energy in/energy out" mantra and the focus on energy production in university biochemistry courses. Other misconceptions were that the metabolites of fat are excreted in the faeces or converted to muscle. We present a novel calculation to show how we "lose weight."	[Meerman, Ruben; Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Meerman, R (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	rubenmeerman@me.com						Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; HIRSCH J, 1960, AM J CLIN NUTR, V8, P499, DOI 10.1093/ajcn/8.4.499; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; LIFSON N, 1949, J BIOL CHEM, V180, P803	4	9	9	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2014	349								g7257	10.1136/bmj.g7257	http://dx.doi.org/10.1136/bmj.g7257			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HK	25516540	hybrid, Green Published			2022-12-28	WOS:000346763900005
J	Simon, JR				Simon, Jeremy R.			Corporate Research Ethics: Whose Responsibility?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Columbia Univ, Ctr Bioeth, New York, NY 10032 USA	Columbia University	Simon, JR (corresponding author), Columbia Univ, Ctr Bioeth, 630 W 168th St, New York, NY 10032 USA.	js1115@columbia.edu						[Anonymous], 2014, P NATL ACAD SCI  SEP; Cornell University, 1967, CORN U I REV BOARD H; DUNN CM, 2002, PROTECTING STUDY VOL; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Goel V, 2014, NY TIMES, pB2; Goel V., 2014, NEW YORK TIMES  0630, pB1; Kramer ADI, 2014, P NATL ACAD SCI USA, V111, P8788, DOI 10.1073/pnas.1320040111; Verma IM, 2014, P NATL ACAD SCI USA, V111, P10779, DOI 10.1073/pnas.1412469111	8	3	3	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12					917	U113		10.7326/M14-1669	http://dx.doi.org/10.7326/M14-1669			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UW	25506857				2022-12-28	WOS:000347248400036
J	Smith, S; Thomas, R; Cruz, M; Griggs, R; Moscato, B; Ferrara, A				Smith, Sunny; Thomas, Robert, III; Cruz, Michael; Griggs, Ryan; Moscato, Brittany; Ferrara, Ashley			Presence and Characteristics of Student-Run Free Clinics in Medical Schools	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Smith, Sunny; Griggs, Ryan] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Thomas, Robert, III; Cruz, Michael] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Moscato, Brittany; Ferrara, Ashley] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; State University System of Florida; University of Central Florida	Smith, S (corresponding author), Univ Calif San Diego, Dept Family & Prevent Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sdsmith@ucsd.edu		Thomas, Robert/0000-0003-3574-5013				Liberman KM, 2011, J COMMUN HEALTH, V36, P733, DOI 10.1007/s10900-011-9367-5; Meah YS, 2009, MT SINAI J MED, V76, P344, DOI 10.1002/msj.20128; Simpson SA, 2007, J GEN INTERN MED, V22, P352, DOI 10.1007/s11606-006-0073-4; Smith SD, 2014, FAM MED, V46, P198; Zucker J, 2011, ACAD MED, V86, P239, DOI 10.1097/ACM.0b013e31820465e0	5	75	75	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2407	2410		10.1001/jama.2014.16066	http://dx.doi.org/10.1001/jama.2014.16066			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YB	25490333	Bronze, Green Published			2022-12-28	WOS:000346345700017
J	McNeil, BD; Pundir, P; Meeker, S; Han, L; Undem, BJ; Kulka, M; Dong, XZ				McNeil, Benjamin D.; Pundir, Priyanka; Meeker, Sonya; Han, Liang; Undem, Bradley J.; Kulka, Marianna; Dong, Xinzhong			Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; HISTAMINE-RELEASE; SYSTEMIC-ANAPHYLAXIS; HUMAN SKIN; GENE X2; ACTIVATION; PEPTIDES; AGENTS; MRGX2; MICE	Mast cells are primary effectors in allergic reactions, and may have important roles in disease by secreting histamine and various inflammatory and immunomodulatory substances(1,2). Although they are classically activated by immunoglobulin (Ig)E antibodies, a unique property of mast cells is their antibody-independent responsiveness to a range of cationic substances, collectively called basic secretagogues, including inflammatory peptides and drugs associated with allergic-type reactions(1,3). The pathogenic roles of these substances have prompted a decades-long search for their receptor(s). Here we report that basic secretagogues activate mouse mast cells in vitro and in vivo through a single receptor, Mrgprb2, the orthologue of the human G-protein-coupled receptor MRGPRX2. Secretagogue-induced histamine release, inflammation and airway contraction are abolished in Mrgprb2-null mutant mice. Furthermore, we show that most classes of US Food and Drug Administration (FDA)-approved peptidergic drugs associated with allergic-type injection-site reactions also activate Mrgprb2 and MRGPRX2, and that injection-site inflammation is absent in mutant mice. Finally, we determine that Mrgprb2 and MRGPRX2 are targets of many small-molecule drugs associated with systemic pseudo-allergic, or anaphylactoid, reactions; we show that drug-induced symptoms of anaphylactoid responses are significantly reduced in knockout mice; and we identify a common chemical motif in several of these molecules that may help predict side effects of other compounds. These discoveries introduce a mouse model to study mast cell activation by basic secretagogues and identify MRGPRX2 as a potential therapeutic target to reduce a subset of drug-induced adverse effects.	[McNeil, Benjamin D.; Han, Liang; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Solomon H Snyder Dept Neurosci,Ctr Sensory Biol, Baltimore, MD 21205 USA; [Pundir, Priyanka; Kulka, Marianna] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada; [Meeker, Sonya; Undem, Bradley J.] Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA; [Kulka, Marianna] Natl Res Council Canada, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; University of Alberta; Johns Hopkins University; National Research Council Canada; Howard Hughes Medical Institute; Johns Hopkins University	Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Solomon H Snyder Dept Neurosci,Ctr Sensory Biol, Baltimore, MD 21205 USA.	xdong2@jhmi.edu		McNeil, Benjamin/0000-0001-7545-3598; Han, Liang/0000-0001-8674-6433	National Institutes of Health [R01NS054791, R01GM087369]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS087088, R01NS054791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Hawkins and H. Wellington for their assistance in generating MrgprB2-null mice and MrgprB2-Cre BAC transgenic mice. We thank B. Xiao for making MrgprB2-Cre BAC mice and Y. Geng for mouse genotyping. This work was supported by National Institutes of Health grants (R01NS054791 and R01GM087369 to X.D.). X.D. is an Early Career Scientist of the Howard Hughes Medical Institute.	BERGMAN RK, 1968, NATURE, V217, P1173, DOI 10.1038/2171173a0; Blanca-Lopez N, 2013, CLIN EXP ALLERGY, V43, P560, DOI 10.1111/cea.12099; Doyle E, 2013, METHODS MOL BIOL, V1032, P133, DOI 10.1007/978-1-62703-496-8_10; Ferry X, 2002, PEPTIDES, V23, P1507, DOI 10.1016/S0196-9781(02)00090-6; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; HALPERN BN, 1950, BRIT J PHARM CHEMOTH, V5, P510, DOI 10.1111/j.1476-5381.1950.tb00603.x; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Hausmann O, 2012, CHEM IMMUNOL ALLERGY, V97, P32, DOI 10.1159/000335614; Kamohara M, 2005, BIOCHEM BIOPH RES CO, V330, P1146, DOI 10.1016/j.bbrc.2005.03.088; Kashem SW, 2011, EUR J PHARMACOL, V668, P299, DOI 10.1016/j.ejphar.2011.06.027; Kelesidis T, 2010, CLIN THER, V32, P515, DOI 10.1016/j.clinthera.2010.03.002; Koppert W, 2001, ANESTHESIOLOGY, V95, P659, DOI 10.1097/00000542-200109000-00019; LAGUNOFF D, 1983, ANNU REV PHARMACOL, V23, P331, DOI 10.1146/annurev.pa.23.040183.001555; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Lumry WR, 2011, ANN ALLERG ASTHMA IM, V107, P529, DOI 10.1016/j.anai.2011.08.015; MATSUMURA Y, 1976, J ALLERGY CLIN IMMUN, V58, P387, DOI 10.1016/0091-6749(76)90119-6; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; Mertes PM, 2011, J ALLERGY CLIN IMMUN, V128, P366, DOI 10.1016/j.jaci.2011.03.003; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mori K, 2000, J PHARM PHARMACOL, V52, P577, DOI 10.1211/0022357001774228; Mori K, 2000, EUR J PHARMACOL, V394, P51, DOI 10.1016/S0014-2999(00)00147-3; MOUSLI M, 1994, IMMUNOPHARMACOLOGY, V27, P1, DOI 10.1016/0162-3109(94)90002-7; Nel L, 2011, BRIT J CLIN PHARMACO, V71, P647, DOI 10.1111/j.1365-2125.2011.03913.x; Pundir P, 2010, IMMUNOL CELL BIOL, V88, P632, DOI 10.1038/icb.2010.27; Purcell WM, 1996, J NEUROIMMUNOL, V65, P49, DOI 10.1016/0165-5728(95)00182-4; READ GW, 1973, J MED CHEM, V16, P1292, DOI 10.1021/jm00269a016; Robas N, 2003, J BIOL CHEM, V278, P44400, DOI 10.1074/jbc.M302456200; Sick E, 2009, CELL MOL LIFE SCI, V66, P1271, DOI 10.1007/s00018-009-8778-2; SIRAGANIAN RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; Subramanian H, 2013, J IMMUNOL, V191, P345, DOI 10.4049/jimmunol.1300023; Subramanian H, 2011, J BIOL CHEM, V286, P44739, DOI 10.1074/jbc.M111.277152; TANEIKE T, 1988, GEN PHARMACOL, V19, P689, DOI 10.1016/0306-3623(88)90130-9; Tatemoto K, 2006, BIOCHEM BIOPH RES CO, V349, P1322, DOI 10.1016/j.bbrc.2006.08.177; Weigand LA, 2009, J PHYSIOL-LONDON, V587, P3355, DOI 10.1113/jphysiol.2009.173054	34	671	695	7	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					237	+		10.1038/nature14022	http://dx.doi.org/10.1038/nature14022			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25517090	Green Accepted			2022-12-28	WOS:000350770500040
J	Garnick, MB				Garnick, Marc B.			Testosterone Replacement Therapy Faces FDA Scrutiny	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEN		[Garnick, Marc B.] Harvard Univ, Sch Med, Boston, MA USA; [Garnick, Marc B.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Garnick, MB (corresponding author), Beth Israel Deaconess Med Ctr, 375 Longwood Ave,428 MASCO Bldg, Boston, MA 02215 USA.	mgarnick@bidmc.harvard.edu						American Urological Association, AUA POSITION STATEME; Baillargeon J, 2013, JAMA INTERN MED, V173, P1465, DOI 10.1001/jamainternmed.2013.6895; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Bhatt K, SUMMARY MINUTES OF T; Blazer DG, TESTOSTERONE AND AGI; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Hirsch MS, TESTOSTERONE REPLACE; Mohamoud MA, DRUG USE REVIEW; US Food and Drug Administration, 2014, MEETING MATERIALS OF; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386	10	26	29	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2015	313	6					563	564		10.1001/jama.2014.17334	http://dx.doi.org/10.1001/jama.2014.17334			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AZ	25502018				2022-12-28	WOS:000349070700010
J	Haucke, V				Haucke, Volker			On the endocytosis rollercoaster	NATURE			English	Editorial Material							CLATHRIN-INDEPENDENT ENDOCYTOSIS; DOWN-REGULATION; MECHANISMS; RECEPTORS		Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Haucke, V (corresponding author), Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany.	haucke@fmp-berlin.de		Haucke, Volker/0000-0003-3119-6993				Bitsikas V, 2014, ELIFE, V3, DOI 10.7554/eLife.03970; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Kononenko NL, 2014, NEURON, V82, P981, DOI 10.1016/j.neuron.2014.05.007; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Renard HF, 2015, NATURE, V517, P493, DOI 10.1038/nature14064; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Tang YT, 1999, P NATL ACAD SCI USA, V96, P12559, DOI 10.1073/pnas.96.22.12559	13	7	7	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					446	447		10.1038/nature14081	http://dx.doi.org/10.1038/nature14081			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25517097				2022-12-28	WOS:000348196500026
J	Pennisi, E				Pennisi, Elizabeth			Cooperative 'bots' don't need a boss	SCIENCE			English	Editorial Material																			0	2	2	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1444	1444		10.1126/science.346.6216.1444	http://dx.doi.org/10.1126/science.346.6216.1444			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525224				2022-12-28	WOS:000346536500024
J	Isaacs, S; Isaacs, D				Isaacs, Stephen; Isaacs, David			CHRISTMAS 2014 A Christmas carousel	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Isaacs, David] Childrens Hosp Westmead, Dept Infect Dis & Microbiol, Sydney, NSW 2145, Australia; [Isaacs, David] Univ Sydney, Discipline Child Hlth, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Isaacs, D (corresponding author), Childrens Hosp Westmead, Dept Infect Dis & Microbiol, Sydney, NSW 2145, Australia.	david.isaacs@health.nsw.gov.au							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2014	349								g7444	10.1136/bmj.g7444	http://dx.doi.org/10.1136/bmj.g7444			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HK	25515342				2022-12-28	WOS:000346763900011
J	Green, RE; Braun, EL; Armstrong, J; Earl, D; Nguyen, N; Hickey, G; Vandewege, MW; St John, JA; Capella-Gutierrez, S; Castoe, TA; Kern, C; Fujita, MK; Opazo, JC; Jurka, J; Kojima, KK; Caballero, J; Hubley, RM; Smit, AF; Platt, RN; Lavoie, CA; Ramakodi, MP; Finger, JW; Suh, A; Isberg, SR; Miles, L; Chong, AY; Jaratlerdsiri, W; Gongora, J; Moran, C; Iriarte, A; McCormack, J; Burgess, SC; Edwards, SV; Lyons, E; Williams, C; Breen, M; Howard, JT; Gresham, CR; Peterson, DG; Schmitz, J; Pollock, DD; Haussler, D; Triplett, EW; Zhang, G; Irie, N; Jarvis, ED; Brochu, CA; Schmidt, CJ; McCarthy, FM; Faircloth, BC; Hoffmann, FG; Glenn, TC; Gabaldoon, T; Paten, B; Ray, DA				Green, Richard E.; Braun, Edward L.; Armstrong, Joel; Earl, Dent; Nguyen, Ngan; Hickey, Glenn; Vandewege, Michael W.; St John, John A.; Capella-Gutierrez, Salvador; Castoe, Todd A.; Kern, Colin; Fujita, Matthew K.; Opazo, Juan C.; Jurka, Jerzy; Kojima, Kenji K.; Caballero, Juan; Hubley, Robert M.; Smit, Arian F.; Platt, Roy N.; Lavoie, Christine A.; Ramakodi, Meganathan P.; Finger, John W.; Suh, Alexander; Isberg, Sally R.; Miles, Lee; Chong, Amanda Y.; Jaratlerdsiri, Weerachai; Gongora, Jaime; Moran, Christopher; Iriarte, Andres; McCormack, John; Burgess, Shane C.; Edwards, Scott V.; Lyons, Eric; Williams, Christina; Breen, Matthew; Howard, Jason T.; Gresham, Cathy R.; Peterson, Daniel G.; Schmitz, Juergen; Pollock, David D.; Haussler, David; Triplett, Eric W.; Zhang, Guojie; Irie, Naoki; Jarvis, Erich D.; Brochu, Christopher A.; Schmidt, Carl J.; McCarthy, Fiona M.; Faircloth, Brant C.; Hoffmann, Federico G.; Glenn, Travis C.; Gabaldon, Toni; Paten, Benedict; Ray, David A.			Three crocodilian genomes reveal ancestral patterns of evolution among archosaurs	SCIENCE			English	Article							ULTRACONSERVED ELEMENTS; BODY-SIZE; PHYLOGENETIC ANALYSES; DIVERGENCE TIMES; AVIAN GENOME; SPECIES-TREE; SISTER GROUP; ALIGNMENT; TEMPERATURE; SEQUENCE	To provide context for the diversification of archosaurs-the group that includes crocodilians, dinosaurs, and birds-we generated draft genomes of three crocodilians: Alligator mississippiensis (the American alligator), Crocodylus porosus (the saltwater crocodile), and Gavialis gangeticus (the Indian gharial). We observed an exceptionally slow rate of genome evolution within crocodilians at all levels, including nucleotide substitutions, indels, transposable element content and movement, gene family evolution, and chromosomal synteny. When placed within the context of related taxa including birds and turtles, this suggests that the common ancestor of all of these taxa also exhibited slow genome evolution and that the comparatively rapid evolution is derived in birds. The data also provided the opportunity to analyze heterozygosity in crocodilians, which indicates a likely reduction in population size for all three taxa through the Pleistocene. Finally, these data combined with newly published bird genomes allowed us to reconstruct the partial genome of the common ancestor of archosaurs, thereby providing a tool to investigate the genetic starting material of crocodilians, birds, and dinosaurs.	[Green, Richard E.; Armstrong, Joel; Earl, Dent; Nguyen, Ngan; Hickey, Glenn; St John, John A.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Braun, Edward L.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Braun, Edward L.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Armstrong, Joel; Earl, Dent; Nguyen, Ngan; Hickey, Glenn; Haussler, David; Paten, Benedict] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Vandewege, Michael W.; Platt, Roy N.; Lavoie, Christine A.; Ramakodi, Meganathan P.; Hoffmann, Federico G.; Ray, David A.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Path, Mississippi State, MS 39762 USA; [Capella-Gutierrez, Salvador; Gabaldon, Toni] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona 08003, Spain; [Capella-Gutierrez, Salvador; Gabaldon, Toni] Univ Pompeu Fabra, Barcelona 08003, Spain; [Castoe, Todd A.; Pollock, David D.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Castoe, Todd A.; Fujita, Matthew K.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Kern, Colin] Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19717 USA; [Opazo, Juan C.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambient & Evolutivas, Valdivia, Chile; [Jurka, Jerzy; Kojima, Kenji K.] Genet Informat Res Inst, Mountain View, CA 94043 USA; [Caballero, Juan; Hubley, Robert M.; Smit, Arian F.] Inst Syst Biol, Seattle, WA 98109 USA; [Platt, Roy N.; Ramakodi, Meganathan P.; Gresham, Cathy R.; Peterson, Daniel G.; Hoffmann, Federico G.; Ray, David A.] Mississippi State Univ, Inst Gen Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Finger, John W.; Glenn, Travis C.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA; [Suh, Alexander; Schmitz, Juergen] Univ Mnster, Inst Expt Pathol ZMBE, D-48149 Munster, Germany; [Suh, Alexander] Uppsala Univ, Dept Evolutionary Biol EBC, S-75236 Uppsala, Sweden; [Isberg, Sally R.] Porosus Pty Ltd, Palmerston, NT 0831, Australia; [Isberg, Sally R.; Miles, Lee; Chong, Amanda Y.; Jaratlerdsiri, Weerachai; Gongora, Jaime; Moran, Christopher] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Isberg, Sally R.] Ctr Crocodile Res, Noonamah, NT 0837, Australia; [Iriarte, Andres] Univ Republica, Fac Medicina, Inst Higiene, Departamento Desarrollo Biotecnol, Montevideo, Uruguay; [McCormack, John] Occidental Coll, Moore Lab Zool, Los Angeles, CA 90041 USA; [Burgess, Shane C.] Univ Arizona, Coll Agr & Life Sci, Tucson, AZ 85721 USA; [Edwards, Scott V.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Lyons, Eric] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Williams, Christina; Breen, Matthew] N Carolina State Univ, Dept Mol Biomed Sci, Raleigh, NC 27607 USA; [Howard, Jason T.; Jarvis, Erich D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA; [Peterson, Daniel G.] Mississippi State Univ, Dept Plant & Soil Sci, Mississippi State, MS 39762 USA; [Haussler, David] Howard Hughes Med Inst, Bethesda, MD 20814 USA; [Triplett, Eric W.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Zhang, Guojie] BGI Shenzhen, China Natl GeneBank, Shenzhen, Peoples R China; [Zhang, Guojie] Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark; [Irie, Naoki] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan; [Brochu, Christopher A.] Univ Iowa, Dept Earth & Environm Sci, Iowa City, IA 52242 USA; [Schmidt, Carl J.] Univ Delaware, Dept Anim & Food Sci, Newark, DE 19717 USA; [McCarthy, Fiona M.] Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ 85721 USA; [Faircloth, Brant C.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90019 USA; [Faircloth, Brant C.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Gabaldon, Toni] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain; [Ray, David A.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	University of California System; University of California Santa Cruz; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Santa Cruz; Mississippi State University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Arlington; University of Delaware; Universidad Austral de Chile; Institute for Systems Biology (ISB); Mississippi State University; University System of Georgia; University of Georgia; Uppsala University; University of Sydney; Universidad de la Republica, Uruguay; Occidental College; University of Arizona; Harvard University; University of Arizona; University of North Carolina; North Carolina State University; Duke University; Howard Hughes Medical Institute; Mississippi State University; Howard Hughes Medical Institute; State University System of Florida; University of Florida; Beijing Genomics Institute (BGI); University of Copenhagen; University of Tokyo; University of Iowa; University of Delaware; University of Arizona; University of California System; University of California Los Angeles; Louisiana State University System; Louisiana State University; ICREA; Texas Tech University System; Texas Tech University	Green, RE (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	ed@soe.ucsc.edu; david.a.ray@ttu.edu	Jaratlerdsiri, Weerachai/ABE-3372-2021; Capella-Gutierrez, Salvador/H-5053-2015; Pollock, David D/M-4740-2016; IRIE, NAOKI/G-5012-2014; Edwards, Scott V./D-9071-2018; Faircloth, Brant C/Y-3978-2019; Zhang, Guojie/J-7273-2019; Kojima, Kenji/AAO-2213-2021; Jarvis, Erich D/A-2319-2008; Finger, John/HDM-8207-2022; Gabaldón, Toni/A-7336-2008; Glenn, Travis C/A-2390-2008; Zhang, Guojie/B-6188-2014; Hoffmann, Federico/B-7134-2009	Capella-Gutierrez, Salvador/0000-0002-0309-604X; Pollock, David D/0000-0002-7627-4214; Edwards, Scott V./0000-0003-2535-6217; Zhang, Guojie/0000-0001-6860-1521; Jarvis, Erich D/0000-0001-8931-5049; Gabaldón, Toni/0000-0003-0019-1735; Glenn, Travis C/0000-0001-7725-3637; Zhang, Guojie/0000-0001-6860-1521; Braun, Edward/0000-0003-1643-5212; Gongora, Jaime/0000-0003-2215-656X; Faircloth, Brant/0000-0002-1943-0217; Isberg, Sally/0000-0002-8895-2414; Ray, David/0000-0002-3340-3987; Iriarte, Andres/0000-0002-5862-0152; Suh, Alexander/0000-0002-8979-9992; Howard, Jason/0000-0003-3265-5127; Finger, John/0000-0003-0661-7821; Chong, Amanda/0000-0003-4919-2632; Peterson, Daniel/0000-0002-0274-5968; Opazo, Juan C./0000-0001-7938-4083; Hoffmann, Federico/0000-0001-5056-4929; Irie, Naoki/0000-0002-6720-381X; Lyons, Eric/0000-0002-3348-8845; Schmidt, Carl/0000-0002-8386-4781; Green, Richard/0000-0003-0516-5827; Jaratlerdsiri, Weerachai/0000-0001-9100-1807; Breen, Matthew/0000-0002-8901-4155; Caballero Perez, Juan/0000-0002-6160-3644	NSF [MCB-1052500, DEB-1020865, MCB-0841821, DUE-0920151, DBI-0905714, DEB-1242260]; Institute for Genomics, Biocomputing and Biotechnology at Mississippi State University; Australian Rural Industries Research and Development Corporation [RIRDC PRJ-000549, RIRDC PRJ-005355, RIRDC PRJ-002461]; Howard Hughes Medical Institute; National Institutes of Health [1U41HG007234-01, 1U41HG006992-2, 5U01HG004695]; Gordon and Betty Moore Foundation [3383]; Direct For Biological Sciences [0841821] Funding Source: National Science Foundation; ICREA Funding Source: Custom; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002939, U41HG006992, U41HG007234, U01HG004695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097251] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24570243, 22128003] Funding Source: KAKEN	NSF(National Science Foundation (NSF)); Institute for Genomics, Biocomputing and Biotechnology at Mississippi State University; Australian Rural Industries Research and Development Corporation(Rural Industries R&D Corp); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); ICREA(ICREA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Genome drafts have been submitted to the National Center for Biotechnology Information repository under the following accession numbers: Alligator mississippiensis, AKHW00000000; Crocodylus porosus, JRXG00000000; Gavialis gangeticus, JRWT00000000. Supplemental files have been archived at GigaScience (DOIs: 10.5524/100125, 10.5524/100126, 10.5524/100127, and 10.5524/100128) and at crocgenomes.org. This project was conducted by the International Crocodilian Genomes Working Group (ICGWG; www.crocgenomes.org). Supported by NSF grants MCB-1052500 and DEB-1020865 (D.A.R.), MCB-0841821 (D.A.R., D.G.P., F.M.M., C.J.S.), DUE-0920151 (E.L.B., E.W.T.), DBI-0905714 (M.K.F.), and DEB-1242260 (B.C.F.). D.A.R., F.M.M., and D.G.P. were also supported by the Institute for Genomics, Biocomputing and Biotechnology at Mississippi State University. S.R.I., L.G.M., J.G., and C.M. were supported by Australian Rural Industries Research and Development Corporation grants (RIRDC PRJ-000549, RIRDC PRJ-005355, RIRDC PRJ-002461). R.E.G. is a Searle Scholar, Sloan Fellow, and consultant for Dovetail Genomics.. E.D.J. was supported by the Howard Hughes Medical Institute and the National Institutes of Health. E.L. received support from the Gordon and Betty Moore Foundation (#3383). R. Elsey, S. Lance, and T. Tuberville aided in collecting alligator samples. The following centers were vital in permitting the computational analyses required for this project: The High Performance Computing Collaborative (HPC2) at Mississippi State University, the High Performance Computing Center at Texas Tech University, the Georgia Advanced Computing Resource Center at the University of Georgia, the University of Florida High Performance Computing Center. The National Institutes of Health provided funding for UCSC infrastructure used in computing whole genome alignments and ancestral genome reconstructions (1U41HG007234-01, 1U41HG006992-2, 5U01HG004695). Finally, we are grateful to K. Vliet and D. Barber for providing access to fresh gharial blood.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Blanchette M, 2004, GENOME RES, V14, P2412, DOI 10.1101/gr.2800104; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Brochu CA, 1997, SYST BIOL, V46, P479, DOI 10.2307/2413693; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Castoe TA, 2013, P NATL ACAD SCI USA, V110, P20645, DOI 10.1073/pnas.1314475110; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; COHEN M M, 1970, Cytogenetics (Basel), V9, P81, DOI 10.1159/000130080; Cordaux R, 2006, GENE, V373, P138, DOI 10.1016/j.gene.2006.01.020; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Elsey RM, 2010, CROCODILES STATUS SU, P1; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Gabaldon T, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-235; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grigg G, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P297; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harshman J, 2003, SYST BIOL, V52, P386, DOI 10.1080/10635150390197028; Hickey G, 2013, BIOINFORMATICS, V29, P1341, DOI 10.1093/bioinformatics/btt128; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; Huerta-Cepas J, 2008, NUCLEIC ACIDS RES, V36, pD491, DOI 10.1093/nar/gkm899; Huerta-Cepas J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r109; Huerta-Cepas J, 2014, NUCLEIC ACIDS RES, V42, pD897, DOI 10.1093/nar/gkt1177; Huerta-Cepas J, 2011, BIOINFORMATICS, V27, P38, DOI 10.1093/bioinformatics/btq609; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Janke A, 1997, MOL BIOL EVOL, V14, P1266, DOI 10.1093/oxfordjournals.molbev.a025736; Janke A, 2005, J MOL EVOL, V61, P620, DOI 10.1007/s00239-004-0336-9; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kunstner A, 2011, GENOME BIOL EVOL, V3, P1381, DOI 10.1093/gbe/evr112; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANG JW, 1994, J EXP ZOOL, V270, P28, DOI 10.1002/jez.1402700105; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lin YH, 2002, GENE, V294, P119, DOI 10.1016/S0378-1119(02)00695-9; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; McCormack JE, 2012, GENOME RES, V22, P746, DOI 10.1101/gr.125864.111; Nguyen N, 2014, LECT N BIOINFORMAT, V8394, P207, DOI 10.1007/978-3-319-05269-4_17; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Oaks JR, 2011, EVOLUTION, V65, P3285, DOI 10.1111/j.1558-5646.2011.01373.x; OLMO E, 1981, GENETICA, V57, P39, DOI 10.1007/BF00057541; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Paten B, 2011, GENOME RES, V21, P1512, DOI 10.1101/gr.123356.111; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Sennikov AG, 2012, PALEONTOL J+, V46, P499, DOI 10.1134/S0031030112050097; Shaffer HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r28; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smit A. F. A., 2001, REPEATMODELER OPEN 1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Steiger SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-446; Stephen S, 2008, MOL BIOL EVOL, V25, P402, DOI 10.1093/molbev/msm268; Stevenson C., 2010, CROCODILES STATUS SU, P139; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomson RC, 2010, SYST BIOL, V59, P42, DOI 10.1093/sysbio/syp075; Tzika AC, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-19; van de Wal RSW, 2011, CLIM PAST, V7, P1459, DOI 10.5194/cp-7-1459-2011; Vonk FJ, 2013, P NATL ACAD SCI USA, V110, P20651, DOI 10.1073/pnas.1314702110; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; Wan QH, 2013, CELL RES, V23, P1091, DOI 10.1038/cr.2013.104; Wang Z, 2013, NAT GENET, V45, P701, DOI 10.1038/ng.2615; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wehe A, 2008, BIOINFORMATICS, V24, P1540, DOI 10.1093/bioinformatics/btn230; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385	82	218	226	2	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1335	+		10.1126/science.1254449	http://dx.doi.org/10.1126/science.1254449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504731	Green Accepted, Green Published			2022-12-28	WOS:000346189600040
J	Vaharautio, A; Taipale, J				Vaehaerautio, Anna; Taipale, Jussi			Cancer by super-enhancer	SCIENCE			English	Editorial Material							TERT PROMOTER MUTATIONS; BETA-GLOBIN GENE; TRANSGENIC MICE; GENOME; EXPRESSION; MELANOMA		[Vaehaerautio, Anna; Taipale, Jussi] Univ Helsinki, Genome Scale Biol Program, FIN-00014 Helsinki, Finland; [Taipale, Jussi] Karolinska Inst, Dept Biosci & Nutr, Sci Life Lab, Stockholm, Sweden	University of Helsinki; Karolinska Institutet	Vaharautio, A (corresponding author), Univ Helsinki, Genome Scale Biol Program, FIN-00014 Helsinki, Finland.	jussi.taipale@ki.se	Vähärautio, Anna/K-4279-2015	Vähärautio, Anna/0000-0003-4721-3954				Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Edelmann J, 2012, BLOOD, V120, P4783, DOI 10.1182/blood-2012-04-423517; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Rhodes JM, 2010, DEV BIOL, V344, P637, DOI 10.1016/j.ydbio.2010.05.493; RYAN TM, 1989, GENE DEV, V3, P314, DOI 10.1101/gad.3.3.314; Sur I, 2013, CANCER RES, V73, P4180, DOI 10.1158/0008-5472.CAN-13-0789; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122	13	19	22	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1291	1292		10.1126/science.aaa3247	http://dx.doi.org/10.1126/science.aaa3247			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW3MA	25504702				2022-12-28	WOS:000346189600022
J	Zhou, Q; Zhang, JL; Bachtrog, D; An, N; Huang, QF; Jarvis, ED; Gilbert, MTP; Zhang, GJ				Zhou, Qi; Zhang, Jilin; Bachtrog, Doris; An, Na; Huang, Quanfei; Jarvis, Erich D.; Gilbert, M. Thomas P.; Zhang, Guojie			Complex evolutionary trajectories of sex chromosomes across bird taxa	SCIENCE			English	Article							HUMAN X-CHROMOSOME; HUMAN Y-CHROMOSOME; CHICKEN Z; INDEPENDENT CESSATION; EUDROMIA-ELEGANS; GENE-EXPRESSION; W-CHROMOSOME; GENOME; DIFFERENTIATION; STRATA	Sex-specific chromosomes, like the W of most female birds and the Y of male mammals, usually have lost most genes owing to a lack of recombination. We analyze newly available genomes of 17 bird species representing the avian phylogenetic range, and find that more than half of them do not have as fully degenerated W chromosomes as that of chicken. We show that avian sex chromosomes harbor tremendous diversity among species in their composition of pseudoautosomal regions and degree of Z/W differentiation. Punctuated events of shared or lineage-specific recombination suppression have produced a gradient of "evolutionary strata" along the Z chromosome, which initiates from the putative avian sex-determining gene DMRT1 and ends at the pseudoautosomal region. W-linked genes are subject to ongoing functional decay after recombination was suppressed, and the tempo of degeneration slows down in older strata. Overall, we unveil a complex history of avian sex chromosome evolution.	[Zhou, Qi; Bachtrog, Doris] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Zhang, Jilin; An, Na; Huang, Quanfei; Zhang, Guojie] BGI Shenzhen, China Natl Genebank, Shenzhen 518083, Peoples R China; [Jarvis, Erich D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA; [Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Gilbert, M. Thomas P.] Curtin Univ, Dept Environm & Agr, Trace & Environm DNA Lab, Perth, WA 6102, Australia; [Zhang, Guojie] Univ Copenhagen, Dept Biol, Ctr Social Evolut, DK-2100 Copenhagen, Denmark	University of California System; University of California Berkeley; Beijing Genomics Institute (BGI); Duke University; Howard Hughes Medical Institute; University of Copenhagen; Curtin University; University of Copenhagen	Zhou, Q (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	zhouqi@berke-ley.edu; zhanggj@genomics.org.cn	Zhang, Guojie/B-6188-2014; Zhang, Guojie/J-7273-2019; Gilbert, Marcus TP/A-8936-2013; Jarvis, Erich D/A-2319-2008	Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; Gilbert, Marcus TP/0000-0002-5805-7195; Jarvis, Erich D/0000-0001-8931-5049; Zhang, Jilin/0000-0002-9976-1605	National Key Basic Research Program of China (973 Program) [2013CB945200]; National Institutes of Health [GM076007, GM093182]; Packard Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093182, R01GM076007] Funding Source: NIH RePORTER	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Vicoso, R. Bowie, M. Sayres, I. Nanda, and D. Charlesworth for insightful comments and discussions; A. Thais for sharing the green anole lizard photo; O. Ryder and W. Wang for providing the ostrich sample; and the teams of N. Xiao and Z. Bin at OpGen Inc. for performing the optical mapping and technical assistance. We also thank five anonymous reviewers for constructive comments and suggestion. This work was supported by the National Key Basic Research Program of China (973 Program: 2013CB945200) to G.Z. Q.Z. is supported by grants from the National Institutes of Health (GM076007 and GM093182) and a Packard Fellowship to D. B. Raw sequence reads and assembled genomes and gene annotation are deposited at http://phybirds.genomics.org.cn/genome.jsp	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Ayers KL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r26; Bachtrog D, 2008, GENETICS, V179, P1513, DOI 10.1534/genetics.107.084012; Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; Berlin S, 2006, J MOL EVOL, V62, P66, DOI 10.1007/s00239-005-0067-6; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Bull JJ, 1983, EVOLUTION OF SEX DET; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; CHARLESWORTH D, 1980, GENET RES, V35, P205, DOI 10.1017/S0016672300014051; Cortez D, 2014, NATURE, V508, P488, DOI 10.1038/nature13151; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; de Kloet RS, 2003, GENETICA, V119, P333, DOI 10.1023/B:GENE.0000003842.72339.df; Ellegren H, 2001, GENETICS, V158, P325; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Fan WL, 2013, GENOME BIOL EVOL, V5, P1376, DOI 10.1093/gbe/evt097; Fridolfsson AK, 1998, P NATL ACAD SCI USA, V95, P8147, DOI 10.1073/pnas.95.14.8147; Garcia-Moreno J, 2000, MOL BIOL EVOL, V17, P1826, DOI 10.1093/oxfordjournals.molbev.a026283; Guioli S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002560; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Handley LL, 2004, GENETICS, V167, P367, DOI 10.1534/genetics.167.1.367; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Pigozzi MI, 2011, GENETICA, V139, P771, DOI 10.1007/s10709-011-9581-1; Itoh Y, 2009, CHROMOSOMA, V118, P323, DOI 10.1007/s00412-008-0199-8; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Kawai A, 2007, CYTOGENET GENOME RES, V117, P92, DOI 10.1159/000103169; Kawai A, 2009, CHROMOSOMA, V118, P43, DOI 10.1007/s00412-008-0176-2; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lemaitre C, 2009, GENOME BIOL EVOL, V1, P56, DOI 10.1093/gbe/evp006; Li G, 2013, GENOME RES, V23, P1486, DOI 10.1101/gr.154286.112; Nam K, 2008, GENETICS, V180, P1131, DOI 10.1534/genetics.108.090324; Nanda I, 2008, CYTOGENET GENOME RES, V122, P150, DOI 10.1159/000163092; Nishida-Umehara C, 1999, CHROMOSOME RES, V7, P635, DOI 10.1023/A:1009236103013; Ogawa A, 1998, P NATL ACAD SCI USA, V95, P4415, DOI 10.1073/pnas.95.8.4415; Pigozzi LI, 1999, BIOCELL, V23, P79; RICE WR, 1987, EVOLUTION, V41, P911, DOI 10.1111/j.1558-5646.1987.tb05864.x; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rutkowska J, 2012, BIOL LETTERS, V8, P636, DOI 10.1098/rsbl.2012.0083; Sandstedt SA, 2004, GENOME RES, V14, P267, DOI 10.1101/gr.1796204; Sayres MAW, 2013, MOL BIOL EVOL, V30, P781, DOI 10.1093/molbev/mss267; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Tsuda Y, 2007, CHROMOSOMA, V116, P159, DOI 10.1007/s00412-006-0088-y; Vicoso B, 2013, P NATL ACAD SCI USA, V110, P6453, DOI 10.1073/pnas.1217027110; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wright AE, 2012, GENETICS, V192, P1433, DOI 10.1534/genetics.112.145102; Yazdi HP, 2014, MOL BIOL EVOL, V31, P1444, DOI 10.1093/molbev/msu101; Ye L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r31; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385	50	178	188	6	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1332	+		10.1126/science.1246338	http://dx.doi.org/10.1126/science.1246338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504727	Green Published, Green Accepted			2022-12-28	WOS:000346189600037
J	Ayanian, JZ; Landon, BE; Newhouse, JP; Zaslavsky, AM				Ayanian, John Z.; Landon, Bruce E.; Newhouse, Joseph P.; Zaslavsky, Alan M.			Racial and Ethnic Disparities among Enrollees in Medicare Advantage Plans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-CARE; LIFE EXPECTANCY GAP; UNITED-STATES; MANAGED CARE; TRADITIONAL MEDICARE; PART D; TRENDS; HEALTH; HYPERTENSION; PREVALENCE	BACKGROUND Differences in the control of blood pressure, cholesterol, and glucose among the various racial and ethnic groups of Medicare enrollees may contribute to persistent disparities in health outcomes. METHODS Among elderly enrollees in Medicare Advantage health plans in 2011 who had hypertension (94,171 persons), cardiovascular disease (112,039), or diabetes (105,848), we compared the respective age-and-sex-adjusted proportions with blood pressure lower than 140/90 mm Hg, low-density lipoprotein cholesterol levels below 100 mg per deciliter (2.6 mmol per liter), and a glycated hemoglobin value of 9.0% or lower, according to race or ethnic group. Comparisons were made nationally and within regions and health plans, and changes since 2006 were assessed. RESULTS Black enrollees in 2006 and 2011 were substantially less likely than white enrollees to have adequate control of blood pressure (adjusted absolute differences in proportions of enrollees in the 2 years, 7.9 percentage points and 10.3 percentage points, respectively), cholesterol (11.4 percentage points and 10.2 percentage points, respectively), and glycated hemoglobin (10.1 percentage points and 9.4 percentage points, respectively) (P<0.001 for all comparisons). Differing distributions of enrollees among health plans accounted for 39 to 59% of observed disparities in 2011. These differences persisted in 2011 in the Northeast, Midwest, and South (6.9 to 14.1 percentage points, P<0.001 for all comparisons) but were eliminated in the West for all three measures (<1.5 percentage points, P >= 0.15). Hispanic enrollees were less likely than whites in 2011 to have adequate control of blood pressure (adjusted difference, 1.6 percentage points), cholesterol (adjusted difference, 1.0 percentage points), and glycated hemoglobin (adjusted difference, 3.4 percentage points) (P <= 0.02 for all comparisons). Asians and Pacific Islanders were more likely than whites to have adequate control of blood pressure (difference, 4.4 percentage points; P<0.001) and cholesterol (5.5 percentage points, P<0.001) and had similar control of glycated hemoglobin (0.3 percentage points, P = 0.63). CONCLUSIONS Disparities in control of blood pressure, cholesterol, and glucose have not improved nationally for blacks in Medicare Advantage plans, but these disparities were eliminated in the West in 2011.	[Ayanian, John Z.] Univ Michigan, Inst Healthcare Policy & Innovat, Div Gen Med, Sch Med, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Ayanian, John Z.; Landon, Bruce E.; Newhouse, Joseph P.; Zaslavsky, Alan M.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Landon, Bruce E.] Harvard Univ, Sch Med, Boston, MA USA; [Newhouse, Joseph P.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Newhouse, Joseph P.] Harvard Kennedy Sch, Cambridge, MA USA; [Newhouse, Joseph P.] Natl Bur Econ Res, Cambridge, MA 02138 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; National Bureau of Economic Research	Ayanian, JZ (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, 2800 Plymouth Rd,North Campus Res Complex,Bldg 16, Ann Arbor, MI 48109 USA.	ayanian@umich.edu	Newhouse, Joseph/AGJ-5632-2022; Newhouse, Joseph/AAD-9763-2019		National Institute on Aging; NATIONAL INSTITUTE ON AGING [P01AG032952] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institute on Aging.	Agency for Healthcare Research and Quality, 2012, CREAT NEW RAC ETHN C; [Anonymous], QUAL MEAS PERF STAND; Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; August KJ, 2011, J GEN INTERN MED, V26, P245, DOI 10.1007/s11606-010-1514-7; Ayanian JZ, 2013, JNCI-J NATL CANCER I, V105, P1891, DOI 10.1093/jnci/djt333; Ayanian JZ, 2013, HEALTH AFFAIR, V32, P1228, DOI 10.1377/hlthaff.2012.0773; Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Harper S, 2007, JAMA-J AM MED ASSOC, V297, P1224, DOI 10.1001/jama.297.11.1224; Harper S, 2012, JAMA-J AM MED ASSOC, V307, P2257, DOI 10.1001/jama.2012.5059; Heisler M, 2007, ARCH INTERN MED, V167, P1853, DOI 10.1001/archinte.167.17.1853; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jones RG, 2010, SOC SCI MED, V70, P337, DOI 10.1016/j.socscimed.2009.10.030; *KAIS FAM FDN, 2013, MED D; Kuklina E. V., 2011, Morbidity and Mortality Weekly Report, V60, P109; Lewey J, 2013, AM HEART J, V165, P665, DOI 10.1016/j.ahj.2013.02.011; Li PX, 2012, ANN INTERN MED, V156, P776, DOI 10.7326/0003-4819-156-11-201206050-00004; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; National Committee for Quality Assurance, 2012, HEDIS 2012, V2; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Reed M, 2013, JAMA-J AM MED ASSOC, V310, P1060, DOI 10.1001/jama.2013.276733; Reed M, 2012, ANN INTERN MED, V157, P482, DOI 10.7326/0003-4819-157-7-201210020-00004; Schneider EC, 2002, JAMA-J AM MED ASSOC, V287, P1288, DOI 10.1001/jama.287.10.1288; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Sequist TD, 2006, ARCH INTERN MED, V166, P675, DOI 10.1001/archinte.166.6.675; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thorlby R, 2011, MILBANK Q, V89, P226, DOI 10.1111/j.1468-0009.2011.00627.x; Trivedi AN, 2006, JAMA-J AM MED ASSOC, V296, P1998, DOI 10.1001/jama.296.16.1998; Trivedi AN, 2011, HEALTH AFFAIR, V30, P707, DOI 10.1377/hlthaff.2011.0074; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Vulic D, 2010, AM J CARDIOVASC DRUG, V10, P109, DOI 10.2165/11535240-000000000-00000; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zaslavsky AM, 2012, HEALTH SERV RES, V47, P1300, DOI 10.1111/j.1475-6773.2012.01411.x; Zhang Y, 2009, NEW ENGL J MED, V361, P52, DOI 10.1056/NEJMsa0807998; Zhou YY, 2010, HEALTH AFFAIR, V29, P1370, DOI 10.1377/hlthaff.2010.0048	37	90	90	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					2288	2297		10.1056/NEJMsa1407273	http://dx.doi.org/10.1056/NEJMsa1407273			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW1KQ	25494268	Green Accepted			2022-12-28	WOS:000346048800009
J	Foden, N; Ellis, M; Shepherd, K; Joseph, T				Foden, N.; Ellis, M.; Shepherd, K.; Joseph, T.			A feeling of a lump in the throat	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLOBUS PHARYNGEUS; MANAGEMENT; DIAGNOSIS; PERSPECTIVE; REFLUX		[Foden, N.; Ellis, M.; Joseph, T.] Royal Natl Throat Nose & Ear Hosp, London WC1X 8DA, England; [Shepherd, K.] Manor Hlth Ctr, Wirral, Merseyside, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Foden, N (corresponding author), Royal Natl Throat Nose & Ear Hosp, Grays Inn Rd, London WC1X 8DA, England.	neilfoden@hotmail.com						Burns P, 2008, CURR OPIN OTOLARYNGO, V16, P503, DOI 10.1097/MOO.0b013e3283169258; Corso MJ, 1998, DIGEST DIS SCI, V43, P1513, DOI 10.1023/A:1018862814873; Ford CN, 2005, JAMA-J AM MED ASSOC, V294, P1534, DOI 10.1001/jama.294.12.1534; Galmiche JP, 2006, GASTROENTEROLOGY, V130, P1459, DOI 10.1053/j.gastro.2005.08.060; Karkos PD, 2008, CURR OPIN OTOLARYNGO, V16, P521, DOI 10.1097/MOO.0b013e328316933b; Lee BE, 2012, WORLD J GASTROENTERO, V18, P2462, DOI 10.3748/wjg.v18.i20.2462; MOLOY PJ, 1982, ARCH OTOLARYNGOL, V108, P740, DOI 10.1001/archotol.1982.00790590062017	7	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2014	348								f7195	10.1136/bmj.f7195	http://dx.doi.org/10.1136/bmj.f7195			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	288KF	25489929				2022-12-28	WOS:000329610000001
J	Ness, PM; Frank, SM				Ness, Paul M.; Frank, Steven M.			Enhancing patient blood management: a long-term FOCUS	LANCET			English	Editorial Material							TRANSFUSION REQUIREMENTS; RESTRICTIVE TRANSFUSION; STRATEGIES; SURGERY		[Ness, Paul M.] Johns Hopkins Univ Hosp, Transfus Med, Baltimore, MD 21287 USA; [Frank, Steven M.] Johns Hopkins Univ Hosp, Johns Hopkins Hlth Syst, Blood Management Program, Baltimore, MD 21287 USA; [Ness, Paul M.; Frank, Steven M.] Johns Hopkins Univ, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Ness, PM (corresponding author), Johns Hopkins Univ Hosp, Transfus Med, Baltimore, MD 21287 USA.	pness@jhmi.edu	Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899				BERNSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V260, P2700; Carson JL, 2013, AM HEART J, V165, P964, DOI 10.1016/j.ahj.2013.03.001; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Carson JL, 2014, LANCET; Chalfin HJ, 2014, TRANSFUSION, V54, P2168, DOI 10.1111/trf.12611; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; NESS PM, 1992, TRANSFUSION, V32, P31, DOI 10.1046/j.1537-2995.1992.32192116429.x; Rohde JM, 2014, JAMA-J AM MED ASSOC, V311, P1317, DOI 10.1001/jama.2014.2726; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Waters JW, 2008, BLOOD MANAGEMENT OPT	13	2	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1157	1159		10.1016/S0140-6736(14)62344-8	http://dx.doi.org/10.1016/S0140-6736(14)62344-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CE3GQ	25499166				2022-12-28	WOS:000351715100007
J	Cahova, H; Winz, ML; Hofer, K; Nubel, G; Jaschke, A				Cahova, Hana; Winz, Marie-Luise; Hoefer, Katharina; Nuebel, Gabriele; Jaeschke, Andres			NAD captureSeq indicates NAD as a bacterial cap for a subset of regulatory RNAs	NATURE			English	Article							ESCHERICHIA-COLI K-12; INTEGRATION HOST FACTOR; GENE-EXPRESSION; MESSENGER-RNA; ACID RESISTANCE; NUCLEOTIDE-SEQUENCE; BIOFILM FORMATION; TERMINAL ALKYNES; PRIMER FORMATION; STRESS-RESPONSE	Adistinctive feature of prokaryotic gene expression is the absence of 5'-capped RNA. In eukaryotes, 5',5'-triphosphate-linked 7-methyl-guanosine protects messenger RNA from degradation and modulates maturation, localization and translation(1). Recently, the cofactor nicotinamide adenine dinucleotide (NAD) was reported as a covalent modification of bacterial RNA(2). Given the central role of NAD in redox biochemistry, posttranslational protein modification and signalling(3,4), its attachment to RNA indicates that there are unknown functions of RNA in these processes and undiscovered pathways in RNA metabolism and regulation. The unknown identity of NAD-modified RNAs has so far precluded functional analyses. Here we identify NAD-linked RNAs from bacteria by chemo-enzymatic capture and next-generation sequencing(NAD captureSeq). A mong those identified, specific regulatory small RNAs (sRNAs) and sRNA-like 5'-terminal fragments of certain mRNAs are particularly abundant. Analogous to a eukaryotic cap, 5'-NAD modification is shown in vitro to stabilize RNA against 5'-processing by the RNA-pyrophosphohydrolase RppH(5) and against endonucleolytic cleavage by ribonuclease (RNase) E-6. The nudix phosphohydrolase NudC(7) decaps NAD-RNA and thereby triggers RNase-E-mediated RNA decay, while being inactive against triphosphate-RNA. In vivo, similar to 13% of the abundant sRNA RNAI is NAD-capped in the presence, and similar to 26% in the absence, of functional NudC. To our knowledge, this is the first description of a cap-like structure and a decapping machinery in bacteria.	[Cahova, Hana; Winz, Marie-Luise; Hoefer, Katharina; Nuebel, Gabriele; Jaeschke, Andres] Heidelberg Univ, IPMB, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Jaschke, A (corresponding author), Heidelberg Univ, IPMB, D-69120 Heidelberg, Germany.	jaeschke@uni-hd.de	Jäschke, Andres/F-1575-2010; Winz, Marie-Luise/AAZ-4601-2020; Cahova, Hana/O-4595-2014	Jäschke, Andres/0000-0002-4625-2655; Winz, Marie-Luise/0000-0003-0740-8618; Cahova, Hana/0000-0002-4986-7858; Hofer, Katharina/0000-0002-7472-9887	Alexander-von-Humboldt Foundation; Hartmut Hoffmann-Berling International Graduate School of Molecular & Cellular Biology; Deutsche Forschungsgemeinschaft [SFB 623]; Federal Ministry of Education and Research (BMBF); Helmholtz Initiative on Synthetic Biology	Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); Hartmut Hoffmann-Berling International Graduate School of Molecular & Cellular Biology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Initiative on Synthetic Biology	We thank the CellNetworks Deep Sequencing Core Facility for Solexa sequencing, M. Brunner for access to the light cycler, M. Helm for advice on RNA mass spectrometry and B. Luisi for the RNase E expression vector, as well as A. Krause, J. Becker, A. Samanta, M. Tesch, F. Siebert, L. Obenauer and other members of the Jaschke laboratory for help and discussions. H.C. was supported by a postdoctoral fellowship from the Alexander-von-Humboldt Foundation. M.-L.W. acknowledges a PhD fellowship from the Hartmut Hoffmann-Berling International Graduate School of Molecular & Cellular Biology. A.J. is supported by the Deutsche Forschungsgemeinschaft, SFB 623, the Federal Ministry of Education and Research (BMBF), and the Helmholtz Initiative on Synthetic Biology.	Agafonov DE, 1999, P NATL ACAD SCI USA, V96, P12345, DOI 10.1073/pnas.96.22.12345; Agafonov DE, 2001, EMBO REP, V2, P399; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; ANDERSEN J, 1989, J BIOL CHEM, V264, P17961; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; Bandyra KJ, 2013, BBA-GENE REGUL MECH, V1829, P514, DOI 10.1016/j.bbagrm.2013.02.011; Bandyra KJ, 2012, MOL CELL, V47, P943, DOI 10.1016/j.molcel.2012.07.015; BERNOFSKY C, 1981, BIOCHIM BIOPHYS ACTA, V659, P1, DOI 10.1016/0005-2744(81)90264-3; BLASI F, 1973, P NATL ACAD SCI USA, V70, P2692, DOI 10.1073/pnas.70.9.2692; BLOMBERG P, 1990, EMBO J, V9, P2331, DOI 10.1002/j.1460-2075.1990.tb07405.x; BURR B, 1976, EUR J BIOCHEM, V62, P519, DOI 10.1111/j.1432-1033.1976.tb10186.x; Caldas T, 2000, J BIOL CHEM, V275, P16414, DOI 10.1074/jbc.M001854200; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Celesnik H, 2008, METHOD ENZYMOL, V447, P83, DOI 10.1016/S0076-6879(08)02205-2; CLARK RB, 1972, BIOCHEMISTRY-US, V11, P1278, DOI 10.1021/bi00757a025; COLE ST, 1988, J BACTERIOL, V170, P2448, DOI 10.1128/jb.170.6.2448-2456.1988; DALESSIO G, 1971, J BIOL CHEM, V246, P4319; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; De Lay N, 2009, J BACTERIOL, V191, P461, DOI 10.1128/JB.01157-08; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Deighan P, 2000, MOL MICROBIOL, V38, P126, DOI 10.1046/j.1365-2958.2000.02120.x; Dhavan GM, 2002, J MOL BIOL, V315, P1027, DOI 10.1006/jmbi.2001.5303; Dumelin CE, 2012, NAT CHEM BIOL, V8, P913, DOI [10.1038/nchembio.1070, 10.1038/NCHEMBIO.1070]; EGUCHI Y, 1990, CELL, V60, P199, DOI 10.1016/0092-8674(90)90736-X; ELOVSON J, 1968, J BIOL CHEM, V243, P3603; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fozo EM, 2008, MOL MICROBIOL, V70, P1076, DOI 10.1111/j.1365-2958.2008.06394.x; FREUNDLICH M, 1992, MOL MICROBIOL, V6, P2557, DOI 10.1111/j.1365-2958.1992.tb01432.x; FRICK DN, 1995, J BIOL CHEM, V270, P1529, DOI 10.1074/jbc.270.4.1529; Gherardini PF, 2010, NUCLEIC ACIDS RES, V38, P3809, DOI 10.1093/nar/gkq090; GHRIST AC, 1995, MICROBIOL-UK, V141, P133, DOI 10.1099/00221287-141-1-133; Gopel Y, 2013, GENE DEV, V27, P552, DOI 10.1101/gad.210112.112; Gustavsson N, 2002, MOL MICROBIOL, V43, P107, DOI 10.1046/j.1365-2958.2002.02720.x; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Halbritter F, 2012, NAT METHODS, V9, P7, DOI 10.1038/nmeth.1809; Hayes ET, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-89; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; HUGOVIEUXCOTTEPATTAT N, 1982, J MOL BIOL, V156, P221, DOI 10.1016/0022-2836(82)90468-5; Imamura R, 1996, J BIOL CHEM, V271, P25423, DOI 10.1074/jbc.271.41.25423; JEANNINGROS R, 1976, BIOCHIM BIOPHYS ACTA, V438, P186, DOI 10.1016/0005-2744(76)90235-7; Jin Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-165; Johansen J, 2008, J MOL BIOL, V383, P1, DOI 10.1016/j.jmb.2008.06.058; JOLY JC, 1993, EMBO J, V12, P255, DOI 10.1002/j.1460-2075.1993.tb05651.x; Jorgensen MG, 2013, GENE DEV, V27, P1132, DOI 10.1101/gad.214734.113; Jorgensen MG, 2012, MOL MICROBIOL, V84, P36, DOI 10.1111/j.1365-2958.2012.07976.x; KAISER K, 1979, MOL GEN GENET, V175, P159, DOI 10.1007/BF00425532; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; KARSTEN WE, 1991, ARCH BIOCHEM BIOPHYS, V287, P60, DOI 10.1016/0003-9861(91)90388-Y; KAWAMUKAI M, 1991, J BACTERIOL, V173, P2644, DOI 10.1128/jb.173.8.2644-2648.1991; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Kim EY, 2004, J MICROBIOL, V42, P103; Kim KS, 2004, NUCLEIC ACIDS RES, V32, P6057, DOI 10.1093/nar/gkh939; LACATENA RM, 1981, NATURE, V294, P623, DOI 10.1038/294623a0; LANGLEY KE, 1978, J BACTERIOL, V136, P85, DOI 10.1128/JB.136.1.85-95.1978; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAWTHER RP, 1980, P NATL ACAD SCI-BIOL, V77, P1862, DOI 10.1073/pnas.77.4.1862; Lease RA, 2000, P NATL ACAD SCI USA, V97, P9919, DOI 10.1073/pnas.170281497; Lease RA, 2004, J BACTERIOL, V186, P6179, DOI 10.1128/JB.186.18.6179-6185.2004; Lease RA, 1998, P NATL ACAD SCI USA, V95, P12456, DOI 10.1073/pnas.95.21.12456; LHOEST J, 1981, EUR J BIOCHEM, V121, P33, DOI 10.1111/j.1432-1033.1981.tb06425.x; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; LONG CW, 1967, J BIOL CHEM, V242, P4715; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Maki Y, 2000, GENES CELLS, V5, P965, DOI 10.1046/j.1365-2443.2000.00389.x; Mandin P, 2009, MOL MICROBIOL, V72, P551, DOI 10.1111/j.1365-2958.2009.06665.x; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; MASUKATA H, 1986, CELL, V44, P125, DOI 10.1016/0092-8674(86)90491-5; McLennan AG, 2013, CELL MOL LIFE SCI, V70, P373, DOI 10.1007/s00018-012-1210-3; Migaud ME, 1999, BIOCHEMISTRY-US, V38, P9105, DOI 10.1021/bi9903392; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Muto A, 1996, BIOCHIMIE, V78, P985, DOI 10.1016/S0300-9084(97)86721-1; NELSON WC, 1995, J BIOL CHEM, V270, P28374; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Nobelmann B, 1996, J BACTERIOL, V178, P6790, DOI 10.1128/jb.178.23.6790-6795.1996; Opdyke JA, 2004, J BACTERIOL, V186, P6698, DOI 10.1128/JB.186.20.6698-6705.2004; Opdyke JA, 2011, J MOL BIOL, V406, P29, DOI 10.1016/j.jmb.2010.12.009; Oppenheimer N. J., 2010, ELS; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Peng CA, 2005, PLANT BIOLOGY, V7, P315, DOI 10.1055/s-2005-865653; PLUMBRIDGE JA, 1991, MOL MICROBIOL, V5, P2053, DOI 10.1111/j.1365-2958.1991.tb00828.x; Preugschat F, 2008, ARCH BIOCHEM BIOPHYS, V479, P114, DOI 10.1016/j.abb.2008.09.005; Pulvermacher SC, 2009, MICROBIOL-SGM, V155, P106, DOI 10.1099/mic.0.023598-0; Purta E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-23; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Rasmussen AA, 2009, MOL MICROBIOL, V72, P566, DOI 10.1111/j.1365-2958.2009.06688.x; Reichenbach B, 2008, NUCLEIC ACIDS RES, V36, P2570, DOI 10.1093/nar/gkn091; Richards J, 2012, MOL MICROBIOL, V86, P1063, DOI 10.1111/mmi.12040; ROBBINS JC, 1973, J BACTERIOL, V116, P12, DOI 10.1128/JB.116.1.12-18.1973; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Rodionov DA, 2000, MOL MICROBIOL, V38, P673, DOI 10.1046/j.1365-2958.2000.02115.x; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; RUDOLPH FB, 1971, ARCH BIOCHEM BIOPHYS, V147, P92, DOI 10.1016/0003-9861(71)90313-4; SCHRYVERS A, 1978, J BIOL CHEM, V253, P783; Serres MH, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-9-research0035; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Sledjeski DD, 1996, EMBO J, V15, P3993, DOI 10.1002/j.1460-2075.1996.tb00773.x; Song MG, 2013, RNA, V19, P390, DOI 10.1261/rna.037309.112; SPARROW CP, 1985, J BIOL CHEM, V260, P2084; STARNES WL, 1972, BIOCHEMISTRY-US, V11, P677, DOI 10.1021/bi00755a003; SUMMERS MC, 1977, J AM CHEM SOC, V99, P4475, DOI 10.1021/ja00455a044; Takeda K, 2001, BIOSCI BIOTECH BIOCH, V65, P213, DOI 10.1271/bbb.65.213; THEOBALD A, 1988, EUR J BIOCHEM, V175, P511, DOI 10.1111/j.1432-1033.1988.tb14223.x; Thomason MK, 2012, MOL MICROBIOL, V84, P17, DOI 10.1111/j.1365-2958.2012.07965.x; TOMCSANYI T, 1985, J MOL BIOL, V185, P713, DOI 10.1016/0022-2836(85)90056-7; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Trotochaud AE, 2004, J BACTERIOL, V186, P4978, DOI 10.1128/JB.186.15.4978-4985.2004; Tschowri N, 2009, GENE DEV, V23, P522, DOI 10.1101/gad.499409; Tucker DL, 2002, J BACTERIOL, V184, P6551, DOI 10.1128/JB.184.23.6551-6558.2002; Urban JH, 2008, PLOS BIOL, V6, P631, DOI 10.1371/journal.pbio.0060064; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; WADA A, 1987, J BIOCHEM, V101, P817, DOI 10.1093/jb/101.3.817; Wagner EGH, 1986, NUCLEIC ACIDS RES, V14, P2523, DOI 10.1093/nar/14.6.2523; WALSETH TF, 1993, BIOCHIM BIOPHYS ACTA, V1178, P235, DOI 10.1016/0167-4889(93)90199-Y; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Weber MM, 2010, MICROBIOL-SGM, V156, P139, DOI 10.1099/mic.0.031468-0; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; WHITE PJ, 1988, BIOCHEM J, V251, P313, DOI 10.1042/bj2510313; WHITE RJ, 1968, BIOCHEM J, V106, P847, DOI 10.1042/bj1060847; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889	128	155	156	2	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					374	+		10.1038/nature14020	http://dx.doi.org/10.1038/nature14020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25533955				2022-12-28	WOS:000351171900046
J	Jandzik, D; Garnett, AT; Square, TA; Cattell, MV; Yu, JK; Medeiros, DM				Jandzik, David; Garnett, Aaron T.; Square, Tyler A.; Cattell, Maria V.; Yu, Jr-Kai; Medeiros, Daniel M.			Evolution of the new vertebrate head by co-option of an ancient chordate skeletal tissue	NATURE			English	Article							FIBROBLAST-GROWTH-FACTOR; NEURAL CREST; CARTILAGINOUS TISSUES; GENE; AMPHIOXUS; LAMPREY; SOXE; EXPRESSION; ORIGIN; FGF	A defining feature of vertebrates (craniates) is a pronounced head that is supported and protected by a robust cellular endoskeleton. In the first vertebrates, this skeleton probably consisted of collagenous cellular cartilage, which forms the embryonic skeleton of all vertebrates and the adult skeleton of modern jawless and cartilaginous fish. In the head, most cellular cartilage is derived from a migratory cell population called the neural crest, which arises from the edges of the central nervous system. Because collagenous cellular cartilage and neural crest cells have not been described in invertebrates', the appearance of cellular cartilage derived from neural crest cells is considered a turning point in vertebrate evolution'. Here we show that a tissue with many of the defining features of vertebrate cellular cartilage transiently forms in the larvae of the invertebrate chordate Branchiostoma floridae (Florida amphioxus). We also present evidence that during evolution, a key regulator of vertebrate cartilage development, SoxE, gained new cis-regulatory sequences that subsequently directed its novel expression in neural crest cells. Together, these results suggest that the origin of the vertebrate head skeleton did not depend on the evolution of a new skeletal tissue, as is commonly thought, but on the spread of this tissue throughout the head. We further propose that the evolution of cis-regulatory elements near an ancient regulator of cartilage differentiation was a major factor in the evolution of the vertebrate head skeleton.	[Jandzik, David; Garnett, Aaron T.; Square, Tyler A.; Cattell, Maria V.; Medeiros, Daniel M.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Jandzik, David] Comenius Univ, Dept Zool, Bratislava 84215, Slovakia; [Yu, Jr-Kai] Acad Sinica, Inst Cellular & Organism Biol, Taipei 11529, Taiwan	University of Colorado System; University of Colorado Boulder; Comenius University Bratislava; Academia Sinica - Taiwan	Medeiros, DM (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	Daniel.Medeiros@Colorado.edu	Yu, Jr-Kai/H-4822-2019; jandzik, david/AAT-5002-2021; jandzik, david/N-7985-2016; Square, Tyler Alexander/J-6271-2019	Yu, Jr-Kai/0000-0001-8591-0529; jandzik, david/0000-0002-4239-0014; jandzik, david/0000-0002-4239-0014; Square, Tyler/0000-0002-7579-5122; MEDEIROS, DANIEL/0000-0002-8182-6028	National Science Foundation [IOS 1257040, IOS 1160733, DBI 0905991]; University of Colorado, Boulder start-up funds; National Science Council Taiwan [NSC101-2923-B-001-004-MY2, NSC102-2311-B-001-011-MY3]; Academia Sinica Taiwan [AS-98-CDA-L06]	National Science Foundation(National Science Foundation (NSF)); University of Colorado, Boulder start-up funds; National Science Council Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica Taiwan(Academia Sinica - Taiwan)	We thank D. Brunelle, C-H. Tung and T.-K. Huang for assistance with amphioxus husbandry, and P. Tsai and D. W. Stock for use of their microtomes. D.M.M., D.J., TA.S. and M.V.C. were supported by National Science Foundation grants IOS 1257040 and IOS 1160733 (D.M.M.) and University of Colorado, Boulder start-up funds (D.M.M.). A.T.G. was supported by National Science Foundation grant DBI 0905991. J.-K.Y. was supported by National Science Council Taiwan grants NSC101-2923-B-001-004-MY2 and NSC102-2311-B-001-011-MY3 and Career Development Award AS-98-CDA-L06 from Academia Sinica Taiwan.	Betancur P, 2010, P NATL ACAD SCI USA, V107, P3570, DOI 10.1073/pnas.0906596107; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Chen JY, 1999, NATURE, V402, P518, DOI 10.1038/990080; Cole AG, 2004, ZOOLOGY, V107, P261, DOI 10.1016/j.zool.2004.05.001; Conklin EG, 1932, J MORPHOL, V54, P69, DOI 10.1002/jmor.1050540103; Cossais F, 2010, DEV BIOL, V341, P267, DOI 10.1016/j.ydbio.2010.01.038; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Jandzik D, 2014, DEVELOPMENT, V141, P629, DOI 10.1242/dev.097261; Kaneto S, 2011, J EXP ZOOL PART B, V316B, P409, DOI 10.1002/jez.b.21411; Kumar M, 2012, DEV DYNAM, V241, P1091, DOI 10.1002/dvdy.23768; Lakiza O, 2011, DEV BIOL, V359, P149, DOI 10.1016/j.ydbio.2011.08.012; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Li W, 2007, DEV BIOL, V304, P338, DOI 10.1016/j.ydbio.2006.12.042; Manzanares M, 2000, NATURE, V408, P854, DOI 10.1038/35048570; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; Medeiros DM, 2013, WIRES DEV BIOL, V2, P1, DOI 10.1002/wdev.85; Meulemans D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000787; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Ohtanii K, 2008, J EXP ZOOL PART B, V310B, P596, DOI 10.1002/jez.b.21231; Paris M, 2008, CURR BIOL, V18, P825, DOI 10.1016/j.cub.2008.04.078; Rychel AL, 2007, J EXP ZOOL PART B, V308B, P325, DOI 10.1002/jez.b.21157; Sauka-Spengler T, 2007, DEV CELL, V13, P405, DOI 10.1016/j.devcel.2007.08.005; Van Otterloo E, 2012, DEVELOPMENT, V139, P720, DOI 10.1242/dev.071308; Walshe J, 2003, DEV BIOL, V264, P522, DOI 10.1016/j.ydbio.2003.08.010; Witten PE, 2010, J APPL ICHTHYOL, V26, P257, DOI 10.1111/j.1439-0426.2010.01416.x; Wright GM, 2001, CELL TISSUE RES, V304, P165, DOI 10.1007/s004410100374; Znosko WA, 2010, DEV BIOL, V342, P11, DOI 10.1016/j.ydbio.2010.03.011	29	57	57	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					534	537		10.1038/nature14000	http://dx.doi.org/10.1038/nature14000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25487155				2022-12-28	WOS:000350097300046
J	Bayer, R; Santelli, J; Klitzman, R				Bayer, Ronald; Santelli, John; Klitzman, Robert			New Challenges for Electronic Health Records Confidentiality and Access to Sensitive Health Information About Parents and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Bayer, Ronald; Klitzman, Robert] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA; [Santelli, John] Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, New York, NY USA	Columbia University; Columbia University	Bayer, R (corresponding author), Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, 722 W 168th St,Ninth Floor, New York, NY 10032 USA.	rb8@cumc.columbia.edu	Santelli, John/AAG-3046-2021		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD058486] Funding Source: NIH RePORTER; NICHD NIH HHS [P2C HD058486] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		American College of Obstetrics and Gynecology (ACOG) Committee on Adolescent Health Care, 2014, ADOLESCENT CONFIDENT; Anoshiravani A, 2012, J ADOLESCENT HEALTH, V51, P409, DOI 10.1016/j.jadohealth.2012.08.003; English A, 2010, STATE MINOR CONSENT; Ford C, 2004, J ADOLESCENT HEALTH, V35, P160, DOI 10.1016/j.jadohealth.2004.03.002; Gray SH, 2014, J ADOLESCENT HEALTH, V54, P487, DOI 10.1016/j.jadohealth.2014.01.011; Harvard School of Public Health; Mathematica Policy Research; RobertWood Johnson Foundation (RWJF), 2013, BETTER INFORMATION S; Klein JD, 1999, J ADOLESCENT HEALTH, V25, P120, DOI 10.1016/S1054-139X(98)00146-3; Schneider JH, 2012, PEDIATRICS, V130, P987, DOI 10.1542/peds.2012-2580	8	34	34	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					29	30		10.1001/jama.2014.15391	http://dx.doi.org/10.1001/jama.2014.15391			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY3IQ	25562260				2022-12-28	WOS:000347478000009
J	Borgeaud, S; Metzger, LC; Scrignari, T; Blokesch, M				Borgeaud, Sandrine; Metzger, Lisa C.; Scrignari, Tiziana; Blokesch, Melanie			The type VI secretion system of Vibrio cholerae fosters horizontal gene transfer	SCIENCE			English	Article							BACTERIAL TRANSFORMATION; NATURAL TRANSFORMATION; DNA-UPTAKE; STRAINS; IDENTIFICATION; COMPETENCE; MECHANISMS; REGULATOR; EFFECTORS; PROTEINS	Natural competence for transformation is a common mode of horizontal gene transfer and contributes to bacterial evolution. Transformation occurs through the uptake of external DNA and its integration into the genome. Here we show that the type VI secretion system (T6SS), which serves as a predatory killing device, is part of the competence regulon in the naturally transformable pathogen Vibrio cholerae. The T6SS-encoding gene cluster is under the positive control of the competence regulators TfoX and QstR and is induced by growth on chitinous surfaces. Live-cell imaging revealed that deliberate killing of nonimmune cells via competence-mediated induction of T6SS releases DNA and makes it accessible for horizontal gene transfer in V. cholerae.	[Borgeaud, Sandrine; Metzger, Lisa C.; Scrignari, Tiziana; Blokesch, Melanie] Ecole Polytech Fed Lausanne, Mol Microbiol Lab, Global Hlth Inst, Sch Life Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Blokesch, M (corresponding author), Ecole Polytech Fed Lausanne, Mol Microbiol Lab, Global Hlth Inst, Sch Life Sci, CH-1015 Lausanne, Switzerland.	melanie.blokesch@epfl.ch	Blokesch, Melanie/A-4057-2013	Blokesch, Melanie/0000-0002-7024-1489; Metzger, Lisa Christina/0000-0001-7398-0941	Swiss National Science Foundation [31003A_143356]; European Research Council [309064-VIR4ENV]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission)	We thank A. Boehm, M. Miller, members of the Institut National de Recherche Biomedicale of the Democratic Republic of the Congo, and M. Lo Scrudato for providing V. cholerae strains. We also acknowledge the service provided by Microsynth and members of the Blokesch laboratory for scientific discussions. This work was supported by the Swiss National Science Foundation (grant 31003A_143356) and the European Research Council (grant 309064-VIR4ENV). Supporting data are provided in the supplementary materials.	Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Blokesch M, 2012, ENVIRON MICROBIOL, V14, P1898, DOI 10.1111/j.1462-2920.2011.02689.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Claverys JP, 2007, NAT REV MICROBIOL, V5, P219, DOI 10.1038/nrmicro1613; Dalia AB, 2014, MBIO, V5, DOI 10.1128/mBio.01028-13; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; Dong TG, 2012, NUCLEIC ACIDS RES, V40, P7766, DOI 10.1093/nar/gks567; Durand E, 2014, TRENDS MICROBIOL, V22, P498, DOI 10.1016/j.tim.2014.06.004; Ishikawa T, 2012, INFECT IMMUN, V80, P575, DOI 10.1128/IAI.05510-11; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Keymer DP, 2007, APPL ENVIRON MICROB, V73, P3705, DOI 10.1128/AEM.02736-06; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Lo Scrudato M, 2013, NUCLEIC ACIDS RES, V41, P3644, DOI 10.1093/nar/gkt041; Lo Scrudato M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002778; Marvig RL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-155; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Miller MC, 2007, APPL ENVIRON MICROB, V73, P3695, DOI 10.1128/AEM.02735-06; Miyata ST, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003752; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Seitz P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004066; Seitz P, 2013, P NATL ACAD SCI USA, V110, P17987, DOI 10.1073/pnas.1315647110; Seitz P, 2013, FEMS MICROBIOL REV, V37, P336, DOI 10.1111/j.1574-6976.2012.00353.x; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Suckow G, 2011, J BACTERIOL, V193, P4914, DOI 10.1128/JB.05396-11; Unterweger D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4549; Yamamoto S, 2014, MOL MICROBIOL, V91, P326, DOI 10.1111/mmi.12462	31	223	232	9	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					63	67		10.1126/science.1260064	http://dx.doi.org/10.1126/science.1260064			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554784				2022-12-28	WOS:000347102300048
J	Rustgi, AK; El-Serag, HB				Rustgi, Anil K.; El-Serag, Hashem B.			Esophageal Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SQUAMOUS-CELL CARCINOMA; GENOME-WIDE ASSOCIATION; HELICOBACTER-PYLORI INFECTION; NUTRITION INTERVENTION TRIALS; DISEASE-SPECIFIC MORTALITY; BARRETTS-ESOPHAGUS; SUSCEPTIBILITY LOCI; GASTRIC CARDIA; GASTROESOPHAGEAL-REFLUX; ORAL BISPHOSPHONATES		[Rustgi, Anil K.] Univ Penn, Dept Med, Div Gastroenterol, Abramson Canc Ctr,Perelman Sch Med, Philadelphia, PA 19104 USA; [Rustgi, Anil K.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Dept Genet, Philadelphia, PA 19104 USA; [El-Serag, Hashem B.] Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center	El-Serag, HB (corresponding author), Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd 152, Houston, TX 77030 USA.	hasheme@bcm.edu						Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Ando N, 2003, J CLIN ONCOL, V21, P4592, DOI 10.1200/JCO.2003.12.095; Bang YJ, 2010, LANCET, V376, P1302; Bass AJ, 2013, CELL STEM CELL, V12, P266, DOI 10.1016/j.stem.2013.02.004; Bennett C, 2012, COCHRANE DB SYST REV, V11; Bird-Lieberman EL, 2012, GASTROENTEROLOGY, V143, P927, DOI 10.1053/j.gastro.2012.06.041; Blaydon DC, 2012, AM J HUM GENET, V90, P340, DOI 10.1016/j.ajhg.2011.12.008; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Cardwell CR, 2010, JAMA-J AM MED ASSOC, V304, P657, DOI 10.1001/jama.2010.1098; Chan Andrew T, 2013, Recent Results Cancer Res, V191, P1, DOI 10.1007/978-3-642-30331-9_1; Coleman HG, 2013, NUTR REV, V71, P474, DOI 10.1111/nure.12032; Cook MB, 2010, JNCI-J NATL CANCER I, V102, P1344, DOI 10.1093/jnci/djq289; Cooper GS, 2009, AM J GASTROENTEROL, V104, P1356, DOI 10.1038/ajg.2009.159; Corey KE, 2003, AM J GASTROENTEROL, V98, P2390, DOI 10.1016/j.amjgastroenterol.2003.08.008; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Das D, 2009, RECENT RES CANCER, V181, P161; de Jonge PJF, 2010, GUT, V59, P1030, DOI 10.1136/gut.2009.176701; Dulai GS, 2002, GASTROENTEROLOGY, V122, P26, DOI 10.1053/gast.2002.30297; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Dunbar KB, 2012, AM J GASTROENTEROL, V107, P850, DOI 10.1038/ajg.2012.78; Dutton SJ, 2014, LANCET ONCOL, V15, P894, DOI 10.1016/S1470-2045(14)70024-5; El-Sepag HB, 2009, GASTROENTEROLOGY, V137, P763, DOI 10.1053/j.gastro.2009.07.031; El-Serag HB, 2008, GUT, V57, DOI 10.1136/gut.2007.127878; El-Serag HB, 2011, GASTROENTEROLOGY, V140, P386, DOI 10.1053/j.gastro.2010.12.019; Fischbach LA, 2014, AM J GASTROENTEROL, V109, P357, DOI 10.1038/ajg.2013.443; Fitzgerald RC, 2014, GUT, V63, P7, DOI 10.1136/gutjnl-2013-305372; Ford HER, 2014, LANCET ONCOL, V15, P78, DOI 10.1016/S1470-2045(13)70549-7; Green J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4444; Hampel H, 2005, ANN INTERN MED, V143, P199, DOI 10.7326/0003-4819-143-3-200508020-00006; Hardefeldt HA, 2014, EPIDEMIOL INFECT, V142, P1119, DOI 10.1017/S0950268814000016; Heath EI, 2007, J NATL CANCER I, V99, P545, DOI 10.1093/jnci/djk112; Herbella FA, 2010, WORLD J GASTROENTERO, V16, P3811, DOI 10.3748/wjg.v16.i30.3811; Hillman LC, 2004, MED J AUSTRALIA, V180, P387, DOI 10.5694/j.1326-5377.2004.tb05991.x; Ho YF, 2012, CANCER EPIDEM BIOMAR, V21, P993, DOI 10.1158/1055-9965.EPI-12-0259; Hur C, 2013, CANCER-AM CANCER SOC, V119, P1149, DOI 10.1002/cncr.27834; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Kastelein F, 2013, CLIN GASTROENTEROL H, V11, P382, DOI 10.1016/j.cgh.2012.11.014; Kearney DJ, 2003, GASTROINTEST ENDOSC, V57, P823, DOI 10.1016/S0016-5107(03)70015-7; Kosoff RE, 2012, J CELL PHYSIOL, V227, P2654, DOI 10.1002/jcp.23007; Kubo A, 2006, CANCER EPIDEM BIOMAR, V15, P872, DOI 10.1158/1055-9965.EPI-05-0860; Kubo A, 2010, NUTR RES REV, V23, P230, DOI 10.1017/S0954422410000132; Levine DM, 2013, NAT GENET, V45, P1487, DOI 10.1038/ng.2796; LI JY, 1993, J NATL CANCER I, V85, P1492, DOI 10.1093/jnci/85.18.1492; Liao LM, 2012, GASTROENTEROLOGY, V142, P442, DOI 10.1053/j.gastro.2011.11.019; Limburg PJ, 2005, GASTROENTEROLOGY, V129, P863, DOI 10.1053/j.gastro.2005.06.024; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Malthaner R, 2010, CLIN ONCOL-UK, V22, P250, DOI 10.1016/j.clon.2010.02.005; Morgan MA, 2009, BRIT J SURG, V96, P1300, DOI 10.1002/bjs.6705; MUNOZ N, 1985, LANCET, V2, P111; Ngamruengphong S, 2013, CLIN GASTROENTEROL H, V11, P1424, DOI 10.1016/j.cgh.2013.05.025; Nguyen DM, 2009, CLIN GASTROENTEROL H, V7, P1299, DOI 10.1016/j.cgh.2009.06.001; Okawa T, 2007, GENE DEV, V21, P2788, DOI 10.1101/gad.1544507; Orloff M, 2011, JAMA-J AM MED ASSOC, V306, P410, DOI 10.1001/jama.2011.1029; Orman ES, 2013, CLIN GASTROENTEROL H, V11, P1245, DOI 10.1016/j.cgh.2013.03.039; Pechz O, 2008, GUT, V57, P1200, DOI 10.1136/gut.2007.142539; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; REIS A, 1992, HUM GENET, V90, P113; Rokkas T, 2007, CLIN GASTROENTEROL H, V5, P1413, DOI 10.1016/j.cgh.2007.08.010; Rubenstein JH, 2010, ALIMENT PHARM THER, V32, P1222, DOI 10.1111/j.1365-2036.2010.04471.x; Rubenstein JH, 2014, CLIN GASTROENTEROL H, V12, P239, DOI 10.1016/j.cgh.2013.08.029; Scozzari G, 2013, SURG OBES RELAT DIS, V9, P133, DOI 10.1016/j.soard.2012.10.002; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shaheen N, 2002, JAMA-J AM MED ASSOC, V287, P1972, DOI 10.1001/jama.287.15.1972; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Sharma P, 2010, NEW ENGL J MED, V362, P1450; Sharma P, 2009, NEW ENGL J MED, V361, P2548, DOI 10.1056/NEJMcp0902173; Singh S, 2014, GUT, V63, P1229, DOI 10.1136/gutjnl-2013-305997; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1399, DOI 10.1016/j.cgh.2013.05.009; Singh S, 2013, CLIN GASTROENTEROL H, V11, P620, DOI 10.1016/j.cgh.2012.12.036; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Spechler SJ, 2014, NEW ENGL J MED, V371, P836, DOI 10.1056/NEJMra1314704; Spechler SJ, 2011, GASTROENTEROLOGY, V140, pE18, DOI 10.1053/j.gastro.2011.01.031; Sreedharan A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005048.pub2; Stairs DB, 2011, CANCER CELL, V19, P470, DOI 10.1016/j.ccr.2011.02.007; Stairs DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003534; Tepper J, 2008, J CLIN ONCOL, V26, P1086, DOI 10.1200/JCO.2007.12.9593; Tramacere I, 2012, ANN ONCOL, V23, P287, DOI 10.1093/annonc/mdr136; Tramacere I, 2011, EPIDEMIOLOGY, V22, P344, DOI 10.1097/EDE.0b013e31821092cd; Tran T, 2005, AM J GASTROENTEROL, V100, P1002, DOI 10.1111/j.1572-0241.2005.41007.x; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; van Vliet EPM, 2008, BRIT J CANCER, V98, P547, DOI 10.1038/sj.bjc.6604200; Wang GQ, 2005, GUT, V54, P187, DOI 10.1136/gut.2004.046631; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang X, 2011, CELL, V145, P1023, DOI 10.1016/j.cell.2011.05.026; Wouters MWJM, 2012, CANCER-AM CANCER SOC, V118, P1754, DOI 10.1002/cncr.26383; Wu C, 2013, NAT GENET, V45, P632, DOI 10.1038/ng.2638; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Wysowski DK, 2009, NEW ENGL J MED, V360, P89, DOI 10.1056/NEJMc0808738; Xie FJ, 2013, WORLD J GASTROENTERO, V19, P6098, DOI 10.3748/wjg.v19.i36.6098; Yang S, 2012, COCHRANE DB SYST REV, V12; Zendehdel K, 2011, AM J GASTROENTEROL, V106, P57, DOI 10.1038/ajg.2010.449; Zhu HD, 2014, LANCET ONCOL, V15, P612, DOI 10.1016/S1470-2045(14)70131-7	97	817	866	15	174	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2499	2509		10.1056/NEJMra1314530	http://dx.doi.org/10.1056/NEJMra1314530			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX4RZ	25539106				2022-12-28	WOS:000346920300009
J	Alinikula, J; Schatz, DG				Alinikula, Jukka; Schatz, David G.			Super-Enhancer Transcription Converges on AID	CELL			English	Editorial Material							SOMATIC HYPERMUTATION; MECHANISMS; GENES	AID mis-targeting is poorly understood but contributes significantly to B cell genome instability. Two new papers in Cell reveal that AID mistargeting occurs primarily in gene bodies within a nuclear microenvironment characterized by high levels of transcriptional activity, interconnected transcriptional regulatory elements, and overlapping sense and antisense (convergent) transcription.	[Alinikula, Jukka; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Alinikula, Jukka; Schatz, David G.] Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute	Schatz, DG (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St,Box 208011, New Haven, CT 06520 USA.	david.schatz@yale.edu	Alinikula, Jukka/AAD-1594-2020	Alinikula, Jukka/0000-0001-9926-6439	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Keim C, 2013, GENE DEV, V27, P1, DOI 10.1101/gad.200014.112; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Pefanis E, 2014, NATURE, V514, P389, DOI 10.1038/nature13580; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Storb U, 2014, ADV IMMUNOL, V122, P253, DOI 10.1016/B978-0-12-800267-4.00007-9; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035	9	4	4	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1490	1492		10.1016/j.cell.2014.12.007	http://dx.doi.org/10.1016/j.cell.2014.12.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525869	Bronze			2022-12-28	WOS:000347922500003
J	Rabani, M; Raychowdhury, R; Jovanovic, M; Rooney, M; Stumpo, DJ; Pauli, A; Hacohen, N; Schier, AF; Blackshear, PJ; Friedman, N; Amit, I; Regev, A				Rabani, Michal; Raychowdhury, Raktima; Jovanovic, Marko; Rooney, Michael; Stumpo, Deborah J.; Pauli, Andrea; Hacohen, Nir; Schier, Alexander F.; Blackshear, Perry J.; Friedman, Nir; Amit, Ido; Regev, Aviv			High-Resolution Sequencing and Modeling Identifies Distinct Dynamic RNA Regulatory Strategies	CELL			English	Article							MESSENGER-RNA; HUMAN TRANSCRIPTOME; GENE-EXPRESSION; WIDESPREAD RNA; NUCLEOTIDE RESOLUTION; WIDE IDENTIFICATION; ZYGOTIC TRANSITION; PROFILING REVEALS; MAMMALIAN-CELLS; NONCODING RNAS	Cells control dynamic transitions in transcript levels by regulating transcription, processing, and/or degradation through an integrated regulatory strategy. Here, we combine RNA metabolic labeling, rRNA-depleted RNA-seq, and DRiLL, a novel computational framework, to quantify the level; editing sites; and transcription, processing, and degradation rates of each transcript at a splice junction resolution during the LPS response of mouse dendritic cells. Four key regulatory strategies, dominated by RNA transcription changes, generate most temporal gene expression patterns. Noncanonical strategies that also employ dynamic posttranscriptional regulation control only a minority of genes, but provide unique signal processing features. We validate Tristetraprolin (TTP) as a major regulator of RNA degradation in one noncanonical strategy. Applying DRiLL to the regulation of noncoding RNAs and to zebrafish embryogenesis demonstrates its broad utility. Our study provides a new quantitative approach to discover transcriptional and posttranscriptional events that control dynamic changes in transcript levels using RNA sequencing data.	[Rabani, Michal; Raychowdhury, Raktima; Jovanovic, Marko; Rooney, Michael; Hacohen, Nir; Schier, Alexander F.; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Rabani, Michal] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02140 USA; [Rooney, Michael] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02141 USA; [Stumpo, Deborah J.; Blackshear, Perry J.] NIEHS, Lab Signal Transduct, Res Triangle Pk, NC 27709 USA; [Pauli, Andrea; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Schier, Alexander F.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci & Inst Life Sci, IL-91904 Jerusalem, Israel; [Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02140 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Harvard University; Duke University; Duke University; Hebrew University of Jerusalem; Weizmann Institute of Science; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Regev, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	aregev@broadinstitute.org	Blackshear, Perry J./C-6206-2019; Friedman, Nir/H-9692-2012	Blackshear, Perry J./0000-0002-9561-8529; Friedman, Nir/0000-0002-9678-3550; Schier, Alexander Franz/0000-0001-7645-5325	William Asbjornsen Albert Memorial fellowship; Xerox-MIT fellowship; Swiss National Science Foundation (SNSF); NIH [R01GM056211, K99-HD076935]; Human Frontier Science Program (HFSP); Centers of Excellence in Genomic Sciences (CEGS) [1P50HG006193-01]; Pioneer Award [DP1OD003958-01]; Howard Hughes Medical Institute (HHMI); Klarman Cell Observatory; United States-Israel Binational Science Foundation (BSF); European Research Council (ERC) [309788, 340712]; Israel Science Foundation (ISF) [1782/11]; I-CORE; Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (NIEHS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD076935] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056211] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	William Asbjornsen Albert Memorial fellowship; Xerox-MIT fellowship; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Centers of Excellence in Genomic Sciences (CEGS); Pioneer Award; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Klarman Cell Observatory; United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); European Research Council (ERC)(European Research Council (ERC)); Israel Science Foundation (ISF)(Israel Science Foundation); I-CORE; Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Broad Genomics Platform for sequencing and C. de Boer for comments on the manuscript. Work was supported by William Asbjornsen Albert Memorial and Xerox-MIT fellowships (M.R.), the Swiss National Science Foundation (SNSF) for advanced researchers and Marie Sklodowska-Curie IOF fellowships (M.J.), NIH R01GM056211 (A.F.S.), the Human Frontier Science Program (HFSP) and NIH K99-HD076935 (A.P.), the Centers of Excellence in Genomic Sciences (CEGS) (1P50HG006193-01, N.H., I.A., A.R.), and Pioneer Award (DP1OD003958-01, A.R.), the Howard Hughes Medical Institute (HHMI), the Klarman Cell Observatory (A.R.), the United States-Israel Binational Science Foundation (BSF) (N.F.), the European Research Council (ERC) (309788, I.A.; 340712 N.F.), the Israel Science Foundation (ISF) (1782/11, I.A.), I-CORE (I.A. and N.F.), and the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (NIEHS) (P.J.B.).	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Audibert A, 2002, MOL CELL BIOL, V22, P6706, DOI 10.1128/MCB.22.19.6706-6718.2002; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Chew GL, 2013, DEVELOPMENT, V140, P2828, DOI 10.1242/dev.098343; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Eser P, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134886; Fuchs G, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r69; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kleinman CL, 2012, SCIENCE, V335, DOI [10.1126/science.1209658, 10.1126/science.1210624]; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; Neeman Y, 2006, RNA, V12, P1802, DOI 10.1261/rna.165106; Pandya-Jones A, 2013, RNA, V19, P811, DOI 10.1261/rna.039081.113; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Windhager L, 2012, GENOME RES, V22, P2031, DOI 10.1101/gr.131847.111; Zeisel A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.62; Zhang Y, 2014, GENOME RES, V24, P260, DOI 10.1101/gr.157750.113	45	127	130	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1698	1710		10.1016/j.cell.2014.11.015	http://dx.doi.org/10.1016/j.cell.2014.11.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25497548	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000347922500021
J	Takeoka, A; Vollenweider, I; Courtine, G; Arber, S				Takeoka, Aya; Vollenweider, Isabel; Courtine, Gregoire; Arber, Silvia			Muscle Spindle Feedback Directs Locomotor Recovery and Circuit Reorganization after Spinal Cord Injury	CELL			English	Article							RATS; PLASTICITY; NEURONS; AFFERENTS; NETWORKS; STIMULATION; GENERATION; MOVEMENTS; HUMANS; INPUTS	Spinal cord injuries alter motor function by disconnecting neural circuits above and below the lesion, rendering sensory inputs a primary source of direct external drive to neuronal networks caudal to the injury. Here, we studied mice lacking functional muscle spindle feedback to determine the role of this sensory channel in gait control and locomotor recovery after spinal cord injury. High-resolution kinematic analysis of intact mutant mice revealed proficient execution in basic locomotor tasks but poor performance in a precision task. After injury, wildtype mice spontaneously recovered basic locomotor function, whereas mice with deficient muscle spindle feedback failed to regain control over the hindlimb on the lesioned side. Virus-mediated tracing demonstrated that mutant mice exhibit defective rearrangements of descending circuits projecting to deprived spinal segments during recovery. Our findings reveal an essential role for muscle spindle feedback in directing basic locomotor recovery and facilitating circuit reorganization after spinal cord injury.	[Takeoka, Aya; Arber, Silvia] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland; [Takeoka, Aya; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Vollenweider, Isabel; Courtine, Gregoire] Ecole Polytech Fed Lausanne, Brain Mind Inst & Ctr Neuroprosthet, CH-1015 Lausanne, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Arber, S (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.	silvia.arber@unibas.ch	Takeoka, Aya/AFS-3398-2022; courtine, gregoire/AAJ-1694-2020	Takeoka, Aya/0000-0003-0322-677X; courtine, gregoire/0000-0002-5744-4142; Arber, Silvia/0000-0002-6261-250X	ERC Advanced Grant; Swiss National Science Foundation; Kanton Basel-Stadt; Novartis Research Foundation; European Neuroscience Campus (ENC) network; ERC Starting Grant; International Foundation for Research in Paraplegia (IRP)	ERC Advanced Grant(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Basel-Stadt; Novartis Research Foundation; European Neuroscience Campus (ENC) network; ERC Starting Grant(European Research Council (ERC)); International Foundation for Research in Paraplegia (IRP)	We are grateful to M. Sigrist, M. Mielich, P. Capelli, and S. Esposito for expert technical help, M. Kirschmann, S. Bourke, and L. Gelman from the FMI imaging facility, N. Ehrenfurchter from the Biozentrum Imaging facility for help and advice with image acquisition and analysis, and P. Caroni for discussions and comments on the manuscript. A.T. and S.A. were supported by an ERC Advanced Grant, the Swiss National Science Foundation, the Kanton Basel-Stadt, and the Novartis Research Foundation. I.V. was supported by the European Neuroscience Campus (ENC) network. G.C. was supported by an ERC Starting Grant and the International Foundation for Research in Paraplegia (IRP).	Andreae LC, 2014, CURR OPIN NEUROBIOL, V27, P47, DOI 10.1016/j.conb.2014.02.008; Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; Arshavskii Iu I, 1965, Biofizika, V10, P665; Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3640, DOI 10.1152/jn.00497.2003; Boyce VS, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00059; Brown AG, 1981, ORG SPINAL CORD; Cajal S., 1928, DEGENERATION REGENER; Capogrosso M, 2013, J NEUROSCI, V33, P19326, DOI 10.1523/JNEUROSCI.1688-13.2013; Chen HH, 2002, J NEUROSCI, V22, P3512; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Curt A, 2008, J NEUROTRAUM, V25, P677, DOI 10.1089/neu.2007.0468; Dietz V, 2014, BRAIN, V137, P654, DOI 10.1093/brain/awt262; Dougherty KJ, 2013, NEURON, V80, P920, DOI 10.1016/j.neuron.2013.08.015; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; Edgerton VR, 2008, BRAIN RES REV, V57, P241, DOI 10.1016/j.brainresrev.2007.09.002; Esposito MS, 2014, NATURE, V508, P351, DOI 10.1038/nature13023; GRUNER JA, 1980, EXP BRAIN RES, V40, P374; HALBERTSMA JM, 1983, ACTA PHYSIOL SCAND, P1; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; JANKOWSKA E, 1993, PROG BRAIN RES, V97, P161; Kaas JH, 2008, EXP NEUROL, V209, P407, DOI 10.1016/j.expneurol.2007.06.014; Knikou M, 2014, J NEUROPHYSIOL, V111, P2264, DOI 10.1152/jn.00871.2013; Lavrov I, 2008, J NEUROSCI, V28, P7774, DOI 10.1523/JNEUROSCI.1069-08.2008; Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890; Martinez M, 2010, EXP NEUROL, V221, P186, DOI 10.1016/j.expneurol.2009.10.022; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Oakley RA, 1997, J NEUROSCI, V17, P4262; Paxinos G, 2012, MOUSE BRAIN STEREOTA; Pearson KG, 2008, BRAIN RES REV, V57, P222, DOI 10.1016/j.brainresrev.2007.06.014; Petruska JC, 2007, J NEUROSCI, V27, P4460, DOI 10.1523/JNEUROSCI.2302-06.2007; Pivetta C, 2014, CELL, V156, P537, DOI 10.1016/j.cell.2013.12.014; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Roy RR, 2012, ARCH PHYS MED REHAB, V93, P1487, DOI 10.1016/j.apmr.2012.04.034; Scott SA, 1992, SENSORY NEURONS DIVE; Talpalar AE, 2011, NEURON, V71, P1071, DOI 10.1016/j.neuron.2011.07.011; Tello F., 1907, TRAB LAB INVEST BIOL, V5, P237; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Wang Z, 2008, J NEUROPHYSIOL, V100, P185, DOI 10.1152/jn.90354.2008; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Ying Z, 2008, NEUROSCIENCE, V155, P1070, DOI 10.1016/j.neuroscience.2008.06.057; Zorner B, 2014, BRAIN, V137, P1716, DOI 10.1093/brain/awu078; Zorner B, 2010, NAT METHODS, V7, P701, DOI 10.1038/nmeth.1484	48	175	180	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1626	1639		10.1016/j.cell.2014.11.019	http://dx.doi.org/10.1016/j.cell.2014.11.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525880	Bronze			2022-12-28	WOS:000347922500016
J	Whitney, O; Pfenning, AR; Howard, JT; Blatti, CA; Liu, F; Ward, JM; Wang, R; Audet, JN; Kellis, M; Mukherjee, S; Sinha, S; Hartemink, AJ; West, AE; Jarvis, ED				Whitney, Osceola; Pfenning, Andreas R.; Howard, Jason T.; Blatti, Charles A.; Liu, Fang; Ward, James M.; Wang, Rui; Audet, Jean-Nicolas; Kellis, Manolis; Mukherjee, Sayan; Sinha, Saurabh; Hartemink, Alexander J.; West, Anne E.; Jarvis, Erich D.			Core and region-enriched networks of behaviorally regulated genes and the singing genome	SCIENCE			English	Article							IMMEDIATE-EARLY GENE; LONG-TERM-MEMORY; NEURONAL-ACTIVITY; FOREBRAIN CIRCUIT; EXPRESSION; SONG; BRAIN; TRANSCRIPTION; PLASTICITY; BIRDSONG	Songbirds represent an important model organism for elucidating molecular mechanisms that link genes with complex behaviors, in part because they have discrete vocal learning circuits that have parallels with those that mediate human speech. We found that similar to 10% of the genes in the avian genome were regulated by singing, and we found a striking regional diversity of both basal and singing-induced programs in the four key song nuclei of the zebra finch, a vocal learning songbird. The region-enriched patterns were a result of distinct combinations of region-enriched transcription factors (TFs), their binding motifs, and presinging acetylation of histone 3 at lysine 27 (H3K27ac) enhancer activity in the regulatory regions of the associated genes. RNA interference manipulations validated the role of the calcium-response transcription factor (CaRF) in regulating genes preferentially expressed in specific song nuclei in response to singing. Thus, differential combinatorial binding of a small group of activity-regulated TFs and predefined epigenetic enhancer activity influences the anatomical diversity of behaviorally regulated gene networks.	[Whitney, Osceola; Pfenning, Andreas R.; Howard, Jason T.; Ward, James M.; Wang, Rui; Jarvis, Erich D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA; [Pfenning, Andreas R.; Kellis, Manolis] MIT, Computer Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Pfenning, Andreas R.; Kellis, Manolis] MIT, Broad Inst, Cambridge, MA 02139 USA; [Pfenning, Andreas R.; Kellis, Manolis] Harvard Univ, MIT, Cambridge, MA 02139 USA; [Blatti, Charles A.; Sinha, Saurabh] Univ Illinois, Dept Comp Sci, Urbana, IL USA; [Liu, Fang; West, Anne E.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Audet, Jean-Nicolas] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Mukherjee, Sayan] Duke Univ, Dept Stat, Durham, NC USA; [Hartemink, Alexander J.] Duke Univ, Dept Comp Sci, Durham, NC 27708 USA	Duke University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); University of Illinois System; University of Illinois Urbana-Champaign; Duke University; McGill University; Duke University; Duke University	Whitney, O (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA.	owhitney@gmail.com; apfenning@csail.mit.edu; west@neuro.duke.edu; jarvis@neuro.duke.edu	Jarvis, Erich D/A-2319-2008; Kellis, Manolis/ABE-7385-2020; Audet, Jean-Nicolas/P-2535-2014	Jarvis, Erich D/0000-0001-8931-5049; Kellis, Manolis/0000-0001-7113-9630; Audet, Jean-Nicolas/0000-0002-0511-183X; Whitney, Osceola/0000-0002-5701-7722; Ward, James/0000-0002-9510-2848; /0000-0002-3447-9801; Mukherjee, Sayan/0000-0002-6715-3920; Howard, Jason/0000-0003-3265-5127	American Psychological Association - National Institute of Mental Health [5T32MH018882-18]; National Science Foundation [0610337]; National Institute on Deafness and Other Communication Disorders [R01DC007218]; Howard Hughes Medical Institute; Division Of Mathematical Sciences [1209155] Funding Source: National Science Foundation; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007218] Funding Source: NIH RePORTER	American Psychological Association - National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank S. Augustin, J. Coleman, and N. Diaz Nelson for help collecting and processing singing bird samples for microarray analysis; H. Dressman and L.-L. Rowlette at the Duke Institute for Genome Science and Policy for microarray hybridizations; We thank A. Cavanaugh, M. Lawson, and M. Dean for useful comments after careful reading of an earlier version of this manuscript. O.W. was supported by postdoctoral training grants from American Psychological Association fellowship funded by the National Institute of Mental Health grant 5T32MH018882-18 and the National Science Foundation grant 0610337. This work was supported by grants from the National Institute on Deafness and Other Communication Disorders grant R01DC007218 and the Howard Hughes Medical Institute to E.D.J.. Microarray data have been submitted to the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) under accession no. GSE33365. Annotations are also available in table S1. Raw files of the Chip-seq H3K27ac experiments are available at www.broadinstitute.org/similar to pfenning/finchWig.	Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; CAO XM, 1993, J BIOL CHEM, V268, P16949; Dong S, 2009, P NATL ACAD SCI USA, V106, P11364, DOI 10.1073/pnas.0812998106; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Hill C S, 1999, Sci STKE, V1999, pPE1, DOI 10.1126/stke.1999.3.pe1; Hilliard AT, 2012, NEURON, V73, P537, DOI 10.1016/j.neuron.2012.01.005; Horita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042173; Horita H, 2010, J COMP NEUROL, V518, P2873, DOI 10.1002/cne.22370; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jarvis ED, 2013, J COMP NEUROL, V521, P3614, DOI 10.1002/cne.23404; Jin H, 1997, NEURON, V19, P1049, DOI 10.1016/S0896-6273(00)80396-7; Johnsen O, 1996, NUCLEIC ACIDS RES, V24, P4289, DOI 10.1093/nar/24.21.4289; Kim J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000652; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kimpo RR, 1997, NEURON, V18, P315, DOI 10.1016/S0896-6273(00)80271-8; Kubikova L, 2007, EUR J NEUROSCI, V25, P2145, DOI 10.1111/j.1460-9568.2007.05368.x; Kubikova L, 2010, J COMP NEUROL, V518, P741, DOI 10.1002/cne.22255; Li XC, 2000, P NATL ACAD SCI USA, V97, P8584, DOI 10.1073/pnas.140222497; Li XC, 2007, P NATL ACAD SCI USA, V104, P6834, DOI 10.1073/pnas.0701619104; Loebrich S, 2009, PHYSIOL REV, V89, P1079, DOI 10.1152/physrev.00013.2009; Lombardino AJ, 2005, P NATL ACAD SCI USA, V102, P8036, DOI 10.1073/pnas.0503239102; Lovell PV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003440; Luo MM, 1999, J NEUROSCI, V19, P6700; Lyons MR, 2011, PROG NEUROBIOL, V94, P259, DOI 10.1016/j.pneurobio.2011.05.003; Malik AN, 2014, NAT NEUROSCI, V17, P1330, DOI 10.1038/nn.3808; McDowell KA, 2010, J NEUROSCI, V30, P7453, DOI 10.1523/JNEUROSCI.3997-09.2010; Miller JE, 2008, J NEUROPHYSIOL, V100, P2015, DOI 10.1152/jn.90415.2008; MOONEY R, 1991, P NATL ACAD SCI USA, V88, P4075, DOI 10.1073/pnas.88.10.4075; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Pfenning AR, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-20; Pfenning AR, 2014, SCIENCE, V346, P1333, DOI 10.1126/science.1256846; Pfenning AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010870; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Scharff C, 2011, PHILOS T R SOC B, V366, P2124, DOI 10.1098/rstb.2011.0001; Sinha S, 2006, BIOINFORMATICS, V22, pE454, DOI 10.1093/bioinformatics/btl227; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teramitsu I, 2006, J NEUROSCI, V26, P7390, DOI 10.1523/JNEUROSCI.1662-06.2006; Wada K, 2004, J COMP NEUROL, V476, P44, DOI 10.1002/cne.20201; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Whitney O, 2005, J NEUROBIOL, V65, P251, DOI 10.1002/neu.20187; Whitney O, 2000, MOL BRAIN RES, V80, P279, DOI 10.1016/S0169-328X(00)00178-9; Williams H, 1999, TLS-TIMES LIT SUPPL, P16; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385	65	65	68	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1334	+		10.1126/science.1256780	http://dx.doi.org/10.1126/science.1256780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504732	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000346189600039
J	Arroll, B; Alrutz, S; Moyes, S				Arroll, Bruce; Alrutz, Stowe; Moyes, Simon			CHRISTMAS 2014: ON THE WARDS, IN THE SURGERY An exploration of the basis for patient complaints about the oldness of magazines in practice waiting rooms: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; IMPACT; WOMEN	Objective To explore the basis for patient complaints about the oldness of most magazines in practice waiting rooms. Design Cohort study. Setting Waiting room of a general practice in Auckland, New Zealand. Participants 87 magazines stacked into three mixed piles and placed in the waiting room: this included non-gossipy magazines (Time magazine, the Economist, Australian Women's Weekly, National Geographic, BBC History) and gossipy ones (not identified for fear of litigation). Gossipy was defined as having five or more photographs of celebrities on the front cover and most gossipy as having up to 10 such images. Interventions The magazines were marked with a unique number on the back cover, placed in three piles in the waiting room, and monitored twice weekly. Main outcome measures Disappearance of magazines less than 2 months old versus magazines 3-12 months old, the overall rate of loss of magazines, and the rate of loss of gossipy versus non-gossipy magazines. Results 47 of the 82 magazines with a visible date on the front cover were aged less than 2 months. 28 of these 47 (60%) magazines and 10 of the 35 (29%) older magazines disappeared (P=0.002). After 31 days, 41 of the 87 (47%, 95% confidence interval 37% to 58%) magazines had disappeared. None of the 19 non-gossipy magazines (the Economist and Time magazine) had disappeared compared with 26 of the 27 (96%) gossipy magazines (P<0.001). All 15 of the most gossipy magazines and all 19 of the non-gossipy magazines had disappeared by 31 days. The study was terminated at this point. Conclusions General practice waiting rooms contain mainly old magazines. This phenomenon relates to the disappearance of the magazines rather than to the supply of old ones. Gossipy magazines were more likely to disappear than non-gossipy ones. On the grounds of cost we advise practices to supply old copies of non-gossipy magazines. A waiting room science curriculum is urgently needed.	[Arroll, Bruce; Alrutz, Stowe; Moyes, Simon] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand	University of Auckland	Arroll, B (corresponding author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Private Bag 92019, Auckland 1, New Zealand.	bruce.arroll@auckland.ac.nz	Moyes, Simon A/D-2574-2017	Moyes, Simon A/0000-0001-9580-1545; Alrutz, Stowe/0000-0002-1877-6697				Arneill AB, 2002, J ENVIRON PSYCHOL, V22, P345, DOI 10.1006/jevp.2002.0274; Beukeboom CJ, 2012, J ALTERN COMPLEM MED, V18, P329, DOI 10.1089/acm.2011.0488; Bournes DA, 2002, RES NURS HEALTH, V25, P58, DOI 10.1002/nur.10019; Boyle H., 1970, OCALA STAR BANN 0227; de Tommaso M, 2013, PAIN RES TREAT, V2013, DOI 10.1155/2013/515730; Deitrick Lynn, 2005, J Healthc Qual, V27, P17; Donnelly L, 2012, TELEGRAPH; Fenko A, 2013, HERD, V7, P38; Kutash M, 2007, J ADV NURS, V60, P384, DOI 10.1111/j.1365-2648.2007.04388.x; LI VC, 1984, PREV MED, V13, P477, DOI 10.1016/0091-7435(84)90016-1; Macher J.M., 1992, APPL OCCUPATIONAL EN, V7, P505, DOI DOI 10.1080/1047322X.1992.10390201; Montazeri A, 2004, J PUBLIC HEALTH-UK, V26, P355, DOI 10.1093/pubmed/fdh178; Tansik DA, 1999, INT J SERV IND MANAG, V10, P68, DOI 10.1108/09564239910255389; WARD K, 1994, BRIT J GEN PRACT, V44, P583; WICKE DM, 1994, FAM PRACT, V11, P292, DOI 10.1093/fampra/11.3.292	15	2	2	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2014	349								g7262	10.1136/bmj.g7262	http://dx.doi.org/10.1136/bmj.g7262			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW3DK	25500116	Green Published, hybrid			2022-12-28	WOS:000346165500005
J	Masanja, H; Smith, ER; Muhihi, A; Briegleb, C; Mshamu, S; Ruben, J; Noor, RA; Khudyakov, P; Yoshida, S; Martines, J; Bahl, R; Fawzi, WW				Masanja, Honorati; Smith, Emily R.; Muhihi, Alfa; Briegleb, Christina; Mshamu, Salum; Ruben, Julia; Noor, Ramadhani Abdallah; Khudyakov, Polyna; Yoshida, Sachiyo; Martines, Jose; Bahl, Rajiv; Fawzi, Wafaie W.		Neovita Tanzania Study Grp	Effect of neonatal vitamin A supplementation on mortality in infants in Tanzania (Neovita): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							IMPACT	Background Supplementation of vitamin A in children aged 6-59 months improves child survival and is implemented as global policy. Studies of the efficacy of supplementation of infants in the neonatal period have inconsistent results. We aimed to assess the efficacy of oral supplementation with vitamin A given to infants in the first 3 days of life to reduce mortality between supplementation and 180 days (6 months). Methods We did an individually randomised, double-blind, placebo-controlled trial of infants born in the Morogoro and Dares Salaam regions of Tanzania. Women were identified during antenatal clinic visits or in the labour wards of public health facilities in Dares Salaam. In Kilombero, Ulanga, and Kilosa districts, women were seen at home as part of the health and demographic surveillance system. Newborn infants were eligible for randomisation if they were able to feed orally and if the family intended to stay in the study area for at least 6 months. We randomly assigned infants to receive one dose of 50 000 IU of vitamin A or placebo in the first 3 days after birth. Infants were randomly assigned in blocks of 20, and investigators, participants' families, and data analysis teams were masked to treatment assignment. We assessed infants on day 1 and day 3 after dosing, as well as at 1, 3, 6, and 12 months after birth. The primary endpoint was mortality at 6 months, assessed by field interviews. The primary analysis included only children who were not lost to follow-up. Findings Between Aug 26, 2010, and March 3, 2013, 31 999 newborn babies were randomly assigned to receive vitamin A (n=15 995) or placebo (n=16 004; 15 428 and 15 464 included in analysis of mortality at 6 months, respectively). We did not find any evidence for a beneficial effect of vitamin A supplementation on mortality in infants at 6 months (26 deaths per 1000 livebirths in vitamin A vs 24 deaths per 1000 livebirths in placebo group; risk ratio 1.10, 95% CI 0.95-1.26; p=0.193). There was no evidence of a differential effect for vitamin A supplementation on mortality by sex; risk ratio for mortality at 6 months for boys was 1.08 (0.90-1.29) and for girls was 1.12 (0.91-1.39). There was also no evidence of adverse effects of supplementation within 3 days of dosing. Interpretation Neonatal vitamin A supplementation did not result in any immediate adverse events, but had no beneficial effect on survival in infants in Tanzania. These results strengthen the evidence against a global policy recommendation for neonatal vitamin A supplementation. Copyright (C) 2014 World Health Organization. Published by Elsevier Ltd. All rights reserved.	[Masanja, Honorati] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Smith, Emily R.; Briegleb, Christina; Ruben, Julia; Noor, Ramadhani Abdallah; Khudyakov, Polyna; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Muhihi, Alfa; Mshamu, Salum; Noor, Ramadhani Abdallah] African Acad Publ Hlth, Dar Es Salaam, Tanzania; [Yoshida, Sachiyo; Martines, Jose; Bahl, Rajiv] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland	Ifakara Health Institute; Harvard University; Harvard T.H. Chan School of Public Health; World Health Organization	Masanja, H (corresponding author), Ifakara Hlth Inst, Dar Es Salaam, Tanzania.	hmasanja@ihi.or.tz	Muhihi, Alfa/AAL-1893-2021	Muhihi, Alfa/0000-0002-4477-7300	Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007358] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Bill & Melinda Gates Foundation to WHO.	Bahl R, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-22; Benn CS, 2008, BMJ-BRIT MED J, V336, P1416, DOI 10.1136/bmj.39542.509444.AE; Benn Christine Stabell, 2010, BMJ, V340, pc1101, DOI 10.1136/bmj.c1101; Benn CS, 2003, BMJ-BRIT MED J, V327, P254; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Edmond KM, 2014, LANCET; FAWZI WW, 1993, JAMA-J AM MED ASSOC, V269, P898, DOI 10.1001/jama.269.7.898; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; GLASZIOU PP, 1993, BMJ-BRIT MED J, V306, P366, DOI 10.1136/bmj.306.6874.366; Gogia S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007480.pub2; Humphrey JH, 1996, J PEDIATR-US, V128, P489, DOI 10.1016/S0022-3476(96)70359-1; Imdad A, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008524.pub2, 10.1002/14651858.CD008524.pub4]; INDEPTH Network, 2002, POP HLTH DEV COUNTR, V1; Kirkwood B, 2010, LANCET, V376, P1643, DOI 10.1016/S0140-6736(10)61895-8; Klemm RDW, 2008, PEDIATRICS, V122, pE242, DOI 10.1542/peds.2007-3448; Malaba LC, 2005, AM J CLIN NUTR, V81, P454, DOI 10.1093/ajcn.81.2.454; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; Mazumder S, 2014, LANCET; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Rahmathullah L, 2003, BMJ-BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254; UNICEF, 2017, LEVELS TRENDS CHILD; WEST KP, 1995, AM J CLIN NUTR, V62, P143, DOI 10.1093/ajcn/62.1.143; WHO, 2009, WHO TECH REP SER, V958, P1; WHO, 2000, NUTR HLTH DEV GLOB A; WHO/UNICEF/VACG Task Force, 1997, VIT A SUPPL GUID THE	27	53	53	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1324	1332		10.1016/S0140-6736(14)61731-1	http://dx.doi.org/10.1016/S0140-6736(14)61731-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25499543	Green Accepted, Green Published			2022-12-28	WOS:000352272400038
J	Yin, J; Mobarec, JC; Kolb, P; Rosenbaum, DM				Yin, Jie; Mobarec, Juan Carlos; Kolb, Peter; Rosenbaum, Daniel M.			Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; MEMBRANE-PROTEINS; ANTAGONIST; DISCOVERY; BINDING; SLEEP; ACTIVATION; NARCOLEPSY; INSIGHTS	The orexin (also known as hypocretin) G protein-coupled receptors (GPCRs) respond to orexin neuropeptides in the central nervous system to regulate sleep and other behavioural functions in humans(1). Defects in orexin signalling are responsible for the human diseases of narcolepsy and cataplexy; inhibition of orexin receptors is an effective therapy for insomnia(2). The human OX2 receptor (OX2R) belongs to the beta branch of the rhodopsin family of GPCRs(3), and can bind to diverse compounds including the native agonist peptides orexin-A and orexin-Band the potent therapeutic inhibitor suvorexant(4). Here, using lipid-mediated crystallization and protein engineering with a novel fusion chimaera, we solved the structure of the human OX2R bound to suvorexant at 2.5 angstrom resolution. The structure reveals how suvorexant adopts pi-stacked horseshoe-like conformation and binds to the receptor deep in the orthosteric pocket, stabilizing a network of extracellular salt bridges and blocking transmembrane helix motions necessary for activation. Computational docking suggests how other classes of synthetic antagonists may interact with the receptor at a similar position in an analogous pi-stacked fashion. Elucidation of the molecular architecture of the human OX2R expands our understanding of peptidergic GPCR ligand recognition and will aid further efforts to modulate orexin signalling for therapeutic ends.	[Yin, Jie; Rosenbaum, Daniel M.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Mobarec, Juan Carlos; Kolb, Peter] Univ Marburg, Dept Pharmaceut Chem, D-35032 Marburg, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; Philipps University Marburg	Rosenbaum, DM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.	dan.rosenbaum@utsouthwestern.edu	Yin, Jie/J-8932-2016; Ying, Chieh/E-4296-2016; Kolb, Peter/A-3782-2008	Kolb, Peter/0000-0003-4089-614X; Mobarec, Juan Carlos/0000-0001-9482-4294	Welch Foundation [I-1770]; Searle Scholars Program; Packard Foundation Fellowship; Emmy Noether Fellowship of the German Research Foundation [KO-4095/1-1]; COST Action GLISTEN [CM1207]; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]	Welch Foundation(The Welch Foundation); Searle Scholars Program; Packard Foundation Fellowship; Emmy Noether Fellowship of the German Research Foundation(German Research Foundation (DFG)); COST Action GLISTEN(European Cooperation in Science and Technology (COST)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from the Welch Foundation (I-1770 to D.M.R.), the Searle Scholars Program (D.M.R.), a Packard Foundation Fellowship (D.M.R.), an Emmy Noether Fellowship of the German Research Foundation (KO-4095/1-1 to P.K.) and COST Action GLISTEN (CM1207 to P.K.). We thank D. Borek and Z. Otwinowski for assistance with diffraction data processing. The National Institute of General Medical Sciences and National Cancer Institute Structural Biology Facility at the Advanced Photon Source is funded in whole or in part with federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Brisbare-Roch C, 2007, NAT MED, V13, P150, DOI 10.1038/nm1544; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cox CD, 2010, J MED CHEM, V53, P5320, DOI 10.1021/jm100541c; Cox CD, 2009, BIOORG MED CHEM LETT, V19, P2997, DOI 10.1016/j.bmcl.2009.04.026; Tran DT, 2011, EUR J PHARMACOL, V667, P120, DOI 10.1016/j.ejphar.2011.05.074; Egloff P, 2014, P NATL ACAD SCI USA, V111, pE655, DOI 10.1073/pnas.1317903111; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Kirchmair J, 2006, J CHEM INF MODEL, V46, P1848, DOI 10.1021/ci060084g; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Langmead CJ, 2004, BRIT J PHARMACOL, V141, P340, DOI 10.1038/sj.bjp.0705610; Li JC, 2014, BRIT J PHARMACOL, V171, P332, DOI 10.1111/bph.12415; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Malherbe P, 2009, BRIT J PHARMACOL, V156, P1326, DOI 10.1111/j.1476-5381.2009.00127.x; Malherbe P, 2010, MOL PHARMACOL, V78, P81, DOI 10.1124/mol.110.064584; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michelson D, 2014, LANCET NEUROL, V13, P461, DOI 10.1016/S1474-4422(14)70053-5; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Neudert G, 2011, J CHEM INF MODEL, V51, P2731, DOI 10.1021/ci200274q; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Winrow CJ, 2014, BRIT J PHARMACOL, V171, P283, DOI 10.1111/bph.12261; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhu Y, 2003, J PHARMACOL SCI, V92, P259	47	158	161	3	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					247	+		10.1038/nature14035	http://dx.doi.org/10.1038/nature14035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25533960				2022-12-28	WOS:000350770500042
J	Rosenbaum, L				Rosenbaum, Lisa			License to Serve - US Trainees and the Ebola Epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Frieden TR, 2014, NEW ENGL J MED, V371, P1177, DOI 10.1056/NEJMp1409903; Shamasunder S, 2014, HUFFINGTON POST; Sunstein C, 2005, LAWS FEAR PRECAUTION, V1st; Wildes R, 2014, DISASTER MED PUBLIC; Willyard C, 2014, NAT MED, V20, P1359, DOI [10.1038/nm1214-1359, 10.1038/nm.3763]	5	11	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2015	372	6					504	506		10.1056/NEJMp1415192	http://dx.doi.org/10.1056/NEJMp1415192			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA8CH	25517575				2022-12-28	WOS:000349143600003
J	Skov, AL				Skov, Anne Ladegaard			MATERIALS SCIENCE Like cartilage, but simpler	NATURE			English	Editorial Material									Tech Univ Denmark, Dept Chem & Biochem Engn, Danish Polymer Ctr, DK-2800 Lyngby, Denmark	Technical University of Denmark	Skov, AL (corresponding author), Tech Univ Denmark, Dept Chem & Biochem Engn, Danish Polymer Ctr, DK-2800 Lyngby, Denmark.	al@kt.dtu.dk	Skov, Anne L/A-1614-2013; Skov, Anne Ladegaard/N-2320-2019	Skov, Anne L/0000-0003-1223-6638; Skov, Anne Ladegaard/0000-0003-1223-6638				Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Liu MJ, 2015, NATURE, V517, P68, DOI 10.1038/nature14060; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; Vudayagiri S, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/10/105017	4	4	4	3	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					25	26		10.1038/517025a	http://dx.doi.org/10.1038/517025a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25557709				2022-12-28	WOS:000347178400024
J	Bobb, JF; Obermeyer, Z; Wang, Y; Dominici, F				Bobb, Jennifer F.; Obermeyer, Ziad; Wang, Yun; Dominici, Francesca			Cause-Specific Risk of Hospital Admission Related to Extreme Heat in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MORTALITY DISPLACEMENT; AMBIENT-TEMPERATURE; CLIMATE-CHANGE; WAVES; WEATHER; DISEASES; DEATHS	IMPORTANCE Heat exposure is known to have a complex set of physiological effects on multiple organ systems, but current understanding of the health effects is mostly based on studies investigating a small number of prespecified health outcomes such as cardiovascular and respiratory diseases. OBJECTIVES To identify possible causes of hospital admissions during extreme heat events and to estimate their risks using historical data. DESIGN, SETTING, AND POPULATION Matched analysis of time series data describing daily hospital admissions of Medicare enrollees (23.7 million fee-for-service beneficiaries [aged >= 65 years] per year; 85% of all Medicare enrollees) for the period 1999 to 2010 in 1943 counties in the United States with at least 5 summers of near-complete (>95%) daily temperature data. EXPOSURES Heat wave periods, defined as 2 or more consecutive days with temperatures exceeding the 99th percentile of county-specific daily temperatures, matched to non-heat wave periods by county and week. MAIN OUTCOMES AND MEASURES Daily cause-specific hospitalization rates by principal discharge diagnosis codes, grouped into 283 disease categories using a validated approach. RESULTS Risks of hospitalization for fluid and electrolyte disorders, renal failure, urinary tract infection, septicemia, and heat stroke were statistically significantly higher on heat wave days relative to matched non-heat wave days, but risk of hospitalization for congestive heart failure was lower (P<.05). Relative risks for these disease groups were 1.18 (95% CI, 1.12-1.25) for fluid and electrolyte disorders, 1.14 (95% CI, 1.06-1.23) for renal failure, 1.10 (95% CI, 1.04-1.16) for urinary tract infections, 1.06 (95% CI, 1.00-1.11) for septicemia, and 2.54 (95% CI, 2.14-3.01) for heat stroke. Absolute risk differences were 0.34 (95% CI, 0.22-0.46) excess admissions per 100 000 individuals at risk for fluid and electrolyte disorders, 0.25 (95% CI, 0.12-0.39) for renal failure, 0.24 (95% CI, 0.09-0.39) for urinary tract infections, 0.21 (95% CI, 0.01-0.41) for septicemia, and 0.16 (95% CI, 0.10-0.22) for heat stroke. For fluid and electrolyte disorders and heat stroke, the risk of hospitalization increased during more intense and longer-lasting heat wave periods (P<.05). Risks were generally highest on the heat wave day but remained elevated for up to 5 subsequent days. CONCLUSIONS AND RELEVANCE Among older adults, periods of extreme heat were associated with increased risk of hospitalization for fluid and electrolyte disorders, renal failure, urinary tract infection, septicemia, and heat stroke. However, the absolute risk increase was small and of uncertain clinical importance.	[Bobb, Jennifer F.; Wang, Yun; Dominici, Francesca] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Obermeyer, Ziad] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Dominici, F (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, 655 Huntington Ave,Bldg 2,Room 441, Boston, MA 02115 USA.	fdominic@hsph.harvard.edu			National Institute of Environmental Health Sciences [R21ES022585, P30ES000002, 2001196559, R01ES019560, R21ES020152, 2001382807, 5R21ES021427-02]; Environmental Protection Agency [RD-83479801, 4909-RFA11-1/12-3, 83489401-0]; National Institutes of Health Office of the Director [DP5 OD012161]; National Cancer Institute [2P01CA134294-06]; Agency for Healthcare Research and Quality [1K18HS021991-01A1]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K18HS021991] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA134294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES022585, P30ES000002, R21ES020152, R21ES021427, T32ES007142, R01ES019560] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012161] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Environmental Protection Agency(United States Environmental Protection Agency); National Institutes of Health Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Institute of Environmental Health Sciences grants R21ES022585 (to Drs Bobb and Dominici), P30ES000002 (to Drs Bobb and Wang), 2001196559 (to Drs Wang and Dominici), and R01ES019560, R21ES020152, 2001382807, and 5R21ES021427-02 (to Dr Dominici); Environmental Protection Agency grants RD-83479801, 4909-RFA11-1/12-3, and 83489401-0 (to Dr Dominici); National Institutes of Health Office of the Director grant DP5 OD012161 (to Dr Obermeyer); National Cancer Institute grant 2P01CA134294-06 (to Drs Wang and Dominici); and Agency for Healthcare Research and Quality grant 1K18HS021991-01A1 (to Drs Wang and Dominici).	Agency for Healthcare Research and Quality, 2012, AHRQ QI PREV QUAL IN; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Anderson GB, 2013, AM J RESP CRIT CARE, V187, P1098, DOI 10.1164/rccm.201211-1969OC; Armstrong B, 2014, AM J EPIDEMIOL, V179, P1405, DOI 10.1093/aje/kwu083; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bobb JF, 2011, BIOMETRICS, V67, P1605, DOI 10.1111/j.1541-0420.2011.01583.x; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110859; D'Ippoliti D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-37; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Elixhauser A, 2014, CLIN CLASSIFICATIONS; Gasparrini A, 2012, OCCUP ENVIRON MED, V69, P56, DOI 10.1136/oem.2010.059782; Green RS, 2010, INT J PUBLIC HEALTH, V55, P113, DOI 10.1007/s00038-009-0076-0; Gronlund CJ, 2014, ENVIRON HEALTH PERSP, V122, P1187, DOI 10.1289/ehp.1206132; Hansen AL, 2008, INT J EPIDEMIOL, V37, P1359, DOI 10.1093/ije/dyn165; HOLM S, 1979, SCAND J STAT, V6, P65; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Lin S, 2009, EPIDEMIOLOGY, V20, P738, DOI 10.1097/EDE.0b013e3181ad5522; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Medina-Ramon M, 2007, OCCUP ENVIRON MED, V64, P827, DOI 10.1136/oem.2007.033175; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; National Climatic Data Center, 2013, GLOB SUMM DAY; National Weather Service, 2013, NAT WEATH SERV 73 YE; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; Patz JA, 2014, JAMA-J AM MED ASSOC, V312, P1565, DOI 10.1001/jama.2014.13186; Saha MV, 2014, AM J EPIDEMIOL, V179, P467, DOI 10.1093/aje/kwt264; Schwartz J, 2004, EPIDEMIOLOGY, V15, P755, DOI 10.1097/01.ede.0000134875.15919.0f; Semenza JC, 1999, AM J PREV MED, V16, P269, DOI 10.1016/S0749-3797(99)00025-2; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Turner LR, 2012, EPIDEMIOLOGY, V23, P594, DOI 10.1097/EDE.0b013e3182572795; Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI [10.1289/ehp.1003198, 10.1289/ehp.120-a19]	34	147	147	5	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2014	312	24					2659	2667		10.1001/jama.2014.15715	http://dx.doi.org/10.1001/jama.2014.15715			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX5KW	25536257	Green Accepted, Bronze			2022-12-28	WOS:000346966100018
J	West, KP; Shamim, AA; Mehra, S; Labrique, AB; Ali, H; Shaikh, S; Klemm, RDW; Wu, LSF; Mitra, M; Haque, R; Hanif, AAM; Massie, AB; Merrill, RD; Schulze, KJ; Christian, P				West, Keith P., Jr.; Shamim, Abu Ahmed; Mehra, Sucheta; Labrique, Alain B.; Ali, Hasmot; Shaikh, Saijuddin; Klemm, Rolf D. W.; Wu, Lee S-F.; Mitra, Maithilee; Haque, Rezwanul; Hanif, Abu A. M.; Massie, Allan B.; Merrill, Rebecca Day; Schulze, Kerry J.; Christian, Parul			Effect of Maternal Multiple Micronutrient vs Iron-Folic Acid Supplementation on Infant Mortality and Adverse Birth Outcomes in Rural Bangladesh The JiVitA-3 Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BETA-CAROTENE SUPPLEMENTATION; MIDDLE-INCOME COUNTRIES; FOR-GESTATIONAL-AGE; DOUBLE-BLIND; VITAMIN-A; PRETERM BIRTH; FETAL LOSS; PREGNANCY; WEIGHT; WOMEN	IMPORTANCE Maternal micronutrient deficiencies may adversely affect fetal and infant health, yet there is insufficient evidence of effects on these outcomes to guide antenatal micronutrient supplementation in South Asia. OBJECTIVE To assess effects of antenatal multiple micronutrient vs iron-folic acid supplementation on 6-month infant mortality and adverse birth outcomes. DESIGN, SETTING, AND PARTICIPANTS Cluster randomized, double-masked trial in Bangladesh, with pregnancy surveillance starting December 4, 2007, and recruitment on January 11, 2008. Six-month infant follow-up ended August 30, 2012. Surveillance included 127 282 women; 44 567 became pregnant and were included in the analysis and delivered 28 516 live-born infants. Median gestation at enrollment was 9 weeks (interquartile range, 7-12). INTERVENTIONS Women were provided supplements containing 15 micronutrients or iron-folic acid alone, taken daily from early pregnancy to 12 weeks postpartum. MAIN OUTCOMES AND MEASURES The primary outcome was all-cause infant mortality through 6 months (180 days). Prespecified secondary outcomes in this analysis included stillbirth, preterm birth (<37 weeks), and low birth weight (<2500 g). To maintain overall significance of a=.05, a Bonferroni-corrected a=.01 was calculated to evaluate statistical significance of primary and 4 secondary risk outcomes (.05/5). RESULTS Among the 22 405 pregnancies in the multiple micronutrient group and the 22 162 pregnancies in the iron-folic acid group, there were 14 374 and 14 142 live-born infants, respectively, included in the analysis. At 6 months, multiple micronutrients did not significantly reduce infant mortality; there were 764 deaths (54.0 per 1000 live births) in the iron-folic acid group and 741 deaths (51.6 per 1000 live births) in the multiple micronutrient group (relative risk [RR], 0.95; 95% CI, 0.86-1.06). Multiple micronutrient supplementation resulted in a non-statistically significant reduction in stillbirths (43.1 vs 48.2 per 1000 births; RR, 0.89; 95% CI, 0.81-0.99; P=.02) and significant reductions in preterm births (18.6 vs 21.8 per 100 live births; RR, 0.85; 95% CI, 0.80-0.91; P<.001) and low birth weight (40.2 vs 45.7 per 100 live births; RR, 0.88; 95% CI, 0.85-0.91; P<.001). CONCLUSIONS AND RELEVANCE In Bangladesh, antenatal multiple micronutrient compared with iron-folic acid supplementation did not reduce all-cause infant mortality to age 6 months but resulted in a non-statistically significant reduction in stillbirths and significant reductions in preterm births and low birth weight.	[West, Keith P., Jr.; Shamim, Abu Ahmed; Mehra, Sucheta; Labrique, Alain B.; Ali, Hasmot; Shaikh, Saijuddin; Klemm, Rolf D. W.; Wu, Lee S-F.; Mitra, Maithilee; Massie, Allan B.; Schulze, Kerry J.; Christian, Parul] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD 21205 USA; [Shamim, Abu Ahmed; Ali, Hasmot; Shaikh, Saijuddin; Haque, Rezwanul; Hanif, Abu A. M.] JiVitA Project, Gaibandha, Bangladesh; [Massie, Allan B.] Johns Hopkins Sch Med, Dept Surg, Baltimore, MD USA; [Merrill, Rebecca Day] Ctr Dis Control & Prevent, Atlanta, GA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Centers for Disease Control & Prevention - USA	West, KP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W2041,615 N Wolfe St, Baltimore, MD 21205 USA.	kwest1@jhu.edu	Ali, Hasmot/I-8700-2019; Hanif, Abu Abdullah Mohammad/AAG-4636-2020	Ali, Hasmot/0000-0003-0044-1992; Hanif, Abu Abdullah Mohammad/0000-0001-6274-5612; Labrique, Alain/0000-0003-2502-7819; Abu Ahmed, Shamim/0000-0002-7071-8558	Global Control of Micronutrient Deficiency from Bill and Melinda Gates Foundation [OPP614]	Global Control of Micronutrient Deficiency from Bill and Melinda Gates Foundation	The JiVitA-3 Trial was funded through grant OPP614 (Global Control of Micronutrient Deficiency) from the Bill and Melinda Gates Foundation (Ellen Piwoz, ScD, Senior Program Officer). Additional assistance was received from the Sight and Life Global Nutrition Research Institute. DSM formulated, prepared, and delivered in-country micronutrient premixes for supplement production gratis and tested supplement potency throughout the trial gratis. Beximco Pharmaceuticals produced, bottled, labeled, and delivered to the field site 16 million study tablets during the trial gratis and delivered an additional 1 million multiple micronutrient supplements gratis to support posttrial antenatal supplement delivery services in the community.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; [Anonymous], COMP MULT SUPPL BE U; Arsenault JE, 2013, J NUTR, V143, P197, DOI 10.3945/jn.112.169524; Berti C, 2011, CLIN NUTR, V30, P689, DOI 10.1016/j.clnu.2011.08.004; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; Christian P, 2003, J NUTR, V133, P3492, DOI 10.1093/jn/133.11.3492; Christian P, 2003, BMJ-BRIT MED J, V326, P571, DOI 10.1136/bmj.326.7389.571; Christian PS, 2012, ARCH DIS CHILD-FETAL, V97, pF312, DOI 10.1136/adc.2006.114009; Christian P, 2013, AM J CLIN NUTR, V97, P188, DOI 10.3945/ajcn.112.042275; Christian P, 2010, ANNU REV NUTR, V30, P83, DOI 10.1146/annurev.nutr.012809.104813; Cohen J., 1988, STAT POWER ANAL BEHA, V2, P1, DOI DOI 10.4324/9780203771587; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Gunnsteinsson S, 2010, J HEALTH POPUL NUTR, V28, P509; Haider BA, 2012, COCHRANE DB SYST REV, V11; Hindle LJ, 2006, AM J CLIN NUTR, V84, P1086, DOI 10.1093/ajcn/84.5.1086; Hovdenak N, 2012, EUR J OBSTET GYN R B, V164, P127, DOI 10.1016/j.ejogrb.2012.06.020; Jiang TN, 2005, J NUTR, V135, P1106, DOI 10.1093/jn/135.5.1106; Katz J, 2006, J NUTR, V136, P1389, DOI 10.1093/jn/136.5.1389; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Klemm R, 2008, PEDIATRICS, V120, pe240; Klemm RDW, 2015, MATERN CHILD NUTR, V11, P583, DOI 10.1111/mcn.12041; Labrique AB, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-102; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; Lee ACC, 2009, ARCH PEDIAT ADOL MED, V163, P616, DOI 10.1001/archpediatrics.2009.75; Lee SE, 2013, PUBLIC HLTH NUTR, V16, P1340; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Merrill RD, 2012, ASIA PAC J CLIN NUTR, V21, P416; Merrill RD, 2011, J NUTR, V141, P944, DOI 10.3945/jn.111.138628; Mistry HD, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/841749; Osrin D, 2005, LANCET, V365, P955, DOI 10.1016/S0140-6736(05)71084-9; Otten JJ, 2008, ESSENTIAL GUIDE NUTR; Palmer AC, 2011, ADV NUTR, V2, P377, DOI 10.3945/an.111.000570; Pathak Priyali, 2004, Indian Journal of Pediatrics, V71, P1007; Persson LA, 2012, JAMA-J AM MED ASSOC, V307, P2050, DOI 10.1001/jama.2012.4061; Poston L, 2011, AM J CLIN NUTR S, V94, p1980S; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P153, DOI 10.1111/j.1365-3016.2012.01276.x; Roberfroid D, 2010, AM J CLIN NUTR, V91, P1649, DOI 10.3945/ajcn.2009.28855; Romero R, 2003, J NUTR, V133, p1668S, DOI 10.1093/jn/133.5.1668S; Shankar AH, 2008, LANCET, V371, P215, DOI 10.1016/S0140-6736(08)60133-6; Torheim LE, 2010, J NUTR, V140, p2051S, DOI 10.3945/jn.110.123463; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; West KP, 2011, JAMA-J AM MED ASSOC, V305, P1986, DOI 10.1001/jama.2011.656; West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570	45	79	79	2	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2014	312	24					2649	2658		10.1001/jama.2014.16819	http://dx.doi.org/10.1001/jama.2014.16819			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX5KW	25536256				2022-12-28	WOS:000346966100017
J	Ghosh, E; Nidhi, K; Shukla, AK				Ghosh, Eshan; Nidhi, Kumari; Shukla, Arun K.			Snap Shot: GPCR-Ligand Interactions	CELL			English	Editorial Material							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; COMPLEX		[Ghosh, Eshan; Nidhi, Kumari; Shukla, Arun K.] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Ghosh, E (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.			shukla, arun/0000-0003-2910-8288; Ghosh, Eshan/0000-0003-4532-1329	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Dore AS, 2014, NATURE, V511, P557, DOI 10.1038/nature13396; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489	10	14	14	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7							1712.e1	10.1016/j.ce11.2014.12.008	http://dx.doi.org/10.1016/j.ce11.2014.12.008			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CB3RU	25525884				2022-12-28	WOS:000349546800002
J	Goncalves, MJ; Romao, VC				Goncalves, Maria Joao; Romao, Vasco C.			Saber Tibia in Paget's Disease of Bone	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goncalves, Maria Joao; Romao, Vasco C.] Hosp Santa Maria, Lisbon, Portugal	Universidade de Lisboa; Hospital Santa Maria	Goncalves, MJ (corresponding author), Hosp Santa Maria, Lisbon, Portugal.	mjoaomgoncalves@gmail.com	Romão, Vasco C/O-8224-2014	Romão, Vasco C/0000-0002-5603-9436					0	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2417	2417		10.1056/NEJMicm1403255	http://dx.doi.org/10.1056/NEJMicm1403255			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW7DX	25517708				2022-12-28	WOS:000346425800011
J	Heron, JT; Bosse, JL; He, Q; Gao, Y; Trassin, M; Ye, L; Clarkson, JD; Wang, C; Liu, J; Salahuddin, S; Ralph, DC; Schlom, DG; Iniguez, J; Huey, BD; Ramesh, R				Heron, J. T.; Bosse, J. L.; He, Q.; Gao, Y.; Trassin, M.; Ye, L.; Clarkson, J. D.; Wang, C.; Liu, Jian; Salahuddin, S.; Ralph, D. C.; Schlom, D. G.; Iniguez, J.; Huey, B. D.; Ramesh, R.			Deterministic switching of ferromagnetism at room temperature using an electric field	NATURE			English	Article							DOMAINS; OXIDE	The technological appeal of multiferroics is the ability to control magnetism with electric field(1-3). For devices to be useful, such control must be achieved at room temperature. The only single-phase multiferroic material exhibiting unambiguous magnetoelectric coupling at room temperature is BiFeO3 (refs 4 and 5). Its weak ferromagnetism arises from the canting of the antiferromagnetically aligned spins by the Dzyaloshinskii-Moriya (DM) interaction(6-9). Prior theory considered the symmetry of the thermodynamic ground state and concluded that direct 180-degree switching of the DM vector by the ferroelectric polarization was forbidden(10,11). Instead, we examined the kinetics of the switching process, something not considered previously in theoretical work(10-12). Here we show a deterministic reversal of the DM vector and canted moment using an electric field at room temperature. First-principles calculations reveal that the switching kinetics favours a two-step switching process. In each step the DM vector and polarization are coupled and 180-degree deterministic switching of magnetization hence becomes possible, in agreement with experimental observation. We exploit this switching to demonstrate energy-efficient control of a spin-valve device at room temperature. The energy per unit area required is approximately an order of magnitude less than that needed for spin-transfer torque switching(13,14). Given that the DM interaction is fundamental to singlephase multiferroics and magnetoelectrics(3,9), our results suggest ways to engineer magnetoelectric switching and tailor technologically pertinent functionality for nanometre-scale, low-energy-consumption, non-volatile magnetoelectronics.	[Heron, J. T.; Schlom, D. G.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Bosse, J. L.; Ye, L.; Huey, B. D.] Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA; [He, Q.] Univ Durham, Dept Phys, Durham DH1 3LE, England; [Gao, Y.; Liu, Jian; Ramesh, R.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Gao, Y.] Tsinghua Univ, Sch Mat Sci & Engn, Beijing 100084, Peoples R China; [Gao, Y.] Tsinghua Univ, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China; [Trassin, M.] ETH, Dept Mat, CH-8093 Zurich, Switzerland; [Clarkson, J. D.; Ramesh, R.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Wang, C.; Ralph, D. C.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Salahuddin, S.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Ralph, D. C.; Schlom, D. G.] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA; [Iniguez, J.] Inst Ciencia Mat Barcelona ICMAB CSIC, Bellaterra 08193, Spain; [Huey, B. D.] Univ Connecticut, Inst Mat Sci, Storrs, CT 06269 USA; [Ramesh, R.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	Cornell University; University of Connecticut; Durham University; University of California System; University of California Berkeley; Tsinghua University; Tsinghua University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Berkeley; Cornell University; University of California System; University of California Berkeley; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Barcelona (ICMAB); University of Connecticut; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Heron, JT (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	jth247@cornell.edu	He, Qing/E-3202-2010; Schlom, Darrell G/J-2412-2013; Íñiguez, Jorge/B-6856-2009; Liu, Jian/I-6746-2013; Íñiguez, Jorge/K-3828-2019; Ramesh, Ramamoorthy/ABI-4883-2020; Huey, Bryan/G-7512-2014	He, Qing/0000-0002-0563-6134; Schlom, Darrell G/0000-0003-2493-6113; Íñiguez, Jorge/0000-0001-6435-3604; Liu, Jian/0000-0001-7962-2547; Íñiguez, Jorge/0000-0001-6435-3604; Huey, Bryan/0000-0002-1441-1180	National Science Foundation (Nanosystems Engineering Research Center for Translational Applications of Nanoscale Multiferroic Systems) [EEC-1160504]; DOD-ARO MURI - Army Research Office [W911NF-08-2-0032]; FENA-FAME; NSF/MRSEC through the Cornell Center for Materials Research [DMR-1120296]; MINECO-Spain [MAT2010-18113, CSD2007-00041]; DOE ESPM [DE-SC0005037]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]	National Science Foundation (Nanosystems Engineering Research Center for Translational Applications of Nanoscale Multiferroic Systems)(National Science Foundation (NSF)); DOD-ARO MURI - Army Research Office; FENA-FAME; NSF/MRSEC through the Cornell Center for Materials Research; MINECO-Spain; DOE ESPM; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE))	This work was supported by the National Science Foundation (Nanosystems Engineering Research Center for Translational Applications of Nanoscale Multiferroic Systems) under grant number EEC-1160504 and the DOD-ARO MURI supported by the Army Research Office through agreement number W911NF-08-2-0032 and partially by the FENA-FAME and NSF/MRSEC (DMR-1120296), through the Cornell Center for Materials Research, programs. J.I. acknowledges financial support from MINECO-Spain (grant numbers MAT2010-18113 and CSD2007-00041). J.L.B., L.Y. and B.D.H. acknowledge support from the DOE ESPM (grant number DE-SC0005037). The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract number DE-AC02-05CH11231. We thank C. Fennie for discussions, C. Zollner for the figure edits, and H. Nair, G. Stiehl and N. Dawley for their comments on the manuscript.	Baek SH, 2010, NAT MATER, V9, P309, DOI [10.1038/NMAT2703, 10.1038/nmat2703]; Bea H, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/43/434221; Belik AA, 2006, CHEM MATER, V18, P798, DOI 10.1021/cm052334z; Benedek NA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.107204; Binek C, 2005, J PHYS-CONDENS MAT, V17, pL39, DOI 10.1088/0953-8984/17/2/L06; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Cheong SW, 2007, NAT MATER, V6, P13, DOI 10.1038/nmat1804; Cherifi RO, 2014, NAT MATER, V13, P345, DOI [10.1038/NMAT3870, 10.1038/nmat3870]; Chu YH, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2897304; Chu YH, 2008, NAT MATER, V7, P478, DOI 10.1038/nmat2184; Chu YH, 2009, NANO LETT, V9, P1726, DOI 10.1021/nl900723j; Couet S, 2014, ADV FUNCT MATER, V24, P71, DOI 10.1002/adfm.201301160; Desmarais J, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3643155; Dieguez O, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.094105; Dudarev SL, 1998, PHYS REV B, V57, P1505, DOI 10.1103/PhysRevB.57.1505; DZIALOSHINSKII IE, 1957, SOV PHYS JETP-USSR, V5, P1259; Ederer C, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.060401; Ederer C, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/43/434219; Eerenstein W, 2007, NAT MATER, V6, P348, DOI 10.1038/nmat1886; Eerenstein W, 2006, NATURE, V442, P759, DOI 10.1038/nature05023; Evans DM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2548; Fennie CJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.167203; Fiebig M, 2005, J PHYS D APPL PHYS, V38, pR123, DOI 10.1088/0022-3727/38/8/R01; Fusil S, 2014, ANNU REV MATER RES, V44, P91, DOI 10.1146/annurev-matsci-070813-113315; Heron JT, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.217202; Huey BD, 2012, J AM CERAM SOC, V95, P1147, DOI 10.1111/j.1551-2916.2012.05099.x; Hunter D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1529; Hur N, 2004, NATURE, V429, P392, DOI 10.1038/nature02572; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Lebeugle D, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.257601; Li MR, 2012, J AM CHEM SOC, V134, P3737, DOI 10.1021/ja208395z; Liu H, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3527962; Liu LQ, 2012, SCIENCE, V336, P555, DOI 10.1126/science.1218197; Maruyama T, 2009, NAT NANOTECHNOL, V4, P158, DOI [10.1038/nnano.2008.406, 10.1038/NNANO.2008.406]; MILLS G, 1995, SURF SCI, V324, P305, DOI 10.1016/0039-6028(94)00731-4; MORIYA T, 1960, PHYS REV, V120, P91, DOI 10.1103/PhysRev.120.91; Perdew JP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136406; Radaelli G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4404; RADO GT, 1984, PHYS REV B, V29, P4041, DOI 10.1103/PhysRevB.29.4041; RAMESH R, 1992, APPL PHYS LETT, V61, P1537, DOI 10.1063/1.107488; Rowlands GE, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3565162; Scott JF, 2013, NPG ASIA MATER, V5, DOI 10.1038/am.2013.58; Sergienko IA, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.094434; Sheppard PW, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3677230; Spaldin NA, 2005, SCIENCE, V309, P391, DOI 10.1126/science.1113357; Trassin M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.134426; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615; Wang WG, 2012, NAT MATER, V11, P64, DOI [10.1038/NMAT3171, 10.1038/nmat3171]; Wang WB, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.237601; Wu SM, 2010, NAT MATER, V9, P756, DOI [10.1038/nmat2803, 10.1038/NMAT2803]; Yang YR, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.057202; Yu P, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.027201; Zanolli Z, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.060102; Zhang S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.137203; Zhao T, 2006, NAT MATER, V5, P823, DOI 10.1038/nmat1731	56	466	473	20	854	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					370	+		10.1038/nature14004	http://dx.doi.org/10.1038/nature14004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25519134				2022-12-28	WOS:000346484800041
J	Sacks, FM; Carey, VJ; Anderson, CAM; Miller, ER; Copeland, T; Charleston, J; Harshfield, BJ; Laranjo, N; McCarron, P; Swain, J; White, K; Yee, K; Appel, LJ				Sacks, Frank M.; Carey, Vincent J.; Anderson, Cheryl A. M.; Miller, Edgar R., III; Copeland, Trisha; Charleston, Jeanne; Harshfield, Benjamin J.; Laranjo, Nancy; McCarron, Phyllis; Swain, Janis; White, Karen; Yee, Karen; Appel, Lawrence J.			Effects of Flig,,h vs Low Glycemic Index of Dietary Carbohydrate on Cardiovascula Disease Risk Factors and Insulin Sensitivity The OmniCarb Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WEIGHT-LOSS; BLOOD-PRESSURE; GLYCATED HEMOGLOBIN; MEDITERRANEAN DIET; SERUM-LIPIDS; LOAD; GLUCOSE; METAANALYSIS; PROTEIN; CHOLESTEROL	IMPORTANCE Foods that have similar carbohydrate content can differ in the amount they raise blood glucose. The effects of this property, called the glycemic index, on risk factors for cardiovascular disease and diabetes are not well understood. OBJECTIVE To determine the effect of glycemic index and amount of total dietary carbohydrate on risk factors for cardiovascular disease and diabetes. DESIGN, SETTING, AND PARTICIPANTS Randomized crossover-controlled feeding trial conducted in research units in academic medical centers, in which 163 overweight adults (systolic blood pressure, 120-159 mm Hg) were given 4 complete diets that contained all of their meals, snacks, and calorie-containing beverages, each for 5 weeks, and completed at least 2 study diets. The first participant was enrolled April 1, 2008; the last participant finished December 22, 2010. For any pair of the 4 diets, there were 135 to 150 participants contributing at least 1primary outcome measure. INTERVENTIONS (1) A high-glycemic index (65% on the glucose scale), high-carbohydrate diet (58% energy); (2) a low-glycemic index (40%), high-carbohydrate diet; (3) a high-glycemic index, low-carbohydrate diet (40% energy); and (4) a low-glycemic index, low-carbohydrate diet. Each diet was based on a healthful DASH-type diet. MAIN OUTCOMES AND MEASURES The 5 primary outcomes were insulin sensitivity, determined from the areas under the curves of glucose and insulin levels during an oral glucose tolerance test; levels of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides; and systolic blood pressure. RESULTS At high dietary carbohydrate content, the low- compared with high-glycemic index level decreased insulin sensitivity from 8.9 to 7.1 units (-20%, P = .002); increased LDL cholesterol from 139 to 147 mg/dL (6%, P <= .001); and did not affect levels of HDL cholesterol, triglycerides, or blood pressure. At low carbohydrate content, the low- compared with high-glycemic index level did not affect the outcomes except for decreasing triglycerides from 91 to 86 mg/dL (-5%, P = .02). In the primary diet contrast, the low-glycemic index, low-carbohydrate diet, compared with the high-glycemic index, high-carbohydrate diet, did not affect insulin sensitivity, systolic blood pressure, LDL cholesterol, or HDL cholesterol but did lower triglycerides from 111 to 86 mg/dL (-23%, P <= .001). CONCLUSIONS AND RELEVANCE In this 5-week controlled feeding study, diets with low glycemic index of dietary carbohydrate, compared with high glycemic index of dietary carbohydrate, did not result in improvements in insulin sensitivity, lipid levels, or systolic blood pressure. In the context of an overall DASH-type diet, using glycemic index to select specific foods may not improve cardiovascular risk factors or insulin resistance.	[Sacks, Frank M.; Carey, Vincent J.; Copeland, Trisha; Harshfield, Benjamin J.; Laranjo, Nancy] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Sacks, Frank M.; Carey, Vincent J.; Copeland, Trisha; Harshfield, Benjamin J.; Laranjo, Nancy] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Sacks, Frank M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Anderson, Cheryl A. M.; Charleston, Jeanne; Appel, Lawrence J.] Johns Hopkins Med Inst, Dept Epidemiol, Baltimore, MD 21205 USA; [Miller, Edgar R., III; Charleston, Jeanne; McCarron, Phyllis; White, Karen; Appel, Lawrence J.] Johns Hopkins Med Inst, Div Gen Internal Med, Baltimore, MD 21205 USA; [Miller, Edgar R., III; Charleston, Jeanne; Appel, Lawrence J.] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Swain, Janis; Yee, Karen] Brigham & Womens Hosp, Ctr Clin Invest, Boston, MA 02115 USA; [Anderson, Cheryl A. M.] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Diego	Sacks, FM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	fsacks@hsph.harvard.edu	Appel, Larry/GLT-2608-2022		National Heart, Lung, and Blood Institute [R01HL084568]; National Institute of Diabetes and Digestive and Kidney Diseases [R21 DK098720-02]; Harvard Clinical and Translational Science Center from the National Center for Advancing Translational Science [8UL1TR0001750-05]; general clinical research center at Brigham and Women's Hospital [M01-02635]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK098720] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Harvard Clinical and Translational Science Center from the National Center for Advancing Translational Science; general clinical research center at Brigham and Women's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by an investigator-initiated grant from the National Heart, Lung, and Blood Institute (R01HL084568) and received additional support from National Institute of Diabetes and Digestive and Kidney Diseases (R21 DK098720-02); the Harvard Clinical and Translational Science Center (8UL1TR0001750-05) from the National Center for Advancing Translational Science; and the general clinical research center at Brigham and Women's Hospital (M01-02635).	Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Brown L, 1999, AM J CLIN NUTR, V69, P30; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; De Rougemont A, 2007, BRIT J NUTR, V98, P1288, DOI 10.1017/S0007114507778674; Dong JY, 2011, BRIT J NUTR, V106, P1649, DOI 10.1017/S000711451100540X; Ebbeling CB, 2012, JAMA-J AM MED ASSOC, V307, P2627, DOI 10.1001/jama.2012.6607; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Fabricatore AN, 2011, DIABETES RES CLIN PR, V92, P37, DOI 10.1016/j.diabres.2010.12.016; Fabricatore AN, 2011, AM J CLIN NUTR, V94, P1519, DOI 10.3945/ajcn.111.020354; Gannon MC, 1998, DIABETES CARE, V21, P1619, DOI 10.2337/diacare.21.10.1619; Gogebakan O, 2011, CIRCULATION, V124, P2829, DOI 10.1161/CIRCULATIONAHA.111.033274; Goff LM, 2013, NUTR METAB CARDIOVAS, V23, P1, DOI 10.1016/j.numecd.2012.06.002; Hartman TJ, 2010, J NUTR, V140, P60, DOI 10.3945/jn.109.114249; Heilbronn LK, 2002, J AM COLL NUTR, V21, P120, DOI 10.1080/07315724.2002.10719204; Jarvi AE, 1999, DIABETES CARE, V22, P10, DOI 10.2337/diacare.22.1.10; Jebb SA, 2010, AM J CLIN NUTR, V92, P748, DOI 10.3945/ajcn.2009.29096; Jenkins DJA, 2008, JAMA-J AM MED ASSOC, V300, P2742, DOI 10.1001/jama.2008.808; Jones G, 2003, DESIGN ANAL CROSS OV; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; Livesey G, 2008, AM J CLIN NUTR, V87, p258S, DOI 10.1093/ajcn/87.1.258S; Ludbrook J, 2000, CLIN EXP PHARMACOL P, V27, P212, DOI 10.1046/j.1440-1681.2000.03223.x; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; McMillan-Price J, 2006, ARCH INTERN MED, V166, P1466, DOI 10.1001/archinte.166.14.1466; MENSINK RP, 1992, ARTERIOSCLER THROMB, V12, P911, DOI 10.1161/01.ATV.12.8.911; Michaud DS, 2005, CANCER EPIDEM BIOMAR, V14, P138, DOI 10.1158/1055-9965.EPI-05-0428; Mirrahimi A, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000752; Obarzanek E, 2001, AM J CLIN NUTR, V74, P80; Raatz SK, 2005, J NUTR, V135, P2387, DOI 10.1093/jn/135.10.2387; Reynolds RC, 2009, EUR J CLIN NUTR, V63, P872, DOI 10.1038/ejcn.2008.52; Runchey SS, 2012, EUR J CLIN NUTR, V66, P1146, DOI 10.1038/ejcn.2012.107; Schwingshackl L, 2013, NUTR METAB CARDIOVAS, V23, P699, DOI 10.1016/j.numecd.2013.04.008; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Shikany JM, 2009, METABOLISM, V58, P1793, DOI 10.1016/j.metabol.2009.06.006; Sichieri R, 2007, AM J CLIN NUTR, V86, P707, DOI 10.1093/ajcn/86.3.707; Sloth B, 2004, AM J CLIN NUTR, V80, P337, DOI 10.1093/ajcn/80.2.337; Thomas DE, 2010, BRIT J NUTR, V104, P797, DOI 10.1017/S0007114510001534; Vrolix R, 2010, AM J CLIN NUTR, V92, P366, DOI 10.3945/ajcn.2009.28339; White WB, 2001, BLOOD PRESS MONIT, V6, P107, DOI 10.1097/00126097-200104000-00007; Wolever TMS, 2008, AM J CLIN NUTR, V87, P114, DOI 10.1093/ajcn/87.1.114; WOLEVER TMS, 1991, AM J CLIN NUTR, V54, P846, DOI 10.1093/ajcn/54.5.846	42	139	140	4	68	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2531	2541		10.1001/jama.2014.16658	http://dx.doi.org/10.1001/jama.2014.16658			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25514303	Green Published, Green Accepted			2022-12-28	WOS:000346346900016
J	Chen, C; Petterson, S; Phillips, R; Bazemore, A; Mullan, F				Chen, Candice; Petterson, Stephen; Phillips, Robert; Bazemore, Andrew; Mullan, Fitzhugh			Spending Patterns in Region of Residency Training and Subsequent Expenditures for Care Provided by Practicing Physicians for Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE Graduate medical education trainingmay imprint young physicians with skills and experiences, but few studies have evaluated imprinting on physician spending patterns. OBJECTIVE To examine the relationship between spending patterns in the region of a physician's graduate medical education training and subsequent mean Medicare spending per beneficiary. DESIGN, SETTING, AND PARTICIPANTS Secondary multilevel multivariable analysis of 2011 Medicare claims data (Part A hospital and Part B physician) for a random, nationally representative sample of family medicine and internal medicine physicians completing residency between 1992 and 2010 with Medicare patient panels of 40 or more patients (2851 physicians providing care to 491 948 Medicare beneficiaries). EXPOSURES Locations of practice and residency training were matched with Dartmouth Atlas Hospital Referral Region (HRR) files. Training and practice HRRs were categorized into low-, average-, and high-spending groups, with approximately equal distribution of beneficiary numbers. There were 674 physicians in low-spending training and low-spending practice HRRs, 180 in average-spending training/low-spending practice, 178 in high-spending training/low-spending practice, 253 in low-spending training/average-spending practice, 417 in average-spending training/average-spending practice, 210 in high-spending training/average-spending practice, 97 in low-spending training/high-spending practice, 275 in average-spending training/high-spending practice, and 567 in high-spending training/high-spending practice. MAIN OUTCOMES AND MEASURES Mean physician spending per Medicare beneficiary. RESULTS For physicians practicing in high-spending regions, those trained in high-spending regions had a mean spending per beneficiary per year $1926 higher (95% CI, $889-$2963) than those trained in low-spending regions. For practice in average-spending HRRs, mean spending was $897 higher (95% CI, $71-$1723) for physicians trained in high-vs low-spending regions. For practice in low-spending HRRs, the difference across training HRR levels was not significant ($533; 95% CI, -$46 to $1112). After controlling for patient, community, and physician characteristics, there was a 7% difference (95% CI, 2%-12%) in patient expenditures between low-and high-spending training HRRs. Across all practice HRRs, this corresponded to an estimated $522 difference (95% CI, $146-$919) between low-and high-spending training regions. For physicians 1 to 7 years in practice, there was a 29% difference ($2434; 95% CI, $1004-$4111) in spending between those trained in low-and high-spending regions; however, after 16 to 19 years, there was no significant difference. CONCLUSIONS AND RELEVANCE Among general internists and family physicians who completed residency training between 1992 and 2010, the spending patterns in the HRR in which their residency program was located were associated with expenditures for subsequent care they provided as practicing physicians for Medicare beneficiaries. Interventions during residency trainingmay have the potential to help control future health care spending. Copyright 2014 American Medical Association. All rights reserved.	[Chen, Candice; Mullan, Fitzhugh] George Washington Univ, Sch Publ Hlth, Milken Inst, Dept Hlth Policy, Washington, DC 20037 USA; [Petterson, Stephen; Bazemore, Andrew] Robert Graham Ctr, Washington, DC USA; [Phillips, Robert] Amer Board Family Med, Washington, DC USA	George Washington University	Chen, C (corresponding author), George Washington Univ, Sch Publ Hlth, Milken Inst, Dept Hlth Policy, 2175 K St NW,Ste 500, Washington, DC 20037 USA.	candicepchen@hotmail.com		Bazemore, Andrew/0000-0002-6028-2279	American Board of Family Medicine Foundation; National Institute of Minority Health and Health Disparities Research and Education Advancing Mission Career Transition Award [5K22MD006135-02]; National Institute on Minority Health and Health Disparities [K22MD006135] Funding Source: NIH RePORTER	American Board of Family Medicine Foundation; National Institute of Minority Health and Health Disparities Research and Education Advancing Mission Career Transition Award; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was supported by the American Board of Family Medicine Foundation. Dr Chen was supported through a National Institute of Minority Health and Health Disparities Research and Education Advancing Mission Career Transition Award (grant 5K22MD006135-02).	[Anonymous], 2013, GEOGRAPHIC VARIATION; [Anonymous], 2008, GEOGRAPHIC VARIATION; [Anonymous], 2013, IMPROVING VALUE GRAD; [Anonymous], 2013, MED GRADUATE MED ED; Asch DA, 2009, JAMA-J AM MED ASSOC, V302, P1277, DOI 10.1001/jama.2009.1356; Centers for Medicare & Medicaid Services, HOSP COST REP; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Eicheldinger C, 2013, HLTH CARE FINANC REV, V29, P27; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2004, HEALTH AFFAIR, V23, pVAR19, DOI 10.1377/hlthaff.var.19; Institute of Medicine, 2014, GRADUATE MED ED MEET; Kuo Y, 2009, NEW ENGL J MED, V360, P1102, DOI 10.1056/NEJMsa0802381; Mullan F, 2013, HEALTH AFFAIR, V32, P1914, DOI 10.1377/hlthaff.2013.0545; Pham HH, 2009, ANN INTERN MED, V150, P236, DOI 10.7326/0003-4819-150-4-200902170-00004; Wennberg DE, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2392; WWAMI Rural Health Research Center, RUCA DAT TRAV DIST T	16	138	138	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2385	2393		10.1001/jama.2014.15973	http://dx.doi.org/10.1001/jama.2014.15973			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YB	25490329	Bronze			2022-12-28	WOS:000346345700013
J	Straimer, J; Gnadig, NF; Witkowski, B; Amaratunga, C; Duru, V; Ramadani, AP; Dacheux, M; Khim, N; Zhang, L; Lam, S; Gregory, PD; Urnov, FD; Mercereau-Puijalon, O; Benoit-Vical, F; Fairhurst, RM; Menard, D; Fidock, DA				Straimer, Judith; Gnaedig, Nina F.; Witkowski, Benoit; Amaratunga, Chanaki; Duru, Valentine; Ramadani, Arba Pramundita; Dacheux, Melanie; Khim, Nimol; Zhang, Lei; Lam, Stephen; Gregory, Philip D.; Urnov, Fyodor D.; Mercereau-Puijalon, Odile; Benoit-Vical, Francoise; Fairhurst, Rick M.; Menard, Didier; Fidock, David A.			K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates	SCIENCE			English	Article							DIHYDROARTEMISININ-PIPERAQUINE; MALARIA PARASITES; WESTERN CAMBODIA; CLEARANCE; POPULATIONS	The emergence of artemisinin resistance in Southeast Asia imperils efforts to reduce the global malaria burden. We genetically modified the Plasmodium falciparum K13 locus using zinc-finger nucleases and measured ring-stage survival rates after drug exposure in vitro; these rates correlate with parasite clearance half-lives in artemisinin-treated patients. With isolates from Cambodia, where resistance first emerged, survival rates decreased from 13 to 49% to 0.3 to 2.4% after the removal of K13 mutations. Conversely, survival rates in wild-type parasites increased from <= 0.6% to 2 to 29% after the insertion of K13 mutations. These mutations conferred elevated resistance to recent Cambodian isolates compared with that of reference lines, suggesting a contemporary contribution of additional genetic factors. Our data provide a conclusive rationale for worldwide K13-propeller sequencing to identify and eliminate artemisinin-resistant parasites.	[Straimer, Judith; Gnaedig, Nina F.; Dacheux, Melanie; Fidock, David A.] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Witkowski, Benoit; Duru, Valentine; Khim, Nimol; Menard, Didier] Inst Pasteur Cambodge, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Amaratunga, Chanaki; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Ramadani, Arba Pramundita; Benoit-Vical, Francoise] CNRS, Chim Coordinat Lab, UPR8241, F-31077 Toulouse, France; [Ramadani, Arba Pramundita; Benoit-Vical, Francoise] Univ Toulouse, Inst Natl Polytech Toulouse, UPS, Toulouse, France; [Zhang, Lei; Lam, Stephen; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci, Richmond, CA USA; [Mercereau-Puijalon, Odile] Inst Pasteur, Parasite Mol Immunol Unit, Paris, France; [Fidock, David A.] Columbia Univ Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY 10032 USA	Columbia University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Sangamo Therapeutics, Inc.; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Columbia University	Fidock, DA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, 630 W 168th St, New York, NY 10032 USA.	df2260@columbia.edu	Witkowski, Benoit/T-1118-2019; Mercereau-Puijalon, Odile/AAA-2242-2020; Benoit-Vical, Francoise/E-3938-2016; ramadani, arba pramundita/GQP-2155-2022; Menard, Didier/O-3294-2013	Benoit-Vical, Francoise/0000-0002-9468-4823; Menard, Didier/0000-0003-1357-4495; Gregory, Philip/0000-0001-9249-2468; Ramadani, Arba Pramundita/0000-0001-6304-5757; Fidock, David/0000-0001-6753-8938	NIH [R01 AI109023]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH; French "Agence Nationale de la Recherche" [ANR-13-BSV3-0018-01]; French "Agence Nationale de la Recherche" (Laboratoire d'Excellence IBEID); Institut Pasteur, Division International (ACIP) [A-10-2010]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001066, R01AI109023, ZIAAI001000] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); French "Agence Nationale de la Recherche"(French National Research Agency (ANR)); French "Agence Nationale de la Recherche" (Laboratoire d'Excellence IBEID)(French National Research Agency (ANR)); Institut Pasteur, Division International (ACIP); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	D.A.F. gratefully acknowledges funding from the NIH (R01 AI109023). This study was supported in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH, the French "Agence Nationale de la Recherche" (ANR-13-BSV3-0018-01 and the Laboratoire d'Excellence IBEID), and the Institut Pasteur, Division International (ACIP A-10-2010). Parental and transgenic parasite lines have been deposited and are being made available through BEI Resources (www.mr4.org) with the following accession numbers: MRA-1240, Cam3.IR539T (also known as IPC 5202); MRA-1252, Cam3.Irev; MRA-1241, Cam5I543T (also known as IPC 4912); MRA-1253, Cam5rev; MRA-1236, Cam2C580Y (also known as IPC 3445); MRA-1254, Cam2rev; MRA-1250, CamWT; MRA-1251, CamWTC580Y; MRA-150, Dd2; MRA-1255, Dd2R539T. Parasite lines generated for this study will also be provided upon request from D.A.F. Requests for ZFNs should be directed to F.D.U. (FUrnov@sangamo.com); a materials transfer agreement is required. We extend our gratitude to F. Ariey (Institut Pasteur, Paris) for his important contribution to initiating this study, I. McKeague and O. Lieberman (Columbia University Medical Center) for their statistical and scientific input, and E. Rebar and the Production Group at Sangamo BioSciences for ZFN assembly and validation. L.Z., S.L., P.D.G., and F.D.U. declare that they are full-time employees of Sangamo, which designed, validated, and provided the ZFNs used in this study. B.W., O. M.-P., F. B.-V., and D.M., are co-inventors on the pending patents US61/904651 and US62/062439, and N.K. is a co-inventor on the pending patent US62/062439. Both patents are filed by Institut Pasteur. These patents cover the use of K13 mutations as a molecular marker of P. falciparum ART resistance. Sangamo holds patents on engineered DNA-binding proteins and the use thereof in targeted genome engineering and gene-specific regulation. All other authors declare no competing financial interests.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Amaratunga C, 2014, ANTIMICROB AGENTS CH, V58, P4935, DOI 10.1128/AAC.03055-14; Amaratunga C, 2014, LANCET INFECT DIS, V14, P449, DOI 10.1016/S1473-3099(14)70777-7; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Antoine T, 2014, J ANTIMICROB CHEMOTH, V69, P1005, DOI 10.1093/jac/dkt486; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Conrad MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105690; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Flegg JA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-411; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Hartwig CL, 2009, BIOCHEM PHARMACOL, V77, P322, DOI 10.1016/j.bcp.2008.10.015; Keum YS, 2014, MOLECULES, V19, P10074, DOI 10.3390/molecules190710074; Klonis N, 2013, CURR OPIN MICROBIOL, V16, P722, DOI 10.1016/j.mib.2013.07.005; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Leang R, 2013, ANTIMICROB AGENTS CH, V57, P818, DOI 10.1128/AAC.00686-12; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P242, DOI 10.1016/0035-9203(82)90289-9; Saralamba S, 2011, P NATL ACAD SCI USA, V108, P397, DOI 10.1073/pnas.1006113108; Saunders DL, 2014, NEW ENGL J MED, V371, P484, DOI 10.1056/NEJMc1403007; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; White NJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P301; WHO, WORLD MAL REP 2013; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09	32	428	438	1	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					428	431		10.1126/science.1260867	http://dx.doi.org/10.1126/science.1260867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25502314	Green Accepted			2022-12-28	WOS:000348225800045
J	Irie, N; Weinberger, L; Tang, WWC; Kobayashi, T; Viukov, S; Manor, YS; Dietmann, S; Hanna, JH; Surani, MA				Irie, Naoko; Weinberger, Leehee; Tang, Walfred W. C.; Kobayashi, Toshihiro; Viukov, Sergey; Manor, Yair S.; Dietmann, Sabine; Hanna, Jacob H.; Surani, M. Azim			SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate	CELL			English	Article							EMBRYONIC STEM-CELLS; NAIVE PLURIPOTENCY; DNA DEMETHYLATION; GROUND-STATE; SELF-RENEWAL; IN-VITRO; MOUSE; SPECIFICATION; MICE; DIFFERENTIATION	Specification of primordial germ cells (PGCs) marks the beginning of the totipotent state. However, without a tractable experimental model, the mechanism of human PGC (hPGC) specification remains unclear. Here, we demonstrate specification of hPGC-like cells (hPGCLCs) from germline competent pluripotent stem cells. The characteristics of hPGCLCs are consistent with the embryonic hPGCs and a germline seminoma that share a CD38 cell-surface marker, which collectively defines likely progression of the early human germline. Remarkably, SOX17 is the key regulator of hPGC-like fate, whereas BLIMP1 represses endodermal and other somatic genes during specification of hPGCLCs. Notable mechanistic differences between mouse and human PGC specification could be attributed to their divergent embryonic development and pluripotent states, which might affect other early cell-fate decisions. We have established a foundation for future studies on resetting of the epigenome in hPGCLCs and hPGCs for totipotency and the transmission of genetic and epigenetic information.	[Irie, Naoko; Tang, Walfred W. C.; Kobayashi, Toshihiro; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Irie, Naoko; Tang, Walfred W. C.; Kobayashi, Toshihiro; Surani, M. Azim] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Irie, Naoko; Tang, Walfred W. C.; Kobayashi, Toshihiro; Dietmann, Sabine; Surani, M. Azim] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 3EG, England; [Weinberger, Leehee; Viukov, Sergey; Manor, Yair S.; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	University of Cambridge; University of Cambridge; University of Cambridge; Weizmann Institute of Science	Hanna, JH (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	jacob.hanna@weizmann.ac.il; a.surani@gurdon.cam.ac.uk	Hanna, Jacob/K-1339-2012	Hanna, Jacob/0000-0003-2042-9974; Dietmann, Sabine./0000-0001-6672-8457; Surani, Azim/0000-0002-8640-4318; Kobayashi, Toshihiro/0000-0001-8019-0008	JSPS; BIRAX (the Britain Israel Research and Academic Exchange Partnership) initiative; ERC [StG-2011-281906]; Helmsley Charitable Trust; ISF (Bikura, Morasha, ICORE); ICRF; Abisch Frenkel Foundation; Fritz Thyssen Stiftung; Erica and Robert Drake; Benoziyo Endowment fund; Flight Attendant Medical Research Institute (FAMRI); New York Stem Cell Foundation; Croucher Foundation and Cambridge Trust; HFSP; Wellcome Trust; The British Council [15BX12ASJH] Funding Source: researchfish	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); BIRAX (the Britain Israel Research and Academic Exchange Partnership) initiative; ERC(European Research Council (ERC)European Commission); Helmsley Charitable Trust; ISF (Bikura, Morasha, ICORE); ICRF; Abisch Frenkel Foundation; Fritz Thyssen Stiftung; Erica and Robert Drake; Benoziyo Endowment fund; Flight Attendant Medical Research Institute (FAMRI); New York Stem Cell Foundation; Croucher Foundation and Cambridge Trust; HFSP(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); The British Council	We thank Rick Livesey and his lab for help with the culture of hESCs; Sohei Kitazawa and Janet Shipley for the TCam-2 cells; Nigel Miller and Andy Riddell for cell sorting, Roger Barker, Xiaoling He, and Pam Tyers for collection of human embryos; and Charles Bradshaw for help with bioinformatics. We thank members of the Surani and Hanna labs for important discussions and technical help. N.I. is supported by Grant-in-Aid for fellows of the JSPS and by BIRAX (the Britain Israel Research and Academic Exchange Partnership) initiative, who provided a project grant to J.H.H. and M.A.S. J.H.H. is supported by Ilana and Pascal Mantoux, the Kimmel Award, ERC (StG-2011-281906), Helmsley Charitable Trust, ISF (Bikura, Morasha, ICORE), ICRF, the Abisch Frenkel Foundation, the Fritz Thyssen Stiftung, Erica and Robert Drake, Benoziyo Endowment fund, and the Flight Attendant Medical Research Institute (FAMRI). J.H.H. is a New York Stem Cell Foundation Robertson Investigator. W.C.C.T. is supported by Croucher Foundation and Cambridge Trust; M.A.S. is supported by HFSP and a Wellcome Trust Investigator Award.	Aramaki S, 2013, DEV CELL, V27, P516, DOI 10.1016/j.devcel.2013.11.001; Barrios F, 2013, INT J DEV BIOL, V57, P123, DOI 10.1387/ijdb.130132fb; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Brocard J, 1998, NUCLEIC ACIDS RES, V26, P4086, DOI 10.1093/nar/26.17.4086; Chen YY, 2013, STEM CELL REP, V1, P209, DOI 10.1016/j.stemcr.2013.07.003; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Clarke RL, 2013, NAT CELL BIOL, V15, P502, DOI 10.1038/ncb2724; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; De Felici M, 2013, OOGENESIS, P19, DOI DOI 10.1007/978-0-85729-826-3_2; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; De Miguel MP, 2010, STEM CELL REV REP, V6, P633, DOI 10.1007/s12015-010-9170-1; Eckert D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-106; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Grabole N, 2013, EMBO REP, V14, P629, DOI 10.1038/embor.2013.67; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; Hara K, 2009, DEV BIOL, V330, P427, DOI 10.1016/j.ydbio.2009.04.012; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Imamura M, 2014, MOL REPROD DEV, V81, P2, DOI 10.1002/mrd.22259; Irie Naoko, 2014, Reproductive Medicine and Biology, V13, P203, DOI 10.1007/s12522-014-0184-2; Julaton VTA, 2011, HUM MOL GENET, V20, P2238, DOI 10.1093/hmg/ddr114; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kim S, 2014, MOL CELL, V56, P564, DOI 10.1016/j.molcel.2014.10.003; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lin IY, 2014, STEM CELL REP, V2, P189, DOI 10.1016/j.stemcr.2013.12.009; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; Looijenga LHJ, 2014, VIRCHOWS ARCH, V464, P301, DOI 10.1007/s00428-013-1522-1; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Magnusdottir E, 2014, DEVELOPMENT, V141, P245, DOI 10.1242/dev.098269; Magnusdottir E, 2013, NAT CELL BIOL, V15, P905, DOI 10.1038/ncb2798; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; Nakajima-Takagi Y, 2013, BLOOD, V121, P447, DOI 10.1182/blood-2012-05-431403; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pera RAR, 2013, REPROD FERT DEVELOP, V25, P396, DOI 10.1071/RD12047; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Schafer S, 2011, INT J ANDROL, V34, pE152, DOI 10.1111/j.1365-2605.2011.01167.x; Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012; SKAKKEBAEK NE, 1972, LANCET, V2, P516; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Weber S, 2010, BIOL REPROD, V82, P214, DOI 10.1095/biolreprod.109.078717; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001	55	479	505	3	116	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					253	268		10.1016/j.cell.2014.12.013	http://dx.doi.org/10.1016/j.cell.2014.12.013			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25543152	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000347923200023
J	Eliasson, J				Eliasson, Jan			The rising pressure of global water shortages	NATURE			English	Editorial Material												valdrep@un.org							0	206	216	29	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					6	6		10.1038/517006a	http://dx.doi.org/10.1038/517006a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8SI	25557695	Bronze			2022-12-28	WOS:000347178400002
J	Dasari, TW; Paliotta, M				Dasari, Tarun W.; Paliotta, Marco			Cervical Aortic Arch	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dasari, Tarun W.; Paliotta, Marco] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73106 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Dasari, TW (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73106 USA.	tarun-dasari@ouhsc.edu	Dasari, Tarun/E-6428-2015	Dasari, Tarun/0000-0002-4204-1279					0	6	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					E38	E38		10.1056/NEJMicm1400771	http://dx.doi.org/10.1056/NEJMicm1400771			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX4RZ	25539125				2022-12-28	WOS:000346920300011
J	Rongvaux, A; Jackson, R; Harman, CCD; Li, T; West, AP; de Zoete, MR; Wu, YT; Yordy, B; Lakhani, SA; Kuan, CY; Taniguchi, T; Shadel, GS; Chen, ZJJ; Iwasaki, A; Flavell, RA				Rongvaux, Anthony; Jackson, Ruaidhri; Harman, Christian C. D.; Li, Tuo; West, A. Phillip; de Zoete, Marcel R.; Wu, Youtong; Yordy, Brian; Lakhani, Saquib A.; Kuan, Chia-Yi; Taniguchi, Tadatsugu; Shadel, Gerald S.; Chen, Zhijian J.; Iwasaki, Akiko; Flavell, Richard A.			Apoptotic Caspases Prevent the Induction of Type I Interferons by Mitochondrial DNA	CELL			English	Article							PROGRAMMED CELL-DEATH; TRANSCRIPTION FACTORS; ANTIVIRAL DEFENSE; IMMUNE-RESPONSES; FAMILY; PATHWAYS; MICE; RECEPTORS; ROLES; BRAIN	The mechanism by which cells undergo death determines whether dying cells trigger inflammatory responses or remain immunologically silent. Mitochondria play a central role in the induction of cell death, as well as in immune signaling pathways. Here, we identify a mechanism by which mitochondria and downstream proapoptotic caspases regulate the activation of antiviral immunity. In the absence of active caspases, mitochondrial outer membrane permeabilization by Bax and Bak results in the expression of type I interferons (IFNs). This induction is mediated by mitochondrial DNA-dependent activation of the cGAS/STING pathway and results in the establishment of a potent state of viral resistance. Our results show that mitochondria have the capacity to simultaneously expose a cell-intrinsic inducer of the IFN response and to inactivate this response in a caspase-dependent manner. This mechanism provides a dual control, which determines whether mitochondria initiate an immunologically silent or a proinflammatory type of cell death.	[Rongvaux, Anthony; Jackson, Ruaidhri; Harman, Christian C. D.; de Zoete, Marcel R.; Yordy, Brian; Lakhani, Saquib A.; Iwasaki, Akiko; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunol, New Haven, CT 06520 USA; [Li, Tuo; Wu, Youtong; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [West, A. Phillip; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Shadel, Gerald S.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Kuan, Chia-Yi] Emory Univ, Sch Med, Div Neurol, Dept Pediat, Atlanta, GA 30322 USA; [Kuan, Chia-Yi] Emory Univ, Sch Med, CND, Atlanta, GA 30322 USA; [Taniguchi, Tadatsugu] Univ Tokyo, Inst Ind Sci, Dept Mol Immunol, Tokyo 1538505, Japan; [de Zoete, Marcel R.; Chen, Zhijian J.; Iwasaki, Akiko; Flavell, Richard A.] Univ S Dakota, Sanford Sch Med, Howard Hughes Med Inst, Sioux Falls, SD 57117 USA	Yale University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; Yale University; Emory University; Emory University; University of Tokyo; Howard Hughes Medical Institute; University of South Dakota	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunol, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	de Zoete, Marcel/ABA-7918-2021; West, A. Phillip/W-8171-2019; Iwasaki, Akiko/Z-1591-2019; de Zoete, Marcel R/O-3012-2014; Chen, Zhijian/C-6039-2012; Li, Tuo/L-6958-2015	West, A. Phillip/0000-0003-2884-6895; Iwasaki, Akiko/0000-0002-7824-9856; Chen, Zhijian/0000-0002-8475-8251; de Zoete, Marcel/0000-0002-6561-5810; Flavell, Richard/0000-0003-4461-0778; Lakhani, Saquib/0000-0003-3235-3460	NIAID [AI082030]; DOD [W81XWH-11-1-0745]; Blavatnik Family Foundation [M157176]; NIH [R01-AI093967, R01-AG047632]; Cancer Prevention and Research Institute of Texas [RP120718-P3]; United Mitochondrial Disease Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; American Cancer Society [PF-13-035-01-DMC]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082030, R01AI093967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047632] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DOD(United States Department of Defense); Blavatnik Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; United Mitochondrial Disease Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Thompson, G. Barber, T. Mak, R. Medzhitov, B. Beutler, and R. Verma for providing reagents; A. Ferrandino, L. Evangelisti, J. Stein, and C. Hughes for ES cell work; F. Sutterwala and N. Palm for comments on the manuscript; J. Alderman for managerial support; and C. Lieber for manuscript submission. This work was funded by NIAID AI082030, DOD W81XWH-11-1-0745, and Blavatnik Family Foundation M157176 (to R.A.F.); by NIH R01-AI093967 and Cancer Prevention and Research Institute of Texas RP120718-P3 (to Z.J.C.); NIH R01-AG047632 and the United Mitochondrial Disease Foundation (to G.S.S.); by a Grant-In-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T.T.); and by a postdoctoral fellowship PF-13-035-01-DMC from the American Cancer Society (to A.P.W.). C.C.D.H. is a Howard Hughes Medical Institute International Student Research fellow. Z.J.C., A.I., and R.A.F. are Investigators of the Howard Hughes Medical Institute.	Best SM, 2008, ANNU REV MICROBIOL, V62, P171, DOI 10.1146/annurev.micro.62.081307.163009; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hashiguchi K, 2009, METHODS MOL BIOL, V554, P383, DOI 10.1007/978-1-59745-521-3_23; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Martin SJ, 2012, MOL CELL, V46, P387, DOI 10.1016/j.molcel.2012.04.026; Masud A, 2007, J BIOL CHEM, V282, P14132, DOI 10.1074/jbc.M700077200; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stetson DB, 2009, CURR OPIN IMMUNOL, V21, P244, DOI 10.1016/j.coi.2009.05.005; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tait SWG, 2014, J CELL SCI, V127, P2135, DOI 10.1242/jcs.093575; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Upton JW, 2014, MOL CELL, V54, P273, DOI 10.1016/j.molcel.2014.01.027; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vilcek J, 2006, IMMUNITY, V25, P343, DOI 10.1016/j.immuni.2006.08.008; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yatim N, 2011, IMMUNITY, V35, P478, DOI 10.1016/j.immuni.2011.10.010; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	49	447	462	5	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1563	1577		10.1016/j.cell.2014.11.037	http://dx.doi.org/10.1016/j.cell.2014.11.037			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525875	Bronze, Green Accepted			2022-12-28	WOS:000347922500011
J	Rosenbaum, S				Rosenbaum, Sara			Medicaid Payments and Access to Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Hlth Policy, Washington, DC 20052 USA	George Washington University	Rosenbaum, S (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Hlth Policy, Washington, DC 20052 USA.							[Anonymous], 2011, C MED CHIP MAR, P124; Felland L. E., 2013, IMPROVING ACCESS SPE; Goin D., 2012, MUCH WILL MED PHYS F; Sommers BD, 2014, NEW ENGL J MED, V371, P867, DOI 10.1056/NEJMsr1406753; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099	5	30	30	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2345	2347		10.1056/NEJMp1412488	http://dx.doi.org/10.1056/NEJMp1412488			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW7DX	25517705				2022-12-28	WOS:000346425800001
J	Aronson, JK				Aronson, Jeffrey K.			CHRISTMAS 2014: ON THE WARDS, IN THE SURGERY Medical eponyms: taxonomies, natural history, and the evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford OX2 6GG, England	University of Oxford	Aronson, JK (corresponding author), Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford OX2 6GG, England.	jeffrey.aronson@phc.ox.ac.uk						Anderson JB, 1996, J ROY COLL PHYS LOND, V30, P174; Aresti N, 2012, J PEDIATR ORTHOP B, V21, P606, DOI 10.1097/BPB.0b013e328356f9a5; Arnold J, 1891, BEITR PATH ANAT, V10, P1; Aronson JK, 2005, J EVAL CLIN PRACT, V11, P195, DOI 10.1111/j.1365-2753.2005.00527.x; Aronson JK, 2005, BMJ-BRIT MED J, V331, P383; Collins FM, 1996, MED MICROBIOLOGY; ERB W, 1887, DTSCH ARCH KLIN MED, V42, P295; Friedreich N., 1868, VIRCHOWS ARCH, V43, P83, DOI DOI 10.1007/BF02117271; Jacobs Noah J, 1958, NAMING DAY EDEN CREA; JANSEN T, 1995, HAUTARZT, V46, P429, DOI 10.1007/s001050050279; Kondziella D, 2009, EUR NEUROL, V62, P56, DOI 10.1159/000215880; MacAskill MR, 2013, PEERJ, V1, DOI 10.7717/peerj.67; Planner H, 1922, ARCH DERMATOL SYPH-G, V140, P162, DOI 10.1007/BF01826806; Ritter RM, 2003, OXFORD STYLE MANUAL, P373; Ross J M, 1982, Psychoanal Study Child, V37, P169; Sarton G, 1936, STUDY HIST SCI, P36; Spence D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2503; Stigler Stephen M., 1980, SCI SOCIAL STRUCTURE, P147, DOI [10.1111/j.2164-0947.1980.tb02775.x, DOI 10.1111/J.2164-0947.1980.TB02775.X]; Strous RD, 2007, ISR MED ASSOC J, V9, P207; Sweet F, 2012, ISR MED ASSOC J, V14, P719; Thurnam J, 1848, Med Chir Trans, V31, P71; TOURAINE A, 1941, ANN DERMATOL SYPHIL, V8, P453; Touraine A, 1935, PRESSE MED, V43, P1820; Virchow R., 1859, ARCH PATHOL ANAT, V16, P180, DOI DOI 10.1007/BF01945262; Whitworth JA, 2007, BMJ, V335, P0; Woywodt A, 2007, BMJ-BRIT MED J, V335, P424, DOI 10.1136/bmj.39308.342639.AD; Zeidman LA, 2012, J CHILD NEUROL, V27, P1310, DOI 10.1177/0883073812449907	27	10	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2014	349								g7586	10.1136/bmj.g7586	http://dx.doi.org/10.1136/bmj.g7586			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HK	25515058				2022-12-28	WOS:000346763900015
J	Delamothe, T				Delamothe, Tony			CHRISTMAS 2014: IN LOVE AND INAR Don't look away now	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com						[Anonymous], 1938, BMJ, V2, P386; [Anonymous], 1933, BMJ, V2, P692; [Anonymous], 1934, BMJ, V1, P433; [Anonymous], 1937, BMJ, V2, P663; [Anonymous], 1937, BMJ, V2, P72; [Anonymous], 1938, BMJ, V2, P268; [Anonymous], 1933, BMJ, V1, P757; [Anonymous], 1936, BMJ, V2, P1295; [Anonymous], 1938, BMJ, V2, P155; [Anonymous], 1933, WEEKLY NEWS BRO 0315; Arnold P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7520; BARTRIP PWJ, 1990, MIRROR MED HIST BMJ; Bland Lucy, 2010, OXFORD HDB HIST EUGE; Delamothe T, 2002, BMJ-BRIT MED J, V325, P1431, DOI 10.1136/bmj.325.7378.1431; Elliott C., 2014, GUARDIAN; Evans Richard J., 2005, 3 REICH POWER; Goldhagen DJ., 1996, HITLERS WILLING EXEC; Health Cluster, 2014, GAZA STRIP JOINT HLT; Lightstone L, 2009, BMJ; Proctor AH, 1937, BMJ-BRIT MED J, V2, P542	20	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2014	349								g7622	10.1136/bmj.g7622	http://dx.doi.org/10.1136/bmj.g7622			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HK	25515190				2022-12-28	WOS:000346763900018
J	Conrad, PG				Conrad, Pamela G.			Scratching the surface of martian habitability	SCIENCE			English	Editorial Material							MARS		NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Conrad, PG (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	pamela.g.conrad@nasa.gov						Bougher SW, 2015, SPACE SCI REV, V195, P423, DOI 10.1007/s11214-014-0053-7; Farley KA, 2014, SCIENCE, V343, DOI 10.1126/science.1247166; Gomez-Elvira J, 2014, J GEOPHYS RES-PLANET, V119, P1680, DOI 10.1002/2013JE004576; Grotzinger JP, 2014, SCIENCE, V343, DOI 10.1126/science.1242777; Haberle RM, 2014, J GEOPHYS RES-PLANET, V119, P440, DOI 10.1002/2013JE004488; Hassler DM, 2014, SCIENCE, V343, DOI 10.1126/science.1244797; HESS SL, 1972, ICARUS, V16, P196, DOI 10.1016/0019-1035(72)90146-7; KLEIN HP, 1978, ICARUS, V34, P666, DOI 10.1016/0019-1035(78)90053-2; McLennan SM, 2014, SCIENCE, V343, DOI 10.1126/science.1244734; Ming DW, 2014, SCIENCE, V343, DOI 10.1126/science.1245267; Vaniman DT, 2014, SCIENCE, V343, DOI 10.1126/science.1243480	11	4	4	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1288	1289		10.1126/science.1259943	http://dx.doi.org/10.1126/science.1259943			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW3MA	25504700				2022-12-28	WOS:000346189600020
J	Zhang, GJ; Li, C; Li, QY; Li, B; Larkin, DM; Lee, C; Storz, JF; Antunes, A; Greenwold, MJ; Meredith, RW; Odeen, A; Cui, J; Zhou, Q; Xu, LH; Pan, HL; Wang, ZJ; Jin, LJ; Zhang, P; Hu, HF; Yang, W; Hu, J; Xiao, J; Yang, ZK; Liu, Y; Xie, QL; Yu, H; Lian, JM; Wen, P; Zhang, F; Li, H; Zeng, YL; Xiong, ZJ; Liu, SP; Zhou, L; Huang, ZY; An, N; Wang, J; Zheng, QM; Xiong, YQ; Wang, GB; Wang, B; Wang, JJ; Fan, Y; da Fonseca, RR; Alfaro-Nunez, A; Schubert, M; Orlando, L; Mourier, T; Howard, JT; Ganapathy, G; Pfenning, A; Whitney, O; Rivas, MV; Hara, E; Smith, J; Farre, M; Narayan, J; Slavov, G; Romanov, MN; Borges, R; Machado, JP; Khan, I; Springer, MS; Gatesy, J; Hoffmann, FG; Opazo, JC; Hastad, O; Sawyer, RH; Kim, H; Kim, KW; Kim, HJ; Cho, S; Li, N; Huang, YH; Bruford, MW; Zhan, XJ; Dixon, A; Bertelsen, MF; Derryberry, E; Warren, W; Wilson, RK; Li, SB; Ray, DA; Green, RE; O'Brien, SJ; Griffin, D; Johnson, WE; Haussler, D; Ryder, OA; Willerslev, E; Graves, GR; Alstrom, P; Fjeldsa, J; Mindell, DP; Edwards, SV; Braun, EL; Rahbek, C; Burt, DW; Houde, P; Zhang, Y; Yang, HM; Wang, J; Jarvis, ED; Gilbert, MTP; Wang, J				Zhang, Guojie; Li, Cai; Li, Qiye; Li, Bo; Larkin, Denis M.; Lee, Chul; Storz, Jay F.; Antunes, Agostinho; Greenwold, Matthew J.; Meredith, Robert W.; Odeen, Anders; Cui, Jie; Zhou, Qi; Xu, Luohao; Pan, Hailin; Wang, Zongji; Jin, Lijun; Zhang, Pei; Hu, Haofu; Yang, Wei; Hu, Jiang; Xiao, Jin; Yang, Zhikai; Liu, Yang; Xie, Qiaolin; Yu, Hao; Lian, Jinmin; Wen, Ping; Zhang, Fang; Li, Hui; Zeng, Yongli; Xiong, Zijun; Liu, Shiping; Zhou, Long; Huang, Zhiyong; An, Na; Wang, Jie; Zheng, Qiumei; Xiong, Yingqi; Wang, Guangbiao; Wang, Bo; Wang, Jingjing; Fan, Yu; da Fonseca, Rute R.; Alfaro-Nunez, Alonzo; Schubert, Mikkel; Orlando, Ludovic; Mourier, Tobias; Howard, Jason T.; Ganapathy, Ganeshkumar; Pfenning, Andreas; Whitney, Osceola; Rivas, Miriam V.; Hara, Erina; Smith, Julia; Farre, Marta; Narayan, Jitendra; Slavov, Gancho; Romanov, Michael N.; Borges, Rui; Machado, Joao Paulo; Khan, Imran; Springer, Mark S.; Gatesy, John; Hoffmann, Federico G.; Opazo, Juan C.; Hastad, Olle; Sawyer, Roger H.; Kim, Heebal; Kim, Kyu-Won; Kim, Hyeon Jeong; Cho, Seoae; Li, Ning; Huang, Yinhua; Bruford, Michael W.; Zhan, Xiangjiang; Dixon, Andrew; Bertelsen, Mads F.; Derryberry, Elizabeth; Warren, Wesley; Wilson, Richard K.; Li, Shengbin; Ray, David A.; Green, Richard E.; O'Brien, Stephen J.; Griffin, Darren; Johnson, Warren E.; Haussler, David; Ryder, Oliver A.; Willerslev, Eske; Graves, Gary R.; Alstroem, Per; Fjeldsa, Jon; Mindell, David P.; Edwards, Scott V.; Braun, Edward L.; Rahbek, Carsten; Burt, David W.; Houde, Peter; Zhang, Yong; Yang, Huanming; Wang, Jian; Jarvis, Erich D.; Gilbert, M. Thomas P.; Wang, Jun		Avian Genome Consortium	Comparative genomics reveals insights into avian genome evolution and adaptation	SCIENCE			English	Article							FUNCTIONAL DIVERSIFICATION; TRANSPOSABLE ELEMENTS; GENE DUPLICATION; RAPID EVOLUTION; MUTATION-RATE; INTRON SIZE; VERTEBRATE; BIRDS; DIVERSITY; CHICKEN	Birds are the most species-rich class of tetrapod vertebrates and have wide relevance across many research fields. We explored bird macroevolution using full genomes from 48 avian species representing all major extant clades. The avian genome is principally characterized by its constrained size, which predominantly arose because of lineage-specific erosion of repetitive elements, large segmental deletions, and gene loss. Avian genomes furthermore show a remarkably high degree of evolutionary stasis at the levels of nucleotide sequence, gene synteny, and chromosomal structure. Despite this pattern of conservation, we detected many non-neutral evolutionary changes in protein-coding genes and noncoding regions. These analyses reveal that pan-avian genomic diversity covaries with adaptations to different lifestyles and convergent evolution of traits.	[Zhang, Guojie; Li, Cai; Li, Qiye; Li, Bo; Xu, Luohao; Pan, Hailin; Wang, Zongji; Jin, Lijun; Zhang, Pei; Hu, Haofu; Yang, Wei; Hu, Jiang; Xiao, Jin; Yang, Zhikai; Liu, Yang; Xie, Qiaolin; Yu, Hao; Lian, Jinmin; Wen, Ping; Zhang, Fang; Li, Hui; Zeng, Yongli; Xiong, Zijun; Liu, Shiping; Zhou, Long; Huang, Zhiyong; An, Na; Wang, Jie; Zheng, Qiumei; Xiong, Yingqi; Wang, Guangbiao; Wang, Bo; Wang, Jingjing; Zhang, Yong; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, China Natl GeneBank, Shenzhen 518083, Peoples R China; [Zhang, Guojie] Univ Copenhagen, Dept Biol, Ctr Social Evolut, DK-2100 Copenhagen, Denmark; [Li, Cai; Li, Qiye; da Fonseca, Rute R.; Alfaro-Nunez, Alonzo; Schubert, Mikkel; Orlando, Ludovic; Mourier, Tobias; Willerslev, Eske; Gilbert, M. Thomas P.] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Larkin, Denis M.; Farre, Marta] Univ London, Royal Vet Coll, London, England; [Lee, Chul; Kim, Heebal; Kim, Kyu-Won] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul 151742, South Korea; [Lee, Chul; Kim, Heebal; Kim, Hyeon Jeong; Cho, Seoae] Seoul Natl Univ, Cho & Kim Genomics, Seoul 151919, South Korea; [Storz, Jay F.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Antunes, Agostinho; Borges, Rui; Machado, Joao Paulo; Khan, Imran] Univ Porto, Ctr Invest Ciencias Mar & Limnol CIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental C, P-4050123 Oporto, Portugal; [Antunes, Agostinho; Borges, Rui; Khan, Imran] Univ Porto, Fac Ciencias, Dept Biol, P-4169007 Oporto, Portugal; [Greenwold, Matthew J.; Sawyer, Roger H.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Meredith, Robert W.] Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ 07043 USA; [Odeen, Anders] Uppsala Univ, Dept Anim Ecol, S-75236 Uppsala, Sweden; [Cui, Jie] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Charles Perkins Ctr, Sch Biol Sci, Sydney, NSW 2006, Australia; [Cui, Jie] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Cui, Jie] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore 169857, Singapore; [Zhou, Qi] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Xu, Luohao] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Wang, Zongji; Liu, Shiping] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Wang, Jie] Univ Chinese Acad Sci, BGI Educ Ctr, Shenzhen 518083, Peoples R China; [Fan, Yu] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Fan, Yu] Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China; [Howard, Jason T.; Ganapathy, Ganeshkumar; Pfenning, Andreas; Whitney, Osceola; Rivas, Miriam V.; Hara, Erina; Smith, Julia; Jarvis, Erich D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA; [Narayan, Jitendra; Slavov, Gancho] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Romanov, Michael N.; Griffin, Darren] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Machado, Joao Paulo] Univ Porto, ICBAS, P-4100 Oporto, Portugal; [Springer, Mark S.; Gatesy, John] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Hoffmann, Federico G.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Hoffmann, Federico G.; Ray, David A.] Mississippi State Univ, Inst Gen Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Opazo, Juan C.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Hastad, Olle] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, S-75007 Uppsala, Sweden; [Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea; [Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151742, South Korea; [Li, Ning; Huang, Yinhua] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Huang, Yinhua] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Bruford, Michael W.; Zhan, Xiangjiang] Cardiff Univ, Cardiff Sch Biosci, Organisms & Environm Div, Cardiff CF10 3AX, S Glam, Wales; [Zhan, Xiangjiang] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing 100101, Peoples R China; [Dixon, Andrew] Int Wildlife Consultants, Carmarthen SA33 5YL, Dyfed, Wales; [Bertelsen, Mads F.] Copenhagen Zoo, Ctr Zoo & Wild Anim Hlth, DK-2000 Frederiksberg, Denmark; [Derryberry, Elizabeth] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Derryberry, Elizabeth] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Warren, Wesley; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Li, Shengbin] Xi An Jiao Tong Univ, Cole Med & Forens, Xian 710061, Peoples R China; [Green, Richard E.; Haussler, David] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [O'Brien, Stephen J.] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bioinformat, St Petersburg 199034, Russia; [O'Brien, Stephen J.] Nova SE Univ, Oceanog Ctr, Dania, FL 33004 USA; [Johnson, Warren E.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA; [Ryder, Oliver A.] San Diego Zoo Inst Conservat Res, Genet Div, Escondido, CA 92027 USA; [Graves, Gary R.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20013 USA; [Graves, Gary R.; Fjeldsa, Jon; Rahbek, Carsten] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen O, Denmark; [Alstroem, Per] Chinese Acad Sci, Inst Zool, Key Lab Zool Syst & Evolut, Beijing 100101, Peoples R China; [Alstroem, Per] Swedish Univ Agr Sci, Swedish Species Informat Ctr, SE-75007 Uppsala, Sweden; [Mindell, David P.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Edwards, Scott V.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Edwards, Scott V.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Braun, Edward L.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Braun, Edward L.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Rahbek, Carsten] Imperial Coll London, Grand Challenges Ecosyst & Environm Initiat, Ascot SL5 7PY, Berks, England; [Burt, David W.] Univ Edinburgh, Roslin Inst, Div Genet & Gen, Roslin EH25 9RG, Midlothian, Scotland; [Burt, David W.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9RG, Midlothian, Scotland; [Houde, Peter] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Yang, Huanming; Wang, Jun] Macau Univ Sci & Technol, Taipa 999078, Macau, Peoples R China; [Gilbert, M. Thomas P.] Curtin Univ, Dept Environm & Agr, Trace & Environm DNA Lab, Perth, WA 6102, Australia; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21589, Saudi Arabia; [Wang, Jun] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China	Beijing Genomics Institute (BGI); University of Copenhagen; University of Copenhagen; University of London; University of London Royal Veterinary College; Seoul National University (SNU); Seoul National University (SNU); University of Nebraska System; University of Nebraska Lincoln; Universidade do Porto; Universidade do Porto; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Montclair State University; Uppsala University; University of Sydney; University of Sydney; National University of Singapore; University of California System; University of California Berkeley; Wuhan University; South China University of Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Duke University; Howard Hughes Medical Institute; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Kent; Universidade do Porto; University of California System; University of California Riverside; Mississippi State University; Mississippi State University; Universidad Austral de Chile; Swedish University of Agricultural Sciences; Seoul National University (SNU); Seoul National University (SNU); China Agricultural University; China Agricultural University; Cardiff University; Chinese Academy of Sciences; Institute of Zoology, CAS; Tulane University; Louisiana State University System; Louisiana State University; Washington University (WUSTL); Xi'an Jiaotong University; University of California System; University of California Santa Cruz; Saint Petersburg State University; Nova Southeastern University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Zoological Society of San Diego; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Copenhagen; Chinese Academy of Sciences; Institute of Zoology, CAS; Swedish University of Agricultural Sciences; University of California System; University of California San Francisco; Harvard University; Harvard University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Imperial College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; New Mexico State University; Macau University of Science & Technology; Curtin University; University of Copenhagen; King Abdulaziz University; University of Hong Kong	Zhang, GJ (corresponding author), BGI Shenzhen, China Natl GeneBank, Shenzhen 518083, Peoples R China.	zhanggj@genomics.cn; jarvis@neuro.duke.edu; mtpgilbert@gmail.com; wangj@genomics.cn	Bertelsen, Mads/AAA-5746-2022; Alfaro-Núñez, Alonzo/H-2972-2019; Bruford, Michael/Y-7463-2019; da Fonseca, Rute R/F-9143-2013; Mourier, Tobias/C-1164-2015; Kim, Heebal/A-8889-2016; Jarvis, Erich D/A-2319-2008; Kim, Kyu Won/AAJ-7213-2020; Willerslev, Eske/AAA-5686-2019; Edwards, Scott V./D-9071-2018; Willerslev, Eske/A-9619-2011; Ribeiro, Ângela M./AAI-1223-2019; Larkin, Denis/AAB-2249-2022; Samaniego Castruita, José Alfredo/B-9033-2015; Graves, Gary R/P-1003-2017; wang, jing/GRS-7509-2022; Rahbek, Carsten/L-1129-2013; yu, hao/HIK-0596-2022; OBRIEN, STEPHEN/ABD-1346-2020; Borges, Rui/H-5873-2016; Wilson, Richard K./AAF-4139-2019; Stadler, Peter F. F/L-7857-2015; Cui, Jie/ABB-3831-2020; Fjeldså, Jon/A-9699-2013; Bruford, Michael W/D-3750-2009; Maldonado, Emanuel/X-1620-2019; WANG, JINGYI/GSJ-1241-2022; Mendoza, Marie Lisandra Zepeda/C-2001-2015; Pitel, Frédérique/C-2847-2009; Pereira, Joana/AAU-6247-2020; Zhang, Guojie/J-7273-2019; Larkin, Denis/AAB-1633-2022; Romanov, Michael N/O-9419-2014; Almeida, Daniela/D-1956-2019; Gilbert, Marcus TP/A-8936-2013; Campos, Paula F/B-1634-2010; Li, Qiye/C-1348-2015; Burt, David W/C-7802-2013; Farré, Marta/L-7791-2019; Alström, Per/C-1619-2015; Håstad, Olle E/H-6235-2017; Gardner, Paul P./B-1978-2009; Barnett, Ross/G-1920-2011; Schubert, Mikkel/I-6911-2013; Orlando, Ludovic/A-8932-2013; Hoffmann, Federico/B-7134-2009; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016; Johnson, Warren/D-4149-2016	Bertelsen, Mads/0000-0001-9201-7499; Alfaro-Núñez, Alonzo/0000-0002-4050-5041; Bruford, Michael/0000-0001-6357-6080; da Fonseca, Rute R/0000-0002-2805-4698; Mourier, Tobias/0000-0003-2727-1903; Kim, Heebal/0000-0003-3064-1303; Jarvis, Erich D/0000-0001-8931-5049; Edwards, Scott V./0000-0003-2535-6217; Willerslev, Eske/0000-0002-7081-6748; Ribeiro, Ângela M./0000-0003-0666-3449; Samaniego Castruita, José Alfredo/0000-0001-5904-1198; Graves, Gary R/0000-0003-1406-5246; Rahbek, Carsten/0000-0003-4585-0300; Borges, Rui/0000-0002-5905-3778; Wilson, Richard K./0000-0002-1992-1358; Stadler, Peter F. F/0000-0002-5016-5191; Cui, Jie/0000-0001-8176-9951; Fjeldså, Jon/0000-0003-0790-3600; Bruford, Michael W/0000-0001-6357-6080; Maldonado, Emanuel/0000-0002-0084-6116; Mendoza, Marie Lisandra Zepeda/0000-0002-1126-8219; Pitel, Frédérique/0000-0002-1477-7633; Pereira, Joana/0000-0002-5588-6588; Zhang, Guojie/0000-0001-6860-1521; Larkin, Denis/0000-0001-7859-6201; Romanov, Michael N/0000-0003-3584-4644; Almeida, Daniela/0000-0002-9874-933X; Gilbert, Marcus TP/0000-0002-5805-7195; Campos, Paula F/0000-0003-1285-4671; Li, Qiye/0000-0002-5993-0312; Burt, David W/0000-0002-9991-1028; Farré, Marta/0000-0001-9170-5767; Alström, Per/0000-0001-7182-2763; Håstad, Olle E/0000-0001-9280-3051; Gardner, Paul P./0000-0002-7808-1213; Barnett, Ross/0000-0003-4023-0284; Schubert, Mikkel/0000-0003-2401-9921; Orlando, Ludovic/0000-0003-3936-1850; Fan, Yu/0000-0002-5978-5004; Mello, Claudio/0000-0002-9826-8421; Yang, Zhikai/0000-0001-6104-5083; /0000-0002-3447-9801; Hu, Haofu/0000-0001-8145-3009; Sunagar, Kartik/0000-0003-0998-1581; Xiong, Zijun/0000-0003-3923-0703; Hoffmann, Federico/0000-0001-5056-4929; Lambert, David/0000-0002-5821-3637; Huang, Yinhua/0000-0001-5714-2403; Burge, Sarah/0000-0002-2506-927X; Machado, Joao Paulo/0000-0002-7404-9670; Martin, Michael/0000-0002-2010-5139; Wang, Jun/0000-0002-2113-5874; Green, Richard/0000-0003-0516-5827; Wang, Jun/0000-0002-8540-8931; Derryberry, Elizabeth/0000-0002-8248-9748; LIU, Shiping/0000-0003-0019-619X; Opazo, Juan C./0000-0001-7938-4083; OBRIEN, STEPHEN/0000-0001-7857-0757; Holmes, Edward/0000-0001-9596-3552; Xu, Luohao/0000-0002-3714-8047; Li, Cai/0000-0001-7843-2151; Antunes, Agostinho/0000-0002-1328-1732; Lyons, Eric/0000-0002-3348-8845; Braun, Edward/0000-0003-1643-5212; Bunce, Michael/0000-0002-0302-4206; Johnson, Warren/0000-0002-5954-186X; Borges, Rui/0000-0003-3931-9476; khan, imran/0000-0002-9892-7271; Howard, Jason/0000-0003-3265-5127; Whitney, Osceola/0000-0002-5701-7722; Narayan, Jitendra/0000-0002-2065-2861; Ray, David/0000-0002-3340-3987; Vargas Velazquez, Amhed Missael/0000-0001-7692-0012; Lee, Chul/0000-0002-9403-0774	BGI; Marie Curie International Incoming Fellowship [300837]; Danish National Research Foundation [DNRF94]; Lundbeck Foundation [R52-A5062]; Danish Council for Independent Research [10-081390]; Howard Hughes Medical Institute; NIH [DP1OD000448]; Direct For Biological Sciences [0841821] Funding Source: National Science Foundation; Division Of Environmental Biology [1241059] Funding Source: National Science Foundation; Biotechnology and Biological Sciences Research Council [BB/J010170/2, BB/K008226/2, BB/J010170/1, BB/K008226/1] Funding Source: researchfish; Villum Fonden [00007370] Funding Source: researchfish; BBSRC [BB/J010170/1, BB/J010170/2, BB/K008226/2, BB/K008226/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087216] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000448] Funding Source: NIH RePORTER	BGI; Marie Curie International Incoming Fellowship(European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Villum Fonden(Villum Fonden); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Genome assemblies and annotations of avian genomes in this study are available on the avian phylogenomics website (http://phybirds.genomics.org.cn), GigaDB (http://dx.doi.org/10.5524/101000), National Center for Biotechnology Information (NCBI), and ENSEMBL (NCBI and Ensembl accession numbers are provided in table S2). The majority of this study was supported by an internal funding from BGI. In addition, G.Z. was supported by a Marie Curie International Incoming Fellowship grant (300837); M.T.P.G. was supported by a Danish National Research Foundation grant (DNRF94) and a Lundbeck Foundation grant (R52-A5062); C.L. and Q.L. were partially supported by a Danish Council for Independent Research Grant (10-081390); and E.D.J. was supported by the Howard Hughes Medical Institute and NIH Directors Pioneer Award DP1OD000448.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Axelsson E, 2005, GENOME RES, V15, P120, DOI 10.1101/gr.3021305; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Birdsey GM, 2004, MOL BIOL EVOL, V21, P632, DOI 10.1093/molbev/msh054; Birkhead TR, 1998, SPERM COMPETITION SE; Blirt A., 1987, NATURE, V326, P803; Bohne A, 2008, CHROMOSOME RES, V16, P203, DOI 10.1007/s10577-007-1202-6; BOWMAKER JK, 1985, J COMP PHYSIOL A, V156, P71, DOI 10.1007/BF00610668; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; CHATTERJEE IB, 1973, SCIENCE, V182, P1271, DOI 10.1126/science.182.4118.1271; Chiappe L. M., 2002, MESOZOIC BIRDS HEADS; Chittka L, 1996, NATURWISSENSCHAFTEN, V83, P136, DOI 10.1007/BF01142181; CRACRAFT J, 1982, SYST ZOOL, V31, P35, DOI 10.2307/2413412; Cui J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027114; Cui J, 2011, MOL BIOL EVOL, V28, P1025, DOI 10.1093/molbev/msq286; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Darwin C., 1871, DESCENT MAN SELECTIO; Davies WIL, 2012, MOL ECOL, V21, P3121, DOI 10.1111/j.1365-294X.2012.05617.x; Dickinson E. C., 2013, HOWARD MOORE COMPLET; Dumont ER, 2010, P ROY SOC B-BIOL SCI, V277, P2193, DOI 10.1098/rspb.2010.0117; Duncker HR, 2004, RESP PHYSIOL NEUROBI, V144, P111, DOI 10.1016/j.resp.2004.07.020; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dyke G., 2011, LIVING DINOSAURS EVA; Feduccia A, 2003, TRENDS ECOL EVOL, V18, P172, DOI 10.1016/S0169-5347(03)00017-X; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Ganapathy G, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-11; Gill F, 2013, IOC WORLD BIRD LIST; Gill F. B., 1995, ORNITHOLOGY; Goodarzi MO, 2007, J CLIN ENDOCR METAB, V92, P2659, DOI 10.1210/jc.2006-2600; Green RE, 2014, SCIENCE, V346, P1335, DOI 10.1126/science.1254449; Gregory TR, 2005, ANIMAL GENOME SIZE D; Griffin DK, 2007, CYTOGENET GENOME RES, V117, P64, DOI 10.1159/000103166; Grispo MT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375600; Guraya SS., 1989, OVARIAN FOLLICLES RE; Gutzwiller SC, 2013, ANAT REC, V296, P867, DOI 10.1002/ar.22691; HAAKE AR, 1984, DEV BIOL, V106, P406, DOI 10.1016/0012-1606(84)90240-9; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hoffmann FG, 2008, MOL BIOL EVOL, V25, P591, DOI 10.1093/molbev/msn004; Hoffmann FG, 2012, MOL BIOL EVOL, V29, P303, DOI 10.1093/molbev/msr207; Hoffmann FG, 2010, MOL BIOL EVOL, V27, P1126, DOI 10.1093/molbev/msp325; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; HUGHES AL, 1995, NATURE, V377, P391, DOI 10.1038/377391a0; Hughes AL, 2008, MOL BIOL EVOL, V25, P2681, DOI 10.1093/molbev/msn207; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jo M, 2004, BIOL REPROD, V71, P1796, DOI 10.1095/biolreprod.104.031823; Karten HJ, 2013, J COMP NEUROL, V521, P3702, DOI 10.1002/cne.23443; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Kim J, 2013, P NATL ACAD SCI USA, V110, P1785, DOI 10.1073/pnas.1220349110; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LATHROP WF, 1990, J CELL BIOL, V111, P2939, DOI 10.1083/jcb.111.6.2939; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Louchart A, 2011, TRENDS ECOL EVOL, V26, P663, DOI 10.1016/j.tree.2011.09.004; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Mank JE, 2007, GENOME RES, V17, P618, DOI 10.1101/gr.6031907; Mateos C, 1997, ANIM BEHAV, V54, P1205, DOI 10.1006/anbe.1997.0516; Meredith RW, 2014, SCIENCE, V346, P1336, DOI 10.1126/science.1254390; Morand S, 2001, TRENDS GENET, V17, P567, DOI 10.1016/S0168-9525(01)02414-3; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; Odeen A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-313; Organ CL, 2007, NATURE, V446, P180, DOI 10.1038/nature05621; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pfenning AR, 2014, SCIENCE, V346, P1333, DOI 10.1126/science.1256846; Pires SS, 2007, P R SOC B, V274, P2791, DOI 10.1098/rspb.2007.0976; Quinlan AR, 2012, TRENDS GENET, V28, P43, DOI 10.1016/j.tig.2011.10.002; Rho M, 2009, GENOME BIOL EVOL, V1, P2, DOI 10.1093/gbe/evp007; Ross-Ibarra J, 2004, AM NAT, V163, P105, DOI 10.1086/380606; Sela N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r59; Shapiro MD, 2013, SCIENCE, V339, P1063, DOI 10.1126/science.1230422; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Storz JF, 2013, MOL PHYLOGENET EVOL, V66, P469, DOI 10.1016/j.ympev.2012.07.013; Suh A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1448; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Venditti C, 2010, TRENDS ECOL EVOL, V25, P14, DOI 10.1016/j.tree.2009.06.010; Waltari E, 2002, AM NAT, V160, P539, DOI 10.1086/342079; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; West JB, 2007, RESP PHYSIOL NEUROBI, V157, P382, DOI 10.1016/j.resp.2006.12.005; Whitney O, 2014, SCIENCE, V346, P1334, DOI 10.1126/science.1256780; Zeigler H., 2002, BEHAV NEUROBIOLOGY B; Zhan XJ, 2013, NAT GENET, V45, P563, DOI 10.1038/ng.2588; Zhang GJ, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-26; Zhang Q, 2012, GENOME BIOL EVOL, V4, P1033, DOI 10.1093/gbe/evs070; Zheng XT, 2013, NATURE, V495, P507, DOI 10.1038/nature11985; Zhou Q, 2014, SCIENCE, V346, P1332, DOI 10.1126/science.1246338; ZUK M, 1992, ANIM BEHAV, V44, P999, DOI 10.1016/S0003-3472(05)80312-4	90	599	621	30	496	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1311	1320		10.1126/science.1251385	http://dx.doi.org/10.1126/science.1251385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504712	Green Submitted, Green Accepted			2022-12-28	WOS:000346189600035
J	Wu, J; Belmonte, JCI				Wu, Jun; Belmonte, Juan Carlos Izpisua			STEM CELLS A designer's guide to pluripotency	NATURE			English	Editorial Material							INDUCTION; CULTURE; ROUTES		[Wu, Jun; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Wu, J (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Wu, Jun/AAF-1830-2019	Wu, Jun/0000-0001-9863-1668				Benevento M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6613; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Clancy JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6522; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hussein SMI, 2014, NATURE, V516, P198, DOI 10.1038/nature14046; Lee DS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6619; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Tonge PD, 2014, NATURE, V516, P192, DOI 10.1038/nature14047; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	18	11	11	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					172	173		10.1038/516172a	http://dx.doi.org/10.1038/516172a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25503227				2022-12-28	WOS:000346383500027
J	Edmond, KM; Newton, S; Shannon, C; O'Leary, M; Hurt, L; Thomas, G; Amenga-Etego, S; Tawiah-Agyemang, C; Gram, L; Hurt, CN; Bahl, R; Owusu-Agyei, S; Kirkwood, BR				Edmond, Karen M.; Newton, Sam; Shannon, Caitlin; O'Leary, Maureen; Hurt, Lisa; Thomas, Gyan; Amenga-Etego, Seeba; Tawiah-Agyemang, Charlotte; Gram, Lu; Hurt, Chris N.; Bahl, Rajiv; Owusu-Agyei, Seth; Kirkwood, Betty R.			Effect of early neonatal vitamin A supplementation on mortality during infancy in Ghana (Neovita): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							CHILD UNDERNUTRITION; MORBIDITY; SURVIVAL; EFFICACY; PROTOCOL; MOTHERS; IMPACT	Background Results of randomised controlled trials of newborn (age 1-3 days) vitamin A supplementation have been inconclusive. The WHO is coordinating three large randomised trials in Ghana, India, and Tanzania (Neovita trials). We present the findings of the Neovita trial in Ghana. Methods This study was a population-based, individually randomised, double-blind, placebo-controlled trial in the Brong Ahafo region of Ghana. The trial participants were infants aged at least 2 h, identified at home or facilities on the day of birth or in the next 2 days, able to feed orally, and likely to stay in the study area for at least 6 months. They were randomly assigned (ratio 1: 1) to receive either one oral dose of vitamin A (50 000 IU) or placebo immediately after recruitment. The research team and parents of the infants were masked to treatment assignment. Follow-up home visits were undertaken every 4 weeks, when data were recorded for deaths, facility use, and care seeking. The primary outcome was post-supplementation mortality to 6 months of age. Analysis was by intention to treat. Potential adverse events were recorded at 1 and 3 days after supplementation. This trial is registered with the Australian New Zealand Clinical Trials Registry (ANZCTR) CTRN12610000582055. Findings We assessed 26 414 livebirths for eligibility between Aug 16, 2010, and Nov 7, 2011. We recruited 22 955 newborn infants, with 11 474 randomly assigned to receive vitamin A and 11 481 to receive placebo. Loss to follow-up was low with vital status at 6 months of age reported for 22 698 (98.9%) infants. We recorded 278 post-supplementation deaths to 6 months of age in the vitamin A group (mortality risk 24.5 in 1000 supplemented infants) and 248 deaths in the placebo group (mortality risk 21.8 per 1000 supplemented infants), relative risk (RR) 1.12 (95% CI 0.95-1.33; p=0.183) and risk difference (RD) 2.66 (95% CI -1.25 to 6.57; p=0.18). Adverse events within 3 days of supplementation did not diff er by trial group. 122 infants died in the first 3 days after supplementation; 70 (0.6%) in the vitamin A and 52 (0.5%) in the placebo group (risk ratio [RR] 1.35, 95% CI 0.94-1.93, p=0.102). 53 infants were reported to have a bulging fontanelle; 32 (0.3%) in the vitamin A group and 21 (0.2%) in the placebo group (RR 1.53, 0.88-2.62, p=0.130). Interpretation The results of this trial do not support inclusion of newborn vitamin A supplementation as a child survival strategy in Ghana.	[Edmond, Karen M.] Univ Western Australia, Sch Paediat & Hlth, Perth, WA 6008, Australia; [Newton, Sam; Thomas, Gyan; Amenga-Etego, Seeba; Tawiah-Agyemang, Charlotte; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Newton, Sam; Shannon, Caitlin; O'Leary, Maureen; Gram, Lu; Owusu-Agyei, Seth; Kirkwood, Betty R.] London Sch Hyg & Trop Med, London WC1, England; [Hurt, Lisa; Hurt, Chris N.] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Bahl, Rajiv] WHO, CH-1211 Geneva, Switzerland	University of Western Australia; Kintampo Health Research Centre; University of London; London School of Hygiene & Tropical Medicine; Cardiff University; World Health Organization	Edmond, KM (corresponding author), Univ Western Australia, Sch Paediat & Hlth, Roberts Rd, Perth, WA 6008, Australia.	karen.edmond@uwa.edu.au	Hurt, Lisa/GZG-4796-2022; Gyan, thomas/J-6009-2013	Kirkwood, Betty/0000-0001-5274-6072; `, Caitlin/0000-0002-1680-421X; Hurt, Chris/0000-0003-1206-8355; Owusu-Agyei, Seth/0000-0002-0807-1781; Gyan, thomas/0000-0003-2972-964X; Hurt, Lisa/0000-0002-2741-5383	Bill & Melinda Gates Foundation; Cancer Research UK [15954] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Cancer Research UK(Cancer Research UK)	The trial was funded by a grant from the Bill & Melinda Gates Foundation to WHO, who was the sponsor for this trial. We acknowledge the support of the chiefs, elders, and opinion leaders in the trial area, and the substantial contribution of all families who participated in the trial. We thank Angela Vega and Linda Vesel for their administrative support throughout the trial. We thank all staff at Kintampo Health Research Centre involved in the trial, especially site leaders, coordinators, supervisors, fieldworkers, data managers, data supervisors, data entry clerks, and administrative support staff. We thank the trial steering committee and data monitoring and ethics committee for their support and guidance. The Department of Maternal, Newborn, Child and Adolescent Health of the WHO coordinated this trial. The views and opinions expressed in this paper are those of the authors and not necessarily the views and opinions of the WHO.	[Anonymous], 2011, GHAN COUNTR AIDS PRO; Bahl R, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-22; Benn CS, 2008, BMJ-BRIT MED J, V336, P1416, DOI 10.1136/bmj.39542.509444.AE; Benn CS, 2011, LANCET, V377, P1314, DOI 10.1016/S0140-6736(11)60533-3; Benn CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1101; Bhutta ZA, 2008, LANCET, V371, P1746, DOI 10.1016/S0140-6736(08)60751-5; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Darboe MK, 2007, LANCET, V369, P2088, DOI 10.1016/S0140-6736(07)60981-7; Gogia S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b919; Humphrey JH, 1996, J PEDIATR-US, V128, P489, DOI 10.1016/S0022-3476(96)70359-1; Idindili B, 2007, AM J CLIN NUTR, V85, P1312, DOI 10.1093/ajcn/85.5.1312; Imdad A, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008524.pub2, 10.1002/14651858.CD008524.pub4]; Kirkwood B, 2010, LANCET, V376, P1643, DOI 10.1016/S0140-6736(10)61895-8; Klemm RDW, 2008, PEDIATRICS, V122, pE242, DOI 10.1542/peds.2007-3448; Malaba LC, 2005, AM J CLIN NUTR, V81, P454, DOI 10.1093/ajcn.81.2.454; Martines J, 1998, LANCET, V352, P1257, DOI 10.1016/S0140-6736(98)02487-8; Masanja H, 2014, LANCET; Mazumder S, 2014, LANCET; Moher D, BMJ, V340, pc869; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Rahmathullah L, 2003, BMJ-BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254; WEST KP, 1995, AM J CLIN NUTR, V62, P143, DOI 10.1093/ajcn/62.1.143; WHO, 2009, TECHN CONS NEON VIT	24	50	50	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1315	1323		10.1016/S0140-6736(14)60880-1	http://dx.doi.org/10.1016/S0140-6736(14)60880-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25499545				2022-12-28	WOS:000352272400037
J	Sajish, M; Schimmel, P				Sajish, Mathew; Schimmel, Paul			A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol	NATURE			English	Article							SMALL-MOLECULE ACTIVATORS; HISTONE ACETYLTRANSFERASE; CRYSTAL-STRUCTURE; TUMOR-SUPPRESSOR; DNA-DAMAGE; HEAT-SHOCK; LIFE-SPAN; KAPPA-B; STRESS; POLY(ADP-RIBOSE)	Resveratrol is reported to extend lifespan(1,2) and provide cardioneuro-protective(3), anti-diabetic(4), and anti-cancer effects(3,5) by initiating a stress response(2) that induces survival genes. Because human tyrosyl transfer-RNA(tRNA) synthetase (TyrRS) translocates to the nucleus under stress conditions(6), we considered the possibility that the tyrosine-like phenolic ring of resveratrol might fit into the active site pocket to effect a nuclear role. Here we present a 2.1 angstrom co-crystal structure of resveratrol bound to the active site of TyrRS. Resveratrol nullifies the catalytic activity and redirects TyrRS to a nuclear function, stimulating NAD(+)-dependent auto-poly-ADP-ribosylation of poly(ADP-ribose) polymerase 1 (PARP1). Downstream activation of key stress signalling pathways are causally connected to TyrRS-PARP1-NAD(+) collaboration. This collaborationis also demonstrated in the mouse, and is specifically blocked in vivo by a resveratrol-displacing tyrosyl adenylate analogue. In contrast to functionally diverse tRNA synthetase catalytic nulls created by alternative splicing events that ablate active sites(7), here a non-spliced TyrRS catalytic null reveals a new PARP1- and NAD(+)-dependent dimension to the physiological mechanism of resveratrol.	[Sajish, Mathew; Schimmel, Paul] Scripps Res Inst, Dept Mol & Cell Biol, Scripps Labs TRNA Synthetase Res, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Schimmel, Paul] Scripps Florida Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute; State University System of Florida; University of Florida	Schimmel, P (corresponding author), Scripps Res Inst, Dept Mol & Cell Biol, Scripps Labs TRNA Synthetase Res, Skaggs Inst Chem Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Thekkel, Sajish Mathew/AAM-3548-2021	Thekkel, Sajish Mathew/0000-0001-6715-5953	National Cancer Institute [CA92577]; National Foundation for Cancer Research; aTyr Pharma; Scripps Research Institute; NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Foundation for Cancer Research; aTyr Pharma(Dexcel Pharma); Scripps Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part the National Cancer Institute grant CA92577, by a fellowship from the National Foundation for Cancer Research, and by aTyr Pharma through an agreement with The Scripps Research Institute. We thank the The Scripps Research Institute mouse facility for their efforts for this project. We also thank P. Chang for the ZZ-PARP1 clone, and the PARG and PARG-MT proteins, and Y. Shi for independently repeating some of the key experiments. We thank P. Chang, J. H. Chung, L. Guarente, L. Krauss, D. Sinclair, and C. Westphal for comments and suggestions on this work.	Bastide B, 2002, BIOCHEM BIOPH RES CO, V296, P1267, DOI 10.1016/S0006-291X(02)02073-9; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Butin-Israeli V, 2010, J VIROL, V84, P3431, DOI 10.1128/JVI.01735-09; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Formentini L, 2009, J BIOL CHEM, V284, P17668, DOI 10.1074/jbc.M109.002931; Fu GS, 2012, J BIOL CHEM, V287, P9330, DOI 10.1074/jbc.C111.325902; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hegan DC, 2010, P NATL ACAD SCI USA, V107, P2201, DOI 10.1073/pnas.0904783107; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kapoor M, 2009, CHEM BIOL, V16, P531, DOI 10.1016/j.chembiol.2009.03.006; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Lee PS, 2012, J BIOL CHEM, V287, P20504, DOI 10.1074/jbc.C112.369439; Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; Matheny CJ, 2013, CHEM BIOL, V20, P1352, DOI 10.1016/j.chembiol.2013.09.014; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nwachukwu JC, 2014, ELIFE, V3, DOI 10.7554/eLife.02057; Orlando G, 2014, NUCLEIC ACIDS RES, V42, P2320, DOI 10.1093/nar/gkt1185; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Petesch SJ, 2012, MOL CELL, V45, P64, DOI 10.1016/j.molcel.2011.11.015; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Renault VM, 2011, ONCOGENE, V30, P3207, DOI 10.1038/onc.2011.35; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/NCHEMBIO.937, 10.1038/nchembio.937]; Shin SM, 2009, MOL PHARMACOL, V76, P884, DOI 10.1124/mol.109.058479; Sinclair DA, 2014, ANNU REV PHARMACOL, V54, P363, DOI 10.1146/annurev-pharmtox-010611-134657; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Vyas S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5426; Vyas S, 2013, MOL CELL, V49, P1, DOI 10.1016/j.molcel.2012.12.017; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Yang XL, 2003, HELV CHIM ACTA, V86, P1246, DOI 10.1002/hlca.200390107; Yang XL, 2002, P NATL ACAD SCI USA, V99, P15369, DOI 10.1073/pnas.242611799; Yang YB, 2011, MOL CELL BIOL, V31, P2774, DOI 10.1128/MCB.01139-10; Zhang P, 2014, P NATL ACAD SCI USA, V111, P10684, DOI 10.1073/pnas.1411026111	54	97	106	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					370	+		10.1038/nature14028	http://dx.doi.org/10.1038/nature14028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25533949	Green Accepted			2022-12-28	WOS:000351171900045
J	Evans, JP; Watson, MS				Evans, James P.; Watson, Michael S.			Genetic Testing and FDA Regulation Overregulation Threatens the Emergence of Genomic Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Evans, James P.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Evans, James P.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Watson, Michael S.] Amer Coll Med Genet & Genom, Bethesda, MD USA; [Watson, Michael S.] ACMG Fdn Genet & Genom Med, Bethesda, MD USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Evans, JP (corresponding author), Univ N Carolina, Dept Genet, CB 7264, Chapel Hill, NC 27599 USA.	jpevans@med.unc.edu						American Medical Association (AMA), 2014, AMA STATEMENT ON FDA; Gostin LO, 2013, JAMA-J AM MED ASSOC, V310, P791, DOI 10.1001/jama.2013.177833; Javitt G., FDAS LEGALLY SUSPECT; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Office of Science Policy National Institutes of Health (NIH), GENE PATENTS AND LIC; US Food and Drug Administration (FDA), FDA NOTIFICATION AND; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601	7	39	42	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2015	313	7					669	670		10.1001/jama.2014.18145	http://dx.doi.org/10.1001/jama.2014.18145			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB2RQ	25560537				2022-12-28	WOS:000349476100009
J	van Bergeijk, P; Adrian, M; Hoogenraad, CC; Kapitein, LC				van Bergeijk, Petra; Adrian, Max; Hoogenraad, Casper C.; Kapitein, Lukas C.			Optogenetic control of organelle transport and positioning	NATURE			English	Article							AMPA RECEPTORS; MITOCHONDRIAL TRANSPORT; AXONAL MITOCHONDRIA; RECYCLING ENDOSOMES; DENDRITIC SPINES; LIVING CELLS; NEURONS; TRAFFICKING; GROWTH; NEURODEGENERATION	Proper positioning of organelles by cytoskeleton-based motor proteins underlies cellular events such as signalling, polarization and growth(1-8). For many organelles, however, the precise connection between position and function has remainedunclear, because strategies to control intracellular organelle positioning with spatiotemporal precision are lacking. Here we establish optical control of intracellular transport by using light-sensitive heterodimerization to recruit specific cytoskeletal motor proteins (kinesin, dynein or myosin) to selected cargoes. We demonstrate that the motility of peroxisomes, recycling endosomes and mitochondria can be locally and repeatedly induced or stopped, allowing rapid organelle repositioning. We applied this approach in primary rat hippocampal neurons to test how local positioning of recycling endosomes contributes to axon outgrowth and found that dynein-driven removal of endosomes from axonal growth cones reversibly suppressed axon growth, whereas kinesin-driven endosome enrichment enhanced growth. Our strategy for optogenetic control of organelle positioning will be widely applicable to explore site-specific organelle functions in different model systems.	[van Bergeijk, Petra; Adrian, Max; Hoogenraad, Casper C.; Kapitein, Lukas C.] Univ Utrecht, Fac Sci, Dept Biol, NL-3584 CH Utrecht, Netherlands	Utrecht University	Hoogenraad, CC (corresponding author), Univ Utrecht, Fac Sci, Dept Biol, NL-3584 CH Utrecht, Netherlands.	c.hoogenraad@uu.nl; l.kapitein@uu.nl	Kapitein, Lukas C/J-4776-2016; Hoogenraad, Casper/B-8866-2011	Kapitein, Lukas C/0000-0001-9418-6739; Hoogenraad, Casper/0000-0002-2666-0758; Adrian, Max/0000-0002-4926-1258	Dutch Technology Foundation STW part of the Netherlands Organisation for Scientific Research (NWO); Foundation for Fundamental Research on Matter (FOM) part of the Netherlands Organisation for Scientific Research (NWO); NWO (NWO-ALW-VICI); NWO (NWO-ALW-VIDI); European Research Council (ERC starting grant)	Dutch Technology Foundation STW part of the Netherlands Organisation for Scientific Research (NWO); Foundation for Fundamental Research on Matter (FOM) part of the Netherlands Organisation for Scientific Research (NWO); NWO (NWO-ALW-VICI); NWO (NWO-ALW-VIDI); European Research Council (ERC starting grant)(European Research Council (ERC))	We are grateful to C. Tucker, T. Inoue, Z.-H. Sheng, G. Banker, R. Prekeris, P. Schatzle and M. Esteves da Silva for sharing reagents and to C. Wierenga and A. Akhmanova for discussions. This research is supported by the Dutch Technology Foundation STW and the Foundation for Fundamental Research on Matter (FOM), which are part of the Netherlands Organisation for Scientific Research (NWO). Additional support came from NWO (NWO-ALW-VICI to C.C.H and NWO-ALW-VIDI to L.C.K.) and the European Research Council (ERC starting grant to L.C.K.).	Bhuin T, 2009, CELL TISSUE RES, V335, P349, DOI 10.1007/s00441-008-0711-8; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Chen YM, 2013, J CELL BIOL, V202, P351, DOI 10.1083/jcb.201302040; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Courchet J, 2013, CELL, V153, P1510, DOI 10.1016/j.cell.2013.05.021; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Encalada SE, 2014, ANNU REV BIOPHYS, V43, P141, DOI 10.1146/annurev-biophys-051013-022746; Eva R, 2012, J NEUROSCI, V32, P10352, DOI 10.1523/JNEUROSCI.1409-12.2012; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Golachowska MR, 2010, TRENDS CELL BIOL, V20, P618, DOI 10.1016/j.tcb.2010.08.004; Hammer JA, 2013, J BIOL CHEM, V288, P28428, DOI 10.1074/jbc.R113.514497; Higuchi Y, 2014, J CELL BIOL, V204, P343, DOI 10.1083/jcb.201307164; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hoogenraad CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000283; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kapitein LC, 2013, CURR BIOL, V23, P828, DOI 10.1016/j.cub.2013.03.068; Kapitein LC, 2010, METHOD CELL BIOL, V97, P111, DOI 10.1016/S0091-679X(10)97007-6; Kapitein LC, 2010, BIOPHYS J, V99, P2143, DOI 10.1016/j.bpj.2010.07.055; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Miyamoto T, 2012, NAT CHEM BIOL, V8, P465, DOI [10.1038/NCHEMBIO.922, 10.1038/nchembio.922]; Niopek D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5404; Ori-McKenney KM, 2012, NEURON, V76, P921, DOI 10.1016/j.neuron.2012.10.008; Peden AA, 2004, MOL BIOL CELL, V15, P3530, DOI 10.1091/mbc.E03-12-0918; Russ JC, 2007, IMAGE PROCESSING HDB; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Schlager MA, 2010, EMBO J, V29, P1637, DOI 10.1038/emboj.2010.51; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Spillane M, 2013, CELL REP, V5, P1564, DOI 10.1016/j.celrep.2013.11.022; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wagner W, 2011, NAT CELL BIOL, V13, P40, DOI 10.1038/ncb2132; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Yadav S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005322	38	180	181	4	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					111	+		10.1038/nature14128	http://dx.doi.org/10.1038/nature14128			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25561173	Green Accepted			2022-12-28	WOS:000349098000042
J	Zalatan, JG; Lee, ME; Almeida, R; Gilbert, LA; Whitehead, EH; La Russa, M; Tsai, JC; Weissman, JS; Dueber, JE; Qi, LS; Lim, WA				Zalatan, Jesse G.; Lee, Michael E.; Almeida, Ricardo; Gilbert, Luke A.; Whitehead, Evan H.; La Russa, Marie; Tsai, Jordan C.; Weissman, Jonathan S.; Dueber, John E.; Qi, Lei S.; Lim, Wendell A.			Engineering Complex Synthetic Transcriptional Programs with CRISPR RNA Scaffolds	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; COAT PROTEIN; CAS9; COMBINATORIAL; OPTIMIZATION; REPRESSION; PATHWAY; SPECIFICITY; AFFINITY; CELLS	Eukaryotic cells execute complex transcriptional programs in which specific loci throughout the genome are regulated in distinct ways by targeted regulatory assemblies. We have applied this principle to generate synthetic CRISPR-based transcriptional programs in yeast and human cells. By extending guide RNAs to include effector protein recruitment sites, we construct modular scaffold RNAs that encode both target locus and regulatory action. Sets of scaffold RNAs can be used to generate synthetic multigene transcriptional programs in which some genes are activated and others are repressed. We apply this approach to flexibly redirect flux through a complex branched metabolic pathway in yeast. Moreover, these programs can be executed by inducing expression of the dCas9 protein, which acts as a single master regulatory control point. CRISPR-associated RNA scaffolds provide a powerful way to construct synthetic gene expression programs for a wide range of applications, including rewiring cell fates or engineering metabolic pathways.	[Zalatan, Jesse G.; Almeida, Ricardo; Gilbert, Luke A.; Whitehead, Evan H.; La Russa, Marie; Tsai, Jordan C.; Weissman, Jonathan S.; Qi, Lei S.; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Zalatan, Jesse G.; Almeida, Ricardo; Gilbert, Luke A.; Tsai, Jordan C.; Weissman, Jonathan S.; Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Whitehead, Evan H.; La Russa, Marie; Qi, Lei S.; Lim, Wendell A.] Univ Calif San Francisco, Ctr Syst & Synthet Biol, San Francisco, CA 94158 USA; [La Russa, Marie] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94158 USA; [Lee, Michael E.; Dueber, John E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Lee, Michael E.; Dueber, John E.] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Gilbert, Luke A.; Weissman, Jonathan S.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Weissman, Jonathan S.; Qi, Lei S.; Lim, Wendell A.] Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Qi, LS (corresponding author), Stanford Univ, Dept Bioengn, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	slqi@stanford.edu; wendell.lim@ucsf.edu	Gilbert, Luke/AAC-5300-2019; Qi, Lei S/AAC-5088-2019	Zalatan, Jesse/0000-0002-1458-0654; Gilbert, Luke/0000-0001-5854-0825; Tsai, Jordan/0000-0001-5202-722X; Whitehead, Evan/0000-0002-4132-2140; Weissman, Jonathan/0000-0003-2445-670X; Qi, Lei S/0000-0002-3965-3223	Career Award at the Scientific Interface from the Burroughs Wellcome Fund; NIH [P50 GM081879, R01 DA036858, DP5 OD017887]; Leukemia and Lymphoma Society Postdoctoral Fellowship; NSF SynBERC [EEC-0540879]; Energy Biosciences Institute; National Defense Science & Engineering Graduate Fellowship Program; Genentech Predoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, T32GM008568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036858] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017887] Funding Source: NIH RePORTER	Career Award at the Scientific Interface from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Postdoctoral Fellowship(Leukemia and Lymphoma Society); NSF SynBERC(National Science Foundation (NSF)); Energy Biosciences Institute; National Defense Science & Engineering Graduate Fellowship Program; Genentech Predoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank J. Park, K. McNally, T. Hsu, M. Larson, S. Torres, M. Horlbeck, W. DeLoache, and members of the Lim lab for technical assistance, advice, and helpful discussions. This work was supported by a Career Award at the Scientific Interface from the Burroughs Wellcome Fund (J.G.Z.), NIH P50 GM081879 (L.S.Q. and W.A.L.), NIH R01 DA036858 (J.S.W., L.S.Q., and W.A.L.), Howard Hughes Medical Institute (J.S.W. and W.A.L.), Leukemia and Lymphoma Society Postdoctoral Fellowship (L.A.G.), NSF SynBERC EEC-0540879 (W.A.L.), Energy Biosciences Institute (J.E.D.), National Defense Science & Engineering Graduate Fellowship Program (M.E.L.), Genentech Predoctoral Fellowship (M.L.), and NIH DP5 OD017887 (L.S.Q.).	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Andronescu M, 2004, J MOL BIOL, V336, P607, DOI 10.1016/j.jmb.2003.12.041; Chan Sunny Sun-Kin, 2013, J Stem Cell Res Ther, V3; Chao JA, 2008, NAT STRUCT MOL BIOL, V15, P103, DOI 10.1038/nsmb1327; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Du J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks549; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hattman S, 1999, PHARMACOL THERAPEUT, V84, P367, DOI 10.1016/S0163-7258(99)00042-X; Hirao I, 1998, MOL DIVERS, V4, P75, DOI 10.1023/A:1026401917416; Hoshino T, 2011, APPL MICROBIOL BIOT, V91, P1463, DOI 10.1007/s00253-011-3468-z; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, METHODS, V69, P188, DOI 10.1016/j.ymeth.2014.06.014; Keasling JD, 2012, METAB ENG, V14, P189, DOI 10.1016/j.ymben.2012.01.004; Keung AJ, 2014, CELL, V158, P110, DOI 10.1016/j.cell.2014.04.047; Latimer LN, 2014, METAB ENG, V25, P20, DOI 10.1016/j.ymben.2014.06.002; Lee ME, 2013, NUCLEIC ACIDS RES, V41, P10668, DOI 10.1093/nar/gkt809; LIM F, 1994, NUCLEIC ACIDS RES, V22, P3748, DOI 10.1093/nar/22.18.3748; Lim F, 2001, J BIOL CHEM, V276, P22507, DOI 10.1074/jbc.M102411200; LOWARY PT, 1987, NUCLEIC ACIDS RES, V15, P10483, DOI 10.1093/nar/15.24.10483; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Spitale RC, 2011, EPIGENETICS-US, V6, P539, DOI 10.4161/epi.6.5.15221; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596	42	594	662	16	288	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					339	350		10.1016/j.cell.2014.11.052	http://dx.doi.org/10.1016/j.cell.2014.11.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25533786	Green Accepted, Bronze			2022-12-28	WOS:000347923200029
J	Kienzler, D; Lo, HY; Keitch, B; de Clercq, L; Leupold, F; Lindenfelser, F; Marinelli, M; Negnevitsky, V; Home, JP				Kienzler, D.; Lo, H. -Y.; Keitch, B.; de Clercq, L.; Leupold, F.; Lindenfelser, F.; Marinelli, M.; Negnevitsky, V.; Home, J. P.			Quantum harmonic oscillator state synthesis by reservoir engineering	SCIENCE			English	Article							TRAPPED IONS; DECOHERENCE; DRIVEN; BITS	The robust generation of quantum states in the presence of decoherence is a primary challenge for explorations of quantum mechanics at larger scales. Using the mechanical motion of a single trapped ion, we utilize reservoir engineering to generate squeezed, coherent, and displaced-squeezed states as steady states in the presence of noise. We verify the created state by generating two-state correlated spin-motion Rabi oscillations, resulting in high-contrast measurements. For both cooling and measurement, we use spin-oscillator couplings that provide transitions between oscillator states in an engineered Fock state basis. Our approach should facilitate studies of entanglement, quantum computation, and open-system quantum simulations in a wide range of physical systems.	[Kienzler, D.; Lo, H. -Y.; Keitch, B.; de Clercq, L.; Leupold, F.; Lindenfelser, F.; Marinelli, M.; Negnevitsky, V.; Home, J. P.] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Kienzler, D (corresponding author), ETH, Inst Quantum Elect, Otto Stern Weg 1, CH-8093 Zurich, Switzerland.	daniel.kienzler@phys.ethz.ch; jhome@phys.ethz.ch		Home, Jonathan/0000-0002-4093-1550; Keitch, Ben/0000-0001-7030-1966; Kienzler, Daniel/0000-0002-2557-6589	Swiss National Science Foundation [200021_134776]; National Centre of Competence in Research for Quantum Science and Technology (QSIT)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research for Quantum Science and Technology (QSIT)	We thank J. Alonso, A. Imamoglu, and D. Wineland for comments on the manuscript and useful discussions. We thank J. Alonso, M. Sepiol, K. Fisher, and C. Fluhmann for contributions to the experimental apparatus. We acknowledge support from the Swiss National Science Foundation under grant 200021_134776 and through the National Centre of Competence in Research for Quantum Science and Technology (QSIT).	Barreiro JT, 2011, NATURE, V470, P486, DOI 10.1038/nature09801; Carvalho ARR, 2001, PHYS REV LETT, V86, P4988, DOI 10.1103/PhysRevLett.86.4988; CIRAC JI, 1993, PHYS REV LETT, V70, P556, DOI 10.1103/PhysRevLett.70.556; Diehl S, 2008, NAT PHYS, V4, P878, DOI 10.1038/nphys1073; Kraus B, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.042307; Krauter H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.080503; Kronwald A, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.063833; Lin Y, 2013, NATURE, V504, P415, DOI 10.1038/nature12801; Meekhof DM, 1996, PHYS REV LETT, V76, P1796, DOI 10.1103/PhysRevLett.76.1796; Navarrete-Benlloch C, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.193601; Pastawski F, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.012304; Poyatos JF, 1996, PHYS REV LETT, V77, P4728, DOI 10.1103/PhysRevLett.77.4728; Roos C., 2000, THESIS U INNSBRUCK A; Roos CF, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/013002; Sarlette A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.010402; Schleich W. P., 2001, QUANTUM OPTICS PHASE; Shankar S, 2013, NATURE, V504, P419, DOI 10.1038/nature12802; Verstraete F, 2009, NAT PHYS, V5, P633, DOI 10.1038/NPHYS1342; YUEN HP, 1976, PHYS REV A, V13, P2226, DOI 10.1103/PhysRevA.13.2226	22	143	144	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					53	56		10.1126/science.1261033	http://dx.doi.org/10.1126/science.1261033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25525161	Green Submitted			2022-12-28	WOS:000347102300045
J	Smith, C; Saint, S; Price, R; Al-Zoubi, A; Callaghan, B				Smith, Christopher; Saint, Sanjay; Price, Raymond; Al-Zoubi, Ammar; Callaghan, Brian			Diagnosing One Letter at a Time	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEM-CELL TRANSPLANTATION; POEMS-SYNDROME; THERAPY; PATIENT	A 45-year-old woman presented to a tertiary care center with weakness in the lower extremities. She first noted weakness in her ankles and feet 5 months previously. The weakness progressed to involve her knees and hips, and she had been unable to walk without support for the prior 2 months. She said that her grip strength had weakened and that she had numbness in her toes and fingertips. She also noted progressive swelling in her feet and ankles. She was coughing intermittently but said that she did not have sputum production, hemoptysis, dyspnea, or orthopnea. She reported losing several pounds unintentionally over a 6-month period but said that she did not have fever, chills, or sweats.	[Smith, Christopher; Saint, Sanjay] Vet Affairs VA Ann Arbor Med Ctr, Ann Arbor, MI USA; [Smith, Christopher; Saint, Sanjay; Al-Zoubi, Ammar; Callaghan, Brian] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Price, Raymond] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine	Smith, C (corresponding author), VA Ann Arbor Med Ctr, 2215 Fuller Rd,11A, Ann Arbor, MI 48105 USA.	casz@med.umich.edu	Saint, Sanjay/AAF-5126-2019		Doximity; Jvion; Critical Thinking Company	Doximity; Jvion; Critical Thinking Company	Dr. Saint reports receiving fees for board membership from Doximity and Jvion; and Dr. Price, receiving consulting and lecture fees from the Critical Thinking Company. No other potential conflict of interest relevant to this article was reported.	D'Souza A, 2012, BLOOD, V120, P56, DOI 10.1182/blood-2012-04-423178; Dispenzieri A, 2004, BLOOD, V104, P3400, DOI 10.1182/blood-2004-05-2046; Dispenzieri A, 2007, BLOOD REV, V21, P285, DOI 10.1016/j.blre.2007.07.004; Dispenzieri A, 2007, BLOOD, V110, P1075, DOI 10.1182/blood-2007-03-082354; Dispenzieri A, 2012, BLOOD, V119, P5650, DOI 10.1182/blood-2012-03-378992; Endo I, 2002, INTERNAL MED, V41, P1196, DOI 10.2169/internalmedicine.41.1196; Jaccard A, 2002, BLOOD, V99, P3057, DOI 10.1182/blood.V99.8.3057; Kanai K, 2012, NEUROLOGY, V79, P575, DOI 10.1212/WNL.0b013e318263c42b; Kuwabara S, 2008, NEUROLOGY, V71, P1691, DOI 10.1212/01.wnl.0000323811.42080.a4; Kuwabara S, 2008, J NEUROL NEUROSUR PS, V79, P1255, DOI 10.1136/jnnp.2008.150177; Kuwabara S, 1997, J NEUROL NEUROSUR PS, V63, P385, DOI 10.1136/jnnp.63.3.385; Kuwabara S, 2008, COCHRANE DB SYST REV, V4; Tang XW, 2009, EUR J HAEMATOL, V83, P609, DOI 10.1111/j.1600-0609.2009.01330.x	13	1	1	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2015	372	1					67	73		10.1056/NEJMcps1308732	http://dx.doi.org/10.1056/NEJMcps1308732			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX7MU	25551528				2022-12-28	WOS:000347100800012
J	Gandhi, RT; Alkasab, TK; Nardi, V; Branda, JA				Gandhi, Rajesh T.; Alkasab, Tarik K.; Nardi, Valentina; Branda, John A.			Case 40-2014: A 57-Year-Old Man with Inguinal Pain, Lymphadenopathy, and HIV Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CAT-SCRATCH DISEASE; SYPHILITIC HEPATITIS; INFLAMMATORY PSEUDOTUMOR; BARTONELLA-HENSELAE; SECONDARY SYPHILIS; UNITED-STATES; CT; PREVALENCE; SARCOMA; CANCER		[Gandhi, Rajesh T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Alkasab, Tarik K.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Nardi, Valentina; Branda, John A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Gandhi, Rajesh T.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Alkasab, Tarik K.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Nardi, Valentina; Branda, John A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gandhi, RT (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Branda, John/ABD-5620-2020		Gilead; Janssen; ViiV; Roche; DiaSorin; Alere; bioMerieux; Immunetics; AdvanDx	Gilead(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); ViiV; Roche(Roche Holding); DiaSorin; Alere; bioMerieux; Immunetics; AdvanDx	Dr. Gandhi reports receiving grant support from Gilead, Janssen, ViiV, and Roche; and Dr. Branda, receiving grant support from DiaSorin, Alere, bioMerieux, and Immunetics and fees for serving on an advisory board from AdvanDx. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2014, MMWR MORB MORTAL WKL, V63, P402; Bereswill S, 1999, J CLIN MICROBIOL, V37, P3159, DOI 10.1128/JCM.37.10.3159-3166.1999; Bogoch II, 2013, HIV MED, V14, P182, DOI 10.1111/j.1468-1293.2012.01035.x; CARITHERS HA, 1985, AM J DIS CHILD, V139, P1124, DOI 10.1001/archpedi.1985.02140130062031; Carucci LR, 2004, ABDOM IMAGING, V29, P631, DOI 10.1007/s00261-004-0180-9; CHAPEL TA, 1980, SEX TRANSM DIS, V7, P161, DOI 10.1097/00007435-198010000-00002; CHOMEL BB, 1995, J CLIN MICROBIOL, V33, P2445, DOI 10.1128/JCM.33.9.2445-2450.1995; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; CONNELLY JH, 1990, SURG GYNECOL OBSTET, V170, P309; Crum-Cianflone N, 2009, INT J STD AIDS, V20, P278, DOI 10.1258/ijsa.2008.008324; DONG PR, 1995, RADIOLOGY, V195, P837, DOI 10.1148/radiology.195.3.7754017; Facchetti F, 2009, AM J SURG PATHOL, V33, P447, DOI 10.1097/PAS.0b013e318187bfc6; FEHER J, 1975, LANCET, V2, P896; HARTSOCK RJ, 1970, AM J CLIN PATHOL, V53, P304; Maurer T, 2007, NEW ENGL J MED, V357, P1352, DOI 10.1056/NEJMc070508; Montes-Moreno S, 2010, HISTOPATHOLOGY, V56, P656, DOI 10.1111/j.1365-2559.2010.03521.x; Motyckova G, 2012, HEMATOL ONCOL CLIN N, V26, P395, DOI 10.1016/j.hoc.2012.02.005; Mullick CJ, 2004, CLIN INFECT DIS, V39, pE100, DOI 10.1086/425501; PANGALIS GA, 1993, SEMIN ONCOL, V20, P570; RADIN DR, 1993, AM J ROENTGENOL, V160, P1133, DOI 10.2214/ajr.160.5.8470595; Robbins HA, 2014, AIDS, V28, P881, DOI 10.1097/QAD.0000000000000163; Saleeby E, 1931, J AMER MED ASSOC, V96, P98, DOI 10.1001/jama.1931.02720280016005; SEHGAL VN, 1974, BRIT J VENER DIS, V50, P237; TERRY SI, 1984, BRIT J VENER DIS, V60, P83; Yanik EL, 2013, CLIN INFECT DIS, V57, P756, DOI 10.1093/cid/cit369	25	2	2	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2511	2520		10.1056/NEJMcpc1404518	http://dx.doi.org/10.1056/NEJMcpc1404518			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX4RZ	25539108				2022-12-28	WOS:000346920300012
J	Skolnick, BE; Maas, AI; Narayan, RK; van der Hoop, RG; MacAllister, T; Ward, JD; Nelson, NR; Stocchetti, N				Skolnick, Brett E.; Maas, Andrew I.; Narayan, Raj K.; van der Hoop, Roland Gerritsen; MacAllister, Thomas; Ward, John D.; Nelson, Neta R.; Stocchetti, Nino		SYNAPSE Trial Investigators	A Clinical Trial of Progesterone for Severe Traumatic Brain Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEUROPROTECTION; CLASSIFICATION; RECOVERY	BACKGROUND Progesterone has been associated with robust positive effects in animal models of traumatic brain injury (TBI) and with clinical benefits in two phase 2 randomized, controlled trials. We investigated the efficacy and safety of progesterone in a large, prospective, phase 3 randomized clinical trial. METHODS We conducted a multinational placebo-controlled trial, in which 1195 patients, 16 to 70 years of age, with severe TBI (Glasgow Coma Scale score, <= 8 [on a scale of 3 to 15, with lower scores indicating a reduced level of consciousness] and at least one reactive pupil) were randomly assigned to receive progesterone or placebo. Dosing began within 8 hours after injury and continued for 120 hours. The primary efficacy end point was the Glasgow Outcome Scale score at 6 months after the injury. RESULTS Proportional-odds analysis with covariate adjustment showed no treatment effect of progesterone as compared with placebo (odds ratio, 0.96; confidence interval, 0.77 to 1.18). The proportion of patients with a favorable outcome on the Glasgow Outcome Scale (good recovery or moderate disability) was 50.4% with progesterone, as compared with 50.5% with placebo. Mortality was similar in the two groups. No relevant safety differences were noted between progesterone and placebo. CONCLUSIONS Primary and secondary efficacy analyses showed no clinical benefit of progesterone in patients with severe TBI. These data stand in contrast to the robust preclinical data and results of early single-center trials that provided the impetus to initiate phase 3 trials.	[Skolnick, Brett E.; Narayan, Raj K.] Hofstra North Shore LIJ Sch Med, Cushing Neurosci Inst, Dept Neurosurg, Manhasset, NY USA; [Maas, Andrew I.] Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I.] Univ Antwerp, Edegem, Belgium; [van der Hoop, Roland Gerritsen; MacAllister, Thomas; Nelson, Neta R.] BHR Pharma, Herndon, VA USA; [Ward, John D.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Stocchetti, Nino] Univ Milan, Dept Physiopathol & Transplantat, Milan, Italy; [Stocchetti, Nino] Ca Granda Osped Maggiore Policlin, Neuro Intens Care Fdn Ist Ricovero & Cura Caratte, Milan, Italy	Hofstra University; Northwell Health; University of Antwerp; University of Antwerp; Virginia Commonwealth University; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Skolnick, BE (corresponding author), N Shore Univ Hosp, Dept Neurosurg, 300 Community Dr,9 Tower, Manhasset, NY 11030 USA.	bskolnick2@nshs.edu	Laha, Shondipon/AAN-9181-2020; Stocchetti, Nino/O-7444-2017; Verma, Vishwajit/K-8289-2019; Citerio, Giuseppe/B-1839-2015; Sahuquillo, Juan/B-3577-2008; Dominguez-Roldan, Jose-Maria/M-1728-2016; Nimsky, Christopher/E-3702-2014; Leone, Marc/P-4835-2016; Badenes, Rafael/K-6628-2019	Laha, Shondipon/0000-0001-8748-9766; Stocchetti, Nino/0000-0003-3250-6834; Citerio, Giuseppe/0000-0002-5374-3161; Sahuquillo, Juan/0000-0003-0713-5875; Dominguez-Roldan, Jose-Maria/0000-0003-1933-1478; Nimsky, Christopher/0000-0002-8216-9410; Leone, Marc/0000-0002-3097-758X; Badenes, Rafael/0000-0001-7017-0150; Quah, Boon Leong/0000-0001-9094-5857; Verma, Vishwajit/0000-0003-2428-2391; Fakhry, Samir/0000-0002-6781-0863; LAURENT, PETIT/0000-0003-1530-5678; Vincent, Jean-Louis/0000-0001-6011-6951; Barnes, Stephen/0000-0001-6186-1435; Bulters, Diederik/0000-0001-9884-9050	BHR Pharma, a division of Besins Healthcare	BHR Pharma, a division of Besins Healthcare	Supported by BHR Pharma, a division of Besins Healthcare.	Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons, 2008, J NEUROTRAUM, V25, P276; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Centers for Disease Control and Prevention, 2010, TRAUMATIC BRAIN INJU; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Lu J, 2010, J NEUROTRAUM, V27, P843, DOI 10.1089/neu.2010.1293; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI 10.1089/neu.2008-0794; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Morris GF, 1998, NEUROSURGERY, V43, P1369, DOI 10.1097/00006123-199812000-00063; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; WHITEHEAD J, 1994, STAT MED, V13, P871; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	29	310	322	2	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2467	2476		10.1056/NEJMoa1411090	http://dx.doi.org/10.1056/NEJMoa1411090			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX4RZ	25493978	Green Published, Bronze			2022-12-28	WOS:000346920300006
J	Shankaran, S; Laptook, AR; Pappas, A; McDonald, SA; Das, A; Tyson, JE; Poindexter, BB; Schibler, K; Bell, EF; Heyne, RJ; Pedroza, C; Bara, R; Van Meurs, KP; Grisby, C; Huitema, CMP; Garg, M; Ehrenkranz, RA; Shepherd, EG; Chalak, LF; Hamrick, SEG; Khan, AM; Reynolds, AM; Laughon, MM; Truog, WE; Dysart, KC; Carlo, WA; Walsh, MC; Watterberg, KL; Higgins, RD				Shankaran, Seetha; Laptook, Abbot R.; Pappas, Athina; McDonald, Scott. A.; Das, Abhik; Tyson, Jon E.; Poindexter, Brenda B.; Schibler, Kurt; Bell, Edward F.; Heyne, Roy J.; Pedroza, Claudia; Bara, Rebecca; Van Meurs, Krisa P.; Grisby, Cathy; Huitema, Carolyn M. Petrie; Garg, Meena; Ehrenkranz, Richard A.; Shepherd, Edward G.; Chalak, Lina F.; Hamrick, Shannon E. G.; Khan, Amir M.; Reynolds, Anne Marie; Laughon, Matthew M.; Truog, William E.; Dysart, Kevin C.; Carlo, Waldemar A.; Walsh, Michele C.; Watterberg, Kristi L.; Higgins, Rosemary D.		Eunice Kennedy Shriver Natl Inst C	Effect of Depth and Duration of Cooling on Deaths in the NICU Among Neonates With Hypoxic Ischemic Encephalopathy A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WHOLE-BODY HYPOTHERMIA; SYSTEMIC HYPOTHERMIA; OUTCOMES; NEUROPROTECTION; TEMPERATURE; SAFETY; RISK	IMPORTANCE Hypothermia at 33.5 degrees C for 72 hours for neonatal hypoxic ischemic encephalopathy reduces death or disability to 44% to 55%; longer cooling and deeper cooling are neuroprotective in animal models. OBJECTIVE To determine if longer duration cooling (120 hours), deeper cooling (32.0 degrees C), or both are superior to cooling at 33.5 degrees C for 72 hours in neonates who are full-term with moderate or severe hypoxic ischemic encephalopathy. DESIGN, SETTING, AND PARTICIPANTS A randomized, 2 x 2 factorial design clinical trial performed in 18 US centers in the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Neonatal Research Network between October 2010 and November 2013. INTERVENTIONS Neonates were assigned to 4 hypothermia groups; 33.5 degrees C for 72 hours, 32.0 degrees C for 72 hours, 33.5 degrees C for 120 hours, and 32.0 degrees C for 120 hours. MAIN OUTCOMES AND MEASURES The primary outcome of death or disability at 18 to 22 months is ongoing. The independent data and safety monitoring committee paused the trial to evaluate safety (cardiac arrhythmia, persistent acidosis, major vessel thrombosis and bleeding, and death in the neonatal intensive care unit [NICU]) after the first 50 neonates were enrolled, then after every subsequent 25 neonates. The trial was closed for emerging safety profile and futility analysis after the eighth review with 364 neonates enrolled (of 726 planned). This report focuses on safety and NICU deaths by marginal comparisons of 72 hours' vs 120 hours' duration and 33.5 degrees C depth vs 32.0 degrees C depth (predefined secondary outcomes). RESULTS The NICU death rates were 7 of 95 neonates (7%) for the 33.5 degrees C for 72 hours group, 13 of 90 neonates (14%) for the 32.0 degrees C for 72 hours group, 15 of 96 neonates (16%) for the 33.5 degrees C for 120 hours group, and 14 of 83 neonates (17%) for the 32.0 degrees C for 120 hours group. The adjusted risk ratio (RR) for NICU deaths for the 120 hours group vs 72 hours group was 1.37 (95% CI, 0.92-2.04) and for the 32.0 degrees C group vs 33.5 degrees C group was 1.24 (95% CI, 0.69-2.25). Safety outcomes were similar between the 120 hours group vs 72 hours group and the 32.0 degrees C group vs 33.5 degrees C group, except major bleeding occurred among 1% in the 120 hours group vs 3% in the 72 hours group (RR, 0.25 [95% CI, 0.07-0.91]). Futility analysis determined that the probability of detecting a statistically significant benefit for longer cooling, deeper cooling, or both for NICU death was less than 2%. CONCLUSIONS AND RELEVANCE Among neonates who were full-term with moderate or severe hypoxic ischemic encephalopathy, longer cooling, deeper cooling, or both compared with hypothermia at 33.5 degrees C for 72 hours did not reduce NICU death. These results have implications for patient care and design of future trials.	[Shankaran, Seetha; Pappas, Athina; Bara, Rebecca] Wayne State Univ, Dept Pediat, Detroit, MI 48201 USA; [Laptook, Abbot R.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [McDonald, Scott. A.] RTI Int, Social Stat & Environm Sci Unit, Res Triangle Pk, NC USA; [Das, Abhik; Huitema, Carolyn M. Petrie] RTI Int, Social Stat & Environm Sci Unit, Rockville, MD USA; [Tyson, Jon E.; Khan, Amir M.] Univ Texas Houston, Sch Med, Dept Pediat, Houston, TX USA; [Poindexter, Brenda B.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Schibler, Kurt; Pedroza, Claudia; Grisby, Cathy] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45229 USA; [Bell, Edward F.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Heyne, Roy J.; Chalak, Lina F.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Van Meurs, Krisa P.] Stanford Univ, Sch Med, Div Neonatal & Dev Med, Dept Pediat,Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA; [Garg, Meena] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Ehrenkranz, Richard A.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Shepherd, Edward G.] Ohio State Univ, Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43210 USA; [Hamrick, Shannon E. G.] Emory Univ, Sch Med, Dept Pediat, Childrens Healthcare Atlanta, Atlanta, GA USA; [Reynolds, Anne Marie] SUNY Buffalo, Dept Pediat, Buffalo, NY 14260 USA; [Laughon, Matthew M.] Univ N Carolina, Dept Pediat, Div Neonatal Perinatal Med, Chapel Hill, NC USA; [Truog, William E.] Univ Missouri, Childrens Mercy Hosp, Kansas City Sch Med, Dept Pediat, Columbia, MO 65211 USA; [Dysart, Kevin C.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Carlo, Waldemar A.] Univ Alabama Birmingham, Div Neonatol, Birmingham, AL USA; [Walsh, Michele C.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Watterberg, Kristi L.] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Higgins, Rosemary D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pregnancy & Perinatol Branch, NIH, Bethesda, MD USA	Wayne State University; Brown University; Women & Infants Hospital Rhode Island; Research Triangle Institute; Research Triangle Institute; University of Texas System; University of Texas Health Science Center Houston; Indiana University System; Indiana University Bloomington; Cincinnati Children's Hospital Medical Center; University of Iowa; University of Texas System; University of Texas Southwestern Medical Center Dallas; Lucile Packard Children's Hospital (LPCH); Stanford University; University of California System; University of California Los Angeles; Yale University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Children's Healthcare of Atlanta (CHOA); Emory University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of North Carolina; University of North Carolina Chapel Hill; Children's Mercy Hospital; University of Missouri System; University of Missouri Columbia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Alabama System; University of Alabama Birmingham; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University of New Mexico; University of New Mexico's Health Sciences Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shankaran, S (corresponding author), Wayne State Univ, Childrens Hosp Michigan, Dept Pediat, 3901 Beaubien Blvd, Detroit, MI 48201 USA.	sshankar@med.wayne.edu	Dysart, Kevin/AAQ-6155-2021; Truog, William/R-5576-2019; Shah, Birju A./C-4811-2014; Shepherd, Edward/E-4080-2011; Ambalavanan, Namasivayam/AAI-4088-2020; Das, Abhik/AAF-1883-2020; Keszler, Martin/H-7260-2019	Shah, Birju A./0000-0002-9051-1183; Ambalavanan, Namasivayam/0000-0003-0731-9092; Das, Abhik/0000-0003-2722-0479; Keszler, Martin/0000-0002-9964-664X; Bell, Edward/0000-0002-5568-0889; Shankaran, Seetha/0000-0001-5512-9571; Dysart, Kevin/0000-0003-2715-2293; Lakshminrusimha, Satyan/0000-0001-6098-2155; Boyle, Robert/0000-0002-4913-7580; Pedroza, Claudia/0000-0003-4235-1282; Roghair, Robert/0000-0002-0321-582X; Colaizy, Tarah/0000-0003-2582-1633; Barks, John/0000-0003-1320-905X; Parikh, Nehal/0000-0002-1375-1247; Klein, Jonathan/0000-0002-6693-1823; Gantz, Marie/0000-0001-8528-0184; Nolen, Tracy/0000-0003-2512-343X; Rabe, Glenda/0000-0003-4884-255X; Dagle, John/0000-0002-8238-6159; McDonald, Scott/0000-0002-0054-1099; Segar, Jeffrey/0000-0001-7311-8948; McElroy, Steven/0000-0002-4321-723X; Lindower, Julie/0000-0003-0213-315X	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Advancing Translational Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD040492, U10HD036790, U10HD027904, U10HD068270, U10HD040689, UG1HD087229, U10HD027880, U10HD068263, U10HD053089, UG1HD053089, U10HD068284, U10HD053109, UG1HD068270, U10HD021364, U10HD027856, U10HD034216, U10HD068244, U10HD068278, U10HD027853, U10HD027851, U10HD021385, U10HD021373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371, UL1TR002529, UL1TR001108, UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The National Institutes of Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Center for Advancing Translational Sciences provided grant support for the Neonatal Research Network's Optimizing Cooling trial through cooperative agreements.	Azzopardi D, 2014, NEW ENGL J MED, V371, P140, DOI 10.1056/NEJMoa1315788; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bennet L, 2007, J PHYSIOL-LONDON, V578, P491, DOI 10.1113/jphysiol.2006.119602; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Cavallaro G, 2011, ARCH DIS CHILD-FETAL, V96, pF374, DOI 10.1136/adc.2009.181826; Compagnoni G, 2008, NEONATOLOGY, V93, P230, DOI 10.1159/000111101; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Guillet R, 2012, PEDIATR RES, V71, P205, DOI 10.1038/pr.2011.30; Hallberg B, 2009, ACTA PAEDIATR, V98, P942, DOI 10.1111/j.1651-2227.2009.01303.x; Iwata O, 2005, ANN NEUROL, V58, P75, DOI 10.1002/ana.20528; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Johnston MV, 2011, LANCET NEUROL, V10, P372, DOI 10.1016/S1474-4422(11)70016-3; Kendall GS, 2012, PEDIATRICS, V130, pE451, DOI 10.1542/peds.2011-3496; Kendall GS, 2010, ARCH DIS CHILD-FETAL, V95, pF408, DOI 10.1136/adc.2010.187211; Laptook A, 2008, PEDIATRICS, V122, P491, DOI 10.1542/peds.2007-1673; Laptook AR, 2013, ANN NEUROL, V73, P520, DOI 10.1002/ana.23843; O'Reilly KM, 2011, ACTA PAEDIATR, V100, P1084, DOI 10.1111/j.1651-2227.2011.02249.x; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Papile LA, 2014, PEDIATRICS, V133, P1146, DOI 10.1542/peds.2014-0899; Perlman JM, 2006, PEDIATRICS, V117, pS28, DOI 10.1542/peds.2005-0620E; POCOCK SJ, 1977, BIOMETRIKA, V64, P191, DOI 10.1093/biomet/64.2.191; Shah SK, 2010, EUR J PEDIATR SURG, V20, P205, DOI 10.1055/s-0029-1241872; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2008, PEDIATRICS, V122, pE791, DOI 10.1542/peds.2008-0456; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Simbruner G, 2010, PEDIATRICS, V126, pE771, DOI 10.1542/peds.2009-2441; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; THORESEN M, 1995, PEDIATR RES, V37, P667, DOI 10.1203/00006450-199505000-00019; Williams GD, 1997, PEDIATR RES, V42, P700, DOI 10.1203/00006450-199711000-00024; Wyatt JS, 2007, PEDIATRICS, V119, P912, DOI 10.1542/peds.2006-2839	31	150	158	2	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2014	312	24					2629	2639		10.1001/jama.2014.16058	http://dx.doi.org/10.1001/jama.2014.16058			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX5KW	25536254	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000346966100015
J	Becher, OJ; Wechsler-Reya, RJ				Becher, Oren J.; Wechsler-Reya, Robert J.			For pediatric glioma, leave no histone unturned	SCIENCE			English	Editorial Material							INTRINSIC PONTINE GLIOMA; GENE-EXPRESSION; GLIOBLASTOMA; METHYLATION; MUTATION		[Becher, Oren J.] Duke Univ, Div Pediat Hematol Oncol, Dept Pathol, Durham, NC 27710 USA; [Becher, Oren J.] Duke Univ, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; [Wechsler-Reya, Robert J.] Sanford Burnham Med Res Inst, NCI Designated Canc Ctr, Tumor Initiat & Maintenance Program, La Jolla, CA 92037 USA	Duke University; Duke University; Sanford Burnham Prebys Medical Discovery Institute	Becher, OJ (corresponding author), Duke Univ, Div Pediat Hematol Oncol, Dept Pathol, Durham, NC 27710 USA.	becher@duke.edu; rwreya@sanfordburnham.org	Becher, Oren/AAI-7495-2020	Becher, Oren/0000-0003-4016-8492	NCI NIH HHS [R01 CA159859] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA159859] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Buczkowicz P, 2014, ACTA NEUROPATHOL, V128, P573, DOI 10.1007/s00401-014-1319-6; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; Funato K, 2014, SCIENCE, V346, P1529, DOI 10.1126/science.1253799; Hashizume R, 2014, NAT MED, V20, P1394, DOI 10.1038/nm.3716; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025	12	7	7	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1458	1459		10.1126/science.aaa3814	http://dx.doi.org/10.1126/science.aaa3814			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525232				2022-12-28	WOS:000346536500038
J	Funato, K; Major, T; Lewis, PW; Allis, CD; Tabar, V				Funato, Kosuke; Major, Tamara; Lewis, Peter W.; Allis, C. David; Tabar, Viviane			Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation	SCIENCE			English	Article							HIGH-GRADE GLIOMAS; GENE-EXPRESSION; HUMAN ES; GLIOBLASTOMA; MENIN; INHIBITION; SUBGROUPS; PROTEIN; CANCER	Over 70% of diffuse intrinsic pediatric gliomas, an aggressive brainstem tumor, harbor heterozygous mutations that create a K27M amino acid substitution (methionine replaces lysine 27) in the tail of histone H3.3. The role of the H3.3K27M mutation in tumorigenesis is not fully understood. Here, we use a human embryonic stem cell system to model this tumor. We show that H3.3K27M expression synergizes with p53 loss and PDGFRA activation in neural progenitor cells derived from human embryonic stem cells, resulting in neoplastic transformation. Genome-wide analyses indicate a resetting of the transformed precursors to a developmentally more primitive stem cell state, with evidence of major modifications of histone marks at several master regulator genes. Drug screening assays identified a compound targeting the protein menin as an inhibitor of tumor cell growth in vitro and in mice.	[Funato, Kosuke; Major, Tamara; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, Dept Neurosurg, New York, NY 10065 USA; [Funato, Kosuke; Major, Tamara; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10065 USA; [Lewis, Peter W.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53715 USA; [Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Wisconsin System; University of Wisconsin Madison; Rockefeller University	Tabar, V (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, Dept Neurosurg, New York, NY 10065 USA.	tabarv@mskcc.org		Lewis, Peter/0000-0002-9816-7823; Major, Tamara/0000-0003-1383-3418; Funato, Kosuke/0000-0003-2437-1116	Brain Tumor Center; Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center; Rockefeller University; Geoffrey Beene Cancer Center; Starr Cancer Consortium; New York State Stem Cell Board (NYSTEM); NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Brain Tumor Center; Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center; Rockefeller University; Geoffrey Beene Cancer Center; Starr Cancer Consortium; New York State Stem Cell Board (NYSTEM); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	K.F. was supported by grants from the Brain Tumor Center and the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center; C.D.A. is supported by The Rockefeller University. Funding in part from The Geoffrey Beene Cancer Center, The Starr Cancer Consortium and the New York State Stem Cell Board (NYSTEM). Microarray data generated in this manuscript are deposited in GEO (GSE55541). We thank J. Huse, Sloan Kettering, for the pathology assessment of the mouse tumors, and M. Monje, Stanford University, for the human DIPG line, which is available from her under a material transfer agreement. V.T. and K.F. are coinventors on a patent application filed by Memorial Sloan Kettering Cancer Center related to the use of the MI-2 drug in tumors and the ES-based modeling system.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Grembecka J, 2012, NAT CHEM BIOL, V8, P277, DOI [10.1038/NCHEMBIO.773, 10.1038/nchembio.773]; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Lewis PW, 2013, CELL CYCLE, V12, P3241, DOI 10.4161/cc.26356; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Matkar S, 2013, TRENDS BIOCHEM SCI, V38, P394, DOI [10.1016/j.tibs.2013.0S.005, 10.1016/j.tibs.2013.05.005]; Paugh BS, 2013, CANCER RES, V73, P6219, DOI 10.1158/0008-5472.CAN-13-1491; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sethi R, 2011, J NEURO-ONCOL, V102, P121, DOI 10.1007/s11060-010-0301-y; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611	21	243	247	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1529	1533		10.1126/science.1253799	http://dx.doi.org/10.1126/science.1253799			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525250	Green Accepted			2022-12-28	WOS:000346536500068
J	Ravelo, AC; Lawrence, KT; Fedorov, A; Ford, HL				Ravelo, Ana Christina; Lawrence, Kira Trillium; Fedorov, Alexey; Ford, Heather Louise			Comment on "A 12-million-year temperature history of the tropical Pacific Ocean"	SCIENCE			English	Editorial Material							EQUATORIAL PACIFIC; PLIOCENE CLIMATE; MODEL; CALIBRATION; MECHANISMS; EVOLUTION; RECORD	Zhang et al. (Reports, 4 April 2014, p. 84) interpret TEX86 and U-37(K') paleotemperature data as providing a fundamentally new view of tropical Pacific climate during the warm Pliocene period. We argue that, within error, their Pliocene data actually support previously published data indicating average western warm-pool temperature similar to today and a reduced zonal gradient, referred to as a permanent El Nio-like state.	[Ravelo, Ana Christina] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Lawrence, Kira Trillium] Lafayette Coll, Dept Geol & Environm Geosci, Easton, PA 18042 USA; [Fedorov, Alexey] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Ford, Heather Louise] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	University of California System; University of California Santa Cruz; Lafayette College; Yale University; Columbia University	Ravelo, AC (corresponding author), Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA.	acr@ucsc.edu	Ford, Heather/CAG-7894-2022	Ravelo, Ana Christina/0000-0003-3929-677X	Directorate For Geosciences [1204254] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		[Anonymous], 2007, GEOPHYS RES LETT, DOI DOI 10.1029/2006GL028443; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Chan WL, 2011, GEOSCI MODEL DEV, V4, P1035, DOI 10.5194/gmd-4-1035-2011; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Conte MH, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001054; Dekens PS, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001394; Dekens PS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000200; Dowsett HJ, 2009, PHILOS T R SOC A, V367, P109, DOI 10.1098/rsta.2008.0206; Dubois N, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2009PA001781; Fedorov AV, 2006, SCIENCE, V312, P1485, DOI 10.1126/science.1122666; Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Ford HL, 2012, EARTH PLANET SC LETT, V355, P152, DOI 10.1016/j.epsl.2012.08.027; Groeneveld J, 2006, P ODP SCI RESULTS, V202, DOI [DOI 10.2973/ODP.PROC.SR.202.209.2006, 10.2973/odp.proc.sr.202.209.2006]; Haywood AM, 2013, CLIM PAST, V9, P191, DOI 10.5194/cp-9-191-2013; Jia GD, 2012, ORG GEOCHEM, V50, P68, DOI 10.1016/j.orggeochem.2012.07.002; Kim JH, 2010, GEOCHIM COSMOCHIM AC, V74, P4639, DOI 10.1016/j.gca.2010.05.027; Lawrence KT, 2006, SCIENCE, V312, P79, DOI 10.1126/science.1120395; Lea DW, 2014, SCIENCE, V344, P52, DOI 10.1126/science.1252246; Li L, 2011, EARTH PLANET SC LETT, V309, P10, DOI 10.1016/j.epsl.2011.04.016; Liu ZH, 2004, NATURE, V427, P720, DOI 10.1038/nature02338; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Ravelo A., 2006, GSA TODAY GEOL SOC A, V16, DOI [DOI 10.1130/1052-5173(2006)0162.0.CO;2, 10.1130/1052-5173(2006)0162.0.CO;2]; Rousselle G, 2013, EARTH PLANET SC LETT, V361, P412, DOI 10.1016/j.epsl.2012.11.003; Schneider von Deimling T, 2006, CLIM DYNAM, V27, P149, DOI 10.1007/s00382-006-0126-8; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Seki O, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002158; Tierney JE, 2014, GEOCHIM COSMOCHIM AC, V127, P83, DOI 10.1016/j.gca.2013.11.026; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Zhang YG, 2014, SCIENCE, V344, P84, DOI 10.1126/science.1246172; Zhang YG, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0096	30	40	43	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216							1467-a	10.1126/science.1257618	http://dx.doi.org/10.1126/science.1257618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525238				2022-12-28	WOS:000346536500052
J	Lo, JCL; Gui, JH; Yabe, YK; Pan, CM; Baran, PS				Lo, Julian C.; Gui, Jinghan; Yabe, Yuki; Pan, Chung-Mao; Baran, Phil S.			Functionalized olefin cross-coupling to construct carbon-carbon bonds	NATURE			English	Article							CONJUGATE ADDITION; UNACTIVATED OLEFINS; TERTIARY ALCOHOLS; HYDROGENATION; REAGENTS; ESTERS; PHENYLSILANE; CHEMISTRY; MECHANISM; RADICALS	Carbon-carbon (C-C) bonds form the backbone of many important molecules, including polymers, dyes and pharmaceutical agents. The development of new methods to create these essential connections in a rapid and practical fashion has been the focus of numerous organic chemists. This endeavour relies heavily on the ability to form C-C bonds in the presence of sensitive functional groups and congested structural environments. Here we report a chemical transformation that allows the facile construction of highly substituted and uniquely functionalized C-C bonds. Using a simple iron catalyst, an inexpensive silane and a benign solvent under ambient atmosphere, heteroatom-substituted olefins are easily reacted with electron-deficient olefins to create molecular architectures that were previously difficult or impossible to access. More than 60 examples are presented with a wide array of substrates, demonstrating the chemoselectivity and mildness of this simple reaction.	[Lo, Julian C.; Gui, Jinghan; Yabe, Yuki; Pan, Chung-Mao; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu		Gui, Jinghan/0000-0002-4786-5779	NIH/NIGMS [GM-097444]; National Science Foundation; Shanghai Institute of Organic Chemistry; Zhejiang Medicine Co.; Pharmaron; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097444] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Shanghai Institute of Organic Chemistry; Zhejiang Medicine Co.; Pharmaron; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this work was provided by NIH/NIGMS (GM-097444). The National Science Foundation supported a predoctoral fellowship for J.C.L.; the Shanghai Institute of Organic Chemistry, Zhejiang Medicine Co. and Pharmaron supported a postdoctoral fellowship for J.G.; and the Japan Society for the Promotion of Science supported a postdoctoral fellowship for Y.Y. We are grateful to D.-H. Huang and L. Pasternack (TSRI) for assistance with NMR spectroscopy, and A. L. Rheingold and C. E. Moore (UCSD) for X-ray crystallographic analysis. We thank R. A. Shenvi (TSRI) and Y. Ji (TSRI) for discussions.	[Anonymous], 1988, IARC MONOGRAPHS EVAL, V44, P71; Aurell MJ, 1999, TETRAHEDRON, V55, P815, DOI 10.1016/S0040-4020(98)01073-4; BARTON DHR, 1984, TETRAHEDRON LETT, V25, P1055, DOI 10.1016/S0040-4039(01)80099-X; BARTON DHR, 1985, TETRAHEDRON LETT, V26, P757, DOI 10.1016/S0040-4039(00)89129-7; BLUMENKOPF TA, 1986, CHEM REV, V86, P857, DOI 10.1021/cr00075a009; BULLOCK RM, 1990, J AM CHEM SOC, V112, P6886, DOI 10.1021/ja00175a024; Chu LL, 2014, J AM CHEM SOC, V136, P10886, DOI 10.1021/ja505964r; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; Dal Zotto C, 2011, J ORGANOMET CHEM, V696, P296, DOI 10.1016/j.jorganchem.2010.09.031; Diederich F., 1998, METAL CATALYZED CROS; DJERASSI C, 1954, J AM CHEM SOC, V76, P4092, DOI 10.1021/ja01645a010; Dubbaka SR, 2005, ANGEW CHEM INT EDIT, V44, P7674, DOI 10.1002/anie.200463007; Gao X, 2013, J AM CHEM SOC, V135, P4223, DOI 10.1021/ja4008722; Gillis EP, 2007, J AM CHEM SOC, V129, P6716, DOI 10.1021/ja0716204; Girijavallabhan V, 2011, J ORG CHEM, V76, P6442, DOI 10.1021/jo201016z; HUTCHINSON DK, 1987, J AM CHEM SOC, V109, P4930, DOI 10.1021/ja00250a029; ISAYAMA S, 1989, CHEM LETT, P1071, DOI 10.1246/cl.1989.1071; Ishikawa H, 2009, J AM CHEM SOC, V131, P4904, DOI 10.1021/ja809842b; Iwasaki K, 2014, J AM CHEM SOC, V136, P1300, DOI 10.1021/ja412342g; Jana R, 2011, CHEM REV, V111, P1417, DOI 10.1021/cr100327p; Juaristi E, 1999, TETRAHEDRON-ASYMMETR, V10, P2441, DOI 10.1016/S0957-4166(99)00242-6; KATO K, 1992, CHEM LETT, P1137, DOI 10.1246/cl.1992.1137; King SM, 2014, J AM CHEM SOC, V136, P6884, DOI 10.1021/ja502885c; Kolb HC, 2003, DRUG DISCOV TODAY, V8, P1128, DOI 10.1016/S1359-6446(03)02933-7; Lackner GL, 2013, J AM CHEM SOC, V135, P15342, DOI 10.1021/ja408971t; Leggans EK, 2012, ORG LETT, V14, P1428, DOI 10.1021/ol300173v; Lo JC, 2014, J AM CHEM SOC, V136, P1304, DOI 10.1021/ja4117632; Magnus P, 2000, TETRAHEDRON LETT, V41, P9731, DOI 10.1016/S0040-4039(00)01728-7; MANCILLA T, 1986, J ORGANOMET CHEM, V307, P1, DOI 10.1016/0022-328X(86)80169-3; Matsuo J, 2013, ANGEW CHEM INT EDIT, V52, P9109, DOI 10.1002/anie.201303192; Meek SJ, 2011, NATURE, V471, P461, DOI 10.1038/nature09957; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Nakao Y, 2011, CHEM SOC REV, V40, P4893, DOI 10.1039/c1cs15122c; Noguchi H, 2007, J AM CHEM SOC, V129, P758, DOI 10.1021/ja067975p; SEEBACH D, 1979, ANGEW CHEM INT EDIT, V18, P239, DOI 10.1002/anie.197902393; Shigehisa H, 2013, ORG LETT, V15, P5158, DOI 10.1021/ol402696h; Shigehisa H, 2013, J AM CHEM SOC, V135, P10306, DOI 10.1021/ja405219f; Srikanth GSC, 2005, TETRAHEDRON, V61, P10377, DOI 10.1016/j.tet.2005.07.077; STORK G, 1963, J AM CHEM SOC, V85, P207, DOI 10.1021/ja00885a021; Streuff J, 2013, SYNTHESIS-STUTTGART, V45, P281, DOI 10.1055/s-0032-1316840; Taniguchi T, 2010, ORG LETT, V12, P112, DOI 10.1021/ol902562j; Utsunomiya K., 1968, B I CHEM RES KYOTO U, V46, P256; Wang LC, 2002, J AM CHEM SOC, V124, P9448, DOI 10.1021/ja020223k; Waser J, 2006, J AM CHEM SOC, V128, P11693, DOI 10.1021/ja062355+; Werner EW, 2012, SCIENCE, V338, P1455, DOI 10.1126/science.1229208; YAMAMOTO Y, 1978, J AM CHEM SOC, V100, P3240, DOI 10.1021/ja00478a060; Zbieg JR, 2012, SCIENCE, V336, P324, DOI 10.1126/science.1219274	47	262	265	11	303	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					343	348		10.1038/nature14006	http://dx.doi.org/10.1038/nature14006			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25519131	Green Accepted			2022-12-28	WOS:000346484800036
J	Tedeschi, A; Bradke, F				Tedeschi, Andrea; Bradke, Frank			A New "Spin'' on Recovery after Spinal Cord Injury	CELL			English	Editorial Material							COMPENSATION; LOCOMOTION	Functional recovery can occur after incomplete spinal cord injury. Takeoka et al. now report that such recovery relies on muscle spindle feedback that is necessary for neuronal circuit remodeling, suggesting novel targets to restore motor functions following spinal cord injuries.	[Tedeschi, Andrea; Bradke, Frank] German Ctr Neurodegenerat Dis DZNE, Lab Axon Growth & Regenerat, D-53175 Bonn, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Tedeschi, A (corresponding author), German Ctr Neurodegenerat Dis DZNE, Lab Axon Growth & Regenerat, Ludwig Erhard Allee 2, D-53175 Bonn, Germany.	andrea.tedeschi@dzne.de; frank.bradke@dzne.de		Bradke, Frank/0000-0002-0345-3772				Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Chen HH, 2002, J NEUROSCI, V22, P3512; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Curt A, 2008, J NEUROTRAUM, V25, P677, DOI 10.1089/neu.2007.0468; HELGREN ME, 1993, EXP NEUROL, V123, P17, DOI 10.1006/exnr.1993.1137; Martinez M, 2012, J NEUROPHYSIOL, V108, P124, DOI 10.1152/jn.00073.2012; Takeoka A, 2014, CELL, V159, P1626, DOI 10.1016/j.cell.2014.11.019; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416	9	3	3	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1494	1496		10.1016/j.cell.2014.12.014	http://dx.doi.org/10.1016/j.cell.2014.12.014			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525871	Bronze			2022-12-28	WOS:000347922500005
J	Chinthapalli, K				Chinthapalli, Krishna			CHRISTMAS 2014: GOING TO EXTREMES Against the odds in Las Vegas	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIAC-ARREST; OUTCOMES; RISK					kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				Adams BD, 2009, RESUSCITATION, V80, P65, DOI 10.1016/j.resuscitation.2008.09.016; [Anonymous], 2014, LAS VEGAS REV J 0618; [Anonymous], 2013, DAILY MAIL; Bernick C, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt177; Brooks SC, 2013, ANN EMERG MED, V61, P530, DOI 10.1016/j.annemergmed.2012.10.037; Dow Schull N, 2012, ADDICTION BY DESIGN, DOI DOI 10.1515/9781400834655; Griffiths MD, 2009, CASINO GAMING INT, V5, P21; Harasim P, 2008, LAS VEGAS REV J 0316; Ioannidis JPA, 2012, JAMA-J AM MED ASSOC, V307, P1257, DOI 10.1001/jama.2012.360; Karch SB, 1998, AM J EMERG MED, V16, P249, DOI 10.1016/S0735-6757(98)90094-8; Robison J., 2013, LAS VEGAS REV J 0203; United Health Foundation, AM HLTH RANK; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Whaley S, 2014, LAS VEGAS REV J 0108; Wray M, 2008, SOC SCI MED, V67, P1882, DOI 10.1016/j.socscimed.2008.09.002	15	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2014	349								g7669	10.1136/bmj.g7669	http://dx.doi.org/10.1136/bmj.g7669			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX3DZ	25520277				2022-12-28	WOS:000346821900008
J	Holmes, D				Holmes, David			David Evans: putting universal health coverage on the agenda	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2101	2101		10.1016/S0140-6736(14)62361-8	http://dx.doi.org/10.1016/S0140-6736(14)62361-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BK	25497190	Bronze			2022-12-28	WOS:000346354300012
J	Jarvis, ED; Mirarab, S; Aberer, AJ; Li, B; Houde, P; Li, C; Ho, SYW; Faircloth, BC; Nabholz, B; Howard, JT; Suh, A; Weber, CC; da Fonseca, RR; Li, JW; Zhang, F; Li, H; Zhou, L; Narula, N; Liu, L; Ganapathy, G; Boussau, B; Bayzid, MS; Zavidovych, V; Subramanian, S; Gabaldon, T; Capella-Gutierrez, S; Huerta-Cepas, J; Rekepalli, B; Munch, K; Schierup, M; Lindow, B; Warren, WC; Ray, D; Green, RE; Bruford, MW; Zhan, XJ; Dixon, A; Li, SB; Li, N; Huang, YH; Derryberry, EP; Bertelsen, MF; Sheldon, FH; Brumfield, RT; Mello, CV; Lovell, PV; Wirthlin, M; Schneider, MPC; Prosdocimi, F; Samaniego, JA; Velazquez, AMV; Alfaro-Nunez, A; Campos, PF; Petersen, B; Sicheritz-Ponten, T; Pas, A; Bailey, T; Scofield, P; Bunce, M; Lambert, DM; Zhou, Q; Perelman, P; Driskell, AC; Shapiro, B; Xiong, ZJ; Zeng, YL; Liu, SP; Li, ZY; Liu, BH; Wu, K; Xiao, J; Yinqi, X; Zheng, QM; Zhang, Y; Yang, HM; Wang, J; Smeds, L; Rheindt, FE; Braun, M; Fjeldsa, J; Orlando, L; Barker, FK; Jonsson, KA; Johnson, W; Koepfli, KP; O'Brien, S; Haussler, D; Ryder, OA; Rahbek, C; Willerslev, E; Graves, GR; Glenn, TC; McCormack, J; Burt, D; Ellegren, H; Alstrom, P; Edwards, SV; Stamatakis, A; Mindell, DP; Cracraft, J; Braun, EL; Warnow, T; Jun, W; Gilbert, MTP; Zhang, GJ				Jarvis, Erich D.; Mirarab, Siavash; Aberer, Andre J.; Li, Bo; Houde, Peter; Li, Cai; Ho, Simon Y. W.; Faircloth, Brant C.; Nabholz, Benoit; Howard, Jason T.; Suh, Alexander; Weber, Claudia C.; da Fonseca, Rute R.; Li, Jianwen; Zhang, Fang; Li, Hui; Zhou, Long; Narula, Nitish; Liu, Liang; Ganapathy, Ganesh; Boussau, Bastien; Bayzid, Md. Shamsuzzoha; Zavidovych, Volodymyr; Subramanian, Sankar; Gabaldon, Toni; Capella-Gutierrez, Salvador; Huerta-Cepas, Jaime; Rekepalli, Bhanu; Munch, Kasper; Schierup, Mikkel; Lindow, Bent; Warren, Wesley C.; Ray, David; Green, Richard E.; Bruford, Michael W.; Zhan, Xiangjiang; Dixon, Andrew; Li, Shengbin; Li, Ning; Huang, Yinhua; Derryberry, Elizabeth P.; Bertelsen, Mads Frost; Sheldon, Frederick H.; Brumfield, Robb T.; Mello, Claudio V.; Lovell, Peter V.; Wirthlin, Morgan; Cruz Schneider, Maria Paula; Prosdocimi, Francisco; Samaniego, Jose Alfredo; Vargas Velazquez, Amhed Missael; Alfaro-Nunez, Alonzo; Campos, Paula F.; Petersen, Bent; Sicheritz-Ponten, Thomas; Pas, An; Bailey, Tom; Scofield, Paul; Bunce, Michael; Lambert, David M.; Zhou, Qi; Perelman, Polina; Driskell, Amy C.; Shapiro, Beth; Xiong, Zijun; Zeng, Yongli; Liu, Shiping; Li, Zhenyu; Liu, Binghang; Wu, Kui; Xiao, Jin; Yinqi, Xiong; Zheng, Qiuemei; Zhang, Yong; Yang, Huanming; Wang, Jian; Smeds, Linnea; Rheindt, Frank E.; Braun, Michael; Fjeldsa, Jon; Orlando, Ludovic; Barker, F. Keith; Jonsson, Knud Andreas; Johnson, Warren; Koepfli, Klaus-Peter; O'Brien, Stephen; Haussler, David; Ryder, Oliver A.; Rahbek, Carsten; Willerslev, Eske; Graves, Gary R.; Glenn, Travis C.; McCormack, John; Burt, Dave; Ellegren, Hans; Alstrom, Per; Edwards, Scott V.; Stamatakis, Alexandros; Mindell, David P.; Cracraft, Joel; Braun, Edward L.; Warnow, Tandy; Jun, Wang; Gilbert, M. Thomas P.; Zhang, Guojie			Whole-genome analyses resolve early branches in the tree of life of modern birds	SCIENCE			English	Article							BIASED GENE CONVERSION; PHYLOGENETIC TREES; SPECIES TREES; SEQUENCE ALIGNMENTS; PARALLEL RADIATIONS; CRETACEOUS ORIGIN; COALESCENT MODEL; MASS EXTINCTION; PASSERINE BIRDS; FOSSIL RECORD	To better determine the history of modern birds, we performed a genome-scale phylogenetic analysis of 48 species representing all orders of Neoaves using phylogenomic methods created to handle genome-scale data. We recovered a highly resolved tree that confirms previously controversial sister or close relationships. We identified the first divergence in Neoaves, two groups we named Passerea and Columbea, representing independent lineages of diverse and convergently evolved land and water bird species. Among Passerea, we infer the common ancestor of core landbirds to have been an apex predator and confirm independent gains of vocal learning. Among Columbea, we identify pigeons and flamingoes as belonging to sister clades. Even with whole genomes, some of the earliest branches in Neoaves proved challenging to resolve, which was best explained by massive protein-coding sequence convergence and high levels of incomplete lineage sorting that occurred during a rapid radiation after the Cretaceous-Paleogene mass extinction event about 66 million years ago.	[Jarvis, Erich D.; Howard, Jason T.; Ganapathy, Ganesh; Zavidovych, Volodymyr] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA; [Jarvis, Erich D.; Howard, Jason T.; Ganapathy, Ganesh; Zavidovych, Volodymyr] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Mirarab, Siavash; Bayzid, Md. Shamsuzzoha; Warnow, Tandy] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA; [Aberer, Andre J.; Stamatakis, Alexandros] Heidelberg Inst Theoret Studies, Sci Comp Grp, Heidelberg, Germany; [Li, Bo; Li, Cai; Li, Jianwen; Zhang, Fang; Li, Hui; Zhou, Long; Xiong, Zijun; Zeng, Yongli; Liu, Shiping; Li, Zhenyu; Liu, Binghang; Wu, Kui; Xiao, Jin; Yinqi, Xiong; Zheng, Qiuemei; Zhang, Yong; Zhang, Guojie] BGI Shenzhen, China Natl GeneBank, Shenzhen 518083, Peoples R China; [Li, Bo; Li, Shengbin] Xi An Jiao Tong Univ, Coll Med & Forens, Xian 710061, Peoples R China; [Li, Bo; Li, Cai; da Fonseca, Rute R.; Lindow, Bent; Samaniego, Jose Alfredo; Vargas Velazquez, Amhed Missael; Alfaro-Nunez, Alonzo; Campos, Paula F.; Orlando, Ludovic; Willerslev, Eske; Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Houde, Peter; Narula, Nitish] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Ho, Simon Y. W.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Faircloth, Brant C.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Faircloth, Brant C.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Nabholz, Benoit] Univ Montpellier 2, Inst Sci Evolut Montpellier, CNRS, UMR 5554, Montpellier, France; [Suh, Alexander; Weber, Claudia C.; Smeds, Linnea; Ellegren, Hans] Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, SE-75236 Uppsala, Sweden; [Narula, Nitish] Okinawa Inst Sci & Technol Onna Son, Biodivers & Biocomplex Unit, Okinawa 9040495, Japan; [Liu, Liang] Univ Georgia, Dept Stat, Athens, GA 30602 USA; [Liu, Liang] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Boussau, Bastien] Univ Lyon, Ctr Natl Rech Sci, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Subramanian, Sankar; Lambert, David M.] Griffith Univ, Environm Futures Res Inst, Nathan, Qld 4111, Australia; [Gabaldon, Toni; Capella-Gutierrez, Salvador; Huerta-Cepas, Jaime] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona 08003, Spain; [Gabaldon, Toni; Capella-Gutierrez, Salvador; Huerta-Cepas, Jaime] Univ Pompeu Fabra, Barcelona, Spain; [Gabaldon, Toni] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Rekepalli, Bhanu] Univ Tennessee, Oak Ridge Natl Lab, Joint Inst Computat Sci, Oak Ridge, TN 37831 USA; [Munch, Kasper; Schierup, Mikkel] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus C, Denmark; [Warren, Wesley C.] Washington Univ, Sch Med, Genome Inst, St Louis, MI 63108 USA; [Ray, David] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Ray, David] Mississippi State Univ, Inst Gen Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Ray, David] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Green, Richard E.; Shapiro, Beth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Bruford, Michael W.; Zhan, Xiangjiang] Cardiff Univ, Cardiff Sch Biosci, Organisms & Environm Div, Cardiff CF10 3AX, S Glam, Wales; [Zhan, Xiangjiang] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing 100101, Peoples R China; [Dixon, Andrew] Int Wildlife Consultants, Carmarthen SA33 5YL, Dyfed, Wales; [Li, Ning; Huang, Yinhua] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Derryberry, Elizabeth P.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Derryberry, Elizabeth P.; Sheldon, Frederick H.; Brumfield, Robb T.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Derryberry, Elizabeth P.; Sheldon, Frederick H.; Brumfield, Robb T.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Bertelsen, Mads Frost] Ctr Zoo & Wild Anim Hlth, DK-2000 Frederiksberg, Denmark; [Mello, Claudio V.; Lovell, Peter V.; Wirthlin, Morgan] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; [Mello, Claudio V.; Cruz Schneider, Maria Paula; Prosdocimi, Francisco] Fed Univ Para, Brazilian Avian Genome Consortium CNPq FAPESPA SI, BR-66059 Belem, Para, Brazil; [Cruz Schneider, Maria Paula] Fed Univ Para, Inst Biol Sci, BR-66059 Belem, Para, Brazil; [Prosdocimi, Francisco] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil; [Petersen, Bent; Sicheritz-Ponten, Thomas] Tech Univ, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Pas, An] Breeding Ctr Endangered Arabian Wildlife, Sharjah, U Arab Emirates; [Bailey, Tom] Dubai Falcon Hosp, Dubai, U Arab Emirates; [Scofield, Paul] Canterbury Museum, Christchurch 8050, New Zealand; [Bunce, Michael; Gilbert, M. Thomas P.] Curtin Univ, Dept Environm & Agr, Trace & Environm DNA Lab, Perth, WA 6102, Australia; [Zhou, Qi] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Perelman, Polina] NCI, Lab Genom Div, Frederick, MD 21702 USA; [Perelman, Polina] SB RAS, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Perelman, Polina] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Driskell, Amy C.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20013 USA; [Yang, Huanming; Wang, Jian; Jun, Wang] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Rheindt, Frank E.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Braun, Michael] Natl Museum Nat Hist, Dept Vertebrate Zool, Smithsonian Suitland, MD 20746 USA; [Fjeldsa, Jon; Jonsson, Knud Andreas; Rahbek, Carsten; Graves, Gary R.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen O, Denmark; [Barker, F. Keith] Univ Minnesota, Bell Museum Nat Hist, St Paul, MN 55108 USA; [Jonsson, Knud Andreas] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Jonsson, Knud Andreas; Rahbek, Carsten] Imperial Coll London, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Johnson, Warren] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA; [Koepfli, Klaus-Peter] Smithsonian Conservat Biol Inst, Washington, DC 20008 USA; [O'Brien, Stephen] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bioinformat, St Petersburg 199004, Russia; [O'Brien, Stephen] Nova SE Univ, Oceanog Ctr, Ft Lauderdale, FL 33004 USA; [Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Ryder, Oliver A.] San Diego Zoo Inst Conservat Res, Escondido, CA 92027 USA; [Graves, Gary R.] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, MRC 116, Washington, DC 20013 USA; [Glenn, Travis C.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA; [McCormack, John] Occidental Coll, Moore Lab Zool, Los Angeles, CA 90041 USA; [McCormack, John] Occidental Coll, Dept Biol, Los Angeles, CA 90041 USA; [Burt, Dave] Univ Edinburgh, Roslin Inst, Dept Genom & Genet, Roslin EH25 9RG, Midlothian, Scotland; [Burt, Dave] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9RG, Midlothian, Scotland; [Alstrom, Per] Swedish Univ Agr Sci, Swedish Species Informat Ctr, SE-75007 Uppsala, Sweden; [Alstrom, Per] Chinese Acad Sci, Inst Zool, Key Lab Zool Syst & Evolut, Beijing 100101, Peoples R China; [Edwards, Scott V.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Edwards, Scott V.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Stamatakis, Alexandros] Karlsruhe Inst Technol, Inst Theoret Informat, Dept Informat, D-76131 Karlsruhe, Germany; [Mindell, David P.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Cracraft, Joel] Amer Museum Nat Hist, Dept Ornithol, New York, NY 10024 USA; [Braun, Edward L.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Braun, Edward L.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Warnow, Tandy] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Warnow, Tandy] Univ Illinois, Dept Comp Sci, Urbana, IL 61801 USA; [Jun, Wang] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Jun, Wang] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21589, Saudi Arabia; [Jun, Wang] Macau Univ Sci & Technol, Taipa 999078, Macau, Peoples R China; [Jun, Wang] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Zhang, Guojie] Univ Copenhagen, Dept Biol, Ctr Social Evolut, DK-2100 Copenhagen, Denmark	Duke University; Howard Hughes Medical Institute; Duke University; University of Texas System; University of Texas Austin; Heidelberg Institute for Theoretical Studies; Beijing Genomics Institute (BGI); Xi'an Jiaotong University; University of Copenhagen; New Mexico State University; University of Sydney; University of California System; University of California Los Angeles; Louisiana State University System; Louisiana State University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Uppsala University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; Griffith University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; Aarhus University; Washington University (WUSTL); Mississippi State University; Mississippi State University; Texas Tech University System; Texas Tech University; University of California System; University of California Santa Cruz; Cardiff University; Chinese Academy of Sciences; Institute of Zoology, CAS; China Agricultural University; Tulane University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Oregon Health & Science University; Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA); Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Rio de Janeiro; Technical University of Denmark; Curtin University; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Russian Academy of Sciences; Novosibirsk State University; Smithsonian Institution; Smithsonian National Museum of Natural History; Beijing Genomics Institute (BGI); National University of Singapore; University of Copenhagen; University of Minnesota System; University of Minnesota Twin Cities; Natural History Museum London; Imperial College London; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Saint Petersburg State University; Nova Southeastern University; University of California System; University of California Santa Cruz; Zoological Society of San Diego; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Georgia; University of Georgia; Occidental College; Occidental College; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Swedish University of Agricultural Sciences; Chinese Academy of Sciences; Institute of Zoology, CAS; Harvard University; Harvard University; Helmholtz Association; Karlsruhe Institute of Technology; University of California System; University of California San Francisco; American Museum of Natural History (AMNH); State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Copenhagen; King Abdulaziz University; Macau University of Science & Technology; University of Hong Kong; University of Copenhagen	Jarvis, ED (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA.	jarvis@neuro.duke.edu; tandywarnow@gmail.com; wangj@genomics.cn; mtpgilbert@gmail.com; zhanggj@genomics.cn	Burt, David W/C-7802-2013; Schierup, Mikkel H/F-1675-2010; Brumfield, Robb T/K-6108-2015; Campos, Paula/ABF-9898-2021; da Fonseca, Rute R/F-9143-2013; Willerslev, Eske/A-9619-2011; Faircloth, Brant C/Y-3978-2019; Capella-Gutierrez, Salvador/H-5053-2015; Willerslev, Eske/AAA-5686-2019; Barker, Keith/K-2795-2012; Alström, Per/C-1619-2015; Ganesh, Dunna Sai/AGX-5170-2022; Prosdocimi, Francisco/F-6847-2012; Ho, Igor Osorio/AAG-8616-2020; Zhang, Guojie/B-6188-2014; Jarvis, Erich D/A-2319-2008; Samaniego Castruita, José Alfredo/B-9033-2015; Zhang, Guojie/J-7273-2019; OBRIEN, STEPHEN/ABD-1346-2020; Gilbert, Marcus TP/A-8936-2013; Perelman, Polina/N-8088-2015; Schierup, Mikkel Heide/AAM-4997-2020; Koepfli, Klaus-Peter/AAT-9320-2020; Rahbek, Carsten/L-1129-2013; Gabaldón, Toni/A-7336-2008; Bruford, Michael W/D-3750-2009; Subramanian, Sankar/B-6647-2008; Scofield, R. Paul/A-4271-2011; Bertelsen, Mads/AAA-5746-2022; Jønsson, Knud/GMW-5310-2022; Narula, Nitish/G-5784-2015; Nabholz, Benoit/AAE-2864-2021; Alfaro-Núñez, Alonzo/H-2972-2019; Fjeldså, Jon/A-9699-2013; Huerta-Cepas, Jaime/H-5093-2013; Perelman, Polina/AAD-9030-2019; Graves, Gary R/P-1003-2017; Prosdocimi, Francisco/V-5252-2019; Bruford, Michael/Y-7463-2019; Wirthlin, Morgan/AAE-4119-2020; Glenn, Travis C/A-2390-2008; Campos, Paula F/B-1634-2010; Jonsson, Knud A/F-6902-2012; Stamatakis, Alexandros/B-8740-2009; Orlando, Ludovic/A-8932-2013; Edwards, Scott V./D-9071-2018; Ho, Simon YW/A-8417-2008; Munch, Kasper/A-1434-2010; Johnson, Warren/D-4149-2016; Wang, Jun/B-9503-2016; Weber, Claudia/F-4884-2010; Wang, Jun/C-8434-2016; Sicheritz-Ponten, Thomas/A-4325-2017	Burt, David W/0000-0002-9991-1028; Schierup, Mikkel H/0000-0002-5028-1790; Brumfield, Robb T/0000-0003-2307-0688; da Fonseca, Rute R/0000-0002-2805-4698; Willerslev, Eske/0000-0002-7081-6748; Capella-Gutierrez, Salvador/0000-0002-0309-604X; Barker, Keith/0000-0001-7488-2470; Alström, Per/0000-0001-7182-2763; Prosdocimi, Francisco/0000-0002-6761-3069; Zhang, Guojie/0000-0001-6860-1521; Jarvis, Erich D/0000-0001-8931-5049; Samaniego Castruita, José Alfredo/0000-0001-5904-1198; Zhang, Guojie/0000-0001-6860-1521; Gilbert, Marcus TP/0000-0002-5805-7195; Perelman, Polina/0000-0002-0982-5100; Schierup, Mikkel Heide/0000-0002-5028-1790; Rahbek, Carsten/0000-0003-4585-0300; Gabaldón, Toni/0000-0003-0019-1735; Bruford, Michael W/0000-0001-6357-6080; Subramanian, Sankar/0000-0002-2375-3254; Scofield, R. Paul/0000-0002-7510-6980; Bertelsen, Mads/0000-0001-9201-7499; Jønsson, Knud/0000-0002-1875-9504; Narula, Nitish/0000-0002-8309-8642; Alfaro-Núñez, Alonzo/0000-0002-4050-5041; Fjeldså, Jon/0000-0003-0790-3600; Huerta-Cepas, Jaime/0000-0003-4195-5025; Perelman, Polina/0000-0002-0982-5100; Graves, Gary R/0000-0003-1406-5246; Prosdocimi, Francisco/0000-0002-6761-3069; Bruford, Michael/0000-0001-6357-6080; Wirthlin, Morgan/0000-0001-7967-7070; Glenn, Travis C/0000-0001-7725-3637; Campos, Paula F/0000-0003-1285-4671; Stamatakis, Alexandros/0000-0003-0353-0691; Orlando, Ludovic/0000-0003-3936-1850; Edwards, Scott V./0000-0003-2535-6217; Ho, Simon YW/0000-0002-0361-2307; Munch, Kasper/0000-0003-2880-6252; Suh, Alexander/0000-0002-8979-9992; Smeds, Linnea/0000-0002-8415-9259; LIU, Shiping/0000-0003-0019-619X; OBRIEN, STEPHEN/0000-0001-7857-0757; Vargas Velazquez, Amhed Missael/0000-0001-7692-0012; Huang, Yinhua/0000-0001-5714-2403; Johnson, Warren/0000-0002-5954-186X; Li, Cai/0000-0001-7843-2151; Petersen, Bent/0000-0002-2472-8317; Wang, Jun/0000-0002-2113-5874; Xiong, Zijun/0000-0003-3923-0703; Weber, Claudia/0000-0002-5910-8898; Braun, Edward/0000-0003-1643-5212; Faircloth, Brant/0000-0002-1943-0217; Bunce, Michael/0000-0002-0302-4206; Mirarab, Siavash/0000-0001-5410-1518; Mello, Claudio/0000-0002-9826-8421; Shapiro, Beth/0000-0002-2733-7776; Howard, Jason/0000-0003-3265-5127; Green, Richard/0000-0003-0516-5827; Wang, Jun/0000-0002-8540-8931; Boussau, Bastien/0000-0003-0776-4460; Lambert, David/0000-0002-5821-3637; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Derryberry, Elizabeth/0000-0002-8248-9748	BGI; NIH [DP1OD000448]; HHMI; Marie Curie International Incoming Fellowship [300837]; NSF [DEB 0733029, DBI 1062335]; NSF IR/D program; Danish National Research Foundation [DNRF94]; Lundbeck Foundation [R52-A5062]; Villum Fonden [00007370] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM092842] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000448] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0841821] Funding Source: National Science Foundation; ICREA Funding Source: Custom	BGI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Marie Curie International Incoming Fellowship(European Commission); NSF(National Science Foundation (NSF)); NSF IR/D program; Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Villum Fonden(Villum Fonden); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); ICREA(ICREA)	Genome assemblies, annotations, alignments, tree files, and other data sets used or generated in this study are available at GigaScience, the National Center for Biotechnology Information (NCBI), ENSEMBL, CoGe, UCSC, and other sources listed in SM13 (table S17). We thank S. Edmunds at GigaScience, K. Pruit at NCBI, and P. Flicek at ENSEMBL for making this possible. The majority of genome sequencing and annotation was supported by internal funding from BGI. Additional major support is from the coordinators of the project: E.D.J. from the HHMI and NIH Directors Pioneer Award DP1OD000448; S.M. from an HHMI International Student Fellowship; G.Z. from Marie Curie International Incoming Fellowship grant (300837); T.W. from NSF DEB 0733029, NSF DBI 1062335, and NSF IR/D program; and M.T.P.G. from a Danish National Research Foundation grant (DNRF94) and a Lundbeck Foundation grant (R52-A5062). J. Fjeldsa generated the bird drawings used in the figures. O.A.R. acknowledges a uniform biological material transfer agreement between San Diego Zoo Global and BGI used for some tissue samples. R.E.G. declares that he is President of Dovetail Genomics, with no conflicts of interest. Additional acknowledgements are listed in the supplementary materials. We thank the following for allowing us to conduct the computationally intensive analyses for this study: Heidelberg Institute for Theoretical Studies; San Diego Supercomputer Center, with support by an NSF grant; SuperMUC Petascale System at the Leibniz Supercomputing Center; Technical University of Denmark; Texas Advanced Computing Center; Georgia Advanced Computing Resource Center, a partnership between the University of Georgia's Office of the Vice President for Research and Office of the Vice President for Information Technology; Amazon Web Services; BGI; the Nautilus supercomputer at the National Institute for Computational Sciences of the University of Tennessee and Smithsonian; and Duke University Institute for Genome Sciences and Policy.	Alfoldi J, 2013, GENOME RES, V23, P1063, DOI 10.1101/gr.157503.113; Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Alvarenga Herculano M.F., 2003, Pap. Avulsos Zool. (São Paulo), V43, P55, DOI 10.1590/S0031-10492003000400001; Avise JC, 2008, SYST BIOL, V57, P503, DOI 10.1080/10635150802164587; Bayzid MS, 2013, BIOINFORMATICS, V29, P2277, DOI 10.1093/bioinformatics/btt394; Benton MJ, 2010, PHILOS T R SOC B, V365, P3667, DOI 10.1098/rstb.2010.0269; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Chojnowski JL, 2008, GENE, V410, P89, DOI 10.1016/j.gene.2007.11.016; Clarke JA, 2005, NATURE, V433, P305, DOI 10.1038/nature03150; Clayton DF, 2009, CURR BIOL, V19, pR865, DOI 10.1016/j.cub.2009.07.006; Cohen K.M., 2013, INT CHRONOSTRATIGRAP; Cracraft Joel, 2013, pxxi; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Dickinson E. C., 2013, HOWARD MOORE COMPLET; dos Reis M, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1003; dos Reis M, 2011, MOL BIOL EVOL, V28, P2161, DOI 10.1093/molbev/msr045; Edwards AWF, 2009, GENETICS, V183, P5, DOI 10.1534/genetics.109.107847; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Ericson PGP, 2012, J BIOGEOGR, V39, P813, DOI 10.1111/j.1365-2699.2011.02650.x; Fain MG, 2004, EVOLUTION, V58, P2558; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; Felsenstein J., 2004, INFERRING PHYLOGENIE; FORBESWATSON AD, 1967, IBIS, V109, P425, DOI 10.1111/j.1474-919X.1967.tb04015.x; Ganapathy G, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-11; Green RE, 2014, SCIENCE, V346, P1335, DOI 10.1126/science.1254449; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Haddrath O, 2012, P ROY SOC B-BIOL SCI, V279, P4617, DOI 10.1098/rspb.2012.1630; Han KL, 2011, SYST BIOL, V60, P375, DOI 10.1093/sysbio/syq100; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HOUDE P, 1986, NATURE, V324, P563, DOI 10.1038/324563a0; Houde P., 1992, NATURAL HIST MUSEUM, V36, P137; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Huerta-Cepas J, 2014, NUCLEIC ACIDS RES, V42, pD897, DOI 10.1093/nar/gkt1177; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kim J, 2000, MOL PHYLOGENET EVOL, V17, P58, DOI 10.1006/mpev.2000.0816; Kimball RT, 2013, MOL PHYLOGENET EVOL, V69, P1021, DOI 10.1016/j.ympev.2013.05.029; Kroodsma D, 2013, WILSON J ORNITHOL, V125, P1; Ksepka DT, 2012, PALEOBIOLOGY, V38, P112, DOI 10.1666/10059.1; Lee MSY, 2014, SYST BIOL, V63, P442, DOI 10.1093/sysbio/syt110; Lemmon EM, 2013, ANNU REV ECOL EVOL S, V44, P99, DOI 10.1146/annurev-ecolsys-110512-135822; Li C, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-27; Li SB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0557-1; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Liu K, 2009, SCIENCE, V324, P1561, DOI 10.1126/science.1171243; Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Longrich NR, 2011, P NATL ACAD SCI USA, V108, P15253, DOI 10.1073/pnas.1110395108; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mahmood MT, 2014, GENOME BIOL EVOL, V6, P326, DOI 10.1093/gbe/evu016; Matzke A, 2012, MOL BIOL EVOL, V29, P1497, DOI 10.1093/molbev/msr319; Mayr G., 2009, PALEOGENE FOSSIL BIR, P139; Mayr G, 2013, SYST BIODIVERS, V11, P7, DOI 10.1080/14772000.2013.765521; Mayr G, 2011, J ZOOL SYST EVOL RES, V49, P58, DOI 10.1111/j.1439-0469.2010.00586.x; McCormack JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054848; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Mirarab S, 2014, SCIENCE, V346, P1337, DOI 10.1126/science.1250463; Mugal CF, 2013, MOL BIOL EVOL, V30, P1700, DOI 10.1093/molbev/mst067; Nabholz B, 2011, MOL BIOL EVOL, V28, P2197, DOI 10.1093/molbev/msr047; NOTTEBOHM F, 1972, AM NAT, V106, P116, DOI 10.1086/282756; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Olson S. L., 1980, SMITHSONIAN CONTRIB, V316, P1; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Parker J, 2013, NATURE, V502, P228, DOI 10.1038/nature12511; Patel S., 2013, J PHYLOGENETICS EVOL, V1, P9; Peters J. L., 1937, CHECK LIST BIRDS WOR; Pratt RC, 2009, MOL BIOL EVOL, V26, P313, DOI 10.1093/molbev/msn248; Ray DA, 2006, SYSTEMATIC BIOL, V55, P928, DOI 10.1080/10635150600865419; REDFORD KH, 1986, J FIELD ORNITHOL, V57, P261; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Romiguier J, 2010, GENOME RES, V20, P1001, DOI 10.1101/gr.104372.109; Rosenberg NA, 2013, MOL BIOL EVOL, V30, P2709, DOI 10.1093/molbev/mst160; Rudd MK, 2007, PLOS GENET, V3, P319, DOI 10.1371/journal.pgen.0030032; Salichos L, 2014, MOL BIOL EVOL, V31, P1261, DOI 10.1093/molbev/msu061; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Saranathan V, 2007, MOL ECOL, V16, P3689, DOI 10.1111/j.1365-294X.2007.03415.x; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Shapiro MD, 2013, SCIENCE, V339, P1063, DOI 10.1126/science.1230422; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Smith JV, 2013, SYST BIOL, V62, P35, DOI 10.1093/sysbio/sys067; Stamatakis A, 2012, BIOINFORMATICS, V28, P2064, DOI 10.1093/bioinformatics/bts309; Stamatakis A, 2013, INT PARALL DISTRIB P, P1195, DOI 10.1109/IPDPS.2013.70; Suh A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1448; Twyford AD, 2012, HEREDITY, V108, P179, DOI 10.1038/hdy.2011.68; Venditti C, 2010, NATURE, V463, P349, DOI 10.1038/nature08630; Wang N, 2012, MOL BIOL EVOL, V29, P737, DOI 10.1093/molbev/msr230; Wang Z, 2013, NAT GENET, V45, P701, DOI 10.1038/ng.2615; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Weber CC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0549-1; Weber CC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0542-8; Wolf YI, 2002, TRENDS GENET, V18, P472, DOI 10.1016/S0168-9525(02)02744-0; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Yuri Tamaki, 2013, Biology - Basel, V2, P419, DOI 10.3390/biology2010419; Zhan XJ, 2013, NAT GENET, V45, P563, DOI 10.1038/ng.2588; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385; Zhang JJ, 2012, IEEE SYM PARA DISTR, P691, DOI 10.1109/IPDPSW.2012.86	101	1145	1184	30	708	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1320	1331		10.1126/science.1253451	http://dx.doi.org/10.1126/science.1253451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504713	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000346189600036
J	Magro, R; Borg, A				Magro, Rosalie; Borg, Andrew			PICTURE QUIZ A man with generalised lymphadenopathy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AA-AMYLOIDOSIS SECONDARY; DIFFERENTIAL-DIAGNOSIS; ARTHRITIS; EFFICACY		[Magro, Rosalie; Borg, Andrew] Mater Dei Hosp, Dept Med, Msida 2090, MSD, Malta		Magro, R (corresponding author), Mater Dei Hosp, Dept Med, Msida 2090, MSD, Malta.	rosaliemagro@gmail.com						Bely M, 2000, AMYLOID, V7, P212, DOI 10.3109/13506120009146836; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; Ferrer R, 1998, AM FAM PHYSICIAN, V58, P1313; FITER J, 1995, J RHEUMATOL, V22, P569; Gottenberg JE, 2003, ARTHRITIS RHEUM, V48, P2019, DOI 10.1002/art.11163; Hawkins PN, 2002, CURR OPIN NEPHROL HY, V11, P649, DOI 10.1097/00041552-200211000-00013; Karnath B, 2005, HOSP PHYS, V7, P29; Keersmaekers T, 2009, ANN RHEUM DIS, V68, P759, DOI 10.1136/ard.2008.095505; Kyle RA, 1997, NEW ENGL J MED, V336, P1202, DOI 10.1056/NEJM199704243361702; Obici L, 2005, BBA-PROTEINS PROTEOM, V1753, P11, DOI 10.1016/j.bbapap.2005.08.014; Perfetto F, 2010, NAT REV RHEUMATOL, V6, P417, DOI 10.1038/nrrheum.2010.84; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; Uthman E., AMYLOIDOSIS	13	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2014	349								g7445	10.1136/bmj.g7445	http://dx.doi.org/10.1136/bmj.g7445			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3DU	25499577				2022-12-28	WOS:000346166700001
J	Lendrem, BD; Lendrem, DW; Gray, A; Isaacs, JD				Lendrem, Ben Alexander Daniel; Lendrem, Dennis William; Gray, Andy; Isaacs, John Dudley			CHRISTMAS 2014: GOING TO EXTREMES The Darwin Awards: sex differences in idiotic behaviour	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GENDER-DIFFERENCES; FINANCIAL RISK; EPIDEMIOLOGY; INJURIES; AGE; CHILDHOOD; CHILDREN; MEN	Sex differences in risk seeking behaviour, emergency hospital admissions, and mortality are well documented. However, little is known about sex differences in idiotic risk taking behaviour. This paper reviews the data on winners of the Darwin Award over a 20 year period (1995-2014). Winners of the Darwin Award must eliminate themselves from the gene pool in such an idiotic manner that their action ensures one less idiot will survive. This paper reports a marked sex difference in Darwin Award winners: males are significantly more likely to receive the award than females (P < 0.0001). We discuss some of the reasons for this difference.	[Lendrem, Ben Alexander Daniel] King Edward VI Sch, Morpeth NE61 1DN, England; [Lendrem, Dennis William; Isaacs, John Dudley] Newcastle Univ, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Gray, Andy] Royal Victoria Infirm, Major Trauma Ctr, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Lendrem, BD (corresponding author), King Edward VI Sch, Morpeth NE61 1DN, England.	ben.lendrem@gmail.com	Lendrem, Dennis/L-9273-2019; Lendrem, Dennis/H-2590-2013	Isaacs, John/0000-0002-6103-7056; Lendrem, Dennis/0000-0001-6268-5509	National Institute for Health Research [IS-BRC-0211-10046] Funding Source: researchfish; NIHR Newcastle Biomedical Research Centre [BH142386, BH120307, BH121055] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Newcastle Biomedical Research Centre		Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; DEHAVEN KE, 1986, AM J SPORT MED, V14, P218, DOI 10.1177/036354658601400307; Eagly A.H., 2013, SEX DIFFERENCES SOCI; Eckel CC., 2008, HDB EXPT EC RESULTS, DOI 10.1016/S1574-0722(07)00113-8; Fehr-Duda H, 2006, THEOR DECIS, V60, P283, DOI 10.1007/s11238-005-4590-0; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Giesbrecht N, 2003, DRINKING CASUALTIES; GINSBURG HJ, 1982, CHILD DEV, V53, P426, DOI 10.2307/1128985; GRATZ RR, 1979, J TRAUMA, V19, P551, DOI 10.1097/00005373-197908000-00001; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; McPherson J, 2011, WOMEN ARE VENUS MEN; Northcutt W, 2006, DARWIN AWARDS 4 INTE; Northcutt W, 2001, DARWIN AWARDS 2 UNNA; Northcutt W., 2001, DARWIN AWARDS 180 BI; Northcutt W, 2008, DARWIN AWARDS NEXT E; Northcutt W, 2010, DARWIN AWARDS COUNTD; RIVARA FP, 1982, AM J DIS CHILD, V136, P502, DOI 10.1001/archpedi.1982.03970420026004; Sapienza P, 2009, P NATL ACAD SCI USA, V106, P15268, DOI 10.1073/pnas.0907352106; SCHEIDT PC, 1995, AM J PUBLIC HEALTH, V85, P932, DOI 10.2105/AJPH.85.7.932; Singer BR, 1998, J BONE JOINT SURG BR, V80B, P243, DOI 10.1302/0301-620X.80B2.7762; SLOVIC P, 1966, CHILD DEV, V37, P169, DOI 10.1111/j.1467-8624.1966.tb05377.x	21	13	13	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2014	349								g7094	10.1136/bmj.g7094	http://dx.doi.org/10.1136/bmj.g7094			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW3DK	25500113	Green Published, hybrid			2022-12-28	WOS:000346165500002
J	Neville, R; Austin, S				Neville, Ron; Austin, Simon			CHRISTMAS 2014: ON THE WARDS, IN SURGERY The King Canute GP appointment system	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Neville, Ron; Austin, Simon] Westgate Hlth Ctr, Dundee DD2 4AD, Scotland	University of Dundee	Neville, R (corresponding author), Westgate Hlth Ctr, Dundee DD2 4AD, Scotland.	rondelnev@gmail.com						Health & Social Care Information Centre, QUAL OUTC FRAM; HM Government, HLTH SOC CAR ACT 201; Practice Management Networks, IMPR ACC RESP PAT HO	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2014	349								g7228	10.1136/bmj.g7228	http://dx.doi.org/10.1136/bmj.g7228			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3DK	25500115				2022-12-28	WOS:000346165500004
J	Campbell, JI				Campbell, Jeffrey I.			Art and the Uncertainty of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02138 USA	Harvard University; Harvard Medical School	Campbell, JI (corresponding author), Harvard Univ, Sch Med, Boston, MA 02138 USA.	jeffrey_campbell@hms.harvard.edu						Christakis N.A., 2003, SOC MED ESSAYS HONOR, P135, DOI [10.4324/9781315129891-9, DOI 10.4324/9781315129891-9]; Foucault M, 1994, ORDER THINGS ARCHAEO, P8; Fox R., 1957, STUDENT PHYSICIAN, P207; Lingard L, 2003, SOC SCI MED, V56, P603, DOI 10.1016/S0277-9536(02)00057-6; Miller A, 2013, J MED HUMANIT, V34, P433, DOI 10.1007/s10912-013-9250-8; Naghshineh S, 2008, J GEN INTERN MED, V23, P991, DOI 10.1007/s11606-008-0667-0; Ofri D, 2013, NY TIMES; Perry M, 2011, MED EDUC, V45, P141, DOI 10.1111/j.1365-2923.2010.03848.x; Wellbery C, 2010, LANCET, V375, P1686, DOI 10.1016/S0140-6736(10)60725-8	9	8	8	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2337	2339		10.1001/jama.2014.10773	http://dx.doi.org/10.1001/jama.2014.10773			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YB	25490321				2022-12-28	WOS:000346345700005
J	Curry, RH				Curry, Raymond H.			Meaningful Roles for Medical Students in the Provision of Longitudinal Patient Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Curry, RH (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, 420 E Super St,Rubloff Bldg 643, Chicago, IL 60611 USA.	rcurry@northwestern.edu	Curry, Raymond H./ABD-2043-2020	Curry, Raymond H./0000-0003-3381-0125				Association of American Medical Colleges, 2014, COR ENTR ACT ENT RES; Gorrindo P, 2014, ACAD MED, V89, P625, DOI 10.1097/ACM.0000000000000164; Grumbach K, 2014, JAMA-J AM MED ASSOC, V311, P1109, DOI 10.1001/jama.2014.705; Lin SY, 2015, J GEN INTERN MED, V30, P150, DOI 10.1007/s11606-014-3018-3; Martinez Jacqueline, 2011, Am J Public Health, V101, pe1, DOI 10.2105/AJPH.2011.300335; Norris TE, 2009, ACAD MED, V84, P902, DOI 10.1097/ACM.0b013e3181a85776; O'Neill SM, 2013, ACAD MED, V88, P1564, DOI 10.1097/ACM.0b013e3182a36bb5; Seiden SC, 2006, QUAL SAF HEALTH CARE, V15, P272, DOI 10.1136/qshc.2006.018044; Smith SE, 2013, MED EDUC, V47, P1184, DOI 10.1111/medu.12217; Vanderbilt University School of Medicine, VAND PROGR INT LEARN	10	21	21	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2335	2336		10.1001/jama.2014.16541	http://dx.doi.org/10.1001/jama.2014.16541			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW5YB	25490320				2022-12-28	WOS:000346345700004
J	Pitts, SR; Morgan, SR; Schrager, JD; Berger, TJ				Pitts, Stephen R.; Morgan, Sofie R.; Schrager, Justin D.; Berger, Todd J.			Emergency Department Resource Use by Supervised Residents vs Attending Physicians Alone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TEACHING HOSPITALS; CARE; COST; QUALITY; PATIENT	IMPORTANCE Few studies have evaluated the common assumption that graduate medical education is associated with increased resource use. OBJECTIVE To compare resources used in supervised vs attending-only visits in a nationally representative sample of patient visits to US emergency departments (EDs). DESIGN, SETTING, AND PARTICIPANTS Cross-sectional study of the National Hospital Ambulatory Medical Care Survey (2010), a probability sample of US EDs and ED visits. EXPOSURES Supervised visits, defined as visits involving both resident and attending physicians. Three ED teaching types were defined by the proportion of sampled visits that were supervised visits: nonteaching ED, minor teaching ED (half or fewer supervised visits), and major teaching ED (more than half supervised visits). MAIN OUTCOMES AND MEASURES Association of supervised visits with hospital admission, advanced imaging (computed tomography, ultrasound, or magnetic resonance imaging), any blood test, and ED length of stay, adjusted for visit acuity, demographic characteristics, payer type, and geographic region. RESULTS Of 29 182 ED visits to the 336 nonpediatric EDs in the sample, 3374 visits were supervised visits. Compared with the 25 808 attending-only visits, supervised visits were significantly associated with more frequent hospital admission (21% vs 14%; adjusted odds ratio [aOR], 1.42; 95% CI, 1.09-1.85), advanced imaging (28% vs 21%; aOR, 1.27; 95% CI, 1.06-1.51), and a longer median ED stay (226 vs 153 minutes; adjusted geometric mean ratio, 1.32; 95% CI, 1.19-1.45), but not with blood testing (53% vs 45%; aOR, 1.18; 95% CI, 0.96-1.46). Of visits to the sample of 121 minor teaching EDs, a weighted estimate of 9% were supervised visits, compared with 82% of visits to the 34 major teaching EDs. Supervised visits in major teaching EDs compared with attending-only visits were not associated with hospital admission (aOR, 1.15; 95% CI, 0.83-1.58), advanced imaging (aOR, 1.21; 95% CI, 0.96-1.53), or any blood test (aOR, 1.02; 95% CI, 0.79-1.33), but had longer ED stays (adjusted geometric mean ratio, 1.32; 95% CI, 1.14-1.53). CONCLUSIONS AND RELEVANCE In a sample of US EDs, supervised visits were associated with a greater likelihood of hospital admission and use of advanced imaging and with longer ED stays. Whether these associations are different in EDs in which more than half of visits are seen by residents requires further investigation. Copyright 2014 American Medical Association. All rights reserved.	[Pitts, Stephen R.; Morgan, Sofie R.; Schrager, Justin D.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA; [Morgan, Sofie R.] St Vincent Infirm Med Ctr, Emergency Dept, Little Rock, AR USA; [Berger, Todd J.] Univ Texas Southwestern Med Sch, Austin, TX USA	Emory University	Pitts, SR (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, 531 Asbury Circle,Annex Ste N340, Atlanta, GA 30322 USA.	srpitts@emory.edu			Emergency Care Coordination Center of the US Department of Health and Human Services	Emergency Care Coordination Center of the US Department of Health and Human Services	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. For a period during the study's inception, Dr Pitts received partial salary support through a contract with the Emergency Care Coordination Center of the US Department of Health and Human Services. Dr Schrager is currently a resident in the Emory University Emergency Medicine residency. Dr Berger is the program director for the University of Texas Southwestern Medical School Emergency Medicine residency in Austin. No other disclosures were reported.	[Anonymous], EM MED MIL PROJ; [Anonymous], 2010 NHAMCS MICR FIL; [Anonymous], DAT RES BOOK AC YEAR; Ayanian JZ, 2002, MILBANK Q, V80, P569, DOI 10.1111/1468-0009.00023; Brunetti M, 2013, J CLIN EPIDEMIOL, V66, P140, DOI 10.1016/j.jclinepi.2012.04.012; Burt Catharine W, 2004, Vital Health Stat 13, P1; Cooke M, 2010, NEW ENGL J MED, V362, P1253, DOI 10.1056/NEJMp0911502; Farnan JM, 2012, ACAD MED, V87, P428, DOI 10.1097/ACM.0b013e31824822cc; Goodman DC, 2013, HEALTH AFFAIR, V32, P1887, DOI 10.1377/hlthaff.2013.0451; Hackbarth G, 2011, NEW ENGL J MED, V364, P693, DOI 10.1056/NEJMp1012691; Hodges BD, 2012, ACAD MED, V87, P25, DOI 10.1097/ACM.0b013e318238e069; Kocher KE, 2013, MED CARE, V51, P689, DOI 10.1097/MLR.0b013e3182992c7b; Marcotte L, 2014, JAMA-J AM MED ASSOC, V312, P231, DOI 10.1001/jama.2014.6762; MCNAMARA RM, 1992, ANN EMERG MED, V21, P956, DOI 10.1016/S0196-0644(05)82935-X; Morganti KG, RAND RES REPORTS; National Center for Health Statistics CfDCaPC, REL EST; Newhouse JP, 2003, HEALTH AFFAIR, V22, P126, DOI 10.1377/hlthaff.22.6.126; Pitts SR, 2014, ACAD EMERG MED, V21, P497, DOI 10.1111/acem.12375; Pitts SR, 2010, HEALTH AFFAIR, V29, P1620, DOI 10.1377/hlthaff.2009.1026; Raven MC, 2013, JAMA-J AM MED ASSOC, V309, P1145, DOI 10.1001/jama.2013.1948; Scholer SJ, 1996, ARCH PEDIAT ADOL MED, V150, P1154, DOI 10.1001/archpedi.1996.02170360044006; Smith CD, 2012, ANN INTERN MED, V157, P284, DOI 10.7326/0003-4819-157-4-201208210-00496; Zaman O. S., 2010, AM SAFETY NET HOSP H	24	26	26	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2394	2400		10.1001/jama.2014.16172	http://dx.doi.org/10.1001/jama.2014.16172			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YB	25490330	Bronze			2022-12-28	WOS:000346345700014
J	Smith, M				Smith, Matthew			The art of medicine Another person's poison	LANCET			English	Editorial Material									[Smith, Matthew] Univ Strathclyde, Sch Humanities, Glasgow G4 0LT, Lanark, Scotland; [Smith, Matthew] Univ Strathclyde, Ctr Social Hist Hlth & Healthcare, Glasgow G4 0LT, Lanark, Scotland	University of Strathclyde; Glasgow Caledonian University; University of Strathclyde	Smith, M (corresponding author), Univ Strathclyde, Sch Humanities, Glasgow G4 0LT, Lanark, Scotland.	m.smith@strath.ac.uk		Smith, Matthew/0000-0002-9267-2124					0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2014	384	9959					2019	2020		10.1016/S0140-6736(14)62327-8	http://dx.doi.org/10.1016/S0140-6736(14)62327-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	AW6BD	25489647				2022-12-28	WOS:000346353600014
J	Chandler, C; Fairhead, J; Kelly, A; Leach, M; Martineau, F; Mokuwa, E; Parker, M; Richards, P; Wilkinson, A				Chandler, Clare; Fairhead, James; Kelly, Ann; Leach, Melissa; Martineau, Frederick; Mokuwa, Esther; Parker, Melissa; Richards, Paul; Wilkinson, Annie		Ebola Response Anthropology Platfo	Ebola: limitations of correcting misinformation	LANCET			English	Editorial Material							HEALTH; AFRICA		[Chandler, Clare; Martineau, Frederick; Parker, Melissa] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England; [Fairhead, James] Univ Sussex, Dept Anthropol, Brighton, E Sussex, England; [Kelly, Ann] Univ Exeter, Dept Sociol Philosophy & Anthropol, Exeter, Devon, England; [Leach, Melissa; Wilkinson, Annie] Inst Dev Studies, Brighton, E Sussex, England; [Mokuwa, Esther; Richards, Paul] Njala Univ, Sch Environm Sci, Njala, Sierra Leone	University of London; London School of Hygiene & Tropical Medicine; University of Sussex; University of Exeter; Njala University	Chandler, C (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England.	clare.chandler@lshtm.ac.uk		Chandler, Clare/0000-0001-6499-7522; Wilkinson, Annie/0000-0002-2114-7023; Martineau, Fred/0000-0001-7137-8252; Richards, Paul/0000-0001-5813-0228	ESRC [ES/J017620/1, ES/I021620/1, ES/M009203/1] Funding Source: UKRI; Wellcome Trust [100714] Funding Source: Medline; Economic and Social Research Council [ES/I021620/1, ES/M009203/1, ES/J017620/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Aboud FE, 2010, SOC SCI MED, V71, P1897, DOI 10.1016/j.socscimed.2010.09.002; Anoko J.N., 2014, COMMUNICATION REBELL; Centers for Disease Control and Prevention, 2014, TOG WE CAN PREV EB; Fischer M, 2014, IS SENSITISATION EFF; Forrester JD, 2014, MMWR-MORBID MORTAL W, V63, P925; Hewlett BS, 2007, EBOLA CULTURE POLITI; Jones J, 2011, J GLOB HEALTH, V1, P1; Leach MA, 2008, SOC SCI MED, V66, P2157, DOI 10.1016/j.socscimed.2008.01.039; McMahon B., 2014, AWOKO           1013, V13; Oyeyemi SO, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6178; Piot P, 2014, LANCET INFECT DIS, V14, P1034, DOI 10.1016/S1473-3099(14)70956-9; Richards P, 2014, PLOS NEGLECTED  1031, V31; The Communication Initiative, 2014, EB POEM LIV VID; World Health Organization, 2014, EB VIR DIS OUTBR RES; Yoder PS, 1997, MED ANTHROPOL Q, V11, P131, DOI 10.1525/maq.1997.11.2.131	15	77	77	3	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1275	1277		10.1016/S0140-6736(14)62382-5	http://dx.doi.org/10.1016/S0140-6736(14)62382-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25534188				2022-12-28	WOS:000352272400016
J	Naik, S; Bouladoux, N; Linehan, JL; Han, SJ; Harrison, OJ; Wilhelm, C; Conlan, S; Himmelfarb, S; Byrd, AL; Deming, C; Quinones, M; Brenchley, JM; Kong, HH; Tussiwand, R; Murphy, KM; Merad, M; Segre, JA; Belkaid, Y				Naik, Shruti; Bouladoux, Nicolas; Linehan, Jonathan L.; Han, Seong-Ji; Harrison, Oliver J.; Wilhelm, Christoph; Conlan, Sean; Himmelfarb, Sarah; Byrd, Allyson L.; Deming, Clayton; Quinones, Mariam; Brenchley, Jason M.; Kong, Heidi H.; Tussiwand, Roxanne; Murphy, Kenneth M.; Merad, Miriam; Segre, Julia A.; Belkaid, Yasmine			Commensal-dendritic-cell interaction specifies a unique protective skin immune signature	NATURE			English	Article							T-CELLS; MICROBIOTA; RESIDENT; SUBSETS; MACROPHAGES; EXPRESSION; DIVERSITY; INFECTION; CHILDREN; ANTIGENS	The skin represents the primary interface between the host and the environment. This organ is also home to trillions of microorganisms that play an important role in tissue homeostasis and local immunity(1-4). Skin microbial communities are highly diverse and can be remodelled over time or in response to environmental challenges(5-7). How, in the context of this complexity, individual commensal microorganisms may differentially modulate skin immunity and the consequences of these responses for tissue physiology remains unclear. Here we show that defined commensals dominantly affect skin immunity and identify the cellular mediators involved in this specification. In particular, colonization with Staphylococcus epidermidis induces IL-17A(+) CD8(+) T cells that home to the epidermis, enhance innate barrier immunity and limit pathogen invasion. Commensal-specific T-cell responses result from the coordinated action of skin-resident dendritic cell subsets and are not associated with inflammation, revealing that tissue-resident cells are poised to sense and respond to alterations in microbial communities. This interaction may represent an evolutionary means by which the skin immune system uses fluctuating commensal signals to calibrate barrier immunity and provide heterologous protection against invasive pathogens. These findings reveal that the skin immune landscape is a highly dynamic environment that can be rapidly and specifically remodelled by encounters with defined commensals, findings that have profound implications for our understanding of tissue-specific immunity and pathologies.	[Naik, Shruti; Bouladoux, Nicolas; Linehan, Jonathan L.; Han, Seong-Ji; Harrison, Oliver J.; Wilhelm, Christoph; Himmelfarb, Sarah; Byrd, Allyson L.; Brenchley, Jason M.; Belkaid, Yasmine] NIAID, Immun Barrier Sites Initiat, NIH, Bethesda, MD 20892 USA; [Naik, Shruti; Bouladoux, Nicolas; Linehan, Jonathan L.; Han, Seong-Ji; Harrison, Oliver J.; Wilhelm, Christoph; Himmelfarb, Sarah; Byrd, Allyson L.; Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Conlan, Sean; Byrd, Allyson L.; Deming, Clayton; Segre, Julia A.] NHGRI, Translat & Funct Genom Branch, Bethesda, MD 20892 USA; [Quinones, Mariam] NIAID, Bioinformat & Computat Biosci Branch, NIH, Bethesda, MD 20892 USA; [Brenchley, Jason M.] NIAID, Immunopathogenesis Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Kong, Heidi H.] NCI, Dermatol Branch, NIH, Bethesda, MD 20892 USA; [Tussiwand, Roxanne; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Tisch Canc Inst, New York, NY 10029 USA; [Merad, Miriam] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Washington University (WUSTL); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Belkaid, Y (corresponding author), NIAID, Immun Barrier Sites Initiat, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Kong, Heidi H/L-4856-2018; Brenchley, Jason/AAC-5085-2019; Conlan, Sean/B-4401-2008; Wilhelm, Christoph/ABE-7176-2020	Kong, Heidi H/0000-0003-4424-064X; Conlan, Sean/0000-0001-6848-3465; Wilhelm, Christoph/0000-0002-9839-0291; Belkaid, Yasmine/0000-0001-9962-3571; Tussiwand, Roxane/0000-0002-1712-868X; Himmelfarb, Sarah Talia/0000-0002-5681-1094; Brenchley, Jason/0000-0001-8357-2984; Quinones, Mariam/0000-0002-8520-5114; Harrison, Oliver/0000-0003-1515-9586; Bouladoux, Nicolas/0000-0003-1593-671X	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID); Human Frontier Science Program; NATIONAL CANCER INSTITUTE [R01CA154947, R01CA190400, ZIABC010938, R01CA173861] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001194, ZIAAI001115, U01AI095611, ZIAAI001029] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID) and by the Human Frontier Science Program (C.W.). We thank the NIAID animal facility staff, in particular A. Gozalo (isolation of S. xylosus); D. Trageser-Cesler and C. Acevedo (NIAID gnotobiotic facility); K. Holmes, C. Eigsti and E. Stregevsky (NIAID sorting facility); K. Frank and F. Stock (MALDI-TOF analysis); B. Malissen (Langerin-GFP reporter mice); H. C. Morse (Irf8<SUP>-/-</SUP> mice); D. Kaplan (Langerin-DTA mice); R. Bosselut (B2m<SUP>-/-</SUP> mice); S. B. Hopping (collection of human skin tissue samples); J. Oh, K. Lore, and the Brenchley laboratory (technical advice and reagents); and K. Beacht and L. Martins dos Santos for technical assistance. We also thank the Belkaid laboratory for critical reading of the manuscript.	Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Caux C, 2002, TRANSPLANTATION, V73, pS7, DOI 10.1097/00007890-200201151-00005; Chehoud C, 2013, P NATL ACAD SCI USA, V110, P15061, DOI 10.1073/pnas.1307855110; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Conlan S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r64; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Gozalo AS, 2010, J AM ASSOC LAB ANIM, V49, P480; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Helft J, 2010, METHODS MOL BIOL, V595, P231, DOI 10.1007/978-1-60761-421-0_15; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; LEHMANNGRUBE F, 1994, J IMMUNOL, V153, P595; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Martin DA, 2013, J INVEST DERMATOL, V133, P17, DOI 10.1038/jid.2012.194; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mittal A, 2013, VACCINE, V31, P3442, DOI 10.1016/j.vaccine.2012.12.048; Mose M, 2013, EXP DERMATOL, V22, P476, DOI 10.1111/exd.12187; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Murphy KM, 2013, ADV IMMUNOL, V120, P239, DOI 10.1016/B978-0-12-417028-5.00009-0; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; Rittig MG, 1998, INFECT IMMUN, V66, P4331; Sanford JA, 2013, SEMIN IMMUNOL, V25, P370, DOI 10.1016/j.smim.2013.09.005; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	38	438	448	4	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					104	U244		10.1038/nature14052	http://dx.doi.org/10.1038/nature14052			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25539086	Green Accepted			2022-12-28	WOS:000352027700046
J	Piper, MA; Evans, CV; Burda, BU; Margolis, KL; O'Connor, E; Whitlock, EP				Piper, Margaret A.; Evans, Corinne V.; Burda, Brittany U.; Margolis, Karen L.; O'Connor, Elizabeth; Whitlock, Evelyn P.			Diagnostic and Predictive Accuracy of Blood Pressure Screening Methods With Consideration of Rescreening Intervals: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							WHITE-COAT HYPERTENSION; 10-YEAR FOLLOW-UP; CARDIOVASCULAR RISK; INCIDENT HYPERTENSION; MASKED HYPERTENSION; PROGNOSTIC VALUE; GENERAL-POPULATION; LABELING PATIENTS; AUTOMATED OFFICE; OLDER PATIENTS	Background: Elevated blood pressure (BP) is the largest contributing risk factor to all-cause and cardiovascular mortality. Purpose: To update a systematic review on the benefits and harms of screening for high BP in adults and to summarize evidence on rescreening intervals and diagnostic and predictive accuracy of different BP methods for cardiovascular events. Data Sources: Selected databases searched through 24 February 2014. Study Selection: Fair-and good-quality trials and diagnostic accuracy and cohort studies conducted in adults and published in English. Data Extraction: One investigator abstracted data, and a second checked for accuracy. Study quality was dual-reviewed. Data Synthesis: Ambulatory BP monitoring (ABPM) predicted long-term cardiovascular outcomes independently of office BP (hazard ratio range, 1.28 to 1.40, in 11 studies). Across 27 studies, 35% to 95% of persons with an elevated BP at screening remained hypertensive after nonoffice confirmatory testing. Cardiovascular outcomes in persons who were normotensive after confirmatory testing (isolated clinic hypertension) were similar to outcomes in those who were normotensive at screening. In 40 studies, hypertension incidence after rescreening varied considerably at each yearly interval up to 6 years. Intrastudy comparisons showed at least 2-fold higher incidence in older adults, those with high-normal BP, overweight and obese persons, and African Americans. Limitation: Few diagnostic accuracy studies of office BP methods and protocols in untreated adults. Conclusion: Evidence supports ABPM as the reference standard for confirming elevated office BP screening results to avoid misdiagnosis and overtreatment of persons with isolated clinic hypertension. Persons with BP in the high-normal range, older persons, those with an above-normal body mass index, and African Americans are at higher risk for hypertension on rescreening within 6 years than are persons without these risk factors.	[Piper, Margaret A.; Evans, Corinne V.; Burda, Brittany U.; O'Connor, Elizabeth; Whitlock, Evelyn P.] Kaiser Permanente Ctr Hlth Res, Portland, OR 97227 USA; [Margolis, Karen L.] HealthPartners Inst Educ & Res, Minneapolis, MN 55440 USA	Kaiser Permanente	Piper, MA (corresponding author), Kaiser Permanente Ctr Hlth Res, 3800 North Interstate Ave, Portland, OR 97227 USA.			Piper, Margaret/0000-0002-6231-9653; Margolis, Karen/0000-0003-1862-7402	AHRQ [HHSA-290-2012-00151-I]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By contract HHSA-290-2012-00151-I, Task Order no. 2 from the AHRQ.	AMELING EH, 1991, J CARDIOVASC PHARM, V18, P752, DOI 10.1097/00005344-199111000-00014; Andreadis EA, 2012, BLOOD PRESS MONIT, V17, P24, DOI 10.1097/MBP.0b013e3283503760; APOSTOLIDES AY, 1982, PREV MED, V11, P487, DOI 10.1016/0091-7435(82)90063-9; Arima H, 2002, J CLIN EPIDEMIOL, V55, P863, DOI 10.1016/S0895-4356(02)00441-9; Asayama K, 2006, HYPERTENSION, V48, P737, DOI 10.1161/01.HYP.0000240332.01877.11; Aylett M, 2001, J HUM HYPERTENS, V15, P131, DOI 10.1038/sj.jhh.1001133; Bakx C, 1997, J HUM HYPERTENS, V11, P439, DOI 10.1038/sj.jhh.1000470; BAKX JC, 1987, FAM PRACT, V4, P11, DOI 10.1093/fampra/4.1.11; Bobrie G, 2004, JAMA-J AM MED ASSOC, V291, P1342, DOI 10.1001/jama.291.11.1342; Boyko EJ, 2008, J HUM HYPERTENS, V22, P168, DOI 10.1038/sj.jhh.1002316; Brantsma AH, 2006, J AM SOC NEPHROL, V17, P331, DOI 10.1681/ASN.2005111153; Burgess SE, 2011, J AM SOC HYPERTENS, V5, P484, DOI 10.1016/j.jash.2011.08.007; Cacciolati C, 2013, J HYPERTENS, V31, P680, DOI 10.1097/HJH.0b013e32835ee0ca; Calonge N, 2007, ANN INTERN MED, V147, P783, DOI 10.7326/0003-4819-147-11-200712040-00009; Celis H, 2002, BLOOD PRESSURE, V11, P352, DOI 10.1080/080370502321095311; Cheung BMY, 2012, J HUM HYPERTENS, V26, P108, DOI 10.1038/jhh.2010.125; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; Cuspidi C, 2011, BLOOD PRESSURE, V20, P335, DOI 10.3109/08037051.2011.587280; Dernellis J, 2005, HYPERTENSION, V45, P426, DOI 10.1161/01.HYP.0000157818.58878.93; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Everson SA, 2000, HYPERTENSION, V35, P561, DOI 10.1161/01.HYP.35.2.561; Fagard RH, 2005, J HUM HYPERTENS, V19, P801, DOI 10.1038/sj.jhh.1001903; FagotCampagna A, 1997, INT J EPIDEMIOL, V26, P542, DOI 10.1093/ije/26.3.542; Fitchett G, 2009, ANN BEHAV MED, V37, P257, DOI 10.1007/s12160-009-9110-y; Fogari, 1996, Blood Press Monit, V1, P51; Gasowski J, 2008, AM J HYPERTENS, V21, P994, DOI 10.1038/ajh.2008.231; Gerc V, 2000, BLOOD PRESS MONIT, V5, P203, DOI 10.1097/00126097-200008000-00002; Giubertoni E, 2013, J HYPERTENS, V31, P501, DOI 10.1097/HJH.0b013e32835c1742; Go AS, 2014, HYPERTENSION, V63, P878, DOI 10.1161/HYP.0000000000000003; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Graves JW, 2010, BLOOD PRESS MONIT, V15, P146, DOI 10.1097/MBP.0b013e328337ce76; Graves JW, 2004, AM J HYPERTENS, V17, P354, DOI 10.1016/j.amjhyper.2003.12.007; Guagnano MT, 1996, J HUM HYPERTENS, V10, P619; Gustavsen PH, 2003, J HUM HYPERTENS, V17, P811, DOI 10.1038/sj.jhh.1001643; Handler J, 2012, J CLIN HYPERTENS, V14, P751, DOI 10.1111/jch.12009; Hansen TW, 2011, HYPERTENSION, V57, P3, DOI 10.1161/HYPERTENSIONAHA.109.133900; Hansen TW, 2005, HYPERTENSION, V45, P499, DOI 10.1161/01.HYP.0000160402.39597.3b; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hartung J, 2001, STAT MED, V20, P3875, DOI 10.1002/sim.1009; HAYNES RB, 1978, NEW ENGL J MED, V299, P741, DOI 10.1056/NEJM197810052991403; Hermida RC, 2011, J AM COLL CARDIOL, V58, P1165, DOI 10.1016/j.jacc.2011.04.043; HOLLEMAN DR, 1993, J GEN INTERN MED, V8, P325, DOI 10.1007/BF02600148; Hond ED, 2003, J HYPERTENS, V21, P717, DOI 10.1097/00004872-200304000-00014; Hozawa A, 2002, HYPERTENS RES, V25, P57, DOI 10.1291/hypres.25.57; Inden Y, 1998, CLIN CARDIOL, V21, P801, DOI 10.1002/clc.4960211104; Ingelsson E, 2006, JAMA-J AM MED ASSOC, V295, P2859, DOI 10.1001/jama.295.24.2859; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Juhaeri, 2002, INT J OBESITY, V26, P58, DOI 10.1038/sj.ijo.0801846; Jung DH, 2014, DIABETES RES CLIN PR, V103, P51, DOI 10.1016/j.diabres.2013.09.018; Kaczorowski J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d442; Kahan E, 2003, FAM PRACT, V20, P730, DOI 10.1093/fampra/cmg618; Kario K, 2014, J HUM HYPERTENS, V28, P176, DOI 10.1038/jhh.2013.73; Kay L E, 1998, J Am Board Fam Pract, V11, P252; KHOURY S, 1992, AM J HYPERTENS, V5, P616, DOI 10.1093/ajh/5.9.616; Kim J, 2006, J HYPERTENS, V24, P2177, DOI 10.1097/01.hjh.0000249694.81241.7c; Kim SJ, 2011, CIRC J, V75, P135, DOI 10.1253/circj.CJ-09-0948; Kivimaki M, 2009, HYPERTENSION, V54, P496, DOI 10.1161/HYPERTENSIONAHA.109.132373; Klein Ronald, 2006, Trans Am Ophthalmol Soc, V104, P98; Kroke A, 1998, J HYPERTENS, V16, P739, DOI 10.1097/00004872-199816060-00004; Kubo T, 2013, J OCCUP ENVIRON MED, V55, P1041, DOI 10.1097/JOM.0b013e31829731fd; Lakoski SG, 2011, J HUM HYPERTENS, V25, P73, DOI 10.1038/jhh.2010.91; Lee DH, 2004, J HUM HYPERTENS, V18, P803, DOI 10.1038/sj.jhh.1001742; Lee JH, 2011, J KOREAN MED SCI, V26, P1286, DOI 10.3346/jkms.2011.26.10.1286; Lee JS, 2004, INT J OBESITY, V28, P391, DOI 10.1038/sj.ijo.0802568; Levine DA, 2011, HYPERTENSION, V57, P39, DOI 10.1161/HYPERTENSIONAHA.110.160341; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Licitra Rosaria, 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P44; Lim YH, 2014, AM J HYPERTENS, V27, P537, DOI 10.1093/ajh/hpt100; MANN AH, 1977, PSYCHOL MED, V7, P431, DOI 10.1017/S0033291700004402; Manning G, 2000, AM J HYPERTENS, V13, P1035, DOI 10.1016/S0895-7061(00)00261-2; Manning G, 1999, J HUM HYPERTENS, V13, P817, DOI 10.1038/sj.jhh.1000924; Martinez MA, 1999, AM J HYPERTENS, V12, P251, DOI 10.1016/S0895-7061(98)00262-3; Matsuo T, 2011, INT J OBESITY, V35, P1056, DOI 10.1038/ijo.2010.226; Mesquita-Bastos J, 2010, BLOOD PRESS MONIT, V15, P240, DOI 10.1097/MBP.0b013e32833c8b08; Minor DS, 2012, J CLIN HYPERTENS, V14, P222, DOI 10.1111/j.1751-7176.2012.00599.x; Morikawa Y, 1999, SCAND J WORK ENV HEA, V25, P100, DOI 10.5271/sjweh.411; Myers MG, 2010, J HYPERTENS, V28, P703, DOI 10.1097/HJH.0b013e328335d091; Nakanishi N, 2003, J CARDIOVASC RISK, V10, P213, DOI 10.1097/00043798-200306000-00010; Nasothimiou EG, 2014, J HUM HYPERTENS, V28, P224, DOI 10.1038/jhh.2013.104; Nasothimiou EG, 2012, HYPERTENS RES, V35, P750, DOI 10.1038/hr.2012.19; National Clinical Guideline Centre (UK), 2011, HYP CLIN MAN PRIM HY; Niiranen TJ, 2010, HYPERTENSION, V55, P1346, DOI 10.1161/HYPERTENSIONAHA.109.149336; Ohkubo T, 2005, J AM COLL CARDIOL, V46, P508, DOI 10.1016/j.jacc.2005.03.070; Ohkubo T, 1998, J HYPERTENS, V16, P971, DOI 10.1097/00004872-199816070-00010; Okubo Y, 2004, DRUG ALCOHOL DEPEN, V73, P167, DOI 10.1016/j.drugalcdep.2003.10.005; Okubo Y, 2014, HYPERTENSION, V63, P41, DOI 10.1161/HYPERTENSIONAHA.113.01585; Ostchega Y, 2010, J CLIN HYPERTENS, V12, P22, DOI 10.1111/j.1751-7176.2009.00199.x; Pavlik Valory N., 2000, J Clin Hypertens (Greenwich), V2, P81; Pessanha P, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-57; Peters G L, 1999, Blood Press Monit, V4, P97, DOI 10.1097/00126097-199902000-00007; Pickering Thomas G, 2005, J Clin Hypertens (Greenwich), V7, P102, DOI 10.1111/j.1524-6175.2005.04377.x; Pierdomenico SD, 2011, AM J HYPERTENS, V24, P52, DOI 10.1038/ajh.2010.203; PIERDOMENICO SD, 1995, EUR HEART J, V16, P692, DOI 10.1093/oxfordjournals.eurheartj.a060975; Pincomb GA, 1996, AM J CARDIOL, V77, P270, DOI 10.1016/S0002-9149(97)89392-7; Piper MA, 2014, SCREENING HIGH BLOOD; Radi S, 2004, J HUM HYPERTENS, V18, P487, DOI 10.1038/sj.jhh.1001682; Roush G, 2014, J AM SOC HYPERTENS, V8, pe59, DOI DOI 10.1016/J.JASH.2014.03.132; Satoh Hiroki, 2011, Environmental Health and Preventive Medicine, V16, P217, DOI 10.1007/s12199-010-0189-3; SCHERWITZ LW, 1982, MED CARE, V20, P727, DOI 10.1097/00005650-198207000-00008; Schulz M, 2005, J HUM HYPERTENS, V19, P61, DOI 10.1038/sj.jhh.1001776; Sheridan S, 2003, AM J PREV MED, V25, P151, DOI 10.1016/S0749-3797(03)00121-1; Shook RP, 2012, HYPERTENSION, V59, P1220, DOI 10.1161/HYPERTENSIONAHA.112.191676; Spruill TM, 2013, J PSYCHOSOM RES, V74, P433, DOI 10.1016/j.jpsychores.2013.01.009; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Sung KC, 2014, J HEPATOL, V60, P1040, DOI 10.1016/j.jhep.2014.01.009; Talleruphuus U, 2006, BLOOD PRESSURE, V15, P347, DOI 10.1080/08037050601103885; Tanabe P, 2008, ANN EMERG MED, V51, P221, DOI 10.1016/j.annemergmed.2007.10.017; TAYLOR DW, 1981, CLIN INVEST MED, V4, P173; Terent A, 1994, Blood Press, V3, P156, DOI 10.3109/08037059409102246; Toyama H, 2008, HYPERTENS RES, V31, P1063, DOI 10.1291/hypres.31.1063; Tozawa M, 2002, HYPERTENS RES, V25, P811; Ungar A, 2004, J HUM HYPERTENS, V18, P897, DOI 10.1038/sj.jhh.1001756; United Nations Development Programme, 2013, HUM DEV REP 2013 RIS; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Verberk WJ, 2005, J AM COLL CARDIOL, V46, P743, DOI 10.1016/j.jacc.2005.05.058; VERDECCHIA P, 1995, AM J HYPERTENS, V8, P790, DOI 10.1016/0895-7061(95)00151-E; Verdecchia P, 2007, HYPERTENSION, V49, P777, DOI 10.1161/01.HYP.0000258215.26755.20; Viera AJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-59; Viera AJ, 2010, J AM BOARD FAM MED, V23, P571, DOI 10.3122/jabfm.2010.05.100047; Volzke H, 2013, J HYPERTENS, V31, P2142, DOI 10.1097/HJH.0b013e328364a16d; Wells G., 2014, NEWCASTLE OTTAWA SCA; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Widener J, 1999, AAOHN J, V47, P107; Wolff T, 2007, ANN INTERN MED, V147, P787, DOI 10.7326/0003-4819-147-11-200712040-00010; YAMADA Y, 1991, HYPERTENSION, V18, P819, DOI 10.1161/01.HYP.18.6.819; Yambe M, 2007, J HYPERTENS, V25, P87, DOI 10.1097/01.hjh.0000254375.73241.e2; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; ZABLUDOWSKI JR, 1992, ISRAEL J MED SCI, V28, P345; Zambrana RE, 2014, AM J HYPERTENS, V27, P372, DOI 10.1093/ajh/hpt279; Zawadzka A, 1998, J HUM HYPERTENS, V12, P249, DOI 10.1038/sj.jhh.1000583; Zheng DC, 2011, ANN BIOMED ENG, V39, P2584, DOI 10.1007/s10439-011-0347-9	133	248	253	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2015	162	3					192	U101		10.7326/M14-1539	http://dx.doi.org/10.7326/M14-1539			27	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NP	25531400				2022-12-28	WOS:000350108100005
J	Gruber, N				Gruber, Nicolas			OCEAN BIOGEOCHEMISTRY Carbon at the coastal interface	NATURE			English	Editorial Material									ETH, Inst Biogeochem & Pollutant Dynam, Environm Phys Grp, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Gruber, N (corresponding author), ETH, Inst Biogeochem & Pollutant Dynam, Environm Phys Grp, CH-8092 Zurich, Switzerland.	nicolas.gruber@env.ethz.ch	Gruber, Nicolas/B-7013-2009	Gruber, Nicolas/0000-0002-2085-2310				Bakker DCE, 2014, EARTH SYST SCI DATA, V6, P69, DOI 10.5194/essd-6-69-2014; Bauer JE, 2013, NATURE, V504, P61, DOI 10.1038/nature12857; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Gruber N, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003349; Koch N, 2014, ENERG POLICY, V73, P676, DOI 10.1016/j.enpol.2014.06.024; Landschutzer P, 2014, GLOBAL BIOGEOCHEM CY, V28, P927, DOI 10.1002/2014GB004853; Laruelle G. G., 2014, GLOB BIOGEOCHEM CYCL; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/NGEO1830, 10.1038/ngeo1830]; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Tsunogai S, 1999, TELLUS B, V51, P701, DOI 10.1034/j.1600-0889.1999.t01-2-00010.x	12	47	51	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					148	149		10.1038/nature14082	http://dx.doi.org/10.1038/nature14082			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25487156	Green Published			2022-12-28	WOS:000347477600020
J	Bannuru, RR; Schmid, CH; Kent, DM; Vaysbrot, EE; Wong, JB; McAlindon, TE				Bannuru, Raveendhara R.; Schmid, Christopher H.; Kent, David M.; Vaysbrot, Elizaveta E.; Wong, John B.; McAlindon, Timothy E.			Comparative Effectiveness of Pharmacologic Interventions for Knee Osteoarthritis A Systematic Review and Network Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							HYALURONIC-ACID; RELATIVE EFFICACY; PAIN; VISCOSUPPLEMENTATION; THERAPY; TRIALS	Background: The relative efficacy of available treatments of knee osteoarthritis (OA) must be determined for rational treatment algorithms to be formulated. Purpose: To examine the efficacy of treatments of primary knee OA using a network meta-analysis design, which estimates relative effects of all treatments against each other. Data Sources: MEDLINE, EMBASE, Web of Science, Google Scholar, Cochrane Central Register of Controlled Trials from inception through 15 August 2014, and unpublished data. Study Selection: Randomized trials of adults with knee OA comparing 2 or more of the following: acetaminophen, diclofenac, ibuprofen, naproxen, celecoxib, intra-articular (IA) corticosteroids, IA hyaluronic acid, oral placebo, and IA placebo. Data Extraction: Two reviewers independently abstracted study data and assessed study quality. Standardized mean differences were calculated for pain, function, and stiffness at 3-month follow-up. Data Synthesis: Network meta-analysis was performed using a Bayesian random-effects model; 137 studies comprising 33 243 participants were identified. For pain, all interventions significantly outperformed oral placebo, with effect sizes from 0.63 (95% credible interval [CrI], 0.39 to 0.88) for the most efficacious treatment (hyaluronic acid) to 0.18 (CrI, 0.04 to 0.33) for the least efficacious treatment (acetaminophen). For function, all interventions except IA corticosteroids were significantly superior to oral placebo. For stiffness, most of the treatments did not significantly differ from one another. Limitation: Lack of long-term data, inadequate reporting of safety data, possible publication bias, and few head-to-head comparisons. Conclusion: This method allowed comparison of common treatments of knee OA according to their relative efficacy. Intra-articular treatments were superior to nonsteroidal anti-inflammatory drugs, possibly because of the integrated IA placebo effect. Small but robust differences were observed between active treatments. All treatments except acetaminophen showed clinically significant improvement from baseline pain. This information, along with the safety profiles and relative costs of included treatments, will be helpful for individualized patient care decisions.	[Bannuru, Raveendhara R.; Vaysbrot, Elizaveta E.; McAlindon, Timothy E.] Tufts Med Ctr, Div Rheumatol, Ctr Treatment Comparison & Integrat Anal, Boston, MA 02111 USA; [Kent, David M.; Wong, John B.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Schmid, Christopher H.] Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA	Tufts Medical Center; Tufts Medical Center; Brown University	Bannuru, RR (corresponding author), Tufts Med Ctr, Div Rheumatol, Ctr Treatment Comparison & Integrat Anal, 800 Washington St,Box 406, Boston, MA 02111 USA.	rbannuru@tuftsmedicalcenter.org	Schmid, Christopher H./J-2398-2014; Bannuru, Raveendhara/G-2601-2011	Schmid, Christopher H./0000-0002-0855-5313; Bannuru, Raveendhara/0000-0002-8069-5783; Wong, John/0000-0003-4203-9010	Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018574, F32HS021396] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	[Anonymous], 1995, INCIDENCE PREVALENCE, P592; Arroll B, 2004, BMJ-BRIT MED J, V328, P869, DOI 10.1136/bmj.38039.573970.7C; Baker Stuart G, 2002, BMC Med Res Methodol, V2, P13, DOI 10.1186/1471-2288-2-13; Bannuru RR, 2011, OSTEOARTHR CARTILAGE, V19, P611, DOI 10.1016/j.joca.2010.09.014; Bannuru RR, 2014, SEMIN ARTHRITIS RHEU, V43, P593, DOI 10.1016/j.semarthrit.2013.10.002; Bannuru RR, 2009, ARTHRIT RHEUM-ARTHR, V61, P1704, DOI 10.1002/art.24925; Bellamy N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005321.pub2; Bellamy N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005328; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cooper NJ, 2009, STAT MED, V28, P1861, DOI 10.1002/sim.3594; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2013, MED DECIS MAKING, V33, P597, DOI 10.1177/0272989X13487604; Dias S, 2013, MED DECIS MAKING, V33, P618, DOI 10.1177/0272989X13485157; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Franchini AJ, 2012, RES SYNTH METHODS, V3, P142, DOI 10.1002/jrsm.1049; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Gulen H, 2009, ORAL SURG ORAL MED O, V107, pE1, DOI 10.1016/j.tripleo.2009.02.006; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Juhl C, 2012, ARTHRITIS, DOI 10.1155/2012/136245; Kirwan JR, 1997, BAILLIERE CLIN RHEUM, V11, P769, DOI 10.1016/S0950-3579(97)80009-X; KOSOROK MR, 1992, AM J PUBLIC HEALTH, V82, P1263, DOI 10.2105/AJPH.82.9.1263; Lee C, 2005, ARTHRIT RHEUM-ARTHR, V53, P510, DOI 10.1002/art.21328; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Meng QS., 2019, THESIS CHANGCHUN U C; Orwin R.G., 1994, HDB RES SYNTHESIS; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P389, DOI 10.1016/j.joca.2004.02.001; Rutjes AWS, 2012, ANN INTERN MED, V157, P180, DOI 10.7326/0003-4819-157-3-201208070-00473; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Smith TC, 1995, STAT MED, V14, P2685, DOI 10.1002/sim.4780142408; Stam Wb, 2012, Open Rheumatol J, V6, P6, DOI 10.2174/1874312901206010006; Thorlund K, 2011, RES SYNTH METHODS, V2, P188, DOI 10.1002/jrsm.46; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; White AG, 2008, J OCCUP ENVIRON MED, V50, P998, DOI 10.1097/JOM.0b013e3181715111; Zhang RX, 2013, OSTEOARTHR CARTILAGE, V21, P1308, DOI 10.1016/j.joca.2013.06.013; Zhang W, 2004, ANN RHEUM DIS, V63, P901, DOI 10.1136/ard.2003.018531	39	373	395	5	118	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2015	162	1					46	U189		10.7326/M14-1231	http://dx.doi.org/10.7326/M14-1231			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1LU	25560713				2022-12-28	WOS:000350103000006
J	Maron, BJ; Winkel, BG; Tfelt-Hansen, J				Maron, Barry J.; Winkel, Bo Gregers; Tfelt-Hansen, Jacob			Perspectives on Cardiovascular Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SUDDEN CARDIAC DEATH; OF-CARDIOLOGY; ASSOCIATION; NATIONWIDE; STATEMENT		[Maron, Barry J.] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN 55407 USA; [Winkel, Bo Gregers; Tfelt-Hansen, Jacob] Univ Copenhagen, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, DK-1168 Copenhagen, Denmark; [Winkel, Bo Gregers; Tfelt-Hansen, Jacob] Copenhagen Univ Hosp, Rigshosp, Mol Cardiol Lab, Dept Cardiol,Heart Ctr, Copenhagen, Denmark	Minneapolis Heart Institute Foundation; Danmarks Grundforskningsfond; University of Copenhagen; Rigshospitalet; University of Copenhagen	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, 920 E 28th St, Minneapolis, MN 55407 USA.	hcm.maron@mhif.org	Tfelt-Hansen, Jacob/AAU-8691-2020; Winkel, Bo/AAZ-9190-2021	Tfelt-Hansen, Jacob/0000-0003-3895-9316; Winkel, Bo Gregers/0000-0002-3063-4712				Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Maron BJ, 2014, CIRCULATION, V130, P1303, DOI 10.1161/CIR.0000000000000025; Maron BJ, 2009, AM J CARDIOL, V104, P276, DOI 10.1016/j.amjcard.2009.03.037; Risgaard B, 2014, HEART RHYTHM, V11, P1673, DOI 10.1016/j.hrthm.2014.05.026; Statistics Denmark, POPULATIONS AND ELEC; Thiene G, 2013, HEART, V99, P304, DOI 10.1136/heartjnl-2012-302411; Winkel BG, 2011, EUR HEART J, V32, P983, DOI 10.1093/eurheartj/ehq428; Wissenberg M, 2013, JAMA-J AM MED ASSOC, V310, P1377, DOI 10.1001/jama.2013.278483	8	23	23	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					31	32		10.1001/jama.2014.16253	http://dx.doi.org/10.1001/jama.2014.16253			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25562261				2022-12-28	WOS:000347478000010
J	Burr, DM; Bridges, NT; Marshall, JR; Smith, JK; White, BR; Emery, JP				Burr, Devon M.; Bridges, Nathan T.; Marshall, John R.; Smith, James K.; White, Bruce R.; Emery, Joshua P.			Higher-than-predicted saltation threshold wind speeds on Titan	NATURE			English	Article							PARTICLE-SIZE; MARS; EARTH; FORCES; VENUS; SAND; SIMULATIONS; ROUGHNESS; TRANSPORT; SURFACES	Titan, the largest satellite of Saturn, exhibits extensive aeolian, that is, wind-formed, dunes(1,2), features previously identified exclusively on Earth, Mars and Venus. Wind tunnel data collected under ambient and planetary-analogue conditions inform our models of aeolian processes on the terrestrial planets(3,4). However, the accuracy of these widely used formulations in predicting the threshold wind speeds required to move sand by saltation, or by short bounces, has not been tested under conditions relevant for non-terrestrial planets. Here we derive saltation threshold wind speeds under the thick-atmosphere, low-gravity and low-sediment-density conditions on Titan, using a high-pressure wind tunnel(5) refurbished to simulate the appropriate kinematic viscosity for the near-surface atmosphere of Titan. The experimentally derived saltation threshold wind speeds are higher than those predicted by models based on terrestrial-analogue experiments(6,7), indicating the limitations of these models for such extreme conditions. The models can be reconciled with the experimental results by inclusion of the extremely low ratio of particle density to fluid density(8) on Titan. Whereas the density ratio term enables accurate modelling of aeolian entrainment in thick atmospheres, such as those inferred for some extrasolar planets, our results also indicate that for environments with high density ratios, such as in jets on icy satellites or in tenuous atmospheres or exospheres, the correction for low-density-ratio conditions is not required.	[Burr, Devon M.; Emery, Joshua P.] Univ Tennessee, Earth & Planetary Sci Dept, Knoxville, TN 37996 USA; [Bridges, Nathan T.] Johns Hopkins Univ, Dept Space, Appl Phys Lab, Laurel, MD 20723 USA; [Marshall, John R.] SETI Inst, Mountain View, CA 94043 USA; [Smith, James K.] Arizona State Univ, Tempe, AZ 85287 USA; [White, Bruce R.] Univ Calif Davis, Dept Mech Engn, Davis, CA 95616 USA	University of Tennessee System; University of Tennessee Knoxville; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Arizona State University; Arizona State University-Tempe; University of California System; University of California Davis	Burr, DM (corresponding author), Univ Tennessee, Earth & Planetary Sci Dept, 306 EPS Bldg,1412 Circle Dr, Knoxville, TN 37996 USA.	dburr1@utk.edu	Bridges, Nathan T/D-6341-2016		NASA	NASA(National Aeronautics & Space Administration (NASA))	This research was supported by grants from NASA's Planetary Geology and Geophysics Program and the Outer Planets Research Program. We dedicate this manuscript to our colleague R. Greeley, who was the motivating force behind the construction of the Planetary Aeolian Laboratory at the NASA Ames Research Center and used it over several decades to make fundamental and long- lasting contributions to understanding aeolian processes on other bodies.	Bagnold R.A., 1941, PHYS BLOWN SAND DESE, P1; Barnes JW, 2008, ICARUS, V195, P400, DOI 10.1016/j.icarus.2007.12.006; Burr DM, 2006, ICARUS, V181, P235, DOI 10.1016/j.icarus.2005.11.012; Charbonneau D, 2009, NATURE, V462, P891, DOI 10.1038/nature08679; Cheng AF, 2013, ICARUS, V222, P808, DOI 10.1016/j.icarus.2012.10.004; GREELEY R, 1984, ICARUS, V57, P112, DOI 10.1016/0019-1035(84)90013-7; GREELEY R, 1974, P ROY SOC LOND A MAT, V341, P331, DOI 10.1098/rspa.1974.0191; GREELEY R, 1980, GEOPHYS RES LETT, V7, P121, DOI 10.1029/GL007i002p00121; GREELEY R, 1976, GEOPHYS RES LETT, V3, P417, DOI 10.1029/GL003i008p00417; Greeley R., 1985, WIND GEOLOGICAL PROC, V4, P67; Hodges CS, 2002, LANGMUIR, V18, P5741, DOI 10.1021/la025604q; IVERSEN JD, 1987, SEDIMENTOLOGY, V34, P699, DOI 10.1111/j.1365-3091.1987.tb00795.x; IVERSEN JD, 1976, ICARUS, V29, P381, DOI 10.1016/0019-1035(76)90140-8; IVERSEN JD, 1982, SEDIMENTOLOGY, V29, P111, DOI 10.1111/j.1365-3091.1982.tb01713.x; IVERSEN JD, 1976, J GEOPHYS RES, V81, P4846, DOI 10.1029/JB081i026p04846; Jones R, 2002, LANGMUIR, V18, P8045, DOI 10.1021/la0259196; Kok JF, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/106901; Lopes RMC, 2010, ICARUS, V205, P540, DOI 10.1016/j.icarus.2009.08.010; Lorenz RD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036850; Lorenz RD, 2006, SCIENCE, V312, P724, DOI 10.1126/science.1123257; MARSHALL JR, 1992, J GEOPHYS RES-PLANET, V97, P1007, DOI 10.1029/91JE02862; Merrison JP, 2012, AEOLIAN RES, V4, P1, DOI 10.1016/j.aeolia.2011.12.003; Quintana EV, 2014, SCIENCE, V344, P277, DOI 10.1126/science.1249403; Rubin DM, 2009, NAT GEOSCI, V2, P653, DOI 10.1038/NGEO610; SAGAN C, 1990, NATURE, V346, P546, DOI 10.1038/346546a0; Scheeres DJ, 2010, ICARUS, V210, P968, DOI 10.1016/j.icarus.2010.07.009; Shao YP, 2000, J GEOPHYS RES-ATMOS, V105, P22437, DOI 10.1029/2000JD900304; Tokano T, 2010, AEOLIAN RES, V2, P113, DOI 10.1016/j.aeolia.2010.04.003; WHITE BR, 1979, J GEOPHYS RES, V84, P4643, DOI 10.1029/JB084iB09p04643	29	47	48	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					60	U137		10.1038/nature14088	http://dx.doi.org/10.1038/nature14088			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25487154				2022-12-28	WOS:000347178400034
J	Kannan, L; Figueredo, VM				Kannan, Lakshmi; Figueredo, Vincent M.			Wellens' Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kannan, Lakshmi; Figueredo, Vincent M.] Albert Einstein Med Ctr, Philadelphia, PA 19141 USA	Yeshiva University	Kannan, L (corresponding author), Albert Einstein Med Ctr, Philadelphia, PA 19141 USA.	kannanla@einstein.edu	Figueredo, Vincent/AAV-7610-2021						0	9	10	3	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2015	372	1					66	66		10.1056/NEJMicm1400946	http://dx.doi.org/10.1056/NEJMicm1400946			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX7MU	25551527				2022-12-28	WOS:000347100800011
J	Yan, Z; Bai, XC; Yan, CY; Wu, JP; Li, ZQ; Xie, T; Peng, W; Yin, CC; Li, XM; Scheres, SHW; Shi, YG; Yan, N				Yan, Zhen; Bai, Xiao-chen; Yan, Chuangye; Wu, Jianping; Li, Zhangqiang; Xie, Tian; Peng, Wei; Yin, Chang-cheng; Li, Xueming; Scheres, Sjors H. W.; Shi, Yigong; Yan, Nieng			Structure of the rabbit ryanodine receptor RyR1 at near-atomic resolution	NATURE			English	Article							CALCIUM-RELEASE CHANNEL; SARCOPLASMIC-RETICULUM; ELECTRON CRYOMICROSCOPY; TRANSMEMBRANE DOMAINS; CRYO-EM; SKELETAL; PURIFICATION; REGION; RECONSTITUTION; IDENTIFICATION	The ryanodine receptors (RyRs) are high-conductance intracellular Ca2+ channels that play a pivotal role in the excitation-contraction coupling of skeletal and cardiac muscles. RyRs are the largest known ion channels, with a homotetrameric organization and approximately 5,000 residues in each protomer. Here we report the structure of the rabbit RyR1 in complex with its modulator FKBP12 at an overall resolution of 3.8 angstrom, determined by single-particle electron cryomicroscopy. Three previously uncharacterized domains, named central, handle and helical domains, display the armadillo repeat fold. These domains, together with the amino-terminal domain, constitute a network of superhelical scaffold for binding and propagation of conformational changes. The channel domain exhibits the voltage-gated ion channel superfamily fold with distinct features. A negative-charge-enriched hairpin loop connecting S5 and the pore helix is positioned above the entrance to the selectivity-filter vestibule. The four elongated S6 segments form a right-handed helical bundle that closes the pore at the cytoplasmic border of the membrane. Allosteric regulation of the pore by the cytoplasmic domains is mediated through extensive interactions between the central domains and the channel domain. These structural features explain high ion conductance by RyRs and the long-range allosteric regulation of channel activities.	[Yan, Zhen; Li, Zhangqiang; Peng, Wei; Yan, Nieng] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Yan, Zhen; Yan, Chuangye; Wu, Jianping; Li, Zhangqiang; Xie, Tian; Peng, Wei; Li, Xueming; Shi, Yigong; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Yan, Zhen; Yan, Chuangye; Wu, Jianping; Xie, Tian; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Ministry Educ Key Lab Prot Sci, Beijing 100084, Peoples R China; [Yan, Zhen; Yan, Chuangye; Wu, Jianping; Li, Zhangqiang; Xie, Tian; Peng, Wei; Li, Xueming; Shi, Yigong; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Bai, Xiao-chen; Scheres, Sjors H. W.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Yin, Chang-cheng] Peking Univ, Dept Biophys, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Yin, Chang-cheng] Peking Univ, Ctr Prot Sci, Beijing 100191, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; MRC Laboratory Molecular Biology; Peking University; Peking University	Yan, N (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	scheres@mrc-lmb.cam.ac.uk; shi-lab@tsinghua.edu.cn; nyan@tsinghua.edu.cn	Scheres, Sjors H.W./AAY-2265-2021; Yan, Chuangye/AAJ-5832-2021; Bai, Xiao-chen/HGV-1244-2022	Scheres, Sjors H.W./0000-0002-0462-6540; Bai, Xiao-chen/0000-0002-4234-5686; Peng, Wei/0000-0001-7541-1494; Wu, Jianping/0000-0001-9869-7691; Yan, Zhen/0000-0002-1999-8451; Shi, Yigong/0000-0003-2030-168X; Yan, Chuangye/0000-0001-9338-8048; Xie, Tian/0000-0002-5445-664X	Ministry of Science and Technology of China [2015CB910101, 2011CB910501, 2014ZX09507003006]; National Natural Science Foundation of China [31321062, 31130002, 31125009]; European Union; UK Medical Research Council [MC_UP_A025_1013]; MRC [MC_UP_A025_1013] Funding Source: UKRI; Medical Research Council [MC_UP_A025_1013] Funding Source: researchfish	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Union(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funds from the Ministry of Science and Technology of China (2015CB910101, 2011CB910501 and 2014ZX09507003006), National Natural Science Foundation of China (projects 31321062, 31130002 and 31125009), a European Union Marie Curie Fellowship (to X. B.), and the UK Medical Research Council (MC_UP_A025_1013, to S. H. W. S.). The research of N. Yanwas supportedin part byanInternational Early Career Scientist grant from the Howard Hughes Medical Institute and an endowed professorship from Bayer Healthcare.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AFONINE PV, 2013, COMPUT CRYSTALLOGR N, V0004; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bhat MB, 1997, BIOPHYS J, V73, P1329, DOI 10.1016/S0006-3495(97)78166-9; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen SRW, 2002, BIOPHYS J, V82, P2436, DOI 10.1016/S0006-3495(02)75587-2; Chen Y, 2012, CELL RES, V22, P598, DOI 10.1038/cr.2012.9; CHU A, 1988, METHOD ENZYMOL, V157, P36; DeLano W.L, PYMOL MOL GRAPHICS S; Du GG, 2001, J BIOL CHEM, V276, P31760, DOI 10.1074/jbc.M102751200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENDO M, 1970, NATURE, V228, P34, DOI 10.1038/228034a0; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Fessenden JD, 2004, J BIOL CHEM, V279, P53028, DOI 10.1074/jbc.M411136200; FRANZINI.C, 1970, J CELL BIOL, V47, P488, DOI 10.1083/jcb.47.2.488; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; INUI M, 1987, J BIOL CHEM, V262, P1740; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; MacMillan D, 2013, EUR J PHARMACOL, V700, P181, DOI 10.1016/j.ejphar.2012.12.029; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Meng X, 2009, J MOL BIOL, V387, P320, DOI 10.1016/j.jmb.2009.01.059; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; PALADE P, 1983, J BIOL CHEM, V258, P8098; PESSAH IN, 1985, BIOCHEM BIOPH RES CO, V128, P449, DOI 10.1016/0006-291X(85)91699-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RADERMACHER M, 1992, BIOPHYS J, V61, P936, DOI 10.1016/S0006-3495(92)81900-8; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Ross D, 2002, CELL CALCIUM, V32, P307, DOI 10.1016/S0143-4160(02)00198-7; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; SERYSHEVA II, 1995, NAT STRUCT BIOL, V2, P18, DOI 10.1038/nsb0195-18; Serysheva II, 2008, P NATL ACAD SCI USA, V105, P9610, DOI 10.1073/pnas.0803189105; Sharma P, 2012, FEBS J, V279, P3952, DOI 10.1111/j.1742-4658.2012.08755.x; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; SMITH JS, 1986, J GEN PHYSIOL, V88, P573, DOI 10.1085/jgp.88.5.573; Szep S, 2009, PROTEINS, V74, P603, DOI 10.1002/prot.22176; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Van Petegem F., 2014, J MOL BIOL; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; WIEDERRECHT G, 1992, J BIOL CHEM, V267, P21753; XIN HB, 1995, BIOCHEM BIOPH RES CO, V214, P263, DOI 10.1006/bbrc.1995.2283; Xiong H, 1998, BIOCHEMISTRY-US, V37, P4804, DOI 10.1021/bi971198b; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Yuchi ZG, 2012, STRUCTURE, V20, P1201, DOI 10.1016/j.str.2012.04.015; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	67	306	314	15	369	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					50	+		10.1038/nature14063	http://dx.doi.org/10.1038/nature14063			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25517095	Green Accepted			2022-12-28	WOS:000347178400032
J	Maeda, Y; Nishikawa, H; Sugiyama, D; Ha, D; Hamaguchi, M; Saito, T; Nishioka, M; Wing, JB; Adeegbe, D; Katayama, I; Sakaguchi, S				Maeda, Yuka; Nishikawa, Hiroyoshi; Sugiyama, Daisuke; Ha, Danbee; Hamaguchi, Masahide; Saito, Takuro; Nishioka, Megumi; Wing, James B.; Adeegbe, Dennis; Katayama, Ichiro; Sakaguchi, Shimon			Detection of self-reactive CD8(+) T cells with an anergic phenotype in healthy individuals	SCIENCE			English	Article							CHRONIC VIRAL-INFECTION; E3 UBIQUITIN LIGASE; IN-VIVO; MOLECULAR-BASIS; LYMPHOCYTES; EXHAUSTION; CTLA-4; DIFFERENTIATION; AUTOIMMUNITY; TOLERANCE	Immunological tolerance to self requires naturally occurring regulatory T (T-reg) cells. Yet how they stably control autoimmune T cells remains obscure. Here, we show that T-reg cells can render self-reactive human CD8(+) T cells anergic (i.e., hypoproliferative and cytokine hypoproducing upon antigen restimulation) in vitro, likely by controlling the costimulatory function of antigen-presenting cells. Anergic T cells were naive in phenotype, lower than activated T cells in T cell receptor affinity for cognate antigen, and expressed several coinhibitory molecules, including cytotoxic T lymphocyte-associated antigen-4 (CTLA-4). Using these criteria, we detected in healthy individuals anergic T cells reactive with a skin antigen targeted in the autoimmune disease vitiligo. Collectively, our results suggest that T-reg cell-mediated induction of anergy in autoimmune T cells is important for maintaining self-tolerance.	[Maeda, Yuka; Nishikawa, Hiroyoshi; Sugiyama, Daisuke; Ha, Danbee; Hamaguchi, Masahide; Saito, Takuro; Nishioka, Megumi; Wing, James B.; Adeegbe, Dennis; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr IFReC WPI, Osaka 5650871, Japan; [Nishioka, Megumi; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Osaka 5650871, Japan	Osaka University; Osaka University	Sakaguchi, S (corresponding author), Osaka Univ, Immunol Frontier Res Ctr IFReC WPI, Osaka 5650871, Japan.	nisihiro@ifrec.osaka-u.ac.jp; shimon@ifrec.osaka-u.ac.jp	Nishikawa, Hiroyoshi/AAI-7044-2020; Saito, Takuro/AAN-9682-2021; Wing, James Badger/H-6256-2019; Sakaguchi, Shimon/C-9535-2009	Wing, James Badger/0000-0002-3462-1003; Adeegbe, Dennis/0000-0001-9233-3328; Hamaguchi, Masahide/0000-0002-8651-4445; Sugiyama, Daisuke/0000-0003-1490-3211; yi lang, pian shan/0000-0002-3270-1085	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20002007, 26253030, 23300354, 26290054]; Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency; Health and Labor Sciences Research Grants, Research on Applying Health Technology from the Ministry of Health, Labor, and Welfare, Japan [H24-Clinical Cancer Research-general-006]; Cancer Research Institute CLIP grant	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Health and Labor Sciences Research Grants, Research on Applying Health Technology from the Ministry of Health, Labor, and Welfare, Japan; Cancer Research Institute CLIP grant	We thank Y. Tada, K. Teshima, and Y. Funabiki for technical assistance. The data presented in this paper are tabulated in the main paper and in the supplementary materials. Microarray data are deposited in GSE63129. This study was supported by Grants-in-Aid for Specially Promoted Research (to S.S., no. 20002007) and for Scientific Research (i) (to S.S., no. 26253030) and (ii) (to H.N., no. 23300354 and 26290054) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (to S.S.); Health and Labor Sciences Research Grants, Research on Applying Health Technology (H24-Clinical Cancer Research-general-006 to H.N.) from the Ministry of Health, Labor, and Welfare, Japan, the Cancer Research Institute CLIP grant to H.N. All authors have no competing financial interest.	Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Itoh M, 1999, J IMMUNOL, V162, P5317; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458; Macian F, 2004, CURR OPIN IMMUNOL, V16, P209, DOI 10.1016/j.coi.2004.01.013; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Ogg GS, 1998, J EXP MED, V188, P1203, DOI 10.1084/jem.188.6.1203; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Wells AD, 2009, J IMMUNOL, V182, P7331, DOI 10.4049/jimmunol.0803917; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yamaguchi T, 2013, P NATL ACAD SCI USA, V110, pE2116, DOI 10.1073/pnas.1307185110; Zheng Y, 2012, J EXP MED, V209, P2157, DOI 10.1084/jem.20120342	30	116	117	3	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1536	1540		10.1126/science.aaa1292	http://dx.doi.org/10.1126/science.aaa1292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525252				2022-12-28	WOS:000346536500070
J	Halioua, B; Ichou, A; Halioua, B; Haiat, R; Prasquier, R				Halioua, Bruno; Ichou, Alexandre; Halioua, Bethsabee; Haiat, Robert; Prasquier, Richard			CHRISTMAS 2014: IN LOVE AND WAR Righteous Among the Nations: doctors and medical students	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Halioua, Bruno] Univ Paris 11, St Louis Hosp, Dept Res Eth, F-75010 Paris, France; [Ichou, Alexandre] Hop Avicenne, Dept Gen Med, F-93009 Bobigny, France; [Halioua, Bethsabee] Prepa Commercia, Paris, France; [Haiat, Robert] Assoc Med Israelites France, St Germain En Laye, France; [Prasquier, Richard] Keren Hayessod, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Halioua, B (corresponding author), Univ Paris 11, St Louis Hosp, Dept Res Eth, F-75010 Paris, France.	haliouab@yahoo.fr						Gutman I, 2003, ENCY RIGHTEOUS NATON, P2003; Paldiel M., 1993, PATH RIGHTEOUS GENTI, P7; Presser J., 1968, ASHES WIND DESTRUCTI, P307	3	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2014	349								g7657	10.1136/bmj.g7657	http://dx.doi.org/10.1136/bmj.g7657			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX3EE	25524154				2022-12-28	WOS:000346822400007
J	Rafelson, W; Brown, T				Rafelson, William; Brown, Theresa			The Half-Wall	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rafelson, William] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Med, Providence, RI 02903 USA; [Brown, Theresa] Home Hosp, Pittsburgh, PA USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Rafelson, W (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Med, Providence, RI 02903 USA.	wrafelson@lifespan.org							0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2501	2502		10.1001/jama.2014.12937	http://dx.doi.org/10.1001/jama.2014.12937			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25514299				2022-12-28	WOS:000346346900010
J	Ramirez, JDE				Ramirez, Edith J. D.			Antitrust Enforcement in Health Care - Controlling Costs, Improving Quality	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Fed Trade Commiss, Washington, DC 20580 USA		Ramirez, JDE (corresponding author), Fed Trade Commiss, Washington, DC 20580 USA.							[Anonymous], 2013, NY TIMES; Baker LC, 2014, JAMA-J AM MED ASSOC, V312, P1653, DOI 10.1001/jama.2014.10921; Gaynor M., 2012, IMPACT HOSP CONSOLID	3	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					2245	2247		10.1056/NEJMp1408009	http://dx.doi.org/10.1056/NEJMp1408009			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW1KQ	25494265				2022-12-28	WOS:000346048800002
J	Dunning, J; Fischer, W				Dunning, Jake; Fischer, William, II			Ebola: the battle plan must include specific treatments	LANCET			English	Editorial Material							VIRUS DISEASE		[Dunning, Jake] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford OX3 7FZ, England; [Fischer, William, II] Univ N Carolina, Sch Med, Div Pulm & Crit Care Med, Chapel Hill, NC USA	University of Oxford; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Dunning, J (corresponding author), Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford OX3 7FZ, England.	jake.dunning@ndm.ox.ac.uk	Dunning, Jake/U-7181-2019	Dunning, Jake/0000-0002-4035-4562				Butler D, 2014, NATURE, DOI [10.1038/nature.2014.16564, DOI 10.1038/NATURE.2014.16564]; Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084; Hayden E. C., 2014, NATURE, DOI [10.1038/nature.2014.16342, DOI 10.1038/NATURE.2014.16342]; Lamontagne F, 2014, NEW ENGL J MED, V371, P1565, DOI 10.1056/NEJMp1411310; MCHE, 2014, FX 06 POT NEW DRUG P; Roberts I, 2014, LANCET, V384, P2001, DOI 10.1016/S0140-6736(14)62316-3; Wolf T, 2014, LANCET; World Health Organization, 2014, EB RESP ROADM SIT RE; World Health Organization, 2014, M SCI TECHN ADV COMM	9	5	5	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1373	+		10.1016/S0140-6736(14)62353-9	http://dx.doi.org/10.1016/S0140-6736(14)62353-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF7EU	25534189				2022-12-28	WOS:000352719800008
J	Haider, BA; Bhutta, ZA				Haider, Batool A.; Bhutta, Zulfiqar A.			Neonatal vitamin A supplementation: time to move on	LANCET			English	Editorial Material							INFANT-MORTALITY; CHILD UNDERNUTRITION; RANDOMIZED-TRIAL; INTERVENTIONS; VACCINATION; CLUSTER; MOTHERS; DEATHS; IMPACT; BIRTH		[Haider, Batool A.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Bhutta, Zulfiqar A.] Hosp Sick Children, Robert Harding Chair Global Child Hlth & Policy, Ctr Global Child Hlth, Toronto, ON M5G 0A4, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan	Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University	Bhutta, ZA (corresponding author), Hosp Sick Children, Robert Harding Chair Global Child Hlth & Policy, Ctr Global Child Hlth, Toronto, ON M5G 0A4, Canada.	zulfiqar.bhutta@sickkids.ca						Bahl R, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-22; Benn CS, 2014, VACCINE, V32, P5468, DOI 10.1016/j.vaccine.2014.07.090; Benn CS, 2008, VACCINE, V26, P4111, DOI 10.1016/j.vaccine.2008.04.021; Benn CS, 2008, BMJ-BRIT MED J, V336, P1416, DOI 10.1136/bmj.39542.509444.AE; Benn CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1101; Bhutta ZA, INT J EPIDE IN PRESS; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Edmond KM, 2014, LANCET; Haider BA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006980.pub2; Humphrey JH, 1996, J PEDIATR-US, V128, P489, DOI 10.1016/S0022-3476(96)70359-1; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S20; Independent Expert Group, 2014, GLOB NUTR REP ACT AC; Kirkwood BR, 2010, LANCET, V375, P1640, DOI 10.1016/S0140-6736(10)60311-X; Klemm RDW, 2008, PEDIATRICS, V122, pE242, DOI 10.1542/peds.2007-3448; Kongnyuy EJ, 2009, INT J GYNECOL OBSTET, V104, P5, DOI 10.1016/j.ijgo.2008.08.023; Liu L, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2014.00010; Lund N, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-214; Malaba LC, 2005, AM J CLIN NUTR, V81, P454, DOI 10.1093/ajcn.81.2.454; Masanja H, 2014, LANCET; Mason J, 2015, INT J EPIDEMIOL, V44, P283, DOI 10.1093/ije/dyu194; Mayo-Wilson E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5094; Mazumder S, 2014, LANCET; Rahmathullah L, 2003, BMJ-BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254; Solomons NW, 2014, FOOD NUTR BULL, V35, P200, DOI 10.1177/156482651403500206; van den Broek N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008666.pub2; WEST KP, 1995, AM J CLIN NUTR, V62, P143, DOI 10.1093/ajcn/62.1.143; World Health Organization (WHO), 2011, GUID NEON VIT A SUPP	29	26	26	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1268	1271		10.1016/S0140-6736(14)62342-4	http://dx.doi.org/10.1016/S0140-6736(14)62342-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25499547				2022-12-28	WOS:000352272400013
J	Ziller, MJ; Edri, R; Yaffe, Y; Donaghey, J; Pop, R; Mallard, W; Issner, R; Gifford, CA; Goren, A; Xing, J; Gu, HC; Cacchiarelli, D; Tsankov, AM; Epstein, C; Rinn, JL; Mikkelsen, TS; Kohlbacher, O; Gnirke, A; Bernstein, BE; Elkabetz, Y; Meissner, A				Ziller, Michael J.; Edri, Reuven; Yaffe, Yakey; Donaghey, Julie; Pop, Ramona; Mallard, William; Issner, Robbyn; Gifford, Casey A.; Goren, Alon; Xing, Jeffrey; Gu, Hongcang; Cacchiarelli, Davide; Tsankov, Alexander M.; Epstein, Charles; Rinn, John L.; Mikkelsen, Tarjei S.; Kohlbacher, Oliver; Gnirke, Andreas; Bernstein, Bradley E.; Elkabetz, Yechiel; Meissner, Alexander			Dissecting neural differentiation regulatory networks through epigenetic footprinting	NATURE			English	Article							PARTIAL LEAST-SQUARES; COUP-TFI; HUMAN ES; DNA; EXPRESSION; BINDING; CELLS; GENE; REGIONALIZATION; IDENTIFICATION	Models derived from human pluripotent stem cells that accurately recapitulate neural development in vitro and allow for the generation of specific neuronal subtypes are of major interest to the stem cell and biomedical community. Notch signalling, particularly through the Notch effector HES5, is a major pathway critical for the onset and maintenance of neural progenitor cells in the embryonic and adult nervous system(1-3). Here we report the transcriptional and epigenomic analysis of six consecutive neural progenitor cell stages derived from a HES5::eGFPreporter human embryonic stem cell line(4). Using this system, we aimed to model cell-fate decisions including specification, expansion and patterning during the ontogeny of cortical neural stem and progenitor cells. In order to dissect regulatory mechanisms that orchestrate the stage-specific differentiation process, we developed a computational framework to infer key regulators of each cell-state transition based on the progressive remodelling of the epigenetic landscape and then validated these through a pooled short hairpin RNA screen. We were also able to refine our previous observations on epigenetic priming at transcription factor binding sites and suggest here that they are mediated by combinations of core and stage-specific factors. Taken together, we demonstrate the utility of our system and outline a general framework, not limited to the context of the neural lineage, to dissect regulatory circuits of differentiation.	[Ziller, Michael J.; Donaghey, Julie; Pop, Ramona; Mallard, William; Issner, Robbyn; Gifford, Casey A.; Goren, Alon; Xing, Jeffrey; Gu, Hongcang; Cacchiarelli, Davide; Tsankov, Alexander M.; Epstein, Charles; Rinn, John L.; Mikkelsen, Tarjei S.; Gnirke, Andreas; Bernstein, Bradley E.; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ziller, Michael J.; Donaghey, Julie; Pop, Ramona; Gifford, Casey A.; Tsankov, Alexander M.; Rinn, John L.; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ziller, Michael J.; Donaghey, Julie; Pop, Ramona; Mallard, William; Gifford, Casey A.; Tsankov, Alexander M.; Rinn, John L.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Edri, Reuven; Yaffe, Yakey; Elkabetz, Yechiel] Tel Aviv Univ, Dept Cell & Dev Biol, Sackler Sch Med, IL-6997801 Ramat Aviv, Israel; [Goren, Alon; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Goren, Alon; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Goren, Alon; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Goren, Alon; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Kohlbacher, Oliver] Univ Tubingen, Ctr Bioinformat, D-72076 Tubingen, Germany; [Kohlbacher, Oliver] Univ Tubingen, Quantitat Biol Ctr, D-72076 Tubingen, Germany	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Elkabetz, Y (corresponding author), Tel Aviv Univ, Dept Cell & Dev Biol, Sackler Sch Med, IL-6997801 Ramat Aviv, Israel.	elkabetz@tauex.tau.ac.il; alexander_meissner@harvard.edu	Mikkelsen, Tarjei S/A-1306-2007; Kohlbacher, Oliver/AAF-3297-2021; Cacchiarelli, Davide/AAC-2693-2022	Mikkelsen, Tarjei S/0000-0002-8133-3135; Kohlbacher, Oliver/0000-0003-1739-4598; Cacchiarelli, Davide/0000-0002-9621-6716; Gifford, Casey/0000-0002-7757-573X; Issner, Robbyn/0000-0003-4132-9219; Xing, Jeffrey/0000-0003-0696-1390; Rinn, John/0000-0002-7231-7539; Gu, Hongcang/0000-0002-1439-7606; Epstein, Charles B./0000-0001-8358-8345; Goren, Alon/0000-0001-5669-9357	NIH [U01ES017155]; NHGRI [HG006911]; NIGMS [P01GM099117]; New York Stem Cell Foundation; Israel Science Foundation (ISF) [1126/10, 1710/10]; Marie Curie International Reintegration Grant [IRG277151]; Charles H. Hood Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); New York Stem Cell Foundation; Israel Science Foundation (ISF)(Israel Science Foundation); Marie Curie International Reintegration Grant(European Commission); Charles H. Hood Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank all members of the Meissner and Elkabetz laboratories; we thank L. Studer (Sloan-Kettering Institute) for the HES5::eGFP reporter line; we also thank F. Kelley and other members of the Broad Sequencing Platform, J. Doench and members of the Genome Perturbation Platform at the Broad Institute, D.-A. Landau for critical reading of the manuscript, as well as to I. Shur and O. Sagi-Assif at Tel Aviv University for their extensive FACS operation. We also thank L. Gaffney for graphical support. This work was funded by the NIH Common Fund (U01ES017155), NHGRI (HG006911), NIGMS (P01GM099117), the New York Stem Cell Foundation, the Israel Science Foundation (ISF) (1126/10, 1710/10) and a Marie Curie International Reintegration Grant (IRG277151). A.Go. is supported by the Charles H. Hood Foundation and A.M. is a New York Stem Cell Foundation Robertson Investigator.	Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackshear PJ, 2003, DEVELOPMENT, V130, P4539, DOI 10.1242/dev.00661; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Boulesteix AL, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-23; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058; Dabney A, 2013, QVALUE Q VALUE ESTIM; Dai Zhiyin, 2014, F1000Res, V3, P95, DOI 10.12688/f1000research.3928.2; DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Faedo A, 2008, CEREB CORTEX, V18, P2117, DOI 10.1093/cercor/bhm238; Fogel GB, 2005, BIOSYSTEMS, V81, P137, DOI 10.1016/j.biosystems.2005.03.003; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Goff L, 2012, CUMMERBUND ANAL EXPL; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Manke T, 2010, HUM MUTAT, V31, P477, DOI 10.1002/humu.21209; Manke T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000039; Martinez-Barbera JP, 2001, DEVELOPMENT, V128, P4789; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Piper M, 2010, J NEUROSCI, V30, P9127, DOI 10.1523/JNEUROSCI.6167-09.2010; Placantonakis DG, 2009, STEM CELLS, V27, P521, DOI 10.1634/stemcells.2008-0884; Qureshi IA, 2010, CELL CYCLE, V9, P4477, DOI 10.4161/cc.9.22.13973; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Shimojo H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00078; Sims D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r104; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Strezoska Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042341; Thompson CL, 2014, NEURON, V83, P309, DOI 10.1016/j.neuron.2014.05.033; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uittenbogaard M., 2002, Gene Expression Patterns, V1, P115, DOI 10.1016/S1567-133X(01)00022-9; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	63	132	135	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					355	359		10.1038/nature13990	http://dx.doi.org/10.1038/nature13990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25533951	Green Accepted, Bronze			2022-12-28	WOS:000349547400033
J	Duca, L; Li, T; Reitter, M; Bloch, I; Schleier-Smith, M; Schneider, U				Duca, L.; Li, T.; Reitter, M.; Bloch, I.; Schleier-Smith, M.; Schneider, U.			An Aharonov-Bohm interferometer for determining Bloch band topology	SCIENCE			English	Article							ELECTRONIC-PROPERTIES; BERRYS PHASE; GRAPHENE; FERMIONS; LATTICE; GAS	The geometric structure of a single-particle energy band in a solid is fundamental for a wide range of many-body phenomena and is uniquely characterized by the distribution of Berry curvature over the Brillouin zone. We realize an atomic interferometer to measure Berry flux in momentum space, in analogy to an Aharonov-Bohm interferometer that measures magnetic flux in real space. We demonstrate the interferometer for a graphene-type hexagonal optical lattice loaded with bosonic atoms. By detecting the singular pi Berry flux localized at each Dirac point, we establish the high momentum resolution of this interferometric technique. Our work forms the basis for a general framework to fully characterize topological band structures.	[Duca, L.; Li, T.; Reitter, M.; Bloch, I.; Schneider, U.] Univ Munich, Fak Phys, D-80799 Munich, Germany; [Duca, L.; Li, T.; Reitter, M.; Bloch, I.; Schneider, U.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Schleier-Smith, M.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	University of Munich; Max Planck Society; Stanford University	Schneider, U (corresponding author), Univ Munich, Fak Phys, Schellingstr 4, D-80799 Munich, Germany.	ulrich.schneider@lmu.de	Duca, Lucia/AFO-6835-2022; Duca, Lucia/N-2465-2016; Bloch, Immanuel/N-9169-2019; Bloch, Immanuel/G-3174-2010; Schneider, Ulrich/N-4820-2015	Duca, Lucia/0000-0002-4598-4918; Duca, Lucia/0000-0002-4598-4918; Bloch, Immanuel/0000-0002-0679-4759; Schneider, Ulrich/0000-0003-4345-9498; Schleier-Smith, Monika/0000-0002-4686-3528	Deutsche Forschungsgemeinschaft [FOR801]; European Commission (UQUAM); U.S. Defense Advanced Research Projects Agency Optical Lattice Emulator program; Nanosystems Initiative Munich; Alfred P. Sloan Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission (UQUAM); U.S. Defense Advanced Research Projects Agency Optical Lattice Emulator program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Nanosystems Initiative Munich; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	We acknowledge technical assistance by M. Boll, H. Luschen, and J. Bernardoff during the setup of the experiment and thank E. Demler, D. Abanin, and X.-L. Qi for helpful discussions. We acknowledge financial support by the Deutsche Forschungsgemeinschaft (FOR801), the European Commission (UQUAM), the U.S. Defense Advanced Research Projects Agency Optical Lattice Emulator program, the Nanosystems Initiative Munich, and the Alfred P. Sloan Foundation.	Abanin DA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.165304; AHARONOV Y, 1959, PHYS REV, V115, P485, DOI 10.1103/PhysRev.115.485; Aidelsburger M, 2015, NAT PHYS, V11, P162, DOI 10.1038/NPHYS3171; Aidelsburger M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185301; Aidelsburger M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.255301; Atala M, 2013, NAT PHYS, V9, P795, DOI [10.1038/nphys2790, 10.1038/NPHYS2790]; BenDahan M, 1996, PHYS REV LETT, V76, P4508, DOI 10.1103/PhysRevLett.76.4508; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Carusotto I, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.299; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; D'Errico C, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/7/223; Dauphin A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.135302; Dietl P, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.236405; Fallani L, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.140406; Goldman N, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/12/126401; Greiner M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.160405; Grusdt F, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.043621; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hauke P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.045303; Hwang C, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.125422; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Liu Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.166803; Mikitik GP, 1999, PHYS REV LETT, V82, P2147, DOI 10.1103/PhysRevLett.82.2147; Miyake H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185302; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Parameswaran SA, 2013, CR PHYS, V14, P816, DOI 10.1016/j.crhy.2013.04.003; Price HM, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.033620; Shapere A., 1989, ADV SERIES MATH PHYS, V5; Spielman IB, 2013, ANN PHYS-BERLIN, V525, P797, DOI 10.1002/andp.201300110; Struck J, 2013, NAT PHYS, V9, P738, DOI [10.1038/nphys2750, 10.1038/NPHYS2750]; Tarruell L, 2012, NATURE, V483, P302, DOI 10.1038/nature10871; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Tuchman AK, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.130403; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Zanardi P, 1999, PHYS LETT A, V264, P94, DOI 10.1016/S0375-9601(99)00803-8; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhu SL, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.260402	37	184	185	3	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					288	292		10.1126/science.1259052	http://dx.doi.org/10.1126/science.1259052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25525160	Green Submitted			2022-12-28	WOS:000347915300040
J	Xiong, HY; Alipanahi, B; Lee, LJ; Bretschneider, H; Merico, D; Yuen, RKC; Hua, YM; Gueroussov, S; Najafabadi, HS; Hughes, TR; Morris, Q; Barash, Y; Krainer, AR; Jojic, N; Scherer, SW; Blencowe, BJ; Frey, BJ				Xiong, Hui Y.; Alipanahi, Babak; Lee, Leo J.; Bretschneider, Hannes; Merico, Daniele; Yuen, Ryan K. C.; Hua, Yimin; Gueroussov, Serge; Najafabadi, Hamed S.; Hughes, Timothy R.; Morris, Quaid; Barash, Yoseph; Krainer, Adrian R.; Jojic, Nebojsa; Scherer, Stephen W.; Blencowe, Benjamin J.; Frey, Brendan J.			The human splicing code reveals new insights into the genetic determinants of disease	SCIENCE			English	Article							AUTISM SPECTRUM DISORDER; COPY NUMBER VARIATION; MESSENGER-RNA; MISSENSE MUTATIONS; FUNCTIONAL IMPACT; MISMATCH REPAIR; EXONIC VARIANTS; HUMAN CANCERS; PREDICTION; GENOME	To facilitate precision medicine and whole-genome annotation, we developed a machine-learning technique that scores how strongly genetic variants affect RNA splicing, whose alteration contributes to many diseases. Analysis of more than 650,000 intronic and exonic variants revealed widespread patterns of mutation-driven aberrant splicing. Intronic disease mutations that are more than 30 nucleotides from any splice site alter splicing nine times as often as common variants, and missense exonic disease mutations that have the least impact on protein function are five times as likely as others to alter splicing. We detected tens of thousands of disease-causing mutations, including those involved in cancers and spinal muscular atrophy. Examination of intronic and exonic variants found using whole-genome sequencing of individuals with autism revealed misspliced genes with neurodevelopmental phenotypes. Our approach provides evidence for causal variants and should enable new discoveries in precision medicine.	[Xiong, Hui Y.; Alipanahi, Babak; Lee, Leo J.; Bretschneider, Hannes; Najafabadi, Hamed S.; Morris, Quaid; Barash, Yoseph; Frey, Brendan J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [Xiong, Hui Y.; Alipanahi, Babak; Lee, Leo J.; Gueroussov, Serge; Najafabadi, Hamed S.; Hughes, Timothy R.; Morris, Quaid; Barash, Yoseph; Blencowe, Benjamin J.; Frey, Brendan J.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Xiong, Hui Y.; Alipanahi, Babak; Lee, Leo J.; Bretschneider, Hannes; Najafabadi, Hamed S.; Hughes, Timothy R.; Morris, Quaid; Scherer, Stephen W.; Frey, Brendan J.] Canadian Inst Adv Res, Program Genet Networks, Toronto, ON M5G 1Z8, Canada; [Xiong, Hui Y.; Alipanahi, Babak; Lee, Leo J.; Bretschneider, Hannes; Najafabadi, Hamed S.; Hughes, Timothy R.; Morris, Quaid; Scherer, Stephen W.; Frey, Brendan J.] Canadian Inst Adv Res, Program Neural Computat & Adapt Percept, Toronto, ON M5G 1Z8, Canada; [Bretschneider, Hannes; Frey, Brendan J.] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3G4, Canada; [Merico, Daniele; Yuen, Ryan K. C.; Scherer, Stephen W.; Blencowe, Benjamin J.; Frey, Brendan J.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5G 0A4, Canada; [Merico, Daniele; Yuen, Ryan K. C.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada; [Merico, Daniele; Yuen, Ryan K. C.; Gueroussov, Serge; Hughes, Timothy R.; Morris, Quaid; Scherer, Stephen W.; Blencowe, Benjamin J.; Frey, Brendan J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Hua, Yimin; Krainer, Adrian R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Barash, Yoseph] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Jojic, Nebojsa; Frey, Brendan J.] Microsoft Res, eSci Grp, Redmond, WA 98052 USA	University of Toronto; University of Toronto; Canadian Institute for Advanced Research (CIFAR); Canadian Institute for Advanced Research (CIFAR); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Cold Spring Harbor Laboratory; University of Pennsylvania; Microsoft	Frey, BJ (corresponding author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada.	frey@psi.toronto.edu	Scherer, Stephen W./B-3785-2013; Morris, Quaid/ABE-8343-2020; Yuen, Ryan K. C./J-4876-2012; Hua, Yimin/U-6911-2018	Scherer, Stephen W./0000-0002-8326-1999; Yuen, Ryan K. C./0000-0001-7273-4968; Barash, Yoseph/0000-0003-3005-5048; Morris, Quaid/0000-0002-2760-6999; Hua, Yimin/0000-0003-0905-7989; Najafabadi, Hamed/0000-0003-2735-4231; Merico, Daniele/0000-0002-3728-4401; Alipanahi, Babak/0000-0001-8216-7178; Bretschneider, Hannes/0000-0003-0109-3774	Canadian Institutes for Advanced Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); University of Toronto McLaughlin Centre; Ontario Genomics Institute (OGI); CIHR; Genome Canada; OGI; Autism Speaks; NIH [R37-GM42699a]; Autism Research Training Fellowship; CIHR Banting Fellowship; NSERC Alexander Graham Bell Scholarship; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM042699] Funding Source: NIH RePORTER	Canadian Institutes for Advanced Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Toronto McLaughlin Centre; Ontario Genomics Institute (OGI); CIHR(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); OGI; Autism Speaks; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Research Training Fellowship; CIHR Banting Fellowship(Canadian Institutes of Health Research (CIHR)); NSERC Alexander Graham Bell Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	B.J.F. designed the study and wrote the manuscript, input from B.J.B., S.W.S., B.A., N.J., Y.B., ON., and other co-authors. H.Y.X. trained the models. H.Y.X., B.J.F., N.J., and L.J.L. developed the bootstrap method for quantifying Psi L.J.L. mined exons, mapped reads and designed additional features, extending the original feature set developed by Y.B. B.J.F., and B.J.B. H.Y.X., B.J.F., H.S.N., Q.M., and T.R.H. analyzed RNAcompete data B.J.F., H.Y.X., L.J.L., and B.A. performed the genome-wide SNV analysis. L.J.L., Y.H., B.J.F., and A.R.K. tested predictions for SMN1/2. B.A. and B.J.F. tested predictions for MLH1/MSH2. BA, D.M., R.K.C.Y., B.J.F., and SINS. analyzed ASD genomes. S.G. conducted wild-type PT-POP assays. H.B. developed the Web tool and feature visualization, with input from B.J.F., H.Y.X., B.A, and L.J.L. We tank the Center of Applied Genomics at the Toronto Hospital for Sick Children for providing HGMD annotations, G. Schroth at Illumina for providing the BodyMap RNA-seq data, and id. Brudno, O. Buske, A. Delong, C. Srnith, T. Sterne-Weiler, J. Wilson, and J. Valcarel for comments on the manuscript and the Web tool. Supported by Canadian Institutes for Advanced Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), John C. Polanyi, the University of Toronto McLaughlin Centre, and the Ontario Genomics Institute (OGI) (B.J.F.); CIHR and McLaughlin (B.J.B.): McLaughlin, Genome Canada, OGI, and Autism Speaks (S.W.S.); NIH grant R37-GM42699a (A.R.K.); CIHR (Q.M.); an Autism Research Training Fellowship (B.A.); a CIHR Banting Fellowship (H.S.N.); an NSERC Alexander Graham Bell Scholarship (S.G.). S.W.S. holds the GlaxoSmithKline-CIHR Chair in Genome Sciences. B.J.B. holds the Banbury Chair of Medical Research at the University of Toronto. B.J.F., S.W.S., and. T.R.H. are Fellows of the Canadian Institute for Advanced Research. B.J.F. holds the Canada Research Chair in Biological Computation.	Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Arnold S, 2009, HUM MUTAT, V30, P757, DOI 10.1002/humu.20936; Barash Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r114; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Barnetson RA, 2008, HUM MUTAT, V29, P367, DOI 10.1002/humu.20635; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Betz B, 2010, J CANCER RES CLIN, V136, P123, DOI 10.1007/s00432-009-0643-z; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gnad F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S7; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kashima T, 2007, P NATL ACAD SCI USA, V104, P3426, DOI 10.1073/pnas.0700343104; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kimura M., 1983, NEUTRAL THEORY MOL E; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kosinski J, 2010, HUM MUTAT, V31, P975, DOI 10.1002/humu.21301; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lastella P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-243; Lim KH, 2011, P NATL ACAD SCI USA, V108, P11093, DOI 10.1073/pnas.1101135108; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Mort M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r19; Nystrom-Lahti M, 1999, GENE CHROMOSOME CANC, V26, P372, DOI 10.1002/(SICI)1098-2264(199912)26:4<372::AID-GCC12>3.0.CO;2-V; Peltomaki P, 2004, DIS MARKERS, V20, P269, DOI 10.1155/2004/305058; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Robinson EB, 2014, MOL PSYCHIATR, V19, P859, DOI 10.1038/mp.2013.125; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singh RN, 2007, RNA BIOL, V4, P7, DOI 10.4161/rna.4.1.4535; Skafidas E, 2014, MOL PSYCHIATR, V19, P504, DOI 10.1038/mp.2012.126; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Sterne-Weiler T, 2014, GENOME BIOL, V15, DOI 10.1186/gb4150; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Uddin M, 2014, NAT GENET, V46, P742, DOI 10.1038/ng.2980; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wintle RF, 2011, AUTISM RES, V4, P89, DOI 10.1002/aur.173; Woolfe A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r20; Xiong HY, 2011, BIOINFORMATICS, V27, P2554, DOI 10.1093/bioinformatics/btr444; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150	54	721	764	11	280	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218							1254806	10.1126/science.1254806	http://dx.doi.org/10.1126/science.1254806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25525159	Green Accepted			2022-12-28	WOS:000347918900035
J	Clark, AG; Messer, PW				Clark, Andrew G.; Messer, Philipp W.			Conundrum of jumbled mosquito genomes	SCIENCE			English	Editorial Material							EVOLUTION		[Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Clark, Andrew G.; Messer, Philipp W.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Clark, AG (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	ac347@cornell.edu		Messer, Philipp/0000-0001-8453-9377; Clark, Andrew/0000-0001-7159-8511				Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Fontaine MC, 2015, SCIENCE, V347, DOI 10.1126/science.1258524; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Pool JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003080; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707	12	16	18	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					27	28		10.1126/science.aaa3600	http://dx.doi.org/10.1126/science.aaa3600			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554775				2022-12-28	WOS:000347102300034
J	Folick, A; Oakley, HD; Yu, Y; Armstrong, EH; Kumari, M; Sanor, L; Moore, DD; Ortlund, EA; Zechner, R; Wang, MC				Folick, Andrew; Oakley, Holly D.; Yu, Yong; Armstrong, Eric H.; Kumari, Manju; Sanor, Lucas; Moore, David D.; Ortlund, Eric A.; Zechner, Rudolf; Wang, Meng C.			Lysosomal signaling molecules regulate longevity in Caenorhabditis elegans	SCIENCE			English	Article							ACID-BINDING PROTEINS; C-ELEGANS; OLEOYLETHANOLAMIDE; RESTRICTION; METABOLISM; DIET	Lysosomes are crucial cellular organelles for human health that function in digestion and recycling of extracellular and intracellular macromolecules. We describe a signaling role for lysosomes that affects aging. In the worm Caenorhabditis elegans, the lysosomal acid lipase LIPL-4 triggered nuclear translocalization of a lysosomal lipid chaperone LBP-8, which promoted longevity by activating the nuclear hormone receptors NHR-49 and NHR-80. We used high-throughput metabolomic analysis to identify several lipids in which abundance was increased in worms constitutively overexpressing LIPL-4. Among them, oleoylethanolamide directly bound to LBP-8 and NHR-80 proteins, activated transcription of target genes of NHR-49 and NHR-80, and promoted longevity in C. elegans. These findings reveal a lysosome-to-nucleus signaling pathway that promotes longevity and suggest a function of lysosomes as signaling organelles in metazoans.	[Folick, Andrew; Moore, David D.; Wang, Meng C.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Oakley, Holly D.; Yu, Yong; Sanor, Lucas; Wang, Meng C.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Oakley, Holly D.; Yu, Yong; Wang, Meng C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Armstrong, Eric H.; Ortlund, Eric A.] Emory Univ, Sch Med, Winship Canc Inst, Dept Biochem Discovery & Dev Therapeut, Atlanta, GA 30322 USA; [Kumari, Manju; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Moore, David D.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Emory University; University of Graz; Baylor College of Medicine	Wang, MC (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	wmeng@bcm.edu	Ortlund, Eric Anthony/P-3121-2019; Ortlund, Eric Anthony/F-4672-2014; Wang, Meng/F-2951-2019	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029; Wang, Meng/0000-0002-5898-6007; Zechner, Rudolf/0000-0001-5483-1182; Oakley, Holly/0000-0001-7347-1100; Folick, Andrew/0000-0002-2093-034X	NIH [T32GM008602, R01DK095750, T32HD055200, F30AG046043, R00AG034988, R01AG045183]; Ellison New Scholar Award; Welch Chair in Science [Q-0022]; European Research Council Advanced Grant; Fondation Leducq; Austrian Science Fund (FWF) [F 3002, Z 136] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045183, F30AG046043, R00AG034988] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison New Scholar Award; Welch Chair in Science; European Research Council Advanced Grant(European Research Council (ERC)); Fondation Leducq(Leducq Foundation); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Y. Mak and A. Antebi for providing strains; A. Dervisefendic and H. Jen for experimental support; N. Timchenko, J. Wang, Z. Yu, and D. Chow for instrumental support; H. Dierick, C. Herman, H. Zheng, F. Xia, S. Rosenberg, and H. Zoghbi for critical reading of the manuscript; P. P. Metoyer for scientific editing. Supported by NIH grants T32GM008602 (E.H.A.), R01DK095750 (E.A.O.), T32HD055200 (A.F.), F30AG046043 (A.F.), R00AG034988 (M.C.W.), and R01AG045183 (M.C.W.); Ellison New Scholar Award (M.C.W.); Welch Chair in Science (Q-0022) (D.D.M.); European Research Council Advanced Grant (R.Z.); and Fondation Leducq (R.Z.). Requests for materials should be addressed to M.C.W.	Astarita G, 2006, J PHARMACOL EXP THER, V318, P563, DOI 10.1124/jpet.106.105221; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Hadwiger G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010161; Heestand BN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003651; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lucanic M, 2011, NATURE, V473, P226, DOI 10.1038/nature10007; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Pathare PP, 2012, PLOS GENET, V8, P333, DOI 10.1371/journal.pgen.1002645; Patrick A D, 1969, Nature, V222, P1067, DOI 10.1038/2221067a0; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011	18	155	160	5	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					83	86		10.1126/science.1258857	http://dx.doi.org/10.1126/science.1258857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554789	Green Accepted			2022-12-28	WOS:000347102300054
J	Zhang, LJ; Guerrero-Juarez, CF; Hata, T; Bapat, SP; Ramos, R; Plikus, MV; Gallo, RL				Zhang, Ling-juan; Guerrero-Juarez, Christian F.; Hata, Tissa; Bapat, Sagar P.; Ramos, Raul; Plikus, Maksim V.; Gallo, Richard L.			Dermal adipocytes protect against invasive Staphylococcus aureus skin infection	SCIENCE			English	Article							ANTIMICROBIAL PEPTIDES; TRANSCRIPTIONAL CONTROL; ANTIBACTERIAL PEPTIDES; STEM-CELLS; DIFFERENTIATION; CATHELICIDIN; ZFP423; PRECURSORS; EXPRESSION; IMMUNITY	Adipocytes have been suggested to be immunologically active, but their role in host defense is unclear. We observed rapid proliferation of preadipocytes and expansion of the dermal fat layer after infection of the skin by Staphylococcus aureus. Impaired adipogenesis resulted in increased infection as seen in Zfp423(nur12) mice or in mice given inhibitors of peroxisome proliferator-activated receptor gamma. This host defense function was mediated through the production of cathelicidin antimicrobial peptide from adipocytes because cathelicidin expression was decreased by inhibition of adipogenesis, and adipocytes from Camp(-/-) mice lost the capacity to inhibit bacterial growth. Together, these findings show that the production of an antimicrobial peptide by adipocytes is an important element for protection against S. aureus infection of the skin.	[Zhang, Ling-juan; Hata, Tissa; Gallo, Richard L.] Univ Calif San Diego, Div Dermatol, La Jolla, CA 92093 USA; [Guerrero-Juarez, Christian F.; Ramos, Raul; Plikus, Maksim V.] Univ Calif Irvine, Dept Dev & Cell Biol, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA; [Guerrero-Juarez, Christian F.; Ramos, Raul; Plikus, Maksim V.] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92697 USA; [Bapat, Sagar P.] Salk Inst Biol Studies, Nomis Fdn Labs Immunobiol & Microbial Pathogenesi, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California Irvine; Salk Institute	Gallo, RL (corresponding author), Univ Calif San Diego, Div Dermatol, La Jolla, CA 92093 USA.	rgallo@ucsd.edu	Zhang, Ling-juan/V-6141-2019; Gallo, Richard L/A-8931-2009; Zhang, Lingjuan/K-3080-2017	Zhang, Ling-juan/0000-0001-6937-4578; Gallo, Richard L/0000-0002-1401-7861; Zhang, Lingjuan/0000-0001-6937-4578; Plikus, Maksim/0000-0002-8845-2559	NIH [R01 AI083358, R01AI052453, AR052728, DK096828]; Atopic Dermatitis Research Network [HHSN272201000020C]; Edward Mallinckrodt Jr. Foundation Research Grant; Dermatology Foundation Research Grant; NIH NIAMS [R01-AR067273]; NIH MBRS-IMSD training grant [GM055246]; NSF Graduate Research Fellowship [DGE-1321846]; California Institute for Regenerative Medicine training grant [TG2-01152]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116576, R01AI052453, R37AI052453, U19AI117673, R01AI083358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064781, R01AR052728, R01AR067273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK096828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055246, T32GM007198] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Atopic Dermatitis Research Network; Edward Mallinckrodt Jr. Foundation Research Grant; Dermatology Foundation Research Grant; NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH MBRS-IMSD training grant; NSF Graduate Research Fellowship(National Science Foundation (NSF)); California Institute for Regenerative Medicine training grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH R01 AI083358, R01AI052453, and AR052728 (R.L.G.). Human serum collections were funded by The Atopic Dermatitis Research Network (HHSN272201000020C). S.P.B. was supported by the NIH (DK096828). M.V.P. is supported by the Edward Mallinckrodt Jr. Foundation Research Grant, the Dermatology Foundation Research Grant, and NIH NIAMS R01-AR067273; C.F.G.-J. is supported by the NIH MBRS-IMSD training grant (GM055246) and NSF Graduate Research Fellowship number DGE-1321846; and R.R. is supported by California Institute for Regenerative Medicine training grant (TG2-01152). The authors declare no competing financial interests. We thank T. Nakatuji for advice relating to bacterial infections and C. Aguilera for mouse technical expertise, UCSD Bio-Core facility for reagents, UCSD mouse hematology core laboratory for serum studies, and J. M. Olefsky for comments on the manuscript. Zfp423-GFP mice are available from R. Gupta under a material transfer agreement with Dana-Farber Cancer Institute. All the data reported in this manuscript are presented in the main paper and in the supplementary materials.	Alcaraz WA, 2006, P NATL ACAD SCI USA, V103, P19424, DOI 10.1073/pnas.0609184103; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Cheng LE, 2007, DEV BIOL, V307, P43, DOI 10.1016/j.ydbio.2007.04.005; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hudak CS, 2014, CELL REP, V8, P678, DOI 10.1016/j.celrep.2014.06.060; Kawaguchi N, 2002, AM J PATHOL, V160, P1895, DOI 10.1016/S0002-9440(10)61136-4; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; MUSSER JM, 1990, P NATL ACAD SCI USA, V87, P225, DOI 10.1073/pnas.87.1.225; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Schaffaler A, 2010, TRENDS IMMUNOL, V31, P228, DOI 10.1016/j.it.2010.03.001; Schmidt BA, 2013, DEVELOPMENT, V140, P1517, DOI 10.1242/dev.087593; Sillat T, 2012, J CELL MOL MED, V16, P1485, DOI 10.1111/j.1582-4934.2011.01442.x; Sorensen OE, 2003, J BIOL CHEM, V278, P28540, DOI 10.1074/jbc.M301608200; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616	30	258	267	13	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					67	71		10.1126/science.1260972	http://dx.doi.org/10.1126/science.1260972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554785	Green Accepted			2022-12-28	WOS:000347102300049
J	Liu, MJ; Ishida, Y; Ebina, Y; Sasaki, T; Hikima, T; Takata, M; Aida, T				Liu, Mingjie; Ishida, Yasuhiro; Ebina, Yasuo; Sasaki, Takayoshi; Hikima, Takaaki; Takata, Masaki; Aida, Takuzo			An anisotropic hydrogel with electrostatic repulsion between cofacially aligned nanosheets	NATURE			English	Article							LONG-RANGE; CLAY; DIFFUSION; ALIGNMENT	Machine technology frequently puts magnetic or electrostatic repulsive forces to practical use, as in maglev trains, vehicle suspensions or non-contact bearings(1,2). In contrast, materials design overwhelmingly focuses on attractive interactions, such as in the many advanced polymer-based composites, where inorganic fillers interact with a polymer matrix to improve mechanical properties. However, articular cartilage strikingly illustrates how electrostatic repulsion can be harnessed to achieve unparalleled functional efficiency: it permits virtually friction-less mechanical motion within joints, even under high compression(3,4). Here we describe a composite hydrogel with anisotropic mechanical properties dominated by electrostatic repulsion between negatively charged unilamellar titanate nanosheets(5) embedded within it. Crucial to the behaviour of this hydrogel is the serendipitous discovery of cofacial nanosheet alignment in aqueous colloidal dispersions subjected to a strong magnetic field, which maximizes electrostatic repulsion(6) and thereby induces a quasi-crystalline structural ordering(7,8) over macroscopic length scales and with uniformly large face-to-face nanosheet separation. We fix this transiently induced structural order by transforming the dispersion into a hydrogel(9,10) using light-triggered in situ vinyl polymerization(11). The resultant hydrogel, containing charged inorganic structures that align cofacially in a magnetic flux(12-19), deforms easily under shear forces applied parallel to the embedded nanosheets yet resists compressive forces applied orthogonally. We anticipate that the concept of embedding anisotropic repulsive electrostatics within a composite material, inspired by articular cartilage, will open up new possibilities for developing soft materials with unusual functions.	[Liu, Mingjie; Ishida, Yasuhiro; Aida, Takuzo] RIKEN Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Ebina, Yasuo; Sasaki, Takayoshi] Int Ctr Mat Nanoarchitecton, Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Hikima, Takaaki; Takata, Masaki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795198, Japan; [Aida, Takuzo] Univ Tokyo, Dept Chem & Biotechnol, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	RIKEN; National Institute for Materials Science; RIKEN; University of Tokyo	Ishida, Y (corresponding author), RIKEN Ctr Emergent Matter Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	y-ishida@riken.jp; aida@macro.t.u-tokyo.ac.jp	EBINA, Yasuo/H-2730-2011; SASAKI, Takayoshi/H-2956-2011; Aida, Takuzo/I-9117-2012; Ishida, Yasuhiro/I-8204-2012; Liu, Mingjie/G-1109-2010	EBINA, Yasuo/0000-0003-3471-9825; Liu, Mingjie/0000-0003-0824-9858; liu, ming jie/0000-0002-8399-2134	 [25000005]		This work was financially supported by a Grant-in-Aid for Specially Promoted Research (25000005) on "Physically Perturbed Assembly for Tailoring High-Performance Soft Materials with Controlled Macroscopic Structural Anisotropy''. We also acknowledge the ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). The synchrotron X-ray diffraction experiments were performed at BL45XUin SPring-8 with the approval of the RIKEN SPring-8 Center (proposal 20140073).	ANANDARAJAH A, 1991, INT J NUMER ANAL MET, V15, P683, DOI 10.1002/nag.1610151002; Budtova T, 1997, MACROMOLECULES, V30, P6556, DOI 10.1021/ma970304e; Cui HG, 2010, SCIENCE, V327, P555, DOI 10.1126/science.1182340; Dean D, 2006, J BIOMECH, V39, P2555, DOI 10.1016/j.jbiomech.2005.09.007; Eguchi M, 2008, J PHYS CHEM C, V112, P11280, DOI 10.1021/jp802702m; Erb RM, 2012, SCIENCE, V335, P199, DOI 10.1126/science.1210822; Feng S, 2009, MACROMOLECULES, V42, P281, DOI 10.1021/ma8015932; Haque MA, 2010, ADV MATER, V22, P5110, DOI 10.1002/adma.201002509; Hull JR, 2000, SUPERCOND SCI TECH, V13, pR1, DOI 10.1088/0953-2048/13/2/201; Ida S, 2008, J AM CHEM SOC, V130, P7052, DOI 10.1021/ja7114772; Kleinschmidt F, 2005, MACROMOLECULES, V38, P9772, DOI 10.1021/ma051479o; Liu MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3029; Lowen H, 2001, J PHYS-CONDENS MAT, V13, pR415, DOI 10.1088/0953-8984/13/24/201; MARET G, 1985, TOP APPL PHYS, V57, P143; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; Osada M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.153301; Palmer LC, 2014, J AM CHEM SOC, V136, P14377, DOI [10.1021/ja5082519, 10.1021/ja50825191]; Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176; Prosser RS, 1996, J AM CHEM SOC, V118, P269, DOI 10.1021/ja953598x; RHIM WK, 1993, REV SCI INSTRUM, V64, P2961, DOI 10.1063/1.1144475; Sasaki T, 1996, J AM CHEM SOC, V118, P8329, DOI 10.1021/ja960073b; Scott JE, 2003, J PHYSIOL-LONDON, V553, P335, DOI 10.1113/jphysiol.2003.050179; Tamesue S, 2013, J AM CHEM SOC, V135, P15650, DOI 10.1021/ja408547g; Tan CB, 2002, J AM CHEM SOC, V124, P11827, DOI 10.1021/ja027079n; TORBET J, 1981, NATURE, V289, P91, DOI 10.1038/289091a0; UYEDA C, 1993, PHYS CHEM MINER, V20, P77; Verwey E.J., 1948, THEORY STABILITY LYO; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693; Wu JJ, 2012, SOFT MATTER, V8, P3620, DOI 10.1039/c2sm07411g; Wu ZL, 2011, MACROMOLECULES, V44, P3535, DOI 10.1021/ma2001228	30	346	362	64	1434	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					68	72		10.1038/nature14060	http://dx.doi.org/10.1038/nature14060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25557713				2022-12-28	WOS:000347178400036
J	Jess, T				Jess, Tine			Microbiota, Antibiotics, and Obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OVERWEIGHT		[Jess, Tine] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Jess, Tine] Aalborg Univ, Dept Clin Epidemiol, Aalborg, Denmark	Statens Serum Institut; Aalborg University	Jess, T (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.							Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Li HT, 2013, INT J OBESITY, V37, P893, DOI 10.1038/ijo.2012.195	4	31	35	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2526	2528		10.1056/NEJMcibr1409799	http://dx.doi.org/10.1056/NEJMcibr1409799			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX4RZ	25539109				2022-12-28	WOS:000346920300015
J	Mathias, RA; Greco, TM; Oberstein, A; Budayeva, HG; Chakrabarti, R; Rowland, EA; Kang, YB; Shenk, T; Cristea, IM				Mathias, Rommel A.; Greco, Todd M.; Oberstein, Adam; Budayeva, Hanna G.; Chakrabarti, Rumela; Rowland, Elizabeth A.; Kang, Yibin; Shenk, Thomas; Cristea, Ileana M.			Sirtuin 4 Is a Lipoamidase Regulating Pyruvate Dehydrogenase Complex Activity	CELL			English	Article							HUMAN-SERUM LIPOAMIDASE; BOVINE HEART; PROTEIN; METABOLISM; SIR2; GLUTAMINE; MUSCLE; NAD; BIOTINIDASE; INHIBITION	Sirtuins (SIRTs) are critical enzymes that govern genome regulation, metabolism, and aging. Despite conserved deacetylase domains, mitochondrial SIRT4 and SIRT5 have little to no deacetylase activity, and a robust catalytic activity for SIRT4 has been elusive. Here, we establish SIRT4 as a cellular lipoamidase that regulates the pyruvate dehydrogenase complex (PDH). Importantly, SIRT4 catalytic efficiency for lipoyl-and biotinyl-lysine modifications is superior to its deacetylation activity. PDH, which converts pyruvate to acetyl-CoA, has been known to be primarily regulated by phosphorylation of its E1 component. We determine that SIRT4 enzymatically hydrolyzes the lipoamide cofactors from the E2 component dihydrolipoyllysine acetyltransferase (DLAT), diminishing PDH activity. We demonstrate SIRT4-mediated regulation of DLAT lipoyl levels and PDH activity in cells and in vivo, in mouse liver. Furthermore, metabolic flux switching via glutamine stimulation induces SIRT4 lipoamidase activity to inhibit PDH, highlighting SIRT4 as a guardian of cellular metabolism.	[Mathias, Rommel A.; Greco, Todd M.; Oberstein, Adam; Budayeva, Hanna G.; Chakrabarti, Rumela; Rowland, Elizabeth A.; Kang, Yibin; Shenk, Thomas; Cristea, Ileana M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Mathias, Rommel A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3086, Australia	Princeton University; La Trobe University	Cristea, IM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	icristea@princeton.edu		Mathias, Rommel/0000-0003-3064-4897; Kang, Yibin/0000-0002-1626-6730	NIDA [DP1DA026192]; NIAID [R21AI102187, AI78063]; NICHD [R21HD073044]; NCI [CA82396]; ASMS research award; NHMRC of Australia Early CJ Martin Fellowship [APP1037043]; NJCCR postdoctoral fellowship; NSF graduate fellowships; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD073044] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA082396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI102187, R01AI078063, R21AI102187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026192] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ASMS research award; NHMRC of Australia Early CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NJCCR postdoctoral fellowship; NSF graduate fellowships; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the PRIDE team for assistance in submitting the mass spectrometry data and interactions to the ProteomeXchange and Intact repositories. The authors are supported by grants from the NIDA (DP1DA026192), NIAID (R21AI102187), and NICHD (R21HD073044) to I.M.C., and NIAID (AI78063) and NCI (CA82396) to T.S., and an ASMS research award to I.M.C. R.A.M. is funded by a NHMRC of Australia Early CJ Martin Fellowship #APP1037043, T.M.G. by an NJCCR postdoctoral fellowship, and H.G.B. and E.A.R. by NSF graduate fellowships.	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Guarente L, 2000, GENE DEV, V14, P1021; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Harris RA, 1997, J BIOL CHEM, V272, P19746, DOI 10.1074/jbc.272.32.19746; HAUSSINGER D, 1982, EUR J BIOCHEM, V126, P69, DOI 10.1111/j.1432-1033.1982.tb06747.x; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Jing EX, 2013, DIABETES, V62, P3404, DOI 10.2337/db12-1650; Joshi P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.26; Laurent G, 2013, MOL CELL BIOL, V33, P4552, DOI 10.1128/MCB.00087-13; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; Lin HN, 2012, ACS CHEM BIOL, V7, P947, DOI 10.1021/cb3001793; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Nasrin N, 2010, J BIOL CHEM, V285, P31995, DOI 10.1074/jbc.M110.124164; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863; NILSSON L, 1993, BIOCHEM J, V291, P545, DOI 10.1042/bj2910545; NILSSON L, 1992, EUR J CLIN CHEM CLIN, V30, P119; OIZUMI J, 1989, BIOCHEM BIOPH RES CO, V162, P658, DOI 10.1016/0006-291X(89)92361-9; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; RADKE GA, 1993, BIOCHEM BIOPH RES CO, V190, P982, DOI 10.1006/bbrc.1993.1146; RAHMATULLAH M, 1990, J BIOL CHEM, V265, P14512; Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013; Rauh D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3327; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; ROCHE TE, 1993, BIOCHEMISTRY-US, V32, P5629, DOI 10.1021/bi00072a019; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Sherrod SD, 2012, J PROTEOME RES, V11, P3467, DOI 10.1021/pr201240a; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Tsai YC, 2012, MOL CELL PROTEOMICS, V11, P60, DOI 10.1074/mcp.A111.015156; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; WIELAND O, 1969, FEBS LETT, V3, P271, DOI 10.1016/0014-5793(69)80156-0; Wirth M, 2013, MITOCHONDRION, V13, P705, DOI 10.1016/j.mito.2013.02.002; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P14802, DOI 10.1073/pnas.011597698; Zhu YM, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-15	47	274	277	3	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1615	1625		10.1016/j.cell.2014.11.046	http://dx.doi.org/10.1016/j.cell.2014.11.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525879	Green Accepted, Bronze			2022-12-28	WOS:000347922500015
J	Colman, I; Kingsbury, M; Weeks, M; Ataullahjan, A; Belair, MA; Dykxhoorn, J; Hynes, K; Loro, A; Martin, MS; Naicker, K; Pollock, N; Rusu, C; Kirkbride, JB				Colman, Ian; Kingsbury, Mila; Weeks, Murray; Ataullahjan, Anushka; Belair, Marc-Andre; Dykxhoorn, Jennifer; Hynes, Katie; Loro, Alexandra; Martin, Michael S.; Naicker, Kiyuri; Pollock, Nathaniel; Rusu, Corneliu; Kirkbride, James B.			CHRISTMAS 2014: MEDIA STUDIES CARTOONS KILL: casualties in animated recreational theater in an objective observational new study of kids' introduction to loss of life	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILDRENS; EXPOSURE; VIOLENCE	Objectives To assess the risk of on-screen death of important characters in children's animated films versus dramatic films for adults. Design Kaplan-Meier survival analysis with Cox regression comparing time to first on-screen death. Setting Authors' television screens, with and without popcorn. Participants Important characters in 45 top grossing children's animated films and a comparison group of 90 top grossing dramatic films for adults. Main outcome measures Time to first on-screen death. Results Important characters in children's animated films were at an increased risk of death compared with characters in dramatic films for adults (hazard ratio 2.52, 95% confidence interval 1.30 to 4.90). Risk of on-screen murder of important characters was higher in children's animated films than in comparison films (2.78, 1.02 to 7.58). Conclusions Rather than being the innocuous form of entertainment they are assumed to be, children's animated films are rife with on-screen death and murder.	[Colman, Ian; Kingsbury, Mila; Weeks, Murray; Belair, Marc-Andre; Dykxhoorn, Jennifer; Hynes, Katie; Loro, Alexandra; Martin, Michael S.; Naicker, Kiyuri; Rusu, Corneliu] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Ataullahjan, Anushka] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Pollock, Nathaniel] Mem Univ, Div Community Hlth & Humanities, St John, NF, Canada; [Kirkbride, James B.] UCL, Div Psychiat, London, England	University of Ottawa; University of Alberta; Memorial University Newfoundland; University of London; University College London	Colman, I (corresponding author), Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada.	icolman@uottawa.ca	Rusu, Corneliu/B-9753-2013; Ataullahjan, Anushka/AAV-8082-2021; Dykxhoorn, Jennifer/J-1759-2019; Martin, Michael S./AAA-1290-2020; Kirkbride, James B./A-9345-2008	Ataullahjan, Anushka/0000-0001-5261-5523; Dykxhoorn, Jennifer/0000-0001-6391-8626; Martin, Michael S./0000-0002-5056-618X; Kirkbride, James B./0000-0003-3401-0824; Colman, Ian/0000-0001-5924-0277	Canada Research Chairs program; Wellcome Trust [101272/Z/13/Z]; Royal Society [101272/Z/13/Z]	Canada Research Chairs program(Canada Research Chairs); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	This research was supported, in part, by funding from the Canada Research Chairs program for IC. JBK is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant No 101272/Z/13/Z).	[Anonymous], 2012, SPSS STAT WIND PROGR; Box Office Mojo, DOM GROSS ADJ TICK P; Boxer S, 2014, ATLANTIC; Brent SB, 1996, OMEGA-J DEATH DYING, V33, P67, DOI 10.2190/27L7-G7Q1-DY5Q-J9F3; Busso DS, 2014, DEPRESS ANXIETY, V31, P551, DOI 10.1002/da.22282; Cantor J, 2000, J ADOLESCENT HEALTH, V27, P30, DOI 10.1016/S1054-139X(00)00129-4; Cantor J, 1999, WESTERN J COMM, V63, P57; Cantor J, 1996, J COMMUN, V46, P139, DOI 10.1111/j.1460-2466.1996.tb01510.x; Cantor J, 2001, HDB CHILDREN MEDIA; Cox M, 2004, OMEGA-J DEATH DYING, V50, P267; Dobrow JR, 1990, SOCIAL CULTURAL ASPE, P181; Ehrenrelch JT, 2008, BEHAV PSYCHOL, V16, P389; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Haas L, 1995, MOUSE MERMAID POLITI, P193; HAPKIEWICZ WG, 1979, J CLIN CHILD PSYCHOL, V8, P30, DOI 10.1080/15374417909532878; Hoekstra SJ, 1999, MEDIA PSYCHOL, V1, P117, DOI DOI 10.1207/S1532785XMEP0102_; McDonald P, 2013, ORG POPULAR CULTURE; McDonough P, 2009, TV VIEWING KIDS 8 YE; Moss JP, 1972, ELEM ENGL, V49, P530; Motion Picture Association of America, FILM RAT; Poulton S, 2010, DAILY MAIL ONLINE 20; Schultz NW, 2000, OMEGA-J DEATH DYING, V42, P137; Sedney MA, 2002, AM J ORTHOPSYCHIAT, V72, P279, DOI 10.1037/0002-9432.72.2.279; Slyter M, 2012, J CREAT MENT HEALTH, V7, P17, DOI 10.1080/15401383.2012.657593; Stearns DC, 2004, GRIEF DEATH FUNERALS; Tatar Maria, 1987, HARD FACTS GRIMMSFAI; Vianello R, 1989, EARLY CHILD DEV CARE, V46, P97; Willis C.A., 2002, EARLY CHILD EDUC J, V29, P221, DOI DOI 10.1023/A:1015125422643	28	5	5	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2014	349								g7184	10.1136/bmj.g7184	http://dx.doi.org/10.1136/bmj.g7184			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX2HK	25515715	Green Published, hybrid			2022-12-28	WOS:000346763900003
J	Trivedi, AN; Nsa, W; Hausmann, LRM; Lee, JS; Ma, A; Bratzler, DW; Mor, MK; Baus, K; Larbi, F; Fine, MJ				Trivedi, Amal N.; Nsa, Wato; Hausmann, Leslie R. M.; Lee, Jonathan S.; Ma, Allen; Bratzler, Dale W.; Mor, Maria K.; Baus, Kristie; Larbi, Fiona; Fine, Michael J.			Quality and Equity of Care in US Hospitals	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TO-BALLOON TIME; ACUTE MYOCARDIAL-INFARCTION; HEALTH-CARE; OF-CARE; ETHNIC DISPARITIES; RACIAL DISPARITIES; BLACK PATIENTS; PERFORMANCE; RACE; VACCINATION	BACKGROUND Nearly every U.S. hospital publicly reports its performance on quality measures for patients who are hospitalized for acute myocardial infarction, heart failure, or pneumonia. Because performance rates are not reported according to race or ethnic group, it is unclear whether improvements in equity of care have accompanied aggregate improvements in health care quality over time. METHODS We assessed performance rates for quality measures covering three conditions (six measures for acute myocardial infarction, four for heart failure, and seven for pneumonia). These rates, adjusted for patient-and hospital-level covariates, were compared among non-Hispanic white, non-Hispanic black, and Hispanic patients who received care between 2005 and 2010 in acute care hospitals throughout the United States. RESULTS Adjusted performance rates for the 17 quality measures improved by 3.4 to 57.6 percentage points between 2005 and 2010 for white, black, and Hispanic adults (P<0.001 for all comparisons). In 2005, as compared with adjusted performance rates for white patients, adjusted performance rates were more than 5 percentage points lower for black patients on 3 measures (range of differences, 12.3 to 14.2) and for Hispanic patients on 6 measures (5.6 to 14.5). Gaps decreased significantly on all 9 of these measures between 2005 and 2010, with adjusted changes for differences between white patients and black patients ranging from -8.5 to -11.8 percentage points and from -6.2 to -15.1 percentage points for differences between white patients and Hispanic patients. Decreasing differences according to race or ethnic group were attributable to more equitable care for white patients and minority patients treated in the same hospital, as well as to greater performance improvements among hospitals that disproportionately serve minority patients. CONCLUSIONS Improved performance on quality measures for white, black, and Hispanic adults hospitalized for acute myocardial infarction, heart failure, or pneumonia was accompanied by increased racial and ethnic equity in performance rates both within and among U.S. hospitals.	[Trivedi, Amal N.] Brown Univ, Sch Publ Hlth, Providence Vet Affairs VA Med Ctr, Providence, RI 02903 USA; [Trivedi, Amal N.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02903 USA; [Nsa, Wato; Ma, Allen] Oklahoma Fdn Med Qual, Oklahoma City, OK USA; [Bratzler, Dale W.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Oklahoma City, OK 73190 USA; [Bratzler, Dale W.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK 73190 USA; [Hausmann, Leslie R. M.; Mor, Maria K.; Fine, Michael J.] VA Ctr Hlth Equ Res & Promot, VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Hausmann, Leslie R. M.; Lee, Jonathan S.; Fine, Michael J.] Univ Pittsburgh, Sch Med, Dept Med, Div Gen Internal Med, Pittsburgh, PA 15213 USA; [Mor, Maria K.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Baus, Kristie; Larbi, Fiona] Ctr Medicare & Medicaid Serv, Baltimore, MD USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Medicare & Medicaid Services	Trivedi, AN (corresponding author), Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, 121 S Main St,6th Fl, Providence, RI 02903 USA.	amal_trivedi@brown.edu		Bratzler, Dale/0000-0002-8033-7521	Centers for Medicare and Medicaid Services; Veterans Affairs Health Services Research and Development Career Development Program	Centers for Medicare and Medicaid Services; Veterans Affairs Health Services Research and Development Career Development Program	Funded by the Centers for Medicare and Medicaid Services and the Veterans Affairs Health Services Research and Development Career Development Program.	Al-Dehneh A, 2009, J INVASIVE CARDIOL, V21, P506; [Anonymous], 2003, MMWR MORB MORTAL WKL, V52, P68; BERWICK DM, 1991, MED CARE, V29, P1212, DOI 10.1097/00005650-199112000-00004; BLUSTEIN J, 1994, AM J PUBLIC HEALTH, V84, P1018, DOI 10.2105/AJPH.84.6.1018; Bradley EH, 2004, JAMA-J AM MED ASSOC, V292, P1563, DOI 10.1001/jama.292.13.1563; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Centers for Medicare and Medicaid Services, APU REC HOSP INP QUA; Centers for Medicare and Medicaid Services the Joint Commission, SPEC MAN NAT HOSP QU; Cohen MG, 2010, CIRCULATION, V121, P2294, DOI 10.1161/CIRCULATIONAHA.109.922286; Curtis JP, 2010, ARCH INTERN MED, V170, P992, DOI 10.1001/archinternmed.2010.165; Department of Health and Human Services, 2013, NAT HEALTHC QUAL REP; Dexter PR, 2004, JAMA-J AM MED ASSOC, V292, P2366, DOI 10.1001/jama.292.19.2366; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Hasnain-Wynia R, 2007, ARCH INTERN MED, V167, P1233, DOI 10.1001/archinte.167.12.1233; Hausmann LRM, 2014, MED CARE, V52, P328, DOI 10.1097/MLR.0000000000000099; Hausmann LRM, 2009, MED CARE, V47, P1009, DOI 10.1097/MLR.0b013e3181a80fdc; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Institute of Medicine, 2009, RACE ETHNICITY LANGU, DOI [10.17226/12696, DOI 10.17226/12696]; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Jha AK, 2008, HEALTH AFFAIR, V27, P528, DOI 10.1377/hlthaff.27.2.528; Jha AK, 2007, ARCH INTERN MED, V167, P1177, DOI 10.1001/archinte.167.11.1177; Jha AK, 2012, J GEN INTERN MED, V27, P297, DOI 10.1007/s11606-011-1880-9; Jones RG, 2010, SOC SCI MED, V70, P337, DOI 10.1016/j.socscimed.2009.10.030; Krumholz HM, 2011, CIRCULATION, V124, P1038, DOI 10.1161/CIRCULATIONAHA.111.044107; Landon BE, 2006, ARCH INTERN MED, V166, P2511, DOI 10.1001/archinte.166.22.2511; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770; Schwartz KL, 2006, J GEN INTERN MED, V21, P346, DOI 10.1111/j.1525-1497.2006.00401.x; Sehgal AR, 2003, JAMA-J AM MED ASSOC, V289, P996, DOI 10.1001/jama.289.8.996; Smith DB, 2007, HEALTH AFFAIR, V26, P1448, DOI 10.1377/hlthaff.26.5.1448; Thorlby R, 2011, MILBANK Q, V89, P226, DOI 10.1111/j.1468-0009.2011.00627.x; Trivedi AN, 2006, JAMA-J AM MED ASSOC, V296, P1998, DOI 10.1001/jama.296.16.1998; Trivedi AN, 2011, HEALTH AFFAIR, V30, P707, DOI 10.1377/hlthaff.2011.0074; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Zaslavsky AM, 2005, MED CARE, V43, P303, DOI 10.1097/01.mlr.0000159975.43573.8d	39	49	49	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					2298	2308		10.1056/NEJMoa1405003	http://dx.doi.org/10.1056/NEJMoa1405003			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW1KQ	25494269				2022-12-28	WOS:000346048800010
J	Beeching, NJ; Fenech, M; Houlihan, CF				Beeching, Nicholas J.; Fenech, Manuel; Houlihan, Catherine F.			Ebola virus disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HEMORRHAGIC-FEVER; NONHUMAN-PRIMATES; KIKWIT; CONGO; INFECTION; TRANSMISSION; PATHOGENESIS; PROTECTION; EPIDEMIC; OUTBREAK		[Beeching, Nicholas J.] Royal Liverpool Univ Hosp, Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Beeching, Nicholas J.; Fenech, Manuel] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England; [Houlihan, Catherine F.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Liverpool School of Tropical Medicine; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine	Beeching, NJ (corresponding author), Royal Liverpool Univ Hosp, Liverpool Sch Trop Med, Liverpool, Merseyside, England.	nicholas.beeching@rlbuht.nhs.uk	Y.J.Peter/W-5057-2019; Beckett, Gail/K-1519-2019; MALVY, Denis/T-7930-2019; Beeching, Nicholas J/L-5363-2017					[Anonymous], 2015, JOGNN-J OBST GYN NEO, V44, P164, DOI 10.1111/1552-6909.12518; [Anonymous], 1978, Bull World Health Organ, V56, P271; [Anonymous], 2014, AR EB OUTBR NIG SEN; [Anonymous], N ENGL J MED; [Anonymous], ANN PHARMACOTHER; [Anonymous], CAS DEF EB MARB VIR; [Anonymous], 2014, LAB GUID DIAGN EB VI; [Anonymous], AJR AM J ROENTGENOL; [Anonymous], LASS FEV OR RES TRAN; [Anonymous], MARB VIR DIS OR RES; [Anonymous], N ENGL J MED; [Anonymous], GUID PERS PROT EQUIP; [Anonymous], J AM SOC NEPHROL; [Anonymous], J INFECT DIS S1; [Anonymous], EB CLIN CAR GUID GUI; [Anonymous], 2014, CAS DEF EB VIR DIS E; [Anonymous], ANN INTERN MED; [Anonymous], OBSTET GYNECOL; [Anonymous], EB FACT SHEET; [Anonymous], EP UPD OUTBR EB VIR; [Anonymous], INT GUID MON MOV PER; [Anonymous], EB VIR DIS CLIN MAN; [Anonymous], CRIM CONG HAEM FEV O; [Anonymous], 2013, J THROMB HAEMOST; [Anonymous], JAMA PEDIAT; [Anonymous], INFECT DIS; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Beeching NJ, 2010, INT J ANTIMICROB AG, V36, pS26, DOI 10.1016/j.ijantimicag.2010.06.017; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Centers for Disease Control and Prevention, 2014, EB VIR DIS; Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084; Choi JH, 2013, BIODRUGS, V27, P565, DOI 10.1007/s40259-013-0046-1; Dananche C, 2014, LANCET, V384, P1743, DOI 10.1016/S0140-6736(14)61787-6; De Roo A, 1998, TROP MED INT HEALTH, V3, P883, DOI 10.1046/j.1365-3156.1998.00322.x; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284; EMOND RTD, 1977, BMJ-BRIT MED J, V2, P541, DOI 10.1136/bmj.2.6086.541; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Fletcher TE, 2014, INTENS CARE MED, V40, P1936, DOI 10.1007/s00134-014-3515-1; Fletcher TE, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5079; Formenty P, 1999, J INFECT DIS, V179, pS48, DOI 10.1086/514285; Fowler RA, 2014, AM J RESP CRIT CARE, V190, P733, DOI 10.1164/rccm.201408-1514CP; Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Goodman JL, 2014, NEW ENGL J MED, V371, P1086, DOI 10.1056/NEJMp1409817; Gulland A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6827; Hartskeerl RA, 2011, CLIN MICROBIOL INFEC, V17, P494, DOI 10.1111/j.1469-0691.2011.03474.x; Iversen PL, 2012, VIRUSES-BASEL, V4, P2806, DOI 10.3390/v4112806; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]; Leroy EM, 2011, CLIN MICROBIOL INFEC, V17, P964, DOI 10.1111/j.1469-0691.2011.03535.x; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Locsin R C, 2003, Int Nurs Rev, V50, P156, DOI 10.1046/j.1466-7657.2003.00194.x; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; Mahanty S, 2004, LANCET INFECT DIS, V4, P487, DOI 10.1016/S1473-3099(04)01103-X; McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5488; McElroy AK, 2014, EMERG INFECT DIS, V20, P1683, DOI 10.3201/eid2010.140430; McElroy AK, 2014, J INFECT DIS, V210, P558, DOI 10.1093/infdis/jiu088; Mendelson M, 2014, EMERG INFECT DIS, V20, P532, DOI 10.3201/eid2004.131128; Mupapa K, 1999, J INFECT DIS, V179, pS11, DOI 10.1086/514289; Mupere E, 2001, Afr Health Sci, V1, P60; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Ramanan P, 2012, P NATL ACAD SCI USA, V109, P20661, DOI 10.1073/pnas.1213559109; Ramanan P, 2011, VIRUSES-BASEL, V3, P1634, DOI 10.3390/v3091634; Reiter P, 1999, J INFECT DIS, V179, pS148, DOI 10.1086/514304; Roddy P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052986; Rollin PE, 2007, J INFECT DIS, V196, pS364, DOI 10.1086/520613; Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318; Sadek RF, 1999, J INFECT DIS, V179, pS24, DOI 10.1086/514311; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Thi EP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009706; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; Turone F, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7198; Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027; WHO, 2014, POT EB THER VACC; World Health Organization, 2014, CLIN MAN PAT VIR HAE; Zapata JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002858; Zhang YF, 2014, SCI CHINA LIFE SCI, V57, P987, DOI 10.1007/s11427-014-4746-7	84	66	71	2	123	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2014	349								g7348	10.1136/bmj.g7348	http://dx.doi.org/10.1136/bmj.g7348			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3DF	25497512	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000346165000008
J	Patel, MS; Volpp, KG; Small, DS; Hill, AS; Even-Shoshan, O; Rosenbaum, L; Ross, RN; Bellini, L; Zhu, JS; Silber, JH				Patel, Mitesh S.; Volpp, Kevin G.; Small, Dylan S.; Hill, Alexander S.; Even-Shoshan, Orit; Rosenbaum, Lisa; Ross, Richard N.; Bellini, Lisa; Zhu, Jingsan; Silber, Jeffrey H.			Association of the 2011 ACGME Resident Duty Hour Reforms With Mortality and Readmissions Among Hospitalized Medicare Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-CARE; COMORBIDITY MEASURES; INTERNAL-MEDICINE; ICD-9-CM; RECOMMENDATIONS; INFORMATION; EDUCATION; RULES; COST	IMPORTANCE Patient outcomes associated with the 2011 Accreditation Council for Graduate Medical Education (ACGME) duty hour reforms have not been evaluated at a national level. OBJECTIVE To evaluate the association of the 2011 ACGME duty hour reforms with mortality and readmissions. DESIGN, SETTING, AND PARTICIPANTS Observational study of Medicare patient admissions (6 384 273 admissions from 2 790 356 patients) to short-term, acute care, nonfederal hospitals (n = 3104) with principal medical diagnoses of acute myocardial infarction, stroke, gastrointestinal bleeding, or congestive heart failure or a Diagnosis Related Group classification of general, orthopedic, or vascular surgery. Of the hospitals, 96 (3.1%) were very major teaching, 138 (4.4%) major teaching, 442 (14.2%) minor teaching, 443 (14.3%) very minor teaching, and 1985 (64.0%) nonteaching. EXPOSURE Resident-to-bed ratio as a continuous measure of hospital teaching intensity. MAIN OUTCOMES AND MEASURES Change in 30-day all-location mortality and 30-day all-cause readmission, comparing patients in more intensive relative to less intensive teaching hospitals before (July 1, 2009-June 30, 2011) and after (July 1, 2011-June 30, 2012) duty hour reforms, adjusting for patient comorbidities, time trends, and hospital site. RESULTS In the 2 years before duty hour reforms, there were 4 325 854 admissions with 288 422 deaths and 602 380 readmissions. In the first year after the reforms, accounting for teaching hospital intensity, there were 2 058 419 admissions with 133 547 deaths and 272 938 readmissions. There were no significant postreform differences in mortality accounting for teaching hospital intensity for combined medical conditions (odds ratio [OR], 1.00; 95% CI, 0.96-1.03), combined surgical categories (OR, 0.99; 95% CI, 0.94-1.04), or any of the individual medical conditions or surgical categories. There were no significant postreform differences in readmissions for combined medical conditions (OR, 1.00; 95% CI, 0.97-1.02) or combined surgical categories (OR, 1.00; 95% CI, 0.98-1.03). For the medical condition of stroke, there were higher odds of readmissions in the postreform period (OR, 1.06; 95% CI, 1.001-1.13). However, this finding was not supported by sensitivity analyses and there were no significant postreform differences for readmissions for any other individual medical condition or surgical category. CONCLUSIONS AND RELEVANCE Among Medicare beneficiaries, there were no significant differences in the change in 30-day mortality rates or 30-day all-cause readmission rates for those hospitalized in more intensive relative to less intensive teaching hospitals in the year after implementation of the 2011 ACGME duty hour reforms compared with those hospitalized in the 2 years before implementation. Copyright 2014 American Medical Association. All rights reserved.	[Patel, Mitesh S.; Volpp, Kevin G.] Vet Adm Hosp, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Patel, Mitesh S.; Volpp, Kevin G.; Bellini, Lisa; Zhu, Jingsan] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Patel, Mitesh S.; Volpp, Kevin G.; Silber, Jeffrey H.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA; [Patel, Mitesh S.; Volpp, Kevin G.; Small, Dylan S.; Zhu, Jingsan] Univ Penn, Leonard Davis Inst, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Volpp, Kevin G.] Univ Penn, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Small, Dylan S.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Hill, Alexander S.; Even-Shoshan, Orit; Ross, Richard N.; Silber, Jeffrey H.] Childrens Hosp Philadelphia, Ctr Outcomes Res, Philadelphia, PA 19104 USA; [Even-Shoshan, Orit; Silber, Jeffrey H.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Rosenbaum, Lisa] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Silber, Jeffrey H.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Patel, MS (corresponding author), Univ Penn, 423 Guardian Dr,12th Floor,Blockley Hall, Philadelphia, PA 19104 USA.	mpatel@upenn.edu		Volpp, Kevin/0000-0003-1423-4599	National Heart, Lung, and Blood Institute [RO1-HLO94593]; Department of Veteran Affairs; Robert Wood Johnson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094593] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veteran Affairs(US Department of Veterans Affairs); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was funded in part through National Heart, Lung, and Blood Institute grant RO1-HLO94593. Dr Patel was supported by the Department of Veteran Affairs and the Robert Wood Johnson Foundation.	Allison JJ, 2000, JAMA-J AM MED ASSOC, V284, P1256, DOI 10.1001/jama.284.10.1256; Antiel RM, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMp1008305; Campbell D. T., 1963, EXPT QUASIEXPERIMENT, P171; Centers for Medicare and Medicaid Services, READM RED PROGR; Centers for Medicare & Medicaid Services, 30 DAY UNPL READM DE; Centers for Medicare & Medicaid Services, PARTN FOR PAT; Davison AC, 1997, BOOTSTRAP METHODS TH, DOI [10.1017/CBO9780511802843, DOI 10.2307/1271471]; Desai SV, 2013, JAMA INTERN MED, V173, P649, DOI 10.1001/jamainternmed.2013.2973; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Drolet BC, 2013, JAMA SURG, V148, P427, DOI 10.1001/jamasurg.2013.169; Efron Bradley., 1993, INTRO BOOTSTRAP, DOI 10.1007/978-1-4899-4541-9; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Field CA, 2007, J R STAT SOC B, V69, P369, DOI 10.1111/j.1467-9868.2007.00593.x; Gerhardt G, 2013, MEDICARE MEDICAID RE, V3, P1; Glance LG, 2006, HEALTH SERV RES, V41, P231, DOI 10.1111/j.1475-6773.2005.00419.x; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; IEZZONI LI, 1988, ANN INTERN MED, V109, P745, DOI 10.7326/0003-4819-109-9-745; Iezzoni LI, 2003, RISK ADJUSTMENT MEAS; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; KEELER EB, 1992, JAMA-J AM MED ASSOC, V268, P1709, DOI 10.1001/jama.268.13.1709; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; MEYER BD, 1995, J BUS ECON STAT, V13, P151, DOI 10.2307/1392369; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; Nuckols TK, 2012, J GEN INTERN MED, V27, P241, DOI 10.1007/s11606-011-1775-9; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Press MJ, 2011, J GEN INTERN MED, V26, P405, DOI 10.1007/s11606-010-1539-y; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Romano PS, 2012, J GEN INTERN MED, V27, P136, DOI 10.1007/s11606-011-1936-x; Rosen AK, 2009, MED CARE, V47, P723, DOI 10.1097/MLR.0b013e31819a588f; Rosenbaum PR, 2001, J AM STAT ASSOC, V96, P210, DOI 10.1198/016214501750333072; Sen S, 2013, JAMA INTERN MED, V173, P657, DOI 10.1001/jamainternmed.2013.351; Shadish W. R., 2001, EXPT QUASIEXPERIMENT, V2nd; Shea JA, 2012, ACAD MED, V87, P895, DOI 10.1097/ACM.0b013e3182584118; Silber JH, 2009, MED CARE, V47, P1191, DOI 10.1097/MLR.0b013e3181adcbff; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Stukenborg GJ, 2001, MED CARE, V39, P727, DOI 10.1097/00005650-200107000-00009; Suter LG, 2014, J GEN INTERN MED, V29, P1333, DOI 10.1007/s11606-014-2862-5; Szymczak JE, 2010, MILBANK Q, V88, P350, DOI 10.1111/j.1468-0009.2010.00603.x; Taylor DH, 1999, NEW ENGL J MED, V340, P293, DOI 10.1056/NEJM199901283400408; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Volpp KG, 2013, J GEN INTERN MED, V28, P1048, DOI 10.1007/s11606-013-2401-9; Volpp KG, 2009, J GEN INTERN MED, V24, P1149, DOI 10.1007/s11606-009-1011-z	46	81	82	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2364	2373		10.1001/jama.2014.15273	http://dx.doi.org/10.1001/jama.2014.15273			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YB	25490327	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000346345700011
J	[Anonymous]				[Anonymous]			Choice of a Medical School (Reprinted from JAMA, vol 63, pg 690-691, 1914)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1914, JAMA, V63, P690	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2415	2415		10.1001/jama.2013.279888	http://dx.doi.org/10.1001/jama.2013.279888			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YB	25490342				2022-12-28	WOS:000346345700025
J	Mazumder, S; Taneja, S; Bhatia, K; Yoshida, S; Kaur, J; Dube, B; Toteja, GS; Bahl, R; Fontaine, O; Martines, J; Bhandari, N				Mazumder, Sarmila; Taneja, Sunita; Bhatia, Kiran; Yoshida, Sachiyo; Kaur, Jasmine; Dube, Brinda; Toteja, G. S.; Bahl, Rajiv; Fontaine, Olivier; Martines, Jose; Bhandari, Nita		Neovita India Study Grp	Efficacy of early neonatal supplementation with vitamin A to reduce mortality in infancy in Haryana, India (Neovita): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							CHILDREN; RETINOL; MORBIDITY; ILLNESS; MOTHERS; IMPACT	Background Vitamin A supplementation in children aged 6 months to 5 years has been shown to reduce mortality. The efficacy of neonatal supplementation with vitamin A to reduce mortality in the first 6 months of life is plausible but not established. We aimed to assess the efficacy of neonatal oral supplementation with vitamin A to reduce mortality between supplementation and 6 months of age. Methods We undertook an individually randomised, double-blind, placebo-controlled trial in Haryana, India. We identified pregnant women through a surveillance programme undertaken every 3 months of all female residents in two districts of Haryana, India, aged 15-49 years, and screened every identified livebirth. Eligible participants were neonates whose parents consented to participate, were likely to stay in the study area until at least 6 months of age, and were able to feed orally at the time of enrolment. Participants were randomly assigned to receive oral capsules containing vitamin A (retinol palmitate 50 000 IU plus vitamin E 9.5-12.6 IU) or placebo (vitamin E 9.5-12.6 IU) within 72 h of birth. Randomisation was in blocks of 20 according to a randomisation list prepared by a statistician not otherwise involved with the trial. Investigators, participants' families, and the data analysis team were masked to treatment allocation. The primary outcome was mortality between supplementation and 6 months of age. Analysis included all participants assigned to study groups. This trial is registered with ClinicalTrials.gov, number NCT01138449, and the Indian Council of Medical Research Clinical Trial Registry, number CTRI/2010/091/000220. Findings Between June 24, 2010, and July 1, 2012 we screened 47 777 neonates and randomly assigned 44 984 to receive vitamin A (22 493) or placebo (22 491). Between supplementation and 6 months of age, 656 infants died in the vitamin A group compared with 726 in the placebo group (29.2 per 1000 vs 32.3 per 1000; difference -3.1 per 1000, 95% CI -6.3 to 0.1; risk ratio 0.90, 95% CI 0.81 to 1.00). We noted no significant interactions between the intervention effect and sex on mortality at 6 months (p=0.409). Supplementation with 50 000 IU vitamin A within the first 72 h of life was generally safe and well tolerated, with the exception of a small excess risk of transient bulging fontanelle (205 cases in the vitamin A group confirmed by physician vs 80 cases in the placebo group, risk ratio 2.56 [95% CI 1.8-3.32]). Interpretation The findings of this study, done in a population in which vitamin A deficiency is a moderate public health problem, are consistent with a modest reduction in mortality between supplementation and 6 months of age. These findings must be viewed together with similar trials in other populations to enable determination of appropriate public health policy.	[Mazumder, Sarmila; Taneja, Sunita; Bhatia, Kiran; Kaur, Jasmine; Dube, Brinda; Bhandari, Nita] Soc Appl Studies, Ctr Hlth Res & Dev, New Delhi 110016, India; [Toteja, G. S.] Indian Council Med Res, Ctr Promot Nutr Res & Training, New Delhi, India; [Yoshida, Sachiyo; Bahl, Rajiv; Fontaine, Olivier] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Martines, Jose] Univ Bergen, Ctr Int Hlth, Ctr Intervent Sci Maternal & Child Hlth CISMAC, Bergen, Norway	Indian Council of Medical Research (ICMR); World Health Organization; University of Bergen	Bhandari, N (corresponding author), Soc Appl Studies, Ctr Hlth Res & Dev, New Delhi 110016, India.	CHRD@sas.org.in	Mazumder, Sarmila/AAD-8952-2020; Martines, Jose Carlos/ABE-4082-2020	Mazumder, Sarmila/0000-0003-4200-6112; 	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Anand K, 2007, INDIAN PEDIATR, V44, P823; [Anonymous], 2009, WHO GLOBAL DATABASE; Awasthi S, 2013, LANCET, V381, P1469, DOI 10.1016/S0140-6736(12)62125-4; Benn CS, 2008, BMJ-BRIT MED J, V336, P1416, DOI 10.1136/bmj.39542.509444.AE; Benn CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1101; Bhandari N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1634; Bhutta ZA, 2008, LANCET, V371, P1746, DOI 10.1016/S0140-6736(08)60751-5; BIERI JG, 1979, AM J CLIN NUTR, V32, P2143, DOI 10.1093/ajcn/32.10.2143; Darboe MK, 2007, LANCET, V369, P2088, DOI 10.1016/S0140-6736(07)60981-7; de Pee S, 2002, J NUTR, V132, p2895S, DOI 10.1093/jn/132.9.2895S; Edmond KM, 2014, LANCET; Gogia S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b919; Haider BA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006980.pub2; Humphrey JH, 1996, J PEDIATR-US, V128, P489, DOI 10.1016/S0022-3476(96)70359-1; Idindili B, 2007, AM J CLIN NUTR, V85, P1312, DOI 10.1093/ajcn/85.5.1312; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S20; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Klemm RDW, 2008, PEDIATRICS, V122, pE242, DOI 10.1542/peds.2007-3448; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Malaba LC, 2005, AM J CLIN NUTR, V81, P454, DOI 10.1093/ajcn.81.2.454; Martines J, 1998, LANCET, V352, P1257, DOI 10.1016/S0140-6736(98)02487-8; Masanja H, 2014, LANCET; Mayo-Wilson E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5094; National AIDS Control Organisation, 2007, HIV SENT SURV HIV ES; Neovita Study Author Group, 2012, TRIALS, V13, P22; Rahmathullah L, 2003, BMJ-BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254; Rotondi MA, 2010, B WORLD HEALTH ORGAN, V88, P697, DOI 10.2471/BLT.09.068080; Sachdev HS, 2010, B WORLD HEALTH ORGAN, V88, p875A; UNICEF, LEV TRENDS CHILD MOR; WEST KP, 1995, AM J CLIN NUTR, V62, P143, DOI 10.1093/ajcn/62.1.143; WHO, 2009, TECHN CONS NEON VIT	31	54	54	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1333	1342		10.1016/S0140-6736(14)60891-6	http://dx.doi.org/10.1016/S0140-6736(14)60891-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25499546				2022-12-28	WOS:000352272400039
J	Mandl, JN; Ahmed, R; Barreiro, LB; Daszak, P; Epstein, JH; Virgin, HW; Feinberg, MB				Mandl, Judith N.; Ahmed, Rafi; Barreiro, Luis B.; Daszak, Peter; Epstein, Jonathan H.; Virgin, Herbert W.; Feinberg, Mark B.			Reservoir Host Immune Responses to Emerging Zoonotic Viruses	CELL			English	Review							AFRICAN-GREEN MONKEYS; NONPATHOGENIC SIV INFECTION; EBOLA HEMORRHAGIC-FEVER; CD4(+) T-CELLS; NIPAH VIRUS; INFLUENZA-VIRUS; PTEROPID BATS; RISK-FACTORS; NATURAL RESERVOIR; GENETIC-ANALYSIS	Zoonotic viruses, such as HIV, Ebola virus, coronaviruses, influenza A viruses, hantaviruses, or henipaviruses, can result in profound pathology in humans. In contrast, populations of the reservoir hosts of zoonotic pathogens often appear to tolerate these infections with little evidence of disease. Why are viruses more dangerous in one species than another? Immunological studies investigating quantitative and qualitative differences in the host-virus equilibrium in animal reservoirs will be key to answering this question, informing new approaches for treating and preventing zoonotic diseases. Integrating an understanding of host immune responses with epidemiological, ecological, and evolutionary insights into viral emergence will shed light on mechanisms that minimize fitness costs associated with viral infection, facilitate transmission to other hosts, and underlie the association of specific reservoir hosts with multiple emerging viruses. Reservoir host studies provide a rich opportunity for elucidating fundamental immunological processes and their underlying genetic basis, in the context of distinct physiological and metabolic constraints that contribute to host resistance and disease tolerance.	[Mandl, Judith N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Barreiro, Luis B.] Univ Montreal, St Justine Hosp Res Ctr, Dept Pediat, Montreal, PQ H3T 1J4, Canada; [Daszak, Peter; Epstein, Jonathan H.] EcoHlth Alliance, New York, NY 10001 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Feinberg, Mark B.] Merck & Co Inc, Merck Vaccines, West Point, PA 19486 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; EcoHealth Alliance; Washington University (WUSTL); Merck & Company	Mandl, JN (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ H3G 0B1, Canada.	mandlj@niaid.nih.gov	Barreiro, Luis/I-7772-2015; daszak, peter/U-4588-2017	daszak, peter/0000-0002-2046-5695; Barreiro, Luis/0000-0001-9456-367X; Virgin, Herbert/0000-0001-8580-7628	Intramural Research Program of NIAID, NIH; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Intramural Research Program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Nienke Vrisekoop, Roland Regoes, and Ronald Germain for insightful comments, support, and advice during the preparation of this manuscript. We are also extremely grateful to Tony Schountz and our anonymous reviewers for their reading of the manuscript and their very thoughtful feedback. This work was supported, in part, by the Intramural Research Program of NIAID, NIH.	AHMED R, 1988, J VIROL, V62, P3301, DOI 10.1128/JVI.62.9.3301-3308.1988; Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Barreiro LB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001249; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Beaumier CM, 2009, NAT MED, V15, P879, DOI 10.1038/nm.1970; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Biek R, 2006, PLOS PATHOG, V2, P885, DOI 10.1371/journal.ppat.0020090; Blackwood JC, 2013, P NATL ACAD SCI USA, V110, P20837, DOI 10.1073/pnas.1308817110; Bosinger SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003597; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; Breed AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061316; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brinkworth JF, 2012, J MED PRIMATOL, V41, P388, DOI 10.1111/jmp.12002; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Cameron MJ, 2008, VIRUS RES, V133, P13, DOI 10.1016/j.virusres.2007.02.014; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Demma LJ, 2005, PLOS PATHOG, V1, P29, DOI 10.1371/journal.ppat.0010003; Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284; Easterbrook JD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000172; Epstein JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067584; Feuer R, 1999, J VIROL, V73, P9544, DOI 10.1128/JVI.73.11.9544-9554.1999; Figueiredo N, 2013, IMMUNITY, V39, P874, DOI 10.1016/j.immuni.2013.08.039; Frebel H, 2012, J EXP MED, V209, P2485, DOI 10.1084/jem.20121015; Geisbert TW, 2012, CURR TOP MICROBIOL, V359, P153, DOI 10.1007/82_2012_208; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Hastie KM, 2012, CURR OPIN VIROL, V2, P151, DOI 10.1016/j.coviro.2012.01.003; Herbst MM, 2002, CYTOKINE, V17, P203, DOI 10.1006/cyto.2001.0998; Holmes EC, 2007, CURR TOP MICROBIOL, V315, P51; Iwasaki A, 2012, ANNU REV MICROBIOL, V66, P177, DOI 10.1146/annurev-micro-092611-150203; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Jeney V, 2014, CELL REP, V8, P126, DOI 10.1016/j.celrep.2014.05.054; Jin CC, 2013, CELL METAB, V17, P873, DOI 10.1016/j.cmet.2013.05.011; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kaur A, 1998, J VIROL, V72, P9597, DOI 10.1128/JVI.72.12.9597-9611.1998; Keele BF, 2009, NATURE, V460, P515, DOI 10.1038/nature08200; Kominsky DJ, 2010, J IMMUNOL, V184, P4062, DOI 10.4049/jimmunol.0903002; Kornfeld C, 2005, J CLIN INVEST, V115, P1082, DOI 10.1172/JCI200523006; Kuiken T, 2012, CURR OPIN VIROL, V2, P276, DOI 10.1016/j.coviro.2012.02.013; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Mackenzie JS, 2013, CURR OPIN VIROL, V3, P170, DOI 10.1016/j.coviro.2013.02.002; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Mandl JN, 2011, J IMMUNOL, V186, P6406, DOI 10.4049/jimmunol.1001191; Marston HD, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009872; Martinez O, 2012, ANTIVIR RES, V93, P416, DOI 10.1016/j.antiviral.2012.01.011; Menachery VD, 2014, MBIO, V5, DOI 10.1128/mBio.01174-14; Meteyer CU, 2012, VIRULENCE, V3, P583, DOI 10.4161/viru.22330; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Miedema F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00298; Misasi J, 2014, CELL, V159, P477, DOI 10.1016/j.cell.2014.10.006; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Oldstone MBA, 2014, CURR TOP MICROBIOL, V378, P129, DOI 10.1007/978-3-319-05879-5_6; Olival K.J., 2013, NEW DIRECTIONS CONSE, P195; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Paiardini M, 2011, NAT MED, V17, P830, DOI 10.1038/nm.2395; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Pandrea Ivona, 2010, Curr HIV/AIDS Rep, V7, P28, DOI 10.1007/s11904-009-0034-8; Parashar UD, 2000, J INFECT DIS, V181, P1755, DOI 10.1086/315457; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Peiris JSM, 2010, CURR OPIN IMMUNOL, V22, P475, DOI 10.1016/j.coi.2010.06.003; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Penaloza-MacMaster P, 2014, J EXP MED, V211, P1905, DOI 10.1084/jem.20132577; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Pothlichet J, 2013, INT REV IMMUNOL, V32, P157, DOI 10.3109/08830185.2013.777064; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; Quan PL, 2013, P NATL ACAD SCI USA, V110, P8194, DOI 10.1073/pnas.1303037110; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rahman SA, 2013, EMERG INFECT DIS, V19, P51, DOI 10.3201/eid1901.120221; Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Regoes RR, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001951; Rodrigue-Gervais IG, 2014, CELL HOST MICROBE, V15, P23, DOI 10.1016/j.chom.2013.12.003; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Sauter D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00163; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schountz T, 2014, VIRUSES-BASEL, V6, P1317, DOI 10.3390/v6031317; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sohayati AR, 2011, EPIDEMIOL INFECT, V139, P1570, DOI 10.1017/S0950268811000550; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Totura AL, 2012, CURR OPIN VIROL, V2, P264, DOI 10.1016/j.coviro.2012.04.004; Turmelle AS, 2010, J GEN VIROL, V91, P2360, DOI 10.1099/vir.0.020073-0; Verhagen JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038256; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Weber B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003900; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zampieri CA, 2007, NAT IMMUNOL, V8, P1159, DOI 10.1038/ni1519; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111	124	91	91	3	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					20	35		10.1016/j.cell.2014.12.003	http://dx.doi.org/10.1016/j.cell.2014.12.003			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25533784	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000347923200006
J	Bagley, N; Jones, DK; Jost, TS				Bagley, Nicholas; Jones, David K.; Jost, Timothy Stoltzfus			Predicting the Fallout from King v. Burwell - Exchanges and the ACA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bagley, Nicholas] Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA; [Jones, David K.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Jost, Timothy Stoltzfus] Washington & Lee Univ Sch Law, Lexington, VA USA	University of Michigan System; University of Michigan; Boston University; Washington & Lee University	Bagley, N (corresponding author), Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA.							Centers for Medicare & Medicaid Services, BLUEPR APPR AFF STAT; Levitt L, POTENTIAL SIDE EFFEC; Your Health Idaho, AB US	3	10	10	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2015	372	2					101	104		10.1056/NEJMp1414191	http://dx.doi.org/10.1056/NEJMp1414191			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY2UA	25493976	Bronze, Green Published			2022-12-28	WOS:000347443300002
J	Adams, B				Adams, Ben			The pioneers of transparency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEURAMINIDASE INHIBITORS					benjohnadams26@gmail.com						Abbasi K., 2014, BMJ-BRIT MED J, V358, pg2695, DOI [DOI 10.1136/BMJ.G2695, 10.1136/bmj.g2695]; ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; COWLEY AJ, 1993, INT J CARDIOL, V40, P161, DOI 10.1016/0167-5273(93)90279-P; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; Eichler HG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001202; European Medicines Agency, 2014, EUR MED AG POL PUBL; Gotzsche PC, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8522; Gotzsche PC, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2686; Goyens M, EMA TRANSPARENCY POL; Groves T, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6276; Jefferson Tom, 2009, BMJ, V339, pb5106, DOI 10.1136/bmj.b5106; Liberati A, 2004, BMJ-BRIT MED J, V328, P531, DOI 10.1136/bmj.328.7438.531; O'Reilly E., OMBUDSMAN CHANGE POL; Payne D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7303; Savulescu J, 1996, BMJ-BRIT MED J, V313, P1390, DOI 10.1136/bmj.313.7069.1390; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374; Smith R., 2012, BMJ-BRIT MED J, V344, pe1101; Vedula SS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001378; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wieseler B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001526; Wieseler B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4942	23	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2015	350								g7717	10.1136/bmj.g7717	http://dx.doi.org/10.1136/bmj.g7717			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2ZG	25555823				2022-12-28	WOS:000365564700002
J	Yang, TG; Chen, J; Huang, L; Wang, T; Xiao, CL; Sun, ZG; Dai, DX; Yang, XM; Zhang, DH				Yang, Tiangang; Chen, Jun; Huang, Long; Wang, Tao; Xiao, Chunlei; Sun, Zhigang; Dai, Dongxu; Yang, Xueming; Zhang, Dong H.			Extremely short-lived reaction resonances in Cl plus HD (v=1) -> DCl plus H due to chemical bond softening	SCIENCE			English	Article							DIFFERENTIAL CROSS-SECTIONS; TRANSITION-STATE; DYNAMICAL RESONANCES; SCATTERING; SPECTROSCOPY; MOLECULES; BEAM	The Cl + H-2 reaction is an important benchmark system in the study of chemical reaction dynamics that has always appeared to proceed via a direct abstraction mechanism, with no clear signature of reaction resonances. Here we report a high-resolution crossed-molecular beam study on the Cl + HD (v = 1, j = 0) -> DCl + H reaction (where v is the vibrational quantum number and j is the rotational quantum number). Very few forward scattered products were observed. However, two distinctive peaks at collision energies of 2.4 and 4.3 kilocalories per mole for the DCl (v' = 1) product were detected in the backward scattering direction. Detailed quantum dynamics calculations on a highly accurate potential energy surface suggested that these features originate from two very short-lived dynamical resonances trapped in the peculiar H-DCl (v' = 2) vibrational adiabatic potential wells that result from chemical bond softening. We anticipate that dynamical resonances trapped in such wells exist in many reactions involving vibrationally excited molecules.	[Yang, Tiangang; Chen, Jun; Huang, Long; Wang, Tao; Xiao, Chunlei; Sun, Zhigang; Dai, Dongxu; Yang, Xueming; Zhang, Dong H.] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Liaoning, Peoples R China; [Yang, Tiangang] Dalian Univ Technol, Sch Phys & Optoelect Engn, Dalian 116023, Liaoning, Peoples R China; [Sun, Zhigang; Yang, Xueming; Zhang, Dong H.] Univ Sci & Technol China, Ctr Adv Chem Phys, Hefei 230026, Peoples R China; [Sun, Zhigang; Yang, Xueming; Zhang, Dong H.] Univ Sci & Technol China, Frontier Ctr Quantum Sci & Technol 2011, Hefei 230026, Peoples R China	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Dalian University of Technology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Xiao, CL (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Liaoning, Peoples R China.	chunleixiao@dicp.ac.cn; zsun@dicp.ac.cn; xmyang@dicp.ac.cn; zhangdh@dicp.ac.cn	Sun, Zhigang/B-5757-2011; Yang, Tiangang/A-3962-2015; Yang, Xueming/C-8764-2013; Yang, Tiangang/C-8788-2013; CHEN, Jun/A-6437-2014; xiao, chunlei/D-1019-2014	Yang, Tiangang/0000-0002-8940-8875; CHEN, Jun/0000-0002-8021-7458; xiao, chunlei/0000-0002-1549-5945	National Natural Science Foundation of China; Ministry of Science and Technology of China; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China, the Ministry of Science and Technology of China, and the Key Research Program of the Chinese Academy of Sciences.	Alagia M, 1996, SCIENCE, V273, P1519, DOI 10.1126/science.273.5281.1519; Alexander MH, 2002, SCIENCE, V296, P715, DOI 10.1126/science.1070472; Althorpe SC, 2003, ANNU REV PHYS CHEM, V54, P493, DOI 10.1146/annurev.physchem.54.011002.103750; Ferguson MJ, 2002, J CHEM PHYS, V117, P8181, DOI 10.1063/1.1518998; Fernandez-Alonso F, 2002, ANNU REV PHYS CHEM, V53, P67, DOI 10.1146/annurev.physchem.53.091001.094554; Garand E, 2008, SCIENCE, V319, P72, DOI 10.1126/science.1150602; Hirschfelder J, 1936, J CHEM PHYS, V4, P170, DOI 10.1063/1.1749815; Johnston H.S., 1966, GAS PHASE REACTION R; Kandel SA, 2000, J CHEM PHYS, V112, P670, DOI 10.1063/1.480602; KUMARAN SS, 1994, J CHEM PHYS, V101, P9487, DOI 10.1063/1.468486; LEVINE RD, 1971, CHEM PHYS LETT, V11, P557, DOI 10.1016/0009-2614(71)87003-3; Liu KP, 2012, ADV CHEM PHYS, V149, P1; MANOLOPOULOS DE, 1993, SCIENCE, V262, P1852, DOI 10.1126/science.262.5141.1852; Mukherjee N, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4790402; Mukherjee N, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3657832; NEUMARK DM, 1984, PHYS REV LETT, V53, P226, DOI 10.1103/PhysRevLett.53.226; Neumark DN, 1996, SCIENCE, V272, P1446, DOI 10.1126/science.272.5267.1446; Otto R, 2014, SCIENCE, V343, P396, DOI 10.1126/science.1247424; Qiu MH, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1960718; Qiu MH, 2006, SCIENCE, V311, P1440, DOI 10.1126/science.1123452; Ren ZF, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2140338; Schatz GC, 2000, SCIENCE, V288, P1599, DOI 10.1126/science.288.5471.1599; SCHATZ GC, 1973, J CHEM PHYS, V58, P4023, DOI 10.1063/1.1679760; Schnieder L, 1997, J CHEM PHYS, V107, P6175, DOI 10.1063/1.474283; Skodje RT, 2000, PHYS REV LETT, V85, P1206, DOI 10.1103/PhysRevLett.85.1206; Skouteris D, 1999, SCIENCE, V286, P1713, DOI 10.1126/science.286.5445.1713; Skouteris D, 2001, J CHEM PHYS, V114, P10662, DOI 10.1063/1.1372764; Srinivasan J, 1999, J PHYS CHEM A, V103, P1487, DOI 10.1021/jp984549k; Sun ZG, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3328109; WALLER IM, 1990, J PHYS CHEM-US, V94, P2240, DOI 10.1021/j100369a009; Wang T, 2013, SCIENCE, V342, P1499, DOI 10.1126/science.1246546; Wang T, 2013, J PHYS CHEM LETT, V4, P368, DOI 10.1021/jz302103u; Wang XG, 2008, SCIENCE, V322, P573, DOI 10.1126/science.1163195; Wang YJ, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4941380; Zhang BL, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1871894; Zhou JG, 2004, J CHEM PHYS, V121, P813, DOI 10.1063/1.1761051; Zhou JG, 2010, MOL PHYS, V108, P957, DOI 10.1080/00268971003601589	37	82	89	12	363	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					60	63		10.1126/science.1260527	http://dx.doi.org/10.1126/science.1260527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554783				2022-12-28	WOS:000347102300047
J	Hartmann, LC; Degnim, AC; Santen, RJ; Dupont, WD; Ghosh, K				Hartmann, Lynn C.; Degnim, Amy C.; Santen, Richard J.; Dupont, William D.; Ghosh, Karthik			Atypical Hyperplasia of the Breast - Risk Assessment and Management Options	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURGICAL ADJUVANT BREAST; CARCINOMA IN-SITU; TERM-FOLLOW-UP; CANCER-RISK; DUCTAL HYPERPLASIA; BOWEL PROJECT; CORE BIOPSY; PROPHYLACTIC MASTECTOMY; POSTMENOPAUSAL WOMEN; LOBULAR HYPERPLASIA		[Hartmann, Lynn C.] Mayo Clin, Dept Oncol, Rochester, MN 55902 USA; [Degnim, Amy C.] Mayo Clin, Dept Surg, Rochester, MN USA; [Ghosh, Karthik] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Santen, Richard J.] Univ Virginia, Dept Endocrinol & Metab Med, Charlottesville, VA USA; [Dupont, William D.] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Virginia; Vanderbilt University	Hartmann, LC (corresponding author), Mayo Clin, Dept Oncol, Rochester, MN 55902 USA.				NCATS NIH HHS [UL1 TR000445] Funding Source: Medline; NCI NIH HHS [1P50 CA098131, K12 CA090628, P30 CA015083, P50 CA116201, P30 CA068485, R01 CA050468, P50 CA098131] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA068485, P50CA098131, R01CA050468, P50CA116201, P30CA015083, K12CA090628] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Allred DC, 2012, J CLIN ONCOL, V30, P1268, DOI 10.1200/JCO.2010.34.0141; Allred DC, 2001, ENDOCR-RELAT CANCER, V8, P47, DOI 10.1677/erc.0.0080047; American Cancer Society, 2014, REC EARL BREAST CANC; [Anonymous], 1986, Arch Pathol Lab Med, V110, P171; Baer HJ, 2009, CANCER, V115, P1404, DOI 10.1002/cncr.24167; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Bombonati A, 2011, J PATHOL, V223, P307, DOI 10.1002/path.2808; Boughey JC, 2010, J CLIN ONCOL, V28, P3591, DOI 10.1200/JCO.2010.28.0784; Cauley, 2001, BREAST CANCER RES TR, V67, P191; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Collins LC, 2006, CANCER-AM CANCER SOC, V107, P1240, DOI 10.1002/cncr.22136; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; Cummings SR, 2011, J BONE MINER RES, V26, P397, DOI 10.1002/jbmr.191; Cuzick J, 2014, LANCET, V383, P1040; Cuzick J, 2002, LANCET, V360, P817; Cuzick J, 2007, JNCI-J NATL CANCER I, V99, P272, DOI 10.1093/jnci/djk049; Cuzick J, 2013, LANCET, V381, P1827, DOI 10.1016/S0140-6736(13)60140-3; Cuzick J, 2011, J NATL CANCER I, V103, P744, DOI 10.1093/jnci/djr079; Degnim AC, 2007, J CLIN ONCOL, V25, P2671, DOI 10.1200/JCO.2006.09.0217; Deshaies I, 2011, BREAST, V20, P50, DOI 10.1016/j.breast.2010.06.004; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; Ellis IO, 2010, MODERN PATHOL, V23, pS1, DOI 10.1038/modpathol.2010.56; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fitzgibbons PL, 1998, ARCH PATHOL LAB MED, V122, P1053; Freedman AN, 2013, J CLIN ONCOL, V31, P4167, DOI 10.1200/JCO.2013.53.9015; Fritcher EGB, 2011, CANCER PREV RES, V4, P435, DOI 10.1158/1940-6207.CAPR-10-0242; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829; Gail MH, 2000, J NATL CANCER I, V92, P758, DOI 10.1093/jnci/92.9.758; Giuliano AE, 2007, ANN SURG ONCOL, V14, P2425, DOI 10.1245/s10434-007-9447-z; Goss PE, 2011, NEW ENGL J MED, V365, P1361; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; Gutwein LG, 2011, AM J SURG, V202, P127, DOI 10.1016/j.amjsurg.2010.09.005; Hartmann LC, 2005, NEW ENGL J MED, V353, P229, DOI 10.1056/NEJMoa044383; Hartmann LC, 2014, CANCER PREV RES, V7, P211, DOI 10.1158/1940-6207.CAPR-13-0222; Jacobs TW, 2001, AM J SURG PATHOL, V25, P229, DOI 10.1097/00000478-200102000-00011; Jain RK, 2011, MODERN PATHOL, V24, P917, DOI 10.1038/modpathol.2011.66; Kaplan CP, 2005, PREV MED, V41, P7, DOI 10.1016/j.ypmed.2004.09.041; Kohr JR, 2010, RADIOLOGY, V255, P723, DOI 10.1148/radiol.09091406; LaCroix AZ, 2010, JNCI-J NATL CANCER I, V102, P1706, DOI 10.1093/jnci/djq415; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P941, DOI 10.1001/jama.267.7.941; Lopez-Garcia MA, 2010, HISTOPATHOLOGY, V57, P171, DOI 10.1111/j.1365-2559.2010.03568.x; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; McGhan LJ, 2012, ANN SURG ONCOL, V19, P3264, DOI 10.1245/s10434-012-2575-0; Milanese TR, 2006, J NATL CANCER I, V98, P1600, DOI 10.1093/jnci/djj439; Murray MP, 2013, CANCER-AM CANCER SOC, V119, P1073, DOI 10.1002/cncr.27841; National Comprehensive Cancer Network, 2015, CLIN PRACT GUID BREA; National Comprehensive Cancer Network, 2014, CLIN PRACT GUID ONC; Niell B, 2012, AM J ROENTGENOL, V199, P929, DOI 10.2214/AJR.11.8447; Ozanne EM, 2010, BREAST J, V16, P38, DOI 10.1111/j.1524-4741.2009.00857.x; Page DL, 2003, LANCET, V361, P125, DOI 10.1016/S0140-6736(03)12230-1; PAGE DL, 1985, CANCER, V55, P2698, DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A; Pankratz VS, 2008, J CLIN ONCOL, V26, P5374, DOI 10.1200/JCO.2007.14.8833; Port ER, 2007, ANN SURG ONCOL, V14, P1051, DOI 10.1245/s10434-006-9195-5; Port ER, 2001, ANN SURG ONCOL, V8, P580; Powles TJ, 2007, JNCI-J NATL CANCER I, V99, P283, DOI 10.1093/jnci/djk050; Powles TJ, 2012, BREAST CANCER RES TR, V134, P299, DOI 10.1007/s10549-012-2041-5; Rueth NM, 2011, ANN SURG ONCOL, V18, P2515, DOI 10.1245/s10434-011-1642-2; Santen RJ, 2005, NEW ENGL J MED, V353, P275, DOI 10.1056/NEJMra035692; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; SCHNITT SJ, 1992, AM J SURG PATHOL, V16, P1133, DOI 10.1097/00000478-199212000-00001; Shah-Khan MG, 2012, ANN SURG ONCOL, V19, P3131, DOI 10.1245/s10434-012-2534-9; Simpson JF, 2009, PATHOLOGY, V41, P36, DOI 10.1080/00313020802568097; Taylor R, 2005, ANN FAM MED, V3, P242, DOI 10.1370/afm.284; Tyrer J, 2005, STAT MED, V24, P156, DOI 10.1002/sim.1913; U. S. Preventive Services Task Force, 2013, REC STAT BREAST CANC; Veronesi U, 1998, LANCET, V352, P93; Visvanathan K, 2013, J CLIN ONCOL, V31, P2942, DOI 10.1200/JCO.2013.49.3122; Vogel VG, 2007, JAMA-J AM MED ASSOC, V298, P973; Vogel VG, 2006, JAMA-J AM MED ASSOC, V296, P2946; Vogel VG, 2010, CANCER PREV RES, V3, P696, DOI 10.1158/1940-6207.CAPR-10-0076; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Waters EA, 2012, BREAST CANCER RES TR, V134, P875, DOI 10.1007/s10549-012-2089-2; Worsham MJ, 2007, BREAST J, V13, P115, DOI 10.1111/j.1524-4741.2007.00388.x	77	172	180	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2015	372	1					78	89		10.1056/NEJMsr1407164	http://dx.doi.org/10.1056/NEJMsr1407164			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX7MU	25551530	Bronze, Green Accepted			2022-12-28	WOS:000347100800015
J	Lu, W; Zhang, Y; McDonald, DO; Jing, HE; Carroll, B; Robertson, N; Zhang, Q; Griffin, H; Sanderson, S; Lakey, JH; Morgan, NV; Reynard, LN; Zheng, L; Murdock, HM; Turvey, SE; Hackett, SJ; Prestidge, T; Hall, JM; Cant, AJ; Matthews, HF; Koref, MFS; Simon, AK; Korolchuk, VI; Lenardo, MJ; Hambleton, S; Su, HC				Lu, Wei; Zhang, Yu; McDonald, David O.; Jing, Huie; Carroll, Bernadette; Robertson, Nic; Zhang, Qian; Griffin, Helen; Sanderson, Sharon; Lakey, Jeremy H.; Morgan, Neil V.; Reynard, Louise N.; Zheng, Lixin; Murdock, Heardley M.; Turvey, Stuart E.; Hackett, Scott J.; Prestidge, Tim; Hall, Julie M.; Cant, Andrew J.; Matthews, Helen F.; Koref, Mauro F. Santibanez; Simon, Anna Katharina; Korolchuk, Viktor I.; Lenardo, Michael J.; Hambleton, Sophie; Su, Helen C.			Dual Proteolytic Pathways Govern Glycolysis and Immune Competence	CELL			English	Article							TRIPEPTIDYL PEPTIDASE-II; CHAPERONE-MEDIATED AUTOPHAGY; CELL-ACTIVATION; AEROBIC GLYCOLYSIS; GENE-EXPRESSION; T-LYMPHOCYTES; HEXOKINASE 2; HUMAN BRAIN; DEGRADATION; GLUCOSE	Proteasomes and lysosomes constitute the major cellular systems that catabolize proteins to recycle free amino acids for energy and new protein synthesis. Tripeptidyl peptidase II (TPPII) is a large cytosolic proteolytic complex that functions in tandem with the proteasome-ubiquitin protein degradation pathway. We found that autosomal recessive TPP2 mutations cause recurrent infections, autoimmunity, and neurodevelopmental delay in humans. We show that a major function of TPPII in mammalian cells is to maintain amino acid levels and that TPPII-deficient cells compensate by increasing lysosome number and proteolytic activity. However, the overabundant lysosomes derange cellular metabolism by consuming the key glycolytic enzyme hexokinase-2 through chaperone-mediated autophagy. This reduces glycolysis and impairs the production of effector cytokines, including IFN-gamma and IL-1 beta. Thus, TPPII controls the balance between intracellular amino acid availability, lysosome number, and glycolysis, which is vital for adaptive and innate immunity and neurodevelopmental health.	[Lu, Wei; Zheng, Lixin; Matthews, Helen F.; Lenardo, Michael J.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Lu, Wei; Zhang, Yu; Jing, Huie; Zhang, Qian; Zheng, Lixin; Murdock, Heardley M.; Matthews, Helen F.; Lenardo, Michael J.; Su, Helen C.] NIAID, Clin Genom Program, NIH, Bethesda, MD 20892 USA; [Zhang, Yu; Jing, Huie; Zhang, Qian; Murdock, Heardley M.; Su, Helen C.] NIAID, Lab Host Def, NIH, Bethesda, MD 20892 USA; [McDonald, David O.; Robertson, Nic; Reynard, Louise N.; Cant, Andrew J.; Hambleton, Sophie] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Carroll, Bernadette; Lakey, Jeremy H.; Korolchuk, Viktor I.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Robertson, Nic; Hall, Julie M.; Cant, Andrew J.; Hambleton, Sophie] Newcastle Upon Tyne Hosp NHS Fdn Trust, Great North Childrens Hosp, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Griffin, Helen; Koref, Mauro F. Santibanez] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Sanderson, Sharon; Simon, Anna Katharina] Univ Oxford, John Radcliffe Hosp, NIHR BRC Translat Immunol Lab, Oxford OX3 9DU, England; [Morgan, Neil V.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Turvey, Stuart E.] Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Turvey, Stuart E.] Univ British Columbia, BC Childrens Hosp, Vancouver, BC V5Z 4H4, Canada; [Hackett, Scott J.] Birmingham Heartlands Hosp, Paediat Immunol Dept, Birmingham B9 5SS, W Midlands, England; [Prestidge, Tim] Starship Childrens Hosp, Blood & Canc Ctr, Auckland 1142, New Zealand; [Simon, Anna Katharina] Univ Oxford, MRC Unit Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; University of Oxford; University of Birmingham; Child & Family Research Institute; University of British Columbia; BC Childrens Hospital; University of British Columbia; Heart of England NHS Foundation Trust; University of Birmingham; Starship Children's Hospital; University of Oxford	Hambleton, S (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	sophie.hambleton@newcastle.ac.uk; hsu@niaid.nih.gov	Su, Helen C/H-9541-2015; Turvey, Stuart/HGV-1191-2022; Morgan, Neil V/A-5475-2009; Jing, Hui/GXM-4109-2022	Su, Helen C/0000-0002-5582-9110; Morgan, Neil V/0000-0001-6433-5692; Jing, Hui/0000-0002-8389-8252; Robertson, Nic/0000-0002-2941-7526; Simon, Anna Katharina/0000-0002-4077-7995; Reynard, Louise/0000-0002-6613-1797; Murdock, H. Moses/0000-0003-4098-8968; Korolchuk, Viktor/0000-0002-4071-592X; Turvey, Stuart/0000-0003-1599-1065; Lakey, Jeremy/0000-0003-4646-9085; Hambleton, Sophie/0000-0001-7954-3267; Zhang, Qian/0000-0002-9040-3289; Griffin, Helen R/0000-0002-5288-3322; Carroll, Bernadette/0000-0001-5673-9371	Intramural Research Program of the NIAID, NIH; UK MRC; Sir Jules Thorn Charitable Trust; NIHR Newcastle Biomedical Research Centre; Newcastle upon Tyne Hospitals NHS Charity; UK BBSRC; NIHR Oxford Biomedical Research Centre; Canadian Institutes of Health Research [MOP-133691]; BBSRC [BB/J007803/1, BB/G021422/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000718, ZIAAI001059] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G021422/1, BB/J007803/1] Funding Source: researchfish; National Institute for Health Research [ACF-2014-01-003] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [12JTA] Funding Source: researchfish	Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sir Jules Thorn Charitable Trust; NIHR Newcastle Biomedical Research Centre; Newcastle upon Tyne Hospitals NHS Charity; UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); The Sir Jules Thorn Charitable Trust	We thank the following people: for technical help, David Dorward, Louise Tee, Sonia Majri, Matt Biancalana, Alex Leney-Greene, Sam Drain, and Yaobo Xu; for clinical support, Angela Wang, Emily Jewel, Shanaz Pasha, and colleagues at the BC Children's Hospital and the Great North Children's Hospital; for sharing reagents, data, and equipment, Kenneth Rock, Beate Rockel, Thomas von Zglinicki, and Richard Siegel; for help with genetic investigations, Eamonn Maher and the Newcastle Exome Consortium, especially John Loughlin and Patrick Chinnery; for advice and critically reading the manuscript, Karin Engelhardt, Richard Siegel, Fengyi Wan, and Li Yu; and the patients and their families for participating in this study. This work was supported by the Intramural Research Program of the NIAID, NIH (H.C.S., M.J.L.); the UK MRC (S.H.); the Sir Jules Thorn Charitable Trust (S.H., M.F.S.K.); the NIHR Newcastle Biomedical Research Centre and the Newcastle upon Tyne Hospitals NHS Charity (S.H., M.F.S.K., V.I.K.); UK BBSRC (B.C., V.I.K.); NIHR Oxford Biomedical Research Centre (S.S., A.K.S.); and the Canadian Institutes of Health Research (S.E.T., MOP-133691). S.E.T. is a Clinical Scholar of the Michael Smith Foundation for Health Research.	BALOW RM, 1986, J BIOL CHEM, V261, P2409; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; BARNES DM, 1992, BIOCHEM J, V283, P583, DOI 10.1042/bj2830583; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Gavioli R, 2001, NAT CELL BIOL, V3, P283, DOI 10.1038/35060076; Gershon TR, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-2; Goyal MS, 2014, CELL METAB, V19, P49, DOI 10.1016/j.cmet.2013.11.020; GREINER EF, 1994, J BIOL CHEM, V269, P31484; Huai J, 2008, P NATL ACAD SCI USA, V105, P5177, DOI 10.1073/pnas.0801413105; Kaushik S, 2011, J CELL SCI, V124, P495, DOI 10.1242/jcs.073874; Kawahara M, 2009, J IMMUNOL, V183, P6069, DOI 10.4049/jimmunol.0803564; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Lampidis TJ, 2006, CANCER CHEMOTH PHARM, V58, P725, DOI 10.1007/s00280-006-0207-8; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mckay RM, 2007, EMBO REP, V8, P1183, DOI 10.1038/sj.embor.7401086; MILLER ES, 1994, J NEUROIMMUNOL, V52, P165, DOI 10.1016/0165-5728(94)90110-4; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rose C, 1996, NATURE, V380, P403, DOI 10.1038/380403a0; Ryhanen T, 2009, J CELL MOL MED, V13, P3616, DOI 10.1111/j.1582-4934.2008.00577.x; Schonegge AM, 2012, STRUCTURE, V20, P593, DOI 10.1016/j.str.2012.01.025; Schutz Y, 2011, INT J VITAM NUTR RES, V81, P101, DOI 10.1024/0300-9831/a000064; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Stentz FB, 2004, BIOCHEM BIOPH RES CO, V324, P692, DOI 10.1016/j.bbrc.2004.09.113; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Taylor PM, 2014, AM J CLIN NUTR, V99, p223S, DOI 10.3945/ajcn.113.070086; Tomkinson B, 1999, TRENDS BIOCHEM SCI, V24, P355, DOI 10.1016/S0968-0004(99)01435-8; Valdor R, 2014, NAT IMMUNOL, V15, P1046, DOI 10.1038/ni.3003; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; WILSON C, 1993, NEUROCHEM RES, V18, P743, DOI 10.1007/BF00966768; Wolf A, 2011, NEUROBIOL DIS, V44, P84, DOI 10.1016/j.nbd.2011.06.007; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470	42	36	37	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1578	1590		10.1016/j.cell.2014.12.001	http://dx.doi.org/10.1016/j.cell.2014.12.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525876	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000347922500012
J	Mashimo, T; Pichumani, K; Vemireddy, V; Hatanpaa, KJ; Singh, DK; Sirasanagandla, S; Nannepaga, S; Piccirillo, SG; Kovacs, Z; Foong, C; Huang, ZG; Barnett, S; Mickey, BE; DeBerardinis, RJ; Tu, BP; Maher, EA; Bachoo, RM				Mashimo, Tomoyuki; Pichumani, Kumar; Vemireddy, Vamsidhara; Hatanpaa, Kimmo J.; Singh, Dinesh Kumar; Sirasanagandla, Shyam; Nannepaga, Suraj; Piccirillo, Sara G.; Kovacs, Zoltan; Foong, Chan; Huang, Zhiguang; Barnett, Samuel; Mickey, Bruce E.; DeBerardinis, Ralph J.; Tu, Benjamin P.; Maher, Elizabeth A.; Bachoo, Robert M.			Acetate Is a Bioenergetic Substrate for Human Glioblastoma and Brain Metastases	CELL			English	Article							CITRIC-ACID CYCLE; C-13 NMR; C-11-ACETATE PET; CARBON FLUX; METABOLISM; HEART; OXIDATION; PATHWAYS; STATE; CELL	Glioblastomas and brain metastases are highly proliferative brain tumors with short survival times. Previously, using C-13-NMR analysis of brain tumors resected from patients during infusion of C-13-glucose, we demonstrated that there is robust oxidation of glucose in the citric acid cycle, yet glucose contributes less than 50% of the carbons to the acetyl-CoA pool. Here, we show that primary and metastatic mouse orthotopic brain tumors have the capacity to oxidize [1,2-C-13]acetate and can do so while simultaneously oxidizing [1,6-C-13]glucose. The tumors do not oxidize [U-C-13]glutamine. In vivo oxidation of [1,2-C-13]acetate was validated in brain tumor patients and was correlated with expression of acetyl-CoA synthetase enzyme 2, ACSS2. Together, the data demonstrate a strikingly common metabolic phenotype in diverse brain tumors that includes the ability to oxidize acetate in the citric acid cycle. This adaptation may be important for meeting the high biosynthetic and bioenergetic demands of malignant growth.	[Mashimo, Tomoyuki; Vemireddy, Vamsidhara; Sirasanagandla, Shyam; Maher, Elizabeth A.; Bachoo, Robert M.] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; [Mashimo, Tomoyuki; Vemireddy, Vamsidhara; Hatanpaa, Kimmo J.; Singh, Dinesh Kumar; Sirasanagandla, Shyam; Nannepaga, Suraj; Mickey, Bruce E.; DeBerardinis, Ralph J.; Maher, Elizabeth A.; Bachoo, Robert M.] UT Southwestern Med Ctr, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Mashimo, Tomoyuki; Vemireddy, Vamsidhara; Hatanpaa, Kimmo J.; Singh, Dinesh Kumar; Sirasanagandla, Shyam; Nannepaga, Suraj; Piccirillo, Sara G.; Mickey, Bruce E.; Maher, Elizabeth A.; Bachoo, Robert M.] UT Southwestern Med Ctr, Annette G Strauss Ctr Neurooncol, Dallas, TX 75390 USA; [Pichumani, Kumar; Kovacs, Zoltan] UT Southwestern Med Ctr, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Hatanpaa, Kimmo J.; Foong, Chan] UT Southwestern Med Ctr, Dept Pathol, Dallas, TX 75390 USA; [Singh, Dinesh Kumar; Nannepaga, Suraj; Piccirillo, Sara G.; Maher, Elizabeth A.; Bachoo, Robert M.] UT Southwestern Med Ctr, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Huang, Zhiguang; Tu, Benjamin P.] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX 75390 USA; [Barnett, Samuel; Mickey, Bruce E.] UT Southwestern Med Ctr, Dept Neurol Surg, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] UT Southwestern Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] UT Southwestern Med Ctr, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Maher, EA (corresponding author), UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA.	elizabeth.maher@utsouthwestern.edu; robert.bachoo@utsouthwestern.edu	Singh, Dinesh/S-3636-2019	Singh, Dinesh/0000-0002-3594-2431; vemireddy, vamsidhara/0000-0001-7068-6640; Piccirillo, Sara Grazia Maria/0000-0003-4109-1992	Cancer Prevention Research Institute of Texas [RP101243]; NIH [5R01CA154843, R01 CA157996]; NIH Resource Grant [EB015908]; Simmons Cancer Center NIH support grant [5P30 CA142543-04]; Annette G. Strauss Center for Neuro-Oncology; Miller Family Fund in Neuro-Oncology; Gladie Jo Salvino Fund for Glioblastoma Research at UT Southwestern Medical Center; Kenny Can Foundation in Dallas, Texas; NATIONAL CANCER INSTITUTE [R01CA154843, R01CA157996, P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065195] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Resource Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simmons Cancer Center NIH support grant; Annette G. Strauss Center for Neuro-Oncology; Miller Family Fund in Neuro-Oncology; Gladie Jo Salvino Fund for Glioblastoma Research at UT Southwestern Medical Center; Kenny Can Foundation in Dallas, Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Craig Malloy and Dean Sherry for analytical assistance with the NMR spectral data, critical reading of the manuscript, and helpful discussions. We thank Sarah McNeil and Christie Sheppard for significant contributions to the patient studies, Jessica Sudderth for analyzing plasma glucose enrichment, and Dinesh Ramesh for assistance with figure preparation. This work was supported by grants from the Cancer Prevention Research Institute of Texas (RP101243 to R.J.D., E.A.M., and R.M.B.), by grants from the NIH (5R01CA154843 to E.A.M.; R01 CA157996 to R.J.D.), by an NIH Resource Grant (EB015908), and by a Simmons Cancer Center NIH support grant (5P30 CA142543-04). This work was also supported by philanthropic funds from The Annette G. Strauss Center for Neuro-Oncology, The Miller Family Fund in Neuro-Oncology, The Gladie Jo Salvino Fund for Glioblastoma Research at UT Southwestern Medical Center, and the Kenny Can Foundation in Dallas, Texas.	Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bartnik-Olson BL, 2010, J NEUROTRAUM, V27, P2191, DOI 10.1089/neu.2010.1508; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; Deelchand DK, 2009, J MAGN RESON, V196, P157, DOI 10.1016/j.jmr.2008.11.001; Dienel GA, 2006, NEUROCHEM INT, V48, P586, DOI 10.1016/j.neuint.2006.01.004; Ebert D, 2003, J NEUROSCI, V23, P5928; Fine HA, 2014, NEW ENGL J MED, V370, P764, DOI 10.1056/NEJMe1313309; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; Ho CL, 2003, J NUCL MED, V44, P213; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jiang LH, 2013, J CLIN INVEST, V123, P1605, DOI 10.1172/JCI65153; Lu-Emerson Christine, 2012, Continuum (Minneap Minn), V18, P295, DOI 10.1212/01.CON.0000413659.12304.a6; Maher EA, 2012, NMR BIOMED, V25, P1234, DOI 10.1002/nbm.2794; MALLOY CR, 1990, AM J PHYSIOL, V259, pH987, DOI 10.1152/ajpheart.1990.259.3.H987; MALLOY CR, 1990, BIOCHEMISTRY-US, V29, P6756, DOI 10.1021/bi00481a002; MALLOY CR, 1987, FEBS LETT, V212, P58, DOI 10.1016/0014-5793(87)81556-9; MALLOY CR, 1988, J BIOL CHEM, V263, P6964; Marin-Valencia I, 2012, NEUROCHEM INT, V61, P1036, DOI 10.1016/j.neuint.2012.07.020; Marin-Valencia I, 2012, NMR BIOMED, V25, P1177, DOI 10.1002/nbm.2787; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Owonikoko T.K., 2014, NAT REV CLIN ONCOL; Oyama N, 2002, J NUCL MED, V43, P181; Sagiyama K, 2014, P NATL ACAD SCI USA, V111, P4542, DOI 10.1073/pnas.1323855111; Schurr Avital, 2002, P25; SHERRY AD, 1992, BIOCHEMISTRY-US, V31, P4833, DOI 10.1021/bi00135a014; SKUTCHES CL, 1979, J CLIN INVEST, V64, P708, DOI 10.1172/JCI109513; Taylor A, 1996, DEV NEUROSCI-BASEL, V18, P434, DOI 10.1159/000111438; TOLLINGER CD, 1979, CLIN CHEM, V25, P1787; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Yamamoto Y, 2008, MOL IMAGING BIOL, V10, P281, DOI 10.1007/s11307-008-0152-5	32	441	458	4	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1603	1614		10.1016/j.cell.2014.11.025	http://dx.doi.org/10.1016/j.cell.2014.11.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525878	Bronze, Green Accepted			2022-12-28	WOS:000347922500014
J	Korownyk, C; Kolber, MR; McCormack, J; Lam, V; Overbo, K; Cotton, C; Finley, C; Turgeon, RD; Garrison, S; Lindblad, AJ; Banh, HL; Campbell-Scherer, D; Vandermeer, B; Allan, GM				Korownyk, Christina; Kolber, Michael R.; McCormack, James; Lam, Vanessa; Overbo, Kate; Cotton, Candra; Finley, Caitlin; Turgeon, Ricky D.; Garrison, Scott; Lindblad, Adrienne J.; Banh, Hoan Linh; Campbell-Scherer, Denise; Vandermeer, Ben; Allan, G. Michael			CHRISTMAS 2014: MEDIA STUDIES Televised medical talk shows-what they recommend and the evidence to support their recommendations: a prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEWSPAPER COVERAGE; KNOWLEDGE; PREVENTION; BELIEFS; CANCER; HEALTH; NEWS	Objective To determine the quality of health recommendations and claims made on popular medical talk shows. Design Prospective observational study. Setting Mainstream television media. Sources Internationally syndicated medical television talk shows that air daily (The Dr Oz Show and The Doctors). Interventions Investigators randomly selected 40 episodes of each of The Dr Oz Show and The Doctors from early 2013 and identified and evaluated all recommendations made on each program. A group of experienced evidence reviewers independently searched for, and evaluated as a team, evidence to support 80 randomly selected recommendations from each show. Main outcomes measures Percentage of recommendations that are supported by evidence as determined by a team of experienced evidence reviewers. Secondary outcomes included topics discussed, the number of recommendations made on the shows, and the types and details of recommendations that were made. Results We could find at least a case study or better evidence to support 54% (95% confidence interval 47% to 62%) of the 160 recommendations (80 from each show). For recommendations in The Dr Oz Show, evidence supported 46%, contradicted 15%, and was not found for 39%. For recommendations in The Doctors, evidence supported 63%, contradicted 14%, and was not found for 24%. Believable or somewhat believable evidence supported 33% of the recommendations on The Dr Oz Show and 53% on The Doctors. On average, The Dr Oz Show had 12 recommendations per episode and The Doctors 11. The most common recommendation category on The Dr Oz Show was dietary advice (39%) and on The Doctors was to consult a healthcare provider (18%). A specific benefit was described for 43% and 41% of the recommendations made on the shows respectively. The magnitude of benefit was described for 17% of the recommendations on The Dr Oz Show and 11% on The Doctors. Disclosure of potential conflicts of interest accompanied 0.4% of recommendations. Conclusions Recommendations made on medical talk shows often lack adequate information on specific benefits or the magnitude of the effects of these benefits. Approximately half of the recommendations have either no evidence or are contradicted by the best available evidence. Potential conflicts of interest are rarely addressed. The public should be skeptical about recommendations made on medical talk shows. Additional details of methods used and changes made to study protocol	[Korownyk, Christina; Kolber, Michael R.; Cotton, Candra; Finley, Caitlin; Garrison, Scott; Lindblad, Adrienne J.; Banh, Hoan Linh; Campbell-Scherer, Denise; Allan, G. Michael] Univ Alberta, Dept Family Med, Edmonton, AB T6G 2T4, Canada; [Lam, Vanessa; Overbo, Kate] Univ Alberta, Fac Med & Dent, WC Mackenzie Hlth Sci Ctr 2J2 00, Edmonton, AB T6G 2R7, Canada; [McCormack, James; Turgeon, Ricky D.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada; [Vandermeer, Ben] Univ Alberta, Edmonton Clin Hlth Acad, Alberta Res Ctr Hlth Evidence, Edmonton, AB T6G 1C9, Canada	University of Alberta; University of Alberta; University of British Columbia; University of Alberta	Korownyk, C (corresponding author), Univ Alberta, Dept Family Med, 6-10 Univ Terrace, Edmonton, AB T6G 2T4, Canada.	tina.korownyk@ualberta.ca	Turgeon, Ricky/V-3522-2019; Campbell-Scherer, Denise/E-1897-2016	Turgeon, Ricky/0000-0002-3967-1528; Korownyk, Christina/0000-0003-4953-9392; /0000-0003-1997-7156; Campbell-Scherer, Denise/0000-0002-2500-8207; McCormack, James/0000-0002-7801-5515	David and Beatrice Reidford Research Scholarship through the University of Alberta	David and Beatrice Reidford Research Scholarship through the University of Alberta	This study was supported in part by the David and Beatrice Reidford Research Scholarship through the University of Alberta (valued at $2400). The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	[Anonymous], 2013, HOLLYWOOD REPORTER; [Anonymous], 2012, HOLLYWOOD REPORTER; Bala MM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004704.pub3; Cassels A, 2003, CAN MED ASSOC J, V168, P1133; Chew F, 2002, J HEALTH COMMUN, V7, P179, DOI 10.1080/10810730290088076; Cifu AS, 2014, J GEN INTERN MED, V29, P417, DOI 10.1007/s11606-013-2646-3; Greatist, 2012, GREATIST; Hagenbruch Joseph F, 2013, CDS Rev, V106, P5; Imrie R, 2000, COMPLEMENT THER MED, V8, P123, DOI 10.1054/ctim.2000.0370; Inoue-Choi M, 2013, NUTR CANCER, V65, P165, DOI 10.1080/01635581.2013.748921; Marx JJ, 2008, J NEUROL, V255, P378, DOI 10.1007/s00415-008-0673-5; Milazzo S, 2006, SUPPORT CARE CANCER, V14, P885, DOI 10.1007/s00520-006-0068-z; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; OAKLEY A, 1995, BRIT MED J, V310, P1029, DOI 10.1136/bmj.310.6986.1029; Statistic Brain, 2012, STAT BRAIN; Tong A, 2008, AM J KIDNEY DIS, V52, P159, DOI 10.1053/j.ajkd.2008.02.304	16	50	51	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2014	349								g7346	10.1136/bmj.g7346	http://dx.doi.org/10.1136/bmj.g7346			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX3DZ	25520234	Green Published, hybrid			2022-12-28	WOS:000346821900001
J	Gao, H; Hu, YW; Xuan, Y; Li, J; Yang, YL; Martinez, RV; Li, CY; Luo, J; Qi, MH; Cheng, GJ				Gao, Huang; Hu, Yaowu; Xuan, Yi; Li, Ji; Yang, Yingling; Martinez, Ramses V.; Li, Chunyu; Luo, Jian; Qi, Minghao; Cheng, Gary J.			Large-scale nanoshaping of ultrasmooth 3D crystalline metallic structures	SCIENCE			English	Article							MICROMETER-SCALE; DIRECT IMPRINT; PLASMONICS; ALLOYS; SUPERPLASTICITY; NANOSTRUCTURES; METAMATERIALS; LITHOGRAPHY; COMPOSITES; PLASTICITY	We report a low-cost, high-throughput benchtop method that enables thin layers of metal to be shaped with nanoscale precision by generating ultrahigh-strain-rate deformations. Laser shock imprinting can create three-dimensional crystalline metallic structures as small as 10 nanometers with ultrasmooth surfaces at ambient conditions. This technique enables the successful fabrications of large-area, uniform nanopatterns with aspect ratios as high as 5 for plasmonic and sensing applications, as well as mechanically strengthened nanostructures and metal-graphene hybrid nanodevices.	[Gao, Huang; Hu, Yaowu; Li, Ji; Yang, Yingling; Cheng, Gary J.] Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA; [Xuan, Yi; Qi, Minghao] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Gao, Huang; Hu, Yaowu; Xuan, Yi; Li, Ji; Yang, Yingling; Li, Chunyu; Qi, Minghao; Cheng, Gary J.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Martinez, Ramses V.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Martinez, Ramses V.] IMDEA Nanosci, Madrid Inst Adv Studies, Madrid 28049, Spain; [Li, Chunyu] Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA; [Luo, Jian] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA; [Cheng, Gary J.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Harvard University; IMDEA Nanociencia; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California San Diego; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Cheng, GJ (corresponding author), Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA.	gjcheng@purdue.edu	Luo, Jian/A-4777-2008; Luo, jian/HGE-7331-2022; Hu, Yaowu/HCI-0798-2022; Martinez, Ramses V./C-5219-2009; Cheng, Gary/A-3671-2008	Luo, Jian/0000-0002-5424-0216; Hu, Yaowu/0000-0002-2200-9431; Martinez, Ramses V./0000-0002-0234-7732; Cheng, Gary/0000-0002-1184-2946	National Research Council; FP7 People program under project Marie Curie [IOF-275148]; National Security Science and Engineering Faculty Fellowship [N00014-15-1-0030]; NSF [CMMI-0547636, CMMI-1436305, CMMI-1120577, CNS-1126688]; NIH [1R01RR026273-01]; Defense Threat Reduction Agency [HDTRA1-10-1-0106]; Office of Naval Research [N00014-11-1-0678]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR026273] Funding Source: NIH RePORTER	National Research Council(Consiglio Nazionale delle Ricerche (CNR)); FP7 People program under project Marie Curie; National Security Science and Engineering Faculty Fellowship; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Office of Naval Research(Office of Naval Research); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by a National Research Council Senior Research Associateship (G.J.C.), the FP7 People program under the project Marie Curie IOF-275148 (R.V.M.), National Security Science and Engineering Faculty Fellowship N00014-15-1-0030 (J.L.); NSF grants CMMI-0547636, CMMI-1436305, CMMI-1120577, and CNS-1126688; NIH grant 1R01RR026273-01; Defense Threat Reduction Agency grant HDTRA1-10-1-0106; and Office of Naval Research grant N00014-11-1-0678. We thank S. Suslov for assistance with TEM and X. Xu for help with NSOM.	Bozhevolnyi SI, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.046802; Chou SY, 2002, NATURE, V417, P835, DOI 10.1038/nature00792; Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85; Csikor FF, 2007, SCIENCE, V318, P251, DOI 10.1126/science.1143719; Cui B, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/4/045303; FABBRO R, 1990, J APPL PHYS, V68, P775, DOI 10.1063/1.346783; Gramotnev DK, 2010, NAT PHOTONICS, V4, P83, DOI 10.1038/nphoton.2009.282; Greer JR, 2011, PROG MATER SCI, V56, P654, DOI 10.1016/j.pmatsci.2011.01.005; Guo LJ, 2007, ADV MATER, V19, P495, DOI 10.1002/adma.200600882; Kumar G, 2009, NATURE, V457, P868, DOI 10.1038/nature07718; Kurnia W, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/12/125028; Lakowicz JR, 2006, PLASMONICS, V1, P5, DOI 10.1007/s11468-005-9002-3; Li J, 2012, NANO LETT, V12, P4577, DOI 10.1021/nl301817t; Li QA, 1999, J MATER SCI TECHNOL, V15, P435; Liang CC, 2011, OPT EXPRESS, V19, P4768, DOI 10.1364/OE.19.004768; Lin J, 2013, SCIENCE, V340, P331, DOI 10.1126/science.1233746; Lister KA, 2004, J VAC SCI TECHNOL B, V22, P3257, DOI 10.1116/1.1825010; MISHRA RS, 1995, ACTA METALL MATER, V43, P877, DOI 10.1016/0956-7151(94)00323-A; Nagpal P, 2009, SCIENCE, V325, P594, DOI 10.1126/science.1174655; NIEH TG, 1992, SCRIPTA METALL MATER, V26, P703, DOI 10.1016/0956-716X(92)90423-C; Oulton RF, 2012, NAT PHOTONICS, V6, P219, DOI 10.1038/nphoton.2012.72; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; Poddubny A, 2013, NAT PHOTONICS, V7, P948, DOI [10.1038/NPHOTON.2013.243, 10.1038/nphoton.2013.243]; Uchic MD, 2004, SCIENCE, V305, P986, DOI 10.1126/science.1098993; Uchic MD, 2009, ANNU REV MATER RES, V39, P361, DOI 10.1146/annurev-matsci-082908-145422; Vollertsen F, 2006, INT J MACH TOOL MANU, V46, P1172, DOI 10.1016/j.ijmachtools.2006.01.033; Watts CM, 2012, ADV MATER, V24, pOP98, DOI 10.1002/adma.201200674; Yin LL, 2005, NANO LETT, V5, P1399, DOI 10.1021/nl050723m; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Zhou W, 2011, NAT NANOTECHNOL, V6, P423, DOI [10.1038/nnano.2011.72, 10.1038/NNANO.2011.72]	30	142	148	27	425	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1352	1356		10.1126/science.1260139	http://dx.doi.org/10.1126/science.1260139			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504717				2022-12-28	WOS:000346189600047
J	Ollerton, J; Erenler, H; Edwards, M; Crockett, R				Ollerton, Jeff; Erenler, Hilary; Edwards, Mike; Crockett, Robin			Extinctions of aculeate pollinators in Britain and the role of large-scale agricultural changes	SCIENCE			English	Article							DECLINES; PLANTS; BUTTERFLIES; RATES; BEE	Pollinators are fundamental to maintaining both biodiversity and agricultural productivity, but habitat destruction, loss of flower resources, and increased use of pesticides are causing declines in their abundance and diversity. Using historical records, we assessed the rate of extinction of bee and flower-visiting wasp species in Britain from the mid-19th century to the present. The most rapid phase of extinction appears to be related to changes in agricultural policy and practice beginning in the 1920s, before the agricultural intensification prompted by the Second World War, often cited as the most important driver of biodiversity loss in Britain. Slowing of the extinction rate from the 1960s onward may be due to prior loss of the most sensitive species and/or effective conservation programs.	[Ollerton, Jeff; Erenler, Hilary; Crockett, Robin] Univ Northampton, Sch Sci & Technol, Dept Environm & Geog Sci, Northampton NN2 6JD, England; [Edwards, Mike] Lea Side, Midhurst GU29 9LB, England	University of Northampton	Ollerton, J (corresponding author), Univ Northampton, Sch Sci & Technol, Dept Environm & Geog Sci, Ave Campus, Northampton NN2 6JD, England.	jeff.ollerton@northampton.ac.uk	Ollerton, Jeff/AAE-3946-2020	Ollerton, Jeff/0000-0002-0887-8235				[Anonymous], 1993, WASPS ANTS REC SOC S; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Brassley P, 2000, AGR HIST REV, V48, P60; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; Godfray HCJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0558; Goulson Dave, 2001, British Journal of Entomology and Natural History, V14, P129; Hambler C, 1996, CONSERV BIOL, V10, P892, DOI 10.1046/j.1523-1739.1996.10030892.x; Hambler C, 2004, SCIENCE, V305, P1563; Hambler C, 2011, BIOL CONSERV, V144, P713, DOI 10.1016/j.biocon.2010.09.004; McCollin D, 2000, BIOL CONSERV, V92, P249, DOI 10.1016/S0006-3207(99)00070-1; Morales CL, 2013, FRONT ECOL ENVIRON, V11, P529, DOI 10.1890/120321; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Smil V., 2001, ENRICHING EARTH FRIT; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Wedin DA, 1996, SCIENCE, V274, P1720, DOI 10.1126/science.274.5293.1720	22	241	249	12	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1360	1362		10.1126/science.1257259	http://dx.doi.org/10.1126/science.1257259			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504719	Green Accepted			2022-12-28	WOS:000346189600049
J	Moberly, T				Moberly, Tom			PRESCRIBING Physician, don't heal thyself: the perils of self prescribing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tmoberly@bmj.com						Christie JD, 1998, JAMA-J AM MED ASSOC, V280, P1253, DOI 10.1001/jama.280.14.1253; Frank E, 2009, CAN FAM PHYSICIAN, V55, P810; Hem E, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-16; NHS England, TREAT YOURS FAM MEMB	4	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2014	349								g7401	10.1136/bmj.g7401	http://dx.doi.org/10.1136/bmj.g7401			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY5RE	25487279				2022-12-28	WOS:000347628600001
J	Garway-Heath, DF; Crabb, DP; Bunce, C; Lascaratos, G; Amalfitano, F; Anand, N; Azuara-Blanco, A; Bourne, RR; Broadway, DC; Cunliffe, IA; Diamond, JP; Fraser, SG; Ho, TA; Martin, KR; McNaught, AI; Negi, A; Patel, K; Russell, RA; Shah, A; Spry, PG; Suzuki, K; White, ET; Wormald, RP; Xing, W; Zeyen, TG				Garway-Heath, David F.; Crabb, David P.; Bunce, Catey; Lascaratos, Gerassimos; Amalfitano, Francesca; Anand, Nitin; Azuara-Blanco, Augusto; Bourne, Rupert R.; Broadway, David C.; Cunliffe, Ian A.; Diamond, Jeremy P.; Fraser, Scott G.; Ho, Tuan A.; Martin, Keith R.; McNaught, Andrew I.; Negi, Anil; Patel, Krishna; Russell, Richard A.; Shah, Ameet; Spry, Paul G.; Suzuki, Katsuyoshi; White, Edward T.; Wormald, Richard P.; Xing, Wen; Zeyen, Thierry G.			Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial	LANCET			English	Article							VISUAL-FIELD PROGRESSION; INTRAOCULAR-PRESSURE; RISK-FACTORS; REDUCTION	Background Treatments for open-angle glaucoma aim to prevent vision loss through lowering of intraocular pressure, but to our knowledge no placebo-controlled trials have assessed visual function preservation, and the observation periods of previous (unmasked) trials have typically been at least 5 years. We assessed vision preservation in patients given latanoprost compared with those given placebo. Methods In this randomised, triple-masked, placebo-controlled trial, we enrolled patients with newly diagnosed open-angle glaucoma at ten UK centres (tertiary referral centres, teaching hospitals, and district general hospitals). Eligible patients were randomly allocated (1: 1) with a website-generated randomisation schedule, stratified by centre and with a permuted block design, to receive either latanoprost 0.005% (intervention group) or placebo (control group) eye drops. Drops were administered from identical bottles, once a day, to both eyes. The primary outcome was time to visual field deterioration within 24 months. Analyses were done in all individuals with follow-up data. The Data and Safety Monitoring Committee (DSMC) recommended stopping the trial on Jan 6, 2011 (last patient visit July, 2011), after an interim analysis, and suggested a change in primary outcome from the difference in proportions of patients with incident progression between groups to time to visual field deterioration within 24 months. This trial is registered, number ISRCTN96423140. Findings We enrolled 516 individuals between Dec 1, 2006, and March 16, 2010. Baseline mean intraocular pressure was 19.6 mm Hg (SD 4.6) in 258 patients in the latanoprost group and 20.1 mm Hg (4.8) in 258 controls. At 24 months, mean reduction in intraocular pressure was 3.8 mm Hg (4.0) in 231 patients assessed in the latanoprost group and 0.9 mm Hg (3.8) in 230 patients assessed in the placebo group. Visual field preservation was significantly longer in the latanoprost group than in the placebo group: adjusted hazard ratio (HR) 0.44 (95% CI 0.28-0.69; p=0.0003). We noted 18 serious adverse events, none attributable to the study drug. Interpretation This is the first randomised placebo-controlled trial to show preservation of the visual field with an intraocular-pressure-lowering drug in patients with open-angle glaucoma. The study design enabled significant differences in vision to be assessed in a relatively short observation period.	[Garway-Heath, David F.; Bunce, Catey; Lascaratos, Gerassimos; Amalfitano, Francesca; Ho, Tuan A.; Patel, Krishna; Russell, Richard A.; Shah, Ameet; Suzuki, Katsuyoshi; White, Edward T.; Wormald, Richard P.; Xing, Wen] Moorfields Eye Hosp NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Garway-Heath, David F.; Bunce, Catey; Lascaratos, Gerassimos; Amalfitano, Francesca; Ho, Tuan A.; Patel, Krishna; Russell, Richard A.; Shah, Ameet; Suzuki, Katsuyoshi; White, Edward T.; Wormald, Richard P.; Xing, Wen] UCL Inst Ophthalmol, London, England; [Crabb, David P.; Russell, Richard A.] City Univ London, Dept Optometry & Visual Sci, London, England; [Anand, Nitin] Huddersfield Royal Infirm, Huddersfield, W Yorkshire, England; [Azuara-Blanco, Augusto] Aberdeen Royal Infirm, Aberdeen, Scotland; [Bourne, Rupert R.] Hinchingbrooke Hosp, Huntingdon, England; [Broadway, David C.] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England; [Cunliffe, Ian A.; Negi, Anil] Birmingham Heartlands & Solihull, Birmingham, W Midlands, England; [Diamond, Jeremy P.; Spry, Paul G.] Bristol Eye Hosp, Bristol BS1 2LX, Avon, England; [Fraser, Scott G.] Sunderland Eye Infirmary, Sunderland, England; [Martin, Keith R.] Addenbrookes Hosp, Cambridge, England; [McNaught, Andrew I.] Cheltenham Gen Hosp, Cheltenham, Glos, England; [Zeyen, Thierry G.] Univ Hosp Leuven, Leuven, Belgium	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; City University London; University of Aberdeen; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Bristol Eye Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital; KU Leuven; University Hospital Leuven	Garway-Heath, DF (corresponding author), Moorfields Eye Hosp, City Rd, London EC1V 2PD, England.	david.garway-heath@moorfields.nhs.uk	Lascaratos, Gerassimos/AAL-6344-2020	Azuara-Blanco, Augusto/0000-0002-4805-9322; Bunce, Catey/0000-0002-0935-3713; Garway-Heath, David/0000-0003-2907-6992; Crabb, David/0000-0001-8754-3902; McNaught, Andrew/0000-0002-5425-751X	Pfizer; UK National Institute for Health Research Biomedical Research Centre; National Institute for Health Research [NF-SI-0514-10170, NF-SI-0509-10116] Funding Source: researchfish	Pfizer(Pfizer); UK National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Pfizer, UK National Institute for Health Research Biomedical Research Centre.	Boland M. V., 2012, TREATMENT GLAUCOMA C; Bunce C, 2008, EYE, V22, P905, DOI 10.1038/sj.eye.6702767; Chauhan BC, 2008, ARCH OPHTHALMOL-CHIC, V126, P1030, DOI 10.1001/archopht.126.8.1030; Crabb DP, 2012, INVEST OPHTH VIS SCI, V53, P2770, DOI 10.1167/iovs.12-9476; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Ernest PJ, 2013, OPHTHALMOLOGY, V120, P512, DOI 10.1016/j.ophtha.2012.09.005; Friedman DS, 2007, OPHTHALMOLOGY, V114, P2232, DOI 10.1016/j.ophtha.2007.02.001; Garway-Heath DF, 2013, OPHTHALMOLOGY, V120, P68, DOI 10.1016/j.ophtha.2012.07.028; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Heijl A, 2003, ACTA OPHTHALMOL SCAN, V81, P286, DOI 10.1034/j.1600-0420.2003.00070.x; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Heijl A, 2009, OPHTHALMOLOGY, V116, P2271, DOI 10.1016/j.ophtha.2009.06.042; HOLMIN C, 1988, ACTA OPHTHALMOL, V66, P170; JAY JL, 1988, BRIT J OPHTHALMOL, V72, P881, DOI 10.1136/bjo.72.12.881; Krupin T, 2011, AM J OPHTHALMOL, V151, P671, DOI 10.1016/j.ajo.2010.09.026; Lascaratos G, 2013, OPHTHALMOLOGY, V120, P2540, DOI 10.1016/j.ophtha.2013.07.054; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Leske MC, 1999, OPHTHALMOLOGY, V106, P2144, DOI 10.1016/S0161-6420(99)90497-9; MIGDAL C, 1994, OPHTHALMOLOGY, V101, P1651; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; National Institute for Health and Care Excellence, 2009, CG85 GLAUC DIAGN MAN; Pajic B, 2010, CURR MED RES OPIN, V26, P2213, DOI 10.1185/03007995.2010.508702; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Russell RA, 2012, INVEST OPHTH VIS SCI, V53, P2760, DOI 10.1167/iovs.11-7976; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; Sehi M, 2011, VISION RES, V51, P235, DOI 10.1016/j.visres.2010.08.036; Sena DF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006539.pub3; SOMMER A, 1991, NEW ENGL J MED, V325, P1412, DOI 10.1056/NEJM199111143252004; Tsuda M, 2009, J OCUL PHARMACOL TH, V25, P441, DOI 10.1089/jop.2008.0097; van der Valk R, 2005, OPHTHALMOLOGY, V112, P1177, DOI 10.1016/j.ophtha.2005.01.042; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Vass C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003167.pub3	33	351	361	2	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1295	1304		10.1016/S0140-6736(14)62111-5	http://dx.doi.org/10.1016/S0140-6736(14)62111-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25533656	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000352272400035
J	Fitzgerald, TW; Gerety, SS; Jones, WD; van Kogelenberg, M; King, DA; McRae, J; Morley, KI; Parthiban, V; Al-Turki, S; Ambridge, K; Barrett, DM; Bayzetinova, T; Clayton, S; Coomber, EL; Gribble, S; Jones, P; Krishnappa, N; Mason, LE; Middleton, A; Miller, R; Prigmore, E; Rajan, D; Sifrim, A; Tivey, AR; Ahmed, M; Akawi, N; Andrews, R; Anjum, U; Archer, H; Armstrong, R; Balasubramanian, M; Banerjee, R; Baralle, D; Batstone, P; Baty, D; Bennett, C; Berg, J; Bernhard, B; Bevan, AP; Blair, E; Blyth, M; Bohanna, D; Bourdon, L; Bourn, D; Brady, A; Bragin, E; Brewer, C; Brueton, L; Brunstrom, K; Bumpstead, SJ; Bunyan, DJ; Burn, J; Burton, J; Canham, N; Castle, B; Chandler, K; Clasper, S; Clayton-Smith, J; Cole, T; Collins, A; Collinson, MN; Connell, F; Cooper, N; Cox, H; Cresswell, L; Cross, G; Crow, Y; D'Alessandro, M; Dabir, T; Davidson, R; Davies, S; Dean, J; Deshpande, C; Devlin, G; Dixit, A; Dominiczak, A; Donnelly, C; Donnelly, D; Douglas, A; Duncan, A; Eason, J; Edkins, S; Ellard, S; Ellis, P; Elmslie, F; Evans, K; Everest, S; Fendick, T; Fisher, R; Flinter, F; Foulds, N; Fryer, A; Fu, B; Gardiner, C; Gaunt, L; Ghali, N; Gibbons, R; Pereira, SLG; Goodship, J; Goudie, D; Gray, E; Greene, P; Greenhalgh, L; Harrison, L; Hawkins, R; Hellens, S; Henderson, A; Hobson, E; Holden, S; Holder, S; Hollingsworth, G; Homfray, T; Humphreys, M; Hurst, J; Ingram, S; Irving, M; Jarvis, J; Jenkins, L; Johnson, D; Jones, D; Jones, E; Josifova, D; Joss, S; Kaemba, B; Kazembe, S; Kerr, B; Kini, U; Kinning, E; Kirby, G; Kirk, C; Kivuva, E; Kraus, A; Kumar, D; Lachlan, K; Lam, W; Lampe, A; Langman, C; Lees, M; Lim, D; Lowther, G; Lynch, SA; Magee, A; Maher, E; Mansour, S; Marks, K; Martin, K; Maye, U; McCann, E; McConnell, V; McEntagart, M; McGowan, R; McKay, K; McKee, S; McMullan, DJ; McNerlan, S; Mehta, S; Metcalfe, K; Miles, E; Mohammed, S; Montgomery, T; Moore, D; Morgan, S; Morris, A; Morton, J; Mugalaasi, H; Murday, V; Nevitt, L; Newbury-Ecob, R; Norman, A; O'Shea, R; Ogilvie, C; Park, S; Parker, MJ; Patel, C; Paterson, J; Payne, S; Phipps, J; Pilz, DT; Porteous, D; Pratt, N; Prescott, K; Price, S; Pridham, A; Procter, A; Purnell, H; Ragge, N; Rankin, J; Raymond, L; Rice, D; Robert, L; Roberts, E; Roberts, G; Roberts, J; Roberts, P; Ross, A; Rosser, E; Saggar, A; Samant, S; Sandford, R; Sarkar, A; Schweier, S; Scott, C; Scott, R; Selby, A; Seller, A; Sequeira, C; Shannon, N; Shanrif, S; Shaw-Smith, C; Shearing, E; Shears, D; Simonic, I; Simpkin, D; Singzon, R; Skitt, Z; Smith, A; Smith, B; Smith, K; Smithson, S; Sneddon, L; Splitt, M; Squires, M; Stewart, F; Stewart, H; Suri, M; Sutton, V; Swaminathan, GJ; Sweeney, E; Tatton-Brown, K; Taylor, C; Taylor, R; Tei, M; Temple, IK; Thomson, J; Tolmie, J; Torokwa, A; Treacy, B; Turner, C; Turnpenny, P; Tysoe, C; Vandersteen, A; Vasudevan, P; Vogt, J; Wakeling, E; Walker, D; Waters, J; Weber, A; Wellesley, D; Whiteford, M; Widaa, S; Wilcox, S; Williams, D; Williams, N; Woods, G; Wragg, C; Wright, M; Yang, F; Yau, M; Carter, NP; Parker, M; Firth, HV; FitzPatrick, DR; Wright, CF; Barrett, JC; Hurles, ME				Fitzgerald, T. W.; Gerety, S. S.; Jones, W. D.; van Kogelenberg, M.; King, D. A.; McRae, J.; Morley, K. I.; Parthiban, V.; Al-Turki, S.; Ambridge, K.; Barrett, D. M.; Bayzetinova, T.; Clayton, S.; Coomber, E. L.; Gribble, S.; Jones, P.; Krishnappa, N.; Mason, L. E.; Middleton, A.; Miller, R.; Prigmore, E.; Rajan, D.; Sifrim, A.; Tivey, A. R.; Ahmed, M.; Akawi, N.; Andrews, R.; Anjum, U.; Archer, H.; Armstrong, R.; Balasubramanian, M.; Banerjee, R.; Baralle, D.; Batstone, P.; Baty, D.; Bennett, C.; Berg, J.; Bernhard, B.; Bevan, A. P.; Blair, E.; Blyth, M.; Bohanna, D.; Bourdon, L.; Bourn, D.; Brady, A.; Bragin, E.; Brewer, C.; Brueton, L.; Brunstrom, K.; Bumpstead, S. J.; Bunyan, D. J.; Burn, J.; Burton, J.; Canham, N.; Castle, B.; Chandler, K.; Clasper, S.; Clayton-Smith, J.; Cole, T.; Collins, A.; Collinson, M. N.; Connell, F.; Cooper, N.; Cox, H.; Cresswell, L.; Cross, G.; Crow, Y.; D'Alessandro, M.; Dabir, T.; Davidson, R.; Davies, S.; Dean, J.; Deshpande, C.; Devlin, G.; Dixit, A.; Dominiczak, A.; Donnelly, C.; Donnelly, D.; Douglas, A.; Duncan, A.; Eason, J.; Edkins, S.; Ellard, S.; Ellis, P.; Elmslie, F.; Evans, K.; Everest, S.; Fendick, T.; Fisher, R.; Flinter, F.; Foulds, N.; Fryer, A.; Fu, B.; Gardiner, C.; Gaunt, L.; Ghali, N.; Gibbons, R.; Pereira, S. L. Gomes; Goodship, J.; Goudie, D.; Gray, E.; Greene, P.; Greenhalgh, L.; Harrison, L.; Hawkins, R.; Hellens, S.; Henderson, A.; Hobson, E.; Holden, S.; Holder, S.; Hollingsworth, G.; Homfray, T.; Humphreys, M.; Hurst, J.; Ingram, S.; Irving, M.; Jarvis, J.; Jenkins, L.; Johnson, D.; Jones, D.; Jones, E.; Josifova, D.; Joss, S.; Kaemba, B.; Kazembe, S.; Kerr, B.; Kini, U.; Kinning, E.; Kirby, G.; Kirk, C.; Kivuva, E.; Kraus, A.; Kumar, D.; Lachlan, K.; Lam, W.; Lampe, A.; Langman, C.; Lees, M.; Lim, D.; Lowther, G.; Lynch, S. A.; Magee, A.; Maher, E.; Mansour, S.; Marks, K.; Martin, K.; Maye, U.; McCann, E.; McConnell, V.; McEntagart, M.; McGowan, R.; McKay, K.; McKee, S.; McMullan, D. J.; McNerlan, S.; Mehta, S.; Metcalfe, K.; Miles, E.; Mohammed, S.; Montgomery, T.; Moore, D.; Morgan, S.; Morris, A.; Morton, J.; Mugalaasi, H.; Murday, V.; Nevitt, L.; Newbury-Ecob, R.; Norman, A.; O'Shea, R.; Ogilvie, C.; Park, S.; Parker, M. J.; Patel, C.; Paterson, J.; Payne, S.; Phipps, J.; Pilz, D. T.; Porteous, D.; Pratt, N.; Prescott, K.; Price, S.; Pridham, A.; Procter, A.; Purnell, H.; Ragge, N.; Rankin, J.; Raymond, L.; Rice, D.; Robert, L.; Roberts, E.; Roberts, G.; Roberts, J.; Roberts, P.; Ross, A.; Rosser, E.; Saggar, A.; Samant, S.; Sandford, R.; Sarkar, A.; Schweier, S.; Scott, C.; Scott, R.; Selby, A.; Seller, A.; Sequeira, C.; Shannon, N.; Shanrif, S.; Shaw-Smith, C.; Shearing, E.; Shears, D.; Simonic, I.; Simpkin, D.; Singzon, R.; Skitt, Z.; Smith, A.; Smith, B.; Smith, K.; Smithson, S.; Sneddon, L.; Splitt, M.; Squires, M.; Stewart, F.; Stewart, H.; Suri, M.; Sutton, V.; Swaminathan, G. J.; Sweeney, E.; Tatton-Brown, K.; Taylor, C.; Taylor, R.; Tein, M.; Temple, I. K.; Thomson, J.; Tolmie, J.; Torokwa, A.; Treacy, B.; Turner, C.; Turnpenny, P.; Tysoe, C.; Vandersteen, A.; Vasudevan, P.; Vogt, J.; Wakeling, E.; Walker, D.; Waters, J.; Weber, A.; Wellesley, D.; Whiteford, M.; Widaa, S.; Wilcox, S.; Williams, D.; Williams, N.; Woods, G.; Wragg, C.; Wright, M.; Yang, F.; Yau, M.; Carter, N. P.; Parker, M.; Firth, H. V.; FitzPatrick, D. R.; Wright, C. F.; Barrett, J. C.; Hurles, M. E.		Deciphering Dev Disorders Study	Large-scale discovery of novel genetic causes of developmental disorders	NATURE			English	Article							DE-NOVO MUTATIONS; AUTISM SPECTRUM DISORDERS; COPY-NUMBER VARIATION; INTELLECTUAL DISABILITY; HUMAN-DISEASE; FRAMEWORK; CHILDREN; MODEL	Despite three decades of successful, predominantly phenotype-driven discovery of the genetic causes of monogenic disorders(1), up to half of children with severe developmental disorders of probable genetic origin remain without a genetic diagnosis. Particularly challenging are those disorders rare enough to have eluded recognition as a discrete clinical entity, those with highly variable clinical manifestations, and those that are difficult to distinguish from other, very similar, disorders. Here we demonstrate the power of using an unbiased genotype-driven approach(2) to identify subsets of patients with similar disorders. By studying 1,133 children with severe, undiagnosed developmental disorders, and their parents, using a combination of exome sequencing(3-11) and array-based detection of chromosomal rearrangements, we discovered 12 novel genes associated with developmental disorders. These newly implicated genes increase by 10% (from 28% to 31%) the proportion of children that could be diagnosed. Clustering of missense mutations in six of these newly implicated genes suggests that normal development is being perturbed by an activating or dominant-negative mechanism. Our findings demonstrate the value of adopting a comprehensive strategy, both genome-wide and nationwide, to elucidate the underlying causes of rare genetic disorders.	[Fitzgerald, T. W.; Gerety, S. S.; Jones, W. D.; van Kogelenberg, M.; King, D. A.; McRae, J.; Morley, K. I.; Parthiban, V.; Al-Turki, S.; Ambridge, K.; Barrett, D. M.; Bayzetinova, T.; Clayton, S.; Coomber, E. L.; Gribble, S.; Jones, P.; Krishnappa, N.; Mason, L. E.; Middleton, A.; Miller, R.; Prigmore, E.; Rajan, D.; Sifrim, A.; Tivey, A. R.; Akawi, N.; Andrews, R.; Banerjee, R.; Bevan, A. P.; Bragin, E.; Bumpstead, S. J.; Burton, J.; Edkins, S.; Ellis, P.; Fu, B.; Pereira, S. L. Gomes; Gray, E.; Jones, D.; Scott, C.; Simpkin, D.; Swaminathan, G. J.; Walker, D.; Widaa, S.; Yang, F.; Carter, N. P.; Firth, H. V.; Wright, C. F.; Barrett, J. C.; Hurles, M. E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Ahmed, M.; Baralle, D.; Bunyan, D. J.; Collins, A.; Collinson, M. N.; Foulds, N.; Harrison, L.; Lachlan, K.; Temple, I. K.; Torokwa, A.; Wellesley, D.] Princess Anne Hosp, Southampton Univ Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England; [Ahmed, M.; Baralle, D.; Bunyan, D. J.; Collins, A.; Collinson, M. N.; Foulds, N.; Harrison, L.; Lachlan, K.; Temple, I. K.; Torokwa, A.; Wellesley, D.] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury NHS Fdn Trust, Salisbury SP2 8BJ, Wilts, England; [Ahmed, M.; Baralle, D.; Bunyan, D. J.; Collins, A.; Collinson, M. N.; Foulds, N.; Harrison, L.; Lachlan, K.; Temple, I. K.; Torokwa, A.; Wellesley, D.] Univ Southampton, Fac Med, Southampton SO16 6YD, Hants, England; [Anjum, U.; Elmslie, F.; Homfray, T.; Mansour, S.; Marks, K.; McEntagart, M.; Saggar, A.; Tatton-Brown, K.; Taylor, R.] Univ London, South West Thames Regonal Genet Ctr, St Georges Healthcare NHS Trust, London SW17 0RE, England; [Archer, H.; Davies, S.; Evans, K.; Kumar, D.; McCann, E.; Morgan, S.; Mugalaasi, H.; Pilz, D. T.; Procter, A.] Univ Wales Hosp, Inst Med Genet, Cardiff CF14 4XW, Wales; [Archer, H.; Davies, S.; Evans, K.; Kumar, D.; McCann, E.; Morgan, S.; Mugalaasi, H.; Pilz, D. T.; Procter, A.] Glan Clwyd Gen Hosp, Dept Clin Genet, Rhyl LL18 5UJ, Denbighshire, England; [Armstrong, R.; Holden, S.; Mehta, S.; Park, S.; Paterson, J.; Raymond, L.; Roberts, J.; Sandford, R.; Simonic, I.; Treacy, B.; Wilcox, S.; Woods, G.; Firth, H. V.] Cambridge Univ Hosp NHS Fdn Trust, East Anglian Med Genet Serv, Cambridge CB2 0QQ, England; [Balasubramanian, M.; Ingram, S.; Johnson, D.; Nevitt, L.; Parker, M. J.; Shearing, E.; Smith, K.; Taylor, C.] Sheffield Childrens NHS Trust, Sheffield Reg Genet Serv, Sheffield S10 2TH, S Yorkshire, England; [Batstone, P.; D'Alessandro, M.; Dean, J.; McGowan, R.; Ross, A.; Samant, S.] North Scotland Regonal Genet Serv, Dept Med Genet, NHS Grampian, Sch Med, Aberdeen AB25 2ZD, Scotland; [Baty, D.; Berg, J.; Goudie, D.; Pratt, N.; Rice, D.; Schweier, S.] Ninewel Is Hosp, East Scotland Reg Genet Serv, Human Genet Unit, Pathol Dept,NHS Tayside, Dundee DD1 9SY, Scotland; [Bennett, C.; Blyth, M.; Hobson, E.; Kraus, A.; Prescott, K.; Roberts, P.; Smith, A.; Squires, M.; Thomson, J.] Chapel Allerton Hosp, Yorkshire Regonal Genet Serv, Leeds Teaching Hosp NHS Trust, Dept Clin Genet, Leeds LS7 4SA, W Yorkshire, England; [Bernhard, B.; Bourdon, L.; Brady, A.; Canham, N.; Ghali, N.; Holder, S.; Payne, S.; Sequeira, C.; Singzon, R.; Vandersteen, A.; Wakeling, E.] North West London Hosp NHS Trust, North West Thames Reg Genet Ctr, Kennedy Galton Ctr, Harrow HA1 3UJ, Middx, England; [Blair, E.; Clasper, S.; Gibbons, R.; Kini, U.; Phipps, J.; Price, S.; Pridham, A.; Purnell, H.; Seller, A.; Shears, D.; Stewart, H.] Oxford Radcliffe Hosp NHS Trust, Oxford Reg Genet Serv, Oxford OX3 7LJ, England; [Bohanna, D.; Brueton, L.; Cole, T.; Cooper, N.; Cox, H.; Jarvis, J.; Kirby, G.; Lim, D.; McKay, K.; McMullan, D. J.; Morton, J.; Norman, A.; Patel, C.; Ragge, N.; Shanrif, S.; Tein, M.; Vogt, J.; Williams, D.] Birmingham Womens Hosp, West Midlands Reg Genet Serv, Birmingham Womens NHS Fdn Trust, Birmingham B15 2TG, W Midlands, England; [Bourn, D.; Burn, J.; Fisher, R.; Goodship, J.; Hellens, S.; Henderson, A.; Montgomery, T.; Sneddon, L.; Splitt, M.; Wright, M.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Northern Genet Serv, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Brewer, C.; Castle, B.; Devlin, G.; Ellard, S.; Everest, S.; Kivuva, E.; Rankin, J.; Shaw-Smith, C.; Turner, C.; Turnpenny, P.; Tysoe, C.] Royal Devon & Exeter Hosp Heavitree, Peninsula Clin Genet Serv, Royal Devon & Exeter NHS Fdn Trust, Dept Clin Genet, Exeter EX1 2ED, Devon, England; [Brunstrom, K.; Hollingsworth, G.; Hurst, J.; Jenkins, L.; Lees, M.; Rosser, E.; Scott, R.; Waters, J.] Great Ormond St Hosp Sick Children, North East Thames Regonal Genet Serv, Great Ormond St Hosp Children NHS Fdn Trust, London WC1N 3JH, England; [Chandler, K.; Clayton-Smith, J.; Crow, Y.; Donnelly, C.; Gaunt, L.; Jones, E.; Kerr, B.; Metcalfe, K.; Miles, E.; Skitt, Z.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Connell, F.; Deshpande, C.; Fendick, T.; Flinter, F.; Irving, M.; Josifova, D.; Langman, C.; Mohammed, S.; Ogilvie, C.; Robert, L.; Yau, M.] Guys Hosp, South East Thames Reg Genet Ctr, Guys & St Thomas NHS Fdn Trust, London SE1 9RT, England; [Cresswell, L.; Kaemba, B.; Kazembe, S.; Vasudevan, P.] Leicester Royal Infirm NHS Trust, Univ Hosp Leicester NHS Trust, Leicestershire Genet Ctr, Leicester LE1 5WW, Leics, England; [Cross, G.; Dixit, A.; Eason, J.; Martin, K.; Sarkar, A.; Selby, A.; Shannon, N.; Suri, M.] Nottingham Univ Hosp NHS Trust, Nottingham Reg Genet Serv, Nottingham NG5 1PB, England; [Dabir, T.; Donnelly, D.; Humphreys, M.; Joss, S.; Kirk, C.; Magee, A.; McConnell, V.; McKee, S.; McNerlan, S.; Stewart, F.] Belfast City Hosp, Northern Ireland Regonal Genet Ctr, Belfast Hlth & Social Care Trust, Belfast BT9 7AB, Antrim, North Ireland; [Davidson, R.; Duncan, A.; Gardiner, C.; Kinning, E.; Lowther, G.; Murday, V.; Tolmie, J.; Whiteford, M.; Williams, N.] Yorkhill Hosp, West Scotland & Reg Genet Cs Serv, NHS Greater Glasgow & Clyde, Inst Med Genet, Glasgow G3 8SJ, Lanark, Scotland; [Dominiczak, A.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Douglas, A.; Fryer, A.; Greenhalgh, L.; Maye, U.; Roberts, G.; Sutton, V.; Sweeney, E.; Weber, A.] Royal Liverpool Childrens Hosp Alder Hey, Merseyside & Cheshire Genet Serv, Liverpool Womens NHS Fdn Trust, Dept Clin Genet, Liverpool L12 2AP, Merseyside, England; [Greene, P.; Lam, W.; Lampe, A.; Maher, E.; Moore, D.; FitzPatrick, D. R.] Univ Edinburgh, Western Gen Hosp, MRC IGMM, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Hawkins, R.; Newbury-Ecob, R.; Roberts, E.; Smithson, S.; Wragg, C.] St Michaels Hosp, Bristol Genet Serv Avon Somerset Gloucs & West Wi, Univ Hosp Bristol NHS Fdn Trust, Bristol BS2 8DT, Avon, England; [Lynch, S. A.; O'Shea, R.] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin 12, Ireland; [Morris, A.] Univ Edinburgh, Sch Mol Genet & Populat Hlth Sci, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland; [Porteous, D.] Univ Edinburgh, Inst Genet & Mol Med, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Smith, B.] Univ Dundee, Sch Med, Ninewells Hosp & Med Sch, Dundee DD2 4RB, Scotland; [Parker, M.] Univ Oxford, Ethox Ctr, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England	Wellcome Trust Sanger Institute; University of Southampton; Salisbury District Hospital; University of Southampton; St Georges University London; University of London; Cardiff University; University of Cambridge; Sheffield Children's NHS Foundation Trust; University of Aberdeen; Chapel Allerton Hospital; University of Leeds; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Birmingham Women's Hospital; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Exeter; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Manchester; Guy's & St Thomas' NHS Foundation Trust; University Hospitals of Leicester NHS Trust; University of Leicester; Nottingham University Hospital NHS Trust; Belfast City Hospital; University of Glasgow; University of Glasgow; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Edinburgh; University of Bristol; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; University of Edinburgh; University of Edinburgh; University of Dundee; University of Oxford	Hurles, ME (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	meh@sanger.ac.uk	LACHLAN, KATHERINE/ABH-6991-2020; King, Daniel/AAM-8024-2021; temple, isabel K/K-2391-2015; Dominiczak, Anna F/P-9390-2017; Wright, Caroline/N-5355-2015; Suri, Mohnish/HIK-0223-2022; Kalra, D/H-6661-2019; Ghali, Neeti/L-5665-2019; KRISHNAPPA, NETRAVATHI/AAD-9576-2021; Balasubramanian, Meena/AGB-4083-2022; Porteous, David/AAA-3446-2021; Morley, Katherine I/A-2986-2011; Crow, Yanick J/N-6120-2014; Akawi, Nadia/AAX-2650-2020; Ogilve, Caroline/AAW-3793-2021; Sifrim, Alejandro/AAY-2019-2021; Smith, Blair/G-2834-2012	LACHLAN, KATHERINE/0000-0002-3816-7346; King, Daniel/0000-0001-6451-712X; Dominiczak, Anna F/0000-0003-4913-3608; Suri, Mohnish/0000-0001-9037-701X; Kalra, D/0000-0001-5254-4067; Ghali, Neeti/0000-0003-2847-1376; Balasubramanian, Meena/0000-0003-1488-3695; Porteous, David/0000-0003-1249-6106; Morley, Katherine I/0000-0002-2725-5535; Crow, Yanick J/0000-0001-7211-7564; Akawi, Nadia/0000-0001-6311-7028; Sifrim, Alejandro/0000-0001-8247-4020; Gerety, Sebastian/0000-0002-6126-5040; Fitzgerald, Tomas/0000-0002-2370-8496; Swaminathan, Jawahar/0000-0002-0215-4084; Bevan, Paul/0000-0002-0656-9164; FitzPatrick, David R./0000-0003-4861-969X; Burn, John/0000-0002-9823-2322; Lim, Derek/0000-0002-6915-1363; Ellard, Sian/0000-0002-7620-5526; Middleton, Anna/0000-0003-3103-8098; Barrett, Jeffrey/0000-0002-1152-370X; Baralle, Diana/0000-0003-3217-4833; Temple, Isabel Karen/0000-0002-6045-1781; Lynch, Sally Ann/0000-0003-3540-1333; Smith, Blair/0000-0002-5362-9430; Edkins, Sarah/0000-0003-0717-1972; Sneddon, Linda/0000-0002-3519-0057; Blyth, Moira/0000-0002-4312-413X; Roberts, Jonathan/0000-0003-3153-1077; Wright, Caroline/0000-0003-2958-5076	Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6]; Scottish Funding Council [HR03006]; Health Innovation Challenge Fund [HICF-1009-003]; Wellcome Trust; Department of Health; Wellcome Trust Sanger Institute [WT098051]; National Institute for Health Research, through the Comprehensive Clinical Research Network; Cambridge South REC [10/H0305/83]; Republic of Ireland REC [GEN/284/12]; MRC [MC_PC_U127561093] Funding Source: UKRI; Cancer Research UK [15934] Funding Source: researchfish; Medical Research Council [MC_PC_U127561093] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10282] Funding Source: researchfish	Chief Scientist Office of the Scottish Government Health Directorates; Scottish Funding Council; Health Innovation Challenge Fund; Wellcome Trust(Wellcome Trust); Department of Health; Wellcome Trust Sanger Institute(Wellcome Trust); National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); Cambridge South REC; Republic of Ireland REC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We dedicate this paper to J. Tolmie and L. Brueton for their unwavering and enthusiastic support of the Deciphering Developmental Disorders project. We thank the families for their participation and patience. We thank M. Daly and K. Samocha for access to unpublished mutation rate estimates. We are grateful to S. Saunders, D. Smedley, D. Conrad, A. Ramu and N. Huang for access to data and algorithms. We thank the UK National Blood Service and the Generation Scotland: Scottish Family Health Study for access to DNA from controls. Generation Scotland has received core funding from the Chief Scientist Office of the Scottish Government Health Directorates CZD/16/6 and the Scottish Funding Council HR03006. The Deciphering Developmental Disorders study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant number WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The study has UK Research Ethics Committee approval (10/H0305/83, granted by the Cambridge South REC, and GEN/284/12 granted by the Republic of Ireland REC). The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Boumil RM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001046; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Craddock N, 2010, BRIT J PSYCHIAT, V196, P92, DOI 10.1192/bjp.bp.109.073429; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; Helsmoortel C, 2014, NAT GENET, V46, P380, DOI 10.1038/ng.2899; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; King DA, 2014, GENOME RES, V24, P673, DOI 10.1101/gr.160465.113; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; OMIM, 2014, ONLINE MENDELIAN INH; Pickart MA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000104; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Smith BH, 2013, INT J EPIDEMIOL, V42, P689, DOI 10.1093/ije/dys084; Walter G, 2012, CELL CYCLE, V11, P451, DOI 10.4161/cc.11.3.19057; Wright C.F., 2014, LANCET; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	27	665	681	7	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					223	+		10.1038/nature14135	http://dx.doi.org/10.1038/nature14135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25533962	Green Accepted, Green Submitted			2022-12-28	WOS:000350770500037
J	McDonough, JE; Adashi, EY				McDonough, John E.; Adashi, Eli Y.			In Defense of the Employer Mandate Hedging Against Uninsurance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McDonough, John E.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Publ Hlth Leadership, Boston, MA 02115 USA; [Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA	Harvard University; Harvard T.H. Chan School of Public Health; Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	eli_adashi@brown.edu						Blumberg Linda J., 2014, WHY NOT JUST ELIMINA; Jost T., 2014, HLTH AFFAIRS BL 0604; Kaiser Family Foundation, 2013, KAIS HLTH TRACK POLL; Mercer, 2014, MOD HLTH BEN COST GR; Singhal Shubham, 2011, MCKIN Q, V1, P1; State Health Access Data Assistance Center, 2013, STAT LEV TRENDS EMPL, P47; US Congressional Budget Office, 2014, MED PAYM PHYS BUDG E	7	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2015	313	7					665	666		10.1001/jama.2014.17658	http://dx.doi.org/10.1001/jama.2014.17658			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB2RQ	25521209				2022-12-28	WOS:000349476100007
J	Crocker, J; Abe, N; Rinaldi, L; McGregor, AP; Frankel, N; Wang, S; Alsawadi, A; Valenti, P; Plaza, S; Payre, F; Mann, RS; Stern, DL				Crocker, Justin; Abe, Namiko; Rinaldi, Lucrezia; McGregor, Alistair P.; Frankel, Nicolas; Wang, Shu; Alsawadi, Ahmad; Valenti, Philippe; Plaza, Serge; Payre, Francois; Mann, Richard S.; Stern, David L.			Low Affinity Binding Site Clusters Confer Hox Specificity and Regulatory Robustness	CELL			English	Article							COOPERATIVE DNA-BINDING; TRANSCRIPTION FACTORS; DROSOPHILA EMBRYO; GENE-EXPRESSION; MORPHOLOGICAL EVOLUTION; HOMEODOMAIN PROTEIN; GRADIENT MORPHOGEN; COMPLEX; EXTRADENTICLE; SEGMENTATION	In animals, Hox transcription factors define regional identity in distinct anatomical domains. How Hox genes encode this specificity is a paradox, because different Hox proteins bind with high affinity in vitro to similar DNA sequences. Here, we demonstrate that the Hox protein Ultrabithorax (Ubx) in complex with its cofactor Extradenticle (Exd) bound specifically to clusters of very low affinity sites in enhancers of the shavenbaby gene of Drosophila. These low affinity sites conferred specificity for Ubx binding in vivo, but multiple clustered sites were required for robust expression when embryos developed in variable environments. Although most individual Ubx binding sites are not evolutionarily conserved, the overall enhancer architecture-clusters of low affinity binding sites-is maintained and required for enhancer function. Natural selection therefore works at the level of the enhancer, requiring a particular density of low affinity Ubx sites to confer both specific and robust expression.	[Crocker, Justin; Stern, David L.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Abe, Namiko; Rinaldi, Lucrezia; Mann, Richard S.] Columbia Univ, Med Ctr, New York, NY 10032 USA; [McGregor, Alistair P.] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Frankel, Nicolas] Univ Buenos Aires, Dept Ecol Genet & Evoluc, IEGEBA CONICET, Fac Ciencias Exactas & Nat, RA-1428 Buenos Aires, DF, Argentina; [Wang, Shu] New Jersey Neurosci Inst, Edison, NJ 08820 USA; [Alsawadi, Ahmad; Valenti, Philippe; Plaza, Serge; Payre, Francois] Univ Toulouse, Ctr Biol Dev, UPS, F-31062 Toulouse 9, France; [Alsawadi, Ahmad; Valenti, Philippe; Plaza, Serge; Payre, Francois] CNRS, UMR5547, Ctr Biol Dev, F-31062 Toulouse 9, France	Howard Hughes Medical Institute; Columbia University; Oxford Brookes University; University of Buenos Aires; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Mann, RS (corresponding author), Columbia Univ, Med Ctr, 701 West 168th St,HHSC 1104, New York, NY 10032 USA.	rsm10@columbia.edu; sternd@janelia.hhmi.org	plaza, serge/F-5290-2015	PAYRE, Francois/0000-0002-8144-6711; Stern, David/0000-0002-1847-6483; McGregor, Alistair/0000-0002-2908-2420	NIH [GM054510]; ANR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118336, R01GM054510] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANR(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Sterling for technical assistance with EMSA experiments, A. Lemire and V. FitzPatrick for bioinformatics assistance, E. Preger for use of her 7::GFP reporter construct, and J. Cande, Y. Ding, A. Lemire, J. Mast, E. Preger, and T. Shirangi for helpful discussions. This work was supported in part by NIH grant GM054510 to R.S.M. and ANR grant (ChronoNet) to F.P.	AKAM M, 1989, CELL, V57, P347, DOI 10.1016/0092-8674(89)90909-4; Arnone MI, 1997, DEVELOPMENT, V124, P1851; Belyi V.A., 2010, PERSPECT BIOL, V2; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Busser BW, 2012, DEVELOPMENT, V139, P1164, DOI 10.1242/dev.077362; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Choo SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014778; Coiffier D, 2008, DEVELOPMENT, V135, P291, DOI 10.1242/dev.009662; Crocker J, 2013, NAT METHODS, V10, P762, DOI [10.1038/NMETH.2543, 10.1038/nmeth.2543]; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; Doniger SW, 2007, PLOS COMPUT BIOL, V3, P932, DOI 10.1371/journal.pcbi.0030099; Doniger SW, 2005, GENOME RES, V15, P701, DOI 10.1101/gr.3578205; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Dror I, 2014, NUCLEIC ACIDS RES, V42, P430, DOI 10.1093/nar/gkt862; Estella C, 2008, DEV CELL, V14, P86, DOI 10.1016/j.devcel.2007.11.002; Frankel N, 2012, P NATL ACAD SCI USA, V109, P20975, DOI 10.1073/pnas.1207715109; Frankel N, 2011, NATURE, V474, P598, DOI 10.1038/nature10200; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Giorgianni MW, 2011, DEV CELL, V20, P455, DOI 10.1016/j.devcel.2011.03.017; GONZALEZREYES A, 1990, CELL, V61, P515, DOI 10.1016/0092-8674(90)90533-K; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Hasan R, 2002, MOL MICROBIOL, V45, P233, DOI 10.1046/j.1365-2958.2002.03011.x; He X, 2012, MOL BIOL EVOL, V29, P1059, DOI 10.1093/molbev/msr277; Hersh BM, 2005, DEVELOPMENT, V132, P1567, DOI 10.1242/dev.01737; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Ju rgens G., 1984, ROUX ARCH DEVEL BIOL, V193, P283; KARCH F, 1990, GENE DEV, V4, P1573, DOI 10.1101/gad.4.9.1573; KUROIWA A, 1985, EMBO J, V4, P3757, DOI 10.1002/j.1460-2075.1985.tb04145.x; Lebrecht D, 2005, P NATL ACAD SCI USA, V102, P13176, DOI 10.1073/pnas.0506462102; Lelli KM, 2011, P NATL ACAD SCI USA, V108, P21122, DOI 10.1073/pnas.1114118109; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435; Papatsenko DA, 2002, GENOME RES, V12, P470, DOI 10.1101/gr.212502. Article published online before print in February ; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; PEIFER M, 1990, GENE DEV, V4, P1209, DOI 10.1101/gad.4.7.1209; Peterson KA, 2012, GENE DEV, V26, P2802, DOI 10.1101/gad.207142.112; POWSNER LOUIS, 1935, PHYSIOL ZOOL, V8, P474; Ramos AI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0018; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; Saramaki A, 2006, NUCLEIC ACIDS RES, V34, P543, DOI 10.1093/nar/gkj460; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; Stewart-Ornstein J, 2013, CURR BIOL, V23, P2336, DOI 10.1016/j.cub.2013.09.043; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; WAKIMOTO BT, 1981, DEV BIOL, V81, P51, DOI 10.1016/0012-1606(81)90347-X	71	190	193	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					191	203		10.1016/j.cell.2014.11.041	http://dx.doi.org/10.1016/j.cell.2014.11.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25557079	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000347923200018
J	Krinner, S; Stadler, D; Husmann, D; Brantut, JP; Esslinger, T				Krinner, Sebastian; Stadler, David; Husmann, Dominik; Brantut, Jean-Philippe; Esslinger, Tilman			Observation of quantized conductance in neutral matter	NATURE			English	Article							POINT CONTACTS; QUANTUM; RESISTANCE; TRANSPORT; DROP	In transport experiments, the quantum nature of matter becomes directly evident when changes in conductance occur only in discrete steps(1), with a size determined solely by Planck's constant h. Observations of quantized steps in electrical conductance(2,3) have provided important insights into the physics of mesoscopic systems(4) and have allowed the development of quantum electronic devices(5). Even though quantized conductance should not rely on the presence of electric charges, it has never been observed for neutral, massive particles(6). In its most fundamental form, it requires a quantum-degenerate Fermi gas, a ballistic and adiabatic transport channel, and a constriction with dimensions comparable to the Fermi wavelength. Here we report the observation of quantized conductance in the transport of neutral atoms driven by a chemical potential bias. The atoms are in an ultra-ballistic regime, where their mean free path exceeds not only the size of the transport channel, but also the size of the entire system, including the atom reservoirs. We use high-resolution lithography to shape light potentials that realize either a quantum point contact or a quantum wire for atoms. These constrictions are imprinted on a quasi-two-dimensional ballistic channel connecting the reservoirs(7). By varying either a gate potential or the transverse confinement of the constrictions, we observe distinct plateaux in the atom conductance. The conductance in the first plateau is found to be equal to the universal conductance quantum, 1/h. We use Landauer's formula to model our results and find good agreement for low gate potentials, with all parameters determined a priori. Our experiment lets us investigate quantum conductors with wide control not only over the channel geometry, but also over the reservoir properties, such as interaction strength, size and thermalization rate.	[Krinner, Sebastian; Stadler, David; Husmann, Dominik; Brantut, Jean-Philippe; Esslinger, Tilman] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Brantut, JP (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	brantutj@phys.ethz.ch	Husmann, Dominik/AAM-4052-2021; Esslinger, Tilman/M-9022-2016; Brantut, Jean-Philippe/G-2793-2013	Husmann, Dominik/0000-0003-4291-1075; Esslinger, Tilman/0000-0002-8333-107X; Brantut, Jean-Philippe/0000-0002-4610-6682	SNF	SNF	We acknowledge discussions with G. Blatter, K. Ensslin, C. Glattli, T. Giamarchi, C. Grenier and M. Lebrat, and thank C. Chin, T. Ihn, Y. Imry, and W. Zwerger for their careful reading of the manuscript and for discussions. We acknowledge financing from NCCR QSIT, the ERC Project SQMS, the FP7 project SIQS and ETHZ. J.- P. B. is supported by the Ambizione program of SNF.	Albiez M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010402; Beria M, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.043611; Bouchoule I., 2010, ATOM CHIPS, P331; Brantut JP, 2013, SCIENCE, V342, P713, DOI 10.1126/science.1242308; Brantut JP, 2012, SCIENCE, V337, P1069, DOI 10.1126/science.1223175; BUTTIKER M, 1985, PHYS REV B, V31, P6207, DOI 10.1103/PhysRevB.31.6207; BUTTIKER M, 1986, PHYS REV B, V33, P3020, DOI 10.1103/PhysRevB.33.3020; Du X, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.250402; Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744; Gattobigio GL, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.254104; GLAZMAN LI, 1988, JETP LETT+, V48, P238; Gorlitz A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.130402; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hung CL, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.011604; Ihn T., 2010, SEMICONDUCTOR NANOST; Imry Y., 1986, DIRECTIONS CONDENSED, P120; Imry Y., 2002, INTRO MESOSCOPIC PHY, V2nd edn; Kinoshita T, 2004, SCIENCE, V305, P1125, DOI 10.1126/science.1100700; KOUWENHOVEN LP, 1989, PHYS REV B, V39, P8040, DOI 10.1103/PhysRevB.39.8040; KRANS JM, 1995, NATURE, V375, P767, DOI 10.1038/375767a0; Krinner S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.100601; LANDAUER R, 1957, IBM J RES DEV, V1, P223, DOI 10.1147/rd.13.0223; LEE PA, 1985, PHYS REV LETT, V55, P1622, DOI 10.1103/PhysRevLett.55.1622; Migdal A., 2000, QUALITATIVE METHODS, P115; Moritz H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.250402; O'Hara KM, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.051403; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; Sachdev S., 2011, QUANTUM PHASE TRANSI, P260; Sato Y, 2005, J LOW TEMP PHYS, V141, P99, DOI 10.1007/s10909-005-8223-3; Serwane F, 2011, SCIENCE, V332, P336, DOI 10.1126/science.1201351; Stadler D, 2012, NATURE, V491, P736, DOI 10.1038/nature11613; SZAFER A, 1989, PHYS REV LETT, V62, P300, DOI 10.1103/PhysRevLett.62.300; Thywissen JH, 1999, PHYS REV LETT, V83, P3762, DOI 10.1103/PhysRevLett.83.3762; Ulreich S, 1998, SUPERLATTICE MICROST, V23, P719, DOI 10.1006/spmi.1997.0535; Ulreich S., 1997, THESIS LMU MUNCHEN, P44; vanHouten H, 1996, PHYS TODAY, V49, P22, DOI 10.1063/1.881503; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; Vignale G, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.014201; WHARAM DA, 1988, J PHYS C SOLID STATE, V21, pL209, DOI 10.1088/0022-3719/21/8/002; YACOBY A, 1990, PHYS REV B, V41, P5341, DOI 10.1103/PhysRevB.41.5341; Zimmermann B, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043007; Zurn G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.135301	42	144	144	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					64	U148		10.1038/nature14049	http://dx.doi.org/10.1038/nature14049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25557712	Green Submitted			2022-12-28	WOS:000347178400035
J	Gotzsche, PC				Gotzsche, Peter C.			"Human guinea pig" asks for animal studies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SAFETY		Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Gotzsche, PC (corresponding author), Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark.	pcg@cochrane.dk						American Cancer Society, 2014, SMALL INT CANC; American Cancer Society, 2014, CANC FACTS FIG; Andrade M, 2009, BMJ-BRIT MED J, V339, P538; Butler D, 2012, NATURE, V490, P322, DOI 10.1038/490322a; Coombes R, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1458; Eichler HG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001202; Gotzsche PC, 2013, DEADLY MED ORGANISED; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Gotzsche PC, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2686; ICH, 2009, GUID M3 R2 NONCL SAF; International Conference on Harmonisation, 1995, HARM TRIP GUID NEED; International Conference on Harmonisation, 1997, HARM TRIP GUID CARC; Mello MM, 2012, NEW ENGL J MED, V367, P959, DOI 10.1056/NEJMhle1207160; Mitka M, 2010, JAMA-J AM MED ASSOC, V303, P2341, DOI 10.1001/jama.2010.788; United States General Accounting Office, 2002, FOOD DRUG ADM EFF US; US Senate Committee on Finance, 2010, GRASSL BAUC REL COMM	16	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2014	349								g6714	10.1136/bmj.g6714	http://dx.doi.org/10.1136/bmj.g6714			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY4JI	25550276				2022-12-28	WOS:000347543800001
J	Bonini, S; Eichler, HG; Wathion, N; Rasi, G				Bonini, Sergio; Eichler, Hans-Georg; Wathion, Noel; Rasi, Guido			Transparency and the European Medicines Agency - Sharing of Clinical Trial Data	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bonini, Sergio; Eichler, Hans-Georg; Wathion, Noel; Rasi, Guido] European Med Agcy, London, England; [Bonini, Sergio] Univ Naples 2, Naples, Italy; [Bonini, Sergio] Italian Natl Res Council, Inst Translat Pharmacol, Rome, Italy; [Rasi, Guido] Univ Roma Tor Vergata, Rome, Italy; [Eichler, Hans-Georg] Med Univ Vienna, Vienna, Austria	Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); University of Rome Tor Vergata; Medical University of Vienna	Bonini, S (corresponding author), European Med Agcy, London, England.		Bonini, Sergio/T-6594-2019; Rasi, Guido/AAC-8172-2021	Bonini, Sergio/0000-0003-0079-3031; Rasi, Guido/0000-0002-2191-1386				Eichler HG, 2013, NEW ENGL J MED, V369, P1577, DOI 10.1056/NEJMp1310771; Strom BL, 2014, NEW ENGL J MED, V371, P2052, DOI 10.1056/NEJMp1411794	2	56	58	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2452	2455		10.1056/NEJMp1409464	http://dx.doi.org/10.1056/NEJMp1409464			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX4RZ	25539105				2022-12-28	WOS:000346920300004
J	Foltz, C; Strum, W				Foltz, Cainan; Strum, Williamson			Epiphrenic Diverticulum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Foltz, Cainan; Strum, Williamson] Scripps Clin, La Jolla, CA 92037 USA	Scripps Research Institute	Foltz, C (corresponding author), Scripps Clin, La Jolla, CA 92037 USA.	foltz.cainan@scrippshealth.org							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2510	2510		10.1056/NEJMicm1400734	http://dx.doi.org/10.1056/NEJMicm1400734			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX4RZ	25539107				2022-12-28	WOS:000346920300010
J	Wright, DW; Yeatts, SD; Silbergleit, R; Palesch, YY; Hertzberg, VS; Frankel, M; Goldstein, FC; Caveney, AF; Howlett-Smith, H; Bengelink, EM; Manley, GT; Merck, LH; Janis, LS; Barsan, WG				Wright, David W.; Yeatts, Sharon D.; Silbergleit, Robert; Palesch, Yuko Y.; Hertzberg, Vicki S.; Frankel, Michael; Goldstein, Felicia C.; Caveney, Angela F.; Howlett-Smith, Harriet; Bengelink, Erin M.; Manley, Geoffrey T.; Merck, Lisa H.; Janis, L. Scott; Barsan, William G.		NETT Investigators	Very Early Administration of Progesterone for Acute Traumatic Brain Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; PRACTICAL SCALE; NEUROPROTECTION; COMA	BACKGROUND Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Progesterone has been shown to improve neurologic outcome in multiple experimental models and two early-phase trials involving patients with TBI. METHODS We conducted a double-blind, multicenter clinical trial in which patients with severe, moderate-to-severe, or moderate acute TBI (Glasgow Coma Scale score of 4 to 12, on a scale from 3 to 15, with lower scores indicating a lower level of consciousness) were randomly assigned to intravenous progesterone or placebo, with the study treatment initiated within 4 hours after injury and administered for a total of 96 hours. Efficacy was defined as an increase of 10 percentage points in the proportion of patients with a favorable outcome, as determined with the use of the stratified dichotomy of the Extended Glasgow Outcome Scale score at 6 months after injury. Secondary outcomes included mortality and the Disability Rating Scale score. RESULTS A total of 882 of the planned sample of 1140 patients underwent randomization before the trial was stopped for futility with respect to the primary outcome. The study groups were similar with regard to baseline characteristics; the median age of the patients was 35 years, 73.7% were men, 15.2% were black, and the mean Injury Severity Score was 24.4 (on a scale from 0 to 75, with higher scores indicating greater severity). The most frequent mechanism of injury was a motor vehicle accident. There was no significant difference between the progesterone group and the placebo group in the proportion of patients with a favorable outcome (relative benefit of progesterone, 0.95; 95% confidence interval [CI], 0.85 to 1.06; P = 0.35). Phlebitis or thrombophlebitis was more frequent in the progesterone group than in the placebo group (relative risk, 3.03; CI, 1.96 to 4.66). There were no significant differences in the other prespecified safety outcomes. CONCLUSIONS This clinical trial did not show a benefit of progesterone over placebo in the improvement of outcomes in patients with acute TBI.	[Wright, David W.; Howlett-Smith, Harriet] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA; [Frankel, Michael; Goldstein, Felicia C.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Grady Mem Hosp, Atlanta, GA USA; [Hertzberg, Vicki S.] Emory Univ, Dept Biostat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Yeatts, Sharon D.; Palesch, Yuko Y.] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC USA; [Silbergleit, Robert; Bengelink, Erin M.; Barsan, William G.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Caveney, Angela F.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; [Merck, Lisa H.] Brown Univ, Dept Emergency Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [Janis, L. Scott] NINDS, NIH, Bethesda, MD 20892 USA	Emory University; Emory University; Emory University; Rollins School Public Health; Medical University of South Carolina; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; Brown University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wright, DW (corresponding author), 49 Jesse Hill Jr Dr, Atlanta, GA 30303 USA.	david.wright@emory.edu	Meurer, William J/A-7547-2010; Bebarta, Vikhyat S/M-1513-2015; Pascual, Jose/ABI-2291-2020; Shutter, Lori A/G-2957-2013; Brandler, Ethan S/H-6505-2019; Milling, Truman J/N-6601-2017; Rosenthal, Eric/A-2085-2017	Meurer, William J/0000-0002-1158-5302; Pascual, Jose/0000-0002-1613-7912; Brandler, Ethan S/0000-0003-4647-8483; Milling, Truman J/0000-0002-5588-0426; Quinn, James/0000-0002-3694-2118; Hirsch, Karen/0000-0002-5474-3243; Shutter, Lori/0000-0002-1390-0628; Legome, Eric/0000-0003-3567-8308; Foreman, Brandon/0000-0002-5418-674X; Healy, Megan/0000-0001-8145-1898; Rosenthal, Eric/0000-0003-3900-356X; Feldman, James/0000-0003-3962-0189; McMullan, Jason/0000-0002-7656-7447; Jallo, Jack/0000-0002-5512-1729; Miller, Kathleen/0000-0001-9130-578X	National Institute of Neurological Disorders and Stroke of the National Institutes of Health [NS062778, 5U10NS059032, U01NS056975]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]; Emory Emergency Neurosciences Laboratory in the Department of Emergency Medicine, Emory School of Medicine; Grady Memorial Hospital; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U10NS080369, U10NS059032, U01NS062778, U01NS059041, U10NS059012, U10NS058940, U10NS058927, U01NS056975, U10NS080377, U10NS058960] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Emory Emergency Neurosciences Laboratory in the Department of Emergency Medicine, Emory School of Medicine; Grady Memorial Hospital; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NS062778, 5U10NS059032, and U01NS056975) and the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR000454) and by the Emory Emergency Neurosciences Laboratory in the Department of Emergency Medicine, Emory School of Medicine, and Grady Memorial Hospital.	[Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P549; [Anonymous], 2017, ANAL CLIN TRIALS USI; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Ducharme N, 2010, EUR J PHARMACOL, V641, P128, DOI 10.1016/j.ejphar.2010.05.033; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; JENNETT B, 1975, LANCET, V1, P480; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; TEASDALE G, 1974, LANCET, V2, P81; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	17	366	374	2	226	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2457	2466		10.1056/NEJMoa1404304	http://dx.doi.org/10.1056/NEJMoa1404304			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX4RZ	25493974	Green Accepted			2022-12-28	WOS:000346920300005
J	Chapron, G; Kaczensky, P; Linnell, JDC; von Arx, M; Huber, D; Andren, H; Lopez-Bao, JV; Adamec, M; Alvares, F; Anders, O; Balciauskas, L; Balys, V; Bedo, P; Bego, F; Blanco, JC; Breitenmoser, U; Broseth, H; Bufka, L; Bunikyte, R; Ciucci, P; Dutsov, A; Engleder, T; Fuxjager, C; Groff, C; Holmala, K; Hoxha, B; Iliopoulos, Y; Ionescu, O; Jeremic, J; Jerina, K; Kluth, G; Knauer, F; Kojola, I; Kos, I; Krofel, M; Kubala, J; Kunovac, S; Kusak, J; Kutal, M; Liberg, O; Majic, A; Mannil, P; Manz, R; Marboutin, E; Marucco, F; Melovski, D; Mersini, K; Mertzanis, Y; Myslajek, RW; Nowak, S; Odden, J; Ozolins, J; Palomero, G; Paunovic, M; Persson, J; Potocnik, H; Quenette, PY; Rauer, G; Reinhardt, I; Rigg, R; Ryser, A; Salvatori, V; Skrbinsek, T; Stojanov, A; Swenson, JE; Szemethy, L; Trajce, A; Tsingarska-Sedefcheva, E; Vana, M; Veeroja, R; Wabakken, P; Wofl, M; Wolfl, S; Zimmermann, F; Zlatanova, D; Boitani, L				Chapron, Guillaume; Kaczensky, Petra; Linnell, John D. C.; von Arx, Manuela; Huber, Djuro; Andren, Henrik; Vicente Lopez-Bao, Jose; Adamec, Michal; Alvares, Francisco; Anders, Ole; Balciauskas, Linas; Balys, Vaidas; Bedo, Peter; Bego, Ferdinand; Carlos Blanco, Juan; Breitenmoser, Urs; Broseth, Henrik; Bufka, Ludek; Bunikyte, Raimonda; Ciucci, Paolo; Dutsov, Alexander; Engleder, Thomas; Fuxjaeger, Christian; Groff, Claudio; Holmala, Katja; Hoxha, Bledi; Iliopoulos, Yorgos; Ionescu, Ovidiu; Jeremic, Jasna; Jerina, Klemen; Kluth, Gesa; Knauer, Felix; Kojola, Ilpo; Kos, Ivan; Krofel, Miha; Kubala, Jakub; Kunovac, Sasa; Kusak, Josip; Kutal, Miroslav; Liberg, Olof; Majic, Aleksandra; Maennil, Peep; Manz, Ralph; Marboutin, Eric; Marucco, Francesca; Melovski, Dime; Mersini, Kujtim; Mertzanis, Yorgos; Myslajek, Robert W.; Nowak, Sabina; Odden, John; Ozolins, Janis; Palomero, Guillermo; Paunovic, Milan; Persson, Jens; Potocnik, Hubert; Quenette, Pierre-Yves; Rauer, Georg; Reinhardt, Ilka; Rigg, Robin; Ryser, Andreas; Salvatori, Valeria; Skrbinsek, Tomaz; Stojanov, Aleksandar; Swenson, Jon E.; Szemethy, Laszlo; Trajce, Aleksander; Tsingarska-Sedefcheva, Elena; Vana, Martin; Veeroja, Rauno; Wabakken, Petter; Woefl, Manfred; Woelfl, Sybille; Zimmermann, Fridolin; Zlatanova, Diana; Boitani, Luigi			Recovery of large carnivores in Europe's modern human-dominated landscapes	SCIENCE			English	Article							CONSERVATION; POLICY	The conservation of large carnivores is a formidable challenge for biodiversity conservation. Using a data set on the past and current status of brown bears (Ursus arctos), Eurasian lynx (Lynx lynx), gray wolves (Canis lupus), and wolverines (Gulo gulo) in European countries, we show that roughly one-third of mainland Europe hosts at least one large carnivore species, with stable or increasing abundance in most cases in 21st-century records. The reasons for this overall conservation success include protective legislation, supportive public opinion, and a variety of practices making coexistence between large carnivores and people possible. The European situation reveals that large carnivores and people can share the same landscape.	[Chapron, Guillaume; Andren, Henrik; Vicente Lopez-Bao, Jose; Liberg, Olof; Persson, Jens] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, S-73091 Riddarhyttan, Sweden; [Kaczensky, Petra; Knauer, Felix; Rauer, Georg] Univ Vet Med, Res Inst Wildlife Ecol, A-1160 Vienna, Austria; [Linnell, John D. C.; Broseth, Henrik; Odden, John; Swenson, Jon E.] Norwegian Inst Nat Res, N-7485 Trondheim, Norway; [von Arx, Manuela; Breitenmoser, Urs; Manz, Ralph; Ryser, Andreas; Zimmermann, Fridolin] KORA, CH-3074 Muri Bei Bern, Switzerland; [Huber, Djuro; Kusak, Josip] Univ Zagreb, Fac Vet Med, Biol Dept, Zagreb 10000, Croatia; [Vicente Lopez-Bao, Jose] Univ Oviedo, Res Unit Biodivers UO CSIC PA, Mieres 33600, Spain; [Adamec, Michal] State Nat Conservancy Slovak Republ, Banska Bystrica 97401, Slovakia; [Alvares, Francisco] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBio, P-4485661 Vairao, Portugal; [Anders, Ole] Harz Natl Pk, D-38855 Wernigerode, Germany; [Balciauskas, Linas] Natl Res Ctr, LT-08412 Vilnius, Lithuania; [Balys, Vaidas] Assoc Nat Conservat Baltijos Vilkas, LT-08300 Vilnius, Lithuania; [Bedo, Peter; Rigg, Robin] Slovak Wildlife Soc, Liptovsky Hradok 03301, Slovakia; [Bego, Ferdinand] Univ Tirana, Fac Nat Sci, Biol Dept, Tirana, Albania; [Carlos Blanco, Juan] Wolf Project, Madrid 28004, Spain; [Breitenmoser, Urs] Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth, CH-3012 Bern, Switzerland; [Bufka, Ludek] Czech Univ Life Sci Prague, Dept Game Management & Wildlife Biol, Prague 16521, Czech Republic; [Bunikyte, Raimonda] Minist Environm Republ Lithuania, LT-01105 Vilnius, Lithuania; [Ciucci, Paolo; Boitani, Luigi] Univ Roma La Sapienza, Dept Biol & Biotechnol, I-00185 Rome, Italy; [Dutsov, Alexander; Tsingarska-Sedefcheva, Elena] Balkani Wildlife Soc, Sofia 1164, Bulgaria; [Engleder, Thomas] Lynx Project Austria Northwest, A-4170 Haslach Muhl, Austria; [Fuxjaeger, Christian] Nationalpark Zentrum Molln, A-4591 Molln, Austria; [Groff, Claudio] Prov Autonoma Trento Serv Foreste & Fauna, I-38100 Trento, Italy; [Holmala, Katja] Finnish Game & Fisheries Res Inst, Helsinki 00790, Finland; [Hoxha, Bledi; Trajce, Aleksander] Protect & Preservat Nat Environm Albania, Tirana, Albania; [Iliopoulos, Yorgos; Mertzanis, Yorgos] Callisto Wildlife & Nat Conservat Soc, Thessaloniki 54621, Greece; [Ionescu, Ovidiu] Transilvania Univ, Dept Silviculture, Fac Silviculture & Forest Engn, Braov 500123, Romania; [Ionescu, Ovidiu] Forest Res Inst ICAS, Voluntari 077190, Ilfov, Romania; [Jeremic, Jasna] State Inst Nat Protect, Zagreb 10000, Croatia; [Jerina, Klemen; Kos, Ivan; Krofel, Miha; Majic, Aleksandra; Potocnik, Hubert; Skrbinsek, Tomaz] Univ Ljubljana, Biotech Fac, Ljubljana 1000, Slovenia; [Kluth, Gesa; Reinhardt, Ilka] LUPUS German Inst Wolf Mnitoring & Res, D-02979 Spreewitz, Germany; [Kojola, Ilpo] Oulu Game & Fisheries Res, Finnish Game & Fisheries Res Inst, Oulu 90570, Finland; [Kubala, Jakub] Tech Univ Zvolen, Fac Forestry, Dept Forest Protect & Game Management, Zvolen 96053, Slovakia; [Kunovac, Sasa] Univ Sarajevo, Fac Forestry, Sarajevo 71000, Bosnia & Herceg; [Kutal, Miroslav] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Protect & Wildlife Management, Brno 61300, Czech Republic; [Kutal, Miroslav; Vana, Martin] Friends Earth Czech Republ, Olomouc Branch, Olomouc 77900, Czech Republic; [Maennil, Peep; Veeroja, Rauno] Estonian Environm Agcy, EE-51013 Tartu, Estonia; [Marboutin, Eric] Off Natl Chasse & Faune Sauvage, F-38610 Gieres, France; [Marucco, Francesca] Ctr Gest & Conservaz Grandi Carnivori, I-12010 Valdieri, Italy; [Melovski, Dime; Stojanov, Aleksandar] Macedonian Ecol Soc, Skopje 1000, Macedonia; [Melovski, Dime] Georg August Univ, Dept Wildlife Sci, D-37077 Gottingen, Germany; [Mersini, Kujtim] Food Safety & Vet Inst, Natl Vet Epidemiol Unit, Tirana, Albania; [Myslajek, Robert W.] Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, PL-02106 Warsaw, Poland; [Nowak, Sabina] Assoc Nat Wolf, PL-34324 Lipowa, Poland; [Ozolins, Janis] Latvian State Forest Res Inst Silava, LV-2169 Salaspils, Latvia; [Palomero, Guillermo] Fdn Oso Pardo, Santander 39010, Spain; [Paunovic, Milan] Nat Hist Museum, Belgrade 11000, Serbia; [Quenette, Pierre-Yves] Equipe Ours, ONCFS CNERA PAD, F-31800 Villeneuve De Riviere, France; [Salvatori, Valeria] Ist Ecol Applicata, I-00161 Rome, Italy; [Swenson, Jon E.] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, N-1432 As, Norway; [Szemethy, Laszlo] St Istvan Univ, Inst Wildlife Conservat, H-2103 Godollo, Hungary; [Wabakken, Petter] Hedmark Univ Coll, N-2480 Koppang, Norway; [Woefl, Manfred] Bavarian Agcy Environm, D-95030 Hof, Germany; [Woelfl, Sybille] Lynx Project Bavaria, D-93462 Lam, Germany; [Zlatanova, Diana] Sofia Univ St Kliment Ohridski, Fac Biol, Dept Zool & Anthropol, Sofia 1164, Bulgaria	Swedish University of Agricultural Sciences; University of Veterinary Medicine Vienna; Norwegian Institute Nature Research; University of Zagreb; Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Universidade do Porto; Nature Research Center - Lithuania; University of Tirana (UT); University of Bern; Czech University of Life Sciences Prague; Sapienza University Rome; Natural Resources Institute Finland (Luke); National Research & Development Institute in Forestry "Marin Dracea"; University of Ljubljana; Natural Resources Institute Finland (Luke); Technical University Zvolen; University of Sarajevo; Mendel University in Brno; University of Gottingen; University of Warsaw; Latvian State Forest Research Institute "Silava"; Norwegian University of Life Sciences; Hungarian University of Agriculture & Life Sciences; Inland Norway University of Applied Sciences; University of Sofia	Chapron, G (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, S-73091 Riddarhyttan, Sweden.	gchapron@carnivoreconservation.org	Kos, Ivan/AAB-7566-2020; Álvares, Francisco/K-6353-2013; Linnell, John/V-4177-2019; Ciucci, Paolo/C-7677-2009; Huber, Djuro/P-3493-2016; Zimmermann, Fridolin/H-7877-2019; Odden, John/F-6088-2019; Marucco, Francesca/J-1609-2012; Andrén, Henrik/C-8995-2015; Mysłajek, Robert W./AAD-9569-2022; Krofel, Miha/I-4495-2019; Swenson, Jon/AAE-2890-2019; Bego, Ferdinand/GSD-7425-2022; Kutal, Miroslav/B-9612-2014; Balčiauskas, Linas/ABE-2454-2021; Mersini, Kujtim/B-6393-2019; VICENTE, LIERN/B-6112-2008; Kusak, Josip/T-8344-2019; Szemethy, László/GVT-8218-2022; Zlatanova, Diana/A-2434-2013; Lobo, Diele/I-9106-2012; Balciauskas, Linas/GRS-8910-2022; Myslajek, Robert/K-8248-2015	Álvares, Francisco/0000-0002-4033-6989; Linnell, John/0000-0002-8370-5633; Ciucci, Paolo/0000-0002-0994-3422; Zimmermann, Fridolin/0000-0003-3861-246X; Odden, John/0000-0002-6275-8648; Marucco, Francesca/0000-0002-1390-6106; Krofel, Miha/0000-0002-2010-5219; Bego, Ferdinand/0000-0002-3975-5959; Kutal, Miroslav/0000-0003-3857-5419; Balčiauskas, Linas/0000-0001-9672-5265; Mersini, Kujtim/0000-0001-8520-3373; VICENTE, LIERN/0000-0001-5883-9640; Zlatanova, Diana/0000-0002-4115-2786; Kusak, Josip/0000-0002-5544-6486; Broseth, Henrik/0000-0003-3795-891X; Skrbinsek, Tomaz/0000-0003-4435-7477; Trajce, Aleksander/0000-0002-6815-7421; Rigg, Robin/0000-0002-5020-9756; Andren, Henrik/0000-0002-5616-2426; Persson, Jens/0000-0003-1405-7561; Huber, Djuro/0000-0002-3912-3812; Kaczensky, Petra/0000-0001-5428-1176; Lopez-Bao, Jose Vicente/0000-0001-9213-998X; Nowak, Sabina/0000-0002-7771-8032; Myslajek, Robert/0000-0001-9619-2868; Reinhardt, Ilka/0000-0003-4314-3362	European Commission [070307/2012/629085/SER/B3]	European Commission(European CommissionEuropean Commission Joint Research Centre)	Shape files of all maps are available in Dryad at this address: http://doi.org/10.5061/dryad.986mp. This study was partly funded by European Commission contract 070307/2012/629085/SER/B3. P.K., G.C., J.D.C.L., M.v.A., D.H., H.A., J.V.L.-B., and L.B. designed the study; G.C. and J.V.L.B. wrote the paper with help from P.K., J.D.C.L., M.v.A., D.H., H.A., and L.B.; and all authors contributed data.	Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Basille M, 2009, ECOGRAPHY, V32, P683, DOI 10.1111/j.1600-0587.2009.05712.x; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Chapron G, 2014, SCIENCE, V343, P1199, DOI 10.1126/science.343.6176.1199-b; Copeland JP, 2010, CAN J ZOOL, V88, P233, DOI 10.1139/Z09-136; Gangaas KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068849; Gehrt SD., 2010, URBAN CARNIVORES ECO; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Kaczensky P., 2013, STATUS MANAGEMENT 2; KACZENSKY P, 2013, STATUS MANAGEMENT 1; Knott EJ, 2014, EUR J WILDLIFE RES, V60, P85, DOI 10.1007/s10344-013-0754-3; Kruckenhauser L, 2009, CONSERV GENET, V10, P1223, DOI 10.1007/s10592-008-9654-6; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Linnell JDC, 2012, HYSTRIX, V23, P80, DOI 10.4404/hystrix-23.1-4676; Linnell John D.C., 2011, P12; Linnell JDC, 2012, TECH ECOL CONSERVAT, P314; Lopez-Bao JV, 2013, CONSERV LETT, V6, P448, DOI 10.1111/conl.12014; Navarro LM, 2012, ECOSYSTEMS, V15, P900, DOI 10.1007/s10021-012-9558-7; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Vynne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028939; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Zimmermann Alexandra, 2010, P129, DOI 10.1002/9781444317091.ch6	26	1022	1041	35	828	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1517	1519		10.1126/science.1257553	http://dx.doi.org/10.1126/science.1257553			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525247	Green Published			2022-12-28	WOS:000346536500065
J	Ott, C; Kaldun, A; Argenti, L; Raith, P; Meyer, K; Laux, M; Zhang, YZ; Blattermann, A; Hagstotz, S; Ding, T; Heck, R; Madronero, J; Martin, F; Pfeifer, T				Ott, Christian; Kaldun, Andreas; Argenti, Luca; Raith, Philipp; Meyer, Kristina; Laux, Martin; Zhang, Yizhu; Blaettermann, Alexander; Hagstotz, Steffen; Ding, Thomas; Heck, Robert; Madronero, Javier; Martin, Fernando; Pfeifer, Thomas			Reconstruction and control of a time-dependent two-electron wave packet	NATURE			English	Article							DOUBLE-EXCITATION STATES; AUTOIONIZING STATES; IONIZATION; ABSORPTION; HELIUM; PHASE; PHOTOIONIZATION; SPECTROSCOPY; RESONANCES; DYNAMICS	The concerted motion of two or more bound electrons governs atomic(1) and molecular(2,3) non-equilibrium processes including chemical reactions, and hence there is much interest in developing a detailed understanding of such electron dynamics in the quantum regime. However, there is no exact solution for the quantum three-body problem, and as a result even the minimal system of two active electrons and a nucleus is analytically intractable(4). This makes experimental measurements of the dynamics of two bound and correlated electrons, as found in the helium atom, an attractive prospect. However, although the motion of single active electrons and holes has been observed with attosecond time resolution(5-7), comparable experiments on two-electron motion have so far remained out of reach. Here we show that a correlated two-electron wave packet can be reconstructed from a 1.2-femtosecond quantum beat among low-lying doubly excited states in helium. The beat appears in attosecond transient-absorption spectra(5,7-9) measured with unprecedentedly high spectral resolution and in the presence of an intensity-tunable visible laser field. We tune the coupling(10-12) between the two low-lying quantum states by adjusting the visible laser intensity, and use the Fano resonance as a phase-sensitive quantum interferometer(13) to achieve coherent control of the two correlated electrons. Given the excellent agreement with large-scalequantum-mechanical calculations for the helium atom, we anticipate that multidimensional spectroscopy experiments of the type we report here will provide benchmark data for testing fundamental few-body quantum dynamics theory in more complex systems. They might also provide a route to the site-specific measurement and control of metastable electronic transition states that are at the heart of fundamental chemical reactions.	[Ott, Christian; Kaldun, Andreas; Raith, Philipp; Meyer, Kristina; Laux, Martin; Zhang, Yizhu; Blaettermann, Alexander; Hagstotz, Steffen; Ding, Thomas; Heck, Robert; Pfeifer, Thomas] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Argenti, Luca; Martin, Fernando] Univ Autonoma Madrid, Dept Quim, E-28049 Madrid, Spain; [Madronero, Javier] Tech Univ Munich, Phys Dept, D-85747 Garching, Germany; [Martin, Fernando] Inst Madrileno Estudios Avanzados Nanociencia, Madrid 28049, Spain; [Pfeifer, Thomas] Heidelberg Univ, Ctr Quantum Dynam, D-69120 Heidelberg, Germany	Max Planck Society; Autonomous University of Madrid; Technical University of Munich; Ruprecht Karls University Heidelberg	Pfeifer, T (corresponding author), Max Planck Inst Kernphys, Saupfercheckweg 1, D-69117 Heidelberg, Germany.	fernando.martin@uam.es; thomas.pfeifer@mpi-hd.mpg.de	Ott, Christian/GXV-1144-2022; Martin, Fernando/C-3972-2014; Zhang, Yizhu/C-3519-2013; Argenti, Luca/D-2546-2015	Ott, Christian/0000-0003-4110-0916; Martin, Fernando/0000-0002-7529-925X; Zhang, Yizhu/0000-0003-2158-6541; Argenti, Luca/0000-0003-1093-4379; Heck, Robert/0000-0003-4511-7731	Max Planck Research Group Program of the Max Planck Gesellschaft (MPG); Deutsche Forschungsgemeinschaft [PF 790/1-1]; European COST Action [CM1204 XLIC]; European Research Council [290853 XCHEM]; Ministerio de Economia y Competitividad [FIS2010-15127, FIS2013-42002-R, ERA-Chemistry PIM2010EEC-00751]; European grant MC-ITN CORINF	Max Planck Research Group Program of the Max Planck Gesellschaft (MPG); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European COST Action; European Research Council(European Research Council (ERC)European Commission); Ministerio de Economia y Competitividad(Spanish Government); European grant MC-ITN CORINF	We thank E. Lindroth for calculating the dipole moment < 2 rho<SUP>2</SUP>vertical bar r vertical bar sp<INF>2,3+</INF>>, and A. Voitkiv, Z.-H. Loh and R. Moshammer for discussions. We acknowledge financial support from the Max Planck Research Group Program of the Max Planck Gesellschaft (MPG), the Deutsche Forschungsgemeinschaft (grant no. PF 790/1-1) and the European COST Action CM1204 XLIC. L.A. and F.M. acknowledge computer time from the CCC-UAM and Mare Nostrum supercomputer centres and financial support from the European Research Council under the ERC Advanced Grant no. 290853 XCHEM; the Ministerio de Economia y Competitividad projects FIS2010-15127, FIS2013-42002-R and ERA-Chemistry PIM2010EEC-00751; and the European grant MC-ITN CORINF.	Argenti L, 2006, J PHYS B-AT MOL OPT, V39, P2773, DOI 10.1088/0953-4075/39/12/012; Argenti L, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053002; Argenti L, 2008, J PHYS B-AT MOL OPT, V41, DOI 10.1088/0953-4075/41/3/035002; Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; AUGST S, 1991, J OPT SOC AM B, V8, P858, DOI 10.1364/JOSAB.8.000858; Beutler H, 1935, Z PHYS, V93, P177, DOI 10.1007/BF01365116; BURGERS A, 1995, J PHYS B-AT MOL OPT, V28, P3163, DOI 10.1088/0953-4075/28/15/010; Chu WC, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.033426; Domke M, 1996, PHYS REV A, V53, P1424, DOI 10.1103/PhysRevA.53.1424; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Gilbertson S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.263003; Goulielmakis E, 2010, NATURE, V466, P739, DOI 10.1038/nature09212; HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013; HICKS PJ, 1975, J PHYS B-AT MOL OPT, V8, P1866, DOI 10.1088/0022-3700/8/11/022; Holler M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.123601; Kim KT, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.093001; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; LAMBROPOULOS P, 1981, PHYS REV A, V24, P379, DOI 10.1103/PhysRevA.24.379; LIN CD, 1995, PHYS REP, V257, P2; Loh ZH, 2008, CHEM PHYS, V350, P7, DOI 10.1016/j.chemphys.2007.11.005; Mauritsson J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053001; MEYER HD, 1990, CHEM PHYS LETT, V165, P73, DOI 10.1016/0009-2614(90)87014-I; Morishita T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.083003; Ott C, 2013, SCIENCE, V340, P716, DOI 10.1126/science.1234407; Palaudoux J, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.043419; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; Pisharody SN, 2004, SCIENCE, V303, P813, DOI 10.1126/science.1092220; POLLARD WT, 1992, ANNU REV PHYS CHEM, V43, P497, DOI 10.1146/annurev.physchem.43.1.497; REINHARDT WP, 1982, ANNU REV PHYS CHEM, V33, P223, DOI 10.1146/annurev.pc.33.100182.001255; Remacle F, 2006, P NATL ACAD SCI USA, V103, P6793, DOI 10.1073/pnas.0601855103; Rost JM, 1997, J PHYS B-AT MOL OPT, V30, P4663, DOI 10.1088/0953-4075/30/21/010; SAMSON JAR, 1994, J PHYS B-AT MOL OPT, V27, P887, DOI 10.1088/0953-4075/27/5/008; Santra R, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.033405; Schulz K, 1996, PHYS REV LETT, V77, P3086, DOI 10.1103/PhysRevLett.77.3086; Themelis SI, 2004, J PHYS B-AT MOL OPT, V37, P4281, DOI 10.1088/0953-4075/37/21/005; Ullrich J, 2003, REP PROG PHYS, V66, P1463, DOI 10.1088/0034-4885/66/9/203; Vanroose W, 2005, SCIENCE, V310, P1787, DOI 10.1126/science.1120263; Wang H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.143002	38	215	221	2	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					374	+		10.1038/nature14026	http://dx.doi.org/10.1038/nature14026			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25519135	Green Accepted			2022-12-28	WOS:000346484800042
J	Pfenning, AR; Hara, E; Whitney, O; Rivas, MV; Wang, R; Roulhac, PL; Howard, JT; Wirthlin, M; Lovell, PV; Ganapathy, G; Mouncastle, J; Moseley, MA; Thompson, JW; Soderblom, EJ; Iriki, A; Kato, M; Gilbert, MTP; Zhang, G; Bakken, T; Bongaarts, A; Bernard, A; Lein, E; Mello, CV; Hartemink, AJ; Jarvis, ED				Pfenning, Andreas R.; Hara, Erina; Whitney, Osceola; Rivas, Miriam V.; Wang, Rui; Roulhac, Petra L.; Howard, Jason T.; Wirthlin, Morgan; Lovell, Peter V.; Ganapathy, Ganeshkumar; Mouncastle, Jacquelyn; Moseley, M. Arthur; Thompson, J. Will; Soderblom, Erik J.; Iriki, Atsushi; Kato, Masaki; Gilbert, M. Thomas P.; Zhang, Guojie; Bakken, Trygve; Bongaarts, Angie; Bernard, Amy; Lein, Ed; Mello, Claudio V.; Hartemink, Alexander J.; Jarvis, Erich D.			Convergent transcriptional specializations in the brains of humans and song-learning birds	SCIENCE			English	Article							FINCH TAENIOPYGIA-GUTTATA; LARYNGEAL MOTOR CORTEX; MALE ZEBRA FINCH; HUMAN SPEECH; PROJECTION NEURONS; FOXP2 EXPRESSION; FUNCTIONAL MRI; CHANNEL GENES; AREA-X; EVOLUTION	Song-learning birds and humans share independently evolved similarities in brain pathways for vocal learning that are essential for song and speech and are not found in most other species. Comparisons of brain transcriptomes of song-learning birds and humans relative to vocal nonlearners identified convergent gene expression specializations in specific song and speech brain regions of avian vocal learners and humans. The strongest shared profiles relate bird motor and striatal song-learning nuclei, respectively, with human laryngeal motor cortex and parts of the striatum that control speech production and learning. Most of the associated genes function in motor control and brain connectivity. Thus, convergent behavior and neural connectivity for a complex trait are associated with convergent specialized expression of multiple genes.	[Pfenning, Andreas R.; Hara, Erina; Whitney, Osceola; Rivas, Miriam V.; Wang, Rui; Roulhac, Petra L.; Howard, Jason T.; Ganapathy, Ganeshkumar; Mouncastle, Jacquelyn; Jarvis, Erich D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA; [Wirthlin, Morgan; Lovell, Peter V.; Mello, Claudio V.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; [Moseley, M. Arthur; Thompson, J. Will; Soderblom, Erik J.] Duke Univ, Med Ctr, Ctr Genom & Computat Biol, Duke Prote & Metabol Core Facil, Durham, NC 27710 USA; [Iriki, Atsushi; Kato, Masaki] RIKEN, Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama 3510198, Japan; [Gilbert, M. Thomas P.] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Gilbert, M. Thomas P.] Curtin Univ, Dept Environm & Agr, Trace & Environm DNA Lab, Perth, WA 6102, Australia; [Zhang, Guojie] BGI Shenzhen, China Natl GeneBank, Shenzhen 518083, Peoples R China; [Zhang, Guojie] Univ Copenhagen, Dept Biol, Ctr Social Evolut, DK-2100 Copenhagen, Denmark; [Bakken, Trygve; Bongaarts, Angie; Bernard, Amy; Lein, Ed] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Hartemink, Alexander J.] Duke Univ, Dept Comp Sci, Durham, NC 27708 USA	Duke University; Howard Hughes Medical Institute; Oregon Health & Science University; Duke University; RIKEN; University of Copenhagen; Curtin University; Beijing Genomics Institute (BGI); University of Copenhagen; Allen Institute for Brain Science; Duke University	Pfenning, AR (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA.	apfenning@csail.mit.edu; amink@cs.duke.edu; jarvis@neuro.duke.edu	Bakken, Trygve E./R-4622-2017; Zhang, Guojie/B-6188-2014; Wirthlin, Morgan/AAE-4119-2020; Kato, Masaki/B-5846-2018; Gilbert, Marcus TP/A-8936-2013; Jarvis, Erich D/A-2319-2008; Zhang, Guojie/J-7273-2019	Bakken, Trygve E./0000-0003-3373-7386; Zhang, Guojie/0000-0001-6860-1521; Wirthlin, Morgan/0000-0001-7967-7070; Kato, Masaki/0000-0002-5184-1841; Gilbert, Marcus TP/0000-0002-5805-7195; Jarvis, Erich D/0000-0001-8931-5049; Zhang, Guojie/0000-0001-6860-1521; Bernard, Amy/0000-0003-2540-1153; Howard, Jason/0000-0003-3265-5127; /0000-0002-3447-9801; Mello, Claudio/0000-0002-9826-8421; Whitney, Osceola/0000-0002-5701-7722	NIH [DP1 OD000448]; National Institute on Deafness and Other Communication Disorders [R01DC007218]; Howard Hughes Medical Institute; National Institute of General Medical Sciences [R24GM092842]; Funding Program for World-leading Innovative R&D on Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM092842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007218, R21DC007478] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000448] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Funding Program for World-leading Innovative R&D on Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Dressman and L.-L. Rowlette for microarray hybridizations, the Allen Institute for Brain Science for early access to human microarray data and human brain in situ hybridizations (and the Allen Institute founders, P. G. Allen and J. Allen, for their encouragement of that project), K. Simonyan for her coordinates of meta-analyses for speech regions, and S. Jarvis for help with imaging. Supported by NIH Directors Pioneer Award DP1 OD000448, National Institute on Deafness and Other Communication Disorders grant R01DC007218, and the Howard Hughes Medical Institute (E.D.J.). The brain gene expression atlas (ZEBrA) is supported by National Institute of General Medical Sciences grant R24GM092842 (C.V.M.). Marmoset experiments were supported by the Funding Program for World-leading Innovative R&D on Science and Technology (A. I.). Microarray data are available in the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) under accession numbers GSE33365 and GSE34819 (for songbird Area X), GSE28395 (for avian arcopallium regions), GSE33667 (for avian brainstem regions), and GSE31613 (for macaque brain regions); human microarray data are available from the Allen Human Brain Atlas site (http://human.brain-map.org/static/download). E.D.J., A.R.P., E.H., M.R., and P.R. conceived and designed the project; E.D.J., A.R.P., and A. J. H. wrote the paper; E.D.J., A. J. H., M.A.M., A. I., E.L., and C.V.M. co-supervised parts of the project; A.R.P. conducted most computational analyses; G. G., T.B., E.J.S., and A. J. H. conducted other computational analyses and supervision; E.H., M.R., O.W., and J.T.H. collected avian samples and performed microarray experiments; J.M., M.W., P.V.L., E.H., R.W., M.K., A.Bo., A. Be., C.V.M., and E.D.J. performed in situ hybridizations and analyses across species; G.Z., M.T.P.G., and E.D.J. provided genomes; and P.R., M.A.M., J.W.T., and E.J.S. performed proteomic experiments.	Adret P, 2002, J COMP NEUROL, V454, P409, DOI 10.1002/cne.10459; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Arriaga G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046610; Arriaga G, 2013, BRAIN LANG, V124, P96, DOI 10.1016/j.bandl.2012.10.002; Barrett HC, 2012, P NATL ACAD SCI USA, V109, P10733, DOI 10.1073/pnas.1201898109; Belgard TG, 2013, P NATL ACAD SCI USA, V110, P13150, DOI 10.1073/pnas.1307444110; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Bohland JW, 2006, NEUROIMAGE, V32, P821, DOI 10.1016/j.neuroimage.2006.04.173; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; Bottjer SW, 2000, J COMP NEUROL, V420, P244; Brainard MS, 2013, ANNU REV NEUROSCI, V36, P489, DOI 10.1146/annurev-neuro-060909-152826; Brown S, 2008, CEREB CORTEX, V18, P837, DOI 10.1093/cercor/bhm131; Brown S, 2009, BRAIN COGNITION, V70, P31, DOI 10.1016/j.bandc.2008.12.006; Carrillo GD, 2004, J COMP NEUROL, V473, P415, DOI 10.1002/cne.20099; Deregnaucourt S, 2009, P ROY SOC B-BIOL SCI, V276, P2153, DOI 10.1098/rspb.2009.0016; Doupe AJ, 2005, TRENDS NEUROSCI, V28, P353, DOI 10.1016/j.tins.2005.05.005; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Dubbeldam JL, 1998, ACTA ANAT, V163, P157; Egnor SER, 2004, TRENDS NEUROSCI, V27, P649, DOI 10.1016/j.tins.2004.08.009; Cornide-Petronio ME, 2013, DEV NEUROSCI-BASEL, V35, P285, DOI 10.1159/000351023; Farries MA, 2002, J NEUROSCI, V22, P3776; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Fisher SE, 2006, TRENDS COGN SCI, V10, P250, DOI 10.1016/j.tics.2006.04.003; Grabski K, 2012, HUM BRAIN MAPP, V33, P2306, DOI 10.1002/hbm.21363; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hara E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029457; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hilliard AT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002773; Hisaoka T, 2010, NEUROSCIENCE, V166, P551, DOI 10.1016/j.neuroscience.2009.12.055; Horita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042173; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 2002, J COMP PHYSIOL A, V188, P961, DOI 10.1007/s00359-002-0358-y; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jarvis ED, 2013, J COMP NEUROL, V521, P3614, DOI 10.1002/cne.23404; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Jurgens U, 2009, J VOICE, V23, P1, DOI 10.1016/j.jvoice.2007.07.005; Karten H J, 1989, J Cogn Neurosci, V1, P291, DOI 10.1162/jocn.1989.1.4.291; KARTEN HJ, 1991, BRAIN BEHAV EVOLUT, V38, P264, DOI 10.1159/000114393; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Liu Y, 2010, CURR BIOL, V20, pR53, DOI 10.1016/j.cub.2009.11.058; Lovell PV, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-470; Lovell PV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003440; Mandelblat-Cerf Y, 2014, ELIFE, V3, DOI 10.7554/eLife.02152; MARGOLIASH D, 1994, BRAIN BEHAV EVOLUT, V44, P247, DOI 10.1159/000113580; Matsunaga E, 2011, DEV GROWTH DIFFER, V53, P961, DOI 10.1111/j.1440-169X.2011.01302.x; Mello CV, 1998, J COMP NEUROL, V395, P137; Nii Y, 1996, NEUROLOGY, V46, P360, DOI 10.1212/WNL.46.2.360; NOTTEBOHM F, 1971, ANIM BEHAV, V19, P313, DOI 10.1016/S0003-3472(71)80012-X; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Oakley TH, 2008, CURR OPIN GENET DEV, V18, P479, DOI 10.1016/j.gde.2008.12.002; Okanoya K., 2007, EMERGENCE COMMUNICAT, P421, DOI [10.1007/978-1-84628-779-4_22, DOI 10.1007/978-1-84628-779-4_22]; Parker J, 2013, NATURE, V502, P228, DOI 10.1038/nature12511; Petkov Christopher I, 2012, Front Evol Neurosci, V4, P12, DOI 10.3389/fnevo.2012.00012; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Reiner A, 2004, J COMP NEUROL, V469, P239, DOI 10.1002/cne.11012; Roulhac Petra L, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5573; Sasaki T, 2010, CEREB CORTEX, V20, P2496, DOI 10.1093/cercor/bhp319; Scharff C, 2011, PHILOS T R SOC B, V366, P2124, DOI 10.1098/rstb.2011.0001; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Sherwood CC, 2004, BRAIN BEHAV EVOLUT, V63, P82, DOI 10.1159/000075673; Simonyan K, 2014, CURR OPIN NEUROBIOL, V28, P15, DOI 10.1016/j.conb.2014.05.006; Simonyan K, 2012, BRAIN LANG, V122, P142, DOI 10.1016/j.bandl.2011.12.009; Simonyan K, 2011, NEUROSCIENTIST, V17, P197, DOI 10.1177/1073858410386727; Simonyan K, 2009, J NEUROSCI, V29, P14912, DOI 10.1523/JNEUROSCI.4897-09.2009; Soros P, 2006, NEUROIMAGE, V32, P376, DOI 10.1016/j.neuroimage.2006.02.046; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Wada K, 2004, J COMP NEUROL, V476, P44, DOI 10.1002/cne.20201; Wang R, 2011, THESIS; Wang R, 2015, J COMP NEUROL, V523, P892, DOI 10.1002/cne.23719; Whitney O, 2014, SCIENCE, V346, P1334, DOI 10.1126/science.1256780; Wild JM, 1997, J COMP NEUROL, V377, P392, DOI 10.1002/(SICI)1096-9861(19970120)377:3<392::AID-CNE7>3.0.CO;2-Y; Wild JM, 2001, BRAIN RES, V917, P235; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Yokoyama S, 2001, GENETICS, V158, P1697; Zakon HH, 2006, P NATL ACAD SCI USA, V103, P3675, DOI 10.1073/pnas.0600160103; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385	85	267	271	10	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1333	+		10.1126/science.1256846	http://dx.doi.org/10.1126/science.1256846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504733	Green Accepted, Green Published			2022-12-28	WOS:000346189600038
J	Casadevall, A; Pirofski, LA				Casadevall, Arturo; Pirofski, Liise-anne			Ditch the term pathogen	NATURE			English	Editorial Material							CARRIAGE; DISEASE		[Casadevall, Arturo; Pirofski, Liise-anne] Yeshiva Univ, Albert Einstein Coll Med, New York, NY 10033 USA	Yeshiva University	Casadevall, A (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, New York, NY 10033 USA.	arturo.casadevall@einstein.yu.edu; l.pirofski@einstein.yu.edu						Biron CA, 2010, MBIO, V1, DOI 10.1128/mBio.00260-10; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; De Chiara M, 2014, P NATL ACAD SCI USA, V111, P5439, DOI 10.1073/pnas.1403353111; Howden BP, 2013, MBIO, V4, DOI 10.1128/mBio.00412-13; Pirofski LA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-6; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109	6	80	85	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					165	166		10.1038/516165a	http://dx.doi.org/10.1038/516165a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6ML	25503219	Bronze			2022-12-28	WOS:000346383500019
J	Falenty, A; Hansen, TC; Kuhs, WF				Falenty, Andrzej; Hansen, Thomas C.; Kuhs, Werner F.			Formation and properties of ice XVI obtained by emptying a type sII clathrate hydrate	NATURE			English	Article							NEGATIVE THERMAL-EXPANSION; THERMODYNAMIC STABILITY; HYDROGEN; PHASE; DISORDER	Gas hydrates are ice-like solids, in which guest molecules or atoms are trapped inside cages formed within a crystalline host framework (clathrate) of hydrogen-bonded water molecules(1). They are naturally present in large quantities on the deep ocean floor and as permafrost, can form in and block gas pipelines, and are thought to occur widely on Earth and beyond. A natural point of reference for this large and ubiquitous family of inclusion compounds is the empty hydrate lattice(1-6), which is usually regarded as experimentally inaccessible because the guest species stabilize the host framework. However, it has been suggested that sufficiently small guests may be removed to leave behind metastable empty clathrates(7,8), and guest-free Si-and Ge-clathrates have indeed been obtained(9,10). Here we show that this strategy can also be applied to water-based clathrates: five days of continuous vacuum pumping on small particles of neon hydrate (of structure sII) removes all guests, allowing us to determine the crystal structure, thermal expansivity and limit of metastability of the empty hydrate. It is the seventeenth experimentally established crystalline ice phase(11), ice XVI according to the current ice nomenclature, has a density of 0.81 grams per cubic centimetre (making it the least dense of all known crystalline water phases) and is expected(7,12) to be the stable low-temperature phase of water at negative pressures (that is, under tension). We find that the empty hydrate structure exhibits negative thermal expansion below about 55 kelvin, and that it is mechanically more stable and has at low temperatures larger lattice constants than the filled hydrate. These observations attest to the importance of kinetic effects and host-guest interactions in clathrate hydrates, with further characterization of the empty hydrate expected to improve our understanding of the structure, properties and behaviour of these unique materials.	[Falenty, Andrzej; Kuhs, Werner F.] Univ Gottingen, GZG Abt Kristallog, Goldschmidtstr 1, D-37077 Gottingen, Germany; [Hansen, Thomas C.] Inst Max Von Laue Paul Langevin, F-38000 Grenoble, France	University of Gottingen; Institut Laue-Langevin (ILL)	Kuhs, WF (corresponding author), Univ Gottingen, GZG Abt Kristallog, Goldschmidtstr 1, D-37077 Gottingen, Germany.	wkuhs1@gwdg.de	Hansen, Thomas/GWZ-2858-2022; Hansen, Thomas C/A-2729-2012	Hansen, Thomas C/0000-0003-4611-2393; Falenty, Andrzej/0000-0001-5995-9900	Bundesministeriums fur Bildung und Forschung (BMBF)	Bundesministeriums fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank the Bundesministeriums fur Bildung und Forschung (BMBF) for financial support in the context of the first and second phase of the German SUGAR (SUbmarine Gashydrat-Lagerstatten: Erkundung, Abbau und TRansport) project. We thank the Institut Laue-Langevin (ILL) for beam time and support. We are also grateful for the assistance of H. Bartels (Gottingen), U. Kahmann (Gottingen) and A. Daramsy (ILL), as well as for discussions with P. Lafond (Gottingen).	Alavi S, 2007, ANGEW CHEM INT EDIT, V46, P6102, DOI 10.1002/anie.200700250; Anderson BJ, 2005, J PHYS CHEM B, V109, P8153, DOI 10.1021/jp045551g; Ballard AL, 2002, FLUID PHASE EQUILIBR, V194, P371, DOI 10.1016/S0378-3812(01)00697-5; Bartels-Rausch T, 2012, REV MOD PHYS, V84, P885, DOI 10.1103/RevModPhys.84.885; Belosludov V.R., 2002, J SUPRAMOL CHEM, V2, P453, DOI DOI 10.1016/S1472-7862(03)00072-8; Buch V, 2009, PHYS CHEM CHEM PHYS, V11, P10245, DOI 10.1039/b911600c; Conde MM, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3182727; Demurov A, 2002, J CHEM PHYS, V116, P702, DOI 10.1063/1.1425821; Dyadin YA, 1999, J STRUCT CHEM+, V40, P790, DOI 10.1007/BF02903454; Evans JSO, 1999, J CHEM SOC DALTON, P3317, DOI 10.1039/a904297k; Falenty A, 2013, J PHYS CHEM C, V117, P8443, DOI 10.1021/jp310972b; GIES H, 1982, ANGEW CHEM INT EDIT, V21, P206, DOI 10.1002/anie.198202061; Gryko J, 2000, PHYS REV B, V62, pR7707, DOI 10.1103/PhysRevB.62.R7707; Guloy AM, 2006, NATURE, V443, P320, DOI 10.1038/nature05145; Hansen TC, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/3/034001; Jacobson LC, 2009, J PHYS CHEM B, V113, P10298, DOI 10.1021/jp903439a; JAMES F, 1980, REP PROG PHYS, V43, P1145, DOI 10.1088/0034-4885/43/9/002; Koyama Y, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1850904; Kuhs WF, 2012, P NATL ACAD SCI USA, V109, P21259, DOI 10.1073/pnas.1210331110; KUHS WF, 1992, ACTA CRYSTALLOGR A, V48, P80, DOI 10.1107/S0108767391009510; Kumar P, 2011, J PHYS CHEM A, V115, P14276, DOI 10.1021/jp2089565; Kuo JL, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2036971; Lobban C, 1998, NATURE, V391, P268, DOI 10.1038/34622; Mao WL, 2002, SCIENCE, V297, P2247, DOI 10.1126/science.1075394; Matsumoto M, 2011, J PHYS CHEM B, V115, P8257, DOI 10.1021/jp203478z; Pamuk B, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.193003; Peters B, 2008, J AM CHEM SOC, V130, P17342, DOI 10.1021/ja802014m; RODGER PM, 1991, AICHE J, V37, P1511, DOI 10.1002/aic.690371008; RODRIGUEZCARVAJAL J, 1993, PHYSICA B, V192, P55, DOI 10.1016/0921-4526(93)90108-I; Rottger K, 2012, ACTA CRYSTALLOGR B, V68, P91, DOI 10.1107/S0108768111046908; Senadheera L, 2007, J PHYS CHEM B, V111, P12097, DOI 10.1021/jp074517+; Sloan ED, 2008, CHEM IND-SER, V119, pXIX; Tanaka H, 1998, J CHEM PHYS, V108, P4887, DOI 10.1063/1.475897; Tang XL, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.014109; VANDERWAALS JH, 1959, ADV CHEM PHYS, V2, P1; WEAIRE D, 1994, PHIL MAG LETT, V69, P107, DOI 10.1080/09500839408241577; WOOLDRIDGE PJ, 1987, J CHEM PHYS, V87, P4126, DOI 10.1063/1.452917	37	216	218	5	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					231	+		10.1038/nature14014	http://dx.doi.org/10.1038/nature14014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25503235				2022-12-28	WOS:000346383500041
J	Dimick, JB; Ryan, AM				Dimick, Justin B.; Ryan, Andrew M.			Methods for Evaluating Changes in Health Care Policy The Difference-in-Differences Approach	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dimick, Justin B.; Ryan, Andrew M.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Dimick, Justin B.; Ryan, Andrew M.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Dimick, Justin B.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Dimick, Justin B.; Ryan, Andrew M.] Univ Michigan, Sch Publ Hlth, Dept Hlth Policy & Management, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dimick, JB (corresponding author), Univ Michigan, Sch Med, 2800 Plymouth Rd,Bldg 16,Off 136E, Ann Arbor, MI 48109 USA.	jdimick@umich.edu						Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Patel MS, 2014, JAMA-J AM MED ASSOC, V312, P2364, DOI 10.1001/jama.2014.15273; Rajaram R, 2014, JAMA-J AM MED ASSOC, V312, P2374, DOI 10.1001/jama.2014.15277; Ryan AM, HEALTH SERV RES, DOI [10.1111/1475-6773.12270, DOI 10.1111/1475-6773.12270]	5	690	694	7	89	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2401	2402		10.1001/jama.2014.16153	http://dx.doi.org/10.1001/jama.2014.16153			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW5YB	25490331				2022-12-28	WOS:000346345700015
J	Oliver, D				Oliver, David			PERSONAL VIEW Stop wasting taxpayers' money on management consultancy for the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									City Univ London, Sch Community & Hlth Sci, London EC1V OHB, England	City University London	Oliver, D (corresponding author), City Univ London, Sch Community & Hlth Sci, London EC1V OHB, England.	david.oliver.1@city.ac.uk						[Anonymous], 2010, DAILY MAIL; [Anonymous], 2014, BBC NEWS KENT; Barnes S, 2014, MCKINSEY CHOSEN WIDE; Cameron D., 2009, COMMUNICATION; Care Quality Commission, 2014, GUID NHS BOD FIT PRO; Clover B, 2014, BARTS PAYS MANAGEMEN; Craig D., 2005, RIP SCANDALOUS INSID; Craig D., 2006, PLUNDERING PUBLIC SE; Doward J, 2013, CALLS GREATER DISCLO; King's Fund, 2014, NEW SETTL HLTH SOC C; National Audit Office, 2011, DEL EFF SAV NHS; Parliamentary Public Accounts Committee, 2014, MON REG NHS FDN TRUS; Peedell C, 2014, BMJ; Roderick P, 2014, BMJ; Tallis R, 2013, NHS SOS NHS WAS BETR; Triggle N, 2014, NHS STAFF STRIKE DIS	16	6	6	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2014	349								g7243	10.1136/bmj.g7243	http://dx.doi.org/10.1136/bmj.g7243			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3DF	25491703				2022-12-28	WOS:000346165000004
J	Rollig, C; Knop, S; Bornhauser, M				Roellig, Christoph; Knop, Stefan; Bornhaeuser, Martin			Multiple myeloma	LANCET			English	Article							STEM-CELL TRANSPLANTATION; HIGH-DOSE THERAPY; THALIDOMIDE PLUS DEXAMETHASONE; UNDETERMINED SIGNIFICANCE MGUS; SINGLE-AGENT CARFILZOMIB; PHASE-III; INDUCTION THERAPY; MAINTENANCE THERAPY; ELDERLY-PATIENTS; AUTOLOGOUS TRANSPLANTATION	Multiple myeloma is a malignant disease characterised by proliferation of clonal plasma cells in the bone marrow and typically accompanied by the secretion of monoclonal immunoglobulins that are detectable in the serum or urine. Increased understanding of the microenvironmental interactions between malignant plasma cells and the bone marrow niche, and their role in disease progression and acquisition of therapy resistance, has helped the development of novel therapeutic drugs for use in combination with cytostatic therapy. Together with autologous stem cell transplantation and advances in supportive care, the use of novel drugs such as proteasome inhibitors and immunomodulatory drugs has increased response rates and survival substantially in the past several years. Present clinical research focuses on the balance between treatment efficacy and quality of life, the optimum sequencing of treatment options, the question of long-term remission and potential cure by multimodal treatment, the pre-emptive treatment of high-risk smouldering myeloma, and the role of maintenance. Upcoming results of ongoing clinical trials, together with a pipeline of promising new treatments, raise the hope for continuous improvements in the prognosis of patients with myeloma in the future.	[Roellig, Christoph; Bornhaeuser, Martin] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, D-01062 Dresden, Germany; [Knop, Stefan] Univ Klinikum Wurzburg, Med Klin & Poliklin 1, Wurzburg, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Wurzburg	Rollig, C (corresponding author), Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, Fetscherstr 74, D-01307 Dresden, Germany.	christoph.roellig@uniklinikum-dresden.de			Amgen; Celgene; Janssen; Novartis; Mundipharma; Onyx; MedA; Genzyme; Gilead; Astellas	Amgen(Amgen); Celgene(Bristol-Myers SquibbCelgene Corporation); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Mundipharma; Onyx; MedA; Genzyme(Sanofi-AventisGenzyme Corporation); Gilead(Gilead Sciences); Astellas(Astellas Pharmaceuticals)	CR has received speaker's fees from Amgen, Celgene, Janssen, Novartis, and Amgen. SK has received consultancies, honoraria, and speaker's fees from Celgene, Mundipharma, Janssen, Onyx, and travel or accommodation payments from Celgene. MB has received speaker's fees from Celgene, Novartis, MedA, Genzyme, and Gilead, received a travel grant from Astellas, and has served on an advisory board for Riemser.	Alvares CL, 2006, HAEMATOLOGICA, V91, P141; Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Attal M, 2012, NEW ENGL J MED, V366, P1782, DOI 10.1056/NEJMoa1114138; Beksac M, 2011, EUR J HAEMATOL, V86, P16, DOI 10.1111/j.1600-0609.2010.01524.x; Berenson JR, 2002, BLOOD, V99, P3163, DOI 10.1182/blood.V99.9.3163; Boccadoro M, 2013, ASCO M, V31, P8509; Casassus P, 2001, BRIT J HAEMATOL, V113, P1020; Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; Chanan-Khan A, 2008, J CLIN ONCOL, V26, P4784, DOI 10.1200/JCO.2007.14.9641; Chanan-Khan AA, 2012, CLIN CANCER RES, V18, P2145, DOI 10.1158/1078-0432.CCR-11-0498; Chanan-Khan AA, 2010, J CLIN ONCOL, V28, P2612, DOI 10.1200/JCO.2009.25.4250; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Dickinson M, 2009, INTERN MED J, V39, P304, DOI 10.1111/j.1445-5994.2008.01824.x; Dimopoulos M, 2009, LEUKEMIA, V23, P1545, DOI 10.1038/leu.2009.89; DIMOPOULOS MA, 1992, J CLIN ONCOL, V10, P587, DOI 10.1200/JCO.1992.10.4.587; Dimopoulos MA, 2012, ASH ANN M, V120, P944; Dispenzieri A, 2009, LEUKEMIA, V23, P215, DOI 10.1038/leu.2008.307; Dispenzieri A, 2012, BLOOD REV, V26, P137, DOI 10.1016/j.blre.2012.03.001; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Durie Brian G M, 2003, Hematol J, V4, P379; Egan JB, 2012, BLOOD, V120, P1060, DOI 10.1182/blood-2012-01-405977; Facon T, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.2.2; Fermand JP, 1998, BLOOD, V92, P3131, DOI 10.1182/blood.V92.9.3131.421k30_3131_3136; Fritz E, 2000, ANN ONCOL, V11, P1427, DOI 10.1023/A:1026548226770; Garderet L, 2012, J CLIN ONCOL, V30, P2475, DOI 10.1200/JCO.2011.37.4918; Giralt S, 2009, LEUKEMIA, V23, P1904, DOI 10.1038/leu.2009.127; Gorgun GT, 2013, BLOOD, V121, P2975, DOI 10.1182/blood-2012-08-448548; Hahn A., 2011, HAEMATOLOGICA S2, V96, P884; Harousseau JL, 2010, BLOOD, V116, P3743, DOI 10.1182/blood-2010-03-275800; Harousseau JL, 2010, J CLIN ONCOL, V28, P4621, DOI 10.1200/JCO.2009.27.9158; Harousseau JL, 2009, BLOOD, V114, P3139, DOI 10.1182/blood-2009-03-201053; He Y., 2003, COCHRANE DATABASE SY, V2003, DOI [DOI 10.1002/14651858.CD004023, 10.1002/14651858.CD004023]; Hu K, 2000, ONCOLOGY-NY, V14, P101; Lahuerta JJ, 2008, J CLIN ONCOL, V26, P5775, DOI 10.1200/JCO.2008.17.9721; Kapoor P, 2011, LEUKEMIA, V25, P689, DOI 10.1038/leu.2010.313; Kastritis E, 2013, EXPERT OPIN PHARMACO, V14, P1477, DOI 10.1517/14656566.2013.803068; Koreth J, 2007, BIOL BLOOD MARROW TR, V13, P183, DOI 10.1016/j.bbmt.2006.09.010; Kristinsson SY, 2007, J CLIN ONCOL, V25, P1993, DOI 10.1200/JCO.2006.09.0100; Kropff M, 2009, ANN HEMATOL, V88, P1125, DOI 10.1007/s00277-009-0726-6; Kuehl WM, 2012, J CLIN INVEST, V122, P3456, DOI 10.1172/JCI61188; Kumar A, 2011, AM J HEMATOL, V86, P18, DOI 10.1002/ajh.21904; Kumar A, 2011, ACTA HAEMATOL-BASEL, V125, P8, DOI 10.1159/000318880; Kumar A, 2009, J NATL CANCER I, V101, P100, DOI 10.1093/jnci/djn439; Kumar S, 2012, BLOOD, V119, P4375, DOI 10.1182/blood-2011-11-395749; Kumar S, 2011, BLOOD, V118, P1979, DOI 10.1182/blood-2011-02-337329; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kumar SK, 2012, CANCER-AM CANCER SOC, V118, P1585, DOI 10.1002/cncr.26422; Kumar SK, 2012, ASH ANN M ABSTR, V120, P3972, DOI DOI 10.1038/LEU.2013.313; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Kyle RA, 2007, NEW ENGL J MED, V356, P2582, DOI 10.1056/NEJMoa070389; Lacy MQ, 2006, MAYO CLIN PROC, V81, P1047, DOI 10.4065/81.8.1047; Ladetto M, 2010, J CLIN ONCOL, V28, P2077, DOI 10.1200/JCO.2009.23.7172; Landgren O, 2006, BLOOD, V107, P904, DOI 10.1182/blood-2005-08-3449; Larocca A, 2012, BLOOD, V119, P933, DOI 10.1182/blood-2011-03-344333; Leung N, 2012, ADV CHRONIC KIDNEY D, V19, P297, DOI 10.1053/j.ackd.2012.06.001; Lokhorst HM, 2010, BLOOD, V115, P1113, DOI 10.1182/blood-2009-05-222539; Ludwig H, 2012, ONCOLOGIST, V17, P592, DOI 10.1634/theoncologist.2011-0391; Ludwig H, 2012, BLOOD, V119, P3003, DOI 10.1182/blood-2011-11-374249; Ludwig H, 2009, BLOOD, V113, P3435, DOI 10.1182/blood-2008-07-169565; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; McCarthy PL, 2012, NEW ENGL J MED, V366, P1770, DOI 10.1056/NEJMoa1114083; Mellqvist UH, 2013, BLOOD, V121, P4647, DOI 10.1182/blood-2012-11-464503; Merlini G, 2013, BLOOD, V121, P5124, DOI 10.1182/blood-2013-01-453001; Mhaskar R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003188.pub3; Mohty B, 2012, LEUKEMIA, V26, P73, DOI 10.1038/leu.2011.310; Moreau P, 2011, BLOOD, V117, P3041, DOI 10.1182/blood-2010-08-300863; Morgan GJ, 2012, HAEMATOL-HEMATOL J, V97, P442, DOI 10.3324/haematol.2011.043372; Morgan GJ, 2012, BLOOD, V119, P7, DOI 10.1182/blood-2011-06-357038; National Cancer Institute, 2013, SURV EP END RES PROG; National Comprehensive Cancer Network, 2013, NCCN GUID DER INF PR; Neben K, 2012, ASH ANN M, V120, P3086; Nooka AK, 2011, ASH ANN M, V118, P1855; Palumbo A, 2008, LEUKEMIA, V22, P414, DOI 10.1038/sj.leu.2405062; Palumbo A, 2009, LEUKEMIA, V23, P1716, DOI 10.1038/leu.2009.122; Palumbo A, 2006, LANCET, V367, P825, DOI 10.1016/S0140-6736(06)68338-4; Palumbo A, 2012, NEW ENGL J MED, V366, P1759, DOI 10.1056/NEJMoa1112704; Palumbo A, 2011, CLIN CANCER RES, V17, P1253, DOI 10.1158/1078-0432.CCR-10-1925; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Palumbo A, 2010, BLOOD, V115, P1873, DOI 10.1182/blood-2009-09-241737; Popat R, 2008, BRIT J HAEMATOL, V141, P512, DOI 10.1111/j.1365-2141.2008.06997.x; Puig N, 2014, LEUKEMIA, V28, P391, DOI 10.1038/leu.2013.217; Rajkumar SV, 2012, AM J HEMATOL, V87, P79, DOI 10.1002/ajh.22237; Rajkumar SV, 2011, AM J HEMATOL, V86, P57, DOI 10.1002/ajh.21913; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; Rajkumar SV, 2006, J CLIN ONCOL, V24, P431, DOI 10.1200/JCO.2005.03.0221; Reed V, 2011, CANCER-AM CANCER SOC, V117, P4468, DOI 10.1002/cncr.26031; Reeder CB, 2009, LEUKEMIA, V23, P1337, DOI 10.1038/leu.2009.26; Reeder CB, 2010, BLOOD, V115, P3416, DOI 10.1182/blood-2010-02-271676; RICCARDI A, 1991, EUR J CANCER, V27, P1401, DOI 10.1016/0277-5379(91)90020-E; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Rosinol L, 2012, BLOOD, V120, P1589, DOI 10.1182/blood-2012-02-408922; Miguel JS, 2013, LANCET ONCOL, V14, P1055, DOI 10.1016/S1470-2045(13)70380-2; San Miguel JF, 2013, J CLIN ONCOL, V31, P448, DOI 10.1200/JCO.2012.41.6180; Shustik C, 2007, BRIT J HAEMATOL, V136, P203, DOI 10.1111/j.1365-2141.2006.06405.x; Siegel DS, 2012, BLOOD, V120, P2817, DOI 10.1182/blood-2012-05-425934; Sonneveld P, 2012, J CLIN ONCOL, V30, P2946, DOI 10.1200/JCO.2011.39.6820; Stewart AK, 2009, BLOOD, V114, P5436, DOI 10.1182/blood-2009-07-204651; Terpos E, 2013, J CLIN ONCOL, V31, P2347, DOI 10.1200/JCO.2012.47.7901; van de Velde HJK, 2007, HAEMATOLOGICA, V92, P1399, DOI 10.3324/haematol.11534; Vesole DH, 1999, J CLIN ONCOL, V17, P2173, DOI 10.1200/JCO.1999.17.7.2173; Vickrey E, 2009, CANCER-AM CANCER SOC, V115, P229, DOI 10.1002/cncr.24006; Vij R, 2012, BRIT J HAEMATOL, V158, P739, DOI 10.1111/j.1365-2141.2012.09232.x; Waage A, 2010, BLOOD, V116, P1405, DOI 10.1182/blood-2009-08-237974; Wang M, 2010, BONE MARROW TRANSPL, V45, P498, DOI 10.1038/bmt.2009.176; Wijermans P, 2010, J CLIN ONCOL, V28, P3160, DOI 10.1200/JCO.2009.26.1610; Yeh Y, 2008, BLOOD, V112, P825; Zonder JA, 2010, BLOOD, V116, P5838, DOI 10.1182/blood-2010-08-303487	109	416	447	5	106	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2197	2208		10.1016/S0140-6736(14)60493-1	http://dx.doi.org/10.1016/S0140-6736(14)60493-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ6DG	25540889				2022-12-28	WOS:000355583000030
J	De Cruz, P; Kamm, MA; Hamilton, AL; Ritchie, KJ; Krejany, EO; Gorelik, A; Liew, D; Prideaux, L; Lawrance, IC; Andrews, JM; Bampton, PA; Gibson, PR; Sparrow, M; Leong, RW; Florin, TH; Gearry, RB; Radford-Smith, G; Macrae, FA; Debinski, H; Selby, W; Kronborg, I; Johnston, MJ; Woods, R; Elliott, PR; Bell, SJ; Brown, SJ; Connell, WR; Desmond, PV				De Cruz, Peter; Kamm, Michael A.; Hamilton, Amy L.; Ritchie, Kathryn J.; Krejany, Efrosinia O.; Gorelik, Alexandra; Liew, Danny; Prideaux, Lani; Lawrance, Ian C.; Andrews, Jane M.; Bampton, Peter A.; Gibson, Peter R.; Sparrow, Miles; Leong, Rupert W.; Florin, Timothy H.; Gearry, Richard B.; Radford-Smith, Graham; Macrae, Finlay A.; Debinski, Henry; Selby, Warwick; Kronborg, Ian; Johnston, Michael J.; Woods, Rodney; Elliott, P. Ross; Bell, Sally J.; Brown, Steven J.; Connell, William R.; Desmond, Paul V.			Crohn's disease management after intestinal resection: a randomised trial	LANCET			English	Article							POSTOPERATIVE RECURRENCE; ILEOCOLIC RESECTION; INFLIXIMAB; ADALIMUMAB; PREVENTION; THERAPY; SURGERY; AZATHIOPRINE; MAINTENANCE; RISK	Background Most patients with Crohn's disease need an intestinal resection, but a majority will subsequently experience disease recurrence and require further surgery. This study aimed to identify the optimal strategy to prevent postoperative disease recurrence. Methods In this randomised trial, consecutive patients from 17 centres in Australia and New Zealand undergoing intestinal resection of all macroscopic Crohn's disease, with an endoscopically accessible anastomosis, received 3 months of metronidazole therapy. Patients at high risk of recurrence also received a thiopurine, or adalimumab if they were intolerant to thiopurines. Patients were randomly assigned to parallel groups: colonoscopy at 6 months (active care) or no colonoscopy (standard care). We used computer-generated block randomisation to allocate patients in each centre to active or standard care in a 2: 1 ratio. For endoscopic recurrence (Rutgeerts score >= i2) at 6 months, patients stepped-up to thiopurine, fortnightly adalimumab with thiopurine, or weekly adalimumab. The primary endpoint was endoscopic recurrence at 18 months. Patients and treating physicians were aware of the patient's study group and treatment, but central reading of the endoscopic findings was undertaken blind to the study group and treatment. Analysis included all patients who received at least one dose of study drug. This trial is registered with ClinicalTrials.gov, number NCT00989560. Findings Between Oct 13, 2009, and Sept 28, 2011, 174 (83% high risk across both active and standard care groups) patients were enrolled and received at least one dose of study drug. Of 122 patients in the active care group, 47 (39%) stepped-up treatment. At 18 months, endoscopic recurrence occurred in 60 (49%) patients in the active care group and 35 (67%) patients in the standard care group (p=0.03). Complete mucosal normality was maintained in 27 (22%) of 122 patients in the active care group versus four (8%) in the standard care group (p=0.03). In the active care arm, of those with 6 months recurrence who stepped up treatment, 18 (38%) of 47 patients were in remission 12 months later; conversely, of those in remission at 6 months who did not change therapy recurrence occurred in 31 (41%) of 75 patients 12 months later. Smoking (odds ratio [OR] 2.4, 95% CI 1.2-4.8, p=0.02) and the presence of two or more clinical risk factors including smoking (OR 2.8, 95% CI 1.01-7.7, p=0.05) increased the risk of endoscopic recurrence. The incidence and type of adverse and severe adverse events did not differ significantly between patients in the active care and standard care groups (100 [82%] of 122 vs 45 [87%] of 52; p=0.51) and (33 [27%] of 122 vs 18 [35%] of 52; p=0.36), respectively. Interpretation Treatment according to clinical risk of recurrence, with early colonoscopy and treatment step-up for recurrence, is better than conventional drug therapy alone for prevention of postoperative Crohn's disease recurrence. Selective immune suppression, adjusted for early recurrence, rather than routine use, leads to disease control in most patients. Clinical risk factors predict recurrence, but patients at low risk also need monitoring. Early remission does not preclude the need for ongoing monitoring.	[De Cruz, Peter; Kamm, Michael A.; Hamilton, Amy L.; Ritchie, Kathryn J.; Krejany, Efrosinia O.; Prideaux, Lani; Elliott, P. Ross; Bell, Sally J.; Brown, Steven J.; Connell, William R.; Desmond, Paul V.] St Vincents Hosp, Dept Gastroenterol, Melbourne, Vic 3065, Australia; [Johnston, Michael J.; Woods, Rodney] St Vincents Hosp, Dept Colorectal Surg, Melbourne, Vic 3065, Australia; [Johnston, Michael J.; Woods, Rodney] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Kamm, Michael A.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [De Cruz, Peter] Univ Melbourne, Austin Hlth, Austin Acad Ctr, Heidelberg, Vic, Australia; [Gorelik, Alexandra; Liew, Danny] Univ Melbourne, Melbourne EpiCtr, Melbourne, Vic, Australia; [Gorelik, Alexandra; Liew, Danny] Melbourne Hlth, Melbourne, Vic, Australia; [Lawrance, Ian C.] Fremantle Hosp, Ctr Infl ammatory Bowel Dis, Fremantle, WA, Australia; [Lawrance, Ian C.] Univ Western Australia, Fremantle, WA, Australia; [Andrews, Jane M.] Royal Adelaide Hosp, Dept Gastroenterol & Hepatol, Adelaide, SA 5000, Australia; [Andrews, Jane M.] Univ Adelaide, Adelaide, SA, Australia; [Bampton, Peter A.] Flinders Med Ctr, Dept Gastroenterol & Hepatol, Adelaide, SA, Australia; [Bampton, Peter A.] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Gibson, Peter R.; Sparrow, Miles] Alfred Hlth, Dept Gastroenterol, Melbourne, Vic, Australia; [Gibson, Peter R.] Monash Univ, Melbourne, Vic 3004, Australia; [Leong, Rupert W.] Concord Hosp, Gastroenterol Serv, Sydney, NSW, Australia; [Leong, Rupert W.] Concord Hosp, Liver Serv, Sydney, NSW, Australia; [Leong, Rupert W.] Bankstown Hosp, Gastroenterol Serv, Sydney, NSW, Australia; [Leong, Rupert W.] Bankstown Hosp, Liver Serv, Sydney, NSW, Australia; [Leong, Rupert W.] Univ New S Wales, Sydney, NSW, Australia; [Florin, Timothy H.] Univ Queensland, Dept Gastroenterol, Mater Hlth Serv, Brisbane, Qld, Australia; [Gearry, Richard B.] Univ Otago, Dept Med, Christchurch, New Zealand; [Radford-Smith, Graham] Univ Queensland, QIMR Berghofer Med Res Inst, Sch Med, Ammatory Bowel Dis Unit,Royal Brisbane & Womens H, Brisbane, Qld, Australia; [Macrae, Finlay A.] Royal Melbourne Hosp, Dept Colorectal Med & Genet, Melbourne, Vic, Australia; [Macrae, Finlay A.] Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia; [Macrae, Finlay A.] Univ Melbourne, Melbourne, Vic, Australia; [Debinski, Henry] Cabrini Hosp, Melbourne Gastrointestinal Invest Unit, Melbourne, Vic, Australia; [Selby, Warwick] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia; [Kronborg, Ian] Western Hosp, Dept Gastroenterol, Melbourne, Vic, Australia	St Vincent's Hospital Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Imperial College London; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Western Australia; Royal Adelaide Hospital; University of Adelaide; Flinders Medical Centre; Flinders University South Australia; Monash University; Concord Repatriation General Hospital; Concord Repatriation General Hospital; University of New South Wales Sydney; Mater Health Services; University of Queensland; University of Otago; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland; Royal Melbourne Hospital; Royal Melbourne Hospital; University of Melbourne; Cabrini Health; University of Sydney; Western Hospital	Kamm, MA (corresponding author), St Vincents Hosp, Melbourne, Vic 3065, Australia.	mkamm@unimelb.edu.au	Hamilton, Amy/AAI-8459-2020; Leong, Rupert WL/J-7839-2012; Radford-Smith, Graham/H-2792-2013; Gorelik, Alexandra/Z-6361-2019; Radford-Smith, Graham L/G-5749-2017; Gearry, Richard B/H-3959-2019; Lawrance, Ian C/H-5252-2014	Hamilton, Amy/0000-0002-1627-2057; Leong, Rupert WL/0000-0001-5944-3488; Radford-Smith, Graham/0000-0002-2047-6239; Radford-Smith, Graham L/0000-0002-2047-6239; Gearry, Richard B/0000-0002-2298-5141; Gorelik, Alexandra/0000-0003-1032-0457; Liew, Danny/0000-0002-0131-623X; Johnston, Michael/0000-0003-1081-609X; Krejany, Efrosinia/0000-0003-3420-3677; Bell, Sally/0000-0002-7002-453X	AbbVie; Gutsy Group; Gandel Philanthropy; Angior Foundation; Crohn's Colitis Australia; National Health and Medical Research Council	AbbVie(AbbVie); Gutsy Group; Gandel Philanthropy; Angior Foundation; Crohn's Colitis Australia; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	AbbVie, Gutsy Group, Gandel Philanthropy, Angior Foundation, Crohn's Colitis Australia, and the National Health and Medical Research Council.	Aguas M, 2012, WORLD J GASTROENTERO, V18, P4391, DOI 10.3748/wjg.v18.i32.4391; Ananthakrishnan AN, 2011, AM J GASTROENTEROL, V106, P2009, DOI 10.1038/ajg.2011.237; Baert F, 2010, GASTROENTEROLOGY, V138, P463, DOI 10.1053/j.gastro.2009.09.056; Bernell O, 2000, ANN SURG, V231, P38, DOI 10.1097/00000658-200001000-00006; BINDER V, 1985, GUT, V26, P146, DOI 10.1136/gut.26.2.146; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Cosnes J, 2005, GUT, V54, P237, DOI 10.1136/gut.2004.045294; D'Haens GR, 2008, GASTROENTEROLOGY, V135, P1123, DOI 10.1053/j.gastro.2008.07.010; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; De Cruz P, 2013, COLORECTAL DIS, V15, P187, DOI 10.1111/j.1463-1318.2012.03168.x; De Cruz P, 2012, GASTROENTEROLOGY, V142, pS212; De Cruz P, 2012, INFLAMM BOWEL DIS, V18, P758, DOI 10.1002/ibd.21825; Doherty GA, 2012, INFLAMM BOWEL DIS, V18, P1608, DOI 10.1002/ibd.21904; Froslie KF, 2007, GASTROENTEROLOGY, V133, P412, DOI 10.1053/j.gastro.2007.05.051; Hebuterne X, 2013, GUT, V62, P201, DOI 10.1136/gutjnl-2012-302262; Landsend E, 2006, SCAND J GASTROENTERO, V41, P1204, DOI 10.1080/00365520600731018; MARY JY, 1989, GUT, V30, P983, DOI 10.1136/gut.30.7.983; McLeod RS, 2009, DIS COLON RECTUM, V52, P919, DOI 10.1007/DCR.0b013e3181a4fa58; MUNKHOLM P, 1993, GASTROENTEROLOGY, V105, P1716, DOI 10.1016/0016-5085(93)91068-S; Ng SC, 2009, EUR J GASTROEN HEPAT, V21, P551, DOI 10.1097/MEG.0b013e328326a01e; OLAISON G, 1992, GUT, V33, P331, DOI 10.1136/gut.33.3.331; Papamichael K, 2012, J CROHNS COLITIS, V6, P924, DOI 10.1016/j.crohns.2012.02.012; Peyrin-Biroulet L, 2012, AM J GASTROENTEROL, V107, P1693, DOI 10.1038/ajg.2012.298; Reese G, 2008, INT J COLORECTAL DIS, V23, P1213, DOI 10.1007/s00384-008-0542-9; Regueiro M, 2014, CLIN GASTROENTEROL H, V12, P1494, DOI 10.1016/j.cgh.2013.12.035; Regueiro M, 2013, GASTROENTEROLOGY, V144, pS173; Regueiro M, 2009, GASTROENTEROLOGY, V136, P441, DOI 10.1053/j.gastro.2008.10.051; RUTGEERTS P, 1995, GASTROENTEROLOGY, V108, P1617, DOI 10.1016/0016-5085(95)90121-3; Rutgeerts P, 2006, GASTROINTEST ENDOSC, V63, P433, DOI 10.1016/j.gie.2005.08.011; RUTGEERTS P, 1984, GUT, V25, P665, DOI 10.1136/gut.25.6.665; RUTGEERTS P, 1990, GASTROENTEROLOGY, V99, P956, DOI 10.1016/0016-5085(90)90613-6; Rutgeerts P, 2008, INFLAMM BOWEL DIS, V14, pS179, DOI 10.1002/ibd.20655; Rutgeerts P, 2012, GASTROENTEROLOGY, V142, P1102, DOI 10.1053/j.gastro.2012.01.035; Sachar DB, 2009, INFLAMM BOWEL DIS, V15, P1071, DOI 10.1002/ibd.20872; Savarino E, 2013, AM J GASTROENTEROL, V108, P1731, DOI 10.1038/ajg.2013.287; Schnitzler F, 2009, INFLAMM BOWEL DIS, V15, P1295, DOI 10.1002/ibd.20927; Simillis C, 2008, AM J GASTROENTEROL, V103, P196, DOI 10.1111/j.1572-0241.2007.01548.x; Sorrentino D, 2007, ARCH INTERN MED, V167, P1804, DOI 10.1001/archinte.167.16.1804; Van Assche G, 2010, J CROHNS COLITIS, V4, P63, DOI 10.1016/j.crohns.2009.09.009; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Viscido A, 1999, ITAL J GASTROENTEROL, V31, P274; Walters TD, 2011, INFLAMM BOWEL DIS, V17, P1547, DOI 10.1002/ibd.21524	42	351	358	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1406	1417		10.1016/S0140-6736(14)61908-5	http://dx.doi.org/10.1016/S0140-6736(14)61908-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF7EU	25542620				2022-12-28	WOS:000352719800029
J	Brestoff, JR; Kim, BS; Saenz, SA; Stine, RR; Monticelli, LA; Sonnenberg, GF; Thome, JJ; Farber, DL; Lutfy, K; Seale, P; Artis, D				Brestoff, Jonathan R.; Kim, Brian S.; Saenz, Steven A.; Stine, Rachel R.; Monticelli, Laurel A.; Sonnenberg, Gregory F.; Thome, Joseph J.; Farber, Donna L.; Lutfy, Kabirullah; Seale, Patrick; Artis, David			Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity	NATURE			English	Article							TYPE-2; FAT; EOSINOPHILS; BROWN; HOMEOSTASIS; EXPRESSION; ABLATION; GLUCOSE; UNIQUE; UCP1	Obesity is an increasingly prevalent disease regulated by genetic and environmental factors. Emerging studies indicate that immune cells, including monocytes, granulocytes and lymphocytes, regulate metabolic homeostasis and are dysregulated in obesity(1,2). Group 2 innate lymphoid cells (ILC2s) can regulate adaptive immunity(3,4) and eosinophil and alternatively activated macrophage responses(5), and were recently identified in murine white adipose tissue (WAT)(5) where they may act to limit the development of obesity(6). However, ILC2s have not been identified inhuman adipose tissue, and the mechanisms by which ILC2s regulate metabolic homeostasis remain unknown. Here we identify ILC2s in human WAT and demonstrate that decreased ILC2 responses in WAT are a conserved characteristic of obesity in humans and mice. Interleukin (IL)-33 was found to be critical for the maintenance of ILC2s in WAT and in limiting adiposity in mice by increasing caloric expenditure. This was associated with recruitment of uncoupling protein 1 (UCP1)(+) beige adipocytes in WAT, a process known as beiging or browning that regulates caloric expenditure(7-9). IL-33-induced beiging was dependent on ILC2s, and IL-33 treatment or transfer of IL-33-elicited ILC2s was sufficient to drive beiging independently of the adaptive immune system, eosinophils or IL-4 receptor signalling. We found that ILC2s produce methionine-enkephalin peptides that can act directly on adipocytes to upregulate Ucp1 expression in vitro and that promote beiging in vivo. Collectively, these studies indicate that, in addition to responding to infection or tissue damage, ILC2s can regulate adipose function and metabolic homeostasis in part via production of enkephalin peptides that elicit beiging.	[Brestoff, Jonathan R.; Monticelli, Laurel A.; Sonnenberg, Gregory F.; Artis, David] Cornell Univ, Weill Cornell Med Coll, Dept Microbiol & Immunol, Jill Roberts Inst Res IBD,Joan & Sanford I Weill, New York, NY 10021 USA; [Brestoff, Jonathan R.; Kim, Brian S.; Saenz, Steven A.; Monticelli, Laurel A.; Artis, David] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Brestoff, Jonathan R.; Kim, Brian S.; Saenz, Steven A.; Monticelli, Laurel A.; Artis, David] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Stine, Rachel R.; Seale, Patrick] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Thome, Joseph J.; Farber, Donna L.] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10032 USA; [Thome, Joseph J.; Farber, Donna L.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Farber, Donna L.] Columbia Univ, Med Ctr, Dept Surg, New York, NY 10032 USA; [Lutfy, Kabirullah] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA	Cornell University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Columbia University; Columbia University; Columbia University; Western University of Health Sciences	Artis, D (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Microbiol & Immunol, Jill Roberts Inst Res IBD,Joan & Sanford I Weill, New York, NY 10021 USA.	dartis@med.cornell.edu	Brestoff, Jonathan R./I-7000-2019; Lutfy, Kabirullah/H-9995-2019; Kim, Brian/GZK-6649-2022	Brestoff, Jonathan R./0000-0002-7018-7400; Lutfy, Kabirullah/0000-0003-0350-3693; Kim, Brian/0000-0002-8100-7161; Artis, David/0000-0002-1753-4100	National Institutes of Health [AI061570, AI074878, AI095466, AI095608, AI102942, AI097333]; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Crohn's & Colitis Foundation of America; NIH [F30-AI112023, T32-AI060516, T32-AI007532, KL2-RR024132, DP5OD012116, P01AI06697, F31AG047003, DP2OD007288]; Searle Scholars Award; Penn Diabetes Endocrine Research Center [P30DK19525]; NCI Comprehensive Cancer Center Support Grant [2-P30 CA016520]; NIH/NIDDK P30 Center for Molecular Studies in Digestive and Liver Diseases [P30-DK050306]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095466, R01AI074878, F30AI112023, U01AI095608, P01AI106697, T32AI007532, R01AI102942, R01AI097333, R01AI061570, T32AI060516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057217, T32AR007465, K08AR065577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK105743, P30DK019525, P30DK050306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG047003] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007288, DP5OD012116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Crohn's & Colitis Foundation of America; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Award; Penn Diabetes Endocrine Research Center; NCI Comprehensive Cancer Center Support Grant; NIH/NIDDK P30 Center for Molecular Studies in Digestive and Liver Diseases; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors wish to thank members of the Artis laboratory for the critical reading of this manuscript. Research in the Artis laboratory is supported by the National Institutes of Health (AI061570, AI074878, AI095466, AI095608, AI102942, and AI097333 to D.A.), the Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (D.A.) and Crohn's & Colitis Foundation of America (D.A.). Additional funding was provided by NIH F30-AI112023 (J.R.B.), T32-AI060516 (J.R.B.), T32-AI007532 (L.A.M.), KL2-RR024132 (B.S.K.), DP5OD012116 (G.F.S.), P01AI06697 (D.L.F.), F31AG047003 (J.J.T.) and DP2OD007288 (P.S.) and by the Searle Scholars Award (P.S.). We thank M.A. Lazar for scientific and technical advice, D.E. Smith for providing Il33<SUP>-/-</SUP> mice, A. Goldrath for providing Id2<SUP>-/-</SUP> chimaeras, and A. Bhandoola for providing Tcf7<SUP>-/-</SUP> mice. We also thank the Mouse Phenotyping, Physiology & Metabolism Core at the Diabetes Research Center (DRC) of the Institute for Diabetes, Obesity & Metabolism(IDOM) as well as the Penn Diabetes Endocrine Research Center Grant (P30DK19525). In addition, we thank the Matthew J. Ryan Veterinary Hospital Pathology Laboratory, the Penn Microarray Facility, and the Mucosal Immunology Studies Team(MIST) of the NIH NIAID for shared expertise and resources. The authors would also like to thank the Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory for technical advice and support. The ACC Flow Cytometry and Cell Sorting Shared Resource is partially supported by NCI Comprehensive Cancer Center Support Grant (no. 2-P30 CA016520). This work was supported by the NIH/NIDDK P30 Center for Molecular Studies in Digestive and Liver Diseases (P30-DK050306), its pilot grant program and scientific core facilities (Molecular Pathology and Imaging, Molecular Biology, Cell Culture and Mouse), as well as the Joint CHOP-Penn Center in Digestive, Liver and Pancreatic Medicine and its pilot grant program. In addition, we would like to acknowledge and thank the New York Organ Donor Network, the Cooperative Human Tissue Network-Eastern Division and especially the donors and their families. We apologize to colleagues whose work we were unable to quote owing to space constraints.	Brestoff J. R., 2013, EPIDEMIOLOGY PRINCIP, P137; Carey AL, 2013, DIABETOLOGIA, V56, P147, DOI 10.1007/s00125-012-2748-1; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hams E, 2013, J IMMUNOL, V191, P5349, DOI 10.4049/jimmunol.1301176; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Lloyd DJ, 2006, HUM MOL GENET, V15, P1884, DOI 10.1093/hmg/ddl111; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Miller AM, 2010, CIRC RES, V107, P650, DOI 10.1161/CIRCRESAHA.110.218867; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Zagon IS, 2010, BRAIN RES, V1310, P154, DOI 10.1016/j.brainres.2009.11.026	34	609	636	2	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					242	+		10.1038/nature14115	http://dx.doi.org/10.1038/nature14115			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25533952	Green Accepted, Green Published			2022-12-28	WOS:000350770500041
J	Graham, MJ; Djorgovski, SG; Stern, D; Glikman, E; Drake, AJ; Mahabal, AA; Donalek, C; Larson, S; Christensen, E				Graham, Matthew J.; Djorgovski, S. G.; Stern, Daniel; Glikman, Eilat; Drake, Andrew J.; Mahabal, Ashish A.; Donalek, Ciro; Larson, Steve; Christensen, Eric			A possible close supermassive black-hole binary in a quasar with optical periodicity	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; DIGITAL SKY SURVEY; SURVEY SPECTROSCOPIC SAMPLE; PHOTOMETRIC STANDARD STARS; TIME TRANSIENT SURVEY; ACCRETION DISK; JET PRECESSION; VARIABILITY; PARSEC; MASS	Quasars have long been known to be variable sources at all wavelengths. Their optical variability is stochastic and can be due to a variety of physical mechanisms; it is also well-described statistically in terms of a damped random walk model(1). The recent availability of large collections of astronomical timeseries of flux measurements (light curves(2-5)) offers new data sets for a systematic exploration of quasar variability. Here we report the detection of a strong, smooth periodic signal in the optical variability of the quasar PG 1302-102 with a mean observed period of 1,884 +/- 88 days. It was identified in a search for periodic variability in a data set of light curves for 247,000 known, spectroscopically confirmed quasars with a temporal baseline of about 9 years. Although the interpretation of this phenomenon is still uncertain, the most plausible mechanisms involve a binary system of two supermassive black holes with a subparsec separation. Such systems are an expected consequence of galaxy mergers and can provide important constraints on models of galaxy formation and evolution.	[Graham, Matthew J.; Djorgovski, S. G.; Drake, Andrew J.; Mahabal, Ashish A.; Donalek, Ciro] CALTECH, Pasadena, CA 91125 USA; [Stern, Daniel] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Glikman, Eilat] Middlebury Coll, Dept Phys, Middlebury, VT 05753 USA; [Larson, Steve; Christensen, Eric] Univ Arizona, Lunar & Planetary Lab, Dept Planetary Sci, Tucson, AZ 85721 USA	California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona	Graham, MJ (corresponding author), CALTECH, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	mjg@caltech.edu		Stern, Daniel/0000-0003-2686-9241	NSF [AST-0909182, IIS-1118031, AST-1313422]; W.M. Keck Foundation; NASA; Direct For Mathematical & Physical Scien [1413600, 1518308] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); W.M. Keck Foundation(W.M. Keck Foundation); NASA(National Aeronautics & Space Administration (NASA)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by NSF grants AST-0909182, IIS-1118031 and AST-1313422. We thank J. S. Stuart, MIT Lincoln Laboratory, for assistance with the LINEAR data. We also thank the staff of the Keck and Palomar Observatories for their help with observations, and the CRTS team. Some of the data presented here were obtained at the W.M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and NASA. The observatory was made possible by the financial support of the W.M. Keck Foundation. The work of D.S. was performed at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA.	Alexander T., 2013, IMPROVED AGN LIGHT C; BAHCALL JN, 1995, ASTROPHYS J, V450, P486, DOI 10.1086/176159; Benitez E, 1996, ASTROPHYS J, V464, pL47, DOI 10.1086/310082; Bogdanovic T, 2008, ASTROPHYS J SUPPL S, V174, P455, DOI 10.1086/521828; Cushing MC, 2004, PUBL ASTRON SOC PAC, V116, P362, DOI 10.1086/382907; Djorgovski S. G., 2010, JAXA SPECIAL PUBLICA, P263; Drake AJ, 2009, ASTROPHYS J, V696, P870, DOI 10.1088/0004-637X/696/1/870; Eggers D, 2000, ASTRON J, V119, P460, DOI 10.1086/301212; Fan JH, 2002, ASTRON ASTROPHYS, V381, P1, DOI 10.1051/0004-6361:20011356; Farris BD, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/134; Foster G, 1996, ASTRON J, V112, P1709, DOI 10.1086/118137; Garcia A, 1999, MON NOT R ASTRON SOC, V309, P803, DOI 10.1046/j.1365-8711.1999.02884.x; Gaskell CM, 2010, NATURE, V463, pE1, DOI 10.1038/nature08665; Glikman E, 2007, ASTROPHYS J, V667, P673, DOI 10.1086/521073; Greene JE, 2004, ASTROPHYS J, V610, P722, DOI 10.1086/421719; Greenhill LJ, 2003, ASTROPHYS J, V590, P162, DOI 10.1086/374862; Haiman Z, 2009, ASTROPHYS J, V700, P1952, DOI 10.1088/0004-637X/700/2/1952; Herrnstein JR, 2005, ASTROPHYS J, V629, P719, DOI 10.1086/431421; Hinshaw G, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/19; HUTCHINGS JB, 1994, PUBL ASTRON SOC PAC, V106, P642, DOI 10.1086/133425; JACKSON N, 1992, ASTRON ASTROPHYS, V262, P17; Ju WH, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/44; Kelly BC, 2009, ASTROPHYS J, V698, P895, DOI 10.1088/0004-637X/698/1/895; Kim D, 2010, ASTROPHYS J, V724, P386, DOI 10.1088/0004-637X/724/1/386; Kondratko PT, 2008, ASTROPHYS J, V678, P87, DOI 10.1086/586879; Kudryavtseva NA, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201014968; Kuo CY, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/20; Landolt AU, 2007, ASTRON J, V133, P2502, DOI 10.1086/518000; Landolt AU, 2009, ASTRON J, V137, P4186, DOI 10.1088/0004-6256/137/5/4186; Larson S., 2003, BAAS, V35, P982; Lu JF, 2005, ASTROPHYS J, V635, pL17, DOI 10.1086/499333; MacLeod CL, 2010, ASTROPHYS J, V721, P1014, DOI 10.1088/0004-637X/721/2/1014; Mahabal AA, 2011, B ASTRON SOC INDIA, V39, P387; McLure RJ, 1999, MON NOT R ASTRON SOC, V308, P377, DOI 10.1046/j.1365-8711.1999.02676.x; McQuillan A, 2013, MON NOT R ASTRON SOC, V432, P1203, DOI 10.1093/mnras/stt536; OKE JB, 1995, PUBL ASTRON SOC PAC, V107, P375, DOI 10.1086/133562; Pojmanski G, 2002, ACTA ASTRONOM, V52, P397; Rafikov RR, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/144; Rau A, 2009, PUBL ASTRON SOC PAC, V121, P1334, DOI 10.1086/605911; Sesar B, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/6/190; Shen Y, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/49; Shen Y, 2013, B ASTRON SOC INDIA, V41, P61; Shen Y, 2011, ASTROPHYS J SUPPL S, V194, DOI 10.1088/0067-0049/194/2/45; Shen Y, 2010, ASTROPHYS J, V725, P249, DOI 10.1088/0004-637X/725/1/249; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Tremaine S, 2014, MON NOT R ASTRON SOC, V441, P1408, DOI 10.1093/mnras/stu663; Tsalmantza P, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/20; UDALSKI A, 1993, ACTA ASTRONOM, V43, P289; Vacca WD, 2003, PUBL ASTRON SOC PAC, V115, P389, DOI 10.1086/346193; Valtonen MJ, 2008, NATURE, V452, P851, DOI 10.1038/nature06896; Valtonen MJ, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/33; Volonteri M, 2009, ASTROPHYS J LETT, V703, pL86, DOI 10.1088/0004-637X/703/1/L86	53	209	211	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					74	+		10.1038/nature14143	http://dx.doi.org/10.1038/nature14143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25561176	Green Submitted			2022-12-28	WOS:000349098000033
J	Vaughan, AE; Brumwell, AN; Xi, Y; Gotts, JE; Brownfield, DG; Treutlein, B; Tan, K; Tan, V; Liu, FC; Looney, MR; Matthay, MA; Rock, JR; Chapman, HA				Vaughan, Andrew E.; Brumwell, Alexis N.; Xi, Ying; Gotts, Jeffrey E.; Brownfield, Doug G.; Treutlein, Barbara; Tan, Kevin; Tan, Victor; Liu, Feng Chun; Looney, Mark R.; Matthay, Michael A.; Rock, Jason R.; Chapman, Harold A.			Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury	NATURE			English	Article							STEM-CELLS; IN-VITRO; ALVEOLAR; MAINTENANCE; REPAIR; AIRWAY; MOUSE; NOTCH; TRANSPLANTATION; BIOLOGY	Broadly, tissue regeneration is achieved in two ways: by proliferation of common differentiated cells and/or by deployment of specialized stem/progenitor cells. Which of these pathways applies is both organ-and injury-specific(1-4). Current models in the lung posit that epithelial repair can be attributed to cells expressing mature lineage markers(5-8). By contrast, here we define the regenerative role of previously uncharacterized, rare lineage-negative epithelial stem/progenitor (LNEP) cells present within normal distal lung. Quiescent LNEPs activate a Delta Np63 (a p63 splice variant) and cytokeratin 5 remodelling program after influenza or bleomycin injury in mice. Activated cells proliferate and migrate widely to occupy heavily injured areas depleted of mature lineages, at which point they differentiate towards mature epithelium. Lineage tracing revealed scant contribution of pre-existing mature epithelial cells in such repair, whereas orthotopic transplantation of LNEPs, isolated by a definitive surface profile identified through single-cell sequencing, directly demonstrated the proliferative capacity and multipotency of this population. LNEPs require Notch signalling to activate the DNp63 and cytokeratin 5 program, and subsequent Notch blockade promotes an alveolar cell fate. Persistent Notch signalling after injury led to parenchymal 'micro-honeycombing' (alveolar cysts), indicative of failed regeneration. Lungs from patients with fibrosis show analogous honeycomb cysts with evidence of hyperactive Notch signalling. Our findings indicate that distinct stem/progenitor cell pools repopulate injured tissue depending on the extent of the injury, and the outcomes of regeneration or fibrosis may depend in part on the dynamics of LNEP Notch signalling.	[Vaughan, Andrew E.; Brumwell, Alexis N.; Xi, Ying; Gotts, Jeffrey E.; Tan, Kevin; Tan, Victor; Liu, Feng Chun; Looney, Mark R.; Matthay, Michael A.; Chapman, Harold A.] Univ Calif San Francisco, Dept Med, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Brownfield, Doug G.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Brownfield, Doug G.] Howard Hughes Med Inst, Stanford, CA 94305 USA; [Treutlein, Barbara] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Rock, Jason R.] Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Stanford University; Howard Hughes Medical Institute; Max Planck Society; University of California System; University of California San Francisco	Vaughan, AE (corresponding author), Univ Calif San Francisco, Dept Med, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	andrew.vaughan@ucsf.edu; hal.chapman@ucsf.edu		Tan, Victor/0000-0001-5869-2773; Vaughan, Andrew/0000-0001-5740-643X; Brownfield, Doug/0000-0003-4769-1518; Treutlein, Barbara/0000-0002-3299-5597	National Institutes of Health (NIH) [R01 HL44712, U01 HL111054]; Daiichi Pharmaceuticals;  [F32 HL117600-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL051856, U01HL111054, U01HL099995, R01HL044712, F32HL117600, U01HL099999] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Daiichi Pharmaceuticals(Daiichi Sankyo Company Limited); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants R01 HL44712 and U01 HL111054 and a sponsored research agreement with Daiichi Pharmaceuticals. A.E.V. is supported by F32 HL117600-01. The authors thank T. Kim for assistance with animal work and K. Corbin for assistance with Imaris software. Mouse line art was created by A. van de Wiel. We also thank P. Wolters at the UCSF Interstitial Lung Disease Blood and Tissue Repository for procuring diseased lung tissues. We thank the Nina Ireland Program for Lung Health that supported the tracheal/lung transplant experiments.	Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Chakrabarti R, 2012, STEM CELLS, V30, P1496, DOI 10.1002/stem.1112; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Giangreco A, 2009, P NATL ACAD SCI USA, V106, P9286, DOI 10.1073/pnas.0900668106; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; King RS, 2012, J CELL BIOL, V196, P553, DOI 10.1083/jcb.201105099; Krupnick AS, 2009, NAT PROTOC, V4, P86, DOI 10.1038/nprot.2008.218; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schrepfer S, 2007, MICROSURG, V27, P187, DOI 10.1002/micr.20329; Seibold MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058658; Tanimizu N, 2014, ORGANOGENESIS, V10, P208, DOI 10.4161/org.27591; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC	24	374	392	5	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					621	U211		10.1038/nature14112	http://dx.doi.org/10.1038/nature14112			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25533958	Green Accepted, Green Submitted			2022-12-28	WOS:000348775000045
J	Deyo, RA; Von Korff, M; Duhrkoop, D				Deyo, Richard A.; Von Korff, Michael; Duhrkoop, David			Opioids for low back pain	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHRONIC NONCANCER PAIN; TRAMADOL/ACETAMINOPHEN COMBINATION TABLETS; BUPRENORPHINE TRANSDERMAL SYSTEM; OXYMORPHONE EXTENDED-RELEASE; PLACEBO-CONTROLLED TRIAL; SUBSTANCE USE DISORDERS; TOTAL DISC REPLACEMENT; DOUBLE-BLIND; PRIMARY-CARE; PHYSICAL-DEPENDENCE	Back pain affects most adults, causes disability for some, and is a common reason for seeking healthcare. In the United States, opioid prescription for low back pain has increased, and opioids are now the most commonly prescribed drug class. More than half of regular opioid users report back pain. Rates of opioid prescribing in the US and Canada are two to three times higher than in most European countries. The analgesic efficacy of opioids for acute back pain is inferred from evidence in other acute pain conditions. Opioids do not seem to expedite return to work in injured workers or improve functional outcomes of acute back pain in primary care. For chronic back pain, systematic reviews find scant evidence of efficacy. Randomized controlled trials have high dropout rates, brief duration (four months or less), and highly selected patients. Opioids seem to have short term analgesic efficacy for chronic back pain, but benefits for function are less clear. The magnitude of pain relief across chronic non-cancer pain conditions is about 30%. Given the brevity of randomized controlled trials, the long term effectiveness and safety of opioids are unknown. Loss of long term efficacy could result from drug tolerance and emergence of hyperalgesia. Complications of opioid use include addiction and overdose related mortality, which have risen in parallel with prescription rates. Common short term side effects are constipation, nausea, sedation, and increased risk of falls and fractures. Longer term side effects may include depression and sexual dysfunction. Screening for high risk patients, treatment agreements, and urine testing have not reduced overall rates of opioid prescribing, misuse, or overdose. Newer strategies for reducing risks include more selective prescription of opioids and lower doses; use of prescription monitoring programs; avoidance of co-prescription with sedative hypnotics; and reformulations that make drugs more difficult to snort, smoke, or inject.	[Deyo, Richard A.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Dept Family Med, Portland, OR 97239 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Dept Internal Med, Portland, OR 97239 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Dept Publ Hlth & Prevent Med, Portland, OR 97239 USA; [Deyo, Richard A.] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA; [Von Korff, Michael] Grp Hlth Res Inst, Seattle, WA USA; [Duhrkoop, David] Amer Chron Pain Assoc, Rocklin, CA USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Kaiser Permanente	Deyo, RA (corresponding author), Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97239 USA.	deyor@ohsu.edu		VonKorff, Michael/0000-0001-5386-8477	Pfizer; NATIONAL INSTITUTE ON AGING [R01AG034181] Funding Source: NIH RePORTER	Pfizer(Pfizer); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We have read and understood BMJ policy on declaration of interests and declare the following interests: RAD receives honorariums from UpToDate for authoring topics on low back pain. He benefits from an endowment to his university from Kaiser Permanente. He has been a member of the board of directors for the Informed Medical Decisions Foundation, a non-profit organization. MVK has several research grants from Pfizer awarded to the Group Health Research Institute. He is also a co-investigator on Food and Drug Administration mandated post-marketing surveillance studies of opioid safety funded by a consortium of drug companies.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; [Anonymous], 2010 SUMM TABL; Ashworth J, 2013, PAIN, V154, P1038, DOI 10.1016/j.pain.2013.03.011; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Ballantyne JC, 2008, CLIN J PAIN, V24, P469, DOI 10.1097/AJP.0b013e31816b2f26; Ballantyne JC, 2011, ANESTHESIOLOGY, V114, P243, DOI 10.1097/ALN.0b013e3182039f87; Baron Michael J, 2006, J Opioid Manag, V2, P277; Blumenthal S, 2005, SPINE, V30, P1565, DOI 10.1097/01.brs.0000170587.32676.0e; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Boscarino JA, 2010, ADDICTION, V105, P1776, DOI 10.1111/j.1360-0443.2010.03052.x; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Braden JB, 2009, GEN HOSP PSYCHIAT, V31, P564, DOI 10.1016/j.genhosppsych.2009.07.003; Brush DE, 2012, J MED TOXICOL, V8, P387, DOI 10.1007/s13181-012-0260-0; Butler SF, 2013, J PAIN, V14, P351, DOI 10.1016/j.jpain.2012.08.008; Buynak R, 2010, EXPERT OPIN PHARMACO, V11, P1787, DOI 10.1517/14656566.2010.497720; Chaparro LE, 2014, SPINE, V39, P556, DOI 10.1097/BRS.0000000000000249; Choi BKL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006555.pub2; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Chu LF, 2012, PAIN, V153, P1583, DOI 10.1016/j.pain.2012.02.028; Chung JWY, 2013, PAIN PHYSICIAN, V16, pE685; CICERO TJ, 1975, NEW ENGL J MED, V292, P882, DOI 10.1056/NEJM197504242921703; CICERO TJ, 1979, ENDOCRINOLOGY, V104, P1286, DOI 10.1210/endo-104-5-1286; Coffin P, 2014, ANN INTERN MED, V160, P207, DOI 10.7326/M13-2781; Cohen SP, 2010, ANESTHESIOLOGY, V113, P395, DOI 10.1097/ALN.0b013e3181e33ae5; Compton P, 2004, PHARMACOL BIOCHEM BE, V77, P263, DOI 10.1016/j.pbb.2003.10.017; Compton P, 2003, J PAIN, V4, P511, DOI 10.1016/j.jpain.2003.08.003; Crisostomo RA, 2008, AM J PHYS MED REHAB, V87, P527, DOI 10.1097/PHM.0b013e31817c124f; Daniell HW, 2008, J PAIN, V9, P28, DOI 10.1016/j.jpain.2007.08.005; Daniell HW, 2002, J PAIN, V3, P377, DOI 10.1054/jpai.2002.126790; Deyo RA, 2013, SPINE, V38, P909, DOI 10.1097/BRS.0b013e3182830482; Deyo RA, 2013, HEALTH AFFAIR, V32, P603, DOI 10.1377/hlthaff.2012.0945; Deyo RA, 2011, J AM BOARD FAM MED, V24, P717, DOI 10.3122/jabfm.2011.06.100232; Dhalla IA, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5142; Dormuth CR, 2012, CAN MED ASSOC J, V184, pE852, DOI 10.1503/cmaj.120465; Dowell D, 2013, JAMA-J AM MED ASSOC, V309, P2219, DOI 10.1001/jama.2013.5794; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Edlund MJ, 2010, CLIN J PAIN, V26, P1, DOI 10.1097/AJP.0b013e3181b99f35; Eriksen J, 2006, PAIN, V125, P172, DOI 10.1016/j.pain.2006.06.009; Ferrell B, 2009, J AM GERIATR SOC, V57, P1331, DOI 10.1111/j.1532-5415.2009.02376.x; Fishbain DA, 2008, PAIN MED, V9, P444, DOI 10.1111/j.1526-4637.2007.00370.x; Fleming MF, 2007, J PAIN, V8, P573, DOI 10.1016/j.jpain.2007.02.432; Franklin GM, 2008, SPINE, V33, P199, DOI 10.1097/BRS.0b013e318160455c; Franklin GM, 2012, AM J IND MED, V55, P325, DOI 10.1002/ajim.21998; Franklin GM, 2009, CLIN J PAIN, V25, P743, DOI 10.1097/AJP.0b013e3181b01710; Fraser LA, 2009, EXP CLIN ENDOCR DIAB, V117, P38, DOI 10.1055/s-2008-1076715; Fulton-Kehoe D, 2013, AM J IND MED, V56, P1452, DOI 10.1002/ajim.22266; Furlan AD, 2011, PAIN RES MANAG, V16, P337, DOI 10.1155/2011/465281; Furlan AD, 2010, CAN MED ASSOC J, V182, P923, DOI 10.1503/cmaj.100187; General Accounting Office, 2003, PRESCR DRUGS OXYCONT; GIRI M, 1994, ENDOCRINOLOGY, V135, P2137, DOI 10.1210/en.135.5.2137; Gomes T, 2013, JAMA INTERN MED, V173, P196, DOI 10.1001/2013.jamainternmed.733; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Gordon A, 2010, CLIN THER, V32, P844, DOI 10.1016/j.clinthera.2010.04.018; Hale M, 2010, CURR MED RES OPIN, V26, P1505, DOI 10.1185/03007995.2010.484723; Hale ME, 2007, J PAIN, V8, P175, DOI 10.1016/j.jpain.2006.09.011; Henschke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub3; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Hudson TJ, 2008, J PAIN SYMPTOM MANAG, V36, P280, DOI 10.1016/j.jpainsymman.2007.10.003; International Narcotics Control Board, ANN REP; Ivanova JI, 2011, SPINE J, V11, P622, DOI 10.1016/j.spinee.2011.03.017; Jamison RN, 1998, SPINE, V23, P2591, DOI 10.1097/00007632-199812010-00014; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Juratli SM, 2009, SPINE, V34, P740, DOI 10.1097/BRS.0b013e31819b2176; Juurlink DN, 2013, JAMA-J AM MED ASSOC, V309, P879, DOI 10.1001/jama.2013.1139; Kalso E, 2004, PAIN, V112, P372, DOI 10.1016/j.pain.2004.09.019; Katz N, 2007, CURR MED RES OPIN, V23, P117, DOI 10.1185/030079906X162692; Khoromi S, 2007, PAIN, V130, P66, DOI 10.1016/j.pain.2006.10.029; Kobus AM, 2012, J PAIN, V13, P1131, DOI 10.1016/j.jpain.2012.09.003; Krebs EE, 2011, PAIN MED, V12, P740, DOI 10.1111/j.1526-4637.2011.01099.x; Kroenke K, 2009, GEN HOSP PSYCHIAT, V31, P206, DOI 10.1016/j.genhosppsych.2008.12.006; Kuijpers T, 2011, EUR SPINE J, V20, P40, DOI 10.1007/s00586-010-1541-4; Kumar S, 2013, INT J GEN MED, V6, P733, DOI 10.2147/IJGM.S50243; Lamb SE, 2010, LANCET, V375, P916, DOI 10.1016/S0140-6736(09)62164-4; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Li L, 2013, AM J EPIDEMIOL, V178, P559, DOI 10.1093/aje/kwt013; Mafi JN, 2013, JAMA INTERN MED, V173, P1573, DOI 10.1001/jamainternmed.2013.8992; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; Martin BC, 2011, J GEN INTERN MED, V26, P1450, DOI 10.1007/s11606-011-1771-0; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Martin BI, 2009, SPINE, V34, P2077, DOI 10.1097/BRS.0b013e3181b1fad1; Mayer TG, 2014, SPINE J, V14, P263, DOI 10.1016/j.spinee.2013.10.041; McQuay H, 1999, LANCET, V353, P2229, DOI 10.1016/S0140-6736(99)03528-X; MENDELSON JH, 1975, J PHARMACOL EXP THER, V192, P211; Meuleners LB, 2011, J AM GERIATR SOC, V59, P1575, DOI 10.1111/j.1532-5415.2011.03561.x; Miller M, 2011, J AM GERIATR SOC, V59, P430, DOI 10.1111/j.1532-5415.2011.03318.x; Monarrez-Espino J, 2013, ACCIDENT ANAL PREV, V57, P157, DOI 10.1016/j.aap.2013.04.012; Monticone M, 2013, CLIN J PAIN, V29, P929, DOI 10.1097/AJP.0b013e31827fef7e; Morasco BJ, 2010, PAIN, V151, P625, DOI 10.1016/j.pain.2010.08.002; Murphy JL, 2013, CLIN J PAIN, V29, P109, DOI 10.1097/AJP.0b013e3182579935; National Institute for Health and Care Excellence, 2009, LOW BACK PAIN EARL M; Nuckols TK, 2014, ANN INTERN MED, V160, P38, DOI 10.7326/0003-4819-160-1-201401070-00732; O'Donnell JB, 2009, J INT MED RES, V37, P1789, DOI 10.1177/147323000903700615; Oesch P, 2010, J REHABIL MED, V42, P193, DOI 10.2340/16501977-0524; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Paulozzi LJ, 2014, J AM BOARD FAM MED, V27, P329, DOI 10.3122/jabfm.2014.03.130290; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Peloso PM, 2004, J RHEUMATOL, V31, P2454; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; PORTENOY RK, 1986, PAIN, V25, P171, DOI 10.1016/0304-3959(86)90091-6; PORTER J, 1980, NEW ENGL J MED, V302, P123; Reid MC, 2002, J GEN INTERN MED, V17, P173, DOI 10.1046/j.1525-1497.2002.10435.x; Rodriguez-Raecke R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054475; Rubinstein SM, 2013, SPINE, V38, pE158, DOI 10.1097/BRS.0b013e31827dd89d; Rubinstein SM, 2011, SPINE, V36, pE825, DOI 10.1097/BRS.0b013e3182197fe1; Ruoff GE, 2003, CLIN THER, V25, P1123, DOI 10.1016/S0149-2918(03)80071-1; Saunders KW, 2010, J GEN INTERN MED, V25, P310, DOI 10.1007/s11606-009-1218-z; Scherrer JF, 2014, J GEN INTERN MED, V29, P491, DOI 10.1007/s11606-013-2648-1; Schnitzer TJ, 2000, J RHEUMATOL, V27, P772; Sehgal N, 2012, PAIN PHYSICIAN, V15, pES67; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Severtson SG, 2013, J PAIN, V14, P1122, DOI 10.1016/j.jpain.2013.04.011; Sjogren P, 2000, J PAIN SYMPTOM MANAG, V19, P100, DOI 10.1016/S0885-3924(99)00143-8; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; Starrels JL, 2010, ANN INTERN MED, V152, P712, DOI 10.7326/0003-4819-152-11-201006010-00004; Steiner DJ, 2011, J PAIN SYMPTOM MANAG, V42, P903, DOI 10.1016/j.jpainsymman.2011.04.006; Strand MC, 2013, TRAFFIC INJ PREV, V14, P26, DOI 10.1080/15389588.2012.689451; Sullivan MD, 2013, PAIN, V154, pS94, DOI 10.1016/j.pain.2013.09.009; Takkouche B, 2007, DRUG SAFETY, V30, P171, DOI 10.2165/00002018-200730020-00006; Townsend CO, 2008, PAIN, V140, P177, DOI 10.1016/j.pain.2008.08.005; Turk DC, 2008, CLIN J PAIN, V24, P497, DOI 10.1097/AJP.0b013e31816b1070; Uberall MA, 2012, CURR MED RES OPIN, V28, P1617, DOI 10.1185/03007995.2012.726216; US Department of Health and Human Services, 2014, VITAL HLTH STAT SERI, V10; van Middelkoop M, 2010, BEST PRACT RES CL RH, V24, P193, DOI 10.1016/j.berh.2010.01.002; Vestergaard P, 2006, J INTERN MED, V260, P76, DOI 10.1111/j.1365-2796.2006.01667.x; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b; Von Korff M, 2011, ANN INTERN MED, V155, P325, DOI 10.7326/0003-4819-155-5-201109060-00011; Von Korff MR, 2013, BEST PRACT RES CL RH, V27, P663, DOI 10.1016/j.berh.2013.09.011; VonKorff M, 1996, SPINE, V21, P2833, DOI 10.1097/00007632-199612150-00004; Vorsanger Gary J, 2008, J Opioid Manag, V4, P87; Webster BS, 2007, SPINE, V32, P2127, DOI 10.1097/BRS.0b013e318145a731; Webster LR, 2006, J PAIN, V7, P937, DOI 10.1016/j.jpain.2006.05.005; Weisner CM, 2009, PAIN, V145, P287, DOI 10.1016/j.pain.2009.05.006; Williams CM, 2014, LANCET; World Health Organization, ICD 10 CLASS MENT BE; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714; Zerzan JT, 2006, MED CARE, V44, P1005, DOI 10.1097/01.mlr.0000228025.04535.25; Zigler J, 2007, SPINE, V32, P1155, DOI 10.1097/BRS.0b013e318054e377	145	280	285	5	62	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2015	350								g6380	10.1136/bmj.g6380	http://dx.doi.org/10.1136/bmj.g6380			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3LU	25561513	Green Published			2022-12-28	WOS:000348129900001
J	Bailey, JE; Nagayama, T; Loisel, GP; Rochau, GA; Blancard, C; Colgan, J; Cosse, P; Faussurier, G; Fontes, CJ; Gilleron, F; Golovkin, I; Hansen, SB; Iglesias, CA; Kilcrease, DP; MacFarlane, JJ; Mancini, RC; Nahar, SN; Orban, C; Pain, JC; Pradhan, AK; Sherrill, M; Wilson, BG				Bailey, J. E.; Nagayama, T.; Loisel, G. P.; Rochau, G. A.; Blancard, C.; Colgan, J.; Cosse, Ph.; Faussurier, G.; Fontes, C. J.; Gilleron, F.; Golovkin, I.; Hansen, S. B.; Iglesias, C. A.; Kilcrease, D. P.; MacFarlane, J. J.; Mancini, R. C.; Nahar, S. N.; Orban, C.; Pain, J-C.; Pradhan, A. K.; Sherrill, M.; Wilson, B. G.			A higher-than-predicted measurement of iron opacity at solar interior temperatures	NATURE			English	Article							DETAILED CONFIGURATION; PHOTOABSORPTION; RADIATION; MODELS; FILMS; ABUNDANCES; PLASMA; REGION; HOT; CR	Nearly a century ago it was recognized(1) that radiation absorption by stellar matter controls the internal temperature profiles within stars. Laboratory opacity measurements, however, have never been performed at stellar interior conditions, introducing uncertainties in stellar models(2-5). A particular problem arose(2,3,6-8) when refined photosphere spectral analysis(9,10) led to reductions of 30-50 per cent in the inferred amounts of carbon, nitrogen and oxygen in the Sun. Standard solar models(11) using the revised element abundances disagree with helioseismic observations that determine the internal solar structure using acoustic oscillations. This could be resolved if the true mean opacity for the solar interior matter were roughly 15 per cent higher than predicted(2,3,6-8), because increased opacity compensates for the decreased element abundances. Iron accounts for a quarter of the total opacity(2,12) at the solar radiation/convection zone boundary. Here we report measurements of wavelength-resolved iron opacity at electron temperatures of 1.9-2.3 million kelvin and electron densities of (0.7-4.0) x 10(22) per cubic centimetre, conditions very similar to those in the solar region that affects the discrepancy the most: the radiation/convection zone boundary. The measured wavelength-dependent opacity is 30-400 per cent higher than predicted. This represents roughly half the change in the mean opacity needed to resolve the solar discrepancy, even though iron is only one of many elements that contribute to opacity.	[Bailey, J. E.; Nagayama, T.; Loisel, G. P.; Rochau, G. A.; Hansen, S. B.] Sandia Natl Labs, Albuquerque, NM 87185 USA; [Blancard, C.; Cosse, Ph.; Faussurier, G.; Gilleron, F.; Pain, J-C.] Commissariat Energie Atom CEA & Energie Alternat, F-91297 Arpajon, France; [Colgan, J.; Fontes, C. J.; Kilcrease, D. P.; Sherrill, M.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Golovkin, I.; MacFarlane, J. J.] Prism Computat Sci, Madison, WI 53711 USA; [Iglesias, C. A.; Wilson, B. G.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Mancini, R. C.] Univ Nevada, Reno, NV 89557 USA; [Nahar, S. N.; Orban, C.; Pradhan, A. K.] Ohio State Univ, Columbus, OH 43210 USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Nevada System of Higher Education (NSHE); University of Nevada Reno; University System of Ohio; Ohio State University	Bailey, JE (corresponding author), Sandia Natl Labs, 1515 Eubank SE, Albuquerque, NM 87185 USA.	jebaile@sandia.gov	Golovkin, Igor/HHN-1097-2022; Golovkin, Igor/AAV-6705-2020; Pain, Jean-Christophe/HHS-9704-2022	Nagayama, Taisuke/0000-0001-9114-6977; Pain, Jean-Christophe/0000-0002-7825-1315; Kilcrease, David/0000-0002-2319-5934; Orban, Chris/0000-0003-1200-4538	United States Department of Energy [DE-AC04-94AL85000, DE-AC5206NA25396]	United States Department of Energy(United States Department of Energy (DOE))	Sandia is a multiprogramme laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the United States Department of Energy under contract DE-AC04-94AL85000. The Los AlamosNational Laboratory is operated by Los Alamos National Security, LLC, for the NNSA of the US DOE under contract number DE-AC5206NA25396. J. E. B. acknowledges support from a DOE High Energy Density Laboratory Plasmas grant. A. K. P. and C. O. also acknowledge support from a DOE High Energy Density Laboratory Plasmas grant. We appreciate the efforts of the entire Z facility team. We thank S. Turck-Chieze, H. Morris, and M. Pinsonneault for discussions. We also thank R. W. Lee for critiquing the manuscript. We appreciate support for the experiments provided by R. J. Leeper, J. L. Porter, M. K. Matzen and M. Herrmann.	Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Badnell NR, 2005, MON NOT R ASTRON SOC, V360, P458, DOI 10.1111/j.1365-2966.2005.08991.x; BAHCALL JN, 1982, REV MOD PHYS, V54, P767, DOI 10.1103/RevModPhys.54.767; Bahcall JN, 2004, ASTROPHYS J, V614, P464, DOI 10.1086/423027; Bailey JE, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2177640; Bailey JE, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3020710; Bailey JE, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3089604; Bailey JE, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.265002; Basu S., 2014, SPACE SCI REV; Basu S, 2008, PHYS REP, V457, P217, DOI 10.1016/j.physrep.2007.12.002; Blancard C, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/10; Caffau E, 2011, SOL PHYS, V268, P255, DOI 10.1007/s11207-010-9541-4; Christensen-Dalsgaard J., 2009, P IAU S AG STARS CAM, V258, P431; Colgan J, 2013, HIGH ENERG DENS PHYS, V9, P369, DOI 10.1016/j.hedp.2013.03.001; COWAN RD, 1981, THEORY ATOMIC SPECTR; DAVIDSON SJ, 1988, APPL PHYS LETT, V52, P847, DOI 10.1063/1.99304; Delahaye F, 2005, ASTROPHYS J, V625, P563, DOI 10.1086/429583; DELGRANDE NK, 1990, PHYS SCRIPTA, V41, P110, DOI 10.1088/0031-8949/41/1/027; Eddington A.S., 1926, INTERNAL CONSTITUTIO; FOSTER JM, 1991, PHYS REV LETT, V67, P3255, DOI 10.1103/PhysRevLett.67.3255; Hansen SB, 2007, HIGH ENERG DENS PHYS, V3, P109, DOI 10.1016/j.hedp.2007.02.032; HENKE BL, 1984, J OPT SOC AM B, V1, P828, DOI 10.1364/JOSAB.1.000828; HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013; IGLESIAS CA, 1991, ASTROPHYS J, V371, P408, DOI 10.1086/169902; Jeynes C, 2012, ANAL CHEM, V84, P6061, DOI 10.1021/ac300904c; Loisel G, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4740269; MacFarlane J. J., 2003, P IN FUS SCI APPL, P457; MacFarlane JJ, 2006, J QUANT SPECTROSC RA, V99, P381, DOI 10.1016/j.jqsrt.2005.05.031; Nagayama T, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4889776; Nagayama T, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4872324; Nagayama T, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4738662; Nahar SN, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.053417; Nash TJ, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3483230; Perry TS, 1996, PHYS REV E, V54, P5617, DOI 10.1103/PhysRevE.54.5617; Porcherot Q, 2011, HIGH ENERG DENS PHYS, V7, P234, DOI 10.1016/j.hedp.2011.05.001; Rochau GA, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4875330; Rosseland S, 1924, MNRAS, V84, P525, DOI [10.1093/mnras/84.7.525, DOI 10.1093/MNRAS/84.7.525]; SEATON MJ, 1994, MON NOT R ASTRON SOC, V266, P805, DOI 10.1093/mnras/266.4.805; Serenelli AM, 2009, ASTROPHYS J LETT, V705, pL123, DOI 10.1088/0004-637X/705/2/L123; Turck-Chieze S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.211102; Zheng L, 2004, HIGH ENERG PHYS NUC, V28, P1121	41	276	279	1	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					56	U120		10.1038/nature14048	http://dx.doi.org/10.1038/nature14048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25557711				2022-12-28	WOS:000347178400033
J	Cohen, J				Cohen, Jon			Breakdown of the year: Ebola	SCIENCE			English	Editorial Material																			0	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1450	1451		10.1126/science.346.6216.1450-b	http://dx.doi.org/10.1126/science.346.6216.1450-b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW8UI	25525227				2022-12-28	WOS:000346536500033
J	Fear, RC; Milan, SE; Maggiolo, R; Fazakerley, AN; Dandouras, I; Mende, SB				Fear, R. C.; Milan, S. E.; Maggiolo, R.; Fazakerley, A. N.; Dandouras, I.; Mende, S. B.			Direct observation of closed magnetic flux trapped in the high-latitude magnetosphere	SCIENCE			English	Article							THETA-AURORA; TRANSPOLAR ARC; PLASMA; ELECTRON; FIELD; WIND; MOTION	The structure of Earth's magnetosphere is poorly understood when the interplanetary magnetic field is northward. Under this condition, uncharacteristically energetic plasma is observed in the magnetotail lobes, which is not expected in the textbook model of the magnetosphere. Using satellite observations, we show that these lobe plasma signatures occur on high-latitude magnetic field lines that have been closed by the fundamental plasma process of magnetic reconnection. Previously, it has been suggested that closed flux can become trapped in the lobe and that this plasma-trapping process could explain another poorly understood phenomenon: the presence of auroras at extremely high latitudes, called transpolar arcs. Observations of the aurora at the same time as the lobe plasma signatures reveal the presence of a transpolar arc. The excellent correspondence between the transpolar arc and the trapped closed flux at high altitudes provides very strong evidence of the trapping mechanism as the cause of transpolar arcs.	[Fear, R. C.; Milan, S. E.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Milan, S. E.] Univ Bergen, Birkeland Ctr Space Sci, Bergen, Norway; [Maggiolo, R.] Belgian Inst Space Aeron, Brussels, Belgium; [Fazakerley, A. N.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Dandouras, I.] Univ Toulouse, Univ Toulouse 3, Observ Midi Pyrenees, IRAP,UMR 5277, Toulouse, France; [Dandouras, I.] CNRS, IRAP, Toulouse, France; [Mende, S. B.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA	University of Leicester; University of Bergen; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California Berkeley	Fear, RC (corresponding author), Univ Southampton, Sch Phys & Astron, Southampton, Hants, England.	r.c.fear@soton.ac.uk	Maggiolo, Romain/A-6621-2017; Dandouras, Iannis/V-2709-2017	Maggiolo, Romain/0000-0002-5658-1313; Dandouras, Iannis/0000-0002-7121-1118; Fear, Robert/0000-0003-0589-7147; Milan, Steve/0000-0001-5050-9604	Science and Technology Facilities Council (STFC) Ernest Rutherford Fellowship [ST/K004298/1]; STFC [ST/K001000/1, ST/K000977/1]; Belgian Science Policy Office through the Solar-Terrestrial Center of Excellence; Centre National d'Etudes Spatiales (CNES); Southwest Research Institute subcontract under NASA [NAS5-96020]; International Space Science Institute through International Team on Polar Cap Arcs; Science and Technology Facilities Council [ST/K004298/1, ST/K000977/1, ST/K001000/1] Funding Source: researchfish; STFC [ST/K000977/1, ST/K004298/1] Funding Source: UKRI	Science and Technology Facilities Council (STFC) Ernest Rutherford Fellowship; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Belgian Science Policy Office through the Solar-Terrestrial Center of Excellence; Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); Southwest Research Institute subcontract under NASA; International Space Science Institute through International Team on Polar Cap Arcs; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Work in the UK was supported by Science and Technology Facilities Council (STFC) Ernest Rutherford Fellowship ST/K004298/1 and STFC grants ST/K001000/1 and ST/K000977/1. R.M. is supported by the Belgian Science Policy Office through the Solar-Terrestrial Center of Excellence. French participation in the Cluster project is funded by the Centre National d'Etudes Spatiales (CNES). IMAGE satellite work at the University of California, Berkeley, was supported through a Southwest Research Institute subcontract under NASA contract NAS5-96020. We acknowledge support from the International Space Science Institute through funding of its International Team on Polar Cap Arcs, and we are grateful for discussions with members of the team. Cluster data were obtained from the Cluster Active Archive (http://caa.estec.esa.int/caa/), and the IMAGE FUV data were provided by the NASA Space Science Data Center (http://nssdc.gsfc.nasa.gov/space/). The OMNI IMF data were obtained through NASA's CDAWeb (http://cdaweb.gsfc.nasa.gov/), for which we acknowledge J.H. King, N. Papatashvilli, and the principal investigators of the magnetic field and plasma instruments on the Geotail and Advanced Composition Explorer (ACE) spacecraft. The DMSP particle detectors were designed by D. Hardy of Air Force Research Laboratory, and data were obtained from the Johns Hopkins University Applied Physics Laboratory.	Cumnock JA, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA015912; Dungey J., 1963, GEOPHYS EARTHS ENV, P505; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; Fazakerley AN, 2010, ASTROPHYSICS SPACE, P129, DOI 10.1007/978-90-481-3499-1_8; Fear RC, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017830; Fear RC, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017209; FRANK LA, 1986, J GEOPHYS RES, V91, P3177, DOI 10.1029/JA091iA03p03177; FRANK LA, 1982, GEOPHYS RES LETT, V9, P1001, DOI 10.1029/GL009i009p01001; Goudarzi A, 2008, ANN GEOPHYS-GERMANY, V26, P201, DOI 10.5194/angeo-26-201-2008; GUSSENHOVEN MS, 1989, J GEOPHYS RES-SPACE, V94, P17121, DOI 10.1029/JA094iA12p17121; HARDY DA, 1982, J GEOPHYS RES-SPACE, V87, P2413, DOI 10.1029/JA087iA04p02413; HUANG CY, 1987, J GEOPHYS RES, V92, P2349, DOI 10.1029/JA092iA03p02349; HUANG CY, 1989, J GEOPHYS RES, V94, P10137, DOI 10.1029/JA094iA08p10137; King JH, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010649; Kullen A, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2002JA009245; Kullen A, 2012, GEOPHYS MONOGR SER, V197, P69, DOI 10.1029/2011GM001183; Mende SB, 2000, SPACE SCI REV, V91, P271, DOI 10.1023/A:1005227915363; MENIETTI JD, 1987, J GEOPHYS RES, V92, P7503, DOI 10.1029/JA092iA07p07503; Milan SE, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010835; Ostgaard N, 2007, J ATMOS SOL-TERR PHY, V69, P249, DOI 10.1016/j.jastp.2006.05.026; Ostgaard N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017914; PETERSON WK, 1984, J GEOPHYS RES-SPACE, V89, P6729, DOI 10.1029/JA089iA08p06729; Reme H, 2001, ANN GEOPHYS-GERMANY, V19, P1303, DOI 10.5194/angeo-19-1303-2001; Russell C. T., 1971, Cosmic Electrodynamics, V2, P184; Shi QQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2476; TSYGANENKO NA, 1996, SPEC PUBL, V389, P181; Walsh AP, 2013, J GEOPHYS RES-SPACE, V118, P6042, DOI 10.1002/jgra.50553	27	37	37	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1506	1510		10.1126/science.1257377	http://dx.doi.org/10.1126/science.1257377			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525244	Green Submitted, Green Accepted			2022-12-28	WOS:000346536500062
J	Song, WJ; Tezcan, FA				Song, Woon Ju; Tezcan, F. Akif			A designed supramolecular protein assembly with in vivo enzymatic activity	SCIENCE			English	Article							METALLO-BETA-LACTAMASE; EVOLUTION; ENZYMES; CATALYSIS; RESISTANCE; STABILITY; MODEL; FOLD; LOOP	The generation of new enzymatic activities has mainly relied on repurposing the interiors of preexisting protein folds because of the challenge in designing functional, three-dimensional protein structures from first principles. Here we report an artificial metallo-beta-lactamase, constructed via the self-assembly of a structurally and functionally unrelated, monomeric redox protein into a tetrameric assembly that possesses catalytic zinc sites in its interfaces. The designed metallo-beta-lactamase is functional in the Escherichia coli periplasm and enables the bacteria to survive treatment with ampicillin. In vivo screening of libraries has yielded a variant that displays a catalytic proficiency [(k(cat)/K-m)/k(uncat)] for ampicillin hydrolysis of 2.3 x 10(6) and features the emergence of a highly mobile loop near the active site, a key component of natural beta-lactamases to enable substrate interactions.	[Song, Woon Ju; Tezcan, F. Akif] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Tezcan, FA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	tezcan@ucsd.edu	Song, Woon Ju/ABE-7778-2021	Song, Woon Ju/0000-0003-0434-2684	NSF [CHE1306646]; U. S. Department of Energy, Offices of Basic Energy Sciences and Biological and Environmental Research; NIH	NSF(National Science Foundation (NSF)); U. S. Department of Energy, Offices of Basic Energy Sciences and Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Rees, T. Ward, N. Gianneschi, S. Cohen, U. Muller, and D. Puerta for helpful discussions. This work was funded by the NSF (CHE1306646 to F.A.T.). Crystallographic data were collected at Stanford Synchrotron Radiation Lightsource, which is supported by the U. S. Department of Energy, Offices of Basic Energy Sciences and Biological and Environmental Research, as well as by the NIH. A description of experimental methods and additional figures and data are provided in the supplementary materials. Coordinate and structure factor files were deposited into the Protein Data Bank under accession numbers 4U9D and 4U9E.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Brodin JD, 2010, J AM CHEM SOC, V132, P8610, DOI 10.1021/ja910844n; Channon K, 2008, CURR OPIN STRUC BIOL, V18, P491, DOI 10.1016/j.sbi.2008.06.006; Coelho PS, 2013, SCIENCE, V339, P307, DOI 10.1126/science.1231434; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; Der BS, 2012, BIOCHEMISTRY-US, V51, P3933, DOI 10.1021/bi201881p; Der BS, 2012, J AM CHEM SOC, V134, P375, DOI 10.1021/ja208015j; Faiella M, 2009, NAT CHEM BIOL, V5, P882, DOI 10.1038/nchembio.257; Faraone-Mennella J, 2006, BIOCHEMISTRY-US, V45, P10504, DOI 10.1021/bi060242x; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Giger L, 2013, NAT CHEM BIOL, V9, P494, DOI 10.1038/nchembio.1276; Hyster TK, 2012, SCIENCE, V338, P500, DOI 10.1126/science.1226132; Kaminskaia NV, 2000, INORG CHEM, V39, P3365, DOI 10.1021/ic000169d; Khare SD, 2012, NAT CHEM BIOL, V8, P294, DOI [10.1038/NCHEMBIO.777, 10.1038/nchembio.777]; Kiss G, 2013, ANGEW CHEM INT EDIT, V52, P5700, DOI 10.1002/anie.201204077; KOIKE T, 1994, J AM CHEM SOC, V116, P8443, DOI 10.1021/ja00098a002; Kries H, 2013, CURR OPIN CHEM BIOL, V17, P221, DOI 10.1016/j.cbpa.2013.02.012; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; Medina-Morales A, 2013, J AM CHEM SOC, V135, P12013, DOI 10.1021/ja405318d; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Privett HK, 2012, P NATL ACAD SCI USA, V109, P3790, DOI 10.1073/pnas.1118082108; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Rufo CM, 2014, NAT CHEM, V6, P303, DOI [10.1038/NCHEM.1894, 10.1038/nchem.1894]; Salgado EN, 2007, J AM CHEM SOC, V129, P13374, DOI 10.1021/ja075261o; Salgado EN, 2010, ACCOUNTS CHEM RES, V43, P661, DOI 10.1021/ar900273t; Scrofani SDB, 1999, BIOCHEMISTRY-US, V38, P14507, DOI 10.1021/bi990986t; Song WJ, 2014, ANNU REV BIOPHYS, V43, P409, DOI 10.1146/annurev-biophys-051013-023038; Sterner R, 2005, CHEM REV, V105, P4038, DOI 10.1021/cr030191z; Tawfik DS, 2006, SCIENCE, V311, P475, DOI 10.1126/science.1123883; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Vanhove M, 2003, CELL MOL LIFE SCI, V60, P2501, DOI 10.1007/s00018-003-3092-x; Yeung N, 2009, NATURE, V462, P1079, DOI 10.1038/nature08620; Zastrow ML, 2012, NAT CHEM, V4, P118, DOI [10.1038/NCHEM.1201, 10.1038/nchem.1201]	35	178	178	3	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1525	1528		10.1126/science.1259680	http://dx.doi.org/10.1126/science.1259680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525249				2022-12-28	WOS:000346536500067
J	Castle, SL				Castle, Steven L.			ORGANIC SYNTHESIS Better chemistry through radicals	NATURE			English	Editorial Material									Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Brigham Young University	Castle, SL (corresponding author), Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA.	scastle@chem.byu.edu						de Meijere A., 2004, METAL CATALYZED CROS, V2nd, DOI 10.1002/9783527619535; KATO K, 1992, CHEM LETT, P1137, DOI 10.1246/cl.1992.1137; Lo JCL, 2014, NATURE, V516, P343, DOI 10.1038/nature14006; Lo JC, 2014, J AM CHEM SOC, V136, P1304, DOI 10.1021/ja4117632; Nakamura E., 2014, ORG REACTIONS, V83, P1, DOI DOI 10.1002/0471264180.0R083.01; Rowlands GJ, 2010, TETRAHEDRON, V66, P1593, DOI 10.1016/j.tet.2009.12.023; Rowlands GJ, 2009, TETRAHEDRON, V65, P8603, DOI 10.1016/j.tet.2009.07.001	7	4	4	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					332	333		10.1038/516332a	http://dx.doi.org/10.1038/516332a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25519124				2022-12-28	WOS:000346484800030
J	Chapron, G				Chapron, Guillaume			Challenge the abuse of science in setting policy	NATURE			English	Editorial Material									Swedish Univ Agr Sci, Riddarhyttan, Sweden	Swedish University of Agricultural Sciences	Chapron, G (corresponding author), Swedish Univ Agr Sci, Riddarhyttan, Sweden.	guillaume.chapron@slu.se							0	16	16	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					289	289		10.1038/516289a	http://dx.doi.org/10.1038/516289a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW8BE	25519096	Bronze			2022-12-28	WOS:000346484800005
J	Pouzols, FM; Toivonen, T; Di Minin, E; Kukkala, AS; Kullberg, P; Kuustera, J; Lehtomaki, J; Tenkanen, H; Verburg, PH; Moilanen, A				Pouzols, Federico Montesino; Toivonen, Tuuli; Di Minin, Enrico; Kukkala, Aija S.; Kullberg, Peter; Kuustera, Johanna; Lehtomaki, Joona; Tenkanen, Henrikki; Verburg, Peter H.; Moilanen, Atte			Global protected area expansion is compromised by projected land-use and parochialism	NATURE			English	Article							KEY BIODIVERSITY AREAS; SPECIES-RICHNESS; CONSERVATION PRIORITIZATION; RESERVE SELECTION; WORLDS; COSTS; SCALE; RESOLUTION; DIVERSITY; REGIONS	Protected areas are one of the main tools for halting the continuing global biodiversity crisis(1-4) caused by habitat loss, fragmentation and other anthropogenic pressures(5-8). According to the Aichi Biodiversity Target 11 adopted by the Convention on Biological Diversity, the protected area network should be expanded to at least 17% of the terrestrial world by 2020 (http://www.cbd.int/sp/targets). To maximize conservation outcomes, it is crucial to identify the best expansion areas. Here we show that there is a very high potential to increase protection of ecoregions and vertebrate species by expanding the protected area network, but also identify considerable risk of ineffective outcomes due to land-use change and uncoordinated actions between countries. We use distribution data for 24,757 terrestrial vertebrates assessed under the International Union for the Conservation of Nature (IUCN) 'red list of threatened species' 9, and terrestrial ecoregions(10) (827), modified by land-use models for the present and 2040, and introduce techniques for global and balanced spatial conservation prioritization. First, we show that with a coordinated global protected area network expansion to 17% of terrestrial land, average protection of species ranges and ecoregions could triple. Second, if projected land-use change by 2040 (ref. 11) takes place, it becomes infeasible to reach the currently possible protection levels, and over 1,000 threatened species would lose more than 50% of their present effective ranges worldwide. Third, we demonstrate a major efficiency gap between national and global conservation priorities. Strong evidence is shown that further biodiversity loss is unavoidable unless international action is quickly taken to balance land-use and biodiversity conservation. The approach used here can serve as a framework for repeatable and quantitative assessment of efficiency, gaps and expansion of the global protected area network globally, regionally andnationally, considering current and projected land-use pressures.	[Pouzols, Federico Montesino; Toivonen, Tuuli; Di Minin, Enrico; Kukkala, Aija S.; Kullberg, Peter; Kuustera, Johanna; Lehtomaki, Joona; Moilanen, Atte] Univ Helsinki, Dept Biosci, Finnish Ctr Excellence Metapopulat Biol, Bioctr, FI-00014 Helsinki, Finland; [Toivonen, Tuuli] Univ Helsinki, Dept Geosci & Geog, FI-00014 Helsinki, Finland; [Di Minin, Enrico] Univ KwaZulu Natal, Dept Life Sci, ZA-4000 Durban, South Africa; [Kuustera, Johanna] Reg Council Helsinki Uusimaa, FI-00240 Helsinki, Finland; [Verburg, Peter H.] Vrije Univ Amsterdam, Inst Environm Studies, NL-1081 HV Amsterdam, Netherlands	University of Helsinki; University of Helsinki; University of Kwazulu Natal; Vrije Universiteit Amsterdam	Pouzols, FM (corresponding author), Rutherford Appleton Lab, Sci & Technol Facil Council, Harwell Oxford Campus, Didcot OX11 0QX, Oxon, England.	federico.montesino-pouzols@stfc.ac.uk; tuuli.toivonen@helsinki.fi; atte.moilanen@helsinki.fi	Di Minin, Enrico/J-6904-2013; Verburg, Peter H/Z-1582-2019; Verburg, Peter h./A-8469-2010; Moilanen, Atte/A-5005-2011; Kukkala, Aija/B-7962-2015; Tenkanen, Henrikki/N-2183-2019; Montesino Pouzols, Federico/D-7995-2014; Lehtomaki, Joona/A-3048-2009	Di Minin, Enrico/0000-0002-5562-318X; Verburg, Peter h./0000-0002-6977-7104; Kukkala, Aija/0000-0003-0812-8722; Tenkanen, Henrikki/0000-0002-0918-4710; Montesino Pouzols, Federico/0000-0002-2981-5612; Lehtomaki, Joona/0000-0002-7891-0843; Toivonen, Tuuli/0000-0002-6625-4922	European Research Council Starting Grant (ERC-StG) [260393]; Academy of Finland centre of excellence programme; Natural Heritage Services (Metsahallitus); ERC [311819]; CSC-IT Center for Science Ltd	European Research Council Starting Grant (ERC-StG)(European Research Council (ERC)); Academy of Finland centre of excellence programme(Academy of Finland); Natural Heritage Services (Metsahallitus); ERC(European Research Council (ERC)European Commission); CSC-IT Center for Science Ltd	F.M.P., T.T., E.D.M., A.S.K., P.K., J.L. and A.M. thank the European Research Council Starting Grant (ERC-StG) 260393 (Global Environmental Decision Analysis, GEDA), the Academy of Finland centre of excellence programme 2012-2017 and the Natural Heritage Services (Metsahallitus) for support. P.H.V. thanks the ERC grant 311819 (GLOLAND). We thank A. Santangeli, I. Hanski and H. Tuomisto for comments on the manuscript, and CSC-IT Center for Science Ltd, administered by the Ministry of Education, Science and Culture of Finland, for its support and high-performance computing services. We are grateful for the efforts of data providers, IUCN, BirdLife International, Conservation International, the IUCN Species Survival Commission Specialist Groups and IUCN Red List Partners, the World Wildlife Fund, the United Nations Environment Programme (UNEP) World Conservation Monitoring Centre and the IUCN World Commission on Protected Areas, and their partners and contributors for kindly providing publicly available data, without which this and many other studies would not have been possible.	Ambal R. G. R., 2012, Journal of Threatened Taxa, V4, P2788; Arponen A, 2005, CONSERV BIOL, V19, P2009, DOI 10.1111/j.1523-1739.2005.00218.x; Arponen A, 2012, CONSERV BIOL, V26, P294, DOI 10.1111/j.1523-1739.2011.01814.x; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Balmford A, 2012, P ROY SOC B-BIOL SCI, V279, P2714, DOI 10.1098/rspb.2012.0515; Beger M, 2010, BIOL CONSERV, V143, P565, DOI 10.1016/j.biocon.2009.11.006; Bird Life International and NatureServe, 2013, BIRD SPEC DISTR MAPS; BirdLife International, 2013, BIRDL GLOB SPEC PROG; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart Stuart H M, 2012, PLoS One, V7, pe32529, DOI 10.1371/journal.pone.0032529; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cantu-Salazar L, 2013, DIVERS DISTRIB, V19, P782, DOI 10.1111/ddi.12034; Conservation International, 2006, PRIOR SIT CONS PHIL; Davis S., 2013, CTR PLANT DIVERSITY; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Eklund J, 2011, PHILOS T R SOC B, V366, P2661, DOI 10.1098/rstb.2011.0114; Ficetola GF, 2013, J BIOGEOGR, V40, P1202, DOI [10.1111/jbi.12060, 10.1111/jbi.12206]; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gustafsson L, 2014, CONSERV LETT; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; HRDictionary, 2012, KEY RES AR KRA KEY P; HUNTER ML, 1994, CONSERV BIOL, V8, P1163, DOI 10.1046/j.1523-1739.1994.08041163.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; International Union for Conservation of Nature, 2013, IUCN RED LIST THREAT; IUCN and UNEP-WCMC, 2013, WORLD DAT PROT AR WD; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Jetz W, 2008, CONSERV BIOL, V22, P110, DOI 10.1111/j.1523-1739.2007.00847.x; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Joppa LN, 2013, SCIENCE, V341, P1100, DOI 10.1126/science.1241706; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Knight AT, 2007, BIOSCIENCE, V57, P256, DOI 10.1641/B570309; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kukkala AS, 2013, BIOL REV, V88, P443, DOI 10.1111/brv.12008; Laitila J, 2012, ECOL MODEL, V247, P40, DOI 10.1016/j.ecolmodel.2012.08.010; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Leathwick JR, 2010, BIOL CONSERV, V143, P984, DOI 10.1016/j.biocon.2010.01.012; Lehtomaki J, 2013, ENVIRON MODELL SOFTW, V47, P128, DOI 10.1016/j.envsoft.2013.05.001; Lehtomaki J, 2009, FOREST ECOL MANAG, V258, P2439, DOI 10.1016/j.foreco.2009.08.026; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mascia MB, 2011, CONSERV LETT, V4, P9, DOI 10.1111/j.1755-263X.2010.00147.x; Mazor T, 2013, DIVERS DISTRIB, V19, P1380, DOI 10.1111/ddi.12095; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; Mittermeier R.A., 2005, HOTSPOTS REV EARTHS; Moilanen A, 2009, SPATIAL CONSERVATION; Moilanen A., 2014, SPATIAL CONSERVATION; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Moilanen A, 2013, DIVERS DISTRIB, V19, P171, DOI 10.1111/ddi.12000; Moilanen A, 2011, BIOL CONSERV, V144, P1719, DOI 10.1016/j.biocon.2011.03.007; Mokany K, 2011, ECOL LETT, V14, P1043, DOI 10.1111/j.1461-0248.2011.01675.x; Moore J, 2004, BIOL CONSERV, V117, P343, DOI 10.1016/j.biocon.2003.12.013; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Myers J. L., 2010, RES DESIGN STAT ANAL; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naidoo R, 2007, BIOL CONSERV, V140, P40, DOI 10.1016/j.biocon.2007.07.025; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Organisation for Economic Cooperation and Development OECD, 2011, OECD ENV OUTL 2050 C, DOI DOI 10.1787/9789264122246-EN; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rodrigues ASL, 2011, ANIM CONSERV, V14, P108, DOI 10.1111/j.1469-1795.2011.00451.x; Rodrigues ASL, 2002, CONSERV BIOL, V16, P674, DOI 10.1046/j.1523-1739.2002.00455.x; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Salafsky N, 2008, CONSERV BIOL, V22, P897, DOI 10.1111/j.1523-1739.2008.00937.x; SAPM. Les sites du Systeme des Aires Protegees de Madagascar. Shapefile des sites du SAPM, 2014, ARR INT 9874 2013 MO; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schulman L, 2007, J BIOGEOGR, V34, P1388, DOI 10.1111/j.1365-2699.2007.01716.x; Somveille M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070907; Strassburg BBN, 2012, NAT CLIM CHANGE, V2, P350, DOI [10.1038/NCLIMATE1375, 10.1038/nclimate1375]; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thomas CD, 2012, P NATL ACAD SCI USA, V109, P14063, DOI 10.1073/pnas.1210251109; Tordoff A. W., 2012, Journal of Threatened Taxa, V4, P2779; Van Asselen S, 2013, GLOBAL CHANGE BIOL, V19, P3648, DOI 10.1111/gcb.12331; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891; Vincent JR, 2014, P NATL ACAD SCI USA, V111, P10113, DOI 10.1073/pnas.1312246111; Waldron A, 2013, P NATL ACAD SCI USA, V110, P12144, DOI 10.1073/pnas.1221370110; Watson JEM, 2013, NAT CLIM CHANGE, V3, P989, DOI [10.1038/NCLIMATE2007, 10.1038/nclimate2007]; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104	91	228	243	14	285	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					383	+		10.1038/nature14032	http://dx.doi.org/10.1038/nature14032			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25494203	Green Submitted			2022-12-28	WOS:000346484800044
J	Vespa, PM				Vespa, Paul M.			Oral Anticoagulants and the Risk of Intracranial Hemorrhage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTRACEREBRAL HEMORRHAGE; ATRIAL-FIBRILLATION; WARFARIN; DABIGATRAN	IMPORTANCE Randomized studies have shown a decreased risk of intracranial hemorrhage (ICH) with use of novel oral anticoagulants (NOACs). However, it is unclear whether the magnitude of benefit is similar for all NOACs currently available. OBJECTIVE To perform a systematic review and meta-analysis to quantitatively assess the rates of ICH within the framework of both conventional and Bayesian statistics. DATA SOURCES The ME DLINE, CENTRAL, CINAHL, and EBSCO databases, supplemented with conference abstracts, were searched up to December 1, 2012, with no language restriction. STUDY SELECTION Randomized trials comparing NOACs vs a comparator and reporting on ICH events. DATA EXTRACTION AND SYNTHESIS The NOACs were pooled to perform a comparison with all comparators and among themselves in both traditional frequentist and Bayesian random-effects models using vague priors and Markov chain Monte Carlo simulation with Gibbs sampling, calculating pooled odds ratios and associated 95% confidence intervals as well as numbers needed to treat and 95% credible intervals for the Bayesian analysis. MAIN OUTCOMES AND MEASURES Intracranial hemorrhage events associated with NOACs in comparison with comparators, expressed as odds ratios. RESULTS Six studies (1 administering dabigatran etexilate mesylate, 2 administering rivaroxaban, and 3 administering apixa ban) enrolling a total of 57 491 patients were included for analysis. The NOACs significantly reduced the risk of ICH against all comparators (odds ratio = 0.49; 95% CI, 0.36-0.65). Each of the 3 drugs reduced the risk of ICH, with Bayesian indirect comparison analysis not revealing a significant credible difference between the specific medications. CONCLUSIONS AND RELEVANCE Novel oral anticoagulants are uniformly associated with an overall reduced risk of ICH when used for stroke prevention in atrial fibrillation. Any of the currently available NOACs can be considered first line for patients at high risk for ICH.	Univ Calif Los Angeles, David Geffen Sch Med, 757 Westwood Blvd,Room 6236A, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vespa, PM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, 757 Westwood Blvd,Room 6236A, Los Angeles, CA 90095 USA.	pvespa@mednet.ucla.edu						Aguilar MI, 2007, MAYO CLIN PROC, V82, P82, DOI 10.1016/s0025-6196(11)60970-1; Chatterjee S, 2013, JAMA NEUROL, V70, P1486, DOI 10.1001/jamaneurol.2013.4021; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Liew A, 2013, CAN J CARDIOL, V29, pS34, DOI 10.1016/j.cjca.2013.04.013; Majeed A, 2013, BEST PRACT RES CL HA, V26, P191, DOI 10.1016/j.beha.2013.07.001; Zhou W, 2013, STROKE, V44, P771, DOI 10.1161/STROKEAHA.112.675231	7	4	4	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2562	+		10.1001/jama.2014.12180	http://dx.doi.org/10.1001/jama.2014.12180			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25514305				2022-12-28	WOS:000346346900019
J	Jalink, MB; Heineman, E; Pierie, JPEN; Hoedemaker, HOT				Jalink, Maarten B.; Heineman, Erik; Pierie, Jean-Pierre E. N.; Hoedemaker, Henk O. ten Cate			CHRISTMAS 2014: GOING TO EXTREMES Nintendo related injuries and other problems: review	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							REPETITIVE STRAIN INJURY; ACTIVE VIDEO GAMES; FIT BALANCE BOARD; LAPAROSCOPIC SKILLS; COMPUTER GAMES; ACUTE WIIITIS; WEIGHT-LOSS; WII CAUSE; EXERCISES; EPILEPSY	Objective To identify all reported cases of injury and other problems caused by using a Nintendo video gaming system. Design Review. Data sources and review methods Search of PubMed and Embase in June 2014 for reports on injuries and other problems caused by using a Nintendo gaming system. Results Most of the 38 articles identified were case reports or case series. Injuries and problems ranged from neurological and psychological to surgical. Traditional controllers with buttons were associated with tendinitis of the extensor of the thumb. The joystick on the Nintendo 64 controller was linked to palmar ulceration. The motion sensitive Wii remote was associated with musculoskeletal problems and various traumas. Conclusions Most problems are mild and prevalence is low. The described injuries were related to the way the games are controlled, which varies according to the video game console.	[Jalink, Maarten B.; Heineman, Erik; Hoedemaker, Henk O. ten Cate] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9700 RB Groningen, Netherlands; [Pierie, Jean-Pierre E. N.; Hoedemaker, Henk O. ten Cate] Univ Groningen, Univ Med Ctr Groningen, Postgrad Sch Med, NL-9713 AV Groningen, Netherlands; [Pierie, Jean-Pierre E. N.] Med Ctr Leeuwarden, Dept Surg, Leeuwarden, Netherlands	University of Groningen; University of Groningen; Medical Center Leeuwarden	Jalink, MB (corresponding author), Univ Groningen, Univ Med Ctr Groningen, POB 30 001, NL-9700 RB Groningen, Netherlands.	maartenjalink@hotmail.com	Heineman, Erik/ABG-9592-2021	Jalink, Maarten B./0000-0002-9521-7469				Almedghio Sami M, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.11.2008.1189; [Anonymous], 2000, BBC NEWS; Baxter R D, 2011, Scott Med J, V56, P236, DOI 10.1258/smj.2011.011174; Beddy P, 2009, AM J ROENTGENOL, V192, pW79, DOI 10.2214/AJR.08.1654; Bhangu A, 2009, J HAND SURG-EUR VOL, V34E, P399, DOI 10.1177/1753193408098906; Bieryla KA, 2013, CLIN INTERV AGING, V8, P775, DOI 10.2147/CIA.S46164; Boehm KM, 2009, J EMERG MED, V36, P80, DOI 10.1016/j.jemermed.2007.11.104; Bokhari R, 2010, AM SURGEON, V76, P583; Bonis J, 2007, NEW ENGL J MED, V356, P2431, DOI 10.1056/NEJMc070670; BRASINGTON R, 1990, NEW ENGL J MED, V322, P1473; Brichetto G, 2013, MULT SCLER J, V19, P1219, DOI 10.1177/1352458512472747; BRIGHT DA, 1992, WESTERN J MED, V156, P667; Brodmann M, 2014, PHLEBOLOGY; Brown CN, 2009, THESCIENTIFICWORLDJO, V9, P1190, DOI 10.1100/tsw.2009.134; CASANOVA J, 1991, J HAND SURG-AM, V16A, P181, DOI 10.1016/S0363-5023(10)80043-7; Chang WD, 2013, J PHYS THER SCI, V25, P1251, DOI 10.1589/jpts.25.1251; CORKERY JC, 1990, AM J DIS CHILD, V144, P959, DOI 10.1001/archpedi.1990.02150330017012; Cowley AD, 2008, BRIT MED J, V336, P110, DOI 10.1136/bmj.39461.631181.BE; Eley KA, 2010, NEW ENGL J MED, V362, P473, DOI 10.1056/NEJMc0909544; Faivre A, 2009, NEUROLOGY, V73, P1242, DOI 10.1212/WNL.0b013e3181bc0172; Fysh T, 2009, J ROY SOC MED, V102, P501, DOI 10.1258/jrsm.2009.090228; Galanopoulos Ilias, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-2012-006967; George AJ, 2012, INJURY, V43, P390, DOI 10.1016/j.injury.2010.11.028; Goncalves GB, 2013, ARQ NEURO-PSIQUIAT, V71, P828; Harrison M, 2009, EMERG MED J, V26, P150, DOI 10.1136/emj.2008.058958; HART EJ, 1990, NEW ENGL J MED, V322, P1473; Herz NB, 2013, PARKINSONISM RELAT D, V19, P1039, DOI 10.1016/j.parkreldis.2013.07.014; Hirpara KM, 2008, INJURY EXTRA, V39, P86; Jalink MB, 2014, SURG ENDOSC, V28, P537, DOI 10.1007/s00464-013-3199-6; Jones C, 2009, PHYSICIAN SPORTSMED, V37, P138, DOI 10.3810/psm.2009.04.1695; Khan OA, 2013, ACTA CHIR BELG, V113, P58; Koh THHG, 2000, MED J AUSTRALIA, V173, P671, DOI 10.5694/j.1326-5377.2000.tb139392.x; Macgregor DM, 2000, SCOT MED J, V45, P150, DOI 10.1177/003693300004500507; Mhatre PV, 2013, PM&R, V5, P769, DOI 10.1016/j.pmrj.2013.05.019; MILLER DLG, 1991, CAN MED ASSOC J, V145, P1202; Naugle KE, 2014, J STRENGTH COND RES, V28, P443, DOI 10.1519/JSC.0b013e31829999c3; Nett MP, 2008, SKELETAL RADIOL, V37, P481, DOI 10.1007/s00256-008-0456-1; Nintendo, CONS SAL TRANS REG; Nintendo, HIST NINT WORLDW 188; Nintendo, WII REM JACK ACC OFF; O'Donovan C, 2014, J CYST FIBROS, V13, P341, DOI 10.1016/j.jcf.2013.10.008; Peek A C, 2008, Ann R Coll Surg Engl, V90, pW9, DOI 10.1308/147870808X303100; Puh U, 2014, KNEE SURG SPORT TR A, V22, P1124, DOI 10.1007/s00167-013-2513-0; Razavi H, 2011, J AAPOS, V15, P491, DOI 10.1016/j.jaapos.2011.05.022; Robinson RJ, 2008, EMERG RADIOL, V15, P255, DOI 10.1007/s10140-008-0712-7; Rubin D, 2010, J CHIROPR MED, V9, P84, DOI 10.1016/j.jcm.2010.02.003; SCHINK JC, 1991, AM J DIS CHILD, V145, P1094, DOI 10.1001/archpedi.1991.02160100026017; Schnicke Michael, 2011, MMW Fortschr Med, V153, P5; SIEGEL IM, 1991, ORTHOPEDICS, V14, P745; Singh Rohit, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2013-202657; Sparks Dorothy, 2009, Inform Prim Care, V17, P55; Sparks DA, 2011, J FAM PRACTICE, V60, P404; SPENCE SA, 1993, IRISH J PSYCHOL MED, V10, P98, DOI 10.1017/S0790966700012970; Staiano AE, 2013, OBESITY, V21, P598, DOI 10.1002/oby.20282; Trenite DGAKN, 1999, EPILEPSIA, V40, P70, DOI 10.1111/j.1528-1157.1999.tb00910.x; Tripette J, 2014, MED SCI SPORT EXER, V46, P472, DOI 10.1249/MSS.0000000000000136; Wells JJ, 2008, J TRAUMA, V65, P1203, DOI 10.1097/TA.0b013e318185e83f; Wood J, 2001, ARCH DIS CHILD, V84, P288, DOI 10.1136/adc.84.4.288	58	24	24	1	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2014	349								g7267	10.1136/bmj.g7267	http://dx.doi.org/10.1136/bmj.g7267			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HK	25515525	Green Published, hybrid			2022-12-28	WOS:000346763900007
J	Arnold, P				Arnold, Peter			CHRISTMAS 2014: IN LOVE AND WAR Another time: England, 1936	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Edgecliff, Sydney, NSW 2027, Australia		Arnold, P (corresponding author), Edgecliff, Sydney, NSW 2027, Australia.	parnold@ozemail.com.au							0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2014	349								g7520	10.1136/bmj.g7520	http://dx.doi.org/10.1136/bmj.g7520			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HD	25512371				2022-12-28	WOS:000346763200008
J	Gray, BM; Vandergrift, JL; Johnston, MM; Reschovsky, JD; Lynn, LA; Holmboe, ES; McCullough, JS; Lipner, RS				Gray, Bradley M.; Vandergrift, Jonathan L.; Johnston, Mary M.; Reschovsky, James D.; Lynn, Lorna A.; Holmboe, Eric S.; McCullough, Jeffrey S.; Lipner, Rebecca S.			Association Between Imposition of a Maintenance of Certification Requirement and Ambulatory Care-Sensitive Hospitalizations and Health Care Costs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; AMERICAN-BOARD; MEDICAL-SPECIALTIES	IMPORTANCE In 1990, the American Board of Internal Medicine (ABIM) ended lifelong certification by initiating a 10-year Maintenance of Certification (MOC) program that first took effect in 2000. Despite the importance of this change, there has been limited research examining associations between the MOC requirement and patient outcomes. OBJECTIVE To measure associations between the original ABIM MOC requirement and outcomes of care. DESIGN, SETTING, AND PARTICIPANTS Quasi-experimental comparison between outcomes for Medicare beneficiaries treated in 2001 by 2 groups of ABIM-certified internal medicine physicians (general internists). One group (n = 956), initially certified in 1991, was required to fulfill the MOC program in 2001 (MOC-required) and treated 84 215 beneficiaries in the sample; the other group (n = 974), initially certified in 1989, was grandfathered out of the MOC requirement (MOC-grandfathered) and treated 69 830 similar beneficiaries in the sample. We compared differences in outcomes for the beneficiary cohort treated by the MOC-required general internists before (1999-2000) and after (2002-2005) they were required to complete MOC, using the beneficiary cohort treated by the MOC-grandfathered general internists as the control. MAIN OUTCOMES AND MEASURES Quality measures were ambulatory care-sensitive hospitalizations (ACSHs), measured using prevention quality indicators. Ambulatory care-sensitive hospitalizations are hospitalizations triggered by conditions thought to be potentially preventable through better access to and quality of outpatient care. Other outcomes included health care cost measures (adjusted to 2013 dollars). RESULTS Annual incidence of ACSHs (per 1000 beneficiaries) increased from the pre-MOC period (37.9 for MOC-required beneficiaries vs 37.0 for MOC-grandfathered beneficiaries) to the post-MOC period (61.8 for MOC-required beneficiaries vs 61.4 for MOC-grandfathered beneficiaries) for both cohorts, as did annual per-beneficiary health care costs (pre-MOC period, $5157 for MOC-required beneficiaries vs $5133 for MOC-grandfathered beneficiaries; post-MOC period, $7633 for MOC-required beneficiaries vs $7793 for MOC-grandfathered beneficiaries). The MOC requirement was not statistically associated with cohort differences in the growth of the annual ACSH rate (per 1000 beneficiaries, 0.1 [95% CI, -1.7 to 1.9]; P = .92), but was associated with a cohort difference in the annual, per-beneficiary cost growth of -$167 (95% CI, -$270.5 to - $63.5; P = .002; 2.5% of overall mean cost). CONCLUSION AND RELEVANCE Imposition of the MOC requirement was not associated with a difference in the increase in ACSHs but was associated with a small reduction in the growth differences of costs for a cohort of Medicare beneficiaries. Copyright 2014 American Medical Association. All rights reserved.	[Gray, Bradley M.; Vandergrift, Jonathan L.; Lynn, Lorna A.; Lipner, Rebecca S.] Amer Board Internal Med, Philadelphia, PA USA; [Johnston, Mary M.] James Madison Univ, Harrisonburg, VA 22807 USA; [Reschovsky, James D.] Math Policy Res, Washington, DC USA; [Holmboe, Eric S.] Accreditat Council Grad Med Educ, Chicago, IL USA; [McCullough, Jeffrey S.] Univ Minnesota, Minneapolis, MN USA	American Board of Internal Medicine; James Madison University; Mathematica; University of Minnesota System; University of Minnesota Twin Cities	Gray, BM (corresponding author), 510 Walnut St,Ste 1700, Philadelphia, PA 19106 USA.	bradleygraypub2014@gmail.com			American Board of Internal Medicine (ABIM)	American Board of Internal Medicine (ABIM)	Financial and material support was provided by the American Board of Internal Medicine (ABIM).	Agency for Healthcare Research and Quality, QUAL IND US GUID PRE; Alemayehu B, 2004, HEALTH SERV RES, V39, P627, DOI 10.1111/j.1475-6773.2004.00248.x; American Board of Internal Medicine, WHER DOES THE MON GO; American Board of Internal Medicine, WGAT CHANG IN 2014; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Colla CH, 2012, JAMA-J AM MED ASSOC, V308, P1015, DOI 10.1001/2012.jama.10812; Davies S, 2011, MED CARE, V49, P679, DOI 10.1097/MLR.0b013e3182159e65; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Hawkins RE, 2013, J CONTIN EDUC HEALTH, V33, pS7, DOI 10.1002/chp.21201; Holmboe ES, 2008, ARCH INTERN MED, V168, P1396, DOI 10.1001/archinte.168.13.1396; Iglehart JK, 2012, NEW ENGL J MED, V367, P2543, DOI 10.1056/NEJMhpr1211043; Kritek Patricia A, 2010, N Engl J Med, V362, pe54, DOI 10.1056/NEJMclde1003227; Landon BE, 2014, J GEN INTERN MED, V29, P1188, DOI 10.1007/s11606-014-2840-y; Levinson W, 2010, NEW ENGL J MED, V362, P948, DOI 10.1056/NEJMclde0911205; McWilliams JM, 2013, JAMA-J AM MED ASSOC, V310, P829, DOI 10.1001/jama.2013.276302; Medicare Payment Advisory Commission, DAT BOOK HLTH CAR SP; Meerding WJ, 1998, BRIT MED J, V317, P111, DOI 10.1136/bmj.317.7151.111; Miller SH, 2005, J CONTIN EDUC HEALTH, V25, P151, DOI 10.1002/chp.22; Norcini JJ, 2002, MED EDUC, V36, P853, DOI 10.1046/j.1365-2923.2002.01293.x; Norcini J, 2011, MED TEACH, V33, P206, DOI 10.3109/0142159X.2011.551559; Petterson SM, 2012, ANN FAM MED, V10, P503, DOI 10.1370/afm.1431; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; Pham HH, 2009, ARCH INTERN MED, V169, P972, DOI 10.1001/archinternmed.2009.78; Pope GC, 2011, EVALUATION CMS HCC R; Roos LL, 2005, HEALTH SERV RES, V40, P1167, DOI 10.1111/j.1475-6773.2005.00407.x; Sirovich BE, 2014, JAMA INTERN MED, V174, P1640, DOI 10.1001/jamainternmed.2014.3337; Song Z, 2011, NEW ENGL J MED, V365, P909, DOI 10.1056/NEJMsa1101416; STARFIELD B, 1994, JAMA-J AM MED ASSOC, V272, P1903, DOI 10.1001/jama.272.24.1903; StataCorp, STAT STAT SOFTW REL; US Bureau of Labor Statistics, CONS PRIC IND ALL UR; Zhan CL, 2004, HEALTH SERV RES, V39, P345, DOI 10.1111/j.1475-6773.2004.00231.x	32	42	42	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2348	2357		10.1001/jama.2014.12716	http://dx.doi.org/10.1001/jama.2014.12716			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW5YB	25490325				2022-12-28	WOS:000346345700009
J	Anderson, P				Anderson, Peter			ALCOHOL AND PUBLIC HEALTH Commentary: David Cameron and the death of responsibility for alcohol policy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Anderson, Peter] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Anderson, Peter] Maastricht Univ, Fac Hlth Med & Life Sci, Maastricht, Netherlands	Newcastle University - UK; Maastricht University	Anderson, P (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	peteranderson.mail@gmail.com						Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Anderson P, 2011, J HEALTH COMMUN, V16, P107, DOI 10.1080/10810730.2011.601531; Anderson P, 2011, J HEALTH COMMUN, V16, P27, DOI 10.1080/10810730.2011.596609; [Anonymous], 2013, ECONOMIST, P85; BLOOMBERG MR, COMMUNICATION; Crook C., 2005, ECONOMIST, P1; Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7646; HM Government, 2012, GOV ALC STRAT; Jones L., 2008, ALCOHOL ATTRIBUTABLE; Jones L., 2012, CAN PROMOTION LOWER; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; World Health Organization, 2011, GLOB STAT REP ALC HL; World Health Organization, NCD GLOB MON FRAM	13	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2014	348								g49	10.1136/bmj.g49	http://dx.doi.org/10.1136/bmj.g49			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	288KI	25489931				2022-12-28	WOS:000329610300010
J	Satcher, D				Satcher, David			The Past and Future Office of the Surgeon General	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Morehouse Sch Med, Atlanta, GA 30310 USA	Morehouse School of Medicine	Satcher, D (corresponding author), Morehouse Sch Med, 720 Westview Dr, Atlanta, GA 30310 USA.	dsatcher@msm.edu			NIMHD NIH HHS [U54 MD008173] Funding Source: Medline; National Institute on Minority Health and Health Disparities [U54MD008173] Funding Source: NIH RePORTER	NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Bell H., 2001, NEW PHYS, P51; Centers for Disease Control and Prevention, 2014, CHILDH OB FACTS PREV; U.S. Department of Health and Human Services, 2014, NAT PREV COUNC; U.S. Department of Health and Human Services, 2014, HLTH CONSEQUENCES SM; U. S. Department of Health and Human Services, 2014, HIST OFF SURG GEN; United States Surgeon General, 1964, PUBL HLTH SERV PUBL; US Department of Human and Health Services, 2012, PREV TOB UYOUTH YO; *US DHHS, 1999, MENT HLTH REP SURG G; *US DHHS, 2001, SURG GEN CALL ACT PR	9	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2015	162	6					450	U98		10.7326/M14-1393	http://dx.doi.org/10.7326/M14-1393			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7OH	25545239				2022-12-28	WOS:000351279600019
J	Konermann, S; Brigham, MD; Trevino, AE; Joung, J; Abudayyeh, OO; Barcena, C; Hsu, PD; Habib, N; Gootenberg, JS; Nishimasu, H; Nureki, O; Zhang, F				Konermann, Silvana; Brigham, Mark D.; Trevino, Alexandro E.; Joung, Julia; Abudayyeh, Omar O.; Barcena, Clea; Hsu, Patrick D.; Habib, Naomi; Gootenberg, Jonathan S.; Nishimasu, Hiroshi; Nureki, Osamu; Zhang, Feng			Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; HUMAN-CELLS; RAF INHIBITION; TARGET DNA; RNA; RESISTANCE; CANCER; MELANOMA; CAS9; PATHWAY	Systematic interrogation of gene function requires the ability to perturb gene expression in a robust and generalizable manner. Here we describe structure-guided engineering of a CRISPR-Cas9 complex to mediate efficient transcriptional activation at endogenous genomic loci. We used these engineered Cas9 activation complexes to investigate single-guide RNA (sgRNA) targeting rules for effective transcriptional activation, to demonstrate multiplexed activation of ten genes simultaneously, and to upregulate long intergenic non-coding RNA (lincRNA) transcripts. We also synthesized a library consisting of 70,290 guides targeting all human RefSeq coding isoforms to screen for genes that, upon activation, confer resistance to a BRAF inhibitor. The top hits included genes previously shown to be able to confer resistance, and novel candidates were validated using individual sgRNA and complementary DNA overexpression. A gene expression signature based on the top screening hits correlated with markers of BRAF inhibitor resistance in cell lines and patient-derived samples. These results collectively demonstrate the potential of Cas9-based activators as a powerful genetic perturbation technology.	[Konermann, Silvana; Brigham, Mark D.; Trevino, Alexandro E.; Joung, Julia; Abudayyeh, Omar O.; Barcena, Clea; Hsu, Patrick D.; Habib, Naomi; Gootenberg, Jonathan S.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Konermann, Silvana; Brigham, Mark D.; Trevino, Alexandro E.; Abudayyeh, Omar O.; Barcena, Clea; Hsu, Patrick D.; Gootenberg, Jonathan S.; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Konermann, Silvana; Brigham, Mark D.; Trevino, Alexandro E.; Abudayyeh, Omar O.; Barcena, Clea; Hsu, Patrick D.; Gootenberg, Jonathan S.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Konermann, Silvana; Brigham, Mark D.; Trevino, Alexandro E.; Joung, Julia; Abudayyeh, Omar O.; Barcena, Clea; Hsu, Patrick D.; Gootenberg, Jonathan S.; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Nishimasu, Hiroshi; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130032, Japan; [Nishimasu, Hiroshi] JST, Tokyo 1130032, Japan	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; University of Tokyo; Japan Science & Technology Agency (JST)	Zhang, F (corresponding author), Broad Inst MIT & Harvard, 75 Ames St, Cambridge, MA 02142 USA.	zhang@broadinstitute.org	Barcena, Clea/AAB-4606-2020; Gootenberg, Jonathan/AAY-8174-2021; Macrae, Rhiannon/AAX-1536-2020; NUREKI, OSAMU/G-4960-2014; Hsu, Patrick/ABD-5749-2021; Habib, Naomi/AAA-8937-2020; Joung, Julia/HCH-8944-2022; Abudayyeh, Omar/ABF-1746-2020	Barcena, Clea/0000-0002-7452-2536; Gootenberg, Jonathan/0000-0003-2757-2175; Abudayyeh, Omar/0000-0002-7979-3220; Brigham, Mark/0000-0002-7196-2261; Hsu, Patrick/0000-0002-9380-2648	NSF Graduate Research Fellowship; D.O.E. Computational Science Graduate Fellowship; PRESTO from JST; JSPS; CREST program; JST; NIMH [DP1-MH100706]; NINDS [R01-N507312401]; NSF; Keck, Searle Scholars; Klingenstein Foundation; Vallee Foundation; Simons Foundation; Bob Metcalfe; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062849, R01NS073124] Funding Source: NIH RePORTER	NSF Graduate Research Fellowship(National Science Foundation (NSF)); D.O.E. Computational Science Graduate Fellowship(United States Department of Energy (DOE)); PRESTO from JST(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST program(Core Research for Evolutional Science and Technology (CREST)); JST(Japan Science & Technology Agency (JST)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NSF(National Science Foundation (NSF)); Keck, Searle Scholars; Klingenstein Foundation(Klingenstein Philanthropies); Vallee Foundation; Simons Foundation; Bob Metcalfe; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank S. Shehata, K. Zheng, C. Johannessen, L. Garraway, O. Shalem and members of the Zhang laboratory for assistance and helpful discussions. O.O.A. is supported by a NSF Graduate Research Fellowship, J.S.G. is supported by a D.O.E. Computational Science Graduate Fellowship, H.N. is supported by PRESTO from JST and Grant-in-Aid for Scientific Research (B) from JSPS, O.N. is supported by the CREST program and JST, and F.Z. is supported by the NIMH (DP1-MH100706), the NINDS (R01-N507312401), NSF, the Keck, Searle Scholars, Klingenstein, Vallee, and Simons Foundations, and Bob Metcalfe. CRISPR reagents are available to the academic community through Addgene, and associated protocols, support forum and computational tools are available via the Zhang laboratory website (http://www.genome-engineering.org).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ikeda K, 2002, GENES CELLS, V7, P49, DOI 10.1046/j.1356-9597.2001.00492.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; PEABODY DS, 1993, EMBO J, V12, P595, DOI 10.1002/j.1460-2075.1993.tb05691.x; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Rizos H, 2014, CLIN CANCER RES, V20, P1965, DOI 10.1158/1078-0432.CCR-13-3122; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi HB, 2011, CANCER RES, V71, P5067, DOI 10.1158/0008-5472.CAN-11-0140; Smalley KSM, 2010, J INVEST DERMATOL, V130, P28, DOI 10.1038/jid.2009.177; van Essen D, 2009, PLOS BIOL, V7, P549, DOI 10.1371/journal.pbio.1000073; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wilks C, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau093; Wong PP, 2012, MOL CELL BIOL, V32, P1633, DOI 10.1128/MCB.06373-11; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	51	1540	1731	34	810	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					583	U332		10.1038/nature14136	http://dx.doi.org/10.1038/nature14136			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25494202	Green Accepted, Green Submitted			2022-12-28	WOS:000348775000036
J	Sacks, CA; Warren, CE				Sacks, Chana A.; Warren, Celestine E.			Foreseeable Risks? Informed Consent for Studies within the Standard of Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EXTREMELY PRETERM INFANTS; OXYGEN-SATURATION; SUPPORT		[Sacks, Chana A.; Warren, Celestine E.] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA	Harvard University	Sacks, CA (corresponding author), Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA.							[Anonymous], 2013, COMMUNICATION, p[9, 13]; Carlo WA, 2013, NEW ENGL J MED, V368, P1949, DOI 10.1056/NEJMc1304827; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Drazen JM, 2013, NEW ENGL J MED, V368, P1929, DOI 10.1056/NEJMe1304996; Hudson KL, 2013, NEW ENGL J MED, V368, P2349, DOI 10.1056/NEJMp1306986	5	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2015	372	4					306	307		10.1056/NEJMp1415113	http://dx.doi.org/10.1056/NEJMp1415113			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ4PJ	25517574				2022-12-28	WOS:000348204500004
J	Fried, SD; Bagchi, S; Boxer, SG				Fried, Stephen D.; Bagchi, Sayan; Boxer, Steven G.			Extreme electric fields power catalysis in the active site of ketosteroid isomerase	SCIENCE			English	Article							PUTIDA BIOTYPE-B; ENZYME CATALYSIS; DELTA(5)-3-KETOSTEROID ISOMERASE; DELTA-5-3-KETOSTEROID ISOMERASE; 3-OXO-DELTA-5-STEROID ISOMERASE; DIRECTED MUTAGENESIS; RAMAN-SPECTROSCOPY; OXYANION HOLE; ENERGETICS; MUTATIONS	Enzymes use protein architecture to impose specific electrostatic fields onto their bound substrates, but the magnitude and catalytic effect of these electric fields have proven difficult to quantify with standard experimental approaches. Using vibrational Stark effect spectroscopy, we found that the active site of the enzyme ketosteroid isomerase (KSI) exerts an extremely large electric field onto the C=O chemical bond that undergoes a charge rearrangement in KSI's rate-determining step. Moreover, we found that the magnitude of the electric field exerted by the active site strongly correlates with the enzyme's catalytic rate enhancement, enabling us to quantify the fraction of the catalytic effect that is electrostatic in origin. The measurements described here may help explain the role of electrostatics in many other enzymes and biomolecular systems.	[Fried, Stephen D.; Bagchi, Sayan; Boxer, Steven G.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Boxer, SG (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	sboxer@stanford.edu	Bagchi, Sayan/AAW-7311-2020	Fried, Stephen/0000-0003-2494-2193; Boxer, Steven/0000-0001-9167-4286	NSF predoctoral fellowship program; Stanford Bio-X interdisciplinary graduate fellowship; NIH [GM27738]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027738, R01GM027738] Funding Source: NIH RePORTER	NSF predoctoral fellowship program; Stanford Bio-X interdisciplinary graduate fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the laboratory of D. Herschlag for providing plasmids of some of the KSI mutants. S.D.F thanks the NSF predoctoral fellowship program and the Stanford Bio-X interdisciplinary graduate fellowship for support. This work was supported in part by a grant from NIH (grant GM27738). S.D.F. designed the study. S.D.F. and S.B. performed experiments and collected data. S.D.F. analyzed the data. S.D.F. and S.G.B. discussed results and wrote the manuscript.	Andrews SS, 2000, J PHYS CHEM A, V104, P11853, DOI 10.1021/jp002242r; AUSTIN JC, 1992, PROTEIN SCI, V1, P259; BELASCO JG, 1980, BIOCHEMISTRY-US, V19, P472, DOI 10.1021/bi00544a012; Boxer SG, 2009, J PHYS CHEM B, V113, P2972, DOI 10.1021/jp8067393; CAREY PR, 1995, ACCOUNTS CHEM RES, V28, P8, DOI 10.1021/ar00049a002; Childs W, 2010, J AM CHEM SOC, V132, P6474, DOI 10.1021/ja1007849; Choi G, 2001, BIOCHEMISTRY-US, V40, P6828, DOI 10.1021/bi002767+; Fafarman AT, 2010, J AM CHEM SOC, V132, P12811, DOI 10.1021/ja104573b; Fried SD, 2013, J PHYS CHEM B, V117, P16236, DOI 10.1021/jp410720y; Fried SD, 2013, J AM CHEM SOC, V135, P11181, DOI 10.1021/ja403917z; HAWKINSON DC, 1991, BIOCHEMISTRY-US, V30, P10849, DOI 10.1021/bi00109a007; Herschlag D, 2013, BIOCHEMISTRY-US, V52, P2050, DOI 10.1021/bi4000113; Houck WJ, 2004, J AM CHEM SOC, V126, P16416, DOI 10.1021/ja046819k; Kamerlin SCL, 2010, P NATL ACAD SCI USA, V107, P4075, DOI 10.1073/pnas.0914579107; KIM SW, 1995, J BACTERIOL, V177, P2602, DOI 10.1128/jb.177.9.2602-2605.1995; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Kraut DA, 2006, PLOS BIOL, V4, P501, DOI 10.1371/journal.pbio.0040099; Kraut DA, 2010, P NATL ACAD SCI USA, V107, P1960, DOI 10.1073/pnas.0911168107; KULIOPULOS A, 1989, BIOCHEMISTRY-US, V28, P149, DOI 10.1021/bi00427a022; Liu CT, 2014, J AM CHEM SOC, V136, P10349, DOI 10.1021/ja5038947; Massiah MA, 1998, BIOCHEMISTRY-US, V37, P14701, DOI 10.1021/bi981447b; Nam GH, 2001, BIOCHEMISTRY-US, V40, P13529, DOI 10.1021/bi015547k; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Pollack RM, 2004, BIOORG CHEM, V32, P341, DOI 10.1016/j.bioorg.2004.06.005; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Stafford AJ, 2012, BIOCHEMISTRY-US, V51, P2757, DOI 10.1021/bi201225p; WARSHEL A, 1978, P NATL ACAD SCI USA, V75, P5250, DOI 10.1073/pnas.75.11.5250; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106	28	286	286	9	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1510	1514		10.1126/science.1259802	http://dx.doi.org/10.1126/science.1259802			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525245	Green Accepted			2022-12-28	WOS:000346536500063
J	Lorsch, JR; Collins, FS; Lippincott-Schwartz, J				Lorsch, Jon R.; Collins, Francis S.; Lippincott-Schwartz, Jennifer			Fixing problems with cell lines	SCIENCE			English	Editorial Material							REPRODUCIBILITY		[Lorsch, Jon R.] NIGMS, Bethesda, MD 20892 USA; [Collins, Francis S.] NIH, Bethesda, MD 20892 USA; [Lippincott-Schwartz, Jennifer] Amer Soc Cell Biol, Bethesda, MD 20814 USA; [Lippincott-Schwartz, Jennifer] NICHHD, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lorsch, JR (corresponding author), NIGMS, Bethesda, MD 20892 USA.	jon.lorsch@nih.gov		Lorsch, Jon/0000-0002-4521-4999				[Anonymous], 2007, NOTOD08017; [Anonymous], 2014, RFAGM15006; Armstrong SE, 2010, BIOLOGICALS, V38, P211, DOI 10.1016/j.biologicals.2010.03.002; Boonstra JJ, 2010, JNCI-J NATL CANCER I, V102, P271, DOI 10.1093/jnci/djp499; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; MacLeod RAF, 2006, NATURE, V439, P912, DOI 10.1038/439912b; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; McNutt M, 2014, SCIENCE, V346, P679, DOI 10.1126/science.aaa1724; Olarerin-George A. O., 2014, BIOR, VX, piv; Vasilevsky NA, 2013, PEERJ, V1, DOI 10.7717/peerj.148; Weinstein JN, 2012, NATURE, V483, P544, DOI 10.1038/483544a; Zhao M, 2011, CLIN CANCER RES, V17, P7248, DOI 10.1158/1078-0432.CCR-11-0690	13	121	126	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1452	1453		10.1126/science.1259110	http://dx.doi.org/10.1126/science.1259110			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525228	Green Published			2022-12-28	WOS:000346536500034
J	Yang, L; Chen, LL				Yang, Li; Chen, Ling-Ling			Microexons Go Big	CELL			English	Editorial Material							EXONIC SPLICING ENHANCERS	Microexons are frequently underestimated in transcriptome analyses. Two studies published in Cell and Genome Research now independently report the identification of hundreds of microexons. Alternative splicing of some microexons is regulated by neuronal-specific RNA-binding proteins and modifies the function of proteins involved in neurogenesis, with misregulation linked to autism.	[Yang, Li] CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai 200031, Peoples R China; [Yang, Li] CAS Ctr Excellence Brain Sci, Shanghai 200031, Peoples R China; [Chen, Ling-Ling] Chinese Acad Sci, State Key Lab Mol Biol, Shanghai Key Lab Mol Androl, Shanghai Inst Biol Sci,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Chen, Ling-Ling] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Yang, L (corresponding author), CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai 200031, Peoples R China.	liyang@picb.ac.cn; linglingchen@sibcb.ac.cn	Chen, Ling-Ling/AAY-3547-2021	yang, li/0000-0001-8833-7473; chen, ling ling/0000-0001-9501-0305				BLACK DL, 1991, GENE DEV, V5, P389, DOI 10.1101/gad.5.3.389; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Carlo T, 2000, MOL CELL BIOL, V20, P3988, DOI 10.1128/MCB.20.11.3988-3995.2000; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Li Y.I., 2015, GENOME RES; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Zibetti C, 2010, J NEUROSCI, V30, P2521, DOI 10.1523/JNEUROSCI.5500-09.2010	9	10	10	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1488	1489		10.1016/j.cell.2014.12.004	http://dx.doi.org/10.1016/j.cell.2014.12.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525868	Bronze			2022-12-28	WOS:000347922500002
J	Howard, L; Lorains, J; Foex, BA				Howard, Laura; Lorains, Jo; Foex, Bernard A.			CHRISTMAS 2014: ON THE WARDS, IN THE SURGERY Medical training: some "forgotten" common competencies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Howard, Laura; Foex, Bernard A.] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England; [Lorains, Jo] North Western Deanery, Manchester, Lancs, England	University of Manchester	Foex, BA (corresponding author), Manchester Royal Infirm, Oxford Rd, Manchester M13 9WL, Lancs, England.	bernard.foex@cmft.nhs.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2014	349								g7384	10.1136/bmj.g7384	http://dx.doi.org/10.1136/bmj.g7384			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX3DZ	25520055				2022-12-28	WOS:000346821900002
J	Campbell, TG; Trachter, R				Campbell, Thomas Gordon; Trachter, Robert			CHRISTMAS 2014: ON THE WARDS, IN THE SURGERY A novel clinical entity: the Campbell-Trachter syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Campbell, Thomas Gordon] Univ Queensland, Sch Med, Brisbane, Qld 4072, Australia; [Campbell, Thomas Gordon] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Trachter, Robert] Nambour Hosp, Nambour, Qld, Australia	University of Queensland	Campbell, TG (corresponding author), Univ Queensland, Sch Med, Brisbane, Qld 4072, Australia.	thomasgordoncampbell@gmail.com	Campbell, Thomas G/C-2498-2014	Campbell, Thomas G/0000-0002-4508-0089					0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2014	349								g7423	10.1136/bmj.g7423	http://dx.doi.org/10.1136/bmj.g7423			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HD	25512396				2022-12-28	WOS:000346763200004
J	Travis, E; Woodhouse, S; Tan, R; Patel, S; Donovan, J; Brogan, K				Travis, Elizabeth; Woodhouse, Sarah; Tan, Ruth; Patel, Sandeep; Donovan, Jason; Brogan, Kit			CHRISTMAS 2014: ON THE WARDS, IN THE SURGERY Operating theatre time, where does it all go? A prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ORTHOPEDIC SURGEONS; ANESTHESIA	Objective To assess the accuracy of surgeons and anaesthetists in predicting the time it will take them to complete an operation or procedure and therefore explain some of the difficulties encountered in operating theatre scheduling. Design Single centre, prospective observational study. Setting Plastic, orthopaedic, and general surgical operating theatres at a level 1 trauma centre serving a population of about 370 000. Participants 92 operating theatre staff including surgical consultants, surgical registrars, anaesthetic consultants, and anaesthetic registrars. Intervention Participants were asked how long they thought their procedure would take. These data were compared with actual time data recorded at the end of the case. Primary outcome measure Absolute difference between predicted and actual time. Results General surgeons underestimated the time required for the procedure by 31 minutes (95% confidence interval 7.6 to 54.4), meaning that procedures took, on average, 28.7% longer than predicted. Plastic surgeons underestimated by 5 minutes (-12.4 to 22.4), with procedures taking an average of 4.5% longer than predicted. Orthopaedic surgeons overestimated by 1 minute (-16.4 to 14.0), with procedures taking an average of 1.1% less time than predicted. Anaesthetists underestimated by 35 minutes (21.7 to 48.7), meaning that, on average, procedures took 167.5% longer than they predicted. The four specialty mean time overestimations or underestimations are significantly different from each other (P=0.01). The observed time differences between anaesthetists and both orthopaedic and plastic surgeons are significantly different (P< 0.05), but the time difference between anaesthetists and general surgeons is not significantly different. Conclusion The inability of clinicians to predict the necessary time for a procedure is a significant cause of delay in the operating theatre. This study suggests that anaesthetists are the most inaccurate and highlights the potential differences between specialties in what is considered part of the "anaesthesia time."	[Travis, Elizabeth; Tan, Ruth; Patel, Sandeep; Donovan, Jason; Brogan, Kit] Waikato Hosp, Hamilton, New Zealand; [Woodhouse, Sarah] Univ Sussex, Brighton BN1 9RH, E Sussex, England	Waikato Hospital; University of Sussex	Travis, E (corresponding author), Waikato Hosp, Hamilton, New Zealand.	elizabeth.travis@waikatodhb.health.nz	Brogan, Kit/Q-2720-2019	Bond, Elizabeth/0000-0002-1343-5658				[Anonymous], 2014, DOCTORS SLANG MED SL; BARRETT DS, 1988, BRIT MED J, V297, P1638, DOI 10.1136/bmj.297.6664.1638; Delaney CL, 2010, ANZ J SURG, V80, P217, DOI 10.1111/j.1445-2197.2009.05043.x; FOX JS, 1990, BRIT MED J, V301, P1425, DOI 10.1136/bmj.301.6766.1425; Kodali BS, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0011-7; Koenig T, 2011, ANAESTHESIA, V66, P556, DOI 10.1111/j.1365-2044.2011.06661.x; NHS Institute for Innovation and Improvement, PROD OP THEATR; Subramanian P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7506; World_Health_Organization, 2014, WHO SURG SAF CHECKL	9	11	11	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2014	349								g7182	10.1136/bmj.g7182	http://dx.doi.org/10.1136/bmj.g7182			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HD	25510241	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000346763200001
J	Abu-Zaid, A; Azzam, A				Abu-Zaid, Ahmed; Azzam, Ayman			Esophageal Duplication Cyst	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Abu-Zaid, Ahmed] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia; [Azzam, Ayman] Univ Alexandria, Fac Med, Alexandria, Egypt	Alfaisal University; Egyptian Knowledge Bank (EKB); Alexandria University	Abu-Zaid, A (corresponding author), Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.	aabuzaid@live.com	Azzam, Ayman Zaki/H-2987-2019	Azzam, Ayman Zaki/0000-0001-8464-4660; Abu-Zaid, Ahmed/0000-0003-2286-2181					0	8	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					E36	E36		10.1056/NEJMicm1313198	http://dx.doi.org/10.1056/NEJMicm1313198			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW1KQ	25494286				2022-12-28	WOS:000346048800001
J	Koven, S				Koven, Suzanne			The Disease of the Little Paper	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Koven, Suzanne] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Koven, Suzanne] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Koven, S (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							BURNUM JF, 1985, NEW ENGL J MED, V313, P690, DOI 10.1056/NEJM198509123131110; Gray JAM, 1999, BRIT MED J, V319, P1476, DOI 10.1136/bmj.319.7223.1476; MEIGE H, 1893, JUIF ERRANT SALPETRI; Osler W, 1950, APHROISMS; Sontag Susan., 2012, CONSCIOUSNESS IS HAR	5	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					2251	2253		10.1056/NEJMp1411685	http://dx.doi.org/10.1056/NEJMp1411685			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW1KQ	25494267				2022-12-28	WOS:000346048800005
J	Kraut, JA; Madias, NE				Kraut, Jeffrey A.; Madias, Nicolaos E.			DISORDERS OF FLUIDS AND ELECTROLYTES Lactic Acidosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							VENOUS OXYGEN-SATURATION; CRITICALLY-ILL PATIENTS; LACTATE CLEARANCE; MICROCIRCULATORY ALTERATIONS; METABOLIC-ACIDOSIS; SEVERE SEPSIS; ANION GAP; HOSPITAL MORTALITY; SEPTIC SHOCK; HYPERLACTATEMIA		[Kraut, Jeffrey A.] Univ Calif Los Angeles, Med Serv, Membrane Biol Lab, Los Angeles, CA USA; [Kraut, Jeffrey A.] Univ Calif Los Angeles, Res Serv, Membrane Biol Lab, Los Angeles, CA USA; [Kraut, Jeffrey A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA 90095 USA; [Kraut, Jeffrey A.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Madias, Nicolaos E.] St Elizabeths Med Ctr, Dept Med, Div Nephrol, Boston, MA USA; [Madias, Nicolaos E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; St. Elizabeth's Medical Center; Tufts University	Kraut, JA (corresponding author), VHAGLA Healthcare Syst, Div Nephrol, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	jkraut@ucla.edu; nicolaos.madias@steward.org						ADROGUE HJ, 1989, NEW ENGL J MED, V320, P1312, DOI 10.1056/NEJM198905183202004; Adrogue HJ, 1998, NEW ENGL J MED, V338, P26, DOI 10.1056/NEJM199801013380106; Andersen LW, 2013, MAYO CLIN PROC, V88, P1127, DOI 10.1016/j.mayocp.2013.06.012; Bakker J, 2007, INTENS CARE MED, V33, P1863, DOI 10.1007/s00134-007-0679-y; Bakker J, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-12; COOPER DJ, 1990, ANN INTERN MED, V112, P492, DOI 10.7326/0003-4819-112-7-492; De Backer D, 2006, CRIT CARE MED, V34, P403, DOI 10.1097/01.CCM.0000198107.61493.5A; De Backer D, 2013, CRIT CARE MED, V41, P791, DOI 10.1097/CCM.0b013e3182742e8b; del Portal DA, 2010, ACAD EMERG MED, V17, P260, DOI 10.1111/j.1553-2712.2010.00681.x; Didwania A, 1997, CRIT CARE MED, V25, P1851, DOI 10.1097/00003246-199711000-00024; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Fall Pamela J, 2005, J Intensive Care Med, V20, P255, DOI 10.1177/0885066605278644; Fuller BM, 2012, CURR OPIN CRIT CARE, V18, P267, DOI 10.1097/MCC.0b013e3283532b8a; Gennari FJ, 2013, AM J KIDNEY DIS, V62, P20, DOI 10.1053/j.ajkd.2013.01.009; Gunnerson KJ, 2006, CRIT CARE, V10, DOI 10.1186/cc3987; Hood VL, 1998, NEW ENGL J MED, V339, P819, DOI 10.1056/NEJM199809173391207; IBERTI TJ, 1990, CRIT CARE MED, V18, P275, DOI 10.1097/00003246-199003000-00005; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; James JH, 1999, LANCET, V354, P505, DOI 10.1016/S0140-6736(98)91132-1; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; Jeppesen JB, 2013, SCAND J CLIN LAB INV, V73, P293, DOI 10.3109/00365513.2013.773591; Jones AE, 2011, CHEST, V140, P1406, DOI 10.1378/chest.11-2560; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Jung B, 2011, CRIT CARE, V15, DOI 10.1186/cc10487; Khosravani H, 2009, CRIT CARE, V13, DOI 10.1186/cc7918; Kim HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065283; Kliegel A, 2004, MEDICINE, V83, P274, DOI 10.1097/01.md.0000141098.46118.4c; Kraut JA, 2001, AM J KIDNEY DIS, V38, P703, DOI 10.1053/ajkd.2001.27688; Kraut JA, 2007, CLIN J AM SOC NEPHRO, V2, P162, DOI 10.2215/CJN.03020906; Kraut JA, 2012, NAT REV NEPHROL, V8, P589, DOI 10.1038/nrneph.2012.186; Kruse O, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-74; KUZE S, 1992, ANESTH ANALG, V75, P702, DOI 10.1213/00000539-199211000-00008; Lee SW, 2008, EMERG MED J, V25, P659, DOI 10.1136/emj.2007.055558; Levraut J, 1998, AM J RESP CRIT CARE, V157, P1021, DOI 10.1164/ajrccm.157.4.9705037; Levy B, 2008, SHOCK, V30, P417, DOI 10.1097/SHK.0b013e318167378f; MADIAS NE, 1986, KIDNEY INT, V29, P752, DOI 10.1038/ki.1986.62; MADIAS NE, 1984, J LAB CLIN MED, V104, P15; Murphy ND, 2001, CRIT CARE MED, V29, P2111, DOI 10.1097/00003246-200111000-00011; Murtuza B, 2011, EUR J CARDIO-THORAC, V40, P1207, DOI 10.1016/j.ejcts.2011.01.081; Mustafa I, 2002, SHOCK, V18, P306, DOI 10.1097/00024382-200210000-00003; Myburgh JA, 2013, NEW ENGL J MED, V369, P1243, DOI 10.1056/NEJMra1208627; Nichol AD, 2010, CRIT CARE, V14, DOI 10.1186/cc8888; O'Dell E, 2007, CRIT CARE MED, V35, P2390, DOI 10.1097/01.CCM.0000284588.17760.99; Okorie ON, 2011, CRIT CARE CLIN, V27, P299, DOI 10.1016/j.ccc.2010.12.013; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; Sakr Y, 2010, TRANSFUS APHER SCI, V43, P79, DOI 10.1016/j.transci.2010.05.012; SCHELLING JR, 1990, ANN INTERN MED, V113, P580, DOI 10.7326/0003-4819-113-8-580; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Swietach P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0099; TAYLOR DJ, 1992, CIRC SHOCK, V37, P105; Textoris J, 2012, CRIT CARE, V16, DOI 10.1186/cc11414; van Beest PA, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-6; van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x; Vanni S, 2013, ANN EMERG MED, V61, P330, DOI 10.1016/j.annemergmed.2012.10.022; Vincent JL, 2013, NEW ENGL J MED, V369, P1726, DOI 10.1056/NEJMra1208943; Wu DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056624, 10.1371/journal.pone.0053932, 10.1371/journal.pone.0055431]; Wu DM, 2010, CLIN EXP PHARMACOL P, V37, P337, DOI 10.1111/j.1440-1681.2009.05296.x; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	61	403	425	5	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					2309	2319		10.1056/NEJMra1309483	http://dx.doi.org/10.1056/NEJMra1309483			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW1KQ	25494270				2022-12-28	WOS:000346048800011
J	Chi, J; Verghese, A				Chi, Jeffrey; Verghese, Abraham			Clinical Education and the Electronic Health Record The Flipped Patient	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chi, Jeffrey; Verghese, Abraham] Stanford Univ, Sch Med, Dept Internal Med, Program Bedside Med, Stanford, CA 94305 USA	Stanford University	Chi, J (corresponding author), Stanford Sch Med, Div Gen Med Disciplines, 300 Pasteur Dr,MC 5209, Stanford, CA 94305 USA.	jeffrey.chi@stanford.edu						Chi J., 2013, ABSTRACT PRESENTED A; Dhaliwal G, 2013, JAMA-J AM MED ASSOC, V310, P2247, DOI 10.1001/jama.2013.282322; Gunderman R., 2013, THE ATLANTIC; HAMPTON JR, 1975, BRIT MED J, V2, P486, DOI 10.1136/bmj.2.5969.486; Massey PR, 2014, JAMA INTERN MED, V174, P1440, DOI 10.1001/jamainternmed.2014.3233; McGee S, 2014, JAMA-J AM MED ASSOC, V311, P1971, DOI 10.1001/jama.2013.286201; Prober CG, 2012, NEW ENGL J MED, V366, P1657, DOI 10.1056/NEJMp1202451; Verghese A, 2008, NEW ENGL J MED, V359, P2748, DOI 10.1056/NEJMp0807461	8	34	34	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2331	2332		10.1001/jama.2014.12820	http://dx.doi.org/10.1001/jama.2014.12820			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YB	25490318				2022-12-28	WOS:000346345700002
J	Gellert, GA; Ramirez, R; Webster, SL				Gellert, George A.; Ramirez, Ricardo; Webster, S. Luke			The Rise of the Medical Scribe Industry Implications for the Advancement of Electronic Health Records	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gellert, George A.; Ramirez, Ricardo] CHRISTUS Hlth, Dept Hlth Informat, San Antonio, TX 78260 USA; [Webster, S. Luke] CHRISTUS Hlth, Dept Hlth Informat, Dallas, TX USA		Gellert, GA (corresponding author), CHRISTUS Hlth, Dept Hlth Informat, 703 Sentry Hill, San Antonio, TX 78260 USA.	george.gellert@christushealth.org						[Anonymous], 2014, DAILY BRIEF; Campbell Lisa L, 2012, J AHIMA, V83, P64; Centers for Medicare & Medicaid Services (CMS) HHS, 2010, Fed Regist, V75, P44313; Crosby J., 2014, MINNEAPOLIS STARTRIB; Friedberg M.W., 2013, FACTORS AFFECTING PH; The Joint Commission, US UNL PERS ACT SCRI	6	75	76	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2015	313	13					1315	1316		10.1001/jama.2014.17128	http://dx.doi.org/10.1001/jama.2014.17128			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF1OL	25504341				2022-12-28	WOS:000352315900014
J	Meibom, S; Barnes, SA; Platais, I; Gilliland, RL; Latham, DW; Mathieu, RD				Meibom, Soren; Barnes, Sydney A.; Platais, Imants; Gilliland, Ronald L.; Latham, David W.; Mathieu, Robert D.			A spin-down clock for cool stars from observations of a 2.5-billion-year-old cluster	NATURE			English	Article							WIYN OPEN CLUSTER; ANGULAR-MOMENTUM LOSS; TIME-SERIES ANALYSIS; MAIN-SEQUENCE STARS; OLD OPEN CLUSTER; SOLAR-TYPE STARS; NGC 6819; STELLAR ROTATION; ERROR-CORRECTION; CCD PHOTOMETRY	The ages of the most common stars-low-mass (cool) stars like the Sun, and smaller-are difficult to derive(1,2) because traditional dating methods use stellar properties that either change little as the stars age(3,4) or are hard to measure(5-8). The rotation rates of all cool stars decrease substantially with time as the stars steadily lose their angular momenta. If properly calibrated, rotation therefore can act as a reliable determinant of their ages based on the method of gyrochronology(2,9-11). To calibrate gyrochronology, the relationship between rotation period and age must be determined for cool stars of different masses, which is best accomplished with rotation period measurements for stars in clusters with well-known ages. Hitherto, such measurements have been possible only in clusters with ages of less than about one billion years(12-16), and gyrochronology ages for older stars have been inferred from model predictions(2,7,11,17). Here we report rotation period measurements for 30 cool stars in the 2.5-billion-year-old cluster NGC 6819. The periods reveal a well-defined relationship between rotation period and stellar mass at the cluster age, suggesting that ages with a precision of order 10 per cent can be derived for large numbers of cool Galactic field stars.	[Meibom, Soren; Latham, David W.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Barnes, Sydney A.] Leibniz Inst Astrophys, D-14482 Potsdam, Germany; [Barnes, Sydney A.] Space Sci Inst, Boulder, CO 80301 USA; [Platais, Imants] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Gilliland, Ronald L.] Penn State Univ, Ctr Exoplanets & Habitable Worlds, University Pk, PA 16802 USA; [Mathieu, Robert D.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Leibniz Institut fur Astrophysik Potsdam (AIP); Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Wisconsin System; University of Wisconsin Madison	Meibom, S (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	smeibom@cfa.harvard.edu		Latham, David/0000-0001-9911-7388	NASA [NNX09AH18A]; NSF [1312882]; Smithsonian Institution's Competitive Grants Program for Science; German Science Foundation (DFG); Research in Astronomy, Inc., under NASA [NAS5-26555]; NASA Office of Space Science [NNX13AC07G]	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Smithsonian Institution's Competitive Grants Program for Science; German Science Foundation (DFG)(German Research Foundation (DFG)); Research in Astronomy, Inc., under NASA; NASA Office of Space Science(National Aeronautics & Space Administration (NASA))	S.M. acknowledges support through NASA grant NNX09AH18A (The Kepler ClusterStudy), NSF grant 1312882 (The Kepler ClusterStudy: Planets and Gyrochronology) and the Smithsonian Institution's Competitive Grants Program for Science in 2012 and 2013. S.A.B. acknowledges support from the German Science Foundation (DFG) during a crucial phase of this work via a Mercator Guest Professorship at the University of Potsdam and the Leibniz Institute for Astrophysics Potsdam, Germany. This paper includes data collected by the Kepler mission. Kepler was competitively selected as the tenth Discovery mission. Funding for the Kepler mission is provided by the NASA Science Mission directorate. Some or all of the data presented in this paper were obtained from the Mikulski Archive for Space Telescopes (MAST). STScl is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555. Support for MAST for non-HST data is provided by the NASA Office of Space Science via grant NNX13AC07G and by other grants and contracts. Spectroscopic observations of NGC 6819 with the Hectochelle spectrograph were obtained at the MMT Observatory, a joint facility of the Smithsonian Institution and the University of Arizona.	Anthony-Twarog BJ, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/3/51; Balona LA, 2013, MON NOT R ASTRON SOC, V430, P3472, DOI 10.1093/mnras/stt148; Barnes SA, 2003, ASTROPHYS J, V586, P464, DOI 10.1086/367639; Barnes SA, 2007, ASTROPHYS J, V669, P1167, DOI 10.1086/519295; Barnes SA, 2010, ASTROPHYS J, V722, P222, DOI 10.1088/0004-637X/722/1/222; Barnes SA, 2010, ASTROPHYS J, V721, P675, DOI 10.1088/0004-637X/721/1/675; Bragaglia A, 2001, ASTRON J, V121, P327, DOI 10.1086/318042; Brown TM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/112; Delorme P, 2011, MON NOT R ASTRON SOC, V413, P2218, DOI 10.1111/j.1365-2966.2011.18299.x; DEMARQUE PR, 1964, ASTROPHYS J, V140, P544, DOI 10.1086/147948; Epstein CR, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/159; Hartman JD, 2010, MON NOT R ASTRON SOC, V408, P475, DOI 10.1111/j.1365-2966.2010.17147.x; HUT P, 1981, ASTRON ASTROPHYS, V99, P126; Jeffries MW, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/3/58; Jeffries R. D., 2014, P 23 EVRY SCHATZM SC, P289; Kalirai JS, 2001, ASTRON J, V122, P266, DOI 10.1086/321141; KAWALER SD, 1988, ASTROPHYS J, V333, P236, DOI 10.1086/166740; KAWALER SD, 1989, ASTROPHYS J, V343, pL65, DOI 10.1086/185512; KRAFT RP, 1967, ASTROPHYS J, V150, P551, DOI 10.1086/149359; Lasker BM, 2008, ASTRON J, V136, P735, DOI 10.1088/0004-6256/136/2/735; Mamajek EE, 2008, ASTROPHYS J, V687, P1264, DOI 10.1086/591785; McQuillan A, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/2/24; Meibom S, 2005, ASTROPHYS J, V620, P970, DOI 10.1086/427082; Meibom S, 2006, ASTROPHYS J, V653, P621, DOI 10.1086/508252; Meibom S, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/115; Meibom S, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/1/L9; Meibom S, 2009, ASTROPHYS J, V695, P679, DOI 10.1088/0004-637X/695/1/679; Milliman KE, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/2/38; NOYES RW, 1984, ASTROPHYS J, V279, P763, DOI 10.1086/161945; PARKER EN, 1958, ASTROPHYS J, V128, P664, DOI 10.1086/146579; Platais I, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/2/43; RADICK RR, 1987, ASTROPHYS J, V321, P459, DOI 10.1086/165645; Raghavan D, 2010, ASTROPHYS J SUPPL S, V190, P1, DOI 10.1088/0067-0049/190/1/1; ROBERTS DH, 1987, ASTRON J, V93, P968, DOI 10.1086/114383; Rosvick JM, 1998, ASTRON J, V115, P1516, DOI 10.1086/300304; SANDAGE A, 1962, ASTROPHYS J, V135, P349, DOI 10.1086/147275; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; SKUMANICH A, 1972, ASTROPHYS J, V171, P565, DOI 10.1086/151310; Smith JC, 2012, PUBL ASTRON SOC PAC, V124, P1000, DOI 10.1086/667697; Soderblom DR, 2010, ANNU REV ASTRON ASTR, V48, P581, DOI 10.1146/annurev-astro-081309-130806; Stumpe MC, 2012, PUBL ASTRON SOC PAC, V124, P985, DOI 10.1086/667698; VANLEEUWEN F, 1987, ASTRON ASTROPHYS SUP, V67, P483; Wright JT, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/160; Yang SC, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/3; ZAHN JP, 1977, ASTRON ASTROPHYS, V57, P383	45	169	169	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					589	U347		10.1038/nature14118	http://dx.doi.org/10.1038/nature14118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25539085	Green Submitted			2022-12-28	WOS:000348775000037
J	Huch, M; Gehart, H; van Boxtel, R; Hamer, K; Blokzijl, F; Verstegen, MMA; Ellis, E; van Wenum, M; Fuchs, SA; de Ligt, J; van de Wetering, M; Sasaki, N; Boers, SJ; Kemperman, H; de Jonge, J; Ijzermans, JNM; Nieuwenhuis, EES; Hoekstra, R; Strom, S; Vries, RRG; van der Laan, LJW; Cuppen, E; Clevers, H				Huch, Meritxell; Gehart, Helmuth; van Boxtel, Ruben; Hamer, Karien; Blokzijl, Francis; Verstegen, Monique M. A.; Ellis, Ewa; van Wenum, Martien; Fuchs, Sabine A.; de Ligt, Joep; van de Wetering, Marc; Sasaki, Nobuo; Boers, Susanne J.; Kemperman, Hans; de Jonge, Jeroen; Ijzermans, Jan N. M.; Nieuwenhuis, Edward E. S.; Hoekstra, Ruurdtje; Strom, Stephen; Vries, Robert R. G.; van der Laan, Luc J. W.; Cuppen, Edwin; Clevers, Hans			Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver	CELL			English	Article							IN-VITRO EXPANSION; COPY NUMBER; ALPHA-1-ANTITRYPSIN DEFICIENCY; ALAGILLE-SYNDROME; MOUSE MODEL; HEPATOCYTES; REGENERATION; LGR5; DIFFERENTIATION; IDENTIFICATION	Despite the enormous replication potential of the human liver, there are currently no culture systems available that sustain hepatocyte replication and/or function in vitro. We have shown previously that single mouse Lgr5+ liver stem cells can be expanded as epithelial organoids in vitro and can be differentiated into functional hepatocytes in vitro and in vivo. We now describe conditions allowing long-term expansion of adult bile duct-derived bipotent progenitor cells from human liver. The expanded cells are highly stable at the chromosome and structural level, while single base changes occur at very low rates. The cells can readily be converted into functional hepatocytes in vitro and upon transplantation in vivo. Organoids from alpha 1-antitrypsin deficiency and Alagille syndrome patients mirror the in vivo pathology. Clonal long-term expansion of primary adult liver stem cells opens up experimental avenues for disease modeling, toxicology studies, regenerative medicine, and gene therapy.	[Huch, Meritxell; Gehart, Helmuth; van Boxtel, Ruben; Hamer, Karien; Blokzijl, Francis; de Ligt, Joep; van de Wetering, Marc; Sasaki, Nobuo; Vries, Robert R. G.; Cuppen, Edwin; Clevers, Hans] Univ Med Ctr Utrecht, CancerGenom Nl, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Verstegen, Monique M. A.; de Jonge, Jeroen; Ijzermans, Jan N. M.; van der Laan, Luc J. W.] Erasmus MC Univ Med Ctr, Dept Surg, NL-3000 CA Rotterdam, Netherlands; [van Wenum, Martien; Hoekstra, Ruurdtje] Univ Amsterdam, Acad Med Ctr, Surg Lab, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Fuchs, Sabine A.; Boers, Susanne J.; Nieuwenhuis, Edward E. S.] Univ Med Ctr Utrecht, Div Pediat Gastroenterol, Wilhelmina Childrens Hosp, NL-3584 EA Utrecht, Netherlands; [Kemperman, Hans] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, NL-3584 EA Utrecht, Netherlands; [Strom, Stephen] Karolinska Inst, Div Pathol, Dept Lab Med, S-14186 Stockholm, Sweden; [Ellis, Ewa] Karolinska Inst, Karolinska Univ Hosp Huddinge, Unit Transplantat Surg, Dept CLINTEC, SE-14186 Stockholm, Sweden; [van de Wetering, Marc; Vries, Robert R. G.] Hubrecht Organoid Technol HUB, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Huch, M (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Wellcome Trust MRC Stem Cell Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	m.huch@gurdon.cam.ac.uk; h.clevers@hubrecht.eu	Sasaki, Nobuo/HDO-8251-2022; Cuppen, Edwin/H-2389-2016; Ellis, Ewa C S/D-5370-2014; Cuppen, Edwin/F-5696-2011; van der Laan, Luc/M-5495-2019	Sasaki, Nobuo/0000-0002-8798-7244; Cuppen, Edwin/0000-0002-0400-9542; Ellis, Ewa C S/0000-0002-3057-5337; Cuppen, Edwin/0000-0002-0400-9542; van der Laan, Luc/0000-0002-0651-5334; Gehart, Helmuth/0000-0002-9165-5824; van Boxtel, Ruben/0000-0003-1285-2836; de Ligt, Joep/0000-0002-0348-419X; de Jonge, Jeroen/0000-0002-1131-027X; Verstegen, Monique/0000-0001-9908-6673	Wellcome Trust; Royal Society [104151/Z/14/Z];  [EU/232814];  [116.005.002];  [93512003];  [EU/232814-StemCellMark];  [NWO/116002008]	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); ; ; ; ; 	We thank The Hubrecht Imaging Center for imaging assistance and the Genome Diagnostics laboratory of the UMC-Utrecht for help with the karyotype analysis. We also thank Lara Elshove, Herold Metselaar, Petra de Ruiter, and the Erasmus MC liver explantation student team for liver biopsies. The Rspo cell line was kindly provided by Calvin Kuo. This work was supported by grants to M.H., H.G., and K.H. (EU/232814 Stem Cell Mark), H.G. (SNF early Postdoc Mobility and EMBO Long-Term fellowship), R.v.B. (NWO/ZonMW 116.005.002), E.C. (NWO/ZonMW Zenith 93512003), and H.C. (The United European Gastroenterology Federation (UEGF) Research Prize 2010, EU/232814-StemCellMark and NWO/116002008). M.H. is a Wellcome Trust Sir Henry Dale Fellow and is jointly funded by the Wellcome Trust and the Royal Society (grant number 104151/Z/14/Z).	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bayart E, 2013, CURR GENE THER, V13, P73, DOI 10.2174/1566523211313020002; Bigorgne AE, 2014, J CLIN INVEST, V124, P328, DOI 10.1172/JCI71471; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Choi TY, 2014, GASTROENTEROLOGY, V146, P776, DOI 10.1053/j.gastro.2013.10.019; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Francis H, 2004, J HEPATOL, V41, P528, DOI 10.1016/j.jhep.2004.06.009; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Gramignoli R, 2012, CELL TRANSPLANT, V21, P1245, DOI 10.3727/096368911X600939; Gu DQ, 2002, TRANSPLANTATION, V73, P1818, DOI 10.1097/00007890-200206150-00020; Hattoum A, 2013, HUM PATHOL, V44, P743, DOI 10.1016/j.humpath.2012.07.018; He ZY, 2010, AM J PATHOL, V177, P1311, DOI 10.2353/ajpath.2010.091154; Heron M., 2012, NATL VITAL STAT REPO; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kamath BM, 2013, NAT REV NEPHROL, V9, P409, DOI 10.1038/nrneph.2013.102; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lawless MW, 2008, INT J BIOCHEM CELL B, V40, P1403, DOI 10.1016/j.biocel.2008.02.008; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; McCright B, 2002, DEVELOPMENT, V129, P1075; Michalopoulos GK, 2014, AM J PATHOL, V184, P1263, DOI 10.1016/j.ajpath.2014.02.020; Mitaka T, 1998, INT J EXP PATHOL, V79, P393, DOI 10.1046/j.1365-2613.1998.00083.x; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Sugimoto H, 2007, FASEB J, V21, P256, DOI 10.1096/fj.06-6837com; Vilarinho S, 2012, CELL, V150, P1096, DOI 10.1016/j.cell.2012.08.030; WANDEL C, 1994, BRIT J ANAESTH, V73, P658, DOI 10.1093/bja/73.5.658; Wiegerinck CL, 2014, GASTROENTEROLOGY, V147, P65, DOI 10.1053/j.gastro.2014.04.002; Wu AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017868; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Yoon SM, 2011, HEPATOLOGY, V53, P964, DOI 10.1002/hep.24122	54	835	873	16	200	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					299	312		10.1016/j.cell.2014.11.050	http://dx.doi.org/10.1016/j.cell.2014.11.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25533785	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000347923200026
J	Berkhemer, OA; Fransen, PSS; Beumer, D; van den Berg, LA; Lingsma, HF; Yoo, AJ; Schonewille, WJ; Vos, JA; Nederkoorn, PJ; Wermer, MJH; van Walderveen, MAA; Staals, J; Hofmeijer, J; van Oostayen, JA; Nijeholt, GJLA; Boiten, J; Brouwer, PA; Emmer, BJ; de Bruijn, SF; van Dijk, LC; Kappelle, LJ; Lo, RH; Van Dijk, EJ; de Vries, J; de Kort, PLM; van Rooij, WJJ; van den Berg, JSP; van Hasselt, BAAM; Aerden, LAM; Dallinga, RJ; Visser, MC; Bot, JCJ; Vroomen, PC; Eshghi, O; Schreuder, THCML; Heijboer, RJJ; Keizer, K; Tielbeek, AV; den Hertog, HM; Gerrits, DG; van den Berg-Vos, RM; Karas, GB; Steyerberg, EW; Flach, HZ; Marquering, HA; Sprengers, MES; Jenniskens, SFM; Beenen, LFM; van den Berg, R; Koudstaal, PJ; van Zwam, WH; Roos, YBWEM; van der Lugt, A; van Oostenbrugge, RJ; Majoie, CBLM; Dippel, DWJ				Berkhemer, O. A.; Fransen, P. S. S.; Beumer, D.; van den Berg, L. A.; Lingsma, H. F.; Yoo, A. J.; Schonewille, W. J.; Vos, J. A.; Nederkoorn, P. J.; Wermer, M. J. H.; van Walderveen, M. A. A.; Staals, J.; Hofmeijer, J.; van Oostayen, J. A.; Nijeholt, G. J. Lycklama A.; Boiten, J.; Brouwer, P. A.; Emmer, B. J.; de Bruijn, S. F.; van Dijk, L. C.; Kappelle, L. J.; Lo, R. H.; Van Dijk, E. J.; de Vries, J.; de Kort, P. L. M.; van Rooij, W. J. J.; van den Berg, J. S. P.; van Hasselt, B. A. A. M.; Aerden, L. A. M.; Dallinga, R. J.; Visser, M. C.; Bot, J. C. J.; Vroomen, P. C.; Eshghi, O.; Schreuder, T. H. C. M. L.; Heijboer, R. J. J.; Keizer, K.; Tielbeek, A. V.; den Hertog, H. M.; Gerrits, D. G.; van den Berg-Vos, R. M.; Karas, G. B.; Steyerberg, E. W.; Flach, H. Z.; Marquering, H. A.; Sprengers, M. E. S.; Jenniskens, S. F. M.; Beenen, L. F. M.; van den Berg, R.; Koudstaal, P. J.; van Zwam, W. H.; Roos, Y. B. W. E. M.; van der Lugt, A.; van Oostenbrugge, R. J.; Majoie, C. B. L. M.; Dippel, D. W. J.		MR CLEAN Investigators	A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOVASCULAR TREATMENT; CEREBRAL INFARCT; RECANALIZATION; OCCLUSIONS; THERAPY; SCORE	BACKGROUND In patients with acute ischemic stroke caused by a proximal intracranial arterial occlusion, intraarterial treatment is highly effective for emergency revascularization. However, proof of a beneficial effect on functional outcome is lacking. METHODS We randomly assigned eligible patients to either intraarterial treatment plus usual care or usual care alone. Eligible patients had a proximal arterial occlusion in the anterior cerebral circulation that was confirmed on vessel imaging and that could be treated intraarterially within 6 hours after symptom onset. The primary outcome was the modified Rankin scale score at 90 days; this categorical scale measures functional outcome, with scores ranging from 0 (no symptoms) to 6 (death). The treatment effect was estimated with ordinal logistic regression as a common odds ratio, adjusted for prespecified prognostic factors. The adjusted common odds ratio measured the likelihood that intraarterial treatment would lead to lower modified Rankin scores, as compared with usual care alone (shift analysis). RESULTS We enrolled 500 patients at 16 medical centers in the Netherlands (233 assigned to intraarterial treatment and 267 to usual care alone). The mean age was 65 years (range, 23 to 96), and 445 patients (89.0%) were treated with intravenous alteplase before randomization. Retrievable stents were used in 190 of the 233 patients (81.5%) assigned to intraarterial treatment. The adjusted common odds ratio was 1.67 (95% confidence interval [CI], 1.21 to 2.30). There was an absolute difference of 13.5 percentage points (95% CI, 5.9 to 21.2) in the rate of functional independence (modified Rankin score, 0 to 2) in favor of the intervention (32.6% vs. 19.1%). There were no significant differences in mortality or the occurrence of symptomatic intracerebral hemorrhage. CONCLUSIONS In patients with acute ischemic stroke caused by a proximal intracranial occlusion of the anterior circulation, intraarterial treatment administered within 6 hours after stroke onset was effective and safe. (Funded by the Dutch Heart Foundation and others; MR CLEAN Netherlands Trial Registry number, NTR1804, and Current Controlled Trials number, ISRCTN10888758.)	[Berkhemer, O. A.; Marquering, H. A.; Sprengers, M. E. S.; Beenen, L. F. M.; van den Berg, R.; Majoie, C. B. L. M.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [van den Berg, L. A.; Nederkoorn, P. J.; Roos, Y. B. W. E. M.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Marquering, H. A.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands; [Visser, M. C.] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Bot, J. C. J.] Vrije Univ Amsterdam Med Ctr, Dept Radiol, Amsterdam, Netherlands; [van den Berg-Vos, R. M.] Sint Lucas Andreas Hosp, Dept Neurol, Amsterdam, Netherlands; [Karas, G. B.] Sint Lucas Andreas Hosp, Dept Radiol, Amsterdam, Netherlands; [Berkhemer, O. A.; Fransen, P. S. S.; Beumer, D.; Koudstaal, P. J.; Dippel, D. W. J.] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Fransen, P. S. S.; Brouwer, P. A.; Emmer, B. J.; van der Lugt, A.] Erasmus Univ, Med Ctr, Dept Radiol, Rotterdam, Netherlands; [Lingsma, H. F.; Steyerberg, E. W.] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Beumer, D.; Staals, J.; van Oostenbrugge, R. J.] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands; [Beumer, D.; Staals, J.; van Oostenbrugge, R. J.] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [van Zwam, W. H.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Schonewille, W. J.] St Antonius Hosp, Dept Neurol, Nieuwegein, Netherlands; [Vos, J. A.] St Antonius Hosp, Dept Radiol, Nieuwegein, Netherlands; [Wermer, M. J. H.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [van Walderveen, M. A. A.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Hofmeijer, J.] Rijnstate Hosp, Dept Neurol, Arnhem, Netherlands; [van Oostayen, J. A.] Rijnstate Hosp, Dept Radiol, Arnhem, Netherlands; [Nijeholt, G. J. Lycklama A.] MC Haaglanden, Dept Radiol, The Hague, Netherlands; [Boiten, J.] MC Haaglanden, Dept Neurol, The Hague, Netherlands; [de Bruijn, S. F.] HAGA Hosp, Dept Neurol, The Hague, Netherlands; [van Dijk, L. C.] HAGA Hosp, Dept Radiol, The Hague, Netherlands; [Kappelle, L. J.] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands; [Kappelle, L. J.] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands; [Lo, R. H.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Van Dijk, E. J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [de Vries, J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, NL-6525 ED Nijmegen, Netherlands; [Jenniskens, S. F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands; [de Kort, P. L. M.] Sint Elisabeth Hosp, Dept Neurol, Tilburg, Netherlands; [van Rooij, W. J. J.] Sint Elisabeth Hosp, Dept Radiol, Tilburg, Netherlands; [van den Berg, J. S. P.] Isala Klin, Dept Neurol, Zwolle, Netherlands; [van Hasselt, B. A. A. M.; Flach, H. Z.] Isala Klin, Dept Radiol, Zwolle, Netherlands; [Aerden, L. A. M.] Reinier Graaf Gasthuis, Dept Neurol, Delft, Netherlands; [Dallinga, R. J.] Reinier Graaf Gasthuis, Dept Radiol, Delft, Netherlands; [Vroomen, P. C.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 AV Groningen, Netherlands; [Eshghi, O.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, NL-9713 AV Groningen, Netherlands; [Schreuder, T. H. C. M. L.] Atrium Med Ctr, Dept Neurol, Heerlen, Netherlands; [Heijboer, R. J. J.] Atrium Med Ctr, Dept Radiol, Heerlen, Netherlands; [Keizer, K.] Catharina Hosp, Dept Neurol, Eindhoven, Netherlands; [Tielbeek, A. V.] Catharina Hosp, Dept Radiol, Eindhoven, Netherlands; [den Hertog, H. M.] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands; [Gerrits, D. G.] Med Spectrum Twente, Dept Radiol, Enschede, Netherlands; [Yoo, A. J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Sint Lucas Andreas Hospital; Sint Lucas Andreas Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Maastricht University; Maastricht University; Maastricht University; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Rijnstate Hospital; Rijnstate Hospital; Haga Hospital; Haga Hospital; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Elisabeth-TweeSteden Ziekenhuis (ETZ); Elisabeth-TweeSteden Ziekenhuis (ETZ); Isala Clinics; Isala Clinics; Reinier de Graaf Hospital; Reinier de Graaf Hospital; University of Groningen; University of Groningen; Atrium Medical Center; Atrium Medical Center; Catharina Hospital; Catharina Hospital; Medical Spectrum Twente; Medical Spectrum Twente; Harvard University; Massachusetts General Hospital	Dippel, DWJ (corresponding author), Erasmus MC Univ Med Ctr, Dept Neurol H643, POB 2040, NL-3000 CA Rotterdam, Netherlands.	d.dippel@erasmusmc.nl	Emmer, Bart/AAA-2817-2021; Jenniskens, S.F.M./L-4415-2015; Roos, Yvo BWEM/B-9843-2013; van Dijk, Ewoud J/J-7951-2012; Beenen, Ludo F/AAA-3114-2021; Dippel, Diederik/AAJ-2192-2020; Demchuk, Andrew M/E-1103-2012	Beenen, Ludo F/0000-0001-9204-1026; Dippel, Diederik/0000-0002-9234-3515; Demchuk, Andrew M/0000-0002-4930-7789; Brouwer, Patrick A./0000-0003-0041-2833; Santos, Emilie/0000-0003-2153-1938; Venema, Esmee/0000-0003-1631-6635	Dutch Heart Foundation; AngioCare Covidien/ev3; Medac/Lamepro; Penumbra; Stryker; BALT; Toshiba; Codman/DePuy Synthes; Sequent Medical; Covidien/ev3; Alberta Innovates [201300690] Funding Source: researchfish	Dutch Heart Foundation(Netherlands Heart Foundation); AngioCare Covidien/ev3; Medac/Lamepro; Penumbra; Stryker; BALT; Toshiba; Codman/DePuy Synthes; Sequent Medical; Covidien/ev3; Alberta Innovates	Supported by the Dutch Heart Foundation and by unrestricted grants from AngioCare Covidien/ev3, Medac/Lamepro, and Penumbra.; Dr. Yoo reports receiving grant support from Penumbra; Dr. Brouwer, lecture fees and fees for trial management from Stryker, lecture fees and fees for proctoring from BALT, lecture fees from Toshiba, teaching fees and fees for research and development from Codman/DePuy Synthes, and teaching fees from Sequent Medical; Dr. de Vries, consulting fees from Stryker and grant support from Covidien/ev3; and Dr. Ren van den Berg, consulting fees from Codman/DePuy Synthes. No other potential conflict of interest relevant to this article was reported.	Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Beumer D, 2013, CEREBROVASC DIS, V35, P66; Boers AM, 2013, AM J NEURORADIOL, V34, P1522, DOI 10.3174/ajnr.A3463; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Christou I, 2001, INT ANGIOL, V20, P208; Ciccone A, 2013, NEW ENGL J MED, V368, P904, DOI 10.1056/NEJMoa1213701; Dorn F, 2012, CEREBROVASC DIS, V34, P70, DOI 10.1159/000338903; Emberson J, 2014, LANCET; Fiorelli M, 1999, STROKE, V30, P2280, DOI 10.1161/01.STR.30.11.2280; Fransen PSS, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-343; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Heldner MR, 2013, STROKE, V44, P1153, DOI 10.1161/STROKEAHA.111.000604; Hernandez AV, 2004, J CLIN EPIDEMIOL, V57, P454, DOI 10.1016/j.jclinepi.2003.09.014; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Khatri P, 2005, STROKE, V36, P2400, DOI 10.1161/01.STR.0000185698.45720.58; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Lee M, 2010, STROKE, V41, P932, DOI 10.1161/STROKEAHA.109.574335; Lima FO, 2014, JAMA NEUROL, V71, P151, DOI 10.1001/jamaneurol.2013.5007; MAHONEY F I, 1965, Md State Med J, V14, P61; Mehta B, 2013, J NEUROINTERV SURG, V5, P52, DOI 10.1136/neurintsurg-2012-010565; Nogueira RG, 2012, LANCET, V380, P1230; Ogawa A, 2007, STROKE, V38, P2633, DOI 10.1161/STROKEAHA.107.488551; Pereira VM, 2013, STROKE, V44, P2802, DOI 10.1161/STROKEAHA.113.001232; Saver JL, 2007, STROKE, V38, P3055, DOI 10.1161/STROKEAHA.107.488536; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WHITEHEAD J, 1994, STAT MED, V13, P871; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zaidat OO, 2013, STROKE, V44, P2650, DOI 10.1161/STROKEAHA.113.001972	29	4089	4298	18	425	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2015	372	1					11	20		10.1056/NEJMoa1411587	http://dx.doi.org/10.1056/NEJMoa1411587			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX7MU	25517348	Green Published			2022-12-28	WOS:000347100800005
J	Schaefer, HF				Schaefer, Henry F.			Paul von Rague Schleyer (1930-2014)	NATURE			English	Biographical-Item									Univ Georgia, Ctr Computat Chem, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Schaefer, HF (corresponding author), Univ Georgia, Ctr Computat Chem, Athens, GA 30602 USA.	ccq@uga.edu						SCHLEYER PV, PUBLICATION LIST	1	3	3	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					22	22		10.1038/517022a	http://dx.doi.org/10.1038/517022a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25557708	Bronze			2022-12-28	WOS:000347178400022
J	Johnston, A; Bailey, M; Horne, S				Johnston, Andrew; Bailey, Mark; Horne, Simon			Operation Gritrock: Christmas bulletin from UK army medics in Sierra Leone	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Johnston, Andrew] Queen Elizabeth Hosp, Royal Ctr Def Med, Birmingham, W Midlands, England; [Johnston, Andrew; Bailey, Mark] Royal Army Med Corps, Camberley, England	Royal Centre for Defence Medicine; University of Birmingham	Johnston, A (corresponding author), Queen Elizabeth Hosp, Royal Ctr Def Med, Birmingham, W Midlands, England.	ebolaintensivist@gmail.com	Johnston, Andy/GOK-2428-2022; Horne, Simon/AAB-4064-2019	Horne, Simon/0000-0002-5098-7996; Johnston, Andrew McDonald/0000-0002-0220-0589					0	2	2	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2014	349								g7721	10.1136/bmj.g7721	http://dx.doi.org/10.1136/bmj.g7721			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY2UJ	25538094	Green Published, Bronze			2022-12-28	WOS:000347444200001
J	Hawkes, N				Hawkes, Nigel			CHRISTMAS 2014: MEDIA STUDIES Doctors: caring extroverts or self deluded chocoholics?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2014	349								g7623	10.1136/bmj.g7623	http://dx.doi.org/10.1136/bmj.g7623			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX3EE	25524024				2022-12-28	WOS:000346822400006
J	Nelson, BA; Kaplan, JL; El Saleeby, CM; Lu, MT; Mark, EJ				Nelson, Benjamin A.; Kaplan, Jess L.; El Saleeby, Chadi M.; Lu, Michael T.; Mark, Eugene J.			Case 39-2014: A 9-Year-Old Girl with Crohn's Disease and Pulmonary Nodules	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; WEGENERS-GRANULOMATOSIS; LUNG LESIONS; PATIENT; AZATHIOPRINE; CHILDREN; BIOPSY		[Nelson, Benjamin A.; Kaplan, Jess L.; El Saleeby, Chadi M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Lu, Michael T.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mark, Eugene J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Nelson, Benjamin A.; Kaplan, Jess L.; El Saleeby, Chadi M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Lu, Michael T.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mark, Eugene J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Nelson, BA (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.			Lu, Michael/0000-0003-4696-9610				Baddley JW, 2011, EMERG INFECT DIS, V17, P1664, DOI 10.3201/eid1709.101987; Boiselle PM, 1997, AM J ROENTGENOL, V169, P661, DOI 10.2214/ajr.169.3.9275873; CAMUS P, 1993, MEDICINE, V72, P151; Casey MB, 2003, AM J SURG PATHOL, V27, P213, DOI 10.1097/00000478-200302000-00010; Codish S, 2000, ISRAEL MED ASSOC J, V2, P630; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Dalal BH, 2009, CHEST, V136, p40S; Faller M, 2000, RESPIRATION, V67, P459, DOI 10.1159/000029550; Fried B, 2010, PARASITOL RES, V106, P1263, DOI 10.1007/s00436-010-1807-0; Golpe R, 2003, RESPIRATION, V70, P306, DOI 10.1159/000072015; HEATLEY RV, 1982, Q J MED, V51, P241; Herrlinger KR, 2002, AM J GASTROENTEROL, V97, P377; Izzedine H, 2001, NEPHROL DIAL TRANSPL, V16, P1511, DOI 10.1093/ndt/16.7.1511; Kandiel A, 2005, GUT, V54, P1121, DOI 10.1136/gut.2004.049460; Krishnan S, 2006, PEDIATRICS, V117, P1440, DOI 10.1542/peds.2005-1559; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; PATWARDHAN RV, 1983, ARCH INTERN MED, V143, P94, DOI 10.1001/archinte.143.1.94; Sanjeevi A, 2003, AM J GASTROENTEROL, V98, P941; SINGH G, 1989, ARTHRITIS RHEUM, V32, P837; STANLEY JH, 1987, RADIOLOGY, V162, P389, DOI 10.1148/radiology.162.2.3797651; Tzanakis N, 1998, RESP MED, V92, P516, DOI 10.1016/S0954-6111(98)90301-8; Vaszar LT, 2014, AM J SURG PATHOL, V38, P354, DOI 10.1097/PAS.0000000000000135; WALLAERT B, 1985, NEW ENGL J MED, V312, P444; Warwick G, 2009, EUR RESPIR REV, V18, P47, DOI 10.1183/09059180.00011114	24	11	11	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2418	2427		10.1056/NEJMcpc1410938	http://dx.doi.org/10.1056/NEJMcpc1410938			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW7DX	25517709				2022-12-28	WOS:000346425800013
J	Bekelman, JE; Sylwestrzak, G; Barron, J; Liu, JA; Epstein, AJ; Freedman, G; Malin, J; Emanuel, EJ				Bekelman, Justin E.; Sylwestrzak, Gosia; Barron, John; Liu, Jinan; Epstein, Andrew J.; Freedman, Gary; Malin, Jennifer; Emanuel, Ezekiel J.			Uptake and Costs of Hypofractionated vs Conventional Whole Breast Irradiation After Breast Conserving Surgery in the United States, 2008-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RADIOTHERAPY HYPOFRACTIONATION; UK STANDARDIZATION; RADIATION-THERAPY; CANCER; FRACTIONATION; TRIAL; WOMEN; MASTECTOMY	IMPORTANCE Based on randomized evidence, expert guidelines in 2011 endorsed shorter, hypofractionated whole breast irradiation (WBI) for selected patients with early-stage breast cancer and permitted hypofractionated WBI for other patients. OBJECTIVES To examine the uptake and costs of hypofractionated WBI among commercially insured patients in the United States. DESIGN, SETTING, AND PARTICIPANTS Retrospective, observational cohort study, using administrative claims data from 14 commercial health care plans covering 7.4% of US adult women in 2013, we classified patients with incident early-stage breast cancer treated with lumpectomy and WBI from 2008 and 2013 into 2 cohorts: (1) the hypofractionation-endorsed cohort (n = 8924) included patients aged 50 years or older without prior chemotherapy or axillary lymph node involvement and (2) the hypofractionation-permitted cohort (n = 6719) included patients younger than 50 years or those with prior chemotherapy or axillary lymph node involvement. EXPOSURES Hypofractionated WBI (3-5 weeks of treatment) vs conventional WBI (5-7 weeks of treatment). MAIN OUTCOMES AND MEASURES Use of hypofractionated and conventional WBI, total and radiotherapy-related health care expenditures, and patient out-of-pocket expenses. Patient and clinical characteristics included year of treatment, age, comorbid disease, prior chemotherapy, axillary lymph node involvement, intensity-modulated radiotherapy, practice setting, and other contextual variables. RESULTS Hypofractionated WBI increased from 10.6% (95% Cl, 8.8%-12.5%) in 2008 to 34.5% (95% Cl, 32.2%-36.8%) in 2013 in the hypofractionation-endorsed cohort and from 8.1% (95% Cl, 6.0%-10.2%) in 2008 to 21.2% (95% Cl, 18.9%-23.6%) in 2013 in the hypofractionation-permitted cohort. Adjusted mean total health care expenditures in the 1 year after diagnosis were $28 747 for hypofractionated and $31 641 for conventional WBI in the hypofractionation-endorsed cohort (difference, $2894; 95% Cl, $1610-$4234; P < .001) and $64 273 for hypofractionated and $72 860 for conventional WBI in the hypofractionation-permitted cohort (difference, $8587; 95% Cl, $5316-$12 017; P < .001). Adjusted mean total 1-year patient out-of-pocket expenses were not significantly different between hypofractionated vs conventional WBlin either cohort. CONCLUSIONS AND RELEVANCE Hypofractionated WBI after breast conserving surgery increased among women with early-stage breast cancer in 14 US commercial health care plans between 2008 and 2013. However, only 34.5% of patients with hypofractionation-endorsed and 21.2% with hypofractionation-permitted early-stage breast cancer received hypofractionated WBI in 2013.	[Bekelman, Justin E.; Freedman, Gary] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Bekelman, Justin E.; Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Bekelman, Justin E.; Epstein, Andrew J.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Sylwestrzak, Gosia; Barron, John; Liu, Jinan] HealthCore, Wilmington, DE USA; [Epstein, Andrew J.] Univ Penn, Div Gen Internal Med, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Epstein, Andrew J.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Malin, Jennifer] WellPoint Inc, Indianapolis, IN USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Bekelman, JE (corresponding author), Univ Penn, Perelman Ctr Adv Med, Dept Radiat Oncol, Perelman Sch Med, 3400 Civ Ctr Blvd,4 West, Philadelphia, PA 19104 USA.	bekelman@uphs.upenn.edu		Epstein, Andrew/0000-0001-5078-6564	National Cancer Institute [K07-CA163616]; WellPoint; NATIONAL CANCER INSTITUTE [K07CA163616] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); WellPoint; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Bekelman received support from grant K07-CA163616 from the National Cancer Institute. WellPoint provided funds to support research at HealthCore, a wholly-owned WellPoint subsidiary.	[Anonymous], AR HLTH RES FIL AHRF; Ashworth A, 2013, INT J RADIAT ONCOL, V86, P51, DOI 10.1016/j.ijrobp.2012.12.015; Bekelman JE, 2013, JAMA-J AM MED ASSOC, V310, P1501, DOI 10.1001/jama.2013.277081; Bentzen SM, 2008, LANCET, V371, P1098, DOI 10.1016/S0140-6736(08)60348-7; Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI [10.1016/S1470-2045(08)70077-9, 10.1016/S1470-2045(08)60348-7]; Clark JM, 2010, POPUL HEALTH MANAG, V13, P201, DOI 10.1089/pop.2009.0051; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dorn PL, 2012, INT J RADIAT ONCOL, V83, P79, DOI 10.1016/j.ijrobp.2011.05.074; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Gold HT, 2007, HEALTH SERV RES, V42, P2056, DOI 10.1111/j.1475-6773.2007.00705.x; Habermann EB, 2010, J CLIN ONCOL, V28, P3437, DOI 10.1200/JCO.2009.27.6774; Harnett A, 2010, BREAST, V19, P159, DOI 10.1016/j.breast.2010.03.029; Haviland JS, 2013, LANCET ONCOL, V14, P1086, DOI 10.1016/S1470-2045(13)70386-3; Hoopes DJ, 2012, INT J RADIAT ONCOL, V82, P674, DOI 10.1016/j.ijrobp.2010.11.077; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Nicholson S, 2006, HEALTH ECON, V15, P111, DOI 10.1002/hec.1052; Owen JR, 2006, LANCET ONCOL, V7, P467, DOI 10.1016/S1470-2045(06)70699-4; Prabhakar R, 2007, AUSTRALAS PHYS ENG S, V30, P42, DOI 10.1007/BF03178408; Smith BD, 2011, INT J RADIAT ONCOL, V81, P59, DOI 10.1016/j.ijrobp.2010.04.042; Smith BD, 2011, JNCI-J NATL CANCER I, V103, P798, DOI 10.1093/jnci/djr100; Smith GL, 2012, JAMA-J AM MED ASSOC, V307, P1827, DOI 10.1001/jama.2012.3481; Smith Grace L, 2010, Epidemiol Perspect Innov, V7, P1, DOI 10.1186/1742-5573-7-1; Warren JL, 2008, J NATL CANCER I, V100, P888, DOI 10.1093/jnci/djn175; Whelan T, 2002, J NATL CANCER I, V94, P1143; Whelan TJ, 2010, NEW ENGL J MED, V362, P513, DOI 10.1056/NEJMoa0906260; Yarnold J, 2005, RADIOTHER ONCOL, V75, P9, DOI 10.1016/j.radonc.2005.01.005; Yarnold J, 2011, INT J RADIAT ONCOL, V79, P1, DOI 10.1016/j.ijrobp.2010.08.035	27	165	166	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2542	2550		10.1001/jama.2014.16616	http://dx.doi.org/10.1001/jama.2014.16616			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25494006	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000346346900017
J	Huang, H; Li, XY; Zhu, J; Ye, S; Zhang, HY; Wang, W; Wu, XY; Peng, JW; Xu, B; Lin, YC; Cao, YB; Li, HR; Lin, SX; Liu, Q; Lin, TY				Huang, He; Li, Xueying; Zhu, Jun; Ye, Sheng; Zhang, Hongyu; Wang, Wei; Wu, Xiangyuan; Peng, Jiewen; Xu, Bing; Lin, Yingcheng; Cao, Yabing; Li, Haoran; Lin, Suxia; Liu, Qing; Lin, Tongyu			Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEROPOSITIVE CANCER-PATIENTS; NON-HODGKINS-LYMPHOMA; HBV REACTIVATION; ELDERLY-PATIENTS; HIGH PREVALENCE; PROPHYLACTIC LAMIVUDINE; CYTOTOXIC CHEMOTHERAPY; PREEMPTIVE LAMIVUDINE; PLUS RITUXIMAB; DES-LYMPHOMES	IMPORTANCE Hepatitis B virus (HBV) reactivation is a serious complication for patients with lymphoma treated with rituximab-containing chemotherapies, despite lamivudine prophylaxis treatment. An optimal prophylactic antiviral protocol has not been determined. OBJECTIVE To compare the efficacy of entecavir and lamivudine in preventing HBV reactivation in patients seropositive for the hepatitis B surface antigen with untreated diffuse large B-cell lymphoma receiving chemotherapy treatment with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). DESIGN, SETTING, AND PATIENTS Randomized, open-label, phase 3 study conducted from February 2008 through December 2012 at 10 medical centers in China. This study was a substudy of a parent study designed to compare a 3-week with a 2-week R-CHOP chemotherapy regimen for untreated diffuse large B-cell lymphoma. Patients enrolled in the parent study who were seropositive for the hepatitis B surface antigen and had normal liver function, serum HBV DNA levels of less than 10(3) copies/mL, and no prior antiviral therapy were randomized to entecavir (n = 61) or lamivudine (n = 60). INTERVENTIONS Daily entecavir (0.5 mg) or lamivudine (100 mg) beginning 1week before the initiation of R-CHOP treatment to 6 months after completion of chemotherapy. MAIN OUTCOMES AND MEASURES The primary efficacy end point was the incidence of HBV-related hepatitis. The secondary end points included rates of HBV reactivation, chemotherapy disruption due to hepatitis, and treatment-related adverse events. RESULTS The date of last patient follow-up was May 25, 2013. Incidence of HBV-related hepatitis was significantly lower for the entecavir group vs the lamivudine group. [GRAPHICS] CONCLUSIONS AND RELEVANCE Among patients seropositive for the hepatitis B surface antigen with diffuse large B-cell lymphoma undergoing R-CHOP chemotherapy, the addition of entecavir compared with lamivudine resulted in a lower incidence of HBV-related hepatitis and HBV reactivation. If replicated, these findings support the use of entecavir in these patients.	[Huang, He; Li, Xueying; Li, Haoran; Lin, Tongyu] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R China; [Zhu, Jun] Beijing Canc Hosp, Dept Med Oncol, Beijing, Peoples R China; [Ye, Sheng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R China; [Zhang, Hongyu] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Med Oncol, Zhuhai, Peoples R China; [Wang, Wei] First Peoples Hosp Foshan, Ctr Canc, Foshan, Peoples R China; [Wu, Xiangyuan] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R China; [Peng, Jiewen] Peoples Hosp Zhongshan, Ctr Canc, Zhongshan, Peoples R China; [Xu, Bing] Southern Med Univ, Dept Hematol, Southern Hosp, Guangzhou, Guangdong, Peoples R China; [Lin, Yingcheng] Shantou Univ, Coll Med, Dept Med Oncol, Canc Hosp, Shantou, Peoples R China; [Cao, Yabing] Kiang Wu Hosp, Ctr Canc, Macau, Peoples R China; [Lin, Suxia] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510060, Guangdong, Peoples R China; [Liu, Qing] Sun Yat Sen Univ, Dept Epidemiol & Biostat, Dept Pathol, Guangzhou 510060, Guangdong, Peoples R China	Sun Yat Sen University; Peking University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China; Shantou University; Sun Yat Sen University; Sun Yat Sen University	Lin, TY (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, 651 Dongfeng Rd E, Guangzhou 510060, Guangdong, Peoples R China.	tongyulin@hotmail.com	Cao, Yabing/X-1168-2018		Foundation of 5010 Clinical Trials of Sun Yat-sen University	Foundation of 5010 Clinical Trials of Sun Yat-sen University	This study was supported by a grant from the Foundation of 5010 Clinical Trials of Sun Yat-sen University.	Cancer Therapy Evaluation Program, 2006, COMM TERM CRIT ADV E; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chen MH, 2008, ANN HEMATOL, V87, P475, DOI 10.1007/s00277-008-0469-9; Cil T, 2008, LEUKEMIA LYMPHOMA, V49, P939, DOI 10.1080/10428190801975568; Coiffier B, 2005, J CLIN ONCOL, V23, P6387, DOI 10.1200/JCO.2005.05.015; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Coiffier B, 2010, BLOOD, V116, P2040, DOI 10.1182/blood-2010-03-276246; Dai MS, 2004, ANN HEMATOL, V83, P769, DOI 10.1007/s00277-004-0899-y; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Evens AM, 2011, ANN ONCOL, V22, P1170, DOI 10.1093/annonc/mdq583; Feugier P, 2005, J CLIN ONCOL, V23, P4117, DOI 10.1200/JCO.2005.09.131; Hsu CH, 2004, ANTICANCER RES, V24, P3035; Hsu C, 2008, HEPATOLOGY, V47, P844, DOI 10.1002/hep.22106; Huang YH, 2013, J CLIN ONCOL, V31, P2765, DOI 10.1200/JCO.2012.48.5938; Idilman R, 2004, J VIRAL HEPATITIS, V11, P141, DOI 10.1046/j.1365-2893.2003.00479.x; Kang J, 2011, ANN HEMATOL, V90, P159, DOI 10.1007/s00277-010-1055-5; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lau GKK, 2003, GASTROENTEROLOGY, V125, P1742, DOI 10.1053/j.gastro.2003.09.026; Lee GW, 2003, J KOREAN MED SCI, V18, P849, DOI 10.3346/jkms.2003.18.6.849; Li HR, 2011, J VIRAL HEPATITIS, V18, P877, DOI 10.1111/j.1365-2893.2010.01386.x; Lim LL, 2002, ALIMENT PHARM THER, V16, P1939, DOI 10.1046/j.1365-2036.2002.01364.x; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; LOK ASF, 1991, GASTROENTEROLOGY, V100, P182, DOI 10.1016/0016-5085(91)90599-G; Long MJ, 2011, BREAST CANCER RES TR, V127, P705, DOI 10.1007/s10549-011-1455-9; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Marcucci F, 2006, HAEMATOLOGICA, V91, P554; National Comprehensive Cancer Network, 2013, PREV TREATM CANC REL; Park SC, 2008, J MED VIROL, V80, P960, DOI 10.1002/jmv.21168; Pei SN, 2010, ANN HEMATOL, V89, P255, DOI 10.1007/s00277-009-0806-7; Pfreundschuh M, 2008, LANCET ONCOL, V9, P105, DOI 10.1016/S1470-2045(08)70002-0; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Takai S, 2005, EUR J HAEMATOL, V74, P158, DOI 10.1111/j.1600-0609.2004.00376.x; Wang F, 2007, CANCER-AM CANCER SOC, V109, P1360, DOI 10.1002/cncr.22549; Yeo W, 2004, J CLIN ONCOL, V22, P927, DOI 10.1200/JCO.2004.05.161; Yeo W, 2004, BRIT J CANCER, V90, P1306, DOI 10.1038/sj.bjc.6601699; Yeo W, 2003, J MED VIROL, V70, P553, DOI 10.1002/jmv.10430; Yeo W, 2000, J MED VIROL, V62, P299, DOI 10.1002/1096-9071(200011)62:3&lt;299::AID-JMV1&gt;3.0.CO;2-0; Yeo WN, 2009, J CLIN ONCOL, V27, P605, DOI 10.1200/JCO.2008.18.0182	38	130	133	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2521	2530		10.1001/jama.2014.15704	http://dx.doi.org/10.1001/jama.2014.15704			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25514302	Bronze			2022-12-28	WOS:000346346900015
J	Burden, ACF				Burden, A. C. Felix			Pooled RCTs: BP-lowering drugs reduced major CV events; absolute reductions were greater with higher baseline risk Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HYPERTENSION		Sandwell & West Birmingham Clin Commissioning Grp, Sandwell West Birmingh, England		Burden, ACF (corresponding author), Sandwell & West Birmingham Clin Commissioning Grp, Sandwell West Birmingh, England.		Burden, Felix/AAE-9711-2020; Sundström, Johan/A-6286-2009; Sundstrom, Johan/R-2139-2019	Sundström, Johan/0000-0003-2247-8454; Sundstrom, Johan/0000-0003-2247-8454; Burden, Andrew/0000-0001-8764-376X				Krause T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4891; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Verdecchia P, 2014, LANCET, V384, P562, DOI 10.1016/S0140-6736(14)61334-9	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12							JC5	10.7326/0003-4819-161-12-201412160-02005	http://dx.doi.org/10.7326/0003-4819-161-12-201412160-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UW	25506877				2022-12-28	WOS:000347248400010
J	Watts, G				Watts, Geoff			Peter Orchard Williams Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2104	2104		10.1016/S0140-6736(14)62363-1	http://dx.doi.org/10.1016/S0140-6736(14)62363-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BK	25517005				2022-12-28	WOS:000346354300014
J	McGuire, AT; Dreyer, AM; Carbonetti, S; Lippy, A; Glenn, J; Scheid, JF; Mouquet, H; Stamatatos, L				McGuire, Andrew T.; Dreyer, Anita M.; Carbonetti, Sara; Lippy, Adriana; Glenn, Jolene; Scheid, Johannes F.; Mouquet, Hugo; Stamatatos, Leonidas			Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies	SCIENCE			English	Article							B-CELL RECEPTORS; STRUCTURAL BASIS; EPITOPE; DESIGN; BINDING; VIRUS; GP120; LINES; SITE	Some HIV-infected individuals develop broadly neutralizing antibodies (bNAbs), whereas most develop antibodies that neutralize only a narrow range of viruses (nNAbs). bNAbs, but not nNAbs, protect animals from experimental infection and are likely a key component of an effective vaccine. nNAbs and bNAbs target the same regions of the viral envelope glycoprotein (Env), but for reasons that remain unclear only nNAbs are elicited by Env immunization. We show that in contrast to germline-reverted (gl) bNAbs, glnNAbs recognized diverse recombinant Envs. Moreover, owing to binding affinity differences, nNAb B cell progenitors had an advantage in becoming activated and internalizing Env compared with bNAb B cell progenitors. We then identified an Env modification strategy that minimized the activation of nNAb B cells targeting epitopes that overlap those of bNAbs.	[McGuire, Andrew T.; Dreyer, Anita M.; Carbonetti, Sara; Lippy, Adriana; Glenn, Jolene; Stamatatos, Leonidas] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Scheid, Johannes F.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Mouquet, Hugo] Inst Pasteur, Dept Immunol, Lab Humoral Response Pathogens, F-75015 Paris, France; [Mouquet, Hugo] CNRS, URA 1961, F-75015 Paris, France; [Stamatatos, Leonidas] Univ Washington, Dept Global Hlth, Seattle, WA 98109 USA	Center for Infectious Disease Research; Rockefeller University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Washington; University of Washington Seattle	Stamatatos, L (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.	lstamata@fhcrc.org	Mouquet, Hugo/M-2750-2014	Mouquet, Hugo/0000-0002-4230-610X; McGuire, Andrew/0000-0003-1841-6859	NIH [P01 AI094419-01, U19 19AI109632-01]; Canadian Institutes of Health Research; Swiss National Science Foundation [PBBSP3_144245, P300P3_151140]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109632, P01AI094419] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Nussenzweig for providing the nNAb antibody expression plasmids, J. Mascola and X. Wu for providing the IgG1 glVRC01 antibody, D. Rawlings for providing the pRRL expression plasmids, and L. Scharf and P. Bjorkman for technical assistance. The data presented in this paper are found in the main paper and in the supplementary materials. Accession numbers for the mutated and germline-reverted nNAbs used in this study can be found at GenBank: KM595240-KM595271. This work was supported by NIH grants P01 AI094419-01 and U19 19AI109632-01 (L.S.), Canadian Institutes of Health Research fellowship (A.T.M), and Swiss National Science Foundation fellowship PBBSP3_144245 and P300P3_151140 (A.M.D.).	Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Changela A, 2011, J VIROL, V85, P2524, DOI 10.1128/JVI.02335-10; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doores KJ, 2013, J VIROL, V87, P2234, DOI 10.1128/JVI.02820-12; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Huber M, 2010, J VIROL, V84, P10700, DOI 10.1128/JVI.01111-10; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; McGuire AT, 2014, J VIROL, V88, P2645, DOI 10.1128/JVI.03228-13; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; Ota T, 2012, J IMMUNOL, V189, P4816, DOI 10.4049/jimmunol.1202165; Robinson JE, 2010, J VIROL, V84, P3443, DOI 10.1128/JVI.02617-09; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Xiao XD, 2009, VIRUSES-BASEL, V1, P802, DOI 10.3390/v1030802; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	30	89	92	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1380	1383		10.1126/science.1259206	http://dx.doi.org/10.1126/science.1259206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504724	Green Accepted			2022-12-28	WOS:000346189600055
J	Bauman, A; Gale, J; Milton, K				Bauman, Adrian; Gale, Joanne; Milton, Karen			CHRISTMAS 2014: GOING TO EXTREMES Are "armchair socialists" still sitting? Cross sectional study of political affiliation and physical activity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACTIVITY QUESTIONNAIRE	Objective To examine the validity of the concept of left wing "armchair socialists" and whether they sit more and move less than their right wing and centrist counterparts. Design Secondary analysis of Eurobarometer data from 32 European countries. Setting The study emanated from the authors' sit-stand desks (rather than from their armchairs). Participants Total of 29 193 European adults, of whom 1985 were left wing, 1902 right wing, 17 657 political centrists, and 7649 politically uncommitted. Main outcome measures Self-reported political affiliation, physical activity, and total daily sitting time. Methods Linear models were used to examine the relation between physical activity, sitting time, and reported political affiliation. Results The findings refute the existence of an "armchair socialist"; people at the extremes of both ends of the political spectrum were more physically active, with the right wing reporting 62.2 more weekly minutes of physical activity (95% confidence interval 23.9 to 100.5), and the left wing 57.8 more minutes (20.6 to 95.1) than those in the political centre. People with right wing political affiliations reported 12.8 minutes less time sitting a day (3.8 to 21.9) than the centrists. It is those sitting in the middle (politically) that are moving less, and possibly sitting more, both on the fence and elsewhere, making them a defined at-risk group. Conclusions There is little evidence to support the notion of armchair socialists, as they are more active than the mainstream in the political centre. Encouraging centrists to adopt stronger political views may be an innovative approach to increasing their physical activity, potentially benefiting population health.	[Bauman, Adrian; Gale, Joanne; Milton, Karen] Univ Sydney, Prevent Res Collaborat, Sch Publ Hlth, Charles Perkins Ctr D17, Sydney, NSW 2006, Australia	University of Sydney	Bauman, A (corresponding author), Univ Sydney, Prevent Res Collaborat, Sch Publ Hlth, Charles Perkins Ctr D17, Level 6 Hub, Sydney, NSW 2006, Australia.	adrian.bauman@sydney.edu.au		Milton, Karen/0000-0002-0506-2214				Bauman AE, 2013, CURR CARDIOVASC RISK, V7, P293, DOI 10.1007/s12170-013-0316-y; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Papacostas A, 2005, EUR 64 3 FOR LANG BI; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Rosenberg DE, 2008, J PHYS ACT HEALTH, V5, pS30, DOI 10.1123/jpah.5.s1.s30; Streeck W., 2001, ORIGINS NONLIBERAL C; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	8	2	2	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2014	349								g7073	10.1136/bmj.g7073	http://dx.doi.org/10.1136/bmj.g7073			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3DK	25500112	Green Published, hybrid			2022-12-28	WOS:000346165500001
J	Schilt, A; Brook, EJ; Bauska, TK; Baggenstos, D; Fischer, H; Joos, F; Petrenko, VV; Schaefer, H; Schmitt, J; Severinghaus, JP; Spahni, R; Stocker, TF				Schilt, Adrian; Brook, Edward J.; Bauska, Thomas K.; Baggenstos, Daniel; Fischer, Hubertus; Joos, Fortunat; Petrenko, Vasilii V.; Schaefer, Hinrich; Schmitt, Jochen; Severinghaus, Jeffrey P.; Spahni, Renato; Stocker, Thomas F.			Isotopic constraints on marine and terrestrial N2O emissions during the last deglaciation	NATURE			English	Article							ATMOSPHERIC NITROUS-OXIDE; ICE CORE; METHANE EMISSIONS; FIRN AIR; MODEL; VEGETATION; RECORDS; PREINDUSTRIAL; HOLOCENE; SURFACE	Nitrous oxide (N2O) is an important greenhouse gas and ozone-depleting substance that has anthropogenic as well as natural marine and terrestrial sources(1). The tropospheric N2O concentrations have varied substantially in the past in concert with changing climate on glacial-interglacial and millennial timescales(2-8). It is not well understood, however, how N2O emissions from marine and terrestrial sources change in response to varying environmental conditions. The distinct isotopic compositions of marine and terrestrial N2O sources can help disentangle the relative changes in marine and terrestrial N2O emissions during past climate variations(4,9,10). Here we present N2O concentration and isotopic data for the last deglaciation, from 16,000 to 10,000 years before present, retrieved from air bubbles trapped in polar ice at Taylor Glacier, Antarctica. With the help of our data and a box model of the N2O cycle, we find a 30 per cent increase in total N2O emissions from the late glacial to the interglacial, with terrestrial and marine emissions contributing equally to the overall increase and generally evolving in parallel over the last deglaciation, even though there is no a priori connection between the drivers of the two sources. However, we find that terrestrial emissions dominated on centennial timescales, consistent with a state-of-the-art dynamic global vegetation and land surface process model that suggests that during the last deglaciation emission changes were strongly influenced by temperature and precipitation patterns over land surfaces. The results improve our understanding of the drivers of natural N2O emissions and are consistent with the idea that natural N2O emissions will probably increase in response to anthropogenic warming(11).	[Schilt, Adrian; Brook, Edward J.; Bauska, Thomas K.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Schilt, Adrian; Fischer, Hubertus; Joos, Fortunat; Schmitt, Jochen; Spahni, Renato; Stocker, Thomas F.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Schilt, Adrian; Fischer, Hubertus; Joos, Fortunat; Schmitt, Jochen; Spahni, Renato; Stocker, Thomas F.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Baggenstos, Daniel; Severinghaus, Jeffrey P.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA; [Petrenko, Vasilii V.] Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; [Schaefer, Hinrich] Natl Inst Water & Atmospher Res, Wellington 6021, New Zealand	Oregon State University; University of Bern; University of Bern; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Rochester; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Schilt, A (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	adrian.schilt@gmail.com	Joos, Fortunat/B-4118-2018; Schmitt, Jochen/B-7893-2009; Fischer, Hubertus/A-1211-2014; Brook, Edward/AAB-7807-2021; Baggenstos, Daniel/AAK-5751-2021	Joos, Fortunat/0000-0002-9483-6030; Schmitt, Jochen/0000-0003-4695-3029; Fischer, Hubertus/0000-0002-2787-4221; Baggenstos, Daniel/0000-0001-9756-6884; Petrenko, Vasilii/0000-0002-0263-8759; Schilt, Adrian/0000-0001-6312-7947; Bauska, Thomas/0000-0003-1901-0367; Schaefer, Hinrich/0000-0002-1163-2818	Swiss National Science Foundation (NSF); US NSF; Swiss NSF [139404]; US NSF [PLR08-38936, PLR08-39031]; Marsden Fund Council from New Zealand Government; US Department of Energy; National Center for Atmospheric Research Supercomputing Facility	Swiss National Science Foundation (NSF)(Swiss National Science Foundation (SNSF)); US NSF(National Science Foundation (NSF)); Swiss NSF(Swiss National Science Foundation (SNSF)); US NSF(National Science Foundation (NSF)); Marsden Fund Council from New Zealand Government(Royal Society of New ZealandMarsden Fund (NZ)); US Department of Energy(United States Department of Energy (DOE)); National Center for Atmospheric Research Supercomputing Facility	Financial support was provided by the Swiss National Science Foundation (NSF) and the US NSF, including a Swiss NSF Fellowship for Prospective Researchers (139404) to A.S., US NSF Grant PLR08-38936 to E.J.B. and US NSF Grant PLR08-39031 to J.P.S. Further support came from the Marsden Fund Council from New Zealand Government funding, administered by the Royal Society of New Zealand. We thank C. Buizert, X. Fain, J. Lee, L. Mitchell and P. Rose for fieldwork, R. Roth for providing the Bern3D Earth System Model run, J. Schwander for providing the NEEM firn air cylinder, S. Jaccard for comments and A. Ross for lab assistance. We thank B. Otto-Bliesner and Z. Liu for providing climate data from the TraCE-21ka model computation, which was carried out at the Oak Ridge Leadership Computational Facility, sponsored by the US Department of Energy, and the National Center for Atmospheric Research Supercomputing Facility, sponsored by the US NSF. The TraCE-21ka project was supported by the US NSF and the US Department of Energy.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bauska TK, 2014, ATMOS MEAS TECH, V7, P3825, DOI 10.5194/amt-7-3825-2014; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Bernard S, 2006, ATMOS CHEM PHYS, V6, P493, DOI 10.5194/acp-6-493-2006; Buizert C, 2013, EARTH PLANET SC LETT, V361, P110, DOI 10.1016/j.epsl.2012.11.039; CRUTZEN PJ, 1993, GEOPHYS RES LETT, V20, P1047, DOI 10.1029/93GL01423; Fluckiger J, 1999, SCIENCE, V285, P227, DOI 10.1126/science.285.5425.227; Fluckiger J, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002122; Fluckiger J, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001417; Fudge TJ, 2013, NATURE, V500, P440, DOI 10.1038/nature12376; Galbraith ED, 2013, NAT GEOSCI, V6, P579, DOI [10.1038/NGEO1832, 10.1038/ngeo1832]; Gerten D, 2004, J HYDROL, V286, P249, DOI 10.1016/j.jhydrol.2003.09.029; Goldstein B, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016418; He F., 2011, SIMULATING TRANSIENT; Hirsch AI, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002443; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; IPCC, 2013, CLIMATE CHANGE 2022; Ishijima K, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007208; Jaccard SL, 2012, NAT GEOSCI, V5, P151, DOI [10.1038/ngeo1352, 10.1038/NGEO1352]; Joos F, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002156; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Kaiser J., 2002, THESIS J GUTENBERG U, P17; KIM KR, 1993, SCIENCE, V262, P1855, DOI 10.1126/science.262.5141.1855; KIM KR, 1990, NATURE, V347, P58, DOI 10.1038/347058a0; Lisiecki LE, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000733; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; MARTINERIE P, 1995, J GEOPHYS RES-ATMOS, V100, P14291, DOI 10.1029/95JD00826; McLauchlan KK, 2013, NATURE, V495, P352, DOI 10.1038/nature11916; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Park S, 2012, NAT GEOSCI, V5, P261, DOI [10.1038/ngeo1421, 10.1038/NGEO1421]; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Perez T, 2000, GLOBAL BIOGEOCHEM CY, V14, P525, DOI 10.1029/1999GB001181; Pfeiffer M, 2013, PALAEOGEOGR PALAEOCL, V391, P74, DOI 10.1016/j.palaeo.2012.06.015; Prather MJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051440; Rahn T, 1997, SCIENCE, V278, P1776, DOI 10.1126/science.278.5344.1776; Ritz SP, 2013, NAT GEOSCI, V6, P208, DOI 10.1038/ngeo1723; Rockmann T, 2003, ATMOS CHEM PHYS, V3, P315; Rockmann T, 2001, J GEOPHYS RES-ATMOS, V106, P10403, DOI 10.1029/2000JD900822; Roth R., 2013, THESIS U BERN; Sapart CJ, 2011, ATMOS MEAS TECH, V4, P2607, DOI 10.5194/amt-4-2607-2011; Schilt A, 2013, GEOPHYS RES LETT, V40, P1888, DOI 10.1002/grl.50380; Schilt A, 2010, EARTH PLANET SC LETT, V300, P33, DOI 10.1016/j.epsl.2010.09.027; Schilt A, 2010, QUATERNARY SCI REV, V29, P182, DOI 10.1016/j.quascirev.2009.03.011; Schmitt J, 2014, ATMOS MEAS TECH, V7, P2645, DOI 10.5194/amt-7-2645-2014; Schmittner A, 2008, NATURE, V456, P373, DOI 10.1038/nature07531; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Sowers T, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001911; Sowers T, 2003, SCIENCE, V301, P945, DOI 10.1126/science.1085293; Sowers T, 2001, J GEOPHYS RES-ATMOS, V106, P31903, DOI 10.1029/2000JD900707; Spahni R, 2005, SCIENCE, V310, P1317, DOI 10.1126/science.1120132; Spahni R, 2013, CLIM PAST, V9, P1287, DOI 10.5194/cp-9-1287-2013; Spahni R, 2011, BIOGEOSCIENCES, V8, P1643, DOI 10.5194/bg-8-1643-2011; Sperlich P, 2013, ATMOS MEAS TECH, V6, P2027, DOI 10.5194/amt-6-2027-2013; Stenni B, 2011, NAT GEOSCI, V4, P46, DOI [10.1038/ngeo1026, 10.1038/NGEO1026]; Stocker BD, 2013, NAT CLIM CHANGE, V3, P666, DOI [10.1038/NCLIMATE1864, 10.1038/nclimate1864]; Tans PP, 1997, GLOBAL BIOGEOCHEM CY, V11, P77, DOI 10.1029/96GB03940; Veres D, 2013, CLIM PAST, V9, P1733, DOI 10.5194/cp-9-1733-2013; Wania R, 2010, GEOSCI MODEL DEV, V3, P565, DOI 10.5194/gmd-3-565-2010; Wania R, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003413; Xu-Ri, 2008, GLOBAL CHANGE BIOL, V14, P1745, DOI 10.1111/j.1365-2486.2008.01625.x; Xu-Ri, 2012, NEW PHYTOL, V196, P472, DOI 10.1111/j.1469-8137.2012.04269.x; Yoshinari T, 1997, MAR CHEM, V56, P253, DOI 10.1016/S0304-4203(96)00073-4; Zurcher S, 2013, BIOGEOSCIENCES, V10, P1963, DOI 10.5194/bg-10-1963-2013	64	30	30	1	105	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					234	+		10.1038/nature13971	http://dx.doi.org/10.1038/nature13971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25503236	Green Published			2022-12-28	WOS:000346383500042
J	Lyratzopoulos, G; Wardle, J; Rubin, G				Lyratzopoulos, Georgios; Wardle, Jane; Rubin, Greg			Rethinking diagnostic delay in cancer: how difficult is the diagnosis?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE; PANCREATIC-CANCER		[Lyratzopoulos, Georgios] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge Ctr Hlth Serv Res, Cambridge CB2 0SR, England; [Wardle, Jane] UCL, Hlth Behav Res Ctr, London, England; [Rubin, Greg] Univ Durham, Sch Med Pharm & Hlth, Durham, England	University of Cambridge; University of London; University College London; Durham University	Lyratzopoulos, G (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge Ctr Hlth Serv Res, Cambridge CB2 0SR, England.	gl290@medschl.cam.ac.uk	Lyratzopoulos, Georgios/O-8260-2019	Lyratzopoulos, Georgios/0000-0002-2873-7421	Cancer Research UK Funding Source: Medline; Department of Health [PDF-2011-04-047] Funding Source: Medline; National Institute for Health Research [PDF-2011-04-047] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], 2011, NAT AUD CANC DIAGN P; Banks J, 2014, LANCET ONCOL, V15, P232, DOI 10.1016/S1470-2045(13)70588-6; Bird JM, 2011, BRIT J HAEMATOL, V154, P32, DOI 10.1111/j.1365-2141.2011.08573.x; Dommett RM, 2013, BRIT J CANCER, V108, P2329, DOI 10.1038/bjc.2013.191; Graber ML, 2014, DIAGNOSIS, V1, P5, DOI 10.1515/dx-2013-0005; Guldbrandt LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112162; Hamilton W, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660751; Howell Debra A, 2013, BMC Hematol, V13, P9, DOI 10.1186/2052-1839-13-9; Jones R, 2007, BMJ-BRIT MED J, V334, P1040, DOI 10.1136/bmj.39171.637106.AE; Keeble S, 2014, INT J CANCER, V135, P1220, DOI 10.1002/ijc.28763; Leaver L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4773; Lyratzopoulos G, 2013, BRIT J CANCER, V108, P686, DOI 10.1038/bjc.2013.1; Lyratzopoulos G, 2012, LANCET ONCOL, V13, P353, DOI 10.1016/S1470-2045(12)70041-4; MALNICK E, 2014, TELEGRAPH; Meechan D, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X654551; Mitchell ED, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660760; Moore CL, 2011, NEW ENGL J MED, V364, P749, DOI 10.1056/NEJMra0909487; Murphy DR, 2014, BMJ QUAL SAF, V23, P8, DOI 10.1136/bmjqs-2013-001874; National Cancer Intelligence Network of Public Health England, GEN PRACT PROF; National Institute for Health and Care Excellence, 2005, REF GUID SUSP CANC; Neal RD, 2009, BRIT J CANCER, V101, pS9, DOI 10.1038/sj.bjc.6605384; Rarer Cancers Foundation, 2011, PRIM CAUS AUD EXP PR; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Risberg T, 1996, ANTICANCER RES, V16, P995; Rogers S, 2014, J PUBLIC HEALTH-UK, V36, P658, DOI 10.1093/pubmed/fdt127; Schultz NA, 2014, JAMA-J AM MED ASSOC, V311, P392, DOI 10.1001/jama.2013.284664; Singh Hardeep, 2012, Qual Manag Health Care, V21, P252; Singh H, 2012, BMJ QUAL SAF, V21, P30, DOI 10.1136/bmjqs-2011-000310; Stapley S, 2012, BRIT J CANCER, V106, P1940, DOI 10.1038/bjc.2012.190; Torring ML, 2012, J CLIN EPIDEMIOL, V65, P669, DOI 10.1016/j.jclinepi.2011.12.006; University of Birmingham, 2013, WORLDS 1 POINT OF CA	31	100	100	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2014	349								g7400	10.1136/bmj.g7400	http://dx.doi.org/10.1136/bmj.g7400			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3DF	25491791	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000346165000009
J	Ananthakrishnan, AN				Ananthakrishnan, Ashwin N.			Surgery for Crohn's disease: look harder, act faster	LANCET			English	Editorial Material							MANAGEMENT; RECURRENCE; TRIAL; RATES		[Ananthakrishnan, Ashwin N.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Ananthakrishnan, Ashwin N.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ananthakrishnan, AN (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.	aananthakrishnan@mgh.harvard.edu						Cho SM, 2009, GASTROENTEROL CLIN N, V38, P753, DOI 10.1016/j.gtc.2009.07.008; Colombel JF, 2010, N ENGL J MED; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; de Chambrun GP, 2010, NAT REV GASTRO HEPAT, V7, P15, DOI 10.1038/nrgastro.2009.203; De Cruz P, 2014, LANCET; Gisbert JP, 2009, AM J GASTROENTEROL; Osterman MT, 2014, GASTROENTEROLOGY, V146, P941, DOI 10.1053/j.gastro.2013.12.025; Regueiro M, 2009, GASTROENTEROLOGY, V136, P441, DOI 10.1053/j.gastro.2008.10.051; Renna S, 2008, GASTROENTEROLOGY, V135, P1500, DOI 10.1053/j.gastro.2008.07.066; RUTGEERTS P, 1990, GASTROENTEROLOGY, V99, P956, DOI 10.1016/0016-5085(90)90613-6; Rutgeerts P, NATURAL HIST RECURRE; Schreiber S, 2010, AM J GASTROENTEROL, V105, P1574, DOI 10.1038/ajg.2010.78	12	5	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1370	1371		10.1016/S0140-6736(14)62117-6	http://dx.doi.org/10.1016/S0140-6736(14)62117-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF7EU	25542619				2022-12-28	WOS:000352719800006
J	Shultz, JM; Baingana, F; Neria, Y				Shultz, James M.; Baingana, Florence; Neria, Yuval			The 2014 Ebola Outbreak and Mental Health Current Status and Recommended Response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRAUMA		[Shultz, James M.] Univ Miami, Miller Sch Med, Ctr Disaster & Extreme Event Preparedness, Miami, FL 33136 USA; [Baingana, Florence] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Neria, Yuval] Columbia Univ, New York State Psychiat Inst, Med Ctr, Dept Psychiat, New York, NY USA; [Neria, Yuval] Columbia Univ, New York State Psychiat Inst, Med Ctr, Dept Epidemiol, New York, NY USA	University of Miami; Makerere University; Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute	Neria, Y (corresponding author), New York State Psychiat Inst & Hosp, Unit 69, 1051 Riverside Dr, New York, NY 10032 USA.	ny126@columbia.edu						[Anonymous], 2014, NEWS BBC        0919; Chan M, 2014, NEW ENGL J MED, V371, P1183, DOI 10.1056/NEJMp1409859; Inter-Agency Standing Committee, 2007, IASC GUID MENT HLTH; Levin A., 2014, PSYCHIAT NEWS, V49; Levin A., 2014, PSYCHIAT NEWS, V49, DOI DOI 10.1176/APPI.PN.2014.10B14.ACCESSED; Neria Y, 2011, JAMA-J AM MED ASSOC, V306, P1374, DOI 10.1001/jama.2011.1358; Shultz James M, 2013, Disaster Health, V1, P4, DOI 10.4161/dish.24011; Shultz JM, 2013, DISASTER MED PUBLIC, V7, P201, DOI 10.1017/dmp.2013.21; WHO, 2014, EB RESP ROADM; World Health Organization, 2014, EB RESP ROADM SIT RE	10	186	191	1	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2015	313	6					567	568		10.1001/jama.2014.17934	http://dx.doi.org/10.1001/jama.2014.17934			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA7AZ	25532102	Bronze			2022-12-28	WOS:000349070700012
J	Francis, PA; Regan, MM; Fleming, GF; Lang, I; Ciruelos, E; Bellet, M; Bonnefoi, HR; Climent, MA; Da Prada, GA; Burstein, HJ; Martino, S; Davidson, NE; Geyer, CE; Walley, BA; Coleman, R; Kerbrat, P; Buchholz, S; Ingle, JN; Winer, EP; Rabaglio-Poretti, M; Maibach, R; Ruepp, B; Giobbie-Hurder, A; Price, KN; Colleoni, M; Viale, G; Coates, AS; Goldhirsch, A; Gelber, RD				Francis, Prudence A.; Regan, Meredith M.; Fleming, Gini F.; Lang, Istvan; Ciruelos, Eva; Bellet, Meritxell; Bonnefoi, Herve R.; Climent, Miguel A.; Da Prada, Gian Antonio; Burstein, Harold J.; Martino, Silvana; Davidson, Nancy E.; Geyer, Charles E., Jr.; Walley, Barbara A.; Coleman, Robert; Kerbrat, Pierre; Buchholz, Stefan; Ingle, James N.; Winer, Eric P.; Rabaglio-Poretti, Manuela; Maibach, Rudolf; Ruepp, Barbara; Giobbie-Hurder, Anita; Price, Karen N.; Colleoni, Marco; Viale, Giuseppe; Coates, Alan S.; Goldhirsch, Aron; Gelber, Richard D.		SOFT Investigators; Int Breast Canc Study Grp	Adjuvant Ovarian Suppression in Premenopausal Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							YOUNG-WOMEN; THERAPY; CHEMOTHERAPY; AMENORRHEA	BACKGROUND Suppression of ovarian estrogen production reduces the recurrence of hormone-receptor-positive early breast cancer in premenopausal women, but its value when added to tamoxifen is uncertain. METHODS We randomly assigned 3066 premenopausal women, stratified according to prior receipt or nonreceipt of chemotherapy, to receive 5 years of tamoxifen, tamoxifen plus ovarian suppression, or exemestane plus ovarian suppression. The primary analysis tested the hypothesis that tamoxifen plus ovarian suppression would improve disease-free survival, as compared with tamoxifen alone. In the primary analysis, 46.7% of the patients had not received chemotherapy previously, and 53.3% had received chemotherapy and remained premenopausal. RESULTS After a median follow-up of 67 months, the estimated disease-free survival rate at 5 years was 86.6% in the tamoxifen-ovarian suppression group and 84.7% in the tamoxifen group (hazard ratio for disease recurrence, second invasive cancer, or death, 0.83; 95% confidence interval [CI], 0.66 to 1.04; P=0.10). Multivariable allowance for prognostic factors suggested a greater treatment effect with tamoxifen plus ovarian suppression than with tamoxifen alone (hazard ratio, 0.78; 95% CI, 0.62 to 0.98). Most recurrences occurred in patients who had received prior chemotherapy, among whom the rate of freedom from breast cancer at 5 years was 82.5% in the tamoxifen-ovarian suppression group and 78.0% in the tamoxifen group (hazard ratio for recurrence, 0.78; 95% CI, 0.60 to 1.02). At 5 years, the rate of freedom from breast cancer was 85.7% in the exemestane-ovarian suppression group (hazard ratio for recurrence vs. tamoxifen, 0.65; 95% CI, 0.49 to 0.87). CONCLUSIONS Adding ovarian suppression to tamoxifen did not provide a significant benefit in the overall study population. However, for women who were at sufficient risk for recurrence to warrant adjuvant chemotherapy and who remained premenopausal, the addition of ovarian suppression improved disease outcomes. Further improvement was seen with the use of exemestane plus ovarian suppression.	[Francis, Prudence A.] Univ Melbourne, St Vincents Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Francis, Prudence A.; Coates, Alan S.] Univ Newcastle, Australia & New Zealand Breast Canc Trials Grp, Newcastle, NSW 2300, Australia; [Coates, Alan S.] Univ Sydney, Sydney, NSW 2006, Australia; [Regan, Meredith M.; Giobbie-Hurder, Anita; Gelber, Richard D.] Dana Farber Canc Inst, IBCSG, Ctr Stat, Boston, MA 02115 USA; [Regan, Meredith M.; Gelber, Richard D.] Harvard Univ, Sch Med, Boston, MA USA; [Burstein, Harold J.; Winer, Eric P.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Susan F Smith Ctr Womens Canc, Boston, MA 02115 USA; [Burstein, Harold J.; Winer, Eric P.] Alliance Clin Trials Oncol, Boston, MA USA; [Price, Karen N.] Frontier Sci & Technol Res Fdn Inc, IBCSG Stat Ctr, Boston, MA USA; [Gelber, Richard D.] Harvard Univ, Sch Publ Hlth, Frontier Sci & Technol Res Fdn, Boston, MA 02115 USA; [Fleming, Gini F.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Fleming, Gini F.] Alliance Clin Trials Oncol, Chicago, IL USA; [Lang, Istvan] Natl Inst Oncol, Budapest, Hungary; [Lang, Istvan] Int Breast Canc Study Grp, Budapest, Hungary; [Ciruelos, Eva] Univ Hosp 12 Octubre, Madrid, Spain; [Bellet, Meritxell] Vall dHebron Inst Oncol, Barcelona, Spain; [Bellet, Meritxell] Vall dHebron Univ Hosp, Barcelona, Spain; [Ciruelos, Eva; Bellet, Meritxell; Climent, Miguel A.] SOLTI Grp, Barcelona, Spain; [Climent, Miguel A.] Inst Valenciano Oncol, Valencia, Spain; [Bonnefoi, Herve R.] Univ Bordeaux, Inst Bergonie Comprehens Canc Ctr, INSERM, U916, Bordeaux, France; [Kerbrat, Pierre] Univ Rennes, Ctr Eugene Marquis, Rennes, France; [Bonnefoi, Herve R.; Kerbrat, Pierre] European Org Res Treatment Canc, Brussels, Belgium; [Da Prada, Gian Antonio] Salvatore Maugeri Fdn, Pavia, Italy; [Da Prada, Gian Antonio] IBCSG, Pavia, Italy; [Colleoni, Marco; Goldhirsch, Aron] Univ Milan, European Inst Oncol, Milan, Italy; [Colleoni, Marco; Goldhirsch, Aron] Univ Milan, Int Breast Canc Study Grp, Milan, Italy; [Viale, Giuseppe] Univ Milan, European Inst Oncol, IBCSG Cent Pathol Ctr, Milan, Italy; [Martino, Silvana] Angeles Clin, Santa Monica, CA USA; [Martino, Silvana] Res Inst, Santa Monica, CA USA; [Martino, Silvana] SWOG, Santa Monica, CA USA; [Davidson, Nancy E.] Univ Pittsburgh, Med Ctr, Inst Canc, Ctr Canc, Pittsburgh, PA USA; [Davidson, Nancy E.] ECOG ACRIN Canc Res Grp, Pittsburgh, PA USA; [Geyer, Charles E., Jr.] Virginia Commonwealth Univ, Massey Canc Ctr, Sch Med, Richmond, VA 23284 USA; [Geyer, Charles E., Jr.] NRG Oncol, Richmond, VA USA; [Walley, Barbara A.] Tom Baker Canc Clin, Calgary, AB, Canada; [Walley, Barbara A.] Natl Canc Inst Canada, Clin Trials Grp, Calgary, AB, Canada; [Coleman, Robert] Weston Pk Hosp, Sheffield, S Yorkshire, England; [Coleman, Robert] Natl Inst Canc Res, Breast Canc Clin Studies Grp, London, England; [Coleman, Robert] Inst Canc Res, Clin Trials & Stat Unit, London SW3 6JB, England; [Buchholz, Stefan] Univ Med Ctr Regensburg, German Breast Grp, Regensburg, Germany; [Buchholz, Stefan] Univ Med Ctr Regensburg, Dept Obstet & Gynecol, Regensburg, Germany; [Ingle, James N.] Mayo Clin, Rochester, MN USA; [Ingle, James N.] Alliance Clin Trials Oncol, Rochester, MN USA; [Rabaglio-Poretti, Manuela] Univ Bern, Inselspital, Univ Hosp, CH-3010 Bern, Switzerland; [Rabaglio-Poretti, Manuela; Maibach, Rudolf; Ruepp, Barbara] IBCSG Coordinating Ctr, Bern, Switzerland	Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; University of Melbourne; University of Newcastle; University of Sydney; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Frontier Science Foundation; Frontier Science Foundation; Harvard University; Harvard T.H. Chan School of Public Health; University of Chicago; University of Chicago Medical Center; National Institute of Oncology Hungary; Hospital Universitario 12 de Octubre; Vall d'Hebron Institut d'Oncologia (VHIO); Hospital Universitari Vall d'Hebron; SOLTI Breast Cancer Research Group; Instituto Valenciano De Oncologia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Centre Eugene Marquis; Universite de Rennes; European Organisation for Research & Treatment of Cancer; Istituti Clinici Scientifici Maugeri IRCCS; IRCCS European Institute of Oncology (IEO); University of Milan; University of Milan; IRCCS European Institute of Oncology (IEO); University of Milan; Angeles Clinic & Research Institute; Southwest Oncology Group; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Tom Baker Cancer Clinic; University of Calgary; Queens University - Canada; Canadian Cancer Trials Group; Weston Park Hospital; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; German Breast Group; University of Regensburg; University of Regensburg; Mayo Clinic; University of Bern; University Hospital of Bern	Francis, PA (corresponding author), Peter MacCallum Canc Ctr, Locked Bag 1,ABeckett St, Melbourne, Vic 8006, Australia.	ibcsgcc@ibcsg.org	Viale, Giuseppe/AAE-8921-2019; Giobbie-Hurder, Anita/AAU-6193-2021; Colleoni, Marco/AAN-8647-2020; Lluch, Ana/R-5493-2019; Geyer, Charles/AGY-0119-2022; Puglisi, Fabio/N-3863-2017; Francis, Prudence A/J-4003-2012; Coleman, Robert/E-4346-2019; Perren, Timothy/D-5387-2013	Colleoni, Marco/0000-0002-5743-3013; Lluch, Ana/0000-0003-2766-407X; Geyer, Charles/0000-0002-2379-5702; Puglisi, Fabio/0000-0003-0573-4938; Francis, Prudence A/0000-0002-7207-9286; Llombart Cussac, Antonio/0000-0003-4515-8293; Rabaglio, Manuela/0000-0002-6764-1844; Ciruelos, Eva/0000-0002-2796-1042; Bliss, Judith/0000-0001-7957-7424; Villanova Biazus, Jorge/0000-0002-3821-5264; Kroep, Judith/0000-0003-2671-1903; Haba Rodriguez, Juan Rafael de la/0000-0001-5111-1702; Perren, Timothy/0000-0001-8472-8856	Pfizer; NATIONAL CANCER INSTITUTE [U10CA180820, U24CA075362, U10CA180867, U10CA180821, UG1CA189867, U10CA180888, P30CA015083] Funding Source: NIH RePORTER	Pfizer(Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Pfizer and others; SOFT ClinicalTrials.gov number, NCT00066690.	Aebi S, 2000, LANCET, V355, P1869, DOI 10.1016/S0140-6736(00)02292-3; Cancer Therapy Evaluation Program, COMM TERM CRIT ADV E; Castiglione-Gertsch M, 2003, JNCI-J NATL CANCER I, V95, P1833, DOI 10.1093/jnci/djg119; Colleoni M, 2006, J CLIN ONCOL, V24, P1332, DOI 10.1200/JCO.2005.03.0783; Cuzick J, 2007, LANCET, V369, P1711; Davidson NE, 2005, J CLIN ONCOL, V23, P5973, DOI 10.1200/JCO.2005.05.551; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; Goldhirsch A, 2001, J Natl Cancer Inst Monogr, P44; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Griggs, 2012, J CLIN ONCOL, V30, P1398, DOI 10.1200/JCO.2012.43.1031; Griggs JJ, 2011, J CLIN ONCOL, V29, P3939, DOI 10.1200/JCO.2011.36.4950; Hackshaw A, 2009, JNCI-J NATL CANCER I, V101, P341, DOI 10.1093/jnci/djn498; Pagani O, 1998, EUR J CANCER, V34, P632, DOI 10.1016/S0959-8049(97)10036-3; Pagani O, 2014, NEW ENGL J MED, V371, P107, DOI 10.1056/NEJMoa1404037; Partridge AH, 2014, BREAST, V23, P209, DOI 10.1016/j.breast.2014.03.011; Regan MM, 2008, ANN ONCOL, V19, P1231, DOI 10.1093/annonc/mdn037; Regan MM, 2013, BREAST, V22, P1094, DOI 10.1016/j.breast.2013.08.009; Swain SM, 2010, NEW ENGL J MED, V363, P2268, DOI 10.1056/NEJMc1009616	19	439	470	0	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2015	372	5					436	446		10.1056/NEJMoa1412379	http://dx.doi.org/10.1056/NEJMoa1412379			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA1CD	25495490	Green Accepted, Green Published			2022-12-28	WOS:000348649700008
J	Altwegg, K; Balsiger, H; Bar-Nun, A; Berthelier, JJ; Bieler, A; Bochsler, P; Briois, C; Calmonte, U; Combi, M; De Keyser, J; Eberhardt, P; Fiethe, B; Fuselier, S; Gasc, S; Gombosi, TI; Hansen, KC; Hassig, M; Jackel, A; Kopp, E; Korth, A; Leroy, L; Mall, U; Marty, B; Mousis, O; Neefs, E; Owen, T; Reme, H; Rubin, M; Semon, T; Tzou, CY; Waite, H; Wurz, P				Altwegg, K.; Balsiger, H.; Bar-Nun, A.; Berthelier, J. J.; Bieler, A.; Bochsler, P.; Briois, C.; Calmonte, U.; Combi, M.; De Keyser, J.; Eberhardt, P.; Fiethe, B.; Fuselier, S.; Gasc, S.; Gombosi, T. I.; Hansen, K. C.; Haessig, M.; Jaeckel, A.; Kopp, E.; Korth, A.; Leroy, L.; Mall, U.; Marty, B.; Mousis, O.; Neefs, E.; Owen, T.; Reme, H.; Rubin, M.; Semon, T.; Tzou, C. -Y.; Waite, H.; Wurz, P.			67P/Churyumov-Gerasimenko, a Jupiter family comet with a high D/H ratio	SCIENCE			English	Article							OORT CLOUD; SOLAR-SYSTEM; NOBLE-GASES; WATER; DEUTERIUM; ORIGIN; ATMOSPHERE; NITROGEN; EARTH	The provenance of water and organic compounds on Earth and other terrestrial planets has been discussed for a long time without reaching a consensus. One of the best means to distinguish between different scenarios is by determining the deuterium-to-hydrogen (D/H) ratios in the reservoirs for comets and Earth's oceans. Here, we report the direct in situ measurement of the D/H ratio in the Jupiter family comet 67P/Churyumov-Gerasimenko by the ROSINA mass spectrometer aboard the European Space Agency's Rosetta spacecraft, which is found to be (5.3 +/- 0.7) x 10(-4)-that is, approximately three times the terrestrial value. Previous cometary measurements and our new finding suggest a wide range of D/H ratios in the water within Jupiter family objects and preclude the idea that this reservoir is solely composed of Earth ocean-like water.	[Altwegg, K.; Balsiger, H.; Bieler, A.; Bochsler, P.; Calmonte, U.; Eberhardt, P.; Gasc, S.; Haessig, M.; Jaeckel, A.; Kopp, E.; Leroy, L.; Rubin, M.; Semon, T.; Tzou, C. -Y.; Wurz, P.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Bar-Nun, A.] Tel Aviv Univ, Dept Geosci, IL-69978 Tel Aviv, Israel; [Berthelier, J. J.] LATMOS, F-94100 St Maur, France; [Bieler, A.; Combi, M.; Gombosi, T. I.; Hansen, K. C.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Hayward, MI USA; [Briois, C.] Univ Orleans, Lab Phys & Chim Environm & Espace LPC2E, CNRS, UMR 6115, F-45067 Orleans, France; [De Keyser, J.; Neefs, E.] IASB, BIRA, Space Phys Div, B-1180 Brussels, Belgium; [Fiethe, B.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Comp & Network Engn IDA, D-38106 Braunschweig, Germany; [Fuselier, S.; Haessig, M.; Waite, H.] SW Res Inst, Dept Space Sci, San Antonio, TX 78228 USA; [Korth, A.; Mall, U.] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Marty, B.] Univ Lorraine, Ctr Rech Petrograph & Geochim, CRPG, CNRS, F-54501 Vandoeuvre Les Nancy, France; [Mousis, O.] Univ Franche Comte, Inst Univers Transport Interfaces Nanostruct Atmo, CNRS, INSU,UMR 6213, F-6213 Besancon, France; [Owen, T.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Reme, H.] Univ Toulouse 3, Univ Toulouse, OMP, IRAP, Toulouse, France; [Reme, H.] CNRS, IRAP, F-31028 Toulouse 4, France	University of Bern; Tel Aviv University; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Braunschweig University of Technology; Southwest Research Institute; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Franche-Comte; University of Hawaii System; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Altwegg, K (corresponding author), Univ Bern, Inst Phys, Sidlerstr 5, CH-3012 Bern, Switzerland.	altwegg@space.unibe.ch	Mousis, Olivier/X-2712-2019; Combi, Michael/J-1697-2012; Wurz, Peter/R-2273-2017; Hansen, Kenneth C/F-3693-2011; Gombosi, Tamas I/G-4238-2011; briois, christelle/B-2170-2015; Rubin, Martin/I-7777-2013	Combi, Michael/0000-0002-9805-0078; Wurz, Peter/0000-0002-2603-1169; Hansen, Kenneth C/0000-0002-8502-1980; Gombosi, Tamas I/0000-0001-9360-4951; Rubin, Martin/0000-0001-6549-3318; BRIOIS, Christelle/0000-0002-5616-0180; Le Roy, Lena/0000-0002-5984-6153; De Keyser, Johan/0000-0003-4805-5695	State of Bern; Swiss National Science Foundation; ESA PRODEX Program; Max Planck Society; BMWI [50QP1302]; Jet Propulsion Laboratory [1496541]; Belgian Science Policy Office via PRODEX/ROSINA PEA [90020]; Centre National d'Etudes Spatiales at IRAP; Centre National d'Etudes Spatiales at LATMOS; Centre National d'Etudes Spatiales at LPC2E; Centre National d'Etudes Spatiales at UTINAM; Centre National d'Etudes Spatiales at CRPG; European Research Council [267255]; NASA [JPL-1266313]	State of Bern; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ESA PRODEX Program; Max Planck Society(Max Planck SocietyFoundation CELLEX); BMWI(Federal Ministry for Economic Affairs and Energy (BMWi)); Jet Propulsion Laboratory; Belgian Science Policy Office via PRODEX/ROSINA PEA; Centre National d'Etudes Spatiales at IRAP; Centre National d'Etudes Spatiales at LATMOS; Centre National d'Etudes Spatiales at LPC2E; Centre National d'Etudes Spatiales at UTINAM; Centre National d'Etudes Spatiales at CRPG; European Research Council(European Research Council (ERC)European Commission); NASA(National Aeronautics & Space Administration (NASA))	A. Morbidelli is acknowledged for helpful discussion. The authors thank the following institutions and agencies, which supported this work: Work at the University of Bern was funded by the State of Bern, the Swiss National Science Foundation, and the ESA PRODEX Program. Work at Max-Planck-Institut fur Sonnensystemforschung was funded by the Max Planck Society and BMWI under contract 50QP1302. Work at Southwest Research institute was supported by subcontract 1496541 from the Jet Propulsion Laboratory. Work at BIRA-IASB was supported by the Belgian Science Policy Office via PRODEX/ROSINA PEA 90020. This work was supported by Centre National d'Etudes Spatiales grants at IRAP, LATMOS, LPC2E, UTINAM, CRPG, and by the the European Research Council (grant 267255). A.B.-N. thanks the Ministry of Science and the Israel Space agency. Work at the University of Michigan was funded by NASA under contract JPL-1266313. ROSINA would not give such outstanding results without the work of the many engineers and technicians involved in this instrument and in the mission over the years whose contributions are gratefully acknowledged. Rosetta is an ESA mission with contributions from its member states and NASA. The work of the ESA Rosetta team is herewith acknowledged. All ROSINA data are available on request until they are released to the PSA archive of ESA and to the PDS archive of NASA.	Albertsson T, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/39; Aleon J, 2010, ASTROPHYS J, V722, P1342, DOI 10.1088/0004-637X/722/2/1342; Alexander CMO, 2012, SCIENCE, V337, P721, DOI 10.1126/science.1223474; Balsiger H, 2007, SPACE SCI REV, V128, P745, DOI 10.1007/s11214-006-8335-3; BALSIGER H, 1995, J GEOPHYS RES-SPACE, V100, P5827, DOI 10.1029/94JA02936; Bockelee-Morvan D, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219744; Brasser R, 2013, ICARUS, V225, P40, DOI 10.1016/j.icarus.2013.03.012; Ceccarelli C., 2014, PROTOSTARS AND PLANE, pVI; Dones L, 2004, SPACE SCI S, P153; Duncan MJ, 1997, SCIENCE, V276, P1670, DOI 10.1126/science.276.5319.1670; EBERHARDT P, 1995, ASTRON ASTROPHYS, V302, P301; Feutchgruber H., 2013, ASTRON ASTROPHYS, V551, pA26; Furuya K, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/11; GEISS J, 1981, ASTRON ASTROPHYS, V93, P189; Geiss J, 1998, SPACE SCI REV, V84, P239, DOI 10.1023/A:1005039822524; Hassig M, 2013, PLANET SPACE SCI, V84, P148, DOI 10.1016/j.pss.2013.05.014; Kavelaars JJ, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/2/L30; Levison HF, 2010, SCIENCE, V329, P187, DOI 10.1126/science.1187535; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; OWEN T, 1992, NATURE, V358, P43, DOI 10.1038/358043a0; Prodanovic T, 2010, MON NOT R ASTRON SOC, V406, P1108, DOI 10.1111/j.1365-2966.2010.16734.x; Schlappi B, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015734; Visser R, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117249; Waite JH, 2009, NATURE, V460, P487, DOI 10.1038/nature08153; Yang L, 2013, ICARUS, V226, P256, DOI 10.1016/j.icarus.2013.05.027	28	225	228	4	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220							1261952	10.1126/science.1261952	http://dx.doi.org/10.1126/science.1261952			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25501976	Green Submitted			2022-12-28	WOS:000348225800030
J	Boucrot, E; Ferreira, APA; Almeida-Souza, L; Debard, S; Vallis, Y; Howard, G; Bertot, L; Sauvonnet, N; McMahon, HT				Boucrot, Emmanuel; Ferreira, Antonio P. A.; Almeida-Souza, Leonardo; Debard, Sylvain; Vallis, Yvonne; Howard, Gillian; Bertot, Laetitia; Sauvonnet, Nathalie; McMahon, Harvey T.			Endophilin marks and controls a clathrin-independent endocytic pathway	NATURE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; SYNAPTIC VESICLE ENDOCYTOSIS; COATED PIT FORMATION; TUMOR-SUPPRESSOR; BINDING PARTNERS; DOWN-REGULATION; BAR DOMAINS; DYNAMIN; CELLS; PROTEINS	Endocytosis is required for internalization of micronutrients and turnover of membrane components. Endophilin has been assigned as a component of clathrin-mediated endocytosis. Here we show in mammalian cells that endophilin marks and controls a fast-acting tubulovesicular endocytic pathway that is independent of AP2 and clathrin, activated upon ligand binding to cargo receptors, inhibited by inhibitors of dynamin, Rac, phosphatidylinositol-3-OH kinase, PAK1 and actin polymerization, and activated upon Cdc42 inhibition. This pathway is prominent at the leading edges of cells where phosphatidylinositol-3,4-bisphosphate-produced by the dephosphorylation of phosphatidylinositol-3,4,5-triphosphate by SHIP1 and SHIP2-recruits lamellipodin, which in turn engages endophilin. This pathway mediates the ligand-triggered uptake of several G-protein-coupled receptors such as alpha(2a)- and beta(1)-adrenergic, dopaminergic D3 and D4 receptors and muscarinic acetylcholine receptor 4, the receptor tyrosine kinases EGFR, HGFR, VEGFR, PDGFR, NGFR and IGF1R, as well as interleukin-2 receptor. We call this new endocytic route fast endophilin-mediated endocytosis (FEME).	[Boucrot, Emmanuel; Almeida-Souza, Leonardo; Vallis, Yvonne; Howard, Gillian; McMahon, Harvey T.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Boucrot, Emmanuel; Ferreira, Antonio P. A.; Debard, Sylvain] UCL, Inst Struct & Mol Biol, London WC1E 6BT, England; [Boucrot, Emmanuel; Ferreira, Antonio P. A.; Debard, Sylvain] Birkbeck Coll, London WC1E 6BT, England; [Debard, Sylvain] Ecole Normale Super, Dept Biol, F-94235 Cachan, France; [Bertot, Laetitia; Sauvonnet, Nathalie] Inst Pasteur, Unite Pathogenie Mol Microbienne, F-75724 Paris 15, France	MRC Laboratory Molecular Biology; University of London; Birkbeck University London; University College London; University of London; Birkbeck University London; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	McMahon, HT (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	e.boucrot@ucl.ac.uk; hmm@mrc-lmb.cam.ac.uk	Almeida-Souza, Leonardo/C-3437-2011	Almeida-Souza, Leonardo/0000-0002-7169-1238; Ferreira, Antonio/0000-0003-4614-8580; sauvonnet, nathalie/0000-0003-0306-3376; Boucrot, Emmanuel/0000-0001-7312-6462	Medical Research Council UK [U105178805]; Royal Society [RG120481]; Fundacao para a Ciencia e Tecnologia; Marie Curie Actions; BBSRC [BB/I018921/1] Funding Source: UKRI; MRC [MC_U105178795] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I018921/1] Funding Source: researchfish; Medical Research Council [MC_U105178795] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Marie Curie Actions(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Y. Peak-Chew for mass spectrometry, M. Edwards and K. McGourty for technical help and P. De Camilli, T. Kirchhausen, G. B. Hammond, P. Robinson, M. Robinson, M. McNiven, B. Nichols, A. Benmerah, M. Krause and Genentech for the gift of reagents, and the members of the McMahon and Boucrot laboratories for comments. The research was funded by the Medical Research Council UK (grant number U105178805) (H.T.M., L.A.-S., G.H., Y.V. and E.B. in part) and a Royal Society grant (research grant number RG120481) (E.B.). A.P.A.F is supported by the Fundacao para a Ciencia e Tecnologia, L.A.-S. is a EMBO Long Term fellow and is supported by Marie Curie Actions, and E.B. is a Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Research Fellow.	Andersson F, 2010, SYNAPSE, V64, P556, DOI 10.1002/syn.20772; Batty IH, 2007, BIOCHEM J, V407, P255, DOI 10.1042/BJ20070558; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Fritsch R, 2013, CELL, V154, P940, DOI 10.1016/j.cell.2013.07.045; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; GIBSON AE, 1989, AM J PHYSIOL, V257, pC182, DOI 10.1152/ajpcell.1989.257.2.C182; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Grassart A, 2008, EMBO REP, V9, P356, DOI 10.1038/embor.2008.28; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Henry EP, 2006, NAT CHEM BIOL, V2, P39, DOI 10.1038/nchembio751; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Joshi S, 2010, MOL CANCER THER, V9, P1995, DOI 10.1158/1535-7163.MCT-10-0161; Kononenko NL, 2014, NEURON, V82, P981, DOI 10.1016/j.neuron.2014.05.007; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Llobet A, 2011, J NEUROSCI, V31, P8512, DOI 10.1523/JNEUROSCI.6223-09.2011; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maldonado-Baez L, 2013, EXP CELL RES, V319, P2759, DOI 10.1016/j.yexcr.2013.08.008; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meinecke M, 2013, J BIOL CHEM, V288, P6651, DOI 10.1074/jbc.M112.444869; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Perera RM, 2006, P NATL ACAD SCI USA, V103, P19332, DOI 10.1073/pnas.0609795104; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Renard H.-F., 2014, NATURE; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Sauvonnet N, 2005, J CELL BIOL, V168, P155, DOI 10.1083/jcb.200406174; SCHLEGEL R, 1982, P NATL ACAD SCI-BIOL, V79, P2291, DOI 10.1073/pnas.79.7.2291; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; SUBTIL A, 1994, J CELL SCI, V107, P3461; Sundborger A, 2011, J CELL SCI, V124, P133, DOI 10.1242/jcs.072686; Tang YT, 1999, P NATL ACAD SCI USA, V96, P12559, DOI 10.1073/pnas.96.22.12559; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; Vehlow A, 2013, EMBO J, V32, P2722, DOI 10.1038/emboj.2013.212; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Watanabe S, 2013, NATURE, V504, P242, DOI 10.1038/nature12809; Xie JW, 2013, BIOESSAYS, V35, P733, DOI 10.1002/bies.201200168; Yip SC, 2008, BIOCHEM J, V411, P441, DOI 10.1042/BJ20071179; Yoon YD, 2012, J BIOL CHEM, V287, P34078, DOI 10.1074/jbc.M112.372789	62	327	330	2	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					460	+		10.1038/nature14067	http://dx.doi.org/10.1038/nature14067			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25517094				2022-12-28	WOS:000348196500029
J	Kim, J; Ishiguro, KI; Nambu, A; Akiyoshi, B; Yokobayashi, S; Kagami, A; Ishiguro, T; Pendas, AM; Takeda, N; Sakakibara, Y; Kitajima, TS; Tanno, Y; Sakuno, T; Watanabe, Y				Kim, Jihye; Ishiguro, Kei-ichiro; Nambu, Aya; Akiyoshi, Bungo; Yokobayashi, Shihori; Kagami, Ayano; Ishiguro, Tadashi; Pendas, Alberto M.; Takeda, Naoki; Sakakibara, Yogo; Kitajima, Tomoya S.; Tanno, Yuji; Sakuno, Takeshi; Watanabe, Yoshinori			Meikin is a conserved regulator of meiosis-I-specific kinetochore function	NATURE			English	Article							SINGLE-DIVISION MEIOSIS; PROTEIN PHOSPHATASE 2A; CENTROMERIC COHESION; HOMOLOGOUS CHROMOSOMES; MONOPOLAR ATTACHMENT; MAMMALIAN OOCYTES; KINASE CDC5; AURORA-B; CLEAVAGE; SEGREGATION	The kinetochore is the crucial apparatus regulating chromosome segregation in mitosis and meiosis. Particularly in meiosis I, unlike in mitosis, sister kinetochores are captured by microtubules emanating from the same spindle pole (mono-orientation) and centromeric cohesion mediated by cohesin is protected in the following anaphase. Although meiotic kinetochore factors have been identified only in budding and fission yeasts, these molecules and their functions are thought to have diverged earlier. Therefore, a conserved mechanism for meiotic kinetochore regulation remains elusive. Here we have identified in mouse a meiosis-specific kinetochore factor that wetermed MEIKIN, which functions in meiosis I but not in meiosis II or mitosis. MEIKIN plays a crucial role in both mono-orientation and centromeric cohesion protection, partly by stabilizing the localization of the cohesin protector shugoshin. These functions are mediated mainly by the activity of Polo-like kinase PLK1, which is enriched to kinetochores in a MEIKIN-dependent manner. Our integrative analysis indicates that the long-awaited key regulator of meiotic kinetochore function is Meikin, which is conserved from yeasts to humans.	[Kim, Jihye; Ishiguro, Kei-ichiro; Nambu, Aya; Akiyoshi, Bungo; Yokobayashi, Shihori; Kagami, Ayano; Ishiguro, Tadashi; Tanno, Yuji; Sakuno, Takeshi; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Pendas, Alberto M.] CSIC, USAL, Inst Biol Mol & Celular Canc, Salamanca 37007, Spain; [Takeda, Naoki] Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8600811, Japan; [Sakakibara, Yogo; Kitajima, Tomoya S.] RIKEN Ctr Dev Biol, Lab Chromosome Segregat, Chuo Ku, Kobe, Hyogo 6500047, Japan	University of Tokyo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Kumamoto University; RIKEN	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, 1-1-1Yayoi, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Kitajima, Tomoya/A-7049-2016; Ishiguro, Kei-ichiro/K-3340-2019; Pendas, Alberto M/L-1017-2014; Sakuno, Takeshi/Y-9478-2019	Kitajima, Tomoya/0000-0002-6486-7143; Ishiguro, Kei-ichiro/0000-0002-7515-1511; Pendas, Alberto M/0000-0001-9264-3721; Akiyoshi, Bungo/0000-0001-6010-394X; Watanabe, Yoshinori/0000-0002-5488-4812; Nambu, Aya/0000-0002-2797-6420	JSPS Research Fellowship; Uehara Memorial Foundation; RIKEN CDB intramural grant; MEXT, Japan;  [SAF2011-25252]; Grants-in-Aid for Scientific Research [26711020, 221S0001] Funding Source: KAKEN	JSPS Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); RIKEN CDB intramural grant; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Tachibana-Konwalski for the C57BL/6 Mlh1<SUP>tm1Liskay</SUP> knockout mice and and J. Ellenberg for a macro for automated microscopy. We also thank J. Lee, T. Hirano, S. Fujiyama, Y. Yamazumi, as well as the Gotoh laboratory for technical advice and all members of the Watanabe laboratory for their support and discussion. This work was supported in part by a JSPS Research Fellowship (to J.K.), SAF2011-25252 (to A.M.P.), a research grant from Uehara Memorial Foundation, a RIKEN CDB intramural grant and a Grant-in-Aid for Young Scientists (B) (to T.S.K.), a Grant-in-Aid for Scientific Research on Innovative Areas, a Grant-in-Aid for Scientific Research (C) (to K.I.), and a Grant-in-Aid for Specially Promoted Research (to Y.W.) from MEXT, Japan.	Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Attner MA, 2013, P NATL ACAD SCI USA, V110, P14278, DOI 10.1073/pnas.1311845110; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Brar GA, 2008, NAT REV GENET, V9, P899, DOI 10.1038/nrg2454; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Chambon Jean-Philippe, 2013, Methods Mol Biol, V957, P203, DOI 10.1007/978-1-62703-191-2_14; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Corbett KD, 2010, CELL, V142, P556, DOI 10.1016/j.cell.2010.07.017; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Gregan J, 2007, CURR BIOL, V17, P1190, DOI 10.1016/j.cub.2007.06.044; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hodges CA, 2005, NAT GENET, V37, P1351, DOI 10.1038/ng1672; Hodges CA, 2002, CHROMOSOMA, V111, P165, DOI 10.1007/s00412-002-0195-3; HUGERAT Y, 1993, GENETICS, V135, P297; Ishiguro K, 2011, EMBO REP, V12, P267, DOI 10.1038/embor.2011.2; Ishiguro T, 2010, NAT CELL BIOL, V12, P500, DOI 10.1038/ncb2052; Jessberger R, 2012, EMBO REP, V13, P539, DOI 10.1038/embor.2012.54; Kagami A, 2011, EMBO REP, V12, P1189, DOI 10.1038/embor.2011.188; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Katis VL, 2010, DEV CELL, V18, P397, DOI 10.1016/j.devcel.2010.01.014; Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kim-Kaneyama J, 2011, J MOL CELL CARDIOL, V50, P77, DOI 10.1016/j.yjmcc.2010.09.024; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; KLAPHOLZ S, 1980, GENETICS, V96, P589; Krapp A, 2010, J CELL SCI, V123, P3284, DOI 10.1242/jcs.069112; Lee BH, 2004, CURR BIOL, V14, P2168, DOI 10.1016/j.cub.2004.12.033; Lee BH, 2002, GENE DEV, V16, P1672, DOI 10.1101/gad.989302; Lee J, 2008, NAT CELL BIOL, V10, P42, DOI 10.1038/ncb1667; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lister LM, 2010, CURR BIOL, V20, P1511, DOI 10.1016/j.cub.2010.08.023; Llano E, 2008, GENE DEV, V22, P2400, DOI 10.1101/gad.475308; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Moore DP, 1998, CURR TOP DEV BIOL, V37, P263; Morimoto A, 2012, J CELL BIOL, V198, P165, DOI 10.1083/jcb.201204085; Nagaoka SI, 2011, CURR BIOL, V21, P651, DOI 10.1016/j.cub.2011.03.003; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Sakuno T, 2011, DEV CELL, V21, P534, DOI 10.1016/j.devcel.2011.08.012; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Sarangapani KK, 2014, SCIENCE, V346, P248, DOI 10.1126/science.1256729; Shibuya H, 2014, NAT CELL BIOL, V16, P145, DOI 10.1038/ncb2896; Shonn MA, 2002, GENE DEV, V16, P1659, DOI 10.1101/gad.975802; Tachibana-Konwalski K, 2013, CURR BIOL, V23, P2534, DOI 10.1016/j.cub.2013.10.052; Tachibana-Konwalski K, 2010, GENE DEV, V24, P2505, DOI 10.1101/gad.605910; Tada K, 2011, NATURE, V474, P477, DOI 10.1038/nature10179; Tanaka K, 2009, DEV CELL, V17, P334, DOI 10.1016/j.devcel.2009.08.004; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Watanabe Y, 2012, NAT REV MOL CELL BIO, V13, P370, DOI 10.1038/nrm3349; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	61	100	107	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					466	+		10.1038/nature14097	http://dx.doi.org/10.1038/nature14097			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25533956	Green Submitted			2022-12-28	WOS:000348196500030
J	Schoene, B; Samperton, KM; Eddy, MP; Keller, G; Adatte, T; Bowring, SA; Khadri, SFR; Gertsch, B				Schoene, Blair; Samperton, Kyle M.; Eddy, Michael P.; Keller, Gerta; Adatte, Thierry; Bowring, Samuel A.; Khadri, Syed F. R.; Gertsch, Brian			U-Pb geochronology of the Deccan Traps and relation to the end-Cretaceous mass extinction	SCIENCE			English	Article							ASTRONOMICAL TIME-SCALE; LARGE IGNEOUS PROVINCE; PALEOGENE BOUNDARY; PLANKTIC FORAMINIFERA; WESTERN-GHATS; FLOOD BASALTS; VOLCANISM; IMPACT; INDIA; STRATIGRAPHY	The Chicxulub asteroid impact (Mexico) and the eruption of the massive Deccan volcanic province (India) are two proposed causes of the end-Cretaceous mass extinction, which includes the demise of nonavian dinosaurs. Despite widespread acceptance of the impact hypothesis, the lack of a high-resolution eruption timeline for the Deccan basalts has prevented full assessment of their relationship to the mass extinction. Here we apply uranium-lead (U-Pb) zircon geochronology to Deccan rocks and show that the main phase of eruptions initiated similar to 250,000 years before the Cretaceous-Paleogene boundary and that >1.1 million cubic kilometers of basalt erupted in similar to 750,000 years. Our results are consistent with the hypothesis that the Deccan Traps contributed to the latest Cretaceous environmental change and biologic turnover that culminated in the marine and terrestrial mass extinctions.	[Schoene, Blair; Samperton, Kyle M.; Keller, Gerta] Princeton Univ, Dept Geosci, Princeton, NJ 08540 USA; [Eddy, Michael P.; Bowring, Samuel A.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Adatte, Thierry; Gertsch, Brian] Univ Lausanne, GEOPOLIS, Inst Sci Terre ISTE, CH-1015 Lausanne, Switzerland; [Khadri, Syed F. R.] Amravati Univ, Dept Geol, Amravati, India	Princeton University; Massachusetts Institute of Technology (MIT); University of Lausanne; Sant Gadge Baba Amravati University	Schoene, B (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08540 USA.	bschoene@princeton.edu	University, Sant Gadge Baba Amravati/AAN-5820-2021; Samperton, Kyle/K-9286-2015; Schoene, Blair/C-3281-2014	University, Sant Gadge Baba Amravati/0000-0002-3759-6755; Samperton, Kyle/0000-0003-0177-5978; Schoene, Blair/0000-0001-7092-8590; Eddy, Michael/0000-0003-0907-5108; Keller, Gerta/0000-0001-5518-2014	Department of Geosciences Scott Fund at Princeton University; U.S. NSF through the Continental Dynamics Program, Sedimentary Geology and Paleobiology Program; Office of International Science and Engineering's India Program [EAR-0447171, EAR-1026271]; Directorate For Geosciences [1454430] Funding Source: National Science Foundation	Department of Geosciences Scott Fund at Princeton University; U.S. NSF through the Continental Dynamics Program, Sedimentary Geology and Paleobiology Program(National Science Foundation (NSF)); Office of International Science and Engineering's India Program; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the Department of Geosciences Scott Fund at Princeton University and the U.S. NSF through the Continental Dynamics Program, Sedimentary Geology and Paleobiology Program, and the Office of International Science and Engineering's India Program under grants EAR-0447171 and EAR-1026271 to G.K. P. Kemeny assisted with fieldwork and sample collection; A. Chen assisted with sample processing. MIT's analytical work was wooer cc by the Robert Shrock chair All data associated with this work can be found in the supplementary materials (17).	Batenburg SJ, 2014, J GEOL SOC LONDON, V171, P165, DOI 10.1144/jgs2013-015; Beane J., 1986, B VOLCANOL, V48, P61, DOI DOI 10.1007/BF01073513; Black BA, 2014, GEOLOGY, V42, P67, DOI 10.1130/G34875.1; Bondre NR, 2004, B VOLCANOL, V66, P29, DOI 10.1007/s00445-003-0294-x; Chenet AL, 2007, EARTH PLANET SC LETT, V263, P1, DOI 10.1016/j.epsl.2007.07.011; Chenet AL, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005644; Chenet AL, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2006JB004635; COURTILLOT V, 1986, EARTH PLANET SC LETT, V80, P361, DOI 10.1016/0012-821X(86)90118-4; Courtillot V, 2000, EARTH PLANET SC LETT, V182, P137, DOI 10.1016/S0012-821X(00)00238-7; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; COX KG, 1985, J PETROL, V26, P355, DOI 10.1093/petrology/26.2.355; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Hilgen FJ, 2010, EARTH PLANET SC LETT, V300, P139, DOI 10.1016/j.epsl.2010.09.044; Hofmann C, 2000, EARTH PLANET SC LETT, V180, P13, DOI 10.1016/S0012-821X(00)00159-X; Jay AE, 2008, J GEOL SOC LONDON, V165, P177, DOI 10.1144/0016-76492006-062; Keller G, 2012, EARTH PLANET SC LETT, V341, P211, DOI 10.1016/j.epsl.2012.06.021; Khadri S. F. R., 1988, M 10 DECCAN FLOOD BA, P281; Li LQ, 1998, GEOLOGY, V26, P995, DOI 10.1130/0091-7613(1998)026<0995:ADSWAT>2.3.CO;2; Macleod N, 1997, J GEOL SOC LONDON, V154, P265, DOI 10.1144/gsjgs.154.2.0265; Mussard M, 2014, GEOL SOC AM SPEC PAP, V505, P339, DOI 10.1130/2014.2505(17); Punekar J, 2014, GEOL SOC AM SPEC PAP, V505, P91, DOI 10.1130/2014.2505(04); Renne PR, 2013, SCIENCE, V339, P684, DOI 10.1126/science.1230492; Robinson N, 2009, EARTH PLANET SC LETT, V281, P159, DOI 10.1016/j.epsl.2009.02.019; Schoene B, 2010, GEOLOGY, V38, P387, DOI 10.1130/G30683.1; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Self S, 2008, SCIENCE, V319, P1654, DOI 10.1126/science.1152830; Simon JI, 2008, EARTH PLANET SC LETT, V266, P182, DOI 10.1016/j.epsl.2007.11.014; VANDAMME D, 1992, PHYS EARTH PLANET IN, V74, P241, DOI 10.1016/0031-9201(92)90013-L; Westerhold T, 2008, PALAEOGEOGR PALAEOCL, V257, P377, DOI 10.1016/j.palaeo.2007.09.016; Widdowson M, 1997, PALAEOSURFACES RECOG, V120, P269, DOI DOI 10.1144/GSL.SP.1997.120.01.17; Wilf P, 2003, P NATL ACAD SCI USA, V100, P599, DOI 10.1073/pnas.0234701100; Wilson G. P., 2014, GEOLOGICAL SOC AM SP, V503, P365, DOI [DOI 10.1130/2014.2503(15), 10.1130/2014.2503(15)]; Wilson GP, 2014, GEOL SOC AM SPEC PAP, V503, DOI [10.1130/2014.2503(10), DOI 10.1130/2014.2503(10)]	33	292	299	9	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					182	184		10.1126/science.aaa0118	http://dx.doi.org/10.1126/science.aaa0118			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25502315				2022-12-28	WOS:000347918900045
J	Steffen, R; Hill, DR; DuPont, HL				Steffen, Robert; Hill, David R.; DuPont, Herbert L.			Traveler's Diarrhea A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ENTEROTOXIGENIC ESCHERICHIA-COLI; NORTH-AMERICAN TRAVELERS; IRRITABLE-BOWEL-SYNDROME; SINGLE-NUCLEOTIDE POLYMORPHISM; PLACEBO-CONTROLLED TRIAL; LONG-TERM TRAVELERS; DOUBLE-BLIND; UNITED-STATES; INFECTIOUS-DISEASES; BACTERIAL ENTEROPATHOGENS	IMPORTANCE Acute diarrhea is the most common illness that affects travelers to low-income regions of the world. Although improved hygiene has reduced the risk of traveler's diarrhea in many destinations, the risk remains high in others. OBJECTIVE To review the current state of knowledge on the etiology, risk factors, prevention, and management of traveler's diarrhea. EVIDENCE REVIEW A search of the PubMed, Google Scholar, and Cochrane Library databases for the period 2012-April 2014 was performed for articles on traveler's diarrhea. The database search yielded 2976 articles, of which 37 were included in this review. These were added to 85 articles previously identified by the authors. FINDINGS Improved hygiene has reduced the risk of traveler's diarrhea from 20% or more (for a 2-week stay) to between 8% and 20% in some parts of the world. Acquiring traveler's diarrhea causes 12% to 46% of travelers to change their travel plans. Returning travelers seeking medical care have a diagnosis of gastrointestinal disturbance in approximately one-third of all cases. Postinfectious irritable bowel syndrome may occur in 3% to 17% of patients who have had traveler's diarrhea. Prevention of traveler's diarrhea by dietary avoidance measures is often not successful. Chemoprophylaxis should be restricted to travelers who are at risk of severe complications of diarrhea. Ciprofloxacin is the standard treatment in self-therapy of traveler's diarrhea except when patients are in South or Southeast Asia, where azithromycin is preferred. CONCLUSIONS AND RELEVANCE Diarrhea remains a common problem for international travelers. Persons intending to travel to at-risk countries should be counseled regarding prevention measures and may be given a travel pack that includes medications for self-treatment should they become ill.	[Steffen, Robert] Univ Zurich, Epidemiol Biostat & Prevent Inst, Div Communicable Dis, WHO Collaborating Ctr Travellers Hlth, CH-8001 Zurich, Switzerland; [Steffen, Robert; DuPont, Herbert L.] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Steffen, Robert; DuPont, Herbert L.] Univ Texas Houston, Sch Med, Houston, TX USA; [Hill, David R.] Quinnipiac Univ, Frank H Netter MD Sch Med, Global Publ Hlth Program, Hamden, CT USA; [DuPont, Herbert L.] Baylor St Lukes Med Ctr, Houston, TX USA; [DuPont, Herbert L.] Baylor Coll Med, Houston, TX 77030 USA	University of Zurich; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; Quinnipiac University; Baylor College of Medicine	Steffen, R (corresponding author), Univ Zurich, Travel Hlth Ctr, Hirschengraben 84-E29, CH-8001 Zurich, Switzerland.	roste@ifspm.uzh.ch	DuPont, Herbert/AAH-6776-2021		Dr Falk Pharmaceuticals; Merck; Cubist; Salix Pharmaceuticals; Satarus; Sanofi Pasteur; GlaxoSmithKline; Viropharma	Dr Falk Pharmaceuticals; Merck(Merck & Company); Cubist; Salix Pharmaceuticals; Satarus; Sanofi Pasteur; GlaxoSmithKline(GlaxoSmithKline); Viropharma	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Steffen reports receipt of consulting fees/honoraria and support for travel from Dr Falk Pharmaceuticals and payment for lectures/speakers bureaus and support for travel from various vaccine producers unrelated to traveler's diarrhea. Dr DuPont reports consultancy for Salix Pharmaceuticals and Cubist and payment for lectures/speakers bureaus from Merck, Cubist, and Salix Pharmaceuticals (paid to him) as well as consultancy for Merck and GlaxoSmithKline and grants from Satarus, Sanofi Pasteur, GlaxoSmithKline, and Viropharma (paid to his institution).	Al-Abri SS, 2005, LANCET INFECT DIS, V5, P349, DOI 10.1016/S1473-3099(05)70139-0; Alajbegovic S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-39; Allen SJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003048.pub3; Angst, 1997, J Travel Med, V4, P118, DOI 10.1111/j.1708-8305.1997.tb00797.x; Antikainen J, 2013, CLIN GASTROENTEROL H, V11, P1300, DOI 10.1016/j.cgh.2013.03.037; Anwar E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001261.pub3; Ashley DVM, 2004, J TRAVEL MED, V11, P364, DOI 10.2310/7060.2004.19205; Baaten GG, 2011, J TRAVEL MED, V18, P318, DOI 10.1111/j.1708-8305.2011.00543.x; BANDRES JC, 1988, ARCH INTERN MED, V148, P2261, DOI 10.1001/archinte.148.10.2261; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Belderok SM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-295; Bottieau E, 2011, ACTA CLIN BELG, V66, P191, DOI 10.2143/ACB.66.3.2062545; Caeiro JP, 1999, CLIN INFECT DIS, V28, P1286, DOI 10.1086/514786; Cartwright RY, 2003, J APPL MICROBIOL, V94, p12S, DOI 10.1046/j.1365-2672.94.s1.2.x; Chongsuvivatwong V, 2009, J TRAVEL MED, V16, P179, DOI 10.1111/j.1708-8305.2009.00331.x; Connor BA, 2013, J TRAVEL MED, V20, P303, DOI 10.1111/jtm.12049; De Bruyn G, 2000, COCHRANE DB SYST REV, DOI 10.1002/; DICKENS DL, 1985, JAMA-J AM MED ASSOC, V253, P3141, DOI 10.1001/jama.253.21.3141; Dupont HL, 2009, ALIMENT PHARM THER, V30, P187, DOI 10.1111/j.1365-2036.2009.04028.x; DuPont HL, 2007, J TRAVEL MED, V14, P16, DOI 10.1111/j.1708-8305.2006.00084.x; DuPont HL, 2014, J TRAVEL MED, V21, P369, DOI 10.1111/jtm.12168; DuPont HL, 2014, NEW ENGL J MED, V370, P1532, DOI 10.1056/NEJMra1301069; DuPont HL, 2010, AM J TROP MED HYG, V82, P301, DOI 10.4269/ajtmh.2010.09-0538; DuPont HL, 2009, J TRAVEL MED, V16, P149, DOI 10.1111/j.1708-8305.2008.00299.x; DuPont HL, 2009, J TRAVEL MED, V16, P161, DOI 10.1111/j.1708-8305.2009.00300.x; DuPont HL, 2005, ANN INTERN MED, V142, P805, DOI 10.7326/0003-4819-142-10-200505170-00005; DUPONT HL, 1982, NEW ENGL J MED, V307, P841, DOI 10.1056/NEJM198209303071401; DuPont HL, 2001, CLIN INFECT DIS, V33, P1807, DOI 10.1086/323814; DUPONT HL, 1977, GASTROENTEROLOGY, V73, P715; DUPONT HL, 1987, JAMA-J AM MED ASSOC, V257, P1347, DOI 10.1001/jama.257.10.1347; Fletcher SM, 2009, J TRAVEL MED, V16, P35, DOI 10.1111/j.1708-8305.2008.00271.x; Flores J, 2008, CLIN VACCINE IMMUNOL, V15, P1194, DOI 10.1128/CVI.00070-08; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Freedman Stephen B, 2013, Evid Based Child Health, V8, P1123, DOI 10.1002/ebch.1932; Galbadage T, 2009, AM J TROP MED HYG, V80, P20, DOI 10.4269/ajtmh.2009.80.20; Gautret P, 2012, J TRAVEL MED, V19, P169, DOI 10.1111/j.1708-8305.2012.00613.x; GORBACH SL, 1975, NEW ENGL J MED, V292, P933, DOI 10.1056/NEJM197505012921801; GORDON MF, 1995, MOVEMENT DISORD, V10, P220, DOI 10.1002/mds.870100215; Greenaway C., 2014, CAN COMMUN DIS REP, V40, P60, DOI [10.14745/ccdr.v40i04a01, DOI 10.14745/CCDR.V40I04A01]; Greenwood Z, 2008, J TRAVEL MED, V15, P221, DOI 10.1111/j.1708-8305.2008.00203.x; GROSS PA, 1994, CLIN INFECT DIS, V18, P421, DOI 10.1093/clinids/18.3.421; Hadler JL, 2011, CLIN INFECT DIS, V53, P269, DOI 10.1093/cid/cir377; Hagmann S, 2010, PEDIATRICS, V125, pE1072, DOI 10.1542/peds.2009-1951; Harris JB, 2005, INFECT IMMUN, V73, P7422, DOI 10.1128/IAI.73.11.7422-7427.2005; Health Protection Agency, 2010, FOR TRAV ASS ILLN FO; Herbinger KH, 2012, J TRAVEL MED, V19, P150, DOI 10.1111/j.1708-8305.2011.00589.x; Hill DR, 2006, CLIN INFECT DIS, V43, P1499, DOI 10.1086/508782; Hill DR, 2006, LANCET INFECT DIS, V6, P361, DOI 10.1016/S1473-3099(06)70494-7; Hill DR, 2010, CURR OPIN INFECT DIS, V23, P481, DOI 10.1097/QCO.0b013e32833dfca5; Hill DR, 2000, AM J TROP MED HYG, V62, P585, DOI 10.4269/ajtmh.2000.62.585; Hlavsa MC, 2014, MMWR-MORBID MORTAL W, V63, P6; Hopkins KL, 2014, INT J ANTIMICROB AG, V43, P431, DOI 10.1016/j.ijantimicag.2014.01.026; Hu YM, 2012, J TRAVEL MED, V19, P352, DOI 10.1111/j.1708-8305.2012.00650.x; Huang DB, 2004, J TRAVEL MED, V11, P143, DOI 10.2310/7060.2004.18560; Hunziker T, 2012, J TRAVEL MED, V19, P158, DOI 10.1111/j.1708-8305.2012.00611.x; Jackson BR, 2014, EPIDEMIOL INFECT, V142, P1089, DOI 10.1017/S0950268813001908; Jiang ZD, 2006, AM J GASTROENTEROL, V101, P1112, DOI 10.1111/j.1572-0241.2006.00482.x; Jiang ZD, 2003, J INFECT DIS, V188, P506, DOI 10.1086/377102; Jiang ZD, 2002, J INFECT DIS, V185, P497, DOI 10.1086/338834; Jiang ZD, 2010, J CLIN MICROBIOL, V48, P1417, DOI 10.1128/JCM.01709-09; JOHNSON PC, 1986, JAMA-J AM MED ASSOC, V255, P757, DOI 10.1001/jama.255.6.757; Kayman T, 2012, J MED MICROBIOL, V61, P1439, DOI 10.1099/jmm.0.044594-0; KEAN BH, 1963, ANN INTERN MED, V59, P605, DOI 10.7326/0003-4819-59-5-605; Kendall ME, 2012, CLIN INFECT DIS, V54, pS480, DOI 10.1093/cid/cis052; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Koo HL, 2008, CLIN INFECT DIS, V47, P218, DOI 10.1086/589249; Koo HL, 2010, J CLIN MICROBIOL, V48, P1673, DOI 10.1128/JCM.02072-09; KOZICKI M, 1985, INT J EPIDEMIOL, V14, P169, DOI 10.1093/ije/14.1.169; Laaveri T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-81; Launders NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083425; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lundkvist J, 2009, J TRAVEL MED, V16, P28, DOI 10.1111/j.1708-8305.2008.00270.x; Mandisodza O, 2012, NEW ZEAL MED J, V125, P40; McFarland Lynne V, 2007, Travel Med Infect Dis, V5, P97, DOI 10.1016/j.tmaid.2005.10.003; McGregor AC, 2012, T ROY SOC TROP MED H, V106, P549, DOI 10.1016/j.trstmh.2012.04.008; Meraz IM, 2008, J TRAVEL MED, V15, P412, DOI 10.1111/j.1708-8305.2008.00249.x; Mohamed JA, 2007, CLIN INFECT DIS, V44, P945, DOI 10.1086/512199; Mohamed JA, 2011, CLIN INFECT DIS, V52, P1332, DOI 10.1093/cid/cir228; Mohamed JA, 2009, J INFECT DIS, V199, P477, DOI 10.1086/596319; Mues KE, 2014, CLIN INFECT DIS, V58, P546, DOI 10.1093/cid/cit746; Mutsch M, 2014, J TRAVEL MED, V21, P141, DOI 10.1111/jtm.12094_1; Nair P, 2014, J TRAVEL MED, V21, P153, DOI 10.1111/jtm.12114; Neuberger A, 2013, J TRAVEL MED, V20, P37, DOI 10.1111/j.1708-8305.2012.00676.x; Okhuysen PC, 2004, AM J GASTROENTEROL, V99, P1774, DOI 10.1111/j.1572-0241.2004.30435.x; Ouyang-Latimer J, 2011, ANTIMICROB AGENTS CH, V55, P874, DOI 10.1128/AAC.00739-10; Pandey P, 2011, J TRAVEL MED, V18, P102, DOI 10.1111/j.1708-8305.2010.00475.x; Paredes-Paredes M, 2011, J TRAVEL MED, V18, P121, DOI 10.1111/j.1708-8305.2010.00488.x; Pitzurra R, 2011, J TRAVEL MED, V18, P250, DOI 10.1111/j.1708-8305.2011.00529.x; Pitzurra R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-231; Piyaphanee W, 2011, J TRAVEL MED, V18, P109, DOI 10.1111/j.1708-8305.2010.00484.x; Pollett S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-193; RADEMAKER CMA, 1989, EUR J CLIN MICROBIOL, V8, P690, DOI 10.1007/BF01963753; Rao G, 2004, J TRAVEL MED, V11, P239, DOI 10.2310/7060.2004.19008; Riddle MS, 2008, CLIN INFECT DIS, V47, P1007, DOI 10.1086/591703; Riddle MS, 2006, AM J TROP MED HYG, V74, P891, DOI 10.4269/ajtmh.2006.74.891; Riddle MS, 2014, J TRAVEL MED, V21, P365, DOI 10.1111/jtm.12162; Ritchie ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034938; Ross AGP, 2013, NEW ENGL J MED, V368, P1817, DOI 10.1056/NEJMra1207777; Ruiz J, 2013, LANCET INFECT DIS, V13, P911, DOI 10.1016/S1473-3099(13)70243-3; SALAM I, 1994, LANCET, V344, P1537, DOI 10.1016/S0140-6736(94)90350-6; Salari Pooneh, 2012, Inflammation & Allergy Drug Targets, V11, P3; Schlagenhauf P, 2010, CLIN INFECT DIS, V50, P826, DOI 10.1086/650575; Sebeny PJ, 2012, AM J TROP MED HYG, V87, P312, DOI 10.4269/ajtmh.2012.11-0318; Shah N, 2009, AM J TROP MED HYG, V80, P609, DOI 10.4269/ajtmh.2009.80.609; Shlim DR, 2005, CLIN INFECT DIS, V41, pS531, DOI 10.1086/432947; Soller JA, 2010, WATER RES, V44, P4736, DOI 10.1016/j.watres.2010.07.064; Soonawala D, 2014, AM J TROP MED HYG, V90, P835, DOI 10.4269/ajtmh.13-0594; Soonawala D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-322; Steffen R, 2005, CLIN INFECT DIS, V41, pS536, DOI 10.1086/432948; Steffen R, 2004, J TRAVEL MED, V11, P231, DOI 10.2310/7060.2004.19007; STEFFEN R, 1983, JAMA-J AM MED ASSOC, V249, P1176; Stermer E, 2006, CLIN INFECT DIS, V43, P898, DOI 10.1086/507540; Svennerholm AM, 2012, EXPERT REV VACCINES, V11, P495, DOI [10.1586/erv.12.12, 10.1586/ERV.12.12]; Swaminathan A, 2009, J INFECTION, V59, P19, DOI 10.1016/j.jinf.2009.05.008; Taylor DN, 2006, AM J TROP MED HYG, V74, P1060, DOI 10.4269/ajtmh.2006.74.1060; Taylor DN, 2006, CLIN INFECT DIS, V42, P1283, DOI 10.1086/503039; Teague NS, 2010, J TRAVEL MED, V17, P118, DOI 10.1111/j.1708-8305.2009.00388.x; Tribble DR, 2007, CLIN INFECT DIS, V44, P338, DOI 10.1086/510589; Virk A, 2013, J TRAVEL MED, V20, P88, DOI 10.1111/jtm.12008; Wieten RW, 2012, J TRAVEL MED, V19, P104, DOI 10.1111/j.1708-8305.2011.00594.x; Wikswo ME, 2011, CLIN INFECT DIS, V52, P1116, DOI 10.1093/cid/cir144; Youmans BP, 2014, AM J TROP MED HYG, V90, P124, DOI 10.4269/ajtmh.13-0383; Zanger P, 2013, LANCET INFECT DIS, V13, P946, DOI 10.1016/S1473-3099(13)70221-4	124	193	197	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					71	80		10.1001/jama.2014.17006	http://dx.doi.org/10.1001/jama.2014.17006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25562268				2022-12-28	WOS:000347478000017
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Rectal feeding is torture masquerading as medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Lifton RJ, 2004, NEW ENGL J MED, V351, P415, DOI 10.1056/NEJMp048065; Rubenstein JD, 2005, JAMA-J AM MED ASSOC, V294, P1544; Short AR, 1913, BRIT MED J, V1913, P1361, DOI 10.1136/bmj.1.2739.1361; United States Senate, 2014, 113288 US SEN	4	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 31	2014	349								g7859	10.1136/bmj.g7859	http://dx.doi.org/10.1136/bmj.g7859			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY4JO	25552464	Bronze, Green Published			2022-12-28	WOS:000347544400006
J	Smith, JM				Smith, Jeanette M.			Oxen and Logging Wagon (1) Maud Lewis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2014	312	24					2596	2597		10.1001/jama.2013.279909	http://dx.doi.org/10.1001/jama.2013.279909			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX5KW	25536239				2022-12-28	WOS:000346966100001
J	Hwang, KC; Sagadevan, A				Hwang, Kuo Chu; Sagadevan, Arunachalam			One-pot room-temperature conversion of cyclohexane to adipic acid by ozone and UV light	SCIENCE			English	Article							CATALYTIC-OXIDATION; BOND; HYDROCARBONS; PHOTOLYSIS; H2O2	Nitric acid oxidation of cyclohexane accounts for similar to 95% of the worldwide adipic acid production and is also responsible for similar to 5 to 8% of the annual worldwide anthropogenic emission of the ozone-depleting greenhouse gas nitrous oxide (N2O). Here we report a N2O-free process for adipic acid synthesis. Treatment of neat cyclohexane, cyclohexanol, or cyclohexanone with ozone at room temperature and 1 atmosphere of pressure affords adipic acid as a solid precipitate. Addition of acidic water or exposure to ultraviolet (UV) light irradiation (or a combination of both) dramatically enhances the oxidative conversion of cyclohexane to adipic acid.	[Hwang, Kuo Chu; Sagadevan, Arunachalam] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan	National Tsing Hua University	Hwang, KC (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan.	kchwang@mx.nthu.edu.tw	ARUNACHALAM, SAGADEVAN/Y-2884-2018; Hwang, Kuo Chu/AAG-8217-2021	ARUNACHALAM, SAGADEVAN/0000-0001-9486-1706; 	Ministry of Science and Technology, Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	We are grateful for financial support from the Ministry of Science and Technology, Taiwan. K.C.H. conceived the idea, designed the experiments, and wrote the manuscript. A.S. conducted the experiments. Metrical parameters for the x-ray structures of 2b and 2g are available free of charge from the Cambridge Crystallographic Data Centre under accession numbers CCDC 1025098 and CCDC 1025099, respectively. A patent application is pending.	[Anonymous], 2014, AD AC ADPA 2014 WORL; Barletta B, 1998, OZONE-SCI ENG, V20, P91, DOI 10.1080/01919519808547278; Blanksby SJ, 2003, ACCOUNTS CHEM RES, V36, P255, DOI 10.1021/ar020230d; Bohstrom Z, 2010, GREEN CHEM, V12, P1861, DOI 10.1039/c0gc00032a; CASTELLAN A, 1991, CATAL TODAY, V9, P237, DOI 10.1016/0920-5861(91)80049-F; Cavani F, 2009, CHEMSUSCHEM, V2, P508, DOI 10.1002/cssc.200900020; Chan SI, 2012, J CATAL, V293, P186, DOI 10.1016/j.jcat.2012.06.024; Chauvel A., 1989, PETROCHEMICAL PROCES; Chen K, 2009, ANGEW CHEM INT EDIT, V48, P9705, DOI 10.1002/anie.200904474; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Davies HML, 2000, J AM CHEM SOC, V122, P3063, DOI 10.1021/ja994136c; Deng YQ, 1999, GREEN CHEM, V1, P275, DOI 10.1039/a908889j; DRATHS KM, 1994, J AM CHEM SOC, V116, P399, DOI 10.1021/ja00080a057; FinlaysonPitts BJ, 1997, SCIENCE, V276, P1045, DOI 10.1126/science.276.5315.1045; Fun HK, 2014, MOLECULES, V19, P10137, DOI 10.3390/molecules190710137; Hoops MD, 2009, J MOL STRUCT, V929, P22, DOI 10.1016/j.molstruc.2009.04.003; Ignatyev I, 2011, PHYS CHEM CHEM PHYS, V13, P18507, DOI 10.1039/c1cp21580a; Matsumi Y, 2003, CHEM REV, V103, P4767, DOI 10.1021/cr0205255; Matsumi Y, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000510; MICHAUD P, 1972, J PHYS CHEM-US, V76, P1375, DOI 10.1021/j100653a027; Newhouse T, 2011, ANGEW CHEM INT EDIT, V50, P3362, DOI 10.1002/anie.201006368; REIMER RA, 1994, ENVIRON PROG, V13, P134, DOI 10.1002/ep.670130217; Reisz E, 2003, ENVIRON SCI TECHNOL, V37, P1941, DOI 10.1021/es0113100; Sato K, 1998, SCIENCE, V281, P1646, DOI 10.1126/science.281.5383.1646; Schneider L., 2010, IND N2O PROJECTS CDM; Schuchardt U, 2001, APPL CATAL A-GEN, V211, P1, DOI 10.1016/S0926-860X(01)00472-0; Timofeeva MN, 2008, APPL CATAL A-GEN, V345, P195, DOI 10.1016/j.apcata.2008.04.039; Van de Vyver S, 2013, CATAL SCI TECHNOL, V3, P1465, DOI 10.1039/c3cy20728e; VARKONY H, 1974, J CHEM SOC CHEM COMM, P437, DOI 10.1039/c39740000437; VARKONY TH, 1975, J CHEM SOC CHEM COMM, P457, DOI 10.1039/c39750000457; Wen YQ, 2012, GREEN CHEM, V14, P2868, DOI 10.1039/c2gc35677e	31	67	70	9	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1495	1498		10.1126/science.1259684	http://dx.doi.org/10.1126/science.1259684			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525242				2022-12-28	WOS:000346536500059
J	Joh, NH; Wang, T; Bhate, MP; Acharya, R; Wu, YB; Grabe, M; Hong, M; Grigoryan, G; DeGrado, WF				Joh, Nathan H.; Wang, Tuo; Bhate, Manasi P.; Acharya, Rudresh; Wu, Yibing; Grabe, Michael; Hong, Mei; Grigoryan, Gevorg; DeGrado, William F.			De novo design of a transmembrane Zn2+-transporting four-helix bundle	SCIENCE			English	Article							COLI ZINC TRANSPORTER; SOLID-STATE NMR; MEMBRANE-PROTEINS; COMPUTATIONAL DESIGN; DIIRON PROTEINS; SPIN-DIFFUSION; BINDING; HELICES; MODEL; ASSOCIATION	The design of functional membrane proteins from first principles represents a grand challenge in chemistry and structural biology. Here, we report the design of a membrane-spanning, four-helical bundle that transports first-row transition metal ions Zn2+ and Co2+, but not Ca2+, across membranes. The conduction path was designed to contain two di-metal binding sites that bind with negative cooperativity. X-ray crystallography and solid-state and solution nuclear magnetic resonance indicate that the overall helical bundle is formed from two tightly interacting pairs of helices, which form individual domains that interact weakly along a more dynamic interface. Vesicle flux experiments show that as Zn2+ ions diffuse down their concentration gradients, protons are antiported. These experiments illustrate the feasibility of designing membrane proteins with predefined structural and dynamic properties.	[Joh, Nathan H.; Bhate, Manasi P.; Wu, Yibing; Grabe, Michael; DeGrado, William F.] Univ Calif San Francisco, Dept Pharmaceut Chem, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Wang, Tuo; Hong, Mei] MIT, Dept Chem, Cambridge, MA 02139 USA; [Acharya, Rudresh] Natl Inst Sci Educ & Res, Sch Biol Sci, Bhubaneswar, Odisha, India; [Grigoryan, Gevorg] Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA; [Grigoryan, Gevorg] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); National Institute of Science Education & Research (NISER); Dartmouth College; Dartmouth College	DeGrado, WF (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	michael.grabe@ucsf.edu; meihong@mit.edu; gevorg.grigoryan@dartmouth.edu; william.degrado@ucsf.edu	Acharya, Rudresh/AAD-1247-2021	Acharya, Rudresh/0000-0002-9012-9849; Hong, Mei/0000-0001-5255-5858; /0000-0002-1801-924X; Joh, Nathan/0000-0003-3221-9325	NIH [F32 GM096727, R01 GM089740, R01 GM088204, R01 GM054616]; XSEDE [MCB080011]; Jane Coffin Childs postdoctoral fellowship; Ramalingaswami Fellowship from the Department of Biotechnology, India; Alfred P. Sloan Foundation Research Fellowship; NSF [DMR 1120901]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088204, F32GM096727, R01GM089740, R01GM054616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); XSEDE; Jane Coffin Childs postdoctoral fellowship; Ramalingaswami Fellowship from the Department of Biotechnology, India; Alfred P. Sloan Foundation Research Fellowship(Alfred P. Sloan Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Authors acknowledge J. Holton and G. Meigs at The Lawrence Berkeley National Laboratory Advanced Light Source 8.3.1; K. Rajashankar, S. Banerjee, and I. Kourinov at Argonne National Laboratory Advanced Photon Source Northeastern Collaborative Access Team for technical support in x-ray data collection; and O. P. Choudhary and J. L. Adelman at the University of Pittsburgh for helpful discussions regarding the simulations. Simulations were carried out in part with XSEDE resources through grant MCB080011 to M.G. This work was supported by NIH F32 GM096727 to N.H.J., The Jane Coffin Childs postdoctoral fellowship to MPB; Ramalingaswami Fellowship from the Department of Biotechnology, India, to R.A.; NIH R01 GM089740 to M.G.; NIH R01 GM088204 to M.H.; Alfred P. Sloan Foundation Research Fellowship to G. G.; NIH R01 GM054616 to W.F.D.; and NSF DMR 1120901 (W.F.D.). The coordinates for the x-ray structures with space groups, P43212, I4122, and I213, are deposited in the Protein Data Bank (PDB) with accession codes, 4P6J, 4P6K, and 4P6L, respectively. The SSNMR structure is deposited in PDB with an accession code, 2MUZ.	Buffy JJ, 2005, J AM CHEM SOC, V127, P4477, DOI 10.1021/ja043621r; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Chao Y, 2004, J BIOL CHEM, V279, P17173, DOI 10.1074/jbc.M400208200; Cobo MF, 2012, J MAGN RESON, V221, P85, DOI 10.1016/j.jmr.2012.05.003; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P685, DOI 10.1107/S0365110X53001952; Cristian L, 2003, P NATL ACAD SCI USA, V100, P14772, DOI 10.1073/pnas.2536751100; Deazevedo ER, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2831798; deAzevedo ER, 1999, J AM CHEM SOC, V121, P8411, DOI 10.1021/ja992022v; DEGRADO WF, 1989, SCIENCE, V243, P622, DOI 10.1126/science.2464850; Grigoryan G, 2013, J COMPUT CHEM, V34, P2726, DOI 10.1002/jcc.23448; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Hong M, 2006, STRUCTURE, V14, P1731, DOI 10.1016/j.str.2006.10.002; Hong M, 2012, PROTEIN SCI, V21, P1620, DOI 10.1002/pro.2158; Huster D, 2002, J AM CHEM SOC, V124, P874, DOI 10.1021/ja017001r; Irving R.J.P.W.H.M.N.H., 1953, J CHEM SOC, P3192; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kiss G, 2013, ANGEW CHEM INT EDIT, V52, P5700, DOI 10.1002/anie.201204077; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Korendovych IV, 2010, J AM CHEM SOC, V132, P15516, DOI 10.1021/ja107487b; Lazaridis T, 2003, PROTEINS, V52, P176, DOI 10.1002/prot.10410; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; Lombardi A, 2000, P NATL ACAD SCI USA, V97, P6298, DOI 10.1073/pnas.97.12.6298; MacKenzie KR, 2008, CURR OPIN STRUC BIOL, V18, P412, DOI 10.1016/j.sbi.2008.04.007; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Pasternak A, 2001, PROTEIN SCI, V10, P958, DOI 10.1110/ps.52101; Perez-Aguilar JM, 2012, STRUCTURE, V20, P5, DOI 10.1016/j.str.2011.12.003; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Reig AJ, 2012, NAT CHEM, V4, P900, DOI [10.1038/NCHEM.1454, 10.1038/nchem.1454]; Schramm CA, 2012, STRUCTURE, V20, P924, DOI 10.1016/j.str.2012.03.016; Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020; Summa CM, 1999, CURR OPIN STRUC BIOL, V9, P500, DOI 10.1016/S0959-440X(99)80071-2; Summa CM, 2002, J MOL BIOL, V321, P923, DOI 10.1016/S0022-2836(02)00589-2; Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443; Unterreitmeier S, 2007, J MOL BIOL, V374, P705, DOI 10.1016/j.jmb.2007.09.056; Zastrow ML, 2013, COORDIN CHEM REV, V257, P2565, DOI 10.1016/j.ccr.2013.02.007; Zastrow ML, 2013, J AM CHEM SOC, V135, P5895, DOI 10.1021/ja401537t; Zastrow ML, 2012, NAT CHEM, V4, P118, DOI [10.1038/NCHEM.1201, 10.1038/nchem.1201]; Zhang Y, 2009, J AM CHEM SOC, V131, P11341, DOI 10.1021/ja904625b	42	206	216	5	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1520	1524		10.1126/science.1261172	http://dx.doi.org/10.1126/science.1261172			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525248	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000346536500066
J	Krug, RM				Krug, Robert M.			INFLUENZA An RNA-synthesizing machine	NATURE			English	Editorial Material							CAP; ENDONUCLEASE; RESISTANCE; SUBUNIT		Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Ctr Infect Dis, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Krug, RM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Ctr Infect Dis, Austin, TX 78712 USA.	rkrug@austin.utexas.edu			NIAID NIH HHS [R01 AI011772] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI011772] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Cauldwell AV, 2014, J GEN VIROL, V95, P1193, DOI 10.1099/vir.0.062836-0; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Lescar J, 2009, CURR OPIN STRUC BIOL, V19, P759, DOI 10.1016/j.sbi.2009.10.011; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; PLOTCH SJ, 1979, P NATL ACAD SCI USA, V76, P1618, DOI 10.1073/pnas.76.4.1618; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Reid AH, 2001, MICROBES INFECT, V3, P81, DOI 10.1016/S1286-4579(00)01351-4; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	12	4	5	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					338	339		10.1038/516338a	http://dx.doi.org/10.1038/516338a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25519129				2022-12-28	WOS:000346484800035
J	LeWinter, MM				LeWinter, Martin M.			Acute Pericarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC RECURRENT PERICARDITIS; RANDOMIZED-TRIAL; COLCHICINE; MANAGEMENT; MULTICENTER; EFFICACY; DISEASES; CORTICOSTEROIDS; GUIDELINES; DIAGNOSIS	A previously healthy 25-year-old man presents with pleuritic pain in the left side of the chest of 3 hours' duration, radiating to the left trapezius ridge and relieved by sitting forward. On physical examination, he appears anxious. His pulse is 104 beats per minute and regular, his blood pressure is 125/80 mm Hg without a paradoxical pulse, and his temperature is 37.8 degrees C. A three-component friction rub is auscultated along the left sternal border. An electrocardiogram (ECG) reveals ST-segment elevations in multiple leads, which are consistent with acute pericarditis. How should this case be managed?	[LeWinter, Martin M.] Univ Vermont, Coll Med, Cardiol Unit, Burlington, VT 05401 USA; [LeWinter, Martin M.] Univ Vermont, Med Ctr, Burlington, VT 05401 USA	University of Vermont; University of Vermont; University of Vermont Medical Center	LeWinter, MM (corresponding author), Univ Vermont, Med Ctr, Cardiol Unit, 111 Colchester Ave, Burlington, VT 05401 USA.	martin.lewinter@vtmednet.org						Artom G, 2005, EUR HEART J, V26, P723, DOI 10.1093/eurheartj/ehi197; Azam S, 2011, CARDIOVASC THER, V29, P308, DOI 10.1111/j.1755-5922.2010.00151.x; Brucato A, 2006, AM J CARDIOL, V98, P267, DOI 10.1016/j.amjcard.2006.01.086; Buiatti A, 2013, J CARDIOVASC MED, V14, P235, DOI 10.2459/JCM.0b013e328351da6e; Cantarini L, 2012, CLIN RES CARDIOL, V101, P525, DOI 10.1007/s00392-012-0422-8; Dudzinski DM, 2012, CURR PROB CARDIOLOGY, V37, P75, DOI 10.1016/j.cpcardiol.2011.10.002; Finetti M, 2014, J PEDIATR-US, V164, P1425, DOI 10.1016/j.jpeds.2014.01.065; Imazio M, 2004, J AM COLL CARDIOL, V43, P1042, DOI 10.1016/j.jacc.2003.09.055; Imazio M, 2007, AM J CARDIOL, V100, P1026, DOI 10.1016/j.amjcard.2007.04.047; Imazio M, 2014, LANCET, V383, P2232, DOI 10.1016/S0140-6736(13)62709-9; Imazio M, 2013, NEW ENGL J MED, V369, P1522, DOI 10.1056/NEJMoa1208536; Imazio M, 2013, CIRCULATION, V128, P42, DOI 10.1161/CIRCULATIONAHA.113.001531; Imazio M, 2013, HEART FAIL REV, V18, P355, DOI 10.1007/s10741-012-9328-9; Imazio M, 2011, CIRCULATION, V124, P1270, DOI 10.1161/CIRCULATIONAHA.111.018580; Imazio M, 2011, CIRCULATION, V123, P1092, DOI 10.1161/CIRCULATIONAHA.110.986372; Imazio M, 2010, CIRCULATION, V121, P916, DOI 10.1161/CIRCULATIONAHA.108.844753; Khandaker MH, 2010, MAYO CLIN PROC, V85, P572, DOI 10.4065/mcp.2010.0046; Kyto V, 2014, CIRCULATION; Lazaros G, 2011, CARDIOLOGY, V118, P55, DOI 10.1159/000324309; Lilly LS, 2013, CIRCULATION, V127, P1723, DOI 10.1161/CIRCULATIONAHA.111.066365; Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002; Moretti M, 2013, AM J CARDIOL, V112, P1493, DOI 10.1016/j.amjcard.2013.06.036; Gonzalez JCN, 2013, CLIN EXP RHEUMATOL, V31, P776; Rigante D, 2011, ANN MED, V43, P341, DOI 10.3109/07853890.2010.547212; Sa MI, 2009, CIRCULATION, V119, pE183, DOI 10.1161/CIRCULATIONAHA.108.771006; Seferovic PM, 2013, HEART FAIL REV, V18, P255, DOI 10.1007/s10741-012-9335-x; Shabetai R, 2003, PERICARDIUM; Thompson JL, 2009, ANN THORAC SURG, V88, P1546, DOI 10.1016/j.athoracsur.2009.08.003; Vianello F, 2011, INT J CARDIOL, V147, P477, DOI 10.1016/j.ijcard.2011.01.027	29	96	98	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2410	2416		10.1056/NEJMcp1404070	http://dx.doi.org/10.1056/NEJMcp1404070			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW7DX	25517707				2022-12-28	WOS:000346425800010
J	Voltz, R; Kamps, R; Greinwald, R; Hellmich, M; Hamacher, S; Becker, G; Kuhr, K; Gaertner, J				Voltz, Raymond; Kamps, Robert; Greinwald, Ralf; Hellmich, Martin; Hamacher, Stefanie; Becker, Gerhild; Kuhr, Kathrin; Gaertner, Jan			CHRISTMAS 2014: ON THE WARDS, IN THE SURGERY Silent night: retrospective database study assessing possibility of "weekend effect" in palliative care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY; DEATH; ADMISSION; ASSOCIATION; HOSPITALS; SERVICE; STROKE; RISK	Objective To compare the mortality of patients in a palliative care unit on working days with that on weekends and public holidays. Design Retrospective database study. Setting Palliative care unit in Germany. Population All admissions to palliative care unit between 1 January 1997 and 31 December 2008. Main outcome measure The impact of day type (working days or weekends and public holidays) on mortality was analysed using Poisson regression models. Results A total of 2565 admitted patients and 1325 deaths were recorded. Of the deaths, 448 (33.8%) occurred on weekends and public holidays. The mortality rate on weekends and public holidays was 18% higher than that on working days (mortality rate ratio 1.18, 95% confidence interval 1.05 to 1.32; P=0.005). Conclusion Patients in the palliative care unit were at higher risk of dying on weekends and public holidays. In the absence of a prospective study, the exact reasons for this correlation are unclear.	[Voltz, Raymond; Greinwald, Ralf] Univ Hosp Cologne, Dept Palliat Care, Cologne, Germany; [Kamps, Robert] Med Clin St Katharinen Hosp, Dept Palliat Care, Frechen, Germany; [Hellmich, Martin; Hamacher, Stefanie; Kuhr, Kathrin] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50931 Cologne, Germany; [Becker, Gerhild; Gaertner, Jan] Univ Hosp Freiburg, Dept Palliat Care, D-79106 Freiburg, Germany; [Becker, Gerhild; Gaertner, Jan] Competence Ctr Palliat Care, Baden Wurttemberg, Germany	University of Cologne; University of Cologne; University of Freiburg	Gaertner, J (corresponding author), Univ Hosp Freiburg, Dept Palliat Care, D-79106 Freiburg, Germany.	jan.gaertner@uniklinik-freiburg.de		Hellmich, Martin/0000-0001-5174-928X; Hamacher, Stefanie/0000-0003-2158-9101				ALSPACH JG, 2010, CRIT CARE NURSE, V30, P10; Anderson CI, 2012, J SURG RES, V177, P43, DOI 10.1016/j.jss.2012.05.007; Bejanyan N, 2010, CANCER-AM CANCER SOC, V116, P3614, DOI 10.1002/cncr.25086; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Cram P, 2004, AM J MED, V117, P151, DOI 10.1016/j.amjmed.2004.02.035; Fang JM, 2010, NEUROLOGY, V75, P1589, DOI 10.1212/WNL.0b013e3181fb84bc; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; Gaertner J, 2012, ONCOLOGIST, V17, P428, DOI 10.1634/theoncologist.2011-0326; Gallerani M, 2012, J VASC SURG, V55, P1247, DOI 10.1016/j.jvs.2011.11.133; Halm EA, 2001, NEW ENGL J MED, V345, P692, DOI 10.1056/NEJM200108303450911; Ibrahimou B, 2012, ARCH GYNECOL OBSTET, V286, P1349, DOI 10.1007/s00404-012-2463-7; Kirkwood BR, 2003, ESSENTIAL MED STAT, P249; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; Mohammed MA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-87; Palmer WL, 2012, ARCH NEUROL-CHICAGO, V69, P1296, DOI 10.1001/archneurol.2012.1030; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; Saposnik G, 2007, STROKE, V38, P1211, DOI 10.1161/01.STR.0000259622.78616.ea; Schneider EB, 2012, J SURG RES, V177, P295, DOI 10.1016/j.jss.2012.06.022; Schwierz C, 2009, DOES QUALITY HOSP TR; SHENG A, 1993, J GEN INTERN MED, V8, P573, DOI 10.1007/BF02599642; WHO Geneva, 2007, PALL CAR, P62	21	8	8	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2014	349								g7370	10.1136/bmj.g7370	http://dx.doi.org/10.1136/bmj.g7370			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HK	25515670	Green Published, hybrid			2022-12-28	WOS:000346763900009
J	Peng, Y; Li, YS; Ban, YJ; Jin, H; Jiao, WM; Liu, XL; Yang, WS				Peng, Yuan; Li, Yanshuo; Ban, Yujie; Jin, Hua; Jiao, Wenmei; Liu, Xinlei; Yang, Weishen			Metal-organic framework nanosheets as building blocks for molecular sieving membranes	SCIENCE			English	Article							GRAPHENE OXIDE MEMBRANES; HYDROGEN SEPARATION; COORDINATION POLYMER; HIGH-SELECTIVITY; ULTRATHIN	Layered metal-organic frameworks would be a diverse source of crystalline sheets with nanometer thickness for molecular sieving if they could be exfoliated, but there is a challenge in retaining the morphological and structural integrity. We report the preparation of 1-nanometer-thick sheets with large lateral area and high crystallinity from layered MOFs. They are used as building blocks for ultrathin molecular sieve membranes, which achieve hydrogen gas (H-2) permeance of up to several thousand gas permeation units (GPUs) with H-2/CO2 selectivity greater than 200. We found an unusual proportional relationship between H-2 permeance and H-2 selectivity for the membranes, and achieved a simultaneous increase in both permeance and selectivity by suppressing lamellar stacking of the nanosheets.	[Peng, Yuan; Li, Yanshuo; Ban, Yujie; Jin, Hua; Jiao, Wenmei; Liu, Xinlei; Yang, Weishen] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Catalysis, Dalian 116023, Peoples R China; [Peng, Yuan; Ban, Yujie; Jin, Hua; Jiao, Wenmei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; State Key Laboratory of Catalysis, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, YS (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Catalysis, 457 Zhongshan Rd, Dalian 116023, Peoples R China.	leeys@dicp.ac.cn; yangws@dicp.ac.cn	Li, Yanshuo/F-2526-2012; Jin, Hua/AAO-3563-2020; Yang, Weishen/P-1623-2014	Li, Yanshuo/0000-0002-7722-7962; Jin, Hua/0000-0001-5814-9607; Yang, Weishen/0000-0001-9615-7421; Ban, Yujie/0000-0002-7336-8514; Liu, Xinlei/0000-0001-7552-1597	National Natural Science Foundation of China; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank the National Natural Science Foundation of China and the Key Research Program of the Chinese Academy of Sciences for funding, L. Liu for experimental assistance in wet ball milling, S. Miao for experimental assistance in TEM and SAED, and H. Duan for experimental assistance in TG analysis. Y.P., Y.L., and W.Y. are inventors on a Chinese patent filed through the Dalian Institute of Chemical Physics (CN102974229A, "Exfoliation and application of two-dimensional layered metal-organic frameworks").	Carta M, 2013, SCIENCE, V339, P303, DOI 10.1126/science.1228032; Cheetham AK, 2006, CHEM COMMUN, P4780, DOI 10.1039/b610264f; de Vos RM, 1998, SCIENCE, V279, P1710, DOI 10.1126/science.279.5357.1710; Gallego A, 2013, ADV MATER, V25, P2141, DOI 10.1002/adma.201204676; Gin DL, 2011, SCIENCE, V332, P674, DOI 10.1126/science.1203771; Joshi RK, 2014, SCIENCE, V343, P752, DOI 10.1126/science.1245711; Junggeburth SC, 2013, J AM CHEM SOC, V135, P6157, DOI 10.1021/ja312567v; Kim WG, 2013, CHEM ENG SCI, V104, P908, DOI 10.1016/j.ces.2013.09.047; Lai ZP, 2003, SCIENCE, V300, P456, DOI 10.1126/science.1082169; Li H, 2013, SCIENCE, V342, P95, DOI 10.1126/science.1236686; Li PZ, 2011, CHEM COMMUN, V47, P8436, DOI 10.1039/c1cc12510a; Lin YS, 2002, SEPAR PURIF METHOD, V31, P229, DOI 10.1081/SPM-120017009; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Ockwig NW, 2007, CHEM REV, V107, P4078, DOI 10.1021/cr0501792; Park HB, 2007, SCIENCE, V318, P254, DOI 10.1126/science.1146744; Park KS, 2006, P NATL ACAD SCI USA, V103, P10186, DOI 10.1073/pnas.0602439103; Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030; Roth WJ, 2014, CHEM REV, V114, P4807, DOI 10.1021/cr400600f; Shiflett MB, 1999, SCIENCE, V285, P1902, DOI 10.1126/science.285.5435.1902; SING KSW, 1982, PURE APPL CHEM, V54, P2201, DOI 10.1351/pac198254112201; Tan JC, 2012, ACS NANO, V6, P615, DOI 10.1021/nn204054k; Varoon K, 2011, SCIENCE, V334, P72, DOI 10.1126/science.1208891; Wang HB, 2014, J MEMBRANE SCI, V450, P425, DOI 10.1016/j.memsci.2013.08.030; Yang QF, 2008, CRYSTENGCOMM, V10, P1531, DOI 10.1039/b806980h	24	1129	1164	101	2434	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1356	1359		10.1126/science.1254227	http://dx.doi.org/10.1126/science.1254227			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504718				2022-12-28	WOS:000346189600048
J	Howard, S				Howard, Sally			INDUSTRIAL DISASTERS Bhopal's legacy: three decades on and residents are still being poisoned	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												admin@sallyhoward.net						Amnesty International, 2014, IND VICT BHOP GAS LE; [Anonymous], 2014, HINDUSTAN TIMES 1115; BHANDARI NR, 1990, INDIAN J MED RES-B, V92, P28; Bozhok Y, 2006, CANCER, V107, P2559; Brown VJ, 2011, ENVIRON HEALTH PERSP, V119, pA306, DOI 10.1289/ehp.119-a306a; Dwivedi M, 1994, HLTH EFFECTS TOXIC G; Eckerman I., PREHOSP DISASTER MED, DOI [10.1017/s1049023x00014102, DOI 10.1017/S1049023X00014102]; Eckerman I., 2001, CHEM IND PUBLIC HLTH; Greenpeace, 2009, BHOP TIM; Johnson S., 2009, CONTAMINATION SOIL W; Raj A., MORBIDITY WOMEN CHIL; Reza D., 2010, GOVERNANCE NOW  0423; Sharma DC, 2013, LANCET, V382, P1870, DOI 10.1016/S0140-6736(13)62562-3; Union Carbide, OTH CIV P IND PUBL I; United Nations Human Rights Council, 2011, GUID PRINC BUS HUM R; United States Environmental Protection Agency, WHAT IS EPCRA	16	1	1	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2014	349								g7602	10.1136/bmj.g7602	http://dx.doi.org/10.1136/bmj.g7602			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3DK	25499143				2022-12-28	WOS:000346165500008
J	Al-Hussaini, A; Latif, F; Berry, S				Al-Hussaini, Ali; Latif, Farah; Berry, Sandeep			PICTURE QUIZ Ear pain, vesicular rash, and facial palsy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RAMSAY-HUNT-SYNDROME; HERPES-ZOSTER; GENICULATE GANGLION; GRADING SYSTEMS; PARALYSIS		[Al-Hussaini, Ali; Berry, Sandeep] Royal Glamorgan Hosp, Dept Otolaryngol Head & Neck Surg, Llantrisant CF72 8XR, Wales; [Latif, Farah] Univ Wales Hosp, Nephrol Dept, Cardiff CF4 4XW, S Glam, Wales	Cardiff University	Al-Hussaini, A (corresponding author), Royal Glamorgan Hosp, Dept Otolaryngol Head & Neck Surg, Llantrisant CF72 8XR, Wales.	alialhussaini@doctors.org.uk		/0000-0002-0576-9623				BURRES S, 1986, ARCH OTOLARYNGOL, V112, P755; Coulson S, 2011, OTOL NEUROTOL, V32, P1025, DOI 10.1097/MAO.0b013e3182255727; DEVRIESE PP, 1988, CLIN OTOLARYNGOL, V13, P289, DOI 10.1111/j.1365-2273.1988.tb01134.x; Grose C, 2002, PEDIATR INFECT DIS J, V21, P615, DOI 10.1097/00006454-200207000-00002; Gross G, 2003, J CLIN VIROL, V26, P277, DOI 10.1016/S1386-6532(03)00005-2; HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202; Hunt JR, 1907, J NERV MENT DIS, V34, P0073, DOI 10.1097/00005053-190702000-00001; Kang TS, 2002, OTOL NEUROTOL, V23, P767, DOI 10.1097/00129492-200209000-00026; Murakami S, 1997, ANN NEUROL, V41, P353, DOI 10.1002/ana.410410310; ROBILLARD RB, 1986, OTOLARYNG HEAD NECK, V95, P292, DOI 10.1177/01945998860953P105; Sweeney CJ, 2001, J NEUROL NEUROSUR PS, V71, P149, DOI 10.1136/jnnp.71.2.149; USCATEGUI T, 2008, COCHRANE DB SYST REV, V4; Wagner G, 2012, J DTSCH DERMATOL GES, V10, P238, DOI 10.1111/j.1610-0387.2012.07894.x; Whitley RJ, 2010, J CLIN VIROL, V48, pS20, DOI 10.1016/S1386-6532(10)70005-6	14	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2014	349								g7572	10.1136/bmj.g7572	http://dx.doi.org/10.1136/bmj.g7572			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3DF	25499558				2022-12-28	WOS:000346165000021
J	Bah, A; Vernon, RM; Siddiqui, Z; Krzeminski, M; Muhandiram, R; Zhao, C; Sonenberg, N; Kay, LE; Forman-Kay, JD				Bah, Alaji; Vernon, Robert M.; Siddiqui, Zeba; Krzeminski, Mickael; Muhandiram, Ranjith; Zhao, Charlie; Sonenberg, Nahum; Kay, Lewis E.; Forman-Kay, Julie D.			Folding of an intrinsically disordered protein by phosphorylation as a regulatory switch	NATURE			English	Article							TRANSLATION INITIATION; ORDER TRANSITION; BINDING; 4E-BP1; EIF4E; EUKARYOTES	Intrinsically disordered proteins play important roles in cell signalling, transcription, translation and cell cycle regulation(1.2). Although they lack stable tertiary structure, many intrinsically disordered proteins undergo disorder-to-order transitions upon binding to partners(3,4). Similarly, several folded proteins use regulated order-to-disorder transitions to mediate biological function(5,6). In principle, the function of intrinsically disordered proteins may be controlled by post-translational modifications that lead to structural changes such as folding, although this has not been observed. Here we show that multisite phosphorylation induces folding of the intrinsically disordered 4E-BP2, the major neural isoform of the family of three mammalian proteins that bind eIF4E and suppress cap-dependent translation initiation. In its non-phosphorylated state, 4E-BP2 interacts tightly with eIF4E using both a canonical YXXXXL Phi motif (starting at Y54) that undergoes a disorder-to-helix transition upon binding and a dynamic secondary binding site(7-11). We demonstrate that phosphorylation at T37 and T46 induces folding of residues P18-R62 of 4E-BP2 into a four-stranded beta-domain that sequesters the helical YXXXXL Phi motif into a partly buried beta-strand, blocking its accessibility to eIF4E. The folded state of pT37pT46 4E-BP2 is wealdy stable, decreasing affinity by 100-fold and leading to an order-to-disorder transition upon binding to eIF4E, whereas fully phosphorylated 4E-BP2 is more stable, decreasing affinity by a factor of approximately 4,000. These results highlight stabilization of a phosphorylation-induced fold as the essential mechanism for phospho-regulation of the 4E-BP:eIF4E interaction and exemplify a new mode of biological regulation mediated by intrinsically disordered proteins.	[Bah, Alaji; Vernon, Robert M.; Siddiqui, Zeba; Krzeminski, Mickael; Zhao, Charlie; Kay, Lewis E.; Forman-Kay, Julie D.] Hosp Sick Children, Mol Struct & Funct Program, Toronto, ON M5G 0A4, Canada; [Bah, Alaji; Vernon, Robert M.; Krzeminski, Mickael; Muhandiram, Ranjith; Kay, Lewis E.; Forman-Kay, Julie D.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Muhandiram, Ranjith; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; McGill University; McGill University; University of Toronto	Forman-Kay, JD (corresponding author), Hosp Sick Children, Mol Struct & Funct Program, Toronto, ON M5G 0A4, Canada.	forman@sickkids.ca		Forman-Kay, Julie/0000-0001-8265-972X; Zhao, Charlie Weige/0000-0002-8670-0985	Canadian Institutes of Health Research [MOP-114985, MOP-119579]; Canadian Cancer Society; Hospital for Sick Children; Canadian Institutes of Health Research (CIHR); CIHR Strategic Training Program in Protein Folding and Interaction Dynamics; Summer Research Program at the Hospital for Sick Children	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Hospital for Sick Children; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Strategic Training Program in Protein Folding and Interaction Dynamics(Canadian Institutes of Health Research (CIHR)); Summer Research Program at the Hospital for Sick Children	We thank R. Augustyniak, Z. Bozoky, V. Csizmok, J. Dawson and P. Farber for discussions, and A. Hansen for help in NMR data processing. A. Chong, R. Hudson and H. Lin are acknowledged for their technical expertise. This work was funded by grants from the Canadian Institutes of Health Research (MOP-114985, MOP-119579) and the Canadian Cancer Society to J.D.F.-K A.B. was partly supported by a Restracomp award from the Hospital for Sick Children and a post-doctoral fellowship from the Canadian Institutes of Health Research (CIHR). R.M.V. was partly supported by a post-doctoral fellowship from the CIHR Strategic Training Program in Protein Folding and Interaction Dynamics. Z.S. was partly supported by the Summer Research Program at the Hospital for Sick Children.	Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Espinoza-Fonseca LM, 2008, J AM CHEM SOC, V130, P12208, DOI 10.1021/ja803143g; Fletcher CM, 1998, BIOCHEMISTRY-US, V37, P9, DOI 10.1021/bi972494r; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Goddard T. D., 2006, SPARKY 3; Gosselin P, 2011, NUCLEIC ACIDS RES, V39, P3496, DOI 10.1093/nar/gkq1306; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Lukhele S, 2013, STRUCTURE, V21, P2186, DOI 10.1016/j.str.2013.08.030; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Mitrea DM, 2014, P NATL ACAD SCI USA, V111, P4466, DOI 10.1073/pnas.1321007111; Mitrea DM, 2013, FEBS LETT, V587, P1081, DOI 10.1016/j.febslet.2013.02.024; Mitrea DM, 2012, BIOCOMPUT-PAC SYM, P152; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Oulhen N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005070; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Schultz JE, 2013, TRENDS BIOCHEM SCI, V38, P538, DOI 10.1016/j.tibs.2013.08.005; Selenko P, 2008, NAT STRUCT MOL BIOL, V15, P321, DOI 10.1038/nsmb.1395; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tait S, 2010, P NATL ACAD SCI USA, V107, P17627, DOI 10.1073/pnas.1008242107; Theillet FX, 2012, J BIOMOL NMR, V54, P217, DOI 10.1007/s10858-012-9674-x; Tomoo K, 2006, J BIOCHEM, V140, P237, DOI 10.1093/jb/mvj143; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Vernon R, 2013, J BIOMOL NMR, V57, P117, DOI 10.1007/s10858-013-9772-4; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004	36	344	349	6	265	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					106	U240		10.1038/nature13999	http://dx.doi.org/10.1038/nature13999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25533957	Green Published			2022-12-28	WOS:000350304000045
J	Zarin, DA; Tse, T; Sheehan, J				Zarin, Deborah A.; Tse, Tony; Sheehan, Jerry			The Proposed Rule for US Clinical Trial Registration and Results Submission	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PUBLICATION		[Zarin, Deborah A.; Tse, Tony; Sheehan, Jerry] NIH, Natl Lib Med, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Zarin, DA (corresponding author), NIH, Natl Lib Med, US Dept HHS, Bldg 10, Bethesda, MD 20892 USA.			Tse, Tony/0000-0002-9906-6864	Intramural Research Program of the National Library of Medicine, National Institutes of Health; NATIONAL LIBRARY OF MEDICINE [ZIALM008926] Funding Source: NIH RePORTER	Intramural Research Program of the National Library of Medicine, National Institutes of Health; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Supported in part by the Intramural Research Program of the National Library of Medicine, National Institutes of Health.	[Anonymous], 2014, NPRM GLANC SUMM KEY; [Anonymous], 2005, GUID IND AC IN PRESS; [Anonymous], 2012, OFFICIAL J EUROPEAN; [Anonymous], 2014, FED REG, V79, P69599; [Anonymous], 2012, GUID IND INV SAF REP; [Anonymous], 2014, WHAT CHANG CURR PRAC; [Anonymous], 2013, 64 WMA GEN ASS FORT; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Earley A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001963; European Medicines Agency, 2013, EUR MED AG LAUNCH NE; Hillman SL, 2010, J CLIN ONCOL, V28, P3002, DOI 10.1200/JCO.2009.27.4282; Hudson KL, 2014, JAMA; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Laine C, 2007, NEW ENGL J MED, V356, P2734, DOI 10.1056/NEJMe078110; McCray AT, 2000, ANN INTERN MED, V133, P609, DOI 10.7326/0003-4819-133-8-200010170-00013; National Institutes of Health, 2014, NIH REQ PUBL COMM DR; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; World Health Organization, WHO TRIAL REG DAT SE; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	22	66	67	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2015	372	2					174	180		10.1056/NEJMsr1414226	http://dx.doi.org/10.1056/NEJMsr1414226			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY2UA	25539444	Green Accepted			2022-12-28	WOS:000347443300014
J	Kearon, C; Spencer, FA; O'Keeffe, D; Parpia, S; Schulman, S; Baglin, T; Stevens, SM; Kaatz, S; Bauer, KA; Douketis, JD; Lentz, SR; Kessler, CM; Moll, S; Connors, JM; Ginsberg, JS; Spadafora, L; Julian, JA				Kearon, Clive; Spencer, Frederick A.; O'Keeffe, Denis; Parpia, Sameer; Schulman, Sam; Baglin, Trevor; Stevens, Scott M.; Kaatz, Scott; Bauer, Kenneth A.; Douketis, James D.; Lentz, Steven R.; Kessler, Craig M.; Moll, Stephan; Connors, Jean M.; Ginsberg, Jeffrey S.; Spadafora, Luciana; Julian, Jim A.		D-Dimer Optimal Duration Study Inv	D-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; SIMPLIFY D-DIMER; RISK; RECURRENCE; DURATION; EPISODE; PROLONG; ASSAY; SEX; AGE	Background: Normal D-dimer levels after withdrawal of anticoagulant therapy are associated with a reduced risk for recurrence in patients with unprovoked venous thromboembolism (VTE) and may justify stopping treatment. Objective: To determine whether patients with a first unprovoked VTE and negative D-dimer test result who stop anticoagulant therapy have a low risk for recurrence. Design: Prospective management study with blinded outcome assessment. (ClinicalTrials.gov: NCT00720915) Setting: 13 university-affiliated clinical centers. Patients: 410 adults aged 75 years or younger with a first unprovoked proximal deep venous thrombosis or pulmonary embolism who had completed 3 to 7 months of anticoagulant therapy. Intervention: Anticoagulant therapy was stopped if D-dimer test results were negative and was not restarted if results were still negative after 1 month. Measurements: Recurrent VTE during an average follow-up of 2.2 years. Results: In 319 patients (78%) who had 2 negative D-dimer results and did not restart anticoagulant therapy, rates of recurrent VTE were 6.7% (95% CI, 4.8% to 9.0%) per patient-year overall (42 of 319), 9.7% (CI, 6.7% to 13.7%) per patient-year in men (33 of 180), 5.4% (CI, 2.5% to 10.2%) per patient-year in women with VTE not associated with estrogen therapy (9 of 81), and 0.0% (CI, 0.0% to 3.0%) per patient-year in women with VTE associated with estrogen therapy (0 of 58) (P = 0.001 for the 3-group comparison). Limitations: Imprecision in female subgroups. Results may not be generalizable to different D-dimer assays from the one used in the study. Conclusion: The risk for recurrence in patients with a first unprovoked VTE who have negative D-dimer results is not low enough to justify stopping anticoagulant therapy in men but may be low enough to justify stopping therapy in women.	[Kearon, Clive] Juravinski Hosp, Hamilton Hlth Sci, Hamilton, ON L8V 1C3, Canada; [Spencer, Frederick A.; Douketis, James D.; Ginsberg, Jeffrey S.] St Josephs Healthcare, Hamilton, ON L8N 4A6, Canada; [O'Keeffe, Denis] Univ Limerick, Univ Hosp Limerick, Grad Entry Med Sch, Limerick, Ireland; [Parpia, Sameer; Spadafora, Luciana; Julian, Jim A.] Ontario Clin Oncol Grp, Hamilton, ON L8V 1C3, Canada; [Schulman, Sam] Hamilton Gen Hosp, Hamilton, ON L8L 2X2, Canada; [Baglin, Trevor] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Treatment Ctr, Cambridge CB2 0QQ, England; Intermt Med Ctr, Murray, UT 84107 USA; [Kaatz, Scott] Hurley Med Ctr, Flint, MI 48098 USA; [Bauer, Kenneth A.] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Lentz, Steven R.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Kessler, Craig M.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Moll, Stephan] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Connors, Jean M.] Brigham & Womens Hosp, Boston, MA 02115 USA	McMaster University; University of Limerick; McMaster University; University of Cambridge; Intermountain Healthcare; Intermountain Medical Center; Harvard University; Beth Israel Deaconess Medical Center; University of Iowa; Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Brigham & Women's Hospital	Kearon, C (corresponding author), Juravinski Hosp, Hamilton Hlth Sci, Room A3-73,711 Concession St, Hamilton, ON L8V 1C3, Canada.		O'Donnell, Martin/ABE-7459-2020; Schulman, Sam/I-7559-2019; ginsberg, jeffrey s/ABC-1065-2020; Douketis, James/AAO-5659-2021	O'Donnell, Martin/0000-0002-7347-7761; Schulman, Sam/0000-0002-8512-9043; Lentz, Steven/0000-0002-8885-4718; Macfarlane, Donald/0000-0001-8785-5690; Broome, Catherine/0000-0003-1507-2851; Kaboli, Peter/0000-0003-0993-0952	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research.	Baglin T, 2012, J THROMB HAEMOST, V10, P1702, DOI [10.1111/j.1538-7836.2012.04806.x, 10.1111/j.1538-7836.2012.04662.x]; Cini M, 2003, J THROMB HAEMOST, V1, P2681, DOI 10.1111/j.1538-7836.2003.0543d.x; Cosmi B, 2010, J THROMB HAEMOST, V8, P1933, DOI 10.1111/j.1538-7836.2010.03955.x; Cosmi B, 2010, BLOOD, V115, P481, DOI 10.1182/blood-2009-08-237354; Douketis J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d813; Douketis J, 2010, ANN INTERN MED, V153, P523, DOI 10.7326/0003-4819-153-8-201010190-00009; Eischer L, 2014, J THROMB HAEMOST, V12, P635, DOI 10.1111/jth.12528; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Iorio A, 2010, ARCH INTERN MED, V170, P1710, DOI 10.1001/archinternmed.2010.367; Kearon C, 2010, J THROMB HAEMOST, V8, P2313, DOI 10.1111/j.1538-7836.2010.03991.x; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1; Neale D, 2004, EMERG MED J, V21, P663, DOI 10.1136/emj.2003.011049; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Palareti G, 2014, BLOOD, V124, P196, DOI 10.1182/blood-2014-01-548065; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108	16	101	109	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2015	162	1					27	U167		10.7326/M14-1275	http://dx.doi.org/10.7326/M14-1275			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1LU	25560712				2022-12-28	WOS:000350103000004
J	Gosnell, EJ				Gosnell, Emma J.			CHRISTMAS 2014: GASTROENTEROLOGICAL TRACTS Christmas dinner for doctors on duty: it's grimmer up north	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Fairfield Hosp, Dept Otolaryngol, Bury BL9 7TD, Lancs, England		Gosnell, EJ (corresponding author), Fairfield Hosp, Dept Otolaryngol, Bury BL9 7TD, Lancs, England.	emma.gosnell@nhs.net							0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2014	349								g7269	10.1136/bmj.g7269	http://dx.doi.org/10.1136/bmj.g7269			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX3EE	25524253				2022-12-28	WOS:000346822400002
J	Gundelly, P; Young, M				Gundelly, Praveen; Young, Michael			Pustulonodular Lesion on the Nose	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLASTOMYCOSIS; VORICONAZOLE; UPDATE		[Gundelly, Praveen; Young, Michael] Univ Kentucky, Dept Infect Dis, Lexington, KY 40536 USA	University of Kentucky	Gundelly, P (corresponding author), Univ Kentucky, Dept Infect Dis, 740 S Limestone,K-512, Lexington, KY 40536 USA.	praveengundelly@gmail.com						Borgia SM, 2006, MED MYCOL, V44, P659, DOI 10.1080/13693780600803870; Chapman SW, 2008, CLIN INFECT DIS, V46, P1801, DOI 10.1086/588300; Connolly P, 2012, CLIN VACCINE IMMUNOL, V19, P53, DOI 10.1128/CVI.05248-11; GNANN JW, 1983, ANN INTERN MED, V98, P48, DOI 10.7326/0003-4819-98-1-48; PAPPAS PG, 1993, MEDICINE, V72, P311, DOI 10.1097/00005792-199309000-00003; Saccente M, 2010, CLIN MICROBIOL REV, V23, P367, DOI 10.1128/CMR.00056-09; Sugar AM, 2001, ANTIMICROB AGENTS CH, V45, P601, DOI 10.1128/AAC.45.2.601-604.2001	7	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2564	2565		10.1001/jama.2014.13527	http://dx.doi.org/10.1001/jama.2014.13527			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25514306				2022-12-28	WOS:000346346900020
J	Meredith, RW; Zhang, GJ; Gilbert, MTP; Jarvis, ED; Springer, MS				Meredith, Robert W.; Zhang, Guojie; Gilbert, M. Thomas P.; Jarvis, Erich D.; Springer, Mark S.			Evidence for a single loss of mineralized teeth in the common avian ancestor	SCIENCE			English	Article							MATRIX METALLOPROTEINASES; MOLECULAR EVOLUTION; BINDING PROTEIN; ENAMEL; BIRDS; EXPRESSION; AMELOGENIN; GENE; AMELOBLASTIN; DEFECTS	Edentulism, the absence of teeth, has evolved convergently among vertebrates, including birds, turtles, and several lineages of mammals. Instead of teeth, modern birds (Neornithes) use a horny beak (rhamphotheca) and a muscular gizzard to acquire and process food. We performed comparative genomic analyses representing lineages of nearly all extant bird orders and recovered shared, inactivating mutations within genes expressed in both the enamel and dentin of teeth of other vertebrate species, indicating that the common ancestor of modern birds lacked mineralized teeth. We estimate that tooth loss, or at least the loss of enamel caps that provide the outer layer of mineralized teeth, occurred about 116 million years ago.	[Meredith, Robert W.] Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ 07043 USA; [Zhang, Guojie] Beijing Genom Inst Shenzhen, China Natl GeneBank, Shenzhen 518083, Peoples R China; [Zhang, Guojie] Univ Copenhagen, Dept Biol, Ctr Social Evolut, DK-2100 Copenhagen, Denmark; [Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Gilbert, M. Thomas P.] Curtin Univ, Dept Environm & Agr, Trace & Environm DNA Lab, Perth, WA 6102, Australia; [Jarvis, Erich D.] Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA; [Jarvis, Erich D.] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Springer, Mark S.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	Montclair State University; Beijing Genomics Institute (BGI); University of Copenhagen; University of Copenhagen; Curtin University; Howard Hughes Medical Institute; Duke University; University of California System; University of California Riverside	Meredith, RW (corresponding author), Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ 07043 USA.	meredithr@mail.montclair.edu; mark.springer@ucr.edu	Zhang, Guojie/B-6188-2014; Jarvis, Erich D/A-2319-2008; Zhang, Guojie/J-7273-2019; Gilbert, Marcus TP/A-8936-2013	Zhang, Guojie/0000-0001-6860-1521; Jarvis, Erich D/0000-0001-8931-5049; Zhang, Guojie/0000-0001-6860-1521; Gilbert, Marcus TP/0000-0002-5805-7195	Montclair State University [FY2014]; NSF [EF0629860]	Montclair State University; NSF(National Science Foundation (NSF))	This work was supported by Montclair State University FY2014 Separately Budgeted Research Internal Reward and Startup Funds to R.W.M. and NSF (EF0629860) to M.S.S. Paintings are by J. Fjeldsa (birds), R.W.M. (green sea turtle, Caroline anole, alligator, and Fig. 3), and C. Buell (all others). Comparative genomic alignments are in the supplementary materials (nexus files 1 to 38).	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Atsawasuwan P, 2013, J DENT RES, V92, P622, DOI 10.1177/0022034513487906; Bartlett JD, 2006, CURR TOP DEV BIOL, V74, P57, DOI 10.1016/S0070-2153(06)74003-0; Chen YP, 2000, P NATL ACAD SCI USA, V97, P10044, DOI 10.1073/pnas.160245097; CHIAPPE LM, 2002, MESOZOIC BIRDS ABOVE; CRACRAFT J, 1986, PALEOBIOLOGY, V12, P383, DOI 10.1017/S0094837300003122; CRACRAFT J, 1982, SYST ZOOL, V31, P35, DOI 10.2307/2413412; Delgado S, 2008, MOL PHYLOGENET EVOL, V47, P865, DOI 10.1016/j.ympev.2008.01.025; delHoyo J., 1992, HANDBOOK OF THE BIRD, V1; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Deutsch D, 2006, EUR J ORAL SCI, V114, P183, DOI 10.1111/j.1600-0722.2006.00301.x; Gasse B, 2012, J DENT RES, V91, P1085, DOI 10.1177/0022034512460551; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Greenwold MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-148; Harris MP, 2006, CURR BIOL, V16, P371, DOI 10.1016/j.cub.2005.12.047; Hatakeyama J, 2009, J DENT RES, V88, P318, DOI 10.1177/0022034509334749; Haze A, 2007, ANAT REC, V290, P455, DOI 10.1002/ar.20520; Hieronymus TL, 2010, AUK, V127, P590, DOI 10.1525/auk.2010.09122; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Kawasaki K, 2008, J DENT RES, V87, P520, DOI 10.1177/154405910808700608; Kawasaki K, 2011, EUR J ORAL SCI, V119, P247, DOI 10.1111/j.1600-0722.2011.00898.x; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Longrich NR, 2011, P NATL ACAD SCI USA, V108, P15253, DOI 10.1073/pnas.1110395108; Louchart A, 2011, TRENDS ECOL EVOL, V26, P663, DOI 10.1016/j.tree.2011.09.004; Mathur Ajay Kishore, 2000, Journal of Mammalian Evolution, V7, P23, DOI 10.1023/A:1009413632741; McKnight DA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-299; Meredith RW, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-20; Meredith RW, 2011, P ROY SOC B-BIOL SCI, V278, P993, DOI 10.1098/rspb.2010.1280; Meredith RW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000634; O'Connor JK, 2013, J SYST PALAEONTOL, V11, P889, DOI 10.1080/14772019.2012.690455; Oliver Brian, 2002, J Biol, V1, P4; Ryu J, 2005, THROMB HAEMOSTASIS, V94, P175, DOI 10.1160/TH04-10-0656; Sire JY, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-246; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Springer MS, 1997, P NATL ACAD SCI USA, V94, P13754, DOI 10.1073/pnas.94.25.13754; Thesleff I, 2006, AM J MED GENET A, V140A, P2530, DOI 10.1002/ajmg.a.31360; Turk BE, 2006, BIOCHEMISTRY-US, V45, P3863, DOI 10.1021/bi052252o; VAN Dijk P.P., 2012, CHELONIAN RES MONOGR, V5, DOI [000.243-000.328, DOI 10.3854/CRM.5.000.CHECKLIST.V5.2012]; Vymetal J, 2008, EUR J ORAL SCI, V116, P124, DOI 10.1111/j.1600-0722.2008.00526.x; Wang YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077693; Wilson DE, 2005, MAMMAL SPECIES OF TH; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200	44	68	71	1	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1336	+	1254390	10.1126/science.1254390	http://dx.doi.org/10.1126/science.1254390			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504730				2022-12-28	WOS:000346189600041
J	Polka, JK; Krukenberg, KA				Polka, Jessica K.; Krukenberg, Kristin A.			Making science a desirable career	SCIENCE			English	Editorial Material									[Polka, Jessica K.; Krukenberg, Kristin A.] Future Res Symposium, Boston, MA USA					Polka, Jessica/0000-0001-6610-9293					0	7	7	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1422	1422		10.1126/science.346.6215.1422	http://dx.doi.org/10.1126/science.346.6215.1422			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW3MA	25504725				2022-12-28	WOS:000346189600057
J	Russo, CJ; Passmore, LA				Russo, Christopher J.; Passmore, Lori A.			Ultrastable gold substrates for electron cryomicroscopy	SCIENCE			English	Article							BEAM-INDUCED MOTION; CRYO-EM; RADIATION-DAMAGE; MICROSCOPY; RESOLUTION; CRYSTALS; CONTRAST; ICE; APOFERRITIN; DETECTORS	Despite recent advances, the structures of many proteins cannot be determined by electron cryomicroscopy because the individual proteins move during irradiation. This blurs the images so that they cannot be aligned with each other to calculate a three-dimensional density. Much of this movement stems from instabilities in the carbon substrates used to support frozen samples in the microscope. Here we demonstrate a gold specimen support that nearly eliminates substrate motion during irradiation. This increases the subnanometer image contrast such that a helices of individual proteins are resolved. With this improvement, we determine the structure of apoferritin, a smooth octahedral shell of alpha-helical subunits that is particularly difficult to solve by electron microscopy. This advance in substrate design will enable the solution of currently intractable protein structures.	[Russo, Christopher J.; Passmore, Lori A.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Passmore, LA (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	passmore@mrc-lmb.cam.ac.uk		Passmore, Lori/0000-0003-1815-3710; Russo, Christopher/0000-0002-4442-744X	European Research Council (ERC) under European Union [261151]; MRC [U105192715]; MRC [MC_U105192715] Funding Source: UKRI; Medical Research Council [MC_U105192715] Funding Source: researchfish	European Research Council (ERC) under European Union(European Research Council (ERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Henderson for guidance and advice throughout this project; D. Mills and W. Kuhlbrandt for the use of the Polara electron microscope at the Max Planck Institute of Biophysics, Frankfurt; I. S. Fernandez and the V. Ramakrishnan lab for the gift of ribosomes; G. McMullan, S. Chen, C. Savva, J. Grimmett, T. Darling, and M. Skehel for technical assistance; our colleagues at the Laboratory of Molecular Biology-especially S. Scheres, G. Murshudov, and R. A. Crowther-for many helpful discussions; and R. A. Crowther, V. Ramakrishnan, and E. Rajendra for a critical reading of the manuscript. This work was supported by the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 261151 and MRC grant U105192715. C. J. R. and L.A.P. are inventors on a patent application filed by the MRC on the gold substrates. The coordinates of the refined apoferritin model are deposited in the Protein Data Bank under accession code 4v1w and the EM density map is deposited in the Electron Microscopy Database under accession code 2788.	Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; BANYARD SH, 1978, NATURE, V271, P282, DOI 10.1038/271282a0; BAUMEISTER W, 1976, ULTRAMICROSCOPY, V1, P377, DOI 10.1016/0304-3991(76)90052-8; Brilot AF, 2012, J STRUCT BIOL, V177, P630, DOI 10.1016/j.jsb.2012.02.003; Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026; Crichton RR, 2010, BBA-GEN SUBJECTS, V1800, P706, DOI 10.1016/j.bbagen.2010.03.019; de Val N, 2012, J INORG BIOCHEM, V112, P77, DOI 10.1016/j.jinorgbio.2012.02.031; Faruqi AR, 2005, NUCL INSTRUM METH A, V546, P170, DOI 10.1016/j.nima.2005.03.023; Glaeser RM, 2011, ULTRAMICROSCOPY, V111, P90, DOI 10.1016/j.ultramic.2010.10.010; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HENDERSON R, 1985, ULTRAMICROSCOPY, V16, P139, DOI 10.1016/0304-3991(85)90069-5; Henderson R, 2013, MICROSCOPY-JPN, V62, P43, DOI 10.1093/jmicro/dfs094; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; MASSOVER WH, 1993, MICRON, V24, P389, DOI 10.1016/0968-4328(93)90005-L; McMullan G, 2014, ULTRAMICROSCOPY, V147, P156, DOI 10.1016/j.ultramic.2014.08.002; McMullan G, 2009, ULTRAMICROSCOPY, V109, P1126, DOI 10.1016/j.ultramic.2009.04.002; Rhinow D, 2008, ULTRAMICROSCOPY, V108, P698, DOI 10.1016/j.ultramic.2007.11.005; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Russo CJ, 2014, J STRUCT BIOL, V187, P112, DOI 10.1016/j.jsb.2014.06.006; Russo CJ, 2014, NAT METHODS, V11, P649, DOI [10.1038/NMETH.2931, 10.1038/nmeth.2931]; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Stark H, 1996, ULTRAMICROSCOPY, V63, P75, DOI 10.1016/0304-3991(96)00045-9; Wright ER, 2006, J STRUCT BIOL, V153, P241, DOI 10.1016/j.jsb.2005.12.003; Yoshioka C, 2010, MICROSC MICROANAL, V16, P43, DOI 10.1017/S1431927609991310	27	230	233	4	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1377	1380		10.1126/science.1259530	http://dx.doi.org/10.1126/science.1259530			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504723	Green Accepted			2022-12-28	WOS:000346189600054
J	Xu, X; Zhou, ZH; Dudley, R; Mackem, S; Chuong, CM; Erickson, GM; Varricchio, DJ				Xu, Xing; Zhou, Zhonghe; Dudley, Robert; Mackem, Susan; Chuong, Cheng-Ming; Erickson, Gregory M.; Varricchio, David J.			An integrative approach to understanding bird origins	SCIENCE			English	Review							UNIDIRECTIONAL AIR-FLOW; NON-AVIAN DINOSAURS; THEROPOD DINOSAUR; EVOLUTIONARY ORIGIN; PROTEIN SEQUENCES; TROODON-FORMOSUS; GROWTH-PATTERNS; SKIN APPENDAGES; SONIC HEDGEHOG; CHINA	Recent discoveries of spectacular dinosaur fossils overwhelmingly support the hypothesis that birds are descended from maniraptoran theropod dinosaurs, and furthermore, demonstrate that distinctive bird characteristics such as feathers, flight, endothermic physiology, unique strategies for reproduction and growth, and a novel pulmonary system originated among Mesozoic terrestrial dinosaurs. The transition from ground-living to flight-capable theropod dinosaurs now probably represents one of the best-documented major evolutionary transitions in life history. Recent studies in developmental biology and other disciplines provide additional insights into how bird characteristics originated and evolved. The iconic features of extant birds for the most part evolved in a gradual and stepwise fashion throughout archosaur evolution. However, new data also highlight occasional bursts of morphological novelty at certain stages particularly close to the origin of birds and an unavoidable complex, mosaic evolutionary distribution of major bird characteristics on the theropod tree. Research into bird origins provides a premier example of how paleontological and neontological data can interact to reveal the complexity of major innovations, to answer key evolutionary questions, and to lead to new research directions. A better understanding of bird origins requires multifaceted and integrative approaches, yet fossils necessarily provide the final test of any evolutionary model.	[Xu, Xing; Zhou, Zhonghe] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Dudley, Robert] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Mackem, Susan] NCI Frederick, Canc & Dev Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Chuong, Cheng-Ming] Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA; [Erickson, Gregory M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Varricchio, David J.] Montana State Univ, Bozeman, MT 59717 USA; [Chuong, Cheng-Ming] Cheng Kung Univ, Lab Wound Repair & Regenerat, Grad Inst Clin Med, Tainan 70101, Taiwan	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University of Southern California; State University System of Florida; Florida State University; Montana State University System; Montana State University Bozeman; National Cheng Kung University	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China.	xu.xing@ivpp.ac.cn			Fukui Prefecture Dinosaur Museum; National Natural Science Foundation of China [41120124002]; 973 program [2012CB821900]; U.S. National Institute of Arthritis and Musculoskeletal Diseases, NIH [AR 60306, 47364]; NSF [DBI 0446224, EAR 044186549, EAR 0847777]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047364, R01AR060306] Funding Source: NIH RePORTER; Division Of Earth Sciences [0847777] Funding Source: National Science Foundation	Fukui Prefecture Dinosaur Museum; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); U.S. National Institute of Arthritis and Musculoskeletal Diseases, NIH; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank Y. Liu, L. Xing, R. Li, X. Ding, P. M. O'Connor, M. Ellison, H. Zang, and K. Womble for illustrations. X. X. and Z.H.Z. thank X. Zheng (Shandong Tianyu Museum of Nature) and H. Li (Jizantang Museum) for access to specimens in their care. D.J.V. thanks the Fukui Prefecture Dinosaur Museum for research support. X. X. and Z.H.Z. are supported by the National Natural Science Foundation of China (41120124002) and 973 program (2012CB821900), C.M.C. by U.S. National Institute of Arthritis and Musculoskeletal Diseases, NIH, grant AR 60306 and 47364, G.M.E. by NSF grants DBI 0446224 and EAR 044186549, and D.J.V. by NSF grant EAR 0847777.	Agnolin F. L., 2013, AVIAN ANCESTORS A RE; Agnolin FL, 2012, CRETACEOUS RES, V35, P33, DOI 10.1016/j.cretres.2011.11.014; Allen V, 2013, NATURE, V497, P104, DOI 10.1038/nature12059; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Balanoff AM, 2013, NATURE, V501, P93, DOI 10.1038/nature12424; Barsbold R, 2000, ACTA PALAEONTOL POL, V45, P97; Barsbold R, 1983, T JOINT SOVIET MONGO, V19, P1; Benson RBJ, 2012, BIOL REV, V87, P168, DOI 10.1111/j.1469-185X.2011.00190.x; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; Birchard GF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0036; Brochu CA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P511; Burke AC, 1997, SCIENCE, V278, P666, DOI 10.1126/science.278.5338.666; Calder I. W. A., 1984, SIZE FUNCTION AND LI, P431; Chang CH, 2004, J INVEST DERMATOL, V122, P1348, DOI 10.1111/j.0022-202X.2004.22611.x; Chatterjee S, 1998, SCIENCE, V280, DOI 10.1126/science.280.5362.355a; Chen C. F., 2014, ANNU REV ANIM BIOSCI; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; CHINSAMY A, 1994, NATURE, V368, P196, DOI 10.1038/368196a0; Chinsamy Anusuya, 2002, P421; Chinsamy A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2377; Chodankar R, 2003, J INVEST DERMATOL, V120, P20, DOI 10.1046/j.1523-1747.2003.12008.x; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Chu QQ, 2014, DEV BIOL, V387, P167, DOI 10.1016/j.ydbio.2014.01.010; Chuong CM, 2012, PHYSIOLOGY, V27, P61, DOI 10.1152/physiol.00028.2011; Clark JM, 2004, DINOSAURIA, 2ND EDITION, P151; de Bakker MAG, 2013, NATURE, V500, P445, DOI 10.1038/nature12336; Deeming D.C., 1991, P307, DOI 10.1017/CBO9780511585739.020; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; Dudley R, 2007, ANNU REV ECOL EVOL S, V38, P179, DOI 10.1146/annurev.ecolsys.37.091305.110014; Dyke G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3489; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Evangelista D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085203; Fanti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031330; Farmer CG, 2010, SCIENCE, V327, P338, DOI 10.1126/science.1180219; Feduccia A., 1999, ORIGIN EVOLUTION BIR, P466; Feduccia A, 2013, AUK, V130, P1, DOI 10.1525/auk.2013.130.1.1; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Foth C, 2014, NATURE, V511, P79, DOI 10.1038/nature13467; Gatesy SM, 1996, EVOLUTION, V50, P331, DOI 10.1111/j.1558-5646.1996.tb04496.x; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Godefroit P, 2014, SCIENCE, V345, P451, DOI 10.1126/science.1253351; Godefroit P, 2013, NATURE, V498, P359, DOI 10.1038/nature12168; Gohlich UB, 2006, NATURE, V440, P329, DOI 10.1038/nature04579; Grady JM, 2014, SCIENCE, V344, P1268, DOI 10.1126/science.1253143; Grellet-Tinner G, 2004, LIFE O PAST, P185; Grellet-Tinner G, 2006, CAN J EARTH SCI, V43, P705, DOI 10.1139/E06-033; Harris MP, 2002, J EXP ZOOL, V294, P160, DOI 10.1002/jez.10157; He T, 2012, J VERTEBR PALEONTOL, V32, P108; Holtz Thomas R. Jr, 2000, Gaia (Lisboa), V15, P5; Hopp TP, 2004, LIFE O PAST, P234; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Jackson FD, 2010, CRETACEOUS RES, V31, P255, DOI 10.1016/j.cretres.2009.11.006; James F.C., 2009, ORNITHOLOGICAL MONOG, V66, P1, DOI [DOI 10.1525/OM.2009.66.1.1, 10.1525/om.2009.66.1.1]; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji Q., 1996, CHINESE GEOL, V233, P30; Jiang TX, 2011, DIFFERENTIATION, V81, P307, DOI 10.1016/j.diff.2011.03.004; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; Li QG, 2014, NATURE, V507, P350, DOI 10.1038/nature12973; Li QG, 2012, SCIENCE, V335, P1215, DOI 10.1126/science.1213780; Lin SJ, 2013, SCIENCE, V340, P1442, DOI 10.1126/science.1230374; Lipkin C, 2007, J PALEONTOL, V81, P1523, DOI 10.1666/06-024.1; Longrich NR, 2012, CURR BIOL, V22, P2262, DOI 10.1016/j.cub.2012.09.052; Lopez-Martinez N, 2012, PALAEONTOLOGY, V55, P325, DOI 10.1111/j.1475-4983.2011.01114.x; Makovicky P. J., 2011, LIVING DINOSAURS EVO, P9, DOI DOI 10.1002/9781119990475.CH1; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; Mayr G, 2013, NATURE, V499, pE1, DOI 10.1038/nature12367; McKellar RC, 2011, SCIENCE, V333, P1619, DOI 10.1126/science.1203344; Mikhailov K.E., 1997, SPEC PAP PALAEONTOL, V56, P1; Moyer AE, 2014, SCI REP-UK, V4, DOI [10.1038/srep04233, 10.1038/srep06191]; Myhrvold NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081917; Newman SA, 2011, BIOESSAYS, V33, P653, DOI 10.1002/bies.201100061; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Novas FE, 1997, NATURE, V387, P390, DOI 10.1038/387390a0; O'Connor J, 2013, P NATL ACAD SCI USA, V110, P17404, DOI 10.1073/pnas.1316979110; O'Connor Jingmai K., 2014, Vertebrata Palasiatica, V52, P3; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Organ CL, 2007, NATURE, V446, P180, DOI 10.1038/nature05621; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Peterson K, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046008; Prum RO, 1999, J EXP ZOOL, V285, P291; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Reisz RR, 2013, NATURE, V496, P210, DOI 10.1038/nature11978; Ruben JA, 1999, SCIENCE, V283, P514, DOI 10.1126/science.283.5401.514; SABATH K, 1991, Acta Palaeontologica Polonica, V36, P151; Sato T, 2005, SCIENCE, V308, P375, DOI 10.1126/science.1110578; Schachner ER, 2014, NATURE, V506, P367, DOI 10.1038/nature12871; Schachner ER, 2013, PEERJ, V1, DOI 10.7717/peerj.60; Scherz PJ, 2007, DEV BIOL, V308, P343, DOI 10.1016/j.ydbio.2007.05.030; Schweitzer MH, 2009, SCIENCE, V324, P626, DOI 10.1126/science.1165069; Schweitzer MH, 1999, J EXP ZOOL, V285, P146; Senter P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036790; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SHUBIN NH, 1986, EVOL BIOL, V20, P319; Tamura K, 2011, SCIENCE, V331, P753, DOI 10.1126/science.1198229; Terres J. K., 1995, THE AUDUBON SOCIETY; Towers M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1437; Turner AH, 2007, SCIENCE, V317, P1721, DOI 10.1126/science.1145076; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Turner AH, 2012, B AM MUS NAT HIST, P5; Vargas AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003325; Varricchio DJ, 2015, ACTA PALAEONTOL POL, V60, P11, DOI 10.4202/app.00085.2014; Varricchio DJ, 2013, PALEOBIOLOGY, V39, P278, DOI 10.1666/11042; Varricchio David J., 2003, Palaeovertebrata (Montpellier), V32, P149; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Varricchio DJ, 1999, J VERTEBR PALEONTOL, V19, P91, DOI 10.1080/02724634.1999.10011125; Varricchio DJ, 2004, J VERTEBR PALEONTOL, V24, P931, DOI 10.1671/0272-4634(2004)024[0931:APAOPD]2.0.CO;2; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Varricchio DJ, 2004, LIFE O PAST, P215; Varricchio DJ, 2002, J VERTEBR PALEONTOL, V22, P564, DOI 10.1671/0272-4634(2002)022[0564:EAEFTC]2.0.CO;2; Vehrencamp SL, 2000, BEHAV ECOL, V11, P334, DOI 10.1093/beheco/11.3.334; Wagner GP, 1999, P NATL ACAD SCI USA, V96, P5111, DOI 10.1073/pnas.96.9.5111; Wang Z, 2011, NATURE, V477, P583, DOI 10.1038/nature10391; Wings O., 2004, THESIS; Witmer Lawrence M., 2002, P3; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X, 2014, SCI REP-UK, V4, DOI 10.1038/srep06042; Xu X, 2013, CURR BIOL, V23, pR538, DOI 10.1016/j.cub.2013.04.071; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Xu X, 2010, CHINESE SCI BULL, V55, P3971, DOI 10.1007/s11434-010-4150-z; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311; Xu X, 2009, NATURE, V459, P940, DOI 10.1038/nature08124; Yu MK, 2002, NATURE, V420, P308, DOI 10.1038/nature01196; Yue ZC, 2006, P NATL ACAD SCI USA, V103, P951, DOI 10.1073/pnas.0506894103; Yue ZC, 2005, NATURE, V438, P1026, DOI 10.1038/nature04222; Yue ZC, 2012, DEV BIOL, V372, P45, DOI 10.1016/j.ydbio.2012.09.004; Zelenitsky DK, 2008, PALAEONTOLOGY, V51, P807, DOI 10.1111/j.1475-4983.2008.00770.x; Zelenitsky DK, 2012, SCIENCE, V338, P510, DOI 10.1126/science.1225376; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740; Zheng XT, 2009, NATURE, V458, P333, DOI 10.1038/nature07856; Zheng XT, 2013, NATURE, V495, P507, DOI 10.1038/nature11985; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753; Zhou ZH, 2003, CAN J EARTH SCI, V40, P731, DOI 10.1139/E03-011; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P455, DOI 10.1007/s00114-004-0570-4; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	150	180	193	15	422	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1341	+	1253293	10.1126/science.1253293	http://dx.doi.org/10.1126/science.1253293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504729	Green Submitted			2022-12-28	WOS:000346189600043
J	Zhang, GJ; Jarvis, ED; Gilbert, MTP				Zhang, Guojie; Jarvis, Erich D.; Gilbert, M. Thomas P.			A flock of Genomes	SCIENCE			English	Editorial Material													Gilbert, Marcus TP/A-8936-2013; Zhang, Guojie/J-7273-2019; Jarvis, Erich D/A-2319-2008; Zhang, Guojie/B-6188-2014	Gilbert, Marcus TP/0000-0002-5805-7195; Zhang, Guojie/0000-0001-6860-1521; Jarvis, Erich D/0000-0001-8931-5049; Zhang, Guojie/0000-0001-6860-1521	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000448] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIH HHS [DP1 OD000448] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)			0	40	40	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1308	1309		10.1126/science.346.6215.1308	http://dx.doi.org/10.1126/science.346.6215.1308			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504710	Green Accepted			2022-12-28	WOS:000346189600033
J	Solebo, AL; Cumberland, PM; Rahi, JS				Solebo, Ameenat Lola; Cumberland, Phillippa M.; Rahi, Jugnoo S.			Whole-population vision screening in children aged 4-5 years to detect amblyopia	LANCET			English	Review							QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; VISUAL IMPAIRMENT; PRESCHOOL-CHILDREN; RESIDUAL AMBLYOPIA; MODERATE AMBLYOPIA; TREATMENT OUTCOMES; OCULAR PATHOLOGY; SCHOOL-CHILDREN; CHILDHOOD EYE	Amblyopia is a neurodevelopmental disorder that affects at least 2% of most populations and can lead to permanently reduced vision if not detected and treated within a specific period in childhood. Whole-population screening of children younger than 5 years is applied in many countries. The substantial diversity in existing programmes reflects their heterogeneous implementation in the absence of the complete evidence base that is now a pre-requisite for instituting screening. The functional importance of amblyopia at an individual level is unclear as data are scarce, but in view of the high prevalence the population-level effect might be notable. Screening of all children aged 4-5 years (eg, at school entry) confers most benefit and addresses inequity in access to timely treatment. Screening at younger ages is associated with increased risk of false-positive results, and at older ages with poor outcomes for children with moderate to severe amblyopia. We suggest that the real-life adverse effects of amblyopia should be characterised and screening and diagnosis should be standardised.	[Solebo, Ameenat Lola; Cumberland, Phillippa M.; Rahi, Jugnoo S.] UCL, Inst Child Hlth, Life Course Epidemiol & Biostat Sect, London WC1N 1EH, England; [Solebo, Ameenat Lola; Cumberland, Phillippa M.; Rahi, Jugnoo S.] UCL, Inst Child Hlth, Ulverscroft Vis Res Grp, London WC1N 1EH, England; [Solebo, Ameenat Lola; Rahi, Jugnoo S.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Moorfields Biomed Res Ctr, London, England; [Solebo, Ameenat Lola; Rahi, Jugnoo S.] UCL, Inst Ophthalmol, London WC1N 1EH, England; [Rahi, Jugnoo S.] Great Ormond St Hosp Sick Children, Inst Child Hlth, Biomed Res Ctr, London WC1N 3JH, England	University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Rahi, JS (corresponding author), UCL, Inst Child Hlth, Life Course Epidemiol & Biostat Sect, 30 Guilford St, London WC1N 1EH, England.	j.rahi@ucl.ac.uk		Solebo, Ameenat/0000-0002-8933-5864; Rahi, Jugnoo/0000-0002-5718-9209	Department of Health; National Institute for Health Research Biomedical Research Centre; MRC [G0400546] Funding Source: UKRI; Medical Research Council [G0400546B, G0400546] Funding Source: researchfish; National Institute for Health Research [CL-2013-18-010] Funding Source: researchfish	Department of Health; National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Part of this Review was written as a commissioned external review for the UK National Screening Committee. JSR has received funding from the Department of Health. ALS and JSR are supported by the National Institute for Health Research Biomedical Research Centre. ALS and PMC are members of the Ulverscroft Vision Research Group. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health, National Health Service, or National Institute for Health Research.	Agervi P, 2010, OPHTHALMOLOGY, V117, P381, DOI 10.1016/j.ophtha.2009.07.020; Agervi P, 2009, OPHTHALMOLOGY, V116, P1475, DOI 10.1016/j.ophtha.2009.02.023; Attebo K, 1998, OPHTHALMOLOGY, V105, P154, DOI 10.1016/S0161-6420(98)91862-0; Awan M, 2005, INVEST OPHTH VIS SCI, V46, P1435, DOI 10.1167/iovs.04-0971; Beck RW, 2003, OPHTHALMOLOGY, V110, P2075, DOI 10.1016/S0161-6420(03)01023-6; Birch EE, 2009, J AAPOS, V13, P67, DOI 10.1016/j.jaapos.2008.07.010; Brown S A, 2000, Ophthalmic Epidemiol, V7, P249, DOI 10.1076/0928-6586(200012)7:4;1-Y;FT249; Carlton J, 2008, Health Technol Assess, V12, pxi; Carlton J, 2008, HEALTH TECHNOL ASSES, V12, pxi; Carlton J, 2013, OPTOMETRY VISION SCI, V90, P867, DOI 10.1097/OPX.0b013e318290cd7b; Carlton J, 2011, BRIT J OPHTHALMOL, V95, P325, DOI 10.1136/bjo.2009.178889; Chia A, 2010, INVEST OPHTH VIS SCI, V51, P3411, DOI 10.1167/iovs.09-4461; Chia EM, 2006, OPHTHAL EPIDEMIOL, V13, P371, DOI 10.1080/09286580600864794; Choong YF, 2004, EYE, V18, P369, DOI 10.1038/sj.eye.6700647; Chou R, 2011, PEDIATRICS, V127, pE442, DOI 10.1542/peds.2010-0462; Chua B, 2004, BRIT J OPHTHALMOL, V88, P1119, DOI 10.1136/bjo.2004.041863; Clarke MP, 2003, BMJ-BRIT MED J, V327, P1251, DOI 10.1136/bmj.327.7426.1251; Cotter SA, 2009, ARCH OPHTHALMOL-CHIC, V127, P22, DOI 10.1001/archophthalmol.2008.520; de Koning HJ, 2013, J MED SCREEN, V20, P66, DOI 10.1177/0969141313497355; Donnelly UM, 2005, OPHTHAL EPIDEMIOL, V12, P243, DOI 10.1080/09286580590967772; European Commission, PERS HLTH CAR; Faghihi M, 2011, STRABISMUS, V19, P147, DOI 10.3109/09273972.2011.622341; Fan DSP, 2011, CLIN EXP OPHTHALMOL, V39, P398, DOI 10.1111/j.1442-9071.2010.02470.x; Friedman DS, 2009, OPHTHALMOLOGY, V116, P2128, DOI 10.1016/j.ophtha.2009.04.034; Friedman DS, 2009, OPHTHALMOLOGY, V116, pe1; Fu J, 2014, GRAEF ARCH CLIN EXP, V252, P137, DOI 10.1007/s00417-013-2451-z; Ganekal S, 2013, OPHTHAL EPIDEMIOL, V20, P228, DOI 10.3109/09286586.2013.809772; Groenewoud JH, 2010, INVEST OPHTH VIS SCI, V51, P3476, DOI 10.1167/iovs.08-3352; Gunnlaugsdottir E, 2008, ACTA OPHTHALMOL, V86, P778, DOI 10.1111/j.1755-3768.2008.01191.x; Hatt S, 2006, COCHRANE DB SYST REV, V3; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; Holmes JM, 2006, LANCET, V367, P1343, DOI 10.1016/S0140-6736(06)68581-4; Holmes JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1625; Holmes JM, 2008, OPHTHALMOLOGY, V115, P2071, DOI 10.1016/j.ophtha.2008.06.031; Holmes JM, 2007, OPHTHALMOLOGY, V114, P1427, DOI 10.1016/j.ophtha.2006.11.023; Holmes JM, 2011, ARCH OPHTHALMOL-CHIC, V129, P1451, DOI 10.1001/archophthalmol.2011.179; Horwood J, 2005, INVEST OPHTH VIS SCI, V46, P1177, DOI 10.1167/iovs.04-0597; Hrisos S, 2004, OPHTHALMOLOGY, V111, P1550, DOI 10.1016/j.ophtha.2003.12.059; Jamali P, 2009, OPTOMETRY VISION SCI, V86, P364, DOI 10.1097/OPX.0b013e3181993f42; Khandekar R, 2009, INDIAN J OPHTHALMOL, V57, P437, DOI 10.4103/0301-4738.57151; Koklanis K, 2006, CLIN EXP OPHTHALMOL, V34, P743, DOI 10.1111/j.1442-9071.2006.01317.x; Lithander J, 1998, ACTA OPHTHALMOL SCAN, V76, P658, DOI 10.1034/j.1600-0420.1998.760604.x; Loudon SE, 2009, BRIT J OPHTHALMOL, V93, P1499, DOI 10.1136/bjo.2008.149815; Majeed M, 2008, BRIT J OPHTHALMOL, V92, P965, DOI 10.1136/bjo.2007.134841; Mathers M, 2010, CHILD CARE HLTH DEV, V36, P756, DOI 10.1111/j.1365-2214.2010.01109.x; Maya-Vetencourt JF, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/631965; McKean-Cowdin R, 2013, OPHTHALMOLOGY, V120, P2117, DOI 10.1016/j.ophtha.2013.03.001; Medghalchi A, 2011, IRAN MED CRESENT MED, V13, P7; Menon V, 2008, J AAPOS, V12, P493, DOI 10.1016/j.jaapos.2008.03.006; Multi-ethnic Pediatric Eye Disease Study Group, 2008, OPHTHALMOLOGY, V115, P36; NICE, NICE MEAS VAL MON RE; O'Connor AR, 2010, INVEST OPHTH VIS SCI, V51, P2019, DOI 10.1167/iovs.09-4434; Ohlsson J, 2003, J AAPOS, V7, P47, DOI 10.1016/S1091-8531(02)42011-3; Ohlsson J, 2001, ACTA OPHTHALMOL SCAN, V79, P589, DOI 10.1034/j.1600-0420.2001.790609.x; Pai ASI, 2012, OPHTHALMOLOGY, V119, P138, DOI 10.1016/j.ophtha.2011.06.024; Pan Y, 2009, OPTOMETRY VISION SCI, V86, P607, DOI 10.1097/OPX.0b013e3181a76e55; Pediat Eye Dis Investigator Grp, 2003, ARCH OPHTHALMOL-CHIC, V121, P603; Polling Jan-Roelof, 2012, Optom Vis Sci, V89, pe44; Powell C, 2009, COCHRANE DB SYST REV, V3; Rahi JS, 2006, BRIT MED J, V332, P820, DOI 10.1136/bmj.38751.597963.AE; Rahi JS, 2002, LANCET, V360, P597, DOI 10.1016/S0140-6736(02)09782-9; Rahi JS, 2010, PEDIATRICS, V126, pE895, DOI 10.1542/peds.2010-0498; Rahi JS, 2009, OPHTHALMOLOGY, V116, P270, DOI 10.1016/j.ophtha.2008.09.018; Repka MX, 2010, ARCH OPHTHALMOL-CHIC, V128, P1215, DOI 10.1001/archophthalmol.2010.178; Repka MX, 2009, J AAPOS, V13, P258, DOI 10.1016/j.jaapos.2009.03.002; Repka MS, 2004, OPHTHALMOLOGY, V111, P2076, DOI 10.1016/j.ophtha.2004.04.032; Repka MX, 2003, OPHTHALMOLOGY, V110, P1632, DOI 10.1016/S0161-6420(03)00500-1; Richardson SR, 2005, INVEST OPHTH VIS SCI, V46, P150, DOI 10.1167/iovs.04-0672; Robaei D, 2008, EYE, V22, P496, DOI 10.1038/sj.eye.6702668; Robaei D, 2006, ARCH OPHTHALMOL-CHIC, V124, P878, DOI 10.1001/archopht.124.6.878; Rutstein RP, 2010, OPHTHALMOLOGY, V117, P998, DOI 10.1016/j.ophtha.2009.10.014; Salomao SR, 2008, INVEST OPHTH VIS SCI, V49, P4308, DOI 10.1167/iovs.08-2073; Scheiman MM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1634, DOI 10.1001/archophthalmol.2008.107; Scheiman MM, 2005, ARCH OPHTHALMOL-CHIC, V123, P437; Schmucker C, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-3; Simons K, 1999, BRIT J OPHTHALMOL, V83, P582, DOI 10.1136/bjo.83.5.582; Snowdon S K, 1997, Health Technol Assess, V1, pi; Stankovic B, 2007, EUR J OPHTHALMOL, V17, P11, DOI 10.1177/112067210701700103; Stewart CE, 2007, BMJ-BRIT MED J, V335, P707, DOI 10.1136/bmj.39301.460150.55; Tadic V, 2013, OPHTHALMOLOGY, V120, P2725, DOI 10.1016/j.ophtha.2013.07.055; Tadic V, 2013, BRIT J OPHTHALMOL, V97, P1369, DOI 10.1136/bjophthalmol-2013-303350; Tananuvat Napaporn, 2004, Journal of the Medical Association of Thailand, V87, P679; Taylor K, 2011, COCHRANE DB SYST REV, V10; Taylor K, 2012, COCHRANE DB SYST REV, V4; Tejedor J, 2008, AM J OPHTHALMOL, V145, P562, DOI 10.1016/j.ajo.2007.10.029; Tsutsui KI, 2005, NEUROSCI RES, V51, P221, DOI 10.1016/j.neures.2004.11.006; van de Graaf ES, 2010, GRAEF ARCH CLIN EXP, V248, P1803, DOI 10.1007/s00417-010-1457-z; van Leeuwen R, 2007, BRIT J OPHTHALMOL, V91, P1450, DOI 10.1136/bjo.2006.113670; Varma R, 2008, OPHTHALMOLOGY, V115, P1229, DOI 10.1016/j.ophtha.2007.08.001; Wallace DK, 2011, J AAPOS, V15, P455, DOI 10.1016/j.jaapos.2011.06.007; Wallace DK, 2011, ARCH OPHTHALMOL-CHIC, V129, P960, DOI 10.1001/archophthalmol.2011.174; Wang Y, 2011, OPHTHALMOLOGY, V118, P279, DOI 10.1016/j.ophtha.2010.05.026; Webber AL, 2008, OPTOMETRY VISION SCI, V85, P1074, DOI 10.1097/OPX.0b013e31818b9911; Wen G, 2011, OPHTHALMOLOGY, V118, P574, DOI 10.1016/j.ophtha.2010.06.039; Williams C, 2008, BRIT J OPHTHALMOL, V92, P959, DOI 10.1136/bjo.2007.134700; Williams C, 2006, BRIT J OPHTHALMOL, V90, P670, DOI 10.1136/bjo.2006.091082; Williams C, 2003, BRIT J OPHTHALMOL, V87, P988, DOI 10.1136/bjo.87.8.988; Williams C, 2002, BMJ-BRIT MED J, V324, P1549, DOI 10.1136/bmj.324.7353.1549; Wilson GA, 2013, CLIN EXP OPHTHALMOL, V41, P127, DOI 10.1111/j.1442-9071.2012.02842.x; Wilson J, 1968, PUBLIC HLTH PAPERS, V34, P473; Yan XK, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/648054; Yang XB, 2013, EUR J OPHTHALMOL, V23, P19, DOI 10.5301/ejo.5000174	102	52	57	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2308	2319		10.1016/S0140-6736(14)60522-5	http://dx.doi.org/10.1016/S0140-6736(14)60522-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	25499167				2022-12-28	WOS:000355943500034
J	Mahaffy, PR; Webster, CR; Stern, JC; Brunner, AE; Atreya, SK; Conrad, PG; Domagal-Goldman, S; Eigenbrode, JL; Flesch, GJ; Christensen, LE; Franz, HB; Freissinet, C; Glavin, DP; Grotzinger, JP; Jones, JH; Leshin, LA; Malespin, C; McAdam, AC; Ming, DW; Navarro-Gonzalez, R; Niles, PB; Owen, T; Pavlov, AA; Steele, A; Trainer, MG; Williford, KH; Wray, JJ				Mahaffy, P. R.; Webster, C. R.; Stern, J. C.; Brunner, A. E.; Atreya, S. K.; Conrad, P. G.; Domagal-Goldman, S.; Eigenbrode, J. L.; Flesch, G. J.; Christensen, L. E.; Franz, H. B.; Freissinet, C.; Glavin, D. P.; Grotzinger, J. P.; Jones, J. H.; Leshin, L. A.; Malespin, C.; McAdam, A. C.; Ming, D. W.; Navarro-Gonzalez, R.; Niles, P. B.; Owen, T.; Pavlov, A. A.; Steele, A.; Trainer, M. G.; Williford, K. H.; Wray, J. J.		Msl Sci Team	The imprint of atmospheric evolution in the D/H of Hesperian clay minerals on Mars	SCIENCE			English	Article							MARTIAN ATMOSPHERE; TERRESTRIAL PLANETS; HYDROGEN ISOTOPES; WATER RESERVOIRS; GALE CRATER; ORIGIN; FRACTIONATION; CONSTRAINTS; DEUTERIUM; ABUNDANCE	The deuterium-to-hydrogen (D/H) ratio in strongly bound water or hydroxyl groups in ancient martian clays retains the imprint of the water of formation of these minerals. Curiosity's Sample Analysis at Mars (SAM) experiment measured thermally evolved water and hydrogen gas released between 550 degrees and 950 degrees C from samples of Hesperian-era Gale crater smectite to determine this isotope ratio. The D/H value is 3.0 (+/- 0.2) times the ratio in standard mean ocean water. The D/H ratio in this similar to 3-billion-year-old mudstone, which is half that of the present martian atmosphere but substantially higher than that expected in very early Mars, indicates an extended history of hydrogen escape and desiccation of the planet.	[Mahaffy, P. R.; Stern, J. C.; Brunner, A. E.; Conrad, P. G.; Domagal-Goldman, S.; Eigenbrode, J. L.; Franz, H. B.; Freissinet, C.; Glavin, D. P.; Malespin, C.; McAdam, A. C.; Pavlov, A. A.; Trainer, M. G.] NASA, Planetary Environm Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Webster, C. R.; Flesch, G. J.; Christensen, L. E.; Williford, K. H.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Brunner, A. E.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85281 USA; [Brunner, A. E.; Franz, H. B.] Univ Maryland, Ctr Res & Explorat Space Sci & Technol, College Pk, MD 20742 USA; [Atreya, S. K.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Freissinet, C.] Oak Ridge Associated Univ, NASA, Postdoctoral Program, Oak Ridge, TN 37831 USA; [Grotzinger, J. P.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Jones, J. H.; Ming, D. W.; Niles, P. B.] NASA, Johnson Space Flight Ctr, Houston, TX 77058 USA; [Leshin, L. A.] Worcester Polytech Inst, Off President, Worcester, MA 01609 USA; [Malespin, C.] NASA, Goddard Earth Sci Technol & Res GESTAR, Univ Space Res Assoc USRA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Navarro-Gonzalez, R.] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico; [Owen, T.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Steele, A.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Wray, J. J.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Arizona State University; Arizona State University-Tempe; University System of Maryland; University of Maryland College Park; University of Michigan System; University of Michigan; National Aeronautics & Space Administration (NASA); United States Department of Energy (DOE); Oak Ridge National Laboratory; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Worcester Polytechnic Institute; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universities Space Research Association (USRA); Universidad Nacional Autonoma de Mexico; University of Hawaii System; Carnegie Institution for Science; University System of Georgia; Georgia Institute of Technology	Mahaffy, PR (corresponding author), NASA, Planetary Environm Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	paul.r.mahaffy@nasa.gov	Wray, James J/B-8457-2008; Zorzano, María-Paz/F-2184-2015; Dworkin, Jason P./C-9417-2012; Glavin, Daniel P/D-6194-2012; Steele, Andrew/A-3573-2013; szopa, cyril/C-6865-2015; Rodriguez-Manfredi, Jose/AAG-9826-2021; Webster, Chris/M-9315-2019; Ramos, Miguel/K-2230-2014; Williford, Kenneth/L-4436-2017; GEFFROY, Claude/AAB-9152-2019; Rodriguez-Manfredi, Jose/L-8001-2014; Trainer, Melissa G/E-1477-2012; Stipp, Susan L.S./B-8494-2019; Eigenbrode, Jennifer L/D-4651-2012; Harri, Ari-Matti/C-7142-2012; Franz, Heather B/F-3508-2012; Navarro-González, Rafael/D-1748-2009; Prats, Benito/F-9467-2019; Lemmon, Mark T/E-9983-2010; Merikallio, Sini/C-7812-2014; Martin-Torres, Javier/G-6329-2015; Muñoz, Guillermo M/L-6370-2014; McAdam, Amy/E-1556-2012	Wray, James J/0000-0001-5559-2179; Zorzano, María-Paz/0000-0002-4492-9650; Dworkin, Jason P./0000-0002-3961-8997; Glavin, Daniel P/0000-0001-7779-7765; Steele, Andrew/0000-0001-9643-2841; szopa, cyril/0000-0002-0090-4056; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Ramos, Miguel/0000-0003-3648-6818; Williford, Kenneth/0000-0003-0633-408X; GEFFROY, Claude/0000-0002-2731-9658; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Stipp, Susan L.S./0000-0001-7009-643X; Eigenbrode, Jennifer L/0000-0003-3089-1986; Harri, Ari-Matti/0000-0001-8541-2802; Navarro-González, Rafael/0000-0002-6078-7621; Prats, Benito/0000-0003-3869-3351; Lemmon, Mark T/0000-0002-4504-5136; Merikallio, Sini/0000-0001-7120-6127; Martin-Torres, Javier/0000-0001-6479-2236; Muñoz, Guillermo M/0000-0001-7003-7368; Matthia, Daniel/0000-0003-1507-0143; McAdam, Amy/0000-0001-9120-2991	NASA's Mars Exploration Program	NASA's Mars Exploration Program	This work was supported by NASA's Mars Exploration Program. The dedicated teams that developed the SAM suite of instruments are acknowledged. All data described can be found in NASA's the Planetary Data System archive pds.nasa.gov.	Alexander CMO, 2012, SCIENCE, V337, P721, DOI 10.1126/science.1223474; Ansan V, 2006, PLANET SPACE SCI, V54, P219, DOI 10.1016/j.pss.2005.12.009; Atreya SK, 2013, GEOPHYS RES LETT, V40, P5605, DOI 10.1002/2013GL057763; Bockelee-Morvan D, 1998, ICARUS, V133, P147, DOI 10.1006/icar.1998.5916; Bristow T. F., 2015, AM MINERAL; Carr M. H., 2014, 45 LUN PLAN SCI C; Carr MH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001963; Carr MH, 2010, EARTH PLANET SC LETT, V294, P185, DOI 10.1016/j.epsl.2009.06.042; Deit L. L., 2013, J GEOPHYS RES-PLANET, V118, P2439; DiBiase RA, 2013, J GEOPHYS RES-PLANET, V118, P1285, DOI 10.1002/jgre.20100; EBERHARDT P, 1995, ASTRON ASTROPHYS, V302, P301; Grant JA, 2014, GEOPHYS RES LETT, V41, P1142, DOI 10.1002/2013GL058909; Greenwood JP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032721; Grotzinger JP, 2014, SCIENCE, V343, DOI 10.1126/science.1242777; Head JW, 2001, SPACE SCI REV, V96, P263, DOI 10.1023/A:1011953424736; HUNTEN DM, 1970, J GEOPHYS RES, V75, P5989, DOI 10.1029/JA075i031p05989; JAKOSKY BM, 1994, ICARUS, V111, P271, DOI 10.1006/icar.1994.1145; Krasnopolsky VA, 1997, J GEOPHYS RES-PLANET, V102, P6525, DOI 10.1029/96JE03766; Kurokawa H, 2014, EARTH PLANET SC LETT, V394, P179, DOI 10.1016/j.epsl.2014.03.027; Lammer H, 2003, ICARUS, V165, P9, DOI 10.1016/S0019-1035(03)00170-2; Lammer H, 2013, SPACE SCI REV, V174, P113, DOI 10.1007/s11214-012-9943-8; Leshin LA, 2013, SCIENCE, V341, DOI 10.1126/science.1238937; Leshin LA, 2000, GEOPHYS RES LETT, V27, P2017, DOI 10.1029/1999GL008455; Lewis KW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002558; Mahaffy PR, 2013, SCIENCE, V341, P263, DOI 10.1126/science.1237966; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; Meier R, 1998, SCIENCE, V279, P1707, DOI 10.1126/science.279.5357.1707; Ming D. W., 2013, SCIENCE, V343, DOI DOI 10.1126/SCIENCE.1245267; Novak RE, 2011, PLANET SPACE SCI, V59, P163, DOI 10.1016/j.pss.2010.06.017; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; Owen T, 2008, SPACE SCI REV, V138, P301, DOI 10.1007/s11214-008-9306-7; PEPIN RO, 1994, ICARUS, V111, P289, DOI 10.1006/icar.1994.1146; Pepin RO, 2006, EARTH PLANET SC LETT, V252, P1, DOI 10.1016/j.epsl.2006.09.014; Shafer JT, 2010, GEOCHIM COSMOCHIM AC, V74, P7307, DOI 10.1016/j.gca.2010.09.009; Sheppard SMF, 1996, CLAY MINER, V31, P1, DOI 10.1180/claymin.1996.031.1.01; Thomson BJ, 2011, ICARUS, V214, P413, DOI 10.1016/j.icarus.2011.05.002; Tian F., 2013, COMP CLIMATOLOGY TER, P567; Usui T., 2013, 44 LUN PLAN SCI C, V1454; Usui T, 2012, EARTH PLANET SC LETT, V357, P119, DOI 10.1016/j.epsl.2012.09.008; Vaniman DT, 2014, SCIENCE, V343, DOI 10.1126/science.1243480; Villanueva GL, 2012, J QUANT SPECTROSC RA, V113, P202, DOI 10.1016/j.jqsrt.2011.11.001; Villanueva G. L., 2010, AGU FALL M, V52, P05; Webster CR, 2013, SCIENCE, V341, P260, DOI 10.1126/science.1237961; Wong MH, 2013, GEOPHYS RES LETT, V40, P6033, DOI 10.1002/2013GL057840	45	95	97	1	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					412	414		10.1126/science.1260291	http://dx.doi.org/10.1126/science.1260291			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25515119				2022-12-28	WOS:000348225800040
J	Deng, K; Pertea, M; Rongvaux, A; Wang, LY; Durand, CM; Ghiaur, G; Lai, J; McHugh, HL; Hao, HP; Zhang, H; Margolick, JB; Gurer, C; Murphy, AJ; Valenzuela, DM; Yancopoulos, GD; Deeks, SG; Strowig, T; Kumar, P; Siliciano, JD; Salzberg, SL; Flavell, RA; Shan, L; Siliciano, RF				Deng, Kai; Pertea, Mihaela; Rongvaux, Anthony; Wang, Leyao; Durand, Christine M.; Ghiaur, Gabriel; Lai, Jun; McHugh, Holly L.; Hao, Haiping; Zhang, Hao; Margolick, Joseph B.; Gurer, Cagan; Murphy, Andrew J.; Valenzuela, David M.; Yancopoulos, George D.; Deeks, Steven G.; Strowig, Till; Kumar, Priti; Siliciano, Janet D.; Salzberg, Steven L.; Flavell, Richard A.; Shan, Liang; Siliciano, Robert F.			Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations	NATURE			English	Article							VIRAL RESERVOIR; VIREMIA; IMMUNODOMINANCE; STABILITY	Despite antiretroviral therapy (ART), human immunodeficiency virus (HIV)-1 persists in a stable latent reservoir(1,2), primarily in resting memory CD4(+) T cells(3,4). This reservoir presents a major barrier to the cure of HIV-1 infection. To purge the reservoir, pharmacological reactivation of latent HIV-1 has been proposed(5) and tested both in vitro and in vivo(6-8). A key remaining question is whether virusspecific immune mechanisms, including cytotoxic T lymphocytes (CTLs), can clear infected cells in ART-treated patients after latency is reversed. Here we show that there is a striking all or none pattern for CTL escape mutations in HIV-1 Gag epitopes. Unless ART is started early, the vast majority (>98%) of latent viruses carry CTL escape mutations that render infected cells insensitive to CTLs directed at common epitopes. To solve this problem, we identified CTLs that could recognize epitopes from latent HIV-1 that were unmutated in every chronically infected patient tested. Upon stimulation, these CTLs eliminated target cells infected with autologous virus derived from the latent reservoir, both in vitro and in patient-derived humanized mice. The predominance of CTL-resistant viruses in the latent reservoir poses a major challenge to viral eradication. Our results demonstrate that chronically infected patients retain abroad-spectrum viral-specific CTL response and that appropriate boosting of this response may be required for the elimination of the latent reservoir.	[Deng, Kai; Pertea, Mihaela; Durand, Christine M.; Lai, Jun; McHugh, Holly L.; Siliciano, Janet D.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Pertea, Mihaela; Salzberg, Steven L.] Johns Hopkins Univ, Sch Med, Ctr Computat Biol, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Rongvaux, Anthony; Strowig, Till; Flavell, Richard A.; Shan, Liang] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Wang, Leyao] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT 06510 USA; [Ghiaur, Gabriel] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Hao, Haiping] Johns Hopkins Univ, Sch Med, Deep Sequencing & Microarray Core, Baltimore, MD 21205 USA; [Zhang, Hao; Margolick, Joseph B.] Johns Hopkins Univ, Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Gurer, Cagan; Murphy, Andrew J.; Valenzuela, David M.; Yancopoulos, George D.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA; [Kumar, Priti] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Salzberg, Steven L.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Flavell, Richard A.] Howard Hughes Med Inst, New Haven, CT 06510 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Yale University; Yale University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Regeneron; University of California System; University of California San Francisco; Yale University; Johns Hopkins University; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Johns Hopkins University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA.	richard.flavell@yale.edu; liang.shan@yale.edu; rsiliciano@jhmi.edu	Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011; Deng, Kai/AAK-4404-2020; Pertea, Mihaela/AAT-2705-2021; Shan, Liang/ABB-9210-2021	Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Deng, Kai/0000-0002-9973-8130; Pertea, Mihaela/0000-0003-0762-8637; Strowig, Till/0000-0003-0185-1459; Durand, Christine M./0000-0003-2605-9257; Flavell, Richard/0000-0003-4461-0778; Hao, Haiping/0000-0002-8826-1568; Ghiaur, Gabriel/0000-0002-3955-7944; Murphy, Andrew/0000-0003-4152-4081; Deeks, Steven/0000-0001-6371-747X	Howard Hughes Medical Institute; Martin Delaney CARE; DARE Collaboratories (NIH grants) [AI096113, 1U19AI096109]; ARCH E Collaborative Research Grant from the Foundation for AIDS Research [amFAR 108165-50-RGRL]; Johns Hopkins Center for AIDS Research [P30AI094189]; NIH [43222, T32 AI07019]; Bill and Melinda Gates Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL127269, T32HL007525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096109, P30AI094189, U19AI096113, R01AI051178, P30AI027763, T32AI007019, K99AI125065, R01AI043222] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Martin Delaney CARE; DARE Collaboratories (NIH grants); ARCH E Collaborative Research Grant from the Foundation for AIDS Research; Johns Hopkins Center for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all study participants. We thank J. Blankson for critical advice to the project; L. Alston and R. Hoh for coordinating patient recruitment; J. Alderman, C. Weibel and E. Henchey for technical assistance in the animal study. We than k the National Institutes of Health (NIH) AIDS Reagent Program for providing HIV-1 consensus B peptides. R.F.S. is supported by the Howard Hughes Medical Institute, by the Martin Delaney CARE and DARE Collaboratories (NIH grants AI096113 and 1U19AI096109), by an ARCH E Collaborative Research Grant from the Foundation for AIDS Research (amFAR 108165-50-RGRL), by the Johns Hopkins Center for AIDS Research (P30AI094189), and by NIH grant43222. L.S. is supported by NIH grant T32 AI07019. R.A.F. is supported by the Bill and Melinda Gates Foundation and the Howard Hughes Medical Institute.	Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; KOUP RA, 1994, J EXP MED, V180, P779, DOI 10.1084/jem.180.3.779; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Gall S, 2007, J CLIN INVEST, V117, P3563, DOI 10.1172/JCI32047; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Siliciano Janet D, 2005, Methods Mol Biol, V304, P3; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Yu XG, 2002, J VIROL, V76, P8690, DOI 10.1128/JVI.76.17.8690-8701.2002	34	380	387	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					381	U544		10.1038/nature14053	http://dx.doi.org/10.1038/nature14053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25561180	Green Submitted, Green Accepted			2022-12-28	WOS:000347810300049
J	Picker, LJ; Lifson, JD				Picker, Louis J.; Lifson, Jeffrey D.			Seeking ultimate victory	NATURE			English	Editorial Material							CURE; HIV		[Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Lifson, Jeffrey D.] Leidos Biomed Res Inc, Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD 21702 USA	Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.	pickerl@ohsu.edu; lifsonj@mail.nih.gov						Barouch DH, 2014, SCIENCE, V345, P169, DOI 10.1126/science.1255512; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Fukazawa Y., NATURE MED; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Margolis DM, 2013, CURR OPIN HIV AIDS, V8, P230, DOI 10.1097/COH.0b013e32835ef089; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Thornhill J., 2014, J CURR OPIN INFECT D; Tzu S., 2007, ART WAR	10	4	4	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					281	282		10.1038/nature14194	http://dx.doi.org/10.1038/nature14194			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY8NK	25561174				2022-12-28	WOS:000347810300030
J	Boeckh, M; Nichols, WG; Chemaly, RF; Papanicolaou, GA; Wingard, JR; Xie, H; Syrjala, KL; Flowers, MED; Stevens-Ayers, T; Jerome, KR; Leisenring, W				Boeckh, Michael; Nichols, W. Garrett; Chemaly, Roy F.; Papanicolaou, Genovefa A.; Wingard, John R.; Xie, Hu; Syrjala, Karen L.; Flowers, Mary E. D.; Stevens-Ayers, Terry; Jerome, Keith R.; Leisenring, Wendy			Valganciclovir for the Prevention of Complications of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; LONG-TERM ACYCLOVIR; STEM-CELL; DOUBLE-BLIND; VIRAL LOAD; GANCICLOVIR PROPHYLAXIS; ANTIVIRAL THERAPY; FUNGAL-INFECTIONS; CMV DISEASE; VIRUS LOAD	Background: Optimal prevention of late cytomegalovirus (CMV) disease is poorly defined. Objective: To compare valganciclovir prophylaxis with polymerase chain reaction-guided preemptive therapy. Design: Randomized, double-blind trial. (ClinicalTrials.gov: NCT00016068) Setting: Multicenter trial. Patients: 184 recipients of hematopoietic cell transplantation (HCT) who were at high risk for late CMV disease (95 patients received valganciclovir and 89 received placebo). Intervention: 6 months of valganciclovir (900 mg/d) or placebo. Patients with polymerase chain reaction positivity at 1000 copies/mL or greater or a 5-fold increase over baseline were treated with ganciclovir or valganciclovir (5 mg/kg or 900 mg twice daily, respectively). Measurements: The composite primary end point was death, CMV disease, or other invasive infections by 270 days after HCT. Secondary end points were CMV disease, CMV DNAemia, death, other infections, resource utilization, ganciclovir resistance, quality of life, immune reconstitution, and safety. Results: The primary composite outcome occurred in 20% of valganciclovir recipients versus 21% of placebo-preemptive therapy recipients (treatment difference, -0.01 [95% CI, -0.13 to 0.10]; P = 0.86). There was no difference in the primary end point or its components 640 days after HCT. The incidence of a CMV DNAemia level of 1000 copies/mL or greater or a 5-fold increase over baseline was reduced in the valganciclovir group (11% vs. 36%; P < 0.001). Neutropenia was not significantly different at the absolute neutrophil count of less than 0.5 x 10(9) cells/L (P = 0.57); however, more patients received hematopoietic growth factors in the valganciclovir group (25.3% vs. 12.4%; P = 0.026). No significant differences were seen in other secondary outcomes. Limitation: Some high-risk patients were not included. Conclusion: Valganciclovir prophylaxis was not superior in reducing the composite end point of CMV disease, invasive bacterial or fungal disease, or death when compared with polymerase chain reaction-guided preemptive therapy. Both strategies performed similarly with regard to most clinical outcomes.	[Boeckh, Michael; Xie, Hu; Syrjala, Karen L.; Flowers, Mary E. D.; Stevens-Ayers, Terry; Jerome, Keith R.; Leisenring, Wendy] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Nichols, W. Garrett] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA; [Chemaly, Roy F.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Papanicolaou, Genovefa A.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Wingard, John R.] Univ Florida, Gainesville, FL 32610 USA	Fred Hutchinson Cancer Center; GlaxoSmithKline; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; State University System of Florida; University of Florida	Boeckh, M (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave North,E4-100,POB 19024, Seattle, WA 98109 USA.	mboeckh@fhcrc.org	Boeckh, Michael/AAA-1607-2022	Leisenring, Wendy/0000-0001-7405-0906; Xie, Hu/0000-0003-0556-6591; Papanicolaou, Genovefa/0000-0002-2891-079X; Wingard, John/0000-0001-7478-5398	Roche Laboratories; NATIONAL CANCER INSTITUTE [R01CA160684, P30CA008748, P30CA016672, P01CA018029] Funding Source: NIH RePORTER	Roche Laboratories; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Roche Laboratories.	Almyroudis NG, 2007, TRANSPL INFECT DIS, V9, P286, DOI 10.1111/j.1399-3062.2007.00235.x; Boeckh M, 2006, BLOOD, V107, P1800, DOI 10.1182/blood-2005-09-3624; Boeckh M, 2004, J CLIN MICROBIOL, V42, P1142, DOI 10.1128/JCM.42.3.1142-1148.2004; Boeckh M, 2003, BLOOD, V101, P407, DOI 10.1182/blood-2002-03-0993; Boeckh M, 1996, BLOOD, V88, P4063, DOI 10.1182/blood.V88.10.4063.bloodjournal88104063; Castor J, 2007, J CLIN MICROBIOL, V45, P2681, DOI 10.1128/JCM.00526-07; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; EFRON B, 1980, BIOSTATISTICS CASEBO, P19; EINSELE H, 1995, BLOOD, V86, P2815; GOODRICH JM, 1993, ANN INTERN MED, V118, P173, DOI 10.7326/0003-4819-118-3-199302010-00003; Green ML, 2012, BIOL BLOOD MARROW TR, V18, P1687, DOI 10.1016/j.bbmt.2012.05.015; Guerrero A, 2012, BIOL BLOOD MARROW TR, V18, P66, DOI 10.1016/j.bbmt.2011.05.010; Hannigan JF, 1982, 74 STANF U; Hodges Jr JL, 1983, ENCY STAT SCI, V3, P463; Junghanss C, 2002, BLOOD, V99, P1978, DOI 10.1182/blood.V99.6.1978; Kopp M, 2000, EUR J HAEMATOL, V65, P97, DOI 10.1034/j.1600-0609.2000.90143.x; Krause H, 1997, BONE MARROW TRANSPL, V19, P1111, DOI 10.1038/sj.bmt.1700801; LJUNGMAN P, 1986, BONE MARROW TRANSPL, V1, P185; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Maris M, 2003, EXP HEMATOL, V31, P941, DOI 10.1016/S0301-472X(03)00201-7; Marty FM, 2011, LANCET INFECT DIS, V11, P284, DOI 10.1016/S1473-3099(11)70024-X; Nakamae H, 2011, HAEMATOL-HEMATOL J, V96, P1838, DOI 10.3324/haematol.2011.044966; Nguyen Q, 1999, CLIN INFECT DIS, V28, P618, DOI 10.1086/515146; Peggs KS, 2000, BRIT J HAEMATOL, V111, P782, DOI 10.1046/j.1365-2141.2000.02419.x; Pollack M, 2011, BIOL BLOOD MARROW TR, V17, P664, DOI 10.1016/j.bbmt.2010.07.026; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Reusser P, 1999, J INFECT DIS, V180, P247, DOI 10.1086/314879; REUSSER P, 1991, BLOOD, V78, P1373; Rothman KJ, 1986, MODERN EPIDEMIOLOGY, P242; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Salzberger B, 1997, BLOOD, V90, P2502; Schenker N, 1996, COMPUT STAT DATA AN, V22, P425, DOI 10.1016/0167-9473(95)00057-7; WINSTON DJ, 1993, ANN INTERN MED, V118, P179, DOI 10.7326/0003-4819-118-3-199302010-00004; Zaia JA, 1997, J INFECT DIS, V176, P782, DOI 10.1086/517301	34	84	88	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2015	162	1					1	U132		10.7326/M13-2729	http://dx.doi.org/10.7326/M13-2729			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1LU	25560711	Green Accepted			2022-12-28	WOS:000350103000001
J	Scheller, NM; Svanstrom, H; Pasternak, B; Arnheim-Dahlstrom, L; Sundstrom, K; Fink, K; Hviid, A				Scheller, Nikolai Madrid; Svanstrom, Henrik; Pasternak, Bjorn; Arnheim-Dahlstrom, Lisen; Sundstrom, Karin; Fink, Katharina; Hviid, Anders			Quadrivalent HPV Vaccination and Risk of Multiple Sclerosis and Other Demyelinating Diseases of the Central Nervous System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CASE SERIES; SAFETY; REGISTER; HEALTH	IMPORTANCE Case reports have suggested a link between human papillomavirus (HPV) vaccination and development of multiple sclerosis and other demyelinating diseases. OBJECTIVE To investigate if quadrivalent HPV (qHPV) vaccination is associated with an increased risk of multiple sclerosis and other demyelinating diseases. DESIGN, SETTING, AND PARTICIPANTS Using nationwide registers we identified a cohort of all females aged 10 years to 44 years in Denmark and Sweden, followed up from 2006 to 2013, information on qHPV vaccination, and data on incident diagnoses of multiple sclerosis and other demyelinating diseases. The primary analysis used a cohort design including vaccinated and unvaccinated study participants. A secondary analysis used a self-controlled case-series design including only cases. Both analyses used a 2-year risk period following vaccination. EXPOSURES Information on qHPV vaccination was obtained through the national vaccination and prescription registers. MAIN OUTCOMES AND MEASURES The primary outcomes were multiple sclerosis and a composite end point of other demyelinating diseases. Incidence rate ratios were estimated using Poisson regression, comparing rates of events in the 2-year risk periods following vaccination and in unvaccinated time periods. RESULTS The study included 3 983 824 females, among whom 789 082 received a total of 1 927 581 qHPV vaccine doses. During follow-up, 4322 multiple sclerosis cases and 3300 cases of other demyelinating diseases were identified, of which 73 and 90, respectively, occurred within the risk period. In the cohort analysis, there was no increased risk of multiple sclerosis (crude incidence rates, 6.12 events/100 000 person-years [95% CI, 4.86-7.69] and 21.54 events/100 000 person-years [95% CI, 20.90-22.20] for the vaccinated and unvaccinated periods; adjusted rate ratio, 0.90 [95% CI, 0.70-1.15]) or other demyelinating diseases (crude incidence rates, 7.54 events/100 000 person-years [95% CI, 6.13-9.27] and 16.14 events/100 000 person-years [95% CI, 15.58-16.71]; adjusted rate ratio, 1.00 [95% CI, 0.80-1.26]) associated with qHPV vaccination. Similarly, no increased risk was found using the self-controlled case-series design (multiple sclerosis: incidence ratio, 1.05 [95% CI, 0.79-1.38]; other demyelinating diseases: incidence ratio, 1.14 [95% CI, 0.88-1.47]). CONCLUSIONS AND RELEVANCE In this study with nationwide coverage of 2 Scandinavian countries, qHPV vaccination was not associated with the development of multiple sclerosis or other demyelinating diseases. These findings do not support concerns about a causal relationship between qHPV vaccination and demyelinating diseases.	[Scheller, Nikolai Madrid; Svanstrom, Henrik; Pasternak, Bjorn; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; [Arnheim-Dahlstrom, Lisen] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Sundstrom, Karin] Karolinska Univ Hosp, Dept Lab Med, Stockholm, Sweden; [Fink, Katharina] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Fink, Katharina] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden	Statens Serum Institut; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Scheller, NM (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	nims@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020; Sundström, Karin/V-5714-2017	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127; Sundström, Karin/0000-0002-6865-0224	Swedish Foundation for Strategic Research; Novo Nordisk Foundation; Danish Medical Research Council; Novo Nordisk Fonden [NNF14OC0008847] Funding Source: researchfish	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Fonden(Novo Nordisk Foundation)	The Swedish Foundation for Strategic Research, Novo Nordisk Foundation, and The Danish Medical Research Council funded the study.	Arnheim-Dahlstrom L, 2013, BMJ-BRIT MED J, V347, P5906, DOI DOI 10.1136/BMJ.F5906; Ascherio A, 2001, NEW ENGL J MED, V344, P327, DOI 10.1056/NEJM200102013440502; Chang JS, 2011, J NEUROL NEUROSUR PS, V82, P1296, DOI 10.1136/jnnp.2010.214924; Chao C, 2012, J INTERN MED, V271, P193, DOI 10.1111/j.1365-2796.2011.02467.x; Chao C, 2012, HUM VACC IMMUNOTHER, V8, P1302, DOI 10.4161/hv.21268; DiMario FJ, 2010, J CHILD NEUROL, V25, P321, DOI 10.1177/0883073809349322; Eisenstein M, 2014, NATURE, V507, pS17, DOI 10.1038/507S17a; European Medicines Agency, EUR PUBL ASS REP SUM; European Medicines Agency, PHARM RISK ASS COMM; European Medicines Agency, 2014, EUR PUBL ASS REP GAR; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; Global Advisory Committee on Vaccine Safety, 2013, WKLY EPIDEMIOL REC, V89, P53; Grimaldi-Bensouda L, 2014, J INTERN MED, V275, P398, DOI 10.1111/joim.12155; Hviid A, 2006, EXPERT REV VACCINES, V5, P641, DOI 10.1586/14760584.5.5.641; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Laz TH, 2013, CANCER-AM CANCER SOC, V119, P1386, DOI 10.1002/cncr.27894; Laz TH, 2012, VACCINE, V30, P3534, DOI 10.1016/j.vaccine.2012.03.067; Leval A, 2013, JNCI-J NATL CANCER I, V105, P469, DOI 10.1093/jnci/djt032; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Lutringer-Magnin D, 2011, VACCINE, V29, P5322, DOI 10.1016/j.vaccine.2011.05.006; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Macartney KK, 2013, DRUG SAFETY, V36, P393, DOI 10.1007/s40264-013-0039-5; Marrie RA, 2005, NEUROLOGY, V65, P1066, DOI 10.1212/01.wnl.0000178891.20579.64; Mason K, 2012, ACTA NEUROL SCAND, V125, P213, DOI 10.1111/j.1600-0404.2011.01558.x; Menge T, 2012, NEUROLOGY, V79, P285, DOI 10.1212/WNL.0b013e31825fdead; Pedersen CB, 2006, DAN MED BULL, V53, P441; Sutton I, 2009, MULT SCLER J, V15, P116, DOI 10.1177/1352458508096868; Trim K, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/921236; Wettermark B, 2008, PHARMACOEPIDEM DR S, V17, P533, DOI 10.1002/pds.1604; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Wildemann B, 2009, NEUROLOGY, V72, P2132, DOI 10.1212/WNL.0b013e3181aa53bb; Wraith DC, 2003, LANCET, V362, P1659, DOI 10.1016/S0140-6736(03)14802-7; Zipp F, 1999, NAT MED, V5, P964, DOI 10.1038/12376	35	118	123	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					54	61		10.1001/jama.2014.16946	http://dx.doi.org/10.1001/jama.2014.16946			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25562266	Bronze			2022-12-28	WOS:000347478000015
J	Quarta, CC; Buxbaum, JN; Shah, AM; Falk, RH; Claggett, B; Kitzman, DW; Mosley, TH; Butler, KR; Boerwinkle, E; Solomon, SD				Quarta, C. Cristina; Buxbaum, Joel N.; Shah, Amil M.; Falk, Rodney H.; Claggett, Brian; Kitzman, Dalane W.; Mosley, Thomas H.; Butler, Kenneth R.; Boerwinkle, Eric; Solomon, Scott D.			The Amyloidogenic V122I Transthyretin Variant in Elderly Black Americans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEART-FAILURE INCIDENCE; ATHEROSCLEROSIS RISK; CARDIAC AMYLOIDOSIS; COMMUNITIES; HEREDITARY; DISEASE; DESIGN; STRAIN; ALLELE	BACKGROUND Approximately 4% of black Americans carry a valine-to-isoleucine substitution (V122I) in the transthyretin protein, which has been associated with late-onset restrictive amyloid cardiomyopathy and increased risks of death and heart failure. METHODS We determined genotype status for the transthyretin gene (TTR) in 3856 black participants in the Atherosclerosis Risk in Communities study and assessed clinical profiles, mortality, and the risk of incident heart failure in V122I TTR variant carriers (124 participants [3%]) versus noncarriers (3732 participants). Cardiac structure and function and features suggestive of cardiac amyloidosis were assessed in participants who underwent echocardiography during visit 5 (2011 to 2013), when they were older than 65 years of age. RESULTS After 21.5 years of follow-up, we did not detect a significant difference in mortality between carriers (41 deaths, 33%) and noncarriers (1382 deaths, 37%; age-and sex-stratified hazard ratio among carriers, 0.99; 95% confidence interval [CI], 0.73 to 1.36; P = 0.97). The TTR variant was associated with an increased risk of incident heart failure (age-and sex-stratified hazard ratio, 1.47; 95% CI, 1.03 to 2.10; P = 0.04). On echocardiography at visit 5, carriers (46 participants) had worse systolic and diastolic function, as well as a higher level of N-terminal pro-brain natriuretic peptide, than noncarriers (1194 participants), although carriers had a low prevalence (7%) of overt manifestations of amyloid cardiomyopathy. CONCLUSIONS We did not detect a significant difference in mortality between V122I TTR allele carriers and noncarriers, a finding that contrasts with prior observations; however, the risk of heart failure was increased among carriers. The prevalence of overt cardiac abnormalities among V122I TTR carriers was low. (Funded by the National Heart, Lung, and Blood Institute and others.)	[Quarta, C. Cristina; Shah, Amil M.; Falk, Rodney H.; Claggett, Brian; Solomon, Scott D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Quarta, C. Cristina] Univ Bologna, Inst Cardiol, Bologna, Italy; [Quarta, C. Cristina] St Orsola Marcello Malpighi Hosp, Bologna, Italy; [Buxbaum, Joel N.] Scripps Res Inst, La Jolla, CA 92037 USA; [Kitzman, Dalane W.] Wake Forest Sch Med, Dept Internal Med, Cardiol Sect, Winston Salem, NC USA; [Kitzman, Dalane W.] Wake Forest Sch Med, Dept Internal Med, Geriatr Sect, Winston Salem, NC USA; [Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Med Geriatr, Jackson, MS USA; [Butler, Kenneth R.] Univ Mississippi, Med Ctr, Div Cardiovasc Dis, Jackson, MS USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Sch Publ Hlth, Houston, TX 77030 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Scripps Research Institute; Wake Forest University; Wake Forest University; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Solomon, SD (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	ssolomon@rics.bwh.harvard.edu	Butler, Kenneth Ray/S-3328-2019	Quarta, Candida Cristina/0000-0003-0935-2873	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; NHLBI [NHLBI-HC-11-08]; National Institutes of Health [R01 AG19259]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL116792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019259, P30AG021332, R01AG018915] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C and HHSN268201100012C), a cooperative agreement from the NHLBI (NHLBI-HC-11-08, to Brigham and Women's Hospital), and a grant from the National Institutes of Health (R01 AG19259, to Dr. Buxbaum).	Ando Y, 2005, ARCH NEUROL-CHICAGO, V62, P1057, DOI 10.1001/archneur.62.7.1057; Bhuiyan T, 2011, CIRC-HEART FAIL, V4, P121, DOI 10.1161/CIRCHEARTFAILURE.109.910455; Buxbaum J, 2010, AM HEART J, V159, P864, DOI 10.1016/j.ahj.2010.02.006; Cheng S, 2013, J AM SOC ECHOCARDIOG, V26, P1258, DOI 10.1016/j.echo.2013.07.002; Coelho T, 2013, CURR MED RES OPIN, V29, P63, DOI 10.1185/03007995.2012.754348; Falk RH, 2010, PROG CARDIOVASC DIS, V52, P445; Folsom AR, 2009, CIRC-HEART FAIL, V2, P11, DOI 10.1161/CIRCHEARTFAILURE.108.794933; Gertz MA, 2005, AM J HEMATOL, V79, P319, DOI 10.1002/ajh.20381; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Jacobson D, 2011, AM J CARDIOL, V108, P440, DOI 10.1016/j.amjcard.2011.03.069; JACOBSON DR, 1990, AM J HUM GENET, V47, P127; Jacobson DR, 1997, NEW ENGL J MED, V336, P466, DOI 10.1056/NEJM199702133360703; Jiang X, 2001, P NATL ACAD SCI USA, V98, P14943, DOI 10.1073/pnas.261419998; Kottgen A, 2007, J AM SOC NEPHROL, V18, P1307, DOI 10.1681/ASN.2006101159; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Rapezzi C, 2013, EUR HEART J, V34, P520, DOI 10.1093/eurheartj/ehs123; Rosamond WD, 2012, CIRC-HEART FAIL, V5, P152, DOI 10.1161/CIRCHEARTFAILURE.111.963199; Rowczenio D., MUTATIONS HEREDITARY; Shah AM, 2014, CIRC-CARDIOVASC IMAG, V7, P173, DOI 10.1161/CIRCIMAGING.113.000736; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yingchoncharoen T, 2013, J AM SOC ECHOCARDIOG, V26, P185, DOI 10.1016/j.echo.2012.10.008	22	136	137	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2015	372	1					21	29		10.1056/NEJMoa1404852	http://dx.doi.org/10.1056/NEJMoa1404852			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX7MU	25551524	Green Accepted, Green Published			2022-12-28	WOS:000347100800006
J	Wabitsch, M; Funcke, JB; Lennerz, B; Kuhnle-Krahl, U; Lahr, G; Debatin, KM; Vatter, P; Gierschik, P; Moepps, B; Fischer-Posovszky, P				Wabitsch, Martin; Funcke, Jan-Bernd; Lennerz, Belinda; Kuhnle-Krahl, Ursula; Lahr, Georgia; Debatin, Klaus-Michael; Vatter, Petra; Gierschik, Peter; Moepps, Barbara; Fischer-Posovszky, Pamela			Biologically Inactive Leptin and Early-Onset Extreme Obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MISSENSE MUTATION; MORBID-OBESITY; DEFICIENCY; GENE; HYPOGONADISM; PROTEIN; DYSFUNCTION; MOUSE	Mutations in the gene encoding leptin (LEP) typically lead to an absence of circulating leptin and to extreme obesity. We describe a 2-year-old boy with early-onset extreme obesity due to a novel homozygous transversion (c.298G -> T) in LEP, leading to a change from aspartic acid to tyrosine at amino acid position 100 (p.D100Y) and high immunoreactive levels of leptin. Overexpression studies confirmed that the mutant protein is secreted but neither binds to nor activates the leptin receptor. The mutant protein failed to reduce food intake and body weight in leptin-deficient ob/ob mice. Treatment of the patient with recombinant human leptin (metreleptin) rapidly normalized eating behavior and resulted in weight loss.	[Wabitsch, Martin; Funcke, Jan-Bernd; Lennerz, Belinda; Fischer-Posovszky, Pamela] Univ Ulm, Div Pediat Endocrinol & Diabet, D-89075 Ulm, Germany; [Lahr, Georgia; Debatin, Klaus-Michael] Univ Ulm, Dept Pediat & Adolescent Med, D-89075 Ulm, Germany; [Vatter, Petra; Gierschik, Peter; Moepps, Barbara] Univ Ulm, Inst Pharmacol & Toxicol, D-89075 Ulm, Germany; [Kuhnle-Krahl, Ursula] Endokrinol Schwerpunkt Praxis Kinder & Jugend, Gauting, Germany	Ulm University; Ulm University; Ulm University	Wabitsch, M (corresponding author), Univ Ulm, Div Pediat Endocrinol & Diabet, Dept Pediat & Adolescent Med, Eythstr 24, D-89075 Ulm, Germany.	martin.wabitsch@uniklinik-ulm.de; pamelafischer@uniklinik-ulm.de	Debatin, Klaus-Michael/J-9704-2014	Debatin, Klaus-Michael/0000-0002-8397-1886; Fischer-Posovszky, Pamela/0000-0003-3402-9840; Funcke, Jan-Bernd/0000-0002-2596-3167; Lennerz, Belinda/0000-0002-8021-7984	Federal Ministry of Education and Research [BMBF 01GI1120A]; International Graduate School in Molecular Medicine Ulm	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); International Graduate School in Molecular Medicine Ulm	Supported by a grant from the Federal Ministry of Education and Research (BMBF 01GI1120A). Mr. Funcke was supported by the International Graduate School in Molecular Medicine Ulm. Amylin Pharmaceuticals, Bristol-Myers Squibb, and AstraZeneca provided metreleptin for the patient.	Boute N, 2004, BIOCHIMIE, V86, P351, DOI 10.1016/j.biochi.2004.06.005; Chekhranova M K, 2008, Bioorg Khim, V34, P854; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Farooqi IS, 2008, FRONT HORM RES, V36, P1, DOI 10.1159/000115333; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Farooqi S, 2006, NAT CLIN PRACT ENDOC, V2, P172, DOI 10.1038/ncpendmet0137; Fatima W, 2011, INT J PEDIATR OBES, V6, P419, DOI 10.3109/17477166.2011.608431; Fischer-Posovszky P, 2010, J CLIN ENDOCR METAB, V95, P2836, DOI 10.1210/jc.2009-2466; Hong CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015333; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; Mazen I, 2009, MOL GENET METAB, V97, P305, DOI 10.1016/j.ymgme.2009.04.002; MedeirosNeto G, 1996, J CLIN INVEST, V97, P1250, DOI 10.1172/JCI118540; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Ozata M, 1999, J CLIN ENDOCR METAB, V84, P3686, DOI 10.1210/jc.84.10.3686; Rau H, 1999, ENDOCRINOLOGY, V140, P1718, DOI 10.1210/en.140.4.1718; Samuels ME, 2013, J CLIN ENDOCR METAB, V98, P736, DOI 10.1210/jc.2012-3199; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Takahashi Y, 1997, J CLIN INVEST, V100, P1159, DOI 10.1172/JCI119627; Thakur S, 2014, CLIN GENET, V86, P391, DOI 10.1111/cge.12289; Wang JL, 1999, NAT MED, V5, P895, DOI 10.1038/11335; WEIGLE DS, 1995, J CLIN INVEST, V96, P2065, DOI 10.1172/JCI118254; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	24	96	99	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2015	372	1					48	54		10.1056/NEJMoa1406653	http://dx.doi.org/10.1056/NEJMoa1406653			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX7MU	25551525				2022-12-28	WOS:000347100800009
J	Lamas, D; Rosenbaum, L				Lamas, Daniela; Rosenbaum, Lisa			Very Complicated Math - Reconfiguring Organ Allocation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LIVER-TRANSPLANTATION		[Lamas, Daniela] Brigham & Womens Hosp, Boston, MA 02115 USA; [Lamas, Daniela] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Lamas, Daniela] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center	Lamas, D (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							Buchanan P, 2009, LIVER TRANSPLANT, V15, P1270, DOI 10.1002/lt.21802; Davis AE, 2014, TRANSPLANTATION, V98, P931, DOI 10.1097/TP.0000000000000446; Gentry SE, 2013, AM J TRANSPLANT, V13, P2052, DOI 10.1111/ajt.12301; OPTN/UNOS Liver and Intestinal Organ Transplantation Committee, 2014, RED LIV DISTR RED VA; Salvalaggio PR, 2011, LIVER TRANSPLANT, V17, P233, DOI 10.1002/lt.22230	5	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2447	2450		10.1056/NEJMp1412764	http://dx.doi.org/10.1056/NEJMp1412764			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX4RZ	25539103				2022-12-28	WOS:000346920300002
J	Gan, L; Cui, CH; Heggen, M; Dionigi, F; Rudi, S; Strasser, P				Gan, Lin; Cui, Chunhua; Heggen, Marc; Dionigi, Fabio; Rudi, Stefan; Strasser, Peter			Element-specific anisotropic growth of shaped platinum alloy nanocrystals	SCIENCE			English	Article							OXYGEN REDUCTION ACTIVITY; FUEL-CELLS; NANOPARTICLES; ELECTROCATALYSIS; SEGREGATION; EVOLUTION; CATALYSTS; STRATEGY; IRON	Morphological shape in chemistry and biology owes its existence to anisotropic growth and is closely coupled to distinct functionality. Although much is known about the principal growth mechanisms of monometallic shaped nanocrystals, the anisotropic growth of shaped alloy nanocrystals is still poorly understood. Using aberration-corrected scanning transmission electron microscopy, we reveal an element-specific anisotropic growth mechanism of platinum (Pt) bimetallic nano-octahedra where compositional anisotropy couples to geometric anisotropy. A Pt-rich phase evolves into precursor nanohexapods, followed by a slower step-induced deposition of an M-rich (M = Ni, Co, etc.) phase at the concave hexapod surface forming the octahedral facets. Our finding explains earlier reports on unusual compositional segregations and chemical degradation pathways of bimetallic polyhedral catalysts and may aid rational synthesis of shaped alloy catalysts with desired compositional patterns and properties.	[Gan, Lin; Cui, Chunhua; Dionigi, Fabio; Rudi, Stefan; Strasser, Peter] Tech Univ Berlin, Div Chem Engn, Dept Chem, Electrochem Energy Catalysis & Mat Sci Lab, D-10623 Berlin, Germany; [Heggen, Marc] Forschungszentrum Julich GmbH, Ernst Ruska Ctr Microscopy & Spect Electrons, D-52425 Julich, Germany; [Gan, Lin] Tsinghua Univ, Grad Sch Shenzhen, Div Energy & Environm, Shenzhen 518055, Peoples R China	Technical University of Berlin; Helmholtz Association; Research Center Julich; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Strasser, P (corresponding author), Tech Univ Berlin, Div Chem Engn, Dept Chem, Electrochem Energy Catalysis & Mat Sci Lab, D-10623 Berlin, Germany.	pstrasser@tu-berlin.de	Cui, Chunhua/C-5715-2008; Heggen, Marc/K-5099-2013; Strasser, Peter/A-1868-2012; Gan, Lin/F-4063-2011; Dionigi, Fabio/E-5663-2011; Heggen, Marc/AAN-2888-2021; Strasser, Peter/ABE-6795-2020	Cui, Chunhua/0000-0002-2774-1576; Heggen, Marc/0000-0002-2646-0078; Strasser, Peter/0000-0002-3884-436X; Gan, Lin/0000-0003-3486-6016; Dionigi, Fabio/0000-0002-0576-024X; Heggen, Marc/0000-0002-2646-0078; Strasser, Peter/0000-0002-3884-436X	U.S. Department of Energy EERE [DE-EE0000458]; U.S. Department of Energy EERE through General Motors; Ernst Ruska Center for Microscopy and Spectroscopy with Electrons, Forschungszentrum Julich GmbH, Germany; Deutsche Forschungsgemeinschaft (DFG) [STR 596/4-1, STR 596/5-1]	U.S. Department of Energy EERE(United States Department of Energy (DOE)); U.S. Department of Energy EERE through General Motors(United States Department of Energy (DOE)); Ernst Ruska Center for Microscopy and Spectroscopy with Electrons, Forschungszentrum Julich GmbH, Germany; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Supported by U.S. Department of Energy EERE award DE-EE0000458 via subcontract through General Motors; the Ernst Ruska Center for Microscopy and Spectroscopy with Electrons, Forschungszentrum Julich GmbH, Germany; and Deutsche Forschungsgemeinschaft (DFG) grants STR 596/4-1 ("Pt stability") and STR 596/5-1 ("Shaped Pt bimetallics"). We thank the Zentraleinrichtung fur Elektronenmikroskopie (Zelmi), Technical University Berlin, for its support of TEM and EDX measurements; N. Erini for carrying out FTIR measurements; and R. Schomack and M. Gleich for analysis of thermal gravimetric data.	ABRIKOSOV IA, 1994, PHYS REV B, V50, P2039, DOI 10.1103/PhysRevB.50.2039; Ahmadi TS, 1996, SCIENCE, V272, P1924, DOI 10.1126/science.272.5270.1924; Carpenter MK, 2012, J AM CHEM SOC, V134, P8535, DOI 10.1021/ja300756y; Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Choi SI, 2013, NANO LETT, V13, P3420, DOI 10.1021/nl401881z; Christoffersen E, 2001, J CATAL, V199, P123, DOI 10.1006/jcat.2000.3136; Cui CH, 2013, NAT MATER, V12, P765, DOI [10.1038/NMAT3668, 10.1038/nmat3668]; Cui CH, 2012, NANO LETT, V12, P5885, DOI 10.1021/nl3032795; Debe MK, 2012, NATURE, V486, P43, DOI 10.1038/nature11115; Ding Y, 2010, J AM CHEM SOC, V132, P12480, DOI 10.1021/ja105614q; Gasteiger HA, 2009, SCIENCE, V324, P48, DOI 10.1126/science.1172083; Liao HG, 2013, J AM CHEM SOC, V135, P5038, DOI 10.1021/ja310612p; Liao HG, 2012, SCIENCE, V336, P1011, DOI 10.1126/science.1219185; Liu XW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01404; Petroski JM, 1998, J PHYS CHEM B, V102, P3316, DOI 10.1021/jp981030f; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Wang GF, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1828033; Wu G, 2011, SCIENCE, V332, P443, DOI 10.1126/science.1200832; Wu JB, 2012, J AM CHEM SOC, V134, P11880, DOI 10.1021/ja303950v; Wu JB, 2011, NANO LETT, V11, P798, DOI 10.1021/nl104094p; Wu Y, 2013, J AM CHEM SOC, V135, P12220, DOI 10.1021/ja4068063; Wu YE, 2012, ANGEW CHEM INT EDIT, V51, P12524, DOI 10.1002/anie.201207491; Wu YE, 2012, J AM CHEM SOC, V134, P8975, DOI 10.1021/ja302606d; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248; Xu D, 2009, ANGEW CHEM INT EDIT, V48, P4217, DOI 10.1002/anie.200900293; Yu T, 2011, ANGEW CHEM INT EDIT, V50, P2773, DOI 10.1002/anie.201007859; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654; Zhang H, 2011, J AM CHEM SOC, V133, P6078, DOI 10.1021/ja201156s; Zhang J, 2010, NANO LETT, V10, P638, DOI 10.1021/nl903717z; Zhang J, 2009, J AM CHEM SOC, V131, P18543, DOI 10.1021/ja908245r; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104	32	253	260	21	687	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1502	1506		10.1126/science.1261212	http://dx.doi.org/10.1126/science.1261212			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525243				2022-12-28	WOS:000346536500061
J	Zeng, M; Hu, ZP; Shi, XL; Li, XH; Zhan, XM; Li, XD; Wang, JH; Choi, JH; Wang, KW; Purrington, T; Tang, M; Fina, M; DeBerardinis, RJ; Moresco, EMY; Pedersen, G; McInerney, GM; Hedestam, GBK; Chen, ZJJ; Beutler, B				Zeng, Ming; Hu, Zeping; Shi, Xiaolei; Li, Xiaohong; Zhan, Xiaoming; Li, Xiao-Dong; Wang, Jianhui; Choi, Jin Huk; Wang, Kuan-wen; Purrington, Tiana; Tang, Miao; Fina, Maggy; DeBerardinis, Ralph J.; Moresco, Eva Marie Y.; Pedersen, Gabriel; McInerney, Gerald M.; Hedestam, Gunilla B. Karlsson; Chen, Zhijian J.; Beutler, Bruce			MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REVERSE-TRANSCRIPTASE; GENE; INITIATION; DISEASE; ANTIGEN; TYPE-1; HIV	Multivalent molecules with repetitive structures including bacterial capsular polysaccharides and viral capsids elicit antibody responses through B cell receptor (BCR) crosslinking in the absence of T cell help. We report that immunization with these T cell-independent type 2 (TI-2) antigens causes up-regulation of endogenous retrovirus (ERV) RNAs in antigen-specific mouse B cells. These RNAs are detected via a mitochondrial antiviral signaling protein (MAVS)-dependent RNA sensing pathway or reverse-transcribed and detected via the cGAS-cGAMP-STING pathway, triggering a second, sustained wave of signaling that promotes specific immunoglobulin M production. Deficiency of both MAVS and cGAS, or treatment of MAVS-deficient mice with reverse transcriptase inhibitors, dramatically inhibits TI-2 antibody responses. These findings suggest that ERV and two innate sensing pathways that detect them are integral components of the TI-2 B cell signaling apparatus.	[Zeng, Ming; Li, Xiaohong; Zhan, Xiaoming; Li, Xiao-Dong; Wang, Jianhui; Choi, Jin Huk; Wang, Kuan-wen; Purrington, Tiana; Tang, Miao; Fina, Maggy; Moresco, Eva Marie Y.; Chen, Zhijian J.; Beutler, Bruce] Univ Texas SW Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA; [Hu, Zeping; Shi, Xiaolei; DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Hu, Zeping; Shi, Xiaolei; DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA; [Hu, Zeping; Shi, Xiaolei; DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Pedersen, Gabriel; McInerney, Gerald M.; Hedestam, Gunilla B. Karlsson] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Li, Xiao-Dong; Wang, Jianhui; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Karolinska Institutet; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Beutler, B (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Genet Host Def, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Bruce.Beutler@UTSouthwestern.edu	McInerney, Gerald/G-5344-2012; Hu, Zeping/F-6205-2010	McInerney, Gerald/0000-0003-2257-7241; Hu, Zeping/0000-0003-4146-7750; Moresco, Eva Marie/0000-0002-2049-7291	NIH [P01 AI070167, U19 AI100627, R01 AI093967, R01 CA157996]; NATIONAL CANCER INSTITUTE [R01CA157996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627, R01AI093967, P01AI070167] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Evans and F. Malik for the generous gift of the 83A25 antibody; P. Jurek for expert assistance in preparing the figures; and the Children's Medical Center Research Institute Flow Cytometry Facility at the University of Texas Southwestern Medical Center for assistance with cell sorting. The data presented in this paper are tabulated in the main paper and in the supplementary materials. This work was supported by generous donations from the Lyda Hill Foundation and the Kent and JoAnn Foster Family Foundation; and by NIH grants P01 AI070167 and U19 AI100627 (to B.B.), R01 AI093967 (to Z.J.C.), and R01 CA157996 (to R.D.).	ALCAMI J, 1995, EMBO J, V14, P1552, DOI 10.1002/j.1460-2075.1995.tb07141.x; Beck-Engeser GB, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-91; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; CRAWFORD S, 1985, J VIROL, V53, P899, DOI 10.1128/JVI.53.3.899-907.1985; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Hidmark AS, 2006, J VIROL, V80, P7100, DOI 10.1128/JVI.02579-05; IKEDA H, 1985, J VIROL, V55, P768, DOI 10.1128/JVI.55.3.768-777.1985; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; LORI F, 1988, AIDS RES HUM RETROV, V4, P393, DOI 10.1089/aid.1988.4.393; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Moreno-Garcia ME, 2006, ADV EXP MED BIOL, V584, P89; ROULSTON A, 1995, MICROBIOL REV, V59, P481, DOI 10.1128/MMBR.59.3.481-505.1995; RUPRECHT RM, 1986, NATURE, V323, P467, DOI 10.1038/323467a0; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Tugnet Nicola, 2013, Open Rheumatol J, V7, P13, DOI 10.2174/1874312901307010013; YOUNG SD, 1995, ANTIMICROB AGENTS CH, V39, P2602, DOI 10.1128/AAC.39.12.2602	21	85	99	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1486	1492		10.1126/science.346.6216.1486	http://dx.doi.org/10.1126/science.346.6216.1486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525240	Green Accepted			2022-12-28	WOS:000346536500057
J	Auslander, S; Fussenegger, M				Auslaender, Simon; Fussenegger, Martin			SYNTHETIC BIOLOGY Toehold gene switches make big footprints	NATURE			English	Editorial Material							CIRCUIT; CELLS; MICE		[Auslaender, Simon; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Auslander, S (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.							Auslander D, 2014, MOL CELL, V55, P397, DOI 10.1016/j.molcel.2014.06.007; Auslander S, 2014, NAT METHODS, V11, P1154, DOI [10.1038/NMETH.3136, 10.1038/nmeth.3136]; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; Rossger K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3825; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527	9	13	13	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					333	334		10.1038/516333a	http://dx.doi.org/10.1038/516333a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25519125				2022-12-28	WOS:000346484800031
J	Li, CY; de Grijs, R; Deng, LC				Li, Chengyuan; de Grijs, Richard; Deng, Licai			The exclusion of a significant range of ages in a massive star cluster	NATURE			English	Article							LARGE-MAGELLANIC-CLOUD; DOUBLE MAIN-SEQUENCE; MULTIPLE STELLAR POPULATIONS; COLOR-MAGNITUDE DIAGRAMS; GLOBULAR-CLUSTERS; FORMATION HISTORY; OMEGA-CENTAURI; NGC 1818; PARAMETERS; ROTATION	Stars spend most of their lifetimes on the main sequence in the Hertzsprung-Russell diagram. The extended main-sequence turn-off regions-containing stars leaving the main sequence after having spent all of the hydrogen in their cores-found in massive (more than a few tens of thousands of solar masses), intermediate-age (about one to three billion years old) star clusters1-8 are usually interpreted as evidence of internal age spreads of more than 300 million years(2,4,5), although young clusters are thought to quickly lose any remaining star-forming fuel following a period of rapid gas expulsion on timescales of order 10(7) years(9,10). Here we report, on the basis of a combination of high-resolution imaging observations and theoretical modelling, that the stars beyond the main sequence in the two-billion-year-old cluster NGC 1651, characterized by a mass of about 1.7 x 10(5) solar masses(3), can be explained only by a single-age stellar population, even though the cluster has a clearly extended main-sequence turn-off region. The most plausible explanation for the existence of such extended regions invokes a population of rapidly rotating stars, although the secondary effects of the prolonged stellar lifetimes associated with such a stellar population mixture are as yet poorly understood. From preliminary analysis of previously obtained data, we find that similar morphologies are apparent in the Hertzsprung-Russell diagrams of at least five additional intermediate-age star clusters(2,3,5,11), suggesting that an extended main-sequence turn-off region does not necessarily imply the presence of a significant internal age dispersion.	[Li, Chengyuan; de Grijs, Richard] Peking Univ, Kavli Inst Astron & Astrophys, Beijing 100871, Peoples R China; [Li, Chengyuan; de Grijs, Richard] Peking Univ, Dept Astron, Beijing 100871, Peoples R China; [Li, Chengyuan; Deng, Licai] Chinese Acad Sci, Natl Astron Observ, Key Lab Opt Astron, Beijing 100012, Peoples R China	Peking University; Peking University; Chinese Academy of Sciences; National Astronomical Observatory, CAS	Li, CY (corresponding author), Peking Univ, Kavli Inst Astron & Astrophys, Yi He Yuan Lu 5, Beijing 100871, Peoples R China.	joshuali@pku.edu.cn	de Grijs, Richard/AAI-5255-2020; Deng, Licai/AAG-8082-2021	de Grijs, Richard/0000-0002-7203-5996; Deng, Licai/0000-0001-9073-9914; Li, Chengyuan/0000-0002-3084-5157	National Natural Science Foundation of China [11073001, 11373010, 11473037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank S. de Mink, Y. Huang and X. Chen for discussions and assistance. Partial financial support for this work was provided by the National Natural Science Foundation of China through grants 11073001, 11373010 and 11473037.	Bastian N, 2006, MON NOT R ASTRON SOC, V369, pL9, DOI 10.1111/j.1745-3933.2006.00162.x; Bastian N, 2014, MON NOT R ASTRON SOC, V443, P3594, DOI 10.1093/mnras/stu1407; Bastian N, 2009, MON NOT R ASTRON SOC, V398, pL11, DOI 10.1111/j.1745-3933.2009.00696.x; Bekki K, 2009, MON NOT R ASTRON SOC, V394, P124, DOI 10.1111/j.1365-2966.2008.14320.x; Carretta E, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/200913451; Davis L. E., 1994, REFERENCE GUIDE IRAF; Dirsch B, 2000, ASTRON ASTROPHYS, V360, P133; ELSON RAW, 1989, ASTROPHYS J, V336, P734, DOI 10.1086/167046; Georgy C, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201423881; Girardi L, 2011, MON NOT R ASTRON SOC, V412, pL103, DOI 10.1111/j.1745-3933.2011.01013.x; Goudfrooij P, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/3; Grocholski AJ, 2007, ASTRON J, V134, P680, DOI 10.1086/519735; Hu Y, 2010, ASTROPHYS J, V724, P649, DOI 10.1088/0004-637X/724/1/649; Keller SC, 2012, ASTROPHYS J LETT, V761, DOI 10.1088/2041-8205/761/1/L5; Lee JW, 2009, NATURE, V462, P480, DOI 10.1038/nature08565; Li CY, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/2/157; Li CY, 2013, MON NOT R ASTRON SOC, V436, P1497, DOI 10.1093/mnras/stt1669; Li ZM, 2012, ASTROPHYS J LETT, V761, DOI 10.1088/2041-8205/761/2/L22; Longmore S. N., 2014, PROTOSTARS IN PRESS; Mackey AD, 2008, ASTROPHYS J LETT, V681, pL17, DOI 10.1086/590343; Mackey AD, 2007, MON NOT R ASTRON SOC, V379, P151, DOI 10.1111/j.1365-2966.2007.11915.x; Mackey AD, 2003, MON NOT R ASTRON SOC, V338, P85, DOI 10.1046/j.1365-8711.2003.06021.x; Marigo P, 2008, ASTRON ASTROPHYS, V482, P883, DOI 10.1051/0004-6361:20078467; MESTEL L, 1987, MON NOT R ASTRON SOC, V226, P57, DOI 10.1093/mnras/226.1.57; Milone AP, 2008, ASTROPHYS J, V673, P241, DOI 10.1086/524188; Milone AP, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/27; Milone AP, 2009, ASTRON ASTROPHYS, V497, P755, DOI 10.1051/0004-6361/200810870; Mucciarelli A, 2014, ASTROPHYS J LETT, V793, DOI 10.1088/2041-8205/793/1/L6; Mucciarelli A, 2008, ASTRON J, V136, P375, DOI 10.1088/0004-6256/136/1/375; Piatti AE, 2014, MON NOT R ASTRON SOC, V444, P1425, DOI 10.1093/mnras/stu1535; Piotto G, 2007, ASTROPHYS J, V661, pL53, DOI 10.1086/518503; Piotto G, 2005, ASTROPHYS J, V621, P777, DOI 10.1086/427796; Piotto G, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/15; Royer F, 2007, ASTRON ASTROPHYS, V463, P671, DOI 10.1051/0004-6361:20065224; Rubele S, 2013, MON NOT R ASTRON SOC, V430, P2774, DOI 10.1093/mnras/stt079; Rubele S, 2010, MON NOT R ASTRON SOC, V403, P1156, DOI 10.1111/j.1365-2966.2010.16201.x; Sollima A, 2007, ASTROPHYS J, V654, P915, DOI 10.1086/509711; Yang WM, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/112	38	52	52	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					367	+		10.1038/nature13969	http://dx.doi.org/10.1038/nature13969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25519133	Green Submitted			2022-12-28	WOS:000346484800040
J	Langa, KM; Levine, DA				Langa, Kenneth M.; Levine, Deborah A.			The Diagnosis and Management of Mild Cognitive Impairment A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ALZHEIMERS ASSOCIATION WORKGROUPS; BLOOD-PRESSURE; OLDER-ADULTS; NATIONAL INSTITUTE; DOUBLE-BLIND; CONTROLLED-TRIAL; RISK-FACTORS; DEMENTIA; DISEASE; PROGRESSION	IMPORTANCE Cognitive decline is a common and feared aspect of aging. Mild cognitive impairment (MCI) is defined as the symptomatic predementia stage on the continuum of cognitive decline, characterized by objective impairment in cognition that is not severe enough to require help with usual activities of daily living. OBJECTIVE To present evidence on the diagnosis, treatment, and prognosis of MCI and to provide physicians with an evidence-based framework for caring for older patients with MCI and their caregivers. EVIDENCE ACQUISITION We searched PubMed for English-language articles in peer-reviewed journals and the Cochrane Library database from inception through July 2014. Relevant references from retrieved articles were also evaluated. FINDINGS The prevalence of MCI in adults aged 65 years and older is 10% to 20%; risk increases with age and men appear to be at higher risk than women. In older patients with MCI, clinicians should consider depression, polypharmacy, and uncontrolled cardiovascular risk factors, all of which may increase risk for cognitive impairment and other negative outcomes. Currently, no medications have proven effective for MCI; treatments and interventions should be aimed at reducing cardiovascular risk factors and prevention of stroke. Aerobic exercise, mental activity, and social engagement may help decrease risk of further cognitive decline. Although patients with MCI are at greater risk for developing dementia compared with the general population, there is currently substantial variation in risk estimates (from <5% to 20% annual conversion rates), depending on the population studied. Current research targets improving early detection and treatment of MCI, particularly in patients at high risk for progression to dementia. CONCLUSIONS AND RELEVANCE Cognitive decline and MCI have important implications for patients and their families and will require that primary care clinicians be skilled in identifying and managing this common disorder as the number of older adults increases in coming decades. Current evidence supports aerobic exercise, mental activity, and cardiovascular risk factor control in patients with MCI.	[Langa, Kenneth M.; Levine, Deborah A.] Univ Michigan, Div Gen Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.; Levine, Deborah A.] Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.; Levine, Deborah A.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Levine, Deborah A.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Levine, Deborah A.] Univ Michigan, Stroke Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Langa, KM (corresponding author), Univ Michigan, Div Gen Med, 2800 Plymouth Rd,Bldg 16,Room 430W, Ann Arbor, MI 48109 USA.	klanga@umich.edu		Langa, Kenneth/0000-0002-2798-1836	National Institutes of Health (NIH) [U01 AG009740]; NIH [K23 AG040278]; SCAN Foundation; NATIONAL INSTITUTE ON AGING [K23AG040278, U01AG009740] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SCAN Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Langa reports receipt of support, in part, by National Institutes of Health (NIH) grant U01 AG009740. Dr Levine reports receipt of support from NIH grant K23 AG040278. The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Banningh LWAJW, 2013, AM J ALZHEIMERS DIS, V28, P228, DOI 10.1177/1533317513481093; Banningh LWAJW, 2011, GERONTOLOGY, V57, P444, DOI 10.1159/000315933; Barnes DE, 2013, JAMA INTERN MED, V173, P797, DOI 10.1001/jamainternmed.2013.189; Barnes DE, 2009, ALZ DIS ASSOC DIS, V23, P205, DOI 10.1097/WAD.0b013e31819c6137; Bosch J, 2002, BMJ-BRIT MED J, V324, P699, DOI 10.1136/bmj.324.7339.699; Brayne C, 2012, LANCET, V380, P1441, DOI 10.1016/S0140-6736(12)61803-0; Brown PJ, 2011, ARCH GEN PSYCHIAT, V68, P617, DOI 10.1001/archgenpsychiatry.2011.57; Buschert VC, 2011, J ALZHEIMERS DIS, V25, P679, DOI 10.3233/JAD-2011-100999; Cai XY, 2013, ALZHEIMERS DEMENT, V9, P377, DOI 10.1016/j.jalz.2012.02.005; Campbell NL, 2013, CLIN GERIATR MED, V29, P873, DOI 10.1016/j.cger.2013.07.009; Carr DB, 2010, JAMA-J AM MED ASSOC, V303, P1632, DOI 10.1001/jama.2010.481; Centers for Medicare & Medicaid Services, DEC MEM BET AM POS E; Clarfield AM, 2003, ARCH INTERN MED, V163, P2219, DOI 10.1001/archinte.163.18.2219; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; Clark CM, 1996, ALZ DIS ASSOC DIS, V10, P31, DOI 10.1097/00002093-199601010-00006; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Doody RS, 2009, NEUROLOGY, V72, P1555, DOI 10.1212/01.wnl.0000344650.95823.03; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Elias-Sonnenschein LS, 2011, J NEUROL NEUROSUR PS, V82, P1149, DOI 10.1136/jnnp.2010.231555; Emmelot-Vonk MH, 2008, JAMA-J AM MED ASSOC, V299, P39, DOI 10.1001/jama.2007.51; Ertel KA, 2008, AM J PUBLIC HEALTH, V98, P1215, DOI 10.2105/AJPH.2007.113654; Farias ST, 2009, ARCH NEUROL-CHICAGO, V66, P1151, DOI 10.1001/archneurol.2009.106; Feart C, 2009, JAMA-J AM MED ASSOC, V302, P638, DOI 10.1001/jama.2009.1146; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; Gao SJ, 2014, HYPERTENSION, V64, P45, DOI 10.1161/HYPERTENSIONAHA.114.03576; Holsinger T, 2007, JAMA-J AM MED ASSOC, V297, P2391, DOI 10.1001/jama.297.21.2391; Institute for Clinical and Economic Review, 2012, DIAGN TESTS ALZH DIS; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P474, DOI 10.1016/j.jalz.2011.04.007; Jack CR, 2010, BRAIN, V133, P3336, DOI 10.1093/brain/awq277; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; JAMES PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI DOI 10.1001/JAMA.2013.284427; Jicha GA, 2006, ARCH NEUROL-CHICAGO, V63, P674, DOI 10.1001/archneur.63.5.674; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007, 10.1016/j.jalz.2013.06.001]; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Koepsell TD, 2012, NEUROLOGY, V79, P1591, DOI 10.1212/WNL.0b013e31826e26b7; Koontz Jennifer, 2005, Am J Alzheimers Dis Other Demen, V20, P295, DOI 10.1177/153331750502000502; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Le Couteur DG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5125; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin J.S., 2013, SCREENING COGNITIVE; Liu H, 2013, J AM GERIATR SOC, V61, P875, DOI 10.1111/jgs.12259; Martin M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006220.pub2; Matthews FE, 2008, J AM GERIATR SOC, V56, P1424, DOI 10.1111/j.1532-5415.2008.01820.x; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; McCarten JR, 2013, CLIN GERIATR MED, V29, P791, DOI 10.1016/j.cger.2013.07.005; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Montero-Odasso M, 2012, J AM GERIATR SOC, V60, P2127, DOI 10.1111/j.1532-5415.2012.04209.x; Nagamatsu LS, 2012, ARCH INTERN MED, V172, P666, DOI 10.1001/archinternmed.2012.379; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Petersen RC, 2010, NEUROLOGY, V75, P889, DOI 10.1212/WNL.0b013e3181f11d85; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Petersen RC, 2013, ANN NEUROL, V74, P199, DOI 10.1002/ana.23931; Petersen RC, 2011, NEW ENGL J MED, V364, P2227, DOI 10.1056/NEJMcp0910237; Petersen RC, 2009, JAMA-J AM MED ASSOC, V302, P436, DOI 10.1001/jama.2009.1073; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; Rapoport MJ, 2013, AM J GERIATR PSYCHIA; Ries ML, 2008, J AM GERIATR SOC, V56, P920, DOI 10.1111/j.1532-5415.2008.01684.x; Roalf DR, 2013, ALZHEIMERS DEMENT, V9, P529, DOI 10.1016/j.jalz.2012.10.001; Rogers MAM, 2010, AM J EPIDEMIOL, V171, P728, DOI 10.1093/aje/kwp453; Russ TC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009132.pub2; Sabayan B, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4600; Salloway S, 2004, NEUROLOGY, V63, P651, DOI 10.1212/01.WNL.0000134664.80320.92; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Small GW, 2008, LANCET NEUROL, V7, P161, DOI 10.1016/S1474-4422(08)70019-X; Snitz BE, 2009, JAMA-J AM MED ASSOC, V302, P2663; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Steinman MA, 2010, JAMA-J AM MED ASSOC, V304, P1592, DOI 10.1001/jama.2010.1482; Suzuki T, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-128; Teng E, 2010, ALZ DIS ASSOC DIS, V24, P348, DOI 10.1097/WAD.0b013e3181e2fc84; van Dijk EJ, 2008, STROKE, V39, P2712, DOI 10.1161/STROKEAHA.107.513176; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; White WB, 2011, CIRCULATION, V124, P2312, DOI 10.1161/CIRCULATIONAHA.111.037036; Widera E, 2011, JAMA-J AM MED ASSOC, V305, P698, DOI 10.1001/jama.2011.164; Wikler EM, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt206; Wolfs CAG, 2008, BRIT J PSYCHIAT, V192, P300, DOI 10.1192/bjp.bp.107.035204; Yaffe K, 2013, JAMA INTERN MED, V173, P1300, DOI 10.1001/jamainternmed.2013.6176; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	92	561	601	16	189	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2551	2561		10.1001/jama.2014.13806	http://dx.doi.org/10.1001/jama.2014.13806			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25514304	Green Accepted			2022-12-28	WOS:000346346900018
J	Pitts, SR				Pitts, Stephen R.			Neither ondansetron nor metoclopramide reduced nausea and vomiting in the emergency department Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Emory Univ, Sch Med, Atlanta, GA 30322 USA	Emory University	Pitts, SR (corresponding author), Emory Univ, Sch Med, Atlanta, GA 30322 USA.							Billio A, 2010, COCHRANE DB SYST REV, V1; Griffiths B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000060.pub2; Sun X, 2014, JAMA-J AM MED ASSOC, V311, P405, DOI 10.1001/jama.2013.285063	3	5	5	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12							JC3	10.7326/0003-4819-161-12-201412160-02003	http://dx.doi.org/10.7326/0003-4819-161-12-201412160-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UW	25506875				2022-12-28	WOS:000347248400006
J	Doyal, L				Doyal, Lesley			A decade of researching the social aspects of HIV and AIDS	LANCET			English	Editorial Material									Univ Bristol, Sch Policy Studies, Bristol BS8 1TZ, Avon, England	University of Bristol	Doyal, L (corresponding author), Univ Bristol, Sch Policy Studies, Social Sci Complex, Bristol BS8 1TZ, Avon, England.	l.doyal@bristol.ac.uk							0	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2102	2103		10.1016/S0140-6736(14)62362-X	http://dx.doi.org/10.1016/S0140-6736(14)62362-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW6BK	25517004				2022-12-28	WOS:000346354300013
J	Pinder, M; Jawara, M; Jarju, LBS; Salami, K; Jeffries, D; Adiamoh, M; Bojang, K; Correa, S; Kandeh, B; Kaur, H; Conway, DJ; D'Alessandro, U; Lindsay, SW				Pinder, Margaret; Jawara, Musa; Jarju, Lamin B. S.; Salami, Kolawole; Jeffries, David; Adiamoh, Majidah; Bojang, Kalifa; Correa, Simon; Kandeh, Balla; Kaur, Harparkash; Conway, David J.; D'Alessandro, Umberto; Lindsay, Steve W.			Efficacy of indoor residual spraying with dichlorodiphenyltrichloroethane against malaria in Gambian communities with high usage of long-lasting insecticidal mosquito nets: a cluster-randomised controlled trial	LANCET			English	Article							VECTOR-CONTROL INTERVENTIONS; TREATED NETS; RESISTANCE; COMBINATION; AFRICA; POWER	Background Although many malaria control programmes in sub-Saharan Africa use indoor residual spraying with long-lasting insecticidal nets (LLINs), the two studies assessing the benefit of the combination of these two interventions gave conflicting results. We aimed to assess whether the addition of indoor residual spraying to LLINs provided a significantly different level of protection against clinical malaria in children or against house entry by vector mosquitoes. Methods In this two-arm cluster, randomised, controlled efficacy trial we randomly allocated clusters of Gambian villages using a computerised algorithm to LLINs alone (n=35) or indoor residual spraying with dichlorodiphenyltrichloroethane plus LLINs (n=35). In each cluster, 65-213 children, aged 6 months to 14 years, were surveyed at the start of the 2010 transmission season and followed in 2010 and 2011 by passive case detection for clinical malaria. Exposure to parasite transmission was assessed by collection of vector mosquitoes with both light and exit traps indoors. Primary endpoints were the incidence of clinical malaria assessed by passive case detection and number of Anopheles gambiae sensu lato mosquitoes collected per light trap per night. Intervention teams had no role in data collection and the data collection teams were not informed of the spray status of villages. The trial is registered at the ISRCTN registry, number ISRCTN01738840. Findings LLIN coverage in 2011 was 3510 (93%) of 3777 children in the indoor residual spraying plus LLIN group and 3622 (95.5%) of 3791 in the LLIN group. In 2010, 7845 children were enrolled, 7829 completed passive case detection, and 7697 (98%) had complete clinical and covariate data. In 2011, 7009 children remained in the study, 648 more were enrolled, 7657 completed passive case detection, and 7545 (98.5%) had complete data. Indoor residual spraying coverage per cluster was more than 80% for both years in the indoor residual spraying plus LLIN group. Incidence of clinical malaria was 0.047 per child-month at risk in the LLIN group and 0.044 per child-month at risk in the indoor residual spraying plus LLIN group in 2010, and 0.032 per child-month at risk in the LLIN group and 0.034 per child-month at risk in the indoor residual spraying plus LLIN group in 2011. The incident rate ratio was 1.08 (95% CI 0.80-1.46) controlling for confounders and cluster by mixed-effect negative binomial regression on all malaria attacks for both years. No significant difference was recorded in the density of vector mosquitoes caught in light traps in houses over the two transmission seasons; the mean number of A gambiae sensu lato mosquitoes per trap per night was 6.7 (4.0-10.1) in the LLIN group and 4.5 (2.4-7.4) in the indoor residual spraying plus LLIN group (p=0.281 in the random-effects linear regression model). Interpretation We identified no significant difference in clinical malaria or vector density between study groups. In this area with high LLIN coverage, moderate seasonal transmission, and susceptible vectors, indoor residual spraying did not provide additional benefit.	[Pinder, Margaret; Jawara, Musa; Salami, Kolawole; Jeffries, David; Adiamoh, Majidah; Bojang, Kalifa; Correa, Simon; Conway, David J.; D'Alessandro, Umberto] MRC Unit, Banjul, Gambia; [Jarju, Lamin B. S.; Kandeh, Balla] Natl Malaria Control Programme, Banjul, Gambia; [Pinder, Margaret; Kaur, Harparkash; Conway, David J.; Lindsay, Steve W.] London Sch Hyg & Trop Med, London WC1, England; [D'Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium; [Pinder, Margaret; Lindsay, Steve W.] Univ Durham, Durham, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Institute of Tropical Medicine (ITM); Durham University	Lindsay, SW (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.	s.w.lindsay@durham.ac.uk	Pinder, Margaret/AAQ-7129-2020	Bojang, Kalifa/0000-0001-7506-0938; Lindsay, Steve/0000-0002-3461-9050; Conway, David/0000-0002-8711-3037	UK Medical Research Council; MRC [G0900220, MC_UP_A900_1118, MC_UP_A900_1117, MC_UP_A900_1119] Funding Source: UKRI; Medical Research Council [G0900220, MC_UP_A900_1119, MC_UP_A900_1118, MC_UP_A900_1117] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Medical Research Council.	[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], 1969, TXB MALARIA ERADICAT; Bennett S, 2002, INT J EPIDEMIOL, V31, P839, DOI 10.1093/ije/31.4.839; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Chitnis N, 2010, AM J TROP MED HYG, V83, P230, DOI 10.4269/ajtmh.2010.09-0179; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Fullman N, 2013, MALARIA J, V12, pe62; Graham K, 2005, MED VET ENTOMOL, V19, P72, DOI 10.1111/j.0269-283X.2005.00543.x; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Hamel MJ, 2011, AM J TROP MED HYG, V85, P1080, DOI 10.4269/ajtmh.2011.10-0684; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Kilian A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-259; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Lengeler C, 1996, NET GAIN NEW METHOD; Levine M, 2001, PHARMACOTHERAPY, V21, P405, DOI 10.1592/phco.21.5.405.34503; LINDSAY SW, 1995, MED VET ENTOMOL, V9, P50, DOI 10.1111/j.1365-2915.1995.tb00116.x; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-46; Okumu FO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-17; Okumu FO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-208; Pinder M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-147; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Quinones ML, 1998, T ROY SOC TROP MED H, V92, P373, DOI 10.1016/S0035-9203(98)91053-7; ROBERTS DR, 1994, AM J TROP MED HYG, V50, P21, DOI 10.4269/ajtmh.1994.50.21; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117; SMITH A, 1969, B ENTOMOL RES, V59, P33, DOI 10.1017/S000748530000300X; Tangena JAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074351; Thomas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068679; Todd J, 2003, INT J EPIDEMIOL, V32, P755, DOI 10.1093/ije/dyg150; Torcia MG, 2008, P NATL ACAD SCI USA, V105, P646, DOI 10.1073/pnas.0709969105; West PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001630; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2006, GUIDELINES TESTING M; World Health Organization, 2006, PEST THEIR APPL CONT; World Health Organization, 2007, MAN IND RES SPRAYING; Yakob L, 2011, J R SOC INTERFACE, V8, P799, DOI 10.1098/rsif.2010.0537; Zhou G, 2013, MALARIA J, V12, pe256	40	65	65	1	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1436	1446		10.1016/S0140-6736(14)61007-2	http://dx.doi.org/10.1016/S0140-6736(14)61007-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF7EU	25498847	Green Accepted			2022-12-28	WOS:000352719800032
J	Wolf, T; Kann, G; Becker, S; Stephan, C; Brodt, HR; de Leuw, P; Grunewald, T; Vogl, T; Kempf, VAJ; Keppler, OT; Zacharowski, K				Wolf, Timo; Kann, Gerrit; Becker, Stephan; Stephan, Christoph; Brodt, Hans-Reinhardt; de Leuw, Philipp; Gruenewald, Thomas; Vogl, Thomas; Kempf, Volkhard A. J.; Keppler, Oliver T.; Zacharowski, Kai			Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care	LANCET			English	Article							INDEX; PHASE	Background In the current epidemic of Ebola virus disease in western Africa, many aid workers have become infected. Some of these aid workers have been transferred to specialised hospitals in Europe and the USA for intensified treatment, providing the potential for unique insight into the clinical course of Ebola virus disease under optimised supportive measures in isolation units. Methods A 38-year-old male doctor who had contracted an Ebola virus infection in Sierra Leone was airlifted to University Hospital Frankfurt, Germany, on day 5 after disease onset. Within 72 h of admission to the hospital's high-level isolation unit, the patient developed signs of severe multiorgan failure, including lungs, kidneys, and gastrointestinal tract. In addition to clinical parameters, the diagnostic work-up included radiography, ultrasound, pulse contour cardiac output technology, and microbiological and clinical chemistry analyses. Respiratory failure with pulmonary oedema and biophysical evidence of vascular leak syndrome needed mechanical ventilation. The patient received a 3 day treatment course with FX06 (MChE-F4Pharma, Vienna, Austria), a fibrin-derived peptide under clinical development for vascular leak syndrome. After FX06 administration and concurrent detection of Ebola-virus-specific antibodies and a fall in viral load, vascular leak syndrome and respiratory parameters substantially improved. We gave broad-spectrum empiric antimicrobial therapy and the patient needed intermittent renal replacement therapy. The patient fully recovered. Findings This case report shows the feasibility of delivery of successful intensive care therapy to patients with Ebola virus disease under biosafety level 4 conditions. Interpretation The effective treatment of vascular leakage and multiorgan failure by combination of ventilatory support, antibiotic treatment, and renal replacement therapy can sustain a patient with severe Ebola virus disease until virological remission. FX06 could potentially be a valuable agent in contribution to supportive therapy.	[Wolf, Timo; Kann, Gerrit; Stephan, Christoph; Brodt, Hans-Reinhardt; de Leuw, Philipp] Univ Hosp Frankfurt, Dept Med, Infect Dis Unit, D-60590 Frankfurt, Germany; [Vogl, Thomas] Univ Hosp Frankfurt, Dept Diagnost & Intervent Radiol, D-60590 Frankfurt, Germany; [Kempf, Volkhard A. J.] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, D-60590 Frankfurt, Germany; [Keppler, Oliver T.] Univ Hosp Frankfurt, Inst Med Virol, D-60590 Frankfurt, Germany; [Zacharowski, Kai] Univ Hosp Frankfurt, Dept Anaesthesiol Intens Care Med & Pain Therapy, D-60590 Frankfurt, Germany; [Becker, Stephan] Univ Marburg, Inst Virol, D-35032 Marburg, Germany; [Becker, Stephan] Univ Marburg, Germany Ctr Infect Res DZIF, Marburg, Germany; [Gruenewald, Thomas] Hosp St Georg, Dept Infect Dis Trop Med & Nephrol, Leipzig, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Philipps University Marburg; German Center for Infection Research; Philipps University Marburg	Zacharowski, K (corresponding author), Univ Hosp Frankfurt, Dept Anaesthesiol Intens Care Med & Pain Therapy, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	kai.zacharowski@kgu.de	Wolf, Timo/AAQ-3521-2021; Stephan, Christoph/D-1305-2014	Wolf, Timo/0000-0002-3819-9540; Stephan, Christoph/0000-0003-3777-9006; Gruenewald, Thomas/0000-0002-2955-3085	University Hospital of Frankfurt	University Hospital of Frankfurt	University Hospital of Frankfurt.	AMLOT PL, 1993, BLOOD, V82, P2624; Atar D, 2009, J AM COLL CARDIOL, V53, P720, DOI 10.1016/j.jacc.2008.12.017; Baluna R, 1997, IMMUNOPHARMACOLOGY, V37, P117, DOI 10.1016/S0162-3109(97)00041-6; Czikora I, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00259; Endo T, 2013, J INTENSIVE CARE, V1, DOI 10.1186/2052-0492-1-11; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Gehring G, 2014, J ANTIMICROB CHEMOTH, V69, P2123, DOI 10.1093/jac/dku091; Groger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005391; Hamada Yoshihiro, 2004, Asian Cardiovasc Thorac Ann, V12, P193; Kreuels B, 2014, NEW ENGL J MED, V371, P2394, DOI 10.1056/NEJMoa1411677; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; Manenzhe RI, 2015, J ANTIMICROB CHEMOTH, V70, P23, DOI 10.1093/jac/dku356; Parra JM, 2014, NEW ENGL J MED, V371, P2439, DOI 10.1056/NEJMc1412662; Martines RB, 2015, J PATHOL, V235, P153, DOI 10.1002/path.4456; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Srikiatkhachorn A, 2014, ANTIVIR RES, V109, P160, DOI 10.1016/j.antiviral.2014.07.005; Ware LB, 2012, CLIN TRANSPLANT, V26, P665, DOI 10.1111/j.1399-0012.2011.01591.x; World Health Organization, 2014, EB RESP ROADM SIT RE	20	156	164	0	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1428	1435		10.1016/S0140-6736(14)62384-9	http://dx.doi.org/10.1016/S0140-6736(14)62384-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF7EU	25534190	Green Published			2022-12-28	WOS:000352719800031
J	Duggin, IG; Aylett, CHS; Walsh, JC; Michie, KA; Wang, Q; Turnbull, L; Dawson, EM; Harry, EJ; Whitchurch, CB; Amos, LA; Lowe, J				Duggin, Iain G.; Aylett, Christopher H. S.; Walsh, James C.; Michie, Katharine A.; Wang, Qing; Turnbull, Lynne; Dawson, Emma M.; Harry, Elizabeth J.; Whitchurch, Cynthia B.; Amos, Linda A.; Loewe, Jan			CetZ tubulin-like proteins control archaeal cell shape	NATURE			English	Article							HALOFERAX-VOLCANII; FTSZ; EVOLUTION; SEQUENCE; VISUALIZATION; HALOBACTERIUM; REFINEMENT; BACTERIA; HOMOLOG; DOMAINS	Tubulin is a major component of the eukaryotic cytoskeleton, controlling cell shape, structure and dynamics, whereas its bacterial homologue FtsZ establishes the cytokinetic ring that constricts during cell division(1,2). How such different roles of tubulin and FtsZ evolved is unknown. Studying Archaea may provide clues as these organisms share characteristics with Eukarya and Bacteria(3). Here we report the structure and function of proteins from a distinct family related to tubulin and FtsZ, named CetZ, which co-exists with FtsZ in many archaea. CetZ X-ray crystal structures showed the FtsZ/tubulin superfamily fold, and one crystal form contained sheets of protofilaments, suggesting a structural role. However, inactivation of CetZ proteins in Haloferax volcanii did not affect cell division. Instead, CetZ1 was required for differentiation of the irregular plate-shaped cells into a rod-shaped cell type that was essential for normal swimming motility. CetZ1 formed dynamic cytoskeletal structures in vivo, relating to its capacity to remodel the cell envelope and direct rod formation. CetZ2 was also implicated in H. volcanii cell shape control. Our findings expand the known roles of the FtsZ/tubulin superfamily to include archaeal cell shape dynamics, suggesting that a cytoskeletal role might predate eukaryotic cell evolution, and they support the premise that a major function of the microbial rod shape is to facilitate swimming.	[Duggin, Iain G.; Aylett, Christopher H. S.; Michie, Katharine A.; Wang, Qing; Amos, Linda A.; Loewe, Jan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Duggin, Iain G.; Walsh, James C.; Turnbull, Lynne; Dawson, Emma M.; Harry, Elizabeth J.; Whitchurch, Cynthia B.] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia; [Walsh, James C.] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia	MRC Laboratory Molecular Biology; University of Technology Sydney; University of New South Wales Sydney	Duggin, IG (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	Iain.Duggin@uts.edu.au	Harry, Liz/AAT-9396-2020; Harry, Elizabeth/G-8123-2017; Michie, Katharine A/B-3858-2011; Duggin, Iain/B-3904-2011; Löwe, Jan/X-6998-2019; Turnbull, Lynne/A-2605-2012; Whitchurch, Cynthia/A-5954-2008	Michie, Katharine A/0000-0002-2133-2237; Duggin, Iain/0000-0003-4868-7350; Turnbull, Lynne/0000-0002-9255-9033; Harry, Elizabeth/0000-0003-0858-9473; Walsh, James/0000-0003-0447-2323; Amos, Linda/0000-0001-8305-5346; Whitchurch, Cynthia/0000-0003-2296-3791	Medical Research Council, UK [U105184326]; University of Technology Sydney, Australia; NHMRC, Australia [SRF 571905]; MRC [MC_U105184326] Funding Source: UKRI; Medical Research Council [MC_U105184326] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Technology Sydney, Australia; NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Allers for discussion, strains and plasmids, F. Pfeiffer, M. Dyall-Smith, R. Cavicchioli, I. Charles, C. Angstmann and P. Curmi for discussion, J. Maupin-Furlow and D. Sherratt for plasmids, M. Johnson and the UTS Microbial Imaging Facility for technical support, F. Gorrec and S. Kuhlmann for help at the MRC-LMB crystallization facility, and the European Synchrotron Radiation Facility and Diamond Light Source for service and support. This work was supported by the Medical Research Council, UK (U105184326 to J.L.) and the University of Technology Sydney, Australia. C.B.W. was supported by the NHMRC, Australia (SRF 571905).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baumann P, 1996, P NATL ACAD SCI USA, V93, P6726, DOI 10.1073/pnas.93.13.6726; Be'er A, 2011, MBIO, V2, DOI 10.1128/mBio.00069-11; Burns DG, 2007, INT J SYST EVOL MICR, V57, P387, DOI 10.1099/ijs.0.64690-0; Cooper S, 1997, FEMS MICROBIOL LETT, V148, P227, DOI 10.1016/S0378-1097(97)00038-4; Dusenbery DB, 1998, J BACTERIOL, V180, P5978, DOI 10.1128/JB.180.22.5978-5983.1998; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kimble M, 2000, CELL MOTIL CYTOSKEL, V47, P48, DOI 10.1002/1097-0169(200009)47:1<48::AID-CM5>3.3.CO;2-H; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Large A, 2007, MOL MICROBIOL, V66, P1092, DOI 10.1111/j.1365-2958.2007.05980.x; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Lowe J, 2009, INT J BIOCHEM CELL B, V41, P323, DOI 10.1016/j.biocel.2008.08.010; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Margolin W, 1996, J BACTERIOL, V178, P1320, DOI 10.1128/jb.178.5.1320-1327.1996; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MULLAKHANBHAI MF, 1975, ARCH MICROBIOL, V104, P207, DOI 10.1007/BF00447326; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oren A, 2002, FEMS MICROBIOL ECOL, V39, P1, DOI 10.1111/j.1574-6941.2002.tb00900.x; Poplawski A, 2000, GENE, V242, P357, DOI 10.1016/S0378-1119(99)00517-X; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Reuter CJ, 2004, APPL ENVIRON MICROB, V70, P7530, DOI 10.1128/AEM.70.12.7530-7538.2004; Richards KL, 2000, MOL BIOL CELL, V11, P1887, DOI 10.1091/mbc.11.5.1887; Scheffers DJ, 2002, BIOCHEMISTRY-US, V41, P521, DOI 10.1021/bi011370i; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stock D, 2005, PROG BIOPHYS MOL BIO, V88, P311, DOI 10.1016/j.pbiomolbio.2004.07.009; Strauss MP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001389; Sun Q, 1998, J BACTERIOL, V180, P2050, DOI 10.1128/JB.180.8.2050-2056.1998; TAKASHINA T, 1990, SYST APPL MICROBIOL, V13, P177, DOI 10.1016/S0723-2020(11)80165-7; Tripepi M, 2010, J BACTERIOL, V192, P3093, DOI 10.1128/JB.00133-10; Turk D, 2013, ACTA CRYSTALLOGR D, V69, P1342, DOI 10.1107/S0907444913008408; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; WALSBY AE, 1980, NATURE, V283, P69, DOI 10.1038/283069a0; Wang X, 1996, MOL MICROBIOL, V21, P313, DOI 10.1046/j.1365-2958.1996.6421360.x; Wendoloski D, 2001, MICROBIOL-SGM, V147, P959, DOI 10.1099/00221287-147-4-959; Wickstead B, 2011, J CELL BIOL, V194, P513, DOI 10.1083/jcb.201102065; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Yutin N, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-10; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	53	71	80	4	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2015	519	7543					362	+		10.1038/nature13983	http://dx.doi.org/10.1038/nature13983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6AY	25533961	Green Accepted			2022-12-28	WOS:000351171900043
J	Cole, TB				Cole, Thomas B.			Radiante	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					10	15		10.1001/jama.2014.11499	http://dx.doi.org/10.1001/jama.2014.11499			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25562249				2022-12-28	WOS:000347478000001
J	Melnychuk, E; Perlmutter, AW; Hossler, E				Melnychuk, Eric; Perlmutter, Alexis Weymann; Hossler, Eric			A 38-Year-Old Man With Extensor Surface Papules	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Melnychuk, Eric] Geisinger Med Ctr, Dept Emergency Med, Danville, PA 17821 USA; [Perlmutter, Alexis Weymann; Hossler, Eric] Geisinger Med Ctr, Dept Dermatol, Danville, PA 17821 USA; [Hossler, Eric] Geisinger Med Ctr, Dept Pathol, Danville, PA 17821 USA	Geisinger Medical Center; Geisinger Medical Center; Geisinger Medical Center	Hossler, E (corresponding author), Geisinger Med Ctr, Dept Dermatol, 100 N Acad Ave, Danville, PA 17821 USA.	ewhossler@geisinger.edu		Melnychuk, Eric/0000-0003-1466-6834				Bolognia JL, 2012, DERMATOLOGY, V2, P1550; Green WL, 2013, ANN EMERG MED, V61, P595, DOI 10.1016/j.annemergmed.2012.08.015; Green WL, 2013, ANN EMERG MED, V61, P603; Kala J, 2012, NEW ENGL J MED, V366, P835, DOI 10.1056/NEJMicm1105301; Kreitzer T, 2006, J FAM PRACTICE, V55, P597; OKI JC, 1995, PHARMACOTHERAPY, V15, P317; PARKER F, 1985, J AM ACAD DERMATOL, V13, P1, DOI 10.1016/S0190-9622(85)70139-9	7	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					83	84		10.1001/jama.2014.15261	http://dx.doi.org/10.1001/jama.2014.15261			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25562270				2022-12-28	WOS:000347478000019
J	Landis, CR				Landis, Clark R.			Construction and deconstruction of aldehydes by transfer hydroformylation	SCIENCE			English	Editorial Material									Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Landis, CR (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	landis@chem.wisc.edu						BRAUNSTEIN A. E., 1937, ENZYMOLOGIA [HAGUE], V2, P129; Franke R, 2012, CHEM REV, V112, P5675, DOI 10.1021/cr3001803; HASHIGUCHI S, 1995, J AM CHEM SOC, V117, P7562, DOI 10.1021/ja00133a037; Murphy SK, 2015, SCIENCE, V347, P56, DOI 10.1126/science.1261232; Willis MC, 2010, CHEM REV, V110, P725, DOI 10.1021/cr900096x	5	16	19	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					29	30		10.1126/science.aaa2329	http://dx.doi.org/10.1126/science.aaa2329			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554776				2022-12-28	WOS:000347102300035
J	Sedgwick, P				Sedgwick, Philip			Meta-analysis: testing for reporting bias	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Chan EY, 2007, BMJ-BRIT MED J, V334, P889, DOI 10.1136/bmj.39136.528160.BE; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1342; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4285	3	9	9	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2015	350								g7857	10.1136/bmj.g7857	http://dx.doi.org/10.1136/bmj.g7857			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY4JT	25555827				2022-12-28	WOS:000347544900004
J	Sterns, RH				Sterns, Richard H.			Disorders of Plasma Sodium - Causes, Consequences, and Correction	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							OSMOTIC DEMYELINATION SYNDROME; INTENSIVE-CARE-UNIT; LONG-TERM TREATMENT; INAPPROPRIATE ANTIDIURESIS; INADVERTENT OVERCORRECTION; CHRONIC HYPONATREMIA; ORGANIC OSMOLYTES; HYPERTONIC SALINE; SERUM SODIUM; NA+ STORAGE		[Sterns, Richard H.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Sterns, Richard H.] Rochester Gen Hosp, Rochester, NY 14621 USA	University of Rochester; Rochester General Hospital	Sterns, RH (corresponding author), Rochester Gen Hosp, 1425 Portland Ave, Rochester, NY 14621 USA.	richard.sterns@rochesterregional.org						Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Adrogue HJ, 2012, J AM SOC NEPHROL, V23, P1140, DOI 10.1681/ASN.2012020128; Alshayeb HM, 2011, AM J MED SCI, V341, P356, DOI 10.1097/MAJ.0b013e31820a3a90; Antunes-Rodrigues J, 2004, PHYSIOL REV, V84, P169, DOI 10.1152/physrev.00017.2003; Atsariyasing W, 2014, PSYCHIAT RES, V217, P129, DOI 10.1016/j.psychres.2014.03.021; Balanescu S, 2011, J CLIN ENDOCR METAB, V96, P1046, DOI 10.1210/jc.2010-2499; Barsony J, 2013, AGE, V35, P271, DOI 10.1007/s11357-011-9347-9; Bataille S, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-37; Berl T, 2008, J AM SOC NEPHROL, V19, P1076, DOI 10.1681/ASN.2007091042; Bhaskar E, 2010, INDIAN J CRIT CARE M, V14, P170, DOI 10.4103/0972-5229.76079; Bhattarai Nimesh, 2010, BMJ Case Rep, V2010, DOI 10.1136/bcr.10.2009.2414; Bhave G, 2011, J AM SOC NEPHROL, V22, P2166, DOI 10.1681/ASN.2011080865; Bichet DG, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13613; Bolat F, 2013, PEDIATR EMERG CARE, V29, P808, DOI 10.1097/PEC.0b013e3182983bac; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; Carlberg DJ, 2013, J EMERG MED, V45, P228, DOI 10.1016/j.jemermed.2012.11.109; Chawla A, 2011, CLIN J AM SOC NEPHRO, V6, P960, DOI 10.2215/CJN.10101110; Corona G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080451; Day RE, 2014, BBA-GEN SUBJECTS, V1840, P1492, DOI 10.1016/j.bbagen.2013.09.033; de Souza A, 2012, NEUROL RES, V34, P262, DOI 10.1179/1743132812Y.0000000009; Decaux G, 2010, CRIT CARE, V14, DOI 10.1186/cc9292; EDELMAN IS, 1958, J CLIN INVEST, V37, P1236, DOI 10.1172/JCI103712; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; FARBER SJ, 1960, CIRCULATION, V21, P941, DOI 10.1161/01.CIR.21.5.941; Fenske W, 2011, AM J MED, V124, pE9; FORBES GILBERT B., 1965, AMER J PHYSIOL, V209, P825; Hannon MJ, 2014, J CLIN ENDOCR METAB, V99, P291, DOI 10.1210/jc.2013-3032; Hannon MJ, 2014, CURR OPIN NEPHROL HY, V23, P370, DOI 10.1097/01.mnh.0000447022.51722.f4; Heer M, 2000, AM J PHYSIOL-RENAL, V278, pF585, DOI 10.1152/ajprenal.2000.278.4.F585; Hew-Butler T, 2013, HORM METAB RES, V45, P697, DOI 10.1055/s-0033-1347263; Hix JK, 2011, SEMIN NEPHROL, V31, P553, DOI 10.1016/j.semnephrol.2011.09.010; Ismail FY, 2013, AM J NEURORADIOL, V34, P2225, DOI 10.3174/ajnr.A3392; Kengne FG, 2011, J AM SOC NEPHROL, V22, P1834, DOI 10.1681/ASN.2010111127; Kengne FG, 2009, KIDNEY INT, V76, P614, DOI 10.1038/ki.2009.254; LEAF A, 1953, J CLIN INVEST, V32, P868, DOI 10.1172/JCI102805; LEE JH, 1994, NEW ENGL J MED, V331, P439, DOI 10.1056/NEJM199408183310704; Lehrich RW, 2013, AM J KIDNEY DIS, V62, P364, DOI 10.1053/j.ajkd.2013.01.034; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Lindner G, 2012, NEPHROL DIAL TRANSPL, V27, P962, DOI 10.1093/ndt/gfr428; Louis G, 2012, CRIT CARE MED, V40, P970, DOI 10.1097/CCM.0b013e318236f152; Mohmand HK, 2007, CLIN J AM SOC NEPHRO, V2, P1110, DOI 10.2215/CJN.00910207; Nguyen MK, 2012, AM J PHYSIOL-REG I, V302, pR899, DOI 10.1152/ajpregu.00700.2011; Noakes TD, 2005, P NATL ACAD SCI USA, V102, P18550, DOI 10.1073/pnas.0509096102; Pasantes-Morales H, 2010, NEUROSCIENCE, V168, P871, DOI 10.1016/j.neuroscience.2009.11.074; Perianayagam A, 2008, CLIN J AM SOC NEPHRO, V3, P331, DOI 10.2215/CJN.03190807; Popli S, 2014, INT UROL NEPHROL, V46, P207, DOI 10.1007/s11255-012-0353-3; ROSE BD, 1986, AM J MED, V81, P1033, DOI 10.1016/0002-9343(86)90401-8; Silver SM, 2006, J NEUROPATH EXP NEUR, V65, P37, DOI 10.1097/01.jnen.0000195938.02292.39; Sladek CD, 2013, AM J PHYSIOL-REG I, V305, pR669, DOI 10.1152/ajpregu.00270.2013; Sood L, 2013, AM J KIDNEY DIS, V61, P571, DOI 10.1053/j.ajkd.2012.11.032; Soupart A, 1996, J NEUROPATH EXP NEUR, V55, P106, DOI 10.1097/00005072-199601000-00011; Soupart A, 2012, CLIN J AM SOC NEPHRO, V7, P742, DOI 10.2215/CJN.06990711; Spasovski G, 2014, NEPHROL DIAL TRANSPL, V29, P1, DOI 10.1093/ndt/gfu040; Steele A, 1997, ANN INTERN MED, V126, P20, DOI 10.7326/0003-4819-126-1-199701010-00003; STERNS RH, 1986, NEW ENGL J MED, V314, P1535, DOI 10.1056/NEJM198606123142402; Sterns RH, 2003, QJM-INT J MED, V96, P549, DOI 10.1093/qjmed/hcg102; Sterns RH, 2008, J AM SOC NEPHROL, V19, P194, DOI 10.1681/ASN.2007101118; Sterns RH, 2009, SEMIN NEPHROL, V29, P282, DOI 10.1016/j.semnephrol.2009.03.002; STORMONT JM, 1961, CIRCULATION, V24, P191, DOI 10.1161/01.CIR.24.2.191; Strange K, 2004, ADV PHYSIOL EDUC, V28, P155, DOI 10.1152/advan.00034.2004; Takagi H, 2014, KIDNEY INT, V86, P954, DOI 10.1038/ki.2014.119; Tian W, 2009, P NATL ACAD SCI USA, V106, P14034, DOI 10.1073/pnas.0904084106; Titze J, 2004, AM J PHYSIOL-HEART C, V287, pH203, DOI 10.1152/ajpheart.01237.2003; Titze J, 2003, AM J PHYSIOL-RENAL, V285, pF1108, DOI 10.1152/ajprenal.00200.2003; Titze J, 2014, KIDNEY INT, V85, P759, DOI 10.1038/ki.2013.367; URBAN JPG, 1994, BRIT J RHEUMATOL, V33, P901; Vandergheynst F, 2012, NEPHRON CLIN PRACT, V120, pC168, DOI 10.1159/000338539; Verbalis JG, 2010, NEUROSCIENCE, V168, P862, DOI 10.1016/j.neuroscience.2010.03.042; Verbalis JG, 2013, AM J MED, V126, pS5, DOI 10.1016/j.amjmed.2013.07.006; Waikar SS, 2009, AM J MED, V122, P857, DOI 10.1016/j.amjmed.2009.01.027; Wiig H, 2013, J CLIN INVEST, V123, P2803, DOI 10.1172/JCI60113; WYNN V, 1957, LANCET, V2, P1212; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Zhang Z, 2014, AM J PHYSIOL-RENAL, V306, pF1534, DOI 10.1152/ajprenal.00585.2013	77	273	282	9	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2015	372	1					55	65		10.1056/NEJMra1404489	http://dx.doi.org/10.1056/NEJMra1404489			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX7MU	25551526				2022-12-28	WOS:000347100800010
J	Hildebrandt, P				Hildebrandt, Peter			More than fine tuning	SCIENCE			English	Editorial Material							PROTEINS; PROBES; FIELDS		Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany	Technical University of Berlin	Hildebrandt, P (corresponding author), Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany.	hildebrandt@chem.tu-berlin.de	Hildebrandt, Peter/J-5658-2014	Hildebrandt, Peter/0000-0003-1030-5900				Boxer SG, 2009, J PHYS CHEM B, V113, P2972, DOI 10.1021/jp8067393; Estephane J, 2009, J PHYS CHEM C, V113, P7305, DOI 10.1021/jp811240m; Fried SD, 2014, SCIENCE, V346, P1510, DOI 10.1126/science.1259802; Fried SD, 2013, J AM CHEM SOC, V135, P11181, DOI 10.1021/ja403917z; Herschlag D, 2013, BIOCHEMISTRY-US, V52, P2050, DOI 10.1021/bi4000113; Jo H, 2010, BIOCHEMISTRY-US, V49, P10354, DOI 10.1021/bi101711a; Kim SW, 1997, BIOCHEMISTRY-US, V36, P14030, DOI 10.1021/bi971546+; Kozuch J, 2014, PHYS CHEM CHEM PHYS, V16, P9546, DOI 10.1039/c4cp00167b; Liu CT, 2014, J AM CHEM SOC, V136, P10349, DOI 10.1021/ja5038947; Schkolnik G, 2012, CHEM COMMUN, V48, P70, DOI 10.1039/c1cc13186a; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106	11	4	4	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1456	1457		10.1126/science.aaa2878	http://dx.doi.org/10.1126/science.aaa2878			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525231				2022-12-28	WOS:000346536500037
J	Kamerow, D				Kamerow, Douglas			My New Year's wish is for an effective sunscreen	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Dennis B., 2014, WASHINGTON POST; Reddy S., 2013, WALL STREET J; Werner MJ, 2014, NATURE	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 19	2014	349								g7729	10.1136/bmj.g7729	http://dx.doi.org/10.1136/bmj.g7729			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX3EN	25526975				2022-12-28	WOS:000346823300003
J	Arul, GS; Bree, S; Sonka, B; Edwards, C; Reavley, P				Arul, G. Suren; Bree, Steve; Sonka, Brian; Edwards, Charlie; Reavley, Paul			CHRISTMAS 2014: IN LOVE AND WAR The secret lives of the Bastion Bakers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Arul, G. Suren] Birmingham Childrens Hosp, Dept Paediat Surg, Birmingham B4 6NH, W Midlands, England; [Bree, Steve; Edwards, Charlie] Derriford Hosp, Dept Anaesthesia, Plymouth PL6 8DH, Devon, England; [Sonka, Brian] William Beaumont Army Med Ctr, Dept Surg, El Paso, TX 79920 USA; [Reavley, Paul] Bristol Royal Infirm & Gen Hosp, Dept Emergency Med, Bristol, Avon, England	University of Birmingham; Derriford Hospital; William Beaumont Army Medical Center; Bristol Royal Infirmary	Arul, GS (corresponding author), Birmingham Childrens Hosp, Dept Paediat Surg, Birmingham B4 6NH, W Midlands, England.	suren.arul@bch.nhs.uk		Arul, Gularaj Suren/0000-0002-1586-6857					0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2014	349								g7448	10.1136/bmj.g7448	http://dx.doi.org/10.1136/bmj.g7448			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX3EE	25523273				2022-12-28	WOS:000346822400005
J	Gao, ZH; Lee, P; Stafford, JM; von Schimmelmann, M; Schaefer, A; Reinberg, D				Gao, Zhonghua; Lee, Pedro; Stafford, James M.; von Schimmelmann, Melanie; Schaefer, Anne; Reinberg, Danny			An AUTS2-Polycomb complex activates gene expression in the CNS	NATURE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; STEM-CELLS; POLYCOMB; PROTEIN; MECHANISMS; CHROMATIN; ENHANCER; H2A; UBIQUITYLATION; VOCALIZATIONS	Naturally occurring variations of Polycomb repressive complex 1 (PRC1) comprise a core assembly of Polycomb group proteins and additional factors that include, surprisingly, autism susceptibility candidate 2 (AUTS2). Although AUTS2 is often disrupted in patients with neuronal disorders, the mechanism underlying the pathogenesis is unclear. We investigated the role of AUTS2 as part of a previously identified PRC1 complex (PRC1-AUTS2), and in the context of neurodevelopment. In contrast to the canonical role of PRC1 in gene repression, PRC1-AUTS2 activates transcription. Biochemical studies demonstrate that the CK2 component of PRC1-AUTS2 neutralizes PRC1 repressive activity, whereas AUTS2-mediated recruitment of P300 leads to gene activation. Chromatin immunoprecipitation followed by sequencing (ChIP-seq) demonstrated that AUTS2 regulates neuronal gene expression through promoter association. Conditional targeting of Auts2 in the mouse central nervous system (CNS) leads to various developmental defects. These findings reveal a natural means of subverting PRC1 activity, linking key epigenetic modulators with neuronal functions and diseases.	[Gao, Zhonghua; Lee, Pedro; Stafford, James M.; Reinberg, Danny] NYU, Howard Hughes Med Inst, Langone Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [von Schimmelmann, Melanie; Schaefer, Anne] Mt Sinai Sch Med, Dept Neurosci, Friedman Brain Inst, New York, NY 10029 USA	Howard Hughes Medical Institute; New York University; NYU Langone Medical Center; Icahn School of Medicine at Mount Sinai	Reinberg, D (corresponding author), NYU, Howard Hughes Med Inst, Langone Sch Med, Dept Biochem & Mol Pharmacol, 550 1St Ave, New York, NY 10016 USA.	danny.reinberg@nyumc.org		Reinberg, Danny/0000-0003-4288-2016	National Institute of Health [GM-64844]; Simons Foundation Autism Research Initiative (SFARI); NIH [1DP2MH100012-01, 5T32CA160002, 1F32GM105275, F32AA022842]; Seaver Autism Foundation; Brain and Behavioral Research Fund [18194]; SFARI; NATIONAL CANCER INSTITUTE [P30CA016087, T32CA160002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064844, F32GM105275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP2MH100012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA022842] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative (SFARI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seaver Autism Foundation; Brain and Behavioral Research Fund; SFARI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank S. Zhang, R. Bonasio, S. Shen, and L. Cohen for assistance in analysis with genome-wide studies; H. Zheng for mass spectrometry analysis; L. Chiriboga, C. Loomis and the Experimental Pathology Cores at NYU Langone Medical Center for assistance in immunohistochemical analysis; D. Hernandez for assistance in various experiments. We appreciate the help of C. Guo and the transgenic facility at Howard Hughes Medical Institute's (HHMI) Janelia Farm Research Campus in generating the Auts2 cKO mice. We are grateful to V. Bardwell and L. Di Croce for providing us PCGF1 and RING1B antibodies, respectively. We also thank A. Tarakhovsky for his generous help to our mouse work after Hurricane Sandy and L. Vales for valuable discussions and extensive reading of the manuscript. This work was supported as follows: the biochemical analysis of AUTS2 by the National Institute of Health grant GM-64844, and the mouse work by a Pilot Award from the Simons Foundation Autism Research Initiative (SFARI). A. S. is supported by grants from NIH (1DP2MH100012-01), Seaver Autism Foundation, and The Brain and Behavioral Research Fund Young Investigator Award (number 18194). Z.G. was supported by the SFARI pilot award and by an NIH training grant (5T32CA160002). P.L. was supported by an NIH postdoctoral fellowship (1F32GM105275). J.M.S was supported by an NIH postdoctoral fellowship (F32AA022842) as well as by the Simons Foundation as a Junior Fellow.	Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Bedogni F, 2010, GENE EXPR PATTERNS, V10, P9, DOI 10.1016/j.gep.2009.11.005; Beunders G, 2013, AM J HUM GENET, V92, P210, DOI 10.1016/j.ajhg.2012.12.011; Boltshauser E, 2004, NEUROPEDIATRICS, V35, P255, DOI 10.1055/s-2004-821036; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Frangini A, 2013, MOL CELL, V51, P647, DOI 10.1016/j.molcel.2013.08.022; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Furukawa-Hibi Y, 2012, NEUROSCI LETT, V526, P79, DOI 10.1016/j.neulet.2012.08.028; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Hofer M. A., 2002, CURR PROTOCOLS NEURO; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; James SJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.8; Kondo T, 2014, DEV CELL, V28, P94, DOI 10.1016/j.devcel.2013.11.021; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Ladd-Acosta C, 2014, MOL PSYCHIATR, V19, P862, DOI 10.1038/mp.2013.114; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morey L, 2013, CELL REP, V3, P60, DOI 10.1016/j.celrep.2012.11.026; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Oksenberg N, 2013, TRENDS GENET, V29, P600, DOI 10.1016/j.tig.2013.08.001; Oksenberg N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003221; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shulha HP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003433; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sultana R, 2002, GENOMICS, V80, P129, DOI 10.1006/geno.2002.6810; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; Yu M, 2012, MOL CELL, V45, P330, DOI 10.1016/j.molcel.2011.11.032	45	187	196	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					349	+		10.1038/nature13921	http://dx.doi.org/10.1038/nature13921			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25519132	Green Accepted			2022-12-28	WOS:000346484800037
J	Irimia, M; Weatheritt, RJ; Ellis, JD; Parikshak, NN; Gonatopoulos-Pournatzis, T; Babor, M; Quesnel-Vallieres, M; Tapial, J; Raj, B; O'Hanlon, D; Barrios-Rodiles, M; Sternberg, MJE; Cordes, SP; Roth, FP; Wrana, JL; Geschwind, DH; Blencowe, BJ				Irimia, Manuel; Weatheritt, Robert J.; Ellis, Jonathan D.; Parikshak, Neelroop N.; Gonatopoulos-Pournatzis, Thomas; Babor, Mariana; Quesnel-Vallieres, Mathieu; Tapial, Javier; Raj, Bushra; O'Hanlon, Dave; Barrios-Rodiles, Miriam; Sternberg, Michael J. E.; Cordes, Sabine P.; Roth, Frederick P.; Wrana, Jeffrey L.; Geschwind, Daniel H.; Blencowe, Benjamin J.			A Highly Conserved Program of Neuronal Microexons Is Misregulated in Autistic Brains	CELL			English	Article							PROTEIN-INTERACTION NETWORKS; AMYLOID PRECURSOR PROTEIN; LINKED MENTAL-RETARDATION; MESSENGER-RNA; FUNCTIONAL DIVERSITY; SPLICING REGULATION; NEURITE OUTGROWTH; NERVOUS-SYSTEM; FE65; ISOFORM	Alternative splicing (AS) generates vast transcriptomic and proteomic complexity. However, which of the myriad of detected AS events provide important biological functions is not well understood. Here, we define the largest program of functionally coordinated, neural-regulated AS described to date in mammals. Relative to all other types of AS within this program, 3-15 nucleotide "microexons'' display the most striking evolutionary conservation and switch-like regulation. These microexons modulate the function of interaction domains of proteins involved in neurogenesis. Most neural microexons are regulated by the neuronal-specific splicing factor nSR100/SRRM4, through its binding to adjacent intronic enhancer motifs. Neural microexons are frequently misregulated in the brains of individuals with autism spectrum disorder, and this misregulation is associated with reduced levels of nSR100. The results thus reveal a highly conserved program of dynamic microexon regulation associated with the remodeling of protein-interaction networks during neurogenesis, the misregulation of which is linked to autism.	[Irimia, Manuel; Weatheritt, Robert J.; Ellis, Jonathan D.; Gonatopoulos-Pournatzis, Thomas; Babor, Mariana; Quesnel-Vallieres, Mathieu; Raj, Bushra; O'Hanlon, Dave; Roth, Frederick P.; Blencowe, Benjamin J.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Irimia, Manuel; Tapial, Javier] CRG, EMBL CRG Res Unit Syst Biol, Barcelona 08003, Spain; [Weatheritt, Robert J.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Parikshak, Neelroop N.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Autism Res & Treatment, Semel Inst,Dept Neurol, Los Angeles, CA 90095 USA; [Sternberg, Michael J. E.] Univ London Imperial Coll Sci Technol & Med, Ctr Integrat Syst Biol & Bioinformat, Dept Life Sci, London SW7 2AZ, England; [Barrios-Rodiles, Miriam; Cordes, Sabine P.; Roth, Frederick P.; Wrana, Jeffrey L.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Cordes, Sabine P.; Roth, Frederick P.; Wrana, Jeffrey L.; Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Roth, Frederick P.] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3G4, Canada; [Roth, Frederick P.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	University of Toronto; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); MRC Laboratory Molecular Biology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Imperial College London; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; Canadian Institute for Advanced Research (CIFAR)	Irimia, M (corresponding author), Univ Toronto, Donnelly Ctr, 160 Coll St, Toronto, ON M5S 3E1, Canada.	mirimia@gmail.com; b.blencowe@utoronto.ca	Wrana, Jeffrey/F-8857-2013; Irimia, Manuel/E-3040-2010; Tapial, Javier/O-7740-2015; Roth, Frederick P/H-6308-2011; Cordes, Sabine P/A-5423-2012	Irimia, Manuel/0000-0002-2179-2567; Tapial, Javier/0000-0002-8527-5024; Raj, Bushra/0000-0002-5833-0251; Parikshak, Neel/0000-0003-2027-1871; Sternberg, Michael/0000-0002-1884-5445; Weatheritt, Robert/0000-0003-3716-1783; Roth, Frederick/0000-0002-6628-649X; Gonatopoulos-Pournatzis, Thomas/0000-0003-2669-2570	Canadian Institute of Health Research (CIHR) Postdoctoral Fellowship; NIMH NRSA fellowship; Department of Cell and Systems Biology, University of Toronto; Banting and Best CIHR Scholarship; EMBO; OSCI; CIHR; Ontario Research Fund; Alzheimer's Society, Canada; University of Toronto McLaughlin Centre; NIH/NHGRI [P50 HG004233, U01HG001715]; Krembil Foundation; Avon Foundation; NIMH [5R37MH060233, 5R01MH094714]; Simons Foundation [SFARI 206744]; Canada Excellence Research Chairs Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG001715, R01HG003224, P50HG004233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060233, F30MH099886, R01MH094714] Funding Source: NIH RePORTER	Canadian Institute of Health Research (CIHR) Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); NIMH NRSA fellowship; Department of Cell and Systems Biology, University of Toronto; Banting and Best CIHR Scholarship; EMBO(European Molecular Biology Organization (EMBO)); OSCI; CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Alzheimer's Society, Canada; University of Toronto McLaughlin Centre; NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Krembil Foundation; Avon Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; Canada Excellence Research Chairs Program(Canada Research Chairs); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank the Eunice Kennedy Shriver NICHD Brain and Tissue Bank for Developmental Disorders, the Autism Tissue Program, and the Harvard Brain Tissue Resource Center for providing brain samples. Dax Torti and Danica Leung of the Donnelly Sequencing Centre are gratefully acknowledged for sequencing samples. The authors also thank Xinchen Wang for initial contributions to the RNA-seq analysis pipeline, Ulrich Braunschweig for assistance with CLIP-seq analyses, Benjamin Lang for advice on surface accessibility measurements, Nuno Barbosa-Morais for guidance on statistical testing, and Serge Gueroussov and Jonathan Roth for helpful discussions and comments on the manuscript. M.I. holds an LTF from the Human Frontiers Science Program Organization. R.J.W. holds a Canadian Institute of Health Research (CIHR) Postdoctoral Fellowship. N.N.P. holds an NIMH NRSA fellowship. M.B. is supported by a fellowship from the Department of Cell and Systems Biology, University of Toronto. M.Q.-V. holds a Banting and Best CIHR Scholarship. T.G.-P. is supported by fellowships from EMBO and OSCI. This research was supported by grants from the CIHR (B.J.B., J.L.W., S.P.C.), Ontario Research Fund (J.L.W., B.J.B., and others), Alzheimer's Society, Canada (B.J.B.), University of Toronto McLaughlin Centre (B.J.B.), NIH/NHGRI (P50 HG004233 and U01HG001715) (F.P.R.), the Krembil Foundation (F.P.R.), the Avon Foundation (F.P.R.), NIMH (5R37MH060233 and 5R01MH094714) (D.H.G.), and the Simons Foundation (SFARI 206744) (D.H.G.). F.P.R. was also supported by the Canada Excellence Research Chairs Program. B.J.B. holds the Banbury Chair of Medical Research at the University of Toronto.	Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; BEACHY PA, 1985, NATURE, V313, P545, DOI 10.1038/313545a0; BLACK DL, 1991, GENE DEV, V5, P389, DOI 10.1101/gad.5.3.389; Borck G, 2008, HUM MUTAT, V29, P966, DOI 10.1002/humu.20531; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Braunschweig U, 2014, GENOME RES, V24, P1774, DOI 10.1101/gr.177790.114; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Calarco JA, 2011, RNA, V17, P775, DOI 10.1261/rna.2603911; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cheung HNM, 2014, FASEB J, V28, P337, DOI 10.1096/fj.13-232694; COLEMAN KG, 1987, GENE DEV, V1, P19, DOI 10.1101/gad.1.1.19; Corominas R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4650; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Dergai M, 2010, BIOCHEM BIOPH RES CO, V399, P307, DOI 10.1016/j.bbrc.2010.07.080; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Eom T, 2013, ELIFE, V2, DOI 10.7554/eLife.00178; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; Farias GG, 2012, NEURON, V75, P810, DOI 10.1016/j.neuron.2012.07.007; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hubbard Kyle S, 2013, F1000Res, V2, P35, DOI 10.12688/f1000research.2-35.v1; Hussman JP, 2011, MOL AUTISM, V2, DOI [10.1186/2040-2392-2-1, 10.1186/2040-2392-2-18]; Ikin AF, 2007, MOL CELL NEUROSCI, V35, P57, DOI 10.1016/j.mcn.2007.02.003; Irimia M, 2012, CURR OPIN CELL BIOL, V24, P323, DOI 10.1016/j.ceb.2012.03.005; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Khare T, 2012, NAT STRUCT MOL BIOL, V19, P1037, DOI 10.1038/nsmb.2372; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Ohnishi T, 2014, GENES CELLS, V19, P97, DOI 10.1111/gtc.12109; Ovadia G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019955; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Pirooznia SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041776; Polymenidou M, 2012, BRAIN RES, V1462, P3, DOI 10.1016/j.brainres.2012.02.059; Raj B, 2014, MOL CELL, V56, P90, DOI 10.1016/j.molcel.2014.08.011; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Rusconi F, 2014, CEREB CORTEX; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Stante M, 2009, P NATL ACAD SCI USA, V106, P5093, DOI 10.1073/pnas.0810869106; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Volfovsky N, 2003, GENOME RES, V13, P1216, DOI 10.1101/gr.677503; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Y, 2009, LEARN MEMORY, V16, P537, DOI 10.1101/lm.1499309; Weatheritt RJ, 2012, NUCLEIC ACIDS RES, V40, P7123, DOI 10.1093/nar/gks442; Wu J, 2013, NUCLEIC ACIDS RES, V41, P5149, DOI 10.1093/nar/gkt216; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhu L, 2014, HUM MOL GENET, V23, P1563, DOI 10.1093/hmg/ddt547	62	328	332	2	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1511	1523		10.1016/j.cell.2014.11.035	http://dx.doi.org/10.1016/j.cell.2014.11.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525873	Green Accepted, Bronze			2022-12-28	WOS:000347922500007
J	Walker, N; Howe, C; Glover, M; McRobbie, H; Barnes, J; Nosa, V; Parag, V; Bassett, B; Bullen, C				Walker, Natalie; Howe, Colin; Glover, Marewa; McRobbie, Hayden; Barnes, Joanne; Nosa, Vili; Parag, Varsha; Bassett, Bruce; Bullen, Christopher			Cytisine versus Nicotine for Smoking Cessation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REPLACEMENT THERAPY; FAGERSTROM TEST; NEW-ZEALAND; TRIAL; VARENICLINE; EFFICACY	BACKGROUND Placebo-controlled trials indicate that cytisine, a partial agonist that binds the nicotinic acetylcholine receptor and is used for smoking cessation, almost doubles the chances of quitting at 6 months. We investigated whether cytisine was at least as effective as nicotine-replacement therapy in helping smokers to quit. METHODS We conducted a pragmatic, open-label, noninferiority trial in New Zealand in which 1310 adult daily smokers who were motivated to quit and called the national quitline were randomly assigned in a 1: 1 ratio to receive cytisine for 25 days or nicotine-replacement therapy for 8 weeks. Cytisine was provided by mail, free of charge, and nicotine-replacement therapy was provided through vouchers for low-cost patches along with gum or lozenges. Low-intensity, telephone-delivered behavioral support was provided to both groups through the quitline. The primary outcome was self-reported continuous abstinence at 1 month. RESULTS At 1 month, continuous abstinence from smoking was reported for 40% of participants receiving cytisine (264 of 655) and 31% of participants receiving nicotine-replacement therapy (203 of 655), for a difference of 9.3 percentage points (95% confidence interval, 4.2 to 14.5). The effectiveness of cytisine for continuous abstinence was superior to that of nicotine-replacement therapy at 1 week, 2 months, and 6 months. In a prespecified subgroup analysis of the primary outcome, cytisine was superior to nicotine-replacement therapy among women and noninferior among men. Self-reported adverse events over 6 months occurred more frequently in the cytisine group (288 events among 204 participants) than in the group receiving nicotine-replacement therapy (174 events among 134 participants); adverse events were primarily nausea and vomiting and sleep disorders. CONCLUSIONS When combined with brief behavioral support, cytisine was found to be superior to nicotine-replacement therapy in helping smokers quit smoking, but it was associated with a higher frequency of self-reported adverse events.	[Walker, Natalie; Howe, Colin; Parag, Varsha; Bullen, Christopher] Univ Auckland, Natl Inst Hlth Innovat, Auckland 1142, New Zealand; [Glover, Marewa] Univ Auckland, Ctr Tobacco Control Res, Dept Social & Community Hlth, Auckland 1142, New Zealand; [Nosa, Vili] Univ Auckland, Dept Pacific Hlth, Auckland 1142, New Zealand; [Barnes, Joanne] Univ Auckland, Sch Populat Hlth, Auckland 1142, New Zealand; [Barnes, Joanne] Univ Auckland, Sch Pharm, Auckland 1142, New Zealand; [Bassett, Bruce] Quit Grp, Wellington, New Zealand; [McRobbie, Hayden] Queen Mary Univ London, Wolfson Inst Prevent Med, London, England; [McRobbie, Hayden] Barts & London Queen Marys Sch Med & Dent, UK Ctr Tobacco & Alcohol Studies, London, England	University of Auckland; University of Auckland; University of Auckland; University of Auckland; University of Auckland; University of London; Queen Mary University London; University of London; Queen Mary University London	Walker, N (corresponding author), Univ Auckland, Natl Inst Hlth Innovat, Sch Populat Hlth, Private Bag 92019, Auckland 1142, New Zealand.	n.walker@auckland.ac.nz	Bullen, Chris/E-4594-2017; Nosa, Vili/AAJ-4476-2020; McRobbie, Hayden/B-4552-2018	Bullen, Chris/0000-0001-6807-2930; McRobbie, Hayden/0000-0002-7777-1845; Barnes, Joanne/0000-0002-1522-8433; Glover, Marewa/0000-0002-1572-3784	Health Research Council of New Zealand; Australian New Zealand Clinical Trials Registry [ACTRN12610000590066]	Health Research Council of New Zealand(Health Research Council of New Zealand); Australian New Zealand Clinical Trials Registry	Funded by the Health Research Council of New Zealand; Australian New Zealand Clinical Trials Registry number, ACTRN12610000590066.	[Anonymous], 2010, TOB US NZ KEY FIND 2; Aubin HJ, 2008, THORAX, V63, P717, DOI 10.1136/thx.2007.090647; Aveyard P, 2013, THORAX, V68, P989, DOI 10.1136/thoraxjnl-2013-203246; Borland R, 2001, ADDICTION, V96, P881, DOI 10.1046/j.1360-0443.2001.9668819.x; Bullen C., 2008, COCHRANE DB SYST REV, V3; Bullen C, 2008, J SMOK CESS, V3, P30, DOI 10.1375/jsc.3.1.30; Bullen C, 2010, ADDICTION, V105, P1474, DOI 10.1111/j.1360-0443.2010.02989.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cahill K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006103.pub2; Cappelleri JC, 2007, ADDICT BEHAV, V32, P912, DOI 10.1016/j.addbeh.2006.06.028; Cepeda-Benito A, 2004, J CONSULT CLIN PSYCH, V72, P712, DOI 10.1037/0022-006X.72.4.712; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Etter JF, 2006, ARCH INTERN MED, V166, P1553, DOI 10.1001/archinte.166.15.1553; Fagerstrom K, 2012, NICOTINE TOB RES, V14, P75, DOI 10.1093/ntr/ntr137; Feigen, 2006, RAPID REV NONNHS TRE; Godley E, 2006, INTRO KOWHAI STYX RE; Hajek P, 2013, THORAX, V68, P1037, DOI 10.1136/thoraxjnl-2012-203035; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; LI J, 2007, QUITLINE CALLERS COM; Li Judy, 2007, N Z Med J, V120, pU2584; Ministry of Health, 2007, NZ SMOK CESS GUID; Perkins KA, 2008, NICOTINE TOB RES, V10, P1245, DOI 10.1080/14622200802097506; Prochaska JJ, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5198; Stapleton JA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5736; Stapleton JA, 2012, NICOTINE TOB RES, V14, P463, DOI 10.1093/ntr/ntr236; Tindle M, 2014, DRUG TEST ANAL; Tutka P, 2006, PHARMACOL REP, V58, P777; Walker N, 2012, ADDICTION, V107, P1857, DOI 10.1111/j.1360-0443.2012.03906.x; Walker N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-880; Walker N, 2011, ADDICTION, V106, P1176, DOI 10.1111/j.1360-0443.2011.03419.x; WEBB CJ, 1980, NEW ZEAL J BOT, V18, P463, DOI 10.1080/0028825X.1980.10425167; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; West R, 2004, PSYCHOPHARMACOLOGY, V177, P195, DOI 10.1007/s00213-004-1923-6; West R, 2011, NEW ENGL J MED, V365, P1193, DOI 10.1056/NEJMoa1102035	34	111	115	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2353	2362		10.1056/NEJMoa1407764	http://dx.doi.org/10.1056/NEJMoa1407764			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW7DX	25517706	Bronze			2022-12-28	WOS:000346425800004
J	White, MJ; McArthur, K; Metcalf, D; Lane, RM; Cambier, JC; Herold, MJ; van Delft, MF; Bedoui, S; Lessene, G; Ritchie, ME; Huang, DCS; Kile, BT				White, Michael J.; McArthur, Kate; Metcalf, Donald; Lane, Rachael M.; Cambier, John C.; Herold, Marco J.; van Delft, Mark F.; Bedoui, Sammy; Lessene, Guillaume; Ritchie, Matthew E.; Huang, David C. S.; Kile, Benjamin T.			Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; ACTIVATION; DNA; REPOPULATION; PROTEINS; NECROSIS; FAMILY; ALPHA; MCL-1; BRAIN	Activated caspases are a hallmark of apoptosis induced by the intrinsic pathway, but they are dispensable for cell death and the apoptotic clearance of cells in vivo. This has led to the suggestion that caspases are activated not just to kill but to prevent dying cells from triggering a host immune response. Here, we show that the caspase cascade suppresses type I interferon (IFN) production by cells undergoing Bak/Bax-mediated apoptosis. Bak and Bax trigger the release of mitochondrial DNA. This is recognized by the cGAS/STING-dependent DNA sensing pathway, which initiates IFN production. Activated caspases attenuate this response. Pharmacological caspase inhibition or genetic deletion of caspase-9, Apaf-1, or caspase-3/7 causes dying cells to secrete IFN-beta. In vivo, this precipitates an elevation in IFN-beta levels and consequent hematopoietic stem cell dysfunction, which is corrected by loss of Bak and Bax. Thus, the apoptotic caspase cascade functions to render mitochondrial apoptosis immunologically silent.	[White, Michael J.; McArthur, Kate; Lane, Rachael M.; Lessene, Guillaume; Kile, Benjamin T.] Walter & Eliza Hall Inst Med Res, ACRF Chem Biol Div, Parkville, Vic 3052, Australia; [Metcalf, Donald; van Delft, Mark F.; Huang, David C. S.] Walter & Eliza Hall Inst Med Res, Can & Haematol Div, Parkville, Vic 3052, Australia; [Ritchie, Matthew E.] Walter & Eliza Hall Inst Med Res, Mol Med Div, Parkville, Vic 3052, Australia; [Herold, Marco J.] Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Parkville, Vic 3052, Australia; [White, Michael J.; McArthur, Kate; Metcalf, Donald; Herold, Marco J.; van Delft, Mark F.; Lessene, Guillaume; Ritchie, Matthew E.; Huang, David C. S.; Kile, Benjamin T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Bedoui, Sammy] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Lessene, Guillaume] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3010, Australia; [Ritchie, Matthew E.] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3010, Australia; [Cambier, John C.] Univ Colorado Denver, Integrated Dept Immunol, Sch Med, Denver, CO 80206 USA; [Cambier, John C.] Natl Jewish Hlth, Denver, CO 80206 USA	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health	White, MJ (corresponding author), Walter & Eliza Hall Inst Med Res, ACRF Chem Biol Div, Parkville, Vic 3052, Australia.	mwhite@wehi.edu.au; kile@wehi.edu.au	Kile, Benjamin T/F-6593-2011; Huang, David C. S./C-7586-2013; Ritchie, Matthew/I-3874-2019; Herold, Marco J/C-8039-2013; Kile, Benjamin/GNP-3246-2022; White, Michael/K-1824-2013	Kile, Benjamin T/0000-0002-8836-8947; Huang, David C. S./0000-0002-3101-4873; Ritchie, Matthew/0000-0002-7383-0609; Herold, Marco J/0000-0001-7539-7581; Kile, Benjamin/0000-0002-8836-8947; White, Michael/0000-0001-9472-7806; BEDOUI, SAMMY/0000-0002-7443-0543; van Delft, Mark/0000-0002-3866-4318; Cambier, John/0000-0002-7803-242X; McArthur, Kate/0000-0002-8838-4146	Australian National Health and Medical Research Council [516725, 575535, 461219, 461221, 1016647, 361646]; Leukemia Foundation of Australia; Cancer Council of Victoria; Australian Postgraduate Award scholarship; Sylvia and Charles Viertel Foundation; Australian Cancer Research Fund; Victorian State Government Operational Infrastructure Support Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099346] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Leukemia Foundation of Australia; Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Australian Postgraduate Award scholarship; Sylvia and Charles Viertel Foundation; Australian Cancer Research Fund; Victorian State Government Operational Infrastructure Support Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank J. Corbin and L. Di Rago for excellent technical assistance; K. Franks, E. Lanera, K. McGregor, S. Ross, K. Stoev, L. Wilkins, and E. Kryan for outstanding animal husbandry; S. Monard for expert flow cytometry assistance; T. Mak for Apaf1<SUP>+/-</SUP> mice; R. Flavell for Casp3<SUP>+/-</SUP> Casp7<SUP>+/-</SUP> mice; C. Thompson for Bak<SUP>+/</SUP> and Bax<SUP>+/</SUP> mice; P. Crack for Ifnar1<SUP>+/</SUP> mice; D. Fairlie and E. Lee for Bim variants; K. Aumann and C. De Nardo for manuscript assistance; and A. Strasser, J. Choi, S. Best, A. Rongvaux, and R. Flavell for insightful discussions. This work was supported by Project Grants (516725 and 575535), Program Grants (461219, 461221, and 1016647), Fellowships (D.C.S.H. and B.T.K.), and an Independent Research Institutes Infrastructure Support Scheme Grant (361646) from the Australian National Health and Medical Research Council; a scholarship from the Leukemia Foundation of Australia (M.J.W.), fellowships from the Cancer Council of Victoria (M.J.W. and D.M.); an Australian Postgraduate Award scholarship (K.M.); a fellowship from the Sylvia and Charles Viertel Foundation (B.T.K.); the Australian Cancer Research Fund; and a Victorian State Government Operational Infrastructure Support Grant.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Crawford ED, 2013, MOL CELL PROTEOMICS, V12, P813, DOI 10.1074/mcp.O112.024372; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Hashiguchi K, 2009, METHODS MOL BIOL, V554, P383, DOI 10.1007/978-1-59745-521-3_23; Honarpour N, 2001, NEUROSCIENCE, V106, P263, DOI 10.1016/S0306-4522(01)00275-5; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Irrinki KM, 2011, MOL CELL BIOL, V31, P3745, DOI 10.1128/MCB.05303-11; Janzen V, 2008, CELL STEM CELL, V2, P584, DOI 10.1016/j.stem.2008.03.012; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Labi V, 2013, EMBO MOL MED, V5, P122, DOI 10.1002/emmm.201201235; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lee EF, 2008, J CELL BIOL, V180, P341, DOI 10.1083/jcb.200708096; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Martin SJ, 2012, MOL CELL, V46, P387, DOI 10.1016/j.molcel.2012.04.026; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Moujalled DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.201; Nonomura K, 2013, DEV CELL, V27, P621, DOI 10.1016/j.devcel.2013.11.015; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Oppenheim RW, 2001, J NEUROSCI, V21, P4752, DOI 10.1523/JNEUROSCI.21-13-04752.2001; Orelio C, 2007, LEUKEMIA LYMPHOMA, V48, P16, DOI 10.1080/10428190601032529; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Prinz M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00067; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; van Delft MF, 2010, CELL DEATH DIFFER, V17, P821, DOI 10.1038/cdd.2009.166; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	53	494	507	6	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1549	1562		10.1016/j.cell.2014.11.036	http://dx.doi.org/10.1016/j.cell.2014.11.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525874	Bronze, Green Accepted			2022-12-28	WOS:000347922500010
J	Ni, MY; Chan, BHY; Leung, GM; Lau, EHY; Pang, H				Ni, Michael Y.; Chan, Brandford H. Y.; Leung, Gabriel M.; Lau, Eric H. Y.; Pang, Herbert			CHRISTMAS 2014: MEDIA STUDIES Transmissibility of the Ice Bucket Challenge among globally influential celebrities: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DYNAMICS	Objectives To estimate the transmissibility of the Ice Bucket Challenge among globally influential celebrities and to identify associated risk factors. Design Retrospective cohort study. Setting Social media (YouTube, Facebook, Twitter, Instagram). Participants David Beckham, Cristiano Ronaldo, Benedict Cumberbatch, Stephen Hawking, Mark Zuckerberg, Oprah Winfrey, Homer Simpson, and Kermit the Frog were defined as index cases. We included contacts up to the fifth generation seeded from each index case and enrolled a total of 99 participants into the cohort. Main outcome measures Basic reproduction number R-0, serial interval of accepting the challenge, and odds ratios of associated risk factors based on fully observed nomination chains; R-0 is a measure of transmissibility and is defined as the number of secondary cases generated by a single index in a fully susceptible population. Serial interval is the duration between onset of a primary case and onset of its secondary cases. Results Based on the empirical data and assuming a branching process we estimated a mean R-0 of 1.43 (95% confidence interval 1.23 to 1.65) and a mean serial interval for accepting the challenge of 2.1 days (median 1 day). Higher log (base 10) net worth of the participants was positively associated with transmission (odds ratio 1.63, 95% confidence interval 1.06 to 2.50), adjusting for age and sex. Conclusions The Ice Bucket Challenge was moderately transmissible among a group of globally influential celebrities, in the range of the pandemic A/H1N1 2009 influenza. The challenge was more likely to be spread by richer celebrities, perhaps in part reflecting greater social influence.	[Ni, Michael Y.; Chan, Brandford H. Y.; Leung, Gabriel M.; Lau, Eric H. Y.; Pang, Herbert] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Ni, MY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	nimy@hku.hk	Lau, Eric/AAJ-6588-2021	Lau, Eric/0000-0002-6688-9637; Leung, Gabriel/0000-0002-2503-6283; Pang, Herbert/0000-0002-7896-6716; Ni, Michael/0000-0002-1217-5858				Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON R M, 1991; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0; Broxton T, 2013, J INTELL INF SYST, V40, P241, DOI 10.1007/s10844-011-0191-2; Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Daley D., 1965, IMA J APPL MATH, V1, P42, DOI [DOI 10.1093/IMAMAT/1.1.42, 10.1093/imamat/1.1.42]; Editors of TIME, 1998, GREAT PEOPL 20 CENT; Facebook newsroom, 2014, FACEBOOK NEWSROOM; Gay NJ, 2004, J INFECT DIS, V189, pS27, DOI 10.1086/381592; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Harford T., 2014, FINANCIAL TIMES; Izadi Elahe, 2014, WASHINGTON POST; Jiang L., 2014, P INT C MULTIMEDIA R, P193; Johnson G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7255; Larson RJ, 2005, J NATL CANCER I, V97, P693, DOI 10.1093/jnci/dji117; Poletto C., 2014, EUROSURVEILLANCE, V19, P1; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Roberts MG, 2007, J R SOC INTERFACE, V4, P949, DOI 10.1098/rsif.2007.1031; Stampler L., 2014, TIME            0815; TIME, 2014, 100 MOST INFL PEOPL; Vink MA, 2014, AM J EPIDEMIOL, V180, P865, DOI 10.1093/aje/kwu209; Wolkewitz M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7799	24	10	11	0	45	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2014	349								g7185	10.1136/bmj.g7185	http://dx.doi.org/10.1136/bmj.g7185			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HK	25514905	Green Published, hybrid			2022-12-28	WOS:000346763900004
J	Neira, M; Campbell-Lendrum, D; Maiero, M; Dora, C; Bustreo, F				Neira, Maria; Campbell-Lendrum, Diarmid; Maiero, Marina; Dora, Carlos; Bustreo, Flavia			Health and climate change: the end of the beginning?	LANCET			English	Editorial Material									[Neira, Maria; Campbell-Lendrum, Diarmid; Maiero, Marina; Dora, Carlos; Bustreo, Flavia] WHO, CH-1211 Geneva, Switzerland	World Health Organization	Neira, M (corresponding author), WHO, CH-1211 Geneva, Switzerland.	neiram@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], CLIMATE CHANGE HLTH; [Anonymous], 2014, CLIM SUMM 2014 NEW Y; Global Commission on the Economy and Climate, 2014, BETT GROWTH BETT CLI; Parry I, 2014, MUCH CARBON PRICING; van Dijk A, 2013, PHOTOCHEM PHOTOBIOL, V89, P234, DOI 10.1111/j.1751-1097.2012.01223.x; WHO, BURD DIS HOUS AIR PO; WHO, 2014, WHO C HLTH CLIM GEN	7	5	6	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2085	2086		10.1016/S0140-6736(14)61899-7	http://dx.doi.org/10.1016/S0140-6736(14)61899-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW6BK	25497187				2022-12-28	WOS:000346354300005
J	Cole, TB				Cole, Thomas B.			The Piano Lesson (Homage to Mary Lou) Romare Bearden	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2322	2323		10.1001/jama.2013.279881	http://dx.doi.org/10.1001/jama.2013.279881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YB	25490317				2022-12-28	WOS:000346345700001
J	Walzman, M				Walzman, Michael			PERSONAL VIEW Every contact is an opportunity to promote healthy lifestyles	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALCOHOL-USE; BEHAVIORS		George Eliot Hosp, Nuneaton CV10 7DJ, Warwick, England		Walzman, M (corresponding author), George Eliot Hosp, Nuneaton CV10 7DJ, Warwick, England.	mike.walzman@geh.nhs.uk						Crawford MJ, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18300; Dodd LJ, 2010, PREV MED, V51, P73, DOI 10.1016/j.ypmed.2010.04.005; Hagell A., 2013, ADOLESCENT SUBSTANCE; Hutton HE, 2008, ALCOHOL CLIN EXP RES, V32, P2008, DOI 10.1111/j.1530-0277.2008.00788.x; Jepson RG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-538; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Public Health England, 2012, LOC ALC PROF ENGL 20; Raistrick D, 2006, REV EFFECTIVENESS TR; Standerwick K, 2007, INT J STD AIDS, V18, P810, DOI 10.1258/095646207782717027; Thorley NL, 2014, INT J STD AIDS, V25, P812, DOI 10.1177/0956462414521168; Varley E, IMPLEMENTATION GUIDE	11	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2014	349								g7222	10.1136/bmj.g7222	http://dx.doi.org/10.1136/bmj.g7222			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3DF	25498888				2022-12-28	WOS:000346165000003
J	Gecz, J; Corbett, M				Gecz, Jozef; Corbett, Mark			Developmental disorders: deciphering exomes on a grand scale	LANCET			English	Editorial Material							DE-NOVO MUTATIONS; INCIDENTAL FINDINGS; AUTISM		[Gecz, Jozef] Univ Adelaide, Womens & Childrens Hosp, Sch Paediat & Reprod Hlth, Adelaide, SA 5006, Australia; Univ Adelaide, Womens & Childrens Hosp, Robinson Res Inst, Adelaide, SA 5006, Australia	University of Adelaide; Womens & Childrens Hospital Australia; Robinson Research Institute; University of Adelaide	Gecz, J (corresponding author), Univ Adelaide, Womens & Childrens Hosp, Sch Paediat & Reprod Hlth, Adelaide, SA 5006, Australia.	jozef.gecz@adelaide.edu.au	Corbett, Mark/A-8063-2010; Gecz, Jozef/X-3469-2019	Corbett, Mark/0000-0001-9298-3072; Gecz, Jozef/0000-0002-7884-6861				Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; Middleton A, 2014, LANCET; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Wright C.F., 2014, LANCET	13	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1266	1267		10.1016/S0140-6736(14)62122-X	http://dx.doi.org/10.1016/S0140-6736(14)62122-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25529583	hybrid, Green Submitted			2022-12-28	WOS:000352272400012
J	Wright, G				Wright, Gerard			An irresistible newcomer	NATURE			English	Editorial Material							ANTIBACTERIAL DISCOVERY; ANTIBIOTIC DISCOVERY; CHALLENGES		McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	McMaster University	Wright, G (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	wrightge@mcmaster.ca	Wright, G/ABB-7666-2021	Wright, Gerard/0000-0002-9129-7131				Brown ED, 2013, CAN J MICROBIOL, V59, P153, DOI 10.1139/cjm-2013-0089; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Marshall CG, 1998, ANTIMICROB AGENTS CH, V42, P2215, DOI 10.1128/AAC.42.9.2215; Nichols D, 2010, APPL ENVIRON MICROB, V76, P2445, DOI 10.1128/AEM.01754-09; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Spellberg B, 2014, CLIN PHARMACOL THER, V96, P151, DOI 10.1038/clpt.2014.106; World Health Organization, 2016, ANTIMICROBIAL RESIST; Wright GD, 2014, CAN J MICROBIOL, V60, P147, DOI 10.1139/cjm-2014-0063	11	29	32	0	277	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					442	444		10.1038/nature14193	http://dx.doi.org/10.1038/nature14193			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25561172				2022-12-28	WOS:000348196500023
J	Hine, C; Harputlugil, E; Zhang, Y; Ruckenstuhl, C; Lee, BC; Brace, L; Longchamp, A; Trevino-Villarreal, JH; Mejia, P; Ozaki, CK; Wang, R; Gladyshev, VN; Madeo, F; Mair, WB; Mitchell, JR				Hine, Christopher; Harputlugil, Eylul; Zhang, Yue; Ruckenstuhl, Christoph; Lee, Byung Cheon; Brace, Lear; Longchamp, Alban; Trevino-Villarreal, Jose H.; Mejia, Pedro; Ozaki, C. Keith; Wang, Rui; Gladyshev, Vadim N.; Madeo, Frank; Mair, William B.; Mitchell, James R.			Endogenous Hydrogen Sulfide Production Is Essential for Dietary Restriction Benefits	CELL			English	Article							EXTENDS LIFE-SPAN; CALORIC RESTRICTION; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; STRESS RESISTANCE; OXIDATIVE STRESS; METHIONINE; MICE; LONGEVITY; INJURY	Dietary restriction (DR) without malnutrition encompasses numerous regimens with overlapping benefits including longevity and stress resistance, but unifying nutritional and molecular mechanisms remain elusive. In a mouse model of DR-mediated stress resistance, we found that sulfur amino acid (SAA) restriction increased expression of the transsulfuration pathway (TSP) enzyme cystathionine gamma-lyase (CGL), resulting in increased hydrogen sulfide (H2S) production and protection from hepatic ischemia reperfusion injury. SAA supplementation, mTORC1 activation, or chemical/genetic CGL inhibition reduced H2S production and blocked DR-mediated stress resistance. In vitro, the mitochondrial protein SQR was required for H2S-mediated protection during nutrient/oxygen deprivation. Finally, TSP-dependent H2S production was observed in yeast, worm, fruit fly, and rodent models of DR-mediated longevity. Together, these data are consistent with evolutionary conservation of TSP-mediated H2S as a mediator of DR benefits with broad implications for clinical translation.	[Hine, Christopher; Harputlugil, Eylul; Zhang, Yue; Brace, Lear; Longchamp, Alban; Trevino-Villarreal, Jose H.; Mejia, Pedro; Mair, William B.; Mitchell, James R.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Lee, Byung Cheon; Gladyshev, Vadim N.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Longchamp, Alban; Ozaki, C. Keith] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Longchamp, Alban; Ozaki, C. Keith] Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ruckenstuhl, Christoph; Madeo, Frank] Graz Univ, Inst Mol Biosci, NAWI Graz, A-8010 Graz, Austria; [Madeo, Frank] BioTechMed Graz, A-8010 Graz, Austria; [Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Graz; Lakehead University	Mitchell, JR (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	jmitchel@hsph.harvard.edu	Wang, Rui/C-7824-2012	Wang, Rui/0000-0003-3825-3620; Gladyshev, Vadim/0000-0002-0372-7016; Hine, Christopher/0000-0003-1926-7939; Longchamp, Alban/0000-0002-1743-4935; Brace, Lear/0000-0001-6961-9758; Mair, William/0000-0002-0661-1342; Lee, Byung Cheon/0000-0003-1467-1940; Madeo, Frank/0000-0002-5070-1329; Ruckenstuhl, Christoph/0000-0002-4338-4679	NIH [RO1DK090629, R01AG036712]; Glenn Foundation; Austrian Science Fund FWF [LIPOTOX, I1000, P23490-B12, P24381-B20]; American Heart Association [12GRNT9510001, 12GRNT1207025]; Canadian Institutes of Health Research;  [T32CA0093823];  [1R01AG044346];  [R01AG021518]; Austrian Science Fund (FWF) [P 23490] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P20CA093823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG044346, R01AG021518, R01AG036712] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; Austrian Science Fund FWF(Austrian Science Fund (FWF)); American Heart Association(American Heart Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ; ; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Bruce Kristal and Jaan-Olle Andressoo for critical reading of the manuscript; Silvia Dichtinger, Manmeet Gujral, and Jason Li for technical assistance; and Paul Ney for sharing the NRF2KO mice. This work was supported by grants from NIH (RO1DK090629, R01AG036712) and the Glenn Foundation to J.R.M.; C.H. was supported by T32CA0093823; F.M. was supported by the Austrian Science Fund FWF (LIPOTOX, I1000, P23490-B12, and P24381-B20); W.B.M. was supported by 1R01AG044346; V.N.G. was supported by R01AG021518; C.K.O. was supported by American Heart Association 12GRNT9510001 and 12GRNT1207025; and R.W. was supported by an operating grant from the Canadian Institutes of Health Research.	Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Calabrese EJ, 2011, J CELL COMMUN SIGNAL, V5, P25, DOI 10.1007/s12079-011-0119-1; Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882; Cuevasanta E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034562; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Harputlugil E, 2014, CELL REP, V8, P1160, DOI 10.1016/j.celrep.2014.07.018; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Hine CM, 2012, J CLIN EXP PATHOL S, VS4; Hu TH, 2005, ENDOCRINOLOGY, V146, P5380, DOI 10.1210/en.2005-0591; Johnson JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097729; Kabil H, 2011, P NATL ACAD SCI USA, V108, P16831, DOI 10.1073/pnas.1102008108; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kang K, 2009, LIVER TRANSPLANT, V15, P1306, DOI 10.1002/lt.21810; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lazarow P B, 1981, Methods Enzymol, V72, P315; Lee BC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4592; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; Lee ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021077; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; Liu M, 2009, KIDNEY INT, V76, P277, DOI 10.1038/ki.2009.157; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Martin F, 1998, BLOOD, V91, P3459, DOI 10.1182/blood.V91.9.3459.3459_3459_3466; Mauro CR, 2014, J VASC SURG, DOI [S0741-5214(14)01295-6, DOI S0741-5214(14)01295-6]; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x; Modis K, 2013, FASEB J, V27, P601, DOI 10.1096/fj.12-216507; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Olson KR, 2013, AM J PHYSIOL-REG I, V305, pR592, DOI 10.1152/ajpregu.00421.2012; ORENTREICH N, 1993, J NUTR, V123, P269; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Pearson KJ, 2008, P NATL ACAD SCI USA, V105, P2325, DOI 10.1073/pnas.0712162105; Peng W, 2012, SCI TRANSL MED, V4; Predmore BL, 2010, AGE, V32, P467, DOI 10.1007/s11357-010-9150-z; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Ruckenstuhl C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004347; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Stipanuk MH, 2011, J INHERIT METAB DIS, V34, P17, DOI 10.1007/s10545-009-9006-9; Tapia PC, 2006, MED HYPOTHESES, V66, P832, DOI 10.1016/j.mehy.2005.09.009; Theissen U, 2003, MOL BIOL EVOL, V20, P1564, DOI 10.1093/molbev/msg174; Troen AM, 2007, AGE, V29, P29, DOI 10.1007/s11357-006-9018-4; Varendi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093911; Wu ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064448; Yan SK, 2006, BIOCHEM BIOPH RES CO, V351, P485, DOI 10.1016/j.bbrc.2006.10.058; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhang Y, 2013, MOL CELL BIOL, V33, P1104, DOI 10.1128/MCB.01215-12	49	338	351	3	108	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					132	144		10.1016/j.cell.2014.11.048	http://dx.doi.org/10.1016/j.cell.2014.11.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25542313	Green Accepted, Bronze			2022-12-28	WOS:000347923200014
J	Orchard, TJ; Nathan, DM; Zinman, B; Cleary, P; Brillon, D; Backlund, JYC; Lachin, JM				Orchard, Trevor J.; Nathan, David M.; Zinman, Bernard; Cleary, Patricia; Brillon, David; Backlund, Jye-Yu C.; Lachin, John M.		DCCT EDIC Res Grp	Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALL-CAUSE MORTALITY; PITTSBURGH EPIDEMIOLOGY; POPULATION; MELLITUS; COMPLICATIONS; DISEASE; TRENDS; COHORT	IMPORTANCE Whether mortality in type 1 diabetes mellitus is affected following intensive glycemic therapy has not been established. OBJECTIVE To determine whether mortality differed between the original intensive and conventional treatment groups in the long-term follow-up of the Diabetes Control and Complications Trial (DCCT) cohort. DESIGN, SETTING, AND PARTICIPANTS After the DCCT (1983-1993) ended, participants were followed up in a multisite (27 US and Canadian academic clinical centers) observational study (Epidemiology of Diabetes Control and Complications [EDIC]) until December 31, 2012. Participants were 1441 healthy volunteers with diabetes mellitus who, at baseline, were 13 to 39 years of age with 1 to 15 years of diabetes duration and no or early microvascular complications, and without hypertension, preexisting cardiovascular disease, or other potentially life-threatening disease. INTERVENTIONS AND EXPOSURES During the clinical trial, participants were randomly assigned to receive intensive therapy (n = 711) aimed at achieving glycemia as close to the nondiabetic range as safely possible, or conventional therapy (n = 730) with the goal of avoiding symptomatic hypoglycemia and hyperglycemia. At the end of the DCCT, after a mean of 6.5 years, intensive therapy was taught and recommended to all participants and diabetes care was returned to personal physicians. MAIN OUTCOMES AND MEASURES Total and cause-specific mortality was assessed through annual contact with family and friends and through records over 27 years' mean follow-up. RESULTS Vital status was ascertained for 1429 (99.2%) participants. There were 107 deaths, 64 in the conventional and 43 in the intensive group. The absolute risk difference was -109 per 100 000 patient-years (95% CI, -218 to -1), with lower all-cause mortality risk in the intensive therapy group (hazard ratio [HR] = 0.67 [95% CI, 0.46-0.99]; P = .045). Primary causes of death were cardiovascular disease (24 deaths; 22.4%), cancer (21 deaths; 19.6%), acute diabetes complications (19 deaths; 17.8%), and accidents or suicide (18 deaths; 16.8%). Higher levels of glycated hemoglobin (HbA(1c)) were associated with all-cause mortality (HR = 1.56 [95% CI, 1.35-1.81 per 10% relative increase in HbA(1c)]; P < .001), as well as the development of albuminuria (HR = 2.20 [95% CI, 1.46-3.31]; P < .001). CONCLUSIONS AND RELEVANCE After a mean of 27 years' follow-up of patients with type 1 diabetes, 6.5 years of initial intensive diabetes therapy was associated with a modestly lower all-cause mortality rate when compared with conventional therapy.	[Orchard, Trevor J.] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Nathan, David M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Zinman, Bernard] Univ Toronto, Mt Sinai Hosp, Lunefeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Cleary, Patricia; Backlund, Jye-Yu C.; Lachin, John M.] George Washington Univ, Biostat Ctr, Rockville, MD USA; [Brillon, David] Cornell Univ, Med Ctr, New York, NY 10021 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; George Washington University; Cornell University	Orchard, TJ (corresponding author), Univ Pittsburgh, 3512 Fifth Ave,Room 207, Pittsburgh, PA 15213 USA.	tjo@pitt.edu	Zinman, Bernard/E-7266-2013	Lachin, John/0000-0001-9838-2841; orchard, trevor/0000-0001-9552-3215	Division of Diabetes Endocrinology and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Disease [U01 DK094176, U01 DK094157]; National Eye Institute; National Institute of Neurological Disorders and Stroke; General Clinical Research Centers Program; Clinical Translational Science Center Program, Bethesda, Maryland; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK094157, U01DK094176] Funding Source: NIH RePORTER	Division of Diabetes Endocrinology and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Disease; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); General Clinical Research Centers Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical Translational Science Center Program, Bethesda, Maryland; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The DCCT/EDIC has been supported by U01 cooperative agreement grants (1982-1993 and 2011-2016) and contracts (1982-2011) with the Division of Diabetes Endocrinology and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Disease (grants U01 DK094176 and U01 DK094157), and through support by the National Eye Institute, the National Institute of Neurological Disorders and Stroke, the General Clinical Research Centers Program (1993-2007), and the Clinical Translational Science Center Program (2006-present), Bethesda, Maryland. The following industry contributors provided free or discounted supplies or equipment to support participants' adherence to the study: Abbott Diabetes Care (Alameda, CA), Animas (Westchester, PA), Bayer Diabetes Care (North America Headquarters, Tarrytown, NY), Becton Dickinson (Franklin Lakes, NJ), Eli Lilly (Indianapolis, IN), Extend Nutrition (St. Louis, MO), Lifescan (Milpitas, CA), Medtronic Diabetes (Minneapolis, MN), Nipro Home Diagnostics (Ft. Lauderdale, FL), Nova Diabetes Care (Billerica, MA), Omron (Shelton, CT), OmniPod Insulin Management System (Bedford, MA), Perrigo Diabetes Care (Allegan, MI), Roche Diabetes Care (Indianapolis, IN), and sanofi-aventis (Bridgewater NJ).	Alsahli M, 2013, ENDOCRIN METAB CLIN, V42, P657, DOI 10.1016/j.ecl.2013.07.002; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bloomgarden Zachary T, 2012, Front Endocrinol (Lausanne), V3, P66, DOI 10.3389/fendo.2012.00066; BORCHJOHNSEN K, 1986, DIABETOLOGIA, V29, P767, DOI 10.1007/BF00873214; DCCT Res Grp, 1986, DIABETES, V35, P530; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; DORMAN JS, 1984, DIABETES, V33, P271, DOI 10.2337/diabetes.33.3.271; Epidemiology of Diabetes Interventions and Complications Research Group, 2013, PROT COR; Genuth S, 1999, DIABETES CARE, V22, P99; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Groop PH, 2009, DIABETES, V58, P1651, DOI 10.2337/db08-1543; Harjutsalo V, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5364; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Lachin JM, 2011, WILEY SER PROBAB ST, P1; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MCNALLY PC, 1995, DIABETIC MED, V12, P961, DOI 10.1111/j.1464-5491.1995.tb00406.x; Miller RG, 2012, DIABETES, V61, P2987, DOI 10.2337/db11-1625; Nathan DM, 2013, DIABETES, V62, P3976, DOI 10.2337/db13-1093; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Orchard TJ, 2010, DIABETOLOGIA, V53, P2312, DOI 10.1007/s00125-010-1860-3; ORCHARD TJ, 1991, DIABETES CARE, V14, P55; Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423; R Core Team, 2013, LANG ENV STAT COMP; Seaquist ER, 2012, DIABETES CARE, V35, P409, DOI 10.2337/dc11-0996; Secrest AM, 2010, DIABETES CARE, V33, P2573, DOI 10.2337/dc10-1170; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shankar A, 2007, AM J EPIDEMIOL, V166, P393, DOI 10.1093/aje/kwm096; Shannon H, 2000, NEW ENGL J MED, V342, P381; Skrivarhaug T, 2006, DIABETOLOGIA, V49, P298, DOI 10.1007/s00125-005-0082-6; Soedamah-Muthu SS, 2006, DIABETOLOGIA, V49, P660, DOI 10.1007/s00125-005-0120-4; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159	31	302	309	2	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					45	53		10.1001/jama.2014.16107	http://dx.doi.org/10.1001/jama.2014.16107			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25562265	Green Accepted			2022-12-28	WOS:000347478000014
J	Shamseer, L; Moher, D; Clarke, M; Ghersi, D; Liberati, A; Petticrew, M; Shekelle, P; Stewart, LA				Shamseer, Larissa; Moher, David; Clarke, Mike; Ghersi, Davina; Liberati, Alessandro; Petticrew, Mark; Shekelle, Paul; Stewart, Lesley A.		Prisma-P Grp	Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; INDUSTRY-SUPPORTED METAANALYSES; CLINICAL-TRIALS; DATA EXTRACTION; EMPIRICAL-EVIDENCE; PUBLICATION BIAS; METHODOLOGICAL QUALITY; DUPLICATE PUBLICATION; MULTICENTER TRIALS; SEARCH STRATEGIES	Protocols of systematic reviews and meta-analyses allow for planning and documentation of review methods, act as a guard against arbitrary decision making during review conduct, enable readers to assess for the presence of selective reporting against completed reviews, and, when made publicly available, reduce duplication of efforts and potentially prompt collaboration. Evidence documenting the existence of selective reporting and excessive duplication of reviews on the same or similar topics is accumulating and many calls have been made in support of the documentation and public availability of review protocols. Several efforts have emerged in recent years to rectify these problems, including development of an international register for prospective reviews (PROSPERO) and launch of the first open access journal dedicated to the exclusive publication of systematic review products, including protocols (BioMed Central's Systematic Reviews). Furthering these efforts and building on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines, an international group of experts has created a guideline to improve the transparency, accuracy, completeness, and frequency of documented systematic review and meta-analysis protocols-PRISMA-P (for protocols) 2015. The PRISMA-P checklist contains 17 items considered to be essential and minimum components of a systematic review or meta-analysis protocol. This PRISMA-P 2015 Explanation and Elaboration paper provides readers with a full understanding of and evidence about the necessity of each item as well as a model example from an existing published protocol. This paper should be read together with the PRISMA-P 2015 statement. Systematic review authors and assessors are strongly	[Shamseer, Larissa; Moher, David] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Shamseer, Larissa; Moher, David] Univ Ottawa, Ottawa, ON, Canada; [Clarke, Mike] Queens Univ Belfast, Belfast BT7 1NN, Antrim, North Ireland; [Ghersi, Davina] Natl Hlth & Med Res Council, Canberra, ACT, Australia; [Liberati, Alessandro] Univ Modena, I-41100 Modena, Italy; [Petticrew, Mark] London Sch Hyg & Trop Med, London, England; [Stewart, Lesley A.] Southern Calif Evidence based Practice Ctr, Los Angeles, CA USA; Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Queens University Belfast; Universita di Modena e Reggio Emilia; University of London; London School of Hygiene & Tropical Medicine; University of York - UK	Shamseer, L (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.	lshamseer@ohri.ca	Petticrew, Mark/AAY-6274-2021; Groves, Trish/A-9119-2009; Booth, Alison/I-8044-2015; Higgins, Julian PT/H-4008-2011; Shamseer, Larissa/E-9645-2017; Simera, Iveta/AFN-5638-2022; Moher, David/I-3408-2019	Groves, Trish/0000-0001-7915-6419; Booth, Alison/0000-0001-7138-6295; Higgins, Julian PT/0000-0002-8323-2514; Shamseer, Larissa/0000-0003-3690-3378; Simera, Iveta/0000-0001-5785-6756; Moher, David/0000-0003-2434-4206; Schunemann, Holger/0000-0003-3211-8479; Page, Matthew/0000-0002-4242-7526; Lohr, Kathleen/0000-0002-3825-0713	Agency for Healthcare Research and Quality, USA [HHSA 290 2007 10059 I]; Canadian Institutes for Health Research [114369]; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MR/K025643/1, G0901530] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10114, NF-SI-0507-10259] Funding Source: researchfish	Agency for Healthcare Research and Quality, USA(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: (1) support from the Agency for Healthcare Research and Quality, USA (Contract No HHSA 290 2007 10059 I) and the Canadian Institutes for Health Research (Reference No 114369) for this work; this manuscript does not reflect the opinions of either agency; one author, SC, is an employee of AHRQ. (2) No financial relationships with any organisations that might have an interest in the submitted work in the previous three years (3) MC, DG, DM, MP, and LAS are members of the Advisory Board for PROSPERO. TG is the deputy editor of The BMJ and was not involved in the handling of or the decision to publish this manuscript.	Adams Denise, 2012, J Evid Based Med, V5, P89, DOI 10.1111/j.1756-5391.2012.01173.x; Ahmadzai N, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-104; AHRQ Agency for Healthcare Research and Quality, RES PROT APR 3 2014; AHRQ Agency for Healthcare Research and Quality, RES PROT JUL 21 2014; [Anonymous], 2013, NAT METHODS, V10, P367, DOI 10.1038/nmeth.2471; [Anonymous], 2010, UNIFORM REQUIREMENTS; [Anonymous], 2011, PLOS MED, V8; ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Bambra CL, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-16; Basch E, 2012, JAMA-J AM MED ASSOC, V307, P1636, DOI 10.1001/jama.2012.466; BEGG CB, 1988, J ROY STAT SOC A STA, V151, P419, DOI 10.2307/2982993; Bell ML, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8668; Beller EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001419; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Bero L, 2013, JAMA INTERN MED, V173, P580, DOI 10.1001/jamainternmed.2013.4190; Bes-Rastrollo M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001578; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Booth A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027319; Booth A, 2011, LANCET, V377, P108, DOI 10.1016/S0140-6736(10)60903-8; Briel Matthias, 2012, J Bone Joint Surg Am, V94 Suppl 1, P56, DOI 10.2106/JBJS.K.01412; Buscemi N, 2006, J CLIN EPIDEMIOL, V59, P697, DOI 10.1016/j.jclinepi.2005.11.010; Busse JW, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-18; Cancelliere C, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-17; CHALMERS I, 1993, MILBANK Q, V71, P411, DOI 10.2307/3350409; Chan A-W, 2013, BMJ-BRIT MED J, V2013, P346, DOI DOI 10.1136/BMJ.E7586; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Chen YF, 2012, COCHRANE DB SYST REV; Chien PFW, 2012, BJOG-INT J OBSTET GY, V119, P903, DOI 10.1111/j.1471-0528.2011.03242.x; Chung A, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-52; Chung M, 2012, J CLIN EPIDEMIOL, V65, P660, DOI 10.1016/j.jclinepi.2011.12.004; Clarke M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004002.pub2; Clinical Data Interchange Standards Consortium (CDISC), 2011, CDISC CLIN RES GLOSS; Cohen D, 2010, BMJ-BRIT MED J, V341, pc4848; COOPER H, 1989, KNOWLEDGE, V10, P179, DOI 10.1177/107554708901000301; Cordoba G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3920; Counsell C, 1997, ANN INTERN MED, V127, P380, DOI 10.7326/0003-4819-127-5-199709010-00008; Daboval T, ANTENATAL COUN UNPUB; DeAngelis CD, 2008, JAMA-J AM MED ASSOC, V299, P1833, DOI 10.1001/jama.299.15.1833; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; Dechartres A, 2011, J CLIN EPIDEMIOL, V64, P136, DOI 10.1016/j.jclinepi.2010.04.015; Deeks JJ, 1998, LANCET, V352, P1908, DOI 10.1016/S0140-6736(05)60399-6; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Dickersin K, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P11; Dickersin K, 2011, J ROY SOC MED, V104, P532, DOI 10.1258/jrsm.2011.11k042; Dwan Kerry, 2011, Cochrane Database Syst Rev, pMR000031, DOI 10.1002/14651858.MR000031.pub2; Dwan K, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-52; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Edwards P, 2002, STAT MED, V21, P1635, DOI 10.1002/sim.1190; Eipe N, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-40; Elamin MB, 2009, J CLIN EPIDEMIOL, V62, P506, DOI 10.1016/j.jclinepi.2008.10.016; Ensor J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-91; Errami M, 2009, NUCLEIC ACIDS RES, V37, pD921, DOI 10.1093/nar/gkn546; Fanelli Daniele, 2009, PLoS One, V4, pe5738, DOI 10.1371/journal.pone.0005738; Founti P, ASS LOXL1 POLYM PSEU; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Garritty C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009914; Getz KA, 2011, DRUG INF J, V45, P265, DOI 10.1177/009286151104500307; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Goodman S, 2011, ANN INTERN MED, V155, P61, DOI 10.7326/0003-4819-155-1-201107050-00010; GOTZSCHE PC, 1989, EUR J CLIN PHARMACOL, V36, P429, DOI 10.1007/BF00558064; Greenhalgh T, 2005, SOC SCI MED, V61, P417, DOI 10.1016/j.socscimed.2004.12.001; Guyatt G, 2013, J CLIN EPIDEMIOL, V66, P151, DOI 10.1016/j.jclinepi.2012.01.006; Guyatt GH, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3863; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hamel C, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-108; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; Hartling L, 2013, J CLIN EPIDEMIOL, V66, P973, DOI 10.1016/j.jclinepi.2012.07.005; Hayden JA, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-64; Helfand M, 2010, J CLIN EPIDEMIOL, V63, P484, DOI 10.1016/j.jclinepi.2009.05.005; Higgins J., 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Higgins J, 2012, RES SYNTH METHODS; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Holden MA, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-10; Honein-AbouHaidar GN, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004508; Hopewell S, 2007, GREY LIT METAANALYSI; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Horsley T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000026.pub2; Horton J, 2010, J CLIN EPIDEMIOL, V63, P289, DOI 10.1016/j.jclinepi.2009.04.007; Hrobjartsson A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1119; Hunter JE, 2000, INT J SELECT ASSESS, V8, P275, DOI 10.1111/1468-2389.00156; Iansavichene AE, 2008, ANN INTERN MED, V148, P714, DOI 10.7326/0003-4819-148-9-200805060-00023; Institute of Medicine, 2011, FIND WHAT WORKS HLTH; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jones AP, 2005, J CLIN EPIDEMIOL, V58, P741, DOI 10.1016/j.jclinepi.2004.11.024; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Jorgensen AW, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-60; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kahan BC, 2013, STAT MED, V32, P1136, DOI 10.1002/sim.5667; Kirkham JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009810; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lawley CM, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-8; Lefebvre C., 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184.CH6; Leucht C, 2011, COCHRANE DB SYST REV; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Macdonald G, 2014, COCHRANE DB SYST REV; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mans CM, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-63; Mao C, 2012, COCHRANE LIB; McGowan J, 2010, EVID BASED LIB INF P, V5, P149, DOI 10.18438/B8SG8R; Moher D, 2006, LANCET, V367, P881, DOI 10.1016/S0140-6736(06)68358-X; Moher D, 2014, BJOG-INT J OBSTET GY, V121, P784, DOI 10.1111/1471-0528.12657; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Moher D, 2007, J CLIN EPIDEMIOL, V60, P1095, DOI 10.1016/j.jclinepi.2007.03.008; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5040; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Moseley AM, 2009, J CLIN EPIDEMIOL, V62, P1021, DOI 10.1016/j.jclinepi.2008.09.018; Mowatt G, 2002, JAMA-J AM MED ASSOC, V287, P2769, DOI 10.1001/jama.287.21.2769; O'Connor AM, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-99; Odgaard-Jensen J, 2011, COCHRANE DB SYST REV; OXMAN AD, 1993, ANN NY ACAD SCI, V703, P125, DOI 10.1111/j.1749-6632.1993.tb26342.x; Page MJ, 2013, J CLIN EPIDEMIOL, V66, P524, DOI 10.1016/j.jclinepi.2012.10.010; Page MJ, 2014, BIAS DUE SELECTIVE I; Parekh-Bhurke S, 2011, J CLIN EPIDEMIOL, V64, P349, DOI 10.1016/j.jclinepi.2010.04.022; Philbrook HT, 2007, J CLIN EPIDEMIOL, V60, P228, DOI 10.1016/j.jclinepi.2006.06.018; Popay J., 2006, GUIDANCE CONDUCT NAR, DOI DOI 10.13140/2.1.1018.4643; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1813, DOI 10.1001/jama.299.15.1813; Reichenbach S, 2008, COCHRANE LIB, DOI [10.1002/14651858.CD007320, DOI 10.1002/14651858]; Relevo R, 2012, AHRQ PUBLICATION, V10(12)-EHC063-EF; Rennie D, 1997, JAMA-J AM MED ASSOC, V278, P579, DOI 10.1001/jama.278.7.579; Richards BL, 2011, COCHRANE DB SYST REV; Rochon Paula A, 2010, Open Med, V4, pe69; Roseman M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5155; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Savovic J, 2011, RES SYNTH METHODS, V2, P78, DOI 10.1002/jrsm.33; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Schmidt FL, 2009, BRIT J MATH STAT PSY, V62, P97, DOI 10.1348/000711007X255327; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500; Shadish WR, 2009, BEHAV RES METHODS, V41, P177, DOI 10.3758/BRM.41.1.177; Shephard RJ, 2002, SPORTS MED, V32, P169, DOI 10.2165/00007256-200232030-00002; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Silagy CA, 2002, JAMA-J AM MED ASSOC, V287, P2831, DOI 10.1001/jama.287.21.2831; Siontis KC, 2013, BMJ-BRIT MED J, V347, pf4501; Sismondo S, 2007, PLOS MED, V4, P1429, DOI 10.1371/journal.pmed.0040286; Smith R, 2001, BRIT MED J, V323, P588, DOI 10.1136/bmj.323.7313.588; Smith R, 1997, BRIT MED J, V315, P696, DOI 10.1136/bmj.315.7110.696; Song F, 2010, PREPRESS PROJECTS; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stevens JW, 2011, PHARM STAT, V10, P374, DOI 10.1002/pst.491; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Stewart LA, PRISMA IPD EXT UNPUB; Stewart L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-7; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; Tharyan P, 2010, 18 COCHR C 10 CAMPB; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tramer MR, 1997, BMJ-BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635; Tricco AC, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-35; Tully PJ, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-127; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Turner EH, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001189; van Enst WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042812; Villar J, 2001, STAT MED, V20, P3635, DOI 10.1002/sim.1096; Viswanathan M, 2012, AHRQ METHODS EF 0308; von Elm E, 2004, JAMA-J AM MED ASSOC, V291, P974, DOI 10.1001/jama.291.8.974; Wen J, 2008, J CLIN EPIDEMIOL, V61, P770, DOI 10.1016/j.jclinepi.2007.10.008; Whitehead PJ, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-49; Whitlock EP, 2010, J CLIN EPIDEMIOL, V63, P491, DOI 10.1016/j.jclinepi.2009.03.008; Wiebe N, 2006, J CLIN EPIDEMIOL, V59, P342, DOI 10.1016/j.jclinepi.2005.08.017; Williamson PR, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-9; Williamson PR, 2005, STAT METHODS MED RES, V14, P515, DOI 10.1191/0962280205sm415oa; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE; Young MM, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-22; Zhang L, 2006, EVID BASED LIB INF P, V1, P3, DOI 10.18438/B85K52	178	2591	2594	35	198	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2015	349								g7647	10.1136/bmj.g7647	http://dx.doi.org/10.1136/bmj.g7647			25	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2ZF	25555855	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000365564600003
J	Bollen, M				Bollen, Mathieu			CELL CYCLE It takes three to find the exit	NATURE			English	Editorial Material							PHOSPHATASES; CHECKPOINT		Katholieke Univ Leuven, Lab Biosignaling & Therapeut, Dept Cellular & Mol Med, B-3000 Leuven, Belgium	KU Leuven	Bollen, M (corresponding author), Katholieke Univ Leuven, Lab Biosignaling & Therapeut, Dept Cellular & Mol Med, B-3000 Leuven, Belgium.	mathieu.bollen@med.kuleuven.be						Grallert A, 2015, NATURE, V517, P94, DOI 10.1038/nature14019; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Mocciaro A, 2010, J CELL SCI, V123, P2867, DOI 10.1242/jcs.074815; Monod J., 1972, CHANCE NECESSITY ESS, P3; Nijenhuis W, 2014, NAT CELL BIOL, V16, P1257, DOI 10.1038/ncb3065; Qian JB, 2013, CURR OPIN CELL BIOL, V25, P697, DOI 10.1016/j.ceb.2013.06.005; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005	9	3	4	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					29	30		10.1038/nature14080	http://dx.doi.org/10.1038/nature14080			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25487157				2022-12-28	WOS:000347178400027
J	Kuo, CF; Grainge, MJ; Mallen, C; Zhang, WY; Doherty, M				Kuo, Chang-Fu; Grainge, Matthew J.; Mallen, Christian; Zhang, Weiya; Doherty, Michael			Eligibility for and Prescription of Urate-Lowering Treatment in Patients With Incident Gout in England	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MANAGEMENT; RECOMMENDATIONS		[Kuo, Chang-Fu] Chang Gung Mem Hosp, Div Rheumatol Allergy & Immunol, Taoyuan, Taiwan; [Grainge, Matthew J.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Mallen, Christian] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Zhang, Weiya; Doherty, Michael] Univ Nottingham, Div Rheumatol Orthopaed & Dermatol, Nottingham NG7 2RD, England	Chang Gung Memorial Hospital; University of Nottingham; Keele University; University of Nottingham	Zhang, WY (corresponding author), City Hosp, Clinical Sci Bldg, Nottingham NG5 1PB, England.	weiya.zhang@nottingham.ac.uk	Kuo, Chang-Fu/Q-1714-2016; Zhang, Weiya/X-9481-2019	Kuo, Chang-Fu/0000-0002-9770-5730; Zhang, Weiya/0000-0003-1142-1460; Doherty, Michael/0000-0002-5763-8326; Mallen, Christian/0000-0002-2677-1028	Arthritis Research UK Funding Source: Medline; Department of Health [RP_2014-04-026] Funding Source: Medline; National Institute for Health Research [RP_2014-04-026] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Doherty M, 2012, ANN RHEUM DIS, V71, P1765, DOI 10.1136/annrheumdis-2012-201687; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Meier CR, 1997, BRIT J CLIN PHARMACO, V44, P175, DOI 10.1046/j.1365-2125.1997.00647.x; Roddy E, 2007, ANN RHEUM DIS, V66, P1311, DOI 10.1136/ard.2007.070755; Williams T, 2012, THER ADV DRUG SAF, V3, P89, DOI 10.1177/2042098611435911; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269	6	51	56	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2014	312	24					2684	2686		10.1001/jama.2014.14484	http://dx.doi.org/10.1001/jama.2014.14484			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX5KW	25536262				2022-12-28	WOS:000346966100023
J	Grasset, EK; Cerutti, A				Grasset, Emilie K.; Cerutti, Andrea			Retroviral help for B cells	SCIENCE			English	Editorial Material							MARGINAL ZONE		[Grasset, Emilie K.; Cerutti, Andrea] Mt Sinai Sch Med, Dept Med, Inst Immunol, New York, NY 10029 USA; [Cerutti, Andrea] IMIM Hosp Mar, Catalan Inst Res & Adv Studies ICREA, Barcelona 08003, Spain	Icahn School of Medicine at Mount Sinai; ICREA; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Grasset, EK (corresponding author), Mt Sinai Sch Med, Dept Med, Inst Immunol, 1425 Madison Ave, New York, NY 10029 USA.	andrea.cerutti@mssm.edu		Cerutti, Andrea/0000-0003-3026-4704	ICREA Funding Source: Custom	ICREA(ICREA)		Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Holmes EC, 2011, CELL HOST MICROBE, V10, P368, DOI 10.1016/j.chom.2011.09.002; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Romeu B, 2012, J DRUG TARGET, V20, P502, DOI 10.3109/1061186X.2012.693497; Szomolanyi-Tsuda E, 1998, CURR OPIN IMMUNOL, V10, P431, DOI 10.1016/S0952-7915(98)80117-9; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Zeng M, 2014, SCIENCE, V346, P1486, DOI 10.1126/science.346.6216.1486	15	2	2	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1454	1455		10.1126/science.aaa3263	http://dx.doi.org/10.1126/science.aaa3263			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525229				2022-12-28	WOS:000346536500035
J	Ramnath, S				Ramnath, Suresh			CHRISTMAS 2014: FOUND IN TRANSLATION English as she is mis-spoke, misread, and miswrote-or, why you should read before you sign	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ramnath, S (corresponding author), Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA.								0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2014	349								g7344	10.1136/bmj.g7344	http://dx.doi.org/10.1136/bmj.g7344			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX3EE	25523364				2022-12-28	WOS:000346822400003
J	Kanaya, AM				Kanaya, Alka M.			Review: Diet and exercise counseling improve intermediate health outcomes in persons with CV risk factors Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DIABETES PREVENTION		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kanaya, AM (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							Kahn R, 2014, DIABETES CARE, V37, P943, DOI 10.2337/dc13-1954; LeFevre ML, 2014, ANN INTERN MED, V161, P587, DOI 10.7326/M14-1796; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9	3	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12							JC7	10.7326/0003-4819-161-12-201412160-02007	http://dx.doi.org/10.7326/0003-4819-161-12-201412160-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UW	25506879				2022-12-28	WOS:000347248400014
J	Klemperer, F; Thomas, ES				Klemperer, Frances; Thomas, Emily Simon			CHRISTMAS 2014: GOING TO EXTREMES Captain Webb's legacy: the perils of swimming the English Channel	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PULMONARY-EDEMA; OPEN WATER; COLD		[Klemperer, Frances] Cent & North West London NHS Fdn Trust, London SW1 1DX, England; [Thomas, Emily Simon] Swansea Univ, Coll Med, Swansea SA2 8PP, W Glam, Wales	Swansea University	Klemperer, F (corresponding author), Cent & North West London NHS Fdn Trust, London SW1 1DX, England.	frances.klemperer@nhs.net						Adir Y, 2004, CHEST, V126, P394, DOI 10.1378/chest.126.2.394; Burnett JW, 2001, HYDROBIOLOGIA, V451, P1, DOI 10.1023/A:1011883019506; Channel Swimming and Piloting Federation, FREQ ASK QUEST; Channel Swimming and Piloting Federation, FACTS CHANN; Channel Swimming and Piloting Federation, RISKS RESP; Channel Swimming and Piloting Federation, CS PF RUL; Channel Swimming and Piloting Federation, TRAINING; Channel Swimming and Piloting Federation, 2012, S JOHNSON CLOCKS AN; Channel Swimming Association, SWIM REG; DiBartolomeo J R, 1979, Ann Otol Rhinol Laryngol Suppl, V88, P2; Doyle, 1927, CASE BOOK SHERLOCK H; Fischer G, 2013, SCAND J MED SCI SPOR, V23, pe48, DOI 10.1111/sms.12008; Gerrard DF, 1999, CLIN SPORT MED, V18, P337, DOI 10.1016/S0278-5919(05)70149-6; Golden F S, 1980, J R Nav Med Serv, V66, P26; HEEGER T, 1992, MAR BIOL, V113, P669, DOI 10.1007/BF00349710; Ito M, 1998, UNDERSEA HYPERBAR M, V25, P59; KEATINGE WR, 1960, J PHYSIOL-LONDON, V153, P166, DOI 10.1113/jphysiol.1960.sp006526; Koehle MS, 2005, SPORTS MED, V35, P183, DOI 10.2165/00007256-200535030-00001; Kroon DF, 2002, OTOLARYNG HEAD NECK, V126, P499, DOI 10.1067/mhn.2002.124474; Mojica AJ, DREAMS REALITY HALLU; MOORHOUSE D, 1956, BRIT MED J, V2, P1512, DOI 10.1136/bmj.2.5008.1512; Sacks Oliver, 2012, HALLUCINATIONS, P34; Schwarz WJ, 1997, MONOGRAPHS CLIN NEUR, V15, P21; Thaning O., DR O THANING OLDEST; Tipton M, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-12; Turner C., 2002, MARATHON CYCLING, P39; Webb M, 1999, ART SWIMMING; WEILERRAVELL D, 1995, BRIT MED J, V311, P361, DOI 10.1136/bmj.311.7001.361	28	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2014	349								g7372	10.1136/bmj.g7372	http://dx.doi.org/10.1136/bmj.g7372			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HK	25516262				2022-12-28	WOS:000346763900010
J	Schulman, KA				Schulman, Kevin A.			Review: In adult outpatients, nurse-managed protocols improve hemoglobin A(1c) levels and blood pressure Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Duke Univ, Duke Clin Res Inst, Durham, NC 27708 USA	Duke University	Schulman, KA (corresponding author), Duke Univ, Duke Clin Res Inst, Durham, NC 27708 USA.							Vaughn BT, 2010, HEALTH AFFAIR, V29, P933, DOI 10.1377/hlthaff.2009.0675	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12							JC6	10.7326/0003-4819-161-12-201412160-02006	http://dx.doi.org/10.7326/0003-4819-161-12-201412160-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UW	25506878				2022-12-28	WOS:000347248400012
J	Smith, R				Smith, Richard			Are some diets "mass murder"?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANS-FATTY-ACIDS; DISEASE; RISK					richardswsmith@yahoo.co.uk						Astrup A, 2011, AM J CLIN NUTR, V93, P684, DOI 10.3945/ajcn.110.004622; Banting W, 1864, COMMUNICATION; Blackburn H., 2014, BIG FAT SURPRISE, P20; Boseley S, 2014, GUARDIAN; Food and Agriculture Organization of the UN, 2010, FATS FATT AC HUM NUT; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Hooper L, 2012, COCHRANE DB SYST REV, V5; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Ioannidis JPA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6698; Jenkins NH., 2014, BIG FAT SURPRISE, P197; JOHNSTON PV, 1957, SCIENCE, V126, P698, DOI 10.1126/science.126.3276.698-a; KEYS A, 1984, PREV MED, V13, P141, DOI 10.1016/0091-7435(84)90047-1; KEYS A, 1970, CIRCULATION, V41, pI1; KEYS ANCEL, 1953, JOUR MT SINAI HOSP, V20, P118; Lustig R., 2014, FAT CHANCE HIDDEN TR; Lustig R, 3 MYTHS BLCK PROGR N; Mayer J., 2011, ZONING, P161; Menotti A, 1999, EUR J EPIDEMIOL, V15, P507, DOI 10.1023/A:1007529206050; MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703; Office of Disease Prevention and Health Promotion, 1980, DIET GUID AM; Ornish D., 1996, EVERYDAY COOKING DEA; PAGE IH, 1961, CIRCULATION, V23, P133, DOI 10.1161/01.CIR.23.1.133; Rees K, 2013, COCHRANE DB SYST REV, V8; Taubes G., 2011, WHY WE GET FAT WHAT; Taubes G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1050; Teicholz N., 2014, BIG FAT SURPRISE, V1st; Teicholz N, 2014, LANCET, P100; White C, 2005, BMJ-BRIT MED J, V331, P281, DOI 10.1136/bmj.331.7511.281; Willett W, 2014, BIG FAT SURPRISE, P265; YERUSHALMY J, 1957, N Y State J Med, V57, P2343; Yudkin J., 2012, PURE WHITE DEADLY	31	14	14	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2014	349								g7654	10.1136/bmj.g7654	http://dx.doi.org/10.1136/bmj.g7654			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HD	25510501	Green Published			2022-12-28	WOS:000346763200011
J	Fratzl, P				Fratzl, Peter			APPLIED PHYSICS The virtues of tiling	NATURE			English	Editorial Material							INTERFACES		Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany	Max Planck Society	Fratzl, P (corresponding author), Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany.	fratzl@mpikg.mpg.de	Fratzl, Peter/H-9095-2012	Fratzl, Peter/0000-0003-4437-7830				Dunlop JWC, 2011, MATER TODAY, V14, P70, DOI 10.1016/S1369-7021(11)70056-6; Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603; Kang D, 2014, NATURE, V516, P222, DOI 10.1038/nature14002; Li YN, 2013, J MECH PHYS SOLIDS, V61, P1144, DOI 10.1016/j.jmps.2012.10.004; Liu XX, 2010, MAT SCI ENG C-MATER, V30, P1077, DOI 10.1016/j.msec.2010.05.006	6	8	8	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					178	179		10.1038/516178a	http://dx.doi.org/10.1038/516178a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25503229				2022-12-28	WOS:000346383500031
J	Iyasere, CA; Simmons, LH; Fintelmann, FJ; Dighe, AS				Iyasere, Christiana A.; Simmons, Leigh H.; Fintelmann, Florian J.; Dighe, Anand S.			Case 38-2014: An 87-Year-Old Man with Sore Throat, Hoarseness, Fatigue, and Dyspnea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CREATINE-KINASE LEVELS; VENA-CAVA SYNDROME; SUBCLINICAL HYPOTHYROIDISM; THYROXINE; MYOPATHY; OVERT		[Iyasere, Christiana A.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Simmons, Leigh H.] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA; [Fintelmann, Florian J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Dighe, Anand S.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Iyasere, Christiana A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Simmons, Leigh H.] Harvard Univ, Sch Med, Dept Internal Med, Boston, MA USA; [Fintelmann, Florian J.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Dighe, Anand S.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Iyasere, CA (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Dighe, Anand/AAP-9640-2020; Simmons, Leigh/AAQ-3009-2021	Simmons, Leigh/0000-0002-2375-8485; Dighe, Anand/0000-0003-4130-0758				Bar SL, 2007, CAN FAM PHYSICIAN, V53, P428; Beyer IW, 1998, THYROID, V8, P1029, DOI 10.1089/thy.1998.8.1029; Buchbinder R, 2001, ANN INTERN MED, V134, P1087, DOI 10.7326/0003-4819-134-12-200106190-00008; Centanni M, 2006, NEW ENGL J MED, V354, P1787, DOI 10.1056/NEJMoa043903; Christopher-Stine L, 2006, CLIN CARE RHEUMATIC, P121; Duyff RF, 2000, J NEUROL NEUROSUR PS, V68, P750, DOI 10.1136/jnnp.68.6.750; Hekimsoy Z, 2005, ENDOCR RES, V31, P171, DOI 10.1080/07435800500371706; Herzinger T, 2002, LANCET, V359, P1308, DOI 10.1016/S0140-6736(02)08271-5; Kreisman SH, 1999, ARCH INTERN MED, V159, P79, DOI 10.1001/archinte.159.1.79; Krishnan STM, 2002, BRIT MED J, V325, P946, DOI 10.1136/bmj.325.7370.946; Liwanpo L, 2009, BEST PRACT RES CL EN, V23, P781, DOI 10.1016/j.beem.2009.06.006; Madariaga M, 2002, THYROID, V12, P331, DOI 10.1089/10507250252949478; PARISH JM, 1981, MAYO CLIN PROC, V56, P407; Rafailidis PI, 2007, CAN MED ASSOC J, V176, P1580, DOI 10.1503/cmaj.061205; SMITH TJ, 1989, ENDOCR REV, V10, P366, DOI 10.1210/edrv-10-3-366; Wilson LD, 2007, NEW ENGL J MED, V356, P1862, DOI 10.1056/NEJMcp067190	16	5	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					2321	2327		10.1056/NEJMcpc1410935	http://dx.doi.org/10.1056/NEJMcpc1410935			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW1KQ	25494272				2022-12-28	WOS:000346048800013
J	Kang, D; Pikhitsa, PV; Choi, YW; Lee, C; Shin, SS; Piao, LF; Park, B; Suh, KY; Kim, TI; Choi, M				Kang, Daeshik; Pikhitsa, Peter V.; Choi, Yong Whan; Lee, Chanseok; Shin, Sung Soo; Piao, Linfeng; Park, Byeonghak; Suh, Kahp-Yang; Kim, Tae-il; Choi, Mansoo			Ultrasensitive mechanical crack-based sensor inspired by the spider sensory system	NATURE			English	Article							ARTIFICIAL SKIN; ELECTRONICS; TRANSISTORS; MATRIX; FRACTURE; FILMS	Recently developed flexible mechanosensors based on inorganic silicon(1-3), organic semiconductors(4-6), carbon nanotubes(7), graphene platelets(8), pressure-sensitive rubber(9) and self-powered devices(10,11) are highly sensitive and can be applied to humanskin. However, the development of a multifunctional sensor satisfying the requirements of ultra-high mechanosensitivity, flexibility and durability remains a challenge. In nature, spiders sense extremely small variations in mechanical stress using crack-shaped slit organs near their leg joints(12). Here we demonstrate that sensors based on nanoscale crack junctions and inspired by the geometry of a spider's slit organ can attain ultrahigh sensitivity and serve multiple purposes. The sensors are sensitive to strain (with a gauge factor of over 2,000 in the 0-2 per cent strain range) and vibration (with the ability to detect amplitudes of approximately 10 nanometres). The device is reversible, reproducible, durable and mechanically flexible, and can thus be easily mounted on human skin as an electronic multipixel array. The ultrahigh mechanosensitivity is attributed to the disconnection-reconnection process undergone by the zip-like nanoscale crack junctions under strain or vibration. The proposed theoretical model is consistent with experimental data that we report here. We also demonstrate that sensors based on nanoscale crack junctions are applicable to highly selective speech pattern recognition and the detection of physiological signals. The nanoscale crack junction-based sensory system could be useful in diverse applications requiring ultrahigh displacement sensitivity.	[Kang, Daeshik; Pikhitsa, Peter V.; Choi, Yong Whan; Lee, Chanseok; Shin, Sung Soo; Piao, Linfeng; Suh, Kahp-Yang; Choi, Mansoo] Seoul Natl Univ, Dept Mech & Aerosp Engn, Global Frontier Ctr Multiscale Energy Syst, Seoul 151742, South Korea; [Kang, Daeshik; Suh, Kahp-Yang; Choi, Mansoo] Seoul Natl Univ, Div WCU Multiscale Mech Design, Dept Mech & Aerosp Engn, Seoul 151742, South Korea; [Park, Byeonghak; Kim, Tae-il] Inst Basic Sci IBS, Ctr Neurosci Imaging Res CNIR, Suwon 440746, South Korea; [Park, Byeonghak; Kim, Tae-il] Sungkyunkwan Univ SKKU, Sch Chem Engn, Suwon 440746, South Korea; [Suh, Kahp-Yang] Seoul Natl Univ, Interdisciplinary Program Bioengn, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU); Seoul National University (SNU)	Choi, M (corresponding author), Seoul Natl Univ, Dept Mech & Aerosp Engn, Global Frontier Ctr Multiscale Energy Syst, Seoul 151742, South Korea.	taeilkim@skku.edu; mchoi@snu.ac.kr	Kim, Tae-il/C-4769-2015; Pikhitsa, Peter/ABB-7625-2021	Kim, Tae-il/0000-0002-6667-5356; Piao, Linfeng/0000-0001-9094-7940; Lee, Chanseok/0000-0002-7969-4345	Global Frontier R&D Program of the Center for Multiscale Energy Systems - National Research Foundation of Korea under the Ministry of Science, ICT and Future Planning [2011-0031561, 2011-0031577, IBS-R015-D1, NRF-2013-R1A1A1061403]; Basic Science Research Program - National Research Foundation of Korea under the Ministry of Science, ICT and Future Planning [IBS-R015-D1, NRF-2013-R1A1A1061403, 2009-0083540]	Global Frontier R&D Program of the Center for Multiscale Energy Systems - National Research Foundation of Korea under the Ministry of Science, ICT and Future Planning; Basic Science Research Program - National Research Foundation of Korea under the Ministry of Science, ICT and Future Planning	This work is dedicated to the late Kahp-Yang Suh, one of the great pioneers of biomimetics. We thank S. J. Kwon for discussion of the theoretical modelling, T. Shin and S. J. Kang for help in relation to speech pattern recognition, K. Park for high-speed camera recording, J.-Y. Lee for LabVIEW programming, J. S. Kim for computational analysis of the audio files, T. Lee for flexibility testing, J. H. Park for playing the violin, and Y. K. Song and J.-P. Kim for their comments about phonetics and spider slit organs, respectively. This work was supported by the Global Frontier R&D Program of the Center for Multiscale Energy Systems (grant nos 2011-0031561 and 2011-0031577) and the Basic Science Research Program (grant no. 2009-0083540), all funded by the National Research Foundation of Korea under the Ministry of Science, ICT and Future Planning and by grants IBS-R015-D1 and NRF-2013-R1A1A1061403 (T.-i.K.).	Bronkhorst AW, 2000, ACUSTICA, V86, P117; Choi SJ, 2004, J AM CHEM SOC, V126, P7744, DOI 10.1021/ja048972k; Chortos A, 2014, ADV MATER, V26, P4253, DOI 10.1002/adma.201305462; DRURY WJ, 1995, METALL MATER TRANS A, V26, P2651, DOI 10.1007/BF02669422; Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603; Graz IM, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3076103; Hossl B, 2006, J BIOMECH, V39, P1761, DOI 10.1016/j.jbiomech.2005.05.031; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; Kim BC, 2013, SCI REP-UK, V3, DOI 10.1038/srep03027; Kim DH, 2012, MRS BULL, V37, P226, DOI 10.1557/mrs.2012.36; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Lacour SP, 2003, APPL PHYS LETT, V82, P2404, DOI 10.1063/1.1565683; Lacour SP, 2005, P IEEE, V93, P1459, DOI 10.1109/JPROC.2005.851502; Li X, 2012, SCI REP-UK, V2, DOI 10.1038/srep00870; Livne A, 2010, SCIENCE, V327, P1359, DOI 10.1126/science.1180476; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/NMAT2834, 10.1038/nmat2834]; Nam KH, 2012, NATURE, V485, P221, DOI 10.1038/nature11002; Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101; Takei K, 2010, NAT MATER, V9, P821, DOI [10.1038/nmat2835, 10.1038/NMAT2835]; Thouless MD, 2011, J MECH PHYS SOLIDS, V59, P1927, DOI 10.1016/j.jmps.2011.04.009; Vandeparre H, 2013, ADV MATER, V25, P3117, DOI 10.1002/adma.201300587; Wang ZL, 2012, ADV MATER, V24, P280, DOI 10.1002/adma.201102958; Wu WZ, 2013, SCIENCE, V340, P952, DOI [10.1126/science.1234855, 10.1126/science.1237145]; Yamada T, 2011, NAT NANOTECHNOL, V6, P296, DOI [10.1038/nnano.2011.36, 10.1038/NNANO.2011.36]	24	907	925	121	1508	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					222	226		10.1038/nature14002	http://dx.doi.org/10.1038/nature14002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25503234				2022-12-28	WOS:000346383500039
J	Goodnough, LT; Murphy, MF				Goodnough, Lawrence Tim; Murphy, Michael F.			Do liberal blood transfusions cause more harm than good?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DECISION-SUPPORT-SYSTEMS; RED-CELL STORAGE; CARDIAC-SURGERY; RESTRICTIVE TRANSFUSION; STRATEGIES; MANAGEMENT; TRIAL; REQUIREMENTS; MEDICINE; AGE	Guidelines and evidence from randomised controlled trials and meta-analyses increasingly support restrictive blood transfusion, but it is being implemented only slowly, explain Lawrence Tim Goodnough and Michael Murphy. They argue that electronic systems for clinical decision support could improve blood use	[Goodnough, Lawrence Tim] Stanford Univ, Med Ctr, Transfus Serv, Stanford, CA 94305 USA; [Murphy, Michael F.] NHS Blood & Transplant, Oxford, England; [Murphy, Michael F.] Univ Oxford, Oxford Univ Hosp, Oxford, England	Stanford University; University of Oxford	Goodnough, LT (corresponding author), 300 Pasteur Dr,Room H-1402, Stanford, CA 94305 USA.	ltgoodno@stanford.edu						Adams ES, 2011, PEDIATRICS, V127, pE1112, DOI 10.1542/peds.2010-3252; Bennett-Guerrero E, 2010, JAMA-J AM MED ASSOC, V304, P1568, DOI 10.1001/jama.2010.1406; Carson JL, 2014, AM J MED, V127, P103, DOI 10.1016/j.amjmed.2013.10.026; Carson JL, 2013, AM HEART J, V165, P964, DOI 10.1016/j.ahj.2013.03.001; Carson JL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub3; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Choosing Wisely, IN ABIM FDN; Collins RA, 2014, AM J CLIN PATHOL, V141, P78, DOI 10.1309/AJCP1OSRTPUJE9XS; Department of Health, 2007, 2007001 HSC DEP HLTH; Frank SM, 2013, TRANSFUSION, V53, P3052, DOI 10.1111/trf.12227; Goodnough LT, 2014, TRANSFUSION, V54, P2753, DOI 10.1111/trf.12723; Goodnough LT, 2014, TRANSFUSION, V54, P1358, DOI 10.1111/trf.12445; Goodnough LT, 2013, LANCET, V381, P1845, DOI 10.1016/S0140-6736(13)60650-9; Goodnough LT, 2013, LANCET, V381, P1791, DOI 10.1016/S0140-6736(13)60673-X; Goodnough LT, 2014, AM J HEMATOL, V89, P88, DOI 10.1002/ajh.23598; Goodnough LT, 2012, ANESTHESIOLOGY, V116, P1367, DOI 10.1097/ALN.0b013e318254d1a3; GOODNOUGH LT, 1991, JAMA-J AM MED ASSOC, V265, P86, DOI 10.1001/jama.265.1.86; Goodnough LT, 1999, NEW ENGL J MED, V340, P438, DOI 10.1056/NEJM199902113400606; Goodnough LT, AM J CLIN P IN PRESS; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Lacroix J, 2011, TRANSFUS MED REV, V25, P197, DOI 10.1016/j.tmrv.2011.03.001; Murphy MF, 2011, VOX SANG, V100, P46, DOI 10.1111/j.1423-0410.2010.01366.x; Murphy MF, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4303; Murphy MF, 2012, TRANSFUSION, V52, P2502, DOI 10.1111/j.1537-2995.2011.03509.x; NHS Blood and Transplant, NAT COMP AUD BLOOD T; Qian F, 2013, ANN SURG, V257, P266, DOI 10.1097/SLA.0b013e31825ffc37; Razavi SA, J AM COLL SURG; Rohde JM, 2014, JAMA-J AM MED ASSOC, V311, P1317, DOI 10.1001/jama.2014.2726; Rothschild JM, 2007, TRANSFUSION, V47, P228, DOI 10.1111/j.1537-2995.2007.01093.x; Salaria ON, 2014, ANESTH ANALG, V118, P1179, DOI 10.1213/ANE.0000000000000227; Salpeter SR, 2014, AM J MED, V127, P124, DOI 10.1016/j.amjmed.2013.09.017; Steiner ME, 2014, TRANSFUSION, V54, p15A; Steiner ME, 2010, TRANSFUS APHER SCI, V43, P107, DOI 10.1016/j.transci.2010.05.014; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801	39	32	33	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 5	2014	349								g6897	10.1136/bmj.g6897	http://dx.doi.org/10.1136/bmj.g6897			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KT	25501327				2022-12-28	WOS:000346117200001
J	Sigmundsson, F; Hooper, A; Hreinsdottir, S; Vogfjord, KS; Ofeigsson, BG; Heimisson, ER; Dumont, S; Parks, M; Spaans, K; Gudmundsson, GB; Drouin, V; Arnadottir, T; Jonsdottir, K; Gudmundsson, MT; Hognadottir, T; Fridriksdottir, HM; Hensch, M; Einarsson, P; Magnusson, E; Samsonov, S; Brandsdottir, B; White, RS; Agustsdottir, T; Greenfield, T; Green, RG; Hjartardottir, AR; Pedersen, R; Bennett, RA; Geirsson, H; La Femina, PC; Bjornsson, H; Palsson, F; Sturkell, E; Bean, CJ; Mollhoff, M; Braiden, AK; Eibl, EPS				Sigmundsson, Freysteinn; Hooper, Andrew; Hreinsdottir, Sigrun; Vogfjord, Kristin S.; Ofeigsson, Benedikt G.; Heimisson, Elias Rafn; Dumont, Stephanie; Parks, Michelle; Spaans, Karsten; Gudmundsson, Gunnar B.; Drouin, Vincent; Arnadottir, Thora; Jonsdottir, Kristin; Gudmundsson, Magnus T.; Hognadottir, Thordis; Fridriksdottir, Hildur Maria; Hensch, Martin; Einarsson, Pall; Magnusson, Eyjolfur; Samsonov, Sergey; Brandsdottir, Bryndis; White, Robert S.; Agustsdottir, Thorbjoerg; Greenfield, Tim; Green, Robert G.; Hjartardottir, Asta Rut; Pedersen, Rikke; Bennett, Richard A.; Geirsson, Halldor; La Femina, Peter C.; Bjornsson, Helgi; Palsson, Finnur; Sturkell, Erik; Bean, Christopher J.; Mollhoff, Martin; Braiden, Aoife K.; Eibl, Eva P. S.			Segmented lateral dyke growth in a rifting event at Bardarbunga volcanic system, Iceland	NATURE			English	Article							CRUSTAL STRUCTURE; DIKE PROPAGATION; DEFORMATION; MAGMA; CONSTRAINTS; ERUPTION; DEFLATION; COLLAPSE; ISLANDS; CALDERA	Crust at many divergent plate boundaries forms primarily by the injection of vertical sheet-like dykes, some tens of kilometres long(1). Previous models of rifting events indicate either lateral dyke growth away from a feeding source, with propagation rates decreasing as the dyke lengthens(2-4), or magma flowing vertically into dykes from an underlying source(5,6), with the role of topography on the evolution of lateral dykes not clear. Here we show how a recent segmented dyke intrusion in the Bardarbunga volcanic system grew laterally for more than 45 kilometres at a variable rate, with topography influencing the direction of propagation. Barriers at the ends of each segment were overcome by the build-up of pressure in the dyke end; then a new segment formed and dyke lengthening temporarily peaked. The dyke evolution, which occurred primarily over 14 days, was revealed by propagating seismicity, ground deformation mapped by Global Positioning System(GPS), interferometric analysis of satellite radar images (InSAR), and graben formation. The strike of the dyke segments varies from an initially radial direction away from the Bardarbunga caldera, towards alignment with that expected from regional stress at the distal end. A model minimizing the combined strain and gravitational potential energy explains the propagation path. Dyke opening and seismicity focused at the most distal segment at any given time, and were simultaneous with magma source deflation and slow collapse at the Bardarbunga caldera, accompanied by a series of magnitude M > 5 earthquakes. Dyke growth was slowed down by an effusive fissure eruption near the end of the dyke. Lateral dyke growth with segment barrier breaking by pressure build-up in the dyke distal end explains how focused upwelling of magma under central volcanoes is effectively redistributed over long distances to create new upper crust at divergent plate boundaries.	[Sigmundsson, Freysteinn; Heimisson, Elias Rafn; Dumont, Stephanie; Parks, Michelle; Drouin, Vincent; Arnadottir, Thora; Gudmundsson, Magnus T.; Hognadottir, Thordis; Fridriksdottir, Hildur Maria; Einarsson, Pall; Magnusson, Eyjolfur; Brandsdottir, Bryndis; Hjartardottir, Asta Rut; Pedersen, Rikke; Bjornsson, Helgi; Palsson, Finnur] Univ Iceland, Inst Earth Sci, Nord Volcanol Ctr, IS-101 Reykjavik, Iceland; [Hooper, Andrew; Spaans, Karsten] Univ Leeds, Sch Earth & Environm, Ctr Observat & Modelling Earthquakes & Tecton CCM, Leeds LS2 9JT, W Yorkshire, England; [Hreinsdottir, Sigrun] GNS Sci, Lower Hutt 5040, New Zealand; [Vogfjord, Kristin S.; Ofeigsson, Benedikt G.; Gudmundsson, Gunnar B.; Jonsdottir, Kristin; Fridriksdottir, Hildur Maria; Hensch, Martin] Iceland Meteorol Off, IS-150 Reykjavik, Iceland; [Samsonov, Sergey] Nat Resources Canada, Canada Ctr Mapping & Earth Observat, Ottawa, ON K1A 0EA, Canada; [White, Robert S.; Agustsdottir, Thorbjoerg; Greenfield, Tim; Green, Robert G.] Univ Cambridge, Dept Earth Sci, Cambridge CB3 0EZ, England; [Bennett, Richard A.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Geirsson, Halldor; La Femina, Peter C.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Sturkell, Erik] Univ Gothenburg, Dept Earth Sci, SE-40530 Gothenburg, Sweden; [Bean, Christopher J.; Mollhoff, Martin; Braiden, Aoife K.; Eibl, Eva P. S.] Univ Coll Dublin, Sch Geol Sci, Seismol Lab, Dublin 4, Ireland	University of Iceland; University of Leeds; GNS Science - New Zealand; Natural Resources Canada; Strategic Policy & Results Sector - Natural Resources Canada; Canada Centre for Mapping & Earth Observation (CCMEO); University of Cambridge; University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Gothenburg; University College Dublin	Sigmundsson, F (corresponding author), Univ Iceland, Inst Earth Sci, Nord Volcanol Ctr, IS-101 Reykjavik, Iceland.	fs@hi.is	White, Robert/B-8453-2015; Parks, Michelle/P-1330-2016; Eibl, Eva P. S./ABH-3374-2021; Gudmundsson, Magnus T/M-3735-2015; LaFemina, Peter C/C-4233-2011; Facility, NERC Geophysical Equipment/G-5260-2010; Dumont, Stéphanie/GWR-2046-2022; Sigmundsson, Freysteinn/F-7160-2015; Eibl, Eva P. S./HIR-7341-2022; Heimisson, Elias Rafn/AAD-4119-2022; DUMONT, Stéphanie/S-9795-2019; Pálsson, Finnur/B-7047-2016; Brandsdottir, Bryndis/D-1763-2014; Arnadottir, Thora/C-7183-2013	Parks, Michelle/0000-0002-1793-5633; Eibl, Eva P. S./0000-0002-0667-0035; Gudmundsson, Magnus T/0000-0001-5325-3368; Dumont, Stéphanie/0000-0002-4779-7788; Sigmundsson, Freysteinn/0000-0001-9052-4665; Eibl, Eva P. S./0000-0002-0667-0035; DUMONT, Stéphanie/0000-0002-4779-7788; Mollhoff, Martin/0000-0003-1848-1554; Greenfield, Tim/0000-0002-4370-7298; LaFemina, Peter/0000-0001-6053-2074; Vogfjord, Kristin S./0000-0003-2658-1838; Hjartardottir, Asta Rut/0000-0002-3520-6709; Samsonov, Sergey/0000-0002-6798-4847; Bean, Christopher/0000-0003-3285-2446; Geirsson, Halldor/0000-0003-2056-1588; Brandsdottir, Bryndis/0000-0002-4018-0697; Arnadottir, Thora/0000-0002-8275-8813; Hognadottir, Thordis/0000-0003-4596-1510; Green, Robert/0000-0002-1614-7133; Einarsson, Pall/0000-0002-6893-9626; Drouin, Vincent/0000-0002-5340-0484; Hooper, Andrew/0000-0003-4244-6652	European Community [308377]; Icelandic Research Fund; Research Fund at the University of Iceland; NERC; Geological Survey of Ireland; US National Science Foundation (NSF); Committee on Earth Observing Satellites (CEOS); DLR [IDEM_GEOL0123]; US NSF and National Aeronautics and Space Administration (NASA) under NSF [EAR-0735156, EAR-0711446]; NERC [NE/H025006/1, come30001, NE/F011407/1, NE/M017427/1] Funding Source: UKRI; Natural Environment Research Council [1210874, NE/H025006/1, come30001, NE/M017427/1, NE/F011407/1] Funding Source: researchfish; Division Of Earth Sciences [1261833] Funding Source: National Science Foundation	European Community(European Commission); Icelandic Research Fund; Research Fund at the University of Iceland; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Geological Survey of Ireland; US National Science Foundation (NSF)(National Science Foundation (NSF)); Committee on Earth Observing Satellites (CEOS); DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); US NSF and National Aeronautics and Space Administration (NASA) under NSF; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Support for this work was received from the European Community's Seventh Framework Programme Grant No. 308377 (Project FUTUREVOLC), the Icelandic Research Fund (Project Volcano Anatomy), the Research Fund at the University of Iceland, NERC, the Geological Survey of Ireland and the US National Science Foundation (NSF). COSMO-SkyMed data were provided by the Italian Space Agency (ASI) and TerraSAR-X data by the German Space Agency (DLR) through the Icelandic Volcanoes Supersite project supported by the Committee on Earth Observing Satellites (CEOS). RADARSAT-2 data were provided by the Canadian Space Agency and MDA Corporation. Natural Resources Canada Earth Sciences Sector contribution number 20140314. An intermediate TanDEM-X digital elevation model was provided by DLR under project IDEM_GEOL0123. We thank the following key persons for help with instrumentation and data: B. H. Bergsson, p. Jonsson, V. H. Kjartansson, S. Steinorsson, P. Erlendsson, H. Olafsson, J. Soring and D. Craig. We also acknowledge the many others who have contributed to GPS, seismic and other field work in the study area. For GPS equipment and support, we acknowledge services provided by the UNAVCO Facility with support from the US NSF and National Aeronautics and Space Administration (NASA) under NSF Cooperative Agreements Nos EAR-0735156 and EAR-0711446. S. Jonsson (KAUST, Saudi Arabia) and T. Villemin (EDYTEM, Universite de Savoie, France) also provided support to GPS. Seismic equipment: The British Geological Survey donated several of the broadband seismic sensors around Vatnajokull. We thank the SEISUK facility for loans to R.S.W. of seismometers under loan 980. Landsvirkjun contributed GPS instruments and seismic sensors north of Vatnajokull. The surveying aeroplane of Isavia (Icelandic Aviation Operation Services) mapped the subsidence of Baroarbunga. The Icelandic Coast Guard provided aeroplane and helicopter support for field studies.	Arnadottir T, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003907; Belachew M, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007908; Bjornsson H., 1990, J KULL J, V40, P147; Bjornsson H., 1988, HYDROLOGY ICE CAPS V, V45; Bodvarsson R., 1998, 6R98005JA04 IC MET O; Buck WR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003879; Dahm T, 2000, GEOPHYS J INT, V141, P623, DOI 10.1046/j.1365-246x.2000.00102.x; Darbyshire FA, 1998, GEOPHYS J INT, V135, P1131, DOI 10.1046/j.1365-246X.1998.00701.x; Decriem J, 2010, GEOPHYS J INT, V181, P1128, DOI 10.1111/j.1365-246X.2010.04565.x; DELANEY PT, 1994, B VOLCANOL, V56, P417, DOI 10.1007/BF00302823; EINARSSON P, 1980, J GEOPHYS-Z GEOPHYS, V47, P160; Einarsson P., 1997, EOS T AM GEOPHYS UN, V78, P369, DOI [10.1029/97EO00237, DOI 10.1029/97EO00237, DOI 10.1029/97E000237]; Fialko Y, 2001, GEOPHYS J INT, V146, P181, DOI 10.1046/j.1365-246X.2001.00452.x; Fialko YA, 1999, J GEOPHYS RES-SOL EA, V104, P23033, DOI 10.1029/1999JB900213; Goldstein RM, 1998, GEOPHYS RES LETT, V25, P4035, DOI 10.1029/1998GL900033; GOLDSTEIN RM, 1988, RADIO SCI, V23, P713, DOI 10.1029/RS023i004p00713; GUDMUNDSSON A, 1995, J VOLCANOL GEOTH RES, V64, P1, DOI 10.1016/0377-0273(95)92782-Q; Gudmundsson MT, 2007, ANN GLACIOL-SER, V45, P66, DOI 10.3189/172756407782282444; Gudmundsson MT, 2007, J GEODYN, V43, P153, DOI 10.1016/j.jog.2006.09.015; Hartley ME, 2013, GEOCHEM GEOPHY GEOSY, V14, P2286, DOI 10.1002/ggge.20151; Herring T. A., 2010, INTRO GAMIT GLOBK; Hooper A, 2013, EARTH PLANET SC LETT, V361, P469, DOI 10.1016/j.epsl.2012.11.013; Hooper A, 2011, NAT GEOSCI, V4, P783, DOI [10.1038/NGEO1269, 10.1038/ngeo1269]; Johannesson T, 2013, ANN GLACIOL, V54, P63, DOI 10.3189/2013AoG63A422; Kampes B.M., 1999, DELFT OBJECT ORIENTE; Lomax A, 2000, ADVANCES IN SEISMIC EVENT LOCATION, P101; Maccaferri F, 2011, J VOLCANOL GEOTH RES, V208, P39, DOI 10.1016/j.jvolgeores.2011.09.001; Magnusson E, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021615; MOSEGAARD K, 1995, J GEOPHYS RES-SOL EA, V100, P12431, DOI 10.1029/94JB03097; OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; Pagli C, 2007, EARTH PLANET SC LETT, V259, P24, DOI 10.1016/j.epsl.2007.04.019; Reddy J. N., 2013, INTRO CONTINUUM MECH, V2nd, DOI DOI 10.1017/CBO9781139178952; ROGNVALDSSON ST, 1993, B SEISMOL SOC AM, V83, P1232; Rosen P.A., 2004, EOS T AM GEOPHYS UN, V85, P47, DOI DOI 10.1029/2004EO050004; Segall P, 2013, J GEOPHYS RES-SOL EA, V118, P5785, DOI 10.1002/2013JB010251; Segall P, 2010, EARTHQUAKE AND VOLCANO DEFORMATION, P1; SLUNGA R, 1995, GEOPHYS J INT, V123, P409, DOI 10.1111/j.1365-246X.1995.tb06862.x; Staudacher T, 2009, J VOLCANOL GEOTH RES, V184, P126, DOI 10.1016/j.jvolgeores.2008.11.005; STEFANSSON R, 1993, B SEISMOL SOC AM, V83, P696; Sturkell E, 2000, J GEOPHYS RES-SOL EA, V105, P25671, DOI 10.1029/2000JB900178; Thordarson T, 2007, J GEODYN, V43, P118, DOI 10.1016/j.jog.2006.09.005; Toda S, 2002, NATURE, V419, P58, DOI 10.1038/nature00997; Werner C., 2000, EUROPEAN SPACE AGENC, V461; Wright TJ, 2012, NAT GEOSCI, V5, P242, DOI [10.1038/ngeo1428, 10.1038/NGEO1428]; Yun S, 2006, J VOLCANOL GEOTH RES, V150, P232, DOI 10.1016/j.jvolgeores.2005.07.009	47	325	327	6	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					191	U158		10.1038/nature14111	http://dx.doi.org/10.1038/nature14111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25517098	Green Submitted, Green Accepted			2022-12-28	WOS:000347477600034
J	Song, ZR; Chokshi, DA				Song, Zirui; Chokshi, Dave A.			The Role of Private Payers in Payment Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Song, Zirui] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Song, Zirui] Harvard Univ, Sch Med, Boston, MA USA; [Chokshi, Dave A.] New York City Hlth & Hosp Corp, New York, NY USA; [Chokshi, Dave A.] NYU, Langone Med Ctr, Dept Populat Hlth, New York, NY USA; [Chokshi, Dave A.] NYU, Langone Med Ctr, Dept Med, New York, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Song, ZR (corresponding author), Massachusetts Gen Hosp, Dept Med, 55 Fruit St, Boston, MA 02114 USA.	zirui_song@post.harvard.edu		Chokshi, Dave/0000-0001-7467-4591	NIA NIH HHS [F30 AG039175] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [F30AG039175] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Accenture, 2012, CLINICAL TRANSFORMAT; Baker LC, 2014, HEALTH AFFAIR, V33, P756, DOI 10.1377/hlthaff.2013.1279; Health Care Cost Institute, 2013, 2013 HEALTH CARE COS; Kary W, 2013, BUNDLED EPISODE PAYM; Muhlestein D., 2014, ACCOUNTABLE CARE GRO; National Center for Health Statistics, 2014, HEALTH INSURANCE COV; Rajkumar R, 2014, JAMA-J AM MED ASSOC, V311, P1967, DOI 10.1001/jama.2014.3703; Shah NR, 2013, JAMA-J AM MED ASSOC, V310, P1561, DOI 10.1001/jama.2013.280015; Song ZR, 2014, NEW ENGL J MED, V371, P1704, DOI 10.1056/NEJMsa1404026	9	10	10	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					25	26		10.1001/jama.2014.15904	http://dx.doi.org/10.1001/jama.2014.15904			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25562259	Green Accepted			2022-12-28	WOS:000347478000007
J	Hall, A				Hall, Alex			Projecting regional change	SCIENCE			English	Editorial Material							CLIMATE-CHANGE PROJECTIONS; UNCERTAINTY		Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Hall, A (corresponding author), Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA.	alexhall@atmos.ucla.edu	Hall, Alex/D-8175-2014		Emerging Frontiers [1065853] Funding Source: National Science Foundation	Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Barsugli J.J., 2013, EOS T AM GEOPHYS UN, V94, P424, DOI [10.1002/2013EO460005, DOI 10.1002/2013EO460005]; Flato G., 2013, CLIMATE CHANGE 2013; Gula J, 2012, J CLIMATE, V25, P7723, DOI 10.1175/JCLI-D-11-00388.1; Harrison P., 2000, AAAS ATLAS POPULATIN; Kerr RA, 2011, SCIENCE, V334, P173, DOI 10.1126/science.334.6053.173; Kumar P, 2013, SCI TOTAL ENVIRON, V468, pS18, DOI 10.1016/j.scitotenv.2013.01.051; Price MF, 2013, MOUNTAIN GEOGRAPHY: PHYSICAL AND HUMAN DIMENSIONS, P1; Schiermeier Q, 2010, NATURE, V463, P284, DOI 10.1038/463284a; Shepherd TG, 2014, NAT GEOSCI, V7, P703, DOI 10.1038/NGEO2253	9	105	107	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1461	1462		10.1126/science.aaa0629	http://dx.doi.org/10.1126/science.aaa0629			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW8UI	25525234				2022-12-28	WOS:000346536500040
J	Lollar, BS; Onstott, TC; Lacrampe-Couloume, G; Ballentine, CJ				Lollar, Barbara Sherwood; Onstott, T. C.; Lacrampe-Couloume, G.; Ballentine, C. J.			The contribution of the Precambrian continental lithosphere to global H-2 production	NATURE			English	Article							WITWATERSRAND BASIN; HYDROGEN GENERATION; RADIOLYTIC H-2; NOBLE-GASES; SERPENTINIZATION; CRUST; ROCKS; WATER; FLUIDS; GEOCHEMISTRY	Microbial ecosystems can be sustained by hydrogen gas (H-2)-producing water-rock interactions in the Earth's subsurface and at deep ocean vents(1-4). Current estimates of global H-2 production from the marine lithosphere by water-rock reactions (hydration) are in the range of 10(11) moles per year(5-9). Recent explorations of saline fracture waters in the Precambrian continental subsurface have identified environments as rich in H-2 as hydrothermal vents and seafloor-spreading centres(1,2) and have suggested a link between dissolved H-2 and the radiolytic dissociation of water(10,11). However, extrapolation of a regional H-2 flux based on the deep gold mines of the Witwatersrand basin in South Africa(11) yields a contribution of the Precambrian lithosphere to global H-2 production that was thought to be negligible (0.009 x 10(11) moles per year)(6). Here we present a global compilation of published and new H-2 concentration data obtained from Precambrian rocks and find that the H-2 production potential of the Precambrian continental lithosphere has been underestimated. We suggest that this can be explained by a lack of consideration of additional H-2-producing reactions, such as serpentinization, and the absence of appropriate scaling of H-2 measurements from these environments to account for the fact that Precambrian crust represents over 70 per cent of global continental crust surface area(12). If H-2 production via both radiolysis and hydration reactions is taken into account, our estimate of H-2 production rates from the Precambrian continental lithosphere of 0.36-2.27 x 10(11) moles per year is comparable to estimates from marine systems.	[Lollar, Barbara Sherwood; Lacrampe-Couloume, G.] Univ Toronto, Dept Earth Sci, Toronto, ON M5S 3B1, Canada; [Onstott, T. C.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Ballentine, C. J.] Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England	University of Toronto; Princeton University; University of Oxford	Lollar, BS (corresponding author), Univ Toronto, Dept Earth Sci, 22 Russell St, Toronto, ON M5S 3B1, Canada.	bslollar@chem.utoronto.ca	Lacrampe-Couloume, Georges/AAW-9291-2020; Lacrampe-Couloume, Georges/P-6093-2019	Onstott, Tullis/0000-0002-2898-3374; Ballentine, Chris/0000-0001-9382-070X	Canada Research Chairs programme; NSERC; Sloan Foundation Deep Carbon Observatory; Canadian Space Agency; National Science Foundation [EAR-0948659.f]; Natural Environment Research Council [NE/F002823/1, NE/F002823/2] Funding Source: researchfish; NERC [NE/F002823/1, NE/F002823/2] Funding Source: UKRI	Canada Research Chairs programme(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sloan Foundation Deep Carbon Observatory; Canadian Space Agency(Canadian Space Agency); National Science Foundation(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The preparation and execution of this work was supported by the Canada Research Chairs programme, NSERC Discovery and Accelerator grants to B.S.L. with additional partial funding from the Sloan Foundation Deep Carbon Observatory, Canadian Space Agency and National Science Foundation grant number EAR-0948659.f. We are grateful to K. Chu, A. Yang and G. S. Lollar (of the University of Toronto) for preparation of the maps and tables and to N. Sleep, H. D. Holland, J. Mungalland M.A. Hamilton for discussions on Precambrian geology and mineralogy. We also thank colleagues and supporters at the mines and underground research laboratories whose efforts resulted in the original primary publications from which a portion of this data set is compiled.	ABRAJANO TA, 1990, APPL GEOCHEM, V5, P625, DOI 10.1016/0883-2927(90)90060-I; Andreani M, 2013, AM MINERAL, V98, P1738, DOI 10.2138/am.2013.4469; [Anonymous], [No title captured]; Aquilina L, 2004, GEOCHIM COSMOCHIM AC, V68, P2405, DOI 10.1016/j.gca.2003.08.023; Bach W, 2003, GEOCHIM COSMOCHIM AC, V67, P3871, DOI 10.1016/S0016-7037(03)00304-1; Ballentine CJ, 2002, REV MINERAL GEOCHEM, V47, P481, DOI 10.2138/rmg.2002.47.12; BETHKE CM, 1985, J GEOPHYS RES-SOLID, V90, P6817, DOI 10.1029/JB090iB08p06817; BICKLE MJ, 1986, EARTH PLANET SC LETT, V80, P314, DOI 10.1016/0012-821X(86)90113-5; Bucher K, 2010, GEOFLUIDS, V10, P241, DOI 10.1111/j.1468-8123.2010.00279.x; Canfield DE, 2006, PHILOS T R SOC B, V361, P1819, DOI 10.1098/rstb.2006.1906; Cannat M, 2010, GEOPHYS MONOGR SER, V188, P241, DOI 10.1029/2008GM000760; Charlou JL, 2002, CHEM GEOL, V191, P345, DOI 10.1016/S0009-2541(02)00134-1; Chorlton L. B., 2007, OPEN FILE 5529; Condie K.C, 1994, ARCHEAN CRUSTAL EVOL, V11, P85, DOI DOI 10.1016/S0166-2635(08)70221-4; CONDIE KC, 1993, CHEM GEOL, V104, P1, DOI 10.1016/0009-2541(93)90140-E; COVENEY RM, 1987, AAPG BULL, V71, P39; D'Hondt S, 2009, P NATL ACAD SCI USA, V106, P11651, DOI 10.1073/pnas.0811793106; Etiope G, 2013, REV GEOPHYS, V51, P276, DOI 10.1002/rog.20011; Flowers RM, 2006, GEOLOGY, V34, P925, DOI 10.1130/G22670A.1; Fritz P., 1992, WATER ROCK INTERACTI, V1, P793; Goodwin A., 1996, PRINCIPLES PRECAMBRI; Helgeson HC, 1979, GEOCHEMISTRY HYDROTH, P568; Holland G, 2013, NATURE, V497, P357, DOI 10.1038/nature12127; JAHNE B, 1987, J GEOPHYS RES-OCEANS, V92, P10767, DOI 10.1029/JC092iC10p10767; Kasting J. F., 2012, FUNDAMENTALS GEOBIOL, P93, DOI [10.1002/9781118280874.ch7, DOI 10.1002/9781118280874.CH7]; Kelemen PB, 2012, EARTH PLANET SC LETT, V345, P81, DOI 10.1016/j.epsl.2012.06.018; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Lang SQ, 2012, GEOCHIM COSMOCHIM AC, V92, P82, DOI 10.1016/j.gca.2012.06.006; Lin LH, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000907; Lin LH, 2005, GEOCHIM COSMOCHIM AC, V69, P893, DOI 10.1016/j.gca.2004.07.032; Lin LH, 2006, SCIENCE, V314, P479, DOI 10.1126/science.1127376; Lippmann J, 2003, GEOCHIM COSMOCHIM AC, V67, P4597, DOI 10.1016/S0016-7037(03)00414-9; Lippmann-Pipke J, 2011, CHEM GEOL, V283, P287, DOI 10.1016/j.chemgeo.2011.01.028; Lollar BS, 2007, ASTROBIOLOGY, V7, P971, DOI 10.1089/ast.2006.0096; Lollar BS, 2006, CHEM GEOL, V226, P328, DOI 10.1016/j.chemgeo.2005.09.027; LOLLAR BS, 1993, GEOCHIM COSMOCHIM AC, V57, P5073; LOLLAR BS, 1993, GEOCHIM COSMOCHIM AC, V57, P5087; Lowenstern JB, 2014, NATURE, V506, P355, DOI 10.1038/nature12992; Mayhew LE, 2013, NAT GEOSCI, V6, P478, DOI [10.1038/ngeo1825, 10.1038/NGEO1825]; McCollom TM, 2009, GEOCHIM COSMOCHIM AC, V73, P856, DOI 10.1016/j.gca.2008.10.032; Morrill PL, 2013, GEOCHIM COSMOCHIM AC, V109, P222, DOI 10.1016/j.gca.2013.01.043; NEAL C, 1983, EARTH PLANET SC LETT, V66, P315, DOI 10.1016/0012-821X(83)90144-9; Neubeck A, 2011, GEOCHEM T, V12, DOI 10.1186/1467-4866-12-6; Newell D. K., 2007, NAT RESOUR RES, V16, P277; NORDSTROM DK, 1989, GEOCHIM COSMOCHIM AC, V53, P1741, DOI 10.1016/0016-7037(89)90295-0; Onstott TC, 2006, ASTROBIOLOGY, V6, P377, DOI 10.1089/ast.2006.6.377; Pedersen K., 2000, TR0004 SWED NUCL FUE; Potter J, 2004, LITHOS, V75, P311, DOI 10.1016/j.lithos.2004.03.003; Proskurowski G, 2008, SCIENCE, V319, P604, DOI 10.1126/science.1151194; RUDNICK RL, 1995, REV GEOPHYS, V33, P267, DOI 10.1029/95RG01302; Salters VJM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000597; Savary V, 1997, GEOCHIM COSMOCHIM AC, V61, P4479, DOI 10.1016/S0016-7037(97)00261-5; Schrenk MO, 2013, REV MINERAL GEOCHEM, V75, P575, DOI 10.2138/rmg.2013.75.18; Silver BJ, 2012, CHEM GEOL, V294, P51, DOI 10.1016/j.chemgeo.2011.11.017; Sleep NH, 2004, P NATL ACAD SCI USA, V101, P12818, DOI 10.1073/pnas.0405289101; Sleep NH, 2007, GEOBIOLOGY, V5, P101, DOI 10.1111/j.1472-4669.2007.00105.x; Stevens TO, 2000, ENVIRON SCI TECHNOL, V34, P826, DOI 10.1021/es990583g; Stober I, 2007, HYDROGEOL J, V15, P213, DOI 10.1007/s10040-006-0094-4; Stober I, 1997, AQUAT GEOCHEM, V3, P43, DOI 10.1023/A:1009623432059; Vovk I. F., 1987, 33 GEOL ASS CAN SPEC, V33, P197; Wankel SD, 2011, NAT GEOSCI, V4, P461, DOI [10.1038/ngeo1183, 10.1038/NGEO1183]; Ward JA, 2004, GEOCHIM COSMOCHIM AC, V68, P3239, DOI 10.1016/j.gca.2004.02.020	62	132	136	4	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					379	+		10.1038/nature14017	http://dx.doi.org/10.1038/nature14017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25519136				2022-12-28	WOS:000346484800043
J	Selimkhanov, J; Taylor, B; Yao, J; Pilko, A; Albeck, J; Hoffmann, A; Tsimring, L; Wollman, R				Selimkhanov, Jangir; Taylor, Brooks; Yao, Jason; Pilko, Anna; Albeck, John; Hoffmann, Alexander; Tsimring, Lev; Wollman, Roy			Accurate information transmission through dynamic biochemical signaling networks	SCIENCE			English	Article							NEGATIVE FEEDBACK; TRANSCRIPTION; ROBUSTNESS	Stochasticity inherent to biochemical reactions (intrinsic noise) and variability in cellular states (extrinsic noise) degrade information transmitted through signaling networks. We analyzed the ability of temporal signal modulation-that is, dynamics-to reduce noise-induced information loss. In the extracellular signal-regulated kinase (ERK), calcium (Ca2+), and nuclear factor kappa-B (NF-kappa B) pathways, response dynamics resulted in significantly greater information transmission capacities compared to nondynamic responses. Theoretical analysis demonstrated that signaling dynamics has a key role in overcoming extrinsic noise. Experimental measurements of information transmission in the ERK network under varying signal-to-noise levels confirmed our predictions and showed that signaling dynamics mitigate, and can potentially eliminate, extrinsic noise-induced information loss. By curbing the information-degrading effects of cell-to-cell variability, dynamic responses substantially increase the accuracy of biochemical signaling networks.	[Selimkhanov, Jangir; Taylor, Brooks] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Yao, Jason; Pilko, Anna; Wollman, Roy] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Albeck, John] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Hoffmann, Alexander; Tsimring, Lev; Wollman, Roy] San Diego Ctr Syst Biol, La Jolla, CA 92093 USA; [Hoffmann, Alexander] Univ Calif Los Angeles, Inst Quantitat & Computat Biosci, Los Angeles, CA 90025 USA; [Hoffmann, Alexander] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90025 USA; [Tsimring, Lev] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Wollman, Roy] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego; University of California System; University of California San Diego	Wollman, R (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	rwollman@ucsd.edu		Tsimring, Lev/0000-0003-0709-3548; Pilko, Anna/0000-0003-2353-6310	NIH [P50-GM085764, R01-GM089976, R01-GM071573]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, R01GM071573, R01GM089976] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to T. Kemp (Univ. of California-San Diego) for discussion of the random Gram matrix theory. Supported by the NIH grants P50-GM085764 (R.W., A.H., L.T.), R01-GM089976 (L.T), and R01-GM071573 (A.H).	Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Behar M, 2013, BIOPHYS J, V105, P231, DOI 10.1016/j.bpj.2013.05.013; Brennan MD, 2012, SCIENCE, V338, P334, DOI 10.1126/science.1227946; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Cover T.M., 2006, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; de Ronde WH, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021913; de Ronde WH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.031914; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Lee REC, 2014, MOL CELL, V53, P867, DOI 10.1016/j.molcel.2014.01.026; Mehta P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.79; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Rhee A, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/045011; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schreiber T, 1999, PHYS REP, V308, P2, DOI 10.1016/S0370-1573(98)00035-0; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Tostevin F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218101; Uda S, 2013, SCIENCE, V341, P558, DOI 10.1126/science.1234511; Voliotis M, 2014, P NATL ACAD SCI USA, V111, pE326, DOI 10.1073/pnas.1314446111; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Walczak AM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041905; Waltermann C, 2011, BBA-GEN SUBJECTS, V1810, P924, DOI 10.1016/j.bbagen.2011.07.009; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	26	208	209	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1370	1373		10.1126/science.1254933	http://dx.doi.org/10.1126/science.1254933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504722	Green Accepted, Green Published			2022-12-28	WOS:000346189600052
J	Spielmann, C				Spielmann, Christian			Electrons take the fast track through silicon	SCIENCE			English	Editorial Material									[Spielmann, Christian] Univ Jena, Inst Opt & Quantum Elect, Abbe Ctr Photon, D-07743 Jena, Germany; [Spielmann, Christian] Helmholtz Inst Jena, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Spielmann, C (corresponding author), Univ Jena, Inst Opt & Quantum Elect, Abbe Ctr Photon, Max Wien Pl 1, D-07743 Jena, Germany.	christian.spielmann@uni-jena.de	Spielmann, Christian/G-9476-2013	Spielmann, Christian/0000-0002-5223-4170				Einstein A, 1905, ANN PHYS-BERLIN, V17, P132; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Johnson SL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.157403; KELDYSH LV, 1965, SOV PHYS JETP-USSR, V20, P1307; Koningsberger D.C., 1988, XRAY ABSORPTION PRIN; Schiffrin A, 2013, NATURE, V493, P70, DOI 10.1038/nature11567; Schultze M, 2014, SCIENCE, V346, P1348, DOI 10.1126/science.1260311; Seres E, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789732; Shah J., 2013, ULTRAFAST SPECTROSCO; Uiberacker M, 2007, NATURE, V446, P627, DOI 10.1038/nature05648	10	3	3	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1293	1294		10.1126/science.aaa1211	http://dx.doi.org/10.1126/science.aaa1211			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW3MA	25504703				2022-12-28	WOS:000346189600023
J	Diamond, L; Grbic, D; Genoff, M; Gonzalez, J; Sharaf, R; Mikesell, C; Gany, F				Diamond, Lisa; Grbic, Douglas; Genoff, Margaux; Gonzalez, Javier; Sharaf, Ravi; Mikesell, Collins; Gany, Francesca			Non-English-Language Proficiency of Applicants to US Residency Programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Diamond, Lisa; Genoff, Margaux; Gonzalez, Javier; Gany, Francesca] Mem Sloan Kettering Canc Ctr, Immigrant Hlth & Canc Dispar Serv, New York, NY 10065 USA; [Grbic, Douglas; Mikesell, Collins] Assoc Amer Med Coll, Washington, DC USA; [Sharaf, Ravi] Northshore Long Isl Jewish Hlth Syst, New Hyde Pk, NY USA	Memorial Sloan Kettering Cancer Center; Association of American Medical Colleges; Northwell Health	Diamond, L (corresponding author), Mem Sloan Kettering Canc Ctr, Immigrant Hlth & Canc Dispar Serv, 300 E 66th St, New York, NY 10065 USA.	diamondl@mskcc.org		Diamond, Lisa/0000-0002-2175-6224	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Diamond L, 2014, MED CARE, V52, P435, DOI 10.1097/MLR.0000000000000102; Diamond LC, 2012, HEALTH SERV RES, V47, P556, DOI 10.1111/j.1475-6773.2011.01338.x; Jacobs EA, 2010, PATIENT EDUC COUNS, V78, P149, DOI 10.1016/j.pec.2009.12.001; PRINCE D, 1995, ACAD EMERG MED, V2, P32, DOI 10.1111/j.1553-2712.1995.tb03076.x; US Census Bureau, AM COMM SURV LANG SP; US Department of Health and Human Services, LTD ENGL PROF LEP LE	6	13	13	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2405	2407		10.1001/jama.2014.15444	http://dx.doi.org/10.1001/jama.2014.15444			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YB	25490332	Green Accepted			2022-12-28	WOS:000346345700016
J	Hartle, A; Gibb, S; Goddard, A				Hartle, Andrew; Gibb, Sarah; Goddard, Andrew			Can doctors be trained in a 48 hour working week?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hartle, Andrew] Assoc Anaesthetists Great Britain & Ireland, London W1B 1PY, England; [Gibb, Sarah] Assoc Anaesthetists Great Britain & Ireland, Grp Anaesthetists Training, London W1B 1PY, England; [Goddard, Andrew] Royal Coll Physicians, London NW1 4LE, England	Royal College of Physicians	Hartle, A (corresponding author), Assoc Anaesthetists Great Britain & Ireland, London W1B 1PY, England.	president@aagbi.org; andrew.goddard@rcplondon.ac.uk						Academy of Medical Royal Colleges, 2012, BEN CONS DEL CAR; [Anonymous], 2013, JOINT ROYAL COLL PHY; BMA, 2013, RESP WORK TIM DIR TA; Cooper CMS, 2012, ANAESTHESIA, V67, P937, DOI 10.1111/j.1365-2044.2012.07262.x; General Medical Council, 2014, NAT TRAIN SURV 2014; Goddard A., CENSUS CONSULTANT PH; Goddard AF, 2010, CLIN MED, V10, P317, DOI 10.7861/clinmedicine.10-4-317; Greenaway D, SECURING FUTURE EXCE; Independent Working Time Regulations Taskforce, 2014, IMPL WORK TIM DIR IT; McIndoe AK, 2012, BRIT J ANAESTH, V109, P16, DOI 10.1093/bja/aes174; Morrow G, 2012, IMPACT WORKING TIME; NHS, 2014, SEC FUT GP WORKF DEL; Paul RG, 2012, ANAESTHESIA, V67, P951, DOI 10.1111/j.1365-2044.2012.07227.x; Rimmer A., 2014, GMC SEES SHARP RISE; Rosta J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005704; Royal College of Anaesthetists, 2013, IMPL WORK TIM DIR IT; Royal College of Paediatrics and Child Health, 2013, RESP WORK TIM TASKF; Royal College of Physicians, SURV MED CCT HOLD CA; Royal College of Physicians, 2013, MED REG EMP UNS HER; Royal College of Surgeons of Edinburgh, 2014, RCSED DEN SUGG WORK; Royal College of Surgeons of England, 2014, TASKF REP IMP EUR WO; Saito Y, 2010, GASTROINTEST ENDOSC, V72, P1217, DOI 10.1016/j.gie.2010.08.004; Temple J., 2010, TIME TRAINING REV IM; Ward ST, 2014, GUT, V63, P1746, DOI 10.1136/gutjnl-2013-305973	24	4	4	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2014	349								g7323	10.1136/bmj.g7323	http://dx.doi.org/10.1136/bmj.g7323			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3DF	25498122				2022-12-28	WOS:000346165000006
J	Sedgwick, P				Sedgwick, Philip			Randomised controlled trials: subgroup analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PITFALLS		Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Pinkney TD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4305; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6820; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5310; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4287; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1041; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5584	6	6	6	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 5	2014	349								g7513	10.1136/bmj.g7513	http://dx.doi.org/10.1136/bmj.g7513			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KT	25500585				2022-12-28	WOS:000346117200016
J	Heijl, A				Heijl, Anders			Glaucoma treatment: by the highest level of evidence	LANCET			English	Editorial Material							TERM CLINICAL-TRIAL; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; OCULAR HYPERTENSION; TIMOLOL THERAPY; PROGRESSION; SUSPECTS; REDUCTION		Lund Univ, Skane Univ Hosp, Dept Ophthalmol, SE-20502 Malmo, Sweden	Lund University; Skane University Hospital	Heijl, A (corresponding author), Lund Univ, Skane Univ Hosp, Dept Ophthalmol, SE-20502 Malmo, Sweden.	anders.heijl@med.lu.se	Heijl, Anders/AAV-3077-2021					Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Chauhan BC, 2008, ARCH OPHTHALMOL-CHIC, V126, P1030, DOI 10.1001/archopht.126.8.1030; EPSTEIN DL, 1989, OPHTHALMOLOGY, V96, P1460; Garway-Heath DF, 2014, LANCET; Heijl A, 2000, GRAEF ARCH CLIN EXP, V238, P877, DOI 10.1007/s004170000189; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; HOLLOWS FC, 1966, BRIT J OPHTHALMOL, V50, P570, DOI 10.1136/bjo.50.10.570; KASS MA, 1989, ARCH OPHTHALMOL-CHIC, V107, P1590, DOI 10.1001/archopht.1989.01070020668025; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; LEYDHECKER W, 1958, Klin Monbl Augenheilkd Augenarztl Fortbild, V133, P662; LUNDBERG L, 1987, ACTA OPHTHALMOL, V65, P705; SCHULZER M, 1991, OPHTHALMOLOGY, V98, P301	13	23	23	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1264	1266		10.1016/S0140-6736(14)62347-3	http://dx.doi.org/10.1016/S0140-6736(14)62347-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25533655	Green Submitted, hybrid			2022-12-28	WOS:000352272400011
J	Perez, F				Perez, Franck			Organelles under light control	NATURE			English	Editorial Material							CELLS; RAB11		Inst Curie, CNRS, UMR 144, F-75248 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Perez, F (corresponding author), Inst Curie, CNRS, UMR 144, F-75248 Paris 05, France.	franck.perez@curie.fr	Perez, Franck/A-1558-2014	Perez, Franck/0000-0002-9129-9401				Bhuin T, 2009, CELL TISSUE RES, V335, P349, DOI 10.1007/s00441-008-0711-8; Bornens M, 2008, NAT REV MOL CELL BIO, V9, P874, DOI 10.1038/nrm2524; de Forges H, 2012, INT J BIOCHEM CELL B, V44, P266, DOI 10.1016/j.biocel.2011.11.009; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Gautier A, 2014, NAT CHEM BIOL, V10, P533, DOI [10.1038/nchembio.1534, 10.1038/NCHEMBIO.1534]; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; van Bergeijk P, 2015, NATURE, V518, P111, DOI 10.1038/nature14128	10	2	2	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					41	42		10.1038/nature14086	http://dx.doi.org/10.1038/nature14086			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25561179				2022-12-28	WOS:000349098000024
J	Dumesic, PA; Homer, CM; Moresco, JJ; Pack, LR; Shanle, EK; Coyle, SM; Strahl, BD; Fujimori, DG; Yates, JR; Madhani, HD				Dumesic, Phillip A.; Homer, Christina M.; Moresco, James J.; Pack, Lindsey R.; Shanle, Erin K.; Coyle, Scott M.; Strahl, Brian D.; Fujimori, Danica G.; Yates, John R., III; Madhani, Hiten D.			Product Binding Enforces the Genomic Specificity of a Yeast Polycomb Repressive Complex	CELL			English	Article							STEM-CELLS; CRYPTOCOCCUS-NEOFORMANS; PRC2 RECRUITMENT; GENE REPRESSION; HISTONE MARKS; HETEROCHROMATIN; METHYLTRANSFERASES; DEACETYLATION; CHROMODOMAIN; MAINTENANCE	We characterize the Polycomb system that assembles repressive subtelomeric domains of H3K27 methylation (H3K27me) in the yeast Cryptococcus neoformans. Purification of this PRC2-like protein complex reveals orthologs of animal PRC2 components as well as a chromodomain-containing subunit, Ccc1, which recognizes H3K27me. Whereas removal of either the EZH or EED ortholog eliminates H3K27me, disruption of mark recognition by Ccc1 causes H3K27me to redistribute. Strikingly, the resulting pattern of H3K27me coincides with domains of heterochromatin marked by H3K9me. Indeed, additional removal of the C. neoformans H3K9 methyltransferase Clr4 results in loss of both H3K9me and the redistributed H3K27me marks. These findings indicate that the anchoring of a chromatin-modifying complex to its product suppresses its attraction to a different chromatin type, explaining how enzymes that act on histones, which often harbor product recognition modules, may deposit distinct chromatin domains despite sharing a highly abundant and largely identical substrate-the nucleosome.	[Dumesic, Phillip A.; Homer, Christina M.; Coyle, Scott M.; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Moresco, James J.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Pack, Lindsey R.; Fujimori, Danica G.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Shanle, Erin K.; Strahl, Brian D.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of California System; University of California San Francisco; Scripps Research Institute; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	hitenmadhani@gmail.com	Strahl, Brian/C-7601-2012; Peptide Synthesis and Array Facility, High-Throughput/AFI-7866-2022	Strahl, Brian/0000-0002-4947-6259; Madhani, Hiten/0000-0001-7400-6657; Moresco, James/0000-0003-1178-1642	National Center for Research Resources [5P41RR011823-17]; National Institute of General Medical Sciences [8 P41 GM103533-17]; National Institute on Aging [R01AG027463-04]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096869, R01AI099206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000678, R01GM071801, P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027463] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Madhani lab for helpful discussions, N. Nguyen for media preparation, Krzysztof Krajewski and the University of North Carolina High-Throughput Peptide Synthesis and Arraying Facility for histone peptide production, and Geeta Narlikar for critical reading of the manuscript. Mass spectrometry experiments were supported by the National Center for Research Resources (5P41RR011823-17), the National Institute of General Medical Sciences (8 P41 GM103533-17), and the National Institute on Aging (R01AG027463-04).	Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; Cao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4127; Chalker D. L., 2013, COLD SPRING HARB PER, V5; Chow EWL, 2012, MOL BIOL EVOL, V29, P1987, DOI 10.1093/molbev/mss066; Chun CD, 2010, METHOD ENZYMOL, V470, P797, DOI 10.1016/S0076-6879(10)70033-1; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Connolly LR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003916; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Derkacheva M, 2013, EMBO J, V32, P2073, DOI 10.1038/emboj.2013.145; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; Eissenberg JC, 2012, GENE, V496, P69, DOI 10.1016/j.gene.2012.01.003; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Hihara S, 2012, CELL REP, V2, P1645, DOI 10.1016/j.celrep.2012.11.008; Jamieson K, 2013, P NATL ACAD SCI USA, V110, P6027, DOI 10.1073/pnas.1303750110; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Klein BJ, 2014, CELL REP, V6, P325, DOI 10.1016/j.celrep.2013.12.021; Klose RJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003717; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Mozzetta C, 2014, MOL CELL, V53, P277, DOI 10.1016/j.molcel.2013.12.005; O'Meara MM, 2012, CHROMOSOMA, V121, P221, DOI 10.1007/s00412-012-0361-1; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Popovic R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004566; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Shaver S, 2010, EPIGENETICS-US, V5, P301, DOI 10.4161/epi.5.4.11608; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Song J, 2012, J CELL SCI, V125, P3723, DOI 10.1242/jcs.084764; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Suganuma T, 2008, GENE DEV, V22, P1265, DOI 10.1101/gad.1676208; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zheng Y, 2013, STEM CELLS DEV, V22, P256, DOI 10.1089/scd.2012.0172; Zhu B, 2011, CELL RES, V21, P435, DOI 10.1038/cr.2011.26	54	91	92	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					204	218		10.1016/j.cell.2014.11.039	http://dx.doi.org/10.1016/j.cell.2014.11.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25533783	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000347923200019
J	Liao, WC; Tu, YK; Wu, MS; Lin, JT; Wang, HP; Chien, KL				Liao, Wei-Chih; Tu, Yu-Kang; Wu, Ming-Shiang; Lin, Jaw-Town; Wang, Hsiu-Po; Chien, Kuo-Liong			Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPAIRED FASTING GLUCOSE; INSULIN-RESISTANCE; METABOLIC FACTORS; TREND ESTIMATION; PLASMA-GLUCOSE; PREVALENCE; MORTALITY; MEN	Objective To evaluate potential linear and non-linear dose-response relations between blood glucose and risk of pancreatic cancer. Design Systematic review and dose-response meta-analysis of prospective observational studies. Data sources Search of PubMed, Scopus, and related reviews before 30 November 2013 without language restriction. Eligibility criteria Prospective studies evaluating the association between blood glucose concentration and pancreatic cancer. Retrospective and cross sectional studies excluded to avoid reverse causality. Data extraction and synthesis Two reviewers independently extracted relevant information and assessed study quality with the Newcastle-Ottawa scale. Random effects dose-response meta-analysis was conducted to assess potential linear and non-linear dose-response relations. Results Nine studies were included for analysis, with a total of 2408 patients with pancreatic cancer. There was a strong linear dose-response association between fasting blood glucose concentration and the rate of pancreatic cancer across the range of prediabetes and diabetes. No non-linear association was detected. The pooled rate ratio of pancreatic cancer per 0.56 mmol/L (10 mg/dL) increase in fasting blood glucose was 1.14 (95% confidence interval 1.06 to 1.22; P<0.001) without significant heterogeneity. Sensitivity analysis excluding blood glucose categories in the range of diabetes showed similar results (pooled rate ratio per 0.56 mmol/L increase in fasting blood glucose was 1.15, 95% confidence interval 1.05 to 1.27; P=0.003), strengthening the association between prediabetes and pancreatic cancer. Conclusions Every 0.56 mmol/L increase in fasting blood glucose is associated with a 14% increase in the rate of pancreatic cancer. As prediabetes can be improved or even reversed through lifestyle changes, early detection of prediabetes coupled with lifestyle changes could represent a viable strategy to curb the increasing incidence of pancreatic cancer.	[Liao, Wei-Chih; Wu, Ming-Shiang; Wang, Hsiu-Po; Chien, Kuo-Liong] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Liao, Wei-Chih; Tu, Yu-Kang; Chien, Kuo-Liong] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 100, Taiwan; [Lin, Jaw-Town] Fu Jen Catholic Univ, Sch Med, New Taipei City 242, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Fu Jen Catholic University	Tu, YK (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, 17 Hsu Chow Rd, Taipei 100, Taiwan.	yukangtu@ntu.edu.tw; klchien@ntu.edu.tw		LIAO, WEI-CHIH/0000-0001-5362-6953; Wu, Ming-Shiang/0000-0002-1940-6428; CHIEN, KUO-LIONG/0000-0003-4979-8351; Tu, Yu-Kang/0000-0002-2461-474X	National Science Council in Taiwan [NSC 101-2314-B-002-197-MY2, NSC 101-2325-B-002-027]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported partly by grants from the National Science Council in Taiwan (grants NSC 101-2314-B-002-197-MY2 and NSC 101-2325-B-002-027). The sponsors had no role in the study design; collection, analysis, and interpretation of data; writing of the report; and decision to submit the article for publication.	Aggarwal G, 2012, PANCREAS, V20, P20; Andersen DK, 2013, CURR OPIN ENDOCRINOL, V20, P81, DOI 10.1097/MED.0b013e32835eddd3; Ansary-Moghaddam A, 2006, CANCER EPIDEM BIOMAR, V15, P2435, DOI 10.1158/1055-9965.EPI-06-0368; BALKAU B, 1993, DIABETES METAB, V19, P458; Batty GD, 2004, CANCER CAUSE CONTROL, V15, P873, DOI 10.1007/s10552-004-1050-z; Butler AE, 2010, DIABETOLOGIA, V53, P21, DOI 10.1007/s00125-009-1556-8; Cancer Research UK, CANC MORT COMM CANC; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chaika NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032996; Cryer PE, 2012, HARRISONS PRINCIPLES; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P450, DOI 10.1097/00001648-199507000-00025; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Grote VA, 2011, DIABETOLOGIA, V54, P3037, DOI 10.1007/s00125-011-2316-0; Han L, 2011, PLOS ONE, V6, P8; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HIATT RA, 1988, INT J CANCER, V41, P794, DOI 10.1002/ijc.2910410603; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Inoue M, 2009, EUR J CANCER PREV, V18, P240, DOI 10.1097/CEJ.0b013e3283240460; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Johansen D, 2010, CANCER EPIDEM BIOMAR, V19, P2307, DOI 10.1158/1055-9965.EPI-10-0234; Kumaravel B, 2012, DIABETES RES CLIN PR, V96, P211, DOI 10.1016/j.diabres.2011.12.004; Li DH, 2012, MOL CARCINOGEN, V51, P64, DOI 10.1002/mc.20771; Li J, 2011, PLOS ONE, V6; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Pannala R, 2008, GASTROENTEROLOGY, V134, P981, DOI 10.1053/j.gastro.2008.01.039; PEARCE N, 1993, INT J EPIDEMIOL, V22, P1189, DOI 10.1093/ije/22.6.1189; Powers AC, 2012, HARRISONS PRINCIPLES; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Regel I, 2012, LANGENBECK ARCH SURG, V397, P507, DOI 10.1007/s00423-012-0933-9; Sah RP, 2013, NAT REV GASTRO HEPAT, V10, P423, DOI 10.1038/nrgastro.2013.49; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Sicree R, 2009, DIABETES ATLAS, P1; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stolzenberg-Solomon RZ, 2005, JAMA-J AM MED ASSOC, V294, P2872, DOI 10.1001/jama.294.22.2872; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; WARBURG O, 1956, SCIENCE, V124, P269; Wells G., NEWCASTLE OTTAWA SCA; White IR, 2009, STATA J, V9, P40, DOI 10.1177/1536867X0900900103; Wolpin BM, 2013, JNCI-J NATL CANCER I, V105, P1027, DOI 10.1093/jnci/djt123	50	93	106	3	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2015	349								g7371	10.1136/bmj.g7371	http://dx.doi.org/10.1136/bmj.g7371			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2ZF	25556126	Green Published, hybrid			2022-12-28	WOS:000365564600001
J	Ankcorn, M; Evans, C; Green, ST				Ankcorn, Michael; Evans, Cariad; Green, Stephen Thomas			Acute painless hepatitis in pregnancy-a cause for concern?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							E VIRUS TRANSMISSION; VIRAL-HEPATITIS; EMERGING INFECTION; MANAGEMENT; FAILURE; ENGLAND; VACCINE; VIREMIA; WOMEN; WALES		[Ankcorn, Michael; Evans, Cariad; Green, Stephen Thomas] Sheffield Teaching Hosp, Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [Ankcorn, Michael; Evans, Cariad] Sheffield Teaching Hosp, No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England	University of Sheffield; Northern General Hospital; University of Sheffield	Ankcorn, M (corresponding author), Sheffield Teaching Hosp, Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England.	mjankcorn@gmail.com						Arankalle VA, 2000, VOX SANG, V79, P72, DOI 10.1046/j.1423-0410.2000.7920072.x; Arends JE, 2014, J CLIN VIROL, V59, P81, DOI 10.1016/j.jcv.2013.11.013; Banks M, 2004, VET REC, V154, P223, DOI 10.1136/vr.154.8.223; Berto A, 2012, EMERG INFECT DIS, V18, P1358, DOI 10.3201/eid1808.111647; CHAUHAN A, 1993, LANCET, V341, P149, DOI 10.1016/0140-6736(93)90008-5; Chibber Rachana M., 2004, Archives of Gynecology and Obstetrics, V270, P15; CLAYSON ET, 1995, J INFECT DIS, V172, P927, DOI 10.1093/infdis/172.4.927; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Ellam H., 2012, HLTH PROT AG C; Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005; FAVOROV MO, 1992, J MED VIROL, V36, P246, DOI 10.1002/jmv.1890360403; Feagins AR, 2007, J GEN VIROL, V88, P912, DOI 10.1099/vir.0.82613-0; Gerolami R, 2011, J CLIN VIROL, V52, P60, DOI 10.1016/j.jcv.2011.06.004; Han YT, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-368; Harvala H, 2014, J CLIN VIROL, V59, P184, DOI 10.1016/j.jcv.2014.01.001; Herremans M, 2007, J VIRAL HEPATITIS, V14, P140, DOI 10.1111/j.1365-2893.2006.00786.x; HIEBER JP, 1977, J PEDIATR-US, V91, P545, DOI 10.1016/S0022-3476(77)80499-X; Ijaz S, 2005, J INFECT DIS, V192, P1166, DOI 10.1086/444396; Ijaz S, 2012, VOX SANG, V102, P272, DOI 10.1111/j.1423-0410.2011.01554.x; Ijaz S, 2014, J INFECT DIS, V209, P1212, DOI 10.1093/infdis/jit652; Jilani N, 2007, J GASTROEN HEPATOL, V22, P676, DOI 10.1111/j.1440-1746.2007.04913.x; Jonas MM, 2009, LIVER INT, V29, P133, DOI 10.1111/j.1478-3231.2008.01933.x; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kamar N, 2010, GASTROENTEROLOGY, V139, P1612, DOI 10.1053/j.gastro.2010.08.002; Kar P, 2008, AM J GASTROENTEROL, V103, P2495, DOI 10.1111/j.1572-0241.2008.02032.x; Khuroo M S, 1992, Indian J Gastroenterol, V11, P113; Khuroo MS, 2009, J VIRAL HEPATITIS, V16, P519, DOI 10.1111/j.1365-2893.2009.01101.x; KHUROO MS, 1981, AM J MED, V70, P252, DOI 10.1016/0002-9343(81)90758-0; Khuroo MS, 2004, J GASTROEN HEPATOL, V19, P778, DOI 10.1111/j.1440-1746.2004.03437.x; Kimberlin DW, 2013, PEDIATRICS, V131, pE635, DOI 10.1542/peds.2012-3216; Kumar A, 2004, INT J GYNECOL OBSTET, V85, P240, DOI 10.1016/j.ijgo.2003.11.018; Labrique AB, 2012, EMERG INFECT DIS, V18, P1401, DOI 10.3201/eid1809.120241; Lee CF, 2006, BMJ-BRIT MED J, V332, P328, DOI 10.1136/bmj.38719.435833.7C; LEVY M, 1991, AM J PERINAT, V8, P227, DOI 10.1055/s-2007-999384; Mandell Anderson D., 2010, PRINCIPLES PRACTIC 3; Matsubayashi K, 2004, TRANSFUSION, V44, P934, DOI 10.1111/j.1537-2995.2004.03300.x; MISHRA L, 1992, GASTROENTEROL CLIN N, V21, P873; Navaneethan U, 2008, LIVER INT, V28, P1190, DOI 10.1111/j.1478-3231.2008.01840.x; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Patra S, 2007, ANN INTERN MED, V147, P28, DOI 10.7326/0003-4819-147-1-200707030-00005; Pischke S, 2013, LIVER INT, V33, P722, DOI 10.1111/liv.12114; Public Health England, 2012, PUBL HLTH OP GUID HE; Singh Sarman, 2003, Indian Journal of Pediatrics, V70, P37, DOI 10.1007/BF02722743; Sookoian Silvia, 2006, Ann Hepatol, V5, P231; Tooyama M, 2013, CLIN J GASTROENTEROL, V6, P173, DOI 10.1007/s12328-013-0370-5; Velosa Mónica, 2013, J Port Gastrenterol., V20, P210, DOI 10.1016/j.jpg.2013.04.005; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	48	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2014	349								g7686	10.1136/bmj.g7686	http://dx.doi.org/10.1136/bmj.g7686			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY4JI	25550169				2022-12-28	WOS:000347543800002
J	Smith, SM; Smucny, J; Fahey, T				Smith, Susan M.; Smucny, John; Fahey, Tom			Antibiotics for Acute Bronchitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								CLINICAL QUESTION Are antibiotics associated with improved outcomes in patients with acute bronchitis? BOTTOM LINE Prescribing antibiotics for acute bronchitis was associated with reduced overall and nighttime cough and with an approximately half-day reduction in duration of cough, in days feeling ill, and in days with impaired activities. However, at follow-up, there were no significant differences in patients receiving antibiotics compared with those receiving placebo in overall clinical improvements or limitations in work or other activities. There was a significant increase in adverse effects in the antibiotic group, particularly gastrointestinal symptoms.	[Smith, Susan M.; Fahey, Tom] Royal Coll Surgeons Ireland, Sch Med, Dept Gen Practice, HRB Ctr Primary Care Res, Dublin 2, Ireland; [Smucny, John] Palo Alto Med Fdn, Dublin Ctr, Dublin, CA USA	Health Research Board - Ireland; Royal College of Surgeons - Ireland; Palo Alto Medical Foundation Research Institute	Smith, SM (corresponding author), Royal Coll Surgeons Ireland, Sch Med, Dept Gen Practice, HRB Ctr Primary Care Res, 123 St Stephens Green, Dublin 2, Ireland.	susansmith@rcsi.ie	Fahey, Tom/C-9367-2012	Fahey, Tom/0000-0002-5896-5783; Smith, Susan/0000-0001-6027-2727				Barnett ML, 2014, JAMA-J AM MED ASSOC, V311, P2020, DOI 10.1001/jama.2013.286141; European Centre for Disease Control, TREND OF ANTIMICROBI; Little P, 2013, LANCET INFECT DIS, V13, P123, DOI 10.1016/S1473-3099(12)70300-6; Moore M, 2008, BRIT J GEN PRACT, V58, P88, DOI 10.3399/bjgp08X264045; National Institute for Health and Care Excellence, COUGH CLINICAL KNOWL; Smith SM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000245.pub3; Snow V, 2001, ANN INTERN MED, V134, P518, DOI 10.7326/0003-4819-134-6-200103200-00020	7	16	17	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2014	312	24					2678	2679		10.1001/jama.2014.12839	http://dx.doi.org/10.1001/jama.2014.12839			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX5KW	25536260	Green Published			2022-12-28	WOS:000346966100021
J	Perkins, K				Perkins, Karen			For the love of ferns	SCIENCE			English	Editorial Material								I attended Hampshire College to major in music. While watering plants in the greenhouse to fulfill my community service requirement, I fell in love with a fern. Intending to make thousands of them, I discovered the college laboratory, where I tweezed the furry rhizomes of Davallia fejeensis into agar-filled test tubes, careful to keep my sleeve out of the Bunsen burner flame used to keep things sterile. Between frat parties and piano practice, I made a discovery: Agar prepared for growing bacteria caused the rhizomes to reprogram and become reproductive-like structures. My discovery set me on a path to research. I would stay on that path for about a dozen years.	Palisades Charter High Sch, Los Angeles, CA 90272 USA		Perkins, K (corresponding author), Palisades Charter High Sch, Los Angeles, CA 90272 USA.								0	0	0	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1586	1586		10.1126/science.346.6216.1586	http://dx.doi.org/10.1126/science.346.6216.1586			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525253				2022-12-28	WOS:000346536500071
J	Zhang, YG; Pagani, M; Liu, ZH				Zhang, Yi Ge; Pagani, Mark; Liu, Zhonghui			Response to Comment on "A 12-million-year temperature history of the tropical Pacific Ocean"	SCIENCE			English	Editorial Material							MG/CA	Contrary to our conclusions, Ravelo et al. argue that our TEX86-based sea surface temperature (SST) records do not conflict with the supposition of "permanent El Nino-like" conditions during the early Pliocene. We show that the way Ravelo et al. treat the existing temperature data perpetuates an inaccurate impression of cooler Pacific warm-pool SSTs and low equatorial temperature gradients in the past.	[Zhang, Yi Ge; Pagani, Mark] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [Liu, Zhonghui] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China	Yale University; University of Hong Kong	Zhang, YG (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	yigezhang@fas.harvard.edu	Zhang, Yige/R-6330-2018; Liu, Zhonghui/D-3163-2009	Liu, Zhonghui/0000-0002-2168-8305; Zhang, Yi Ge/0000-0001-7331-1246				Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Honisch B, 2013, GEOCHIM COSMOCHIM AC, V121, P196, DOI 10.1016/j.gca.2013.07.028; Kim JH, 2010, GEOCHIM COSMOCHIM AC, V74, P4639, DOI 10.1016/j.gca.2010.05.027; Kisakurek B, 2008, EARTH PLANET SC LETT, V273, P260, DOI 10.1016/j.epsl.2008.06.026; Kroenke L. W., 1991, PROC OCEAN DRILL INI, V130, P291; Lear CH, 2003, EARTH PLANET SC LETT, V210, P425, DOI [10.1016/S0012-821X(03)00164-X, 10.1016/S0012-821X(03)-00164-X]; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Medina-Elizalde M, 2008, EARTH PLANET SC LETT, V269, P584, DOI 10.1016/j.epsl.2008.03.014; O'Brien CL, 2014, NAT GEOSCI, V7, P607, DOI 10.1038/NGEO2194; Ravelo AC, 2014, SCIENCE, V346, DOI 10.1126/science.1257618; Russell AD, 2004, GEOCHIM COSMOCHIM AC, V68, P4347, DOI 10.1016/j.gca.2004.03.013; Sosdian S, 2009, SCIENCE, V325, P306, DOI 10.1126/science.1169938; Tierney JE, 2014, GEOCHIM COSMOCHIM AC, V127, P83, DOI 10.1016/j.gca.2013.11.026; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Zhang YG, 2014, SCIENCE, V344, P84, DOI 10.1126/science.1246172	15	16	16	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216								10.1126/science.1257930	http://dx.doi.org/10.1126/science.1257930			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525239				2022-12-28	WOS:000346536500053
J	Cambier, CJ; Falkow, S; Ramakrishnan, L				Cambier, C. J.; Falkow, Stanley; Ramakrishnan, Lalita			Host Evasion and Exploitation Schemes of Mycobacterium tuberculosis	CELL			English	Review							COMPLETE GENOME SEQUENCE; TUMOR-NECROSIS-FACTOR; GRANULOMA-FORMATION; NITRIC-OXIDE; DICTYOSTELIUM-DISCOIDEUM; PATHOGENIC MYCOBACTERIA; INFLAMMATORY RESPONSE; MEDIATES RESISTANCE; MARINUM INFECTION; ZEBRAFISH EMBRYOS	Tuberculosis, an ancient disease of mankind, remains one of the major infectious causes of human death. We examine newly discovered facets of tuberculosis pathogenesis and explore the evolution of its causative organism Mycobacterium tuberculosis from soil dweller to human pathogen. M. tuberculosis has coevolved with the human host to evade and exploit host macrophages and other immune cells in multiple ways. Though the host can often clear infection, the organism can cause transmissible disease in enough individuals to sustain itself. Tuberculosis is a near-perfect paradigm of a host-pathogen relationship, and that may be the challenge to the development of new therapies for its eradication.	[Cambier, C. J.; Ramakrishnan, Lalita] Univ Washington, Seattle, WA 98195 USA; [Falkow, Stanley] Stanford Univ, Stanford, CA 94305 USA; [Ramakrishnan, Lalita] Univ Cambridge, Cambridge CB2 1TN, England	University of Washington; University of Washington Seattle; Stanford University; University of Cambridge	Ramakrishnan, L (corresponding author), Univ Washington, Seattle, WA 98195 USA.	lr404@cam.ac.uk		Ramakrishnan, Lalita/0000-0003-0692-5533	NIH bacterial pathogenesis training grant award; NIH Director's Pioneer Award; Wellcome Trust Principal Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054503] Funding Source: NIH RePORTER	NIH bacterial pathogenesis training grant award; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Principal Research Fellowship(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Kevin Takaki for help with designing and making the figures and Marcel Behr, Pamela Small, and David Tobin for their critique of the paper. C.J.C. was funded by an NIH bacterial pathogenesis training grant award. L.R. is a recipient of the NIH Director's Pioneer Award and a Wellcome Trust Principal Research Fellowship.	ADAMS DO, 1976, AM J PATHOL, V84, P164; Adams KN, 2014, J INFECT DIS, V210, P456, DOI 10.1093/infdis/jiu095; Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Alibaud L, 2011, MOL MICROBIOL, V80, P919, DOI 10.1111/j.1365-2958.2011.07618.x; Alix E, 2011, J CELL BIOL, V195, P943, DOI 10.1083/jcb.201105019; Andersen KG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00113; Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; BATES JH, 1965, NEW ENGL J MED, V272, P714, DOI 10.1056/NEJM196504082721403; Bekker LG, 2010, CLIN INFECT DIS, V50, pS208, DOI 10.1086/651493; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bernut A, 2014, P NATL ACAD SCI USA, V111, pE943, DOI 10.1073/pnas.1321390111; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boritsch EC, 2014, MOL MICROBIOL, V93, P835, DOI 10.1111/mmi.12720; Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591; Bouley DM, 2001, INFECT IMMUN, V69, P7820, DOI 10.1128/IAI.69.12.7820-7831.2001; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Choi HH, 2010, FEBS LETT, V584, P2445, DOI 10.1016/j.febslet.2010.04.050; Cirillo JD, 1997, INFECT IMMUN, V65, P3759, DOI 10.1128/IAI.65.9.3759-3767.1997; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Connolly LE, 2007, PLOS MED, V4, P435, DOI 10.1371/journal.pmed.0040120; Converse SE, 2005, J BACTERIOL, V187, P1238, DOI 10.1128/JB.187.4.1238-1245.2005; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; Cosma CL, 2008, J INFECT DIS, V198, P1851, DOI 10.1086/593175; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; De Leon J, 2012, J BIOL CHEM, V287, P44184, DOI 10.1074/jbc.M112.420869; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Dhama Kuldeep, 2011, Vet Med Int, V2011, P712369, DOI 10.4061/2011/712369; DUMAREY CH, 1994, J LEUKOCYTE BIOL, V56, P36, DOI 10.1002/jlb.56.1.36; Elkington PT, 2007, AM J RESP CELL MOL, V37, P431, DOI 10.1165/rcmb.2007-0011OC; Falkow S, 2006, CELL, V124, P699, DOI 10.1016/j.cell.2006.02.004; Falkow S, 2008, NAT MED, V14, P1053, DOI 10.1038/nm1008-1053; Feldman WH, 1938, AM J PATHOL, V14, P473; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; Gomes MS, 1999, J IMMUNOL, V162, P6734; Gupta S, 2013, AM J RESP CRIT CARE, V188, P600, DOI 10.1164/rccm.201304-0650OC; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Henard CA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00084; Houben ENG, 2009, MOL MICROBIOL, V72, P41, DOI 10.1111/j.1365-2958.2009.06612.x; Houk V N, 1980, Ann N Y Acad Sci, V353, P10, DOI 10.1111/j.1749-6632.1980.tb18901.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Huang CC, 2014, CLIN INFECT DIS, V58, P765, DOI 10.1093/cid/cit948; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Letek M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001145; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Monack DM, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010348; Moran AP, 2007, INT J MED MICROBIOL, V297, P307, DOI 10.1016/j.ijmm.2007.03.008; Onwueme KC, 2005, PROG LIPID RES, V44, P259, DOI 10.1016/j.plipres.2005.07.001; Pagan A. J., 2014, COLD SPRING HARB PER; Parsons LM, 1998, MOL MICROBIOL, V28, P571, DOI 10.1046/j.1365-2958.1998.00818.x; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Ramakrishnan L, 2013, COLD SH Q B, V78, P179, DOI 10.1101/sqb.2013.78.023283; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rittershaus ESC, 2013, CELL HOST MICROBE, V13, P643, DOI 10.1016/j.chom.2013.05.012; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Saunders BM, 2004, CLIN EXP IMMUNOL, V137, P279, DOI 10.1111/j.1365-2249.2004.02518.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Shafiani S, 2013, IMMUNITY, V38, P1261, DOI 10.1016/j.immuni.2013.06.003; SHEPARD CC, 1957, J EXP MED, V105, P39, DOI 10.1084/jem.105.1.39; Siegrist MS, 2014, CELL HOST MICROBE, V15, P1, DOI 10.1016/j.chom.2013.12.005; Solomon JM, 2003, INFECT IMMUN, V71, P3578, DOI 10.1128/IAI.71.6.3578-3586.2003; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Szumowski JD, 2014, CURR TOP MICROBIOL, V374, P81, DOI 10.1007/82_2012_300; Takaki K, 2013, NAT PROTOC, V8, P1114, DOI 10.1038/nprot.2013.068; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Truman RW, 2011, NEW ENGL J MED, V364, P1626, DOI 10.1056/NEJMoa1010536; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wang J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00139; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; WELLS WF, 1948, AM J HYG, V47, P11, DOI 10.1093/oxfordjournals.aje.a119179; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009; Zhang YJJ, 2013, CELL, V155, P1296, DOI 10.1016/j.cell.2013.10.045; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	104	229	237	7	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1497	1509		10.1016/j.cell.2014.11.024	http://dx.doi.org/10.1016/j.cell.2014.11.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525872	Bronze			2022-12-28	WOS:000347922500006
J	Halyo, V				Halyo, Valerie			Martin L. Perl (1927-2014) OBITUARY	NATURE			English	Biographical-Item									Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Halyo, V (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	valerieh@princeton.edu						PERL ML, PUBLICATION LIST, P3509	1	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					330	330		10.1038/516330a	http://dx.doi.org/10.1038/516330a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25519123	Bronze			2022-12-28	WOS:000346484800029
J	Khmelinskii, A; Blaszczak, E; Pantazopoulou, M; Fischer, B; Omnus, DJ; Le Dez, G; Brossard, A; Gunnarsson, A; Barry, JD; Meurer, M; Kirrmaier, D; Boone, C; Huber, W; Rabut, G; Ljungdahl, PO; Knop, M				Khmelinskii, Anton; Blaszczak, Ewa; Pantazopoulou, Marina; Fischer, Bernd; Omnus, Deike J.; Le Dez, Gaelle; Brossard, Audrey; Gunnarsson, Alexander; Barry, Joseph D.; Meurer, Matthias; Kirrmaier, Daniel; Boone, Charles; Huber, Wolfgang; Rabut, Gwenael; Ljungdahl, Per O.; Knop, Michael			Protein quality control at the inner nuclear membrane	NATURE			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; PORE COMPLEX; YEAST GENES; DEGRADATION; DOMAIN; DYNAMICS; LIGASE; CELLS	The nuclear envelope is a double membrane that separates the nucleus from the cytoplasm. The inner nuclear membrane (INM) functions in essential nuclear processes including chromatin organization and regulation of gene expression(1). The outer nuclear membrane is continuous with the endoplasmic reticulum and is the site of membrane protein synthesis. Protein homeostasis in this compartment is ensured by endoplasmic-reticulum-associated protein degradation (ERAD) pathways that in yeast involve the integral membrane E3 ubiquitin ligases Hrd1 and Doa10 operating with the E2 ubiquitin-conjugating enzymes Ubc6 and Ubc7 (refs 2, 3). However, little is known about protein quality control at the INM. Here we describe a protein degradation pathway at the INM in yeast (Saccharomyces cerevisiae) mediated by the Asicomplex consisting of the RING domain proteins Asi1 and Asi3 (ref. 4). We report that the Asi complex functions together with the ubiquitin-conjugating enzymes Ubc6 and Ubc7 to degrade soluble and integral membrane proteins. Genetic evidence suggests that the Asi ubiquitin ligase defines a pathway distinct from, but complementary to, ERAD. Using unbiased screening with a novel genome-wide yeast library based on a tandem fluorescent protein timer(5), we identify more than 50 substrates of the Asi, Hrd1 and Doa10 E3 ubiquitin ligases. We show that the Asi ubiquitin ligase is involved in degradation of mislocalized integral membrane proteins, thus acting to maintain and safeguard the identity of the INM.	[Khmelinskii, Anton; Meurer, Matthias; Kirrmaier, Daniel; Knop, Michael] Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany; [Blaszczak, Ewa; Le Dez, Gaelle; Brossard, Audrey; Rabut, Gwenael] Ctr Natl Rech Sci, UMR 6290, F-35000 Rennes, France; [Blaszczak, Ewa; Le Dez, Gaelle; Brossard, Audrey; Rabut, Gwenael] Univ Rennes 1, Inst Genet & Dev Rennes, F-35000 Rennes, France; [Pantazopoulou, Marina; Omnus, Deike J.; Gunnarsson, Alexander; Ljungdahl, Per O.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden; [Fischer, Bernd; Barry, Joseph D.; Huber, Wolfgang] European Mol Biol Lab EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany; [Fischer, Bernd; Knop, Michael] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Boone, Charles] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Stockholm University; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto	Knop, M (corresponding author), Univ Heidelberg ZMBH, Zentrum Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	gwenael.rabut@inserm.fr; per.ljungdahl@su.se; m.knop@zmbh.uni-heidelberg.de	Ljungdahl, Per O/M-5258-2013; Pantazopoulou, Marina/AAK-9339-2020; Rabut, Gwenaël/E-7257-2011; Khmelinskii, Anton/B-2830-2008; Blaszczak, Ewa/O-5239-2016	Ljungdahl, Per O/0000-0002-6625-3540; Rabut, Gwenaël/0000-0003-2658-2769; Le Dez, Gaelle/0000-0002-9247-9666; Barry, Joseph/0000-0002-1177-5771; Blaszczak, Ewa/0000-0001-8434-1045; Khmelinskii, Anton/0000-0002-0256-5190; pantazopoulou, marina/0000-0001-8262-6274; Huber, Wolfgang/0000-0002-0474-2218	Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 1036 (SFB1036), TP10]; Swedish Research Council [VR2011-5925]; INSERM; ANR [ANR-12-JSV8-0003-001]; Biosit; European Molecular Biology Organization [EMBO ALTF 1124-2010, EMBO ASTF 546-2012]; Ministere de la Recherche et de l'Enseignement Superieur; La Ligue Contre le Cancer; CellNetworks Cluster of Excellence (DFG); EC Network of Excellence Systems Microscopy; Canadian Institute for Advanced Research [GNE-BOON-141871]; National Institutes of Health [R01HG005853-01]; Canadian Institute for Health Research [MOP-102629]; National Science and Engineering Research Council [RGPIN 204899-6]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005853] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); Biosit; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Ministere de la Recherche et de l'Enseignement Superieur; La Ligue Contre le Cancer(Ligue nationale contre le cancer); CellNetworks Cluster of Excellence (DFG)(German Research Foundation (DFG)); EC Network of Excellence Systems Microscopy; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Lemberg, E. Schiebel and B. Bukau for support and discussions, A. Kaufmann, C.-T. Ho, A. Bartosik and B. Besenbeck for help with tFT library construction, K. Ryman for the qRT-PCR analysis of gene expression, M. Hochstrasser for strains, the GeneCore and the media kitchen facilities of the European Molecular Biology Laboratory (EMBL) and Donnelly Centre for support with infrastructure and media. This work was supported by the Sonderforschungsbereich 1036 (SFB1036, TP10) from the Deutsche Forschungsgemeinschaft (DFG) (M. K.), the Swedish Research Council grant VR2011-5925 (P.O.L.), INSERM and grants from ANR (ANR-12-JSV8-0003-001) and Biosit (G.R.), fellowships from the European Molecular Biology Organization (EMBO ALTF 1124-2010 and EMBO ASTF 546-2012) (A. K.) and fellowships from the Ministere de la Recherche et de l'Enseignement Superieur and La Ligue Contre le Cancer (E. B.). M. K. received funds from the CellNetworks Cluster of Excellence (DFG) for support with tFT library construction. W.H. acknowledges funding from the EC Network of Excellence Systems Microscopy. C.B. was supported by funds from the Canadian Institute for Advanced Research (GNE-BOON-141871), National Institutes of Health (R01HG005853-01), Canadian Institute for Health Research (MOP-102629) and the National Science and Engineering Research Council (RGPIN 204899-6).	Andreasson C, 2004, MOL CELL BIOL, V24, P7503, DOI 10.1128/MCB.24.17.7503-7513.2004; Baryshnikova A, 2010, METHOD ENZYMOL, V470, P145, DOI 10.1016/S0076-6879(10)70007-0; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Boban M, 2006, J CELL BIOL, V173, P695, DOI 10.1083/jcb.200601011; Boban M, 2014, J CELL SCI, V127, P3603, DOI 10.1242/jcs.153163; Costanzo M, 2011, CURR OPIN BIOTECH, V22, P66, DOI 10.1016/j.copbio.2010.11.001; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Forsberg H, 2001, GENETICS, V158, P973; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Khmelinskii A, 2014, METHODS MOL BIOL, V1174, P195, DOI 10.1007/978-1-4939-0944-5_13; Khmelinskii A, 2012, NAT BIOTECHNOL, V30, P708, DOI 10.1038/nbt.2281; Khmelinskii A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023794; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kostova Z, 2009, J CELL SCI, V122, P1374, DOI 10.1242/jcs.044255; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Leon S, 2008, MOL BIOL CELL, V19, P2379, DOI 10.1091/mbc.E08-01-0068; Meinema AC, 2012, NUCLEUS-PHILA, V3, P322, DOI 10.4161/nucl.20439; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Metzger MB, 2013, MOL CELL, V50, P516, DOI 10.1016/j.molcel.2013.04.004; Nakamura N, 2011, MEMBRANES-BASEL, V1, P354, DOI 10.3390/membranes1040354; Omnus DJ, 2014, MOL BIOL CELL, V25, P3823, DOI 10.1091/mbc.E14-06-1140; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093; Uttenweiler A, 2007, MOL BIOL CELL, V18, P166, DOI 10.1091/mbc.E06-08-0664; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zargari A, 2007, J BIOL CHEM, V282, P594, DOI 10.1074/jbc.M609201200; Zattas D., 2014, CRIT REV BIOCH MOL B; Zattas D, 2013, MOL BIOL CELL, V24, P890, DOI 10.1091/mbc.E12-11-0838	43	130	132	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					410	+		10.1038/nature14096	http://dx.doi.org/10.1038/nature14096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25519137	Green Accepted			2022-12-28	WOS:000346484800050
J	Rao, SSP; Huntley, MH; Durand, NC; Stamenova, EK; Bochkov, ID; Robinson, JT; Sanborn, AL; Machol, I; Omer, AD; Lander, ES; Aiden, EL				Rao, Suhas S. P.; Huntley, Miriam H.; Durand, Neva C.; Stamenova, Elena K.; Bochkov, Ivan D.; Robinson, James T.; Sanborn, Adrian L.; Machol, Ido; Omer, Arina D.; Lander, Eric S.; Aiden, Erez Lieberman			A 3D Map of the Human Genome at Kilobase Resolution Reveals Principles of Chromatin Looping	CELL			English	Article							LONG-RANGE INTERACTION; BETA-GLOBIN LOCUS; CHROMOSOME CONFORMATION; SUPERCOILED LOOPS; GENE-REGULATION; CTCF; TRANSCRIPTION; ORGANIZATION; ELEMENTS; ARCHITECTURE	We use in situ Hi-C to probe the 3D architecture of genomes, constructing haploid and diploid maps of nine cell types. The densest, in human lymphoblastoid cells, contains 4.9 billion contacts, achieving 1 kb resolution. We find that genomes are partitioned into contact domains (median length, 185 kb), which are associated with distinct patterns of histone marks and segregate into six subcompartments. We identify similar to 10,000 loops. These loops frequently link promoters and enhancers, correlate with gene activation, and show conservation across cell types and species. Loop anchors typically occur at domain boundaries and bind CTCF. CTCF sites at loop anchors occur predominantly (>90%) in a convergent orientation, with the asymmetric motifs "facing'' one another. The inactive X chromosome splits into two massive domains and contains large loops anchored at CTCF-binding repeats.	[Rao, Suhas S. P.; Huntley, Miriam H.; Durand, Neva C.; Stamenova, Elena K.; Bochkov, Ivan D.; Robinson, James T.; Sanborn, Adrian L.; Machol, Ido; Omer, Arina D.; Aiden, Erez Lieberman] Baylor Coll Med, Ctr Genome Architecture, Houston, TX 77030 USA; [Rao, Suhas S. P.; Huntley, Miriam H.; Durand, Neva C.; Stamenova, Elena K.; Bochkov, Ivan D.; Sanborn, Adrian L.; Machol, Ido; Omer, Arina D.; Aiden, Erez Lieberman] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Rao, Suhas S. P.; Huntley, Miriam H.; Durand, Neva C.; Stamenova, Elena K.; Bochkov, Ivan D.; Sanborn, Adrian L.; Machol, Ido; Omer, Arina D.; Aiden, Erez Lieberman] Rice Univ, Dept Computat & Appl Math, Dept Comp Sci, Houston, TX 77005 USA; [Rao, Suhas S. P.; Huntley, Miriam H.; Durand, Neva C.; Stamenova, Elena K.; Robinson, James T.; Lander, Eric S.; Aiden, Erez Lieberman] Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Huntley, Miriam H.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Sanborn, Adrian L.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Aiden, Erez Lieberman] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Rice University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Stanford University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Rice University	Lander, ES (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02139 USA.	lander@broadinstitute.org; erez@erez.com	Aiden, Erez Lieberman/A-2908-2010; Omer, Arina/AAS-7960-2021	Bochkov, Ivan/0000-0001-9973-4220	NSF Graduate Research Fellowship [DGE0946799, DGE1144152]; NIH New Innovator Award [OD008540-01]; NSF Physics Frontier Center (Center for Theoretical Biological Physics) [PHY-1427654]; NHGRI CEGS [HG006193]; NVIDIA; IBM; Google; CPRIT Scholar Award [R1304]; McNair Medical Institute Scholar Award; President's Early Career Award in Science and Engineering; NHGRI grant [HG003067]; Center for Genome Architecture; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL130010] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, P50HG006193] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008540] Funding Source: NIH RePORTER	NSF Graduate Research Fellowship(National Science Foundation (NSF)); NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Physics Frontier Center (Center for Theoretical Biological Physics)(National Science Foundation (NSF)); NHGRI CEGS; NVIDIA; IBM(International Business Machines (IBM)); Google(Google Incorporated); CPRIT Scholar Award; McNair Medical Institute Scholar Award; President's Early Career Award in Science and Engineering; NHGRI grant; Center for Genome Architecture; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This paper is dedicated to the memory of Aharon Lieberman. Our work was supported by an NSF Graduate Research Fellowship (DGE0946799 and DGE1144152) to M.H.H., an NIH New Innovator Award (OD008540-01), an NSF Physics Frontier Center (PHY-1427654, Center for Theoretical Biological Physics), an NHGRI CEGS (HG006193), NVIDIA, IBM, Google, a CPRIT Scholar Award (R1304), a McNair Medical Institute Scholar Award, and the President's Early Career Award in Science and Engineering to E.L.A., and an NHGRI grant (HG003067) to E.S.L. We thank Leslie Gaffney, Lauren Solomon, and Bang Wong for assistance with figures; BCM's Integrated Microscopy Core, Michael Mancini, Justin Demmerle, Wendy Salmon, Fabio Stossi, Radhika Dandekar, Sanjay Krishna, and especially Asha Multani for microscopy assistance; Aharon Lieberman, Aviva Presser Aiden, Nicholas Christakis, James Lupski, Jose Onuchic, Mitchell Guttman, Andreas Gnirke, Louise Williams, Chad Nusbaum, John Bohannon, Olga Dudchenko, and the Aiden laboratory for discussions; and Robbyn Issner and Broad's ENCODE group for several cell lines. The Center for Genome Architecture is grateful to Janice, Robert, and Cary McNair for support. A provisional patent covering in situ Hi-C and related methods has been filed. All sequence data reported in this paper that were not derived from HeLa cells have been deposited at GEO (http://www.ncbi.nlm.nih.gov/geo/) (GSE63525). Some of the genome sequences described in this research were derived from a HeLa cell line. Henrietta Lacks, and the HeLa cell line that was established from her tumor cells without her knowledge or consent in 1951, have made significant contributions to scientific progress and advances in human health. We are grateful to Henrietta Lacks, now deceased, and to her surviving family members for their contributions to biomedical research. The HeLa data generated from this research were submitted to the database of Genotypes and Phenotypes (dbGaP) as a substudy under accession number phs000640.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Chadwick BP, 2008, GENOME RES, V18, P1259, DOI 10.1101/gr.075713.107; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; CULLEN KE, 1993, SCIENCE, V261, P203, DOI 10.1126/science.8327891; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gavrilov AA, 2013, NUCLEIC ACIDS RES, V41, P3563, DOI 10.1093/nar/gkt067; Hahn MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018844; Heidari N., 2014, GENOME RES; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Horakova AH, 2012, HUM MOL GENET, V21, P4367, DOI 10.1093/hmg/dds270; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Knight PA, 2012, IMA J NUMER ANAL; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MUKHERJEE S, 1988, CELL, V52, P375, DOI 10.1016/S0092-8674(88)80030-8; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Sexton T, 2007, NAT STRUCT MOL BIOL, V14, P1049, DOI 10.1038/nsmb1324; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vogel MJ, 2006, GENOME RES, V16, P1493, DOI 10.1101/gr.5391806; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; ZEHNBAUER BA, 1985, BIOESSAYS, V2, P52, DOI 10.1002/bies.950020203	45	3370	3451	27	315	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1665	1680		10.1016/j.cell.2014.11.021	http://dx.doi.org/10.1016/j.cell.2014.11.021			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25497547	Green Accepted, Bronze			2022-12-28	WOS:000347922500019
J	Slow, S; Florkowski, CM; Chambers, ST; Priest, PC; Stewart, AW; Jennings, LC; Livesey, JH; Camargo, CA; Scragg, R; Murdoch, DR				Slow, Sandy; Florkowski, Christopher M.; Chambers, Stephen T.; Priest, Patricia C.; Stewart, Alistair W.; Jennings, Lance C.; Livesey, John H.; Camargo, Carlos A., Jr.; Scragg, Robert; Murdoch, David R.			CHRISTMAS 2014: GOING TO EXTREMES Effect of monthly vitamin D-3 supplementation in healthy adults on adverse effects of earthquakes: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH; DEPRESSION; CHRISTCHURCH; SYMPTOMS; ANXIETY; IMPACT; AREAS	Objective To determine whether supplementation with vitamin D improves resilience to the adverse effects of earthquakes. Design Opportunistic addition to an established randomised double blind placebo controlled trial. Setting Christchurch, New Zealand, where a prolonged series of catastrophic earthquakes beginning on 4 September 2010 occurred, which caused widespread destruction, fatalities, and extensive psychological damage. Participants 322 healthy adults (241 women; 81 men) aged 18-67 who were already participating in the vitamin D and acute respiratory infections study (VIDARIS) between February 2010 and November 2011. Intervention Participants were randomised to receive an oral dose of either 200 000 IU vitamin D-3 monthly for two months then 100 000 IU monthly (n=161) or placebo (n=161) for a total of 18 months. Main outcome measure This is a post hoc analysis from the previously published VIDARIS trial. The primary endpoint in the current analysis was the self reported effects and overall adverse impact of the Christchurch earthquakes as assessed by questionnaire four months after the most destructive earthquake on 22 February 2011, which was used as the index event. The secondary end point was the number of "psychological" adverse events that participants reported at their usual monthly appointments as part of the original VIDARIS trial. Results 308 participants completed the earthquake impact questionnaire (n=152 in the vitamin D group and 156 in the placebo group). There was no significant difference in the number of self reported adverse effects between those receiving vitamin D supplementation and those receiving placebo. There was also no difference in the overall adverse impact score between treatment groups (X-2 P=0.44). The exception was that those in the vitamin D group experienced more adverse effects on family relationships (22% v 13%; X-2 P=0.03). The number of psychological adverse events-such as fatigue, stress, anxiety, and insomnia-that participants reported at their usual monthly appointments was significantly higher after the earthquake (X-2 P=0.007) but did not differ between treatment groups. Conclusion In this trial, vitamin D supplementation did not reduce the adverse impact of earthquakes in healthy adults. Trial registration Australian New Zealand Clinical	[Slow, Sandy; Florkowski, Christopher M.; Chambers, Stephen T.; Jennings, Lance C.; Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Florkowski, Christopher M.; Jennings, Lance C.; Livesey, John H.; Murdoch, David R.] Canterbury Hlth Labs, Christchurch, New Zealand; [Chambers, Stephen T.] Christchurch Hosp, Dept Infect Dis, Christchurch, New Zealand; [Priest, Patricia C.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; [Stewart, Alistair W.; Scragg, Robert] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [Camargo, Carlos A., Jr.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Emergency Med, Boston, MA 02114 USA	University of Otago; Canterbury Health Laboratories; Christchurch Hospital New Zealand; University of Otago; University of Auckland; Harvard University; Harvard Medical School; Massachusetts General Hospital	Slow, S (corresponding author), Univ Otago, Dept Pathol, POB 4345, Christchurch, New Zealand.	sandy.slow@otago.ac.nz	Camargo, Carlos A./C-2145-2008; Florkowski, Christopher/ABF-9504-2020; Murdoch, David/A-2012-2009	Camargo, Carlos A./0000-0002-5071-7654; 	Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	The study was funded by the Health Research Council of New Zealand. The Health Research Council was not involved in the design or conduct of the study, the collection, management, analysis and interpretation of the data, or the preparation, review or approval of the manuscript. All authors were independent from the funders.	Black LJ, 2014, AUST NZ J PSYCHIAT, V48, P464, DOI 10.1177/0004867413512383; Crowe M, 2011, INT J MENT HEALTH NU, V20, P381, DOI 10.1111/j.1447-0349.2011.00772.x; Dean AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025966; DeLuca GC, 2013, NEUROPATH APPL NEURO, V39, P458, DOI 10.1111/nan.12020; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; Fergusson DM, 2014, JAMA PSYCHIAT, V71, P1025, DOI 10.1001/jamapsychiatry.2014.652; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; Glade MJ, 2013, NUTRITION, V29, P37, DOI 10.1016/j.nut.2012.05.010; Hoogendijk WJG, 2008, ARCH GEN PSYCHIAT, V65, P508, DOI 10.1001/archpsyc.65.5.508; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Kalueff AV, 2007, CURR OPIN CLIN NUTR, V10, P12, DOI 10.1097/MCO.0b013e328010ca18; Kjaergaard M, 2012, BRIT J PSYCHIAT, V201, P360, DOI 10.1192/bjp.bp.111.104349; Maddock J, 2013, CLIN NUTR, V32, P758, DOI 10.1016/j.clnu.2013.01.006; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; Milaneschi Y, 2014, MOL PSYCHIATR, V19, P444, DOI 10.1038/mp.2013.36; Murdoch DR, 2012, JAMA-J AM MED ASSOC, V308, P1333, DOI 10.1001/jama.2012.12505; Parker M., 2012, RESERVE BANK NZ BULL, V75, P13; Rucklidge JJ, 2014, HUM PSYCHOPHARM CLIN, V29, P230, DOI 10.1002/hup.2392; Sanders KM, 2011, BRIT J PSYCHIAT, V198, P357, DOI 10.1192/bjp.bp.110.087544; Spittlehouse JK, 2014, AUST NZ J PSYCHIAT, V48, P756, DOI 10.1177/0004867414527522; Suhail K, 2009, PSYCHOL DEV SOC, V21, P183, DOI 10.1177/097133360902100202; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Tovaranonte P, 2013, PREHOSP DISASTER MED, V28, P245, DOI 10.1017/S1049023X1300023X; Wang L, 2010, PSYCHOL REP, V106, P555, DOI 10.2466/PR0.106.2.555-561; Zhang Z, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029651, 10.1371/journal.pone.0046449, 10.1371/journal.pone.0030551]; Zhang Z, 2012, STRESS HEALTH, V28, P61, DOI 10.1002/smi.1403	26	3	3	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2014	349								g7260	10.1136/bmj.g7260	http://dx.doi.org/10.1136/bmj.g7260			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HK	25516139	Green Published, hybrid			2022-12-28	WOS:000346763900006
J	Patil, S; Davies, P				Patil, Sumant; Davies, Patrick			CHRISTMAS 2014: FOUND IN TRANSLATION Use of Google Translate in medical communication: evaluation of accuracy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OVERCOME LANGUAGE BARRIERS		[Patil, Sumant; Davies, Patrick] Nottingham Childrens Hosp, Paediat Intens Care Unit, Nottingham, England		Davies, P (corresponding author), Nottingham Childrens Hosp, Paediat Intens Care Unit, Nottingham, England.	patrick.davies@nuh.nhs.uk	Davies, P/L-7923-2019					Balk EM, 2013, AHRQ METHODS EFFECTI; Borner N, 2013, KLIN PADIATR, V225, P413, DOI 10.1055/s-0033-1349062; Brindley PG, 2014, CAN RESPIR J, V21, P89, DOI 10.1155/2014/780270; General Medical Council, 2013, GOOD MED PRACTICE; Gomes L., 2010, FORBES; Kaliyadan Feroze, 2010, Inform Prim Care, V18, P141; Palluzi J., 2010, RESULTS USING GOOGLE; Rubin Mike, 2013, EMS World, V42, P122; Scullard P, 2010, ARCH DIS CHILD, V95, P580, DOI 10.1136/adc.2009.168856; Wade RG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7217	10	70	71	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2014	349								g7392	10.1136/bmj.g7392	http://dx.doi.org/10.1136/bmj.g7392			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HD	25512386	Green Published, hybrid			2022-12-28	WOS:000346763200003
J	Atkinson, PM				Atkinson, Peter M.			Assess the real cost of research assessment	NATURE			English	Editorial Material									Univ Southampton, Southampton SO9 5NH, Hants, England	University of Southampton	Atkinson, PM (corresponding author), Univ Southampton, Southampton SO9 5NH, Hants, England.	p.m.atkinson@soton.at.uk							0	8	8	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					145	145		10.1038/516145a	http://dx.doi.org/10.1038/516145a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6ML	25503199	Bronze			2022-12-28	WOS:000346383500006
J	Sridhar, S				Sridhar, Saranya			Ebola and Marburg vaccines for Africa: one step closer	LANCET			English	Editorial Material							PROTECTIVE IMMUNITY; MALAWI; BCG; UK		[Sridhar, Saranya] Univ Oxford, Jenner Inst, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LE, England; [Sridhar, Saranya] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	University of Oxford; Jenner Institute; Imperial College London	Sridhar, S (corresponding author), Univ Oxford, Jenner Inst, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LE, England.	saranya.sridhar@ndm.ox.ac.uk		Sridhar, Saranya/0000-0002-4267-3102				Ascenzi P, 2008, MOL ASPECTS MED, V29, P151, DOI 10.1016/j.mam.2007.09.005; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Hur YG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-184; Kanapathipillai R, 2014, NEW ENGL J MED, V371, P2249, DOI 10.1056/NEJMp1412166; Kibuuka H, 2014, LANCET; Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Sarwar UN, 2015, J INFECT DIS, V211, P549, DOI 10.1093/infdis/jiu511; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; World Health Organization, 2014, EB RESP ROADM SIT RE	11	2	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1491	1493		10.1016/S0140-6736(14)62445-4	http://dx.doi.org/10.1016/S0140-6736(14)62445-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG3ZT	25540890				2022-12-28	WOS:000353220000011
J	Casasnovas, O; Coiffier, B				Casasnovas, Olivier; Coiffier, Bertrand			Hodgkin's lymphoma: better outcomes with fewer drugs?	LANCET			English	Editorial Material							TRIAL; ABVD		[Casasnovas, Olivier] CHU Dijon, Hematol Clin, Dijon, France; [Coiffier, Bertrand] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Hematol Clin, F-69310 Pierre Benite, France	CHU Dijon Bourgogne; CHU Lyon	Coiffier, B (corresponding author), Ctr Hosp Lyon Sud, Hosp Civils Lyon, Hematol Clin, F-69310 Pierre Benite, France.	bertrand.coiffier@univ-lyon1.fr		Casasnovas, Rene-Olivier/0000-0002-1156-8983				Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Behringer K, 2015, LANCET, V385, P1418, DOI 10.1016/S0140-6736(14)61469-0; BONADONNA G, 1975, CANCER, V36, P252, DOI 10.1002/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7; Eghbali H, 2005, BLOOD, V106, p240A; Engert A, 2010, NEW ENGL J MED, V363, P640, DOI 10.1056/NEJMoa1000067; Federico M, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8507; Meyer RM, 2012, NEW ENGL J MED, V366, P399, DOI 10.1056/NEJMoa1111961; Radford J, 2012, BLOOD, V120, P547, DOI 10.1182/blood.V120.21.547.547; Raemaekers JMM, 2014, J CLIN ONCOL, V32, P1188, DOI 10.1200/JCO.2013.51.9298; Viviani S, 2011, NEW ENGL J MED, V365, P203, DOI 10.1056/NEJMoa1100340; von Tresckow B, 2012, J CLIN ONCOL, V30, P907, DOI 10.1200/JCO.2011.38.5807	11	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1371	+		10.1016/S0140-6736(14)61701-3	http://dx.doi.org/10.1016/S0140-6736(14)61701-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF7EU	25539731				2022-12-28	WOS:000352719800007
J	Wand, AJ				Wand, A. Joshua			BIOPHYSICS Enzymes surf the heat wave	NATURE			English	Editorial Material							DYNAMICS; DIFFUSION; MOTION; SITE; NMR		Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania	Wand, AJ (corresponding author), Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	wand@upenn.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102447] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM102447] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Englander SW, 2014, P NATL ACAD SCI USA, V111, P15873, DOI 10.1073/pnas.1411798111; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Fu YN, 2012, J AM CHEM SOC, V134, P8543, DOI 10.1021/ja3004655; Golestanian R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.188305; Grossman M, 2011, NAT STRUCT MOL BIOL, V18, P1102, DOI 10.1038/nsmb.2120; Heyden M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.218101; Igumenova TI, 2006, CHEM REV, V106, P1672, DOI 10.1021/cr040422h; Muddana HS, 2010, J AM CHEM SOC, V132, P2110, DOI 10.1021/ja908773a; Nucci NV, 2011, NAT STRUCT MOL BIOL, V18, P245, DOI 10.1038/nsmb.1955; Paxton WF, 2006, ANGEW CHEM INT EDIT, V45, P5420, DOI 10.1002/anie.200600060; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Riedel C, 2015, NATURE, V517, P227, DOI 10.1038/nature14043; Sengupta S, 2013, J AM CHEM SOC, V135, P1406, DOI 10.1021/ja3091615; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; Sharp K, 2006, PROTEINS, V65, P347, DOI 10.1002/prot.21146	16	3	3	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					149	150		10.1038/nature14079	http://dx.doi.org/10.1038/nature14079			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25487158				2022-12-28	WOS:000347477600021
J	Arterburn, DE; Olsen, MK; Smith, VA; Livingston, EH; Van Scoyoc, L; Yancy, WS; Eid, G; Weidenbacher, H; Maciejewski, ML				Arterburn, David E.; Olsen, Maren K.; Smith, Valerie A.; Livingston, Edward H.; Van Scoyoc, Lynn; Yancy, William S., Jr.; Eid, George; Weidenbacher, Hollis; Maciejewski, Matthew L.			Association Between Bariatric Surgery and Long-term Survival	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; GASTRIC BYPASS; TASK-FORCE; OBESITY; MANAGEMENT; ADULTS; OVERWEIGHT; TRENDS; IMPACT	IMPORTANCE Accumulating evidence suggests that bariatric surgery improves survival among patients with severe obesity, but research among veterans has shown no evidence of benefit. OBJECTIVE To examine long-term survival in a large multisite cohort of patients who underwent bariatric surgery compared with matched control patients. DESIGN, SETTING, AND PARTICIPANTS In a retrospective cohort study, we identified 2500 patients (74% men) who underwent bariatric surgery in Veterans Affairs (VA) bariatric centers from 2000-2011 and matched them to 7462 control patients using sequential stratification and an algorithm that included age, sex, geographic region, body mass index, diabetes, and Diagnostic Cost Group. Survival was compared across patients who underwent bariatric surgery and matched controls using Kaplan-Meier estimators and stratified, adjusted Cox regression analyses. EXPOSURES Bariatric procedures, which included 74% gastric bypass, 15% sleeve gastrectomy, 10% adjustable gastric banding, and 1% other. MAIN OUTCOMES AND MEASURES All-cause mortality through December 2013. RESULTS Surgical patients (n = 2500) had a mean age of 52 years and a mean BMI of 47. Matched control patients (n = 7462) had a mean age of 53 years and a mean BMI of 46. At the end of the 14-year study period, there were a total of 263 deaths in the surgical group (mean follow-up, 6.9 years) and 1277 deaths in the matched control group (mean follow-up, 6.6 years). Kaplan-Meier estimated mortality rates were 2.4% at 1 year, 6.4% at 5 years, and 13.8% at 10 years for surgical patients; for matched control patients, 1.7% at 1 year, 10.4% at 5 years, and 23.9% at 10 years. Adjusted analysis showed no significant association between bariatric surgery and all-cause mortality in the first year of follow-up (adjusted hazard ratio [HR], 1.28 [95% CI, 0.98-1.68]), but significantly lower mortality after 1 to 5 years (HR, 0.45 [95% CI, 0.36-0.56]) and 5 to 14 years (HR, 0.47 [95% CI, 0.39-0.58]). The midterm (>1-5 years) and long-term (>5 years) relationships between surgery and survival were not significantly different across subgroups defined by diabetes diagnosis, sex, and period of surgery. CONCLUSIONS AND RELEVANCE Among obese patients receiving care in the VA health system, those who underwent bariatric surgery compared with matched control patients who did not have surgery had lower all-cause mortality at 5 years and up to 10 years following the procedure. These results provide further evidence for the beneficial relationship between surgery and survival that has been demonstrated in younger, predominantly female populations.	[Arterburn, David E.] Grp Hlth Res Inst, Seattle, WA USA; [Arterburn, David E.] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA USA; [Olsen, Maren K.; Smith, Valerie A.; Van Scoyoc, Lynn; Yancy, William S., Jr.; Weidenbacher, Hollis; Maciejewski, Matthew L.] Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA; [Olsen, Maren K.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Livingston, Edward H.] Vet Adm North Texas Hlth Care Syst, Dallas, TX USA; [Livingston, Edward H.] Univ Texas SW Med Ctr Dallas, Div Gastrointestinal & Endocrine Surg, Dallas, TX 75390 USA; [Livingston, Edward H.] Northwestern Univ, Div Gen Surg, Chicago, IL 60611 USA; [Yancy, William S., Jr.; Maciejewski, Matthew L.] Duke Univ, Dept Med, Div Gen Internal Med, Durham, NC USA; [Eid, George] Pittsburgh Vet Affairs Med Ctr, Pittsburgh, PA USA; [Eid, George] Temple Univ, Allegheny Hlth Network, Dept Surg, Div Minimally Invas Surg, Philadelphia, PA 19122 USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; Northwestern University; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Maciejewski, ML (corresponding author), Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Mail Stop 152,411 W Chapel Hill St,Ste 600, Durham, NC 27705 USA.	matthew.maciejewski@va.gov		Smith, Valerie/0000-0001-5170-9819	Health Services Research and Development, Department of Veterans Affairs [IIR 10-159]; research career scientist award from the Department of Veterans Affairs [RCS 10-391]	Health Services Research and Development, Department of Veterans Affairs(US Department of Veterans Affairs); research career scientist award from the Department of Veterans Affairs(US Department of Veterans Affairs)	This research was funded by the Health Services Research and Development, Department of Veterans Affairs (IIR 10-159) and by a research career scientist award from the Department of Veterans Affairs (RCS 10-391; Dr Maciejewski).	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Arterburn D, 2013, SURG OBES RELAT DIS, V9, P837, DOI 10.1016/j.soard.2013.05.006; Arterburn D, 2009, ARCH SURG-CHICAGO, V144, P914, DOI 10.1001/archsurg.2009.134; Arterburn DE, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3961; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; Courcoulas AP, 2014, JAMA SURG, V149, P1323, DOI 10.1001/jamasurg.2014.2440; Davis CL, 2007, J AM COLL SURGEONS, V204, P550, DOI 10.1016/j.jamcollsurg.2007.01.012; Dimick JB, 2013, JAMA-J AM MED ASSOC, V309, P792, DOI 10.1001/jama.2013.755; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flum David R, 2006, Surg Obes Relat Dis, V2, P78, DOI 10.1016/j.soard.2006.02.008; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Kahwati LC, 2011, TRANSL BEHAV MED, V1, P551, DOI 10.1007/s13142-011-0077-4; Karlsson J, 2007, INT J OBESITY, V31, P1248, DOI 10.1038/sj.ijo.0803573; Kennedy EH, 2010, STAT MED, V29, P2569, DOI 10.1002/sim.4017; Khan MA, 2013, SURG ENDOSC, V27, P1772, DOI 10.1007/s00464-012-2678-5; Kinsinger LS, 2009, PREV CHRONIC DIS, V6; Kolotkin RL, 2012, SURG OBES RELAT DIS, V8, P625, DOI 10.1016/j.soard.2012.01.011; Li YFP, 2001, J AM STAT ASSOC, V96, P870, DOI 10.1198/016214501753208573; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Livingston EH, 2006, ARCH SURG-CHICAGO, V141, P1115, DOI 10.1001/archsurg.141.11.1115; Lu B, 2005, BIOMETRICS, V61, P721, DOI 10.1111/j.1541-0420.2005.00356.x; Maciejewski ML, 2012, SURG OBES RELAT DIS, V8, P671, DOI 10.1016/j.soard.2012.07.020; Maciejewski ML, 2011, JAMA-J AM MED ASSOC, V305, P2419, DOI 10.1001/jama.2011.817; Maciejewski ML, 2010, MED CARE, V48, P989, DOI 10.1097/MLR.0b013e3181ef9cf7; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; Nguyen NT, 2013, SURG OBES RELAT DIS, V9, P239, DOI 10.1016/j.soard.2011.12.010; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Padwal RS, 2013, JAMA SURG, V148, P1109, DOI 10.1001/jamasurg.2013.3953; Patterson EJ, 2011, JAMA-J AM MED ASSOC, V306, P1323, DOI 10.1001/jama.2011.1350; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Therneau TM, 2000, MODELING SURVIVAL DA; Wolfe BM, 2014, JAMA-J AM MED ASSOC, V312, P1792, DOI 10.1001/jama.2014.12966	38	288	296	3	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					62	70		10.1001/jama.2014.16968	http://dx.doi.org/10.1001/jama.2014.16968			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25562267	Bronze			2022-12-28	WOS:000347478000016
J	Murphy, SK; Park, JW; Cruz, FA; Dong, VM				Murphy, Stephen K.; Park, Jung-Woo; Cruz, Faben A.; Dong, Vy M.			Rh-catalyzed C-C bond cleavage by transfer hydroformylation	SCIENCE			English	Article							OLEFINS; COMPLEXES; CYTOCHROME-P450; ACTIVATION; ALCOHOLS	The dehydroformylation of aldehydes to generate olefins occurs during the biosynthesis of various sterols, including cholesterol in humans. Here, we implement a synthetic version that features the transfer of a formyl group and hydride from an aldehyde substrate to a strained olefin acceptor. A Rhodium(Xantphos)(benzoate) catalyst activates aldehyde carbon-hydrogen (C-H) bonds with high chemoselectivity to trigger carbon-carbon (C-C) bond cleavage and generate olefins at low loadings (0.3 to 2 mole percent) and temperatures (22 degrees to 80 degrees C). This mild protocol can be applied to various natural products and was used to achieve a three-step synthesis of (+)-yohimbenone. A study of the mechanism reveals that the benzoate counterion acts as a proton shuttle to enable transfer hydroformylation.	[Murphy, Stephen K.; Park, Jung-Woo; Cruz, Faben A.; Dong, Vy M.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Murphy, Stephen K.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada	University of California System; University of California Irvine; University of Toronto	Dong, VM (corresponding author), Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA.	dongv@uci.edu	Park, Jung-Woo/F-9465-2015	Park, Jung-Woo/0000-0002-4019-217X; Murphy, Stephen/0000-0002-5954-6441	NIH's National Institute of General Medical Sciences [GM105938]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105938] Funding Source: NIH RePORTER	NIH's National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful for financial support provided by the NIH's National Institute of General Medical Sciences (GM105938). S.K.M. is grateful for a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada. We acknowledge C. M. Rathbun for contributions during the optimization stage of reaction development.	Ahuja R, 2011, NAT CHEM, V3, P167, DOI [10.1038/nchem.946, 10.1038/NCHEM.946]; Breslow R, 1997, P NATL ACAD SCI USA, V94, P11156, DOI 10.1073/pnas.94.21.11156; Chen MS, 2010, SCIENCE, V327, P566, DOI 10.1126/science.1183602; Cortes M, 2001, J NAT PROD, V64, P348, DOI 10.1021/np0004146; Dermenci A, 2014, ORG CHEM FRONT, V1, P567, DOI 10.1039/c4qo00053f; Franke R, 2012, CHEM REV, V112, P5675, DOI 10.1021/cr3001803; Garralda MA, 2009, DALTON T, P3635, DOI 10.1039/b817263c; Goto Y, 1998, J INORG BIOCHEM, V69, P241, DOI 10.1016/S0162-0134(97)10029-0; Groves JT, 2003, P NATL ACAD SCI USA, V100, P3569, DOI 10.1073/pnas.0830019100; IMAI H, 1974, J ORG CHEM, V39, P1622, DOI 10.1021/jo00925a004; Iwai T, 2008, CHEM COMMUN, P6215, DOI 10.1039/b813171f; Jun CH, 2004, CHEM SOC REV, V33, P610, DOI 10.1039/b308864m; Jun CH, 1998, ANGEW CHEM INT EDIT, V37, P145, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<145::AID-ANIE145>3.0.CO;2-0; Ko HM, 2014, NAT CHEM, V6, P739, DOI [10.1038/NCHEM.1989, 10.1038/nchem.1989]; KONDO T, 1990, J ORG CHEM, V55, P1286, DOI 10.1021/jo00291a035; KRANENBURG M, 1995, ORGANOMETALLICS, V14, P3081, DOI 10.1021/om00006a057; Kreis M, 2006, ADV SYNTH CATAL, V348, P2148, DOI 10.1002/adsc.200600228; Lebold TP, 2013, NAT CHEM, V5, P126, DOI [10.1038/NCHEM.1528, 10.1038/nchem.1528]; Lenges CP, 1999, ANGEW CHEM INT EDIT, V38, P3533, DOI 10.1002/(SICI)1521-3773(19991203)38:23<3533::AID-ANIE3533>3.3.CO;2-5; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Liu YY, 2014, ADV SYNTH CATAL, V356, P130, DOI 10.1002/adsc.201301109; Makado G, 2010, ADV SYNTH CATAL, V352, P299, DOI 10.1002/adsc.200900713; Manger M, 1998, ORGANOMETALLICS, V17, P3210, DOI 10.1021/om980062m; McCombs C. A., 1980, U. S. Patent, Patent No. [4272444 A, 4272444]; Phan DHT, 2010, J AM CHEM SOC, V132, P16354, DOI 10.1021/ja107738a; Prince R. H., 1966, CHEM COMMUN, V1966, P156; Sigel A., 2007, UBIQUITOUS ROLES CYT, V3; Stearman CJ, 2009, J ORG CHEM, V74, P3491, DOI 10.1021/jo9003579; TSUJI J, 1965, TETRAHEDRON LETT, P3969; Wertz DL, 1998, J AM CHEM SOC, V120, P5331, DOI 10.1021/ja980395a; Willis MC, 2010, CHEM REV, V110, P725, DOI 10.1021/cr900096x; ZHANG W, 1990, J AM CHEM SOC, V112, P2801, DOI 10.1021/ja00163a052; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525	33	153	156	6	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					56	60		10.1126/science.1261232	http://dx.doi.org/10.1126/science.1261232			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554782	Green Accepted			2022-12-28	WOS:000347102300046
J	Shen, PS; Park, J; Qin, YD; Li, XM; Parsawar, K; Larson, MH; Cox, J; Cheng, YF; Lambowitz, AM; Weissman, JS; Brandman, O; Frost, A				Shen, Peter S.; Park, Joseph; Qin, Yidan; Li, Xueming; Parsawar, Krishna; Larson, Matthew H.; Cox, James; Cheng, Yifan; Lambowitz, Alan M.; Weissman, Jonathan S.; Brandman, Onn; Frost, Adam			Rqc2p and 60S ribosomal subunits mediate mRNA-independent elongation of nascent chains	SCIENCE			English	Article							ADENOSINE-DEAMINASE; PROTEIN-SYNTHESIS; ANTICODON LOOP; TRANSLATION; SURVEILLANCE; COMPLEX; NEURODEGENERATION; LISTERIN; LIGASE; YEAST	In Eukarya, stalled translation induces 40S dissociation and recruitment of the ribosome quality control complex (RQC) to the 60S subunit, which mediates nascent chain degradation. Here we report cryo-electron microscopy structures revealing that the RQC components Rqc2p (YPL009C/Tae2) and Ltn1p (YMR247C/Rkr1) bind to the 60S subunit at sites exposed after 40S dissociation, placing the Ltn1p RING (Really Interesting New Gene) domain near the exit channel and Rqc2p over the P-site transfer RNA (tRNA). We further demonstrate that Rqc2p recruits alanine-and threonine-charged tRNA to the A site and directs the elongation of nascent chains independently of mRNA or 40S subunits. Our work uncovers an unexpected mechanism of protein synthesis, in which a protein-not an mRNA-determines tRNA recruitment and the tagging of nascent chains with carboxy-terminal Ala and Thr extensions ("CAT tails").	[Shen, Peter S.; Cox, James; Frost, Adam] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Park, Joseph; Brandman, Onn] Stanford Univ, Dept Biochem, Palo Alto, CA 94305 USA; [Larson, Matthew H.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Larson, Matthew H.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Larson, Matthew H.; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Larson, Matthew H.; Weissman, Jonathan S.] Univ Calif San Francisco, Ctr RNA Syst Biol, San Francisco, CA 94158 USA; [Li, Xueming; Cheng, Yifan; Frost, Adam] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Qin, Yidan; Lambowitz, Alan M.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Qin, Yidan; Lambowitz, Alan M.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Parsawar, Krishna; Cox, James] Univ Utah, Mass Spectrometry & Prote Core Facil, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Stanford University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Utah System of Higher Education; University of Utah	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	jonathan.weissman@ucsf.edu; onn@stanford.edu; adam.frost@ucsf.edu	; Larson, Matthew/C-8289-2014	Cheng, Yifan/0000-0001-9535-0369; Shen, Peter/0000-0002-6256-6910; Frost, Adam/0000-0003-2231-2577; Larson, Matthew/0000-0002-6778-2604; Weissman, Jonathan/0000-0003-2445-670X	Searle Scholars Program; Stanford University; NIH [1DP2GM110772-01, GM37949, GM37951]; Center for RNA Systems Biology [P50 GM102706, U01 GM098254]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037949, R01GM115968, DP2GM110772, R01GM037951, U01GM098254, P50GM102706, R37GM037951] Funding Source: NIH RePORTER	Searle Scholars Program; Stanford University(Stanford University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for RNA Systems Biology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Electron microscopy was performed at the University of Utah and the University of California. We thank D. Belnap (University of Utah) and M. Braunfeld (University of California, San Francisco) for supervision of the electron microscopes; A. Orendt and the Utah Center for High Performance Computing and the NSF Extreme Science and Engineering Discovery Environment consortium for computational support; D. Sidote (University of Texas at Austin) for help processing RNA-seq data; and D. Herschlag and P. Harbury for helpful comments. Amino acid analysis was performed by J. Shulze at the University of California, Davis Proteomics Core. Edman sequencing was performed at Stanford University's Protein and Nucleic Acid Facility by D. Winant. This work was supported by the Searle Scholars Program (A.F.); Stanford University (O.B.); NIH grants 1DP2GM110772-01 (A.F.), GM37949, and GM37951 (A.M.L.); the Center for RNA Systems Biology grants P50 GM102706 (J.S.W.) and U01 GM098254 (J.S.W.); and the Howard Hughes Medical Institute (J.S.W.). The authors declare no competing financial interests. The cryo-EM structures have been deposited at the Electron Microscopy Data Bank (accession codes 2811, 2812, 6169, 6170, 6171, 6172, 6176, and 6201).	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Burroughs AM, 2014, RNA BIOL, V11, P360, DOI 10.4161/rna.28302; Chu D, 2011, NUCLEIC ACIDS RES, V39, P6705, DOI 10.1093/nar/gkr300; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Delannoy E, 2009, PLANT CELL, V21, P2058, DOI 10.1105/tpc.109.066654; Gaston KW, 2007, NUCLEIC ACIDS RES, V35, P6740, DOI 10.1093/nar/gkm745; Gerber A, 1998, EMBO J, V17, P4780, DOI 10.1093/emboj/17.16.4780; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Katibah GE, 2014, P NATL ACAD SCI USA, V111, P12025, DOI 10.1073/pnas.1412842111; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P17575, DOI 10.1073/pnas.1009598107; Letzring DP, 2010, RNA, V16, P2516, DOI 10.1261/rna.2411710; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; LILL R, 1986, BIOCHEMISTRY-US, V25, P3245, DOI 10.1021/bi00359a025; Lyumkis D, 2013, P NATL ACAD SCI USA, V110, P1702, DOI 10.1073/pnas.1210041110; MONRO RE, 1969, NATURE, V223, P903, DOI 10.1038/223903a0; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Rubio MAT, 2006, J BIOL CHEM, V281, P115, DOI 10.1074/jbc.M510136200; Shao SC, 2014, MOL CELL, V55, P880, DOI 10.1016/j.molcel.2014.07.006; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308	26	173	181	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					75	78		10.1126/science.1259724	http://dx.doi.org/10.1126/science.1259724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554787	Green Accepted			2022-12-28	WOS:000347102300051
J	Bansal, M; Kasliwal, RR				Bansal, Manish; Kasliwal, Ravi R.			Mobile Large Left Atrial Thrombus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bansal, Manish; Kasliwal, Ravi R.] Medanta Medicity, Gurgaon, India		Bansal, M (corresponding author), Medanta Medicity, Gurgaon, India.	manishaiims@hotmail.com	Bansal, Manish/O-7899-2015	Bansal, Manish/0000-0002-2125-8073					0	2	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 1	2015	372	1					E2	E2		10.1056/NEJMicm1310149	http://dx.doi.org/10.1056/NEJMicm1310149			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX7MU	25551545				2022-12-28	WOS:000347100800001
J	Comerford, SA; Huang, Z; Du, X; Wang, Y; Cai, L; Witkiewicz, AK; Walters, H; Tantawy, MN; Fu, A; Manning, HC; Horton, JD; Hammer, RE; McKnight, SL; Tu, BP				Comerford, Sarah A.; Huang, Zhiguang; Du, Xinlin; Wang, Yun; Cai, Ling; Witkiewicz, Agnes K.; Walters, Holly; Tantawy, Mohammed N.; Fu, Allie; Manning, H. Charles; Horton, Jay D.; Hammer, Robert E.; McKnight, Steven L.; Tu, Benjamin P.			Acetate Dependence of Tumors	CELL			English	Article							COENZYME-A-SYNTHETASE; ACETYL-COA SYNTHETASE; HISTONE ACETYLATION; HEPATOCELLULAR-CARCINOMA; GLUTAMINE-METABOLISM; CELL-SURVIVAL; IN-VIVO; CANCER; C-11-ACETATE; GROWTH	Acetyl-CoA represents a central node of carbon metabolism that plays a key role in bioenergetics, cell proliferation, and the regulation of gene expression. Highly glycolytic or hypoxic tumors must produce sufficient quantities of this metabolite to support cell growth and survival under nutrient-limiting conditions. Here, we show that the nucleocytosolic acetyl-CoA synthetase enzyme, ACSS2, supplies a key source of acetyl-CoA for tumors by capturing acetate as a carbon source. Despite exhibiting no gross deficits in growth or development, adult mice lacking ACSS2 exhibit a significant reduction in tumor burden in two different models of hepatocellular carcinoma. ACSS2 is expressed in a large proportion of human tumors, and its activity is responsible for the majority of cellular acetate uptake into both lipids and histones. These observations may qualify ACSS2 as a targetable metabolic vulnerability of a wide spectrum of tumors.	[Comerford, Sarah A.; Walters, Holly; Horton, Jay D.] UT Southwestern Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; [Huang, Zhiguang; Du, Xinlin; Wang, Yun; Cai, Ling; Hammer, Robert E.; McKnight, Steven L.; Tu, Benjamin P.] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX 75390 USA; [Witkiewicz, Agnes K.] UT Southwestern Med Ctr, Dept Pathol, Dallas, TX 75390 USA; [Tantawy, Mohammed N.; Fu, Allie; Manning, H. Charles] Vanderbilt Univ, Med Ctr, Inst Imaging Sci, Nashville, TN 37232 USA; [Tantawy, Mohammed N.; Manning, H. Charles] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Vanderbilt University; Vanderbilt University	McKnight, SL (corresponding author), UT Southwestern Med Ctr, Dept Biochem, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu; benjamin.tu@utsouthwestern.edu		Comerford, Sarah Ann/0000-0002-7452-7759; Hammer, Robert E./0000-0001-5487-7551	Damon Runyon-Rachleff Innovation Award; Packard Fellowship; CPRIT High-Risk/High-Impact grant [R01CA185169]; UTSW; NATIONAL CANCER INSTITUTE [R01CA185169, P50CA095103] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	Damon Runyon-Rachleff Innovation Award; Packard Fellowship(The David & Lucile Packard Foundation); CPRIT High-Risk/High-Impact grant; UTSW; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank B. Posner and the staff of the UTSW High-Throughput Screening Core Facility for assistance with the ACSS2 inhibitor screen; V. Vemireddy, E. Maher, R. Bachoo, S. Altschuler, and L. Wu for use of slide scanners; and E. Maher, R. Bachoo, and D. Nijhawan for helpful discussions. This work was supported by a Damon Runyon-Rachleff Innovation Award, Packard Fellowship, and a CPRIT High-Risk/High-Impact grant to B.P.T., R01CA185169 to B.P.T. and S.L.M., unrestricted funds provided to S.L.M. by an anonymous donor, and Excellence in Education funds (EEF) from UTSW to R.E.H. S.L.M. is the founder and Chairman of the Scientific Advisory Board, X.D. is an employee, B.P.T., S.A.C., and R.E.H. are consultants, and S.L.M., B.P.T., S.A.C., X.D., R.E.H., and L.C. are shareholders of Peloton Therapeutics, Inc.	Ariyannur PS, 2010, J COMP NEUROL, V518, P2952, DOI 10.1002/cne.22373; BERG P, 1956, J BIOL CHEM, V222, P991; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; Cai L, 2011, COLD SH Q B, V76, P195, DOI 10.1101/sqb.2011.76.010769; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Comerford SA, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.27; DEVIRGILIO C, 1992, YEAST, V8, P1043, DOI 10.1002/yea.320081207; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; HILZ H, 1953, J AM CHEM SOC, V75, P3285; Ho CL, 2003, J NUCL MED, V44, P213; JACKSON V, 1975, J BIOL CHEM, V250, P4856; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kawate S, 1999, ONCOLOGY-BASEL, V57, P157, DOI 10.1159/000012024; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Leonardi R, 2012, J BIOL CHEM, V287, P14615, DOI 10.1074/jbc.C112.353946; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; LIPMANN F, 1945, J BIOL CHEM, V161, P415; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nomori H, 2008, J THORAC ONCOL, V3, P1427, DOI 10.1097/JTO.0b013e31818ddfdc; Oyama N, 2002, J NUCL MED, V43, P181; Peng Shian-Yang, 1993, Journal of the Formosan Medical Association, V92, P866; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; SANDGREN EP, 1989, ONCOGENE, V4, P715; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shi L, 2013, P NATL ACAD SCI USA, V110, P7318, DOI 10.1073/pnas.1302490110; SRERE PA, 1959, J BIOL CHEM, V234, P2544; SRERE PA, 1953, J AM CHEM SOC, V75, P4874, DOI 10.1021/ja01115a547; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; TOLLINGER CD, 1979, CLIN CHEM, V25, P1787; Tsuchida T, 2008, NUCL MED BIOL, V35, P171, DOI 10.1016/j.nucmedbio.2007.11.004; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Waterborg JH, 2002, BIOCHEM CELL BIOL, V80, P363, DOI 10.1139/O02-080; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Yao YJ, 1999, ONCOGENE, V18, P3181, DOI 10.1038/sj.onc.1202659; Yoshii Y, 2009, NUCL MED BIOL, V36, P771, DOI 10.1016/j.nucmedbio.2009.05.006; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x; Yun M, 2009, J NUCL MED, V50, P1222, DOI 10.2967/jnumed.109.062703	48	384	402	2	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1591	1602		10.1016/j.cell.2014.11.020	http://dx.doi.org/10.1016/j.cell.2014.11.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525877	Green Accepted, Bronze			2022-12-28	WOS:000347922500013
J	Kuo, CY; Wang, CH				Kuo, Chao-Yin; Wang, Chih-Hung			Patulous Eustachian Tube Causing Hypermobile Eardrums	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kuo, Chao-Yin; Wang, Chih-Hung] Triserv Gen Hosp, Taipei, Taiwan	Tri-Service General Hospital	Kuo, CY (corresponding author), Triserv Gen Hosp, Taipei, Taiwan.	chw@ms3.hinet.net							0	2	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					E37	E37		10.1056/NEJMicm1403262	http://dx.doi.org/10.1056/NEJMicm1403262			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW7DX	25517722				2022-12-28	WOS:000346425800012
J	Steinberg, DI				Steinberg, Daniel I.			In acute calculous cholecystitis, antibiotics after cholecystectomy did not reduce infection Commentary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mt Sinai Beth Israel, New York, NY 10003 USA		Steinberg, DI (corresponding author), Mt Sinai Beth Israel, New York, NY 10003 USA.							Gomi H, 2013, J HEPATO-BIL-PAN SCI, V20, P60, DOI 10.1007/s00534-012-0572-0	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2014	161	12							JC4	10.7326/0003-4819-161-12-201412160-02004	http://dx.doi.org/10.7326/0003-4819-161-12-201412160-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UW	25506876				2022-12-28	WOS:000347248400008
J	Barber, MF; Elde, NC				Barber, Matthew F.; Elde, Nels C.			Escape from bacterial iron piracy through rapid evolution of transferrin	SCIENCE			English	Article							NEISSERIA-MENINGITIDIS; NUTRITIONAL IMMUNITY; STRUCTURAL BASIS; BINDING; RECEPTORS; PROTEIN; INFECTION; DISEASE; ASSOCIATION; LACTOFERRIN	Can a single conversation change minds on divisive social issues, such as same-sex marriage? A randomized placebo-controlled trial assessed whether gay (n = 22) or straight (n = 19) messengers were effective at encouraging voters (n = 972) to support same-sex marriage and whether attitude change persisted and spread to others in voters' social networks. The results, measured by an unrelated panel survey, show that both gay and straight canvassers produced large effects initially, but only gay canvassers' effects persisted in 3-week, 6-week, and 9-month follow-ups. We also find strong evidence of within-household transmission of opinion change, but only in the wake of conversations with gay canvassers. Contact with gay canvassers further caused substantial change in the ratings of gay men and lesbians more generally. These large, persistent, and contagious effects were confirmed by a follow-up experiment. Contact with minorities coupled with discussion of issues pertinent to them is capable of producing a cascade of opinion change.	[Barber, Matthew F.; Elde, Nels C.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Elde, NC (corresponding author), Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA.	nelde@genetics.utah.edu		Barber, Matthew/0000-0003-2008-2165	Pew Charitable Trusts; NIH [GM090042, 1F32GM108288]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM108288, R00GM090042] Funding Source: NIH RePORTER	Pew Charitable Trusts; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Mulvey and members of the Mulvey laboratory for assistance with bacterial genetics and helpful discussions; V. Chandrasekaran and W. Sundquist for assistance with baculoviral protein purification; J. Kaplan and D. Ward for helpful advice and discussions; J. St. Geme III and E. Porsch for Haemophilus strains and helpful discussions; M. So for providing Neisseria DNA and strains; S. Wong for providing rhesus macaque liver samples; Z. Kronenberg for assistance with human population genetics; and C. Cornelissen for the gift of the TbpA antibody as well as helpful discussions. J. Iwasa created the molecular animation of transferrin and TbpA evolution. We are grateful to N. Barber, H. Malik, S. Sawyer, N. Phadnis, and members of the Elde laboratory for comments on the manuscript. GenBank accession numbers of transferrin and TbpA variants are KM972645 to KM972665. Also see the supplementary materials. This work is supported by awards from the Pew Charitable Trusts and NIH to N. C. E. (GM090042) and M.F.B. (1F32GM108288). N. C. E. is a Pew Scholar in the Biomedical Sciences and Mario R. Capecchi Endowed Chair in Genetics.	ALCANTARA J, 1993, MOL MICROBIOL, V8, P1135, DOI 10.1111/j.1365-2958.1993.tb01658.x; Calmettes C, 2012, NAT STRUCT MOL BIOL, V19, P358, DOI 10.1038/nsmb.2251; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; CORNELISSEN CN, 1993, J BACTERIOL, V175, P2448, DOI 10.1128/JB.175.8.2448-2450.1993; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Demogines A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001571; Elde NC, 2009, NATURE, V457, P485, DOI 10.1038/nature07529; Emerman M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000301; Frieden T., 2013, ANTIBIOTIC RESISTANC; GRAYOWEN SD, 1993, MICROB PATHOGENESIS, V14, P389, DOI 10.1006/mpat.1993.1038; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Kaelber JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002666; KUHNL P, 1978, HUM GENET, V43, P91, DOI 10.1007/BF00396483; LEE BC, 1988, MOL MICROBIOL, V2, P827, DOI 10.1111/j.1365-2958.1988.tb00095.x; Namekata K, 1997, HUM GENET, V101, P126, DOI 10.1007/s004390050600; Noinaj N, 2012, NATURE, V483, P53, DOI 10.1038/nature10823; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; PARK I, 1985, P NATL ACAD SCI USA, V82, P3149, DOI 10.1073/pnas.82.10.3149; Patel MR, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001282; SCHRYVERS AB, 1992, J INFECT DIS, V165, pS103, DOI 10.1093/infdis/165-Supplement_1-S103; SCHRYVERS AB, 1989, CAN J MICROBIOL, V35, P409, DOI 10.1139/m89-063; SCHRYVERS AB, 1989, INFECT IMMUN, V57, P2425, DOI 10.1128/IAI.57.8.2425-2429.1989; SCHRYVERS AB, 1988, MOL MICROBIOL, V2, P281, DOI 10.1111/j.1365-2958.1988.tb00029.x; Shapiro BJ, 2009, TRENDS MICROBIOL, V17, P196, DOI 10.1016/j.tim.2009.02.002; Wang Y, 2013, CAN J NEUROL SCI, V40, P691, DOI 10.1017/S0317167100014931; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; Zarantonelli ML, 2007, INFECT IMMUN, V75, P5609, DOI 10.1128/IAI.00781-07; Zatta P, 2005, BBA-MOL BASIS DIS, V1741, P264, DOI 10.1016/j.bbadis.2005.04.009	29	126	129	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1362	1366		10.1126/science.1259329	http://dx.doi.org/10.1126/science.1259329			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504720	Green Accepted			2022-12-28	WOS:000346189600050
J	LaCour, MJ; Green, DP				LaCour, Michael J.; Green, Donald P.			RETRACTED: When contact changes minds: An experiment on transmission of support for gay equality (Retracted article. See vol 348, pg 1100, 2015)	SCIENCE			English	Article; Retracted Publication							INTERGROUP CONTACT; HYPOTHESIS; PREJUDICE	Can a single conversation change minds on divisive social issues, such as same-sex marriage? A randomized placebo-controlled trial assessed whether gay (n = 22) or straight (n = 19) messengers were effective at encouraging voters (n = 972) to support same-sex marriage and whether attitude change persisted and spread to others in voters' social networks. The results, measured by an unrelated panel survey, show that both gay and straight canvassers produced large effects initially, but only gay canvassers' effects persisted in 3-week, 6-week, and 9-month follow-ups. We also find strong evidence of within-household transmission of opinion change, but only in the wake of conversations with gay canvassers. Contact with gay canvassers further caused substantial change in the ratings of gay men and lesbians more generally. These large, persistent, and contagious effects were confirmed by a follow-up experiment. Contact with minorities coupled with discussion of issues pertinent to them is capable of producing a cascade of opinion change.	[LaCour, Michael J.] Univ Calif Los Angeles, Dept Polit Sci, Los Angeles, CA 90024 USA; [Green, Donald P.] Columbia Univ, Dept Polit Sci, New York, NY 10027 USA	University of California System; University of California Los Angeles; Columbia University	LaCour, MJ (corresponding author), Univ Calif Los Angeles, Dept Polit Sci, Los Angeles, CA 90024 USA.		Green, Donald P./E-4565-2010	Green, Donald P./0000-0002-8850-438X	Williams Institute; Ford Foundation; Evelyn and Walter Haas, Jr., Fund	Williams Institute; Ford Foundation; Evelyn and Walter Haas, Jr., Fund	M.J.L. received research funding from the Williams Institute, Ford Foundation, and Evelyn and Walter Haas, Jr., Fund, which bear no responsibility for the findings or interpretations given here. Replication data and accompanying R code are available at OpenICPSR (http://doi.org/10.3886/E19260V1). Neither of the authors is affiliated with the Los Angeles LGBT Center or received compensation for this research. The experiments reported here were registered at the Experiments in Governance and Politics site before the launch of each study. This research was approved by the UCLA institutional review board, case no. 12-001750.	Allport G.W., 1954, NATURE PREJUDICE; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Gerber A.S., 2012, FIELD EXPT DESIGN AN; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; Hewstone M, 2011, BRIT J SOC PSYCHOL, V50, P374, DOI 10.1111/j.2044-8309.2011.02047.x; Hitlin P., 2013, NEWS COVERAGE CONVEY; Jackman S., 2012, COMMON CONTENT CODEB; LEWIN Kurt, 1952, READINGS SOCIAL PSYC, P459; Paluck EL, 2009, ANNU REV PSYCHOL, V60, P339, DOI 10.1146/annurev.psych.60.110707.163607; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Scarberry NC, 1997, PERS SOC PSYCHOL B, V23, P1291, DOI 10.1177/01461672972312006; Wright SC, 1997, J PERS SOC PSYCHOL, V73, P73, DOI 10.1037/0022-3514.73.1.73	12	60	65	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1366	1369		10.1126/science.1256151	http://dx.doi.org/10.1126/science.1256151			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW3MA	25504721				2022-12-28	WOS:000346189600051
J	Sundstrom, J; Arima, H; Jackson, R; Turnbull, F; Rahimi, K; Chalmers, J; Woodward, M; Neal, B				Sundstrom, Johan; Arima, Hisatomi; Jackson, Rod; Turnbull, Fiona; Rahimi, Kazem; Chalmers, John; Woodward, Mark; Neal, Bruce		Blood Pressure Lowering Treatment	Effects of Blood Pressure Reduction in Mild Hypertension A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							PROSPECTIVELY-DESIGNED OVERVIEWS; MAJOR CARDIOVASCULAR EVENTS; PLACEBO-CONTROLLED TRIAL; DIABETES-MELLITUS; LOWERING REGIMENS; OUTCOMES; RISK; GUIDELINES; MANAGEMENT; RAMIPRIL	Background: Effects of blood pressure reduction in persons with grade 1 hypertension are unclear. Purpose: To investigate whether pharmacologic blood pressure reduction prevents cardiovascular events and deaths in persons with grade 1 hypertension. Data Sources: Trials included in the BPLTTC (Blood Pressure Lowering Treatment Trialists' Collaboration) and trials identified from a previous review and electronic database searches. Study Selection: Patients without cardiovascular disease with blood pressures in the grade 1 hypertension range (140 to 159/90 to 99 mm Hg) who were randomly assigned to an active (antihypertensive drug or more intensive regimen) or control (placebo or less intensive regimen) blood pressure-lowering regimen. Data Extraction: Individual-patient data from BPLTTC trials and aggregate data from other trials were extracted. Risk of bias was assessed for all trials. Data Synthesis: Individual-patient data involved 10 comparisons from trials where most patients had diabetes, and aggregate data involved 3 comparisons from trials of patients without diabetes. The average blood pressure reduction was about 3.6/2.4 mm Hg. Over 5 years, odds ratios were 0.86 (95% CI, 0.74 to 1.01) for total cardiovascular events, 0.72 (CI, 0.55 to 0.94) for strokes, 0.91 (CI, 0.74 to 1.12) for coronary events, 0.80 (CI, 0.57 to 1.12) for heart failure, 0.75 (CI, 0.57 to 0.98) for cardiovascular deaths, and 0.78 (CI, 0.67 to 0.92) for total deaths. Results were similar in secondary analyses. Withdrawal from treatment due to adverse effects was more common in the active groups. Limitation: Blood pressure reductions and numbers of events were small. Conclusion: Blood pressure-lowering therapy is likely to prevent stroke and death in patients with uncomplicated grade 1 hypertension.	Uppsala Univ, Uppsala, Sweden; Univ Sydney, Sydney, NSW 2006, Australia; Univ Auckland, Auckland 1, New Zealand; Univ Oxford, Oxford OX1 3BD, England; Univ London Imperial Coll Sci Technol & Med, London, England	Uppsala University; University of Sydney; University of Auckland; University of Oxford; Imperial College London	Rahimi, K (corresponding author), Univ Oxford, Oxford Martin Sch, George Inst Global Hlth, 34 Broad St, Oxford OX1 3BD, England.		Sundstrom, Johan/R-2139-2019; Rahimi, Kazem/Q-1279-2015; Rahimi, Kazem/AAA-4250-2022; Woodward, Mark/L-6817-2017; Sundström, Johan/A-6286-2009; Woodward, Mark/D-8492-2015; de Zeeuw, Dick/E-9080-2014	Sundstrom, Johan/0000-0003-2247-8454; Rahimi, Kazem/0000-0002-4807-4610; Sundström, Johan/0000-0003-2247-8454; de Zeeuw, Dick/0000-0003-3434-7777; Jackson, Rod/0000-0001-5914-6934; Yusuf, Salim/0000-0003-4776-5601; Neal, Bruce/0000-0002-0490-7465; Chalmers, John/0000-0002-9931-0580; Woodward, Mark/0000-0001-9800-5296	Swedish Heart-Lung Foundation [20041151]; Kjell och Marta Beijers Stiftelse; Swedish Research Council [2007-5942, 2010-1078]; U.K. National Institute for Health Research (NIHR Oxford Biomedical Research Centre and NIHR Career Development Fellowship); Australian Research Council Future Fellowship; National Health and Medical Research Council of Australia Senior Research Fellowships; National Health and Medical Research Council of Australia Program Grant; Astra Hassle; Bayer; British Heart Foundation; Bristol-Myers Squibb; Glaxo Wellcome; Hoechst Marion Roussel; Knoll, Merck Co.; Pfizer; Searle; Institut de Recherches Internationales Servier; National Institute for Health Research [NF-SI-0513-10059, CDF-2013-06-012] Funding Source: researchfish	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Kjell och Marta Beijers Stiftelse; Swedish Research Council(Swedish Research CouncilEuropean Commission); U.K. National Institute for Health Research (NIHR Oxford Biomedical Research Centre and NIHR Career Development Fellowship); Australian Research Council Future Fellowship(Australian Research Council); National Health and Medical Research Council of Australia Senior Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Astra Hassle; Bayer(Bayer AG); British Heart Foundation(British Heart Foundation); Bristol-Myers Squibb(Bristol-Myers Squibb); Glaxo Wellcome; Hoechst Marion Roussel; Knoll, Merck Co.; Pfizer(Pfizer); Searle; Institut de Recherches Internationales Servier(Servier); National Institute for Health Research(National Institute for Health Research (NIHR))	Dr. Sundstrom was funded by the Swedish Heart-Lung Foundation (grant 20041151), Kjell och Marta Beijers Stiftelse, and the Swedish Research Council (grants 2007-5942 and 2010-1078). Dr. Rahimi was funded by the U.K. National Institute for Health Research (NIHR Oxford Biomedical Research Centre and NIHR Career Development Fellowship). Dr. Neal is supported by an Australian Research Council Future Fellowship, and Dr. Neal and Dr. Woodward are supported by National Health and Medical Research Council of Australia Senior Research Fellowships. This work received partial funding support from a National Health and Medical Research Council of Australia Program Grant. The BPLTTC received funding from the following sources at its initiation: Astra Hassle, Bayer, British Heart Foundation, Bristol-Myers Squibb, Glaxo Wellcome, Hoechst Marion Roussel, Knoll, Merck & Co., Pfizer, Searle, and Institut de Recherches Internationales Servier.	[Anonymous], 1978, Ann N Y Acad Sci, V304, P267; [Anonymous], 1980, LANCET, V1, P1261; [Anonymous], 1998, J Hypertens, V16, P127; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Chalmers J, 2013, J HYPERTENS, V31, P1043, DOI 10.1097/HJH.0b013e32835f7eef; Cobiac LJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-398; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Diao D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006742.pub2; Eddy DM, 2011, ANN INTERN MED, V154, P627, DOI 10.7326/0003-4819-154-9-201105030-00008; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Franklin SS, 2001, HYPERTENSION, V37, P869, DOI 10.1161/01.HYP.37.3.869; Gaziano TA, 2005, CIRCULATION, V112, P3569, DOI 10.1161/CIRCULATIONAHA.105.535922; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kjeldsen SE, 2010, J HUM HYPERTENS, V24, P263, DOI 10.1038/jhh.2009.77; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MacMahon S, 2000, J AM COLL CARDIOL, V36, P438, DOI 10.1016/S0735-1097(00)00736-1; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Marre M, 2004, BRIT MED J, V328, P495, DOI 10.1136/bmj.37970.629537.0D; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Montgomery AA, 2003, J HYPERTENS, V21, P1753, DOI 10.1097/00004872-200309000-00026; Neal B, 2000, LANCET, V356, P1955; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Riley RD, 2008, STAT MED, V27, P1870, DOI 10.1002/sim.3165; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Teo KK, 2000, CIRCULATION, V102, P1748; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; Turnbull F, 2003, LANCET, V362, P1527; Turnbull F., 2007, J HYPERTENS, V25, P951, DOI [DOI 10.1097/HJH.0B013E3280BAD9B4, 10.1097/HJH.0b013-3280bad9b4]	34	184	201	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2015	162	3					184	U74		10.7326/M14-0773	http://dx.doi.org/10.7326/M14-0773			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NP	25531552				2022-12-28	WOS:000350108100004
J	Mok, S; Ashley, EA; Ferreira, PE; Zhu, L; Lin, ZT; Yeo, T; Chotivanich, K; Imwong, M; Pukrittayakamee, S; Dhorda, M; Nguon, C; Lim, P; Amaratunga, C; Suon, S; Hien, TT; Htut, Y; Faiz, MA; Onyamboko, MA; Mayxay, M; Newton, PN; Tripura, R; Woodrow, CJ; Miotto, O; Kwiatkowski, DP; Nosten, F; Day, NPJ; Preiser, PR; White, NJ; Dondorp, AM; Fairhurst, RM; Bozdech, Z				Mok, Sachel; Ashley, Elizabeth A.; Ferreira, Pedro E.; Zhu, Lei; Lin, Zhaoting; Yeo, Tomas; Chotivanich, Kesinee; Imwong, Mallika; Pukrittayakamee, Sasithon; Dhorda, Mehul; Nguon, Chea; Lim, Pharath; Amaratunga, Chanaki; Suon, Seila; Tran Tinh Hien; Htut, Ye; Faiz, M. Abul; Onyamboko, Marie A.; Mayxay, Mayfong; Newton, Paul N.; Tripura, Rupam; Woodrow, Charles J.; Miotto, Olivo; Kwiatkowski, Dominic P.; Nosten, Francois; Day, Nicholas P. J.; Preiser, Peter R.; White, Nicholas J.; Dondorp, Arjen M.; Fairhurst, Rick M.; Bozdech, Zbynek			Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; DIHYDROARTEMISININ-PIPERAQUINE; WESTERN CAMBODIA; CLEARANCE RATE; PROVINCE; PROTEIN; VIVAX	Artemisinin resistance in Plasmodium falciparum threatens global efforts to control and eliminate malaria. Polymorphisms in the kelch domain-carrying protein K13 are associated with artemisinin resistance, but the underlying molecular mechanisms are unknown. We analyzed the in vivo transcriptomes of 1043 P. falciparum isolates from patients with acute malaria and found that artemisinin resistance is associated with increased expression of unfolded protein response (UPR) pathways involving the major PROSC and TRiC chaperone complexes. Artemisinin-resistant parasites also exhibit decelerated progression through the first part of the asexual intraerythrocytic development cycle. These findings suggest that artemisinin-resistant parasites remain in a state of decelerated development at the young ring stage, whereas their up-regulated UPR pathways mitigate protein damage caused by artemisinin. The expression profiles of UPR-related genes also associate with the geographical origin of parasite isolates, further suggesting their role in emerging artemisinin resistance in the Greater Mekong Subregion.	[Mok, Sachel; Ferreira, Pedro E.; Zhu, Lei; Lin, Zhaoting; Yeo, Tomas; Preiser, Peter R.; Bozdech, Zbynek] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Ashley, Elizabeth A.; Newton, Paul N.; Tripura, Rupam; Woodrow, Charles J.; Miotto, Olivo; Day, Nicholas P. J.; White, Nicholas J.; Dondorp, Arjen M.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Ashley, Elizabeth A.; Dhorda, Mehul; Newton, Paul N.; Woodrow, Charles J.; Nosten, Francois; Day, Nicholas P. J.; White, Nicholas J.; Dondorp, Arjen M.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [Chotivanich, Kesinee; Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok 10700, Thailand; [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Dhorda, Mehul] Mahidol Univ, Asia Reg Ctr, WorldWide Antimalarial Resistance Network WWARN, Bangkok 10700, Thailand; [Dhorda, Mehul] Univ Maryland, Sch Med, WorldWide Antimalarial Resistance Network, Baltimore, MD 21201 USA; [Nguon, Chea; Lim, Pharath; Suon, Seila] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Lim, Pharath; Amaratunga, Chanaki; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Tran Tinh Hien] Hosp Trop Dis, OUCRU, Ho Chi Minh City, Vietnam; [Htut, Ye] Dept Med Res, Lower Myanmar, Yangon, Myanmar; [Faiz, M. Abul] Malaria Res Grp & Dev Care Fdn, Dhaka, Bangladesh; [Onyamboko, Marie A.] Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Mayxay, Mayfong; Newton, Paul N.] Lao Oxford Mahosot Hosp, Wellcome Trust Res Unit, Mahosot Hosp, Viangchan, Laos; [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos; [Miotto, Olivo; Kwiatkowski, Dominic P.] Univ Oxford, Ctr Genom & Global Hlth, MRC, Oxford, England; [Miotto, Olivo; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge, England; [Nosten, Francois] Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Mahidol University; Mahidol University; Mahidol University; Worldwide Antimalarial Resistance Network (WWARN); University System of Maryland; University of Maryland Baltimore; Worldwide Antimalarial Resistance Network (WWARN); National Center Parasitology, Entomology & Malaria Control; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford; Wellcome Trust Sanger Institute; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Bozdech, Z (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	zbozdech@ntu.edu.sg	Miotto, Olivo/AAE-7124-2019; Nosten, Francois/AAC-5509-2019; Imwong, Mallika/ABE-6493-2020; White, Nick/AAC-6527-2019; Ferreira, Pedro/HDO-1346-2022; Ferreira, Pedro/AAD-4309-2020; Bozdech, Zbynek/A-2205-2011; Preiser, Peter R/A-2201-2011; Lim, Pharath/AAF-6699-2020; Ferreira, Pedro/Q-6748-2016	Miotto, Olivo/0000-0001-8060-6771; Nosten, Francois/0000-0002-7951-0745; White, Nick/0000-0002-1897-1978; Ferreira, Pedro/0000-0002-2682-7722; Ferreira, Pedro/0000-0002-2682-7722; Lim, Pharath/0000-0002-1012-2461; , Peter/0000-0003-4331-7000; Ashley, Elizabeth/0000-0002-7620-4822; Woodrow, Charles/0000-0002-5134-7165; Mok, Sachel/0000-0002-9605-0154; Kwiatkowski, Dominic/0000-0002-5023-0176; Newton, Paul/0000-0002-4608-6431; Yeo, Tomas/0000-0003-2923-6060; Bozdech, Zbynek/0000-0002-9830-8446	Singapore National Medical Council [NMRC/1265/2010, NMRC/1292/2011]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID); UK Department for International Development (DFID); Wellcome Trust of Great Britain; Wellcome Trust; Wellcome Trust Sanger Institute [098051]; WorldWide Antimalarial Resistance Network; Intramural Research Program of NIAID; Bill AMP; Melinda Gates Foundation	Singapore National Medical Council(National Medical Research Council, Singapore); Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID); UK Department for International Development (DFID); Wellcome Trust of Great Britain(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Sanger Institute(Wellcome Trust); WorldWide Antimalarial Resistance Network; Intramural Research Program of NIAID; Bill AMP; Melinda Gates Foundation(CGIAR)	Supported by Singapore National Medical Council grants NMRC/1265/2010 and NMRC/1292/2011 and by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID). We are very grateful to the patients, doctors, nurses, and laboratory technicians who participated in the TRAC clinical studies. TRAC was funded by the UK Department for International Development (DFID) for the benefit of developing countries and coordinated by the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme funded by the Wellcome Trust of Great Britain. Whole-genome sequencing and genotyping for TRAC were funded by the Wellcome Trust through core funding of the Wellcome Trust Sanger Institute (grant 098051). Additional support was given by the WorldWide Antimalarial Resistance Network, the Intramural Research Program of NIAID, and the Bill & Melinda Gates Foundation. The views expressed and information contained in this publication are not necessarily those of or endorsed by DFID or the other funders, which can accept no responsibility for such views or for any reliance placed on them. We thank W. Guo, K.-Y. Liong, and J. Sim for their assistance. The microarray data have been deposited in NCBI's Gene Expression Omnibus (GEO) and are accessible through GEO Series accession number GSE59099.	Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Cheng Q, 2012, INT J PARASITOL-DRUG, V2, P249, DOI 10.1016/j.ijpddr.2012.01.001; Digaleh H, 2013, CELL MOL LIFE SCI, V70, P4681, DOI 10.1007/s00018-013-1409-y; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Khattak AA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-310; Klonis N, 2013, P NATL ACAD SCI USA, V110, P5157, DOI 10.1073/pnas.1217452110; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Leang R, 2013, ANTIMICROB AGENTS CH, V57, P818, DOI 10.1128/AAC.00686-12; Meshnick SR, 1996, MICROBIOL REV, V60, P301, DOI 10.1128/MMBR.60.2.301-315.1996; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mok S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-391; Oakley MS, 2011, TRENDS PARASITOL, V27, P442, DOI 10.1016/j.pt.2011.06.004; Pavithra SR, 2007, PLOS COMPUT BIOL, V3, P1701, DOI 10.1371/journal.pcbi.0030168; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Saralamba S, 2011, P NATL ACAD SCI USA, V108, P397, DOI 10.1073/pnas.1006113108; Saunders DL, 2014, NEW ENGL J MED, V371, P484, DOI 10.1056/NEJMc1403007; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Tongaonkar P, 2009, J BIOL CHEM, V284, P5602, DOI 10.1074/jbc.M806664200; Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-278; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4	30	245	253	1	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					431	435		10.1126/science.1260403	http://dx.doi.org/10.1126/science.1260403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25502316	Green Accepted			2022-12-28	WOS:000348225800046
J	Ling, LL; Schneider, T; Peoples, AJ; Spoering, AL; Engels, I; Conlon, BP; Mueller, A; Schaberle, TF; Hughes, DE; Epstein, S; Jones, M; Lazarides, L; Steadman, VA; Cohen, DR; Felix, CR; Fetterman, KA; Millett, WP; Nitti, AG; Zullo, AM; Chen, C; Lewis, K				Ling, Losee L.; Schneider, Tanja; Peoples, Aaron J.; Spoering, Amy L.; Engels, Ina; Conlon, Brian P.; Mueller, Anna; Schaeberle, Till F.; Hughes, Dallas E.; Epstein, Slava; Jones, Michael; Lazarides, Linos; Steadman, Victoria A.; Cohen, Douglas R.; Felix, Cintia R.; Fetterman, K. Ashley; Millett, William P.; Nitti, Anthony G.; Zullo, Ashley M.; Chen, Chao; Lewis, Kim			A new antibiotic kills pathogens without detectable resistance	NATURE			English	Article							CELL-WALL BIOSYNTHESIS; PRECURSOR LIPID II; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PNEUMONIAE; PEPTIDOGLYCAN PRECURSOR; VANCOMYCIN-RESISTANCE; ENTEROCOCCUS-FAECIUM; ESCHERICHIA-COLI; IN-VITRO; DISCOVERY	Antibiotic resistance is spreading faster than the introduction of new compounds into clinical practice, causing a public health crisis. Most antibiotics were produced by screening soil microorganisms, but this limited resource of cultivable bacteria was overmined by the 1960s. Synthetic approaches to produce antibiotics have been unable to replace this platform. Uncultured bacteria make up approximately 99% of all species in external environments, and are an untapped source of new antibiotics. We developed several methods to grow uncultured organisms by cultivation in situ or by using specific growth factors. Here we report a new antibiotic that we term teixobactin, discovered in a screen of uncultured bacteria. Teixobactin inhibits cell wall synthesis by binding to a highly conserved motif of lipid II (precursor of peptidoglycan) and lipid III (precursor of cell wall teichoic acid). We did not obtain any mutants of Staphylococcus aureus or Mycobacterium tuberculosis resistant to teixobactin. The properties of this compound suggest a path towards developing antibiotics that are likely to avoid development of resistance.	[Ling, Losee L.; Peoples, Aaron J.; Spoering, Amy L.; Hughes, Dallas E.; Cohen, Douglas R.; Felix, Cintia R.; Fetterman, K. Ashley; Millett, William P.; Nitti, Anthony G.; Zullo, Ashley M.] NovoBiot Pharmaceut, Cambridge, MA 02138 USA; [Schneider, Tanja; Engels, Ina; Mueller, Anna] Univ Bonn, Immunol & Parasitol Pharmaceut Microbiol Sect, Inst Med Microbiol, D-53115 Bonn, Germany; [Schneider, Tanja; Engels, Ina; Mueller, Anna; Schaeberle, Till F.] German Ctr Infect Res DZIF, D-53115 Bonn, Germany; [Conlon, Brian P.; Chen, Chao; Lewis, Kim] Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA; [Schaeberle, Till F.] Univ Bonn, Inst Pharmaceut Biol, D-53115 Bonn, Germany; [Epstein, Slava] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Jones, Michael; Lazarides, Linos; Steadman, Victoria A.] Selcia, Ongar CM5 0GS, Essex, England	University of Bonn; German Center for Infection Research; Northeastern University; University of Bonn; Northeastern University	Lewis, K (corresponding author), Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA.	k.lewis@neu.edu	Chen, Chao/J-7879-2015; Schneider, Tanja/L-8049-2013; Mueller, Anna/L-9779-2017	Mueller, Anna/0000-0001-6420-3868; Conlon, Brian/0000-0002-2155-8375; Schneider, Tanja/0000-0001-7269-4716; Cohen, Douglas/0000-0002-7625-714X	NIH [T-R01 AI085585, AI085612]; Charles A. King Trust; German Research Foundation (DFG) [SCHN1284/1-2]; German Center for Infection Research (DZIF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085585, R43AI085612] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King Trust; German Research Foundation (DFG)(German Research Foundation (DFG)); German Center for Infection Research (DZIF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant T-R01 AI085585 to K.L., by NIH grant AI085612 to A.L.S., by the Charles A. King Trust to B.P.C., and by the German Research Foundation (DFG; SCHN1284/1-2) and the German Center for Infection Research (DZIF) to T.S. and I.E. The NRS strains were provided by the Network on Antimicrobial Resistance in Staphylococcus aureus for distribution by BEI Resources, NIAID, NIH. Preclinical Services offered by NIAID are gratefully acknowledged. We thank H. G. Sahl for reading the manuscript and making comments, A. Makriyannis for suggestions, P. Muller, B. Berdyand S. Kaluziak for taxonomy analysis, and M. Josten for performing mass spectrometry analysis.	Arhin FF, 2008, ANTIMICROB AGENTS CH, V52, P1597, DOI 10.1128/AAC.01513-07; Arthur M, 1996, MOL MICROBIOL, V21, P33, DOI 10.1046/j.1365-2958.1996.00617.x; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Auch AF, 2010, STAND GENOMIC SCI, V2, P142, DOI 10.4056/sigs.541628; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; BIERBAUM G, 1985, ARCH MICROBIOL, V141, P249, DOI 10.1007/BF00408067; Bogdanovich T, 2005, ANTIMICROB AGENTS CH, V49, P4210, DOI 10.1128/AAC.49.10.4210-4219.2005; Brotz H, 1997, EUR J BIOCHEM, V246, P193, DOI 10.1111/j.1432-1033.1997.t01-1-00193.x; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; Degen D, 2014, ELIFE, V3, DOI 10.7554/eLife.02451; Doroghazi JR, 2014, NAT CHEM BIOL, V10, P963, DOI [10.1038/NCHEMBIO.1659, 10.1038/nchembio.1659]; El Ghachi M, 2005, J BIOL CHEM, V280, P18689, DOI 10.1074/jbc.M412277200; El Ghachi M, 2004, J BIOL CHEM, V279, P30106, DOI 10.1074/jbc.M401701200; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kardos N, 2011, APPL MICROBIOL BIOT, V92, P677, DOI 10.1007/s00253-011-3587-6; Kollef MH, 2007, CLIN INFECT DIS, V45, pS191, DOI 10.1086/519470; LAZAREVIC V, 1995, MOL MICROBIOL, V16, P345, DOI 10.1111/j.1365-2958.1995.tb02306.x; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Lewis K, 2012, NATURE, V485, P439, DOI 10.1038/485439a; Marshall CG, 1997, P NATL ACAD SCI USA, V94, P6480, DOI 10.1073/pnas.94.12.6480; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Metzler K, 2013, J ANTIMICROB CHEMOTH, V68, P631, DOI 10.1093/jac/dks461; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Muller A, 2012, MICROB DRUG RESIST, V18, P261, DOI 10.1089/mdr.2011.0242; Nichols D, 2008, APPL ENVIRON MICROB, V74, P4889, DOI 10.1128/AEM.00393-08; Nichols D, 2010, APPL ENVIRON MICROB, V76, P2445, DOI 10.1128/AEM.01754-09; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Sakoulas G, 2004, J CLIN MICROBIOL, V42, P2398, DOI 10.1128/JCM.42.6.2398-2402.2004; Schatz A, 1944, P SOC EXP BIOL MED, V55, P66, DOI 10.3181/00379727-55-14461; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Schneider T, 2009, ANTIMICROB AGENTS CH, V53, P1610, DOI 10.1128/AAC.01040-08; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schneider T, 2010, INT J MED MICROBIOL, V300, P161, DOI 10.1016/j.ijmm.2009.10.005; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; Spellberg B, 2014, CLIN PHARMACOL THER, V96, P151, DOI 10.1038/clpt.2014.106; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Xayarath B, 2007, J BACTERIOL, V189, P3369, DOI 10.1128/JB.01938-06	50	1473	1528	39	2940	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					455	+		10.1038/nature14098	http://dx.doi.org/10.1038/nature14098			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25561178	Green Accepted			2022-12-28	WOS:000348196500028
J	Neafsey, DE; Waterhouse, RM; Abai, MR; Aganezov, SS; Alekseyev, MA; Allen, JE; Amon, J; Arca, B; Arensburger, P; Artemov, G; Assour, LA; Basseri, H; Berlin, A; Birren, BW; Blandin, SA; Brockman, AI; Burkot, TR; Burt, A; Chan, CS; Chauve, C; Chiu, JC; Christensen, M; Costantini, C; Davidson, VLM; Deligianni, E; Dottorini, T; Dritsou, V; Gabriel, SB; Guelbeogo, WM; Hall, AB; Han, MV; Hlaing, T; Hughes, DST; Jenkins, AM; Jiang, XF; Jungreis, I; Kakani, EG; Kamali, M; Kemppainen, P; Kennedy, RC; Kirmitzoglou, IK; Koekemoer, LL; Laban, N; Langridge, N; Lawniczak, MKN; Lirakis, M; Lobo, NF; Lowy, E; MacCallum, RM; Mao, CH; Maslen, G; Mbogo, C; McCarthy, J; Michel, K; Mitchell, SN; Moore, W; Murphy, KA; Naumenko, AN; Nolan, T; Novoa, EM; O'Loughlin, S; Oringanje, C; Oshaghi, MA; Pakpour, N; Papathanos, PA; Peery, AN; Povelones, M; Prakash, A; Price, DP; Rajaraman, A; Reimer, LJ; Rinker, DC; Rokas, A; Russell, TL; Sagnon, N; Sharakhova, MV; Shea, T; Simao, FA; Simard, F; Slotman, MA; Somboon, P; Stegniy, V; Struchiner, CJ; Thomas, GWC; Tojo, M; Topalis, P; Tubio, JMC; Unger, MF; Vontas, J; Walton, C; Wilding, CS; Willis, JH; Wu, YC; Yan, GY; Zdobnov, EM; Zhou, XF; Catteruccia, F; Christophides, GK; Collins, FH; Cornman, RS; Crisanti, A; Donnelly, MJ; Emrich, SJ; Fontaine, MC; Gelbart, W; Hahn, MW; Hansen, IA; Howell, PI; Kafatos, FC; Kellis, M; Lawson, D; Louis, C; Luckhart, S; Muskavitch, MAT; Ribeiro, JM; Riehle, MA; Sharakhov, IV; Tu, ZJ; Zwiebel, LJ; Besansky, NJ				Neafsey, Daniel E.; Waterhouse, Robert M.; Abai, Mohammad R.; Aganezov, Sergey S.; Alekseyev, Max A.; Allen, James E.; Amon, James; Arca, Bruno; Arensburger, Peter; Artemov, Gleb; Assour, Lauren A.; Basseri, Hamidreza; Berlin, Aaron; Birren, Bruce W.; Blandin, Stephanie A.; Brockman, Andrew I.; Burkot, Thomas R.; Burt, Austin; Chan, Clara S.; Chauve, Cedric; Chiu, Joanna C.; Christensen, Mikkel; Costantini, Carlo; Davidson, Victoria L. M.; Deligianni, Elena; Dottorini, Tania; Dritsou, Vicky; Gabriel, Stacey B.; Guelbeogo, Wamdaogo M.; Hall, Andrew B.; Han, Mira V.; Hlaing, Thaung; Hughes, Daniel S. T.; Jenkins, Adam M.; Jiang, Xiaofang; Jungreis, Irwin; Kakani, Evdoxia G.; Kamali, Maryam; Kemppainen, Petri; Kennedy, Ryan C.; Kirmitzoglou, Ioannis K.; Koekemoer, Lizette L.; Laban, Njoroge; Langridge, Nicholas; Lawniczak, Mara K. N.; Lirakis, Manolis; Lobo, Neil F.; Lowy, Ernesto; MacCallum, Robert M.; Mao, Chunhong; Maslen, Gareth; Mbogo, Charles; McCarthy, Jenny; Michel, Kristin; Mitchell, Sara N.; Moore, Wendy; Murphy, Katherine A.; Naumenko, Anastasia N.; Nolan, Tony; Novoa, Eva M.; O'Loughlin, Samantha; Oringanje, Chioma; Oshaghi, Mohammad A.; Pakpour, Nazzy; Papathanos, Philippos A.; Peery, Ashley N.; Povelones, Michael; Prakash, Anil; Price, David P.; Rajaraman, Ashok; Reimer, Lisa J.; Rinker, David C.; Rokas, Antonis; Russell, Tanya L.; Sagnon, N'Fale; Sharakhova, Maria V.; Shea, Terrance; Simao, Felipe A.; Simard, Frederic; Slotman, Michel A.; Somboon, Pradya; Stegniy, Vladimir; Struchiner, Claudio J.; Thomas, Gregg W. C.; Tojo, Marta; Topalis, Pantelis; Tubio, Jose M. C.; Unger, Maria F.; Vontas, John; Walton, Catherine; Wilding, Craig S.; Willis, Judith H.; Wu, Yi-Chieh; Yan, Guiyun; Zdobnov, Evgeny M.; Zhou, Xiaofan; Catteruccia, Flaminia; Christophides, George K.; Collins, Frank H.; Cornman, Robert S.; Crisanti, Andrea; Donnelly, Martin J.; Emrich, Scott J.; Fontaine, Michael C.; Gelbart, William; Hahn, Matthew W.; Hansen, Immo A.; Howell, Paul I.; Kafatos, Fotis C.; Kellis, Manolis; Lawson, Daniel; Louis, Christos; Luckhart, Shirley; Muskavitch, Marc A. T.; Ribeiro, Jose M.; Riehle, Michael A.; Sharakhov, Igor V.; Tu, Zhijian; Zwiebel, Laurence J.; Besansky, Nora J.			Highly evolvable malaria vectors: The genomes of 16 Anopheles mosquitoes	SCIENCE			English	Article							ANTENNAL TRANSCRIPTOME PROFILES; SEX-CHROMOSOME EVOLUTION; GENE-EXPRESSION; AEDES-AEGYPTI; R CONSENSUS; PROTEIN; GAMBIAE; ANNOTATION; FAMILY; DARLINGI	Variation in vectorial capacity for human malaria among Anopheles mosquito species is determined by many factors, including behavior, immunity, and life history. To investigate the genomic basis of vectorial capacity and explore new avenues for vector control, we sequenced the genomes of 16 anopheline mosquito species from diverse locations spanning similar to 100 million years of evolution. Comparative analyses show faster rates of gene gain and loss, elevated gene shuffling on the X chromosome, and more intron losses, relative to Drosophila. Some determinants of vectorial capacity, such as chemosensory genes, do not show elevated turnover but instead diversify through protein-sequence changes. This dynamism of anopheline genes and genomes may contribute to their flexible capacity to take advantage of new ecological niches, including adapting to humans as primary hosts.	[Neafsey, Daniel E.; Berlin, Aaron; Birren, Bruce W.; Shea, Terrance] Broad Inst, Genome Sequencing & Anal Program, Cambridge, MA 02142 USA; [Waterhouse, Robert M.; Chan, Clara S.; Jungreis, Irwin; Novoa, Eva M.; Wu, Yi-Chieh; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Waterhouse, Robert M.; Chan, Clara S.; Jungreis, Irwin; Novoa, Eva M.; Wu, Yi-Chieh; Kellis, Manolis] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Waterhouse, Robert M.; Simao, Felipe A.; Zdobnov, Evgeny M.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Waterhouse, Robert M.; Simao, Felipe A.; Zdobnov, Evgeny M.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Abai, Mohammad R.; Basseri, Hamidreza; Oshaghi, Mohammad A.] Univ Tehran Med Sci, Dept Med Entomol & Vector Control, Sch Publ Hlth, Tehran, Iran; [Abai, Mohammad R.; Basseri, Hamidreza; Oshaghi, Mohammad A.] Univ Tehran Med Sci, Inst Hlth Res, Tehran, Iran; [Aganezov, Sergey S.; Alekseyev, Max A.] George Washington Univ, Dept Math, Ashburn, VA 20147 USA; [Aganezov, Sergey S.; Alekseyev, Max A.] George Washington Univ, Computat Biol Inst, Ashburn, VA 20147 USA; [Allen, James E.; Christensen, Mikkel; Hughes, Daniel S. T.; Langridge, Nicholas; Lowy, Ernesto; Maslen, Gareth; Lawson, Daniel] EMBL EBI, Cambridge CB10 1SD, England; [Amon, James] Minist Hlth, Natl Vector Borne Dis Control Programme, Port Vila, Tafea Province, Vanuatu; [Arca, Bruno] Univ Roma La Sapienza, Div Parasitol, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy; [Arensburger, Peter; McCarthy, Jenny] Calif State Polytech Pomona, Dept Biol Sci, Pomona, CA 91768 USA; [Artemov, Gleb; Stegniy, Vladimir] Tomsk State Univ, Tomsk 634050, Russia; [Assour, Lauren A.; Emrich, Scott J.] Univ Notre Dame, Eck Inst Global Hlth, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Blandin, Stephanie A.] INSERM, U963, F-67084 Strasbourg, France; [Blandin, Stephanie A.] CNRS, UPR9022, IBMC, F-67084 Strasbourg, France; [Brockman, Andrew I.; Dottorini, Tania; Kirmitzoglou, Ioannis K.; Lawniczak, Mara K. N.; MacCallum, Robert M.; Nolan, Tony; Papathanos, Philippos A.; Christophides, George K.; Crisanti, Andrea; Kafatos, Fotis C.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Burkot, Thomas R.; Russell, Tanya L.] James Cook Univ, Australian Inst Trop Hlth Med, Fac Med Hlth & Mol Sci, Cairns 4870, Australia; [Burt, Austin; O'Loughlin, Samantha] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Chauve, Cedric; Rajaraman, Ashok] Simon Fraser Univ, Dept Math, Burnaby, BC V5A 1S6, Canada; [Chiu, Joanna C.; Murphy, Katherine A.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Costantini, Carlo; Simard, Frederic] Inst Rech Dev, Unites Mixtes Rech Malad Infect & Vecteurs Ecol G, F-64501 Montpellier, France; [Davidson, Victoria L. M.; Michel, Kristin] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Deligianni, Elena; Topalis, Pantelis; Louis, Christos] Fdn Res & Technol, Inst Mol Biol & Biotechnol, GR-70013 Iraklion, Crete, Greece; [Dritsou, Vicky; Papathanos, Philippos A.; Crisanti, Andrea; Louis, Christos] Univ Perugia, Ctr Funct Genom, I-06100 Perugia, Italy; [Gabriel, Stacey B.] Broad Inst, Cambridge, MA 02142 USA; [Guelbeogo, Wamdaogo M.; Sagnon, N'Fale] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Hall, Andrew B.; Jiang, Xiaofang; Sharakhov, Igor V.; Tu, Zhijian] Virginia Polytech Inst & State Univ, Program Genet Bioinformat & Computat Biol, Blacksburg, VA 24061 USA; [Han, Mira V.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Hlaing, Thaung] Dept Med Res, Dagon Township 11191, Yangon, Myanmar; [Hughes, Daniel S. T.] Baylor Coll Med, Houston, TX 77030 USA; [Jenkins, Adam M.; Muskavitch, Marc A. T.] Boston Coll, Chestnut Hill, MA 02467 USA; [Jiang, Xiaofang; Tu, Zhijian] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Kakani, Evdoxia G.; Mitchell, Sara N.; Catteruccia, Flaminia] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Kakani, Evdoxia G.; Catteruccia, Flaminia] Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, Perugia, Italy; [Kamali, Maryam; Naumenko, Anastasia N.; Peery, Ashley N.; Sharakhova, Maria V.; Sharakhov, Igor V.] Virginia Polytech Inst & State Univ, Dept Entomol, Blacksburg, VA 24061 USA; [Kemppainen, Petri; Walton, Catherine] Univ Manchester, Fac Life Sci, Computat Evolutionary Biol Grp, Oxford M13 9PT, England; [Kennedy, Ryan C.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Kirmitzoglou, Ioannis K.] Univ Cyprus, Dept Biol Sci, Bioinformat Res Lab, CY-1678 Nicosia, Cyprus; [Koekemoer, Lizette L.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Wits Res Inst Malaria, Fac Hlth Sci, ZA-2131 Johannesburg, South Africa; [Koekemoer, Lizette L.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Vector Control Reference Unit, ZA-2131 Johannesburg, South Africa; [Laban, Njoroge] Natl Museums Kenya, Nairobi, Kenya; [Lirakis, Manolis; Vontas, John; Louis, Christos] Univ Crete, Dept Biol, GR-70013 Iraklion, Greece; [Lobo, Neil F.; Unger, Maria F.; Collins, Frank H.; Fontaine, Michael C.; Besansky, Nora J.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Lobo, Neil F.; Unger, Maria F.; Collins, Frank H.; Fontaine, Michael C.; Besansky, Nora J.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Mao, Chunhong] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Mbogo, Charles] Ctr Geog Med Res, Kenya Med Res Inst, Wellcome Trust Res Programme, Kilifi, Kenya; [Moore, Wendy; Oringanje, Chioma; Riehle, Michael A.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Pakpour, Nazzy; Luckhart, Shirley] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Povelones, Michael] Univ Penn, Sch Vet Med, Dept Pathol, Philadelphia, PA 19104 USA; [Prakash, Anil] Indian Council Med Res, Reg Med Res Ctr NE, Dibrugarh 786001, Assam, India; [Price, David P.; Hansen, Immo A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Price, David P.; Hansen, Immo A.] New Mexico State Univ, Mol Biol Program, Las Cruces, NM 88003 USA; [Reimer, Lisa J.; Donnelly, Martin J.] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Rinker, David C.; Rokas, Antonis] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37235 USA; [Rokas, Antonis; Zhou, Xiaofan] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Slotman, Michel A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77807 USA; [Somboon, Pradya] Chiang Mai Univ, Fac Med, Dept Parasitol, Chiang Mai 50200, Thailand; [Struchiner, Claudio J.] Fundacao Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Struchiner, Claudio J.] Univ Estado Rio de Janeiro, Inst Social Med, BR-20550011 Rio De Janeiro, Brazil; [Thomas, Gregg W. C.; Hahn, Matthew W.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA; [Tojo, Marta] Univ Santiago de Compostela, Inst Invest Sanitarias, Ctr Res Mol Med & Chron Dis, Sch Med,Dept Physiol, La Coruna, Spain; [Tubio, Jose M. C.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Wilding, Craig S.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 3AF, Merseyside, England; [Willis, Judith H.; Cornman, Robert S.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Wu, Yi-Chieh] Harvey Mudd Coll, Dept Comp Sci, Claremont, CA 91711 USA; [Yan, Guiyun] Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92697 USA; [Donnelly, Martin J.] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge CB10 1SJ, England; [Fontaine, Michael C.] Univ Groningen, Ctr Evolutionary & Ecol Studies, Marine Evolut & Conservat Grp, NL-9747 AG Groningen, Netherlands; [Gelbart, William] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hahn, Matthew W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Howell, Paul I.] Ctr Dis Control & Prevent, Atlanta, GA 30329 USA; [Muskavitch, Marc A. T.] Biogen Idec Inc, Cambridge, MA 02142 USA; [Ribeiro, Jose M.] NIAID, Lab Malaria & Vector Res, Rockville, MD 20852 USA; [Zwiebel, Laurence J.] Vanderbilt Univ & Med Ctr, Dept Biol Sci, Inst Chem Biol, Nashville, TN 37235 USA; [Zwiebel, Laurence J.] Vanderbilt Univ & Med Ctr, Dept Pharmacol, Inst Genet & Global Hlth, Nashville, TN 37235 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Geneva; Swiss Institute of Bioinformatics; Tehran University of Medical Sciences; Tehran University of Medical Sciences; George Washington University; George Washington University; European Molecular Biology Laboratory (EMBL); Sapienza University Rome; Tomsk State University; University of Notre Dame; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Imperial College London; James Cook University; Imperial College London; Simon Fraser University; University of California System; University of California Davis; Institut de Recherche pour le Developpement (IRD); Kansas State University; University of Perugia; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Virginia Polytechnic Institute & State University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Baylor College of Medicine; Boston College; Virginia Polytechnic Institute & State University; Harvard University; Harvard T.H. Chan School of Public Health; University of Perugia; Virginia Polytechnic Institute & State University; University of Manchester; University of California System; University of California San Francisco; University of Cyprus; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Crete; University of Notre Dame; University of Notre Dame; Virginia Polytechnic Institute & State University; Kenya Medical Research Institute; University of Arizona; University of California System; University of California Davis; University of Pennsylvania; Indian Council of Medical Research (ICMR); New Mexico State University; New Mexico State University; Liverpool School of Tropical Medicine; Vanderbilt University; Vanderbilt University; Texas A&M University System; Texas A&M University College Station; Chiang Mai University; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Indiana University System; Indiana University Bloomington; Universidade de Santiago de Compostela; Wellcome Trust Sanger Institute; Liverpool John Moores University; University System of Georgia; University of Georgia; Claremont Colleges; Harvey Mudd College; University of California System; University of California Irvine; Wellcome Trust Sanger Institute; University of Groningen; Harvard University; Indiana University System; Indiana University Bloomington; Centers for Disease Control & Prevention - USA; Biogen; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vanderbilt University; Vanderbilt University	Neafsey, DE (corresponding author), Broad Inst, Genome Sequencing & Anal Program, 415 Main St, Cambridge, MA 02142 USA.	neafsey@broadinstitute.org; nbesansk@nd.edu	Vontas, John/X-5112-2018; Riehle, Michael A/O-2852-2017; Frederic, SIMARD/AFV-5001-2022; Artemov, Gleb/E-7935-2019; Zdobnov, Evgeny/AAB-2745-2022; Zdobnov, Evgeny M/K-1133-2012; Kamali, Maryam/AAH-4252-2020; Zhou, Xiaofan/H-2958-2019; Berlin, Aaron M/AFY-6549-2022; Somboon, Pradya/AAL-3458-2020; Struchiner, Claudio Jose/HGB-9492-2022; Novoa, Eva Maria/B-1004-2015; SIMARD, Frederic/J-9489-2016; Mitchell, Sara/AAB-5536-2020; Blandin, Stephanie/I-2786-2016; Stegniy, Vladimir/N-7656-2014; Ribeiro, Jose/J-7011-2015; Kellis, Manolis/ABE-7385-2020; Stegniy, Vladimir/ABC-6763-2020; Tubio, Jose M.C./H-5076-2015; Costantini, Carlo/F-3470-2012; Russell, Tanya/AAF-2296-2020; Sharakhov, Igor/B-1972-2008; Tubio, Jose/AAG-7345-2019; Artemov, Gleb N./N-7651-2014; Papathanos, Philippos/ABE-4869-2021; Oshaghi, Mohammad A/H-8373-2016; Blandin, Stephanie/ABH-2267-2021; Waterhouse, Robert M/A-1858-2010; Alekseyev, Max/D-9362-2016; Rokas, Antonis/A-9775-2008; Simao Neto, Felipe/L-7844-2017; Wilding, Craig S/C-5500-2012; Struchiner, Claudio J/M-9360-2013; Nolan, Tony/I-4925-2012; Mitchell, Sara/I-3104-2014; Fontaine, Michael/G-5350-2011; Arca, Bruno/C-8383-2012; Allen, James/B-2457-2009; Novoa, Eva Maria/B-1004-2015	Vontas, John/0000-0002-8704-2574; Frederic, SIMARD/0000-0002-2871-5329; Zdobnov, Evgeny/0000-0002-5178-1498; Zhou, Xiaofan/0000-0002-2879-6317; Berlin, Aaron M/0000-0002-0714-2808; Novoa, Eva Maria/0000-0002-9367-6311; SIMARD, Frederic/0000-0002-2871-5329; Blandin, Stephanie/0000-0003-4566-1200; Kellis, Manolis/0000-0001-7113-9630; Stegniy, Vladimir/0000-0001-8947-041X; Tubio, Jose M.C./0000-0003-3540-2459; Costantini, Carlo/0000-0003-1016-129X; Russell, Tanya/0000-0002-0920-6844; Sharakhov, Igor/0000-0003-0752-3747; Tubio, Jose/0000-0003-3540-2459; Blandin, Stephanie/0000-0003-4566-1200; Waterhouse, Robert M/0000-0003-4199-9052; Alekseyev, Max/0000-0002-5140-8095; Rokas, Antonis/0000-0002-7248-6551; Wilding, Craig S/0000-0001-5818-2706; Struchiner, Claudio J/0000-0003-2114-847X; Nolan, Tony/0000-0002-2982-8333; Christensen, Mikkel/0000-0003-4291-0611; Lawniczak, Mara/0000-0002-3006-2080; Povelones, Michael/0000-0002-3766-2097; Dottorini, Tania/0000-0001-7733-906X; Rhodes, Victoria/0000-0003-2980-7169; Jiang, Xiaofang/0000-0002-0955-8284; Reimer, Lisa/0000-0002-9711-4981; Crisanti, Andrea/0000-0002-2406-4426; Riehle, Michael/0000-0001-9747-3872; Mitchell, Sara/0000-0002-7926-1881; Chiu, Joanna/0000-0001-7613-8127; Lowy Gallego, Ernesto/0000-0001-9312-1159; Zwiebel, Laurence/0000-0001-6686-7289; Fontaine, Michael/0000-0003-1156-4154; Hahn, Matthew/0000-0002-5731-8808; Lawson, Daniel/0000-0001-7765-983X; Catteruccia, Flaminia/0000-0003-3295-6683; Moore, Wendy/0000-0003-4441-6203; Burt, Austin/0000-0001-5146-9640; Han, Mira/0000-0002-0488-1170; Donnelly, Martin/0000-0001-5218-1497; Arca, Bruno/0000-0002-4029-0984; Somboon, Pradya/0000-0002-0760-4363; chauve, cedric/0000-0001-9837-1878; Ribeiro, Jose/0000-0002-9107-0818; Koekemoer, Lizette/0000-0003-4236-6345; Papathanos, Philippos Aris/0000-0001-8508-4554; Christophides, George/0000-0002-3323-1687; Maslen, Gareth/0000-0001-7318-3678; Allen, James/0000-0002-3894-4854; Walton, Catherine/0000-0001-8801-7103; Novoa, Eva Maria/0000-0001-5567-1299	National Center for Biotechnology Information [PRJNA67511]; MRC [G1100339] Funding Source: UKRI; Medical Research Council [G1100339] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG007234, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095842, R01AI104956, U19AI110818, R21AI101459, R01AI080799, ZIAAI000810, R56AI107263, R01AI063508, U19AI089686, SC1AI109055, R01AI076584, R01AI050243, R01AI073745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation; Div Of Information & Intelligent Systems [1462107] Funding Source: National Science Foundation	National Center for Biotechnology Information; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	All sequencing reads and genome assemblies have been submitted to the National Center for Biotechnology Information (umbrella BioProject ID, PRJNA67511). Genome and transcriptome assemblies are also available from VectorBase (https://vectorbase.org) and the Broad Institute (https://olive.broadinstitute.org/collections/anopheles.4). The authors acknowledge the NIH Eukaryotic Pathogen and Disease Vector Sequencing Project Working Group for guidance and development of this project. Sequence data generation was supported at the Broad Institute by the National Human Genome Research Institute (U54 HG003067). We thank the many members of the Broad Institute Genomics Platform and Genome Sequencing and Analysis Program who contributed to sequencing data generation and analysis.	Altstein M, 2010, ADV EXP MED BIOL, V692, P155; Antonova Y., 2012, INSECT ENDOCRINOL, P63, DOI DOI 10.1016/B978-0-12-384749-2.10002-0; Arca B, 2014, INSECT MOL BIOL, V23, P122, DOI 10.1111/imb.12068; Assis R, 2012, GENOME BIOL EVOL, V4, P1189, DOI 10.1093/gbe/evs093; Bahia AC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001317; Baker DA, 2011, GENETICS, V189, P1117, DOI 10.1534/genetics.111.133157; Baldini F, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001695; Baldini F, 2012, PATHOG GLOB HEALTH, V106, P82, DOI 10.1179/2047773212Y.0000000016; Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959; Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162; Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200; Cipressa F, 2013, GENETICS, V195, P147, DOI 10.1534/genetics.113.153320; Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Cornman RS, 2009, INSECT MOL BIOL, V18, P607, DOI 10.1111/j.1365-2583.2009.00902.x; Cornman RS, 2008, INSECT BIOCHEM MOLEC, V38, P661, DOI 10.1016/j.ibmb.2008.04.001; Cornman RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-22; Cornman RS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008345; de Oliveira CD, 2012, J VECTOR ECOL, V37, P351, DOI 10.1111/j.1948-7134.2012.00238.x; Dottorini T, 2007, P NATL ACAD SCI USA, V104, P16215, DOI 10.1073/pnas.0703904104; Fontaine MC, 2015, SCIENCE, V347, DOI 10.1126/science.1258524; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Goetze JP, 2012, FRONT BIOSCI-LANDMRK, V17, P1804, DOI 10.2741/4020; Grath S, 2012, GENOME BIOL EVOL, V4, P346, DOI 10.1093/gbe/evs012; Guittard E, 2011, DEV BIOL, V349, P35, DOI 10.1016/j.ydbio.2010.09.023; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Han MV, 2013, MOL BIOL EVOL, V30, P1987, DOI 10.1093/molbev/mst100; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Isawa H, 2002, J BIOL CHEM, V277, P27651, DOI 10.1074/jbc.M203505200; Jiang XF, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0459-2; Kamali M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093580; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Manguin S., 2008, BIODIVERSITY OF MALA; Marinotti O, 2013, NUCLEIC ACIDS RES, V41, P7387, DOI 10.1093/nar/gkt484; Moreno M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-127; Neafsey DE, 2013, G3-GENES GENOM GENET, V3, P1191, DOI 10.1534/g3.113.006247; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Perry JC, 2014, MOL BIOL EVOL, V31, P1206, DOI 10.1093/molbev/msu072; Riehle MA, 2006, PEPTIDES, V27, P2547, DOI 10.1016/j.peptides.2006.07.016; Rinker DC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-749; Rinker DC, 2013, P NATL ACAD SCI USA, V110, P8260, DOI 10.1073/pnas.1302562110; Rogers DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000272; Shaw WR, 2014, P NATL ACAD SCI USA, V111, P5854, DOI 10.1073/pnas.1401715111; Stracker TH, 2002, J MED ENTOMOL, V39, P331, DOI 10.1603/0022-2585-39.2.331; Swaminathan A, 2012, FRONT BIOSCI-LANDMRK, V17, P909, DOI 10.2741/3964; Togawa T, 2008, INSECT BIOCHEM MOLEC, V38, P508, DOI 10.1016/j.ibmb.2007.12.008; Toups MA, 2010, GENETICS, V186, P763, DOI 10.1534/genetics.110.118794; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhou D, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-42, 10.1186/1471-2164-15-573]	53	349	363	5	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217							1258522	10.1126/science.1258522	http://dx.doi.org/10.1126/science.1258522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554792	Green Accepted, Green Submitted			2022-12-28	WOS:000347102300042
J	Reich, J				Reich, Justin			Rebooting MOOC Research	SCIENCE			English	Editorial Material									Harvard Univ, HarvardX, Cambridge, MA 02476 USA	Harvard University	Reich, J (corresponding author), Harvard Univ, HarvardX, Cambridge, MA 02476 USA.	justin_reich@harvard.edu						Anderson A, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P687; Collins E. D., 2013, SJSU PLUS AUGMENTED; Colvin K., 2014, IRRODL, V15; D'Mello S, 2014, LEARN INSTR, V29, P153, DOI 10.1016/j.learninstruc.2012.05.003; Daries JP, 2014, COMMUN ACM, V57, P56, DOI 10.1145/2643132; Emanuel EJ, 2013, NATURE, V503, P342, DOI 10.1038/503342a; Fiesler C, 2014, 17 ACM C COMPUTER SU, DOI [10.1145/2531602.2531695, DOI 10.1145/2531602.2531695]; Fisher W. W., 2014, 5 HARV HARVARDX; Kizilcec R. F., 2014, ELEARNING PAPERS, V37, P13; Muller DA, 2008, SCI EDUC, V92, P278, DOI 10.1002/sce.20244; Murphy R., 2014, RES USE KHAN ACAD SC; Nesterko S. O., 2014, P 1 ACM C LEARN SCAL, P193; Reich J., 2014, 3 HARV HARVARDX; SIEGLER RS, 1991, AM PSYCHOL, V46, P606, DOI 10.1037/0003-066X.46.6.606; Siemens G., 2014, J LEARN ANAL, V1, P3, DOI [10.18608/jla.2014.11.2, DOI 10.18608/JLA.2014.11.2]; Stokes P., 2013, INSIDE HIGHER; VANHEUVELEN A, 1991, AM J PHYS, V59, P891, DOI 10.1119/1.16667; Wilkowski J., 2014, P 1 ACM C LEARN SCAL, P3	18	191	195	1	283	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					34	35		10.1126/science.1261627	http://dx.doi.org/10.1126/science.1261627			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7NK	25554779				2022-12-28	WOS:000347102300038
J	Delor, M; Scattergood, PA; Sazanovich, IV; Parker, AW; Greetham, GM; Meijer, AJHM; Towrie, M; Weinstein, JA				Delor, Milan; Scattergood, Paul A.; Sazanovich, Igor V.; Parker, Anthony W.; Greetham, Gregory M.; Meijer, Anthony J. H. M.; Towrie, Michael; Weinstein, Julia A.			Toward control of electron transfer in donor-acceptor molecules by bond-specific infrared excitation	SCIENCE			English	Article							PHOTOSYNTHETIC REACTION CENTERS; CHARGE-TRANSFER; EXCITED-STATE; COHERENT CONTROL; BASIS-SETS; DYNAMICS; SPECTROSCOPY; COMPLEXES; CHEMISTRY; PHOTODISSOCIATION	Electron transfer (ET) from donor to acceptor is often mediated by nuclear-electronic (vibronic) interactions in molecular bridges. Using an ultrafast electronic-vibrational-vibrational pulse-sequence, we demonstrate how the outcome of light-induced ET can be radically altered by mode-specific infrared (IR) excitation of vibrations that are coupled to the ET pathway. Picosecond narrow-band IR excitation of high-frequency bridge vibrations in an electronically excited covalent trans-acetylide platinum(II) donor-bridge-acceptor system in solution alters both the dynamics and the yields of competing ET pathways, completely switching a charge separation pathway off. These results offer a step toward quantum control of chemical reactivity by IR excitation.	[Delor, Milan; Scattergood, Paul A.; Sazanovich, Igor V.; Meijer, Anthony J. H. M.; Weinstein, Julia A.] Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England; [Sazanovich, Igor V.; Parker, Anthony W.; Greetham, Gregory M.; Towrie, Michael] Sci & Technol Facil Council, Rutherford Appleton Lab, Cent Laser Facil, Chilton OX11 0QX, Oxon, England	University of Sheffield; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Towrie, M (corresponding author), Sci & Technol Facil Council, Rutherford Appleton Lab, Cent Laser Facil, Res Complex Harwell,Harwell Sci & Innovat Campus, Chilton OX11 0QX, Oxon, England.	mike.towrie@stfc.ac.uk; julia.weinstein@sheffield.ac.uk	Meijer, Anthony J H M/I-9513-2012; Parker, Anthony W./G-5445-2011	Meijer, Anthony J H M/0000-0003-4803-3488; Parker, Anthony W./0000-0003-3094-9762; Scattergood, Paul/0000-0001-9070-5933; Towrie, Mike/0000-0002-1305-701X; Delor, Milan/0000-0002-9480-9235	Engineering and Physical Sciences Research Council, Univ. of Sheffield; Science and Technology Facilities Council	Engineering and Physical Sciences Research Council, Univ. of Sheffield; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We are grateful to M. Newton (Brookhaven National Laboratory), D. Phillips (Imperial College London), A. Orr-Ewing (Univ. of Bristol), D. Clary (Univ. of Oxford), and G. Worth (Univ. of Birmingham) for comments on the manuscript; to I. Rubtsov and R. Schmehl (Tulane University) for discussions; and to the Engineering and Physical Sciences Research Council, Univ. of Sheffield, and Science and Technology Facilities Council for support.	Adams CJ, 2008, INORG CHEM, V47, P8242, DOI 10.1021/ic800850h; AMSTRUP B, 1992, J CHEM PHYS, V97, P8285, DOI 10.1063/1.463399; Balabin IA, 2000, SCIENCE, V290, P114, DOI 10.1126/science.290.5489.114; Balzani V., 2001, ELECT TRANSFER CHEM; Barbara PF, 1996, J PHYS CHEM-US, V100, P13148, DOI 10.1021/jp9605663; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Beratan DN, 2009, ACCOUNTS CHEM RES, V42, P1669, DOI 10.1021/ar900123t; Best J, 2010, INORG CHEM, V49, P10041, DOI 10.1021/ic101344t; Bredenbeck J, 2004, J CHEM PHYS, V121, P5943, DOI 10.1063/1.1779575; Bressler C, 2009, SCIENCE, V323, P489, DOI 10.1126/science.1165733; Cao XY, 2001, J CHEM PHYS, V115, P7348, DOI 10.1063/1.1406535; Carias H, 2011, J PHYS CHEM B, V115, P5510, DOI 10.1021/jp111097a; Crim FF, 1996, J PHYS CHEM-US, V100, P12725, DOI 10.1021/jp9604812; Davis D, 2009, CHEM PHYS, V358, P45, DOI 10.1016/j.chemphys.2008.12.016; DEVAULT D, 1980, Q REV BIOPHYS, V13, P387, DOI 10.1017/S003358350000175X; ELSAESSER T, 1991, ANNU REV PHYS CHEM, V42, P83; Foxon SP, 2012, INORG CHEM, V51, P463, DOI 10.1021/ic201914h; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gray HB, 1996, ANNU REV BIOCHEM, V65, P537, DOI 10.1146/annurev.bi.65.070196.002541; Greetham GM, 2010, APPL SPECTROSC, V64, P1311, DOI 10.1366/000370210793561673; Halpin A, 2014, NAT CHEM, V6, P196, DOI [10.1038/NCHEM.1834, 10.1038/nchem.1834]; Hamm P., 2011, CONCEPTS METHODS 2D, V1st; HELLER BA, 1995, SCIENCE, V269, P940, DOI 10.1126/science.7638616; Huang YH, 2000, SCIENCE, V290, P111, DOI 10.1126/science.290.5489.111; Irikura KK, 2005, J PHYS CHEM A, V109, P8430, DOI 10.1021/jp052793n; Izmaylov AF, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3667203; Keller JM, 2011, J AM CHEM SOC, V133, P11289, DOI 10.1021/ja202898p; Kwok WM, 1997, J PHYS CHEM A, V101, P9286, DOI 10.1021/jp972374t; Lewis FD, 2002, P NATL ACAD SCI USA, V99, P12536, DOI 10.1073/pnas.192432899; Lin ZW, 2009, J AM CHEM SOC, V131, P18060, DOI 10.1021/ja907041t; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MCCONNELL H, 1961, J CHEM PHYS, V35, P508, DOI 10.1063/1.1731961; MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980; Mennucci B, 1997, J CHEM PHYS, V106, P5151, DOI 10.1063/1.473558; NEWTON MD, 1991, CHEM REV, V91, P767, DOI 10.1021/cr00005a007; O'Boyle NM, 2008, J COMPUT CHEM, V29, P839, DOI 10.1002/jcc.20823; Prokhorenko VI, 2006, SCIENCE, V313, P1257, DOI 10.1126/science.1130747; Repp J, 2010, NAT PHYS, V6, P975, DOI [10.1038/nphys1802, 10.1038/NPHYS1802]; Roberts GM, 2013, CHEM SCI, V4, P993, DOI 10.1039/c2sc21865h; Rosenwaks S, 2009, VIBRATIONALLY MEDIATED PHOTODISSOCIATION, pV; Scattergood PA, 2014, DALTON T, V43, P17677, DOI 10.1039/c4dt01682c; Schrauben JN, 2010, CHEM SCI, V1, P405, DOI 10.1039/c0sc00262c; Shapiro M, 2003, REP PROG PHYS, V66, P859, DOI 10.1088/0034-4885/66/6/201; Shih C, 2008, SCIENCE, V320, P1760, DOI 10.1126/science.1158241; Skourtis SS, 2004, J PHYS CHEM B, V108, P15511, DOI 10.1021/jp0485340; SPEARS KG, 1995, J PHYS CHEM-US, V99, P2469, DOI 10.1021/j100009a004; Spears KG, 1996, J PHYS CHEM-US, V100, P10206, DOI 10.1021/jp960444a; ULSTRUP J, 1975, J CHEM PHYS, V63, P4358, DOI 10.1063/1.431152; Volkovich R, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2401611; Whaley RC, 2005, SOFTWARE PRACT EXPER, V35, P101, DOI 10.1002/spe.626; Xiao DQ, 2009, NANO LETT, V9, P1818, DOI 10.1021/nl8037695	51	127	127	6	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1492	1495		10.1126/science.1259995	http://dx.doi.org/10.1126/science.1259995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525241				2022-12-28	WOS:000346536500058
J	Goetz, CG; Pal, G				Goetz, Christopher G.; Pal, Gian			Initial management of Parkinson's disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COLONY-STIMULATING FACTOR; LEVODOPA-INDUCED DYSKINESIA; GAMMA AGONIST PIOGLITAZONE; 3 ELDERLY POPULATIONS; DOUBLE-BLIND; CONTROLLED-TRIAL; MOUSE MODEL; PHARMACOLOGICAL-TREATMENT; DOPAMINERGIC-NEURONS; SUBTHALAMIC NUCLEUS	Parkinson's disease is one of the most common neurodegenerative disorders seen in the United States and United Kingdom. The disease is characterised by two processes-cellular degeneration and the resulting biochemical deficiency of dopamine. Although these processes are inter-related, they are approached separately in the clinical setting. Currently, no proven neuroprotective or disease modifying treatment is available for Parkinson's disease. Several agents can be used to treat the motor symptoms associated with dopamine deficiency, and it is important to choose wisely when starting treatment. Drugs can have mild, moderate, or high potency, and the patient's goals, comorbidities, and the short and long term implications of choosing a specific agent should be taken into account when selecting the appropriate agent. Non-motor symptoms, such as depression, fatigue, and disorders of sleep and wakefulness, also need to be evaluated and treated. Research is under way to deliver dopaminergic therapy more effectively, but studies aimed at slowing or stopping disease progression have not shown promise.	[Goetz, Christopher G.; Pal, Gian] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA	Rush University	Pal, G (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.	gian_d_pal@rush.edu		Pal, Gian/0000-0003-1048-6182				Ahlskog JE, 2011, NEUROLOGY, V77, P288, DOI 10.1212/WNL.0b013e318225ab66; Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; ALLAIN H, 1993, MOVEMENT DISORD, V8, pS36, DOI 10.1002/mds.870080508; AMBANI LM, 1975, ARCH NEUROL-CHICAGO, V32, P114, DOI 10.1001/archneur.1975.00490440064010; [Anonymous], 2002, Mov Disord, V17 Suppl 4, pS1; Armitage JO, 1998, BLOOD, V92, P4491, DOI 10.1182/blood.V92.12.4491; Aviles-Olmos I, 2013, BRAIN, V136, P374, DOI 10.1093/brain/aws009; Barone P, 2006, J NEUROL, V253, P601, DOI 10.1007/s00415-006-0067-5; Barone P, 2010, LANCET NEUROL, V9, P573, DOI 10.1016/S1474-4422(10)70106-X; Benito-Leon J, 2004, NEUROLOGY, V62, P734, DOI 10.1212/01.WNL.0000113727.73153.68; Benito-Leon J, 2003, MOVEMENT DISORD, V18, P267, DOI 10.1002/mds.10362; Berardelli A, 2013, EFNS MDS ES RECOMMEN; Biglan KM, 2007, NEUROLOGY, V69, P187, DOI 10.1212/01.wnl.0000265593.34438.00; BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787; Bower JH, 1999, NEUROLOGY, V52, P1214, DOI 10.1212/WNL.52.6.1214; Breidert T, 2002, J NEUROCHEM, V82, P615, DOI 10.1046/j.1471-4159.2002.00990.x; Brundin P, 2013, J PARKINSON DIS, V3, P231, DOI 10.3233/JPD-139000; BUTZER JF, 1975, NEUROLOGY, V25, P603; CEDARBAUM JM, 1986, CLIN NEUROPHARMACOL, V9, P153, DOI 10.1097/00002826-198604000-00006; Chauhan NB, 2001, J CHEM NEUROANAT, V21, P277, DOI 10.1016/S0891-0618(01)00115-6; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Cohen AD, 2003, J NEUROCHEM, V85, P299, DOI 10.1046/j.1471-4159.2003.01657.x; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; COTZIAS GC, 1969, NEW ENGL J MED, V280, P337, DOI 10.1056/NEJM196902132800701; COX B, 1973, J NEUROL NEUROSUR PS, V36, P354, DOI 10.1136/jnnp.36.3.354; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dehmer T, 2004, J NEUROCHEM, V88, P494, DOI 10.1046/j.1471-4159.2003.02210.x; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Dobkin RD, 2011, AM J PSYCHIAT, V168, P1066, DOI 10.1176/appi.ajp.2011.10111669; Doo AR, 2010, NEUROL RES, V32, pS88, DOI 10.1179/016164109X12537002794282; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Fahn S, 2005, J NEUROL, V252, P37, DOI 10.1007/s00415-005-4008-5; FAHN S, 1975, NEUROLOGY, V25, P695, DOI 10.1212/WNL.25.8.695; Ferreira JJ, 2010, MOVEMENT DISORD, V25, P139, DOI 10.1002/mds.22855; FIESCHI C, 1970, LANCET, V1, P945; Fox SH, 2011, MOVEMENT DISORD, V26, pS2, DOI 10.1002/mds.23829; Frank T, 2012, BRAIN, V135, P1914, DOI 10.1093/brain/aws054; FRIEDMAN Z, 1972, BRIT MED J, V1, P605, DOI 10.1136/bmj.1.5800.605; Gallagher DA, 2007, MOVEMENT DISORD, V22, P1757, DOI 10.1002/mds.21611; Garbayo E, 2013, MATURITAS, V76, P272, DOI 10.1016/j.maturitas.2013.05.019; Geminiani G, 1996, MOVEMENT DISORD, V11, P495, DOI 10.1002/mds.870110504; Gerecke KM, 2010, BRAIN RES, V1341, P72, DOI 10.1016/j.brainres.2010.01.053; Giladi N, 2007, MOVEMENT DISORD, V22, P2398, DOI 10.1002/mds.21741; GOETZ CG, 1981, NEUROLOGY, V31, P641, DOI 10.1212/WNL.31.5.641-b; Goetz CG, 2008, MOVEMENT DISORD, V23, P690, DOI 10.1002/mds.21894; Hartung T, 1998, Curr Opin Hematol, V5, P221, DOI 10.1097/00062752-199805000-00013; Hauser RA, 2010, MOVEMENT DISORD, V25, P2542, DOI 10.1002/mds.23317; Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044; HORROCKS PM, 1973, J NEUROL NEUROSUR PS, V36, P936, DOI 10.1136/jnnp.36.6.936; HUGHES RC, 1971, BMJ-BRIT MED J, V2, P487, DOI 10.1136/bmj.2.5760.487; Hunter RL, 2007, J NEUROCHEM, V100, P1375, DOI 10.1111/j.1471-4159.2006.04327.x; ING TS, 1979, CAN MED ASSOC J, V120, P695; International Parkinson and Movement Disorder Society, EV BAS MED PUBL; JENNER P, 1993, ACTA NEUROL SCAND, V87, P6; Jung KH, 2006, BRAIN RES, V1073, P190, DOI 10.1016/j.brainres.2005.12.037; Katzenschlager R, 2003, Cochrane Database Syst Rev, pCD003735; Kefalopoulou Z, 2014, JAMA NEUROL, V71, P83, DOI 10.1001/jamaneurol.2013.4749; Kieburtz K, 2011, MOVEMENT DISORD, V26, P37, DOI 10.1002/mds.23396; Kim JI, 2011, INT J NEUROSCI, V121, P209, DOI 10.3109/00207454.2010.548613; KOLLER WC, 1986, ARCH NEUROL-CHICAGO, V43, P126, DOI 10.1001/archneur.1986.00520020020009; Kunkler RB, 1998, BRIT J UROL, V82, P147; LANG AE, 1984, CAN J NEUROL SCI, V11, P210, DOI 10.1017/S0317167100046436; LeWitt PA, 1999, PARKINSON'S DISEASE: THE TREATMENT OPTIONS, P141; Ling LH, 1999, MAYO CLIN PROC, V74, P371, DOI 10.4065/74.4.371; Lund BC, 1999, PHARMACOTHERAPY, V19, P1437, DOI 10.1592/phco.19.18.1437.30888; Macleod A, 2005, COCHRANE DB SYST REV, V3; Maesawa S, 2004, J NEUROSURG, V100, P679, DOI 10.3171/jns.2004.100.4.0679; MALLY J, 1995, J NEUROL SCI, V134, P143, DOI 10.1016/0022-510X(95)00240-1; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; MAWDSLEY C, 1972, CLIN PHARMACOL THER, V13, P575; Mehrholz J, 2010, COCHRANE DB SYST REV, V1; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Medeiros CAM, 2007, J NEUROL, V254, P459, DOI 10.1007/s00415-006-0390-x; Meuer K, 2006, J NEUROCHEM, V97, P675, DOI 10.1111/j.1471-4159.2006.03727.x; Ministry of Health and Long-Term Care Ontario. Committee to Evaluate Drugs, 2010, COMM EV DRUGS REC RE; MORGANTE L, 1992, NEUROLOGY, V42, P1901; Muller B, 2013, PARKINSONISM RELAT D, V19, P1027, DOI 10.1016/j.parkreldis.2013.07.010; Nakao N, 1999, ANN NEUROL, V45, P640, DOI 10.1002/1531-8249(199905)45:5<640::AID-ANA13>3.3.CO;2-L; NELSON MV, 1989, CLIN NEUROPHARMACOL, V12, P91, DOI 10.1097/00002826-198904000-00002; Nicoletti A, 2010, MOVEMENT DISORD, V25, P2387, DOI 10.1002/mds.23297; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Olanow CW, 2013, MOVEMENT DISORD, V28, P1064, DOI 10.1002/mds.25364; Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Olanow CW, 1996, NEUROLOGY, V47, pS210, DOI 10.1212/WNL.47.6_Suppl_3.210S; Palfi S, 2014, LANCET, V383, P1138, DOI 10.1016/S0140-6736(13)61939-X; Palhagen S, 1998, NEUROLOGY, V51, P520, DOI 10.1212/WNL.51.2.520; PARKES JD, 1977, LANCET, V1, P904; PARKES JD, 1974, J NEUROL NEUROSUR PS, V37, P422, DOI 10.1136/jnnp.37.4.422; PARKES JD, 1971, LANCET, V1, P1083; Parkinson Study Group, 2000, JAMA, V284, P1931; Pearce RKB, 1997, J NEURAL TRANSM, V104, P661, DOI 10.1007/BF01291884; Poewe W, 2012, CURR OPIN NEUROL, V25, P448, DOI 10.1097/WCO.0b013e3283542fde; Poewe WH, 1998, MOVEMENT DISORD, V13, P39, DOI 10.1002/mds.870130111; Quik M, 2012, MOVEMENT DISORD, V27, P947, DOI 10.1002/mds.25028; Quinn L, 2008, BRIT J PHARMACOL, V154, P226, DOI 10.1038/bjp.2008.78; RAJPUT AH, 1984, NEUROLOGY, V34, P991, DOI 10.1212/WNL.34.8.991; Rajput AH, 2014, MOVEMENT DISORD, V29, P429, DOI 10.1002/mds.25800; Rascol O, 2006, MOVEMENT DISORD, V21, P2110, DOI 10.1002/mds.21122; REED DJ, 1990, ANNU REV PHARMACOL, V30, P603, DOI 10.1146/annurev.pa.30.040190.003131; Rektorova I, 2003, EUR J NEUROL, V10, P399, DOI 10.1046/j.1468-1331.2003.00612.x; Richard IH, 2012, NEUROLOGY, V78, P1229, DOI 10.1212/WNL.0b013e3182516244; ROMBERG RW, 1995, J FORENSIC SCI, V40, P1100; SADEH M, 1982, ARCH NEUROL-CHICAGO, V39, P666, DOI 10.1001/archneur.1982.00510220064017; Salthun-Lassalle B, 2004, J NEUROSCI, V24, P5922, DOI 10.1523/JNEUROSCI.5668-03.2004; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Schumacher JM, 2000, NEUROLOGY, V54, P1042, DOI 10.1212/WNL.54.5.1042; Shaunak S, 1999, J NEUROL NEUROSUR PS, V66, P79, DOI 10.1136/jnnp.66.1.79; SHOULSON I, 1989, NEW ENGL J MED, V321, P1364; Siderowf A, 2002, ARCH NEUROL-CHICAGO, V59, P1937; Siderowf A, 2004, ARCH NEUROL-CHICAGO, V61, P561; Singer C, 2007, MOVEMENT DISORD, V22, P476, DOI 10.1002/mds.21361; Stern MB, 2004, MOVEMENT DISORD, V19, P916, DOI 10.1002/mds.20145; Stocchi F, 2008, CURR MED RES OPIN, V24, P2883, DOI [10.1185/03007990802387130, 10.1185/03007990802387130 ]; Stowe RL, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006564.pub2; Suchowersky O, 2006, NEUROLOGY, V66, P968, DOI 10.1212/01.wnl.0000215437.80053.d0; SYNDULKO K, 1981, INT J NEUROSCI, V14, P61, DOI 10.3109/00207458108985816; Tajiri N, 2010, BRAIN RES, V1310, P200, DOI 10.1016/j.brainres.2009.10.075; Tanner CM, 2010, MOVEMENT DISORD, V25, pS58, DOI 10.1002/mds.22721; Von Voigtlander P F, 1971, Science, V174, P408, DOI 10.1126/science.174.4007.408; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; Whone AL, 2003, ANN NEUROL, V54, P93, DOI 10.1002/ana.10609; Wilson RE, 2011, NEUROLOGIST, V17, P318, DOI 10.1097/NRL.0b013e31822f6872; Yahr MD, 1970, L DOPA PARKINSONISM, P101	126	43	43	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 19	2014	349								g6258	10.1136/bmj.g6258	http://dx.doi.org/10.1136/bmj.g6258			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX3EN	25527341				2022-12-28	WOS:000346823300001
J	Hayes, CT; Martinez-Garcia, A; Hasenfratz, AP; Jaccard, SL; Hodell, DA; Sigman, DM; Haug, GH; Anderson, RF				Hayes, Christopher T.; Martinez-Garcia, Alfredo; Hasenfratz, Adam P.; Jaccard, Samuel L.; Hodell, David A.; Sigman, Daniel M.; Haug, Gerald H.; Anderson, Robert F.			A stagnation event in the deep South Atlantic during the last interglacial period	SCIENCE			English	Article							ATMOSPHERIC CO2; CLIMATE-CHANGE; ANTARCTIC ICE; SEA-LEVEL; OCEAN; WATER; PRODUCTIVITY; DEGLACIATION; VARIABILITY; POLYNYA	During the last interglacial period, global temperatures were similar to 2 degrees C warmer than at present and sea level was 6 to 8 meters higher. Southern Ocean sediments reveal a spike in authigenic uranium 127,000 years ago, within the last interglacial, reflecting decreased oxygenation of deep water by Antarctic Bottom Water (AABW). Unlike ice age reductions in AABW, the interglacial stagnation event appears decoupled from open ocean conditions and may have resulted from coastal freshening due to mass loss from the Antarctic ice sheet. AABW reduction coincided with increased North Atlantic Deep Water (NADW) formation, and the subsequent reinvigoration in AABW coincided with reduced NADW formation. Thus, alternation of deep water formation between the Antarctic and the North Atlantic, believed to characterize ice ages, apparently also occurs in warm climates.	[Hayes, Christopher T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02142 USA; [Hayes, Christopher T.; Anderson, Robert F.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Martinez-Garcia, Alfredo; Hasenfratz, Adam P.; Haug, Gerald H.] ETH, Geol Inst, CH-8092 Zurich, Switzerland; [Jaccard, Samuel L.] Univ Bern, Inst Geol Sci, CH-3012 Bern, Switzerland; [Jaccard, Samuel L.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Hodell, David A.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Sigman, Daniel M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Massachusetts Institute of Technology (MIT); Columbia University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; University of Bern; University of Cambridge; Princeton University	Hayes, CT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02142 USA.	cthayes@mit.edu	Hayes, Christopher T/P-3145-2016; Martínez-García, Alfredo/A-6244-2010; Sigman, Daniel M/A-2649-2008; Jaccard, Samuel/G-3447-2014	Hayes, Christopher T/0000-0002-5636-2989; Martínez-García, Alfredo/0000-0002-7206-5079; Sigman, Daniel M/0000-0002-7923-1973; Jaccard, Samuel/0000-0002-5793-0896; Anderson, Robert/0000-0002-8472-2494; Hodell, David/0000-0001-8537-1588	Comer Science and Education Foundation (CTH/RFA); W.O. Crosby Fellowship; Swiss National Science Foundation [PZ00P2_142424, PP00P2_144811]; ETH [ETH-0411-1]; NERC [NE/H014292/1] Funding Source: UKRI; Natural Environment Research Council [NE/H014292/1] Funding Source: researchfish	Comer Science and Education Foundation (CTH/RFA); W.O. Crosby Fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH(ETH Zurich); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We acknowledge the Integrated Ocean Drilling Program for providing samples. Data not previously reported are archived at the U.S. National Climate Data Center (http://www.ncdc.noaa.gov/paleo/study/17455) and Pangaea (http://doi.pangaea.de/10.1594/PANGAEA.839454) and can be accessed in tables S3 and S4. Financial support was provided by the Comer Science and Education Foundation (CTH/RFA), the W.O. Crosby Fellowship (C.T.H.), Swiss National Science Foundation grants PZ00P2_142424 (AM-G) and PP00P2_144811 (SLJ), and ETH grant ETH-0411-1 (SLJ/APH).	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Antonov J. I., 2010, NOAA ATLAS NESDIC, V69; Bazin L, 2013, CLIM PAST, V9, P1715, DOI 10.5194/cp-9-1715-2013; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Chase Z, 2001, PALEOCEANOGRAPHY, V16, P468, DOI 10.1029/2000PA000542; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; de Lavergne C, 2014, NAT CLIM CHANGE, V4, P278, DOI [10.1038/nclimate2132, 10.1038/NCLIMATE2132]; Dutton A, 2012, SCIENCE, V337, P216, DOI 10.1126/science.1205749; Fogwill CJ, 2014, J QUATERNARY SCI, V29, P91, DOI 10.1002/jqs.2683; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Frank M, 2000, PALEOCEANOGRAPHY, V15, P642, DOI 10.1029/2000PA000497; Galaasen EV, 2014, SCIENCE, V343, P1129, DOI 10.1126/science.1248667; Garcia H. E., 2010, NOAA ATLAS NESDROS I, V70; Gibson KA, 2014, GEOPHYS RES LETT, V41, P969, DOI 10.1002/2013GL058846; Gordon AL, 2007, J CLIMATE, V20, P2558, DOI 10.1175/JCLI4046.1; Gordon AL, 2014, NAT CLIM CHANGE, V4, P249, DOI 10.1038/nclimate2179; Hain MP, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003790; HODELL DA, 2003, P OCEAN DRILLING PRO, V0177; Jaccard SL, 2013, SCIENCE, V339, P1419, DOI 10.1126/science.1227545; Kaspar F, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022456; KLINKHAMMER GP, 1991, GEOCHIM COSMOCHIM AC, V55, P1799, DOI 10.1016/0016-7037(91)90024-Y; Kopp RE, 2009, NATURE, V462, P863, DOI 10.1038/nature08686; Krueger S, 2012, GLOBAL PLANET CHANGE, V80-81, P180, DOI 10.1016/j.gloplacha.2011.10.001; Lourantou A, 2010, QUATERNARY SCI REV, V29, P1983, DOI 10.1016/j.quascirev.2010.05.002; Martin P, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2003PA000914; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Rayner D, 2011, DEEP-SEA RES PT II, V58, P1744, DOI 10.1016/j.dsr2.2010.10.056; Robinson RS, 2008, QUATERNARY SCI REV, V27, P1076, DOI 10.1016/j.quascirev.2008.02.005; Schneider R, 2013, CLIM PAST, V9, P2507, DOI 10.5194/cp-9-2507-2013; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154	33	36	36	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1514	1517		10.1126/science.1256620	http://dx.doi.org/10.1126/science.1256620			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525246				2022-12-28	WOS:000346536500064
J	Cole, TB				Cole, Thomas B.			Untitled (Composition With Grey Background)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2014	312	23					2470	2471		10.1001/jama.2013.279895	http://dx.doi.org/10.1001/jama.2013.279895			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YN	25514290				2022-12-28	WOS:000346346900001
J	Plymen, CM; Carr-White, GS; Kapetanakis, S				Plymen, C. M.; Carr-White, G. S.; Kapetanakis, S.			CHRISTMAS 2014 The Christmas tree sign: a diagnostic tool for ECG connoisseurs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Plymen, C. M.; Carr-White, G. S.; Kapetanakis, S.] St Thomas Hosp, Dept Cardiol, London, England	Guy's & St Thomas' NHS Foundation Trust	Plymen, CM (corresponding author), St Thomas Hosp, Dept Cardiol, London, England.	carlaplymen@nhs.net							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2014	349								g7342	10.1136/bmj.g7342	http://dx.doi.org/10.1136/bmj.g7342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX2HK	25515604				2022-12-28	WOS:000346763900008
J	McCartney, M				McCartney, Margaret			Margaret McCartney: The Care Quality Commission is not fit for purpose	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Care Quality Commission, 2014, INSP GEN PRACT BAS B; Dioa D, 2012, COCHRANE SUMMAR 1114; McCartney M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6446; NHS England, 2014, FRAM RESP CQC INSP G; Patient D., 2014, E LONDON W ESSE 1120; Western Daily Press, 2014, W DAILY PRESS	6	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2014	349								g7460	10.1136/bmj.g7460	http://dx.doi.org/10.1136/bmj.g7460			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3DU	25499740	hybrid, Green Published			2022-12-28	WOS:000346166700002
J	Sheron, N; Eisenstein, K				Sheron, Nick; Eisenstein, Kate			ALCOHOL AND PUBLIC HEALTH Commentary: Minimum unit price-how the evidence stacks up	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sheron, Nick] Univ Southampton, Southampton, Hants, England; [Eisenstein, Kate] Royal Coll Physicians, London NW1 4LE, England	University of Southampton; Royal College of Physicians	Sheron, N (corresponding author), Univ Southampton, Southampton, Hants, England.	nick.sheron@soton.ac.uk		Sheron, Nick/0000-0001-5232-8292; Sheron, Nick/0000-0002-6156-8367				Babor TF, 2003, ALCOHOL NO ORDINARY; Hatton J, 2009, ADDICTION, V104, P587, DOI 10.1111/j.1360-0443.2008.02493.x; Meng Y, 2013, MODELLED INCOME GROU; Nemtsov AV, 2002, ADDICTION, V97, P1413, DOI 10.1046/j.1360-0443.2002.00262.x; OECD WHO, 2013, PROM HLTH PREV DIS I; Pelletier S, 2002, ALCOHOL ALCOHOLISM, V37, P618, DOI 10.1093/alcalc/37.6.618; Siegler Veronique, 2011, Health Stat Q, P4, DOI 10.1057/hsq.2011.7; University of Stirling, 2013, HLTH 1 EV BAS ALC ST; Zhao JH, 2013, ADDICTION, V108, P1059, DOI 10.1111/add.12139	9	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2014	348								g67	10.1136/bmj.g67	http://dx.doi.org/10.1136/bmj.g67			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	288KI	25489933				2022-12-28	WOS:000329610300011
J	Webster, CR; Mahaffy, PR; Atreya, SK; Flesch, GJ; Mischna, MA; Meslin, PY; Farley, KA; Conrad, PG; Christensen, LE; Pavlov, AA; Martin-Torres, J; Zorzano, MP; McConnochie, TH; Owen, T; Eigenbrode, JL; Glavin, DP; Steele, A; Malespin, CA; Archer, PD; Sutter, B; Coll, P; Freissinet, C; McKay, CP; Moores, JE; Schwenzer, SP; Bridges, JC; Navarro-Gonzalez, R; Gellert, R; Lemmon, MT				Webster, Christopher R.; Mahaffy, Paul R.; Atreya, Sushil K.; Flesch, Gregory J.; Mischna, Michael A.; Meslin, Pierre-Yves; Farley, Kenneth A.; Conrad, Pamela G.; Christensen, Lance E.; Pavlov, Alexander A.; Martin-Torres, Javier; Zorzano, Maria-Paz; McConnochie, Timothy H.; Owen, Tobias; Eigenbrode, Jennifer L.; Glavin, Daniel P.; Steele, Andrew; Malespin, Charles A.; Archer, P. Douglas, Jr.; Sutter, Brad; Coll, Patrice; Freissinet, Caroline; McKay, Christopher P.; Moores, John E.; Schwenzer, Susanne P.; Bridges, John C.; Navarro-Gonzalez, Rafael; Gellert, Ralf; Lemmon, Mark T.		MSL Sci Team	Mars methane detection and variability at Gale crater	SCIENCE			English	Article							MARTIAN DUST DEVILS; OXIDANT ENHANCEMENT; ATMOSPHERE; SEARCH; ORIGIN; STORMS; LIFE	Reports of plumes or patches of methane in the martian atmosphere that vary over monthly time scales have defied explanation to date. From in situ measurements made over a 20-month period by the tunable laser spectrometer of the Sample Analysis at Mars instrument suite on Curiosity at Gale crater, we report detection of background levels of atmospheric methane of mean value 0.69 +/- 0.25 parts per billion by volume (ppbv) at the 95% confidence interval (CI). This abundance is lower than model estimates of ultraviolet degradation of accreted interplanetary dust particles or carbonaceous chondrite material. Additionally, in four sequential measurements spanning a 60-sol period (where 1 sol is a martian day), we observed elevated levels of methane of 7.2 +/- 2.1 ppbv (95% CI), implying that Mars is episodically producing methane from an additional unknown source.	[Webster, Christopher R.; Flesch, Gregory J.; Mischna, Michael A.; Christensen, Lance E.] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA; [Mahaffy, Paul R.; Conrad, Pamela G.; Pavlov, Alexander A.; Eigenbrode, Jennifer L.; Glavin, Daniel P.; Malespin, Charles A.; Freissinet, Caroline] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Atreya, Sushil K.] Univ Michigan, Ann Arbor, MI 48109 USA; [Meslin, Pierre-Yves] Univ Paris Diderot, UPS,CNRS, Inst Rech Astrophys & Planetol, OMP, F-31028 Toulouse, France; [Farley, Kenneth A.] CALTECH, Pasadena, CA 91125 USA; [Martin-Torres, Javier] Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, Granada, Spain; [Martin-Torres, Javier] Lulea Univ Technol, Div Space Technol, Kiruna, Sweden; [Zorzano, Maria-Paz] CSIC, Inst Nacl Tecn Aeroespacial, Ctr Astrobiol, Madrid, Spain; [McConnochie, Timothy H.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Owen, Tobias] Univ Hawaii, Honolulu, HI 96822 USA; [Steele, Andrew] Carnegie Inst Sci, Washington, DC 20015 USA; [Archer, P. Douglas, Jr.; Sutter, Brad] NASA, Jacobs Technol, Johnson Space Ctr, Houston, TX 77058 USA; [Coll, Patrice] Univ Paris Diderot, CNRS, Lab Interuniv Syst Atmospher LISA, UMR 7583, Paris, France; [McKay, Christopher P.] NASA, Ames Res Ctr, Mountain View, CA 94035 USA; [Moores, John E.] York Univ, Toronto, ON M3J 1P3, Canada; [Schwenzer, Susanne P.] Open Univ, Milton Keynes MK7 6AA, Bucks, England; [Bridges, John C.] Univ Leicester, Space Res Ctr, Leicester LE1 7RH, Leics, England; [Navarro-Gonzalez, Rafael] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico; [Gellert, Ralf] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Lemmon, Mark T.] Texas A&M Univ, College Stn, TX 77843 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; California Institute of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; Lulea University of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University System of Maryland; University of Maryland College Park; University of Hawaii System; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; York University - Canada; Open University - UK; University of Leicester; Universidad Nacional Autonoma de Mexico; University of Guelph; Texas A&M University System; Texas A&M University College Station	Webster, CR (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	chris.r.webster@jpl.nasa.gov	Martin-Torres, Javier/M-3779-2019; szopa, cyril/C-6865-2015; Mischna, Michael/AAF-3861-2020; Rodriguez-Manfredi, Jose/L-8001-2014; Lemmon, Mark T/E-9983-2010; Rodriguez-Manfredi, Jose/AAG-9826-2021; Webster, Chris/M-9315-2019; Prats, Benito/F-9467-2019; Stipp, Susan L.S./B-8494-2019; Steele, Andrew/A-3573-2013; Glavin, Daniel P/D-6194-2012; Pavlov, Alexander A./F-3779-2012; Martin-Torres, Javier/G-6329-2015; Lemmon, Mark/X-2333-2019; Zorzano, María-Paz/F-2184-2015; Navarro-González, Rafael/D-1748-2009; Franz, Heather B/F-3508-2012; Dworkin, Jason P./C-9417-2012; Farley, Kenneth/AAE-7735-2020; Muñoz, Guillermo M/L-6370-2014; Benna, Mehdi/F-3489-2012; Romeral Planelló, Julio J./T-1788-2017; Schwenzer, Susanne P/H-6992-2019; Moores, John E./AAO-6622-2021; Teinturier, Samuel/AAS-8663-2020; Ramos, Miguel/K-2230-2014; Merikallio, Sini/C-7812-2014; Eigenbrode, Jennifer L/D-4651-2012; GEFFROY, Claude/AAB-9152-2019; Harri, Ari-Matti/C-7142-2012; Malakhov, Alexey/F-7953-2017; Gasnault, Olivier/F-4327-2010	szopa, cyril/0000-0002-0090-4056; Mischna, Michael/0000-0002-8022-5319; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Lemmon, Mark T/0000-0002-4504-5136; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Prats, Benito/0000-0003-3869-3351; Stipp, Susan L.S./0000-0001-7009-643X; Steele, Andrew/0000-0001-9643-2841; Glavin, Daniel P/0000-0001-7779-7765; Pavlov, Alexander A./0000-0001-8771-1646; Martin-Torres, Javier/0000-0001-6479-2236; Lemmon, Mark/0000-0002-4504-5136; Zorzano, María-Paz/0000-0002-4492-9650; Navarro-González, Rafael/0000-0002-6078-7621; Dworkin, Jason P./0000-0002-3961-8997; Muñoz, Guillermo M/0000-0001-7003-7368; Romeral Planelló, Julio J./0000-0002-2205-067X; Schwenzer, Susanne P/0000-0002-9608-0759; Moores, John E./0000-0001-9435-1095; Teinturier, Samuel/0000-0003-1755-9524; Ramos, Miguel/0000-0003-3648-6818; Merikallio, Sini/0000-0001-7120-6127; Eigenbrode, Jennifer L/0000-0003-3089-1986; GEFFROY, Claude/0000-0002-2731-9658; Harri, Ari-Matti/0000-0001-8541-2802; Malakhov, Alexey/0000-0003-4292-7077; Matthia, Daniel/0000-0003-1507-0143; Farley, Kenneth/0000-0002-7846-7546; Kashyap, Srishti/0000-0003-4950-9636; Gasnault, Olivier/0000-0002-6979-9012	NASA; Spanish Ministry of Economy and Competiveness; UK Space Agency; Canadian Space Agency; Science and Technology Facilities Council [ST/J005193/1] Funding Source: researchfish; UK Space Agency [ST/J005339/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); Spanish Ministry of Economy and Competiveness(Spanish Government); UK Space Agency; Canadian Space Agency(Canadian Space Agency); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	The research described here was carried out in part at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. Data described in the paper are further described in the supplementary materials and have been submitted to NASA's Planetary Data System (PDS) under an arrangement with the Mars Science Laboratory (MSL) project. Funding is acknowledged for J.M.-T. and M.-P.Z. from the Spanish Ministry of Economy and Competiveness, J.C.B. from the UK Space Agency, and R.G. from the Canadian Space Agency.	Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Atreya SK, 2006, ASTROBIOLOGY, V6, P439, DOI 10.1089/ast.2006.6.439; Atreya SK, 2011, PLANET SPACE SCI, V59, P133, DOI 10.1016/j.pss.2010.10.008; Chassefiere E, 2009, ICARUS, V204, P137, DOI 10.1016/j.icarus.2009.06.016; Christensen P. R., 2003, EOS T AGU S, V84; Delory GT, 2006, ASTROBIOLOGY, V6, P451, DOI 10.1089/ast.2006.6.451; Etiope G, 2011, PLANET SPACE SCI, V59, P182, DOI 10.1016/j.pss.2010.06.003; Farrell W. M., 2006, J GEOPHYS RES, V33; Fonti S, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913178; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Freissinet C., 2014, 8 INT C MARS PAS CA; Gaillard F, 2013, SPACE SCI REV, V174, P251, DOI 10.1007/s11214-012-9947-4; Garry JRC, 2006, METEORIT PLANET SCI, V41, P391, DOI 10.1111/j.1945-5100.2006.tb00470.x; Geminale A, 2008, PLANET SPACE SCI, V56, P1194, DOI 10.1016/j.pss.2008.03.004; Geminale A, 2011, PLANET SPACE SCI, V59, P137, DOI 10.1016/j.pss.2010.07.011; Gomez-Elvira J, 2014, J GEOPHYS RES-PLANET, V119, P1680, DOI 10.1002/2013JE004576; Gough RV, 2010, ICARUS, V207, P165, DOI 10.1016/j.icarus.2009.11.030; Hassler DM, 2012, SPACE SCI REV, V170, P503, DOI 10.1007/s11214-012-9913-1; Keppler F, 2012, NATURE, V486, P93, DOI 10.1038/nature11203; Krashnopolsky VA, 2004, ICARUS, V172, P537, DOI 10.1016/j.icarus.2004.07.004; Krasnopolsky V. A., 2011, EPSC ABSTR, V6, P49; Krasnopolsky VA, 2006, ICARUS, V180, P359, DOI 10.1016/j.icarus.2005.10.015; Krasnopolsky VA, 2012, ICARUS, V217, P144, DOI 10.1016/j.icarus.2011.10.019; Lefevre F, 2009, NATURE, V460, P720, DOI 10.1038/nature08228; Lemmon M. T., 2014, 8 INT C MARS PAS CA; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; McConnochie T. H., 2014, 8 INT C MARS PAS CA; McMahon S, 2013, INT J ASTROBIOL, V12, P113, DOI 10.1017/S1473550412000481; Meslin PY, 2011, PLANET SPACE SCI, V59, P247, DOI 10.1016/j.pss.2010.09.022; Mischna MA, 2011, PLANET SPACE SCI, V59, P227, DOI 10.1016/j.pss.2010.07.005; Mumma MJ, 2009, SCIENCE, V323, P1041, DOI 10.1126/science.1165243; Newsom H. K., 2014, 45 LUN PLAN SCI C; Oze C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022691; Poch O, 2014, ICARUS, V242, P50, DOI 10.1016/j.icarus.2014.07.014; Schmidt M. E., 2014, 45 LUN PLAN SCI C; Schuerger AC, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE004023; Villanueva GL, 2013, ICARUS, V223, P11, DOI 10.1016/j.icarus.2012.11.013; Webster CR, 2013, SCIENCE, V341, P260, DOI 10.1126/science.1237961; Webster CR, 2013, SCIENCE, V342, P355, DOI 10.1126/science.1242902; Webster CR, 2011, PLANET SPACE SCI, V59, P271, DOI 10.1016/j.pss.2010.08.021; Zahnle K, 2011, ICARUS, V212, P493, DOI 10.1016/j.icarus.2010.11.027	41	257	261	6	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					415	417		10.1126/science.1261713	http://dx.doi.org/10.1126/science.1261713			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25515120	Green Submitted, Green Accepted			2022-12-28	WOS:000348225800041
J	Jeon, NJ; Noh, JH; Yang, WS; Kim, YC; Ryu, S; Seo, J; Seok, SI				Jeon, Nam Joong; Noh, Jun Hong; Yang, Woon Seok; Kim, Young Chan; Ryu, Seungchan; Seo, Jangwon; Seok, Sang Il			Compositional engineering of perovskite materials for high-performance solar cells	NATURE			English	Article							EFFICIENT; HYSTERESIS	Of the many materials and methodologies aimed at producing low-cost, efficient photovoltaic cells, inorganic-organic lead halide perovskite materials(1-17) appear particularly promising for next-generation solar devices owing to their high power conversion efficiency. The highest efficiencies reported for perovskite solar cells so far have been obtained mainly with methylammonium lead halide materials(1-10). Here we combine the promising-owing to its comparatively narrow bandgap-but relatively unstable formamidinium lead iodide (FAPbI(3)) with methylammonium lead bromide (MAPbBr(3)) as the light-harvesting unit in a bilayer solar-cell architecture(13). We investigated phase stability, morphology of the perovskite layer, hysteresis in current-voltage characteristics, and overall performance as a function of chemical composition. Our results show that incorporation of MAPbBr(3) into FAPbI(3) stabilizes the perovskite phase of FAPbI(3) and improves the power conversion efficiency of the solar cell to more than 18 per cent under a standard illumination of 100 milliwatts per square centimetre. These findings further emphasize the versatility and performance potential of inorganic-organic lead halide perovskite materials for photovoltaic applications.	[Jeon, Nam Joong; Noh, Jun Hong; Yang, Woon Seok; Kim, Young Chan; Ryu, Seungchan; Seo, Jangwon; Seok, Sang Il] Korea Res Inst Chem Technol, Div Adv Mat, Taejon 305600, South Korea; [Seok, Sang Il] Sungkyunkwan Univ, Dept Energy Sci, Suwon 440746, South Korea	Korea Research Institute of Chemical Technology (KRICT); Sungkyunkwan University (SKKU)	Seok, SI (corresponding author), Korea Res Inst Chem Technol, Div Adv Mat, 141 Gajeong Ro, Taejon 305600, South Korea.	seoksi@krict.re.kr	Noh, Jun Hong/A-7769-2010; Seok, Sang Il/R-2778-2016	Noh, Jun Hong/0000-0002-1143-5822; Seok, Sang Il/0000-0001-9976-6628	Global Research Laboratory (GRL) Program; Global Frontier R&D Program of the Center for Multiscale Energy System - National Research Foundation in Korea; Korea Research Institute of Chemical Technology (KRICT) Program for Future Technology in South Korea	Global Research Laboratory (GRL) Program; Global Frontier R&D Program of the Center for Multiscale Energy System - National Research Foundation in Korea; Korea Research Institute of Chemical Technology (KRICT) Program for Future Technology in South Korea	This work was supported by the Global Research Laboratory (GRL) Program, the Global Frontier R&D Program of the Center for Multiscale Energy System, funded by the National Research Foundation in Korea, and by a grant from the Korea Research Institute of Chemical Technology (KRICT) 2020 Program for Future Technology in South Korea.	Amat A, 2014, NANO LETT, V14, P3608, DOI 10.1021/nl5012992; Baek IC, 2009, ELECTROCHEM COMMUN, V11, P909, DOI 10.1016/j.elecom.2009.02.026; Ball JM, 2013, ENERG ENVIRON SCI, V6, P1739, DOI 10.1039/c3ee40810h; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Chung I, 2012, J AM CHEM SOC, V134, P8579, DOI 10.1021/ja301539s; Eperon GE, 2014, ENERG ENVIRON SCI, V7, P982, DOI 10.1039/c3ee43822h; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI [10.1038/NPHOTON.2013.80, 10.1038/nphoton.2013.80]; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/NMAT4014, 10.1038/nmat4014]; Jeon NJ, 2014, J AM CHEM SOC, V136, P7837, DOI 10.1021/ja502824c; Kim HS, 2014, J PHYS CHEM LETT, V5, P2927, DOI 10.1021/jz501392m; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Koh TM, 2014, J PHYS CHEM C, V118, P16458, DOI 10.1021/jp411112k; Lee JW, 2014, ADV MATER, V26, P4991, DOI 10.1002/adma.201401137; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Malinkiewicz O, 2014, NAT PHOTONICS, V8, P128, DOI [10.1038/NPHOTON.2013.141, 10.1038/nphoton.2013.341]; Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Pang SP, 2014, CHEM MATER, V26, P1485, DOI 10.1021/cm404006p; Pellet N, 2014, ANGEW CHEM INT EDIT, V53, P3151, DOI 10.1002/anie.201309361; Ryu S, 2014, ENERG ENVIRON SCI, V7, P2614, DOI 10.1039/c4ee00762j; SCAIFE DE, 1974, J SOLID STATE CHEM, V9, P308, DOI 10.1016/0022-4596(74)90088-7; Seok SI, 2010, J COLLOID INTERF SCI, V346, P66, DOI 10.1016/j.jcis.2010.02.049; Snaith HJ, 2014, J PHYS CHEM LETT, V5, P1511, DOI 10.1021/jz500113x; Stoumpos CC, 2013, INORG CHEM, V52, P9019, DOI 10.1021/ic401215x; Takahashi Y, 2011, DALTON T, V40, P5563, DOI 10.1039/c0dt01601b; Xing GC, 2013, SCIENCE, V342, P344, DOI 10.1126/science.1243167; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050	27	4751	4821	130	4285	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					476	+		10.1038/nature14133	http://dx.doi.org/10.1038/nature14133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25561177				2022-12-28	WOS:000348196500032
J	Peterson, SJ; Krasnow, MA				Peterson, Soren J.; Krasnow, Mark A.			Subcellular Trafficking of FGF Controls Tracheal Invasion of Drosophila Flight Muscle	CELL			English	Article							SKELETAL-MUSCLE; EPITHELIAL POLARITY; NEUROTRANSMITTER RELEASE; RECEPTOR HOMOLOG; ADULT MYOGENESIS; CELL POLARITY; LOCALIZATION; PROTEIN; BREATHLESS; COMPLEX	To meet the extreme oxygen demand of insect flight muscle, tracheal (respiratory) tubes ramify not only on its surface, as in other tissues, but also within T-tubules and ultimately surrounding every mitochondrion. Although this remarkable physiological specialization has long been recognized, its cellular and molecular basis is unknown. Here, we show that Drosophila tracheoles invade flight muscle T-tubules through transient surface openings. Like other tracheal branching events, invasion requires the Branchless FGF pathway. However, localization of the FGF chemoattractant changes from all muscle membranes to T-tubules as invasion begins. Core regulators of epithelial basolateral membrane identity localize to T-tubules, and knockdown of AP-1 gamma, required for basolateral trafficking, redirects FGF from T-tubules to surface, increasing tracheal surface ramification and preventing invasion. We propose that tracheal invasion is controlled by an AP-1-dependent switch in FGF trafficking. Thus, subcellular targeting of a chemoattractant can direct outgrowth to specific domains, including inside the cell.	[Peterson, Soren J.; Krasnow, Mark A.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Peterson, Soren J.; Krasnow, Mark A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Krasnow, MA (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	krasnow@stanford.edu			Stanford Graduate Fellowship; American Heart Association Predoctoral Fellowship; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047735] Funding Source: NIH RePORTER	Stanford Graduate Fellowship(Stanford University); American Heart Association Predoctoral Fellowship(American Heart Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Suzanne Pfeffer, Nipam Patel, James Nelson, and laboratory members for helpful discussions and Drs. Eric Olson, Cahir O'Kane, David Bilder, Jasprien Noordermeer, and Chris Doe for reagents. Figure S2 and the Graphical Abstract were adapted from Hartenstein ( 1993). This work was supported by a Stanford Graduate Fellowship and an American Heart Association Predoctoral Fellowship (S.J.P.) and the Howard Hughes Medical Institute.	Al-Qusairi L, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-26; Anderson MG, 1996, DEVELOPMENT, V122, P4169; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Ayalon G, 2011, J BIOL CHEM, V286, P7370, DOI 10.1074/jbc.M110.187831; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Benhra N, 2011, CURR BIOL, V21, P87, DOI 10.1016/j.cub.2010.12.010; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Blaisdell CJ, 2000, AM J PHYSIOL-LUNG C, V278, pL1248, DOI 10.1152/ajplung.2000.278.6.L1248; Bloch RJ, 2004, J MUSCLE RES CELL M, V25, P590; Bogdanik L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002084; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Bulgakova NA, 2009, J CELL SCI, V122, P2587, DOI 10.1242/jcs.023648; Cajal S.R.y., 1890, Z WISSENSCH MIKR, P332; Chen F, 2014, SCIENCE, V343, P186, DOI 10.1126/science.1241442; CURTIS BM, 1983, J BIOL CHEM, V258, P7280; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Dutta D, 2004, DEVELOPMENT, V131, P3761, DOI 10.1242/dev.01249; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; FOSSET M, 1983, J BIOL CHEM, V258, P6086; Gan YB, 2002, NAT CELL BIOL, V4, P605, DOI 10.1038/ncb827; Genova JL, 2003, J CELL BIOL, V161, P979, DOI 10.1083/jcb.200212054; GINIGER E, 1993, DEVELOPMENT, V117, P431; GLAZER L, 1991, GENE DEV, V5, P697, DOI 10.1101/gad.5.4.697; Guo XL, 2013, DEV CELL, V27, P353, DOI 10.1016/j.devcel.2013.10.006; Hartenstein V., 1993, ATLAS DROSOPHILA DEV; Icking A, 2007, TRAFFIC, V8, P285, DOI 10.1111/j.1600-0854.2006.00526.x; Jareb M, 1998, NEURON, V20, P855, DOI 10.1016/S0896-6273(00)80468-7; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Laprise P, 2011, TRENDS CELL BIOL, V21, P401, DOI 10.1016/j.tcb.2011.03.005; Laprise P, 2009, NATURE, V459, P1141, DOI 10.1038/nature08067; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leydig F., 1859, ANATOMIC INSECTEN 2, P160; Margeta MA, 2009, P NATL ACAD SCI USA, V106, P1632, DOI 10.1073/pnas.0812078106; McGill MA, 2009, J CELL BIOL, V185, P787, DOI 10.1083/jcb.200812146; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; MEYER EP, 1989, CELL TISSUE RES, V256, P1, DOI 10.1007/BF00224712; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Ohshiro T, 1997, DEVELOPMENT, V124, P3975; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; Pena-Munzenmayer G., 2005, J CELL SCI, V118, P4243; Peng YH, 2009, BIOCHEM BIOPH RES CO, V382, P108, DOI 10.1016/j.bbrc.2009.02.139; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Rahkila P, 2001, EXP CELL RES, V267, P61, DOI 10.1006/excr.2001.5101; RANGANAYAKULU G, 1995, DEV BIOL, V171, P169, DOI 10.1006/dbio.1995.1269; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428; Ribeiro I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001295; Rodriguez-Boulan E, 2013, DEV CELL, V27, P247, DOI 10.1016/j.devcel.2013.10.022; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Rosin D, 2004, DEVELOPMENT, V131, P1939, DOI 10.1242/dev.01101; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; SMITH DS, 1961, J BIOPHYS BIOCHEM CY, V10, P61, DOI 10.1083/jcb.10.4.61; SMITH DS, 1961, J BIOPHYS BIOCHEM CY, V10, P123, DOI 10.1083/jcb.10.4.123; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Thomas U, 2000, CURR BIOL, V10, P1108, DOI 10.1016/S0960-9822(00)00696-5; Traub LM, 2003, NAT CELL BIOL, V5, P1045, DOI 10.1038/ncb1203-1045; van der Plas MC, 2006, J NEUROSCI, V26, P333, DOI 10.1523/JNEUROSCI.4069-05.2006; Weaver M, 2008, SCIENCE, V321, P1496, DOI 10.1126/science.1158712; Weis-Fogh J., 1961, J A Ramsay & V B Wigglesworth Eds The Cell & the Organism Cambridge, P283; WEISFOGH T, 1964, J EXP BIOL, V41, P229; WIGGLESWORTH VB, 1982, TISSUE CELL, V14, P501, DOI 10.1016/0040-8166(82)90043-X; Woods DF, 1997, DEV GENET, V20, P111, DOI 10.1002/(SICI)1520-6408(1997)20:2<111::AID-DVG4>3.3.CO;2-O; Zhuravlev PI, 2009, P NATL ACAD SCI USA, V106, P11570, DOI 10.1073/pnas.0812746106	70	17	17	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					313	323		10.1016/j.cell.2014.11.043	http://dx.doi.org/10.1016/j.cell.2014.11.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25557078	Green Accepted, Bronze			2022-12-28	WOS:000347923200027
J	Oberlander, J				Oberlander, Jonathan			Unraveling Obamacare - Can Congress and the Supreme Court Undo Health Care Reform?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ N Carolina, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27514 USA.							Center for Medicare and Medicaid Services, 2014, MED CHIP AUG 2014 MO; Cohn Jonathan, 2014, NEW REPUBLIC; Department of Health and Human Services, 2014, MAN IND MIGHT HAV MA; Jost Timothy, 2014, IMPLEMENTING HLTH RE; Levitt L, 2014, POTENTIAL SIDE EFFEC	5	11	11	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2445	2447		10.1056/NEJMp1413992	http://dx.doi.org/10.1056/NEJMp1413992			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX4RZ	25493977				2022-12-28	WOS:000346920300001
J	Cusano, NE; Bilezikian, JP				Cusano, Natalie E.; Bilezikian, John P.			Parathyroid Hormone in the Evaluation of Hypercalcemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; 4TH INTERNATIONAL WORKSHOP; MANAGEMENT		[Cusano, Natalie E.; Bilezikian, John P.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Endocrinol, New York, NY USA	Columbia University	Cusano, NE (corresponding author), 630 W 168th St,PH8W-864, New York, NY 10032 USA.	nc2433@cumc.columbia.edu			National Institutes of Health (NIH) [DK32333, DK095944]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032333, K23DK095944] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant support was provided by the National Institutes of Health (NIH) grants DK32333 and DK095944.	Bilezikian JP, 2014, J CLIN ENDOCR METAB, V99, P3561, DOI 10.1210/jc.2014-1413; Eastell R, 2014, J CLIN ENDOCR METAB, V99, P3570, DOI 10.1210/jc.2014-1414; GRANT FD, 1990, J CLIN ENDOCR METAB, V71, P370, DOI 10.1210/jcem-71-2-370; Health HI, 2001, PARATHYROIDS BASIC C, P607; Horwitz MJ, 2013, PRIMER METABOLIC BON, V8, P562; Institute of Medicine, 2011, DIETARY REFERENCE IN; Marcocci C, 2014, J CLIN ENDOCR METAB, V99, P3607, DOI 10.1210/jc.2014-1417; Silverberg SJ, 2014, J CLIN ENDOCR METAB, V99, P3580, DOI 10.1210/jc.2014-1415; Udelsman R, 2014, J CLIN ENDOCR METAB, V99, P3595, DOI 10.1210/jc.2014-2000; Waghray A, 2013, ENDOCR PRACT, V19, P451, DOI 10.4158/EP12158.OR	10	8	8	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2014	312	24					2680	2681		10.1001/jama.2014.9195	http://dx.doi.org/10.1001/jama.2014.9195			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX5KW	25536261	Green Accepted			2022-12-28	WOS:000346966100022
J	Fiscella, K; Burstin, HR; Nerenz, DR				Fiscella, Kevin; Burstin, Helen R.; Nerenz, David R.			QualityMeasures and Sociodemographic Risk Factors To Adjust or Not to Adjust	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERFORMANCE; QUALITY		[Fiscella, Kevin] Univ Rochester, Dept Family Med, Sch Med & Dent, Rochester, NY 14620 USA; [Fiscella, Kevin] Univ Rochester, Dept Publ Hlth Sci, Sch Med & Dent, Rochester, NY 14620 USA; [Burstin, Helen R.] Natl Qual Forum, Washington, DC USA; [Nerenz, David R.] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv, Detroit, MI USA	University of Rochester; University of Rochester; Henry Ford Health System; Henry Ford Hospital	Fiscella, K (corresponding author), Univ Rochester, Family Med Res Programs, 1381 South Ave, Rochester, NY 14620 USA.	kevin_fiscella@urmc.rochester.edu	Fiscella, Kevin Anthony/AFO-3350-2022	Fiscella, Kevin Anthony/0000-0003-3613-8012				[Anonymous], RISK ADJUSTMENT FOR; [Anonymous], REPORT TO THE CONGRE; Hearld LR, 2014, MED CARE RES REV, V71, P299, DOI 10.1177/1077558713509018; Hu JH, 2014, HEALTH AFFAIR, V33, P778, DOI 10.1377/hlthaff.2013.0816; Jha AK, 2014, JAMA-J AM MED ASSOC, V312, P225, DOI 10.1001/jama.2014.7204; Lipstein SH, 2014, ANN INTERN MED, V161, P594, DOI 10.7326/M14-1601; VanLare JM, 2012, NEW ENGL J MED, V367, P292, DOI 10.1056/NEJMp1204939; Zaslavsky AM, 2000, MED CARE, V38, P981, DOI 10.1097/00005650-200010000-00002	8	59	59	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2014	312	24					2615	2616		10.1001/jama.2014.15372	http://dx.doi.org/10.1001/jama.2014.15372			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX5KW	25536249				2022-12-28	WOS:000346966100008
J	Inzucchi, SE; Lipska, KJ; Mayo, H; Bailey, CJ; McGuire, DK				Inzucchi, Silvio E.; Lipska, Kasia J.; Mayo, Helen; Bailey, Clifford J.; McGuire, Darren K.			Metformin in Patients With Type 2 Diabetes and Kidney Disease A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FASTING PLASMA LACTATE; LACTIC-ACIDOSIS; RENAL IMPAIRMENT; CARDIOVASCULAR EVENTS; RISK; THERAPY; MELLITUS; CONTRAINDICATIONS; MORTALITY; HEALTH	IMPORTANCE Metformin is widely viewed as the best initial pharmacological option to lower glucose concentrations in patients with type 2 diabetes mellitus. However, the drug is contraindicated in many individuals with impaired kidney function because of concerns of lactic acidosis. OBJECTIVE To assess the risk of lactic acidosis associated with metformin use in individuals with impaired kidney function. EVIDENCE ACQUISITION In July 2014, we searched the MEDLINE and Cochrane databases for English-language articles pertaining to metformin, kidney disease, and lactic acidosis in humans between 1950 and June 2014. We excluded reviews, letters, editorials, case reports, small case series, and manuscripts that did not directly pertain to the topic area or that met other exclusion criteria. Of an original 818 articles, 65 were included in this review, including pharmacokinetic/metabolic studies, large case series, retrospective studies, meta-analyses, and a clinical trial. RESULTS Although metformin is renally cleared, drug levels generally remain within the therapeutic range and lactate concentrations are not substantially increased when used in patients with mild to moderate chronic kidney disease (estimated glomerular filtration rates, 30-60 mL/min per 1.73m(2)). The overall incidence of lactic acidosis in metformin users varies across studies from approximately 3 per 100 000 person-years to 10 per 100 000 person-years and is generally indistinguishable from the background rate in the overall population with diabetes. Data suggesting an increased risk of lactic acidosis in metformin-treated patients with chronic kidney disease are limited, and no randomized controlled trials have been conducted to test the safety of metformin in patients with significantly impaired kidney function. Population-based studies demonstrate that metformin may be prescribed counter to prevailing guidelines suggesting a renal risk in up to 1 in 4 patients with type 2 diabetes mellitus-use which, in most reports, has not been associated with increased rates of lactic acidosis. Observational studies suggest a potential benefit from metformin on macrovascular outcomes, even in patients with prevalent renal contraindications for its use. CONCLUSIONS AND RELEVANCE Available evidence supports cautious expansion of metformin use in patients with mild to moderate chronic kidney disease, as defined by estimated glomerular filtration rate, with appropriate dosage reductions and careful follow-up of kidney function.	[Inzucchi, Silvio E.; Lipska, Kasia J.] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA; [Mayo, Helen] Univ Texas SW Med Ctr Dallas, Hlth Sci Digital Lib & Learning Ctr, Dallas, TX 75390 USA; [Bailey, Clifford J.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [McGuire, Darren K.] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA	Yale University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Aston University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Inzucchi, SE (corresponding author), Yale Univ, Sch Med, Endocrinol Sect, Fitkin 106,333 Cedar St, New Haven, CT 06520 USA.	silvio.inzucchi@yale.edu	Mayo, Helen/F-9734-2011; McGuire, Darren K./AAL-4172-2021; Inzucchi, Silvio/ABF-4121-2021	Mayo, Helen/0000-0003-1238-370X; Bailey, Clifford J/0000-0002-6998-6811	National Institutes of Health; Yale Center for Clinical Investigation Scholar Award; Pepper Center Research Career Development Award; Boehringer Ingelheim; Janssen Research and Development LLC; sanofi-aventis Groupe; Genentech; Merck Sharp Dohme; Medscape Cardiology; Pri-Med Institute; Brigham and Women's Hospital, Inc; Duke Clinical Research Institute; Cleveland Clinic Coordinating Center for Clinical Research; University of Oxford; Daiichi Sankyo; Lilly USA; Novo Nordisk; F. Hoffmann La Roche; Axio Research; INC Research LLC; GlaxoSmithKline; Takeda Pharmaceuticals North America; Bristol-Myers Squibb; AstraZeneca; Orexigen; Lexicon; Eisai; Regeneron; NATIONAL INSTITUTE ON AGING [R03AG045086, P30AG021342, K23AG048359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Center for Clinical Investigation Scholar Award; Pepper Center Research Career Development Award; Boehringer Ingelheim(Boehringer Ingelheim); Janssen Research and Development LLC; sanofi-aventis Groupe; Genentech(Roche HoldingGenentech); Merck Sharp Dohme(Merck & Company); Medscape Cardiology; Pri-Med Institute; Brigham and Women's Hospital, Inc; Duke Clinical Research Institute; Cleveland Clinic Coordinating Center for Clinical Research; University of Oxford; Daiichi Sankyo(Daiichi Sankyo Company Limited); Lilly USA(Eli Lilly); Novo Nordisk(Novo Nordisk); F. Hoffmann La Roche(Hoffmann-La Roche); Axio Research; INC Research LLC; GlaxoSmithKline(GlaxoSmithKline); Takeda Pharmaceuticals North America(Takeda Pharmaceutical Company Ltd); Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); Orexigen; Lexicon; Eisai(Eisai Co Ltd); Regeneron(Regeneron); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Inzucchi reported serving as a consultant for Merck, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen, and Novo Nordisk; serving as a speaker for Merck; and receiving nonfinancial support from Takeda. Dr Lipska reported receiving a grant from the National Institutes of Health and receiving a Yale Center for Clinical Investigation Scholar Award and a Pepper Center Research Career Development Award. Dr Bailey reported serving as a consultant for, and receiving honoraria and travel expenses from, AstraZeneca/Bristol-Myers Squibb, sanofi, Merck Sharp & Dohme, Takeda, Boehringer Ingelheim/Lilly, and Novo. Dr McGuire reported receiving personal fees from Boehringer Ingelheim, Janssen Research and Development LLC, sanofi-aventis Groupe, Genentech, Merck Sharp & Dohme, Medscape Cardiology, Pri-Med Institute, The Brigham and Women's Hospital, Inc, Duke Clinical Research Institute, The Cleveland Clinic Coordinating Center for Clinical Research, The University of Oxford, Daiichi Sankyo, Lilly USA, Novo Nordisk, F. Hoffmann La Roche, Axio Research, INC Research LLC, GlaxoSmithKline, Takeda Pharmaceuticals North America, Bristol-Myers Squibb, AstraZeneca, Orexigen, Lexicon, Eisai, and Regeneron and receiving nonfinancial support from Gilead Sciences.	Abbasi A A, 2000, Endocr Pract, V6, P442; [Anonymous], GLUC METF HYDR; Bailey CJ., 2012, BR J DIABETES VASC D, V12, P167, DOI DOI 10.1177/1474651412458811; Bailey CJ, 2008, CARDIOVASC DRUG THER, V22, P215, DOI 10.1007/s10557-008-6092-0; BERGMAN U, 1978, BRIT MED J, V2, P464, DOI 10.1136/bmj.2.6135.464; Biradar V, 2010, CRIT CARE RESUSC, V12, P191; Bodmer M, 2008, DIABETES CARE, V31, P2086, DOI 10.2337/dc08-1171; Brown JB, 1998, DIABETES CARE, V21, P1659, DOI 10.2337/diacare.21.10.1659; Calabrese AT, 2002, ARCH INTERN MED, V162, P434, DOI 10.1001/archinte.162.4.434; Canadian Diabetes Association (CDA) Clinical Practice Guideline, CLIN PRACT GUID PHAR; Cavallo-Perin P, 1989, Riv Eur Sci Med Farmacol, V11, P45; Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP; Cho YM, 2011, DIABETOLOGIA, V54, P219, DOI 10.1007/s00125-010-1986-3; Connolly V, 1996, POSTGRAD MED J, V72, P352, DOI 10.1136/pgmj.72.848.352; Coresh J, 2001, ARCH INTERN MED, V161, P1207, DOI 10.1001/archinte.161.9.1207; Davis TME, 2001, BRIT J CLIN PHARMACO, V52, P137, DOI 10.1046/j.0306-5251.2001.01423.x; Duong JK, 2012, DIABETES OBES METAB, V14, P963, DOI 10.1111/j.1463-1326.2012.01617.x; Ekstrom N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001076; Emslie-Smith AM, 2001, DIABETIC MED, V18, P483, DOI 10.1046/j.1464-5491.2001.00509.x; Eppenga WL, 2014, DIABETES CARE, V37, P2218, DOI 10.2337/dc13-3023; Frid A, 2010, DIABETES CARE, V33, P1291, DOI 10.2337/dc09-1284; Friesecke S, 2010, CRIT CARE, V14, DOI 10.1186/cc9376; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; Hloch O, 2012, NEUROENDOCRINOL LETT, V33, P792; Holstein A, 1999, DIABETIC MED, V16, P692, DOI 10.1046/j.1464-5491.1999.00115.x; Horlen C, 2002, JAMA-J AM MED ASSOC, V287, P2504, DOI 10.1001/jama.287.19.2504-a; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kajbaf F, 2013, DIABETIC MED, V30, P345, DOI 10.1111/dme.12017; Kamber N, 2008, MED J AUSTRALIA, V188, P446, DOI 10.5694/j.1326-5377.2008.tb01713.x; Kennedy L, 2005, DIABETES CARE, V28, P922, DOI 10.2337/diacare.28.4.922; Kosmalski M, 2012, ADV MED SCI-POLAND, V57, P65, DOI 10.2478/v10039-012-0017-7; Krzymien J, 2013, POL ARCH MED WEWN, V123, P91, DOI 10.20452/pamw.1619; Lalau JD, 1999, DRUG SAFETY, V20, P377, DOI 10.2165/00002018-199920040-00006; LALAU JD, 1994, NEPHROL DIAL TRANSPL, V9, P126; Lalau JD, 2001, DIABETES OBES METAB, V3, P195, DOI 10.1046/j.1463-1326.2001.00128.x; LALAU JD, 1995, DIABETES CARE, V18, P779, DOI 10.2337/diacare.18.6.779; Lim VCC, 2007, INT J CLIN PRACT, V61, P1829, DOI 10.1111/j.1742-1241.2007.01487.x; Lin YC, 2010, J CHIN MED ASSOC, V73, P617, DOI 10.1016/S1726-4901(10)70135-0; Lipska KJ, 2011, DIABETES CARE, V34, P1431, DOI 10.2337/dc10-2361; Liu F, 2009, CHINESE MED J-PEKING, V122, P2547, DOI 10.3760/cma.j.issn.0366-6999.2009.21.005; Lu WYR, 2013, ANN PHARMACOTHER, V47, P1488, DOI 10.1177/1060028013505428; MARCHETTI P, 1987, CLIN PHARMACOL THER, V41, P450, DOI 10.1038/clpt.1987.55; Millican S, 2004, J CLIN PHARM THER, V29, P449, DOI 10.1111/j.1365-2710.2004.00589.x; Mongraw-Chaffin ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051237; Morgan CL, 2014, DIABETES OBES METAB, V16, P957, DOI 10.1111/dom.12302; National Institute for Health and Care Excellence (NICE), NIC GUID MAN TYP 2 D; Nguyen HL, 2011, HEMODIAL INT, V15, pS68, DOI 10.1111/j.1542-4758.2011.00605.x; Nye HJ, 2011, NEPHRON CLIN PRACT, V118, pC380, DOI 10.1159/000323739; Nyirenda MJ, 2006, DIABETIC MED, V23, P432, DOI 10.1111/j.1464-5491.2006.01813.x; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Peters N, 2008, CRIT CARE, V12, DOI 10.1186/cc7137; Pfister R, 2013, INT J CARDIOL, V162, P112, DOI 10.1016/j.ijcard.2011.05.056; Pilmore HL, 2010, NEPHROLOGY, V15, P412, DOI 10.1111/j.1440-1797.2010.01328.x; Pongwecharak J, 2009, PHARM WORLD SCI, V31, P481, DOI 10.1007/s11096-009-9303-2; Renda F, 2013, EUR REV MED PHARMACO, V17, P45; Richy FF, 2014, DIABETES CARE, V37, P2291, DOI 10.2337/dc14-0464; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Rosenwasser RF, 2013, DIABETES METAB SYNDR, V6, P453, DOI 10.2147/DMSO.S34416; Roussel R, 2010, ARCH INTERN MED, V170, P1892, DOI 10.1001/archinternmed.2010.409; Runge S, 2008, HORM METAB RES, V40, P491, DOI 10.1055/s-2008-1065319; Runge S, 2008, DIABETES OBES METAB, V10, P91, DOI 10.1111/j.1463-1326.2006.00657.x; Salpeter SR, 2010, COCHRANE DATABASE SY; SAMBOL NC, 1995, J CLIN PHARMACOL, V35, P1094, DOI 10.1002/j.1552-4604.1995.tb04033.x; Scale T, 2011, CLIN ENDOCRINOL, V74, P191, DOI 10.1111/j.1365-2265.2010.03891.x; Schramm TK, 2011, EUR HEART J, V32, P1900, DOI 10.1093/eurheartj/ehr077; Scott KA, 2010, INTERN MED J, V40, P342, DOI 10.1111/j.1445-5994.2009.01959.x; Scotton David W, 2009, Qual Manag Health Care, V18, P71, DOI 10.1097/01.QMH.0000344595.48510.cb; Seidowsky A, 2009, CRIT CARE MED, V37, P2191, DOI 10.1097/CCM.0b013e3181a02490; Selby JV, 1999, DIABETES CARE, V22, P38, DOI 10.2337/diacare.22.1.38; Selvin E, 2008, ARCH INTERN MED, V168, P2070, DOI 10.1001/archinte.168.19.2070; SIRTORI CR, 1978, CLIN PHARMACOL THER, V24, P683; Solini A, 2013, J AM GERIATR SOC, V61, P1253, DOI 10.1111/jgs.12381; Stades AME, 2004, J INTERN MED, V255, P179, DOI 10.1046/j.1365-2796.2003.01271.x; Stang M, 1999, DIABETES CARE, V22, P925, DOI 10.2337/diacare.22.6.925; Strugaru AM, 2013, MED-SURG J, V117, P1035; Sulkin TV, 1997, DIABETES CARE, V20, P925, DOI 10.2337/diacare.20.6.925; Sweileh WM, 2007, PHARM WORLD SCI, V29, P587, DOI 10.1007/s11096-007-9095-1; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; US Food and Drug Administration, ELIM BOX REG LACT AS; US Food and Drug Administration, REQ REV PRESCR LAB F; van Berlo-van de Laar IRF, 2011, J CLIN PHARM THER, V36, P376, DOI 10.1111/j.1365-2710.2010.01192.x; Vasisht KP, 2010, DIABETES OBES METAB, V12, P1079, DOI 10.1111/j.1463-1326.2010.01295.x; Vecchio S, 2014, CLIN TOXICOL, V52, P129, DOI 10.3109/15563650.2013.860985; Warren RE, 2007, DIABETIC MED, V24, P494, DOI 10.1111/j.1464-5491.2007.02118.x; WATERS AK, 1978, DIABETOLOGIA, V14, P95, DOI 10.1007/BF01263446; Wen YK, 2009, INT UROL NEPHROL, V41, P967, DOI 10.1007/s11255-009-9549-6; WIHOLM BE, 1993, EUR J CLIN PHARMACOL, V44, P589, DOI 10.1007/BF02440866; Yeung CW, 2011, PHARMACOLOGY, V88, P260, DOI 10.1159/000331867	88	359	373	4	98	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2014	312	24					2668	2675		10.1001/jama.2014.15298	http://dx.doi.org/10.1001/jama.2014.15298			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX5KW	25536258	Green Accepted			2022-12-28	WOS:000346966100019
J	Lyssiotis, CA; Cantley, LC				Lyssiotis, Costas A.; Cantley, Lewis C.			Acetate Fuels the Cancer Engine	CELL			English	Editorial Material							METABOLISM	Cancer cells have distinctive nutrient demands to fuel growth and proliferation, including the disproportionate use of glucose, glutamine, and fatty acids. Comerford et al. and Mashimo et al. now demonstrate that several types of cancer are avid consumers of acetate, which facilitates macromolecular biosynthesis and histone modification.	[Lyssiotis, Costas A.; Cantley, Lewis C.] Weill Cornell Med Coll, Meyer Canc Ctr, Dept Med, New York, NY 10065 USA	Cornell University	Lyssiotis, CA (corresponding author), Weill Cornell Med Coll, Meyer Canc Ctr, Dept Med, New York, NY 10065 USA.	col2007@med.cornell.edu; lcantley@med.cornell.edu	Cantley, Lewis C/D-1800-2014; Lyssiotis, Costas A/AAI-1923-2019	Cantley, Lewis C/0000-0002-1298-7653; Lyssiotis, Costas A/0000-0001-9309-6141				Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; TOLLINGER CD, 1979, CLIN CHEM, V25, P1787; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305	8	62	65	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1492	1494		10.1016/j.cell.2014.12.009	http://dx.doi.org/10.1016/j.cell.2014.12.009			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525870	Bronze			2022-12-28	WOS:000347922500004
J	Harkin, A				Harkin, Andrew			Muscling In on Depression	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Trinity Coll Dublin, Trinity Coll Inst Neurosci, Neuropscyhopharmacol Res Grp, Dublin, Ireland	Trinity College Dublin	Harkin, A (corresponding author), Trinity Coll Dublin, Trinity Coll Inst Neurosci, Neuropscyhopharmacol Res Grp, Dublin, Ireland.		Harkin, Andrew/AAS-8590-2020	Harkin, Andrew/0000-0001-9734-216X				Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Mueller N, 2007, MOL PSYCHIATR, V12, P988, DOI 10.1038/sj.mp.4002006	2	15	15	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					2333	2334		10.1056/NEJMcibr1411568	http://dx.doi.org/10.1056/NEJMcibr1411568			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW1KQ	25494274				2022-12-28	WOS:000346048800016
J	Feinmann, J				Feinmann, Jane			THE BMJ CHRISTMAS APPEAL 2014 How MSF is mapping the world's medical emergency zones	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com						Bryson L, 2013, MAPPING SPREAD CHOLE	1	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2014	349								g7540	10.1136/bmj.g7540	http://dx.doi.org/10.1136/bmj.g7540			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3CL	25491572	Bronze, Green Published			2022-12-28	WOS:000346163100003
J	Feinberg, EH; Meister, M				Feinberg, Evan H.; Meister, Markus			Orientation columns in the mouse superior colliculus	NATURE			English	Article							MONKEY STRIATE CORTEX; VISUAL-CORTEX; FUNCTIONAL ARCHITECTURE; ADDITIONAL OBSERVATIONS; ELECTRICAL-STIMULATION; CELLULAR RESOLUTION; RECEPTIVE-FIELDS; NEURAL ACTIVITY; MICE LACKING; ORGANIZATION	More than twenty types of retinal ganglion cells conduct visual information from the eye to the rest of the brain(1,2). Each retinal ganglion cell type tessellates the retina in a regular mosaic, so that every point in visual space is processed for visual primitives such as contrast and motion(3). This information flows to two principal brain centres: the visual cortex and the superior colliculus. The superior colliculus plays an evolutionarily conserved role in visual behaviours(4), but its functional architecture is poorly understood. Here we report on population recordings of visual responses from neurons in the mouse superior colliculus. Many neurons respond preferentially to lines of a certain orientation or movement axis. We show that cells with similar orientation preferences form large patches that span the vertical thickness of the retinorecipient layers. This organization is strikingly different from the randomly interspersed orientation preferences in the mouse's visual cortex(5); instead, it resembles the orientation columns observed in the visual cortices of large mammals(6-8). Notably, adjacent superior colliculus orientation columns have only limited receptive field overlap. This is in contrast to the organization of visual cortex, where each point in the visual field activates neurons with all preferred orientations(9). Instead, the superior colliculus favours specific contour orientations within similar to 30 degrees regions of the visual field, a finding with implications for behavioural responses mediated by this brain centre.	[Feinberg, Evan H.; Meister, Markus] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Meister, Markus] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Harvard University; California Institute of Technology	Meister, M (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, 52 Oxford St, Cambridge, MA 02138 USA.	evan_feinberg@post.harvard.edu; meister@caltech.edu		Meister, Markus/0000-0003-2136-6506	NIH [T32 NS007484]; Howard Hughes Medical Institute-Helen Hay Whitney Foundation fellowship; NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute-Helen Hay Whitney Foundation fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Soucy and J. Greenwood for assistance with instrumentation; M. Joesch, A. Krishnaswamy, D. Kostadinov, S. Pashkovski, A. Giessel, T. Dunn, G. Keller, P. Kaifosh, M. Amoroso, and H. Asari for software; M. Andermann, V. Bonin, and F. Engert for advice on microscope design; J. Cohen for headplate designs; D. Anderson, K. Blum, B. Olveckzy, and J. Sanes for critical reading of the manuscript; and J. Sanes for providing laboratory space and support to E. H. F. E. H. F. was supported by NIH T32 NS007484 and a Howard Hughes Medical Institute-Helen Hay Whitney Foundation fellowship. Additional support was provided by an NIH grant to M.M.	Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; Bosking WH, 2002, NAT NEUROSCI, V5, P874, DOI 10.1038/nn908; Cang JH, 2008, J NEUROSCI, V28, P11015, DOI 10.1523/JNEUROSCI.2478-08.2008; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chevalier G, 2000, J COMP NEUROL, V419, P137, DOI 10.1002/(SICI)1096-9861(20000403)419:2<137::AID-CNE1>3.0.CO;2-6; DEAN P, 1986, NEUROSCIENCE, V19, P367, DOI 10.1016/0306-4522(86)90267-8; DEAN P, 1988, NEUROSCIENCE, V24, P501, DOI 10.1016/0306-4522(88)90345-4; Dhande OS, 2014, CURR OPIN NEUROBIOL, V24, P133, DOI 10.1016/j.conb.2013.08.006; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; DRAGER UC, 1976, J NEUROPHYSIOL, V39, P91, DOI 10.1152/jn.1976.39.1.91; DRAGER UC, 1975, NATURE, V253, P203, DOI 10.1038/253203a0; Gobel W, 2007, PHYSIOLOGY, V22, P358, DOI 10.1152/physiol.00032.2007; GRAYBIEL AM, 1978, NATURE, V272, P539, DOI 10.1038/272539b0; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Hong YK, 2011, J COMP NEUROL, V519, P1691, DOI 10.1002/cne.22595; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Kaifosh P, 2013, NAT NEUROSCI, V16, P1182, DOI 10.1038/nn.3482; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Mana S, 2001, NEUROSCIENCE, V106, P357, DOI 10.1016/S0306-4522(01)00283-4; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; Mrsic-Flogel TD, 2005, J NEUROSCI, V25, P6921, DOI 10.1523/JNEUROSCI.1555-05.2005; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki Kenichi, 2014, Cold Spring Harb Protoc, V2014, P402, DOI 10.1101/pdb.prot081455; Prusky GT, 2004, VISION RES, V44, P3411, DOI 10.1016/j.visres.2004.09.001; Ramon-Moliner E, 1972, Ergeb Anat Entwicklungsgesch, V46, P7; SAHIBZADA N, 1986, J NEUROSCI, V6, P723; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang LP, 2010, J NEUROSCI, V30, P16573, DOI 10.1523/JNEUROSCI.3305-10.2010; Wang LP, 2009, J NEUROSCI, V29, P12909, DOI 10.1523/JNEUROSCI.2128-09.2009; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wong GKC, 2007, ACTA NEUROCHIR, V149, P929, DOI 10.1007/s00701-007-1264-4; Yu H, 2005, NEURON, V47, P267, DOI 10.1016/j.neuron.2005.06.011; Zhao XY, 2013, J NEUROSCI, V33, P12751, DOI 10.1523/JNEUROSCI.0095-13.2013	40	70	70	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					229	+		10.1038/nature14103	http://dx.doi.org/10.1038/nature14103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25517100				2022-12-28	WOS:000350770500038
J	Bishopp, A; Bennett, MJ				Bishopp, Anthony; Bennett, Malcolm J.			Seeing the wood and the trees	NATURE			English	Editorial Material							NETWORK MOTIFS	The identification of the gene regulatory network that controls the formation of xylem - the major component of wood opens up new avenues for manipulating plant biomass. SEE ARTICLE P.571	[Bishopp, Anthony; Bennett, Malcolm J.] Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, Notts, England	University of Nottingham	Bishopp, A (corresponding author), Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, Notts, England.	anthony.bishopp@nottingham.ac.uk; malcolm.bennett@nottingham.ac.uk	Bennett, Malcolm/G-4004-2010	Bennett, Malcolm/0000-0003-0475-390X; Bishopp, Anthony/0000-0003-2962-9542	Biotechnology and Biological Sciences Research Council [BB/G023972/1] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/M001806/1] Funding Source: researchfish; BBSRC [BB/G023972/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Kondo Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00315; Lacayo CI, 2010, PLANT PHYSIOL, V154, P121, DOI 10.1104/pp.110.155242; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Taylor-Teeples M, 2015, NATURE, V517, P571, DOI 10.1038/nature14099; Turner S, 2007, ANNU REV PLANT BIOL, V58, P407, DOI 10.1146/annurev.arplant.57.032905.105236	7	3	3	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					558	559		10.1038/nature14085	http://dx.doi.org/10.1038/nature14085			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25533950				2022-12-28	WOS:000348775000028
J	Whittle, S; Buchbinder, R				Whittle, Samuel; Buchbinder, Rachelle			Rotator Cuff Disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED CONTROLLED-TRIAL; SUPRASCAPULAR NERVE BLOCK; FULL-THICKNESS TEARS; SHOCK-WAVE THERAPY; SHOULDER PAIN; GENERAL-PRACTICE; WORKING POPULATION; PRIMARY-CARE; METAANALYSIS						Buchbinder, Rachelle/G-2952-2011; Whittle, Samuel L/K-7861-2015	Buchbinder, Rachelle/0000-0002-0597-0933; Whittle, Samuel L/0000-0001-7417-7691				Ainsworth R, 2007, BRIT J SPORT MED, V41, P200, DOI 10.1136/bjsm.2006.032524; Arroll B, 2005, BRIT J GEN PRACT, V55, P224; Australian Acute Musculoskeletal Pain Guidelines Group, 2003, EV BAS MAN AC MUSC P; Baima J, 2008, CURR REV MUSCULOSKE, V1, P88, DOI 10.1007/s12178-007-9011-2; Bannuru RR, 2014, ANN INTERN MED, V160, P542, DOI 10.7326/M13-1982; Bennell K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2756; BLOOM JE, 2012, COCHRANE DATABASE SY, V8; Bodin J, 2012, SCAND J WORK ENV HEA, V38, P436, DOI 10.5271/sjweh.3285; Boocock MG, 2007, OCCUP ENVIRON MED, V64, P291, DOI 10.1136/oem.2005.025593; Boudreault J, 2014, J REHABIL MED, V46, P294, DOI 10.2340/16501977-1800; Buchbinder R, 1996, J CLIN EPIDEMIOL, V49, P141, DOI 10.1016/0895-4356(95)00519-6; Buchbinder R, 2003, COCHRANE DATABASE SY; BUCHBINDER R, 2013, PLOS ONE, V8; Bussieres AE, 2007, J MANIP PHYSIOL THER, V30, P617, DOI 10.1016/j.jmpt.2007.10.003; Chen SK, 1999, J SHOULDER ELB SURG, V8, P49, DOI 10.1016/S1058-2746(99)90055-1; COGHLAN JA, 2008, COCHRANE SYST DATAB; Conway R, 2013, CLIN RHEUMATOL, V32, P1811, DOI 10.1007/s10067-013-2350-z; Dorrestijn O, 2011, RHEUMATOLOGY, V50, P389, DOI 10.1093/rheumatology/keq333; Edmonds EW, 2014, AM FAM PHYSICIAN, V89, P537; EKEBERG OM, 2009, BMJ-BRIT MED J, V338, P3112; Ensor KL, 2013, J SHOULDER ELB SURG, V22, P1628, DOI 10.1016/j.jse.2013.01.006; GREEN, 2003, COCHRANE DATABASE SY; GREEN S, 2005, COCHRANE DATABASE S; Ha SM, 2013, J ATHL TRAINING, V48, P346, DOI 10.4085/1062-6050-48.2.18; HALVERSON PB, 1984, ANN RHEUM DIS, V43, P734, DOI 10.1136/ard.43.5.734; HANCHARD NC, 2013, COCHRANE DATABASE RE, V4; Hanchard NCA, 2005, J ORTHOP SPORT PHYS, V35, P147, DOI 10.2519/jospt.2005.35.3.147; Hanratty CE, 2012, SEMIN ARTHRITIS RHEU, V42, P297, DOI 10.1016/j.semarthrit.2012.03.015; HERBERTS P, 1981, ACTA ORTHOP SCAND, V52, P299, DOI 10.3109/17453678109050107; Hermans J, 2013, JAMA-J AM MED ASSOC, V310, P837, DOI 10.1001/jama.2013.276187; Hertel R, 1996, J Shoulder Elbow Surg, V5, P307, DOI 10.1016/S1058-2746(96)80058-9; Karjalainen K.A., 2003, COCHRANE DB SYST REV, V2003, pCD002194, DOI [10.1002/14651858.CD002194, DOI 10.1002/14651858.CD002194]; Kesikburun S, 2013, AM J SPORT MED, V41, P2609, DOI 10.1177/0363546513496542; Krasny C, 2005, J BONE JOINT SURG BR, V87B, P501, DOI 10.1302/0301-620X.87B4; LENZA M, 2013, COCHRANE DB SYST REV, V9, P9020; Linsell L, 2006, RHEUMATOLOGY, V45, P215, DOI 10.1093/rheumatology/kei139; Littlewood C, 2012, PHYSIOTHERAPY, V98, P101, DOI 10.1016/j.physio.2011.08.002; Luime JJ, 2004, SCAND J RHEUMATOL, V33, P73, DOI 10.1080/03009740310004667; Mazieres B, 2005, J RHEUMATOL, V32, P1563; Milano G, 2007, ARTHROSCOPY, V23, P81, DOI 10.1016/j.arthro.2006.10.011; Miller CA, 2008, ARCH PHYS MED REHAB, V89, P1162, DOI 10.1016/j.apmr.2007.10.046; Minagawa H, 2013, J ORTHOP, V10, P8, DOI 10.1016/j.jor.2013.01.008; Molsberger AF, 2010, PAIN, V151, P146, DOI 10.1016/j.pain.2010.06.036; Moraes V. Y., 2014, COCHRANE DATABASE SY, V4; Oh LS, 2007, CLIN ORTHOP RELAT R, P52, DOI 10.1097/BLO.0b013e31802fc175; Ostor AJK, 2005, RHEUMATOLOGY, V44, P800, DOI 10.1093/rheumatology/keh598; PARK HB, 2005, J BONE JOINT SURG AM, V87, P1446, DOI DOI 10.2106/JBJS.D.02335; PETERS D, 1994, BRIT J GEN PRACT, V44, P25; Rahme E, 2008, AM J GASTROENTEROL, V103, P872, DOI 10.1111/j.1572-0241.2008.01811.x; REKOLA KE, 1993, J EPIDEMIOL COMMUN H, V47, P153, DOI 10.1136/jech.47.2.153; Shanahan EM, 2003, ANN RHEUM DIS, V62, P400, DOI 10.1136/ard.62.5.400; Silverstein BA, 2006, SCAND J WORK ENV HEA, V32, P99, DOI 10.5271/sjweh.985; Titchener AG, 2014, J SHOULDER ELB SURG, V23, P1282, DOI 10.1016/j.jse.2013.12.019; Towheed TE, 2006, COCHRANE DATABASE SY; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; Vas J, 2008, RHEUMATOLOGY, V47, P887, DOI 10.1093/rheumatology/ken040; VECCHIO PC, 1993, J RHEUMATOL, V20, P453; Yamaguchi K, 2001, J SHOULDER ELB SURG, V10, P199, DOI 10.1067/mse.2001.113086; YAMAMOTO A, 2010, J SHOULDER ELB SURG, V19, P116, DOI DOI 10.1016/J.JSE.2009.04.006; Zheng XQ, 2014, ARCH PHYS MED REHAB, V95, P1824, DOI 10.1016/j.apmr.2014.04.024	60	40	43	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2015	162	1					ITC1	ITC16		10.7326/AITC201501060	http://dx.doi.org/10.7326/AITC201501060			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1LU	25560729				2022-12-28	WOS:000350103000025
J	Bonaccorso, F; Colombo, L; Yu, GH; Stoller, M; Tozzini, V; Ferrari, AC; Ruoff, RS; Pellegrini, V				Bonaccorso, Francesco; Colombo, Luigi; Yu, Guihua; Stoller, Meryl; Tozzini, Valentina; Ferrari, Andrea C.; Ruoff, Rodney S.; Pellegrini, Vittorio			Graphene, related two-dimensional crystals, and hybrid systems for energy conversion and storage	SCIENCE			English	Review							HOLE TRANSPORT LAYER; SOLAR-CELLS; HYDROGEN STORAGE; SURFACE-AREA; VOLUMETRIC CAPACITANCE; THERMAL-CONDUCTIVITY; ELECTRODE MATERIALS; COUNTER ELECTRODES; ACTIVATED GRAPHENE; LITHIUM INSERTION	Graphene and related two-dimensional crystals and hybrid systems showcase several key properties that can address emerging energy needs, in particular for the ever growing market of portable and wearable energy conversion and storage devices. Graphene's flexibility, large surface area, and chemical stability, combined with its excellent electrical and thermal conductivity, make it promising as a catalyst in fuel and dye-sensitized solar cells. Chemically functionalized graphene can also improve storage and diffusion of ionic species and electric charge in batteries and supercapacitors. Two-dimensional crystals provide optoelectronic and photocatalytic properties complementing those of graphene, enabling the realization of ultrathin-film photovoltaic devices or systems for hydrogen production. Here, we review the use of graphene and related materials for energy conversion and storage, outlining the roadmap for future applications.	[Bonaccorso, Francesco; Pellegrini, Vittorio] Ist Italiano Tecnol, Graphene Labs, I-16163 Genoa, Italy; [Bonaccorso, Francesco; Ferrari, Andrea C.] Univ Cambridge, Cambridge Graphene Ctr, Cambridge CB3 0FA, England; [Colombo, Luigi] Texas Instruments Inc, Dallas, TX 75243 USA; [Yu, Guihua] Univ Texas Austin, Mat Sci & Engn Program, Austin, TX 78712 USA; [Yu, Guihua] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA; [Stoller, Meryl] nCarbon, Austin, TX 78727 USA; [Tozzini, Valentina; Pellegrini, Vittorio] CNR, Ist Nanosci, Natl Enterprise nanoSci & nanoTechnol, I-56126 Pisa, Italy; [Tozzini, Valentina; Pellegrini, Vittorio] Scuola Normale Super Pisa, I-56126 Pisa, Italy; [Ruoff, Rodney S.] Ulsan Natl Inst Sci & Technol, Dept Chem, Inst Basic Sci, Ctr Multidimens Carbon Mat, Ulsan 689798, South Korea	Istituto Italiano di Tecnologia - IIT; University of Cambridge; Texas Instruments; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Scuola Normale Superiore di Pisa; Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST)	Bonaccorso, F (corresponding author), Ist Italiano Tecnol, Graphene Labs, Via Morego 30, I-16163 Genoa, Italy.	francesco.bonaccorso@iit.it	Tozzini, Valentina/E-8206-2011; Ruoff, Rodney/ABE-6532-2020; Bonaccorso, Francesco/N-6752-2015; Colombo, Luigi/T-4677-2018; Ruoff, Rodney S/B-7605-2009	Tozzini, Valentina/0000-0002-7586-5039; Ruoff, Rodney/0000-0002-6599-6764; Bonaccorso, Francesco/0000-0001-7238-9420; Colombo, Luigi/0000-0002-9048-3565; Ruoff, Rodney S/0000-0002-6599-6764	European Union (EU) Graphene Flagship [604391]; Newton International Fellowship; University of Texas-Austin; Welch Foundation [F-1861]; European Research Council [Hetero2D]; Royal Society Wolfson Research Merit Award; EU project GENIUS; EU project CARERAMM; EU project MEM4WIN; Engineering and Physical Sciences Research Council [EP/K01711X/1, EP/K017144/1, EP/L016087/1]; Lancaster University's Distinguished Visitor Program in Physical Sciences; EPSRC [EP/K01711X/1, EP/K017144/1] Funding Source: UKRI	European Union (EU) Graphene Flagship; Newton International Fellowship; University of Texas-Austin; Welch Foundation(The Welch Foundation); European Research Council(European Research Council (ERC)European Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); EU project GENIUS; EU project CARERAMM; EU project MEM4WIN; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Lancaster University's Distinguished Visitor Program in Physical Sciences; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank M. Prato for useful discussions. We acknowledge funding from European Union (EU) Graphene Flagship (contract 604391); Newton International Fellowship; faculty start-up support from the University of Texas-Austin; the Welch Foundation Award F-1861; European Research Council grant Hetero2D; a Royal Society Wolfson Research Merit Award, EU projects GENIUS, CARERAMM, and MEM4WIN; Engineering and Physical Sciences Research Council grants EP/K01711X/1, EP/K017144/1, and EP/L016087/1; and Lancaster University's Distinguished Visitor Program in Physical Sciences.	Ammundsen B, 2001, ADV MATER, V13, P943, DOI 10.1002/1521-4095(200107)13:12/13<943::AID-ADMA943>3.0.CO;2-J; Ao ZM, 2010, J PHYS CHEM C, V114, P14503, DOI 10.1021/jp103835k; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Bak SM, 2011, J MATER CHEM, V21, P17309, DOI 10.1039/c1jm13741g; Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872; Bernardi M, 2013, NANO LETT, V13, P3664, DOI 10.1021/nl401544y; Bonaccorso F, 2010, NAT PHOTONICS, V4, P611, DOI [10.1038/NPHOTON.2010.186, 10.1038/nphoton.2010.186]; Bonaccorso F, 2012, MATER TODAY, V15, P564, DOI 10.1016/S1369-7021(13)70014-2; Borges RS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02572; Boukhvalov DW, 2009, J PHYS CHEM C, V113, P14176, DOI 10.1021/jp905702e; Britnell L, 2013, SCIENCE, V340, P1311, DOI 10.1126/science.1235547; Bruce PG, 2012, NAT MATER, V11, P19, DOI [10.1038/nmat3191, 10.1038/NMAT3191]; Burke A., 2012, RESEARCH REPORT UCD; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; CHAPIN DM, 1954, J APPL PHYS, V25, P676, DOI 10.1063/1.1721711; Chen SS, 2012, NAT MATER, V11, P203, DOI [10.1038/NMAT3207, 10.1038/nmat3207]; Cheng Q, 2011, PHYS CHEM CHEM PHYS, V13, P17615, DOI 10.1039/c1cp21910c; Choi H, 2011, SOL ENERG MAT SOL C, V95, P323, DOI 10.1016/j.solmat.2010.04.044; Conway BE, 2013, ELECTROCHEMICAL SUPE; De Arco LG, 2010, ACS NANO, V4, P2865, DOI 10.1021/nn901587x; Dimitrakakis GK, 2008, NANO LETT, V8, P3166, DOI 10.1021/nl801417w; DiSalvo FJ, 1999, SCIENCE, V285, P703, DOI 10.1126/science.285.5428.703; Divya KC, 2009, ELECTR POW SYST RES, V79, P511, DOI 10.1016/j.epsr.2008.09.017; Dong LF, 2010, CARBON, V48, P781, DOI 10.1016/j.carbon.2009.10.027; Donnet J.-B., 1993, CARBON BLACK SCIENCE; Du GD, 2010, CHEM COMMUN, V46, P1106, DOI 10.1039/b920277c; Echtermeyer TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1464; Elias DC, 2009, SCIENCE, V323, P610, DOI 10.1126/science.1167130; Ferrari AC, 2015, NANOSCALE, V7, P4598, DOI 10.1039/c4nr01600a; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Gogotsi Y, 2011, SCIENCE, V334, P917, DOI 10.1126/science.1213003; Goler S, 2013, J PHYS CHEM C, V117, P11506, DOI 10.1021/jp4017536; GREEN MA, 1995, PROG PHOTOVOLTAICS, V3, P189, DOI 10.1002/pip.4670030303; Green MA, 2013, PROG PHOTOVOLTAICS, V21, P827, DOI 10.1002/pip.2404; Gunst T, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.155449; Hao YF, 2013, SCIENCE, V342, P720, DOI 10.1126/science.1243879; Haskins J, 2011, ACS NANO, V5, P3779, DOI 10.1021/nn200114p; Hassoun J, 2014, NANO LETT, V14, P4901, DOI 10.1021/nl502429m; Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215; Hong WJ, 2008, ELECTROCHEM COMMUN, V10, P1555, DOI 10.1016/j.elecom.2008.08.007; Hoppe H, 2004, J MATER RES, V19, P1924, DOI 10.1557/JMR.2004.0252; Hu LH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2705; Hu QK, 2013, J PHYS CHEM A, V117, P14253, DOI 10.1021/jp409585v; Hu S, 2014, NATURE, V516, P227, DOI 10.1038/nature14015; Jang JT, 2011, J AM CHEM SOC, V133, P7636, DOI 10.1021/ja200400n; Jeon IY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01810; Jeon YJ, 2012, SOL ENERG MAT SOL C, V105, P96, DOI 10.1016/j.solmat.2012.05.024; Kalowekamo J, 2009, SOL ENERGY, V83, P1224, DOI 10.1016/j.solener.2009.02.003; Kavan L, 2011, NANO LETT, V11, P5501, DOI 10.1021/nl203329c; Khomenko V, 2008, J POWER SOURCES, V177, P643, DOI 10.1016/j.jpowsour.2007.11.101; Kim G, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085408; Kim H, 2011, J ELECTROCHEM SOC, V158, pA930, DOI 10.1149/1.3599632; Kobayashi T, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4776707; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Lei ZB, 2011, ENERG ENVIRON SCI, V4, P1866, DOI 10.1039/c1ee01094h; Li MM, 2013, PHYS CHEM CHEM PHYS, V15, P18973, DOI 10.1039/c3cp53283f; Li SS, 2010, ACS NANO, V4, P3169, DOI 10.1021/nn100551j; Li XM, 2010, ADV MATER, V22, P2743, DOI 10.1002/adma.200904383; Li YY, 2013, ADV MATER, V25, P2474, DOI 10.1002/adma.201205332; Liang J, 2012, ADV FUNCT MATER, V22, P1267, DOI 10.1002/adfm.201102809; Liebhafsky H. A., 1969, FUEL CELLS AND FUEL; Lin JY, 2013, CHEM COMMUN, V49, P1440, DOI 10.1039/c2cc38658e; Linden D., 2010, HANDBOOK OF BATTERIE; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Long JW, 2011, MRS BULL, V36, P513, DOI 10.1557/mrs.2011.137; Lukatskaya MR, 2013, SCIENCE, V341, P1502, DOI 10.1126/science.1241488; Mathew S, 2014, NAT CHEM, V6, P242, DOI [10.1038/NCHEM.1861, 10.1038/nchem.1861]; Miao XC, 2012, NANO LETT, V12, P2745, DOI 10.1021/nl204414u; Naguib M, 2012, ELECTROCHEM COMMUN, V16, P61, DOI 10.1016/j.elecom.2012.01.002; NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063; Ohzuku T, 2001, CHEM LETT, P642; Ong MT, 2012, ACS NANO, V6, P1387, DOI 10.1021/nn204198g; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; Parambhath VB, 2011, J PHYS CHEM C, V115, P15679, DOI 10.1021/jp202797q; Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/NNANO.2009.58, 10.1038/nnano.2009.58]; Patchkovskii S, 2005, P NATL ACAD SCI USA, V102, P10439, DOI 10.1073/pnas.0501030102; Paton KR, 2014, NAT MATER, V13, P624, DOI [10.1038/NMAT3944, 10.1038/nmat3944]; Peigney A, 2001, CARBON, V39, P507, DOI 10.1016/S0008-6223(00)00155-X; Peng HL, 2012, NAT CHEM, V4, P281, DOI 10.1038/nchem.1277; Pope MA, 2013, J ELECTROCHEM SOC, V160, pA1653, DOI 10.1149/2.017310jes; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Radich JG, 2011, J PHYS CHEM LETT, V2, P2453, DOI 10.1021/jz201064k; Rowell MW, 2011, ENERG ENVIRON SCI, V4, P131, DOI 10.1039/c0ee00373e; Roy-Mayhew JD, 2010, ACS NANO, V4, P6203, DOI 10.1021/nn1016428; Sevincli H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01228; Shi EZ, 2013, NANO LETT, V13, P1776, DOI 10.1021/nl400353f; Shi Y, 2013, NANO LETT, V13, P4715, DOI 10.1021/nl402237u; Shiva K, 2013, NANO ENERGY, V2, P787, DOI 10.1016/j.nanoen.2013.02.001; Slack GA, 1995, CRC HANDBOOK OF THER; Srinivas G, 2010, CARBON, V48, P630, DOI 10.1016/j.carbon.2009.10.003; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; Stoller MD, 2012, PHYS CHEM CHEM PHYS, V14, P3388, DOI 10.1039/c2cp00017b; Stoller MD, 2011, ENERG ENVIRON SCI, V4, P4685, DOI 10.1039/c1ee02322e; Stoller MD, 2010, ENERG ENVIRON SCI, V3, P1294, DOI 10.1039/c0ee00074d; Tao Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02975; Tarancon A, 2010, J MATER CHEM, V20, P3799, DOI 10.1039/b922430k; THACKERAY MM, 1983, MATER RES BULL, V18, P461, DOI 10.1016/0025-5408(83)90138-1; Tozzini V, 2011, J PHYS CHEM C, V115, P25523, DOI 10.1021/jp208262r; Tsai WY, 2013, NANO ENERGY, V2, P403, DOI 10.1016/j.nanoen.2012.11.006; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; Vining CB, 2009, NAT MATER, V8, P83, DOI 10.1038/nmat2361; Vivekchand SRC, 2008, J CHEM SCI, V120, P9, DOI 10.1007/s12039-008-0002-7; Voiry D, 2013, NANO LETT, V13, P6222, DOI 10.1021/nl403661s; Wang GX, 2009, CARBON, V47, P2049, DOI 10.1016/j.carbon.2009.03.053; WANG H, 2011, PROT PRIV CHIN RES, P1, DOI DOI 10.1002/ANGE.201103163; Wang HX, 2013, SMALL, V9, P1266, DOI 10.1002/smll.201203040; Wang JTW, 2014, NANO LETT, V14, P724, DOI 10.1021/nl403997a; Wang X, 2008, NANO LETT, V8, P323, DOI 10.1021/nl072838r; WHITTINGHAM MS, 1976, SCIENCE, V192, P1126, DOI 10.1126/science.192.4244.1126; Wu MX, 2011, PHYS CHEM CHEM PHYS, V13, P19298, DOI 10.1039/c1cp22819f; Wu Q, 2010, ACS NANO, V4, P1963, DOI 10.1021/nn1000035; Wu YM, 2013, J PHYS CHEM C, V117, P11968, DOI 10.1021/jp402529c; Wu ZS, 2010, ACS NANO, V4, P5835, DOI 10.1021/nn101754k; Xiang QJ, 2012, J AM CHEM SOC, V134, P6575, DOI 10.1021/ja302846n; Xu F, 2013, J PHYS CHEM C, V117, P8619, DOI 10.1021/jp312379b; Yan X, 2010, NANO LETT, V10, P1869, DOI 10.1021/nl101060h; Yang J, 2014, J MATER CHEM A, V2, P5979, DOI 10.1039/c3ta14151a; Yang NL, 2010, ACS NANO, V4, P887, DOI 10.1021/nn901660v; Yang SB, 2010, ANGEW CHEM INT EDIT, V49, P8408, DOI 10.1002/anie.201003485; Yang XW, 2013, SCIENCE, V341, P534, DOI 10.1126/science.1239089; Yong V, 2010, SMALL, V6, P313, DOI 10.1002/smll.200901364; Yoo E, 2008, NANO LETT, V8, P2277, DOI 10.1021/nl800957b; Yoo E, 2009, NANO LETT, V9, P2255, DOI 10.1021/nl900397t; Yum JH, 2007, J AM CHEM SOC, V129, P10320, DOI 10.1021/ja0731470; Zhang F, 2013, ENERG ENVIRON SCI, V6, P1623, DOI 10.1039/c3ee40509e; Zhang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01408; Zhao X, 2011, ADV ENERGY MATER, V1, P1079, DOI 10.1002/aenm.201100426; Zheng XL, 2014, CHEM MATER, V26, P2344, DOI 10.1021/cm500347r; Zhirko YI, 2007, NATO SECUR SCI SER A, P325, DOI 10.1007/978-1-4020-5514-0_43; Zhou GM, 2014, ENERG ENVIRON SCI, V7, P1307, DOI 10.1039/c3ee43182g; Zhou GM, 2010, CHEM MATER, V22, P5306, DOI 10.1021/cm101532x; Zhu YW, 2011, SCIENCE, V332, P1537, DOI 10.1126/science.1200770; Zhu YW, 2010, CARBON, V48, P2118, DOI 10.1016/j.carbon.2010.02.001; Zhu Y, 2011, ACS NANO, V5, P6472, DOI 10.1021/nn201696g	136	2578	2627	130	7306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217							1246501	10.1126/science.1246501	http://dx.doi.org/10.1126/science.1246501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554791				2022-12-28	WOS:000347102300040
J	Zickermann, V; Wirth, C; Nasiri, H; Siegmund, K; Schwalbe, H; Hunte, C; Brandt, U				Zickermann, Volker; Wirth, Christophe; Nasiri, Hamid; Siegmund, Karin; Schwalbe, Harald; Hunte, Carola; Brandt, Ulrich			Mechanistic insight from the crystal structure of mitochondrial complex I	SCIENCE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; 49-KDA SUBUNIT; RESPIRATORY-CHAIN; MEMBRANE DOMAIN; FUNCTIONAL-ROLE; BINDING; TRANSITION; ARCHITECTURE; REDUCTION; RESIDUES	Proton-pumping complex I of the mitochondrial respiratory chain is among the largest and most complicated membrane protein complexes. The enzyme contributes substantially to oxidative energy conversion in eukaryotic cells. Its malfunctions are implicated in many hereditary and degenerative disorders. We report the x-ray structure of mitochondrial complex I at a resolution of 3.6 to 3.9 angstroms, describing in detail the central subunits that execute the bioenergetic function. A continuous axis of basic and acidic residues running centrally through the membrane arm connects the ubiquinone reduction site in the hydrophilic arm to four putative proton-pumping units. The binding position for a substrate analogous inhibitor and blockage of the predicted ubiquinone binding site provide a model for the "deactive" form of the enzyme. The proposed transition into the active form is based on a concerted structural rearrangement at the ubiquinone reduction site, providing support for a two-state stabilization-change mechanism of proton pumping.	[Zickermann, Volker; Siegmund, Karin] Goethe Univ Frankfurt, Inst Biochem 2, Struct Bioenerget Grp, Sch Med, D-60438 Frankfurt, Germany; [Zickermann, Volker; Schwalbe, Harald; Brandt, Ulrich] Goethe Univ Frankfurt, Cluster Excellence Frankfurt Macromol Complexes, D-60438 Frankfurt, Germany; [Wirth, Christophe; Hunte, Carola] Univ Freiburg, Inst Biochem & Mol Biol, BIOSS Ctr Biol Signalling Studies, ZBMZ, D-79104 Freiburg, Germany; [Nasiri, Hamid] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Nasiri, Hamid; Schwalbe, Harald] Ctr Biomol Magnet Resonance, Inst Organ Chem & Chem Biol, D-60438 Frankfurt, Germany; [Brandt, Ulrich] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, NL-6525 GA Nijmegen, Netherlands	Goethe University Frankfurt; Goethe University Frankfurt; University of Freiburg; University of Cambridge; Radboud University Nijmegen	Zickermann, V (corresponding author), Goethe Univ Frankfurt, Inst Biochem 2, Struct Bioenerget Grp, Sch Med, D-60438 Frankfurt, Germany.	zickermann@med.uni-frankfurt.de; carola.hunte@biochemie.uni-freiburg.de; ulrich.brandt@radboudumc.nl	Hunte, Carola/E-4071-2015; Brandt, Ulrich/C-4406-2008; Schwalbe, Harald/AAB-3143-2020; Schwalbe, Harald J/F-9023-2010; Brandt, Ulrich/GLV-1242-2022	Hunte, Carola/0000-0002-0826-3986; Brandt, Ulrich/0000-0003-1869-6811; Schwalbe, Harald/0000-0001-5693-7909; Schwalbe, Harald J/0000-0001-5693-7909; Brandt, Ulrich/0000-0003-1869-6811; Wirth, Christophe/0000-0001-8864-6508	German Research Foundation [CRC 746, ZI 552/3-1]; Excellence Initiative of the German Federal Government [EXC 115, EXC 294 BIOSS]; Excellence Initiative of the German State Government [EXC 115, EXC 294 BIOSS]	German Research Foundation(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	Supported by the German Research Foundation (CRC 746 to C.H.; ZI 552/3-1 to V.Z.) and the Excellence Initiative of the German Federal and State Governments (EXC 115 to H.S., U.B., and V.Z.; EXC 294 BIOSS to C.H.). We thank the Swiss Light Source and European Synchrotron Radiation Facility for beamline access and staff support during visits, and A. Duchene and G. Beyer for excellent technical assistance. Coordinates and structure factors are deposited in the Protein Data Bank with accession code 4wz7.	Abdrakhmanova A, 2006, BBA-BIOENERGETICS, V1757, P1676, DOI 10.1016/j.bbabio.2006.09.003; Angerer H, 2012, BBA-BIOENERGETICS, V1817, P1776, DOI 10.1016/j.bbabio.2012.03.021; Babot M, 2014, BBA-BIOENERGETICS, V1837, P929, DOI 10.1016/j.bbabio.2014.02.013; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brandt U, 2011, BBA-BIOENERGETICS, V1807, P1364, DOI 10.1016/j.bbabio.2011.04.006; Breuer ME, 2013, NEUROBIOL DIS, V51, P27, DOI 10.1016/j.nbd.2012.03.007; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Ciano M, 2013, FEBS LETT, V587, P867, DOI 10.1016/j.febslet.2013.02.039; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Fendel U, 2008, BBA-BIOENERGETICS, V1777, P660, DOI 10.1016/j.bbabio.2008.04.033; Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200; Galkin A, 2006, BBA-BIOENERGETICS, V1757, P1575, DOI 10.1016/j.bbabio.2006.10.001; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kaila VRI, 2014, P NATL ACAD SCI USA, V111, P6988, DOI 10.1073/pnas.1319156111; Kashani-Poor N, 2001, J BIOL CHEM, V276, P24082, DOI 10.1074/jbc.M102296200; Kerscher S, 2002, BBA-BIOENERGETICS, V1555, P83, DOI 10.1016/S0005-2728(02)00259-1; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; Maklashina E, 2003, BBA-BIOENERGETICS, V1606, P95, DOI 10.1016/S0005-2728(03)00087-2; Marreiros BC, 2013, BBA-BIOENERGETICS, V1827, P198, DOI 10.1016/j.bbabio.2012.09.012; Moparthi VK, 2014, BBA-BIOENERGETICS, V1837, P178, DOI 10.1016/j.bbabio.2013.09.012; Okun JG, 1999, J BIOL CHEM, V274, P2625, DOI 10.1074/jbc.274.5.2625; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Tocilescu MA, 2007, J BIOL CHEM, V282, P29514, DOI 10.1074/jbc.M704519200; Tocilescu MA, 2010, BBA-BIOENERGETICS, V1797, P625, DOI 10.1016/j.bbabio.2010.01.029; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Zickermann V, 1998, BIOCHEMISTRY-US, V37, P11792, DOI 10.1021/bi9810555; Zickermann V, 2003, J BIOL CHEM, V278, P29072, DOI 10.1074/jbc.M302713200	38	295	300	3	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					44	49		10.1126/science.1259859	http://dx.doi.org/10.1126/science.1259859			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25554780	Green Submitted			2022-12-28	WOS:000347102300043
J	Hand, E				Hand, Eric			Comet rendezvous	SCIENCE			English	Editorial Material																			0	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1442	1443		10.1126/science.346.6216.1442	http://dx.doi.org/10.1126/science.346.6216.1442			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25525223				2022-12-28	WOS:000346536500023
J	Cho, SH; Szewczyk, J; Pesavento, C; Zietek, M; Banzhaf, M; Roszczenko, P; Asmar, A; Laloux, G; Hov, AK; Leverrier, P; Van der Henst, C; Vertommen, D; Typas, A; Collet, JF				Cho, Seung-Hyun; Szewczyk, Joanna; Pesavento, Christina; Zietek, Matylda; Banzhaf, Manuel; Roszczenko, Paula; Asmar, Abir; Laloux, Geraldine; Hov, Ann-Kristin; Leverrier, Pauline; Van der Henst, Charles; Vertommen, Didier; Typas, Athanasios; Collet, Jean-Francois			Detecting Envelope Stress by Monitoring beta-Barrel Assembly	CELL			English	Article							OUTER-MEMBRANE LIPOPROTEIN; ESCHERICHIA-COLI; RCS PHOSPHORELAY; PROTEIN EXPORT; LIPOPOLYSACCHARIDE; SUBSTRATE; TRANSPORT; ACTIVATE; PATHWAY; COMPLEX	The cell envelope protects bacteria from their surroundings. Defects in its integrity or assembly are sensed by signal transduction systems, allowing cells to rapidly adjust. The Rcs phosphorelay responds to outer membrane (OM)- and peptidoglycan-related stress in enterobacteria. We elucidated how the OM lipoprotein RcsF, the upstream Rcs component, senses envelope stress and activates the signaling cascade. RcsF interacts with BamA, the major component of the beta-barrel assembly machinery. In growing cells, BamA continuously funnels RcsF through the beta-barrel OmpA, displaying RcsF on the cell surface. This process spatially separates RcsF from the downstream Rcs component, which we show is the inner membrane protein IgaA. The Rcs system is activated when BamA fails to bind RcsF and funnel it to OmpA. Newly synthesized RcsF then remains periplasmic, interacting with IgaA to activate the cascade. Thus RcsF senses envelope damage by monitoring the activity of the Bam machinery.	[Cho, Seung-Hyun; Szewczyk, Joanna; Roszczenko, Paula; Asmar, Abir; Van der Henst, Charles; Collet, Jean-Francois] Catholic Univ Louvain, WELBIO, B-1200 Brussels, Belgium; [Cho, Seung-Hyun; Szewczyk, Joanna; Roszczenko, Paula; Asmar, Abir; Laloux, Geraldine; Leverrier, Pauline; Van der Henst, Charles; Vertommen, Didier; Collet, Jean-Francois] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Pesavento, Christina; Zietek, Matylda; Banzhaf, Manuel; Hov, Ann-Kristin; Typas, Athanasios] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany	Universite Catholique Louvain; WELBIO; Universite Catholique Louvain; European Molecular Biology Laboratory (EMBL)	Typas, A (corresponding author), European Mol Biol Lab, Genome Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	typas@embl.de; jfcollet@uclouvain.be	Laloux, Geraldine/N-4373-2017; Van der Henst, Charles/GPX-5265-2022; Laloux, Geraldine/AAF-9009-2021; Van der Henst, Charles/Q-5746-2017	Laloux, Geraldine/0000-0003-3230-1679; Laloux, Geraldine/0000-0003-3230-1679; Van der Henst, Charles/0000-0002-3451-9439; cho, seung-hyun/0000-0002-5548-4239; Leverrier, Pauline/0000-0003-2465-8491; Vertommen, Didier/0000-0001-7648-8282; Roszczenko-Jasinska, Paula/0000-0002-5887-9308; Typas, Athanasios/0000-0002-0797-9018; Banzhaf, Manuel/0000-0002-4682-1037; Collet, Jean-Francois/0000-0001-8069-7036	FRS-FNRS; Interuniversity Attraction Pole Program-Belgian Science Policy [network P7/44]; Sofja Kovalevskaja Award of the Alexander von Humboldt Foundation; EMBL	FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Pole Program-Belgian Science Policy; Sofja Kovalevskaja Award of the Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); EMBL	We are grateful to C.A. Gross, K.C. Huang, and N. Ruiz for critically reading the manuscript and providing feedback. We thank H. Mori (Nara, Japan), S. Gottesman (NIH, USA), D. Kahne (Harvard, USA), and T. Silhavy (Princeton, USA) for providing strains. We thank the members of the two labs for helpful discussions, A. Boujtat, G. Herinckx, A. Koumoutsi, and M. Pruteanu for assistance in experiments and D. Colau for antibody purification. M.S. was performed at the Proteomics Core Facilities of EMBL and of the de Duve Institute. J.S. is a FRIA research fellow, C.P. is an EMBO long-term fellow, P.L. is a "Chargee de Recherche'' and J.F.C. is "Maitre de Recherche'' of the FRS-FNRS. This work was supported by grants from the FRS-FNRS and the Interuniversity Attraction Pole Program-Belgian Science Policy (network P7/44) to JFC, and the Sofja Kovalevskaja Award of the Alexander von Humboldt Foundation and EMBL internal funding to A.T.	Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; Arnold MFF, 2014, J BACTERIOL, V196, P436, DOI 10.1128/JB.01179-13; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Cano DA, 2002, GENETICS, V162, P1513; Castanie-Cornet MP, 2006, J BACTERIOL, V188, P4264, DOI 10.1128/JB.00004-06; Cowles CE, 2011, MOL MICROBIOL, V79, P1168, DOI 10.1111/j.1365-2958.2011.07539.x; Dominguez-Bernal G, 2004, MOL MICROBIOL, V53, P1437, DOI 10.1111/j.1365-2958.2004.04213.x; Egan AJF, 2014, P NATL ACAD SCI USA, V111, P8197, DOI 10.1073/pnas.1400376111; Evans KL, 2013, J BACTERIOL, V195, P4415, DOI 10.1128/JB.00596-13; Farris C, 2010, J BACTERIOL, V192, P4894, DOI 10.1128/JB.00505-10; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Goemans C, 2014, BBA-MOL CELL RES, V1843, P1517, DOI 10.1016/j.bbamcr.2013.10.014; Gogol EB, 2011, P NATL ACAD SCI USA, V108, P12875, DOI 10.1073/pnas.1109379108; Guo MS, 2014, GENE DEV, V28, P1620, DOI 10.1101/gad.243485.114; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Housden NG, 2013, SCIENCE, V340, P1570, DOI 10.1126/science.1237864; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Leverrier P, 2011, J BIOL CHEM, V286, P16734, DOI 10.1074/jbc.M111.224865; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Lima S, 2013, SCIENCE, V340, P837, DOI 10.1126/science.1235358; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Majdalani N, 2007, METHOD ENZYMOL, V423, P349, DOI 10.1016/S0076-6879(07)23016-2; Okuda S, 2011, ANNU REV MICROBIOL, V65, P239, DOI 10.1146/annurev-micro-090110-102859; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Prehna G, 2012, STRUCTURE, V20, P1154, DOI 10.1016/j.str.2012.04.014; Pride AC, 2013, MBIO, V4, DOI 10.1128/mBio.00305-13; Reusch RN, 2012, FEBS J, V279, P893, DOI 10.1111/j.1742-4658.2012.08486.x; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Shiba Y, 2004, J BACTERIOL, V186, P6526, DOI 10.1128/jb.186.19.6526-6535.2004; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Tao K, 2012, J BACTERIOL, V194, P3643, DOI 10.1128/JB.00553-12; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]; Zuckert WR, 2014, BBA-MOL CELL RES, V1843, P1509, DOI 10.1016/j.bbamcr.2014.04.022	42	116	118	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1652	1664		10.1016/j.cell.2014.11.045	http://dx.doi.org/10.1016/j.cell.2014.11.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525882	Bronze			2022-12-28	WOS:000347922500018
J	Dobson, A				Dobson, Andy			Mathematical models for emerging disease	SCIENCE			English	Editorial Material							EPIDEMIC; DYNAMICS		[Dobson, Andy] Princeton Univ, Dept Ecol & Evolutionary Biol EEB, Princeton, NJ 08544 USA; [Dobson, Andy] Santa Fe Inst, Santa Fe, NM 87501 USA	Princeton University; The Santa Fe Institute	Dobson, A (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol EEB, Eno Hall, Princeton, NJ 08544 USA.	dobson@princeton.edu						ANDERSON R M, 1991; ANDERSON RM, 1989, PHILOS T ROY SOC B, V325, P39, DOI 10.1098/rstb.1989.0073; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Dobson A, 2014, INFLUENCE OF GLOBAL ENVIRONMENTAL CHANGE ON INFECTIOUS DISEASE DYNAMICS: WORKSHOP SUMMARY, P193; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Grenfell BT, 2002, ECOL MONOGR, V72, P185, DOI 10.1890/0012-9615(2002)072[0185:DOMESN]2.0.CO;2; Grenfell BT, 1998, ECOL LETT, V1, P63; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; Laneri K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000898; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Long GH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-128; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; WALLIKER D, 1971, NATURE, V232, P561, DOI 10.1038/232561a0	15	7	7	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1294	1295		10.1126/science.aaa3441	http://dx.doi.org/10.1126/science.aaa3441			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW3MA	25504704				2022-12-28	WOS:000346189600024
J	Quasdorf, KW; Overman, LE				Quasdorf, Kyle W.; Overman, Larry E.			Catalytic enantioselective synthesis of quaternary carbon stereocentres	NATURE			English	Review							ASYMMETRIC CONJUGATE ADDITION; SUBSTITUTED CYCLIC ENONES; ARYL ALUMINUM REAGENTS; DIELS-ALDER REACTIONS; TRISUBSTITUTED ENONES; ALLYLIC ALKYLATION; STEREOGENIC CENTERS; INTRAMOLECULAR ARYLCYANATION; POLYENE CYCLIZATION; OLEFIN METATHESIS	Quaternary carbon stereocentres-carbon atoms to which four distinct carbon substituents are attached-are common features of molecules found in nature. However, before recent advances in chemical catalysis, there were few methods of constructing single stereoisomers of this important structural motif. Here we discuss the many catalytic enantioselective reactions developed during the past decade for the synthesis of single stereoisomers of such organic molecules. This progress now makes it possible to incorporate quaternary stereocentres selectively in many organic molecules that are useful in medicine, agriculture and potentially other areas such as flavouring, fragrances and materials.	[Quasdorf, Kyle W.; Overman, Larry E.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Overman, LE (corresponding author), Univ Calif Irvine, Dept Chem, 1102 Nat Sci 2, Irvine, CA 92697 USA.	leoverma@uci.edu	Overman, Larry Eugene/AAH-3551-2021	Overman, Larry/0000-0001-9462-0195	US National Institutes of Health [R01 GM030859, GM098601]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030859, R01GM098601] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Our research in this area was supported by the US National Institutes of Health (R01 GM030859 and GM098601).	Aikawa K, 2012, J AM CHEM SOC, V134, P10329, DOI 10.1021/ja3032345; Austin JF, 2004, P NATL ACAD SCI USA, V101, P5482, DOI 10.1073/pnas.0308177101; Balskus EP, 2007, SCIENCE, V317, P1736, DOI 10.1126/science.1146939; Bartholow M., 2012, PHARMA TIMES, P48; Behenna DC, 2004, J AM CHEM SOC, V126, P15044, DOI 10.1021/ja044812x; Brazeau JF, 2012, J AM CHEM SOC, V134, P2742, DOI 10.1021/ja210388g; Brown MK, 2008, J AM CHEM SOC, V130, P12904, DOI 10.1021/ja8058414; Chen XH, 2009, J AM CHEM SOC, V131, P13819, DOI 10.1021/ja905302f; Christoffers J, 2005, QUATERNARY STEREOCENTERS: CHALLENGES AND SOLUTIONS FOR ORGANIC SYNTHESIS, P1, DOI 10.1002/3527606858; Corkey BK, 2005, J AM CHEM SOC, V127, P17168, DOI 10.1021/ja055059q; Dabrowski JA, 2011, J AM CHEM SOC, V133, P4778, DOI 10.1021/ja2010829; Das JP, 2011, CHEM COMMUN, V47, P4593, DOI 10.1039/c0cc05222a; DeLorbe JE, 2011, J AM CHEM SOC, V133, P6549, DOI 10.1021/ja201789v; Ding HX, 2013, BIOORGAN MED CHEM, V21, P2795, DOI 10.1016/j.bmc.2013.02.061; Douglas CJ, 2004, P NATL ACAD SCI USA, V101, P5363, DOI 10.1073/pnas.0307113101; Dounay AB, 2008, J AM CHEM SOC, V130, P5368, DOI 10.1021/ja800163v; Doyle AG, 2007, ANGEW CHEM INT EDIT, V46, P3701, DOI 10.1002/anie.200604901; Du C, 2009, ANGEW CHEM INT EDIT, V48, P7853, DOI 10.1002/anie.200902908; Enquist JA, 2008, NATURE, V453, P1228, DOI 10.1038/nature07046; Feng JJ, 2014, J AM CHEM SOC, V136, P8911, DOI 10.1021/ja504625m; Gao F, 2012, ANGEW CHEM INT EDIT, V51, P6613, DOI 10.1002/anie.201202856; Gao L, 2013, J AM CHEM SOC, V135, P14556, DOI 10.1021/ja408196g; Garcia-Fortanet J, 2008, ANGEW CHEM INT EDIT, V47, P8108, DOI 10.1002/anie.200803809; Garcia-Fortanet J, 2009, J AM CHEM SOC, V131, P6676, DOI 10.1021/ja9025193; Giudici RE, 2007, J AM CHEM SOC, V129, P3824, DOI 10.1021/ja070187v; Hawner C, 2008, ANGEW CHEM INT EDIT, V47, P8211, DOI 10.1002/anie.200803436; Hawner C, 2010, ANGEW CHEM INT EDIT, V49, P7769, DOI 10.1002/anie.201003300; Hills ID, 2003, ANGEW CHEM INT EDIT, V42, P3921, DOI 10.1002/anie.200351666; Holder JC, 2013, J AM CHEM SOC, V135, P14996, DOI 10.1021/ja401713g; Hong AY, 2013, EUR J ORG CHEM, V2013, P2745, DOI 10.1002/ejoc.201201761; Ishibashi H, 2004, J AM CHEM SOC, V126, P11122, DOI 10.1021/ja0472026; Jeker OF, 2013, ANGEW CHEM INT EDIT, V52, P12166, DOI 10.1002/anie.201307187; Jones SB, 2011, NATURE, V475, P183, DOI 10.1038/nature10232; Kerr MS, 2004, J AM CHEM SOC, V126, P8876, DOI 10.1021/ja047644h; Kleinbeck F, 2009, J AM CHEM SOC, V131, P9178, DOI 10.1021/ja904055z; Knowles RR, 2010, J AM CHEM SOC, V132, P5030, DOI 10.1021/ja101256v; Krautwald S, 2013, SCIENCE, V340, P1065, DOI 10.1126/science.1237068; Laforteza BN, 2013, ANGEW CHEM INT EDIT, V52, P11269, DOI 10.1002/anie.201305171; Lee KS, 2006, J AM CHEM SOC, V128, P7182, DOI 10.1021/ja062061o; Lian YJ, 2010, J AM CHEM SOC, V132, P440, DOI 10.1021/ja9078094; Liu WB, 2013, J AM CHEM SOC, V135, P10626, DOI 10.1021/ja4052075; Liu YK, 2011, J AM CHEM SOC, V133, P15212, DOI 10.1021/ja206517s; Lovering F, 2013, MEDCHEMCOMM, V4, P515, DOI 10.1039/c2md20347b; Malcolmson SJ, 2008, NATURE, V456, P933, DOI 10.1038/nature07594; Martin D, 2006, J AM CHEM SOC, V128, P8416, DOI 10.1021/ja0629920; Martinez A, 2013, ANGEW CHEM INT EDIT, V52, P9486, DOI 10.1002/anie.201301618; Mase N, 2004, ORG LETT, V6, P2527, DOI 10.1021/ol049196o; May TL, 2008, ANGEW CHEM INT EDIT, V47, P7358, DOI 10.1002/anie.200802910; May TL, 2011, J AM CHEM SOC, V133, P736, DOI 10.1021/ja110054q; Mei TS, 2014, NATURE, V508, P340, DOI 10.1038/nature13231; Mendoza A, 2012, NAT CHEM, V4, P21, DOI 10.1038/nchem.1196; Mermerian AH, 2005, ANGEW CHEM INT EDIT, V44, P949, DOI 10.1002/anie.200461886; Mitsunuma H, 2012, ANGEW CHEM INT EDIT, V51, P5217, DOI 10.1002/anie.201201132; Muller D, 2013, CHEM-EUR J, V19, P15226, DOI 10.1002/chem.201302856; Nakao Y, 2008, J AM CHEM SOC, V130, P12874, DOI 10.1021/ja805088r; Notte GT, 2013, ANNU REP MED CHEM, V48, P451, DOI 10.1016/B978-0-12-417150-3.00027-2; Ohmatsu K, 2014, NAT CHEM, V6, P47, DOI [10.1038/NCHEM.1796, 10.1038/nchem.1796]; Pellissier H, 2008, TETRAHEDRON, V64, P7041, DOI 10.1016/j.tet.2008.04.079; Penon O, 2008, CHEM-EUR J, V14, P4788, DOI 10.1002/chem.200800440; Phan DHT, 2010, J AM CHEM SOC, V132, P16354, DOI 10.1021/ja107738a; Poulsen TB, 2007, J AM CHEM SOC, V129, P441, DOI 10.1021/ja067289q; Rendler S, 2010, J AM CHEM SOC, V132, P5027, DOI 10.1021/ja100185p; Schafroth MA, 2012, J AM CHEM SOC, V134, P20276, DOI 10.1021/ja310386m; Schwartz BD, 2009, J AM CHEM SOC, V131, P8329, DOI 10.1021/ja9019484; Sethofer SG, 2010, J AM CHEM SOC, V132, P8276, DOI 10.1021/ja103544p; Shaw SA, 2006, J AM CHEM SOC, V128, P925, DOI 10.1021/ja056150x; Shi BF, 2010, J AM CHEM SOC, V132, P460, DOI 10.1021/ja909571z; Shibata T, 2008, J AM CHEM SOC, V130, P3451, DOI 10.1021/ja0762083; Shimizu Y, 2010, ANGEW CHEM INT EDIT, V49, P1103, DOI 10.1002/anie.200906678; Shintani R, 2006, J AM CHEM SOC, V128, P5628, DOI 10.1021/ja061430d; Shintani R, 2009, J AM CHEM SOC, V131, P13588, DOI 10.1021/ja905432x; Sidera M, 2013, ANGEW CHEM INT EDIT, V52, P7995, DOI 10.1002/anie.201303202; Snyder SA, 2006, J AM CHEM SOC, V128, P740, DOI 10.1021/ja0576379; Souillart L, 2014, ANGEW CHEM INT EDIT, V53, P3001, DOI 10.1002/anie.201311009; Surendra K, 2014, J AM CHEM SOC, V136, P642, DOI 10.1021/ja4125093; Surendra K, 2012, J AM CHEM SOC, V134, P11992, DOI 10.1021/ja305851h; Tan B, 2011, J AM CHEM SOC, V133, P12354, DOI 10.1021/ja203812h; Taylor AM, 2009, J AM CHEM SOC, V131, P9900, DOI 10.1021/ja903880q; Trost BM, 2006, J AM CHEM SOC, V128, P6314, DOI 10.1021/ja0608139; Trost BM, 2013, J AM CHEM SOC, V135, P16720, DOI 10.1021/ja409013m; Trost BM, 2011, J AM CHEM SOC, V133, P20611, DOI 10.1021/ja209244m; Trost BM, 2011, J AM CHEM SOC, V133, P19483, DOI 10.1021/ja207550t; Trost BM, 2011, J AM CHEM SOC, V133, P8165, DOI 10.1021/ja2029602; Trost BM, 2011, J AM CHEM SOC, V133, P7328, DOI 10.1021/ja2020873; Trost BM, 2005, J AM CHEM SOC, V127, P2846, DOI 10.1021/ja043472c; Trost BM, 2005, ANGEW CHEM INT EDIT, V44, P308, DOI 10.1002/anie.200460335; Van Veldhuizen JJ, 2005, J AM CHEM SOC, V127, P6877, DOI 10.1021/ja050179j; Vuagnoux-d'Augustin M, 2007, CHEM-EUR J, V13, P9647, DOI 10.1002/chem.200701001; Wadamoto M, 2007, J AM CHEM SOC, V129, P10098, DOI 10.1021/ja073987e; Watson MP, 2008, J AM CHEM SOC, V130, P12594, DOI 10.1021/ja805094j; Wilson RM, 2005, J AM CHEM SOC, V127, P11616, DOI 10.1021/ja054008q; Wu FH, 2006, ANGEW CHEM INT EDIT, V45, P947, DOI 10.1002/anie.200502658; Xiao KJ, 2014, J AM CHEM SOC, V136, P8138, DOI 10.1021/ja504196j; Xie XA, 2006, J AM CHEM SOC, V128, P16050, DOI 10.1021/ja066991j; Xu T, 2012, J AM CHEM SOC, V134, P20005, DOI 10.1021/ja309978c; Zhang E, 2009, J AM CHEM SOC, V131, P14626, DOI 10.1021/ja906291n; Zhang HL, 2013, J AM CHEM SOC, V135, P14098, DOI 10.1021/ja408336v; Zhu SL, 2012, J AM CHEM SOC, V134, P10815, DOI 10.1021/ja305100g	98	631	629	17	362	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					181	191		10.1038/nature14007	http://dx.doi.org/10.1038/nature14007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25503231	Green Accepted, Green Submitted			2022-12-28	WOS:000346383500033
J	Stepney, R; Stepney, NS				Stepney, Rob; Stepney, Nick Surawy			CHRISTMAS 2014: MEDIA STUDIES Healer, dealer, heart stealer: portrayals of the doctor in popular music	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Stepney, Nick Surawy] Univ Manchester, Manchester M13 9PL, Lancs, England	University of Manchester		walcot2@freenetname.co.uk						[Anonymous], 2012, GUARDIAN; [Anonymous], 2012, BMA NEWS         OCT; Turner S., 1999, HARD DAYS WRITE	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2014	349								g7179	10.1136/bmj.g7179	http://dx.doi.org/10.1136/bmj.g7179			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3DK	25500114				2022-12-28	WOS:000346165500003
J	Tonge, PD; Corso, AJ; Monetti, C; Hussein, SMI; Puri, MC; Michael, IP; Li, M; Lee, DS; Mar, JC; Cloonan, N; Wood, DL; Gauthier, MLE; Korn, O; Clancy, JL; Preiss, T; Grimmond, SM; Shin, JY; Seo, JS; Wells, CA; Rogers, IM; Nagy, A				Tonge, Peter D.; Corso, Andrew J.; Monetti, Claudio; Hussein, Samer M. I.; Puri, Mira C.; Michael, Iacovos P.; Li, Mira; Lee, Dong-Sung; Mar, Jessica C.; Cloonan, Nicole; Wood, David L.; Gauthier, Maely E.; Korn, Othmar; Clancy, Jennifer L.; Preiss, Thomas; Grimmond, Sean M.; Shin, Jong-Yeon; Seo, Jeong-Sun; Wells, Christine A.; Rogers, Ian M.; Nagy, Andras			Divergent reprogramming routes lead to alternative stem-cell states	NATURE			English	Article							IPS CELLS; SELF-RENEWAL; PLURIPOTENCY; EXPRESSION; MICE; TRANSITION; DERIVATION; INDUCTION; DISTINCT; GENES	Pluripotency is defined by the ability of a cell to differentiate to the derivatives of all the three embryonic germ layers: ectoderm, mesoderm and endoderm. Pluripotent cells can be captured via the archetypal derivation of embryonic stem cells or via somatic cell reprogramming. Somatic cells are induced to acquire a pluripotent stem cell (iPSC) state through the forced expression of key transcription factors, and in the mouse these cells can fulfil the strictest of all developmental assays for pluripotent cells by generating completely iPSC-derived embryos and mice. However, it is not known whether there are additional classes of pluripotent cells, or what the spectrum of reprogrammed phenotypes encompasses. Here we explore alternative outcomes of somatic reprogramming by fully characterizing reprogrammed cells independent of preconceived definitions of iPSC states. We demonstrate that by maintaining elevated reprogramming factor expression levels, mouse embryonic fibroblasts go through unique epigenetic modifications to arrive at a stable, Nanog-positive, alternative pluripotent state. In doing so, we prove that the pluripotent spectrum can encompass multiple, unique cell states.	[Tonge, Peter D.; Corso, Andrew J.; Monetti, Claudio; Hussein, Samer M. I.; Puri, Mira C.; Michael, Iacovos P.; Li, Mira; Rogers, Ian M.; Nagy, Andras] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Corso, Andrew J.; Nagy, Andras] Univ Toronto, Inst Med Sci, Toronto, ON M5T 3H7, Canada; [Puri, Mira C.] Univ Toronto, Dept Med Biophys, Toronto, ON M5T 3H7, Canada; [Michael, Iacovos P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5T 3H7, Canada; [Lee, Dong-Sung; Shin, Jong-Yeon; Seo, Jeong-Sun] Seoul Natl Univ, Genom Med Inst, Med Res Ctr, Seoul 110799, South Korea; [Lee, Dong-Sung; Seo, Jeong-Sun] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 110799, South Korea; [Lee, Dong-Sung; Seo, Jeong-Sun] Seoul Natl Univ, Dept Biochem, Coll Med, Seoul 110799, South Korea; [Mar, Jessica C.] Yeshiva Univ, Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA; [Cloonan, Nicole; Wood, David L.; Gauthier, Maely E.; Grimmond, Sean M.] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, St Lucia, Qld 4072, Australia; [Korn, Othmar; Wells, Christine A.] Univ Queensland, Australina Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia; [Clancy, Jennifer L.; Preiss, Thomas] Australian Natl Univ, John Curtin Sch Med Res, Genome Biol Dept, Canberra, ACT 2601, Australia; [Preiss, Thomas] Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia; [Shin, Jong-Yeon; Seo, Jeong-Sun] Macrogen Inc, Life Sci Inst, Seoul 153781, South Korea; [Rogers, Ian M.] Univ Toronto, Dept Physiol, Toronto, ON M5T 3H7, Canada; [Rogers, Ian M.; Nagy, Andras] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON M5T 3H7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Yeshiva University; Albert Einstein College of Medicine; University of Queensland; University of Queensland; Australian National University; John Curtin School of Medical Research; Victor Chang Cardiac Research Institute; Macrogen, Inc.; University of Toronto; University of Toronto	Nagy, A (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	nagy@lunenfeld.ca	Grimmond, Sean/K-3246-2019; Puri, Mira/C-4412-2014; Rogers, Ian M/D-5092-2015; Michael, Iacovos P/C-8695-2016; Gauthier, Marie-Emilie/Y-5909-2019; Preiss, Thomas/F-7355-2010; Seo, Jeong-Sun/J-2763-2012; Grimmond, Sean M/J-5304-2016; Nagy, Andras/G-6465-2013; Cloonan, Nicole/B-5272-2008; Wells, Christine/A-5071-2010	Grimmond, Sean/0000-0002-8102-7998; Rogers, Ian M/0000-0001-8466-1225; Michael, Iacovos P/0000-0001-7674-1233; Gauthier, Marie-Emilie/0000-0002-5256-9165; Preiss, Thomas/0000-0001-6273-784X; Grimmond, Sean M/0000-0002-8102-7998; Nagy, Andras/0000-0003-4311-0413; Cloonan, Nicole/0000-0001-7802-6647; Wood, David/0000-0002-1001-2019; Wells, Christine/0000-0003-3133-3628; Mar, Jessica/0000-0002-5147-9299	Ontario Research Fund Global Leadership Round in Genomics and Life Sciences grants [GL2]; Canadian stem cell network [9/5254 (TR3)]; Canadian Institutes of Health Research [CIHR MOP102575]; South Korean Ministry of Knowledge Economy [10037410]; SNUCM research fund [0411-20100074]; Macrogen Inc. [MGR03-11, MGR03-12]; Australian Research Council [SR110001002]; Queensland government Smart Futures Fellowship; ARC by Stem Cells Australia; NHMRC; ARC; McEwen Centre of Regenerative Medicine	Ontario Research Fund Global Leadership Round in Genomics and Life Sciences grants; Canadian stem cell network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); South Korean Ministry of Knowledge Economy; SNUCM research fund; Macrogen Inc.; Australian Research Council(Australian Research Council); Queensland government Smart Futures Fellowship; ARC by Stem Cells Australia(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); McEwen Centre of Regenerative Medicine	We are grateful for A. Bang's expertise and assistance regarding flow cytometry. We thank M. Gertsenstein and M. Pereira for chimaera production, and K. Harpal for teratoma sectioning. We would also like to acknowledge the assistance and support of lab colleagues, collaborators and all the members of the Project Grandiose Consortium who are too numerous to name individually but who made a positive impact on this research. A.N. is Tier 1 Canada Research Chair in Stem Cells and Regeneration. This work was supported by grants awarded to A.N. and I.M.R. from the Ontario Research Fund Global Leadership Round in Genomics and Life Sciences grants (GL2), to A.N. from the Canadian stem cell network (9/5254 (TR3)) and Canadian Institutes of Health Research (CIHR MOP102575), to J.-S.S. by the South Korean Ministry of Knowledge Economy (no. 10037410), SNUCM research fund (grant no. 0411-20100074), and Macrogen Inc. (no. MGR03-11 and 12), to S.G. from the Australian Research Council (no. SR110001002), and to C.A.W. by a Queensland government Smart Futures Fellowship and an ARC by Stem Cells Australia and to T.P. grants from NHMRC and ARC. S.M.I.H. received a fellowship from the McEwen Centre of Regenerative Medicine.	Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Benevento M., 2014, NATURE COMMUN; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Clancy JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6522; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fussner E, 2011, EMBO J, V30, P1778, DOI 10.1038/emboj.2011.96; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hu X, 2014, CELL STEM CELL, V14, P512, DOI 10.1016/j.stem.2014.01.001; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Hussein SMI, 2014, NATURE, V516, P198, DOI 10.1038/nature14046; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Larue L, 1996, DEVELOPMENT, V122, P3185; Lee DS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6619; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 2003, MANIPULATING MOUSE E; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Soncin F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021463; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	36	93	96	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					192	+		10.1038/nature14047	http://dx.doi.org/10.1038/nature14047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25503232				2022-12-28	WOS:000346383500034
J	Mullan, PC; Kessler, DO; Cheng, A				Mullan, Paul C.; Kessler, David O.; Cheng, Adam			Educational Opportunities With Postevent Debriefing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SIMULATION		[Mullan, Paul C.] George Washington Univ, Sch Med & Hlth Sci, Div Emergency Med, Childrens Natl Med Ctr, Falls Church, VA 22041 USA; [Kessler, David O.] New York Presbyterian Morgan Stanley Childrens Ho, New York, NY USA; [Kessler, David O.] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Cheng, Adam] Alberta Childrens Prov Gen Hosp, Sect Emergency Med, Calgary, AB T2T 5C7, Canada; [Cheng, Adam] Univ Calgary, Calgary, AB, Canada	George Washington University; NewYork-Presbyterian Hospital; Morgan Stanley Children's Hospital; Columbia University; Alberta Childrens Hospital; University of Calgary; University of Calgary	Mullan, PC (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Div Emergency Med, Childrens Natl Med Ctr, 3381 Ardley Ct, Falls Church, VA 22041 USA.	pmullan@childrensnational.org	Cheng, Adam/L-9496-2017; Mullan, Paul/ABG-6659-2020	Cheng, Adam/0000-0002-1039-7502; Mullan, Paul/0000-0001-5153-1299				Bandari J, 2012, JT COMM J QUAL PATIE, V38, P154, DOI 10.1016/S1553-7250(12)38020-3; Boet S, 2013, ANN SURG, V258, P53, DOI 10.1097/SLA.0b013e31829659e4; Cheng A, 2014, MED EDUC, V48, P657, DOI 10.1111/medu.12432; Cheng A, 2013, JAMA PEDIATR, V167, P528, DOI 10.1001/jamapediatrics.2013.1389; Hatala R, 2014, ADV HEALTH SCI EDUC, V19, P251, DOI 10.1007/s10459-013-9462-8; HOYT DB, 1988, J TRAUMA, V28, P435, DOI 10.1097/00005373-198804000-00003; Mullan PC, 2013, RESUSCITATION, V84, P946, DOI 10.1016/j.resuscitation.2012.12.005; Sandhu N, 2013, CJEM, V15, P1; Weiner E, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.007; Wolfe H, 2014, CRIT CARE MED, V42, P1688, DOI 10.1097/CCM.0000000000000327	10	51	51	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2014	312	22					2333	2334		10.1001/jama.2014.15741	http://dx.doi.org/10.1001/jama.2014.15741			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW5YB	25490319				2022-12-28	WOS:000346345700003
J	Lenzer, J				Lenzer, Jeanne			BRIEFING One year into Obamacare: where is it now?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICAL BANKRUPTCY; HEALTH					jeanne.lenzer@gmail.com						[Anonymous], 2014, BLOOMBERG NEWS; Congressional Budget Office, 2014, BUDG EC OUTL 2014 24; Denniston L., 2014, SUPREME COURT US BLO; Galewitz P., 2013, KAISER HLTH NEW 0917; Geyman J., 2010, HIJACKED STOLEN HLTH; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P785, DOI 10.1001/jama.2014.9455; Graham J, 2014, INVESTORS BUSIN 0905; Henry J, 2013, 1000S CONS GET INS C; Himmelstein DU, 2014, HEALTH AFFAIR, V33, DOI 10.1377/hlthaff.2014.1097; Himmelstein DU, 2011, AM J MED, V124, P224, DOI 10.1016/j.amjmed.2010.11.009; Himmelstein DU, 2006, HEALTH AFFAIR, V25, pW84, DOI 10.1377/hlthaff.25.w84; Martin AB, 2014, HEALTH AFFAIR, V33, P67, DOI 10.1377/hlthaff.2013.1254; McCarthy J., 2014, NEW ENROLLMENT PERIO; Pollitz Karen, 2014, MED DEBT PEOPLE HLTH; Richey W., 2014, CHRISTIAN SCI M 0710; Riffkin R., 2014, GALLUP          1128	16	0	0	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 5	2014	349								g7405	10.1136/bmj.g7405	http://dx.doi.org/10.1136/bmj.g7405			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KT	25500968				2022-12-28	WOS:000346117200002
J	Livingstone, SJ; Levin, D; Looker, HC; Lindsay, RS; Wild, SH; Joss, N; Leese, G; Leslie, P; McCrimmon, RJ; Metcalfe, W; McKnight, JA; Morris, AD; Pearson, DWM; Petrie, JR; Philip, S; Sattar, NA; Traynor, JP; Colhoun, HM				Livingstone, Shona J.; Levin, Daniel; Looker, Helen C.; Lindsay, Robert S.; Wild, Sarah H.; Joss, Nicola; Leese, Graham; Leslie, Peter; McCrimmon, Rory J.; Metcalfe, Wendy; McKnight, John A.; Morris, Andrew D.; Pearson, Donald W. M.; Petrie, John R.; Philip, Sam; Sattar, Naveed A.; Traynor, Jamie P.; Colhoun, Helen M.		Scottish Diabet Res Network Epidem; Scottish Renal Registry	Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALL-CAUSE MORTALITY; PITTSBURGH EPIDEMIOLOGY; CARDIOVASCULAR-DISEASE; TRENDS; RISK	IMPORTANCE Type 1 diabetes has historically been associated with a significant reduction in life expectancy. Major advances in treatment of type 1 diabetes have occurred in the past 3 decades. Contemporary estimates of the effect of type 1 diabetes on life expectancy are needed. OBJECTIVE To examine current life expectancy in people with and without type 1 diabetes in Scotland. We also examined whether any loss of life expectancy in patients with type 1 diabetes is confined to those who develop kidney disease. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort of all individuals alive in Scotland with type 1 diabetes who were aged 20 years or older from 2008 through 2010 and were in a nationwide register (n=24 691 contributing 67 712 person-years and 1043 deaths). MAIN OUTCOMES AND MEASURES Differences in life expectancy between those with and those without type 1 diabetes and the percentage of the difference due to various causes. RESULTS Life expectancy at an attained age of 20 years was an additional 46.2 years among men with type 1 diabetes and 57.3 years among men without it, an estimated loss in life expectancy with diabetes of 11.1 years (95% CI, 10.1-12.1). Life expectancy from age 20 years was an additional 48.1 years among women with type 1 diabetes and 61.0 years among women without it, an estimated loss with diabetes of 12.9 years (95% CI, 11.7-14.1). Even among those with type 1 diabetes with an estimated glomerular filtration rate of 90 mL/min/1.73m(2) or higher, life expectancy was reduced (49.0 years in men, 53.1 years in women) giving an estimated loss from age 20 years of 8.3 years (95% CI, 6.5-10.1) for men and 7.9 years (95% CI, 5.5-10.3) for women. Overall, the largest percentage of the estimated loss in life expectancy was related to ischemic heart disease (36% in men, 31% in women) but death from diabetic coma or ketoacidosis was associated with the largest percentage of the estimated loss occurring before age 50 years (29.4% in men, 21.7% in women). CONCLUSIONS AND RELEVANCE Estimated life expectancy for patients with type 1 diabetes in Scotland based on data from 2008 through 2010 indicated an estimated loss of life expectancy at age 20 years of approximately 11 years for men and 13 years for women compared with the general population without type 1 diabetes.	[Livingstone, Shona J.; Levin, Daniel; Looker, Helen C.; Colhoun, Helen M.] Univ Dundee, Diabet Epidemiol Unit, Dundee, Scotland; [Lindsay, Robert S.; Petrie, John R.; Sattar, Naveed A.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Wild, Sarah H.; McKnight, John A.; Morris, Andrew D.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Joss, Nicola] Natl Hlth Serv Highland, Raigmore Hosp, Inverness, Scotland; [Leese, Graham; McCrimmon, Rory J.] Univ Dundee, Med Res Inst, Dundee, Scotland; [Leslie, Peter] Natl Hlth Serv Borders, Borders Gen Hosp, St Andrews, Fife, Scotland; [Metcalfe, Wendy; Traynor, Jamie P.] Scottish Renal Registry, Paisley, Renfrew, Scotland; [McKnight, John A.] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Pearson, Donald W. M.; Philip, Sam] Grampian Diabet Res Unit, Aberdeen, Scotland	University of Dundee; University of Glasgow; University of Edinburgh; University of Dundee; University of Edinburgh	Colhoun, HM (corresponding author), Diabet Epidemiol Unit, Mackenzie Bldg,Kirsty Semple Way, Dundee DD2 4BF, Scotland.	h.colhoun@dundee.ac.uk	Philip, Sam/AAE-3349-2021; McCrimmon, Rory/I-7593-2019	McCrimmon, Rory/0000-0002-3957-1981; Sattar, Naveed/0000-0002-1604-2593; Philip, Sam/0000-0001-6164-211X; Colhoun, Helen/0000-0002-8345-3288; Lindsay, Robert/0000-0002-9868-5217	MRC [MR/K007017/1] Funding Source: UKRI; Diabetes UK [10/0004010] Funding Source: Medline; Medical Research Council [MR/K007017/1] Funding Source: Medline; Wellcome Trust [086113] Funding Source: Medline; Chief Scientist Office Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Chief Scientist Office		[Anonymous], 2008, LIF EXP AR SCOTL; ARRIAGA EE, 1984, DEMOGRAPHY, V21, P83, DOI 10.2307/2061029; Brown LJ, 2001, DIABETES CARE, V24, P56, DOI 10.2337/diacare.24.1.56; Chiang, 1968, INTRO STOCHASTIC PRO, P189; de Ferranti SD, 2014, DIABETES CARE, V37, P2843, DOI 10.2337/dc14-1720; Diabetes UK, DIAB UK 2010 KEY STA; Flegal KM, 2004, AM J EPIDEMIOL, V160, P331, DOI 10.1093/aje/kwh222; GOODKIN G, 1975, J OCCUP ENVIRON MED, V17, P716; Groop PH, 2009, DIABETES, V58, P1651, DOI 10.2337/db08-1543; Jorgensen ME, 2013, DIABETOLOGIA, V56, P2401, DOI 10.1007/s00125-013-3025-7; Juvenile Diabetes Research Foundation Ltd, WHAT IS LIF EXP SOM; Katzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828; Livingstone SJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001321; Miller RG, 2012, DIABETES, V61, P2987, DOI 10.2337/db11-1625; National Records of Scotland, 2014, NAT REC SCOTL LIF EX; Newell C., 1988, METHODS MODELS DEMOG; Orchard TJ, 2010, DIABETOLOGIA, V53, P2312, DOI 10.1007/s00125-010-1860-3; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Ponnapalli KM, 2005, DEMOGR RES, V12, P141; R Development Core Team, 2009, R LANG ENV STAT COMP; Soedamah-Muthu SS, 2006, DIABETES CARE, V29, P798, DOI 10.2337/diacare.29.04.06.dc05-1433	21	334	340	2	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					37	44		10.1001/jama.2014.16425	http://dx.doi.org/10.1001/jama.2014.16425			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25562264	Green Accepted, Bronze			2022-12-28	WOS:000347478000013
J	Selwyn, PA				Selwyn, Peter A.			Skin Deep	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Montefiore Med Ctr, Albert Einstein Coll Med, Dept Family & Social Med, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Selwyn, PA (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Family & Social Med, Bronx, NY 10467 USA.	peter.selwyn@einstein.yu.edu							0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					33	34		10.1001/jama.2014.14047	http://dx.doi.org/10.1001/jama.2014.14047			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25562262				2022-12-28	WOS:000347478000011
J	Tsilidis, KK; Kasimis, JC; Lopez, DS; Ntzani, EE; Ioannidis, JPA				Tsilidis, Konstantinos K.; Kasimis, John C.; Lopez, David S.; Ntzani, Evangelia E.; Ioannidis, John P. A.			Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PUBLICATION BIAS; INCREASED RISK; INTRAHEPATIC CHOLANGIOCARCINOMA; GASTRIC-CANCER; MELLITUS; MORTALITY; EXCESS; HETEROGENEITY; EPIDEMIOLOGY; ASSOCIATIONS	Objectives To summarise the evidence and evaluate the validity of the associations between type 2 diabetes and the risk of developing or dying from cancer. Design An umbrella review of the evidence across meta-analyses of observational studies of type 2 diabetes with risk of developing or dying from any cancer. Data sources PubMed, Embase, Cochrane database of systematic reviews, and manual screening of references. Eligibility criteria Meta-analyses or systematic reviews of observational studies in humans that examined the association between type 2 diabetes and risk of developing or dying from cancer. Results Eligible meta-analyses assessed associations between type 2 diabetes and risk of developing cancer in 20 sites and mortality for seven cancer sites. The summary random effects estimates were significant at P=0.05 in 20 meta-analyses (74%); and all reported increased risks of developing cancer for participants with versus without diabetes. Of the 27 meta-analyses, eventually only seven (26%) compiled evidence on more than 1000 cases, had significant summary associations at P=0.001 for both random and fixed effects calculations, and had neither evidence of small study effects nor evidence for excess significance. Of those, only six (22%) did not have substantial heterogeneity (I-2>75%), pertaining to associations between type 2 diabetes and risk of developing breast, cholangiocarcinoma (both intrahepatic and extrahepatic), colorectal, endometrial, and gallbladder cancer. The 95% prediction intervals excluded the null value for four of these associations (breast, intrahepatic cholangiocarcinoma, colorectal, and endometrial cancer). Conclusions Though type 2 diabetes has been extensively studied in relation to risk of developing cancer and cancer mortality and strong claims of significance exist for most of the studied associations, only a minority of these associations have robust supporting evidence without hints of bias.	[Tsilidis, Konstantinos K.; Kasimis, John C.; Ntzani, Evangelia E.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Tsilidis, Konstantinos K.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Lopez, David S.] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol, Houston, TX 77030 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA	University of Ioannina; Imperial College London; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Stanford University; Stanford University; Stanford University	Tsilidis, KK (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Stavros Niarchos Ave,Univ Campus, GR-45110 Ioannina, Greece.	ktsilidi@cc.uoi.gr	Ntzani, Evangelina E./K-1565-2019; Ioannidis, John P. A./G-9836-2011	Tsilidis, Konstantinos/0000-0002-8452-8472; Ntzani, Evangelia/0000-0003-3712-4181; Lopez, David S./0000-0002-2321-0372	European Union [PIEF-GA-2010-276017]	European Union(European Commission)	This work was supported by the seventh framework programme of the European Union (PIEF-GA-2010-276017 to KKT and JPAI). The funding source detailed above had no role in the design, conduct, analysis, or reporting of the study. All authors carried out this research independently of the funding body.	[Anonymous], 2013, DIABETES ATLAS; Bansal D, 2013, PROSTATE CANCER P D, V16, P151, DOI 10.1038/pcan.2012.40; Bao CP, 2013, J DIABETES COMPLICAT, V27, P357, DOI 10.1016/j.jdiacomp.2013.01.004; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; Boffetta P, 2008, JNCI-J NATL CANCER I, V100, P988, DOI 10.1093/jnci/djn191; Castillo JJ, 2012, BLOOD, V119, P4845, DOI 10.1182/blood-2011-06-362830; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5; Ge ZM, 2011, EUR J GASTROEN HEPAT, V23, P1127, DOI 10.1097/MEG.0b013e32834b8d73; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Huang W, 2012, CANCER CAUSE CONTROL, V23, P263, DOI 10.1007/s10552-011-9874-9; Ioannidis JPA, 2014, ANN ONCOL, V25, P16, DOI 10.1093/annonc/mdt372; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2013, J MATH PSYCHOL, V57, P184, DOI 10.1016/j.jmp.2013.03.002; Ioannidis JPA, 2012, JAMA-J AM MED ASSOC, V308, P575, DOI 10.1001/jama.2012.8144; Ioannidis JPA, 2011, EPIDEMIOLOGY, V22, P450, DOI 10.1097/EDE.0b013e31821b506e; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jiang Y, 2011, EUR J EPIDEMIOL, V26, P863, DOI 10.1007/s10654-011-9617-y; Jing W, 2012, EUR J CANCER PREV, V21, P24, DOI 10.1097/CEJ.0b013e3283481d89; Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Kavvoura FK, 2007, PLOS MED, V4, P456, DOI 10.1371/journal.pmed.0040079; Khoury MJ, 2013, CANCER EPIDEM BIOMAR, V22, P508, DOI 10.1158/1055-9965.EPI-13-0146; KLAYMAN J, 1987, PSYCHOL REV, V94, P211, DOI 10.1037/0033-295X.94.2.211; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Lee JY, 2013, EUR J CANCER, V49, P2411, DOI 10.1016/j.ejca.2013.02.025; Lee JY, 2013, INT J GYNECOL CANCER, V23, P402, DOI 10.1097/IGC.0b013e31828189b2; Lee TY, 2008, AM J GASTROENTEROL, V103, P1716, DOI 10.1111/j.1572-0241.2008.01796.x; McLaughlin JK, 2013, CANCER EPIDEM BIOMAR, V22, P11, DOI 10.1158/1055-9965.EPI-12-0995; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Noto H, 2011, ENDOCR PRACT, V17, P616, DOI 10.4158/EP10357.RA; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Peairs KS, 2011, J CLIN ONCOL, V29, P40, DOI 10.1200/JCO.2009.27.3011; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Ren HB, 2011, CANCER CAUSE CONTROL, V22, P837, DOI 10.1007/s10552-011-9754-3; Renehan AG, 2012, DIABETOLOGIA, V55, P1619, DOI 10.1007/s00125-012-2526-0; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Rucker G, 2011, BIOSTATISTICS, V12, P122, DOI 10.1093/biostatistics/kxq046; Schmid D, 2013, EUR J EPIDEMIOL, V28, P945, DOI 10.1007/s10654-013-9865-0; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Schoenfeld JD, 2013, AM J CLIN NUTR, V97, P127, DOI 10.3945/ajcn.112.047142; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shaib YH, 2005, GASTROENTEROLOGY, V128, P620, DOI 10.1053/j.gastro.2004.12.048; Shikata K, 2013, CANCER SCI, V104, P9, DOI 10.1111/cas.12043; Snyder CF, 2010, PROSTATE CANCER P D, V13, P58, DOI 10.1038/pcan.2009.39; Stein KB, 2010, DIGEST DIS SCI, V55, P1839, DOI 10.1007/s10620-009-0944-8; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Tian T, 2012, EXP CLIN ENDOCR DIAB, V120, P217, DOI 10.1055/s-0031-1297969; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; Tsilidis KK, 2012, JNCI-J NATL CANCER I, V104, P1867, DOI 10.1093/jnci/djs437; Wang P, 2012, DIABETES-METAB RES, V28, P109, DOI 10.1002/dmrr.1291; World Health Organization, 2008, GLOB BURD DIS 2004 U; Zhu ZW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-310	65	448	458	5	54	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2015	350								g7607	10.1136/bmj.g7607	http://dx.doi.org/10.1136/bmj.g7607			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX2ZG	25555821	hybrid			2022-12-28	WOS:000365564700001
J	Parekh, A; Hardman, S				Parekh, Amit; Hardman, Simon			A 3 month old boy with vomiting, intermittent crying, and lethargy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTUSSUSCEPTION; REDUCTION; DIAGNOSIS; CHILDREN; ENEMA; AIR		[Parekh, Amit] Musgrove Pk Hosp, Dept Radiol, Taunton, Somerset, England; [Hardman, Simon] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England	Musgrove Park Hospital; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital	Parekh, A (corresponding author), Musgrove Pk Hosp, Dept Radiol, Taunton, Somerset, England.	amitparekh@doctors.org.uk						Cameron P, 2006, TXB EMERGENCY PAEDIA; Cogley JR, 2012, RADIOGRAPHICS, V32, P651, DOI 10.1148/rg.323115111; Daneman A, 2004, PEDIATR RADIOL, V34, P97, DOI 10.1007/s00247-003-1082-7; del-Pozo G, 1999, RADIOGRAPHICS, V19, P299, DOI 10.1148/radiographics.19.2.g99mr14299; Digant SM, 2012, J CLIN DIAGN RES, V6, P1722, DOI 10.7860/JCDR/2012/4315.2650; Eflok OA, 1980, PAEDIAT RADIOL, V10, P83; Gunderman RB, 2005, AM J ROENTGENOL, V185, P43, DOI 10.2214/ajr.185.1.01850043; Hannon E, 2014, CLIN RADIOL, V69, P344, DOI 10.1016/j.crad.2013.10.024; Hryhorczuk AL, 2009, PEDIATR RADIOL, V39, P1075, DOI 10.1007/s00247-009-1353-z; Kitagawa S, INTUSSUSCEPTION CHIL; LIM HK, 1994, RADIOLOGY, V191, P781, DOI 10.1148/radiology.191.3.8184064; Nagai BK, 2003, APPL RADIOL, V32, P13; SHIELS WE, 1993, AM J ROENTGENOL, V160, P931, DOI 10.2214/ajr.160.5.8470606; SHIELS WE, 1991, RADIOLOGY, V181, P169, DOI 10.1148/radiology.181.1.1887028; Strouse PJ, 2006, RADIOL CLIN N AM, V44, P911, DOI 10.1016/j.rcl.2006.10.019	15	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 31	2014	349								g7723	10.1136/bmj.g7723	http://dx.doi.org/10.1136/bmj.g7723			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY4JO	25552495				2022-12-28	WOS:000347544400001
J	Mercy, KM; Gordon, KB; Paller, AS				Mercy, Katherine M.; Gordon, Kenneth B.; Paller, Amy S.			Patient Satisfaction and Quality of Life in Psoriasis and Psoriatic Arthritis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYMPTOMS; THERAPY	JAMA DERMATOLOGY Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States: Findings From the National Psoriasis Foundation Surveys, 2003-2011 April W. Armstrong, MD, MPH; Andrew D. Robertson, PhD; Julie Wu, BS; Clayton Schupp, PhD; Mark G. Lebwohl, MD IMPORTANCE Psoriasis and psoriatic arthritis inflict significant morbidity. Data on undertreatment, treatment use, and treatment satisfaction are paramount to identify priority areas for advocacy, education, and research to improve patient outcomes. OBJECTIVES To determine the extent of nontreatment and undertreatment of psoriatic diseases, trends in treatment use, treatment satisfaction, and reasons for medication discontinuation among patients with psoriasis and psoriatic arthritis. DESIGN, SETTING, AND PARTICIPANTS We used the national survey data collected by the National Psoriasis Foundation via biannual surveys conducted from January 1, 2003, through December 31, 2011, in the United States. Survey data were collected from randomly sampled patients with psoriasis and psoriatic arthritis in the US population from a database of more than 76 000 patients with psoriatic diseases. MAIN OUTCOMES AND MEASURES Nontreatment, undertreatment, and treatment trends determined by the use of prescription medication (topical, phototherapeutic, oral systemic, and biologic), as well as treatment satisfaction and reasons for medication discontinuation. RESULTS A total of 5604 patients with psoriasis or psoriatic arthritis completed the survey. From 2003 through 2011, patients who were untreated ranged from 36.6% to 49.2% of patients with mild psoriasis, 23.6% to 35.5% of patients with moderate psoriasis, and 9.4% to 29.7% of patients with severe psoriasis. Among those receiving treatment, 29.5% of patients with moderate psoriasis and 21.5% of patients with severe psoriasis were treated with topical agents alone. The most frequently used phototherapy modality is UV-B, whereas methotrexate is the most commonly used oral agent. Although adverse effects and a lack of effectiveness were primary reasons for discontinuing biological agents, the inability to obtain adequate insurance coverage was among the top reasons for discontinuation. Overall, 52.3% of patients with psoriasis and 45.5% of patients with psoriatic arthritis were dissatisfied with their treatment. CONCLUSIONS AND RELEVANCE Nontreatment and undertreatment of patients with psoriasis and psoriatic arthritis remain a significant problem in the United States. While various treatment modalities are available for psoriasis and psoriatic arthritis, widespread treatment dissatisfaction exists. Efforts in advocacy and education are necessary to ensure that effective treatments are accessible to this patient population. JAMA Dermatol. 2013; 149(10): 1180-1185. doi: 10.1001/jamadermatol.2013.5264.	[Mercy, Katherine M.; Gordon, Kenneth B.; Paller, Amy S.] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Paller, AS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Dermatol, 676 N St Clair,Ste 1600, Chicago, IL 60611 USA.	apaller@northwestern.edu		Paller, Amy/0000-0001-6187-6549	Abbott; Amgen; Celgene; Eli Lilly; Janssen; Novartis; Pfizer; Merck	Abbott(Abbott Laboratories); Amgen(Amgen); Celgene(Bristol-Myers SquibbCelgene Corporation); Eli Lilly(Eli Lilly); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Pfizer(Pfizer); Merck(Merck & Company)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gordon reported having received grants, personal fees, or both from Abbott, Amgen, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, and Merck. Dr Paller reported having received an honorarium for consultating for Abbvie and having been an investigator without personal compensation for Amgen. No other disclosures were reported.	Armstrong AW, 2013, JAMA DERMATOL, V149, P1180, DOI 10.1001/jamadermatol.2013.5264; Duffin KC, 2014, BRIT J DERMATOL, V170, P672, DOI 10.1111/bjd.12745; Finlay AY, 2004, J CUTAN MED SURG, V8, P310, DOI 10.1007/s10227-005-0030-6; Gordon KB, 2014, BRIT J DERMATOL, V170, P705, DOI 10.1111/bjd.12636; Langley RG, 2010, J AM ACAD DERMATOL, V63, P457, DOI 10.1016/j.jaad.2009.09.014; Prodanowich S, 2005, J AM ACAD DERMATOL, V52, P262, DOI 10.1016/j.jaad.2004.06.017; van Cranenburgh OD, 2013, BRIT J DERMATOL, V169, P398, DOI 10.1111/bjd.12372; Wu JJ, 2012, ARCH DERMATOL, V148, P1244, DOI 10.1001/archdermatol.2012.2502	8	8	9	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2014	312	24					2676	2677		10.1001/jama.2014.12494	http://dx.doi.org/10.1001/jama.2014.12494			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX5KW	25536259				2022-12-28	WOS:000346966100020
J	Butchart, A; Mikton, C; Krug, E				Butchart, Alexander; Mikton, Christopher; Krug, Etienne			Governments must do more to address interpersonal violence	LANCET			English	Editorial Material							PREVALENCE; ABUSE; METAANALYSIS		[Butchart, Alexander; Mikton, Christopher; Krug, Etienne] WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Butchart, A (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	butcharta@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; Stoltenborgh M, 2013, INT J PSYCHOL, V48, P81, DOI 10.1080/00207594.2012.697165; Stoltenborgh M, 2011, CHILD MALTREATMENT, V16, P79, DOI 10.1177/1077559511403920; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organisation Department of Reproductive Health and Research London School of Hygiene and Tropical Medicine South African Medical Research Council, 2013, GLOB REG EST VIOL WO; World Health Organization, 2002, WORLD REPORT VIOLENC	6	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2183	2185		10.1016/S0140-6736(14)62124-3	http://dx.doi.org/10.1016/S0140-6736(14)62124-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX0QC	25499544				2022-12-28	WOS:000346655700011
J	Rutlin, M; Ho, CY; Abraira, VE; Cassidy, C; Woodbury, CJ; Ginty, DD				Rutlin, Michael; Ho, Cheng-Ying; Abraira, Victoria E.; Cassidy, Colleen; Woodbury, C. Jeffery; Ginty, David D.			The Cellular and Molecular Basis of Direction Selectivity of A delta-LTMRs	CELL			English	Article							LOW-THRESHOLD MECHANORECEPTORS; TRIGEMINAL GANGLION NEURONS; TYROSINE PROTEIN-KINASE; HAIRY SKIN; SENSORY NEURONS; CUTANEOUS MECHANORECEPTORS; NEUROTROPHIC FACTOR; RECEPTOR; STIMULI; RETINA	The perception of touch, including the direction of stimulus movement across the skin, begins with activation of low-threshold mechanosensory neurons (LTMRs) that innervate the skin. Here, we show that murine A delta-LTMRs are preferentially tuned to deflection of body hairs in the caudal-to-rostral direction. This tuning property is explained by the finding that A delta-LTMR lanceolate endings around hair follicles are polarized; they are concentrated on the caudal (downward) side of each hair follicle. The neurotrophic factor BDNF is synthesized in epithelial cells on the caudal, but not rostral, side of hair follicles, in close proximity to A delta-LTMR lanceolate endings, which express TrkB. Moreover, ablation of BDNF in hair follicle epithelial cells disrupts polarization of A delta-LTMR lanceolate endings and results in randomization of A delta-LTMR responses to hair deflection. Thus, BDNF-TrkB signaling directs polarization of A delta-LTMR lanceolate endings, which underlies direction-selective responsiveness of A delta-LTMRs to hair deflection.	[Abraira, Victoria E.; Ginty, David D.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Rutlin, Michael; Ho, Cheng-Ying; Abraira, Victoria E.; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Ho, Cheng-Ying] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Cassidy, Colleen; Woodbury, C. Jeffery] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; University of Wyoming	Woodbury, CJ (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	woodbury@uwyo.edu; david_ginty@hms.harvard.edu	Ho, Cheng-Ying/AAA-5098-2019		NIH grants [F32 NS077836, NS44094, NS34814, DE022750]; Johns Hopkins NINDS Core Imaging Facility [MH084020]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034814, R01NS044094, R01NS034814, F32NS077836, R37NS034814] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins NINDS Core Imaging Facility; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the D.D.G. laboratory for discussions and comments on this study, Dori Reimert for help with generation of the TrkBCreER mouse line, Kevin Jones and Jeremy Nathans for providing mouse lines, Danilo Boada for help with development of trigeminal preparations, and the Johns Hopkins Transgenic Facility for blastocyst injections. This work was supported by NIH grants F32 NS077836 (V.E.A.), NS44094 (C.J.W.), NS34814 (D.D.G.), and DE022750 (D.D.G.), and the Johns Hopkins NINDS Core Imaging Facility MH084020 (D.D.G.). D.D.G. is an investigator of the Howard Hughes Medical Institute.	Adrian ED, 1926, J PHYSIOL-LONDON, V61, P465, DOI 10.1113/jphysiol.1926.sp002308; Badea TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007859; BENDER MB, 1982, J NEUROL SCI, V53, P531, DOI 10.1016/0022-510X(82)90249-0; Boada MD, 2007, J NEUROPHYSIOL, V98, P668, DOI 10.1152/jn.00264.2007; BROWN AG, 1967, J PHYSIOL-LONDON, V193, P707, DOI 10.1113/jphysiol.1967.sp008390; BURGESS PR, 1968, J NEUROPHYSIOL, V31, P833, DOI 10.1152/jn.1968.31.6.833; Chiang LY, 2011, NAT NEUROSCI, V14, P993, DOI 10.1038/nn.2873; COSTANZO R M, 1980, Journal of Neurophysiology (Bethesda), V43, P1319; Cruz-Martin A, 2014, NATURE, V507, P358, DOI 10.1038/nature12989; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Essick G.K., 1985, BRAIN RES, V357, P213, DOI DOI 10.1016/0165-0173(85)90025-6; ESSICK GK, 1995, J NEUROSCI, V15, P848; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Gorski JA, 2003, J NEUROSCI, V23, P6856; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; GREENSPAN JD, 1992, J NEUROPHYSIOL, V68, P876, DOI 10.1152/jn.1992.68.3.876; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Hamann W, 1995, PROG BIOPHYS MOL BIO, V64, P81, DOI 10.1016/0079-6107(95)00011-9; HORCH KW, 1977, J INVEST DERMATOL, V69, P75, DOI 10.1111/1523-1747.ep12497887; HYVARINEN J, 1978, J PHYSIOL-LONDON, V283, P523, DOI 10.1113/jphysiol.1978.sp012517; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Kwegyir-Afful EE, 2008, SOMATOSENS MOT RES, V25, P209, DOI 10.1080/08990220802467612; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; LICHTENSTEIN SH, 1990, SOMATOSENS MOT RES, V7, P47, DOI 10.3109/08990229009144697; Liu Y, 2012, SCIENCE, V338, P1357, DOI 10.1126/science.1228258; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MARUHASHI J, 1952, J PHYSIOL-LONDON, V117, P129, DOI 10.1113/jphysiol.1952.sp004736; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; RAY RH, 1985, BRAIN RES, V346, P333, DOI 10.1016/0006-8993(85)90867-4; Trenholm S, 2011, NEURON, V71, P683, DOI 10.1016/j.neuron.2011.06.020; TUCKETT RP, 1978, J NEUROPHYSIOL, V41, P150, DOI 10.1152/jn.1978.41.1.150; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; VIERCK CJ, 1974, EXP BRAIN RES, V20, P331; WALL PD, 1977, BRAIN, V100, P641, DOI 10.1093/brain/100.4.641; Wei W, 2011, TRENDS NEUROSCI, V34, P638, DOI 10.1016/j.tins.2011.08.002; WHITSEL BL, 1978, FED PROC, V37, P2223; WHITSEL BL, 1972, J NEUROPHYSIOL, V35, P691, DOI 10.1152/jn.1972.35.5.691; Woodbury CJ, 2007, J COMP NEUROL, V505, P547, DOI 10.1002/cne.21517; Woodbury CJ, 2001, J COMP NEUROL, V436, P304; Zotterman Y, 1939, J PHYSIOL-LONDON, V95, P1	46	82	83	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1640	1651		10.1016/j.cell.2014.11.038	http://dx.doi.org/10.1016/j.cell.2014.11.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25525881	Green Accepted, Bronze			2022-12-28	WOS:000347922500017
J	Ridha, A; Khan, A; Al-Abayechi, S; Puthenveetil, V				Ridha, Ali; Khan, Adnan; Al-Abayechi, Sarah; Puthenveetil, Vidya			Acute compartment syndrome secondary to rhabdomyolysis in a sickle cell trait patient	LANCET			English	Editorial Material									[Ridha, Ali; Khan, Adnan; Puthenveetil, Vidya] Rosalind Franklin Univ Med & Sci, N Chicago, IL 60064 USA; [Al-Abayechi, Sarah] Univ Baghdad, Coll Med, Baghdad, Iraq	Rosalind Franklin University Medical & Science; University of Baghdad	Ridha, A (corresponding author), Rosalind Franklin Univ Med & Sci, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	alimtridha@yahoo.com						HIEB LD, 1988, CLIN ORTHOP RELAT R, P190; Michlitsch J, 2009, PEDIATR BLOOD CANCER, V52, P486, DOI 10.1002/pbc.21883; PALETTA CE, 1993, ANN PLAS SURG, V30, P272, DOI 10.1097/00000637-199303000-00013; Serjeant GR, 2004, SICKLE CELL DIS, P482; Thompson AA, 2013, HEMATOL-AM SOC HEMAT, P632, DOI 10.1182/asheducation-2013.1.632	5	12	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2014	384	9960					2172	2172		10.1016/S0140-6736(14)61944-9	http://dx.doi.org/10.1016/S0140-6736(14)61944-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BK	25497201				2022-12-28	WOS:000346354300034
J	Mirarab, S; Bayzid, MS; Boussau, B; Warnow, T				Mirarab, Siavash; Bayzid, Md. Shamsuzzoha; Boussau, Bastien; Warnow, Tandy			Statistical binning enables an accurate coalescent-based estimation of the avian tree	SCIENCE			English	Article							INFERRING SPECIES TREES; CLOSEST LIVING RELATIVES; GENE TREES; SCALE COESTIMATION; GENOME; INFERENCE; INCONGRUENCE; REVEALS; PHYLUM; TIMES	Gene tree incongruence arising from incomplete lineage sorting (ILS) can reduce the accuracy of concatenation-based estimations of species trees. Although coalescent-based species tree estimation methods can have good accuracy in the presence of ILS, they are sensitive to gene tree estimation error. We propose a pipeline that uses bootstrapping to evaluate whether two genes are likely to have the same tree, then it groups genes into sets using a graph-theoretic optimization and estimates a tree on each subset using concatenation, and finally produces an estimated species tree from these trees using the preferred coalescent-based method. Statistical binning improves the accuracy of MP-EST, a popular coalescent-based method, and we use it to produce the first genome-scale coalescent-based avian tree of life.	[Mirarab, Siavash; Bayzid, Md. Shamsuzzoha; Warnow, Tandy] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA; [Boussau, Bastien] Univ Lyon 1, UMR5558, CNRS, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Warnow, Tandy] Univ Illinois, Dept Bioengn & Comp Sci, Champaign, IL 61820 USA	University of Texas System; University of Texas Austin; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of Illinois System; University of Illinois Urbana-Champaign	Warnow, T (corresponding author), Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA.	warnow@illinois.edu		Boussau, Bastien/0000-0003-0776-4460; Mirarab, Siavash/0000-0001-5410-1518	Howard Hughes Medical Institute (HHMI); Fulbright Foundation; NSF [DBI-10735191, DBI-1062335]; University of Alberta; Human Frontier Science Program; CNRS; Agence Nationale de la Recherche (ANR) [ANR-10-BINF-01-01]	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Fulbright Foundation; NSF(National Science Foundation (NSF)); University of Alberta(University of Alberta); Human Frontier Science Program(Human Frontier Science Program); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	SM was supported by a graduate fellowship from Howard Hughes Medical Institute (HHMI) M.S.B. was supported by a graduate fellowship from the Fulbright Foundation, by NSF under grant DBI-10735191 to iPLANT, and by the University of Alberta, made possible through a donation from Musea Ventures, which is held by G.K.-S. Wong; T.W. was supported by NSF under grant DBI-1062335; and B.B. was supported by a postdoctoral fellowship from the Human Frontier Science Program, the CNRS, and Agence Nationale de la Recherche (ANR) through grant ANR-10-BINF-01-01 Ancestrome. The authors thank E. Braun, G. Chacko, S. Edwards, T. Gilbert, E. Jarvis, L. Liu, D. Posada, and G. Zhang for helpful comments. The computational analyses in this study were performed using generous allocations on TACC (both Lonestar and Stampede) and on the Condor cluster of the University of Texas Computer Science department. All the data sets used in the paper and the software for performing statistical binning can be found at http://www.ideals.illinois.edu/handle/2142/55319.	Bayzid MS, 2013, BIOINFORMATICS, V29, P2277, DOI 10.1093/bioinformatics/btt394; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Boussau B, 2013, GENOME RES, V23, P323, DOI 10.1101/gr.141978.112; BRELAZ D, 1979, COMMUN ACM, V22, P251, DOI 10.1145/359094.359101; Bryant D, 2012, MOL BIOL EVOL, V29, P1917, DOI 10.1093/molbev/mss086; Chifman J, 2014, BIOINFORMATICS, V30, P3317, DOI 10.1093/bioinformatics/btu530; De Maio N, 2013, MOL BIOL EVOL, V30, P2249, DOI 10.1093/molbev/mst131; DeGiorgio M, 2014, SYST BIOL, V63, P66, DOI 10.1093/sysbio/syt059; DeGiorgio M, 2010, MOL BIOL EVOL, V27, P552, DOI 10.1093/molbev/msp250; Degnan JH, 2009, SYST BIOL, V58, P35, DOI 10.1093/sysbio/syp008; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; FELSENSTEIN J, 1978, SYST ZOOL, V27, P27, DOI 10.2307/2412810; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Kimball RT, 2013, MOL PHYLOGENET EVOL, V69, P1021, DOI 10.1016/j.ympev.2013.05.029; Knowles LL, 2009, SYST BIOL, V58, P463, DOI 10.1093/sysbio/syp061; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Lanier HC, 2012, SYST BIOL, V61, P691, DOI 10.1093/sysbio/syr128; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Leache AD, 2014, SYST BIOL, V63, P17, DOI 10.1093/sysbio/syt049; Leigh JW, 2008, SYST BIOL, V57, P104, DOI 10.1080/10635150801910436; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; McCormack JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054848; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Mossel E, 2010, IEEE ACM T COMPUT BI, V7, P166, DOI 10.1109/TCBB.2008.66; Nakhleh L, 2001, Bioinformatics, V17 Suppl 1, pS190; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Patel S., 2013, J PHYLOGENETICS EVOL, V1, P2, DOI DOI 10.4172/2329-9002.1000110; Ragan MA, 1992, MOL PHYLOGENET EVOL, V1, P53, DOI 10.1016/1055-7903(92)90035-F; Rannala B, 2003, GENETICS, V164, P1645; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rosenberg NA, 2013, MOL BIOL EVOL, V30, P2709, DOI 10.1093/molbev/mst160; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Seo TK, 2008, MOL BIOL EVOL, V25, P960, DOI 10.1093/molbev/msn043; Singh TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-534; Smith BT, 2014, SYST BIOL, V63, P83, DOI 10.1093/sysbio/syt061; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suh A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1448; Wang N, 2012, MOL BIOL EVOL, V29, P737, DOI 10.1093/molbev/msr230; WARNOW TJ, 1994, J ALGORITHM, V16, P388, DOI 10.1006/jagm.1994.1018; WEISBURG WG, 1989, SYST APPL MICROBIOL, V11, P128, DOI 10.1016/S0723-2020(89)80051-7; Wilcox TP, 2002, MOL PHYLOGENET EVOL, V25, P361, DOI 10.1016/S1055-7903(02)00244-0; Yu Y, 2011, J COMPUT BIOL, V18, P1543, DOI 10.1089/cmb.2011.0174; Zhao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064642; Zhong BJ, 2013, TRENDS PLANT SCI, V18, P492, DOI 10.1016/j.tplants.2013.04.009	56	143	146	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1337	+	1250463	10.1126/science.1250463	http://dx.doi.org/10.1126/science.1250463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504728				2022-12-28	WOS:000346189600042
J	Schultze, M; Ramasesha, K; Pemmaraju, CD; Sato, SA; Whitmore, D; Gandman, A; Prell, JS; Borja, LJ; Prendergast, D; Yabana, K; Neumark, DM; Leone, SR				Schultze, Martin; Ramasesha, Krupa; Pemmaraju, C. D.; Sato, S. A.; Whitmore, D.; Gandman, A.; Prell, James S.; Borja, L. J.; Prendergast, D.; Yabana, K.; Neumark, Daniel M.; Leone, Stephen R.			Attosecond band-gap dynamics in silicon	SCIENCE			English	Article							COHERENT CONTROL; IONIZATION; BREAKDOWN	We report a low-cost, high-throughput benchtop method that enables thin layers of metal to be shaped with nanoscale precision by generating ultrahigh-strain-rate deformations. Laser shock imprinting can create three-dimensional crystalline metallic structures as small as 10 nanometers with ultrasmooth surfaces at ambient conditions. This technique enables the successful fabrications of large-area, uniform nanopatterns with aspect ratios as high as 5 for plasmonic and sensing applications, as well as mechanically strengthened nanostructures and metal-graphene hybrid nanodevices.	[Schultze, Martin; Ramasesha, Krupa; Whitmore, D.; Gandman, A.; Prell, James S.; Borja, L. J.; Neumark, Daniel M.; Leone, Stephen R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Schultze, Martin] Univ Munich, Fak Phys, D-85748 Garching, Germany; [Pemmaraju, C. D.; Prendergast, D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Sato, S. A.; Yabana, K.] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan; [Yabana, K.] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki 3058577, Japan; [Neumark, Daniel M.; Leone, Stephen R.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Chem Sci Div, Berkeley, CA 94720 USA; [Leone, Stephen R.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of Munich; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Tsukuba; University of Tsukuba; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Schultze, M (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	martin.schultze@mpq.mpg.de; dneumark@berkeley.edu; srl@berkeley.edu	Yabana, Kazuhiro/Q-7396-2019; Prendergast, David/E-4437-2010; Sato, Shunsuke/I-3294-2015; Ramasesha, Krupa/AAZ-8682-2021; Neumark, Daniel M/B-9551-2009	Prendergast, David/0000-0003-0598-1453; Sato, Shunsuke/0000-0001-9543-2620; Neumark, Daniel M/0000-0002-3762-9473; Schultze, Martin/0000-0003-0438-9255	Office of Assistant Secretary of Defense for Research and Engineering through a National Security Science and Engineering Faculty Fellowship (NSSEFF); Defense Advanced Research Projects Agency PULSE program [W31P4Q-13-1-0017]; Department of Energy [DE-AC03-76SF00098]; Institute of Solid State Physics, University of Tokyo under Japan Society for the Promotion of Science KAKENHI [23340113, 25104702]; Marie Curie International Outgoing Fellowship [FP7-PEOPLE-2011-IOF]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]	Office of Assistant Secretary of Defense for Research and Engineering through a National Security Science and Engineering Faculty Fellowship (NSSEFF); Defense Advanced Research Projects Agency PULSE program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Department of Energy(United States Department of Energy (DOE)); Institute of Solid State Physics, University of Tokyo under Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Marie Curie International Outgoing Fellowship(European Commission); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE))	We acknowledge fruitful discussions with P. Feulner and help with sample preparation from R. Rivers. The experimental work is supported by the Office of Assistant Secretary of Defense for Research and Engineering through a National Security Science and Engineering Faculty Fellowship (NSSEFF), with additional funding from the Defense Advanced Research Projects Agency PULSE program through grant W31P4Q-13-1-0017. The W. M. Keck Foundation and the Department of Energy under contract DE-AC03-76SF00098 are acknowledged for additional experimental equipment. S.R.L. and D.M.N. acknowledge Multidisciplinary University Research Initiatives from the Army Research Office (WN911NF-14-1-0383) and the Air Force Office of Scientific Research. S.A.S and K.Y. performed computations at the Institute of Solid State Physics, University of Tokyo under Japan Society for the Promotion of Science KAKENHI grants 23340113 and 25104702. M.S. was supported by a Marie Curie International Outgoing Fellowship (FP7-PEOPLE-2011-IOF). C.D.P. and D.P. performed work at the Molecular Foundry, supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract DE-AC02-05CH11231, with computing resources at Lawrence Berkeley National Laboratory and the National Energy Research Scientific Computing Center (NERSC).	ALLEN PB, 1987, PHYS REV LETT, V59, P1460, DOI 10.1103/PhysRevLett.59.1460; BECKER PC, 1988, PHYS REV LETT, V61, P1647, DOI 10.1103/PhysRevLett.61.1647; Beye M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043011; DU D, 1994, APPL PHYS LETT, V64, P3071, DOI 10.1063/1.111350; Gertsvolf M, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/13/131002; Greenland PT, 2010, NATURE, V465, P1057, DOI 10.1038/nature09112; Hase M, 2012, NAT PHOTONICS, V6, P243, DOI 10.1038/nphoton.2012.35; HULIN D, 1990, SPRINGER SERIES CHEM, V53, P282; KELDYSH LV, 1965, SOV PHYS JETP-USSR, V20, P1307; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Koehl WF, 2011, NATURE, V479, P84, DOI 10.1038/nature10562; Koningsberger D.C., 1988, XRAY ABSORPTION PRIN; Krausz F, 2014, NAT PHOTONICS, V8, P205, DOI 10.1038/nphoton.2014.28; Kuehn W, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.146602; Lenzner M, 1998, PHYS REV LETT, V80, P4076, DOI 10.1103/PhysRevLett.80.4076; Noffsinger J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.167402; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Prendergast D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.215502; Radcliffe P, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043008; Schultze M, 2013, NATURE, V493, P75, DOI 10.1038/nature11720; Shah J., 1996, ULTRAFAST SPECTROSCO; Shinohara Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.155110; Srivastava A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.157401; THURBER WR, 1980, J ELECTROCHEM SOC, V127, P2291, DOI 10.1149/1.2129394; VANOVERSTRAETEN RJ, 1987, SOLID STATE ELECTRON, V30, P1077, DOI 10.1016/0038-1101(87)90070-0; VINA L, 1984, PHYS REV B, V29, P6739, DOI 10.1103/PhysRevB.29.6739; Yabana K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045134	27	342	346	10	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1348	1352		10.1126/science.1260311	http://dx.doi.org/10.1126/science.1260311			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25504716				2022-12-28	WOS:000346189600046
J	Hussein, SMI; Puri, MC; Tonge, PD; Benevento, M; Corso, AJ; Clancy, JL; Mosbergen, R; Li, M; Lee, DS; Cloonan, N; Wood, DLA; Munoz, J; Middleton, R; Korn, O; Patel, HR; White, CA; Shin, JY; Gauthier, ME; Le Cao, KA; Kim, JI; Mar, JC; Shakiba, N; Ritchie, W; Rasko, JEJ; Grimmond, SM; Zandstra, PW; Wells, CA; Preiss, T; Seo, JS; Heck, AJR; Rogers, IM; Nagy, A				Hussein, Samer M. I.; Puri, Mira C.; Tonge, Peter D.; Benevento, Marco; Corso, Andrew J.; Clancy, Jennifer L.; Mosbergen, Rowland; Li, Mira; Lee, Dong-Sung; Cloonan, Nicole; Wood, David L. A.; Munoz, Javier; Middleton, Robert; Korn, Othmar; Patel, Hardip R.; White, Carl A.; Shin, Jong-Yeon; Gauthier, Maely E.; Le Cao, Kim-Anh; Kim, Jong-Il; Mar, Jessica C.; Shakiba, Nika; Ritchie, William; Rasko, John E. J.; Grimmond, Sean M.; Zandstra, Peter W.; Wells, Christine A.; Preiss, Thomas; Seo, Jeong-Sun; Heck, Albert J. R.; Rogers, Ian M.; Nagy, Andras			Genome-wide characterization of the routes to pluripotency	NATURE			English	Article							EMBRYONIC STEM-CELLS; DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; NONCODING RNAS; IPS CELLS; FUNCTIONAL-PROPERTIES; SOMATIC-CELLS; CHROMATIN; METHYLATION; REVEALS	Somatic cell reprogramming to a pluripotent state continues to challenge many of our assumptions about cellular specification, and despite major efforts, we lack a complete molecular characterization of the reprograming process. To address this gap in knowledge, we generated extensive transcriptomic, epigenomic and proteomic data sets describing the reprogramming routes leading from mouse embryonic fibroblasts to induced pluripotency. Through integrative analysis, we reveal that cells transition through distinct gene expression and epigenetic signatures and bifurcate towards reprogramming transgene-dependent and - independent stable pluripotent states. Early transcriptional events, driven by high levels of reprogramming transcription factor expression, are associated with widespread loss of histone H3 lysine 27 (H3K27me3) trimethylation, representing a general opening of the chromatin state. Maintenance of high transgene levels leads to re-acquisition of H3K27me3 and a stable pluripotent state that is alternative to the embryonic stem cell (ESC)-like fate. Lowering transgene levels at an intermediate phase, however, guides the process to the acquisition of ESC-like chromatin and DNA methylation signature. Our data provide a comprehensive molecular description of the reprogramming routes and is accessible through the Project Grandiose portal at http://www.stemformatics.org.	[Hussein, Samer M. I.; Puri, Mira C.; Tonge, Peter D.; Corso, Andrew J.; Li, Mira; Rogers, Ian M.; Nagy, Andras] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Puri, Mira C.] Univ Toronto, Dept Med Biophys, Toronto, ON M5T 3H7, Canada; [Benevento, Marco; Munoz, Javier; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Benevento, Marco; Munoz, Javier; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Benevento, Marco; Munoz, Javier; Heck, Albert J. R.] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands; [Corso, Andrew J.] Univ Toronto, Inst Med Sci, Toronto, ON M5T 3H7, Canada; [Clancy, Jennifer L.; Patel, Hardip R.; Preiss, Thomas] Australian Natl Univ, John Curtin Sch Med Res, Genome Biol Dept, Canberra, ACT 2601, Australia; [Mosbergen, Rowland; Korn, Othmar; Wells, Christine A.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia; [Lee, Dong-Sung; Shin, Jong-Yeon; Kim, Jong-Il; Seo, Jeong-Sun] Seoul Natl Univ, Genom Med Inst, Med Res Ctr, Seoul 110799, South Korea; [Lee, Dong-Sung] Seoul Natl Univ, Coll Med, Dept Biomed Sci & Biochem, Seoul 110799, South Korea; [Cloonan, Nicole; Wood, David L. A.; Gauthier, Maely E.; Le Cao, Kim-Anh; Grimmond, Sean M.] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, St Lucia, Qld 4072, Australia; [Middleton, Robert; Ritchie, William; Rasko, John E. J.] Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW 2050, Australia; [Middleton, Robert; Ritchie, William; Rasko, John E. J.] Centenary Inst, Bioinformat Lab, Camperdown, NSW 2050, Australia; [Middleton, Robert; Ritchie, William; Rasko, John E. J.] 31 Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Patel, Hardip R.] Australian Natl Univ, John Curtin Sch Med Res, Genome Discovery Unit, Canberra, ACT 2601, Australia; [White, Carl A.; Shakiba, Nika; Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON M5S 3G9, Canada; [White, Carl A.; Zandstra, Peter W.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res CCBR, Toronto, ON M5S 3E1, Canada; [Shin, Jong-Yeon] Macrogen Inc, Life Sci Inst, Seoul 153781, South Korea; [Mar, Jessica C.] Yeshiva Univ, Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA; [Rasko, John E. J.] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; [Wells, Christine A.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland; [Preiss, Thomas] Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia; [Rogers, Ian M.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Rogers, Ian M.; Nagy, Andras] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON M5S 1E2, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Utrecht University; Utrecht University; University of Toronto; Australian National University; John Curtin School of Medical Research; University of Queensland; Seoul National University (SNU); Seoul National University (SNU); University of Queensland; University of Sydney; Centenary Institute; University of Sydney; Centenary Institute; University of Sydney; Australian National University; John Curtin School of Medical Research; University of Toronto; University of Toronto; Macrogen, Inc.; Yeshiva University; Albert Einstein College of Medicine; University of Sydney; University of Glasgow; Victor Chang Cardiac Research Institute; University of Toronto; University of Toronto	Nagy, A (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	nagy@lunenfeld.ca	Le Cao, Kim-Anh/B-6637-2013; Heck, Albert/D-7098-2011; Seo, Jeong-Sun/J-2763-2012; Preiss, Thomas/F-7355-2010; Nagy, Andras/G-6465-2013; Gauthier, Marie-Emilie/Y-5909-2019; KIM, JONG-IL/D-1019-2011; Munoz, Javier/I-4891-2012; Grimmond, Sean/K-3246-2019; Cloonan, Nicole/B-5272-2008; Patel, Hardip R/K-6376-2012; Grimmond, Sean M/J-5304-2016; Rogers, Ian M/D-5092-2015; Puri, Mira/C-4412-2014; Wells, Christine/A-5071-2010	Le Cao, Kim-Anh/0000-0003-3923-1116; Heck, Albert/0000-0002-2405-4404; Preiss, Thomas/0000-0001-6273-784X; Nagy, Andras/0000-0003-4311-0413; Gauthier, Marie-Emilie/0000-0002-5256-9165; KIM, JONG-IL/0000-0002-7240-3744; Munoz, Javier/0000-0003-3288-3496; Grimmond, Sean/0000-0002-8102-7998; Cloonan, Nicole/0000-0001-7802-6647; Grimmond, Sean M/0000-0002-8102-7998; Rogers, Ian M/0000-0001-8466-1225; Shakiba, Nika/0000-0003-2985-3130; Wood, David/0000-0002-1001-2019; Mar, Jessica/0000-0002-5147-9299; Wells, Christine/0000-0003-3133-3628; Patel, Hardip/0000-0003-3169-049X; rasko, John/0000-0003-2975-807X	Ontario Research Fund Global Leadership Round in Genomics and Life Sciences grants [GL2-01-028]; Canadian stem cell network [9/5254 (TR3)]; Canadian Institutes of Health Research [CIHR MOP102575]; Korean Ministry of Knowledge Economy [10037410]; SNUCM Research Fund [0411-20100074]; Macrogen Inc. [MGR03-11, MGR03-12]; Australian Research Council [DP1300101928, SR110001002]; National Health and Medical Research Council of Australia [1024852]; Cancer Council of NSW; National Health & Medical Research Council [571156, 1061906]; Cure the Future Tour de Cure; Wound Management Innovation CRC (under the Australian Government's Cooperative Research Centres Program); Netherlands Proteomics Centre; European Community's Seventh Framework Programme (FP7) by the PRIME-XS project [262067]; McEwen Centre of Regenerative Medicine	Ontario Research Fund Global Leadership Round in Genomics and Life Sciences grants; Canadian stem cell network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Korean Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); SNUCM Research Fund; Macrogen Inc.; Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of NSW(Cancer Council New South Wales); National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cure the Future Tour de Cure; Wound Management Innovation CRC (under the Australian Government's Cooperative Research Centres Program)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Netherlands Proteomics Centre; European Community's Seventh Framework Programme (FP7) by the PRIME-XS project; McEwen Centre of Regenerative Medicine	We thank M. Gertsenstein and M. Pereira for chimaera production, C. Monetti for cell culture, R. Cowling for DNA purification, and K. Harpal for chimaera embryo sectioning and staining. We acknowledge the intellectual contributions of P. P. L. Tam and R. P. Harvey. A.N. is Tier 1 Canada Research Chair in Stem Cells and Regeneration. This work was supported by grants awarded to A.N., I. M. R. and P.W.Z. from the Ontario Research Fund Global Leadership Round in Genomics and Life Sciences grants (GL2-01-028), to A.N. from the Canadian stem cell network (9/5254 (TR3)) and from the Canadian Institutes of Health Research (CIHR MOP102575). This work received support from the Korean Ministry of Knowledge Economy (grant 10037410 to J.-S.S.), from the SNUCM Research Fund (grant 0411-20100074 to J.-S.S.), and from Macrogen Inc. (grant MGR03-11 and MGR03-12). The Stemformatics resource is supported by an Australian Research Council special research grant to Stem Cells Australia (C.A.W. and S.M.G.). The analysis of the miRNA was supported by grants from the National Health and Medical Research Council of Australia (1024852 to J.L.C. and T.P.) and the Australian Research Council (DP1300101928 to T.P.). W.R. is a Cancer Institute of NSW Fellow and with J.E.J.R. receives support from the Cancer Council of NSW and National Health & Medical Research Council (571156 and 1061906). J.E.J.R. receives funding from Cure the Future & Tour de Cure. K.-A.L.C. is supported, in part, by the Wound Management Innovation CRC (established and supported under the Australian Government's Cooperative Research Centres Program). S.M.G. received support from the Australian Research Council (SR110001002). C.A.W. is a QLD Smart Futures Fellow. M.B., J.M. and A.J.R.H. are supported by the Netherlands Proteomics Centre, and by the European Community's Seventh Framework Programme (FP7/2007-2013) by the PRIME-XS project grant agreement number 262067. P.W.Z. is the Canada Research Chair in Stem Cell Bioengineering. S.M.I.H. received a fellowship from the McEwen Centre of Regenerative Medicine.	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Behringer R., 2013, MANIPULATING MOUSE E; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Benevento M., 2014, NATURE COMMUN; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Clancy JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6522; Fadloun A, 2013, NAT STRUCT MOL BIOL, V20, P332, DOI 10.1038/nsmb.2495; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Jorgensen HF, 2006, CELL CYCLE, V5, P1411, DOI 10.4161/cc.5.13.2927; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kislinger T, 2003, MOL CELL PROTEOMICS, V2, P96, DOI 10.1074/mcp.M200074-MCP200; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lee D.-S., 2014, NATURE COMMUN; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nagy A, 2013, CURR OPIN GENET DEV, V23, P534, DOI 10.1016/j.gde.2013.07.004; O'Geen H, 2011, METHODS MOL BIOL, V791, P265, DOI 10.1007/978-1-61779-316-5_20; O'Malley J, 2013, NATURE, V499, P88, DOI 10.1038/nature12243; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang SJ, 2011, GENES-BASEL, V2, P502, DOI 10.3390/genes2030502; Tonge PD, 2014, NATURE, V516, P192, DOI 10.1038/nature14047; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wells CA, 2013, STEM CELL RES, V10, P387, DOI 10.1016/j.scr.2012.12.003; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wong JJL, 2013, CELL, V154, P583, DOI 10.1016/j.cell.2013.06.052; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027	59	141	145	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					198	+		10.1038/nature14046	http://dx.doi.org/10.1038/nature14046			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25503233				2022-12-28	WOS:000346383500035
J	Kurokohchi, K; Imataki, O				Kurokohchi, Kazutaka; Imataki, Osamu			Palpitations after Dinner	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kurokohchi, Kazutaka] Uchinomi Hosp, Shodoshima, Japan; [Imataki, Osamu] Kagawa Univ, Kita Ku, Takamatsu, Kagawa 760, Japan	Kagawa University	Kurokohchi, K (corresponding author), Uchinomi Hosp, Shodoshima, Japan.	oima@med.kagawa-u.ac.jp							0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2014	371	24					2320	2320		10.1056/NEJMicm1400585	http://dx.doi.org/10.1056/NEJMicm1400585			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW1KQ	25494271				2022-12-28	WOS:000346048800012
J	Chapman, SJ; Shelton, B; Mahmood, H; Fitzgerald, JE; Harrison, EM; Bhangu, A				Chapman, Stephen J.; Shelton, Bryony; Mahmood, Humza; Fitzgerald, J. Edward; Harrison, Ewen M.; Bhangu, Aneel			Discontinuation and non-publication of surgical randomised controlled trials: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS; REGISTRATION; STATEMENT	Objective To determine the rate of early discontinuation and non-publication of randomised controlled trials involving patients undergoing surgery. Design Cross sectional observational study of registered and published trials. Setting Randomised controlled trials of interventions in patients undergoing a surgical procedure. Data sources The ClinicalTrials.gov database was searched for interventional trials registered between January 2008 and December 2009 using the keyword "surgery". Recruitment status was extracted from the ClinicalTrials.gov database. A systematic search for studies published in peer reviewed journals was performed; if they were not found, results posted on the ClinicalTrials.gov results database were sought. Email queries were sent to trial investigators of discontinued and unpublished completed trials if no reason for the respective status was disclosed. Main outcome measures Trial discontinuation before completion and non-publication after completion. Logistic regression was used to determine the effect of funding source on publication status, with adjustment for intervention type and trial size. Results Of 818 registered trials found using the keyword "surgery", 395 met the inclusion criteria. Of these, 21% (81/395) were discontinued early, most commonly owing to poor recruitment (44%, 36/81). The remaining 314 (79%) trials proceeded to completion, with a publication rate of 66% (208/314) at a median time of 4.9 (interquartile range 4.0-6.0) years from study completion to publication search. A further 6% (20/314) of studies presented results on ClinicalTrials. gov without a corresponding peer reviewed publication. Industry funding did not affect the rate of discontinuation (adjusted odds ratio 0.91, 95% confidence interval 0.54 to 1.55) but was associated with a lower odds of publication for completed trials (0.43, 0.26 to 0.72). Investigators' email addresses for trials with an uncertain fate were identified for 71.4% (10/14) of discontinued trials and 83% (101/122) of unpublished studies. Only 43% (6/14) and 20% (25/122) replies were received. Email responses for completed trials indicated 11 trials in press, five published studies (four in non-indexed peer reviewed journals), and nine trials remaining unpublished. Conclusions One in five surgical randomised controlled trials are discontinued early, one in three completed trials remain unpublished, and investigators of unpublished studies are frequently not contactable. This represents a waste of research resources and raises ethical concerns regarding hidden clinical data and futile participation by patients with its attendant risks. To promote future efficiency and transparency, changes are proposed to research governance frameworks to overcome these concerns.	[Chapman, Stephen J.] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England; [Shelton, Bryony; Bhangu, Aneel] Univ Birmingham, Coll Med & Dent Sci, Birmingham B15 2TH, W Midlands, England; [Mahmood, Humza] St Georges Univ Hosp, Sch Med, London SW17 0RE, England; [Fitzgerald, J. Edward] Royal Free Hosp NHS Trust, High Barnet EN5 3DJ, England; [Harrison, Ewen M.] Univ Edinburgh, Edinburgh EH16 4SA, Midlothian, Scotland	University of Leeds; University of Birmingham; St Georges University London; University of Edinburgh	Bhangu, A (corresponding author), Queen Elizabeth Hosp, Acad Dept Surg, Birmingham B15 2TH, W Midlands, England.	aneelbhangu@doctors.org.uk	Chapman, Stephen J/I-2171-2019; Fitzgerald, James/F-2565-2013	Chapman, Stephen J/0000-0003-2413-5690; Fitzgerald, James/0000-0002-4453-5117; Harrison, Ewen/0000-0002-5018-3066				Bhangu A, 2013, LANCET, V382, P1091, DOI 10.1016/S0140-6736(13)62013-9; Blumle A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087184; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chapman S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1291; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Garas G, 2012, WORLD J SURG, V36, P1723, DOI 10.1007/s00268-012-1597-x; Graf C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4330; Gray R, 2012, ANN ROY COLL SURG, V94, P388, DOI 10.1308/003588412X13171221592339; Huser V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068409; Jones CW, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6104; Kasenda B, 2014, JAMA-J AM MED ASSOC, V311, P1045, DOI 10.1001/jama.2014.1361; Killeen S, 2014, ANN SURG, V259, P193, DOI 10.1097/SLA.0b013e318299d00b; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Lehman R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8158; Manzoli L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3058; National Institutes of Health, 2014, GLOSS COMM SIT TERMS; Rosenthal R, 2014, ANN SURG IN PRESS; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Royal College of Surgeons of England, 2014, INN AD SUCC SPREAD S; US National Institutes of Health, 2014, TRENDS CHARTS MAPS; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	23	109	110	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2014	349								g6870	10.1136/bmj.g6870	http://dx.doi.org/10.1136/bmj.g6870			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW3CL	25491195	Green Published, hybrid			2022-12-28	WOS:000346163100001
J	Martin, EE				Martin, Ellen E.			EARTH SCIENCE Ocean circulation and rapid climate change	NATURE			English	Editorial Material							NORTH-ATLANTIC		Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Martin, EE (corresponding author), Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA.	eemartin@ufl.edu						Bohm E, 2015, NATURE, V517, P73, DOI 10.1038/nature14059; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Foster GL, 2007, GEOLOGY, V35, P37, DOI 10.1130/G23204A.1; JEANDEL C, 1993, EARTH PLANET SC LETT, V117, P581, DOI 10.1016/0012-821X(93)90104-H; Lacan F, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000956; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Roberts NL, 2010, SCIENCE, V327, P75, DOI 10.1126/science.1178068; van de Flierdt T, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001294	11	2	2	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					30	31		10.1038/518304a	http://dx.doi.org/10.1038/518304a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25517092	Bronze			2022-12-28	WOS:000347178400028
J	Collins, GS; Reitsma, JB; Altman, DG; Moons, KGM				Collins, Gary S.; Reitsma, Johannes B.; Altman, Douglas G.; Moons, Karel G. M.			Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD statement	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article							GENETIC RISK PREDICTION; EXTERNAL VALIDATION; INTERNAL VALIDATION; RULES; IMPACT; EXPLANATION; RECOMMENDATIONS; ASSOCIATION; DISEASE; HEART	Prediction models are developed to aid health care providers in estimating the probability or risk that a specific disease or condition is present (diagnostic models) or that a specific event will occur in the future (prognostic models), to inform their decision making. However, the overwhelming evidence shows that the quality of reporting of prediction model studies is poor. Only with full and clear reporting of information on all aspects of a prediction model can risk of bias and potential usefulness of prediction models be adequately assessed. The Transparent Reporting of a multivatiable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) Initiative developed a set of recommendations for the reporting of studies developing, validating, or updating a prediction model, whether for diagnostic or prognostic purposes. This article describes how the TRIPOD Statement was developed. An extensive list of items based on a review of the literature was created, which was reduced after a Web-based survey and revised during a 3-day meeting in June 2011 with methodologists, health care professionals, and journal editors. The list was refined during several meetings of the steering group and in e-mail discussions with the wider group of TRIPOD contributors. The resulting TRIPOD Statement is a checklist of 22 items, deemed essential for transparent reporting of a prediction model study. The TRIPOD Statement aims to improve the transparency of the reporting of a prediction model study regardless of the study methods used. The TRIPOD Statement is best used in conjunction with the TRIPOD explanation and elaboration document. To aid the editorial process and readers of prediction model studies, it is recommended that authors include a completed checklist in their submission (also available at www.tripod-statementorg). (C) 2015 Elsevier Inc. All rights reserved.	[Collins, Gary S.; Altman, Douglas G.] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Ctr Stat Med, Oxford, England; [Reitsma, Johannes B.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	University of Oxford; Utrecht University; Utrecht University Medical Center	Collins, GS (corresponding author), Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Ctr Stat Med, Oxford, England.	gary.collins@csm.ox.ac.uk	Knottnerus, Johannes A/A-3829-2009; Collins, Gary Stephen/A-2258-2014; Groves, Trish/A-9119-2009	Collins, Gary Stephen/0000-0002-2772-2316; Reitsma, Johannes/0000-0003-4026-4345; Vickers, Andrew/0000-0003-1525-6503; Groves, Trish/0000-0001-7915-6419; Macaskill, Petra/0000-0001-5879-6193; Barbour, Virginia/0000-0002-2358-2440	National Institute for Health Research Senior Investigator Award; Cancer Research UK [C5529]; Netherlands Organization for Scientific Research [ZONMW 918.10.615, 91208004]; Medical Research Council [G1100513]; Cancer Research UK [16895] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10259, NF-SI-0513-10131] Funding Source: researchfish	National Institute for Health Research Senior Investigator Award; Cancer Research UK(Cancer Research UK); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	Grant Support: There was no explicit funding for the development of this checklist and guidance document. The consensus meeting in June 2011 was partially funded by a National Institute for Health Research Senior Investigator Award held by Dr. Altman, Cancer Research UK (grant C5529), and the Netherlands Organization for Scientific Research (ZONMW 918.10.615 and 91208004). Drs. Collins and Altman are funded in part by the Medical Research Council (grant G1100513). Dr. Altman is a member of the Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership (G0902393/99558).	Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Canadian CT Head and C-Spine (CCC) Study Group, 2002, CJEM, V4, P185; Canadian CT Head and C-Spine (CCC) Study Group, 2002, CJEM, V4, P84; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Collins GS, 2013, J CLIN EPIDEMIOL, V66, P268, DOI 10.1016/j.jclinepi.2012.06.020; Collins GS, 2012, CURR OSTEOPOROS REP, V10, P199, DOI 10.1007/s11914-012-0108-1; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3186; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Dorresteijn JAN, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5888; Ettema RGA, 2010, CIRCULATION, V122, P682, DOI 10.1161/CIRCULATIONAHA.109.926808; Goff David C Jr, 2014, J Am Coll Cardiol, V63, P2935, DOI 10.1016/j.jacc.2013.11.005; HAYBITTLE JL, 1982, BRIT J CANCER, V45, P361, DOI 10.1038/bjc.1982.62; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Janssens ACJW, 2011, EUR J CLIN INVEST, V41, P1010, DOI 10.1111/j.1365-2362.2011.02493.x; Janssens ACJW, 2011, EUR J CLIN INVEST, V41, P1004, DOI 10.1111/j.1365-2362.2011.02494.x; Jarvinen TLN, 2014, CAN MED ASSOC J, V186, P165, DOI 10.1503/cmaj.121874; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; KNOTTNERUS JA, 1995, PRIMARY CARE, V22, P341; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-20; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Moher D, 2010, PLOS MED, V16; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher David, 2009, Open Med, V3, pe123; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Rabar S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e3698; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Seel RT, 2012, ARCH PHYS MED REHAB, V93, pS138, DOI 10.1016/j.apmr.2012.04.021; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Steyerberg EW, 2001, STAT NEERL, V55, P76, DOI 10.1111/1467-9574.00157; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Steyerberg EW, 2009, CLIN PREDICTION MODE, DOI 10.1007/978-0-387-77244-8; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2012, EUR J CLIN INVEST, V42, P216, DOI 10.1111/j.1365-2362.2011.02562.x; STIELL IG, 1992, ANN EMERG MED, V21, P384, DOI 10.1016/S0196-0644(05)82656-3; Tzoulaki I, 2011, INT J EPIDEMIOL, V40, P1094, DOI 10.1093/ije/dyr013; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wallace E, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-62; Williams Rebecca J, 2010, CMAJ, V182, P1638, DOI 10.1503/cmaj.092252	56	3212	3264	20	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	FEB	2015	68	2					112	121		10.1016/j.jclinepi.2014.11.010	http://dx.doi.org/10.1016/j.jclinepi.2014.11.010			10	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	CA5UX	25569120	Green Published, hybrid			2022-12-28	WOS:000348974400002
J	Collins, GS; Reitsma, JB; Altman, DG; Moons, KGM				Collins, Gary S.; Reitsma, Johannes B.; Altman, Douglas G.; Moons, Karel G. M.			Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement	ANNALS OF INTERNAL MEDICINE			English	Article							GENETIC RISK PREDICTION; EXTERNAL VALIDATION; INTERNAL VALIDATION; RULES; EXPLANATION; IMPACT; RECOMMENDATIONS; ASSOCIATION; DISEASE; HEART	Prediction models are developed to aid health care providers in estimating the probability or risk that a specific disease or condition is present (diagnostic models) or that a specific event will occur in the future (prognostic models), to inform their decision making. However, the overwhelming evidence shows that the quality of reporting of prediction model studies is poor. Only with full and clear reporting of information on all aspects of a prediction model can risk of bias and potential usefulness of prediction models be adequately assessed. The Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) Initiative developed a set of recommendations for the reporting of studies developing, validating, or updating a prediction model, whether for diagnostic or prognostic purposes. This article describes how the TRIPOD Statement was developed. An extensive list of items based on a review of the literature was created, which was reduced after a Web-based survey and revised during a 3-day meeting in June 2011 with methodologists, health care professionals, and journal editors. The list was refined during several meetings of the steering group and in e-mail discussions with the wider group of TRIPOD contributors. The resulting TRIPOD Statement is a checklist of 22 items, deemed essential for transparent reporting of a prediction model study. The TRIPOD Statement aims to improve the transparency of the reporting of a prediction model study regardless of the study methods used. The TRIPOD Statement is best used in conjunction with the TRIPOD explanation and elaboration document. To aid the editorial process and readers of prediction model studies, it is recommended that authors include a completed checklist in their submission (also available at www.tripod-statement.org).	[Collins, Gary S.; Altman, Douglas G.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Botnar Res Ctr, Oxford OX3 7LD, England; [Reitsma, Johannes B.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands	University of Oxford; Utrecht University; Utrecht University Medical Center	Collins, GS (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Botnar Res Ctr, Oxford OX3 7LD, England.	gary.collins@csm.ox.ac.uk	Knottnerus, Johannes A/A-3829-2009; Collins, Gary Stephen/A-2258-2014; Groves, Trish/A-9119-2009	Collins, Gary Stephen/0000-0002-2772-2316; Reitsma, Johannes/0000-0003-4026-4345; Vickers, Andrew/0000-0003-1525-6503; Groves, Trish/0000-0001-7915-6419; Macaskill, Petra/0000-0001-5879-6193; Barbour, Virginia/0000-0002-2358-2440	National Institute for Health Research Senior Investigator Award [C5529]; Netherlands Organization for Scientific Research [ZONMW 918.10.615, 91208004]; Medical Research Council [G1100513]; Cancer Research UK [16895] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10259, NF-SI-0513-10131] Funding Source: researchfish	National Institute for Health Research Senior Investigator Award; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	There was no explicit funding for the development of this checklist and guidance document. The consensus meeting in June 2011 was partially funded by a National Institute for Health Research Senior Investigator Award held by Dr. Altman, Cancer Research UK (grant C5529), and the Netherlands Organization for Scientific Research (ZONMW 918.10.615 and 91208004). Drs. Collins and Altman are funded in part by the Medical Research Council (grant G1100513). Dr. Altman is a member of the Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership (G0902393/99558).	Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Canadian CT Head and C-Spine (CCC) Study Group, 2002, CJEM, V4, P185; Canadian CT Head and C-Spine (CCC) Study Group, 2002, CJEM, V4, P84; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Collins GS, 2013, J CLIN EPIDEMIOL, V66, P268, DOI 10.1016/j.jclinepi.2012.06.020; Collins GS, 2012, CURR OSTEOPOROS REP, V10, P199, DOI 10.1007/s11914-012-0108-1; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3186; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Dorresteijn JAN, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5888; Ettema RGA, 2010, CIRCULATION, V122, P682, DOI 10.1161/CIRCULATIONAHA.109.926808; Goff David C Jr, 2014, J Am Coll Cardiol, V63, P2935, DOI 10.1016/j.jacc.2013.11.005; HAYBITTLE JL, 1982, BRIT J CANCER, V45, P361, DOI 10.1038/bjc.1982.62; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Janssens ACJW, 2011, EUR J CLIN INVEST, V41, P1010, DOI 10.1111/j.1365-2362.2011.02493.x; Janssens ACJW, 2011, EUR J CLIN INVEST, V41, P1004, DOI 10.1111/j.1365-2362.2011.02494.x; Jarvinen TLN, 2014, CAN MED ASSOC J, V186, P165, DOI 10.1503/cmaj.121874; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; KNOTTNERUS JA, 1995, PRIMARY CARE, V22, P341; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-20; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Moher D, 2010, PLOS MED, V16; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher David, 2009, Open Med, V3, pe123; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Rabar S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e3698; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Seel RT, 2012, ARCH PHYS MED REHAB, V93, pS138, DOI 10.1016/j.apmr.2012.04.021; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Steyerberg EW, 2001, STAT NEERL, V55, P76, DOI 10.1111/1467-9574.00157; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Steyerberg EW, 2009, CLIN PREDICTION MODE, DOI 10.1007/978-0-387-77244-8; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2012, EUR J CLIN INVEST, V42, P216, DOI 10.1111/j.1365-2362.2011.02562.x; STIELL IG, 1992, ANN EMERG MED, V21, P384, DOI 10.1016/S0196-0644(05)82656-3; Tzoulaki I, 2011, INT J EPIDEMIOL, V40, P1094, DOI 10.1093/ije/dyr013; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wallace E, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-62; Williams Rebecca J, 2010, CMAJ, V182, P1638, DOI 10.1503/cmaj.092252	56	3212	3264	20	71	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2015	162	1					55	U103		10.7326/M14-0697	http://dx.doi.org/10.7326/M14-0697			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1LU	25569120	Green Submitted			2022-12-28	WOS:000350103000007
J	Collins, GS; Reitsma, JB; Altman, DG; Moons, KGM				Collins, Gary S.; Reitsma, Johannes B.; Altman, Douglas G.; Moons, Karel G. M.			Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) The TRIPOD Statement	CIRCULATION			English	Article						diagnosis; epidemiology; prognosis; research design; risk; statistics	GENETIC RISK PREDICTION; INTERNAL VALIDATION; EXTERNAL VALIDATION; EXPLANATION; RULES; IMPACT; RECOMMENDATIONS; ASSOCIATION; DISEASE; HEART	Background-Prediction models are developed to aid health care providers in estimating the probability or risk that a specific disease or condition is present (diagnostic models) or that a specific event will occur in the future (prognostic models), to inform their decision making. However, the overwhelming evidence shows that the quality of reporting of prediction model studies is poor. Only with full and clear reporting of information on all aspects of a prediction model can risk of bias and potential usefulness of prediction models be adequately assessed. Methods-The Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) Initiative developed a set of recommendations for the reporting of studies developing, validating, or updating a prediction model, whether for diagnostic or prognostic purposes. This article describes how the TRIPOD Statement was developed. An extensive list of items based on a review of the literature was created, which was reduced after a Web-based survey and revised during a 3-day meeting in June 2011 with methodologists, health care professionals, and journal editors. The list was refined during several meetings of the steering group and in e-mail discussions with the wider group of TRIPOD contributors. Results-The resulting TRIPOD Statement is a checklist of 22 items, deemed essential for transparent reporting of a prediction model study. The TRIPOD Statement aims to improve the transparency of the reporting of a prediction model study regardless of the study methods used. The TRIPOD Statement is best used in conjunction with the TRIPOD explanation and elaboration document. Conclusions-To aid the editorial process and readers of prediction model studies, it is recommended that authors include a completed checklist in their submission (also available at www.tripod-statement.org).	[Collins, Gary S.] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford OX3 7LD, England; Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	University of Oxford; Utrecht University; Utrecht University Medical Center	Collins, GS (corresponding author), Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford OX3 7LD, England.	gary.collins@csm.ox.ac.uk	Knottnerus, Johannes A/A-3829-2009; Collins, Gary Stephen/A-2258-2014; Groves, Trish/A-9119-2009	Collins, Gary Stephen/0000-0002-2772-2316; Reitsma, Johannes/0000-0003-4026-4345; Vickers, Andrew/0000-0003-1525-6503; Groves, Trish/0000-0001-7915-6419; Macaskill, Petra/0000-0001-5879-6193; Barbour, Virginia/0000-0002-2358-2440	National Institute for Health Research Senior Investigator Award; Cancer Research UK [C5529]; Netherlands Organization for Scientific Research [ZONMW 918.10.615, 91208004]; Medical Research Council [G1100513]; Cancer Research UK [16895] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10259, NF-SI-0513-10131] Funding Source: researchfish	National Institute for Health Research Senior Investigator Award; Cancer Research UK(Cancer Research UK); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	There was no explicit funding for the development of this checklist and guidance document. The consensus meeting in June 2011 was partially funded by a National Institute for Health Research Senior Investigator Award held by Dr. Altman, Cancer Research UK (grant C5529), and the Netherlands Organization for Scientific Research (ZONMW 918.10.615 and 91208004). Drs. Collins and Altman are funded in part by the Medical Research Council (grant G1100513). Dr. Altman is a member of the Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership (G0902393/99558).	Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Canadian CT Head and C-Spine (CCC) Study Group, 2002, CJEM, V4, P185; Canadian CT Head and C-Spine (CCC) Study Group, 2002, CJEM, V4, P84; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Collins GS, 2013, J CLIN EPIDEMIOL, V66, P268, DOI 10.1016/j.jclinepi.2012.06.020; Collins GS, 2012, CURR OSTEOPOROS REP, V10, P199, DOI 10.1007/s11914-012-0108-1; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3186; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Dorresteijn JAN, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5888; Ettema RGA, 2010, CIRCULATION, V122, P682, DOI 10.1161/CIRCULATIONAHA.109.926808; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; HAYBITTLE JL, 1982, BRIT J CANCER, V45, P361, DOI 10.1038/bjc.1982.62; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Janssens ACJW, 2011, EUR J CLIN INVEST, V41, P1010, DOI 10.1111/j.1365-2362.2011.02493.x; Janssens ACJW, 2011, EUR J CLIN INVEST, V41, P1004, DOI 10.1111/j.1365-2362.2011.02494.x; Jarvinen TLN, 2014, CAN MED ASSOC J, V186, P165, DOI 10.1503/cmaj.121874; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; KNOTTNERUS JA, 1995, PRIMARY CARE, V22, P341; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-20; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Moher D, 2010, PLOS MED, V16; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher David, 2009, Open Med, V3, pe123; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Rabar S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e3698; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Seel RT, 2012, ARCH PHYS MED REHAB, V93, pS138, DOI 10.1016/j.apmr.2012.04.021; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Steyerberg EW, 2001, STAT NEERL, V55, P76, DOI 10.1111/1467-9574.00157; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Steyerberg EW, 2009, CLIN PREDICTION MODE, DOI 10.1007/978-0-387-77244-8; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2012, EUR J CLIN INVEST, V42, P216, DOI 10.1111/j.1365-2362.2011.02562.x; STIELL IG, 1992, ANN EMERG MED, V21, P384, DOI 10.1016/S0196-0644(05)82656-3; Tzoulaki I, 2011, INT J EPIDEMIOL, V40, P1094, DOI 10.1093/ije/dyr013; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wallace E, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-62; Williams Rebecca J, 2010, CMAJ, V182, P1638, DOI 10.1503/cmaj.092252	56	3212	3264	20	71	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-7322	1524-4539		CIRCULATION	Circulation	JAN 13	2015	131	2					211	219		10.1161/CIRCULATIONAHA.114.014508	http://dx.doi.org/10.1161/CIRCULATIONAHA.114.014508			9	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	AY8FY	25569120	Green Published, hybrid			2022-12-28	WOS:000347791000018
